seqs,Enzyme Comission Number,GO Biological Process,GO Cellular Component,GO Molecular Function,InterPro,Gene3D,Uniprot Keywords,cofactor
MATPSKKRCGVLGATGAVGTRFILLLSQHPLLELVAVGASDRSSGKKYRDAVRWKQSAPMPAKVADLTVRCCDPAEFSDCDIIFSGLDPDAAGEIEMAFLKANFAVFSNAKNYRLDPMVPLVVPLVNAGHIDVIPAQRKHFGLDKGMLVCNSNCAVVGLVVPAKALIQKFGPIESVSMVTMQAVSGAGYPGVSSMDIFDNIVPYIPGEEGKISSEARKILGDLNSDLAGFSDQKPLQISVACNRVPVLDGHTVCASLRFVNRPPPTASQVREALREYKPEVQTLGCPSAPKMSIHVMDEVDRPQPRLDRETEGGYACTVGRIREDDSDVFDIQFVALSHNTVLGASGSSILNAESAILKGFV,aspartate-semialdehyde dehydrogenase (1.2.1.11) (0.8930); non-specific serine/threonine protein kinase (2.7.11.1) (0.0511),threonine biosynthetic process (GO:0009088) (0.6797); methionine biosynthetic process (GO:0009086) (0.5065); lysine biosynthetic process via diaminopimelate (GO:0009089) (0.3891); 'de novo' L-methionine biosynthetic process (GO:0071266) (0.2153); diaminopimelate biosynthetic process (GO:0019877) (0.1966); homoserine biosynthetic process (GO:0009090) (0.1964); isoleucine biosynthetic process (GO:0009097) (0.0687); positive regulation of protein-containing complex assembly (GO:0031334) (0.0459),cell surface (GO:0009986) (0.2345); chloroplast stroma (GO:0009570) (0.1554); mitochondrion (GO:0005739) (0.1390); plasma membrane (GO:0005886) (0.1388); mitochondrial matrix (GO:0005759) (0.1356); extracellular region (GO:0005576) (0.0952),NADP binding (GO:0050661) (0.3368); NAD binding (GO:0051287) (0.2091); mRNA binding (GO:0003729) (0.1244),"Aspartate-semialdehyde dehydrogenase-related (IPR051823) (0.4968); Semialdehyde dehydrogenase, dimerisation domain (IPR012280) (0.4696); NAD(P)-binding domain superfamily (IPR036291) (0.2505); Aspartate-semialdehyde dehydrogenase, conserved site (IPR000319) (0.2467); Aspartate-semialdehyde dehydrogenase, peptidoglycan lacking (IPR005676) (0.2271); Semialdehyde dehydrogenase, NAD-binding (IPR000534) (0.0962)",3.40.50.720 (0.3955),Threonine biosynthesis (0.9406); Methionine biosynthesis (0.4594); Reference proteome (0.4540); Oxidoreductase (0.4280); NADP (0.3222); Amino-acid biosynthesis (0.1771); Lysine biosynthesis (0.1588),
MSTPSKKRCGVLGATGAVGTRFILLLEQSPLLELVAVGASERSAGKKYRDAVRWKQASPMPASVADLTVRRCAPSEFSDCDIIFSGLDPVAAGDIEMAFLKANFAVFSNAKNYRLDPIVPLVVPLVNAGHIDVIPAQRKHYGLDKGLIVCNSNCAVVGLVIPAKALIQKFGPIESVSMVTMQAVSGAGYPGVSSMDIFDNIVPFIPGEEGKIATESRKILGNLNPDLAGFSDQQPLQVSVACNRVPVLDGHTVCASLRFVNRPAPTASQVRDALREYKSEVQLLGCPSAPRQAIHVLDDVDRPQPRLDRDTEAGYACSVGRIREDDSGVFDIQFVALSHNTVLGASGSSILNAESAILKGYI,aspartate-semialdehyde dehydrogenase (1.2.1.11) (0.9624),threonine biosynthetic process (GO:0009088) (0.8284); lysine biosynthetic process via diaminopimelate (GO:0009089) (0.3070); methionine biosynthetic process (GO:0009086) (0.2972); diaminopimelate biosynthetic process (GO:0019877) (0.2911); homoserine biosynthetic process (GO:0009090) (0.2854); 'de novo' L-methionine biosynthetic process (GO:0071266) (0.2278); isoleucine biosynthetic process (GO:0009097) (0.1796),cell surface (GO:0009986) (0.3033); plasma membrane (GO:0005886) (0.1586); extracellular region (GO:0005576) (0.1014),aspartate-semialdehyde dehydrogenase activity (GO:0004073) (0.2827); NAD binding (GO:0051287) (0.2512); protein dimerization activity (GO:0046983) (0.1934); NADP binding (GO:0050661) (0.1496),"Aspartate-semialdehyde dehydrogenase-related (IPR051823) (0.7546); Aspartate-semialdehyde dehydrogenase, conserved site (IPR000319) (0.4549); Aspartate-semialdehyde dehydrogenase, peptidoglycan lacking (IPR005676) (0.2650); Semialdehyde dehydrogenase, NAD-binding (IPR000534) (0.2556); Semialdehyde dehydrogenase, dimerisation domain (IPR012280) (0.2401); NAD(P)-binding domain superfamily (IPR036291) (0.0974)",3.40.50.720 (0.2232),Threonine biosynthesis (0.9644); Methionine biosynthesis (0.5710); Oxidoreductase (0.4111); Amino-acid biosynthesis (0.2827); Lysine biosynthesis (0.1781); NADP (0.1748); Reference proteome (0.1549),
MSLSNKLAITDVDLKDKRVLIRVDFNVPLDADKKITNNQRIVGALPTIKYAIENGAKAVVLMSHLGRPDGKANPKYSLKPVATELEKLLSKSVIFAENCVGKETEEIVNKATGGQVILLENLRFHAEEEGSSKDAEGKKVKADKEKVEEFRKGLTALGDVYINDAFGTAHRAHSSMVGVDLPQKASGFLVKKELEYFAKALESPQRPFLAILGGAKVSDKIQLIDNLLPKVNSLIITGAMAFTFKKTLENVKIGNSLFDEAGSKIVGDIVEKAKKNNVKIVLPVDYVTADKFAADAKTGYATDADGIPDGYMGLDVGEKSVELYKKTIAEAKTILWNGPPGVFELEPFANATKKTLDAAVAAAQSGSIVIIGGGDTATVAAKYGAEAKLSHVSTGGGASLELLEGKVLPGVDALSSK,phosphoglycerate kinase (2.7.2.3) (0.9861),gluconeogenesis (GO:0006094) (0.8493); glycolytic process (GO:0006096) (0.7814); phosphorylation (GO:0016310) (0.5381); canonical glycolysis (GO:0061621) (0.1500); plasminogen activation (GO:0031639) (0.1433); response to light stimulus (GO:0009416) (0.1031),cytosol (GO:0005829) (0.2427); membrane raft (GO:0045121) (0.1663); cell surface (GO:0009986) (0.1547); extracellular space (GO:0005615) (0.1164); nucleus (GO:0005634) (0.0739); hyphal cell wall (GO:0030446) (0.0694); mitochondrion (GO:0005739) (0.0547),ADP binding (GO:0043531) (0.2087); phosphoglycerate kinase activity (GO:0004618) (0.1753),"Phosphoglycerate kinase, N-terminal (IPR015824) (0.2380); Phosphoglycerate kinase, conserved site (IPR015911) (0.2204); Phosphoglycerate kinase superfamily (IPR036043) (0.1973)",3.40.50.1260 (0.3327),Reference proteome (0.5939); Glycolysis (0.5632); Phosphoprotein (0.4276); ATP-binding (0.2877); Nucleotide-binding (0.2711); Ubl conjugation (0.2680); Kinase (0.2573); Hydroxylation (0.2272); Transferase (0.1345); 3D-structure (0.1143); Acetylation (0.1132); Direct protein sequencing (0.0801),
MAAKAIQYNIKVDLHEVKDLSFREAAGEKEIVPNPYIEVTVNGVTKTTIQKTQVVSATFNTSFNFTAYLTPDEFARSYVEVAVLHKYMLIGGVGLQSAVIGKYVFSFAYVYTKSQHWIYRQWVTLRNLDQPQDETGLLLITVGVFGPGDAMPVVDETVCVVNEGERTSTDVNVKLTHYSLSVNIFKGQDIPSVAGQFSTVLEPYVKVKHGGAELQTRPLPDSNPDWLASISIPACVPCFDGNVLVELWNGQDSSTAAGTLMGTVVLDYFQLIKNDLPPRWFNFYWRPPAEGLLGAVTDMMASAELREPIAYGGRILLSASAAKVQTPLPLGVRSARPIPDPATQECVWWLDLYEMTSATGYTSELRIEIAFGPHVIKTASLEANALGTYVIGDNLGRLPEMKIFAPVDEVQVWDVMMYVCSPPATTVAAGIADISNWFSGWGGSPTATQNTPEPAETPWTRLAWVRIPYDSRQFQNGKPQWYSLRSLDGSGTDMFSVLLGMEMFPTKAGKQRAPRLEYKLARFYFRALIYEGLHLPAVGYDVFPDPYIQVELASKTLRTSTIRQTLNPSYYEAYEIEIRLPENISLAPDINVEVISESNSLLSSDVVLGSVQYPIQKVPKEWTKAPVWLQLHSKAYPRCKARVLVAFELVPAEKAEDDTYPFYDDIRPSTKEGNIRLFLVGVRLFKPITQPFVTVCFGRDVENTAEPLWSQESSAPRTGEGGNWNFLEEFTVSVSLPKRMQHHSFLEVKIQDRTQGIGGESNVDVGMAYITLNPLLPWLDSRERAESLETFRLQMLEEVLIEDAENARRSADGGLAARTGGGSFDEDATKKKEMLAAERSRKMAIPYNDPDMANLKIEEVDDYVSFKVAPRPQASRLSREGTSRDERGKAPGKSLSGMPGPVARASPGAGEETEKKGDPVAEKKEGGAQAAPPVAPSAHQREALAASPEEETYGFTPEQLNFVLADLEEDDAEEMTRDEVPYELEADFTVDDLPYLRTPIFRPTDAGVPETVGYLKYVCRVFQSTDEDEGAEMDAVCKSLIETYNSTRDLVVRAYVLAARGLVPPSGASDIQTYVWIQDSENAATLPGGLSYNIRDTGYTKKQGFKPEFNRCYTLACSLPENSIVQIAVMNMGRLTDECIGRTYLDVEDRFFNKKVEQMVIEESTPIELRTLKNEGSTVSHGSLRGFFEIMRADYAQLHPPYTLASAEPDEYQLRVVIWRVKAVPLDDNSSISLFVRTIYQLEDSSEIVKDTDTHYNSTDGTAVYNWRMVFDVLIPAQIPVLKLQIWNYALLSSTEPIGEANFDLTADFFRARKRQQHYRVPRMWVRCSHPAHKGKLRGTIEIEASILPREEAEYTPVGNGRDEPNRDPFLPAVTTNRTYIDWQQIGETVGAASSAIMSGLKWTGVWMTVAGIIALVIFVMFLLK,,"plasma membrane organization (GO:0007009) (0.5233); egg activation (GO:0007343) (0.4706); synaptic vesicle exocytosis (GO:0016079) (0.3102); egg-laying behavior (GO:0018991) (0.1634); plasma membrane repair (GO:0001778) (0.1382); liquid clearance, open tracheal system (GO:0035002) (0.1045); nematode larval development (GO:0002119) (0.0772); regulation of nematode pharyngeal pumping (GO:0043051) (0.0758); synaptic vesicle priming (GO:0016082) (0.0660); aggregation involved in sorocarp development (GO:0031152) (0.0625); phagocytosis (GO:0006909) (0.0574)",axon (GO:0030424) (0.3781); membrane (GO:0016020) (0.1250); melanosome membrane (GO:0033162) (0.0964); Golgi membrane (GO:0000139) (0.0824); plasma membrane (GO:0005886) (0.0819); apicolateral plasma membrane (GO:0016327) (0.0799); cytoplasmic vesicle membrane (GO:0030659) (0.0687),,"FerIin domain (IPR012968) (0.4655); C2 domain superfamily (IPR035892) (0.2686); Ferlin, fourth C2 domain (IPR037723) (0.1685); Ferlin, fifth C2 domain (IPR037724) (0.0759); Ferlin, C-terminal domain (IPR032362) (0.0502)",2.60.40.150 (0.5988),Membrane (0.5457); Reference proteome (0.3882); Zinc (0.3427); Transmembrane helix (0.3426); Transmembrane (0.1087); Cytoplasmic vesicle (0.1008); Meiosis (0.0985); Repeat (0.0978),
MRYFIILLALVALGVCAPNVKQRAADQDLLNKQQDVIQLLQKISQPIPNQELQNLGASYDIESNSHQYKNPIIVMYYAGAVKAGLVQPQGTTFSNSISQLRKEVSLLYRILLGAKDYQTFLKTAAWARVHVNEGQFLKAFVAAVLTRQDTQSVIFPPVYEILPQHHLDSRVIQEAQNIAIQNTQGKNNQQNILIPVNYSALLSHDEQQLSYFTQDIGLAAYYAQVNLAGYIQEQNQQQQQQPLTQQQYQQQIVGKYLQQQAGQQDQQANIGRGAQYLYLHQQLLARYELNRLSNGLGPIKDIDYENVQSLYQPHLRGLNGLEFAGRPQNLQLQSQRNQLIQYVATLEKRLRDAIDSGNVITPQGVFLSLYQPQGMNILGDLIEGTGRSVNPRYYGSLQAAARKLLGNAPEVENIWDYTPSSLELGEVAVHDPVFYQLYKKVMNLYQQYQQSLPVYQYNDLILPGVTIQNVDVSQLVTLFTDFYVDLDAVTGHQSQQQQEEQTQSRVRAHLKRLDHQPYQYKIAVHSEQNVPGAVVRVFLGPKHDHQGRPISISKNQHLFVELDQFIQNLHAGENTIIRNSQQAPGQSPDWPSTSQIQRGVNAAIRSQEPFYITEPHQIFSFPARLSLPKGQPQGFPLQFLVVISSSNPLNVPYGPVIPEQSLTYQDQQYQVVSVEQYQQLKEQGQISQVGGGIQQNVEVLPENLVNAQQQVQAVRNYYANLYTKYHGQYPNTQIQNPVGQGQDMTYSVQGVGVVNAGGWLGQQGNSWSQQQVQQAQQVQQQMQAAMAAVQQSQQRHQHAAQMIYGHQQSHHGLHINSSPSSVQSGQQQQSVLQGLGVQGVQQGVQGVQTAQGVQGVQGVQGVQGVQGVQGVQGVPGLLQGVQQVFGQGVQGMNVPYGMQRGQSGGQTWSNSQVQGVAVPGSGIVASGQQHAGGWQSIYAQPQTVQDQIVSEYYQNKPISEVIGGAISLDGKPLGFPLDRPLSLGALSVPNIFVKDVLVFHQGQPTNDITQ,,motor neuron axon guidance (GO:0008045) (0.2804); melanin biosynthetic process from tyrosine (GO:0006583) (0.1060); melanin metabolic process (GO:0006582) (0.0812); chitin-based cuticle development (GO:0040003) (0.0618); synaptic target recognition (GO:0008039) (0.0543); sorocarp development (GO:0030587) (0.0420),,GO:0045735 (0.1600); metal ion binding (GO:0046872) (0.1117),"Hemocyanin, C-terminal (IPR005203) (0.5472); Hemocyanin/hexamerin middle domain (IPR000896) (0.4983); Immunoglobulin E-set (IPR014756) (0.3004); Hemocyanin, N-terminal (IPR005204) (0.2297); Di-copper centre-containing domain superfamily (IPR008922) (0.1422); Hemocyanin/hexamerin (IPR013788) (0.1157); Hemocyanin, C-terminal domain superfamily (IPR037020) (0.1005)",1.20.1370.10 (0.3989); 2.60.40.1520 (0.2131),Storage protein (0.5547); Direct protein sequencing (0.3287); Reference proteome (0.2854); Metal-binding (0.2787); Signal (0.2528); Secreted (0.1823); Sulfation (0.1515); Glycoprotein (0.1263); Zinc (0.1101); Disulfide bond (0.1035); Oxygen transport (0.0883),
MGQTLSEPVVDKTSSEGEDDCCIYGVSAMQGWRISMEDAHAAVLDLHAKYTSPEETSTDPAKRLAFFGVYDGHGGDKVALFAGENVHKIVAKQDSFAKGDIEQALKDGFLATDRAILEDPKYEEEVSGCTAAVSVISKHKIWVANAGDSRSVLGVKGRAKPLSFDHKPQNEGEKARISAAGGFVDFGRVNGNLALSRAIGDFEFKKSPELAPEQQIVTAYPDVTVHELSDDDEFLVIACDGIWDCQSSQAVVEFVRRGIAAKQELYRICENMMDNCLASNSETGGVGCDNMTMIIIGLLNGRTKEECGDAAEFRGPGIRNQFEENPDDYDMENDRARGFSVRSGRIILLGDGTELVPDQNDEELFDQTEEDRDLPSQVQRELPDSARNEREGTPGPQSKTDATSKSEEGSSASTSESTVTPAGSSTSGAPEKSTS,protein-serine/threonine phosphatase (3.1.3.16) (0.9394),protein dephosphorylation (GO:0006470) (0.6097); response to UV-C (GO:0010225) (0.4127); cellular response to osmotic stress (GO:0071470) (0.1431); positive regulation of protein export from nucleus (GO:0046827) (0.0752); positive regulation of canonical Wnt signaling pathway (GO:0090263) (0.0619); mitotic cell cycle (GO:0000278) (0.0554); determination of adult lifespan (GO:0008340) (0.0510); peptidyl-threonine dephosphorylation (GO:0035970) (0.0476),nucleus (GO:0005634) (0.1360),MAP kinase serine/threonine phosphatase activity (GO:1990439) (0.2677); myosin phosphatase activity (GO:0017018) (0.2563); protein serine/threonine phosphatase activity (GO:0004722) (0.1612); metal ion binding (GO:0046872) (0.1599),"PPM-type phosphatase, divalent cation binding (IPR000222) (0.1896)",3.60.40.10 (0.1775),Reference proteome (0.5405); Protein phosphatase (0.5304); Metal-binding (0.4386); Manganese (0.3158); Hydrolase (0.2682); Magnesium (0.2552); Lipoprotein (0.1934); Myristate (0.1242); Cytoplasm (0.1079),Mn(2+) (0.1842); Mg(2+) (0.0950)
MGLLRIMMPPKLQLLAVVAFAVAMLFLENQIQKLEESRAKLERAIARHEVREIEQRHTMDGPRQDAAVDEEEDIVIIYNRVPKTASTSFTNIAYDLCAKNRYHVLHINTTKNNPVMSLQDQVRFVKNITTWNEMKPGFYHGHISYLDFAKFGVKKKPIYINVIRDPIERLVSYYYFLRFGDDYRPGLRRRKQGDKKTFDECVAEGGSDCAPEKLWLQIPFFCGHSSECWNVGSRWAMDQAKYNLINEYFLVGVTEELEDFIMLLEAALPRFFRGATDLYRTGKKSHLRKTTEKKLPTKQTIAKLQQSDIWKMENEFYEFALEQFQFIRAHAVREKDGDLYILAQNFFYEKIYPKSN,2.8.2.- (0.5343),"heparin metabolic process (GO:0030202) (0.3542); ureteric bud formation (GO:0060676) (0.2419); heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014) (0.1954); gene expression (GO:0010467) (0.1622); angiogenesis (GO:0001525) (0.1592); heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015) (0.1299); lung alveolus development (GO:0048286) (0.0846); axon guidance (GO:0007411) (0.0784); apoptotic process (GO:0006915) (0.0758); chondroitin sulfate biosynthetic process (GO:0030206) (0.0724)",membrane (GO:0016020) (0.3492); Golgi apparatus (GO:0005794) (0.2370); Golgi membrane (GO:0000139) (0.1344),heparan sulfate 2-O-sulfotransferase activity (GO:0004394) (0.1865),Sulfotransferase (IPR005331) (0.4073); Heparan sulphate 2-O-sulfotransferase (IPR007734) (0.2719); P-loop containing nucleoside triphosphate hydrolase (IPR027417) (0.1749),3.40.50.300 (0.1976),Transmembrane (0.8842); Signal-anchor (0.8659); Reference proteome (0.6075); Transferase (0.4997); Disulfide bond (0.4971); Membrane (0.4449); Glycoprotein (0.3664); Golgi apparatus (0.2398); Coiled coil (0.0539); Transmembrane helix (0.0492),
MTSTGQDSSTRQRKSRHNPQSPLQDSSATLKRGGKKGAVPHSSPNLAEVKKKGKMKKLSQPAEEDLIVGLQGLDLNSETRVPVGTGLVFDEQLNDFHCLWDDSFPENPERLHAIKEQLILEGLLGRCVSFQARFAEKEELMLVHSLEYIDLMETTQYMNEGELRVLAGTYDSVYLHPNSYSCACLATGSVLRLVDAVMGAEIRNGMAVIRPPGHHAQRSLMDGYCMFNHLAVAARYAQKKHRIQRILIVDWDVHHGQGTQFIFDQDPSVLYFSIHRYEHGRFWPHLKASNWSTTGFGQGQGYTINVPWNQVSFCSHKLSLACFPRGSREMTDYYIAFLCLQVGMRDADYIAAFLHILLPVAFEFQPQLVLVAAGFDALHGDPKGEMSATPAGFAHLTHFLMGLAGGKLILSLEGGYNLHALAKGVSGSLHTLLGDPCPMLESPVAPCASAQTSISCTLEALEPFWEVLERSVEPQDEDEVEGDMLEDEEEEGHWEATALPMDTWPLLQNRTGLVYDERMMSHCNLWDNHHPETPQRILRIMCHLEEVGLAARCLILPARPALDSELLTCHSAEYVERLRATEKMKTRDLHREGANFESIYICPSTFACAQLATGAACRLVEAVLSGEVLNGIAIVRPPGHHAEPDAACGFCFFNSVAVAARHAQVIAGRALRILIVDWDVHHGNGTQHIFEEDPSVLYVSLHRYDRGTFFPMGDEGASSQVGRAAGTGFTVNVPWNGPRMGDADYLATWHRLVLPIAYEFNPELVLISAGFDAAQGDPLGGCQVTPEGYAHLTHLLMGLAGGRIILILEGGYNLTSISESMAACTHSLLGDPPPQLTSLRPPQSGALASISEVIQVHRKYWRSLRLMKMEDKEERSSSRLVIKKLPQSASPVSAKGMTTPKGKVLEAGMRKPTAALPTKESTLGQAKAKTAKALLAQGQSSEQAAKGTTLDLATSKDTVGGATTDQCASVAATENSANQTTSGEEASGETESFGTSPSSNASKQTTGASPLHGAAAQQSPELGLSSTLELSSEAQEVQESEEGLLGEAAGGQDMNSLMLTQGFGDFNTQDVFYAVTPLSWCPHLMAVCPIPAAGLDVSQPCKTCGSVQENWVCLTCYQVYCSRYVNAHMVCHHEASEHPLVLSCVDLSTWCYLCQAYVHHEDLQDVKNAAHQNKFGEGMPHLQ,,"hematopoietic progenitor cell differentiation (GO:0002244) (0.5398); negative regulation of transcription by RNA polymerase II (GO:0000122) (0.3032); epigenetic regulation of gene expression (GO:0040029) (0.2229); regulation of tubulin deacetylation (GO:0090043) (0.1807); positive regulation of signaling receptor activity (GO:2000273) (0.1662); swimming behavior (GO:0036269) (0.1391); negative regulation of gene expression, epigenetic (GO:0045814) (0.1144); protein quality control for misfolded or incompletely synthesized proteins (GO:0006515) (0.1112); response to amphetamine (GO:0001975) (0.1060); definitive hemopoiesis (GO:0060216) (0.0906); negative regulation of microtubule depolymerization (GO:0007026) (0.0825); lysosome localization (GO:0032418) (0.0687)",histone deacetylase complex (GO:0000118) (0.1952),histone deacetylase activity (GO:0004407) (0.3072); zinc ion binding (GO:0008270) (0.1950); potassium ion binding (GO:0030955) (0.1584); deacetylase activity (GO:0019213) (0.1430); tubulin deacetylase activity (GO:0042903) (0.1372),"Histone deacetylase and polyamine deacetylase (IPR050284) (0.3900); Histone deacetylase domain (IPR023801) (0.1757); Histone deacetylase family (IPR000286) (0.1561); Histone deacetylase domain superfamily (IPR037138) (0.1235); Zinc finger, UBP-type (IPR001607) (0.1202)",3.30.40.10 (0.4078); 3.40.800.20 (0.2160),Reference proteome (0.1543),
MTSDMEPIKKDAKSNPSASANLFSQIFFCWLNPLFSIGSKRRLEEDDMFNVLPEDRSKKLGEELQSYWDQEKEKAAKELKTPKLTKAIIRCYWKSYAVLGVFTLIEESIKVIQPVFLGKLIKYFENYRHDDMAALSEAYGYATGVCLSTLGLALLHHLYFYHVQRAGMKIRIAMCHMIYRKALCLSAAAMGQTTTGQIVNLLSNDVNKFDELTIFLHFLWVGPLQAAAVIGLLWQEIGPSCLAGMAVLVFLMPLQTMFGKLFSKYRSKTAALTDSRIRTMNEVVSGIRIIKMYAWEKPFAMLVNDVRRKEISKIMSSSYLRGLNMASFFTANKIILFVTFTVYVLVGNTMSASRVFVAVSLYSAVRLTVTLFFPAAIEKVSESAISIRRIKKFLLLDELVKNHLPLSQEEKKEPSVEMQDLICYWDKTLDAPTLQNVCFTVKPGQLLAVIGPVGAGKSSLLSTVLGELPAEKGVIKVKGELTYASQQPWVFPGTIRSNILFGKELQPQRYERVLRACALKRDMELLPDGDLTVIGDRGATLSGGQKARVNLARAVYQDADIYLLDDPLSAVDAEVSRHLFEQCVCGILKDKPRILVTHQLQYLKAANQILVLKEGHMVARGSYSELQQSGLDFTSLLKKDEEEESGSEKGEAPRSPRSRTVSQNSVRSHSSSVLSVKDDSDQLPAEPVHTMAEELRSEGNIGIRMYWKYFRAGANVVMLVLLLLLNLLAQTFYILQDWWLSYWATEQEKLDHNTNNTNTNNTSAGNTTQQLDLNFYLGIYAGLTGATIVFGFMRCLIMFNALVSSAEMLHNRMFNSILRTPVRFFDINPIGRILNRFSKDIGHLDSLLPWTFVDFIQVFLQIVGVIAVASSVIPWILIPVLPLLICFLFLRRYFLRTSRDVKRIESTTRSPVFSHLSSSLQGLWTIRAFKAEERFQQTFDAHQDLHSEAWFLFLTTSRWFAVRLDGMCSVFVTITAFGCLLLKDTMNAGDVGLALSYAVTLMGMFQWGVRQSAEVENMMTSVERVVEYTELESEAPWETQKRPSPDWPNRGLITFDRVNFSYSSDGPVVLKNISAMFRPREKVGIVGRTGAGKSSLISALFRLSEPEGKILVDGVLTSEIGLHDLRQKMSIIPQDPVLFTGTMRKNLDPFNQHSDHDLWKALEEVQLKAAVEELPGKLETELAESGSNFSVGQRQLVCLARAILRKNRVLIIDEATANVDPRTDELIQKTIRDKFKECTVLTIAHRLNTIIDSDRILVLDAGRIHEYDAPHVLLQNQSGIFYKMVQQTGKAEATSLLQTAKQAYANRSPAHQLNGFATTGDGSLIIFETAL,channel-conductance-controlling ATPase (5.6.1.6) (0.7981),prostaglandin secretion (GO:0032310) (0.1466); cAMP transport (GO:0070730) (0.1365); cilium assembly (GO:0060271) (0.0836),chloride channel complex (GO:0034707) (0.6082); endoplasmic reticulum membrane (GO:0005789) (0.6050); apical plasma membrane (GO:0016324) (0.3849); early endosome membrane (GO:0031901) (0.0936); platelet dense granule membrane (GO:0031088) (0.0681); plasma membrane (GO:0005886) (0.0679),ABC-type transporter activity (GO:0140359) (0.1595); chloride channel activity (GO:0005254) (0.1139),"ATP-binding cassette sub-family C member 4, six-transmembrane helical domain 2 (IPR047083) (0.3813); ABC transporter-like, conserved site (IPR017871) (0.2490); ATP-binding cassette transporter C (IPR050173) (0.1842); P-loop containing nucleoside triphosphate hydrolase (IPR027417) (0.1839); Cystic fibrosis transmembrane conductance regulator (IPR009147) (0.1791); ATP-binding cassette sub-family C member 4, six-transmembrane helical domain 1 (IPR030240) (0.1578); ABC transporter type 1, transmembrane domain superfamily (IPR036640) (0.1573); ABC transporter type 1, transmembrane domain (IPR011527) (0.1426); AAA+ ATPase domain (IPR003593) (0.1006); ABC transporter-like, ATP-binding domain (IPR003439) (0.0995)",,Transport (0.9412); Transmembrane helix (0.8937); Membrane (0.6834); Transmembrane (0.5904); Reference proteome (0.4782); Nucleotide-binding (0.2210); Chloride channel (0.1527); Isomerase (0.1428); Glycoprotein (0.1354); Ion transport (0.1347); Ubl conjugation (0.0481),
MCASGKYGSRGPALIPRMKTKHRIYYITLFSVVLLGLIATGMFQFWPHSIESSAEWSLDRRSVHDAPLVRIPVNSPIPGRGDLSCRMHTCFDVYRCGYNPKNKIKVYIYPLQRFVDEVGVPISSTGLSREYNDLLSAISDSDFYTDDVSRACLFVPSIDVLNQNSLRIRETAQALAMLPRWDKGMNHLLFNMLPGGPPDYNTALDVPRDRALLAGGGFSTWTYRQGYDVSIPVYSPLSAEVDLPERQPGPRRYFILSSQTAIHREYRVELERLKDENGEALLLLDKCSNLSQGLTSVRKRCYKGQVYDYPQILQESSFCVVLRGARLGQATLSDVLQAGCVPVIMADSYILPFSEVLDWKRASVVIPEEKLPEMYTILKSIPHRQVEEMQRQARWFWEAYFSSMKAIGMTTLQIINDRIYPYAAHTYEEWNNPPVVKWSSVNSPLFLPLIPPRSPGFTAVVLTYDRIESLFRVITEISKVPSLAKLLVVWNNQNKSPPEESLWPKVAVPLKVVRTKENKLSNRFFPFDEIETEAVLAIDDDIIMLTSDELQFGYEVWREFPDRLVGYPGRLHLWDHEMGKWKYESEWTNEVSMVLTGAAFYHKYFNYLYTYKMPGDIKNWVDAHMNCEDIAMNFLVANITGKAPIKVTPRKKFKCPECTAIDGLSLDQTHMVERSECINKFASVFGTMPLKVVEHRADPVLYKDDFPEKLKSFPNIGSL,glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase (2.4.1.224) (0.2359),"glycosaminoglycan biosynthetic process (GO:0006024) (0.4007); ossification (GO:0001503) (0.3476); mesoderm formation (GO:0001707) (0.3440); heparan sulfate proteoglycan biosynthetic process (GO:0015012) (0.2822); heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014) (0.2230); chondrocyte differentiation (GO:0002062) (0.1948); heparin biosynthetic process (GO:0030210) (0.1890); protein N-linked glycosylation (GO:0006487) (0.1767); sulfation (GO:0051923) (0.1629); regulation of blood pressure (GO:0008217) (0.1544); protein glycosylation (GO:0006486) (0.1218)",endoplasmic reticulum membrane (GO:0005789) (0.1647); endoplasmic reticulum (GO:0005783) (0.1513); membrane (GO:0016020) (0.0791); Golgi apparatus (GO:0005794) (0.0709); UDP-N-acetylglucosamine transferase complex (GO:0043541) (0.0609),glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity (GO:0050508) (0.3387); N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity (GO:0050509) (0.2759); protein heterodimerization activity (GO:0046982) (0.1192); acetylglucosaminyltransferase activity (GO:0008375) (0.0813); protein homodimerization activity (GO:0042803) (0.0769),"Exostosin, GT47 domain (IPR040911) (0.3297); Glycosyl transferase 64 domain (IPR015338) (0.3226); Nucleotide-diphospho-sugar transferases (IPR029044) (0.2916); Exostosin-like (IPR004263) (0.1933)",,Membrane (0.2468); Transferase (0.2430); Reference proteome (0.2254); Endoplasmic reticulum (0.1753),
MGQQVLALCALLFLCVPQPVTSQTQEVCTGTKNALSSTGTPEQHYNNLKERYTGCEIVMGNLEITQMENDLDFSFLGSIREVTGYILIAMNQFRKLPLNQLRVIRGSSLYDKEWALSVFHNFDTHTGLEDLGLTNLTEILEGGVQIVHNRNLSYAPLINWQDIVRDGDARIQIQDNGGRGSCNPACGEFCWGPSNDQCQKLTKTVCALQCLGHCFGTNPNECCHPECAGGCTGPRDTDCFACRHVNYSGSCVPHCPWPVVYNQQTFQVEPNADAMYQFGSICVPKCPGHFVVDGSACVSSCPPGKTEIEKNQIKQCETCIGLCPKVCEGTGANHRQTVDSSNIDSFINCTKIQGSLHFLILGIKGDVYNNIPPLEPEKLKVFNTVREITGILNIQSWPDELHDLSVFSSLTTIQGRSLYNPKRPFSLLVMKIPSLTSLGLRSLREISDGSVYITQNMNLCYHHTINWTQIFPRNQLQRRRNDIKENKQKIQCEEEGHVCDPLCSDAGCWGPGPEQCLSCRNYSRLGTCVSHCNLYSGEPREFAASNKECLACHSECLLQNGKQTCLGKGADQCVACSNLMDGPHCVSSCPNGVNGEKGQTIFKYSTAAGHCELCHFNCTRGCTGPALRDCVDPDRNVNSSQIAGIAVAVFAGITVLLALFVLGMLYHRGLAIRRKRALRRYLESGESMEPLDPGEKGTKVHARILKPQELRKGKLLGYGVFGTVNKGFWIPEGDSLKIPVAIKTIQNRSSRQTFTEITDHMLSMGSLDHPYIVRLIGICPGASLQLITQLSPHGSLLQHLRQHKDSLDPQRLLNWCVQIAKGMYYLEEHCMAHRNLAARNILLKSDYIVQISDFGVADLLYPDDKKYVYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYASMHPHDVPGLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELASEFTRMARDPPRYLVVRPAQNGSGAEESQRYVKSSHLEVGLEEEDDDEDEGLQVGFATPPLQLSPTRSHSRVRIASYKSTSEHTAPIGYLPMTPGPGDEPRQLRAQRRKIGSVRTESECSEGRGTIVDIEAIEITSQTGSLRRGRSRMDSAYISGGVSVASDPFSPGLEGVDEDHYGYVLPTERDFRSAVPHGRTSRNSKSTPKTDATQEYELMNKQTNKLSSSPTDSTDHLKPASLVSAHICSSLPQKKEMDSAQTQDEILPQKRETDSIQSQENNLPQKSETDSTQTQESEKDASFQPDNLESAENCLIGSETLNDGGQSEDEEQLPRLAMVEYEYMDIRTDEHQQNVAGKRTTNGPNEVEREAIYQNISQPLRFHENPDSAGNTMQRRGEYVDMEASGRSGCEVGDYQNVPVKGRPVVGEESQNTGLRSYIKVCAGVEPQNTSFDNPDYWHSRLFHKQDTVCT,receptor protein-tyrosine kinase (2.7.10.1) (0.9940),cell surface receptor protein tyrosine kinase signaling pathway (GO:0007169) (0.9459); protein phosphorylation (GO:0006468) (0.9272); positive regulation of kinase activity (GO:0033674) (0.8300); neurogenesis (GO:0022008) (0.8043); negative regulation of apoptotic process (GO:0043066) (0.7235); regulation of cell communication (GO:0010646) (0.2822); positive regulation of cell population proliferation (GO:0008284) (0.1099); regulation of signaling (GO:0023051) (0.0919),receptor complex (GO:0043235) (0.8196); basal plasma membrane (GO:0009925) (0.5829),neuregulin binding (GO:0038132) (0.7982); neuregulin receptor activity (GO:0038131) (0.7525); ATP binding (GO:0005524) (0.5731); transmembrane receptor protein tyrosine kinase activity (GO:0004714) (0.3554); protein kinase activity (GO:0004672) (0.2598); protein tyrosine kinase activity (GO:0004713) (0.1322),"Protein kinase domain (IPR000719) (0.7463); Serine-threonine/tyrosine-protein kinase, catalytic domain (IPR001245) (0.5319); Protein kinase-like domain superfamily (IPR011009) (0.4117); Epidermal growth factor receptor, juxtamembrane domain (IPR044912) (0.3068); Growth factor receptor domain 4 (IPR032778) (0.2714); Receptor L-domain (IPR000494) (0.1831); Growth factor receptor cysteine-rich domain superfamily (IPR009030) (0.1676); Receptor L-domain superfamily (IPR036941) (0.1655); Receptor Tyrosine Kinase (IPR050122) (0.1477); Protein kinase, ATP binding site (IPR017441) (0.1165)",1.10.510.10 (0.1481),Tyrosine-protein kinase (0.9715); Signal (0.4500); Receptor (0.4375); ATP-binding (0.4006); Transmembrane (0.3515); Membrane (0.3405); Nucleotide-binding (0.2806); Kinase (0.2413); Transmembrane helix (0.2111); Reference proteome (0.1284); Transferase (0.1141),
MTFRRGSGFHLRLLRENSRLNAALESCRKVNAVMASAPIAPYNSSPLGNSSSQNASRESLKMEPLADVTLLPGEERVIDKDIIYICPYNAAVKGKVFITNYRLYFKNTDSETPVTLNIPLGVISRVEKMGGASSRGENSYGLEITCKDMRNLRFALKQEGHSRRDIFEIIFKYAFPLSHGMQLFAFLSQEKYEENGWNVYEALEEYRRQGLPNNEWRVTFINKNYELCDTYPTILVVPYKATEDDLRKVATFRSRCRIPVMSWFHKENHAVITRCSQPLVGMSGKRNKDDERYLDLIREANGTTKLTIYDARPNVNAVANKATGGGYEGDDAYQNAELVFLDIHNIHVMRESLKKLKDIVYPNVEESHWLSSLESTHWLEHIKLVLSGAIQVADKVSSGSSVMVHCSDGWDRTAQLTSLSMLMLDSYYRTLRGFQVLMEKEWISFGHKFASRIGHGDKNHADQDRSPIFLQFIDCVWQMTKQFPTAFEFNERLLVVILDHLYSCRFGTFLYNCESVRDSNNVRTKTVSLWSYINSDTSLYINPFYTPESSRVLYPVASMRHLELWVTYYIRWNPRIQHQQQSPVEQRYKELLALRDQYLKKLEELQLSDSAPSSTHLTNSSTPNAATPNQHITHLQTPF,"phosphatidylinositol-3,5-bisphosphate 3-phosphatase (3.1.3.95) (0.9918)",muscle cell cellular homeostasis (GO:0046716) (0.3291); negative regulation of autophagosome assembly (GO:1902902) (0.2541); mitochondrion distribution (GO:0048311) (0.1936); endosome to lysosome transport (GO:0008333) (0.1787); phosphatidylinositol dephosphorylation (GO:0046856) (0.1769); protein dephosphorylation (GO:0006470) (0.1733); phosphatidylinositol biosynthetic process (GO:0006661) (0.1708),ruffle (GO:0001726) (0.5692); sarcomere (GO:0030017) (0.4676); late endosome (GO:0005770) (0.2318); filopodium (GO:0030175) (0.0673); cytosol (GO:0005829) (0.0588),"phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity (GO:0052629) (0.1698); phosphatidylinositol-3-phosphate phosphatase activity (GO:0004438) (0.1565); phosphoprotein phosphatase activity (GO:0004721) (0.0776)","GRAM domain (IPR004182) (0.4618); PH-like domain superfamily (IPR011993) (0.3801); Myotubularin family (IPR030564) (0.3696); Protein-tyrosine phosphatase-like (IPR029021) (0.3294); Myotubularin-like, phosphatase domain (IPR010569) (0.1568); Protein-tyrosine phosphatase, catalytic (IPR003595) (0.1344)",2.30.29.30 (0.1210),Reference proteome (0.4091); Protein phosphatase (0.4085); Endosome (0.3476); Membrane (0.3447); Hydrolase (0.3111); Lipid metabolism (0.2704); Cytoplasm (0.1693); Cell projection (0.1149),
MGMDRTVFLLLMLTTLSLAIEVPSDDSVGLLAEPQVAMFCGKLNMHINVQSGKWEPDPTGTKSCISTKEGILQYCQEVYPDLQITNVVEANQPVSIQNWCKMGRRQCRSHTHIVVPYRCLVGEFVSDALLVPDKCKFLHQERMDMCESHLHWHTVAKESCGDRSMNLHDYGMLLPCGIDRFRGVEFVCCPMEEQKDLDSEEQEEANSDVWWGGAETEYTDASVLKEQVTAKPDPAVTEDDEDLNNEEDQVWDNDEDGDGEDDEDEEDDDEDIIDEQDTSEQTSNIAMTTTTTTTTESIEEVVRVPTMAPSPADAVDRYLEAPGDINEHMRFQKAKESLEAKHREKMSEVMREWEEAERQAKNLPRADKKTIIQRFQEKVESLEKEAAGERQQLVETHMARVEALLNDRRRQALESYLSSLQSDQPRPRQVLNLLKKYIRAEQKDRQHTLKHFEHVREVDPKKASQIRPFVMTHLRVIEERMNQSLGYLYKVPQVANDIQDQVAVLVQRDQAEVTQQLSSLQSKMRVSYGNDALMPDLPDSTTPLDNLPPEQDGLGFIHPESFNQANTDNHVEPVDARPIPERGLPTRPEIPKVRLDIEERHNAGYDVRDKRLMFLAEDMGSNKGAIIGLMVGGVVIATVIVITLVMLRKKQYTSIHHGVIEVDAAVTPEERHLAKMQQNGYENPTYKFFEQMQN,,negative regulation of peptidase activity (GO:0010466) (0.3360); central nervous system development (GO:0007417) (0.2666); axonogenesis (GO:0007409) (0.2136),Golgi-associated vesicle (GO:0005798) (0.5006); plasma membrane (GO:0005886) (0.4912); early endosome (GO:0005769) (0.4004); membrane raft (GO:0045121) (0.2927),heparin binding (GO:0008201) (0.4582); transition metal ion binding (GO:0046914) (0.2890); serine-type endopeptidase inhibitor activity (GO:0004867) (0.0967),"Amyloidogenic glycoprotein, extracellular (IPR008154) (0.2812); PH-like domain superfamily (IPR011993) (0.2622); Amyloidogenic glycoprotein, heparin-binding domain superfamily (IPR036454) (0.2124); Amyloidogenic glycoprotein (IPR008155) (0.2008); Amyloidogenic glycoprotein, copper-binding (IPR011178) (0.1740); Amyloidogenic glycoprotein, heparin-binding (IPR015849) (0.1545); Amyloidogenic glycoprotein, copper-binding domain superfamily (IPR036669) (0.1255); Amyloidogenic glycoprotein, intracellular domain, conserved site (IPR019745) (0.1222); Amyloidogenic glycoprotein, amyloid-beta peptide (IPR013803) (0.1222); E2 domain superfamily (IPR036176) (0.1193); Amyloidogenic glycoprotein, copper-binding domain conserved site (IPR019744) (0.1160)",2.30.29.30 (0.3556); 3.30.1490.140 (0.3544); 3.90.570.10 (0.2540); 6.10.250.1670 (0.1659),Coiled coil (0.2431); Disulfide bond (0.2209); Reference proteome (0.2063); Amyloid (0.1653); Membrane (0.1318); Protease inhibitor (0.1216); Signal (0.0804),
MLYLETNAPSSYSEPQYTSLGLLNSMDQNGGSTSTSPYNNDHAQNNVTAPSPYAQPSSTFEALSPSPAIPSNTDYAGPHTFDVSFQQSSTAKSATWTYSTELKKLYCQIAKTCPIQIKVLTNPPQGAVIRAMPVYKKAEHVTEVVKRCPNHELSREFNDGQIAPPSHLIRVEGNSHAQYVEDSITGRQSVLVPYEPPQVGTEFTTILYNFMCNSSCVGGMNRRPILIIVTLETRDGQVLGRRCFEARICACPGRDRKADEDSIRKQHVTDGTKSSEAFRQASSHLSQLNSIKKRRSTDEEVFCLPIKGREIYEILVKIKESLELMQFLPQQTIESYRQQQQNLLQKQSSLPPQPAFGSSSPTLGKNKLPSVSQLINPQQRNALTPSGMPGGLTDSLLQSQPFPLPSVTPPMMGGPVPMNTDLSSLSPNNPLQSQLQMVPSSHCTPPPPYPMDNSISSFLLRLGCSACLDYFTAQGLTNIYQIENYNLEDLSRLKIPTEFQHIIWKGIMEYRQTMEFSPPPHILRTSSGTSTVSVGSTEARGERVIDAVRFTLRQTISFPPRDDWTDFSFDLAPDSRRNKQQRIKEEGE,,protein tetramerization (GO:0051262) (0.7309); apoptotic process (GO:0006915) (0.6884); regulation of transcription by RNA polymerase II (GO:0006357) (0.1906); embryonic cranial skeleton morphogenesis (GO:0048701) (0.1471); regulation of apoptotic signaling pathway (GO:2001233) (0.1118); anatomical structure morphogenesis (GO:0009653) (0.0813); regulation of mitotic cell cycle (GO:0007346) (0.0464),nucleus (GO:0005634) (0.3226); cytoplasm (GO:0005737) (0.1666),"DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981) (0.4621); metal ion binding (GO:0046872) (0.3995); RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978) (0.3832); transcription cis-regulatory region binding (GO:0000976) (0.1591)","p53 tumour suppressor family (IPR002117) (0.6083); p53, tetramerisation domain (IPR010991) (0.5477); p53-like transcription factor, DNA-binding domain superfamily (IPR008967) (0.5339); Sterile alpha motif domain (IPR001660) (0.4834); Sterile alpha motif/pointed domain superfamily (IPR013761) (0.4030); p53, DNA-binding domain (IPR011615) (0.3401); p53/RUNT-type transcription factor, DNA-binding domain superfamily (IPR012346) (0.3342); p53-like tetramerisation domain superfamily (IPR036674) (0.3157)",1.10.150.50 (0.6129); 4.10.170.10 (0.4898); 2.60.40.720 (0.2320),Zinc (0.9521); Ubl conjugation (0.9262); Transcription (0.8494); Transcription regulation (0.7872); Metal-binding (0.4705); Apoptosis (0.4244); Cell cycle (0.4047); DNA-binding (0.4041); Reference proteome (0.3959); Nucleus (0.3188); Activator (0.2819); Cytoplasm (0.1979); Phosphoprotein (0.1282); Endoplasmic reticulum (0.1037),Zn(2+) (0.1318)
MSRDRSRNRGGFQPRGRGGMGMRGGMGMGMGMGMGMGMGMGMGMGNPNFRNQNQHHFQNRGPQMGGGFRQNQGNQGNQVSTQQKPQEPAQNKPVVQTPPAQGPGQAQQAANKGPTPQQTPTVAPPKIQSAPPKIQSPPPKIQSPPPAQNNAKTPEIASPQNQQRKNLPKPAMGNGQKPPAPLKQEQTPAPTPPPAQQQQQQQQQQKQTPANEQSSQPQELKATLSLLRKPGEKTYTQRCRLFIGNLPNDITEPEFRKLFAKYGEPSEIFINQGKGFGFIRLESRALAEVAKAELDDTPMKGRPLRVRFATHSAALSVRNLSPFVSNELLEEAFSQFGLVERAIVIVDDRGRSTGKGIVEFSSKPAARKAMDRISDGVFLLTSSPRPIVVELLEQYDDEDGLPEKLAQKNPSYQKEREQPPRFARPGTFEYEYSQRWKSLDEMEKQQRQQVEKNICEAREKLETEMDDAYHEHQANMLRQDLLRRQEELRRMEELHSQEMQKRKEMQLRQEEERRRREEEMMRQREIEEQLRRKREESYRMNNFMDNRDREMRMNTSGGMGLSDMSFGSPNQKFSLTGMSFDGHQGLSGSTQGGLASNEMRNDRFQQGGSGGQRGIGAGNSGFGRVREEFDGPAKKPRF,,activation of innate immune response (GO:0002218) (0.6269); regulation of DNA-templated transcription (GO:0006355) (0.5401); innate immune response (GO:0045087) (0.4347); positive regulation of transcription by RNA polymerase II (GO:0045944) (0.2461); negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377) (0.1897); embryonic viscerocranium morphogenesis (GO:0048703) (0.1470); negative regulation of DNA-templated transcription (GO:0045892) (0.1414); rhythmic process (GO:0048511) (0.0563),chromatin (GO:0000785) (0.3542); nuclear matrix (GO:0016363) (0.3092); paraspeckles (GO:0042382) (0.2234); nucleus (GO:0005634) (0.1572),chromatin binding (GO:0003682) (0.2500); DNA binding (GO:0003677) (0.1967); RNA binding (GO:0003723) (0.1133),NOPS (IPR012975) (0.4186); Nucleotide-binding alpha-beta plait domain superfamily (IPR012677) (0.2394); RNA-binding domain superfamily (IPR035979) (0.1419),6.10.250.1170 (0.2537); 3.30.70.330 (0.0992),Reference proteome (0.5906); Coiled coil (0.3935); Membrane (0.3376); RNA-binding (0.3300); Innate immunity (0.2336); Biological rhythms (0.2241); Repeat (0.0681),
MSFPQLGYPQYLSASQAVYGGDRPGVLTPSSRAGSAEIGGSASAAAAAVSSVLGMYPYAHNYSAFLPYTSADLALFSQMGSQYDLKDSPGVHPASFAAHTSPAFYPYGQFQYGDPARPKNATRESTSTLKAWLNEHRKNPYPTKGEKIMLAIITKMTLTQVSTWFANARRRLKKENKVTWGARSKDDENIFGSDNEGDAEKNEDEEEIDLESIDIDKIDDNDGDQSNEEDEDKRAELESLQEKRHASKEPSDGNNNTTRVLSPGRQGGFQVPVSNKPKIWSLAETATSPDSAQKPTSPSVPVSHPAFLPSHGLYTCQIGKFHNWTNGAFLGQNSLLNVRSFLGVNQHNHPAQQQQQQTGPASLQVLSAGNTDKMPEDLSPKHIDRENVLRNESPTQPLKSSFRPLHDSPRNQQESTQRVLTALSSA,,proximal/distal pattern formation (GO:0009954) (0.2565); dorsal/ventral pattern formation (GO:0009953) (0.2045); neuron differentiation (GO:0030182) (0.1916); embryonic development via the syncytial blastoderm (GO:0001700) (0.1775); negative regulation of transcription by RNA polymerase II (GO:0000122) (0.1739); mesoderm development (GO:0007498) (0.1654); neural plate development (GO:0001840) (0.1310); positive regulation of DNA-templated transcription (GO:0045893) (0.1105); brain development (GO:0007420) (0.1057); regulation of transcription by RNA polymerase II (GO:0006357) (0.1048); specification of pronephric tubule identity (GO:0039005) (0.0665); negative regulation of neuron differentiation (GO:0045665) (0.0575),nucleus (GO:0005634) (0.2013),RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978) (0.0809),"KN homeodomain (IPR008422) (0.4304); Homeobox, conserved site (IPR017970) (0.2386); Iroquois-class homeodomain protein (IPR003893) (0.1815)",1.10.10.60 (0.1971),Nucleus (0.4359); Reference proteome (0.3884); Neurogenesis (0.2085); Homeobox (0.1680); DNA-binding (0.1622); Transcription (0.1309),
MSFPQLGYPQYLSASQAVYGGDRPGVLTPSSRAGSAEIGGSASAAAAAVSSVLGMYPYAHNYSAFLPYTSADLALFSQMGSQYDLKDSPGVHPASFAAHTSPAFYPYGQFQYGDPARPKNATRESTSTLKAWLNEHRKNPYPTKGEKIMLAIITKMTLTQVSTWFANARRRLKKENKVTWGARSKDDENIFGSDNEGDAEKNEDEEEIDLESIDIDKIDDNDGDQSNEEDEDKRAELESLQEKRHASKEPSDGNNNTTRVLSPGRQGGFQVPVSNKPKIWSLAETATSPDSAQKPTSPSVPVSHPAFLPSHGLYTCQIGKFHNWTNGAFLGQNSLLNVRSFLGVNQHNHPAQQQQQQTGPASLQVLSAGNTDKMPEDLSPKHIVPETSRNQHRGSSQRCPPLDQHICTPKRTDGTNNGH,,proximal/distal pattern formation (GO:0009954) (0.3322); dorsal/ventral pattern formation (GO:0009953) (0.2301); negative regulation of transcription by RNA polymerase II (GO:0000122) (0.1995); mesoderm development (GO:0007498) (0.1973); neuron differentiation (GO:0030182) (0.1765); positive regulation of DNA-templated transcription (GO:0045893) (0.1586); brain development (GO:0007420) (0.1545); regulation of transcription by RNA polymerase II (GO:0006357) (0.1454); embryonic development via the syncytial blastoderm (GO:0001700) (0.1279); specification of pronephric tubule identity (GO:0039005) (0.1071); neural plate development (GO:0001840) (0.1047); positive regulation of neuron differentiation (GO:0045666) (0.0971); negative regulation of neuron differentiation (GO:0045665) (0.0730),nucleus (GO:0005634) (0.1563),"DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981) (0.0942); RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978) (0.0931)","KN homeodomain (IPR008422) (0.4618); Homeobox, conserved site (IPR017970) (0.2926); Iroquois-class homeodomain protein (IPR003893) (0.2223)",1.10.10.60 (0.2364),Nucleus (0.4102); Homeobox (0.3044); Reference proteome (0.2906); Neurogenesis (0.2032); DNA-binding (0.1600); Transcription (0.1012),
MAMFSSQMTSTPFSVRDILNLEQNQEDMVSLDMSQRLDSALIPTSSCMLSTFKQEQFMEMPSGSSLFSEDLQEDKGNKINSINFSASGFYAKNFLEMDYVKDAKTDDTFEDKEKKDIGCCQEDPGEDLKLDDAERPKQRKRRKPRVLFSQAQVYELERRFKQQKYLSAPERDHLANVLKLTSTQVKIWFQNRRYKCKRQRQDQTLEMVGIAPPRRISVPVLVRDGKPCLGDTSTYNTSYNVGINHFTYNTYPAFSNFPSPGNSNYSCNYPSSMSSIQPSQSNSNYMNFGVGDLNNVQASFQSSSVPSLHGIRAW,,regulation of transcription by RNA polymerase II (GO:0006357) (0.2357); plasma cell differentiation (GO:0002317) (0.1607); cell fate determination (GO:0001709) (0.1509); pancreatic A cell fate commitment (GO:0003326) (0.1179); negative regulation of transcription by RNA polymerase II (GO:0000122) (0.1148); leukocyte homeostasis (GO:0001776) (0.1083); positive regulation of gene expression (GO:0010628) (0.1042); digestive tract development (GO:0048565) (0.0949); cardiac muscle cell proliferation (GO:0060038) (0.0791); determination of left/right symmetry (GO:0007368) (0.0706); embryonic hemopoiesis (GO:0035162) (0.0703); pancreas development (GO:0031016) (0.0700); negative regulation of DNA-templated transcription (GO:0045892) (0.0534); positive regulation of neuron differentiation (GO:0045666) (0.0488); pharyngeal arch artery morphogenesis (GO:0061626) (0.0456); epithelial cell proliferation (GO:0050673) (0.0441); cardiac muscle cell differentiation (GO:0055007) (0.0440),nucleus (GO:0005634) (0.1184),RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978) (0.1830),"Homeobox NK-like transcription regulators (IPR050394) (0.4793); Homedomain-like superfamily (IPR009057) (0.3669); Homeodomain (IPR001356) (0.1857); Homeodomain, metazoa (IPR020479) (0.1582); Homeobox, conserved site (IPR017970) (0.1329)",1.10.10.60 (0.3760),Developmental protein (0.3360); Homeobox (0.2951); DNA-binding (0.2789); Reference proteome (0.2768),
MKVTVCFGRTRVVVPCGDGNIKVQSLVQQAAMRYRRAIAKGEEYWVQVYRLEHGDGGILDLDDVLCDVADDKDRLVAVFDEQEPHVGGDGTSASSTGTQSPELYCGEPSTSTPLSAFQPYLPHSEIEVTTSTLRTNMPLHVRRSSDPALLNLTAMSFSEPGSQPEEPSRKNPTRWSTTAGFLKPRFATGTNSLERKGRGVDTYRSLPRDAGQWSNQKEFQREKARSSLSANHPMVDRWLERQEQDEEENGRIEPVGRADTCLEHMGVRSLDDIVKLVEVSNDGGPLGIHVVPFSGRDRRTLGLLVKRLERGGKADVQGLFQENDCIIRINNGDLRNVRFEQAQNMFRQAMRSPVILFHVVPTTMRSQYEQISHNEHNPRANIDLSGRFSPDSLTNDLDSAAHRLAQHRPQQPNNHLDTGSPVHHLVGSSGKPPTGHTSSPQRGLSPAPTTGFTKKVGRRLGIQLKKGPEGLGFSITSRDVPLGGSAPIYVKNILPRGAAIQDGRLKAGDRLLEVNGVDLNGRGQEEVVSLLRATPMGGTVTLVVLRQEETFIPREMNAEPAIQNTREWKVEEEELVLTPDGTREFLTLEVPLNDSGSAGLGVSVKGNRSKESHADLGIFVKSIINGGAACKDGRLRVNDQLIAVNGESLLGKTNQDAMETLRKSMSTEGNKRGMIQLIVARRINKRLEGESRGSPRGLERTLSPSPDDHERRISHSLYGIEGLDDNLRPQASTNNRKMNHYQLSPTVNMPQDDTVIIEDDRPHVLPIQLSDQSSSSSHDDMGFAVETPPPPPWEPELPDSSSSANAEGQFQREGFGRQSMSEKRTKQYGDAGQLDIIKTRKSKSMDLVADEINLTQCTENHTGSSTRDVGPSLGLKKSSSLESLQTAVAEVTLNGDMPFHRPRPRIIRGRGCNESFRAAIDKSYDRPAANEDEEECMDTLEEDTEGSSRSGRDSVSTVADLTPLPVTEQQLINGNQPENDKKKEKGGKDKKKPEKEKGKTKKGMLKGLGEMFRFGKYRKDERLDGAKWKAEETHASEEETRRMKQEQERIQAKTREIRQRQARERDYAEIQDFSRSTLTSLPPEEPPYAGIGSLEHGGYHRIHTPPDSPYTQKQNGRNGHPSTSDRY,,cell adhesion (GO:0007155) (0.9457); microtubule cytoskeleton organization (GO:0000226) (0.9124); establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197) (0.7250); protein localization (GO:0008104) (0.7065); establishment of cell polarity (GO:0030010) (0.1772); establishment of centrosome localization (GO:0051660) (0.1015); cell division (GO:0051301) (0.0656); protein targeting to membrane (GO:0006612) (0.0466),cell cortex (GO:0005938) (0.4206); endomembrane system (GO:0012505) (0.3483); apical plasma membrane (GO:0016324) (0.2638); PAR polarity complex (GO:0120157) (0.2074); bicellular tight junction (GO:0005923) (0.1564); plasma membrane (GO:0005886) (0.1472); adherens junction (GO:0005912) (0.1059),phosphatidylinositol binding (GO:0035091) (0.1784),Partitioning defective 3 homolog (IPR052213) (0.4931),,Tight junction (0.5761); Cell division (0.5312); Reference proteome (0.5219); Cell cycle (0.4699); Repeat (0.4087); Coiled coil (0.0851); Proteomics identification (0.0771),
MRAGRVRPLRASDMKKDVRILLVGEPRVGKTSLIMSLVSEEFPEEVPPRAEEITIPADVTPERVPTHIVDYSEAEQSDEQLHQEISQANVICIVYAVNNKHSIDKVTSRWIPLINERTDKDSRLPLILVGNKSDLVEYSSMETILPIMNQYTEIETCVECSAKNLKNISELFYYAQKAVLHPTGPLYCPEEKEMKPACIKALTRIFKISDQDNDGTLNDAELNFFQRICFNTPLAPQALEDVKNVVRKHLSDGVADSGLTLRGFLFLHTLFIQRGRHETTWTVLRRFGYDDDLDLTPEYLFPLLKIPPDCTTELNHHAYLFLQSTFDKHDLDRDCALSPDELKDLFQVFPYIPWGPDVNNTVCTNESGWITYQGFLSQWTLTTYLDVQRCLEYLGYLGYSILTEQESQASAITVTRDKKIDLQKKQTQRNVFRCNVIGVKGCGKTGVLQSLLGRNLMRQKKIRDDHKSYYAINTVYVYGQEKYLLLHDISESEFLTEAEIVCDVVCLVYDVTNPKSFEYCARIFKQHFMDSRIPCLIVAAKSDLHEVKQEHSVSPTDFCRKHKMPPPQAFTCNTADAPSKDIFVKLTTMAMYPHVTQADLKSSTFWLRASFGATVFAVVGFAMYRALLKQR,3.6.5.- (0.6501),small GTPase-mediated signal transduction (GO:0007264) (0.4565); mitochondrion transport along microtubule (GO:0047497) (0.4170); mitochondrion organization (GO:0007005) (0.3642); cellular homeostasis (GO:0019725) (0.3486); mitochondrial outer membrane permeabilization (GO:0097345) (0.3235); establishment or maintenance of cell polarity (GO:0007163) (0.1304); regulation of cell shape (GO:0008360) (0.0630),mitochondrial outer membrane (GO:0005741) (0.4111),protein kinase binding (GO:0019901) (0.4151); GTPase activity (GO:0003924) (0.3879); GTP binding (GO:0005525) (0.3878); calcium ion binding (GO:0005509) (0.2695),"Mitochondrial Rho GTPase (IPR021181) (0.5277); Small GTPase Rho (IPR003578) (0.3006); MIRO domain (IPR020860) (0.2958); EF-Hand 1, calcium-binding site (IPR018247) (0.2669); EF-hand domain pair (IPR011992) (0.2639); EF-hand domain (IPR002048) (0.2204); Mitochondrial Rho GTPase 1/3, EF hand associated, type-1 (IPR013566) (0.2173); P-loop containing nucleoside triphosphate hydrolase (IPR027417) (0.1948); EF hand associated, type-2 (IPR013567) (0.1899); Small GTPase (IPR001806) (0.1774)",1.10.238.10 (0.1949); 3.40.50.300 (0.1438),Nucleotide-binding (0.6022); Mitochondrion outer membrane (0.4255); GTP-binding (0.3618); Hydrolase (0.3582); Membrane (0.3498); Mitochondrion (0.3495); Ubl conjugation (0.3452); Metal-binding (0.3312); Reference proteome (0.2489); Calcium (0.1437); Repeat (0.1001),
MSAGKRGALIIFEGCDRSGKTTQSRLLVELLKSKGIPTLPMNFPERSSSIGQVINSYLTNSKDLPDEVIHLMFSANRWEHINQVKEKLLEGTTLVVDRYSFSGVAYSAAKGLDFDWCYAPERGLIKPDAVFYLRAPPNDLTHRGQYGKERYEKVEFQGRVAEVFNRICSKEGSYFHQFDARQSVEDLHAQIASITEELLPKVATRPLDTLS,dTMP kinase (2.7.4.9) (0.9712),dUDP biosynthetic process (GO:0006227) (0.6747); dTTP biosynthetic process (GO:0006235) (0.6284); phosphorylation (GO:0016310) (0.4483); dTDP biosynthetic process (GO:0006233) (0.3823); nucleotide biosynthetic process (GO:0009165) (0.0773); response to molecule of bacterial origin (GO:0002237) (0.0588); response to xenobiotic stimulus (GO:0009410) (0.0499); fructose metabolic process (GO:0006000) (0.0495); nucleobase-containing small molecule interconversion (GO:0015949) (0.0440),cytosol (GO:0005829) (0.5147); nucleus (GO:0005634) (0.2361); cytoplasm (GO:0005737) (0.1855); nucleoplasm (GO:0005654) (0.1699); mitochondrion (GO:0005739) (0.0992),ATP binding (GO:0005524) (0.1680),"Thymidylate kinase, conserved site (IPR018095) (0.4362); Thymidylate kinase (IPR018094) (0.2664); Thymidylate kinase-like domain (IPR039430) (0.2092); P-loop containing nucleoside triphosphate hydrolase (IPR027417) (0.1862)",3.40.50.300 (0.2341),Nucleotide biosynthesis (0.4939); Kinase (0.2077); Reference proteome (0.1950); Transferase (0.1828); Ubl conjugation (0.1769); Vacuole (0.1500),
MADFPGKVSTQTSSQEPQRSFAISSSVDMGFIKSIPGILLIAEIVVGLLVWTLIASTPHYLIPALGWVLFVSITLWLLSIALLVILLLSLHQRLPSVPWPLVLLVFYSVAALLYLTAFLANAATVPGGYYQGHLGASAFFGIVETLLYTASSYFAYLGWRGEGQNAAGSTVPV,,chemotaxis (GO:0006935) (0.6153); neutrophil chemotaxis (GO:0030593) (0.1579); negative regulation of epithelial cell migration (GO:0010633) (0.1406); negative regulation of endocytosis (GO:0045806) (0.1078); monoatomic ion transport (GO:0006811) (0.0736); positive regulation of cytokine production (GO:0001819) (0.0669); positive regulation of cell migration (GO:0030335) (0.0599); positive regulation of inflammatory response (GO:0050729) (0.0520); cell surface receptor signaling pathway (GO:0007166) (0.0508); positive regulation of calcium ion-dependent exocytosis (GO:0045956) (0.0403),plasma membrane (GO:0005886) (0.5369); membrane raft (GO:0045121) (0.1591); myelin sheath (GO:0043209) (0.1329); extracellular exosome (GO:0070062) (0.1047); nucleoplasm (GO:0005654) (0.0954); membrane (GO:0016020) (0.0803); nucleus (GO:0005634) (0.0557),structural constituent of myelin sheath (GO:0019911) (0.1772); identical protein binding (GO:0042802) (0.1704),Marvel domain (IPR008253) (0.3329),,Transmembrane (0.7664); Reference proteome (0.6236); Membrane (0.5684); Transmembrane helix (0.3856); Phosphoprotein (0.3232); Transport (0.2080); Alternative splicing (0.1499); Proteomics identification (0.1370); Glycoprotein (0.1360); Cell membrane (0.1228); Synapse (0.0947),
MCGRRLLFLAAFGCLLANAFSLPATRNEEFDDGFPESEFDYEERHTREIPAQAYAPPIVYNSQSSYSPAKDQGYSAPAAPVYSPAAPSYSAPAAPSYSAPAAPSYSAPAAPSYSAPAAPSYSAPAAPSYSAPASSSYSAPAAPSYSAPAAPSYSAPAAPSYSAPASSSYSAPAAPSYSAPAAPSYSAPAAPSYSAPAAPSYSAPAAPSYSAPAAPSYSAPSAPSYSAQKTSSYSAPAAPSYHAPAAPASSYSAPAGPSYSAPAAPSYSAPSYSAPASSYSALKAPSYSAPAAPSYSAPAAPSYSSSASPSYSSPASSSYSAPAAPTYSAPKAQSYSAPAAPSYSAPAAPSYSAPASSSYSAPAAPSYSAPAAPSYSAPAAPSYSAPASSSYSAPAAPSYSAPAAPSYSAPASSSYSAPAAPSYSAPAAPSYSAPAAPSYSAPAAPSYSAPASSGYSAARAYSAGSAAPASGYSAPKTSSGYSAPASSGSPAASSYSAPASSTASSGYSAPASKSSGYARSEMDHQILGMARTAGGYGSAAPSAAYGAASLPSPPCPKNYVFSCSSVFTPAPCSQGYGY,,egg activation (GO:0007343) (0.2351); response to hypoxia (GO:0001666) (0.2028); cell adhesion (GO:0007155) (0.1361); regulation of synaptic assembly at neuromuscular junction (GO:0008582) (0.1283); mitochondrion organization (GO:0007005) (0.0681); sexual reproduction (GO:0019953) (0.0679); positive regulation of developmental process (GO:0051094) (0.0554); chaperone-mediated protein complex assembly (GO:0051131) (0.0452); dorsal/ventral axis specification (GO:0009950) (0.0425); positive regulation of transcription by RNA polymerase II (GO:0045944) (0.0419); negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059) (0.0409),extracellular region (GO:0005576) (0.1347); vitelline envelope (GO:0060388) (0.1194); extracellular space (GO:0005615) (0.0723),receptor ligand activity (GO:0048018) (0.0923),Vitelline membrane cysteine-rich domain (IPR013135) (0.1221),,Secreted (0.7809); Reference proteome (0.5543); Wnt signaling pathway (0.3088); Signal (0.2851); Glycoprotein (0.1688); Repeat (0.1427); Disulfide bond (0.1188); Zinc (0.1149); Direct protein sequencing (0.1127); Nucleus (0.1091); Cleavage on pair of basic residues (0.0742); Phosphoprotein (0.0508),
MFSGSSSPPKDKSNSVPHSGAVDTQSLSVHPEEGSAAQTSKSLPSGGFFTRRTSEDQAPAGEKKRRSSTVTKAATFFTNAKNSLSLSSSPRESSSFNYTVRSPQTLQSLGSMDPALSVPQGSLNNSAGDSLPTPRSSFKVGVTEDRNRKCRRTMEDTHAYLYNFLGTPAPLARADGENEAGSSLAPDEASSVVETDNGYFAIFDGHAGTFAAEWCGKKLHLILEDIMKKNPNTPVPELLDQTFTTVDQQLEKLPVKNSGCTAVIALLRWEDRIPSSHSATGSSALAPAAAAAAAAKGDSNSEADDTPTQATSSGPSILPKLQEKAIRQRVLYTANVGDARIILCRNGKALRLSYDHKGSDENEGKRIANAGGLILNNRVNGVLAVTRALGDAYLKDLVTGHPYTTETVVQPDSDEFIILACDGLWDVCTDQEAVDLVRNVPDAQEASKILVDYALARFSTDNLSCMVIRLDTNRVKEVINKTAEPIGVAGDPSMDVEHGVSEADKIIEGARKSMANADIADDGETAEKGKNDILHKMVDGEPGPEMSLDDSNDAPTVSHLNKTNANNGIP,protein-serine/threonine phosphatase (3.1.3.16) (0.9899),protein dephosphorylation (GO:0006470) (0.6673); abscisic acid-activated signaling pathway (GO:0009738) (0.1786); cellular response to osmotic stress (GO:0071470) (0.1138); cellular response to starvation (GO:0009267) (0.1008); mitochondrion inheritance (GO:0000001) (0.0668),nucleus (GO:0005634) (0.2506),metal ion binding (GO:0046872) (0.3645); protein serine/threonine phosphatase activity (GO:0004722) (0.3426); myosin phosphatase activity (GO:0017018) (0.1662); phosphoprotein phosphatase activity (GO:0004721) (0.1538),"PPM-type phosphatase, divalent cation binding (IPR000222) (0.3477); Protein phosphatase 2C (IPR015655) (0.2807); PPM-type phosphatase-like domain (IPR001932) (0.1714); PPM-type phosphatase-like domain superfamily (IPR036457) (0.1278)",3.60.40.10 (0.3178),Reference proteome (0.8234); Protein phosphatase (0.5741); Manganese (0.4668); Metal-binding (0.3896); Hydrolase (0.2659); Membrane (0.1872); Nucleus (0.1376); Magnesium (0.1215),Mn(2+) (0.3664); Mg(2+) (0.0837)
MERSGGNGAGARAGAPSEGAAKGSSLLSAKSTEGATGRFSQSTPRPTGMDGFLKSDERQRLAKERREEREKCLAAREQQILEKQKRAKLQYEKQIEERWRKLEEQRQREDQKRAAVEEKRKQKLREEEERLEAMMRRSLERTQQLELKKKCSWAGSAASGPGGRDGESENTPPLPLTLAASIPPSDTGTATAAAESTNACDKLSTSTMNLPKQTEPPMSKHLSSSIVAISYSPDRALRSPLKSSYKSSPTRTTEKKKNTLLSGVGDAGKGAMTGGEPSQMEKVKKGRGATSVSSGGLGSPLRRCEPPENISKRSSSPVKSKVTAKTYPQSPKTVKPTYIGSPVKYYFPPTPSEETLKKKAEKEKSNKEKEGATGRQTTVLPREETLEKPMADKDATEKYVADKHATEKHSATGGKAEHSAGKSTAGTTDAGEAAKILAEKRRQARLQKEQEEQERLEKEEQERLEKEELKRKAEEERLRIEKQEEEKKQQEEEEKRKAEEKAKEKAEEELLSKEEQEKEKQEKEKKEKAMIEKQIQAEKEAAEAKAQDAAKQMRLEREQIMLQIEQERLERKKRIDEIMKRTRKSDASLEVKKEDPKVEIQPLPDVENKIKPVVPNKIEINVLNTCQKVNVSERAAPETFPQDIFSNGLKPVGGPVHPDVLDGKSNSLDDSTEEVQSMDVSPVSKEELISIPEFSPVSEMIPGMSLDQNGTGNARALQDILDFTGPPAFPKKSSENLSLDDCNKNLIEGFNSPGQETTLNTFC,,microtubule cytoskeleton organization (GO:0000226) (0.8727); spermatogenesis (GO:0007283) (0.4614); response to retinoic acid (GO:0032526) (0.3502); microtubule bundle formation (GO:0001578) (0.2518); glycosphingolipid metabolic process (GO:0006687) (0.2443); Sertoli cell development (GO:0060009) (0.2174); cell morphogenesis (GO:0000902) (0.1894); microtubule polymerization (GO:0046785) (0.1350); brain development (GO:0007420) (0.1312); cell population proliferation (GO:0008283) (0.1272); protein localization to plasma membrane (GO:0072659) (0.1153); establishment or maintenance of cell polarity (GO:0007163) (0.0931); negative regulation of microtubule depolymerization (GO:0007026) (0.0868); mitotic spindle organization (GO:0007052) (0.0808); cerebellum development (GO:0021549) (0.0686),neuron projection (GO:0043005) (0.1491); microtubule cytoskeleton (GO:0015630) (0.1380); axon (GO:0030424) (0.1325); cytosol (GO:0005829) (0.0734),,Microtubule-associated protein 7 family (IPR008604) (0.2408); Microtubule-associated protein 7 domain-containing protein (IPR051483) (0.2058),,Coiled coil (0.4177); Reference proteome (0.3497); Ubl conjugation (0.2034); Cytoplasm (0.1280); Proteomics identification (0.1200); Microtubule (0.1165),
MAQWWLILLGLWTVLPSLAGGKLLNVCMNSKHHKQEPGPEDKLYFECMPWKDNACCTRDTSWEAHLDEPLLFNFSMTHCGLLTPLCHKHFIQAICFYECSPNLGPWIQPVVPNRQEEQRLWDVPLCLEDCEEWWKDCRTSHTCKADWLHGWVWDQGKNGCPAHAPCLPFSDYFPTPADLCEKIWNNTFKASPERRNSGRCLQKWFEPTHGNPNVEVALHFAGSASAPQLSYSITAFSLCLLLHA,,fusion of sperm to egg plasma membrane involved in single fertilization (GO:0007342) (0.5572); cell adhesion (GO:0007155) (0.5059); single fertilization (GO:0007338) (0.3174); sperm-egg recognition (GO:0035036) (0.2769); heart looping (GO:0001947) (0.2718); cardiac neural crest cell migration involved in outflow tract morphogenesis (GO:0003253) (0.2049); neural crest cell migration involved in heart formation (GO:0003147) (0.0975); folic acid transport (GO:0015884) (0.0856); pharyngeal arch artery morphogenesis (GO:0061626) (0.0686),extracellular region (GO:0005576) (0.1372); basolateral plasma membrane (GO:0016323) (0.1302),signaling receptor activity (GO:0038023) (0.2845); signaling receptor binding (GO:0005102) (0.0823),Folate receptor-like (IPR018143) (0.4510); Folate receptor (IPR004269) (0.2110),,Signal (0.7978); Reference proteome (0.4383); GPI-anchor (0.3226); Lipoprotein (0.1989); Disulfide bond (0.1936); Glycoprotein (0.1431); Fertilization (0.0898); Transport (0.0417),
MDYDDSDFQNQNLHLAGEANNKFPPVLQPYALPKFDFDDTLNTHLRFDSLGESEAFLGIEGNEDNNWIEDFSRGSSGIVFSSGATESCAISRHNNVWSEATSSESVAMLLNSVGQDEVIVREDTIKKSDTSHELGCTMETVEPGQTSHERSLSKEETVNLQPNPSVDDTPGESSVVKTDDGQEQVLVKDDSPTAVEEASVEEKNSILTSNTATVEAIDTTDLGKIGTETTDNLLDQTEEKANVESRMEDDCSDGNVQTIITCSGELNNQSTLLPETSNDENVISDHIQSSYNRNDLTADARSILVEGHSDSHIDSASEVEKVEAENIGKTAKPDLKEIELSDVTVLERGDQAPSTLEVGGQDVSGTECQDLLVSTVHTSVAVEASLELAGELTTITNSVSIEKPELLSHQHMEVITSEHESTFQIETETYPQIHVFETSESVYISTMDSMVEAREGGVSKKSDNEGSARTSNLEQSMELPVNANDRDQDVKNSQILSESVVSGSVGYVSGGSTSELAESESQSDSIPTDKSETMIDSSLNLEELQPLSQDGAPAVSLTSSIDLHMVKTSSDDSDQGSYSETKKVYGEPENGQTVPPVDASCSGSQMDQEARKRAEGTKQSTYSVEGCPRSEGSKDAVDADGVGQVLQQQSEELIFEENVVTEAVKAPETLSVLDKDNKNEMPITSSLPILGSEAGKDGQEEDNTAASGGIMAAGTPVTHPKGDAIVLGDSRASTCSESSVKSYVTAIEDAATNLKTPLDSFPTVKTSELQFNNTETNSVKKPEDQNISGFMSAGSPVLNRNETSSSEMNLTPDQLKAGKISKAVIFSQATLVSPIVVGSPSTSSLDKTAAKSSKAKSERKPRRTSKSVGKETSRKGTSVKGATPIEQFQSGGKTNAVNQSLASHIQITQSTEKQRSLQSPALKAFGSLSTPTASLPDLNSSALSSILRRPFTDLQQVQLRAQIFVYGALIQGTAPDEAYMISAFGGADGGKGSWEKSWRTCVVRAQKSLVATPETPLQSRPGKTETPSAGHTNSKESSGTNPMIPLSSPLWSLSTSVDTLQSSSVQRGSAATHQPLLSASHAHQTPPTQNIVGHNTPWMSPLPFRNAWLASQQTSGFDVGSRFPVYPITDPVKLTPMKESSMTLSGAKHVQSGTSSNVSKVTPTLEPTSTVVAPAQHSTRVKSRKRKKMPVSVESGPNILNSLKQTELAASPLVPFTPTPANLGYNAGTLPSVVSMTAVPMDLVSTFPGKKIKSSFPSPIFGGNLVREVKQRSVLSEDTIEKLKEAKMHAEDASALATAAVSHSEYVWKQIEQQSHAGLQPETQDRLASAAVAIAAAAAVAKAAAAAANVAANAALQAKLMAEEASLPNASDQGLPKSYDSILPGQGTPASILKGEGAVVNSSSVLIAAREASKKRVEAATAATKRAENMDSIVKAAELASEAVSQAGILVSMGHPPLLNKLVEAGPSNYWRQAQESQEVQPCKTVVLEKETVSTSEGTFAGPKIVQTEFGGSVNTADGVSGPVPATGKLKGQEGDKYADLAKNNDVVFEPEVGSKFSIDAQQTIKATKNEDIKEGSNVEVFKEEPGLRTAWYSANVLSLEDDKAYVLFSDLSVEQGTDKLKEWVALKGEGDQAPKIRPARSVTALPYEGTRKRRRAALGDHIWKIGDRVDSWVHDSWLEGVITEKNKKDENTVTVHFPAEEETLTIKAWNLRPSLVWKDGKWIECSSSGETISSSHEGDTPKEKRPRLGTPALVAEVKDTSMKIVDDPDLGKPPQTGVLNLGVSENTFNIGKSTREENKPDPLRMKRTGLQKQGSKVIFGVPKPGKKRKFMDVSKHYVSEASTKTQERKEPVKPVRSIVPQNSGIGSWKMPSKTISIEKQTTISRPKTFKPAPKPKEKPGATARIIPRKDSRNTTASDMESDESAENRGPGSGVSFKGTVEEQTTSSSHDTGSKNSSSLSTNKGRVAPTAGRLAKIEEDKALAENSSKTSEGMEPRRSIRRIQPTSRLLEGLQTSMMTSKIPSVSHSKSHLSQSKK,,flower development (GO:0009908) (0.4757); auxin-activated signaling pathway (GO:0009734) (0.1644); unidimensional cell growth (GO:0009826) (0.1318); regulation of DNA-templated transcription (GO:0006355) (0.1193); defense response to oomycetes (GO:0002229) (0.0800); plant-type secondary cell wall biogenesis (GO:0009834) (0.0763); regulation of defense response to fungus (GO:1900150) (0.0707),chloroplast inner membrane (GO:0009706) (0.1915); plasmodesma (GO:0009506) (0.0960); plant-type cell wall (GO:0009505) (0.0580); nucleus (GO:0005634) (0.0458),hydrolase activity (GO:0016787) (0.1903); protein heterodimerization activity (GO:0046982) (0.0514),"Lactate dehydrogenase/glycoside hydrolase, family 4, C-terminal (IPR015955) (0.0476); Agenet-like domain (IPR008395) (0.0422)",3.40.50.720 (0.0605),Reference proteome (0.5608); Zinc-finger (0.3795); Membrane (0.2772); Plastid (0.2760); Plastid outer membrane (0.2061); Transmembrane helix (0.1980); Transmembrane (0.1161); Transferase (0.1044); 3D-structure (0.0672); Chlorophyll (0.0595); Chloroplast (0.0577); ATP-binding (0.0522); Alternative splicing (0.0429),
MMRRPPSQGRWSASHQKLLLAFAFILIPWLQLADAQQQPQQPQIRIHSQRGDAPLDKVADDANTRWYATHAAPDVHPEAKFDTVNRKQKQQSTASPQQHQKYRRAPYDYASKDKAQNRYAQHPIRESEKPNYVKVPNDASALATLAPAQPVRAPHTSRHHWPSSSAASGLASPQNARSLEDWEVEDFVLLATVDGDLYASDRKTGRHLWHLEVDQPVVETKHYRTNNSVLDDDYRPVDHYIWAVEPSRDGGLYVWIPDSGAGLVRTGFTMKHLVEELAPYAGDEPPVVYTGDKKTTMVTLDAATGRVLKWFGSSGSQVNEAESCLRPNAFDDRDTTECSSMGTITLGRTEYTVGIQRRDGRPIATLKYAEWGPNTFDSDLYQQYHASLDNHYITSQHDGRIYAFDKSQAENDLPLYTHKFSSPVARVFDVCRPWDANAGSNPELVVLPQPPIPALDESTVKMRSNSIFLNQTESGDWYALSGRAYPLILDAPVAQISRDDLWDMAHAFDSINPNKLSKALVGTHFLNPVKSTGYHQPPTLPAGALDEYYEDLENASNNAHAVTNTVPEEPTIITKVKALPQSAANSVIDFVSNPILIIFLIGSLIYNEKKLRRSYHRFRTHGTIKDVYPFFVIESEAGDESGDDKDGVFPSSPSPRSQPQDQNAEDHLSRHKVERNAGDQDKVKDNRSLHDVSDTLEPSNKTVEKTADVVKQVDVAGPDAPSTDSNGAAPEKKKKAHRGRRGGVKHRKGRPTDGSQSHENDPALTTVDEAVSNAKKLGDRPSLEPDVMTIYNDMQAVTGSVISMGNIEVDTDVELGMGSNGTVVFAGRFDGRDVAVKRMTIQFYDIATRETKLLRESDDHPNVIRYYSQVQRGDFLYIALERCAASLADVIEKPYAFGELAKAGQKDLPGVLYQITNGISHLHSLRIVHRDLKPQNILVNLDKDGRPRLLVSDFGLCKKLEDRQSSFGATTGRAAGTSGWRAPELLLDDDGQNPAAIDSSTHSGSHTILVGDPNSLSNGGRATRAIDIFSLGLVFFYVLTNGSHPFDCGDRYMREVNIRKGNYNLDPLDALGDFAYEAKDLIASMLQASPKARPDSREVMAHPFFWSPKKRLAFLCDVSDSLEKEVRDPPSPALVELERHAPEVIKGDFLKVLTRDFVESLGKQRKYTGNKLLDLLRALRNKRNHYEDMSDSLKRSVGSLPDGYLAYWTVKFPMLLLTCWNVVYNLEWEKTDRFREYYEPAGL,non-specific serine/threonine protein kinase (2.7.11.1) (0.9854),protein phosphorylation (GO:0006468) (0.9686); mRNA processing (GO:0006397) (0.7986); IRE1-mediated unfolded protein response (GO:0036498) (0.7414); intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) (0.6170); endoplasmic reticulum unfolded protein response (GO:0030968) (0.1231),IRE1-TRAF2-ASK1 complex (GO:1990604) (0.4971),RNA endonuclease activity (GO:0004521) (0.8531); histone H2AS1 kinase activity (GO:0044024) (0.5283); ATP binding (GO:0005524) (0.2409); unfolded protein binding (GO:0051082) (0.1640); protein serine/threonine kinase activity (GO:0004674) (0.1231),"Quinoprotein alcohol dehydrogenase-like superfamily (IPR011047) (0.6441); Pyrrolo-quinoline quinone repeat (IPR002372) (0.4355); Protein kinase domain (IPR000719) (0.4156); Pyrrolo-quinoline quinone beta-propeller repeat (IPR018391) (0.3767); WD40/YVTN repeat-like-containing domain superfamily (IPR015943) (0.3528); Serine/threonine-protein kinase, active site (IPR008271) (0.3309); KEN domain superfamily (IPR038357) (0.2677); Protein kinase-like domain superfamily (IPR011009) (0.2560); Serine/threonine-protein kinase/endoribonuclease IRE1/2-like (IPR045133) (0.2454)",1.10.510.10 (0.5922); 2.130.10.10 (0.5060); 1.20.1440.180 (0.2511),mRNA processing (0.9153); Nucleotide-binding (0.6272); ATP-binding (0.4544); Reference proteome (0.2689); Kinase (0.2666); Transferase (0.2177); Signal (0.1652),
MAASSMSSLTSSYHTTAMPSSNSVVPPFDARNLEIKTKSIEQTLIPLVTQITTLVNYKESYMASGKPKSERAMRAALKIGSAVEAAIERFVCVGETIADENADIQPEMYDACTEARLAGASMANLSCACNDDPNSVVDKAVLVRASRQLLSSVTRVLLLADRVLVKQVLRAEDKIAFSLSRLESTRSFNDFVKVFAVFGGEMVELAHRSGDRQHDLKSEKRKAQMSIARTSLERLTMLLLTASKTYLRHPDCDSALQCRDGVFYQMKLSLELIAICVCDGILTTEKSRYIQDEPDMPIDIALQLTANAAIKQLTEMLEMIRMTVRVGAGVRERIVSALDALCQLTQDFTDSAYTPHHQREQILDFLEECRFEMTNLIQPDENEQLAASGLEVTVERLNRRLKDLSKQLQIVAMEQISEVLRANEDQVLLSSMKACAVSGDIDGVEKYMHKFREHADHMQEVCRLLHHISITDALHVHTGHVERNMRALAPLTILAGRTLCVHPSSRIARENLEVFCDTWGQAVNDLSRVAKESDVAANGRVAAEKQAYMSLPRPGKHGTTQKPSKPITLDVEDQQKMAKVGLEMKLLTSEVDAEAEKWDEYAENDIVKRAKAMSSMAYNMYLFTRGDGPLKTTHDLFTQAEFFAEQANQMYRTVREFSYEVPGSAEKSDLSAILERIPLHCQQLQVMVKSPTVGKTATFGKVDSVIQETKNLMNEIAKLVTASFVCATKYEIEFRGGSVNGRTGADGERTSRESTVWRRTPSIRRAAPPTSSHLSANNSSSIHI,,cell adhesion (GO:0007155) (0.4668); cell migration (GO:0016477) (0.3896); positive regulation of smoothened signaling pathway (GO:0045880) (0.3307); cell-cell adhesion (GO:0098609) (0.2758); establishment or maintenance of cell polarity (GO:0007163) (0.1637); nematode larval development (GO:0002119) (0.1467); positive regulation of multicellular organism growth (GO:0040018) (0.1332); cell motility (GO:0048870) (0.1326); chemical synaptic transmission (GO:0007268) (0.0959); egg-laying behavior (GO:0018991) (0.0809); locomotory behavior (GO:0007626) (0.0590); cortical actin cytoskeleton organization (GO:0030866) (0.0548); embryonic body morphogenesis (GO:0010172) (0.0541); axonogenesis (GO:0007409) (0.0502),cytoplasm (GO:0005737) (0.1325),actin filament binding (GO:0051015) (0.1837),Vinculin/alpha-catenin (IPR006077) (0.5417); Alpha-catenin/vinculin-like superfamily (IPR036723) (0.3476),1.20.120.230 (0.2149),Cytoplasm (0.4850); Cell adhesion (0.1400); Reference proteome (0.1135),
MNEALDDIDRILVRELAADGRATLSELATRAGLSVSAVQSRVRRLESRGVVQGYSARINPEAVGHLLSAFVAITPLDPSQPDDAPARLEHIEEVESCYSVAGEESYVLLVRVASARALEDLLQRIRTTANVRTRSTIILNTFYSDRQHIP,,response to amino acid (GO:0043200) (0.1053); nucleobase-containing compound metabolic process (GO:0006139) (0.0973); alanine catabolic process (GO:0006524) (0.0950); negative regulation of DNA-templated transcription (GO:0045892) (0.0751); response to oxidative stress (GO:0006979) (0.0703); positive regulation of DNA-templated transcription (GO:0045893) (0.0693); response to cadmium ion (GO:0046686) (0.0425),cytosol (GO:0005829) (0.3038); cytoplasm (GO:0005737) (0.1134),identical protein binding (GO:0042802) (0.5165); sequence-specific DNA binding (GO:0043565) (0.5141); transcription cis-regulatory region binding (GO:0000976) (0.0927); DNA-binding transcription factor activity (GO:0003700) (0.0525),"Winged helix-like DNA-binding domain superfamily (IPR036388) (0.4308); Transcription regulator HTH, AsnC-type, conserved site (IPR019885) (0.2291); Winged helix DNA-binding domain superfamily (IPR036390) (0.2182); AsnC-type HTH domain (IPR000485) (0.1931); Transcription regulator AsnC-like (IPR019888) (0.1893); Dimeric alpha-beta barrel (IPR011008) (0.1079)",3.30.70.920 (0.3210); 1.10.10.10 (0.1240),Transcription (0.7970); Transcription regulation (0.7460); Reference proteome (0.6593); DNA-binding (0.3325); Activator (0.2388); 3D-structure (0.1338); Virulence (0.0550),
MAPAATAAASSGKGSFDLATLFVADKAARDEAGLALADAVKKSGVEFFTQIGFNDAIVKALNDKKSQSAREGACEVISTLCENGAAQLLEPHVISSAENTPFPALLEAFADKVAAVKTAAIAAVKAIVQSMNPWASFVLLPALLNLIRTSGKWQIKAGSLEILQQLITSAPFQMGEAMPDLVPVLAEAVWDTKSDVKKAAKATLEKAVSLVENKDIEKFVPALVKSLLNPIEEVPKTISLLSATTFVSEVTAPTISLIAPLLIRGLDERPTATKRKVCVIADNMSKLVDSEYTVRPFLPQLLPRLIKTSETIADPEARSVANRAIVTLRRIGKVPAESDGSDLPPLPVAEGPHLATNFVALVKKHGGVSVEQTNPGLAYAGVLAASLVNHHNFDQKTWESTLPPYLKLALPSYDSLPAVRELLQKKADEAETDDAKFPDEEEGEDLCNIEQFNLAYGAKILLHHANMRLKRGHRYGLCGRNGSGKSTLMNAIINNQVEGFPPPTEVRTFYVQHDIDGSEAEISILDWVLGDKRLLATPDEIKSTLESVGFDEVKQKNSIGSLSGGWKMKLALARAILFKADILLLDEPTNHLDVLNVDWLINYLTSLTRCTSIIVSHDSDFLNRTVTDVLHLNNFKLKRYPGNLEDFVQHVPEAKSYYQLDVAEDYQFKLPNPPLLDGVKTKEKSLLKMRNVSFQYPGSSIQQLYDISLQVSLSSRVAILGPNGSGKSTLVKLLTGETEPNLGGQVWKHPNLVIGYVAQHAFHHIDNHLDSTPLEYMLWRYQTGEDLEEMHKANRVMTEAEIAKMKEGATVIKDGVKRIIDELVARKKLKQSYEYEVSFKGMSSAENIWISRDELVARGFEKKVMELDTREAQRLGLMRPLVRREIEKHFEDFGLDAEFVSHNSMRGLSGGQKVKVVLGAATWRRPHIICLDEPTNYLDRESLAALIAALKNFEGGVLIITHNREFSESICTEVWAMREGYLEASGHNWVEGQGSGERIDKKAADDDEVEYDALGNPIVKAKKEKKLSAADKRKAKKDRMARRKRGEEVFSDEEL,3.6.4.- (0.0415),chromatin remodeling (GO:0006338) (0.7195),cytoplasm (GO:0005737) (0.6213); nucleus (GO:0005634) (0.0575); cytosol (GO:0005829) (0.0457),translation elongation factor activity (GO:0003746) (0.6136); ATP hydrolysis activity (GO:0016887) (0.5186); RNA binding (GO:0003723) (0.2903); ATP binding (GO:0005524) (0.2154),"Elongation Factor 3, chromodomain-like insertion superfamily (IPR047038) (0.5643); ABC transporter-like, ATP-binding domain (IPR003439) (0.4217); HEAT, type 2 (IPR021133) (0.3686); Chromo/chromo shadow domain (IPR000953) (0.3001); ATP-binding cassette sub-family F member, EF3 subfamily (IPR050611) (0.2298); Armadillo-like helical (IPR011989) (0.2256); P-loop containing nucleoside triphosphate hydrolase (IPR027417) (0.2149); ABC transporter-like, conserved site (IPR017871) (0.1938); Armadillo-type fold (IPR016024) (0.1306); Elongation factor 3, four helical bundle domain superfamily (IPR047036) (0.0854)",1.25.10.10 (0.4308); 2.40.50.990 (0.2963); 3.40.50.300 (0.2480),RNA-binding (0.8467); Nucleotide-binding (0.5393); ATP-binding (0.5056); rRNA-binding (0.3150); Protein biosynthesis (0.2206); Elongation factor (0.1687); Reference proteome (0.1533); Repeat (0.1466); Nucleus (0.1101),
MHQLKKLITVKVIGSGEKTVVLGHGFGTDQSVWKHLVPYLVEDYRVVLYDNMGAGPTNPDYFDFERYASLEGYAYDLLAILEELQIDSCIYLGHSLSSMTGVIASIFRPDLFSKLIMLSASPRFINADDYYGGFEKEDIDQLSQAMDTNYKSWIEGFAPLVIGGDMDSVAVQEFSRTLFNMRPDIALSVFRTIFTFDLRHFLCRVTVPCHIIQSSKDLAVPVAVSEYIHQNLGGKSIVEVISTEGHLPQLSAPEVTIPVLLRHISHDITSNAAP,3.1.-.- (0.3265); 1-acylglycerol-3-phosphate O-acyltransferase (2.3.1.51) (0.1979); 1-acylglycerophosphocholine O-acyltransferase (2.3.1.23) (0.1721); 3.1.1.- (0.0850),response to light stimulus (GO:0009416) (0.2213); cell differentiation (GO:0030154) (0.1625); DNA damage response (GO:0006974) (0.1157); positive regulation of cell population proliferation (GO:0008284) (0.0811); defense response (GO:0006952) (0.0645),cytoplasm (GO:0005737) (0.5293); nucleus (GO:0005634) (0.1909); cytosol (GO:0005829) (0.1797),metal ion binding (GO:0046872) (0.2602); magnesium ion binding (GO:0000287) (0.2089); protein-containing complex binding (GO:0044877) (0.0581); hydrolase activity (GO:0016787) (0.0462),Alpha/beta hydrolase fold-1 (IPR000073) (0.1902); Alpha/Beta hydrolase fold (IPR029058) (0.1107),3.40.50.1820 (0.1207),Hydrolase (0.4059); Nucleus (0.3044); 3D-structure (0.2991); Cytoplasm (0.2812); Reference proteome (0.2427); Metal-binding (0.2406); Zinc (0.2167); Acetylation (0.1590); Direct protein sequencing (0.1332); Membrane (0.0973),
MELCGNVMTNSKYEMFRLKCLYCSIESELKDWELFIVHVKSAHYCEDEDVRINEIKEDTEELYSVVDAADPAIAYGPDEFFEVIENSNGVDQWMEADSKDIQYEEDATAWSAATNNSWEFGPGGSSLELPAGKEVTQMDESSQNHIPLNTDDDDVDCSDFFMSEDDLAPPRKPGRPPRRTRPGQVFKFKVSFIRSNPRVLHLIQAYKEHPCLWNPSDEHYQDEPARSMAYEAIMERMDRKANVLFTVEELKKTLEQLHVQYTLALETKQRGKLVGLAARYFAKCEFLSVAPVVTPRENEEDNDLTAIKLNFKEENLITTSFIETYANYPVLYNQALPDFGSIEIRADAFKRMAKEFQPVVKANETDVYIAVNKLRRWLYDAIRRLKSKELIQKCSKQEVQYLQMCSFLPAKGSESQVLYCDYCDKRFHGDYNLRVHIVKAHEVGDLPYLCSFCPRRFDRHVDMDRHKLRSHFERKLKCQYCEKSFAVDTDLKVHTLIHTGERPHVCDICGKTFRLKLLLDHHVNGVHLNIRPYSCNMCTKTFRKKFELANHIKGHLNIRDKKCEYCDATFYDHSSLSRHRRSHRSE,,ventral cord development (GO:0007419) (0.3355); negative regulation of transcription by RNA polymerase II (GO:0000122) (0.2897); regulation of transcription by RNA polymerase II (GO:0006357) (0.2726); regulation of DNA-templated transcription (GO:0006355) (0.2279); positive regulation of transcription by RNA polymerase II (GO:0045944) (0.2155); negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426) (0.1257); telomere maintenance (GO:0000723) (0.1148); gonad development (GO:0008406) (0.0976); response to ecdysone (GO:0035075) (0.0560); nematode male tail tip morphogenesis (GO:0045138) (0.0475),condensed chromosome (GO:0000793) (0.0833); nucleus (GO:0005634) (0.0791),sequence-specific DNA binding (GO:0043565) (0.3848); DNA-binding transcription factor activity (GO:0003700) (0.1688); chromatin binding (GO:0003682) (0.0736),Zinc finger C2H2-type (IPR013087) (0.3955); Zinc finger C2H2 superfamily (IPR036236) (0.2891),3.30.160.60 (0.2293),Zinc-finger (0.9607); Repeat (0.5919); Transcription (0.4111); Transcription regulation (0.3641); Reference proteome (0.2274); Metal-binding (0.2223); Nucleus (0.1751); Ubl conjugation (0.1242); Zinc (0.1162),
MGRDARRLPLLPFLLLLLAAAAGVAESATDAEAIHDLARSVPALGWDGDNVCGFEGVTCERGGAGKVTELNLADRGLSGTLPDSLSSLTSLTALQLQGNALTGAVPSLARMGSLARLALDGNAFTSLPPDFLHGLTSLQYLTMENLPLPPWPVPDAIANCSSLDTFSASNASISGPFPAVLATLVSLRNLRLSYNNLTGGLPPELSSLIAMESLQLNNQRSDDKLSGPIDVIASMKSLKLLWIQSNKFTGPIPDLNGTQLEAFNVRDNMLTGVVPPSLTGLMSLKNVSLSNNNFQGPKPAFAAIPGQDEDSGNGFCLNTPGPCSPLTTTLLQVAEGFGYPYELAKTWKGNDPCSPAWVGIVCTSSDVSMINLSRKNLSGRISPALANLTRLARLDLSNNNLTGVIPDVLTTLPSLTVLNVANNRLTGEVPKFKPSVNVLAQGNLFGQSSGSSGGGGGSDGDSSSSDSAGGGKSKPNTGMIIGIIVAVIILFACIALLVHHRKKKNVEKFRPVSTKTSPAESEMMKIQVVGANGISNGSSAFPTELYSHVSAANSSNISELFESHGMQLSVEVLLKATNNFSEDCILGRGGFGVVFKGNLNGKLVAVKRCDSGTMGTKGQEEFLAEIDVLRKVRHRHLVALLGYCTHGNERLLVYEYMSGGTLREHLCDLQQSGFIPLTWTQRMTIALDVARGIEYLHGLAQETFIHRDLKPSNILLDQDLRAKVSDFGLVKLAKDTDKSLMTRIAGTFGYLAPEYATTGKVTTKVDVYAYGVILMEMITGRKVLDDSLPDDETHLVTIFRRNILDKEKFRKFVDPTLELSAEGWTSLLEVADLARHCTAREPYQRPDMCHCVNRLSSLVDQWKPTNIDEDDYEGETSEMGLHQQLEKWRCDDFTISDSDTFGSFNVPRKYNG,non-specific serine/threonine protein kinase (2.7.11.1) (0.1417),protein phosphorylation (GO:0006468) (0.7946); response to other organism (GO:0051707) (0.2795),plasma membrane (GO:0005886) (0.3545); membrane (GO:0016020) (0.2213),ATP binding (GO:0005524) (0.2668); protein serine/threonine kinase activity (GO:0004674) (0.1601),"Auxin Signal Transduction Ser/Thr Kinase (IPR052422) (0.6005); Protein kinase domain (IPR000719) (0.5613); Leucine-rich repeat (IPR001611) (0.3930); Leucine-rich repeat, typical subtype (IPR003591) (0.3823); Serine/threonine-protein kinase, active site (IPR008271) (0.3585); Protein kinase, ATP binding site (IPR017441) (0.3094); Protein kinase-like domain superfamily (IPR011009) (0.2424); Leucine-rich repeat-containing N-terminal, plant-type (IPR013210) (0.2112); Leucine-rich repeat domain superfamily (IPR032675) (0.1922); Serine-threonine/tyrosine-protein kinase, catalytic domain (IPR001245) (0.1683)",1.10.510.10 (0.3306); 3.80.10.10 (0.2845),Transmembrane (0.9087); Signal (0.7882); Transmembrane helix (0.6512); Repeat (0.5888); Receptor (0.5663); Kinase (0.4945); Membrane (0.4933); Leucine-rich repeat (0.4723); Nucleotide-binding (0.3740); Reference proteome (0.3681); Serine/threonine-protein kinase (0.3210); ATP-binding (0.3035); Tyrosine-protein kinase (0.1776); Transferase (0.0976),
MAGVEEADKLKQLGNAAFSERKWHLAIDMYTKAIELTKTPTLFCNRALAELRAELPGAALADADAALGIEPTFAKAYYHKASAYLSLGKHKQALTNYKKVVDLAPQNSDAQAKVEFCKKEIRRINFENAIMTPDEAPLSQTIKLGSVRADYDGPRIENETVTVEFVEAMKEHFRLEKLIDRHDVIFILLEVQKILKKCPNFVSINVPVGEEITVCGDTHGQYYDLLNIFKLNGNPLETNRYLFNGDFVDRGSYSFENIMTLFAYKVLYPDHFFLSRGNHEGVSMNRMYGFEGEVTQKYNSEMFRLFTEVFNSLPIGHIINNEVFVVHGGLYSSDKVTLDDLQHPNRFRDIPESGLICESLWSDPQPMPGRAPSKRGVSCLSFGPDVTETFLNNNNLKLLVRSHEVKDEGYEIEHGGKCITVFSAPNYCDQMGNKGAFIRFTGGDMKPRFTTFTHVPHPGKRPMHYATGFGLF,protein-serine/threonine phosphatase (3.1.3.16) (0.9952),chloroplast-nucleus signaling pathway (GO:0010019) (0.2789); mitotic cell cycle (GO:0000278) (0.2421); red or far-red light signaling pathway (GO:0010017) (0.1641); protein dephosphorylation (GO:0006470) (0.1475),nucleus (GO:0005634) (0.4889); cytosol (GO:0005829) (0.2251); cytoplasm (GO:0005737) (0.1888),metal ion binding (GO:0046872) (0.4889); protein serine/threonine phosphatase activity (GO:0004722) (0.4121); myosin phosphatase activity (GO:0017018) (0.1799),"Protein Phosphatase PPP (IPR051134) (0.3363); Tetratricopeptide repeat (IPR019734) (0.3109); Serine/threonine-specific protein phosphatase/bis(5-nucleosyl)-tetraphosphatase (IPR006186) (0.3100); Metallo-dependent phosphatase-like (IPR029052) (0.2501); PP5, C-terminal metallophosphatase domain (IPR041753) (0.1992); Calcineurin-like phosphoesterase domain, ApaH type (IPR004843) (0.1819); Tetratricopeptide-like helical domain superfamily (IPR011990) (0.1806)",3.60.21.10 (0.2781); 1.25.40.10 (0.1415),TPR repeat (0.7172); Metal-binding (0.5485); Reference proteome (0.4836); Repeat (0.4198); Hydrolase (0.2667); Nucleus (0.2066); Manganese (0.1403),Mn(2+) (0.2478)
MRTCGTSSEGQDECCLYGLSAMQGWRISMEDAHAAVLDLQAKSTGGSEKPTDPDKRLAFFGVYDGHGGDKVALFAGENVHKIVAKQEAFAKGDIEQALKDGFLATDRAILEDPKYEEEVSGCTAAVSVISKNKIWVANAGDSRSVLGVKGRAKPLSFDHKPQNEGEKARISAAGGFVDFGRVNGNLALSRAIGDFEFKKSPELSPEQQIVTAYPDVTVHEVTDDDEFLVIACDGIWDCQSSQSVVEFVRRGIAAKQELYRICENMMDNCLASNSETGGVGCDNMTMIIIGLLNGKTKEEWYNQISERVANGDGPCAPPEYGKSEFRGPGIRNQFEETPDNYDLENDRSRGFSVRSGRIILLGDGTELIPEQNDEELFDQREENRDVTNHLQHDKAEETSTAANLSESPSSANKNSSGSGTEATEKSASS,protein-serine/threonine phosphatase (3.1.3.16) (0.9470),protein dephosphorylation (GO:0006470) (0.6428); response to UV-C (GO:0010225) (0.1773); positive regulation of protein export from nucleus (GO:0046827) (0.1137); cellular response to osmotic stress (GO:0071470) (0.0905); negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512) (0.0715); positive regulation of canonical Wnt signaling pathway (GO:0090263) (0.0567); mitotic cell cycle (GO:0000278) (0.0527),nucleus (GO:0005634) (0.2056); cytosol (GO:0005829) (0.0603); plasma membrane (GO:0005886) (0.0558),myosin phosphatase activity (GO:0017018) (0.3280); MAP kinase serine/threonine phosphatase activity (GO:1990439) (0.2920); protein serine/threonine phosphatase activity (GO:0004722) (0.1572); metal ion binding (GO:0046872) (0.1313),"PPM-type phosphatase, divalent cation binding (IPR000222) (0.1697)",3.60.40.10 (0.1609),Reference proteome (0.5924); Protein phosphatase (0.4854); Metal-binding (0.3706); Magnesium (0.2939); Hydrolase (0.2907); Manganese (0.2871); Lipoprotein (0.1544); Cytoplasm (0.1110); Myristate (0.1080); Acetylation (0.0926); Membrane (0.0874),
MASYPKKKCGVLGATGSVGQRFILLLADHPFLELHAIGASNRSAGKKYKDAVRWKQTTAMSERLSNLVLRDCRADQFSDCDLVFSGLNSDVAGEIEMEFIKAEIPVFSNAKNYRKHPLVPLVVPTVNPQHLDLIPHQRKEFGLKKGFLVCNSNCAVIGVVIPFAALQAKFGPVEEVEVFTEQAVSGAGYPGVPSMDIMDNVIPYISGEEDKLENEAQKILGSLNADATAFDEQKGLTVGATCTRVGVTDGHMAFVSLRFKNRPGPSAEEVKQAMREYQSEAQKLGCPSAPREAIKVFDEPDRPQPRLDRDISKGYTVSVGRVREAAPGSYFDLRFAALSHNTVIGAAGSSILNAEVAVIKGYI,aspartate-semialdehyde dehydrogenase (1.2.1.11) (0.9495),threonine biosynthetic process (GO:0009088) (0.7632); methionine biosynthetic process (GO:0009086) (0.3946); 'de novo' L-methionine biosynthetic process (GO:0071266) (0.3107); lysine biosynthetic process via diaminopimelate (GO:0009089) (0.2195); isoleucine biosynthetic process (GO:0009097) (0.2073); diaminopimelate biosynthetic process (GO:0019877) (0.2021); homoserine biosynthetic process (GO:0009090) (0.1519),cell surface (GO:0009986) (0.2412); plasma membrane (GO:0005886) (0.1863); extracellular region (GO:0005576) (0.0960),aspartate-semialdehyde dehydrogenase activity (GO:0004073) (0.2177); protein homodimerization activity (GO:0042803) (0.1753); NADP binding (GO:0050661) (0.1668); protein dimerization activity (GO:0046983) (0.1641); NAD binding (GO:0051287) (0.1481),"Aspartate-semialdehyde dehydrogenase-related (IPR051823) (0.6966); Aspartate-semialdehyde dehydrogenase, conserved site (IPR000319) (0.4532); Semialdehyde dehydrogenase, dimerisation domain (IPR012280) (0.2774); Semialdehyde dehydrogenase, NAD-binding (IPR000534) (0.2242); Aspartate-semialdehyde dehydrogenase, peptidoglycan lacking (IPR005676) (0.1679); NAD(P)-binding domain superfamily (IPR036291) (0.1062)",3.40.50.720 (0.2831),Threonine biosynthesis (0.9329); Oxidoreductase (0.4954); Methionine biosynthesis (0.4910); Amino-acid biosynthesis (0.2744); NADP (0.2272); Lysine biosynthesis (0.1931); Reference proteome (0.1142),
MTFNGRFRATLRGINIRNASMTSLSLTGSHAQKQTVLGSTPGALGTIPTVALNGVNPLPRYRHNLLFGTLSFGDRWDRIQRRLAVLGRASTGNVVVPFSDSADAFRRMWESVDSASDSVLWQTYICKDDFVGQKTVKKLEEAHRRGCKTELLYDCGGNITGRRRLVGDLKKSGANVIEHRPMWEHFFPYFLRGMKWELSPGIRNHRKILIVDNKLGFCGGLNIGDEYCGTSEGGNGRFRDTHCVVMGPAVMHMREVYEDTKAPKPWKWSLARWRQIASATMNLRYLEGMNVKHDYLEPTTTFVRQGGGVYLRRQMERAERSTVRMMERMRWKRQRERLNRCLLTLAKNLREGQGLVFKAATGKGDDVATTDAGSKRNNEVSHGQWKLMKRRIDEYRQRAIKNAEESFFRRLRVVNPSMRLLEDTSPVAEAEAYGQAHAAVTQVLSCNPHSRDWSIPYAFWQVSKFVHQRLWVTTPYYMPHRKLMRALQLAARRGVDVRILAGSNRTTDPWFMWYASNYITGMLMASGVRVYEYKGGQVMHAKTVVADSIWTSIGSYNWDMMSNKNMEICVCHLDHNLALTMEKQFLDDMNVSEEVNYEEYQRRSLWLRFSSWFFYTALRIAEKFTFRTFWDPDLSSEID,2.7.8.- (0.4941); CDP-diacylglycerol-glycerol-3-phosphate 1-phosphatidyltransferase (2.7.8.5) (0.3562),cardiolipin biosynthetic process (GO:0032049) (0.3810); phosphatidic acid biosynthetic process (GO:0006654) (0.1031); lipid catabolic process (GO:0016042) (0.0829); glycerophospholipid biosynthetic process (GO:0046474) (0.0545); phospholipid catabolic process (GO:0009395) (0.0424),,ATP binding (GO:0005524) (0.0907),Phospholipase D-like domain (IPR025202) (0.2986); Phospholipase D/Transphosphatidylase (IPR001736) (0.1124),3.30.870.10 (0.3880),Repeat (0.6748); Transmembrane (0.4988); Lipid metabolism (0.4644); Membrane (0.3300); Mitochondrion (0.3111); Lipid biosynthesis (0.2850); Reference proteome (0.2593); Phospholipid metabolism (0.1348); Transit peptide (0.1304); Mitochondrion inner membrane (0.1278); Zinc (0.1106); Transferase (0.1013); Hydrolase (0.0753),
MSVKKAGVLGATGSVGQRFILLLSKHPEFEIHALGASSRSAGKKYKDAASWKQTETLPETEQDIVVQECKPEGNFLECDVVFSGLDADVAGDIEKSFVEAGLAVVSNAKNYRREKDVPLVVPIVNPEHIDVVENKVKQAVSKGGKKPGFIICISNCSTAGLVAPLKPLVEKFGPIDALTTTTLQAISGAGFSPGVSGMDILDNIVPYISGEEDKLEWETKKILGGVNAEGTEFVPIPESEMKVSAQCNRVPVIDGHTECISLRFANRPAPSVEDVKQCLREYECAASKLGCHSAPKQTIHVLDQPDRPQPRLDRDRDSGYGVSVGRIREDSLLDFKMVVLSHNTIIGAAGAGILIAEILKAKNII,aspartate-semialdehyde dehydrogenase (1.2.1.11) (0.9937),threonine biosynthetic process (GO:0009088) (0.6812); methionine biosynthetic process (GO:0009086) (0.6019); lysine biosynthetic process via diaminopimelate (GO:0009089) (0.3638); homoserine biosynthetic process (GO:0009090) (0.2941); 'de novo' L-methionine biosynthetic process (GO:0071266) (0.2237); diaminopimelate biosynthetic process (GO:0019877) (0.1945); isoleucine biosynthetic process (GO:0009097) (0.1056),cell surface (GO:0009986) (0.3119); plasma membrane (GO:0005886) (0.1188); cytosol (GO:0005829) (0.1032); membrane (GO:0016020) (0.0730); cytoplasm (GO:0005737) (0.0711),NADP binding (GO:0050661) (0.4278); aspartate-semialdehyde dehydrogenase activity (GO:0004073) (0.2507); NAD binding (GO:0051287) (0.2010); protein dimerization activity (GO:0046983) (0.0905),"Aspartate-semialdehyde dehydrogenase-related (IPR051823) (0.4934); Aspartate-semialdehyde dehydrogenase, conserved site (IPR000319) (0.4878); Semialdehyde dehydrogenase, dimerisation domain (IPR012280) (0.4542); Semialdehyde dehydrogenase, NAD-binding (IPR000534) (0.1844); NAD(P)-binding domain superfamily (IPR036291) (0.1392)",3.40.50.720 (0.3705),Threonine biosynthesis (0.9634); Oxidoreductase (0.4396); Methionine biosynthesis (0.4123); Lysine biosynthesis (0.3068); Amino-acid biosynthesis (0.2695); NADP (0.2215); Reference proteome (0.2015),
MTVKVRFDKEVREYAKGEKVKDSVLKITETALAQALEKFHRRMIVIEGDTLKKAELAGILAGASARVLSDIVGELIEKRLRDESEDKIEVLYATDALGEETFGRKRYEAFRKHFDVLAGSEVNVTAVTFKHTREILGRTYDLLILDMSYDYSPNDLGRIIETVRGGGLIFILAHPFEKWKDMWTGFHKSLVTPPYTIEDVKKRFNRRLIRKFTQHDGIYIITESGKAKKKPKKSKSQAKIRARKGVEIPEETLFPKELYEMALTRGQVEVLKAFEELVDKEGMLVLTADRGRGKSVSVGIAAIGLAVALKKRTRIVVTAPELENVQSLFRFAKRALEKLGFKPYVVEEKGLIKELYARKIGLRYYPPAEGYKKNADLYILDEAAGIHVPILHKYLNKPRVVYSSTIHGYEGAGRGFSVKFLKKAREKRSFKELHMEEPIRYAYGDPIEKWLFDVLLLDAEPVELTEEDYELIKRKEVYLEEPDLDDWFENDREDLRHFVGIYILAHYRNRPSDVALLADAPHHEARVLRLKNGKIVTAVQIAKEGGIPKNVIDKMAKGYKPRGNIIPDMMVKHHYLKEFARLKGYRIVRIATHPDAMDMGLGSKALELLEKEAREKGLDWIGSGFGASEELVRFWVRNGFAVVHLSPARNPVSGEFTAIVLKPISKKAKELIKKANDEFRIRFTEWLGDTHRELEPEIARWLFETPFGEAVDYPIHLTEIQKKRLDAFTGKVLTYDTVVDAVKPIVKLYFLDGWMKPYLDERQIKLLIYRVLQAHSWEETAKLIDRTEMFTMIEVRDIIRGLWYYYKRLLT,tRNAMet cytidine acetyltransferase (2.3.1.193) (0.9331); 2.3.1.- (0.0447),tRNA wobble cytosine modification (GO:0002101) (0.9001); tRNA acetylation (GO:0051391) (0.8393); rRNA acetylation involved in maturation of SSU-rRNA (GO:1904812) (0.4350); DNA conformation change (GO:0071103) (0.3127); rRNA processing (GO:0006364) (0.0480),cytoplasm (GO:0005737) (0.5071),"tRNA N-acetyltransferase activity (GO:0051392) (0.6889); tRNA binding (GO:0000049) (0.6794); rRNA cytidine N-acetyltransferase activity (GO:1990883) (0.5897); ATP binding (GO:0005524) (0.5723); catalytic activity, acting on DNA (GO:0140097) (0.0427)","GNAT domain (IPR000182) (0.7310); Acyl-CoA N-acyltransferase (IPR016181) (0.4527); tRNA(Met) cytidine acetyltransferase TmcA, N-terminal (IPR013562) (0.3934); TmcA/NAT10/Kre33 (IPR032672) (0.3367); Helicase domain (IPR007807) (0.2632); Possible tRNA binding domain (IPR027992) (0.2234); tRNA(Met) cytidine acetyltransferase TmcA (IPR024914) (0.1624)",3.40.630.30 (0.5967); 3.40.50.11040 (0.5707); 3.40.50.300 (0.0851),tRNA-binding (0.9752); tRNA processing (0.9202); rRNA processing (0.8707); Nucleotide-binding (0.5574); Cytoplasm (0.4669); RNA-binding (0.4131); Acyltransferase (0.3503); ATP-binding (0.2572); Reference proteome (0.0697),
MSPRPQIKVGVLGATGTVGQRFIELLAAHPYFALHALGASSRSAGQQYARVVRWKLPSPIPDAVRHMVVHECRPDAPGFAECGVVFSGLDADVAGDIENAFRAADLVVYSNAKNYRRDPLCPLIVPLVNPSHLSIIPYQREQLGLKKGYIVTNANCSTTGIVVPLAALEKAFGPLDTVIVTTLQAISGAGYPGVSSLDIMDNVVPLISGEEDKIEWETNKILGGVTPDNKAFDLHAPKQINVSATCTRVPVIDGHTGCVSVKFARSPPPSVAEVENAFREYTCDAQHLGVPSAPAQAIVVHDAPDRPQPRLDKNLHNGACVSVGRIRECPVFDIKFVCLIDNVRLGAATSSIINAEIAVEKGLIQ,aspartate-semialdehyde dehydrogenase (1.2.1.11) (0.9849),threonine biosynthetic process (GO:0009088) (0.7025); lysine biosynthetic process via diaminopimelate (GO:0009089) (0.4827); methionine biosynthetic process (GO:0009086) (0.4430); homoserine biosynthetic process (GO:0009090) (0.2975); 'de novo' L-methionine biosynthetic process (GO:0071266) (0.2859); diaminopimelate biosynthetic process (GO:0019877) (0.1580); isoleucine biosynthetic process (GO:0009097) (0.0980),cell surface (GO:0009986) (0.2085); plasma membrane (GO:0005886) (0.1767); cytosol (GO:0005829) (0.0771),NADP binding (GO:0050661) (0.3881); aspartate-semialdehyde dehydrogenase activity (GO:0004073) (0.3430); NAD binding (GO:0051287) (0.1192); protein dimerization activity (GO:0046983) (0.0732),"Aspartate-semialdehyde dehydrogenase-related (IPR051823) (0.5807); Semialdehyde dehydrogenase, dimerisation domain (IPR012280) (0.4723); Aspartate-semialdehyde dehydrogenase, conserved site (IPR000319) (0.3386); Aspartate-semialdehyde dehydrogenase, peptidoglycan lacking (IPR005676) (0.2713); NAD(P)-binding domain superfamily (IPR036291) (0.1245)",3.40.50.720 (0.3534),Threonine biosynthesis (0.9536); Methionine biosynthesis (0.5885); Oxidoreductase (0.4439); Reference proteome (0.2985); NADP (0.2258); Amino-acid biosynthesis (0.2186); Lysine biosynthesis (0.1519),
MALVRFATIITVLCHLAIQDGAAKSFPHGEKAPFPLTLIHINDLHARFDETNQKSSTCTNSKECIAGIARVYHTIKQLKSEYKTKNPLYLNAGDNFQGTLWYNLLRWNVTAYFIKELPPDAMTLGNHEFDHSPKGLAPYLAELEKMKIPTVVANLEKNGEPALKDSKIARSIVLKVGNRKVGVIGALYDKTHLVAQTGMVTLTNSIEAVRKEAQELKKKNVNIIVVLSHCGLDGDKQLAEEAGDLIDVIVGAHSHSLLLNKDAKVPYDTKYDTIEGDYPLVVKKSNNHTVLITQARSFGKYVGRLTVNFDCEGEVQSWEGYPIYMNNSVKQDEEVLRELEPWRAEVKRLGTQVIGTTEVFLDRESCRWCECTLGDLIADAYADQYTNSTVQPVAFVQAGNFRNPIEKGDITNGLAIEAAPYGSSVDMIKLSGADLWSAIDHSFTLDDEFRYNTAQVSGMAVVADLSKKPYERVQSIDIVGANGAKTALKKDQIYYVVVPSYLADGKDGFAMLKKGTNRVTGPLDSDVLIEYVRKRQTIAKTMFQEKRVVIENHTNGTCSWDLDSQRYKPK,3.1.-.- (0.2847); apyrase (3.6.1.5) (0.1899); 5'-nucleotidase (3.1.3.5) (0.0971),AMP catabolic process (GO:0006196) (0.8711); defense response to Gram-negative bacterium (GO:0050829) (0.1268); determination of adult lifespan (GO:0008340) (0.1059),plasma membrane (GO:0005886) (0.3322); extracellular region (GO:0005576) (0.1277),metal ion binding (GO:0046872) (0.3401); apyrase activity (GO:0004050) (0.2344); nucleotidase activity (GO:0008252) (0.2174); 5'-nucleotidase activity (GO:0008253) (0.2040); nucleotide binding (GO:0000166) (0.0706),"Calcineurin-like phosphoesterase domain, ApaH type (IPR004843) (0.6757); Metallo-dependent phosphatase-like (IPR029052) (0.4945); 5'-Nucleotidase, C-terminal (IPR008334) (0.4718); 5'-Nucleotidase, conserved site (IPR006146) (0.3171); 5'-Nucleotidase, C-terminal domain superfamily (IPR036907) (0.1971); 5'-Nucleotidase/apyrase (IPR006179) (0.1911)",3.60.21.10 (0.3804); 3.90.780.10 (0.2644),Nucleotide-binding (0.6386); Hydrolase (0.5428); Zinc (0.4694); Signal (0.4011); Metal-binding (0.3976); Lipoprotein (0.3315); Reference proteome (0.3127); tRNA processing (0.2250); 3D-structure (0.2101); GPI-anchor (0.1830); Direct protein sequencing (0.1805); Platelet aggregation inhibiting toxin (0.1621); Disulfide bond (0.1600); Cell membrane (0.1040); Glycoprotein (0.1029); Secreted (0.0944),Zn(2+) (0.2204)
MRPNLFSGASRLLTYSRNGKLLTRGRSTKATSSSLDSQHQDAATTEGGRAESVEESPEQQRKLPTREPLAKNFFIGVVDKELLAYPEVIPRDEMAQLENSLLPLKNYFVEPRETEETSPETLRQLGLYGLNVSTDYEGKGYGWSASLMASEPDSTDINVTLGLQTHRVVVDLLKEVGTPLQQQRYLQDLATGKLIGTEAIYEISPPEEDYFNTTAELFPEYGKWQLNGEKSFVICTPGERQLFLVLAQTQQPNVPGVLGRGTTIFLVDSQQEGVRLGEKHATFGCRKAEIRRVHFEGVKLGEDQVVGLPHDGNRYSEQLVRSSRLRGSLVGLSLAKKLLNELAQYTVNTTQCGVQLQDLELTRIHMSRAMCSVYAMESMLYLTAGLLDEFRAQDVTLESAITKYFTLRQVYAIASQNLGVVGPKSLLSGETTELGLRDAAQLCTQGESLDTLGMFIALTGLQHAGQAMNTGVRKSRNPLFNPGHIFGKFLDNNSIDNPKTKMQLSEHVHPSLEAAAQCIELSVARLQMAVELMFTKHGNAVVERQSEMQRLAEVGTLIYAMWASVARASRSYCIGLPLADHELLTATAICSEGRDRVRTLCTEIYGGHFVNNDNNLVRLSKQVAKSKGYFAVHPLTFNF,,generation of precursor metabolites and energy (GO:0006091) (0.2907); negative regulation of cellular response to oxidative stress (GO:1900408) (0.1608); intracellular protein transport (GO:0006886) (0.1333); fatty acid catabolic process (GO:0009062) (0.1281); compound eye morphogenesis (GO:0001745) (0.1137); cerebral cortex development (GO:0021987) (0.0982); lipid metabolic process (GO:0006629) (0.0663); brain development (GO:0007420) (0.0648); centrosome cycle (GO:0007098) (0.0579),mitochondrion (GO:0005739) (0.2110); nucleus (GO:0005634) (0.1584); nucleoplasm (GO:0005654) (0.1513); cytoplasm (GO:0005737) (0.1377); mitochondrial matrix (GO:0005759) (0.0900),flavin adenine dinucleotide binding (GO:0050660) (0.2987); identical protein binding (GO:0042802) (0.1466),"Acyl-CoA oxidase/dehydrogenase, middle domain (IPR006091) (0.3278); ACAD9/ACADV-like, C-terminal domain (IPR049448) (0.3172); Acyl-CoA dehydrogenase/oxidase, C-terminal (IPR009075) (0.2540); Acyl-CoA dehydrogenase/oxidase, N-terminal (IPR013786) (0.1722); Acyl-CoA oxidase/dehydrogenase, middle domain superfamily (IPR046373) (0.1688)",1.20.140.10 (0.3158); 2.40.110.10 (0.1148),Reference proteome (0.8323); Mitochondrion (0.5021); Oxidoreductase (0.2068); Flavoprotein (0.1978); Mitochondrion inner membrane (0.1621); Phosphoprotein (0.1588); Transit peptide (0.0667),FAD (0.3375)
MIVIMKAGFLFLASLCLLVQAVPNKVADKTYVTRQKNIYELFWHVDQPTVYHPELYQKARTFNLVENLDNYNDKEAVNEFMQLLKHGMLPRGQVFTMMNKEMRHQAVVLFRLLYSAKTFDVFYNTAVWARFNVNEQMYLYALSVAVIHRPDTKLMKLPPMYEVMPHLYFNDEVMQKAYNIAMGDTADMKKTYNNIDYYLLAANYTGWYLTKHNVPEQRLNYFTEDVGLNHFYFMLNHNYPPFMLSNSLNFPQIRGEFYFFLHKQVLNRYYLERLSNDMGEVSYVSLDHPIPTGYYPTMRFRNGLAFPQRETGATVPLHMQKYVQMIHDLHTRISTAIDLGYVVDSYGNHVKLYTKQGLNVLGNIVQGNGDSVNVQLYGQLDLLVRKVLGFGYESNVKYQVVPSALQMWSTSLRDPVFFSIYKTILDYYHKYKENLPKYTTEELNFPGVSIESVTVDKLITYFDHFESMLNNGVSIQSHAKAKNTMIKARQYRLNHKPFTYHIVVNSDKNVKGMVRIFLGPKYDEFGHEVDLVHNYMNFMQMDEFVVNLKSGSNTIERNSHESVFVVPDEVPSDVLYNRLVVSEDGSETFKYSSQPYGFPERLLLPKGKKEGMPYNVLVVVSPFDDSNVVQIDSPVWGRHIYDGRAMGFPLDKPVDPLLLVLSNIHVKEVLVHHREMEELNVAL,,motor neuron axon guidance (GO:0008045) (0.2790); synaptic target inhibition (GO:0016201) (0.2716); synaptic target recognition (GO:0008039) (0.1635); negative regulation of gene expression (GO:0010629) (0.1011); melanin metabolic process (GO:0006582) (0.1008); response to wounding (GO:0009611) (0.0506),larval serum protein complex (GO:0005616) (0.0799); cell surface (GO:0009986) (0.0746),GO:0045735 (0.3415),"Immunoglobulin E-set (IPR014756) (0.3842); Hemocyanin, C-terminal (IPR005203) (0.3027); Hemocyanin/hexamerin (IPR013788) (0.2259); Hemocyanin, N-terminal (IPR005204) (0.1919); Hemocyanin, N-terminal domain superfamily (IPR036697) (0.1696); Hemocyanin, C-terminal domain superfamily (IPR037020) (0.1194); Hemocyanin/hexamerin middle domain (IPR000896) (0.1105)",1.20.1370.10 (0.4632); 2.60.40.1520 (0.2569),Storage protein (0.8446); Secreted (0.3564); Glycoprotein (0.3442); Signal (0.2794); Direct protein sequencing (0.2662); Reference proteome (0.1772); 3D-structure (0.1135); Metal-binding (0.0830); Sulfation (0.0627); Transport (0.0555),
MGKEQKEKKDGNLSIKEEVEKELNKKSTAELFRKIKNEKISFFLPFKCLPAQHRKLLFISFVCAVLSGGTLPFFISVFGVILKNMNLGDDINPIILSLVSIGLVQFILSMISSYCMDVITSKILKTLKLEYLRSVFYQDGQFHDNNPGSKLRSDLDFYLEQVSSGIGTKFITIFTYASSFLGLYIWSLIKNARLTLCITCVFPLIYVCGVICNKKVKLNKKTSLLYNNNTMSIIEEALMGIRTVASYCGEKTILNKFNLSETFYSKYILKANFVEALHIGLINGLILVSYAFGFWYGTRIIINSATNQYPNNDFNGASVISILLGVLISMFMLTIILPNITEYMKALEATNSLYEIINRKPLVENNDDGETLPNIKKIEFKNVRFHYDTRKDVEIYKDLSFTLKEGKTYAFVGESGCGKSTILKLIERLYDPTEGDIIVNDSHNLKDINLKWWRSKIGVVSQDPLLFSNSIKNNIKYSLYSLKDLEAMENYYEENTNDTYENKNFSLISNSMTSNELLEMKKEYQTIKDSDVVDVSKKVLIHDFVSSLPDKYDTLVGSNASKLSGGQKQRISIARAIMRNPKILILDEATSSLDNKSEYLVQKTINNLKGNENRITIIIAHRLSTIRYANTIFVLSNRERSDNNNNNNNDDNNNNNNNNNNKINNEGSYIIEQGTHDSLMKNKNGIYHLMINNQKISSNKSSNNGNDNGSDNKSSAYKDSDTGNDADNMNSLSIHENENISNNRNCKNTAENEKEEKVPFFKRMFRRKKKAPNNLRIIYKEIFSYKKDVTIIFFSILVAGGLYPVFALLYARYVSTLFDFANLEYNSNKYSIYILLIAIAMFISETLKNYYNNKIGEKVEKTMKRRLFENILYQEMSFFDQDKNTPGVLSAHINRDVHLLKTGLVNNIVIFSHFIMLFLVSMVMSFYFCPIVAAVLTFIYFINMRVFAVRARLTKSKEIEKKENMSSGVFAFSSDDEMFKDPSFLIQEAFYNMHTVINYGLEDYFCNLIEKAIDYKNKGQKRRIIVNAALWGFSQSAQLFINSFAYWFGSFLIKRGTILVDDFMKSLFTFIFTGSYAGKLMSLKGDSENAKLSFEKYYPLMIRKSNIDVRDDGGIRINKNLIKGKVDIKDVNFRYISRPNVPIYKNLSFTCDSKKTTAIVGETGSGKSTFMNLLLRFYDLKNDHIILKNDMTNFQDYQNNNNNSLVLKNVNEFSNQSGSAEDYTVFNNNGEILLDDINICDYNLRDLRNLFSIVSQEPMLFNMSIYENIKFGREDATLEDVKRVSKFAAIDEFIESLPNKYDTNVGPYGKSLSGGQKQRIAIARALLREPKILLLDEATSSLDSNSEKLIEKTIVDIKDKADKTIITIAHRIASIKRSDKIVVFNNPDRNGTFVQSHGTHDELLSAQDGIYKKYVKLAK,xenobiotic-transporting ATPase (3.6.3.44) (0.2394); 7.-.-.- (0.1717); ABC-type xenobiotic transporter (7.6.2.2) (0.1082); 7.2.2.- (0.0743),transmembrane transport (GO:0055085) (0.2387),cytoplasm (GO:0005737) (0.1157); fungal-type vacuole membrane (GO:0000329) (0.1144); early endosome membrane (GO:0031901) (0.0804); membrane (GO:0016020) (0.0732); mitochondrion (GO:0005739) (0.0444),ATP hydrolysis activity (GO:0016887) (0.4126); ATP binding (GO:0005524) (0.2812); ABC-type xenobiotic transporter activity (GO:0008559) (0.1782); ATPase-coupled transmembrane transporter activity (GO:0042626) (0.1587); ABC-type transporter activity (GO:0140359) (0.0827),"ABC transporter-like, ATP-binding domain (IPR003439) (0.4260); ABC transporter type 1, transmembrane domain superfamily (IPR036640) (0.3361); Type 1 protein exporter (IPR039421) (0.2170); AAA+ ATPase domain (IPR003593) (0.1941); P-loop containing nucleoside triphosphate hydrolase (IPR027417) (0.1871); ABC transporter type 1, transmembrane domain (IPR011527) (0.1324)",1.20.1560.10 (0.2047),Transmembrane (0.5727); Transmembrane helix (0.4565); Nucleotide-binding (0.3432); Transport (0.3295); Reference proteome (0.3064); Membrane (0.2870); Repeat (0.2532); Mitochondrion outer membrane (0.1661); ATP-binding (0.0925),
MRSFYNKCFTNKLISAHSLFCQHVSTLKNNKKECFEDVKRSNRISDEFYSSFLYHSYIENLKSTKEYVYFIYLQDIYYNINIFKNKGRLYISNNGLCNDKLKDNNNNNNINSNNFGNSYNAYTKKKSFYHSFNDLNEAKEIRKKRKNEKSEKNIVEYLLCNIINPNENYHIQNIYNHNLNNNVSIEIHKKNDSVMYHYNNEKKTKTSKMTTDIKLKQINNVYIKYVPYKNKIITLACPNKYYPTLYRYFSSHTNKKEDAEENDKNKNININNVDNRYKEDFMYGCENKNDSEKHKKTTNNNFGDEFEKLKVKELDKILNKLEMLYDNKNNKMNINVKILGYIFKNFLLKNKELKRKIFCSLFFLLCSKMAIIYTPILLSTFIENVNLQKSLSNNIDIYSTNKSSVLLLCAYVFSRVLSSTMNELRNSVFSNISQKISTFVSKLFFYKIHNLNLTYILSKKNGELSFIFNRGCKSITNLLNVMVFQIIPIIIEFILYLYILTYKIHYTVSLVTCFNMFLYVLFTTLITKRRTIIRKHMNKAEQNTFNIFLDSIQNVEQVKYYTNEIHELKKFIKEQKKYEKEAINVQKSLSFLNFGQQIILNTNLFLCMYLTYLNIANDIFPFSYLILVNTLLFQLAMPLNMFGTIYRETKLSLVDIESMIKILVKKIKSPDYGNQMLIKNGNIKFENVYFKYPLNEDINGLEQNYQAKEKDPNIINNINNINNINNINNINNINSINNIYTFESNVKNISSTNMITSSINKLKKWYLDKVKDNKKNVQYNNNDVKKTNPNITKNLNKEIKENINTHLKNHKIINNSPNYNNNNYLFQNFTCNIENGEKVAIIGKSGSGKSSLIKLLLKFYEVNSGNIYIDNKNIDDIDLYTLRKNISVVPQDTILFNNTISYNIKYGNFQCTDKQMIQASIKAELHDKIMKMENKYDTIVGERGTKLSIGEKQRICIARCFLKDSKIIVLDEHASNLDNENKKAIEKALTKLCMGKTTFIITHVMENLKHMDKIIFFCGKNIYVGSHKNLMDDNHFYREYYDSKNNKML,7.-.-.- (0.5879); ABC-type heme transporter (7.6.2.5) (0.0405),intracellular iron ion homeostasis (GO:0006879) (0.2901); transmembrane transport (GO:0055085) (0.2166); mitochondrial cytochrome c oxidase assembly (GO:0033617) (0.1482); bacteriocin transport (GO:0043213) (0.0926),mitochondrial inner membrane (GO:0005743) (0.1502); Golgi membrane (GO:0000139) (0.0992); mitochondrion (GO:0005739) (0.0802); Golgi apparatus (GO:0005794) (0.0678); late endosome membrane (GO:0031902) (0.0409),ATP hydrolysis activity (GO:0016887) (0.5120); ATP binding (GO:0005524) (0.2506); ABC-type transporter activity (GO:0140359) (0.1985); ABC-type xenobiotic transporter activity (GO:0008559) (0.0452),"ABC transporter type 1, transmembrane domain superfamily (IPR036640) (0.4187); Type 1 protein exporter (IPR039421) (0.3614); ABC transporter-like, ATP-binding domain (IPR003439) (0.3556); ABC transporter type 1, transmembrane domain (IPR011527) (0.2348); P-loop containing nucleoside triphosphate hydrolase (IPR027417) (0.1222)",1.20.1560.10 (0.1959); 3.40.50.300 (0.1688),Transmembrane (0.8320); Transmembrane helix (0.3358); Transport (0.3064); Nucleotide-binding (0.2746); Membrane (0.2326); Mitochondrion inner membrane (0.2180); Reference proteome (0.1911); Repeat (0.1643); ATP-binding (0.1544); Bacteriocin transport (0.1153); Zinc (0.1140),
MKSLVAHFSTPLITARLVPRCIIHRASISAVSFSTVRRRFSPLTMASAAQSSSQAVSYGSGNSDTDVFKLIQAHEEKAARLSPVEEIRTVLNGSICGMLSTFSQKYEGYPSGSMVDFACDADGSPILAVSSLAVHTKDLLANPKCSLLIARDPEDRTGLRITLHGDAVLVSEKDQAAVRSAYLAKHPKAFWVDFGDFSFMRIEPKVVRYVSGVATAFLGSGEFSKEEYQAAKVDPIAQYAKPVTSHMNKDHEEDTKAIVHNITSIPVESALMLDLDSLGFNVKATLQGNTFKLRVPFPRRAQDRKDVKTLIVEMLQAAKSN,chalcone isomerase (5.5.1.6) (0.1360),photosynthetic electron transport chain (GO:0009767) (0.3726); heme catabolic process (GO:0042167) (0.1841); flavonoid biosynthetic process (GO:0009813) (0.0430),chloroplast stroma (GO:0009570) (0.3359); cytosol (GO:0005829) (0.2781); chloroplast (GO:0009507) (0.2058); mitochondrion (GO:0005739) (0.1391),metal ion binding (GO:0046872) (0.0667),Haem oxygenase HugZ-like superfamily (IPR037119) (0.2681); Domain of unknown function DUF2470 (IPR019595) (0.2347); FMN-binding split barrel (IPR012349) (0.1838),3.20.180.10 (0.2562),Iron (0.7724); Reference proteome (0.5924); Metal-binding (0.3516); Isomerase (0.2981); Direct protein sequencing (0.1920); Chloroplast (0.1885); Heme (0.1156); Proteomics identification (0.1131); 3D-structure (0.1046); Oxidoreductase (0.0618),
MLPKVESEYLGLARSHGEQGHMPGNMQAPQFKMMDYSYDEDLDEMCPVCGDKVSGYHYGLLTCESCKGFFKRTVQNNKRYTCIENQSCQIDKTQRKRCPYCRFQKCLTVGMKLEAVRADRMRGGRNKFGPMYKRDRALKQQKKALIRANGLKLEAMTQVMQTVPADLTITSAIQNIHSASKGLPLSHHHHHHHHHHHHSSSSAGLPPADFDRSPFVTSPVSMAMPPHAGGLQGYQAYGHFQSRTIKSEYPDPYTSSPESLMGYPYVEAYAGGSPPSFPHLVVELLKCEPDEPQVQAKILAYLQQEQASRGKHEKLNTFGLMCKMADQTLFSIVEWARSSIFFRELKVDDQMKLLQNCWSELLILDHVFRQVMHAKEGSILLVTGQQVDYALIASQAGATLNNLLSHAQELVSKLRSLQLDQREFVCLKFLVLFSLDVKNLENFHLVESVQEQVNAALLDYVMCNYPQQTDKFGQLLLRLPEIRAISLQAEEYLYYKHLNGDVPCNNLLIEMLHAKRA,,hormone-mediated signaling pathway (GO:0009755) (0.3545); positive regulation of viral genome replication (GO:0045070) (0.2656); tissue development (GO:0009888) (0.2539); cellular response to leukemia inhibitory factor (GO:1990830) (0.2450); pancreas morphogenesis (GO:0061113) (0.2072); bile acid metabolic process (GO:0008206) (0.1816); regulation of transcription by RNA polymerase II (GO:0006357) (0.1633); positive regulation of transcription by RNA polymerase II (GO:0045944) (0.0865),RNA polymerase II transcription regulator complex (GO:0090575) (0.2155); cytoplasm (GO:0005737) (0.1380),RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978) (0.2577); nuclear receptor activity (GO:0004879) (0.2149); zinc ion binding (GO:0008270) (0.1166); chromatin binding (GO:0003682) (0.1128); DNA binding (GO:0003677) (0.0928); transcription coregulator binding (GO:0001221) (0.0853),"Nuclear hormone receptor family 5-like (IPR016355) (0.4972); Zinc finger, NHR/GATA-type (IPR013088) (0.2977); Nuclear hormone receptor-like domain superfamily (IPR035500) (0.2413); Nuclear hormone receptor, ligand-binding domain (IPR000536) (0.1647); Zinc finger, nuclear hormone receptor-type (IPR001628) (0.1641); Nuclear hormone receptor (IPR001723) (0.1508)",1.10.565.10 (0.3850); 3.30.50.10 (0.2977),Zinc-finger (0.9860); Ubl conjugation (0.9092); Transcription (0.7371); Receptor (0.5584); Reference proteome (0.5526); Nucleus (0.5368); Transcription regulation (0.4820); Metal-binding (0.4570); DNA-binding (0.2700),
MKSLIGTLGLYCLFILTNNVVSSYGDDLYPLTIMHTNDFHARFEETNVKGNPCKSGEKCIGGLARVLHTIKKIIKEQEKKNIESLYINAGDNFQGTIWYNIGRWNVTSELMNIQPPDVMVLGNHEFDHGIDGLLPFLNNMDKTEIVVANMDARDEPQVAKKIKPFTIIKKKYRNIGVIGVVVEEVPDLANTGKLKFRNESEAILEAARNLKKEDPSVNIIIVVSHVGFDVDKIIAERTGSEVDIIVGGHSHTVLYTGTPPGPEKPEDNYPYVYNHPSGNKVLVVQAVCHAKYVGNLTVFFDKKGKVVTYEGAPIYMDTKVEQDKDVLEAMKPWRKLIDEKTKLVVGRTNVDLPRDICRSEECALGNLYTDSMIYAFGGKENCKSGSTWTTAPIAFVHAGAMRSSLHQGDILYSDALLLSPFTNMVVAYDLPGAQLKAALEFSAAPKNEDEKRRFLQMSGLKVTYNMSRAANNRIVDLKVRTNVCPYDQYENLDEKKTYRVVSPSFLQGGGDGFKMLRDYAKNIQNQKIDLDALVDYLKKFSPLAPKAEGRITIIH,3.1.-.- (0.5062); 5'-nucleotidase (3.1.3.5) (0.0940); 3.-.-.- (0.0590),AMP catabolic process (GO:0006196) (0.9083); defense response to Gram-negative bacterium (GO:0050829) (0.1489); determination of adult lifespan (GO:0008340) (0.0717),plasma membrane (GO:0005886) (0.4396); extracellular region (GO:0005576) (0.1318),5'-nucleotidase activity (GO:0008253) (0.2469); metal ion binding (GO:0046872) (0.2214); nucleotide binding (GO:0000166) (0.2152); nucleotidase activity (GO:0008252) (0.1659); apyrase activity (GO:0004050) (0.1457),"Calcineurin-like phosphoesterase domain, ApaH type (IPR004843) (0.7138); Metallo-dependent phosphatase-like (IPR029052) (0.5521); 5'-Nucleotidase, C-terminal (IPR008334) (0.4539); 5'-Nucleotidase, conserved site (IPR006146) (0.2610); 5'-Nucleotidase/apyrase (IPR006179) (0.1392); 5'-Nucleotidase, C-terminal domain superfamily (IPR036907) (0.1315)",3.60.21.10 (0.3020); 3.90.780.10 (0.2589),Nucleotide-binding (0.7822); Zinc (0.6781); Hydrolase (0.5887); Metal-binding (0.4199); Signal (0.3558); Direct protein sequencing (0.3019); Lipoprotein (0.2318); 3D-structure (0.1908); Reference proteome (0.1720); Disulfide bond (0.1485); ATP-binding (0.1395); Platelet aggregation inhibiting toxin (0.0920); tRNA processing (0.0814); Glycoprotein (0.0788); GPI-anchor (0.0773); Secreted (0.0617),Zn(2+) (0.2692)
MLTIGQLARIFEISTKTLRHYDAIGLFVPARTGSDNGYRYYQPEQIEQLSRILALRRLDVPLEAIDRLKRDGALDDPQRLRHFLQRHQHTLREEISARQRLLAELDRTLATLAHWRIRNMHARIVERPAFSVVGMEYFGSAPGDTIGQLWERFIPREHEIAGKHDPEVSYGICAQQPNGEFHYVAGFEVQEGWPVPEGMVRFQVPAQKYAVFTHKGTAPQIAESFQAIYSHLLAERGLEPKAGVDFEYYDQRFRGPLDPNSQVDLYIPIY,,response to toxic substance (GO:0009636) (0.2712); regulation of DNA-templated transcription (GO:0006355) (0.2529); chromosome segregation (GO:0007059) (0.1185); chromosome condensation (GO:0030261) (0.0910); cellular response to unfolded protein (GO:0034620) (0.0891); protein tetramerization (GO:0051262) (0.0842); mucosal immune response (GO:0002385) (0.0678); nucleosome assembly (GO:0006334) (0.0402),cytoplasm (GO:0005737) (0.8262); cytosol (GO:0005829) (0.0634),"identical protein binding (GO:0042802) (0.2150); protein homodimerization activity (GO:0042803) (0.1808); DNA binding (GO:0003677) (0.1476); DNA-binding transcription factor activity (GO:0003700) (0.1417); DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) inhibitor activity (GO:0008657) (0.0932); transcription cis-regulatory region binding (GO:0000976) (0.0772); DNA-7-methylguanine glycosylase activity (GO:0043916) (0.0723)","Bacterial transcription activator, effector binding (IPR010499) (0.5393); MerR-type HTH domain (IPR000551) (0.3239); Regulatory factor, effector binding domain superfamily (IPR011256) (0.1956); Integron-associated effector binding protein (IPR029441) (0.1116); GyrI-like small molecule binding domain (IPR029442) (0.0741)",3.20.80.10 (0.6775); 1.10.1660.10 (0.0917),3D-structure (0.4411); Direct protein sequencing (0.3119); Cytoplasm (0.3113); Ubl conjugation (0.2785); Reference proteome (0.2623); Repressor (0.2412); Transcription regulation (0.2319); Transcription (0.1754); Translation regulation (0.1606); Stress response (0.1543); DNA-binding (0.1312); Antibiotic resistance (0.0767); Activator (0.0735); Virulence (0.0722),
MISKSIILRFSELSMRKKATLVGLPLLAVAAISSSLNSPTRQQRIELSLPESPLVQFSSAEHTVEVVKVGHPDYEYEIKPGDNLSTIFNQLGFAYTELMKVMETDLNYLALDTLRPGNVLRFWKGSDNTLAKMELEFSLVDRAVYTRLNDGSYEFEERKIPGTWKVEPLIGEVDGSFSLSANRAGLGAADVDQIVTLLKDKINFGRDLRRGDRFEVVLSRQLVGEKLTGNSEIQAIKIFNRGKEITAYLHQDGQYYDKNGDSLQRAFQRYPVDSKWRISSNFDPRRLHPVTKRVAPHNGTDFAMPIGTPVYTSGDGVVVMTRNHPYAGNYVVIQHGNTYMTRYLHLSKILVKKGQKVSRGQRIGLSGNTGRVTGPHLHYELIVRGRPVNAMKANIPMASSVPKKEMAQFIAKRKELDQMLARQESMLAAQ,3.4.24.- (0.4582); lysostaphin (3.4.24.75) (0.1530),proteolysis (GO:0006508) (0.5008); septum digestion after cytokinesis (GO:0000920) (0.4518); peptidoglycan metabolic process (GO:0000270) (0.0754); protein processing (GO:0016485) (0.0673); regulation of cell shape (GO:0008360) (0.0423),plasma membrane (GO:0005886) (0.2852),metalloendopeptidase activity (GO:0004222) (0.3790); peptidoglycan binding (GO:0042834) (0.2672); metal ion binding (GO:0046872) (0.0620),"Opacity-associated protein A (IPR007340) (0.7027); Csd3-like, second N-terminal domain (IPR045834) (0.3423); Bacterial cell wall metabolism enzyme (IPR050570) (0.3275); Peptidase M23 (IPR016047) (0.3074); Duplicated hybrid motif (IPR011055) (0.2349)",3.10.450.350 (0.2721); 2.70.70.10 (0.2060),Zinc (0.9379); Transmembrane helix (0.5260); Metal-binding (0.5016); Metalloprotease (0.4505); Reference proteome (0.4089); Protease (0.3703); Membrane (0.3646); Cell membrane (0.3604); Transmembrane (0.3307); Hydrolase (0.2304); 3D-structure (0.1338); Direct protein sequencing (0.0843),Zn(2+) (0.3769)
MGQFRFLALIVAVLCFSVALFLPTADEPDQDSYSVPLNQSVNTSQPPSSEMVPSDIRLTPLPQPKRIHYMVKVGDTLSGIFAQLGVPYSILQKILSVDLDHLQLDMIQPGEELELMMDDMGQLSRLIYHMSIVEKAIYTRENDGSFSYDFQEISGEWREILFSGEINGSFSVSARRVGLTSSQVANITQVMKDKIDFSRSLRAGDRFDILVKQQYLGEHNTGNSEIKAISFKLAKGDVSAFLAEDGRFYDRAGNSLERAFNRYPVDKAYRQITSGFNPKRKHPVTGRVVPHNGTDFATPIGAPVYSTGDGKVIVVRKHPYAGNYLVIEHNSVYKTRYLHLDKILVKKGQLVKRGQKIALAGATGRLTGPHLHFEVLVRNRPVDAMKADLPIAKSLSSNQKTSFLARVSEFDHLVQANQQEVALDET,3.4.24.- (0.7422); 3.4.11.- (0.0450),proteolysis (GO:0006508) (0.6598); septum digestion after cytokinesis (GO:0000920) (0.1971); peptidoglycan metabolic process (GO:0000270) (0.1737); FtsZ-dependent cytokinesis (GO:0043093) (0.0826); DNA damage response (GO:0006974) (0.0820); regulation of cell shape (GO:0008360) (0.0757),plasma membrane (GO:0005886) (0.4633),metalloendopeptidase activity (GO:0004222) (0.4675); peptidoglycan binding (GO:0042834) (0.4612); metal ion binding (GO:0046872) (0.1163); nucleic acid binding (GO:0003676) (0.0493),"Opacity-associated protein A (IPR007340) (0.6019); Bacterial cell wall metabolism enzyme (IPR050570) (0.5046); Peptidase M23 (IPR016047) (0.4467); Csd3-like, second N-terminal domain (IPR045834) (0.3149); Duplicated hybrid motif (IPR011055) (0.2760); Opacity-associated protein A, N-terminal (IPR013731) (0.1125)",2.70.70.10 (0.4962); 3.10.450.350 (0.1744),Zinc (0.8806); Metalloprotease (0.5530); Metal-binding (0.4957); Transmembrane helix (0.4624); Signal (0.3861); Transmembrane (0.3833); Reference proteome (0.3801); Membrane (0.3594); Protease (0.3371); Hydrolase (0.3064); Cell membrane (0.3057); 3D-structure (0.1109),Zn(2+) (0.2191)
MSQKELAALVATRTSRKRTISSTSFSISTRTDPKSIIEIHIFNDSLPIKRACCEVENPTLKAEQRVQQEEESLGQVPPLTEEEQQRHDEFRNSGSIFLQDLPCFKLQQAQPIAGSSPIPKCRECRRRNLATTEGEPSSVSDVYCRFYEFRRLQFNENGELCVVGFPNPYSEPSPEDIAIWQPDKNTPPTSGYMDIQVCRYILLHAGDQFCYIWHQEAEALSLHQNTDGTIAWKKAVKGTREICDVCDTTLFNYHWTCRKCGFGVCLDCVKDRKEGLRLRRAENAAQKGCDEYHWLLCSDPSGPQEHVLTELMLTQIIAGDALNVLGRLLHEVRTLWQVPQVCGCLLSKQAIEDAQSKEVIQDMIKESQLKQHTSYSSLASEQKVHQQQRLDQLHATKLEFARELGVDYVPGRVWTKETLGKDPITTAFDNLKHINFLRKGLAGLRRFLPPRTMTFAYSTQLAPGVPHEFLCDGRLLRLTDAMHPDNRVLFQEVWKCGQPVMISEVARSLNLDLWHPQAFCRDFGDKPNDLINCLNGNLVPNQPMRHFWEGFQCMTKRLPDAYGKPMLLKLKDWPPGDDFAEILPTRFADLMKGLPMPEYTLRTGNLNIASCLPKMFVPPDLGPKMYNAYGSALHPDKGTTNLHLDISDAVNIMVYVGIPQDGDTRPQMAATQKAIEIGGCDYITRARCQSPDVLPGALWHIFPARDADKIRDLLNRVTLEKGFRLEPDHDPIHDQNWYLDDKLRARLFKEYGVEGHPIVQCLGDAVFIPAGAPHQVQNLHNCIKVAEDFVSPENITHCYHLTHEFRRLSHSHTNHEDKLQIKNIIYHAIKDCCTILTRAVDERLNAELTKLNAD,[histone H3]-dimethyl-L-lysine9 demethylase (1.14.11.65) (0.4965); 1.14.11.- (0.3953),regulation of transcription by RNA polymerase II (GO:0006357) (0.8256); negative regulation of DNA methylation-dependent heterochromatin formation (GO:0090310) (0.4701); regulation of stem cell differentiation (GO:2000736) (0.3832); transcription initiation-coupled chromatin remodeling (GO:0045815) (0.2483); flower development (GO:0009908) (0.1458); heterochromatin formation (GO:0031507) (0.1016); proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161) (0.0620); positive regulation of transcription by RNA polymerase II (GO:0045944) (0.0497); methylation (GO:0032259) (0.0470),chromatin (GO:0000785) (0.1669); cytoplasm (GO:0005737) (0.1273),histone H3K9me/H3K9me2 demethylase activity (GO:0140683) (0.6693); transcription coregulator activity (GO:0003712) (0.0694); chromatin DNA binding (GO:0031490) (0.0647); histone H3K9 demethylase activity (GO:0032454) (0.0522),JmjC domain (IPR003347) (0.1470); Histone demethylase JHDM2-like (IPR045109) (0.1355),2.60.120.650 (0.0845),Reference proteome (0.4282); Nucleus (0.2665); Metal-binding (0.2267); Methyltransferase (0.1960); Cytoplasm (0.1432),
MMMHSRNRSWTLTLLALGVVLATSAEDLPRSNRIAVPGEPLYYLMADAGPVVTPNEALKRTNRSLLKWWDDLFPRNNNNCCNNNNNNLLYPTAPLLPAPAVPNNCNGLQLQDLDPFKQMKLFKKLPELFPTASPCGQCGGGCGQNNYVAPAPQSPSYGGDGYGVLPNGGYIKPDTEYNGPGDGDAGYVAPAAPAYEAPAPPAPAYEAPAPPAPAYEAPAPAAPAYEAPAPAAPAYEAPTTDYSAPAPPAPAYEPPASSYTQGYSQPAQPSYVGAPPAQIVYQPIIYLSTPLASKSSTSQVEYDDQKYVTPTAPPPPPPPAPVYEAPSQNCYQPAAPPAPNYATPSCQTPIRLSLIDQPYRVAPELFEEYNYRLALASQNIL,,regulation of actin cytoskeleton organization (GO:0032956) (0.2655); sexual reproduction (GO:0019953) (0.2300); synapse assembly (GO:0007416) (0.1835); cell adhesion (GO:0007155) (0.1584); positive regulation of epithelial cell proliferation involved in wound healing (GO:0060054) (0.1565); negative regulation of transcription by RNA polymerase II (GO:0000122) (0.1534); response to hypoxia (GO:0001666) (0.1317); ossification (GO:0001503) (0.1059); secretory granule organization (GO:0033363) (0.1056); response to salt (GO:1902074) (0.0801); biomineral tissue development (GO:0031214) (0.0771); neuron migration (GO:0001764) (0.0737); response to bacterium (GO:0009617) (0.0712); amelogenesis (GO:0097186) (0.0557); salivary gland morphogenesis (GO:0007435) (0.0518),extracellular region (GO:0005576) (0.2365); extracellular space (GO:0005615) (0.1539); cytoplasm (GO:0005737) (0.0822),,,,Secreted (0.5194); Reference proteome (0.4851); Signal (0.4380); Glycoprotein (0.2819); Developmental protein (0.2160); Wnt signaling pathway (0.1910); Direct protein sequencing (0.1377); Phosphoprotein (0.1344); Cytoplasm (0.0986); Repeat (0.0922); Alternative splicing (0.0660),
MSEVERALDVLLQEAEELCIGSSVVELDRIPTALEFCREFYSKNQPVVIRKALNWPAIGKWTPKYLIEALGDRSVDVAITPNGYADGLATQNGQEYFVLPLETKMKLSEVVRRLDDPTGAVHYIQKQNSNLSVDLPELAADLRVSDLDFAQQSFNKPPDAVNFWLGDERAVTSMHKDPYENVYCVISGHKDFVLIPPHQLSCVPRGIYPTGVYKTSDSGQFYIEPLRDEEGSDQFTEWVSVDPLSPDLAKYPEYARAKPLKVRVHAGDILYLPNYWFHHVSQSHKCIAVNFWYDLDYDSRYCYYRMLEQMTSARSG,1.14.11.- (0.4659); peptidyl-lysine (3S)-dioxygenase (1.14.11.63) (0.1695); phospholipase A2 (3.1.1.4) (0.0778),response to abscisic acid (GO:0009737) (0.4392); primary root development (GO:0080022) (0.1461); auxin-activated signaling pathway (GO:0009734) (0.1004); regulation of abscisic acid-activated signaling pathway (GO:0009787) (0.0997); proteolysis (GO:0006508) (0.0672),nucleus (GO:0005634) (0.2446); cytoplasm (GO:0005737) (0.2144); cytosol (GO:0005829) (0.2115),metal ion binding (GO:0046872) (0.3521); protein heterodimerization activity (GO:0046982) (0.0914); 2-oxoglutarate-dependent dioxygenase activity (GO:0016706) (0.0689); identical protein binding (GO:0042802) (0.0592),RmlC-like jelly roll fold (IPR014710) (0.3787); JmjC domain (IPR003347) (0.2779); Cupin-like domain 8 (IPR041667) (0.1952),2.60.120.10 (0.5463),Metal-binding (0.5076); Nucleus (0.4924); Iron (0.3150); Dioxygenase (0.2710); Cytoplasm (0.2555); Oxidoreductase (0.2506); Reference proteome (0.1050); 3D-structure (0.0673),Fe(2+) (0.3578)
MDSEFLELTQLLPRWVDLENVVRGEVEARYILKRAADHLANLRSGGDSGAEETGYLVGALVDRNWERIHTGHFSQVPLVTRKIYAIACCFKIFFLLLESTSPAQKDACSEILDEAQLLGCMEDWSELKVALMDYLDKDGAVALNSAPLPTLEPLTRVTSNCDIPQLDAPSLEEFQTKCFEAGQPTLLLNTIQHWPALHKWLDLNYLLQVAGNRTVPIEIGSNYASDEWSQQLVKIRDFLSRQFGKEPSKAGQNIEYLAQHELFAQIPALKEDISIPDYCTISNEDTPGAVDIKAWLGPAGTVSPMHYDPKHNLLCQVFGSKRIILAAPADTDNLYPHDSEFLANTARIDAAQLDPETYPLVAKVKFYQLLLQPGDCLYMPPKWWHYVRSEAPSFSVSFWWE,1.14.11.- (0.4742); [histone H3]-dimethyl-L-lysine36 demethylase (1.14.11.27) (0.2245); 2.1.1.- (0.1194),"response to abscisic acid (GO:0009737) (0.6062); primary root development (GO:0080022) (0.2357); negative regulation of gene expression, epigenetic (GO:0045814) (0.1475); G2/M transition of mitotic cell cycle (GO:0000086) (0.1294); callus formation (GO:1990110) (0.1197); regulation of DNA replication (GO:0006275) (0.1121); regulation of seedling development (GO:1900140) (0.0902); abscisic acid-activated signaling pathway (GO:0009738) (0.0608); mRNA processing (GO:0006397) (0.0554); circadian rhythm (GO:0007623) (0.0483)",nucleus (GO:0005634) (0.2749); cytoplasm (GO:0005737) (0.1824),histone H3K9me2/H3K9me3 demethylase activity (GO:0140684) (0.2986); histone H3K36 demethylase activity (GO:0051864) (0.2463); histone H3K36me/H3K36me2 demethylase activity (GO:0140680) (0.1630); metal ion binding (GO:0046872) (0.0975),JmjC domain (IPR003347) (0.3304); Cupin-like domain 8 (IPR041667) (0.1946),2.60.120.650 (0.1822),Iron (0.0915),Fe(2+) (0.2314)
MAPAPSAAGVPATVPAKAVKGAAGAAAKAGAAAEKKEASAETDALLSGDKDAAQELTNLVKIEGPAALANLGIEAVILKGLGDKKNATAREGACTLLANLCEQGVGHEVEPFIFENVLNSLVEAMGDKEKAVQKASLETLKAFVRVMSPWAAQQVLKVVLHQARTAGKWQVKTGCVALLEEMVTACPERMAALMPEIIPVMTEVIWDTKTDVQKASRAALTKLCALISNKDIERFIPALINSLIHPVEEVPKTIQLLSATTFVQEVDSATLALMVPLLSRGLNERPTATKRKVAVIIDNMTKLVDNERTVRPFLGKLLPGLIKIESTLADPEARSVVQRAIKTLREVGKVTGDGSDVKPLEDVDIKATQEQVNKALGEQSLQAQADLSSYLAVLVANLANARNFELTEWESTLIPYITLIKGSKPEQAKAVAKSLLTALAKSTGDTVEIFDDEEEGEDLCNCQFSLAYGAKILLNTATLRLKRGHKYGLCGRNGSGKSTLMRAITNGQVEGFPSPDEVRTWYVEHDLDGSEGLMTVLEFILADERLSMTRDEAVATLHEVGFDDARQNSPIAGLSGGWKMKVALARAILFKADILLLDEPTNHLDVVNVKWITDYLVNLKTATAIIVSHDSKFLNDVCTDILHLNRFKIKRYPGNLDAFVKRVPEARAYAELNTGEDYSFKLPDPPLLDGVKTKEKSLIKMKDVVFQYPGTPAPQLRGVSIQLSLASRVAILGPNGSGKSTLVKLIVGDTEPGSGEMWKHPNLVIGYVAQHAFHHIDQHLDKTPLDYMLWRYQTGEDLEEHMKANRALTAEEEAAKKQGEVFVIEGVKRLFDEIVGRKKLKNSFQYEVSFKNMSSADNQWVPRDDLINRGLERAVLAFDSKEAQRLGMNRPLVRKEIENHFEDFGLEREFTSHNTMRGLSGGQKVKVVLAAATWRRPHIIILDEPTNFLDRESLAALIKAIESFQGGVGIITHSKEFSEGTCKEIWAMNDGVLVASGHDWTESNSKGTKLEKKEEDDEYTDAMGNVHKKEKKAKKESASDRRKAKKDRMARKKAGTYDSADELEDL,3.6.4.- (0.0664),chromatin remodeling (GO:0006338) (0.5553),cytoplasm (GO:0005737) (0.7002); nucleus (GO:0005634) (0.0527),translation elongation factor activity (GO:0003746) (0.5727); ATP hydrolysis activity (GO:0016887) (0.4531); RNA binding (GO:0003723) (0.2157); ATP binding (GO:0005524) (0.2000),"Elongation Factor 3, chromodomain-like insertion superfamily (IPR047038) (0.6429); ABC transporter-like, ATP-binding domain (IPR003439) (0.4777); HEAT, type 2 (IPR021133) (0.3301); Chromo/chromo shadow domain (IPR000953) (0.3093); ATP-binding cassette sub-family F member, EF3 subfamily (IPR050611) (0.3079); P-loop containing nucleoside triphosphate hydrolase (IPR027417) (0.2512); ABC transporter-like, conserved site (IPR017871) (0.2210); Armadillo-like helical (IPR011989) (0.2113); AAA+ ATPase domain (IPR003593) (0.2030); Elongation Factor 3, ABC2 domain, chromodomain-like insertion (IPR015688) (0.1432); TOG domain (IPR034085) (0.1219); Armadillo-type fold (IPR016024) (0.1213)",1.25.10.10 (0.3971); 2.40.50.990 (0.3344); 3.40.50.300 (0.2406),RNA-binding (0.8535); Nucleotide-binding (0.5041); ATP-binding (0.4858); Elongation factor (0.2924); rRNA-binding (0.2602); Protein biosynthesis (0.2460); Repeat (0.1667); Reference proteome (0.1464); Nucleus (0.0961),
MTKLTLTVALVSALLASGASAQQPTGTGNGPDPRATTDLNRNQPTKSWTQWQPKATYAFSQLPDQYMGANRIESGEGGQPGGEPQSGYNTCARNTWNQDSKCQTAWINSLEDFCLWAPAEYGTVGEKERSGVAYCTTDRHGTRLIPDGTIQGAHFVRTRDYVQVTGVGDFTSILIPDGDDGGEFDPHGADDLGNPIGGIVYTTANPASNGEPFFVSEWTNFMSYNQFCLRACWGERAAAQCEHIYDVMGCRWNIPANYEPGVFETCDGDIGQLQGIYSGSTFRQGDPVTPPAHPAPSSSQCSSVSTIGHGLLARSASASTSSVETSSSSAASSAATDSSASTNSASSMTRVTNSAVSTNVGSGTGSGSGSGSGSGSGSGSGSSSGSSSSGSSSNTQGAASSASSLTISVGLAGLVAIGAAAFAL,,invasive growth in response to glucose limitation (GO:0001403) (0.3491); filamentous growth (GO:0030447) (0.3141); fungal-type cell wall organization (GO:0031505) (0.1795); conjugation with cellular fusion (GO:0000747) (0.1456); filamentous growth of a population of unicellular organisms (GO:0044182) (0.0794); adhesion of symbiont to host (GO:0044406) (0.0690); single-species biofilm formation on inanimate substrate (GO:0044011) (0.0511); filamentous growth of a population of unicellular organisms in response to neutral pH (GO:0036178) (0.0424),fungal-type vacuole (GO:0000324) (0.4698); cell periphery (GO:0071944) (0.4100); cellular bud (GO:0005933) (0.1535); cellular bud scar (GO:0005621) (0.1213); endoplasmic reticulum (GO:0005783) (0.0900); fungal-type cell wall (GO:0009277) (0.0711),,,,Cell wall biogenesis/degradation (0.5965); Virulence (0.5301); Reference proteome (0.4449); Glycoprotein (0.3608); Membrane (0.3225); Signal (0.2955); Transmembrane (0.2112); Cell wall (0.1956); GPI-anchor (0.1009); Zinc (0.0709); Secreted (0.0416),
MPNPKVFFDMTIGGQPAGRIVMELYADVTPSTAENFRALCTGEKGAGRSGKPLHYKGSSFHRVIPNFMCQGGDFTAGNGTGGESIYGAKFADENFVKKHTGPGILSMANAGPGTNGSQFFICTTKTEWLDGKHVVFGQVVEGMDVVKEIEKVGSSSGRTAKPVVVADCGQLS,peptidylprolyl isomerase (5.2.1.8) (0.9917),protein peptidyl-prolyl isomerization (GO:0000413) (0.9586); protein folding (GO:0006457) (0.6310); lipid droplet organization (GO:0034389) (0.2827); apoptotic process (GO:0006915) (0.2072); negative regulation of protein kinase activity (GO:0006469) (0.1801); platelet aggregation (GO:0070527) (0.1505); neutrophil chemotaxis (GO:0030593) (0.1449); response to hypoxia (GO:0001666) (0.0543),cytoplasm (GO:0005737) (0.2660); extracellular region (GO:0005576) (0.2191); nucleus (GO:0005634) (0.1771),cyclosporin A binding (GO:0016018) (0.2446); peptidyl-prolyl cis-trans isomerase activity (GO:0003755) (0.1411),"Cyclophilin-like domain superfamily (IPR029000) (0.2088); Cyclophilin-type peptidyl-prolyl cis-trans isomerase domain (IPR002130) (0.1608); Cyclophilin-type peptidyl-prolyl cis-trans isomerase (IPR024936) (0.1592); Cyclophilin-type peptidyl-prolyl cis-trans isomerase, conserved site (IPR020892) (0.1276)",2.40.100.10 (0.3278),Rotamase (0.8157); Isomerase (0.4949); Ubl conjugation (0.1437); Reference proteome (0.1398); Cytoplasm (0.1267); Acetylation (0.1057); Isopeptide bond (0.0958); Phosphoprotein (0.0930),
MPPKKSNARNASLLKEAVTNAGRSDTASTAREGSIAATFVSDSDSSTTASGPVDEKVAAVAELITTLTTNAASDKRQSAADDIAKFVEAEGVAQMVKTKILHGIATGLHNTKQPVAREGAITAIETLIKSPVSKQIEPYMITFIPVLLERLSDKAKTVCLAADSALKALITRLTPYATKQVLPLLLAGIEYSQKWQTKVGALELMQSLSKTAPRQMTTAVPDLVPPLSEVMHDTKAEAKNAGRQTMEAICELINNKDIEKFIPALIDTIANPEKVPDTVHLLGATTFVSEVLPPTLAIMVPLLSRGLNERQTAIKRKAAVIIINMCKLVEKPQIIAPFLPRLLPTLEKIQDDVADPECRQVCQNATKILTKVGIPAPGTVMDDSYEFKKLDDKALAYLKKAIGHQQITEIPEAYRPVLEYLEHIAAAMVADGNMDNDDWNGSIIPTLKAFIPTEGTVTNAVKEFRELSFGSNVKEAVAEEEEDDAEELCNCEFSLAYGARVLLNRTHLILKRGHRYGLTGANGSGKSTLMRAIANGQVEGFPPADQLKTVAVEHDLDGAHEHDNKEVQAFVLEDPVYAHLPKETVVNMLESVGFKGPMATRPVGQLSGGWRMKLALARAMLHNADILLLDEPTNHLDVINVAWLQDYLIGLKTVTSIIVSHDSSFLDIVCSDIIHLDNFKLKRYRGNLSKFVEAVPEAKAYYELGAAQQTFRFPEPGMLEGVKTKERAILKVQNAVFQYPGTDRRQLNGVTFQCSLGSRVAVVGPNGAGKSTLIKLLCGVIEPDNGVVWRHPNLRIAYVAQHAFEHIEKHTNLTPNQYIQWRYQTGEDREEMEKAARQISAEEEAAMKKVQVISGEKKVVDSVIGRRKLKNSYEYEVSWVGKLSNENSWLPRDTLIEMGFLKKVQEIDQAEAARQGLARPLTQKEIEKHLSDVGIDSEIGTHSHIRGLSGGQKVKVVIAGAMWQRPHLLVLDEPTNFLDRDSLGALKTAIDAYGGGVIMVTHSREFSEAICKEVWKVDNGELTPTGHNWVSGQGSGPRLEDKNKDEEVFDAFGNKIDVAKQKSKLSGKDLRKKRKEREARRKRGEEVSDDDE,,chromatin remodeling (GO:0006338) (0.9607); regulation of biosynthetic process (GO:0009889) (0.0664),cytoplasm (GO:0005737) (0.6447),ATP hydrolysis activity (GO:0016887) (0.4373); translation elongation factor activity (GO:0003746) (0.4140); RNA binding (GO:0003723) (0.3235); ATP binding (GO:0005524) (0.2213),"Elongation Factor 3, chromodomain-like insertion superfamily (IPR047038) (0.6058); ABC transporter-like, ATP-binding domain (IPR003439) (0.4907); ATP-binding cassette sub-family F member, EF3 subfamily (IPR050611) (0.4018); Chromo/chromo shadow domain (IPR000953) (0.3940); P-loop containing nucleoside triphosphate hydrolase (IPR027417) (0.3576); ABC transporter-like, conserved site (IPR017871) (0.2693); HEAT, type 2 (IPR021133) (0.2433); Armadillo-like helical (IPR011989) (0.2210); AAA+ ATPase domain (IPR003593) (0.1751); Elongation Factor 3, ABC2 domain, chromodomain-like insertion (IPR015688) (0.1349); Armadillo-type fold (IPR016024) (0.1318); Chromo-like domain superfamily (IPR016197) (0.1287); Chromo domain (IPR023780) (0.1244); TOG domain (IPR034085) (0.0881)",2.40.50.990 (0.6079); 1.25.10.10 (0.2661); 3.40.50.300 (0.2224),RNA-binding (0.8484); Nucleotide-binding (0.4529); ATP-binding (0.4450); rRNA-binding (0.2600); Elongation factor (0.2457); Reference proteome (0.2331); Protein biosynthesis (0.2150),
MNFSIKATIRAWSAPEHKLACRKQLWRKIVAELERRGKRRHEAGTFLLGIERNGRKEVQSAVYYDDLDPSAYDSGVCILHGDAFAKLWSHCREKGLTVVADVHTHPGAGFQSDSDRTNPMVARQGHIAIILPNFARWPIRQGNLGIYEYCGQHEWLERSPAHAPNFFYTGFWS,3.4.-.- (0.1986); 3.1.-.- (0.0973),proteolysis (GO:0006508) (0.6762); methylation (GO:0032259) (0.0580); DNA repair (GO:0006281) (0.0445),virion component (GO:0044423) (0.2106); Holliday junction helicase complex (GO:0009379) (0.0486),,"JAB domain, prokaryotic (IPR028090) (0.0991)",3.40.140.10 (0.0401),Zinc (0.9309); 3D-structure (0.4600); Metalloprotease (0.3536); Hydrolase (0.3155); Plasmid (0.2456); Metal-binding (0.2420); Virulence (0.2334); Nucleotidyltransferase (0.2333); Protease (0.2076); Ribosome biogenesis (0.1476); Reference proteome (0.1466); Viral release from host cell (0.1422); Methyltransferase (0.1188); DNA-binding (0.0565); Cell cycle (0.0528); Cytoplasm (0.0480); Zymogen (0.0464),
MTLPILLGWFLTLCSSHIVRSCLQCDQVIRYVHEDFLSTVKGIRVRDQIELKKIIDHAYTNYRETSKLLSGVIDPTTLYRARTEYQSEFKRHWKEDRTNSLQWDLITIVEKGKRILQKHLEIFIAEGLCPNKCGLLYQRVMNCTSCQYGLFTCLSAKPPLDCGEHHLEADEGEEVVLDCFLSWHTLVVGQTEYHYSWHPGETNVLFDGEYEELVVTKESKIVLNQLSVSEEGSYRCLLKDQKGTALSRTFFQLEVKPFPSTSPRQVVTLPSLPLGYENTPYSLQKSSFLTVLILLTVLSITGSLIIIEYLRKSLKRQEEARGRDSRTAGDIELNTE,,fusion of sperm to egg plasma membrane involved in single fertilization (GO:0007342) (0.8703); heterotypic cell-cell adhesion (GO:0034113) (0.7396); regulation of immune response (GO:0050776) (0.5432); single fertilization (GO:0007338) (0.4471); sperm-egg recognition (GO:0035036) (0.2029); homeostasis of number of cells within a tissue (GO:0048873) (0.1100); cell adhesion (GO:0007155) (0.0412),membrane (GO:0016020) (0.4724); plasma membrane (GO:0005886) (0.3750); acrosomal membrane (GO:0002080) (0.2927); extracellular region (GO:0005576) (0.1215); acrosomal vesicle (GO:0001669) (0.0966),protein binding involved in heterotypic cell-cell adhesion (GO:0086080) (0.7020); signaling receptor binding (GO:0005102) (0.0907),"Immunoglobulin-like domain superfamily (IPR036179) (0.7310); Immunoglobulin-like fold (IPR013783) (0.2717); Izumo protein, immunoglobulin domain (IPR032699) (0.1165); Immunoglobulin-like domain (IPR007110) (0.0903); Izumo sperm-egg fusion protein (IPR029389) (0.0900)",2.60.40.10 (0.5244),Signal (0.6409); Fertilization (0.3997); Membrane (0.3887); 3D-structure (0.1921); Alternative splicing (0.1513); Reference proteome (0.1484); Transmembrane helix (0.1432); Immunoglobulin domain (0.1335); Cell membrane (0.1313); Disulfide bond (0.1312),
MGKTKIYSVGFTVHEAQTLVTEKGQPVDPLVVVRCCGREYRTEIKYAKSNVVSWDESHTWTDLCLTDEEWETAYITFEVQAANAFWRNTLLGLVSVQLRLIQLRKTHQIRKALPLQHPDDTDVHGSLRVTVFACAPGEAPPSPGEEEVLEEEDHNDYDDLRKAVIDTNQVVEREAGSRLYHVYVTAYRVEDLPRSSKGARDPFVTCEFAGCKLKSTQARGCCSHTFNECFRFPVVTPLPEDAILIKIWDWNFMKADELIAVGRISFSELRTRQMVPRWFNLYGFDDEEVAQATKVAGQGGRLVANCYLGRILLGARAERLTKEDDLMPAHTVAARPYETPPVIPLAVLADVYEVQGAPGEKVSVEIWCGPARARTKWVTGLETKAAQRAGVAPQAFNRAMEGALGVASYLRGDIPEGEDRFPFDNTEGRVEDLRLVVPEDTKQQWDIIISLYVRGTTKGFMGDTRIAFQRLKMSKIPGHVHNNPRAPIWVPLISTPPFESVKPAPAILMVIEKSKVEAFARSKRKHVTAVGYQLRAYVYAARNLLSPSGALPNPFVQVACAGTSRETEVFEQTSSPVFMDCLLLDITMMTDPVSRLPTVAPIVVTLFEQRSWGIQFLGRATCHYDRLRGRLKPGESPTVAEPRWIKLRGGKYANRHLGDVLLLLELIRKRDAEIIPAFPMRPVVNMCNLTFSCLGVRSLYMTQRAKRLDYVSIRKGQDKKTELRRIRGPLLRISVSSYASAGRGNNEAILRYERNLPEDPTTVNKLWTTVTKAANADIFKVVNMEIDVPVDPIYDPRLVVQVYDRKQKPKYFIGEYSMSLVPLIPWVLDQQSAIEAVSPVNDFTDTVDLKHLGGLLRGFHGNSKNRGTGQIGLEALSAADRETADAHKEKTLAQSRFATYDPDNKTFSDSWLLPSGLPKILVSSYAVPGFRCDVIYTNMFTLNVYIPAKFVLFAEGKRAADKKTKEQYARPSVDSTLEQFLDDVIFPSDSLKKSVMGDIDVTGFVKFFVNLTHHEEPNPHVDSSAAEWASSEDRMRRHLRGEDAYPKLLKIRVYVIRAISLYVGDDRILPNPYLLFNLGDKSDTLRAEAKPNTHNPEFFTVWEKDVMFPDDSQFELQVWSAHEGTSGGLDDIFIGSTCIDLEERWFSKEWQKSMSKNQVPMEYRPLKQMPSGSFKGTVEMWVELMDFQKAGEVPKFDLQSPAATEVEIRVIVWGARNLNFKALGKDFVDAMIRCNLDCTGYRGSQPIAQQTDVHYYSKTGAAIFNWRMVYSRVVMPVSTCVLQIAAYDNRNMGESPFIGEVNLELRRYLERVASTLNSIDVDAELKLINRSRESADVSSFGFVQVSLQFISQSEATSKPVGLGREPPNRDPRLTTPQEGRKWEDVLGSAGLRVDYRPLWYWVRVAAVVFLSIWIFVVAFLYPSLLG,,"plasma membrane repair (GO:0001778) (0.3147); plasma membrane organization (GO:0007009) (0.3057); synaptic vesicle exocytosis (GO:0016079) (0.2034); egg activation (GO:0007343) (0.1820); egg-laying behavior (GO:0018991) (0.1230); sorocarp development (GO:0030587) (0.0903); hypotonic response (GO:0006971) (0.0450); liquid clearance, open tracheal system (GO:0035002) (0.0428)",Golgi membrane (GO:0000139) (0.2376); synaptic vesicle membrane (GO:0030672) (0.1893); plasma membrane (GO:0005886) (0.1792); axon (GO:0030424) (0.1102); terminal bouton (GO:0043195) (0.1062); endoplasmic reticulum membrane (GO:0005789) (0.0921); cytoplasmic vesicle membrane (GO:0030659) (0.0798); cytosol (GO:0005829) (0.0631),,"C2 domain superfamily (IPR035892) (0.2595); Tricalbin, C2B domain (IPR037765) (0.0701); C2 domain (IPR000008) (0.0688); FerIin domain (IPR012968) (0.0675)",2.60.40.150 (0.4542),Membrane (0.3919); Zinc (0.3719); Reference proteome (0.3118); Cytoplasmic vesicle (0.2562); Transmembrane helix (0.2197); Transport (0.1942); Repeat (0.1893); Metal-binding (0.1426); Cell membrane (0.1210); Calcium (0.0884); Transmembrane (0.0746),
MAAVGRYSGKVVVVTGGSRGIGAAIVRAFVDSGAQVVFCDKDEAGGRAVEQELLGTVFIPGDVTQEGDLQTLISETVSRFGHLDCVVNNAGYHPPAQLPEETSAQGFRQLLEENLLGAYTLIKLALPHLRKSKGNIINISSLVGAIGQSQALTYVATKGAVTAMTKALALDESRYGVRVNCISPGNIWTPLWQELAAATSDPRATILEGTLAQPLGRMGQPAEVGAAAVFLASEATFCTGLELFMTGGAELGYGRKASSSTLVEVPILPP,17beta-estradiol 17-dehydrogenase (1.1.1.62) (0.3209); 1.1.1.- (0.2425); 7alpha-hydroxysteroid dehydrogenase (1.1.1.159) (0.0644),steroid catabolic process (GO:0006706) (0.1652); fatty acid metabolic process (GO:0006631) (0.1152); digestion (GO:0007586) (0.0947); bile acid biosynthetic process (GO:0006699) (0.0827); steroid metabolic process (GO:0008202) (0.0806); adipose tissue development (GO:0060612) (0.0668); retinal metabolic process (GO:0042574) (0.0530); C21-steroid hormone metabolic process (GO:0008207) (0.0475),peroxisomal membrane (GO:0005778) (0.0870); cytosol (GO:0005829) (0.0596); peroxisome (GO:0005777) (0.0532); mitochondrion (GO:0005739) (0.0442),identical protein binding (GO:0042802) (0.2640); testosterone dehydrogenase (NAD+) activity (GO:0047035) (0.1992); testosterone 17-beta-dehydrogenase (NADP+) activity (GO:0047045) (0.1238),"Short-chain dehydrogenase/reductase, conserved site (IPR020904) (0.3002); Short-chain dehydrogenase/reductase SDR (IPR002347) (0.2264); NAD(P)-binding domain superfamily (IPR036291) (0.1215)",3.40.50.720 (0.1355),Peroxisome (0.3843); Reference proteome (0.3460); Oxidoreductase (0.2247); NAD (0.1523); Acetylation (0.1172); Steroid metabolism (0.0464),
MMKSTFTIIVFGVLVAAVLLSPLAEGGQNPDYMLHGTGVKPGSDPRRAQAGDGSTVAPEDAARFLSCYCSGHCPEDATNNTCETNGHCFAIIEEDEHGEAMLTSGCMKYEGSHFQCKDSPNAQTRRTIECCSTDFCNRDLQPTLPPPIPGKPPFWNAHLLAFLISVTVCCFTLVAITIVCYYRFKLQTGRRHYQRDLGPIEAFIPAGESLKDLISQSSTGSGSGLPLLVQRTIAKHIQMVRQIGKGRYGEVWLGRWRGENVAVKVFFTREEASWFRETEIYQTVLMRHENILGFIAADIKGTGTFTQLFLITDYHENGSLCDYLKYTTLDTQALLRLAYSAACGLCHLHTEIYGTQGKPAIAHRDLKSKNILIKKNGTCCIADLGLAVKYNSDTNEVDVPLSTRMGTRRYMAPEVLDETLNKNQFQAYIMADIYSYGLIVWEMARRCVTGGIVEEYQLPYWDMVPSEPSYEDMREVVCVKSMRPVVSNRWNSDECLRVMLKLMSECWAHNPASRLTALRVKKSLAKMVESQDIKI,receptor protein serine/threonine kinase (2.7.11.30) (0.9660),protein phosphorylation (GO:0006468) (0.9147); BMP signaling pathway (GO:0030509) (0.7317); dorsal/ventral pattern formation (GO:0009953) (0.5218); cell differentiation (GO:0030154) (0.0980); lymph vessel development (GO:0001945) (0.0644),plasma membrane (GO:0005886) (0.6716); receptor complex (GO:0043235) (0.5830),"SMAD binding (GO:0046332) (0.8764); transforming growth factor beta receptor activity, type I (GO:0005025) (0.4360); ATP binding (GO:0005524) (0.3250)","Ser/Thr protein kinase, TGFB receptor (IPR000333) (0.3259); GS domain (IPR003605) (0.2791); Protein kinase domain (IPR000719) (0.2740); Snake toxin-like superfamily (IPR045860) (0.2422); Activin types I and II receptor domain (IPR000472) (0.2401); Protein kinase, ATP binding site (IPR017441) (0.2223); Protein kinase-like domain superfamily (IPR011009) (0.2002); Serine/threonine-protein kinase, active site (IPR008271) (0.1891)",1.10.510.10 (0.3355); 2.10.60.10 (0.2726),Signal (0.5785); Receptor (0.4010); Manganese (0.3419); Serine/threonine-protein kinase (0.3172); Nucleotide-binding (0.3153); Transmembrane helix (0.3137); ATP-binding (0.3036); Kinase (0.3017); Reference proteome (0.2719); Membrane (0.2589); Transferase (0.2508); Transmembrane (0.1470),Mg(2+) (0.2170); Mn(2+) (0.2128)
MSSEMQRDSYAGFQPLFKSFATNAIHVGSEPEQWSSMAVVPPISLSTTFKQHGPGKHEGYEYIKTGNPTRNCLERAVACLDGAKYCVAFASGIAATATITHLLKHGDGIVCMYDIYGGTKEYFREIITEFDIDASFVDFTKLEELKAALKQNTKMVWFETPTNPTLKVVDIQACADIVHKHNKDTLVVVDNTFMSPYFQRPLALGADICMCSGTKYMNGHSDVLMGLISVNREDLYKRLKVLQNAVGAVPSPFDCYMCNRGLKTLHLRMKQHFKNALAVAQFLEADPRVDSVIFPGLPSHPQHELAKRQCRGCSGMVSFYIKGQLEHASTFLSNLKVVALAESLGGIESLAKLPATMPHVSLSKDEREKLGISDTLIRLSVGLEDEEDIIADLDQALSAAHPKK,cystathionine gamma-lyase (4.4.1.1) (0.9650); homocysteine desulfhydrase (4.4.1.2) (0.6437),transsulfuration (GO:0019346) (0.7621); cysteine biosynthetic process via cystathionine (GO:0019343) (0.5666); protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine (GO:0018272) (0.2996); hydrogen sulfide biosynthetic process (GO:0070814) (0.2316); protein homotetramerization (GO:0051289) (0.2220); protein sulfhydration (GO:0044524) (0.2102); cysteine biosynthetic process (GO:0019344) (0.1501); negative regulation of apoptotic process (GO:0043066) (0.1305); positive regulation of aortic smooth muscle cell differentiation (GO:1904831) (0.1028),cytoplasm (GO:0005737) (0.1316),cystathionine gamma-lyase activity (GO:0004123) (0.3763); L-cystine L-cysteine-lyase (deaminating) (GO:0044540) (0.3061); pyridoxal phosphate binding (GO:0030170) (0.3005); L-cysteine desulfhydrase activity (GO:0080146) (0.2609),"Pyridoxal phosphate-dependent transferase, small domain (IPR015422) (0.2527); IPR054542 (0.2398); Cys/Met metabolism, pyridoxal phosphate-dependent enzyme (IPR000277) (0.1609); Pyridoxal phosphate-dependent transferase (IPR015424) (0.1329)",3.90.1150.10 (0.1549),Cysteine biosynthesis (0.4750); Pyridoxal phosphate (0.4418); Reference proteome (0.4281); Amino-acid biosynthesis (0.3018),pyridoxal 5'-phosphate (0.2076)
MTLAGVISFSIVFYMFPPSRNCPPQFVIHEQQSESSSDKSNNSVSNAAEDKPILLLWVWPENYRFEFSDCKKFYNIDNCKLTDDRSLYTNSDAVMVYHRGISWDLSNLPPSPRPPFQKWIWLHLESPTNTKKIPGLENLFNLTLSYRQDADIAVRMRLKTRKKPAEDFVVPKKDKLVCWIVSNNDPSTGVSARNKYYQELSKHIKVTLFGRAYSWFLSYDEYYPTLSSCKFYLSFENSIHKDYITEKINGPLAAGTVPVVLGPPRKNYENFVPGDAFIHVEDFQDPKSLAEYLHLLDRDDVAYRRYFNWRKHLTPTPHLILQTQEFVLAICTACDYIARHRDYKEAHDIYDWYFN,2.4.1.- (0.8225); 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase (2.4.1.152) (0.1228),protein glycosylation (GO:0006486) (0.6695); oligosaccharide biosynthetic process (GO:0009312) (0.3270); fucosylation (GO:0036065) (0.2437); neuronal stem cell division (GO:0036445) (0.2377); N-glycan fucosylation (GO:0036071) (0.2274); glycosphingolipid biosynthetic process (GO:0006688) (0.1941); polysaccharide biosynthetic process (GO:0000271) (0.1772); ceramide metabolic process (GO:0006672) (0.1458); neuron differentiation (GO:0030182) (0.1324); protein N-linked glycosylation (GO:0006487) (0.0426),trans-Golgi network membrane (GO:0032588) (0.3586); Golgi cisterna membrane (GO:0032580) (0.3184); membrane (GO:0016020) (0.2069); Golgi membrane (GO:0000139) (0.1439),alpha-(1->3)-fucosyltransferase activity (GO:0046920) (0.1777),"GT10-like, C-terminal domain superfamily (IPR038577) (0.6096); Fucosyltransferase, N-terminal (IPR031481) (0.4182); Glycosyl transferase family 10 (IPR001503) (0.1573)",3.40.50.11660 (0.2340),Golgi apparatus (0.4634); Membrane (0.4469); Transmembrane (0.4376); Reference proteome (0.4201); Transmembrane helix (0.3894); Lipid metabolism (0.2487); Glycosyltransferase (0.2304),
MLSRLFRLHGLFVASHPWEVIVGTVAVTMCLMSMNAFAGNDQICGWNHQCPKVQEKIISGDMAILTITRCIAIIYIYIQFKNLRQLGSKYILGIAGLFTIFSSFVFSTVVVHFLGKELTGLNEALPFFLLLIDLSKACTLAKFALSSNSQEEVRENIAQGMAILGPTFTLDAVVECLVIGVGTMSGVRQLEIMCCFGCMSVLANYFVFMTFFPACVSLVLELSRESREGRPIWQLSHFARVLEEEEGNKPNPVTQRVKMIMSLVLALVHAHSRLKTESPAHNISSSDVVLPTSNMESDRSMSSVDLEQVITLSLALLLAAKYVFFEQAETESSLSIKTTVATPNCSLINRRGGEERCQRDSAPPKAIKGVNENKSEREAPDRSFSIGNPEDEERDKIQCRPVQECLAILKDPKRGAGFLSNAEVMALVESRGILGYRLEAVMESPERGVAIRREMLSGKLPDSSALENLPYKHYDYSKVVGSNCENVIGYVPVPVGVAGPLLLDGKEFHVPMATTEGCLVASTNRGCRAVTLSGGVSSRVLADGMTRGPVVQMPSACRAAEVKGWLESSEGFTEIKQAFDHTSRFARLDRLQVSLAGRNLYIRFQSQTGDAMGMNMLSKGTEQALGRLQERYPDMRLLAVSGNYCTDKKPAAVNWIHGRGKSTVCEAVIPARVVKEVLKSSTAALVELNISKNLVGSAMAGSIGGFNAHAANIVTAIYIACGQDPAQTVGSSNCITLMECVGTSGEDLYVSCTMPSLELGTIGGGTGLPAQHACLQMLGVDGASVQCPGENSRTLARIVCASVLAGELSLMAALAAGHLVQSHMTHNRSKVNLREPEGQPKEAS,hydroxymethylglutaryl-CoA reductase (NADPH) (1.1.1.34) (0.9913),isoprenoid biosynthetic process (GO:0008299) (0.8279); cholesterol biosynthetic process (GO:0006695) (0.4766); coenzyme A metabolic process (GO:0015936) (0.3429); sterol biosynthetic process (GO:0016126) (0.2814); visual learning (GO:0008542) (0.2575); long-term synaptic potentiation (GO:0060291) (0.2113); negative regulation of protein catabolic process (GO:0042177) (0.1409); skeletal muscle tissue development (GO:0007519) (0.0991),endoplasmic reticulum membrane (GO:0005789) (0.4359); peroxisomal membrane (GO:0005778) (0.3810),hydroxymethylglutaryl-CoA reductase (NADPH) activity (GO:0004420) (0.3573); NADP binding (GO:0050661) (0.2585),"Hydroxymethylglutaryl-CoA reductase, class I/II (IPR002202) (0.5615); Sterol-sensing domain (IPR000731) (0.4235); Hydroxymethylglutaryl-CoA reductase, class I/II, NAD/NADP-binding domain superfamily (IPR009023) (0.3137); Hydroxymethylglutaryl-CoA reductase, class I/II, conserved site (IPR023076) (0.2872); Hydroxymethylglutaryl-CoA reductase, eukaryotic/archaeal type (IPR004554) (0.2272); Hydroxymethylglutaryl-CoA reductase, metazoan (IPR004816) (0.2185); Hydroxymethylglutaryl-CoA reductase, class I/II, substrate-binding domain superfamily (IPR009029) (0.2105); HMGCR/SNAP/NPC1-like, sterol-sensing domain (IPR053958) (0.2030); Hydroxymethylglutaryl-CoA reductase, N-terminal (IPR023282) (0.2029); Hydroxymethylglutaryl-CoA reductase, class I/II, catalytic domain superfamily (IPR023074) (0.1556)",3.30.70.420 (0.1828); 1.10.3270.10 (0.1528),Endoplasmic reticulum (0.3933); Transmembrane (0.2848); NADP (0.2494); Transmembrane helix (0.2460); Membrane (0.1953); Reference proteome (0.1536); Oxidoreductase (0.1278),
MLKVYLMLVLSAAAAVFAESVRETETWVPLKNKAAIEDLESSGNSQNEDFEFTDLNQTDDEDGFDEDDEDDYDDMSGSGFADVIDDIEDEFVNNQIPDDKGPFAPRPTVDENILVQNNEVFLRGAPNQDLDNHSNVLMTHAGDDSLFNNTEVLAAVIAGGAVGLVFAILLIILLVHFVLRIKKKDEGSYDLGKTPIYKKAPTTEIYA,,nematode larval development (GO:0002119) (0.2005); negative regulation of skeletal muscle satellite cell proliferation (GO:1902723) (0.1312); neural tube closure (GO:0001843) (0.1277); cell migration (GO:0016477) (0.1249); positive regulation of stress fiber assembly (GO:0051496) (0.1215); cell adhesion (GO:0007155) (0.1096); ureteric bud development (GO:0001657) (0.1082); positive regulation of protein tyrosine kinase activity (GO:0061098) (0.1067); negative regulation of T cell proliferation (GO:0042130) (0.0838); regulation of fibroblast migration (GO:0010762) (0.0709); wound healing (GO:0042060) (0.0705); regulation of dendrite morphogenesis (GO:0048814) (0.0667); negative regulation of satellite cell differentiation (GO:1902725) (0.0626); positive regulation of protein localization to plasma membrane (GO:1903078) (0.0523),cell surface (GO:0009986) (0.5955); plasma membrane (GO:0005886) (0.1076); extracellular region (GO:0005576) (0.0777); costamere (GO:0043034) (0.0637),identical protein binding (GO:0042802) (0.1264),"Syndecan/Neurexin domain (IPR027789) (0.2659); Syndecan, conserved site (IPR030479) (0.2142); Syndecan (IPR001050) (0.1555)",,Transmembrane helix (0.7002); Proteoglycan (0.5602); Reference proteome (0.4520); Heparan sulfate (0.3147); Membrane (0.1760); Transmembrane (0.1315); Signal (0.1297),
MSRTIGLSLCRLGIVVALAGIVCLSIMFFWFSPSPTCPPQFVQQVQHYESSSAKSSNSLTDTAENKPILLMWFWPEDFRFDLNDCKNIFNIDSCLLTVDRSLYSDADAVLIYHKSISWDLSNLPPSPRPPFQKWIWFHLESPTNTQKKPGLENLFNHTLSYRQDADIFTRLHLTVRKKPADDFVIPKKDKLVCWIVSNNAPVTGVGTRNTFYQEFSKHINVTMFGRAYASHLDPKDYYPTLASCKFYLSFENSIHKDYITEKINGPLSVGTVPVVMGPPRKNYENFFPRDAFIHVQDFPDPKSVAEYLLQLDKDEDAYRRYFDWRKYYSATPHLLQQQEFDLPICTACDYIAKHKEYKEIHDLYEWYFN,2.4.1.- (0.6957); 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase (2.4.1.152) (0.2187),protein glycosylation (GO:0006486) (0.6381); neuronal stem cell division (GO:0036445) (0.3126); N-glycan fucosylation (GO:0036071) (0.2796); polysaccharide biosynthetic process (GO:0000271) (0.2544); oligosaccharide biosynthetic process (GO:0009312) (0.2521); fucosylation (GO:0036065) (0.2227); glycosphingolipid biosynthetic process (GO:0006688) (0.2220); regulation of leukocyte tethering or rolling (GO:1903236) (0.1701); protein O-linked glycosylation (GO:0006493) (0.0861); neuron differentiation (GO:0030182) (0.0860),Golgi cisterna membrane (GO:0032580) (0.4567); trans-Golgi network membrane (GO:0032588) (0.1668); membrane (GO:0016020) (0.1529); Golgi membrane (GO:0000139) (0.1038),4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity (GO:0017083) (0.1607); alpha-(1->3)-fucosyltransferase activity (GO:0046920) (0.0925),"GT10-like, C-terminal domain superfamily (IPR038577) (0.5999); Fucosyltransferase, N-terminal (IPR031481) (0.5705); Glycosyl transferase family 10 (IPR001503) (0.1414)",3.40.50.11660 (0.2072),Golgi apparatus (0.6089); Membrane (0.5410); Reference proteome (0.3558); Glycosyltransferase (0.3406); Transmembrane (0.3077); Transferase (0.2557); Transmembrane helix (0.1578); Glycoprotein (0.1362); Lipid metabolism (0.1267),
MPSDAMPTCHAKRLQIMPGFMLKVPSWRSVCVLYSLCCVLILPDNTEGARARCGRELVDDLEFVCGDRGFYIGKPGAARSGGPRSRGKGIVDQCCVRGCDLQHLELYCAKSKKVRRDVPASVLQTPEDQFWLVFQRRYQKLADLQRDEESASQRIRERTLYQQNLLNTKTSTQTSSTHLSSTTETPTFISHIR,,insulin-like growth factor receptor signaling pathway (GO:0048009) (0.5734); positive regulation of cell population proliferation (GO:0008284) (0.4780); positive regulation of insulin receptor signaling pathway (GO:0046628) (0.3995); positive regulation of MAPK cascade (GO:0043410) (0.3763); cell population proliferation (GO:0008283) (0.3710); positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731) (0.3638); positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction (GO:0051897) (0.3484); sprouting angiogenesis (GO:0002040) (0.1802); MAPK cascade (GO:0000165) (0.1748); positive regulation of transcription by RNA polymerase II (GO:0045944) (0.1357); ossification (GO:0001503) (0.1282); negative regulation of smooth muscle cell apoptotic process (GO:0034392) (0.1222); positive regulation of activated T cell proliferation (GO:0042104) (0.1104); blood vessel development (GO:0001568) (0.1016); response to oxidative stress (GO:0006979) (0.0812),extracellular space (GO:0005615) (0.3626),hormone activity (GO:0005179) (0.4600); insulin-like growth factor receptor binding (GO:0005159) (0.1072),"Insulin-like superfamily (IPR036438) (0.5212); Insulin, conserved site (IPR022353) (0.3315); Insulin-like growth factor (IPR022350) (0.2561); Insulin-like (IPR016179) (0.2305); Insulin family (IPR022352) (0.2144)",1.10.100.10 (0.4701),Secreted (0.8721); Reference proteome (0.7715); Disulfide bond (0.3506),
MLCCIRRTKPVEKNEEADQEIKQDGIKPEENAHKAATKIQASFRGHITRKKMKDGEKEEENGEVPEEQEEEKPTDASTETQEDPKPEQPNSPANEAPPTAAADPAPSDTPAKEEVKEPQQEVEKPKEEEPSSAAADEKPEEEGNAQKEEKEEEKPADVPEAESQETHQIDKPDAAEESKPAEGAVSDAGTEESV,,regulation of growth (GO:0040008) (0.9494); axon regeneration (GO:0031103) (0.6921); axon choice point recognition (GO:0016198) (0.6497); tissue regeneration (GO:0042246) (0.5887); nervous system development (GO:0007399) (0.2615); cell differentiation (GO:0030154) (0.2043),cytoplasm (GO:0005737) (0.6021); growth cone membrane (GO:0032584) (0.4795); filopodium membrane (GO:0031527) (0.4463); postsynaptic density (GO:0014069) (0.3033); perikaryon (GO:0043204) (0.1906); dendrite (GO:0030425) (0.0654),calmodulin binding (GO:0005516) (0.3725); phosphatidylserine binding (GO:0001786) (0.3614); phosphatidylinositol phosphate binding (GO:1901981) (0.1518),"IQ motif, EF-hand binding site (IPR000048) (0.4172); Neuromodulin, palmitoylation site (IPR018243) (0.2337); Neuromodulin (GAP-43), C-terminal (IPR017454) (0.1941); Neuromodulin gap junction N-terminal (IPR018947) (0.1811); Neuromodulin, phosphorylation site (IPR033137) (0.1349)",1.20.5.190 (0.4556),Synapse (0.6378); Phosphoprotein (0.5123); Calmodulin-binding (0.5040); Lipoprotein (0.4893); Differentiation (0.4864); Neurogenesis (0.3531); Membrane (0.3415); Developmental protein (0.2735); Growth regulation (0.2682); Reference proteome (0.2358); Cell projection (0.1837); Cytoplasm (0.1437); Cell membrane (0.0763),
MDKITLTPPSKAVQKLIIATFMLISFVCIFFVYYNPNTTFFKFPAVDVHTNSSCTETCLDVLKTQNYKCTIKNASDNPSTTPVPNPAPTTAKKDDQETILLIWVYPFGARFDLGVCGSQFNIHGCHLTDDRSMIQKAHGVMFHHRDLSADLPQPPRPAFQKWIWWNMESPSNSHPNSLINDGFNLTSSFRKDSDIPVPYGRLIDATDEQKNFTIPKKDKLVCWIVSNFQEHHKRSQYYNELVKHIKVEAYGGHFNNRVNDEDYGNVVSSCKFYLSFENSIHRDYFTEKLFNPLALGTVPVVLGPSRDNYEEFIPRDAFIHVDDFPTPKELADHLKLLDQNEEQYRQYFSWRKHFISMSSSFGLEHACRTCDYLKRNKHYIAIKDLKGWFWG,2.4.1.- (0.8655); 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase (2.4.1.152) (0.0988),protein glycosylation (GO:0006486) (0.4146); polysaccharide biosynthetic process (GO:0000271) (0.4059); N-glycan fucosylation (GO:0036071) (0.3465); glycosphingolipid biosynthetic process (GO:0006688) (0.2810); oligosaccharide biosynthetic process (GO:0009312) (0.2314); fucosylation (GO:0036065) (0.2298); regulation of leukocyte tethering or rolling (GO:1903236) (0.1740); neuron differentiation (GO:0030182) (0.1592); Lewis x epitope biosynthetic process (GO:0106402) (0.1369); axon guidance (GO:0007411) (0.0957); protein O-linked glycosylation (GO:0006493) (0.0687); protein N-linked glycosylation (GO:0006487) (0.0649); lipid metabolic process (GO:0006629) (0.0497),Golgi cisterna membrane (GO:0032580) (0.3391); membrane (GO:0016020) (0.2876); trans-Golgi network membrane (GO:0032588) (0.2095); Golgi membrane (GO:0000139) (0.1245),4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity (GO:0017083) (0.2556),"Fucosyltransferase, N-terminal (IPR031481) (0.7222); GT10-like, C-terminal domain superfamily (IPR038577) (0.5725)",3.40.50.11660 (0.1803),Membrane (0.6729); Golgi apparatus (0.6651); Transferase (0.4946); Reference proteome (0.4053); Glycoprotein (0.3642); Glycosyltransferase (0.3326); Transmembrane (0.2484); Transmembrane helix (0.1691); Lipid metabolism (0.0867),
MKIVSYEISPLFAQLSWRAQSDIAGRKMSCWLREQTLLLAEDYISFCSGIQQTPPSESAEAMRYLAKEMEQQHRTKFRSLSQEFLDTCGADPSKCLQSVMRELVGDGKMNWGRVVSIFTFTGVLASELLSRGENSEGSRRLAETIADYLGGEKQDWLVENGGWEGFCRFFHNARQLNQESSMKTALFAAAGVGLAGLTFLLVR,,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630) (0.8823); release of cytochrome c from mitochondria (GO:0001836) (0.7660); extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192) (0.5385); mitochondrial fusion (GO:0008053) (0.2691); ectopic germ cell programmed cell death (GO:0035234) (0.2069); positive regulation of apoptotic process (GO:0043065) (0.1403); negative regulation of apoptotic process (GO:0043066) (0.1381); fertilization (GO:0009566) (0.0967); negative regulation of autophagy (GO:0010507) (0.0592); somitogenesis (GO:0001756) (0.0504); epiboly (GO:0090504) (0.0415); chordate embryonic development (GO:0043009) (0.0404),mitochondrial outer membrane (GO:0005741) (0.6045); nucleus (GO:0005634) (0.0995); cytosol (GO:0005829) (0.0801); membrane (GO:0016020) (0.0791),BH domain binding (GO:0051400) (0.3128); protein heterodimerization activity (GO:0046982) (0.0828),"Bcl-2-like superfamily (IPR036834) (0.5023); Bcl-2 family (IPR026298) (0.4506); Bcl-2, Bcl-2 homology region 1-3 (IPR046371) (0.3207); Apoptosis regulator, Bcl-2, BH2 motif, conserved site (IPR020726) (0.2573); Apoptosis regulator, Bcl-2, BH1 motif, conserved site (IPR020717) (0.1965); Bcl2-like (IPR002475) (0.1398); Apoptosis regulator, Mcl-1 (IPR013281) (0.0761)",1.10.437.10 (0.4692),Transmembrane (0.5363); Transmembrane helix (0.3495); Reference proteome (0.2252); Apoptosis (0.1463),
MADHWGYDKHNGPDKWGESYPIANGSRQSPIDIKSSTTTYDEKLTPLKLKYDPSTSLDIQNNGHSFQVSFVDDQNSSTLTGGPVTGTFRLKQFHFHWGSADDKGSEHTVNGKCYPAELHLVHWNTKYPSFKDAVDKPDGLAVVGVFLKIGADNPKLQKILDAMDAIKSKGKQTPFPNFDPSVLLPSSLDYWTYLGSLTTPPLLESVTWIVCKQSISVSSAQMKRFRSLLFSGDGEKACCMVNNYRPPQPLKGRVVRASFK,carbonic anhydrase (4.2.1.1) (0.9951); cyanamide hydratase (4.2.1.69) (0.5145),carbon dioxide transport (GO:0015670) (0.3744); regulation of monoatomic anion transport (GO:0044070) (0.3324); regulation of intracellular pH (GO:0051453) (0.2855); angiotensin-activated signaling pathway (GO:0038166) (0.2406); one-carbon metabolic process (GO:0006730) (0.1861); positive regulation of dipeptide transmembrane transport (GO:2001150) (0.1509); regulation of chloride transport (GO:2001225) (0.0727),apical part of cell (GO:0045177) (0.2760); plasma membrane (GO:0005886) (0.1626); cytoplasm (GO:0005737) (0.1284),zinc ion binding (GO:0008270) (0.2036); arylesterase activity (GO:0004064) (0.1978); carbonate dehydratase activity (GO:0004089) (0.1639); cyanamide hydratase activity (GO:0018820) (0.1591),"Alpha carbonic anhydrase domain (IPR001148) (0.3353); Alpha carbonic anhydrase domain superfamily (IPR036398) (0.1680); Carbonic anhydrase, alpha-class, conserved site (IPR018338) (0.1628)",3.10.200.10 (0.1271),Zinc (0.8379); Lyase (0.4459); Reference proteome (0.3812); Membrane (0.2622); Metal-binding (0.1935); Acetylation (0.1826); Cytoplasm (0.1452); 3D-structure (0.1361),Zn(2+) (0.1813)
MAPRVLGFIKGFFVYETAKSVVVKSWSVGIINRVVQLLIILYFICWVFMHEKAHQLRDTGIESAVMTKVKGLGNFNDRVMDVADYVIPSQGASSFSIITNMVVTANQTQGYCPEIEKKFSCTSDGDCEKKIGLNIGNGMITGKCLNDNGTSNDTWRCEIQGWCPAEDDTISGKPMHEVENFTIFIKNSIRFPLFGVARGNFPSSLNRSYIQSCNYDPVRHPFCPIFKVGDILKHLNQSLENITKIGGEIGININWKCNLDYDEENCNPKYFFTRLDAAFEHSSVSKGYNFRFAKYYQSEDGTEYRTLHKAYAIRFEIIVSGNAGKFNVVPFLINLVAAFTSVGLATVFCDIILLNFHKGADEYKAKKFEEVSGFVPESGSNILYKGSQVSIKALEKNSNDSGTFSIGRQE,,response to carbohydrate (GO:0009743) (0.2301); monoatomic cation transport (GO:0006812) (0.2251); calcium ion transmembrane transport (GO:0070588) (0.2221); response to cold (GO:0009409) (0.2142); response to hypoxia (GO:0001666) (0.2024); regulation of synaptic plasticity (GO:0048167) (0.1855); monoatomic ion transmembrane transport (GO:0034220) (0.1850); response to ATP (GO:0033198) (0.1441); response to heat (GO:0009408) (0.1235); positive regulation of calcium-mediated signaling (GO:0050850) (0.0778),plasma membrane (GO:0005886) (0.3018); hippocampal mossy fiber to CA3 synapse (GO:0098686) (0.1445); external side of plasma membrane (GO:0009897) (0.1417); cytoplasm (GO:0005737) (0.0939); cytosol (GO:0005829) (0.0641); axon (GO:0030424) (0.0597); receptor complex (GO:0043235) (0.0584),ATP binding (GO:0005524) (0.3446); purinergic nucleotide receptor activity (GO:0001614) (0.1386); extracellularly ATP-gated monoatomic cation channel activity (GO:0004931) (0.1250),P2X3 purinoceptor (IPR003046) (0.5329); P2X purinoreceptor (IPR001429) (0.1438),2.60.490.10 (0.2665); 1.10.287.940 (0.1198),Transport (0.9344); Transmembrane (0.8030); Transmembrane helix (0.6777); Membrane (0.6636); Ligand-gated ion channel (0.4832); Ion transport (0.4397); Reference proteome (0.3697); Nucleotide-binding (0.3012); Ion channel (0.2709); Receptor (0.2461); Glycoprotein (0.2225),
MAFQEFTSTAVQLFDKWMESSDPRTKGWLLMSNPIPQMLIIVFYIYFVISLGPKIMENRKPFDLKRVLIVYNIFVVSLSVYMCYEFLMAGWGTGYTFGCDLVDYSQSPKAMRMASVCWLYYFSKFIEMLDTVFFVLRKKPKQITFLHVFHHSIMPFTWWFGVRFSPGGLGTFHALLNCIVHVIMYTYYLLSALGPSFQRFLWWKKHLTSLQLIQFVLVTVHISQYFFMKDCPYPYPLFMYIIALYGIIFLLLFLNFWHHAYTKGKRLPKILQKTISPKNNNDIHHKKE,very-long-chain 3-oxoacyl-CoA synthase (2.3.1.199) (0.9983),"unsaturated fatty acid biosynthetic process (GO:0006636) (0.8047); fatty acid elongation, saturated fatty acid (GO:0019367) (0.4937); long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) (0.4700); establishment of skin barrier (GO:0061436) (0.3872); fatty acid elongation, polyunsaturated fatty acid (GO:0034626) (0.3380); very long-chain fatty acid biosynthetic process (GO:0042761) (0.2970); sphingolipid biosynthetic process (GO:0030148) (0.2739); fatty acid elongation, monounsaturated fatty acid (GO:0034625) (0.2612); fatty acid elongation (GO:0030497) (0.1972); long-chain fatty acid biosynthetic process (GO:0042759) (0.0878)",endoplasmic reticulum membrane (GO:0005789) (0.1825); dendritic tree (GO:0097447) (0.1213); dendrite (GO:0030425) (0.1171),fatty acid elongase activity (GO:0009922) (0.1310),"ELO family (IPR002076) (0.3998); ELO family, conserved site (IPR030457) (0.1688); Elongation of very long chain fatty acids protein 1 (IPR033681) (0.1201)",,Membrane (0.7989); Transmembrane (0.6741); Endoplasmic reticulum (0.6150); Reference proteome (0.5272); Transmembrane helix (0.4339); Lipid biosynthesis (0.3593); Fatty acid metabolism (0.3052); Fatty acid biosynthesis (0.2834); Transferase (0.2759); Lipid metabolism (0.2410); Acetylation (0.1558); Cell projection (0.1446); Proteomics identification (0.1353); Glycoprotein (0.1178); Disease variant (0.0622),
MAASIREKQTAALKRMLNFNAPPLKNTTAEPVWKVLIYDRFGQDIISPLLSVKELRDMGITLHLLLHSDRDPIPDVPAIYFIMPTEENIDRICQDLRNQLYESYYLNFISAISRSKLEDIASAALAANAVNQVTKVFDQYLNFITLEDDMFILCNQNKEHISYHAINKPDIMDTDMEGIMDTIVDSLFCFFVTLGAVPIIRCPRGNAAEMVAVKLDKKLRENLRDARNSLFTGDTMGTGQFSFQRPLFVLADRNLDLATPLHHTWTYQALIHDVLDFHLNRVSVDESHGSEASPAGARPKKKNKKSYDLTAADKFWQKHKGSPFPEVAEAVQEELDTYRAQEDEVKRLKSIMGLEGEDDGAISMLSDNTAKLTSAVSSLPELLEKKRLIDLHTNVATAVLDHIKSRKLDVYFEYEEKLMSKSTLDKSLLDIISDPDAGTAEDKMRLFLIYYITSQQPPLEADLEQYKKAMVDAGCDLSPLNYIKQWKAFTKMAATPANYGSSGVKPMGLFSRVMNTGSQFVMEGVKNLVLKQHNLPVTRILDNLMEMKSNPETDDYRYFDPKMLRGSESSIPRNKNPFQEAIVFVVGGGNYIEYQNLVDYTKTRQGKRILYGCSELFNAAQFIKQLSQLGQK,,"endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888) (0.6066); regulation of protein transport (GO:0051223) (0.4711); intracellular protein transport (GO:0006886) (0.4556); response to toxic substance (GO:0009636) (0.4259); post-Golgi vesicle-mediated transport (GO:0006892) (0.3059); cell morphogenesis (GO:0000902) (0.1759); retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890) (0.1307); negative regulation of autophagosome assembly (GO:1902902) (0.1255); regulation of ER to Golgi vesicle-mediated transport (GO:0060628) (0.1049)",Golgi membrane (GO:0000139) (0.2888); cis-Golgi network (GO:0005801) (0.2471); endoplasmic reticulum membrane (GO:0005789) (0.2209); cytosol (GO:0005829) (0.1278); Golgi-associated vesicle (GO:0005798) (0.1025); plasma membrane (GO:0005886) (0.0983),syntaxin binding (GO:0019905) (0.2001),"Sec1-like, domain 1 (IPR043154) (0.4703); Sec1-like superfamily (IPR036045) (0.2561); Sec1-like protein (IPR001619) (0.2374); Sec1-like, domain 3a (IPR043127) (0.1827); Sec1-like, domain 2 (IPR027482) (0.1733)",3.40.50.1910 (0.2304); 3.40.50.2060 (0.2296); 1.25.40.60 (0.2140),Transport (0.7345); Reference proteome (0.5824); Protein transport (0.5360); Membrane (0.2372); Endoplasmic reticulum (0.2273); Cytoplasm (0.1199); Proteomics identification (0.0901); Ubl conjugation (0.0455),
MSDDNSDSAPSNDADSGAGGIEKKAGRSCGMSESSPSSNPESSGSGGLSGPKGSAGGNRGVNSDDTDGLSSGNDSGERESEGGMQRGSGSRGRQSNRSYQSSSSQNGKDSAMGMETTESNKSSNSHSPSPPSSSLAYSLLSASSEQDPPSTSGCSSDQSARVQTQKELMRALNELKIRLPPERKMKGRSSTLNALKYALSCVRQVRANQEYYHQWNVEECHGCSLDLSTFTVEELDNITSEYTLKNTDTFTMAVSFLSGKVVYISPQGSSLLRSKPERLHGVLFSELLAPQDVSTFYSNTAPCKLPAWASCIGSVSPPMECTQEKSMFCRISGDVSSSSDVRYYPFRLTPYLLTLRDSDMAFPQPCCLLIAERVHSGYEAPRIPLDKRIFTTSHTPSCVFQEVDERAVPLLGYLPQDLVGTPVLLCIHPDDRHIMVAIHKKILQFAGQPFEHSPLRMCARNGEYMTIDTSWSSFINPWSRKVAFIVGRHKVRTSPLNEDVFTPPRGLEERALTPDIVQLSEQIHRLLVQPVHCGSSQGYGSLPSNGSHEHQPSAASSSDSSGPGVEDPSQLHKPMTFQQICKDVHMVKTSGQQVFIDSRNRPPPKKHSTAGALKAGESAEVCRSLIPCAAPPSKSSAPSLIVQKEPPTTFSYQQINCLDSIIRYLESCNVPNTVKRKCGSSSCTASSTSDDDKQQEAPGNAKGPSVSLVDDSALLPPLALHNKAESVASVTSQCSFSSTIVHVGDKKPPESDIVMEEAPPTPNIALPVTQPQVPPMATPSLPLSPAPDRDAGRRGGPGASAGGERLGLTKEVLSAHTQQEEQNFMCRFGDLSKLRVFDPTSAVRRRPNAPLSRGVRCSRDYPAAGSSGRRRGRGGKRLKHQESSEQTGSCSPAGPIRGLLPGVPALGRPSNPSIPMGPTASSSSWPTSGSQASVPNVQYPPTVLPFYPVYPPISHPVSDPSMQSGLRFPLQNSQMAPPMVPPMMALVLPNYMFPQPSVGMAQPFFSPNSAFPFAAANMGSPAPCQIQTPIQRAHSRSSTPHSYSQRENGAEREGAESPLFQSRCSSPLNLLQLEESPSNRFEVASGQQTTSPMVGQGGGAGGQASSNQRGSAVDSKTNENGETNESNQDAMSTSSDLLDLLLQEDSRSGTGSAASGSGSSGTGSSGSGSGSSGSGSNGCSSSGSGTRSSQSSNTSKYFGSVDSSENSHSRKQTAEGDGEAQFIKCVLQDPIWLLMANTDEKTMMTYQLPIRDRDSVLKEDRAALRAMQKHQPRFTEEQKSELSQVHPWIRTGRLPRAINISACAGCRSPPSVPSATPFDVEIHEMEFCSVLAVAEEKQTPADTVMEKSETDGQNETCKENNGTVTTAQINDQEMLTEEQEMTSQIEEEMGASHTQMTH,,negative regulation of transcription by RNA polymerase II (GO:0000122) (0.9708); circadian regulation of gene expression (GO:0032922) (0.4912); circadian rhythm (GO:0007623) (0.2830); response to oxidative stress (GO:0006979) (0.2187); entrainment of circadian clock by photoperiod (GO:0043153) (0.2178); response to cold (GO:0009409) (0.1376); positive regulation of transcription by RNA polymerase II (GO:0045944) (0.1304); chromatin remodeling (GO:0006338) (0.1151); positive regulation of circadian rhythm (GO:0042753) (0.1069); post-transcriptional regulation of gene expression (GO:0010608) (0.1020); response to light stimulus (GO:0009416) (0.0737); negative regulation of JNK cascade (GO:0046329) (0.0632); regulation of cytokine production involved in inflammatory response (GO:1900015) (0.0515); regulation of hair cycle (GO:0042634) (0.0509),cytoplasm (GO:0005737) (0.3390); nucleus (GO:0005634) (0.2116); cytosol (GO:0005829) (0.1353),transcription cis-regulatory region binding (GO:0000976) (0.3074); transcription corepressor binding (GO:0001222) (0.1748),"Period circadian-like, C-terminal (IPR022728) (0.4025); Period circadian regulator (IPR050760) (0.2709); PAS domain superfamily (IPR035965) (0.2190); Period circadian protein homolog 1-3, PAS-A domain (IPR048814) (0.1107)",3.30.450.20 (0.1438),Transcription regulation (0.6100); Biological rhythms (0.5154); Transcription (0.4182); Ubl conjugation (0.3716); Cytoplasm (0.3230); Reference proteome (0.3050); Nucleus (0.0943),
MPVSRMRMRPWLESRIDSNTINGLMWVNKEEKMFSIPWKHAARHGWEVDKDACLFKQWAIHTGKYKEGVTQPDPKTWKANFRCAMNSLPDIEEVKDKSINKGCGAVRVYRMLPAVSKKIKRSKSRDSRRRMKSLSQKVKLEDMSSEDTSAEMTQENTIDSTQSTPHTSSPTVGYEVEIGPDSTCNDIYSRFQVSPVHSTDLEDSEAILELTRQLERDSSQWLQNFGKGFLANEVCTTESLSPESQWSVSSGEELELRLYTELTPDLRSDSYTYTELWNSSSMPQSIC,,immune system process (GO:0002376) (0.7341); regulation of transcription by RNA polymerase II (GO:0006357) (0.5968); positive regulation of interleukin-12 production (GO:0032735) (0.3012); cellular response to interferon-beta (GO:0035458) (0.2315); positive regulation of interferon-beta production (GO:0032728) (0.2272); defense response to virus (GO:0051607) (0.2227); apoptotic process (GO:0006915) (0.1663); regulation of DNA-templated transcription (GO:0006355) (0.1050); negative regulation of cell population proliferation (GO:0008285) (0.0852),cytoplasm (GO:0005737) (0.4774); chromatin (GO:0000785) (0.1162); nucleus (GO:0005634) (0.1026),"RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978) (0.1109); DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981) (0.0956)","Winged helix-like DNA-binding domain superfamily (IPR036388) (0.2104); Interferon regulatory factor, DNA-binding domain (IPR001346) (0.1693); Winged helix DNA-binding domain superfamily (IPR036390) (0.1530)",,Ubl conjugation (0.8936); Transcription (0.6253); Reference proteome (0.5039); Isopeptide bond (0.4172); Transcription regulation (0.4039); DNA-binding (0.2623); Cytoplasm (0.2329); Nucleus (0.1963); Tumor suppressor (0.0527),
MKPRQRKQYFRNMKRSDDSEREKRRKRRRLLQELGEQRIPYLSPTDPGFQDLWDSSYAGLALRQSGTLPEGLHEKVQSALLTLQRHGCLLRDLVRVRDRDVFTAVSRALVGQPGYTYRYLDTRLFTIPWHCEGEEGQKDEKGKPCCDSDLRDACKALWELNQFFCSDVKQQTNARGVKRTRSDTENSEDAPGEGMCEEESVKDRLVEEKTIEEEEEDSGQGCSHSSPPSSTPPAAQASLVQFNVTLINYMNPAAMTQLKEEPYYGMGKMAVGWHHDENLVPLSPVAVYSYSCPAEPKNEGVTEKDGEGKSKEKEREAKGEGTSTEEVKKEGEASVKEDVEKEKTCWRVGLKVAWDIHTPGLALPLQSGDCYYMTDDLNRTHQHCVLAGDTARFSSTHRVAQCCTGTLDYIQKRCSEALENLHSDPEKNAKSLISLLPSILQRIEDIHNEVEFEWLRQYWFQGRRYARFCSWWTKPMEQMEKDWKEMERMTQLLLVVVEDEATAQENRREMADVLLNALTDRQQHRQTWRDRCQSSLAQTLPPEEAPVDRPYWSNDDPDMPLPFDLSDIINRVESLLWRM,mRNA N6-methyladenine demethylase (1.14.11.53) (0.9398),DNA alkylation repair (GO:0006307) (0.8503); regulation of multicellular organism growth (GO:0040014) (0.6218); RNA repair (GO:0042245) (0.5016); mRNA destabilization (GO:0061157) (0.1956); regulation of brown fat cell differentiation (GO:0090335) (0.0887); snRNA processing (GO:0016180) (0.0438),nuclear speck (GO:0016607) (0.3723); cytosol (GO:0005829) (0.1011); nucleus (GO:0005634) (0.0978); cytoplasm (GO:0005737) (0.0650),broad specificity oxidative DNA demethylase activity (GO:0035516) (0.3933); ferrous iron binding (GO:0008198) (0.2846); mRNA N6-methyladenosine dioxygenase activity (GO:1990931) (0.2377); tRNA demethylase activity (GO:1990984) (0.1637); oxidative RNA demethylase activity (GO:0035515) (0.1264),"Alpha-ketoglutarate-dependent dioxygenase FTO (IPR032868) (0.3643); Alpha-ketoglutarate-dependent dioxygenase FTO, catalytic domain (IPR024367) (0.2721); Alpha-ketoglutarate-dependent dioxygenase AlkB-like superfamily (IPR037151) (0.1847); Alpha-ketoglutarate-dependent dioxygenase FTO, C-terminal (IPR024366) (0.1102)",2.60.120.590 (0.3882); 1.20.58.1470 (0.2864),Reference proteome (0.6552); Oxidoreductase (0.4120); Metal-binding (0.3447); Dioxygenase (0.2533); Nucleus (0.1960),
METVARQSFQPHPGLQQTLKQFHLSSMISLGGPAAFSARWQHDLLFKKDGKDIPEPVLHLPPMQPPPVMPGPLFIPSDRSTERCETVLEGETISCFVVGGEKRLCLPQILNTVLRDFSLQQINSVCDDLHIYCSRCTADQLEILKVMGILPFAAPSCGLITKTDAERLCNALIYGGTYPPHSKKELYGSIELELTEKSFKIYHECFGKCKGLLVPELYTSPNAPCIQCMDCRLMYPTHKFVVHSHKSLENRTCHWGFDSANWRAYVLLSPDYTGKEEKARLEQLLDDIKEKFDFSNKYKRKASQASDPIPAKKPKHDDFPAQSPSGDKDKQPDWLRSLSASANKGLNCIQPRQRPSAFRPWSPNISVSDKDGAGRPASMLRESFYNYKSLESAVAPNVALTPPQKGGQASPSAPSSSHPHGAESEGASRGRKRRLTGDTQPSPQPCAAATASKPLPASPEEHESDVEVEVESREELTSSLSSLSSPSFPSSSSAKDLSSPSGPVATLPAVVTPAAGPPEGPLLSGGEGHAMNNLESELETLRQALDNGLDSKESKEKFLHEIVKMRVKQEEKLGSALQAKRSLQQELEFLRVAKKEKLREATEAKRNLRKEIERLRAESERKMREANESRMRLKRELEQARQLRVCDKGCEAGRLRAKYSAQIEDLQVKLQHAEADREQLRADLIHEREAREHLERVVKELQEQLWPKSPSKNGTDVAHPPAKDSNN,,negative regulation of transcription by RNA polymerase II (GO:0000122) (0.8099); negative regulation of BMP signaling pathway (GO:0030514) (0.3987); negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512) (0.2925); myotube differentiation (GO:0014902) (0.2810); dorsal/ventral pattern formation (GO:0009953) (0.2135); negative regulation of osteoblast differentiation (GO:0045668) (0.2104); transforming growth factor beta receptor signaling pathway (GO:0007179) (0.1861); smoothened signaling pathway (GO:0007224) (0.1279); heart looping (GO:0001947) (0.1085); intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630) (0.1064); negative regulation of Schwann cell proliferation (GO:0010626) (0.0988); negative regulation of cell differentiation (GO:0045596) (0.0817); cartilage development (GO:0051216) (0.0794); lens fiber cell differentiation (GO:0070306) (0.0686),transcription regulator complex (GO:0005667) (0.4055); cytoplasm (GO:0005737) (0.1356); nucleus (GO:0005634) (0.1276),"RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978) (0.1811); SMAD binding (GO:0046332) (0.1313); DNA-binding transcription factor binding (GO:0140297) (0.1046); protein kinase binding (GO:0019901) (0.0897); DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227) (0.0661)","Putative DNA-binding domain superfamily (IPR009061) (0.5426); Ski-like, DNA-binding domain superfamily (IPR037000) (0.3016); Ski oncogene-like, Dachshund-homology domain (IPR047315) (0.2642); c-SKI SMAD4-binding domain (IPR014890) (0.1711); Transcription regulator SKI/SnoN (IPR023216) (0.1669); SAND-like domain superfamily (IPR010919) (0.1289); SKI/SNO/DAC domain (IPR003380) (0.0905)",3.10.260.20 (0.4302); 3.10.390.10 (0.2740),Reference proteome (0.3191),
MTFQVGFFVLLSVTTIGAFPRNAFQREFHRHVAKDFESSGNGPDEPVRGSVRIVKLNPHFLRRAAVSHVPFRNSPSRGAFPAFLALGRPGPAILTHSKPAPQVSSSADRRKQGLEMWKKVVHKSERKKEAVALRINPKDMNKQSCAAVPFTQRITEEGCETVTVHNNLCYGQCSSMFVPSSGGSHGQQKAQCTRCGPSRARSVLLHLRCGSEVRERRVLIVEECKCETSSEEAKVQNTDMFNL,,anterior/posterior axis specification (GO:0009948) (0.5301); negative regulation of cell population proliferation (GO:0008285) (0.4495); bone mineralization (GO:0030282) (0.3853); determination of heart left/right asymmetry (GO:0061371) (0.3501); ureteric bud development (GO:0001657) (0.3120); determination of left/right asymmetry in lateral mesoderm (GO:0003140) (0.2980); cell migration involved in gastrulation (GO:0042074) (0.2727); determination of dorsal identity (GO:0048263) (0.2100); negative regulation of BMP signaling pathway (GO:0030514) (0.1811); negative regulation of activin receptor signaling pathway (GO:0032926) (0.1750); positive regulation of gene expression (GO:0010628) (0.1330); neuron migration (GO:0001764) (0.1308); growth plate cartilage chondrocyte proliferation (GO:0003419) (0.1075); nervous system development (GO:0007399) (0.1015); signal transduction involved in regulation of gene expression (GO:0023019) (0.1005); anterior/posterior pattern specification (GO:0009952) (0.0674); negative regulation of mesoderm development (GO:2000381) (0.0634),extracellular region (GO:0005576) (0.4890); extracellular space (GO:0005615) (0.1881),,"Cerberus (IPR016860) (0.7813); DAN (IPR004133) (0.1951); Cystine knot, C-terminal (IPR006207) (0.1231); Cystine-knot cytokine (IPR029034) (0.0636)",2.10.90.10 (0.3395),Secreted (0.9042); Signal (0.7312); Disulfide bond (0.5709); Glycoprotein (0.1823); Tumor suppressor (0.1596); Reference proteome (0.1588),
MSITNTPTSNDACLSIVHSLMCHRQGGESETFAKRAIESLVKKLKEKKDELDSLITAITTNGAHPSKCVTIQRTLDGRLQVAGRKGFPHVIYARLWRWPDLHKNELKHVKYCQFAFDLKCDSVCVNPYHYERVVSPGIDLSGLTLSGSGPSGLMVKDEYDYDGPPSLPSTEGHMQTIQHPPSRAVTQEPFSTPALLPPAEGSSSASSSAFSSIAVGSTTQPGSVLSGSHSSDSLLQIASGTGQGSQQNGFPPGQTSTYHHNPTSSWSRNSNFTPSVPHHQNGHLQHHPPMAHPAHYWPVHNEIAFQPPISNHPAPEYWCSIAYFEMDVQVGETFKVPSSCPIVTVDGYVDPSGGDRFCLGQLSNVHRTEAIERARLHIGKGVQLECKGEGDVWVRCLSDHAVFVQSYYLDREAGRAPGDAVHKIYPSAYIKVFDLRQCHRQMQQQAATAQAAAAAQAAAVAGNIPGPGSVGGIAPAISLSAAAGIGVDDLRRLCILRMSFVKGWGPDYPRQSIKETPCWIEIHLHRALQLLDEVLHTMPIADPTPLD,,BMP signaling pathway (GO:0030509) (0.7511); anatomical structure morphogenesis (GO:0009653) (0.7057); cell differentiation (GO:0030154) (0.6685); transforming growth factor beta receptor signaling pathway (GO:0007179) (0.4585); regulation of developmental process (GO:0050793) (0.4151); SMAD protein signal transduction (GO:0060395) (0.3448); regulation of multicellular organismal process (GO:0051239) (0.2918); regulation of DNA-templated transcription (GO:0006355) (0.1427); post-embryonic development (GO:0009791) (0.1385); regulation of transcription by RNA polymerase II (GO:0006357) (0.1234),cytoplasm (GO:0005737) (0.3373); heteromeric SMAD protein complex (GO:0071144) (0.2587),"metal ion binding (GO:0046872) (0.4384); DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981) (0.3023); RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978) (0.2592)","SMAD MH1 domain superfamily (IPR036578) (0.3354); SMAD/FHA domain superfamily (IPR008984) (0.2072); SMAD domain, Dwarfin-type (IPR001132) (0.1984); SMAD-like domain superfamily (IPR017855) (0.1408); MAD homology 1, Dwarfin-type (IPR003619) (0.1246); Dwarfin (IPR013790) (0.1185)",3.90.520.10 (0.5545); 2.60.200.10 (0.1270),Zinc (0.9219); Ubl conjugation (0.6707); Cytoplasm (0.4827); Reference proteome (0.4099); Transcription regulation (0.2435); Nucleus (0.2117); Transcription (0.1961); Coiled coil (0.1738),
MDMQPLHTNKMRSDILIALFLTAVIVPLCTSQSVCPGTDNKLSTLSDLDQQYKTLRKFYENCEVVMGNLEITSIERNRNLSFLKSIREVTGYVLVALNQFDYLPLENLRIIRGTKLYEGRYSLAIFLNYRRDGYFGLRQLGLKNLTEILNGGVYVDQNKFLCHADTIHWHDIIKNPRSELLVVPSNNSGNTCRRCHRSCNGRCWGHQEDQCQSLTKTVCAEQCDGRCFGPYVSNCCHRECAGGCFGPKDTDCFACTNFNDSGACVTQCPQPFVYNPTTFQLEHNPNAKYTYGAFCVKKCPHNFVVDHSSCVRACPSNKMEVEENQTKMCIPCTDICPKVCDGIGTGSLQMAQTVDSSNIEKFVNCTKINGNLIFLITGIKGDMFHGIRALDPDRLNVFRTVREITGFLNVQSWPENMTDLGVFSNLATIGGRSLYSGISLLILKQRWITSLQFQSLREISAGNVYMTNNSQLCFYSTVNWTSLFRTSTQRALIKNNREPRECSKEQKICDPLCSEAGCWGPGPDQCLSCKYFSRGKTCVKSCNLYYGDVREFANGSVCVECDSQCEKAGEKGLTCHGPGPDHCVKCLHLKDGPNCVEKCPDGLQGANSFIFKYAETNNECHPCHPNCTQGCTGPRIQDCVGILDRTPLIAAGLIGGLFVIVIIALGVAVYIRRKSIKKKRALRRFLETELVEPLTPSGAAPNQAQLRILKETELKRVKILGAGAFGMVYKGIWVPEGETVKIPVAIKILNESTGPKANVEFMDEALIMASMEHPHLVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHQDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHIKITDFGLARLLDTDEKEYNSDGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRDIPDILEKGERLPQPPICTIDVYMVMVKCWMIDADSRPRFKELAAEFSRMARDPQRYLVIQGDDRMKLPSPNHSTFFKSLLDEEELDDLMDADEYLVPQTCNISTSTYTSRTTMDASWTLRCRDRVFSPEDGMGACSRDVPASASAVFVPVSTQAAGLNVLEEQHCNGSLKKQQPMSGSGDDCDGQRYSADPTVFLGERSLKNTDEDGYMSPMNKSTSDHLSPVEENPFVNHRKNGNITALDNPGYHSTPDKKSKAEEDEYINEPLYLNAYNTTGGTNLEIMRRNGSSIPLQMTTATSAASSHIILSTQPGKAHHHGQGTHVHFAIPPVQPPQTRAMSQNGQHSQSSHAVESNSSSMSANPSLLSQISLVSQQIQPCLASQSQVPKSTVPNKSISGLPGHLVYPVNMLQTGHTGTVMADRKSKKNFDNPDYWQHSLPPKVTQANPQDPTQTCKSKHLYRHSIRSRLAVADNPEFVSEFNKRPGPVLPPPPYRHRNTVV,receptor protein-tyrosine kinase (2.7.10.1) (0.8944),regulation of signaling (GO:0023051) (0.6354); protein phosphorylation (GO:0006468) (0.5351); regulation of cell communication (GO:0010646) (0.4648); positive regulation of kinase activity (GO:0033674) (0.3630); neurogenesis (GO:0022008) (0.3413); ERBB signaling pathway (GO:0038127) (0.3353); positive regulation of cell population proliferation (GO:0008284) (0.2036); cell surface receptor protein tyrosine kinase signaling pathway (GO:0007169) (0.1172),basal plasma membrane (GO:0009925) (0.4406); receptor complex (GO:0043235) (0.2560); membrane (GO:0016020) (0.0980),ATP binding (GO:0005524) (0.4600); transmembrane receptor protein tyrosine kinase activity (GO:0004714) (0.3051); epidermal growth factor receptor binding (GO:0005154) (0.1311),"Protein kinase domain (IPR000719) (0.5439); Serine-threonine/tyrosine-protein kinase, catalytic domain (IPR001245) (0.3618); Epidermal growth factor receptor-like, transmembrane-juxtamembrane segment (IPR049328) (0.3231); Tyrosine-protein kinase, active site (IPR008266) (0.2504); Growth factor receptor domain 4 (IPR032778) (0.2130); Furin-like cysteine-rich domain (IPR006211) (0.1951); Receptor L-domain (IPR000494) (0.1550); Epidermal growth factor receptor, juxtamembrane domain (IPR044912) (0.1238); Receptor Tyrosine Kinase (IPR050122) (0.1203); Growth factor receptor cysteine-rich domain superfamily (IPR009030) (0.1109)",1.10.510.10 (0.1844),Tyrosine-protein kinase (0.9946); Receptor (0.6512); Phosphoprotein (0.3093); Membrane (0.3086); Nucleotide-binding (0.2988); Kinase (0.1752); Signal (0.1650); Transferase (0.1583); Transmembrane helix (0.1429); ATP-binding (0.1260); Reference proteome (0.1069),
MASGARYAGKVVVVTGAARGIGAGIARAFVDSGAQVVICDKDERGGRALEQELRGAVFIRCDVTREEDVRALLSDTVHRFGRLDCVVNNAGSHPPLQPLEETTAQGFRELLELNLLGTYTLCKLAFPHLRRSRGNIINISTLVGAVGQLQGVPYAATKGAVTALTKALALDESQYGVRVNCISPGNIWTPLWQELAALAPDPRAAIREGAMAQPLGRMGQPAEVGAAAVFLASEASFCTGLELFVTGGAELGSGPENFFRSLGLCVVPEDVPPPTSRPRICSYK,7alpha-hydroxysteroid dehydrogenase (1.1.1.159) (0.3664); carbonyl reductase (NADPH) (1.1.1.184) (0.1093); 1.1.1.- (0.1058); 17beta-estradiol 17-dehydrogenase (1.1.1.62) (0.0570),fatty acid metabolic process (GO:0006631) (0.3215); retinal metabolic process (GO:0042574) (0.2119); steroid catabolic process (GO:0006706) (0.1219); response to toxic substance (GO:0009636) (0.1018); bile acid biosynthetic process (GO:0006699) (0.0905); steroid metabolic process (GO:0008202) (0.0888),peroxisomal membrane (GO:0005778) (0.2081); peroxisome (GO:0005777) (0.1500); plasma membrane (GO:0005886) (0.0812); cytoplasm (GO:0005737) (0.0618),testosterone 17-beta-dehydrogenase (NADP+) activity (GO:0047045) (0.3483); identical protein binding (GO:0042802) (0.3267); retinal dehydrogenase activity (GO:0001758) (0.0757),"Short-chain dehydrogenase/reductase, conserved site (IPR020904) (0.2734); NAD(P)-binding domain superfamily (IPR036291) (0.2233); Short-chain dehydrogenase/reductase SDR (IPR002347) (0.2118)",3.40.50.720 (0.2164),Reference proteome (0.6612); Peroxisome (0.4370); Oxidoreductase (0.3237); 3D-structure (0.2031); Acetylation (0.1915); Direct protein sequencing (0.1004); Proteomics identification (0.0752); Phenylalanine catabolism (0.0494),
MLISSKQLPIGRSQSWDTLGGNEGHWERSDSVYEQQARMAGRRNSLSYGADAGGGWYEPAPGVRPPDLDLKREPEAYQESLYNQGYLDRPDPRNIRKSSVPELNSHYDRPPIAHRGTMPPHDYYQQDPGMPSRPTEGFYRGEQPHSLNRSSSHYGMMAGPRQIWEQGSGGRPGSVAPTPGVPPPPPPTVHDMGRIYRDPMLSGPLPATPGTKMMHEGQRIPSRAQSPARYIMEPNSPRYAAEPPASLTSHTVYSDVNGRPIDPHQPTATCLVVDPVAQGMDGTSRGMVMHPENPSPYTIQQQQQAQQQQQMQQQIQQQQMQQVQPVQQMQQVQPVQQMQQVQPVQQMQQAQPVQQMQQAQPVQQMQPVQPVQQMQPVQQVQQVPQVQPVQQVPHVQPVASPNPIYTPVPPVAPAPVTTPGVAVIPAPLPQLPAQPLTAAPPPSVPQTPVAPVDPKKNADPEFLALLHKEGLSESTINSLLQQGFDSTAMLAVMEENDVRSVAPNLGQARVLSRVVLCCKRPPEIVPATPLHPSAPARGRSNSFSHRSDIYVHQPPPLTPGLESQYIQPPSTPMQTMSPRIGDGYSRRPSSAPSQQLLETSGYPGPRVSGVYSGAMVPVQPRPLSGYNPHSGLPVTAMSQQVAIPAHLPGIQQQMAALPPQIHAMPLPALSAVPQSMTVPALAPQQAPKAYTTNYTVPMELMKRDRSLATMSPMPSPHLSPQVMRKAGVSSDGALVPIGGAVPGQNMNLANQKLSRRTGPPVIVSTMASPDTSIRPQIMNGPMHPRPLVALLDGRDCTVEMPILKDLATVAFCDAQSTQEIHEKVLNEAVGAMMYHTITLTREDLEKFKALRIIIRIGSGYDNIDIKAAGEMGIAVCNIPSAAVEETADSTLCHILNLYRRNTWLYQAMREGTRVQSVEQIREVASGAARIRGETLGLIGFGRSGQAVAVRAKAFGFNVIFYDPYLQDGLERSLGVQRVYTLQDLLYQSDCVSLHCNLNEHNHHLINDFTIKQMRQGAFLVNTARGGLVDEKALAQALKEGRIRGAALDVHESEPFSFTQGPLKDAPNLICTPHTAWYSEQASLEMREAAATEIRRAITGRIPDSLRNCVNKEFFVTTAPWGVMEQQVHPELNGGAYRVAQPLPAVSPGGLQDKMYT,,regulation of transcription by RNA polymerase II (GO:0006357) (0.5003); synaptic vesicle docking (GO:0016081) (0.4666); cellular response to leukemia inhibitory factor (GO:1990830) (0.3654); synaptic vesicle clustering (GO:0097091) (0.2723); positive regulation of transcription by RNA polymerase II (GO:0045944) (0.1947); white fat cell differentiation (GO:0050872) (0.1298),photoreceptor ribbon synapse (GO:0098684) (0.2292); nucleus (GO:0005634) (0.1682),"transcription corepressor activity (GO:0003714) (0.6920); transcription coactivator activity (GO:0003713) (0.1867); chromatin binding (GO:0003682) (0.1811); structural constituent of presynaptic active zone (GO:0098882) (0.1575); DNA-binding transcription factor binding (GO:0140297) (0.0958); oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616) (0.0833)","C-terminal binding protein (IPR043322) (0.5235); C-terminal-binding dehydrogenase (IPR051638) (0.2923); D-isomer specific 2-hydroxyacid dehydrogenase, catalytic domain (IPR006139) (0.2528); D-isomer specific 2-hydroxyacid dehydrogenase, NAD-binding domain conserved site (IPR029753) (0.2470); D-isomer specific 2-hydroxyacid dehydrogenase, NAD-binding domain (IPR006140) (0.1948); NAD(P)-binding domain superfamily (IPR036291) (0.1794)",3.40.50.720 (0.2692),Oxidoreductase (0.2191); Reference proteome (0.1972),
MEPTVPTIPAIMFIFGVISNLIAIVVLCKSRREQKETTFYTLVCGLAVTDLLGTVLASPVTIATYVKGAWPDGDPLCQYFGFVLLFFSLAGLSIICAMSIERYIAINHAYFYNDYVDKRLAGVTLLAIYASNILFCALPSVGFGEVKMQYPQTWCFIDWRTNVSAHAAFSYMYAGCSSLLILVTVVCNVLVCGALIRMHRRFVRRTSLGTDPQRAADPGRSRSFSRLAGAEIQMVILLIATSAVVLICSIPLVVQVFLNQLYKTPVEKRLDKNPDLLAIRFASTNPILDPWIYILLRKAVLSKVVENIKCLFCRSDSRGQQTQNSLLCINGQQFSSRDSPSAVSRELQDVSSTSQTSLNLAKAPDGGQNSSSESCRCSSHDGQCKKQSLQMSITNDSVQEKSI,,negative regulation of cytokine production (GO:0001818) (0.5826); adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193) (0.5018); response to nematode (GO:0009624) (0.4477); negative regulation of inflammatory response (GO:0050728) (0.3911); inflammatory response (GO:0006954) (0.2931); adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189) (0.2630); response to lipopolysaccharide (GO:0032496) (0.2304); T-helper cell differentiation (GO:0042093) (0.1934); positive regulation of cytosolic calcium ion concentration (GO:0007204) (0.1834); regulation of stress fiber assembly (GO:0051492) (0.1801); negative regulation of integrin activation (GO:0033624) (0.1679); adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188) (0.1634); response to prostaglandin E (GO:0034695) (0.1536); negative regulation of eosinophil extravasation (GO:2000420) (0.1246); cellular response to prostaglandin E stimulus (GO:0071380) (0.1111); regulation of ossification (GO:0030278) (0.1051); G protein-coupled receptor signaling pathway (GO:0007186) (0.0929); response to mechanical stimulus (GO:0009612) (0.0679),plasma membrane (GO:0005886) (0.2545),prostaglandin E receptor activity (GO:0004957) (0.4489),"Prostanoid receptor (IPR008365) (0.4818); Prostanoid EP4 receptor (IPR001758) (0.3477); GPCR, rhodopsin-like, 7TM (IPR017452) (0.2204); Prostaglandin DP receptor (IPR001244) (0.2028)",,Transmembrane helix (0.7205); Reference proteome (0.7051); Transducer (0.6107); Membrane (0.5918); Receptor (0.4410); G-protein coupled receptor (0.3350); Phosphoprotein (0.2092); Glycoprotein (0.1944); Disulfide bond (0.1355); Cell membrane (0.1335); Proteomics identification (0.1045); Tumor suppressor (0.1014),
MKHLTWISALSLLLSFTLGTADHRQRRQISVMSGLGVCRYGSRLECCYGWKKNTKGQCEAQCDLGCKHGECVGPNKCKCFPGYTGKTCSQDLNECGLKPRPCEHRCMNTFGSYMCYCLNGYMLMPDGSCANSRTCSLAHCQYGCEEVQSEVRCLCPSPGLQLGSDGKTCEDIDECATGKNQCPFNRQCTNTFGSYYCKCQPGYDLKYINGKYDCVDVNECTSNTHKCSHHAECINTLGSYKCKCKQGFRGSGFDCSVKPFYHRSWDSSKGNTDVLVNAIPDFPSKTRILGKFENSIPEPVLTESPRQHLQPFDYDGEVYIGAPQETPVFPEEEEVEEEEEEDTENQLEDEELTSRGDVFSQDDFVSFYQSELELKEIQAAPLKERFLTDCDFDRGACEWVQDNADDLDWTIKYHPDGREYYLALEGPVGNRREQARMKLLLEDHMRQSSFCLRFDFRIEGPQTGVLRVKLDNSAISIWERKQSQKQSWQSEQISISWTDSNPEAVVFEAERGRSGTGEIALDHVLLISGECSEDKTLDF,,cell adhesion (GO:0007155) (0.8913); regulation of Notch signaling pathway (GO:0008593) (0.5990); ERK1 and ERK2 cascade (GO:0070371) (0.5772); positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050) (0.4584); notochord development (GO:0030903) (0.4498); positive regulation of sprouting angiogenesis (GO:1903672) (0.2632); extracellular matrix organization (GO:0030198) (0.2109); phosphatidylinositol 3-kinase/protein kinase B signal transduction (GO:0043491) (0.1798); positive regulation of cell-substrate adhesion (GO:0010811) (0.0485),basement membrane (GO:0005604) (0.3815); membrane (GO:0016020) (0.3772); extracellular matrix (GO:0031012) (0.1516); extracellular region (GO:0005576) (0.1220),calcium ion binding (GO:0005509) (0.4263); integrin binding (GO:0005178) (0.2818); extracellular matrix binding (GO:0050840) (0.1068),"NOTCH1 EGF-like calcium-binding domain (IPR049883) (0.5718); Concanavalin A-like lectin/glucanase domain superfamily (IPR013320) (0.3815); Nephronectin domain-containing protein (IPR052235) (0.3805); MAM domain (IPR000998) (0.3404); EGF-like calcium-binding, conserved site (IPR018097) (0.3182); EGF-type aspartate/asparagine hydroxylation site (IPR000152) (0.2951); EGF-like domain (IPR000742) (0.2452); EGF-like calcium-binding domain (IPR001881) (0.1703); Growth factor receptor cysteine-rich domain superfamily (IPR009030) (0.1398)",2.10.25.10 (0.3821); 2.60.120.200 (0.1523),Repeat (0.8975); Secreted (0.8127); Signal (0.7121); Calcium (0.6212); Disulfide bond (0.6034); Cell adhesion (0.4826); Extracellular matrix (0.4420); Reference proteome (0.3685); Differentiation (0.3679); EGF-like domain (0.3207); Developmental protein (0.3117); Basement membrane (0.0500),
MALSTLWLVLMLWTSLFSDSQCSTLSQAELQELEQIHTWVVSRSFPCSVTCGLGLLTQELCPIGVTRNISTSSCKLRTISCLDSWQCGLKTQTATVGRRLVLDCLEEVMEAMGRFSFVVSWRFAFAIITTDDSLFTRYEALSLDKVVLDPLREEDSGTYRCDVLDTGKRRVKRMYKGVKVLSPKDLSLDFAQGLIHWEIPESRFANLTSSRKVYSSSTIRNIVIISVPLSFAIAVVIFIFLFCYSRRARRAAHLCQDNI,,fertilization (GO:0009566) (0.3987); fusion of sperm to egg plasma membrane involved in single fertilization (GO:0007342) (0.3287); spermatid development (GO:0007286) (0.2306); apoptotic process (GO:0006915) (0.1487); heterotypic cell-cell adhesion (GO:0034113) (0.1370); negative regulation of cell migration (GO:0030336) (0.1002); negative regulation of regulatory T cell differentiation (GO:0045590) (0.0980); cell differentiation (GO:0030154) (0.0844),extracellular region (GO:0005576) (0.6704); external side of plasma membrane (GO:0009897) (0.1513); plasma membrane (GO:0005886) (0.1429); cell surface (GO:0009986) (0.1046); acrosomal vesicle (GO:0001669) (0.1018); cell projection (GO:0042995) (0.1005),,Immunoglobulin subtype (IPR003599) (0.2465); Immunoglobulin-like domain (IPR007110) (0.1593); Immunoglobulin-like domain superfamily (IPR036179) (0.1382); Immunoglobulin-like fold (IPR013783) (0.1189),2.60.40.10 (0.0665),Signal (0.9729); Cell membrane (0.7099); Reference proteome (0.7043); Membrane (0.6619); Transmembrane helix (0.4713); Disulfide bond (0.3979); Glycoprotein (0.3369); Immunoglobulin domain (0.2342); Transmembrane (0.2287); Alternative splicing (0.2174); Cytoplasmic vesicle (0.0828),
MSDSQQSVEVLNQLLARLSVATPDNRDEVATEVSSFVNGNIIEHDAPEHFFNGLAKAIKDKKSAVNALAAVSHVASTSGLAPSVEPYVVALVPAILEQTGSKDKDVQSAANAALHAVVTAVNPVAVKAVLPHLTKSLSETNKWQEKVAVLSAISALVDQAKSQISLRMTELIPVLSEAMWDTKKEVKNAATATMTKATETVENKDIERFIPKLIECIANPSEVPETVHLLGATTFVAEVTPATLSIMTPLLSRGLAERETPIKRKSAVIIDNMCKLVEDPQIVAPFLNKLLPGLKNNFSVIADPEAREVTLRGLKTLRRVGAVGEGDVLPEISHAGDPATTLGVLDSLLKTENIAKKFRPAVEYISCIGGDLIDERIIDQQTWFTHVLPYMTIFLHQNQAKEILDEFRKRAVDNIPEPPKFDDEEEEGEDLCNCEFSLAYGAKILLNRTQLRLKRGRRYGLCGPNGSGKSTLMRAIANGQVDGFPSQEECRTVYVEHDIDGTHAETSVLDFVFQGDVGTKEAISAKLKEFGFDDEMIVMPIAALSGGWKMKLALARAVLKNADILLLDEPTNHLDTVNVAWLTNYLITCGITSIVVSHDSGFLDNICQYIIHYEGLKLRKYKGNLSALVERVPSAKSYYELGASDLEFRFPEPGYLEGVKTKQKAIVKVSNMTFQYPGTSKPQISDVSFQCSLSSRIAVIGPNGAGKSTLINVLTGELLPTTGEVYTHENIRIAYIKQHAFAHIESHLDKTPSEYIQWRFQTGEDRETMDRANRQINEDDAQAMNKIFKIDGTPRRIAGIHSRRKFKNSYEYECSFLLGENIGMKSERWVPMMSVDNAWLPRGEVIESHGKMVAEVDMKEALASGQFRPLTRKEIEEHCAMLGLDAELVSHSRIRGLSGGQKVKLVLAAGTWQRPHLIVLDEPTNYLDRDSLGALSKALKEFEGGVIIITHSAEFTKDLTEEVWAVRDGLMTPSGHNWVSGQGSGPRLEKKEDEEDKFDAMGNKISSGTKKTKLSSAELRKKKKERMKKKKELGDAYVSDDDADF,3.6.4.- (0.6673); 3.6.1.- (0.0635); adenosinetriphosphatase (3.6.1.3) (0.0478),translational termination (GO:0006415) (0.1170); translation (GO:0006412) (0.1040),cytoplasm (GO:0005737) (0.5968); cytosol (GO:0005829) (0.0689),translation elongation factor activity (GO:0003746) (0.6189); ATP hydrolysis activity (GO:0016887) (0.4495); ATP binding (GO:0005524) (0.2330); RNA binding (GO:0003723) (0.1722); ribosome binding (GO:0043022) (0.1415),"ABC transporter-like, ATP-binding domain (IPR003439) (0.5656); Elongation Factor 3, chromodomain-like insertion superfamily (IPR047038) (0.5121); P-loop containing nucleoside triphosphate hydrolase (IPR027417) (0.4061); ABC transporter-like, conserved site (IPR017871) (0.3806); Elongation factor 3, four helical bundle domain superfamily (IPR047036) (0.2762); AAA+ ATPase domain (IPR003593) (0.2344); ATP-binding cassette sub-family F member, EF3 subfamily (IPR050611) (0.2006); Elongation factor 3, four helical bundle domain (IPR040533) (0.1690); HEAT, type 2 (IPR021133) (0.1670)",2.40.50.990 (0.4513); 1.20.1390.20 (0.3155); 1.25.10.10 (0.2873); 3.40.50.300 (0.2711),RNA-binding (0.8148); Nucleotide-binding (0.3896); ATP-binding (0.3896); Elongation factor (0.3742); rRNA-binding (0.3367); Protein biosynthesis (0.1682); Transmembrane (0.1615); Reference proteome (0.0710),
MAGSEPVRAEGETMAVDAAPRKPRILLAASGSVAAVKFANLCHCFSEWADVRAVSTSASLHFIDRAAMPKDVILYTDDNEWSSWKKLGDSVLHIELRKWADIMVIAPLSANTLGKIAGGLCDNLLTCIVRAWDYSKPFFVAPAMNTFMWNNPFTERHLISIDELGISLIPPVTKRLACGDYGNGAMAEPSTIYSTVRLFYESKAQQGNGDI,phosphopantothenoylcysteine decarboxylase (4.1.1.36) (0.9004),response to salt stress (GO:0009651) (0.3065); regulation of cell growth (GO:0001558) (0.2579); protein homotrimerization (GO:0070207) (0.2524); response to glucose (GO:0009749) (0.2094); response to heat (GO:0009408) (0.1417); response to sucrose (GO:0009744) (0.0968); coenzyme A biosynthetic process (GO:0015937) (0.0960),mitochondrion (GO:0005739) (0.2306); nucleus (GO:0005634) (0.1375); plasma membrane (GO:0005886) (0.1269),identical protein binding (GO:0042802) (0.4638); FMN binding (GO:0010181) (0.2688); phosphopantothenoylcysteine decarboxylase activity (GO:0004633) (0.1879); metal ion binding (GO:0046872) (0.1066),Flavin prenyltransferase-like (IPR036551) (0.3340); Flavoprotein (IPR003382) (0.1826),3.40.50.1950 (0.4546),FMN (0.5131); Reference proteome (0.4934); Flavoprotein (0.3851); Decarboxylase (0.3393); Stress response (0.2612); Isopeptide bond (0.2606); Ubl conjugation (0.2194); Coenzyme A biosynthesis (0.1132); Growth regulation (0.0981); Phosphoprotein (0.0447),FMN (0.5131)
MAGSEPVSAEGESMAVDAAPRKPRILLAASGSVAAVKFANLCHCFSEWADVRAVSSSGSLHFIDRASMPKDVILYTDEDEWSSWKKLGDSVLHIELRKWADIMVIAPLSANTLGKIAGGLCDNLLTCIVRAWDYSKPFFVAPAMNTLMWNNPFTERHFISIDELGISLIPPVTKRLACGDYGNGAMAEPSTIYSTVRLFYESKAQQGRAVVTLR,phosphopantothenoylcysteine decarboxylase (4.1.1.36) (0.9040),response to salt stress (GO:0009651) (0.2789); regulation of cell growth (GO:0001558) (0.2753); protein homotrimerization (GO:0070207) (0.2502); response to glucose (GO:0009749) (0.2371); response to sucrose (GO:0009744) (0.1197); response to heat (GO:0009408) (0.1176); coenzyme A biosynthetic process (GO:0015937) (0.1116); response to abscisic acid (GO:0009737) (0.0768),mitochondrion (GO:0005739) (0.2002); nucleus (GO:0005634) (0.1478); plasma membrane (GO:0005886) (0.1352),identical protein binding (GO:0042802) (0.4964); FMN binding (GO:0010181) (0.2369); phosphopantothenoylcysteine decarboxylase activity (GO:0004633) (0.2031); metal ion binding (GO:0046872) (0.0850),Flavin prenyltransferase-like (IPR036551) (0.3533); Flavoprotein (IPR003382) (0.1883),3.40.50.1950 (0.4497),Reference proteome (0.6174); FMN (0.5394); Decarboxylase (0.3462); Flavoprotein (0.3339); Growth regulation (0.1930); Stress response (0.1812); Isopeptide bond (0.1624); Coenzyme A biosynthesis (0.1368); Ubl conjugation (0.1320); Phosphoprotein (0.0405),FMN (0.5394)
MKKFCLIFLLLALTALHVKGSPIPDEESEETEDAEQEEDAEEEEHAEEEAQEDGDQTQDTDQESDDGQEETANQGSDEQQEEDGSHGTDETDDEAAGSRTEDVESGGDEQNDGEENGSQENGEEVTGGEDDSHGAQDSEGGEEDAAAQEAGGKKSKGKGAKGGQGSNRAGSSSGGEESAAHTYQEVMRILNGIKINAKEPLKSRLVNGLQYLKVDTINRVENIQKFSRIEHCFGNLDHIVQLYAGDAVERNDYCKGTCIDMVSNEFRGQMEELTSRLYPCLQGGYY,,killing of cells of another organism (GO:0031640) (0.2638); innate immune response in mucosa (GO:0002227) (0.2341); fertilization (GO:0009566) (0.1598); biomineral tissue development (GO:0031214) (0.1253); intracellular calcium ion homeostasis (GO:0006874) (0.1113); response to oxidative stress (GO:0006979) (0.1003); negative regulation of gene expression (GO:0010629) (0.0860); embryo implantation (GO:0007566) (0.0825); defense response to fungus (GO:0050832) (0.0819); cell adhesion (GO:0007155) (0.0769); response to calcium ion (GO:0051592) (0.0700); defense response to bacterium (GO:0042742) (0.0600); vasodilation (GO:0042311) (0.0454),extracellular region (GO:0005576) (0.2474); secretory granule (GO:0030141) (0.1126); blood microparticle (GO:0072562) (0.0658),cadmium ion binding (GO:0046870) (0.4795); hormone activity (GO:0005179) (0.0512),,,Secreted (0.8680); Signal (0.7100); Metal-binding (0.3713); Direct protein sequencing (0.3228); Reference proteome (0.2627); Glycoprotein (0.2339); Antimicrobial (0.1492); 3D-structure (0.1104); Disulfide bond (0.1088); Biomineralization (0.0887); Pyrrolidone carboxylic acid (0.0692); Zinc (0.0673),
MFRRERSIPLRGSAAALSNNLSVLQLPARDLTHFGVVHGPSAQLLSAAPEGVPLAQRQLHVKEGAGVSPPLITQVHWCVLPFRVLLVLTSHRGIQMYESDGSVMVYWHALDSGDASSVQAMFARGIAASVHFICVGTWSGRILVFDIPAKGPNIVLNEELAGHQTPITDIATERAQGQDGVADMVTADDSGVLCVWRSGPEFTLLTRIAGFGVPCPSVQLWQGIVAAGYGNGQVRLYDAGTGALHIQISAHARTISALDLAPEVGKLLSAAEDTFVHIWKLNRNPESGSIEVEHCHGECISDTQVCGARFCDPGGSSFAVTGYDLAEILRFGSV,,intraciliary transport (GO:0042073) (0.3199); cilium assembly (GO:0060271) (0.2773); protein transport (GO:0015031) (0.2178); negative regulation of autophagy (GO:0010507) (0.1967); endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888) (0.1503); protein localization to synapse (GO:0035418) (0.0983); ubiquitin-dependent protein catabolic process (GO:0006511) (0.0959); vacuolar protein processing (GO:0006624) (0.0674); establishment of mitotic spindle orientation (GO:0000132) (0.0652); protein secretion (GO:0009306) (0.0582); lysosome localization (GO:0032418) (0.0508); vesicle-mediated transport (GO:0016192) (0.0503),intracellular membrane-bounded organelle (GO:0043231) (0.4606); endosome membrane (GO:0010008) (0.1609); membrane (GO:0016020) (0.1302); cilium (GO:0005929) (0.0933); axoneme (GO:0005930) (0.0645); cytoplasm (GO:0005737) (0.0625),,WD40-repeat-containing domain superfamily (IPR036322) (0.3044); WD40/YVTN repeat-like-containing domain superfamily (IPR015943) (0.2564),2.130.10.10 (0.2117),Reference proteome (0.9158); WD repeat (0.8955); Repeat (0.6397); Proteomics identification (0.4628); Transport (0.4549); Cell projection (0.2147); Differentiation (0.2102); Cytoplasm (0.1783); Cilium (0.1495); Spermatogenesis (0.1417); Cilium biogenesis/degradation (0.1218); Alternative splicing (0.0870); Cytoskeleton (0.0801); Golgi apparatus (0.0781); Developmental protein (0.0764); Protein transport (0.0691); Vacuole (0.0542); Zymogen (0.0507),
MAAVTRYSGKVVVVTGGSRGIGAAIVRAFVDSGAQVVFCDKDEAGGRALEQELSGTVFIPGDVTQERDLQTLVSETLSRFGHLDCVVNNAGYHPPAQLPEETSAQGFRQLLEVNLLGTYTLIKLALPHLRKSRGNIINISSLVGAIGQSQALTYVATKGAVTAMTKALALDESRHGVRVNCISPGNIWTPLWEELAASTSDPRATILEGTLAQPLGRMGQPAEVAAAAVFLASEATFCTGLELLVTGGAELGYGRKASKSSLGEVPTLPPNVH,1.1.1.- (0.3051); 17beta-estradiol 17-dehydrogenase (1.1.1.62) (0.1867); 7alpha-hydroxysteroid dehydrogenase (1.1.1.159) (0.1072),fatty acid metabolic process (GO:0006631) (0.1632); bile acid biosynthetic process (GO:0006699) (0.1469); steroid catabolic process (GO:0006706) (0.1143); C21-steroid hormone metabolic process (GO:0008207) (0.1036); lipid metabolic process (GO:0006629) (0.0862); protein heterotetramerization (GO:0051290) (0.0610); androgen metabolic process (GO:0008209) (0.0582); adipose tissue development (GO:0060612) (0.0439),peroxisomal membrane (GO:0005778) (0.0987); nucleoplasm (GO:0005654) (0.0932); peroxisome (GO:0005777) (0.0641); cytoplasmic microtubule (GO:0005881) (0.0515); cytosol (GO:0005829) (0.0407),identical protein binding (GO:0042802) (0.3981); testosterone 17-beta-dehydrogenase (NADP+) activity (GO:0047045) (0.1792); testosterone dehydrogenase (NAD+) activity (GO:0047035) (0.1361); aldo-keto reductase (NADPH) activity (GO:0004033) (0.0450),"Short-chain dehydrogenase/reductase, conserved site (IPR020904) (0.3683); Short-chain dehydrogenase/reductase SDR (IPR002347) (0.2286); NAD(P)-binding domain superfamily (IPR036291) (0.1242)",,Reference proteome (0.4535); Peroxisome (0.3917); Oxidoreductase (0.2161); Acetylation (0.1601); 3D-structure (0.0872); Plastid (0.0501),
MTVNLTELDAHEQPSDQMRAIWKSYSRADKEELLLNGAIDDLEKPEKAAEFVVAGTVPAATLTKGFAFLGSGFDAAASDAPIYYHPLLPGLLIFPSIVPLEVQKTLLSKLIHRDLSVPAHQTNMHLHYELPYVERKPTDGEGEPEDCRQSFFSHSPDSPVRFQPKDPDVHKPLSMKQVMDRRLHWVTLGGQYDWTNRVYPEEEPPKFPPDVAGFLETVFPDTIAQAAIVNFYTPGDTMMMHRDVSEETDKGLVSLSLGCDGLFMIAPSDIGKMSEEERPEDVKKQYLLLRLRSGDAIYMIKESRYAWHGVPKVLKGTCPEALEDWPAEDGRFEEWRGWMKNKRINLNVRQMRE,DNA-(apurinic or apyrimidinic site) lyase (4.2.99.18) (0.2583); 1.14.11.- (0.2407),DNA repair (GO:0006281) (0.5771); methylation (GO:0032259) (0.0938); mitochondrial genome maintenance (GO:0000002) (0.0691),nucleus (GO:0005634) (0.4805); cytoplasm (GO:0005737) (0.4168); plasma membrane (GO:0005886) (0.0599),dioxygenase activity (GO:0051213) (0.1692); broad specificity oxidative DNA demethylase activity (GO:0035516) (0.1466); class I DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0140078) (0.1463); methyltransferase activity (GO:0008168) (0.0934); ferrous iron binding (GO:0008198) (0.0825),Alkylated DNA repair protein AlkB (IPR004574) (0.3286); Alpha-ketoglutarate-dependent dioxygenase AlkB-like (IPR027450) (0.2018),,Oxidoreductase (0.5110); DNA repair (0.4687); Metal-binding (0.3879); Reference proteome (0.3437); Nucleus (0.2795); Dioxygenase (0.2419); DNA damage (0.2386); Iron (0.1726); Methyltransferase (0.1443),
MGLLLKMKMQNQHHPLASKLQEQTGNKRYTFIQAHRAWLLKLMFLWILLMALISRIIYSKMDVGTKVRRKEVLGSLCDQRARMLQDQFSVSVNHVHALAILVSTFHYYRNPSAIDQETFAEYTARTAFERPLLSGVAYAQRVVNSEREQFEKQHGVVIKTMEREASPVRDEYAPVIFAQETVSYLESIDMMSGEEDRENIMRARATGKAVLTSPFRLLGSHHLGVVLTFPVYKSKLPPNPTTEELIKATAGYVGGSFDVESLVENLLGQLAGHQAILVNVYDVTNSSDPLIMYGNQYEEGDVSLVHESKLDFGDPYRKHQMICRYHQKAPPNWTALSTAILFFVILLLIGYILYGAGNHIVKVEDDFHEMQELKVRAEAADVAKSQFLATVSHEIRTPMNGILGMLGLLLRTELNSTQRDYAQTAQACGKALIALINEVLDRAKIEAGKLELEAVPFDLRSILDDVLSLFSEKSRHKGLELAVFVSDKVPDIVMGDPGRFRQIVTNLVGNSVKFTERGHIFVKVHLSENRKPVTNGKHETYRNGGSEEVVHASGGYNLKTLSGYEAADERNNWDNFNHLIADEEFFCDASTKKVASNEFYEQVTLMVCVEDTGIGIPFSAQDRIFMPFVQADSSTSRNYGGTGIGLSISKCLVELMGGQINFISRPQVGSTFSFTADFGIFKKNPITEVKKVNYEDLPSSFRGLKAVVVDGKPVRAAVTRYHLKRLGIQVKVANAINKAVSLCGKNGASSTGLFQPDIIFVEKDSWVCGEDGIFSVRQLDWKQNGHIFKMPQMILLATNISNDEFDKAKSAGFSDTVIMKPLRASMVGACLQQVLGTGKKRQLGKEMPNGSTSVRSLLFGKKILVVDDNVVNRRVAAGALKNFGADVKCADSGKAALEMLQFPHKFDACFMDIQMPEMDGFEATRRIREMERTANEETNSECGERKSEFHLPILAMTADVIHATYEECLKCGMDGYVSKPFEEENLYQAVAKFFQTKPTSVDS,histidine kinase (2.7.13.3) (0.9800),cytokinin-activated signaling pathway (GO:0009736) (0.5293); response to water deprivation (GO:0009414) (0.0979),plasma membrane (GO:0005886) (0.6777); membrane (GO:0016020) (0.0691),phosphorelay sensor kinase activity (GO:0000155) (0.5292); metal ion binding (GO:0046872) (0.1162),"Signal transduction response regulator, receiver domain (IPR001789) (0.6332); Two-component system histidine kinase (IPR050956) (0.6037); CHASE domain (IPR006189) (0.5934); Signal transduction histidine kinase, dimerisation/phosphoacceptor domain (IPR003661) (0.5765); Histidine kinase domain (IPR005467) (0.5763); Histidine kinase/HSP90-like ATPase (IPR003594) (0.5300); CheY-like superfamily (IPR011006) (0.4403); Signal transduction histidine kinase-related protein, C-terminal (IPR004358) (0.2392); Phosphoribosyltransferase domain (IPR000836) (0.2179); CHASE domain superfamily (IPR042240) (0.2099); Histidine kinase/HSP90-like ATPase superfamily (IPR036890) (0.1892); Signal transduction histidine kinase, dimerisation/phosphoacceptor domain superfamily (IPR036097) (0.1778)",3.30.450.350 (0.2579); 6.10.250.1190 (0.1544); 3.30.565.10 (0.1514); 1.10.287.130 (0.1430); 3.40.50.2300 (0.1409),Cytokinin signaling pathway (0.5631); Transmembrane (0.5529); Transferase (0.4833); Membrane (0.3417); Two-component regulatory system (0.3404); Phosphoprotein (0.2921); Reference proteome (0.2678); Transmembrane helix (0.2090); Metal-binding (0.1371); Kinase (0.0760),
MPAREVYLKRPATRRQLEGICTRYDGQQRITQLDCEEGCSKRTQPPQRLNPRYKSPDLIHISFIIVLLCILSMTSSVVAQTTTGSSSSKAAATPILPRQTLPTTISLPPLNISHPVLQLALPPTSSLYLTFSICSLTSNATILPTVLISTSSPASFNLGSKPIRDASTGGIPTSSGGKGYNYKSGRNGATWGLKWSSGFGNWTLNGTSETQVHLLLGLGLGNDGSTLNTTGVGNGNVVVQMGASTSGPLHALSAVYPLLGDTTSTSALIFSPLLYSSPQPEPSYPNYTLPGAQLAFPDFSYSEPLNSSLSSNLTLIVVPTNASPTSTDLGNSICAINAASANSSVSGANNTILKSFQPEWMTVGDEQGFRSYWVLGDLAEQGNYTAWVSDDKGVLSQPAWFATKPAGFPCQLVMPNDVCPNLGYSAPLDANSTAVTSPSGATISPTSPIQTLPDDLLELIVQNLEAFSTSLLSHACGRDLFSHVSSCLDCYSAYRDWLCRIVVPQCGAANSTSGATVIETATSTSTSSGTFPTPSTVLRTPSSPRNPSLPIPAYSYYELLPCMSTCNRADRSCPVSMGIRCPKRKVNAAKSYAFVGDDHSYGDGSAAQGVAAQDRWGNRWCNG,,fungal-type cell wall organization (GO:0031505) (0.2912); axial cellular bud site selection (GO:0007120) (0.1587); mitotic cell cycle (GO:0000278) (0.1028); cellular response to starvation (GO:0009267) (0.0823); cell division (GO:0051301) (0.0821); filamentous growth (GO:0030447) (0.0749); hyphal growth (GO:0030448) (0.0594); establishment of mitotic spindle orientation (GO:0000132) (0.0587); calcium ion homeostasis (GO:0055074) (0.0550); signal transduction involved in filamentous growth (GO:0001402) (0.0546); intracellular calcium ion homeostasis (GO:0006874) (0.0530); cellular response to glucose starvation (GO:0042149) (0.0486); cell adhesion (GO:0007155) (0.0433),endoplasmic reticulum (GO:0005783) (0.4164); plasma membrane (GO:0005886) (0.0780); cytoplasm (GO:0005737) (0.0692); cellular bud scar (GO:0005621) (0.0689),calcium channel activity (GO:0005262) (0.7454),Frizzled cysteine-rich domain superfamily (IPR036790) (0.2766); Stretch-activated cation channel Mid1/Calcium influx-promoting protein Ehs1 (IPR024338) (0.1840),1.10.2000.10 (0.1803),Disulfide bond (0.3103); Membrane (0.1447); Virulence (0.1069); Cell membrane (0.0944),
MSDNTPTPQKNPDTNPYASLISQQIAIIPSFTLESGVTLNNVPVAYKTWGKLNEKADNCLVICHALTGSADVEDWWGPLLGLNKAFDPTRFFIFCGNVIGSPYGTISSVTTNPETGKPFGPEMPGSSVKDDVRLHYIILKSLGVRSVAAVVGGSMGGMTVLEYPLNTPPGFVRAIIPLATSARHSAWCISWGEAQRQSIYSDPDYKDGYYYEIEEEGGKVDLARQPARGLAAARMAALLTYRSRDSFESRFGRRAGGGKSSVPKGGVRIMGGQETTDPSVPSESDLAAKSPSWRAWREHNDGHRSAGARPISRSGSEGPAHREGDAAQAEVVKTQDVKANGNKIGTGGEAPPKIFSAQSYLRYQGDKFTGRFDANCYIHITRKLDTHDLSAPSRDTSLSSLSSGLPSSPDATEEELNARLIHALSLEPPALVIGIESDGLFTTSEQRELAAGIPDAELVVIPSPDGHDGFLLEFEAINGWVEGWLKRKMPEFYERRVINPEEYVQGEEGFGIKKESVFGEAEADVTRW,2.3.1.- (0.5268); homoserine O-acetyltransferase (2.3.1.31) (0.1717); homoserine O-succinyltransferase (2.3.1.46) (0.0786); 3.1.1.- (0.0684),'de novo' L-methionine biosynthetic process (GO:0071266) (0.3802); methionine biosynthetic process (GO:0009086) (0.3383); cellular response to glucose starvation (GO:0042149) (0.1823); cellular response to amino acid starvation (GO:0034198) (0.1626); homoserine metabolic process (GO:0009092) (0.1188); proteolysis (GO:0006508) (0.1165); response to hypoxia (GO:0001666) (0.0671); sulfur amino acid metabolic process (GO:0000096) (0.0531),peroxisome (GO:0005777) (0.1434); cytoplasm (GO:0005737) (0.0908),homoserine O-acetyltransferase activity (GO:0004414) (0.0944),Alpha/beta hydrolase fold-1 (IPR000073) (0.4340); Alpha/Beta hydrolase fold (IPR029058) (0.3787); Homoserine/serine acetyltransferase MetX-like (IPR008220) (0.1352),3.40.50.1820 (0.1097),Virulence (0.9732); Acyltransferase (0.4868); Peroxisome (0.3681); Methionine biosynthesis (0.3376); Reference proteome (0.2966); 3D-structure (0.1202); Amino-acid biosynthesis (0.0823); Hydrolase (0.0717),
MSSASTPTAPYLEDLVRNSLDQNLPWVVQKYGGTSVGKSLDNITKIVGSYIDNGSKVAIVCSARSTQTKSLGTTNLLLQASREALQPAMSSSGDGRSGSMSGTATPFYPKRVGSGFFGKDQSTSMTSSVSSLSQLESQLGRSGSPSPFQSSSSRSPPRSPATPSQDSSISQEPAFHATVDLIKKGHLEAARASLKGGPLRDELEEEIERDCESLRSFLYAAQIIDEISPRSQDSIVGTGERLACKIVAAALRDRGVDSELVVLDNIVDASMSAASEAVSVDAGDQGVAQLGQEFYDQLSFRLGERLRECGQRVPVVTGYFGPVPGSLLAQIGRGYTDLCAALCAVGLKASELQVWKEVDGIFTADPRKVPSARLVPIITPDEAAELTYYGSEVIHPFTMEQVIRARIPIRIKNVENPSGAGTVIYPDVGFPRGLDTEPPKAERIVEGVDERMPTAVTIKDEIIVLNIHSNRKTLSHGFLARIFGTLDRAGVVVDLISTSEVHVSMAMQDFLNRKRLERLVKDLEKIGEVTVSKDMAILSLVGRNMRNAIGSAGLMFASLARAMINIEMISQGASEINISCVIENKDAIKALNVIHESCLSYPRSPATEMAGLQLQ,aspartate kinase (2.7.2.4) (0.8194),lysine biosynthetic process via diaminopimelate (GO:0009089) (0.5740); phosphorylation (GO:0016310) (0.4748); homoserine biosynthetic process (GO:0009090) (0.3341); methionine biosynthetic process (GO:0009086) (0.1984); threonine biosynthetic process (GO:0009088) (0.1140),cytosol (GO:0005829) (0.8448); mitochondrion (GO:0005739) (0.0517),ATP binding (GO:0005524) (0.4212); aspartate kinase activity (GO:0004072) (0.3943),"Aspartokinase, ACT domain (IPR054352) (0.6873); Aspartate/glutamate/uridylate kinase (IPR001048) (0.5293); Aspartate kinase, conserved site (IPR018042) (0.4966); ACT domain (IPR002912) (0.4681); Acetylglutamate kinase-like superfamily (IPR036393) (0.2950); Aspartate kinase (IPR001341) (0.2723); ACT-like domain (IPR045865) (0.2132); Aspartokinase HOM3, catalytic domain (IPR041747) (0.1916)",3.40.1160.10 (0.1658); 3.30.2130.10 (0.0595),Reference proteome (0.5716); Ubl conjugation (0.5187); ATP-binding (0.4969); Transit peptide (0.3576); Nucleotide-binding (0.2620); Mitochondrion (0.2189); Kinase (0.1738); Repeat (0.1295); Amino-acid biosynthesis (0.1178); Transferase (0.0894); Phosphoprotein (0.0882); Repressor (0.0880); 3D-structure (0.0855),
MNKIILFSAVFLALVFCAEAMPRESVNILNAENEPDDTVDIDEGLPDAFDEDYEQDGHNPYPCRGDC,,intracellular calcium ion homeostasis (GO:0006874) (0.3089); defense response to Gram-positive bacterium (GO:0050830) (0.2214); ossification (GO:0001503) (0.2209); defense response to fungus (GO:0050832) (0.1841); regulation of blood pressure (GO:0008217) (0.1837); innate immune response in mucosa (GO:0002227) (0.1814); inflammatory response (GO:0006954) (0.1509); defense response to Gram-negative bacterium (GO:0050829) (0.1172); cognition (GO:0050890) (0.0749); response to lipopolysaccharide (GO:0032496) (0.0691); vasodilation (GO:0042311) (0.0687); osteoblast differentiation (GO:0001649) (0.0621); disruption of plasma membrane integrity in another organism (GO:0051673) (0.0584); blood circulation (GO:0008015) (0.0529); positive regulation of substrate adhesion-dependent cell spreading (GO:1900026) (0.0489); single fertilization (GO:0007338) (0.0435),extracellular region (GO:0005576) (0.2362); extracellular space (GO:0005615) (0.1921); secretory granule (GO:0030141) (0.0853),,,,Signal (0.8546); Secreted (0.8042); Direct protein sequencing (0.3298); Glycoprotein (0.2588); Toxin (0.2454); Disulfide bond (0.2243); Hydroxylation (0.1474); Phosphoprotein (0.1220); Biomineralization (0.1072); Sulfation (0.1050); Reference proteome (0.0580),
MSDLAKTAQRRALRSSGSARPDEDVPAPNRRGNRLPRDERRGQLLVVASDVFVDRGYHAAGMDEIADRAGVSKPVLYQHFSSKLELYLAVLHRHVENLVSGVHQALSTTTDNRQRLHVAVQAFFDFIEHDSQGYRLIFENDFVTEPEVAAQVRVATESCIDAVFALISADSGLDPHRARMIAVGLVGMSVDCARYWLDADKPISKSDAVEGTVQFAWGGLSHVPLTRS,,response to antibiotic (GO:0046677) (0.2487); response to hypoxia (GO:0001666) (0.2185); response to toxic substance (GO:0009636) (0.1903); regulation of DNA-templated transcription (GO:0006355) (0.1173); hyperosmotic response (GO:0006972) (0.1028); response to heat (GO:0009408) (0.0792); regulation of growth (GO:0040008) (0.0672); protein homotetramerization (GO:0051289) (0.0427),plasma membrane (GO:0005886) (0.1057); peptidoglycan-based cell wall (GO:0009274) (0.0710); membrane (GO:0016020) (0.0410),transcription cis-regulatory region binding (GO:0000976) (0.1123); DNA-binding transcription factor activity (GO:0003700) (0.0973); myosin binding (GO:0017022) (0.0784),"DesT tetracyclin repressor-like, C-terminal domain (IPR054129) (0.4000); Tetracyclin repressor-like MT0489/Rv0472c, C-terminal domain (IPR045823) (0.2218); Homedomain-like superfamily (IPR009057) (0.1901); DNA-binding HTH domain, TetR-type (IPR001647) (0.1411)",,Repressor (0.6440); Transcription (0.6125); Reference proteome (0.4994); DNA-binding (0.3668); 3D-structure (0.2791); Direct protein sequencing (0.0962); Transcription regulation (0.0671),
MKNFYDWIKEFVRDQGEFIAQQSGWLELERSSYAKLIAQTISHVLNGGSLLVSADSSRHWFLNYILSNLNPKDLKERPLLSVIDFNASSFYPKNDANLSLATIEMTYQNPMFWHVGKIENEGLKTILLSKIPSFLWLFEELKEDCLLLKEHDSLLDYKLLQLFKLFENALFSVLYNKVTL,3.1.-.- (0.2155); 7.1.1.- (0.1249); 3.4.24.- (0.0670),defense response to virus (GO:0051607) (0.1980); proteolysis (GO:0006508) (0.1947); aerobic respiration (GO:0009060) (0.0804); methylation (GO:0032259) (0.0684); regulation of translation (GO:0006417) (0.0633); response to salt stress (GO:0009651) (0.0576); DNA restriction-modification system (GO:0009307) (0.0504); response to insect (GO:0009625) (0.0408),mitochondrion (GO:0005739) (0.0940); cytoplasm (GO:0005737) (0.0578),tRNA binding (GO:0000049) (0.4816); cobalt ion binding (GO:0050897) (0.2277); identical protein binding (GO:0042802) (0.1274); protein homodimerization activity (GO:0042803) (0.0463),,,Reference proteome (0.2594); Antiviral defense (0.2124); Transport (0.2082); Transit peptide (0.1923); 3D-structure (0.1877); Transcription regulation (0.1570); RNA-binding (0.1512); Cytoplasm (0.1468); Mitochondrion (0.1212); Zinc (0.1149); mRNA transport (0.1104); Hydrolase (0.0897); Ubl conjugation (0.0891); Metal-binding (0.0848); Oxidoreductase (0.0711); Repressor (0.0474),
MDRLDDTDERILAELAEHARATFAEIGHKVSLSAPAVKRRVDRMLESGVIKGFTTVVDRNALGWNTEAYVQIFCHGRIAPDQLRAAWVNIPEVVSAATVTGTSDAILHVLAHDMRHLEAALERIRSSADVERSESTVVLSNLIDRMPP,,negative regulation of DNA-templated transcription (GO:0045892) (0.1493); response to amino acid (GO:0043200) (0.1322); alanine catabolic process (GO:0006524) (0.1282); response to cadmium ion (GO:0046686) (0.0816); positive regulation of DNA-templated transcription (GO:0045893) (0.0598); response to copper ion (GO:0046688) (0.0524); nitrogen fixation (GO:0009399) (0.0514),cytosol (GO:0005829) (0.2482); cytoplasm (GO:0005737) (0.2217),sequence-specific DNA binding (GO:0043565) (0.5789); identical protein binding (GO:0042802) (0.5616); transcription cis-regulatory region binding (GO:0000976) (0.1589); protein homodimerization activity (GO:0042803) (0.0868); DNA-binding transcription factor activity (GO:0003700) (0.0769),"Winged helix-like DNA-binding domain superfamily (IPR036388) (0.3659); AsnC-type HTH domain (IPR000485) (0.2106); Transcription regulator AsnC-like (IPR019888) (0.1503); Winged helix DNA-binding domain superfamily (IPR036390) (0.1502); Transcription regulator HTH, AsnC-type, conserved site (IPR019885) (0.0876)",3.30.70.920 (0.2993); 1.10.10.10 (0.0984),Transcription regulation (0.7900); Transcription (0.6816); Reference proteome (0.6768); DNA-binding (0.4252); Activator (0.1979); 3D-structure (0.1942); Metal-binding (0.1191); Manganese (0.1141); Repressor (0.0558),
MASSDLEAATALKVQGNKAFGQHEWPTAVDFYTQAIAKYDREPSFFSNRAQAHIKLEAYGFAIADATKALELDPAYTKAYWRRALANTAILNYKDALRDFKVVAKREPNNRDAKVKLADCEKLVRRMEFEKAIEVGDPPSAFEDLDIDAIAVDDSYDGVRLEKEMTQEFIDDMIERFKNGKKIHRKYAFQIVKAVKDIVYAEPTMVEIGVDQGTKLTVCGDTHGQFFDLLEIFRLNGYPSEKHAYLFNGDFVDRGSWSTEIALLLYAYKWLRPNGIFLNRGNHETDDMNKVYGFEGECKAKYNERMFKVFSESFSALPLATLIGNKYLVLHGGLFSDDNTSLDDIRKLDRHNQRQPGQQGLMMEMLWTDPQTEPGRGPSKRGVGLQFGPDVTKRFCEKNGLEAIIRSHEVRMEGYEVEHDGRCITVFSAPKYCDTTENKGAFINVGPELKLDFQVFEAVPHPDIKPMAYAQNSIMSMM,protein-serine/threonine phosphatase (3.1.3.16) (0.9909),red or far-red light signaling pathway (GO:0010017) (0.3658); chloroplast-nucleus signaling pathway (GO:0010019) (0.1884); mitotic cell cycle (GO:0000278) (0.1689); protein dephosphorylation (GO:0006470) (0.0789); negative regulation of chlorophyll biosynthetic process (GO:1902325) (0.0778),nucleus (GO:0005634) (0.4924); cytoplasm (GO:0005737) (0.3017); cytosol (GO:0005829) (0.1645); nuclear envelope (GO:0005635) (0.0971),metal ion binding (GO:0046872) (0.5151); protein serine/threonine phosphatase activity (GO:0004722) (0.2588); myosin phosphatase activity (GO:0017018) (0.1482),"Serine/threonine-specific protein phosphatase/bis(5-nucleosyl)-tetraphosphatase (IPR006186) (0.3707); Metallo-dependent phosphatase-like (IPR029052) (0.2696); PP5, C-terminal metallophosphatase domain (IPR041753) (0.2453); Protein Phosphatase PPP (IPR051134) (0.2318); Tetratricopeptide repeat (IPR019734) (0.2247); Calcineurin-like phosphoesterase domain, ApaH type (IPR004843) (0.1964); PPP domain (IPR013235) (0.1865); Tetratricopeptide-like helical domain superfamily (IPR011990) (0.1461)",3.60.21.10 (0.2535),Reference proteome (0.5438); Metal-binding (0.5344); Repeat (0.4228); TPR repeat (0.3488); Hydrolase (0.3042); Cytoplasm (0.2997); Nucleus (0.2521); Manganese (0.2181),Mn(2+) (0.2332)
MAPAATAAASSGKGSFDLATLFVADKAARDEAGLALADAVKKSGVEFFTQIGFNDAIVKALNDKKSQSAREGACEVISTLCENGAAQLLEPHVISSAENTPFPALLEAFADKVAAVKTAAIAAVKAIVQSMNPWASFVLLPALLNLIRTSGKWQIKAGSLEILQQLITSAPYQMGEAMPDLVPVLAGAVWDTKSDVKKAAKATLEKAVSLVENKDIEKFVPALVKSLLNPIEEVPKTISLLSATTFVSEVTAPTISLIAPLLIRGLDERPTATKRKVCVIADNMSKLVDSEYTVRPFLPQLLPRLIKTAETIADPEARSVANRAIVTLRRIGKVPVESDGSDLPPLPVAEGPHLATNFVALVKKHGGVSVEQTNPGLAYAGVLAASLVNHHNFDQKTWESTLPPYLKLALPSYDSLPAVRELLQKKADEAETDDAKFPDEEEGEDLCNIEQFNLAYGAKILLHHANMRLKRGHRYGLCGRNGSGKSTLMNAIINNQVEGFPPPTEVRTFYVQHDIDGSEAEISILDWVLSDKRLLATPEEIKSTLESVGFDEVKQKNSIGSLSGGWKMKLALARAILFKADILLLDEPTNHLDVLNVDWLINYLTSLTRCTSIIVSHDSDFLNRTVTDVLHLNNFKLKRYPGNLEEFVKHVPEAKSYYQLDVAEDYQFKLPNPPLLDGVKTKEKSLLKMRNVSFQYPGSSIQQLYDISLQVSLSSRVAVLGPNGSGKSTLVKLLTGETEPNLGGQVWKHPNLVIGYVAQHAFHHIDNHLDSTPLEYMLWRYQTGEDLEEMHKANRVMTEAELAKMKEGATVIKDGVKRIIDELVARKKLKQSYEYEVSFKGMSSAENIWISRDELVARGFEKKVMELDTREAQRLGLMRPLVRREIEKHFEDFGLDAEFVSHNSMRGLSGGQKVKVVLGAATWRRPHIICLDEPTNYLDRESLAALIAALKNFEGGVLIITHNREFSESICTEVWAMREGHLEASGHNWVEGQGSGERIDKKAGDDDEVEYDALGNPIVKAKKEKKLSAADKRKAKKDRMARRKRGEEVFSDEEL,,chromatin remodeling (GO:0006338) (0.7259); translation (GO:0006412) (0.0567),cytoplasm (GO:0005737) (0.6087); cytosol (GO:0005829) (0.0445),translation elongation factor activity (GO:0003746) (0.5960); ATP hydrolysis activity (GO:0016887) (0.5009); RNA binding (GO:0003723) (0.2983); ATP binding (GO:0005524) (0.2200),"Elongation Factor 3, chromodomain-like insertion superfamily (IPR047038) (0.5626); ABC transporter-like, ATP-binding domain (IPR003439) (0.4076); HEAT, type 2 (IPR021133) (0.3280); Chromo/chromo shadow domain (IPR000953) (0.3137); ATP-binding cassette sub-family F member, EF3 subfamily (IPR050611) (0.2336); P-loop containing nucleoside triphosphate hydrolase (IPR027417) (0.2191); Armadillo-like helical (IPR011989) (0.2138); ABC transporter-like, conserved site (IPR017871) (0.2013); Armadillo-type fold (IPR016024) (0.1273); Elongation factor 3, four helical bundle domain superfamily (IPR047036) (0.0857)",1.25.10.10 (0.4195); 2.40.50.990 (0.2900); 3.40.50.300 (0.2606),RNA-binding (0.8462); Nucleotide-binding (0.5386); ATP-binding (0.5009); rRNA-binding (0.3200); Protein biosynthesis (0.2162); Elongation factor (0.1738); Reference proteome (0.1490); Repeat (0.1453); Nucleus (0.1061),
MVSTNAGGIASKQASSMAPNPGKATILALGHAFPQQLVMQDYVVDGFMRNTNCDDPELKEKLTRLCKTTTVKTRYVVMSEEILKSYPELAQEGQPTMKQRLDISNKAVTQMATEASLACVRSWGGALSEITHLVYVSSSEARFPGGDLHLARALGLSPDVRRVMLAFTGCSGGVAGLRVAKGLAESCPGARVLLATSETTIVGFRPPSPDRPYDLVGVALFGDGAGAAVVGADPTPVERPLFELHSALQRFLPDTDKTIDGRLTEEGIKFQLGRELPHIIEANVEAFCQKLMQEHPQAADKLTYGDMFWAVHPGGPAILTKMEGRLGLDGGKLRASRSALRDFGNASSNTIVYVLENMVEETRQRREEAAEEEDCEWGLILAFGPGITFEGILARNLQARARARD,chalcone synthase (2.3.1.74) (0.3613); 2.3.1.- (0.2135); trihydroxystilbene synthase (2.3.1.95) (0.0428),defense response (GO:0006952) (0.2496); response to wounding (GO:0009611) (0.2421); response to oxidative stress (GO:0006979) (0.1578); fatty acid metabolic process (GO:0006631) (0.1405); response to jasmonic acid (GO:0009753) (0.1174); flavonoid biosynthetic process (GO:0009813) (0.0917); response to auxin (GO:0009733) (0.0850); response to hydrogen peroxide (GO:0042542) (0.0749); polyketide biosynthetic process (GO:0030639) (0.0723); pollen development (GO:0009555) (0.0659); response to gravity (GO:0009629) (0.0528),cytoplasm (GO:0005737) (0.2843); endoplasmic reticulum (GO:0005783) (0.1777),"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747) (0.1233); identical protein binding (GO:0042802) (0.0605)","Chalcone/stilbene synthase, N-terminal (IPR001099) (0.4017); Chalcone/stilbene synthase, C-terminal (IPR012328) (0.3188); Polyketide synthase, type III (IPR011141) (0.2597); Thiolase-like (IPR016039) (0.1544)",3.40.47.10 (0.3306),Virulence (0.5029); Stress response (0.2888); Acyltransferase (0.1693); Plant defense (0.1094); Transferase (0.1080),
MEKDFTERSTKGQRKLANGVVENIESKLKNHLDNNNVINKSVNYEDVMCSNVKLSVHDDEYDIKNIKKDVCNLSKLSEERLSNNISLKDNNKVVKNPEIDTKTARQQYKKRLNSTQSTMNIEGNINNEKDDIIEDYDDGLIRNMDYEMSIVKNKRNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNSNNVDNRKRNKNEECYDESYCISDNLDEITSYRNKLSLYNKLRMCFNYFGPGWIVAIAYLDPGNLCSNLNVGLIRSPDPTLEKDYSGYYLLWIMVYGHMLGFIFQVLSMRLGHVTGLDLASLCSKEFDRTTSTIIYVLVQIAIWGAHIQAIIGTFIALNLIFGISVKVAIFYTLFEAIIYSFLENKSLGLLENVLSFLVGILAVSFFVNVFMTPINFKELAISILYPRIPKGKEIDALALLGSIISAHIFYLHTNLTAKKKSVICNDLSLRRYNTLGTIESGGSLFLSCLTNCIIVLTFAEVNLKSFERRDQYNLFTAYEVMRKSFGKISMYIWSFGLLSSGNNSSFMCEYASKSVVEGFLNKKINTFVRVFTFRLMLFSLLYMFLTLNKYTLDQLTNFINVIQVLLLPMATIPLYRFSIHENVLGEFRLKKFPKFAVFLIIIAIIISNVLLTFLDFVHKETSLITIFFLVIFSFLYFGFIIYFFNIPIKKNYIQRN,non-specific serine/threonine protein kinase (2.7.11.1) (0.0638),response to heat (GO:0009408) (0.2000); intracellular iron ion homeostasis (GO:0006879) (0.1888); positive regulation of gene expression (GO:0010628) (0.1789); iron ion transmembrane transport (GO:0034755) (0.1770); regulation of DNA-templated transcription (GO:0006355) (0.1439); cellular response to nitrogen starvation (GO:0006995) (0.1012); manganese ion transport (GO:0006828) (0.0909); autophagy (GO:0006914) (0.0614); response to unfolded protein (GO:0006986) (0.0606); negative regulation of endocytosis (GO:0045806) (0.0524); sporulation resulting in formation of a cellular spore (GO:0030435) (0.0524); positive regulation of RNA splicing (GO:0033120) (0.0438); innate immune response (GO:0045087) (0.0402),phagophore assembly site (GO:0000407) (0.0865); cytoplasm (GO:0005737) (0.0730); membrane (GO:0016020) (0.0511),manganese ion transmembrane transporter activity (GO:0005384) (0.4533); cadmium ion transmembrane transporter activity (GO:0015086) (0.1905),NRAMP family (IPR001046) (0.2126),,Membrane (0.5692); Ubl conjugation (0.3186); Vacuole (0.2466); Glycoprotein (0.2335); Transmembrane (0.2164); Transmembrane helix (0.2128); Sporulation (0.1717); Autophagy (0.1304); Lysosome (0.0472),
MILDKFKNIVNLSNSNTEKEEGKNAEINENNDPNTQLAHEPSIVEADEKTFFDEMLGAPQYTYDEFLQVLKNPIEERGDTEDMKKHWGYPRRWKVILWDLHIQNYMNNDFNAFVDFDFGGNREECRIQRGSTMKIYAKGKTKNCLRTPVVTNVATEQKKNMNFRNVFEYRGSYLDLENEKLRIRVWEYKQFTLNKLEGIYEEPLLSFAVGEIYNETTLYKFIKDSRVKRCRLYFQLYFQELYDFELSFLNWSFSDLLSSSYIQAKSYNYLSNKNNVKKRYIDDTSCNIFPHMCKNFKRFHKKKIYRKVRNYDIDKNFSFNTALSDDSDERKNKNDRTIKNLEKLFVRNLTLMQNIEENEDMSYKNLQNINLPNPRVTITLSHTPKGHEGLNIISIEQKSIRFPIWENLGEIYFRGTLRDLDVSYLNIKVEDMSAPKSAREIGTCQISLKGIVDYPYVMHELEAPSWLVKEAKYEGWENKLNEWKLGTVEGKVIINRVPRYRQRGDIYHIDSKQPYLIVHIFNIDKIITVDNIKELDTYVEVSFDETSRRTRLMKKTLSPNYDSQISIPLRFNNKNDINYENLSKKGLIYIDVWGKSEDIVYIGGISISPYEIFFNEKNVRRNKTKLEHIDLETNVKITYDTVVYRGCKKLCFLHDDQRMSNIHFSIWTYPDILGNSTNQKKIVAPVSFNTTMNFPIKLAEKYNKLKKLFMEVLKTIKSIPENCTDVNTSTRFYNYELINQRKEKHFLPTLITSIKSPYCAESMNAIFHYVRCIPFIHKKENIIFTPDFTLQLKGGNALDHSLLLCSLFLGIPVLAFVCFGTLWDKQKHSWVATFEYNDEKNYGIVKFWETTTGNVYILKKRFIDHNRLKGLELKLKESKYKSHLRNGFLQRYENNTDINYIKEQTKRHIKQLFKNRINDIPIGGPSLPYKTIDLIFNHKNIYVNLQHSSPLNIWYDYWKFDFWFPFSSIEYNLQPSFTIKSFTHKMEDMELDKIAKELRTNIEKNINIYRASRNLSTRWNRDETLEIFLQVGLELLHQLNTSRKEDVLLAKLKIEDWKKALYHKVPQSHRLLGFPYHFNTYKSKFISDKLISTLAILESRDRSLCLSLAVCLYSLPGNFISCYIYIITCVKITQRELRKMEIIKEKAQRMAEIKNSQKKKKSSDDQNIDIKTMDDVEEKETFSSTNLDDTLHDEHTDIDTEKKKHEKDNYKNKKIKNTKLKDANIDNEEKDDHHHITDKKVSKSSDLIHSFDKNDISKNTFDKEEFINNLDKDKKYSSFKKGNVVNKKVSIKNEPSINIYEDHKIYDDENISNNIDNMENNQDEIYNLRQGKTIINEFQQVKKPQKYTINEKRDDIKTKKKRSKEKKKQDKLEFEKLIQSNAYFEQEKKKLQEDIKKLEKDKEQFQKEKIRREEKEKQLLLEEKIKLQKEKELFENEKLERKMSYMLKINELEKKKNERNKMEKSYKRMIQKDKEKKKKKESRDKIRRGEEEKMSADENMKEEQKMREEQKVGEEQKVGEEQKVGEEQKLREEQKMREEQKMREEQKMREEQKMREEQKVREEQKMREEQKMREEQKMREEQKVREEQKLREEQKMREEQKMREEQKMREEEKIREEEQMKREKKMRREEKKKRVQEPIKIDEIQVYDIIKNEKMKKKEEKEEKKRKKKKEDIEDKYKIGKEASLDENNNERQIKSKNIQEISDYEYKNIKENKNLNKFDEKLDLNQIYSKASNFYDNQEKKRRTIKVHANRKENSDSTFSHIDDSIKNKKEYLEDSNIARYLYEKRKHDLIGKGNYNFDEPHYGKKMNNVAYQDIKGSNLFKGFIEEPSSKKSPQKKKIVIVRKN,,regulation of centriole replication (GO:0046599) (0.8600),cytoskeleton (GO:0005856) (0.3890); cytoplasm (GO:0005737) (0.1693); centriole (GO:0005814) (0.1523); focal adhesion (GO:0005925) (0.0518),ATP binding (GO:0005524) (0.1332); protein kinase activity (GO:0004672) (0.1198); protein serine/threonine kinase activity (GO:0004674) (0.1008),C2 domain superfamily (IPR035892) (0.5088); C2 domain (IPR000008) (0.4008); Papain-like cysteine peptidase superfamily (IPR038765) (0.1443); Centrosomal protein of 76 kDa (IPR052299) (0.1313); Protein kinase-like domain superfamily (IPR011009) (0.0802); Protein kinase domain (IPR000719) (0.0559),2.60.40.150 (0.6736); 3.10.620.30 (0.0595),Transmembrane (0.2937); Cytoplasm (0.1849); Coiled coil (0.1694); Reference proteome (0.1687); Membrane (0.1074); Transferase (0.1039); Metal-binding (0.0944); ATP-binding (0.0874),
MKFLQIIKHLKLQNKKNALDNFVNCRTYEHISNINKLFLNNFSSTKEHSEHGQVKHENFLNSTLKYEENSQNGSTNNLKNGKYNMYVSEGNVNINEEKYKDNNISSNNTQYNNNSSNSGSLNDEGPLWKEHIDDVVNENKKKKMNRFYLDSQATTMIDPRVLDKMLPYMTYIYGNAHSRNHFFGWESEKAVEDARTNLLNLINGKNNKEIIFTSGATESNNLALIGICTYYNKLNKQKNHIITSQIEHKCILQTCRFLQTKGFEVTYLKPDTNGLVKLDDIKNSIKDNTIMASFIFVNNEIGVIQDIENIGNLCKEKNILFHTDASQAAGKVPIDVQKMNIDLMSMSGHKLYGPKGIGALYIKRKKPNIRLNALIHGGGQERGLRSGTLPTHLIVGFGEAAKVCSLEMNRDEKKVRYFFNYVKDYLTKHLDYIVFNGCQINRYYGNMNISFLFVEGESLLMSLNEIALSSGSACTSSTLEPSYVLRSIGISEDIAHTSIRIGFNRFTTFFEVQQLCINLVKSVERLRSISPLYEMELEKKNPSNDDIPKFIWT,cysteine desulfurase (2.8.1.7) (0.9380); 2.8.1.- (0.0942),iron-sulfur cluster assembly (GO:0016226) (0.8901); tRNA wobble position uridine thiolation (GO:0002143) (0.1972); intracellular iron ion homeostasis (GO:0006879) (0.1266),cytosol (GO:0005829) (0.2486); nucleus (GO:0005634) (0.1860); mitochondrion (GO:0005739) (0.1448); L-cysteine desulfurase complex (GO:1990221) (0.1140); cytoplasm (GO:0005737) (0.0899),metal ion binding (GO:0046872) (0.2567); pyridoxal phosphate binding (GO:0030170) (0.1286); iron-sulfur cluster binding (GO:0051536) (0.1089),"Aminotransferase class V domain (IPR000192) (0.3624); Aminotransferase class-V, pyridoxal-phosphate binding site (IPR020578) (0.2280); Pyridoxal phosphate-dependent transferase, major domain (IPR015421) (0.1766); Pyridoxal phosphate-dependent transferase, small domain (IPR015422) (0.1754); Pyridoxal phosphate-dependent transferase (IPR015424) (0.1688)",3.90.1150.10 (0.3049); 3.40.640.10 (0.2464),Pyridoxal phosphate (0.6152); tRNA processing (0.4126); Metal-binding (0.2404); Reference proteome (0.1520); Nucleus (0.1493); Transferase (0.1115); tRNA-binding (0.1045); Iron (0.0893),pyridoxal 5'-phosphate (0.3005)
MMKINLYKLLCFICVIFLLHKNVVRSGDNMKYNDMKGLDDLSKLNDDQVKDILGLKIDGAKERIEKLFHLIDKNNDKEITEEELNTWSSFLKNEIFLKQVQAEMGQIDSDKDGFISLNELNDAFAQNLDAKEVEKHSEGLLKRFQIVDKDKDGKLSINEVGLLIDPMKDEELKELEINEILEHHDVNKDGKISLDEFKQTRSDESSGVKKDDEMALDDFNFFDANKDGFIDKEEIIKVYFDPAHESGAINVNEIKENIFEGKKITYDLWNEKALKIAVTSLTDYGDVIRYPEDFKLDIGKNVILPTARSRAFEDDDMDADNTEDDKDEADDASQQKSPAIDEL,,axial cellular bud site selection (GO:0007120) (0.1131); calcium-ion regulated exocytosis (GO:0017156) (0.1116); ovulation (GO:0030728) (0.0479); hypotonic response (GO:0006971) (0.0463); protein localization to plasma membrane (GO:0072659) (0.0452),endoplasmic reticulum (GO:0005783) (0.2846); membrane (GO:0016020) (0.2032); cytoplasm (GO:0005737) (0.1474); axon (GO:0030424) (0.1211); Golgi membrane (GO:0000139) (0.0936); intracellular membrane-bounded organelle (GO:0043231) (0.0857),calcium ion binding (GO:0005509) (0.1360),"EF-hand domain pair (IPR011992) (0.1786); EF-Hand 1, calcium-binding site (IPR018247) (0.1538); EF-hand domain (IPR002048) (0.1493)",1.10.238.10 (0.1960),Sarcoplasmic reticulum (0.8760); Calcium (0.3805); Signal (0.2107); Repeat (0.1929); Reference proteome (0.1857); Cytoplasm (0.1830); Transport (0.1641); Membrane (0.1391); Phosphoprotein (0.1385); Virulence (0.1288); Glycoprotein (0.1134); Direct protein sequencing (0.0808),
MTAAGFNSILCLRQLVRLNRRQYSAPAKSVLSGSQTNDQATPPPTSKSADKMRGWQLHNYGDIDELQLSEMLKIPQIRCSNECLVRIRATAVNPIDLAMLRGYGATVLNKMRCQPGDGIEFPLILGREFCGELVQTGMGVSLPLGSRVWGVVPLQATIGSHAEYVAVPSYCLAPAPKELDDYEAASVLYAGLTAWSGLYITGGLGGPCGATTASGGGAHKRVLVLGGSGGVGTLAIQILKSQKVQVLATCSENAIEMVRNLGADLVVDYNNPQAMEELCKYAPYDIVLDCAGQGGQKAAESKYDFRQYITFSSPLLANIDKQGLGVGALKNVFDLFQTNVRSVTQRGGLVKWGFFSPAPQGIQFLQKLVEQRKLMPLIDSSYGFSELPKAFEKMKSGHLRGKIVVKLREETGD,1.1.1.- (0.1211),regulation of multicellular organism growth (GO:0040014) (0.3101); positive regulation of growth rate (GO:0040010) (0.3099); mitochondrion organization (GO:0007005) (0.1974); response to superoxide (GO:0000303) (0.1633); ubiquinone biosynthetic process (GO:0006744) (0.1083); innate immune response (GO:0045087) (0.1021); gene expression (GO:0010467) (0.0915); visual perception (GO:0007601) (0.0799); cellular response to reactive oxygen species (GO:0034614) (0.0484),mitochondrion (GO:0005739) (0.0586); mitochondrial outer membrane (GO:0005741) (0.0528),oxidoreductase activity (GO:0016491) (0.2158); NADPH dehydrogenase (quinone) activity (GO:0008753) (0.1744),"NAD(P)-binding domain superfamily (IPR036291) (0.3241); Polyketide synthase, enoylreductase domain (IPR020843) (0.2243); YIM1 and Zinc-containing Alcohol Dehydrogenase Families (IPR050700) (0.2157); Reticulon-4-interacting protein 1 (IPR037397) (0.1895)",3.40.50.720 (0.2191); 3.90.180.10 (0.1792),Mitochondrion (0.7611); Transit peptide (0.6448); Reference proteome (0.5958); Proteomics identification (0.4427); Disease variant (0.2871); Membrane (0.2042); Mitochondrion outer membrane (0.1880); Phosphoprotein (0.1569); Oxidoreductase (0.1555); Direct protein sequencing (0.1473),
MVNKEQFYDQIRKALEDGNTRYYRNLIYIERDDYFDHVKEIISLFLNFKSNPSVAYGFVPWASGSKERMRTIKEYFSKFDDIDYANAEYYLGNTYDLVILDTVDNFQPINIGRLVDLARGGGLIIIYTNNLIKDKTFRTSIMRNGLILDEYEKRFKRKLYEHEGIFIIDVNEYIPKPFSGNTMPKAEKKVPRNPLMPKEIHELSLSEDQNRVIESFTYLLSGGQRALVLTAARGRGKSAATGLSIAGLIEKLRERKEKSIRIIVTAPSIASASQVMSFAKLGLEALGEELSVKVSDTGHIKSLRGDYFKLEYVPPDAAIEDEGELLIIDEAAALGINYIDLALRAWKKVALVTTVHGYEGSNKAFLRYLRRLIESKRIRVKWVNMEQPLRYAKGDPIEKWLYDALLLDAEPSEPQYLNDTMIYEDVDKSELANDDNRLRAIYGIMVTAHYKNNPDDLMIMLDGIHHKIKAIRIGENSYIAACQIAEEGELSDNMVDIALKGGTFDGDLIPDRIIKHVRIKDFAKLRGWRIVRIAVAPELQDKGFGSELLKMIYEEARDKGVDWVGSSFMSDQKVLNFWIKNGFIPVHISPKKNEKLGDYPVVVIRPISDIATKIVKISAYMLKEKLLNTLHDVYFNMNPEVVRLMLTSTKIVSKTINVSPIILDKTISFLQGVSPYESSADGIHMLTLKYFWDGERDWSLTQDEELVLIAKVLQGKPWSYVSTVLSSNRTHIYELIYSAISKLMKKYYNLTADSKVGLTLKDVMNSQQYD,tRNAMet cytidine acetyltransferase (2.3.1.193) (0.8631); 2.3.1.- (0.0902),tRNA wobble cytosine modification (GO:0002101) (0.9605); DNA conformation change (GO:0071103) (0.3699); rRNA acetylation involved in maturation of SSU-rRNA (GO:1904812) (0.3664); rRNA processing (GO:0006364) (0.2499); tRNA acetylation (GO:0051391) (0.2068),cytoplasm (GO:0005737) (0.6524),"ATP binding (GO:0005524) (0.6104); rRNA cytidine N-acetyltransferase activity (GO:1990883) (0.5900); tRNA binding (GO:0000049) (0.5675); tRNA N-acetyltransferase activity (GO:0051392) (0.2836); catalytic activity, acting on DNA (GO:0140097) (0.0633)","TmcA/NAT10/Kre33 (IPR032672) (0.5692); tRNA(Met) cytidine acetyltransferase TmcA, N-terminal (IPR013562) (0.5455); Acyl-CoA N-acyltransferase (IPR016181) (0.5064); GNAT domain (IPR000182) (0.4519); Helicase domain (IPR007807) (0.1243); P-loop containing nucleoside triphosphate hydrolase (IPR027417) (0.1050); tRNA(Met) cytidine acetyltransferase TmcA (IPR024914) (0.0894)",3.40.50.11040 (0.4055); 3.40.630.30 (0.3799),tRNA-binding (0.9968); rRNA processing (0.9746); tRNA processing (0.7652); Nucleotide-binding (0.5164); Acyltransferase (0.4506); RNA-binding (0.4478); Cytoplasm (0.3765); ATP-binding (0.2514); Reference proteome (0.1872); 3D-structure (0.1499),
MIPGSNPGGRIHNVIEMFENYFMDAVKGYYRHLAIIESQDPLEKINSLIDDYLKVNKKPRVIYGFHPWLDNSKDRMKELKKRFENFLDIDYSNSEKYLGQSADLVILDAMDDFRPNYIARFVDMTKGGGIAIIYSDNILEGKLYKKSLTRYGVVKDLFEARFIELAKRYRGIIFFQGNDRITFTPYSSNETHKPYKKIPKSPKVSMELHELCLSSDQNKVLEESLFIMNLGKRVLVITAARGRGKSASIGLFLSYLMSEGNFGSIIVTSPTYYSSQEIFKFIIRGLEALNVKYKVITSRDGKIMKISTRDSRVKWVSPDLAKNEEGDLIVIDEAAAMGIEFLDYIVRSWDKVILVTTIHGYEGSGKAFLKYVDKLKGKVLLKNIKMDYPIRYAKGDPIEKFLFDVFLLDAEPHEVEYNGKLKIVEVPQEELFRDDDLLKSVYGILVTAHYRNSPDDLMLLGDMAFQKVIVGYSSENPVAVCQVVYEGGLTDKQIWDISNGLKNEGHLIPHRLIKYMRALDFGKLKGWRIMRIAVSPENQGKGIGSRVIEEVIKMAKGVDWIGSSFVADYSVLRFWIKNGFLPVYLSSIKNEELNGYSVIVIKALSERTKEFVVKLSSLLKDKLLRTSHQVYYNLNPQLIVLLLRNTYSERIEGEVPDLYVDKIKAYTEGKVPYNVIAEAAHFLVTKHFLELKADLSIEAEASLVARVLQGKSWYHAGLMLGLSSREVEDNVKQSLGVLLETYT,tRNAMet cytidine acetyltransferase (2.3.1.193) (0.9411),tRNA wobble cytosine modification (GO:0002101) (0.9556); rRNA acetylation involved in maturation of SSU-rRNA (GO:1904812) (0.4469); tRNA acetylation (GO:0051391) (0.4432); DNA conformation change (GO:0071103) (0.3184); rRNA processing (GO:0006364) (0.0691),cytoplasm (GO:0005737) (0.6414),"ATP binding (GO:0005524) (0.7873); tRNA binding (GO:0000049) (0.6646); rRNA cytidine N-acetyltransferase activity (GO:1990883) (0.5944); tRNA N-acetyltransferase activity (GO:0051392) (0.5709); catalytic activity, acting on DNA (GO:0140097) (0.0782)","tRNA(Met) cytidine acetyltransferase TmcA, N-terminal (IPR013562) (0.5664); GNAT domain (IPR000182) (0.5635); Acyl-CoA N-acyltransferase (IPR016181) (0.5483); TmcA/NAT10/Kre33 (IPR032672) (0.5368); Helicase domain (IPR007807) (0.2150); P-loop containing nucleoside triphosphate hydrolase (IPR027417) (0.1504); tRNA(Met) cytidine acetyltransferase TmcA (IPR024914) (0.1075)",3.40.50.11040 (0.4847); 3.40.630.30 (0.4072); 3.40.50.300 (0.1736),tRNA-binding (0.9967); rRNA processing (0.9427); tRNA processing (0.8381); Nucleotide-binding (0.6795); ATP-binding (0.4232); RNA-binding (0.3219); Cytoplasm (0.3189); Acyltransferase (0.3185); 3D-structure (0.1294); Reference proteome (0.1242),
MSSVLKAFERFTIEQELQDRGEEGSIPPETLKSAVKVFVINTPNPTTRYQMLNFCLRIICSQNARASHRVGALITLFSLPSAGMQNHIRLADRSPEAQIERCEIDGFEPGTYRLIPNARANLTANEIAAYALLADDLPPTINNGTPYVHADVEGQPCDEIEQFLDRCYSVLIQAWVMVCKCMTAYDQPAGSADRRFAKYQQQGRLEARYMLQPEAQRLIQTAIRKSLVVRQYLTFELQLARRQGLLSNRYYAMVGDIGKYIENSGLTAFFLTLKYALGTKWSPLSLAAFTGELTKLRSLMMLYRDLGEQARYLALLEAPQIMDFAPGGYPLIFSYAMGVGTVLDVQMRNYTYARPFLNGYYFQIGVETARRQQGTVDNRVADDLGLTPEQRTEVTQLVDRLARGRGAGIPGGPVNPFVPPVQQQQPAAVYEDIPALEESDDDGDEDGGAGFQNGAQAPAVRQGGQNDFRAQPLQDPIQAQLFMPLYPQVSNIPNHQNHQINRIGGMEHQDLLRYNENGDSQQDARGEHGNTFPNNPNQNAQSQVGDWDE,,regulation of DNA-templated transcription (GO:0006355) (0.2783); symbiont entry into host cell (GO:0046718) (0.2221); negative stranded viral RNA replication (GO:0039689) (0.1198); symbiont-mediated suppression of host type I interferon-mediated signaling pathway (GO:0039502) (0.0764); DNA-templated transcription (GO:0006351) (0.0700),helical viral capsid (GO:0019029) (0.4085); viral nucleocapsid (GO:0019013) (0.3399); ribonucleoprotein complex (GO:1990904) (0.2746); host cell cytoplasm (GO:0030430) (0.2331); host cell (GO:0043657) (0.1802); host cell nucleus (GO:0042025) (0.1212),RNA binding (GO:0003723) (0.2784); structural molecule activity (GO:0005198) (0.2433),,,Virion (0.5008); Virus entry into host cell (0.3994); Host cytoplasm (0.3894); 3D-structure (0.3681); Reference proteome (0.3230); Host-virus interaction (0.2744); Viral penetration into host nucleus (0.2725); Helical capsid protein (0.2345); Viral nucleoprotein (0.2247); Viral release from host cell (0.1949); RNA-binding (0.1498); Host nucleus (0.1148); Capsid protein (0.1068); Ribonucleoprotein (0.1058); Viral immunoevasion (0.0911),
MLSLFNRLPWLHRVLITAFSAIIVFAIFFLPNSEDLRKPDAQREVGRHYPVTLDNQLVSTPEEEVIAPPSVMLRWETYQVANGESAALLFQRAGLSSRVLYELTSSNSDINNQLSKLMPKDELKFGFDKDNQLVQLKRTISPYETFVVTRSDSGFTSEFDKKEVTFQLNYAEAKITSNFWNAGVTAGLSANQIIELANMFGWDIDFALDIREGDQFKLLYQEKIVEGSVIGRGNIIAATFINQGSTFTAILDDNTGNYYDQNGRAMKKAFLRSPLDFRRVSSNFNPRRLHPVTGQIKAHRGTDYVAPVGTPIWAAGDGVVEKSSYNQFNGNYVYIRHSNTYITKYLHLQRRLVKTGERVKQGQTIGTLGGTGRVTGPHLHYEFLVNGIHKNPRTVELPQAQSLTGKAKETFIANAKQRMEKLERYSQLLYANQ,3.4.24.- (0.7025),proteolysis (GO:0006508) (0.4056); septum digestion after cytokinesis (GO:0000920) (0.1778); peptidoglycan metabolic process (GO:0000270) (0.1513); cell fate specification (GO:0001708) (0.0831); cell adhesion (GO:0007155) (0.0447),plasma membrane (GO:0005886) (0.4910); membrane (GO:0016020) (0.0475),peptidoglycan binding (GO:0042834) (0.7231); metalloendopeptidase activity (GO:0004222) (0.1528),"Opacity-associated protein A (IPR007340) (0.8398); Csd3-like, second N-terminal domain (IPR045834) (0.6590); Opacity-associated protein A, N-terminal (IPR013731) (0.4634); Bacterial cell wall metabolism enzyme (IPR050570) (0.3762); Peptidase M23 (IPR016047) (0.3105); Duplicated hybrid motif (IPR011055) (0.1429)",3.10.450.350 (0.3907); 2.70.70.10 (0.3173),Zinc (0.9302); Transmembrane (0.6631); Transmembrane helix (0.5567); Membrane (0.5024); Metalloprotease (0.4774); Hydrolase (0.4550); Reference proteome (0.4138); Protease (0.4120); Metal-binding (0.4088); Cell membrane (0.3909); Coiled coil (0.1314); Signal-anchor (0.0938); Cell inner membrane (0.0834); 3D-structure (0.0781),Zn(2+) (0.6499)
MSIIGSFPPGGPRVEVQETRVQTDRVLTIPNILSMARLAGVPLFLWLILRPEFGGPQSDGWALLVLALSGVSDYLDGKLARRWNQISSLGRLLDPAADRLYILSTLVGLTWREILPLWLTLVLLAREAMLLVMVGILRRHGYPPPQVNFLGKAATFNLMYAFPLLLLSDGSGWIASLAAVFGWAFAGWGTTLYWWAGVLYVVQVRRLVRADVAAD,cardiolipin synthase (CMP-forming) (2.7.8.41) (0.4263); 2.7.8.- (0.2079); CDP-diacylglycerol-glycerol-3-phosphate 1-phosphatidyltransferase (2.7.8.5) (0.1897),glycerophospholipid biosynthetic process (GO:0046474) (0.3188); phosphatidylglycerol biosynthetic process (GO:0006655) (0.2807); phospholipid biosynthetic process (GO:0008654) (0.2075); chloroplast organization (GO:0009658) (0.0620),plasma membrane (GO:0005886) (0.1962); cytosol (GO:0005829) (0.1156); peptidoglycan-based cell wall (GO:0009274) (0.1020); mitochondrion (GO:0005739) (0.1018); chloroplast envelope (GO:0009941) (0.0695),CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity (GO:0008444) (0.4717); cardiolipin synthase (CMP-forming) (GO:0043337) (0.1573),"CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase (IPR004570) (0.4163); CDP-alcohol phosphatidyltransferase, transmembrane domain (IPR043130) (0.3020); CDP-alcohol phosphatidyltransferase class-I (IPR050324) (0.2459); CDP-alcohol phosphatidyltransferase, conserved site (IPR048254) (0.2044)",1.20.120.1760 (0.2273),Phospholipid biosynthesis (0.7228); Phospholipid metabolism (0.7106); Transmembrane (0.4983); Lipid biosynthesis (0.4524); Membrane (0.4061); Reference proteome (0.3758); Transferase (0.3738); Transmembrane helix (0.3208); Lipid metabolism (0.2691); Mitochondrion (0.1463); Zinc (0.0818),
MQKQEETLSRLRTIFDIFLRENFSTTNNVYFEKLLTHLQAKENAFVLQAPFVVEWVDRCITAVTEDFKKIHPKVISFMLNLTSFLANNEWMIVRLRELDIVNRAVKLLQREHNLSPSIKLGGIRLMKAITVYSMGLAFLRMHRIWTLLIQYSNNDHTLYVVREARQVLYNMVYKSCDKLHDKAVTLEILSEIMQPIHDNLYKNTDGVERIHVKVDDNEMLHKISSTLDLLSYILQQTLVLEERTTLIILLKEHHDFEITVWKLIDMTHNPYFTEKIFTTLSSYNFALLLHEKLLNPNATEPSEEFTEFGLAFFNLMKFLITRKDGLSFVKLAELNHVLWKKLGPRAPKEIVIQQERVTFENQLICFHMLPLLFSMKYAQKIADEESKIELFDAYVVKLLEISCEQTLRLCYTMRDNFFSADGMAVGLVTAGLANKCIHSLLALENVLDREQAVTVCQALLYVLREAVAMSVITNNGEDDCHSVSSAGSSYLKLYPRGTEQVVNDPQVLHSVMVGLRTLIERFKITWKESVETIGLVNCLAFVLENTSMDARCTVQALKLVQLAVEHFLSPNMALLVDNLQGSALVCLGPIIVKRMHDTMWEVRDTTLELTTSIASISRIKFPAFQRFLIDSKIPPIVYEMAKNDSEVYVRASAFQCLSQMVSINLLWENGLSQLDLVDHLLFVMYRETNDIVRSEAVITLMKIYEHRKIHEKYKNTLFSTLNYCVIGDHHTEVKLNALNFWRREFYRQFSNQGMIDGSFPTVTFSKEQKKIVTLTEKEIQTSIAKVFGEVQQYGYFGILLKCLREETSMEVLEFLIKGVKTMTEKFERYKGIMEEIEMRSPLSDRERPRFDFPSQPQPTPIPQQPPVNPTEADEVIESILNSQDAQLLEKAFETQMQINAQGKTAEKRHIDEFYYKQFAVPLRQFFEELKTIDLDQLVKQHQEWFECKENFTSLLDDILGALKRDDENMISDCY,,positive regulation of protein phosphorylation (GO:0001934) (0.7189); DNA damage response (GO:0006974) (0.2236); DNA repair (GO:0006281) (0.1941); negative regulation of gene expression (GO:0010629) (0.1901); mitotic cell cycle (GO:0000278) (0.1759); glucose metabolic process (GO:0006006) (0.1278); cell population proliferation (GO:0008283) (0.1248); cellular response to starvation (GO:0009267) (0.1186); embryonic viscerocranium morphogenesis (GO:0048703) (0.0976); positive regulation of transcription by RNA polymerase II (GO:0045944) (0.0904); positive regulation of multicellular organism growth (GO:0040018) (0.0842); regulation of DNA-templated DNA replication initiation (GO:0030174) (0.0805); response to ionizing radiation (GO:0010212) (0.0538); mitotic sister chromatid segregation (GO:0000070) (0.0524),nucleus (GO:0005634) (0.4323); membrane (GO:0016020) (0.2755); cytoplasm (GO:0005737) (0.1937),,Armadillo-like helical (IPR011989) (0.2540); BRCA1-associated ATM activator 1 (IPR038904) (0.1781),1.25.10.10 (0.2071),Reference proteome (0.4749); Ubl conjugation (0.4440); Stress response (0.3255); Repeat (0.2841); Cytoplasm (0.2560); Nucleus (0.1221); Transmembrane helix (0.0854); Transport (0.0735),
MSLVRNSSRLLRSQLKRVQSVPVALYHENVVEHYENPRNVGSLDKKDVTVGTGLVGAPACGDVMKLQIKVDENGKIVDAKFKTFGCGSAIASSSLATEWVKGKSIDEAGKLKNTDIAKELRLPPVKLHCSMLAEDAIKAALADYKVKQQKKVAN,,intracellular iron ion homeostasis (GO:0006879) (0.8499); iron-sulfur cluster assembly (GO:0016226) (0.4570); cellular response to oxidative stress (GO:0034599) (0.0563); response to iron ion (GO:0010039) (0.0443); tRNA wobble uridine modification (GO:0002098) (0.0442),mitochondrial matrix (GO:0005759) (0.5657); iron-sulfur cluster assembly complex (GO:1990229) (0.2382); nucleus (GO:0005634) (0.1485); mitochondrion (GO:0005739) (0.1001),"ferrous iron binding (GO:0008198) (0.3014); 2 iron, 2 sulfur cluster binding (GO:0051537) (0.2395)","Iron-sulfur cluster assembly scaffold protein IscU (IPR011339) (0.2128); NIF system FeS cluster assembly, NifU, N-terminal (IPR002871) (0.1772)",3.90.1010.10 (0.2803),Transit peptide (0.6595); Mitochondrion (0.4835); Metal-binding (0.1950); Zinc (0.1801); Reference proteome (0.1315); 2Fe-2S (0.1274),[2Fe-2S] cluster (0.1376)
MFTKSVFIALVAGVLGVTAAYDPAHMPAKTDAKGGQTGYNDCQQRYGATNPKAKCQNIFINSVKDFCLWGPPKTNGADTVGDLEAVMVSYCMKSGYGTRLIPDGTIHGAHFLKTPSFVQITGTGDFTKIHIQAGDEGGELDPHGATGSGNPVGGQVFTRAYTGNWEQLPEWQNFMSATEYCFRACRSGPWDRQWCPHIYDVMGCLWNEPANYDRGVFEQCDGTEGEWPGVYSGSTWYQGVKPTPAAQPAGKSSNCRYYPSISNGPAIKTPSKRSVMATHVKRSPEWEEEP,2.4.1.- (0.2714); non-specific serine/threonine protein kinase (2.7.11.1) (0.0915),invasive growth in response to glucose limitation (GO:0001403) (0.5184); filamentous growth (GO:0030447) (0.1383); cellular response to starvation (GO:0009267) (0.1252); fungal-type cell wall organization (GO:0031505) (0.0914); conjugation with cellular fusion (GO:0000747) (0.0857); cell differentiation (GO:0030154) (0.0772); rRNA processing (GO:0006364) (0.0519),cell periphery (GO:0071944) (0.7509); P-body (GO:0000932) (0.3590); fungal-type vacuole (GO:0000324) (0.2162); extracellular region (GO:0005576) (0.1416); endoplasmic reticulum (GO:0005783) (0.1199); cytoplasm (GO:0005737) (0.0958); plasma membrane (GO:0005886) (0.0777); side of membrane (GO:0098552) (0.0759),,,,Signal (0.6842); Glycoprotein (0.6246); Reference proteome (0.4319); Zinc (0.2618); GPI-anchor (0.2523); Cell wall biogenesis/degradation (0.2188); Membrane (0.1882); Disulfide bond (0.1340); Transferase (0.1298); Secreted (0.1120); Virulence (0.0682),
MSQSPTNVPRSYNSVLDLKLASPTNSASGATGGWIVQKFGGTSVGKFPENIVDNIVKVYSQTNRVAVVCSARSSQTKSEGTTSRLLRSADLAENDKDYQPLLNAIEEDHVTNAERIQSEEIKQELIKDTKQEIEHVRELLHACQIIGEISPRSLDSIMAVGEKLSCLFMTALMKDHGLNAVYINLQDVIPLSYDFQKGFDDSFYQFLSQEIGKRVLQCDKEREGEEDVIPVLTGYFGVVPGGLLNGVGRGYTDLCAALAAVALQADELQIWKEVDGIFTADPRKVPNARLLDSVTPEEAAELTYYGSEVIHPFTMEQVIRAKIPIRIKNVENPTGKGTIIYPDNIGRRGEATPPHPPAAFEQLAMSSLLQRKRSATAITAKQDIVVINIHSNKKTLSHGFLAHVFTTLDKYKLVVDLISTSEVHVSMALSIQSDQESQLKHALVDLRKMGTVDVTKKMTIVSLVGKQMVNFIGIAGNMFKVLADEKINIEMISQGANEINISAVINEKDTIRALKSIHAKLLEGGSAIGDSSAVDTRLEALKLS,aspartate kinase (2.7.2.4) (0.7900),lysine biosynthetic process via diaminopimelate (GO:0009089) (0.7290); homoserine biosynthetic process (GO:0009090) (0.4411); phosphorylation (GO:0016310) (0.3168); methionine biosynthetic process (GO:0009086) (0.2940); threonine biosynthetic process (GO:0009088) (0.1945); response to hypoxia (GO:0001666) (0.1119); aspartate family amino acid biosynthetic process (GO:0009067) (0.0679); amino acid biosynthetic process (GO:0008652) (0.0404),cytosol (GO:0005829) (0.7966),aspartate kinase activity (GO:0004072) (0.3984); ATP binding (GO:0005524) (0.3919),"Aspartokinase, ACT domain (IPR054352) (0.7051); ACT domain (IPR002912) (0.4448); Aspartate kinase (IPR001341) (0.4167); Aspartate kinase, conserved site (IPR018042) (0.3150); Acetylglutamate kinase-like superfamily (IPR036393) (0.2047); ACT-like domain (IPR045865) (0.2008); Aspartate/glutamate/uridylate kinase (IPR001048) (0.1274); Aspartokinase HOM3, catalytic domain (IPR041747) (0.0986)",3.30.2130.10 (0.1403); 3.40.1160.10 (0.0801),Ubl conjugation (0.8113); Reference proteome (0.6046); Nucleotide-binding (0.4761); Kinase (0.3370); ATP-binding (0.2711); Transferase (0.1812); Repeat (0.1372); Phosphoprotein (0.1193); Coiled coil (0.1029); Mitochondrion (0.0738); Metal-binding (0.0647); Sodium (0.0645),
MISAPSPDHLLLEQDLATPEIRCGEIEERWRHIRTSWPHVFFAVSAPQRPNGPKEFGFRFEYTGYRQTPVTAQLWDLEADAPLPHAKWPTGTYVVPSVFRKDWQQGNCLYIPCDRISIQGHTAWLNDHPSRLWQPARGIICYLEQLYELFNQGDYTGLVSA,RING-type E3 ubiquitin transferase (2.3.2.27) (0.1268),protein monoubiquitination (GO:0006513) (0.4961); response to antibiotic (GO:0046677) (0.2510); sporulation resulting in formation of a cellular spore (GO:0030435) (0.1801); defense response to virus (GO:0051607) (0.1644); DNA damage response (GO:0006974) (0.1245); symbiont-mediated suppression of host innate immune response (GO:0052170) (0.1190); protein ubiquitination (GO:0016567) (0.1065); protein ufmylation (GO:0071569) (0.0883); proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161) (0.0799); virus-mediated perturbation of host defense response (GO:0019049) (0.0590); cellular response to interferon-beta (GO:0035458) (0.0533); plasma membrane repair (GO:0001778) (0.0432),cytosol (GO:0005829) (0.2407); cytoplasm (GO:0005737) (0.0456),ubiquitin-like protein transferase activity (GO:0019787) (0.2012); ubiquitin protein ligase activity (GO:0061630) (0.1452); identical protein binding (GO:0042802) (0.1339),Ubiquitin-conjugating enzyme/RWD-like (IPR016135) (0.1280); Ubiquitin-conjugating enzyme E2 (IPR000608) (0.0809),3.10.110.10 (0.1119),Sporulation (0.6212); Zinc (0.5586); Reference proteome (0.4275); Ubl conjugation pathway (0.2917); Virion (0.2596); 3D-structure (0.2403); Viral immunoevasion (0.2340); Cytoplasm (0.1520); Calcium (0.1146); Chromatin regulator (0.1144); Secreted (0.1136); Metal-binding (0.1129),
MNLTLDHTTLHRAAKYFMDSGKAASHEAAMNLLQQFGLTIYVGEEIRSSAAHQIALLTIVNVTRRTLLGGVEVIGLPDCDSLTALAPNTGLKEAVMALGGTPVAVARPEWPTALIGSVEDYSNKDTAWRVTWEGWRAGAAPLMIGDRLSEDNSMALAPALAAAVCAGEVFSHYAGDHPMAGRRTAGLSLWQPGADWLDVDESEPELAFLPSNLWIIGLGNLGQAFAWLLALMPYETPQELQLVLQDYDRIAPSNDSTSLLSYKHDTNKMKARVVADWLDKRGFTTFIEERRFGPWTKRHADEPGVALCGVDNALARSALDQAGFPLIVEAGLGGGPQAFRSLGIHTFPSSRTAAEIWAKQVALADTSTEDMPAYQALKKSGIDACGLTQLASRTVGVPFVGLIAACLAMSELLRRLHGGKAFEFIAGSTATLQDIEFGTLHAPPYAHGYTRAMPMGWPTAP,2.7.7.- (0.1000),proteolysis (GO:0006508) (0.0771); tricarboxylic acid cycle (GO:0006099) (0.0654); regulation of mitotic cell cycle (GO:0007346) (0.0620); auxin-activated signaling pathway (GO:0009734) (0.0456); protein modification by small protein conjugation (GO:0032446) (0.0430); regulation of gene expression (GO:0010468) (0.0418); regulation of type II interferon production (GO:0032649) (0.0410),extracellular region (GO:0005576) (0.1237),identical protein binding (GO:0042802) (0.6131); metal ion binding (GO:0046872) (0.2086); nucleotidyltransferase activity (GO:0016779) (0.1271); ubiquitin-like modifier activating enzyme activity (GO:0008641) (0.1106),Ubiquitin-activating enzyme (IPR035985) (0.1285),3.40.50.720 (0.3669),Zinc (0.9127); 3D-structure (0.4916); Reference proteome (0.3539); Direct protein sequencing (0.3150); Membrane (0.2642); Plasmid (0.2273); NAD (0.1990); Metal-binding (0.1237); Transport (0.1123); Ubl conjugation (0.0952); Nucleotide-binding (0.0885); Host-virus interaction (0.0825),
MTTLVVFIQVQGRPGIIETKLGPATTIGELKAALAAVGVNIDVETFIYVEDAENHLHGEHHEPAYGVKHGCRIHVSRCKRIRATVHYLDKTETRDFAPGARIRAVKAHAVDVFHIPPKDAGEHVLQLCNSLERPASDTPLHTLADHNTCAVCFDLVPEKRIEG,,negative regulation of cell population proliferation (GO:0008285) (0.4953); actin filament organization (GO:0007015) (0.3333); positive regulation of protein-containing complex assembly (GO:0031334) (0.2576); positive regulation of mitotic metaphase/anaphase transition (GO:0045842) (0.1650); stem cell differentiation (GO:0048863) (0.1345); positive regulation of TORC1 signaling (GO:1904263) (0.1190); cell division (GO:0051301) (0.1173); germ cell development (GO:0007281) (0.0947); heart development (GO:0007507) (0.0851); asymmetric protein localization involved in cell fate determination (GO:0045167) (0.0816); dorsal closure (GO:0007391) (0.0814); chaeta morphogenesis (GO:0008407) (0.0744); negative regulation of apoptotic process (GO:0043066) (0.0740); positive regulation of transcription by RNA polymerase II (GO:0045944) (0.0738); cellular response to amino acid stimulus (GO:0071230) (0.0700); somitogenesis (GO:0001756) (0.0676); central nervous system development (GO:0007417) (0.0675); regulation of gene expression (GO:0010468) (0.0659); cell adhesion (GO:0007155) (0.0629); animal organ morphogenesis (GO:0009887) (0.0609); positive regulation of gene expression (GO:0010628) (0.0606); embryo development ending in birth or egg hatching (GO:0009792) (0.0606); calcium-mediated signaling (GO:0019722) (0.0524); mitochondrion inheritance (GO:0000001) (0.0506),bicellular tight junction (GO:0005923) (0.3266); nucleus (GO:0005634) (0.2147); cytoplasm (GO:0005737) (0.2060); cell cortex (GO:0005938) (0.0837),identical protein binding (GO:0042802) (0.3016); ubiquitin-protein transferase activity (GO:0004842) (0.0617),Ubiquitin-like domain superfamily (IPR029071) (0.1569),,Reference proteome (0.4285); Cell junction (0.2874); Cell adhesion (0.0705); Cell cycle (0.0532),
MASGQMAPSLLRRPITFVSSCPPALRSFGALCPPTGSTDLIGGTGRDILIAAAPARRAPLHATLPLLRSLHTSPAPQLSASHQHQAQQQQQQTKQPQQPYDPQQDQVPSTSTASSSKPAADPVYNLPNAVSVARLVSGPLIGYWLVQGHYEAATLALAVSGASDWLDGWLARRLGASSVFGSYLDPLADKVLIGCVAAALLMNGAMPGWVAGVVVGRDVLLVAGSFVFRLRGFGWRWPGAAAFFRTVDTSAAAAGAATGAANGVASGGGGGGEGVSFMRPLLISKANTVLQLLLLGGYLLRGMDGGAGLQLLLPGGGGEELIMGLELATAATTVASGLAYGTMAVQGKLFK,cardiolipin synthase (CMP-forming) (2.7.8.41) (0.3471); CDP-diacylglycerol-glycerol-3-phosphate 1-phosphatidyltransferase (2.7.8.5) (0.2699); 2.7.8.- (0.1522),phospholipid biosynthetic process (GO:0008654) (0.2605); cardiolipin biosynthetic process (GO:0032049) (0.1737); intracellular monoatomic ion homeostasis (GO:0006873) (0.0895); protein targeting to membrane (GO:0006612) (0.0887); chloroplast organization (GO:0009658) (0.0873); response to thyroxine (GO:0097068) (0.0686),mitochondrial inner membrane (GO:0005743) (0.3812); chloroplast envelope (GO:0009941) (0.2451); mitochondrion (GO:0005739) (0.1411); membrane (GO:0016020) (0.1240); Golgi membrane (GO:0000139) (0.0537); plasma membrane (GO:0005886) (0.0468),cardiolipin synthase (CMP-forming) (GO:0043337) (0.2008),"CDP-alcohol phosphatidyltransferase, conserved site (IPR048254) (0.4187); CDP-alcohol phosphatidyltransferase class-I (IPR050324) (0.3344); CDP-alcohol phosphatidyltransferase, transmembrane domain (IPR043130) (0.3182); CDP-alcohol phosphatidyltransferase (IPR000462) (0.2242)",1.20.120.1760 (0.1924),Transmembrane (0.7724); Transferase (0.7422); Reference proteome (0.5820); Transmembrane helix (0.5578); Phospholipid metabolism (0.5564); Lipid biosynthesis (0.4965); Lipid metabolism (0.4757); Phospholipid biosynthesis (0.4652); Mitochondrion (0.4532); Membrane (0.3192); Zinc-finger (0.1638); Transit peptide (0.1311); Proteomics identification (0.0673); Plastid inner membrane (0.0522),
MEVSNMTTVTVFILLGLSNNPQVQALLFVLFLVIYLLTLLGNLLMVLVISTDSHLCTPMYFFLRQLSFLDAFYSSIIVPKLLENLLSKGETISFLECFTQISLVIFSGATEACLLSVMAYDRFQAMCHPLLYVVIINRRVCAGLVGASWAIGMGTGLINTLLLAQQHFCGPNVIHSFACELPPVLLLTCSDPCASIVSILTTMSVLGLGTLVLLLGSYSCIIMTALRINSATGRSKIFSTCSSHFLVVTIFYTSGVLRYMIPASGSALEQVLSVQYSVITPLLNPLIYSLKSQEVKVALRRMLARKSRLPL,,"G protein-coupled receptor signaling pathway (GO:0007186) (0.4320); sensory perception of smell (GO:0007608) (0.2215); regulation of angiogenesis (GO:0045765) (0.2196); adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189) (0.2126); detection of chemical stimulus involved in sensory perception of smell (GO:0050911) (0.1811); sensory perception of sound (GO:0007605) (0.1544); detection of chemical stimulus involved in sensory perception (GO:0050907) (0.1439); signal transduction (GO:0007165) (0.1174); chemotaxis (GO:0006935) (0.1123); G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187) (0.0813)",plasma membrane (GO:0005886) (0.3394); membrane (GO:0016020) (0.0785); cytoplasm (GO:0005737) (0.0546),G protein-coupled receptor activity (GO:0004930) (0.3447); olfactory receptor activity (GO:0004984) (0.1338),"Olfactory receptor (IPR000725) (0.4298); GPCR, rhodopsin-like, 7TM (IPR017452) (0.2751); G protein-coupled receptor, rhodopsin-like (IPR000276) (0.1518)",1.20.1070.10 (0.2288),Transducer (0.9668); Olfaction (0.7968); Reference proteome (0.7554); Transmembrane helix (0.6893); G-protein coupled receptor (0.6237); Glycoprotein (0.4783); Sensory transduction (0.4564); Receptor (0.4006); Membrane (0.3727); Transmembrane (0.2556); Disulfide bond (0.2288),
MGRGRVELKRIENKINRQVTFSKRRNGLLKKAYELSVLCEAEVALIIFSSRGKLYEFGSAGITKTLERYQRCCLNPQDNCGERETQSWYQEVSKLKAKFEALQRTQRHLLGEDLGALSVKELQNLEKQLEGALAQARQRKTQIMMEQMEELRRKERHLGDVNKQLKIKVSLELSSFEGEGQGVPFPWSNCNASLDEAGSSTFHVHHSQSNHMDCDLPDPVLQIGYHQYMAADGASGSRNMAVESNIIHGWGL,,positive regulation of transcription by RNA polymerase II (GO:0045944) (0.2605); flower development (GO:0009908) (0.2329); cell differentiation (GO:0030154) (0.1956); regulation of transcription by RNA polymerase II (GO:0006357) (0.1923); integument development (GO:0080060) (0.1886); specification of floral organ identity (GO:0010093) (0.1602); pollen development (GO:0009555) (0.1448); floral meristem determinacy (GO:0010582) (0.1392); fruit development (GO:0010154) (0.1301); cell fate specification (GO:0001708) (0.1179); specification of floral organ number (GO:0048833) (0.1030); embryo sac development (GO:0009553) (0.0840); positive regulation of DNA-templated transcription (GO:0045893) (0.0524),nucleus (GO:0005634) (0.1147),"protein dimerization activity (GO:0046983) (0.1323); DNA-binding transcription factor activity (GO:0003700) (0.0988); DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981) (0.0963)","MADS-box/MEF2 Transcription Factor (IPR050142) (0.2686); Transcription factor, MADS-box (IPR002100) (0.2646); Transcription factor, K-box (IPR002487) (0.1871); Transcription factor, MADS-box superfamily (IPR036879) (0.1375)",3.40.1810.10 (0.2128),Reference proteome (0.8304); Transcription regulation (0.7508); Flowering (0.6426); Nucleus (0.4742); DNA-binding (0.3661); Developmental protein (0.3227); Differentiation (0.2416); Activator (0.2124); Ubl conjugation (0.1016); Transcription (0.0945),
MESGPRVEPGPGAPAAVLARIPQEPRPSPEGDPSPPPPPTPMSALVPDTPPDTPPAMKNASTPQQLPLEPVSPTGQVSPQPAPPPDECPSSEAKSRGPTPTATGPRDAKPSQRSSQPSPTAVPASDSPSAKQDVKKAGERHKLAKERREERAKYLAAKKAVWLEKEEKAKALREKQLQERRRRLEEQRLKAEQRRAALEERQRQKLEKNKERYEAAIQRSVKKTWAEIRQQRWSWAGALHHNSPGRKTSGSRCSVSAVNLPKHVDSIINKRLSKSSATLWNSPSRNRSLQLSAWESSIVDRLMTPTLSFLARSRSAVTLPRNGRDQGRGSGPGRRPTRARAGASLAPGPHPDRTHPSAAVPVCPRSASASPLTPCSAPRSAHRCTPSGERPERRKPGAGGSPALVRRRLEATPVQKKEKKDKERENEKEKSALARERNLKKRQSLPASIRPRISTGAELSTKSKARPTSPSTTWHRPASPCPSPGPGHTLPPKPPSPRGTTASPKGRIRRKEEAKESPSPSGPEDKNHSKSRTAEEKEPAAPASPAPSPVPSPTPAQPQKEQSSTQIPPDTAVPAVPTVPTFPTAPPTAAPSVTPSKPMAGTTDREEATRLLAEKRRQAREQREREEQERKLQAERDKRMREEQLAREAEARAEREAEARRREEQEAREKAQAEQEEQERLQKQKEEAEARSREEAERQRLEREKHFQKEEQERQERRKRLEEIMKRTRKSEAAETKKQDGKETMANNSGPDPVKAVETRPSGLQKDSMQKEELAPQEPQWSLPSKEMPGSLVNGLQPLPAHQENGFPAKGTAGDKSLGRAAEGLLPFAEADAFLKKAVVQPPQVTEVL,,microtubule cytoskeleton organization (GO:0000226) (0.6649); cell morphogenesis (GO:0000902) (0.4879); actin filament bundle assembly (GO:0051017) (0.4337); microtubule polymerization (GO:0046785) (0.1778); regulation of cell shape (GO:0008360) (0.1342); lipid metabolic process (GO:0006629) (0.1269); establishment or maintenance of cell polarity (GO:0007163) (0.1039); microtubule bundle formation (GO:0001578) (0.0841); glycosphingolipid metabolic process (GO:0006687) (0.0789); negative regulation of microtubule depolymerization (GO:0007026) (0.0708); regulation of microtubule cytoskeleton organization (GO:0070507) (0.0703),cytoplasm (GO:0005737) (0.2951); cytosol (GO:0005829) (0.2809); plasma membrane (GO:0005886) (0.1912); microtubule cytoskeleton (GO:0015630) (0.1671),microtubule binding (GO:0008017) (0.1632),,,Ubl conjugation (0.6563); Phosphoprotein (0.5339); Reference proteome (0.5219); Cytoplasm (0.4692); Coiled coil (0.4372); Isopeptide bond (0.3587); Alternative splicing (0.1585); Methylation (0.1526); Acetylation (0.1524); Nucleus (0.1177); Repeat (0.0984); Proteomics identification (0.0815),
MSRRALRRLRGEQRGQEPLGPDALQFVLLDDDDAEEEGPKTGLGGRRPGGAGKEGVRVNNRFELINIEDLEDDLVVNGERSDCTLPDSASSGNKGRAKHGNPENKQDGDAAAKAGSSEQSNASGKLRKKKKKQKNKKSCTGESSENGLEDIDRILERIEDSSGFSHPGPPPLSSRKHVLYVEHRHLNPDTELKRYFGARAVLGEQRPRQRQRVYPKCTWLTTPKSTWPRYSKPGLSMRLLESKKGLSFFAFEHSEEYQQAQHKFLVAVESMEPNNIVALLQTSPYHVDSLLQLSDACRFQEDQEMARDLIGEPAYPHLLPMEKSWCRRPHWSFYLALYKQMSFLEKRGCPRTALEYCKLILSLEPDEDPLCMLLLIDHMALRARNYEYLIRLFQEWEAHRNLSQLPNFAFSVPLAYFLLSQQTDLPDHELSSARQQASLLIQQALTMFPGVLMPLLEYCSVRPDATVSNHRFFGPDAEISQPPALSQLVSLYLGRSHFLWKEPAIMSWLEENVHEVLEAVDSGDPAVEACENRRKVLYQRAPRNIHRHVILSEIKEAVAALPSDVTTQSVMGFDPLPPVDTIYSYVRPERLSPVSHGNTIALFFRSLLPNYTTEGERLEEGVAGGPNRNQGLNRLMLAVRDMMANFHFNDLEVPREDNPEGEGDWD,,negative regulation of transcription by RNA polymerase II (GO:0000122) (0.8961); regulation of protein K48-linked ubiquitination (GO:0061945) (0.4847); apoptotic process (GO:0006915) (0.3648); positive regulation of DNA-templated transcription (GO:0045893) (0.2712); regulation of transcription elongation by RNA polymerase II (GO:0034243) (0.1252); immune response (GO:0006955) (0.1089); positive regulation of transcription by RNA polymerase II (GO:0045944) (0.0908); chromatin organization (GO:0006325) (0.0841); cell division (GO:0051301) (0.0653); regulation of cell migration (GO:0030334) (0.0572),nucleus (GO:0005634) (0.5379); RQC complex (GO:1990112) (0.2287); nucleoplasm (GO:0005654) (0.1922); cytoplasm (GO:0005737) (0.1433); chromatin (GO:0000785) (0.0475),transcription corepressor activity (GO:0003714) (0.3649); protein phosphatase binding (GO:0019903) (0.1650),Tetratricopeptide-like helical domain superfamily (IPR011990) (0.1395),1.25.40.10 (0.2849),Transcription regulation (0.7499); Reference proteome (0.7098); Transcription (0.4482); 3D-structure (0.4102); Nucleus (0.3598); Phosphoprotein (0.2482); Cytoplasm (0.2478); Proteomics identification (0.2197); Disease variant (0.1943); Acetylation (0.1569); Alternative splicing (0.1511); DNA-binding (0.1505); Translation regulation (0.1198); Repressor (0.1052),
MTTHFKAGKALKVKKEAGENAPALSDDELVAMSVRELNQHLRGLTKEDVVRLKQRRRTLKNRGYAASCRIKRVTQKEELERQKTELQHEVDKLARENASMRLELDALRAKYEALQCFARTVTRGPPGKVAATSVITIVKSANHSPSSAPFSAQS,,regulation of epidermal cell differentiation (GO:0045604) (0.4289); regulation of transcription by RNA polymerase II (GO:0006357) (0.3780); in utero embryonic development (GO:0001701) (0.3675); negative regulation of transcription by RNA polymerase II (GO:0000122) (0.3306); skeletal muscle cell differentiation (GO:0035914) (0.2106); regulation of DNA-templated transcription (GO:0006355) (0.1564); regulation of cell population proliferation (GO:0042127) (0.1236); positive regulation of gene expression (GO:0010628) (0.0817); sensory perception of sound (GO:0007605) (0.0758),nucleoplasm (GO:0005654) (0.2292); cytoplasm (GO:0005737) (0.1601); nucleus (GO:0005634) (0.1514); RNA polymerase II transcription regulator complex (GO:0090575) (0.0871),"protein heterodimerization activity (GO:0046982) (0.2694); DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981) (0.2009); sequence-specific DNA binding (GO:0043565) (0.1840); DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228) (0.1815); RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978) (0.1518)",Transcription factor Maf family (IPR024874) (0.2382); Basic-leucine zipper domain superfamily (IPR046347) (0.2135); Basic-leucine zipper domain (IPR004827) (0.0919),1.20.5.170 (0.1257),Transcription (0.7549); Ubl conjugation (0.5345); Isopeptide bond (0.5328); Reference proteome (0.4749); Transcription regulation (0.4016); DNA-binding (0.2762); Repressor (0.2581); Nucleus (0.2120); Coiled coil (0.1023),
MRIMKRPNILLTGTPGVGKTTLGKELAQRTGLTYVNVGDLAQEAELFDGFDEEYQCPILDEDRVVDELEDQMGDGGVIIDYHGCDFFPERWFHIVFVLRTDNTNLYNRLESRGYTGKKLQDNVQCEIFQTIFEEAVEAYKEEIVHQLPSNTPEDLERNLEQIVQWIEQWMKDNN,adenylate kinase (2.7.4.3) (0.9876),rRNA processing (GO:0006364) (0.8961); ribosomal small subunit biogenesis (GO:0042274) (0.7564); phosphorylation (GO:0016310) (0.2599); unidimensional cell growth (GO:0009826) (0.1035); maturation of SSU-rRNA (GO:0030490) (0.0706),nucleus (GO:0005634) (0.2934); cytoplasm (GO:0005737) (0.2601); nuclear speck (GO:0016607) (0.2264); nucleoplasm (GO:0005654) (0.2105); cytosol (GO:0005829) (0.1227); Cajal body (GO:0015030) (0.0992),adenylate kinase activity (GO:0004017) (0.5864); ATP binding (GO:0005524) (0.2585); ATP hydrolysis activity (GO:0016887) (0.1932),P-loop containing nucleoside triphosphate hydrolase (IPR027417) (0.4071),3.40.50.300 (0.3248),rRNA processing (0.9994); Ribosome biogenesis (0.8871); Reference proteome (0.8168); Cytoplasm (0.5884); Nucleotide-binding (0.5586); Nucleus (0.3388); Phosphoprotein (0.2457); Transferase (0.2409); Kinase (0.2383); ATP-binding (0.1008),
MSAKAISEQTGKEFLYKHICTSASVQNRFRYANVTAETDWERLVQDHPWLLTERLVVKPDQLIKRRGKLGLVGVNLDLNGVKEWLKSRLMQETMVGKAKGILKNFLIEPFVAHKQEEEFYVCIYATREGDYMLFHHEGGVDVGDVDSKALKLLVGVDEKISADTVKSQLLTHAPADKKEILSSFLVGLFNLYEDLYFTYLEINPLVVTKDGVYVLDMAAKIDATADYLCKAKWGDVEFPPPFGREAYPEEAYIADLDAKSGASLKLTLLNPRGRIWTMVAGGGASVVYSDTICDLGGVNELANYGEYSGAPSEQQTYDYAKTILSLMTREKHPDGKVLIIGGSIANFTNVAATFKGIVRAFKDYQDPLKEHEVTIFVRRGGPNYQEGLRVMGEVGKTTGIPIHVFGTETHMTAIVGMALGHRPIATQPRGAAHTANFLLNASGGTTTPASSRSASFSEVRTGAESSSGLKSRAGLPPAKSTTLFSNHTKSIVWGMQTRAVQGMLDFDYVCSRQEPSVAAMVYPFTGDHKQKFYWGHKEILLPVYKNMADAMKKHPEVDVLISFASLRSAYDSTIETMQFPQIHTIAIIAEGIPEALTRKIIKMADEKGITIIGPATVGGIKPGCFKIGNTGGMLDNILASKLYRPGSVAYVSRSGGMSNELNNIISRTTDGVYEGVAIGGDRYPGSVFIDHVLRYQDTPGVKMIVVLGEIGGNEEYKICNAIKEGRITKPVVCWCIGTCATLFSSEVQFGHAGACANQASETAVAKNKALEEAGAFVPKSFDELGDVIKSVYDNLVAKGVIVPAKELPPPTVPMDYSWARELGLIRKPASFMTSICDERGQELIYAGMPITEVFKSEIGLGGTLGLLWFQRRLPRYACQFIEMCLMVTADHGPAVSGAHNTIVCARAGKDLISSLTSGLLTIGDRFGGALDAAAKQFSKAFDSGMLPMEFVNKMKKDGKLIMGIGHRVKSINNPDMRVQILKDFVKQHFPATQLLDYALEVEKITTSKKPNLILNVDGFIGVSFVDLLRTCGGFTRDEADEFVEIGALNGIFVLGRSMGFIGHYLDQKRLKQGLYRHPWDDISYVLPEHMTM,ATP citrate synthase (2.3.3.8) (0.9978),acetyl-CoA biosynthetic process (GO:0006085) (0.8037); fatty acid biosynthetic process (GO:0006633) (0.6445); citrate metabolic process (GO:0006101) (0.5074); lipid metabolic process (GO:0006629) (0.2500),cytosol (GO:0005829) (0.8305),metal ion binding (GO:0046872) (0.4991); ATP citrate synthase activity (GO:0003878) (0.4346); lyase activity (GO:0016829) (0.2545); nucleotide binding (GO:0000166) (0.1648),"Succinyl-CoA synthetase-like (IPR016102) (0.6548); ATP-citrate synthase/succinyl-CoA ligase, C-terminal domain (IPR005811) (0.5383); Citrate synthase (IPR002020) (0.5291); ATP-citrate synthase, citrate-binding domain (IPR032263) (0.5266); ATP-citrate synthase (IPR014608) (0.3629); Citrate synthase superfamily (IPR036969) (0.3358); NAD(P)-binding domain superfamily (IPR036291) (0.3356); ATP-citrate lyase/succinyl-CoA ligase, conserved site (IPR033847) (0.2752); CoA-binding (IPR003781) (0.2569); Succinyl-CoA synthetase, beta subunit, conserved site (IPR017866) (0.2219); Citrate synthase-like, small alpha subdomain (IPR016143) (0.1962); ATP-citrate lyase/succinyl-CoA ligase, active site (IPR017440) (0.0529); Citrate synthase-like, large alpha subdomain (IPR016142) (0.0526)",3.40.50.261 (0.6857); 1.10.230.10 (0.4448); 3.40.50.720 (0.3159); 3.30.470.110 (0.0534),Nucleotide-binding (0.6586); Transferase (0.5878); Cytoplasm (0.4983); Lipid metabolism (0.3801); Reference proteome (0.3737); Magnesium (0.3581); Lipid biosynthesis (0.2811); Metal-binding (0.2225); ATP-binding (0.1733); Ubl conjugation (0.1633); Phosphoprotein (0.1437),
MAQYSGAKQYQSMKTLSPVETMATNDPLPPGWEIKIDPQTGWPFFVDHNNRTTTWNDPRHDTKKIFSNGPSMSPETPQDMHKTFINEMRQPMLRQGYIPIPVCHENPEPRLQQYPSFSYIHPAVQQNLRTDGRTPSPTPAAHCRPRSPVQTPSEACSSCSPTSHGPEGYQPQGTHQQISGLHQQPRSSNTGLRAGYIPIPVIHEGAGGVLPSQLSQSSHPTREKIYREQVPIQIQQNRAASPIQVPLRAQSPVMAQIMGERPQMQQHIGHTAIPSKIEHPVEEIIRVPTFEVPIQRVSEVPQQIHHQPVQQQQQPTQQPQPKAQPSPQVSETSNITIQVPPAPEPQETAAPQTPQEVSSPQLQPEETLEQDLSHPGLVKVQQIVERVEKLAQNVKGFDGKKNDKRYLVLEEMLTKELLALDSVDPEGRPDVRQARRDGVRRVQNILDELEMIGEMQAGNEAKGEQSMIDQLNTERVKEFS,,negative regulation of striated muscle cell apoptotic process (GO:0010664) (0.8625); striated muscle cell apoptotic process (GO:0010658) (0.7696); cellular response to unfolded protein (GO:0034620) (0.7133); protein stabilization (GO:0050821) (0.4531); positive regulation of protein import into nucleus (GO:0042307) (0.3127); muscle cell cellular homeostasis (GO:0046716) (0.2210); extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625) (0.2165); positive regulation of aggrephagy (GO:1905337) (0.1808); positive regulation of actin filament polymerization (GO:0030838) (0.1560); positive regulation of protein export from nucleus (GO:0046827) (0.1316); negative regulation of transcription by RNA polymerase II (GO:0000122) (0.1160),cytosol (GO:0005829) (0.3677); protein folding chaperone complex (GO:0101031) (0.2133); nucleus (GO:0005634) (0.1895); Z disc (GO:0030018) (0.1337); cytoplasm (GO:0005737) (0.1138),adenyl-nucleotide exchange factor activity (GO:0000774) (0.3856); protein-folding chaperone binding (GO:0051087) (0.2147),Molecular chaperone regulator BAG (IPR039773) (0.5150); BAG domain (IPR003103) (0.4271); WW domain (IPR001202) (0.3584); BAG domain superfamily (IPR036533) (0.2212); WW domain superfamily (IPR036020) (0.1917),2.20.70.10 (0.3957); 1.20.58.120 (0.3163),Reference proteome (0.2509); Chaperone (0.1608),
MAAHGLAARLLPLLLLTMLAVAHASIFLSNQRLKPRFQRDRRNIRPNIILILTDDQDIELGSMQVMNKTRRIMEQGGTHFSNAFVTTPMCCPSRSSMLTGKYAHNHNTYTNNENCSSPSWQAQHEPRTFGVYLNNTGYRTAFFGKYLNEYNGTYIPPGWKEWVAMVKNSRFYNYTLCRNGVREKHGFEYPKDYLTDLITNDSINYFRMSKKIYPHRPVLMVISHAAPHGPEDAAPQYTTAFPNASQHITPSYNYAPNPDKHWIMRYTGPMKPIHMEFTNMLQRKRLQTLLSVDDSVEKVYNMLVDTGELDNTYVIYTADHGYHIGQFGLVKGKSMPYEFDIRVPFYIRGPNVEAGGINPHIVLNIDLAPTILDIAGMDVPPDMDGKSILKLLDTDRMMNRFQLNKKGKVWRDSFLVERGKLLHKVLNDGKDMAEEENYLPKYQRVKDLCQRAEYQTPCEQIGQKWQCVEDATGKLRLSKCKGMSSLSAVQKPSVSSIKSQLYLQSISTPDVSLNSEPQECNCQPKSYRLSTYSKSKLFSKKKMKSLKSFSRNRFARALSMETGGDLYAVDLDNEHRNLSLRLSTADEDEEFSGAEPTTISQSNSLSVPSSIKVTHRCSILANETVKCDVGLYKSLQAWKDHKLHIDHEIETLQTKIKNLREVRGHLKKARPEECDCNKYYYKSKYKSKLRKYKTGNVHPFRKGQEKDKKAWMMLEQKRRKKLRKLLKRLRNNDTCSMPGLTCFTHDNQHWQTAPFWTLGPFCACTSANNNTYWCMRTINETHNFLFCEFATGFLEYFDINTDPYQLVNAVNTLDRYVLNQLHVQLMELRGCKGHKQCNPRTRSLDMGGKERSSYDEYRQFQRRKWPKVRKPVSKSLGQIWEGWEG,3.1.6.- (0.6374); arylsulfatase (type I) (3.1.6.1) (0.2633); N-acetylglucosamine-6-sulfatase (3.1.6.14) (0.2056),positive regulation of vascular endothelial growth factor production (GO:0010575) (0.5780); chondrocyte development (GO:0002063) (0.4570); positive regulation of Wnt signaling pathway (GO:0030177) (0.4359); glomerular basement membrane development (GO:0032836) (0.4170); negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) (0.3994); heparan sulfate proteoglycan metabolic process (GO:0030201) (0.3192); embryonic skeletal system development (GO:0048706) (0.2609); bone development (GO:0060348) (0.2142); blood circulation (GO:0008015) (0.1953); glial cell-derived neurotrophic factor receptor signaling pathway (GO:0035860) (0.1613); esophagus smooth muscle contraction (GO:0014846) (0.1516); somitogenesis (GO:0001756) (0.1215); glomerular filtration (GO:0003094) (0.0981),Golgi stack (GO:0005795) (0.4633); cell surface (GO:0009986) (0.3519); endoplasmic reticulum (GO:0005783) (0.2742); plasma membrane (GO:0005886) (0.2711),arylsulfatase activity (GO:0004065) (0.1710); glycosaminoglycan binding (GO:0005539) (0.1668),"Extracellular sulfatase, C-terminal (IPR024609) (0.2645); Sulfatase, N-terminal (IPR000917) (0.1115); Alkaline-phosphatase-like, core domain superfamily (IPR017850) (0.1034)",3.40.720.10 (0.0964),Signal (0.3893); Hydrolase (0.2795); Golgi apparatus (0.2615); Calcium (0.2359); Endoplasmic reticulum (0.2174); Reference proteome (0.1794); Metal-binding (0.0898),Ca(2+) (0.2358)
MAEGELNVDSLISRLLEVRGCRPGKIVQMTEAEVRGLCIKSREIFLSQPILLELEAPLKICGDIHGQYTDLLRLFEYGGFPPEANYLFLGDYVDRGKQSLETICLLLAYKIKYPENFFLLRGNHECASINRIYGFYDECKRRFNIKLWKTFTDCFNCLPIAAIIDEKIFCCHGGLSPDLQSMEQIRRIMRPTDVPDTGLLCDLLWSDPDKDVQGWGENDRGVSFTFGADVVSKFLNRHDLDLICRAHQVVEDGYEFFAKRQLVTLFSAPNYCGEFDNAGGMMSVDESLMCSFQILKPSEKKAKYQYSGVNSGRPVTPPRTAQAPKKR,protein-serine/threonine phosphatase (3.1.3.16) (0.9924),glycogen metabolic process (GO:0005977) (0.7485); protein dephosphorylation (GO:0006470) (0.3704); cell division (GO:0051301) (0.3626); circadian regulation of gene expression (GO:0032922) (0.2239); entrainment of circadian clock by photoperiod (GO:0043153) (0.1436); regulation of circadian rhythm (GO:0042752) (0.0797); response to unfolded protein (GO:0006986) (0.0603); blastocyst development (GO:0001824) (0.0523),PTW/PP1 phosphatase complex (GO:0072357) (0.4916); GO:0000781 (0.1469); nucleoplasm (GO:0005654) (0.1282); nucleus (GO:0005634) (0.0779); cytoplasm (GO:0005737) (0.0729),myosin phosphatase activity (GO:0017018) (0.0797); protein serine/threonine phosphatase activity (GO:0004722) (0.0767),"Serine/threonine-specific protein phosphatase/bis(5-nucleosyl)-tetraphosphatase (IPR006186) (0.2571); Serine/threonine-protein phosphatase PP1 catalytic subunit (IPR050341) (0.2176); Metallo-dependent phosphatase-like (IPR029052) (0.1741); Serine-threonine protein phosphatase, N-terminal (IPR031675) (0.1711); Calcineurin-like phosphoesterase domain, ApaH type (IPR004843) (0.1493)",3.60.21.10 (0.1472),Protein phosphatase (0.3635); Hydrolase (0.3499); Glycogen metabolism (0.2783); Manganese (0.2409); Cell division (0.1979); Carbohydrate metabolism (0.1898); Cell cycle (0.1678),Mn(2+) (0.1144)
MEDPMSEMSMVPFSSPTESSRSNSTDDSQDGKSPAPGKVLNTGLLCKVCSDTSSGKHYGIYACNGCSGFFKRSVRRRLIYRCQAGTGMCPVDKAHRNQCQACRLKKCLQAGMNKDAVQNERQPRSTAQVRLDALDVDKDKEHLATTLEPTSSSTCSVISRPLLGSSISSSISSTDGSQHSNSPKNGHRFMASLMTAETCAKLEPEDVDENIDVTSNEPERSSPMYGSALYPSREPESVYETSARLLFMSVKWAKNLPVFSHLPFRDQVILLEEAWSELFLLCAIQWSLPLDNCPLLSLPDLSPTGQGKGSPSASDVRVLQEVFSRFKPLQVDPTEFACLKAIVLFKPETRGLKDPEQVENLQDQSQVLLAQHIHTLYPSQVARFGRLLLLLPSLHFVSSERIEHLFFQRTIGNTPMEKLLCDMFKN,,negative regulation of transcription by RNA polymerase II (GO:0000122) (0.9745); cell differentiation (GO:0030154) (0.5576); cell population proliferation (GO:0008283) (0.3406); eye photoreceptor cell development (GO:0042462) (0.2197); retina development in camera-type eye (GO:0060041) (0.1669); positive regulation of transcription by RNA polymerase II (GO:0045944) (0.1667); female gonad development (GO:0008585) (0.0897); negative regulation of cell population proliferation (GO:0008285) (0.0888); endothelial cell proliferation (GO:0001935) (0.0700),nucleus (GO:0005634) (0.3196); nucleoplasm (GO:0005654) (0.0420),RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978) (0.2431); zinc ion binding (GO:0008270) (0.1715); nuclear receptor activity (GO:0004879) (0.1713); DNA-binding transcription factor activity (GO:0003700) (0.1429),"Nuclear hormone receptor family NR2 subfamily (IPR050274) (0.7525); Nuclear hormone receptor, ligand-binding domain (IPR000536) (0.4019); Zinc finger, NHR/GATA-type (IPR013088) (0.2577); Nuclear hormone receptor-like domain superfamily (IPR035500) (0.2361); Zinc finger, nuclear hormone receptor-type (IPR001628) (0.1870); Nuclear hormone receptor (IPR001723) (0.1615)",3.30.50.10 (0.5378); 1.10.565.10 (0.3602),Nucleus (0.7560); Reference proteome (0.7157); Transcription regulation (0.6848); Zinc-finger (0.5827); Receptor (0.5501); DNA-binding (0.4428); Transcription (0.4201); Metal-binding (0.3348); Zinc (0.3160); Ubl conjugation (0.1219),
MPQLNGGGGDDLGANDEMIAFKDEGDHEEKIRESAFTESDLADLKSSLVSETEISQSPAVIRRGQQDEQRIYSDKREHLDDVPKHHDGGMYKAPYSGYPFLMLPEPYLPNGPVSPSSNKVSVVQQGMHPLTPLLPYEHFNPSPTHMPTDGGQKPGVHRHQTQEISGFYSLPQGQITPSMNWFSHSLMLQSGMHPTGIPHPAIVPPSGKQEHDQFDRSIYNKSHAEAKREKEPKKPVIKKPLNAFMLYMKEMRAKVIAECTLKESAAINQILGRRWHALTREEQAKYYELARKERQLHMQLYPSWSARDNYVSALGKKKRRKRDKQQDSSTEPGSPKKCRARFGLNQQTDWCGPCR,,fin morphogenesis (GO:0033334) (0.4332); somitogenesis (GO:0001756) (0.3792); regulation of transcription by RNA polymerase II (GO:0006357) (0.3461); forebrain neuron differentiation (GO:0021879) (0.3251); positive regulation of gene expression (GO:0010628) (0.3226); pectoral fin development (GO:0033339) (0.2551); neural crest cell migration (GO:0001755) (0.2515); posterior lateral line neuromast deposition (GO:0048922) (0.1868); Wnt signaling pathway (GO:0016055) (0.1507); caudal fin development (GO:0033336) (0.1452); hypothalamus cell differentiation (GO:0021979) (0.1419); negative regulation of transcription by RNA polymerase II (GO:0000122) (0.0887); canonical Wnt signaling pathway (GO:0060070) (0.0787); fin regeneration (GO:0031101) (0.0758),beta-catenin-TCF complex (GO:1990907) (0.2986),"RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978) (0.1328); DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981) (0.1061)","CTNNB1 binding, N-teminal (IPR013558) (0.4003); Transcription factor TCF/LEF (IPR024940) (0.3931); Catenin binding domain superfamily (IPR027397) (0.2652); High mobility group box domain (IPR009071) (0.1646)",4.10.900.10 (0.4681); 1.10.30.10 (0.1028),Wnt signaling pathway (0.9939); Transcription (0.9370); Transcription regulation (0.8180); Reference proteome (0.5944); DNA-binding (0.4413); Activator (0.4320); Nucleus (0.2251); Repressor (0.0711),
MAAKSDGVLKMKKSDVAFTPLQNSDHSGSVQGLAPGSQPDSGTGEADFVNGESRCCGSNSTCLRLGREQQKYTVWDCLWILAAVTVYFADVGTDIWLSVDYYLRRDYWWFGLTLFFVVLGSFSVQVFSFRWFVHDFSTEESSGGGGGTASCSHMDGKLLSSSASHGDVGAHPSTPQRQASTTSKSNTTSNSSNSATAARTSKTRSASCSLCIWLLQSVIHILQLGQIWRYFHTIYLGIRSRQSGENDRWRFYWRMVYEYADVSMLHLLATFLESAPQLVLQLCIIIQTHKLLAVQGMTAAASLVSLAWALASYQKALRDSRDDKKPVSYLAVIIQFCWHFFTIAARVVTFALFASVFQLYFGIFIVLHWCIMTFWIVHCETEFCITKWEEIVFDMVVGIIYIFSWFNVKEGRTRCRLFIYYFMILLENTALSALWYLYRSPPSTDAFAVPALCVIFSSFFTGIVFMLMYYAFFHPNGPRFGRSASLVQLEDPTATFTLPPEGATNSLRSNRGGTLARDADREAKYSERDGCVPVFQVRPTAPSTPSSRAPRLEETVIKIDLCRNRYPAWERHVLDRSIRKAILAIDSSPTPPRLQYKDDTLVQERLEYETTL,,apoptotic process (GO:0006915) (0.5396); phosphatidylserine exposure on apoptotic cell surface (GO:0070782) (0.4895); intracellular calcium ion homeostasis (GO:0006874) (0.3725); protein tetramerization (GO:0051262) (0.2047); intracellular magnesium ion homeostasis (GO:0010961) (0.1702); apoptotic process involved in development (GO:1902742) (0.1312); skeletal muscle fiber development (GO:0048741) (0.1241); embryonic digit morphogenesis (GO:0042733) (0.0900); regulation of cytosolic calcium ion concentration (GO:0051480) (0.0888); sensory perception of sound (GO:0007605) (0.0731); engulfment of apoptotic cell (GO:0043652) (0.0591); store-operated calcium entry (GO:0002115) (0.0498); autophagosome assembly (GO:0000045) (0.0488),plasma membrane (GO:0005886) (0.3866); nucleoplasm (GO:0005654) (0.1859),,XK-related protein (IPR018629) (0.2644); XK-related phospholipid scramblase (IPR050895) (0.0800),,Reference proteome (0.5679); Cell membrane (0.5335); Membrane (0.5239); Transmembrane helix (0.4369); Transmembrane (0.3907); Phosphoprotein (0.3777); Apoptosis (0.2945); Glycoprotein (0.1869); Ubl conjugation (0.1086); Disease variant (0.0457),
MPAVPSSSESVGTGPVCPHAAKMLSNAANGESGINGDADDVFNGKAGHKLNETNGRHLKSLNGQHMDKGSEVSMERKWIRPDLPSRCTWKLGDLNMESPHNHYQRTKTSGILPNILSKIGETPMVRMNKIPKAFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVKGYRCIIVMPEKMSMEKVDVLRALGAEIVRTPTSARFDSPESHVGVAWRLKNEIPNAHILDQYRNPSNPLAHYDTTAEEILEQCGGKIDMLVAGAGTGGTITGIARKLKEKCPDIKIIGVDPEGSILAEPDELNKTDKTQYEVEGIGYDFIPTVLDRSVVDNWYKSNDEESFAMSRMLIREEGLLCGGSSGTAMSAAVNVAKELKEGQRCVVILPDSIRNYMSKFLSDKWMFEKGFMSEEDLVVNKPWWWNLTLQELRLSAPLTVLPLVSIKKTIQILKEKAFDQAPVVDEAGHILGMVTLGNMLASVLAGKVRPSDPISKVLYKQFKQVRLTDNLGKLSRILETDHFALVVHEQIQYMSDGSPKMRQMVFGVVTAIDLLNYVTMRERRERTLSECSLSEDQ,cystathionine beta-synthase (4.2.1.22) (0.9967),cysteine biosynthetic process via cystathionine (GO:0019343) (0.8212); cysteine biosynthetic process from serine (GO:0006535) (0.8143); hydrogen sulfide biosynthetic process (GO:0070814) (0.2707); transsulfuration (GO:0019346) (0.1465); homocysteine catabolic process (GO:0043418) (0.1380); determination of adult lifespan (GO:0008340) (0.1085); endochondral ossification (GO:0001958) (0.0445),cytoplasm (GO:0005737) (0.2032); nucleus (GO:0005634) (0.1623),cystathionine beta-synthase activity (GO:0004122) (0.4223); heme binding (GO:0020037) (0.1515),"CBS domain (IPR000644) (0.3047); CBS domain superfamily (IPR046342) (0.2446); Tryptophan synthase beta chain-like, PALP domain superfamily (IPR036052) (0.2341); Cystathionine beta-synthase (IPR005857) (0.1574); Cysteine synthase/cystathionine beta-synthase, pyridoxal-phosphate attachment site (IPR001216) (0.1307); Cysteine Synthase/Cystathionine Beta-Synthase (IPR050214) (0.1182)",3.10.580.10 (0.1514),Cysteine biosynthesis (0.4823); Pyridoxal phosphate (0.4657); Reference proteome (0.4394); CBS domain (0.2943); Amino-acid biosynthesis (0.2765); Lyase (0.1823); Ubl conjugation (0.0421),pyridoxal 5'-phosphate (0.2082)
MAASTRLGPKVLLLVHLGVFSWYLFTIWSNCSLQTADRHPGLRSYGGRWKYLTFINLVMHAVFFGLCVLVDAVHSAVSVNQSRSGTPLNLSRARDFYFTVLAFPVGTFVFVSFWTLYTYDRELVYPKLLDEIIPIWLNHAMHTVIMPLLLLQMFLQNHRYPSRTAGIFSLAVFVALYLSWVLWVHHASGIWVYPIMAHLSPVGLCVFLGGASLSMAPLYLLGEKLSLMMWSSTGNQKKKKK,3.1.-.- (0.0707),positive regulation of protein phosphorylation (GO:0001934) (0.7665); negative regulation of protein secretion (GO:0050709) (0.5473); negative regulation of extracellular matrix constituent secretion (GO:0003332) (0.3531); long-chain fatty acid catabolic process (GO:0042758) (0.2502); cholesterol metabolic process (GO:0008203) (0.2071); negative regulation of lymphocyte migration (GO:2000402) (0.1974); cell migration involved in sprouting angiogenesis (GO:0002042) (0.1968); negative regulation of blood coagulation (GO:0030195) (0.1716); neutrophil chemotaxis (GO:0030593) (0.1524); negative regulation of leukocyte migration (GO:0002686) (0.1219); gluconeogenesis (GO:0006094) (0.1038); positive regulation of gene expression (GO:0010628) (0.0996); positive regulation of autophagy (GO:0010508) (0.0739); fatty acid metabolic process (GO:0006631) (0.0609); cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052) (0.0442),caveola (GO:0005901) (0.5639); Golgi membrane (GO:0000139) (0.1444); plasma membrane (GO:0005886) (0.1244); endomembrane system (GO:0012505) (0.1224); membrane (GO:0016020) (0.0910),identical protein binding (GO:0042802) (0.0975),ADTRP/AIG1 (IPR006838) (0.1341),,Membrane (0.8244); Glycoprotein (0.4461); Transmembrane (0.2289); Reference proteome (0.2099); Transmembrane helix (0.1750); 3D-structure (0.1729); Cell membrane (0.1701); Lipoprotein (0.1696); Endosome (0.1170); Alternative splicing (0.1120); Hydrolase (0.1036); Developmental protein (0.0963); Carbohydrate metabolism (0.0411),
MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLSGQEYAAKIINTKKLSTRDHQKLDREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKSKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKAVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVECLKKFNARRKLKGAILTTMLATRNFSGGKSGVSKKTDGVKESSESTNTTIEDEDTRVRKQEIIKVTEQLIEAISNGDFESYTKMCDPSVTAFEPEALGNLVEGLDFHRFYFENLWSKNSKPVHTTILNPHIHLIGEEAACIAYIRITQYLDNNGMPCTAQSEETRIWHRKDGKWQIVHFHRSGSPAAIAK,Ca2+/calmodulin-dependent protein kinase (2.7.11.17) (0.9788),protein phosphorylation (GO:0006468) (0.6756); cellular response to interferon-beta (GO:0035458) (0.1876); positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427) (0.1368); regulation of neuron migration (GO:2001222) (0.1331); cell differentiation (GO:0030154) (0.0808); cellular response to type II interferon (GO:0071346) (0.0505),sarcoplasmic reticulum membrane (GO:0033017) (0.2374); cytoplasm (GO:0005737) (0.1617); dendritic spine (GO:0043197) (0.1046); neuron projection (GO:0043005) (0.0743),ATP binding (GO:0005524) (0.2299); calmodulin binding (GO:0005516) (0.2181); protein homodimerization activity (GO:0042803) (0.1795); calmodulin-dependent protein kinase activity (GO:0004683) (0.1267); protein serine kinase activity (GO:0106310) (0.1129),"Protein kinase domain (IPR000719) (0.1437); Protein kinase, ATP binding site (IPR017441) (0.1356); Protein kinase-like domain superfamily (IPR011009) (0.1118)",6.10.140.620 (0.3486); 3.10.450.50 (0.2418); 1.10.510.10 (0.1164),Calmodulin-binding (0.5222); Serine/threonine-protein kinase (0.4857); Sarcoplasmic reticulum (0.4681); Reference proteome (0.3798); Kinase (0.3792); Transferase (0.3123); Nucleotide-binding (0.2375); cGMP-binding (0.0986),
MVVAGLVSLTILYCWSSTPNNCPAPLPNPKQQESYSAKKSDSLTGTAEDKPILLLWFWPENYFFDFSDCKTIFNIDGCHLTDNRSLYDTSDAVLIFHKAISWDLTNLPQSPRPRFQRWIWFHVESPTNTRKIPGLENLFNLTLSYRHDADILVRWRVRTRKKPEEDFVVPKKDKLVCWIVSNNAASTGVGTRNKFYEEFSKHIQVTMFGKAYANFLDFNEYYPTLSSCKFYLSFENSIHKDYFTEKINGPLAVGTVPVVLGPPRKNYENFVPGDAFIHVEDFPDPKSLAEYLLQLDKDDVAYRRYFNWRKHLTATPHLIQQTQEFILPICTACDYIARHREYKEAHDIYDWYFN,2.4.1.- (0.8326); 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase (2.4.1.152) (0.1142),protein glycosylation (GO:0006486) (0.6965); oligosaccharide biosynthetic process (GO:0009312) (0.2568); fucosylation (GO:0036065) (0.2453); glycosphingolipid biosynthetic process (GO:0006688) (0.2298); N-glycan fucosylation (GO:0036071) (0.2222); neuronal stem cell division (GO:0036445) (0.1598); polysaccharide biosynthetic process (GO:0000271) (0.1352); ceramide metabolic process (GO:0006672) (0.1058); neuron differentiation (GO:0030182) (0.0927); protein N-linked glycosylation (GO:0006487) (0.0510),Golgi cisterna membrane (GO:0032580) (0.3747); membrane (GO:0016020) (0.3224); trans-Golgi network membrane (GO:0032588) (0.2498); Golgi membrane (GO:0000139) (0.1043); Golgi apparatus (GO:0005794) (0.0857),4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity (GO:0017083) (0.1974); alpha-(1->3)-fucosyltransferase activity (GO:0046920) (0.1881),"GT10-like, C-terminal domain superfamily (IPR038577) (0.6284); Fucosyltransferase, N-terminal (IPR031481) (0.3942); Glycosyl transferase family 10 (IPR001503) (0.1863)",3.40.50.11660 (0.2220),Transmembrane (0.5733); Membrane (0.4763); Reference proteome (0.4660); Golgi apparatus (0.4127); Glycosyltransferase (0.3736); Transmembrane helix (0.3502); Lipid metabolism (0.2017); Transferase (0.0975); Signal (0.0848),
MSMPSADMLETPPMYPFEEIDYVDIEVEEVVGRGAFGVVCKAKWKGRDVAIKTIESESEKNAFIVELRQLSRVDHPNIVKLYGSCNNPVCLVMEYAEGGSLYNVLHGAEPLPHYTASHAMSWCLQCSQGVSYLHGMKPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHRGTRPPLIKNLPKAIESLMTRCWSKDPSQRPSMEEIVKIMSHLMGYFPGSEEPLKYPYQYSDEGQSNSATSTGSHLDYTCTSNKNDINMEHTNSPGSNDTIKFPYKPKGISGQSLSRGSSVESLPGRSHFQPSSDSKRMSVELSELEPRLPFASPATCEPHRRRSVQDLPAIGTDASQDSRNNSRSSSPSFRMITPDRTDTNGSDNSIPMAYLTLDHQLQPLAPCPNSKESMAVFEQHCKMAQEYLKVQTEIALLKQRKEELIAELDQDEKDQQNACRLAQEQKKLIEENKSLSTYYQQCKKQLELIRAQQQKRQGTS,mitogen-activated protein kinase kinase kinase (2.7.11.25) (0.9972),protein phosphorylation (GO:0006468) (0.9256); JNK cascade (GO:0007254) (0.7381); immune response (GO:0006955) (0.5212); positive regulation of canonical NF-kappaB signal transduction (GO:0043123) (0.3164); positive regulation of JUN kinase activity (GO:0043507) (0.0891); apoptotic process (GO:0006915) (0.0580),cytoplasm (GO:0005737) (0.2659); plasma membrane (GO:0005886) (0.2591),magnesium ion binding (GO:0000287) (0.5674); MAP kinase kinase kinase activity (GO:0004709) (0.4395); ATP binding (GO:0005524) (0.2508),"Protein kinase domain (IPR000719) (0.5116); Serine/threonine-protein kinase, active site (IPR008271) (0.5002); Mitogen-activated protein kinase kinase kinase 7 (IPR049637) (0.4325); Protein kinase-like domain superfamily (IPR011009) (0.3499); Protein kinase, ATP binding site (IPR017441) (0.3044); Mitogen-activated protein (MAP) kinase kinase kinase 7-like (IPR017421) (0.2485); Serine-threonine/tyrosine-protein kinase, catalytic domain (IPR001245) (0.2459)",,Ubl conjugation (0.9932); Transferase (0.8949); Serine/threonine-protein kinase (0.8438); Magnesium (0.7189); Transcription regulation (0.6755); Phosphoprotein (0.6147); Transcription (0.5724); Cell membrane (0.4799); Stress response (0.4399); Nucleotide-binding (0.4393); Isopeptide bond (0.4279); Coiled coil (0.4162); Apoptosis (0.3870); Kinase (0.3114); Membrane (0.3114); ATP-binding (0.2649); Reference proteome (0.1923); Metal-binding (0.1666); Cytoplasm (0.1381),Mg(2+) (0.3800)
MAAMTEPLCLERDVCRVIELLDRLQRSGQLPPPKLQALQRVLQSKFCAAIREVYEQLYDTLDIIGGPEVRAQATAKATVAAFAASEGHAHPRVVELPKTDEGLGFNIMGGKEQNSPIYISRVIPGGVADRQGGLKRGDQLLSVNGVSVEGEHHEKAVELLKAAQGSVKLVVRYTPKVLEEMEARFEKMRSARRRQQHTSYSSLESRG,,exocytosis (GO:0006887) (0.9557); neurotransmitter secretion (GO:0007269) (0.6668); maintenance of epithelial cell apical/basal polarity (GO:0045199) (0.6555); protein transport (GO:0015031) (0.6465); protein localization to basolateral plasma membrane (GO:1903361) (0.4258); inner ear development (GO:0048839) (0.1012),MPP7-DLG1-LIN7 complex (GO:0097025) (0.4280); bicellular tight junction (GO:0005923) (0.3988); basolateral plasma membrane (GO:0016323) (0.2744); cell-cell junction (GO:0005911) (0.2236); presynapse (GO:0098793) (0.1989); synapse (GO:0045202) (0.1948); postsynaptic density membrane (GO:0098839) (0.1407),L27 domain binding (GO:0097016) (0.1905),"L27 domain superfamily (IPR036892) (0.4135); Membrane-associated multiprotein complex regulator (IPR051109) (0.3439); L27 domain (IPR004172) (0.2447); Protein lin-7 (IPR017365) (0.2161); L27 domain, C-terminal (IPR014775) (0.1986); PDZ superfamily (IPR036034) (0.1806); PDZ domain (IPR001478) (0.1455)",2.30.42.10 (0.3226); 1.10.287.650 (0.2151),Transport (0.8713); Protein transport (0.3419); Cell junction (0.3236); Cell membrane (0.2900); Synapse (0.2449); Reference proteome (0.2426); Exocytosis (0.2053); Membrane (0.1834),
MVSWIISRVIVLVFGTLYPAYYSFKAVKSKNVKEYVRWMMYWIVFALYTVVETITDLSLAWFPVYYELKMAFVFWLLSPYTRGASVIYRKFLHPMLASKEREIDEYIVQARERSYETMVNFGRQGLTIAAAAAVTAAVKGQGAISERLRSFSIPDLTQVPSEQSAIFNSSRRALPPADSEPYKQTGEGHEEETDGIFSEDEASVQKGLRRSQSVKLTRAKAARKEPRYGSLKLKPRRRQLVTSSTYDHP,,nuclear envelope organization (GO:0006998) (0.7062); endoplasmic reticulum tubular network organization (GO:0071786) (0.5221); mitotic nuclear membrane reassembly (GO:0007084) (0.1368); response to glucose (GO:0009749) (0.1095); cell division (GO:0051301) (0.1056),endoplasmic reticulum membrane (GO:0005789) (0.5605); endoplasmic reticulum tubular network (GO:0071782) (0.3857); cytoplasmic microtubule (GO:0005881) (0.1338); microtubule (GO:0005874) (0.0637); endoplasmic reticulum (GO:0005783) (0.0455),microtubule binding (GO:0008017) (0.2339),TB2/DP1/HVA22-related protein (IPR004345) (0.2784),,Mitosis (0.7114); Transmembrane helix (0.4873); Transmembrane (0.4557); Reference proteome (0.4383); Cell cycle (0.3509); Cell division (0.3287); Proteomics identification (0.3135); Membrane (0.2882); Phosphoprotein (0.2599); Microtubule (0.2280); Endoplasmic reticulum (0.2050); Alternative splicing (0.1092),
MMNQIELSVPYDNGYEIDEYMMQEDEWDRDLLLDPAWEKQQRKTFTAWCNSHLRKAGTQIENIEEDFRNGLKLMLLLEVISGERLPKPDRGKMRFHKIANVNKALDFITSKGVKLVSIGAEEIVDGNVKMTLGMIWTIILRFAIQDISVEETSAKEGLLLWCQRKTAPYRNVNVQNFHVSWKDGLALCALIHRHRPDLIDYAKLNKDDPLGNLNLAFDIAEKHLDIPKMLDAEDILSTPKPDERAIMTYVSCFYHAFAGAEQAETAANRICKVLGVNQENEKLMEDYERLASELLEWIRRTIPWLENRAAEKTMVEMQRKLEDFRDYRRMHKPPKVQEKCQLEISFNTLQTKLRISNRPAFMPSEGKMVSDIASAWQGLEQAEKGYEEWLLTEIRRLERVEHLAEKFRQKATNHESWATGKEEMLTRKDYESASLMEVRALLRKHEAFESDLSAHQDRVEQIAAIAQELNELDYHDVASVNQRCQSICDLWDHLGTLTQKRREALERTEKLLETVDQLFLEYAKRSAPFNNWMEGAMEDLQDMFIVHTIEEVQTLIAAHEQFKATLPEADAERQAILGIQQEVLKIFQSYGIRGDLTNPYSTITAEEIAIKWDKVKKLVPQRDSALQEELARQHANERLRRQFAAQANLIGPWIQTRMEEIGHCSMAMGGTLEDQMTQLKQYEHVIVSYKSNIDRLEGDHQLIQESLIFDNKHTNYTMEHVRVGWELLLTTIARTINEIETQILTRDAKGISQEQMHEFRSSFNHFDRKKNGGMDSDDFRACLISMGYDLGEVEFARIMMLVDPNASGNVSFQSFIDFMTRETADTDTAEQVIASFKILAADKPYILSDELRRELPPDQAEYCISRMPPYCGPGALPGALDYTAFSTALYGESDL,,actin cytoskeleton organization (GO:0030036) (0.7400); muscle cell development (GO:0055001) (0.2709); sarcomere organization (GO:0045214) (0.1996); protein localization to plasma membrane (GO:0072659) (0.1247); microspike assembly (GO:0030035) (0.0600),cortical actin cytoskeleton (GO:0030864) (0.4419); cell projection (GO:0042995) (0.3908); Z disc (GO:0030018) (0.3151); cell junction (GO:0030054) (0.2763); plasma membrane (GO:0005886) (0.2281); stress fiber (GO:0001725) (0.1604),calcium ion binding (GO:0005509) (0.2145); actin filament binding (GO:0051015) (0.1899),"Spectrin/alpha-actinin (IPR018159) (0.4235); CH domain superfamily (IPR036872) (0.3215); Actinin-type actin-binding domain, conserved site (IPR001589) (0.3137); Spectrin repeat (IPR002017) (0.2614); EF-hand, Ca insensitive (IPR014837) (0.1704); Calponin homology domain (IPR001715) (0.1225)",1.10.418.10 (0.1491); 1.20.58.60 (0.1380),Repeat (0.7903); Metal-binding (0.6215); Reference proteome (0.3409); Calcium (0.1127); Coiled coil (0.0565),
MAMAPVLNICVVLFFSILAVSCDVGDIVQEQRSESPESQGTDCGCQGLKREVSVGVSDVNTLDHHDDANIYSKTANEGPDKTESDVRSKLVLLQGGWFLMGTDDPGIPQDGEGPQRKVKLDAFYIEEHEVTNQQFQHFTNQTGYITEAERFGDSFVFEGLLSEEVKSTLSHAVAAAPWWSPVKGADWRHPEGPDSTIHNRMNHPALHVSWDDARAYCQWAKRRLPTEAEWELACRGGLQDRCISVMSFPANGFGLYDMVGNAWEWTADWWTVHHSAEDKFNPKGPESGTDRVKKGGSYMCHKSYCYRYRCAARSQNTPDSSASNLGFRCASDVDP,formylglycine-generating enzyme (1.8.3.7) (0.9260),dorsal/ventral pattern formation (GO:0009953) (0.1358); microglia development (GO:0014005) (0.1324); regulation of fibroblast growth factor receptor signaling pathway (GO:0040036) (0.1268); protein oxidation (GO:0018158) (0.1017); post-translational protein modification (GO:0043687) (0.0852); response to temperature stimulus (GO:0009266) (0.0627); glycosaminoglycan metabolic process (GO:0030203) (0.0445),endoplasmic reticulum lumen (GO:0005788) (0.1166); endoplasmic reticulum (GO:0005783) (0.1094); extracellular region (GO:0005576) (0.0822); extracellular exosome (GO:0070062) (0.0742),carbohydrate binding (GO:0030246) (0.2146); formylglycine-generating oxidase activity (GO:0120147) (0.1087); metal ion binding (GO:0046872) (0.0996); cupric ion binding (GO:1903135) (0.0761),Sulfatase Modifying Factor and Kinase (IPR051043) (0.0570),,Reference proteome (0.6198); Glycoprotein (0.4269); Signal (0.3917); Disulfide bond (0.3877); Metal-binding (0.2439); Direct protein sequencing (0.1826); 3D-structure (0.1698); Alternative splicing (0.1618); Calcium (0.1515); Lectin (0.1089); Oxidoreductase (0.0899); Secreted (0.0888); Disease variant (0.0866); Endoplasmic reticulum (0.0772); Proteomics identification (0.0751); Sterol metabolism (0.0679),
MPVRRGHVAPQNTFLDTIIRKFEGQNRKFIIANARVENCAIIFCNDGFCGMCGYTRSEVMQKPCTCSFLYGPHTGRPAVAQMAKALLGSEERKVEISLYRKDGVCLPCLVDVVPVKNEDGLVIMFILNFELADQQDRPLDSSPGRDINNKNPIPWLSKARRRRLRLPLPLLHSLSGSKQSLHEDTEKGFMQPMPHMGHESVALDKLLSLPERSALGGSQLLFWEDKAQTESESELRPSEVSPPLPQGFSQSSPRLHNLTSEASPSSCSMAHSRSCESLCGMRPSPSTNDFNWDRKLPVRPSSTGAMHRKASLQNATSDSDLIRLRSSGRGTQISHNLIDMKPDALIAVPTGEIDIIAPCKLIDRTHNVTEKVTQVLSLGADVLPEYKLQAPRIHKWTILHYSPFKAVWDWVILLLVIYTAIFTPYSAAFLLSDEEEEVIQRCGYSCSTLNVVDLIVDIMFVVDIVINFRTTYVNSNDEVVSQPGRIAVHYFKGWFLIDMVAAIPFDLLIYRSEEETTTSTTLIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNVERSGPSRIGWLNSLGDQLGKPYNSSVRGSGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGALMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRTLLQSCKAFKGSSKGCLRALAMKFKTTHAPPGDTLVHAGDVISALYFISRGSIEILKGDVVVAILGKNDIFGEPINSYARPGKSSADVRALTYCDLHKIHRDDVLEVLEMYPEFSDYFWSNLEITFNLRDTNTKAGSMSSDPDDSDNGGLDHHTRRAKLFFQSKRNSISRDTERTEDRLNRMTFRTQTSGKQHENRQTAHRSSDIFASQSSSDEEEETQRPSVMVDCSQSHINSVSNANRDKDHNSSNSFNALSGAFSGVSNIFSLWGDSSRGHHYQEVPSHSMSFPSSSVPSNTVLHNVTYGQCSEVENRLEMMHRQLYRLEKRMSKDIGAIMQLLQRQMVQVPPAYSSVTSPTEASPIPPKPGQKLVQPVNPLETETPSILSEILDPHDFADSPIKASESLSGAMELQLLDCSSQPPSENPSGAYMGRWSRSVSHHTNTTGDPTAHIHLQQTAIADQAHYSFLDAEPIGTLRQPQAVQSLHLETSECSRRQSLPVKHQVEDDCSMQKRHPSDPGS,,membrane repolarization during action potential (GO:0086011) (0.7830); regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) (0.6931); regulation of heart rate by cardiac conduction (GO:0086091) (0.6625); potassium ion transmembrane transport (GO:0071805) (0.0899); membrane repolarization during cardiac muscle cell action potential (GO:0086013) (0.0814); potassium ion transport (GO:0006813) (0.0742); regulation of muscle contraction (GO:0006937) (0.0591),monoatomic ion channel complex (GO:0034702) (0.6356); plasma membrane (GO:0005886) (0.0916),inward rectifier potassium channel activity (GO:0005242) (0.8528),"Cyclic nucleotide-binding domain (IPR000595) (0.7045); Voltage-gated potassium channel family H (IPR050818) (0.4508); PAS domain (IPR000014) (0.4097); Potassium channel, voltage-dependent, ERG (IPR003967) (0.3957); RmlC-like jelly roll fold (IPR014710) (0.3883); Cyclic nucleotide-binding domain superfamily (IPR018490) (0.3790); Potassium channel, voltage-dependent, EAG/ELK/ERG (IPR003938) (0.3536); Ion transport domain (IPR005821) (0.2070); PAS domain superfamily (IPR035965) (0.1388)",2.60.120.10 (0.5249); 3.30.450.20 (0.4065); 1.10.1200.260 (0.3319); 1.10.287.70 (0.2640),Voltage-gated channel (0.9746); Ion channel (0.6202); Potassium (0.5816); Potassium transport (0.5518); Methylation (0.4965); Transmembrane helix (0.4603); Membrane (0.4402); Potassium channel (0.4304); Transmembrane (0.3722); Ion transport (0.3081); Transport (0.2842); Reference proteome (0.2194); Cell membrane (0.1751); Nucleus (0.1044),
MWTWAYLKKRDSAGTMPGKMSLIWSLTLLLTVVGDVLTHTLTPIPTTEKPLSPRHYHHIDPATGNKLVCDKCPAGTYVSSHCTEASVRECSPCPDGTFTRGENGVQQCHRCQRRCQAPFIEKTPCTSTTDRLCVCPPGSFSQDGKCQRHSSCLPGWGVRKRGSETEDVRCQPCQRGTFSAITSDSLRCQTHTDCPALGLTLLIKGTKKTDNVCGPNPASSVPVLLGEASVSTVSSTESAYRASTAVLPAADIQDEAEPVFSSTDMALGAQNFPTTTAYPEAIDKDGGLLIAATQDLPKSKLKLTLSRDLQLSNHQGVESMSESKAQGLGYRPIRRGAPRPSSHKHFDINEHLPWMIVLLLLLVLVVIVVCSVKRSSRVLKKGPRQDPSSIMEKAIHKKPSSPAQTKERWIYYSNGQGVDILKLVAAQIGSQWIDLYKSLASATEREVAAFSNGYTADHERAYAALQHWTIRDSDANLAKLINALHRQRRIDVVDKIRSVMEDNPQVDLNKLMTAVNVSHCLSPSHKPLESPGVAVEQSPMERSRGFFPDESEPLLRCDSTSSKDSALSRTGSFITKEKKDTVLRQVRLDPCDLQPIFDDMLHILNPDELHVIEEIPMAEDKLDRLFEIAGVKSQEASQTLLDSVYSHLPDLL,,humoral immune response (GO:0006959) (0.8380); adaptive immune response (GO:0002250) (0.8343); negative regulation of myelination (GO:0031642) (0.8030); negative regulation of B cell proliferation (GO:0030889) (0.7620); B cell apoptotic process (GO:0001783) (0.7249); negative regulation of interleukin-10 production (GO:0032693) (0.6758); negative regulation of interleukin-5 production (GO:0032714) (0.6219); T cell receptor signaling pathway (GO:0050852) (0.5010); negative regulation of T cell proliferation (GO:0042130) (0.4710); neuron apoptotic process (GO:0051402) (0.4436); negative regulation of interleukin-13 production (GO:0032696) (0.4424); regulation of oligodendrocyte differentiation (GO:0048713) (0.2704); cellular response to tumor necrosis factor (GO:0071356) (0.1443); oligodendrocyte apoptotic process (GO:0097252) (0.1252); myelination (GO:0042552) (0.1054),plasma membrane (GO:0005886) (0.2343); membrane (GO:0016020) (0.0926),,"Tumor necrosis factor receptor 21, N-terminal (IPR034034) (0.6642); TNFR/NGFR cysteine-rich region (IPR001368) (0.5315); Tumor necrosis factor receptor 21, death domain (IPR034037) (0.2218); Tumour necrosis factor receptor 21 (IPR022330) (0.2215); Death domain (IPR000488) (0.2152); Death-like domain superfamily (IPR011029) (0.1217)",1.10.533.10 (0.5822); 2.10.50.10 (0.2816),Reference proteome (0.7462); Membrane (0.6024); Transmembrane helix (0.4505); Signal (0.4298); Receptor (0.1569); Repeat (0.1225); Disulfide bond (0.1155); Apoptosis (0.0640),
MSVDALGSPVMDPAFSKRNTTLRLVDLAGAHHHHHHHHHTPQSVTGFPGFSSHPHSMAHSHPGEMTAEPRLGPSPFGPEHMGHSAALKISPTHHYPHHHHHHNHHIAGHSEVVSSQTGAFGPVQAATVPYSMSHTAQALSAGRDFLIRRELTAQAMPVLTDQTSGSASHHGMFVSTTGSYPGHYGHHPDPGNHTLFPGLHHDQPSTGAPGGQALNGQIRLGIPAEMYVRSDHLSQVASSRADPFAASPLHGYGGLNLNMNLSAHHHHGAGAFFRYMRQPIKQELICKWLEPEHSAKKLCSKTYSTMHELVTHVTVEHVGGPEQANHICFWEECPREGKPFKAKYKLVNHIRVHTGEKPFPCPFPGCGKVFARSENLKIHKRTHTGEKPFKCEFDGCDRRFANSSDRKKHSHVHTSDKPYNCKVRGCDKSYTHPSSLRKHMKVHCKSPPPSSGYESSTPSLVSPSSDLGREPAPSALSEPLSSSSQPANLSEWYVCHSSGASGPQTPPSGSSTPGHTEGPTYGNPERRDAF,,negative regulation of transcription by RNA polymerase II (GO:0000122) (0.3182); regulation of transcription by RNA polymerase II (GO:0006357) (0.2022); heart looping (GO:0001947) (0.1965); central nervous system development (GO:0007417) (0.1698); anterior/posterior pattern specification (GO:0009952) (0.1258); neuron differentiation (GO:0030182) (0.1252); brain development (GO:0007420) (0.1228); neural plate development (GO:0001840) (0.1122); dorsal/ventral pattern formation (GO:0009953) (0.1116); limb morphogenesis (GO:0035108) (0.0946); hippocampus development (GO:0021766) (0.0858); determination of left/right asymmetry in nervous system (GO:0035545) (0.0770); neural crest cell development (GO:0014032) (0.0762),,"DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981) (0.2214); metal ion binding (GO:0046872) (0.1212); DNA binding (GO:0003677) (0.0520)","ZIC protein, zinc finger domain (IPR041643) (0.3204); GLI C2H2-type zinc-finger (IPR050329) (0.2367); Zinc finger C2H2-type (IPR013087) (0.1500)",3.30.160.60 (0.3208),DNA-binding (0.2934); Differentiation (0.2820); Neurogenesis (0.2375); Developmental protein (0.2173); Zinc-finger (0.1872),
MHGRVKVKTTAQQEEEKRKEREKKLKAFVCARDSVLKKRSAGEHDEEALDLTQQLLSSNPDFATLWNYRREVLLHLETLREKDEVQKLYESELHFIEACLKVNPKSYGCWHHRSWVNTRLPQPDWTRELGLCDRCLSLDERNFHCWDYRRLVVKESGVSVEQELQFTDRLIGSNFSNYSSWHYRSTLLPQLRPQPVLDSAHNTSPSPSASPQSHSHRVCEEQLLKEYELAHNAFFTDPNDQSAWFYYRWLLGRAEREEMISCVYVSREGERVSVAFSKPVHAGSVGLMLVLDGQPQQVQWRNAHPRLRHSPVWLCDLPAGSISDTSNEHNLTIHWTDKHTHRDCALYTGCAESWCRDSATDQELFRSELSVEKSSVLQAELQSCNQLLDLEPQNKWCLLTIILLMRALDPLGHEKETLTHFQTLKEVDAMRSSYYSDLCSKFLIENTILKMEYAEVRVFSLSNKKLTTLCHLDQLLLVTHINLSSNQLQHLPPQFSMLQCLEVLEADDNAIESLEGLYHLPKLEEVSLKNNKICKVSDLETLATCTKLTRLDLRGNPVHKTDDLESELSLILPLVTALSL,protein geranylgeranyltransferase type II (2.5.1.60) (0.8625),protein geranylgeranylation (GO:0018344) (0.3005); endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888) (0.2993); methylation (GO:0032259) (0.2112); signal transduction (GO:0007165) (0.1408); cell migration (GO:0016477) (0.0978); digestive tract development (GO:0048565) (0.0955); cellular response to heat (GO:0034605) (0.0845); fibroblast growth factor receptor signaling pathway (GO:0008543) (0.0702); positive regulation of canonical NF-kappaB signal transduction (GO:0043123) (0.0546); cell differentiation (GO:0030154) (0.0528),cytoplasm (GO:0005737) (0.2841); cytosol (GO:0005829) (0.2525),zinc ion binding (GO:0008270) (0.5850); Rab geranylgeranyltransferase activity (GO:0004663) (0.3376); small GTPase binding (GO:0031267) (0.1521),"Protein prenyltransferase, alpha subunit (IPR002088) (0.3815); Leucine-rich repeat domain superfamily (IPR032675) (0.3586); Rab geranylgeranyltransferase, alpha subunit, insert-domain (IPR009087) (0.0790)",3.80.10.10 (0.4786); 1.25.40.120 (0.3601),Phosphoprotein (0.6366); Ubl conjugation (0.5708); Prenyltransferase (0.4674); Reference proteome (0.4641); Repeat (0.3960); Leucine-rich repeat (0.3587); Transferase (0.2087); Zinc (0.1166); 3D-structure (0.0961),
MLSWIAALLTGILTAHLAQRLCFPYFWKDALYLMKVIRYGARLEIYKRTSLIVTIVDRFVQQAQRFPEKPFVIFEGVTYTYGDLEARSNRVARLFQDTVKKGDTVALLMNNEPDFISVWFGFCKLGCALAFLNTNIKSRSLLHCFNCCGAKQLVVGADLLDNLEDILPSLQEDNITVWSLGHGNSHPGVHSLLDKIEKSSQEPIAAKRRSISCLKTPTLYIFTSGTTGLPKAAVITHLQSLKAAGGFWAYGGTEKDVIYTPLPLYHSAASLVGIGGTIELGATCILKKKFSASQFWNDCRKYNVTIFQYIGELCRYLCNQPMGENEKDHKVHMGVGNGLRQDVWREFLQRFGEIRMCEIYGSTEGNLCFMNHIGKIGAVGRSNFFYKLIFKYDLVKYDLLRDEPVRDHNGFCQRVQKGETGLLLSKICSQSPFFGYAGSKQLTEKKILRDVFVKGDAYFNTGDLMAEDENNFISFKDRVGDTFRWKGENVATTEVTEILGLVDFIQEASVYGVQVPGNEGRAGMAAVIVRPECTFDGKKLFDLVVRELPSYARPLFIRLQESIETTSTFKHQKFGLVESGFNPSTISDPLYFLDYTEKSYIPLTSSIYASISNGQKKV,6.2.1.- (0.3861); arachidonate-CoA ligase (6.2.1.15) (0.3668); long-chain-fatty-acid-CoA ligase (6.2.1.3) (0.1447),fatty acid alpha-oxidation (GO:0001561) (0.5238); long-chain fatty acid metabolic process (GO:0001676) (0.5131); bile acid biosynthetic process (GO:0006699) (0.3171); methyl-branched fatty acid metabolic process (GO:0097089) (0.2546); long-chain fatty acid import into cell (GO:0044539) (0.2209); fatty acid transport (GO:0015908) (0.1414); bile acid metabolic process (GO:0008206) (0.1370); fatty acid beta-oxidation (GO:0006635) (0.0728); positive regulation of apoptotic process (GO:0043065) (0.0407),endoplasmic reticulum membrane (GO:0005789) (0.5497); peroxisomal membrane (GO:0005778) (0.1041); plasma membrane (GO:0005886) (0.0855),very long-chain fatty acid-CoA ligase activity (GO:0031957) (0.3947); long-chain fatty acid-CoA ligase activity (GO:0004467) (0.1826); ATP binding (GO:0005524) (0.1601); enzyme binding (GO:0019899) (0.1438); long-chain fatty acid transmembrane transporter activity (GO:0005324) (0.1121); fatty acid transmembrane transporter activity (GO:0015245) (0.1052),"AMP-binding, conserved site (IPR020845) (0.4537); AMP-dependent synthetase/ligase domain (IPR000873) (0.3265); AMP-binding enzyme, C-terminal domain superfamily (IPR045851) (0.2670); ANL, N-terminal domain (IPR042099) (0.2232); AMP-binding enzyme, C-terminal domain (IPR025110) (0.2157)",3.40.50.12780 (0.2484),Reference proteome (0.6946); Ligase (0.3352); Lipid transport (0.3156); Nucleotide-binding (0.2885); Signal (0.1768); Transport (0.1642); Membrane (0.1462),
MAQEVGLQYEPVAEIGGGAYGTVYKARDRDSGQFVALKSVRVQTNQDGLPLSTVREVALLKRLEQFDHPNIVRLMDVCATLRTDQETKVTLVFEHVDQDLRTYLEKVPAPGLPVDKIRDLMQQLLCGLAFLHTNRVLHRDLKPENILVTSRGQVKLADFGLARIYSCHMALTPVVVTLWYRSPEVLLQSTYATPVDIWSTGCIFAEMFRRKPLFCGDSEADQLGKIFAVIGLPAEDQWPTDVTLSHHNFSPQSPRPITDCVPDITEKGAELLLKMLTFDPLKRISALNALDHPFFSE,cyclin-dependent kinase (2.7.11.22) (0.8433); [RNA-polymerase]-subunit kinase (2.7.11.23) (0.0661),protein phosphorylation (GO:0006468) (0.8563); regulation of gene expression (GO:0010468) (0.5104); signal transduction (GO:0007165) (0.4124); regulation of G2/M transition of mitotic cell cycle (GO:0010389) (0.3610); G1/S transition of mitotic cell cycle (GO:0000082) (0.3579); positive regulation of fibroblast proliferation (GO:0048146) (0.3514); regulation of type B pancreatic cell proliferation (GO:0061469) (0.1090); cellular response to ionomycin (GO:1904637) (0.1045); cellular response to interleukin-4 (GO:0071353) (0.0945); cell dedifferentiation (GO:0043697) (0.0593),cyclin D1-CDK4 complex (GO:0097128) (0.2445); cyclin-dependent protein kinase holoenzyme complex (GO:0000307) (0.2225); cytoplasm (GO:0005737) (0.1574); nucleoplasm (GO:0005654) (0.1059); nucleus (GO:0005634) (0.1032),cyclin binding (GO:0030332) (0.1147); ATP binding (GO:0005524) (0.0906),"Protein kinase, ATP binding site (IPR017441) (0.4706); Cyclin-dependent kinase (IPR050108) (0.2713); Protein kinase domain (IPR000719) (0.2534); Protein kinase-like domain superfamily (IPR011009) (0.1947)",1.10.510.10 (0.2107),Cell division (0.3926); Cell cycle (0.3679); Nucleotide-binding (0.3592); Kinase (0.2020); Reference proteome (0.1418),
MSRLTIKYCRLYQLSLSSRWKCYQQISRLSTMSSGLNSISGGRSVSSANICGRHTQCFDRILNKRDLHLSAPLGEEKAHHLREISEAEYERLAEETLDALADYFEDLTDENFTGLDYDVVFSNGVLTVKVGSDHGTYVINKQTPNRQIWLSSPTSGPKRYDWTGERWVYTHDAVPLHSLLSKELSIIFKTNIDLSHLIHS,ferroxidase (1.16.3.1) (0.9907),intracellular iron ion homeostasis (GO:0006879) (0.4940); iron ion transport (GO:0006826) (0.3970); iron incorporation into metallo-sulfur cluster (GO:0018283) (0.2647); oxidative phosphorylation (GO:0006119) (0.2456); positive regulation of cell growth (GO:0030307) (0.2186); response to iron ion (GO:0010039) (0.1967); positive regulation of cell population proliferation (GO:0008284) (0.1952); determination of adult lifespan (GO:0008340) (0.1770); aerobic respiration (GO:0009060) (0.1653); embryo development ending in birth or egg hatching (GO:0009792) (0.1533); response to hydrogen peroxide (GO:0042542) (0.1516); protein autoprocessing (GO:0016540) (0.1493); positive regulation of succinate dehydrogenase activity (GO:1904231) (0.1478); heme biosynthetic process (GO:0006783) (0.1439); cellular response to hydrogen peroxide (GO:0070301) (0.1085); organ growth (GO:0035265) (0.0977); negative regulation of release of cytochrome c from mitochondria (GO:0090201) (0.0944),mitochondrion (GO:0005739) (0.1607),"2 iron, 2 sulfur cluster binding (GO:0051537) (0.5745); ferrous iron binding (GO:0008198) (0.3264); ferric iron binding (GO:0008199) (0.2619); ferroxidase activity (GO:0004322) (0.1513)",Frataxin/CyaY superfamily (IPR036524) (0.3079); Frataxin conserved site (IPR020895) (0.2458); Frataxin/CyaY (IPR002908) (0.1796),3.30.920.10 (0.2084),Transport (0.9141); Reference proteome (0.6439); Ion transport (0.6140); Transit peptide (0.4424); Iron transport (0.4375); Iron storage (0.4065); Oxidoreductase (0.2606); Mitochondrion (0.2367); Iron (0.2314); Heme biosynthesis (0.1644),
MESLRESILHLTFQMSTYKRATLEEEELLDTGSDGIYHTSSMQVGVQRGLGLRCWAEKTHSERKLVVLVCALSVALFICIMSLGLHYKESHPGLCLSEPCVSVASAVLGSLDRSVDPCQDFYNFACGGWMRKNPLPEGKSRWGPFSNLWEHNMAVMKNLLENTSMKSLSRAEQKAQWYYQACMNESKIEELGAKPLQDLINQTGGWGLKGPWEKDNFQEVLRIVSANFRTSPFFTVFVSTDSKSSNSNIIQVDQSGLGLPSREYYLNKTANEKYLNAYLNFLVELGVLLGGSQDTSQKMMEEIIEFETTLANITVPQVERRDEEKIYYKIQAKELATLAPAIDWMPFLSSVFAPVELNDSEPVVVYAKEYLQKVSELISNTNKSVLNNYMIMKVVRKMVSILDQKFQDAEQRFLEVMYGTKKSCMPRWKLCVSDTDSALGFALGALFVKATFSEDSKAFVEDMVSEIKWAFEDSLKTVSWMDPETKKAAKEKADAIYNMVGYPKFIMNPKELDKVFNDFDVVSDLYFQNVMNYYNFSARVTADQLRKAPNRDQWSMTPPTVNAYYNPTKNEMVLPAGIFQAPFYNHAWPKAMNFGGIGVVMGHELTHAFDDQGRKYDKDGNLAKWWQNSSVEAFQHQTQCMVEQYSNYSINNEPLNGKHTLGENIADNGGLNAAYKAYVNWIKKNGEEASLPALGMNNHQLFFVGFAQVWCSVRTPESSHEGVITDPHSPSRFRVIGTISNSHEFSEHFGCKADSPMNPKRKCELW,endothelin-converting enzyme 1 (3.4.24.71) (0.9822),protein processing (GO:0016485) (0.7889); pharyngeal system development (GO:0060037) (0.3497); bradykinin catabolic process (GO:0010815) (0.2539); calcitonin catabolic process (GO:0010816) (0.2392); peptide hormone processing (GO:0016486) (0.2012); substance P catabolic process (GO:0010814) (0.1899); heart development (GO:0007507) (0.1414); proteolysis (GO:0006508) (0.0536),transport vesicle membrane (GO:0030658) (0.2534); plasma membrane (GO:0005886) (0.1131),metalloendopeptidase activity (GO:0004222) (0.1515),"Peptidase M13, C-terminal domain (IPR018497) (0.3838); Peptidase M13 (IPR000718) (0.3543); Peptidase M13, N-terminal domain (IPR008753) (0.2236); Peptidase M13, domain 2 (IPR042089) (0.1914); Metallopeptidase, catalytic domain superfamily (IPR024079) (0.1348)",3.40.390.10 (0.2603); 1.10.1380.10 (0.1484),Zinc (0.9927); Signal-anchor (0.5366); Transmembrane (0.4969); Reference proteome (0.4580); Membrane (0.3346); Metalloprotease (0.2620); Hydrolase (0.2618); Golgi apparatus (0.2604); Cytoplasmic vesicle (0.1932); Protease (0.1807); Transmembrane helix (0.1389); Metal-binding (0.1386),
MKASWIRLLKRATGNRVKNNIGGSADSYTSRPSDSDVSLEEDKETLRREAERQAQAQLDKAKSKPVAFAVRTNVGYSASSEDDVPVPGTGISFDPKDFLHVKEKFNNDWWIGRLVKEGCDIGFIPSPVKLESSRLRQEQRAKQGRFYSSKSGANSSSSLGDIVSNSRKSTPPSSAKQWQKSTEHAPPYDVVPSMRPVVLVGPSLKGYEVTDMMQKALFDFLKHRFEGRITITRVAADISLAKRSVLNNPSKHAIIERSNTRSNLAEVQSEIERIFELARTLQLVVLDADTINHPSQLGKTCLAPIIVYIKITSPKVLQRLIKSRGKSQAKHLNVQMVAADKLAQCPSELFDIILDENQLEDACEHMADYLELYWKSTHPPSGAPSTPLLDKLSAVTAAAVACKEQLTNTQPKGTGSDEHADRAAANRTSFYEDYHHHHHPQQQHYQTQKQESFEEEEEEEDDDEENTDQRHDNRDQQNHHKNQHSSSTRTERHHHHRHHHHHHHHRHHHSRTARTLSKQETLESTETQTHSQPQQEEEQESVQPNHHRHHHHHHRHHHRNEKEKEYDHNERNSRQRGKQKSQREHHHHHERRKHYIEQ,,chemical synaptic transmission (GO:0007268) (0.4865); neuromuscular junction development (GO:0007528) (0.4307); neuromuscular synaptic transmission (GO:0007274) (0.1181); positive regulation of calcium ion transport (GO:0051928) (0.1077); calcium ion import (GO:0070509) (0.0752); locomotion (GO:0040011) (0.0656); calcium ion transport (GO:0006816) (0.0622),synapse (GO:0045202) (0.2632); voltage-gated calcium channel complex (GO:0005891) (0.2031); cytoplasmic side of plasma membrane (GO:0009898) (0.1369); photoreceptor ribbon synapse (GO:0098684) (0.1244); cytoplasm (GO:0005737) (0.1071); L-type voltage-gated calcium channel complex (GO:1990454) (0.0899),high voltage-gated calcium channel activity (GO:0008331) (0.4438); calcium channel regulator activity (GO:0005246) (0.1052); voltage-gated calcium channel activity (GO:0005245) (0.0771),"SH3-like domain superfamily (IPR036028) (0.4939); SH3 domain (IPR001452) (0.3794); Voltage-dependent L-type calcium channel subunit beta-1-4, N-terminal A domain (IPR046937) (0.2046); Guanylate kinase/L-type calcium channel beta subunit (IPR008145) (0.1725); P-loop containing nucleoside triphosphate hydrolase (IPR027417) (0.1464); Voltage-dependent calcium channel, L-type, beta subunit (IPR000584) (0.1135); Voltage-dependent calcium channel, L-type, beta-2 subunit (IPR005444) (0.1107)",2.30.30.40 (0.1878),Voltage-gated channel (0.8848); Calcium transport (0.4318); Ion transport (0.3340); Ion channel (0.3064); Calcium channel (0.2774); Reference proteome (0.2177); SH3 domain (0.2125); Membrane (0.2053); Cell membrane (0.1597); 3D-structure (0.1532); Transport (0.1081),
MFLHILLSAICLCVLSSSSVLSSATDDSSALKVAIPASSPVSAVLGGSLTLPCLVSLPRTPSLGRHAVLTQPRVKWSFLSSDRETEILVARGERVKVSEAYKGRASLLNYATSSADLTLRLEGLIHNDTGFYRCEVQHGLEDSHDQAQVKVKGVVFLYRHTSSRYAFTFDEARDACKDIGAEIASPEQLLAAYHSGYEQCDAGWLSDRSVRYPIQMPREGCFGDMDGLPGVRNYGTMENDELYDVYCYVENIHGEVFHGSTPQRFSLSEAKAYCEQQDAQLATTGQLYAAWNDGLNHCSPGWLADGSVRYPIVTPRERCGGSEPGVKTVYRFSNQTGFPEPNTRHDAYCFKANSNSQTAPPADYMATSPEETEQHIVTLAEPQEEYSVHQVTQRSENEAQGAVESFSIYSTQTASETEEHNHTSSPQEDIIIGSRKDLTTPTSTEGNTETIEVTWQNVESIPEIYIDPKRNNFMLEGEPEIKASAVDGVKSSNHRHYQPMPDTNLEPGEPIDFIPPTVAHHGTTEEPSSPPKEINGSKHYQPMPDTNLDDEDHMTTQSTTLQYDSSNNTTQDASVQSTYHPDGATLETNAGNITEAPESDDNQGLFTHTTQPTSTSTSSREGWLESSGEDSTTEKAIYLDLTTKEAVNLDSTTEEPIHLDSTTEEAIHLDSTTEEAIHLDSTTEEAIHLDSTTEEAMFSTHNSEIYRASTAETLTESYSSTHLNNISPTDDVTDHFTLSTTLRETELSESSGDHDEVLPVILFTTPMPHLLDSLTTRAPVQLEISSPQQIEGVLSDSTTASALRVVEEEVEKVEQEELGEQPETKITTSTELNHSTVTLSIDGSDEEESSGEPSENWTSVTENPYSNTATITPSNLTDLQEHNETNSDDEDNQAITVEPTTDLEVTFLPHGTQTSIWQSVVTSPGELNADVEFSGEAALTTDDMRALEESESTNAPISEQTEETLKPSSTTDHNDADDDDNDNDDDELITKAITGNEEDENDVKTTHESFIIPVRPTQRVLIRTSYISDACLENPCKNGGTCVDSGGDQRCLCLPTYGGDFCETDLEHCEPGWEKFQGFCYKHFAKRQKWEVAEQHCRMCGGHLVSVMSPEEQLFINDKYREYQWTGLNDKTIEGDFRWSDGNPLLYQNWYRGQPDSYFLSGEDCVVMVWYDDGRWSDIPCNYQLSYTCKKGISAFCGQPPLVLHAKMFGRRQLKYRANSQVRYYCESGFIQRQNPIITCQSNGLWEEPKIMCSPAGPTYSNGDLVTWRTGQNKEIVIEDSTTKTPEYLDIKWNF,,cell adhesion (GO:0007155) (0.9460); positive regulation of neuroblast proliferation (GO:0002052) (0.9419); skeletal system development (GO:0001501) (0.8854); glial cell differentiation (GO:0010001) (0.5203); central nervous system development (GO:0007417) (0.4027),synapse (GO:0045202) (0.5595); perineuronal net (GO:0072534) (0.4429); extracellular space (GO:0005615) (0.1679),hyaluronic acid binding (GO:0005540) (0.8280); carbohydrate binding (GO:0030246) (0.2096),C-type lectin-like/link domain superfamily (IPR016186) (0.5034); Immunoglobulin-like domain superfamily (IPR036179) (0.4962); Sushi/SCR/CCP domain (IPR000436) (0.3836); C-type lectin fold (IPR016187) (0.3227); Immunoglobulin-like domain (IPR007110) (0.2694); Link domain (IPR000538) (0.2689); C-type lectin-like (IPR001304) (0.2546); EGF-like domain (IPR000742) (0.2379); Immunoglobulin subtype (IPR003599) (0.1951); Immunoglobulin-like fold (IPR013783) (0.1655); Sushi/SCR/CCP superfamily (IPR035976) (0.1222),2.10.70.10 (0.4230); 3.10.100.10 (0.3591); 2.10.25.10 (0.3250); 2.60.40.10 (0.2818),Signal (0.9642); Sushi (0.9118); Repeat (0.8632); Secreted (0.7475); Immunoglobulin domain (0.5338); Proteoglycan (0.4433); EGF-like domain (0.4139); Disulfide bond (0.3575); Glycoprotein (0.3505); Reference proteome (0.3189); Lectin (0.2837); Membrane (0.1625),
MEYSAHFHSAQPVKNKLFVFCIMLSLWVYMLYCCVGYCSTTPTFMMDERSNRRALQRQDPEMLLKSQSRDLLNNDSDADSRGDGWEENKGDAAYDEDDSGIAGAVNGSESKKLPQAIIIGVKKGGTRALLEFLRLHPDIRAVGAEPHFFDRNYEKGLEWYRELMPKTLDGQLTMEKTPSYFVTKEVPGRIHAMSRDTKLIVVVRDPVTRAISDYTQTRSKKPDIPSFESLTFKNLSTNVIDTSWSAVQIGMYARHLERWLQFFPMSQLLFVSGERLISDPSGEMARVQHFLGLRREVTHKHFHFNPAKGFPCLKRPESNSKPHCLGKTKGRTHPNINPEVIQRLRDFYKPFNKKFYHMTGHDFGWD,[heparan sulfate]-glucosamine 3-sulfotransferase 1 (2.8.2.23) (0.3772); [heparan sulfate]-glucosamine 3-sulfotransferase 3 (2.8.2.30) (0.2626); 2.8.2.- (0.0791),"angiogenesis (GO:0001525) (0.2850); glycosaminoglycan biosynthetic process (GO:0006024) (0.2039); proteoglycan metabolic process (GO:0006029) (0.1883); protein sulfation (GO:0006477) (0.1296); lipid metabolic process (GO:0006629) (0.1146); chondrocyte development (GO:0002063) (0.1127); cell-cell signaling (GO:0007267) (0.1124); heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015) (0.1023); cholesterol metabolic process (GO:0008203) (0.0828); heparan sulfate proteoglycan biosynthetic process (GO:0015012) (0.0767); cardiac septum development (GO:0003279) (0.0717); lung alveolus development (GO:0048286) (0.0649); protein localization to plasma membrane (GO:0072659) (0.0623); cartilage development (GO:0051216) (0.0522); sperm flagellum assembly (GO:0120316) (0.0467); respiratory gaseous exchange by respiratory system (GO:0007585) (0.0448)",trans-Golgi network membrane (GO:0032588) (0.2970); membrane (GO:0016020) (0.1225); Golgi membrane (GO:0000139) (0.0696); plasma membrane (GO:0005886) (0.0602),sulfotransferase activity (GO:0008146) (0.0692),P-loop containing nucleoside triphosphate hydrolase (IPR027417) (0.5168); Sulfotransferase domain (IPR000863) (0.3994); Heparan sulfate sulfotransferase (IPR037359) (0.1269),,Reference proteome (0.7012); Glycoprotein (0.5524); Disulfide bond (0.5162); Ubl conjugation (0.3354); Membrane (0.2717); 3D-structure (0.1560); Tumor suppressor (0.1119),
MVVAGLVSLTILYCSPSTPKNCPSPLPNLKQEESYSTKKSDALTNKIIEDKPILLLWFWPENYFFDFSDCKTIFNIDGCHLTDNRLLYEKSDNVLIYHKAISWDLSNLPPSPRPLFQKWIWFNVESPTNTRKKPGLENLFNLTLSYREDGDIPVRMRLKTRKTPADDFVIPKKDKLVCWIVSNKATYTGAGTRNKYYEELRKHINVTVFGKAFGKFLDYNQYYPTLASCKFYLSFENSIHKDYITEKLNGPLAVGTVPVVLGPPRKNYENFVPGDAFIHVQDFPDPKSLAEYLLQLDKDDVAYRRYFNWRKYLVATPHLIQRTQEFVLAICTACDYVAHHKEYKDAHNIYDWFFH,2.4.1.- (0.9385),protein glycosylation (GO:0006486) (0.5678); N-glycan fucosylation (GO:0036071) (0.3320); glycosphingolipid biosynthetic process (GO:0006688) (0.2504); polysaccharide biosynthetic process (GO:0000271) (0.2421); oligosaccharide biosynthetic process (GO:0009312) (0.2316); fucosylation (GO:0036065) (0.1884); neuronal stem cell division (GO:0036445) (0.1823); regulation of cell migration (GO:0030334) (0.1477); neuron differentiation (GO:0030182) (0.1208); ceramide metabolic process (GO:0006672) (0.0874); protein N-linked glycosylation (GO:0006487) (0.0643); carbohydrate metabolic process (GO:0005975) (0.0415),membrane (GO:0016020) (0.3381); Golgi cisterna membrane (GO:0032580) (0.3249); trans-Golgi network membrane (GO:0032588) (0.2178); Golgi membrane (GO:0000139) (0.1025),4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity (GO:0017083) (0.1841); alpha-(1->3)-fucosyltransferase activity (GO:0046920) (0.1801),"GT10-like, C-terminal domain superfamily (IPR038577) (0.5869); Fucosyltransferase, N-terminal (IPR031481) (0.4321); Glycosyl transferase family 10 (IPR001503) (0.0916)",3.40.50.11660 (0.2087),Transmembrane (0.4799); Transmembrane helix (0.4659); Membrane (0.4657); Reference proteome (0.4261); Golgi apparatus (0.3633); Glycosyltransferase (0.3168); Lipid metabolism (0.2612); Transferase (0.1284),
MRLASMQHRGRRAAESEEEPNRAPPPLPPPSHHSHNFVNMKNKFFNELGHLPNHKIRMPMWAIGAIIVVVLALVGCFAFCIYKKCLGGKKKTKKVRERKGGRRRMKKEGEEEAGEEQPKEGEGEGEKEYYGKLEYTLDYNFTENQLIVGILQAQDLPAMDIGGTSDPYVKVYMLPDKKKKFETKVQRKNLCPVFNETFIFKIPFNDLAGQTLVLQVFDFDRFGKHDVIGEIKIPMNSIDLGQPIHEYKDLVGGEKEEQEKLGDICISLRYVPTSGKLTVCIMEAKNLKKMDVGGLSDPFVKIVLQHNGKRIKKKKTTVKQNTLNPYFNESFSFEIPFAQIQKVQVLITVYDYDKLGSNDPIGKCWIGFGASGVGLRHWSDMLANPRRPVAQWHTLQPEEEVDAALKAPIR,,synaptic vesicle endocytosis (GO:0048488) (0.7253); regulation of dopamine secretion (GO:0014059) (0.5889); regulation of calcium ion-dependent exocytosis (GO:0017158) (0.5405); calcium ion-regulated exocytosis of neurotransmitter (GO:0048791) (0.5075); cellular response to calcium ion (GO:0071277) (0.1598); calcium-dependent activation of synaptic vesicle fusion (GO:0099502) (0.1321); vesicle organization (GO:0016050) (0.1247); positive regulation of dendrite extension (GO:1903861) (0.0919); synaptic vesicle exocytosis (GO:0016079) (0.0556),dense core granule (GO:0031045) (0.4926); plasma membrane (GO:0005886) (0.3297); synaptic vesicle membrane (GO:0030672) (0.1747); axon (GO:0030424) (0.1268); exocytic vesicle (GO:0070382) (0.1024); presynapse (GO:0098793) (0.0837),phosphatidylserine binding (GO:0001786) (0.2558); SNARE binding (GO:0000149) (0.1391); calcium ion binding (GO:0005509) (0.1375),Synaptotagmin (IPR001565) (0.3220); C2 domain superfamily (IPR035892) (0.2737); C2 domain (IPR000008) (0.2019),2.60.40.150 (0.2249),Metal-binding (0.2835); Membrane (0.2396); Synapse (0.1708); Reference proteome (0.1518),Ca(2+) (0.2303)
MSDSVVSFAKDFLAGGVAAAVSETAVAPIERVKLLLQVQHASKQITTDKQYKGIVDCVVRIPREQGFLSFWRGNLANVIRYFLTQALNFAFKDKYRRIFLDGVDQRTQFWRYFAGNLAAGGAAGATSLCLVYPLDFARTRLAADVGKTGTAGREFKGLANCLVKIYRSDGVRGLYQGFNVSVQGIIIYRAAYFGIYDTAKGMLPDPENTHIAVSWMIAHTVTIVAGFISYPFDTVRRSMMMQSGLKGADVMYSGSIDCWRKIARNEGPKAFFKGAWSNVLRSLGGSIVLVLYDEFKKVI,,mitochondrial ATP transmembrane transport (GO:1990544) (0.4385); chromosome segregation (GO:0007059) (0.4256); spermatogenesis (GO:0007283) (0.3206); regulation of mitochondrial membrane permeability (GO:0046902) (0.2938); mitochondrial ADP transmembrane transport (GO:0140021) (0.2260); positive regulation of mitophagy (GO:1901526) (0.2226); negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029) (0.1967); apoptotic mitochondrial changes (GO:0008637) (0.1839); B cell differentiation (GO:0030183) (0.1471); male meiosis I (GO:0007141) (0.1116),mitochondrial permeability transition pore complex (GO:0005757) (0.2166); mitochondrial inner membrane (GO:0005743) (0.1792); MMXD complex (GO:0071817) (0.0865),ATP:ADP antiporter activity (GO:0005471) (0.1411),"Mitochondrial carrier protein (IPR002067) (0.2210); ADP/ATP carrier protein, eukaryotic type (IPR002113) (0.2176); Mitochondrial substrate/solute carrier (IPR018108) (0.1803)",,Transport (0.7910); Mitochondrion inner membrane (0.4655); Antiport (0.4292); Transmembrane (0.4111); Reference proteome (0.4073); Mitochondrion (0.3997); Membrane (0.3117); Repeat (0.1948); Spermatogenesis (0.1916); Methylation (0.1175); Transmembrane helix (0.0666),
MRPKTFPATPYVGNTRQRLQDIKEGLKQPAKLVSQALHGGSSRGEGGRGGDSKGKDQAARQQQLRPPQKFNNYQSALREIRKSLRPYANDSGPGSSSGHPGEVSRQMLQDLVNAGCDQEMAVRALKQTGSRNIEAALEYISKMSYLDPHTEQIVRVIKQTSPGKSGMPNLMDHRTAMEGSGDGALPPYHQMGAPLYEGASYGAEGEMARAYMGGPPVMNYMPPPANPSQGSQPSGGPGAHYDYRSHMMENSSYGVKRSASFQNKMPQLTTENYVNMPSKAAMGQNAGGYAPNLYLPPHSHPRQASPTSHQVHMMQRPPGVAPGAMGGEFSDVPQGLLTPSRASLNLDLYEHHWPGAQGPEGTPPARQPQGPFRGEVRVPSRTNSFNNHQKVTVRQTLPPTASVAGKPESSLGPPNTITAVTSPPIQPPVKSIRVMRPEPKTAVGPCHPGWLSAQSPEAQDSLGYIPDENFTLEPSQEHRCPPPPYPKTLLVSGSGPEPASLEPVAMSGLQDVSATGRTIQSSSVGKQEESIFKDKVKMGKGEKAVKDKKQIQTSPVPVRKNARDEEKRESRIKSYSPFAFKFYMEQHVENVMKTYQQKLNRRMQLEQEMSKAGLSEAEQEQMRKMLYQKESNYNRLRRAKMDKSMFVKIKTLGIGAFGEVCLTRKVDTGALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVRLYYSFQDRDNLYFVMDYIPGGDMMSLLIRMGVFPEVLARFYVAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGNHIRQDSMEPSDFWDDVSNCRCGDRLMTLEQRATRQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLQVPPQVKLSPEAVDIIGQLCCSAEERLGGNGAGEIKAHPFFSEVDFSSNLRTQPAPYRPKIAHPMDTSNFDPVEEEGGPGAWSDSGDSTRTWDTLCSPHGKHPEHAFYEFTFRRFFDDNGCPFRYPKPLEATQSLSSSDGAGSLKPELEEEEAHEEEEQGEGCEPVYV,non-specific serine/threonine protein kinase (2.7.11.1) (0.1640),protein phosphorylation (GO:0006468) (0.8791); G1/S transition of mitotic cell cycle (GO:0000082) (0.5814); positive regulation of apoptotic process (GO:0043065) (0.5493); hormone-mediated signaling pathway (GO:0009755) (0.2038); regulation of organ growth (GO:0046620) (0.1598); convergent extension involved in gastrulation (GO:0060027) (0.1327); peptidyl-serine phosphorylation (GO:0018105) (0.1140); BMP signaling pathway (GO:0030509) (0.0851); G2/M transition of mitotic cell cycle (GO:0000086) (0.0536); hippo signaling (GO:0035329) (0.0496),spindle pole (GO:0000922) (0.4791); nucleus (GO:0005634) (0.4520); cytoplasm (GO:0005737) (0.1539),protein serine/threonine kinase activity (GO:0004674) (0.3599); ATP binding (GO:0005524) (0.1788),"Ubiquitin-associated domain (IPR015940) (0.4080); UBA-like superfamily (IPR009060) (0.3410); Serine/threonine-protein kinase, active site (IPR008271) (0.2145); Protein kinase domain (IPR000719) (0.1948); Protein kinase-like domain superfamily (IPR011009) (0.1933); Serine/threonine-protein kinases, AGC (IPR050236) (0.1646)",1.10.510.10 (0.4961); 1.10.8.10 (0.4150),Transferase (0.6801); Reference proteome (0.5813); Nucleotide-binding (0.4155); Kinase (0.3802); ATP-binding (0.3693); Serine/threonine-protein kinase (0.3357); Phosphoprotein (0.1986),
MTDPVTSDQLTNAVDSVVHNPESSSLPVRVSQREEEEEDDLNKSLGVQRFQQILSPTARVPGDQHRSYNEKDFEYHRQSSHHIHHPLSKLPGDNRRKKSGRKRRRSSSKPHKVCSSPSGALAIEEGEDEEEEEEEESAENQSVTPAPTTDNDRKDNVQFFVSDDDPHVSTPETSDPVPTRGILIVPTTAVCSEPQDSTSTEASEAAPASPSTAEHGSIPRVSSRSYDLQERRRTGNMTGTEQAKYQRIPTDEYEARTLASADLDGIKSHRFEDVPGVRRHLVRKSTKGQMVHISKDHKERSTRSRKLDRTPHEVFVELNELIMDKNQEMQWRETARWIKFEEDVEEETDRWGKPHVASLSFRSLLELRKTIAHGAVLLDLDQKTLPGISHQVVEQMIISDQIKAEDRANVLRALLLKHSHPSDEKEHITSFPRNISAASLGSLISHHQSSSNHLTIPETSVMEPLMGSSRASQDSTVHIDIDKNEKDSATPIGMHRSKSKHELKLLEKIPENAEATVVLVGSVDFLEQPTMAFVRLQEAVELDSVLEVPVPVRFLFVLLGPPSTNMDYHQIGRSISTLMSDKQFHEAAYLADDRQDLLNAINGFLDCSIVLPPSELGGEDLLRSVAHFQREMLRKREEQGVALMAKEPKSLQEKEALLAPFKPEDDPLKRTGRLFGGLIRDAQRRYPKYISDFRDALNPQCMAAVIFIYFAALSPAITFGGLLGEKTEGLLGVSELIVATCVQGVLFCLLGAQPLLIVGFSGPILVFEEAFFSFCKGNNMEYLTGRVWIGFWLIIIVVLMVAFEGSFMVRFVSRFTQEIFSFLISLIFIYETFSKLAKIFQEHPLQRCSAVLVDVRNSSLNSSMDEVTESPLAVTNSSSQEMLKVVGEPNTALLSLVLMSGTFLIAFYLRKFKNSAFFPGRLRRVIGDFGVPIAILIMVLVDYSVKDTYTQKLSVPRGFSVTSPDKRGWIVNPLGSDGQFPIWMMFASILPALLVFILIFMETQITTLIVSKKERMLVKGSGFHLDLLLIVTLGGTSALFGLPWMAAATVRSVTHANALTVMSKAVAPGDKPRIQEVKEQRVTGLLVAILVGLSIVIGDLLRQIPIAVLFGIFLYMGVMSLNGIQMTERILLLLMPPKYHPDHTYVRKVRTLRMHLFTAIQVVCLAVLWAVMSTVASLAFPFVLIMTVPVKMFLLPRIFSNREMQCLDADDAEPTFDEKEGQDEYTEMHMPV,,bicarbonate transport (GO:0015701) (0.8100); regulation of intracellular pH (GO:0051453) (0.3865); transmembrane transport (GO:0055085) (0.2561); cardiac conduction (GO:0061337) (0.2064); chloride transport (GO:0006821) (0.1146); osteoclast differentiation (GO:0030316) (0.0409),plasma membrane (GO:0005886) (0.3318); basolateral plasma membrane (GO:0016323) (0.3196); apical plasma membrane (GO:0016324) (0.2975),solute:inorganic anion antiporter activity (GO:0005452) (0.2728); chloride:bicarbonate antiporter activity (GO:0140900) (0.1832); transmembrane transporter activity (GO:0022857) (0.1016),"Anion exchange, conserved site (IPR018241) (0.2406); Bicarbonate transporter, eukaryotic (IPR003020) (0.2220); Anion exchange protein (IPR001717) (0.2137); Bicarbonate transporter-like, transmembrane domain (IPR011531) (0.1850)",1.10.287.570 (0.2463),Transmembrane helix (0.9607); Transport (0.9237); Transmembrane (0.9110); Reference proteome (0.7241); Anion exchange (0.5880); Membrane (0.5392); Cell membrane (0.3458); Proteomics identification (0.1783); Ion transport (0.1401); Antiport (0.0725),
MLNMEGFLRSSFLLSRIMSSKQATSPFTSTPDGGEDGVNQERMPWEKEENSESLVAPQLPLHNLLHNKPPLEELQPISSSVPPESDWDSLMSAQQRMESDSNKVCSLYSFRNNSTSPHKPEEGARERGDLLSSSAFGTPERRKGSLADVVDTLKQKKLEEMTKTEQDESSCMEKLLSKDWKEKMERLNTGELLGEIKGTPESLAEKERQLSTMITQLISLREQLLAAHDEQKKLAASQMEKQRQQMELARQQQEQIARQQQQLLQQQHKINLLQQQIQVQGHMPPLMIPIFPHDQRTLAAAAAAQQGFLFPPGMSYKPGDNYPVQFIPSTMAAAAASGLNPLQLQQLYAAQLASMQVSPGAKMPPLPQPPNSAGQISPSGLKNEKRSSTPLAQVKEEGTQPLNLSARPKTAEPIKSPTSPTQSLFPGSKSSPNSLSKSGDIPSPIGGLGRGSSLDILSSLNSTALFGDQDAVMKAIQEARKMREQIQREQLQHHQQGMEVKLSALTSMGLNNCRTEKERSHYDNLGHHLSKLGEDGKIGHRVIDLTRPEDFEGGASTTEARVYREPRGRNSNEPHIKRPMNAFMVWAKDERRKILQAFPDMHNSNISKILGSRWKSMTNQEKQPYYEEQARLSKIHLEKYPNYKYKPRPKRTCIIDGKKLRISEYKQMMRSRRQEMRQFFTVGQQPQTQIPITTSAGVVYPGAITMATTTPSPHMTSDCSSASASPEPTIPVIQSTFNMKMEPGTMVPSDAVNGEDEMDMYEDFEDEPKSDYSSENDTHEPVSAN,,cartilage condensation (GO:0001502) (0.4892); brain development (GO:0007420) (0.4717); positive regulation of chondrocyte differentiation (GO:0032332) (0.4586); negative regulation of transcription by RNA polymerase II (GO:0000122) (0.2760); central nervous system development (GO:0007417) (0.2644); positive regulation of mesenchymal stem cell differentiation (GO:2000741) (0.2543); cell fate commitment (GO:0045165) (0.2240); cellular response to transforming growth factor beta stimulus (GO:0071560) (0.2183); cartilage development (GO:0051216) (0.1579); negative regulation of cardiac muscle cell differentiation (GO:2000726) (0.1558); positive regulation of DNA-templated transcription (GO:0045893) (0.1523); spinal cord oligodendrocyte cell differentiation (GO:0021529) (0.1409); regulation of transcription by RNA polymerase II (GO:0006357) (0.0993),nucleus (GO:0005634) (0.0954),"RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978) (0.3303); protein homodimerization activity (GO:0042803) (0.1691); DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981) (0.1370); DNA binding (GO:0003677) (0.0808)",SOX/SOX-like transcription factors (IPR051356) (0.2455); High mobility group box domain superfamily (IPR036910) (0.1548),1.10.30.10 (0.1522),Isopeptide bond (0.6527); Transcription regulation (0.5689); Reference proteome (0.3732); Transcription (0.3492); Ubl conjugation (0.3330); Nucleus (0.2986); Developmental protein (0.2876); DNA-binding (0.2646); Differentiation (0.2001); Coiled coil (0.1467),
MNPPKMKRRRMAELEPWIEKLIQNFGQNQTETVVKASVIGTCEISDSQRMDRTDACMLFLSDGIAMIPAVLSDAAWERLQELEDLDSFTSLLNHVAFIRSFELEFDMKPDLGSCQFYLKVNQMNTFCIALKRQQPPSCTTLQSVRDQIEKTWRSRGGGSESSVSGVSLSSLLDVWHSDIIVSILNDAMEKINVSATYSPSVATPTHWHRERLQRRAQEQFAIPVPFLLIPEEQRELMTADPGADSETPTGLAPPYEEPHPISTQSANQAVAVQDDAISDLCPDEGPSTLVQTRPEVLCGTGDLSRDTTSPWDMFTEEPGLLGRSTSSGSNATSTQFSKQVSAGPSADGITLSQRPKPTQFSLSRSIGRSIRDPSQEQDKEPAQSPPSWLIHNTAPPSAPPPPRTKPSTPAPSKTRRVHSDGAPFSYLYHPKPQVASALSHFQVPGHLIQWAVCYLGTSDCADINAEAGS,,"telomere maintenance via telomerase (GO:0007004) (0.5712); telomere capping (GO:0016233) (0.4033); telomere maintenance (GO:0000723) (0.3968); establishment of protein localization to telomere (GO:0070200) (0.3093); protection from non-homologous end joining at telomere (GO:0031848) (0.2858); segmentation (GO:0035282) (0.2487); urogenital system development (GO:0001655) (0.2189); telomere assembly (GO:0032202) (0.2133); regulation of establishment of protein localization to telomere (GO:0070203) (0.2033); protein localization to chromosome, telomeric region (GO:0070198) (0.1618); intracellular protein transport (GO:0006886) (0.1310); ovarian follicle development (GO:0001541) (0.1211); negative regulation of telomere maintenance via telomerase (GO:0032211) (0.0960); regulation of transcription by RNA polymerase II (GO:0006357) (0.0448)",telomerase holoenzyme complex (GO:0005697) (0.3252); GO:0000781 (0.0896),protein-containing complex binding (GO:0044877) (0.3576); DNA polymerase binding (GO:0070182) (0.1008),Adrenocortical dysplasia protein (IPR028631) (0.3111); Shelterin complex subunit TPP1/Est3 (IPR019437) (0.2615),2.40.50.960 (0.1569),Telomere (0.8840); Chromosome (0.2534); Proteomics identification (0.2072); Reference proteome (0.1945); Nucleus (0.1548); Ubl conjugation (0.0436),
MALWLSAVLLVLQVTPASSEDSMFEFSTDTPINNVVQDPLTGRVYLGAVNAIYQLDSLLNLEARAETGPKKDAKGCTPPVSTCQDLKDTNNTNKLLLVHSANGSLIVCGSLYRGICSLLNLTNVKEQIYYSDSKGERTYAASTEDYVSVVGVMATLEIDNKPFSVFLVGKGYGSMDSSKLISTRIVQNYRDWVVFESIIEASTVQAVPFVPKYLHDFRFAFKNDNFVYFLFSRTLGRTDNKNFTFISRLCENDNHYYSYTELQLSCGLNNRYNKVQAAYLSDPGKELAQVMTDSGEYGTVKEWDKVLFVVASSEEGATESALCMYPLKNINQKLLAIVTACYTDNGKIDDRLVVESPYTSSKDGPCVKHDKDIVNRYKCGADFLPSPLASRQEFALKANPVFIRQNLLTAVAVAVENDHTIAFLGHNAGEVIKVHLSSSPEPYNPGPGYKTSGYVNKNLFFDKTQAHLYITTEKKIVKVPVQACHLKQDCQSCVAQKDPYCGWCVLEGRCSRRSECSRAEEKHGWLWSPNQQCVKIISFHPPNLSCLKSQQVEINVRSLPVLRDSDRIRCSFGSYNSTARMVDGRISCHLPEQPFIPPTPPNQDFVAVPVQIYVNVSVKVASSEYKFYNCAAAIQKAQNTPCTSCVSSSWGCQWNVAAHTCTDLSDAETGTNIIKQRQNKSCPRFENPDPVLIPVGYKTRISFEGINLDPYKGRDFTIGTELMRGEEDVNTESGPFYSFSGYMFSFDKAHETSVLFHVRDKHTGKKIDSSLNVTLYNCSLGREDCSLCKNADPKYQCVWCRQTSACVYEQLCASRESVECPDPQITDITPRFGPLKGGIAVTIKGSNLGIQKDDIKNITVAGVNCRHLRERYSVSTSVICEIGPASLRKSGVVEIEVGRGRKGVSSKTVQFTYRDPVPLSVFPNRGPKAGGTVLTITGQDLNTASKEDLLILVGDVPCRVESFGDQITCKLSNYLGDTVPSAHLDVKVQYGPQIPTSIKAAFQFSNNPSVSDHQPRSSFICGGRRVVVHGSGFDLVQKASIRVVASAGEWSGQAVPEEFVEDFQHKNDTMVTFLSPAVNESQSFRTFVQLDNLQMELTPFAYYPNPTFDELSKSVITENSMIIVTGRGFSNAMTANEAQAFVGDVQCMVNTLQDDKLFLDPPMSTPRARSKRPRRDTGSDPLDLQIKFGRGEWVVGSVHYERKYSLPLAVIIPAVLVPMLMIIAISVVCYRRKSQQAEREYEKVKHQLENLEESVRDRGKKEVTDGANDVMITGKLDIPESRRATVTQALNQFSNLLNSKTFLINFIRTLEGRPDFNARAKVYFASLLTVALHGKLEYYTDIMRTLLLGLMEDYVHSKNPKLLLRRSETVVERMLSNWMSICLYQYLKDTAGEPLYKLFRAIKHQIEKGPVDVQVKKAKYTLNDTGLLGDDVEYSILTLQVLVQGEGPDITPVNVLNCDTISQVKEKILEQVYKNLPYSQRPKVDSVTLEWRPGSTGQILSDLDVTSQKEGRWRRINTLAHYNVRDNATVILSSVQHTQQSYDQNHDSHEERNALLEDDKVFHLVRPADELDEIKSKRGSIKDKSMTKAITEIYLTRLLSVKGTLQQFVDDFFHSVLCSGAAVPPAVKYFFDFLDEQALRHENVDEETIHIWKTNSLPLRFWVNILKNPHFIFDVHVTEVVDASLSVIAQTFMDACTKTEHKLSRDSPSNKLLYAKEISTYKRNVDEYYKGIRQMVSVSDQEMNTHLAEVSREHTDKLNTQVALHQLYRYASKYYDGIIMSLDEDPTAQSKQLTLRLQQIAAALENKVTDL,,regulation of cell migration (GO:0030334) (0.4277); regulation of protein phosphorylation (GO:0001932) (0.4126); negative regulation of cell adhesion (GO:0007162) (0.3211); regulation of cell shape (GO:0008360) (0.3001); phosphorylation (GO:0016310) (0.2149); semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287) (0.2097); axon guidance (GO:0007411) (0.1163); positive regulation of axonogenesis (GO:0050772) (0.0953),plasma membrane (GO:0005886) (0.8165); semaphorin receptor complex (GO:0002116) (0.1344),semaphorin receptor activity (GO:0017154) (0.1081); kinase activity (GO:0016301) (0.0610); ATP binding (GO:0005524) (0.0441),"Rho GTPase activation protein (IPR008936) (0.5058); WD40/YVTN repeat-like-containing domain superfamily (IPR015943) (0.4690); Plexin repeat (IPR002165) (0.4509); Sema domain (IPR001627) (0.4428); IPT domain (IPR002909) (0.4190); Sema domain superfamily (IPR036352) (0.3971); Plexin, cytoplasmic RasGAP domain (IPR013548) (0.3523); Plexin, cytoplasmic RhoGTPase-binding domain (IPR046800) (0.3471); Plexin family (IPR031148) (0.3359); Immunoglobulin-like fold (IPR013783) (0.2925); PSI domain (IPR016201) (0.1068)",2.130.10.10 (0.3151); 2.60.40.10 (0.3008),Repeat (0.6035); Reference proteome (0.4669); Cell membrane (0.4200); Glycoprotein (0.4103); Membrane (0.3243); Signal (0.2987); Disulfide bond (0.2339); Transmembrane (0.2329); Transmembrane helix (0.1998); Coiled coil (0.1581),
MLTLHMNGELTEDEEENDPENLTSSNQMEKTEEDAMMMMTVKEEETDLHSSSCLKPAQRSDEGLGHVFYDGMNITEASSEEKSTTDLDSVLQCLHHLHQCVLDEESQQDVELLLDLLLQTNFQQAFIMQRSVAQGMSRLCPPPYPLTAHAQQLRGQVESVLQSSKHTEATELTGLLTSPHLQALMEAHDCIAEQELDVDTIEAVDQDEKTTKLVSLEKIRDIPLGVTVRNEQDCVVISRVVSGGTAEKSNLLSEGDEILEINNIPVRGKTVNDVHDLLSSMYGSLTFLLIPNSHNKLPLDRPTVMHVKANFSYDPSEDPYVPCKELGLSFQRGDILHVTSQDDPNWWQAYREGHDDQKPLAGLIPGKNFQQHREAMKKTITDKNEEYKGKLWCAIRSKKHRKKLLYNPNKNIEHYSEDILTYEEVSLYRQPPDRKRPVALIGPANSGQDELRQRLLSSEPERFAAAVPHTTRSPRVHEVNGREYNFVSRQSFESELSAGKFIESGEYGNNLYGTNADSVRQVVNSGKICLLCLQPRSLQVLCSSDLKPYIIFIRPSPPPLSPPPPQERFSTMLARGVKKRMPEDVREMMEKAREMEDSYGHLFDTFITNNEPEKSVCELLSIIQKLDNEPQWIPSAWNR,,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197) (0.8817); establishment or maintenance of polarity of embryonic epithelium (GO:0016332) (0.8068); morphogenesis of an epithelial sheet (GO:0002011) (0.8015); generation of neurons (GO:0048699) (0.6859); protein localization to plasma membrane (GO:0072659) (0.5641); phosphorylation (GO:0016310) (0.0918),axon (GO:0030424) (0.4631); bicellular tight junction (GO:0005923) (0.4169); adherens junction (GO:0005912) (0.3610); Golgi apparatus (GO:0005794) (0.3438); plasma membrane (GO:0005886) (0.2545); perikaryon (GO:0043204) (0.1316),,"L27 domain superfamily (IPR036892) (0.6672); L27 domain (IPR004172) (0.3947); PDZ domain (IPR001478) (0.3078); Membrane-associated guanylate kinase (IPR050716) (0.2971); L27 domain, C-terminal (IPR014775) (0.2271); PDZ superfamily (IPR036034) (0.2079); L27-N (IPR015145) (0.1983); Guanylate kinase-like domain (IPR008144) (0.1774); SH3-like domain superfamily (IPR036028) (0.1201); SH3 domain (IPR001452) (0.1161); P-loop containing nucleoside triphosphate hydrolase (IPR027417) (0.1062)",2.30.30.40 (0.3447); 1.10.287.650 (0.2733); 2.30.42.10 (0.1744),SH3 domain (0.9401); Reference proteome (0.4596); Membrane (0.2074); Tight junction (0.1697),
MMELDEVVYQDDYGAVSVMSERVTGLASSIYQEFERLIKTYDEEVVKELMPLVVNVLENLDSVLTENQEHEVELELLKEDNEQLITQYEREKALRKQAEEKFIEFEDALEADKKDLQTTVETLELQAKQLELKSKNYADQISRLEERESDMKKEYNALHQRHTEMIQTYVEHIERSKLQQSGSNQSESTGCGRSQRHNWRKSKTERPPSLSLYPGGDGMEDGSDSDSVAATPSSTGSKSNTPTSSVPSATVTPLNDGLVSVGEYDTSRGRARDRRTGKRLSRNMEVQVSQETRNVSIGMGSSDEWSEFQEIIDSTPELDMCLDPRIFGGGNSPSQGIVNEAFGINTDSLYHEIKDAKSDIIGDVDAGAELLGEFSVRDDFFGMGKEVENLLTENKQLLETKNALNIVKNDLIAKVDELSSEQEVLREELESVKQSKTKVDQRVKELEEELKRLRAEALGASQDSKDEGGEDYSSPLQDDVTMTQRRRFTRVEMARVLMERNQYKERLMELQEAVRWTEMIRASRESPPLPEKKKSIIWQFFARLFSSSASPPPVKRPYTSVNIHYKSPSPAGYNQRRSQTMCQISTSTCIREFLPEDDSALCTRREQRREQYRQVREHMRRKDGPMQTCGWSVPSRLKQNGCQADSAPDATAKRNQATEKEDNRMKNVPVPVYCRPLVEKDPNRKLWCAAGVDLTGWKTSSQEAASVKPSNGSDPLTAENEGGDGKSEQSSPEKKKPKELHETDPVSSRVWILTSTHSASKVVIIDANLPCSLVDQFNVCNAHVLCISSVPAASESDYPAGEIFLEQQAGDGASEEKGGVEGMLAGITIVGCATNCSVVRSNCSSRTDTPVQDRSNAPTAPVCRSLAVSQSAEEATEAIEVTEEAGPSENADSTLGSFTEHVFTDNTHSEPGVAKEKVSSAPADSEEAADERAGTSAAPTMWLGAQNGWLYVHSAVSNWKKCLHSIKLKDSVLSLVHVKGRVLVALADGTLAIFHRSEDGQWDLSNYHLMDLGRPHHSIRCMAVVHDKVWCGNKNKIHVIQPKSMQIEKSFDAHPRKESQVRQLAWIGDGVWVSIRLDSTLRLYHAHTHQHLQDVDIEPYVSKMLGTGKLGFSFVRITALLIGGNRLWVGTGNGVIISIPLTETVVLHRGQLLGLRANKVSPTSSGGVIHVYADDSTSEKSSFIPYCSMAQAQLCFHGHRDAVKFFVSVPGNVLATLNGSVLDSPSESQGSSAPAETEAQSLQNVLVLSGGEGYIDFRIGDGEDDETEEADDDEAPQMKPALSKAERSHIIVWQVSYVPE,,in utero embryonic development (GO:0001701) (0.6389); JNK cascade (GO:0007254) (0.5290); respiratory gaseous exchange by respiratory system (GO:0007585) (0.4725); axon guidance (GO:0007411) (0.3983); post-embryonic development (GO:0009791) (0.2935); regulation of gene expression (GO:0010468) (0.2839); striated muscle cell differentiation (GO:0051146) (0.2708); vesicle-mediated transport (GO:0016192) (0.1452); negative regulation of dendrite extension (GO:1903860) (0.1121); regulation of JNK cascade (GO:0046328) (0.1033); lung alveolus development (GO:0048286) (0.1018); negative regulation of apoptotic process (GO:0043066) (0.1003); positive regulation of neuron differentiation (GO:0045666) (0.0881); lysosome localization (GO:0032418) (0.0782); axo-dendritic transport (GO:0008088) (0.0564),dendrite (GO:0030425) (0.2583); cytoplasm (GO:0005737) (0.2175); centriolar satellite (GO:0034451) (0.1758); cytosol (GO:0005829) (0.1725); axon cytoplasm (GO:1904115) (0.1454); neuron projection (GO:0043005) (0.1191); lysosomal membrane (GO:0005765) (0.1077); cell body (GO:0044297) (0.0998),JUN kinase binding (GO:0008432) (0.1321),"RH1 domain (IPR034743) (0.2788); WD40/YVTN repeat-like-containing domain superfamily (IPR015943) (0.2348); WD40-repeat-containing domain superfamily (IPR036322) (0.1963); JNK-interacting protein, leucine zipper II (IPR032486) (0.1486); RH2 domain (IPR034744) (0.1435); JNK-interacting protein 3/4 (IPR039911) (0.1012)",1.20.5.1000 (0.4703); 2.130.10.10 (0.2374),Reference proteome (0.4779); Coiled coil (0.2880); Cytoplasm (0.1038),
MPQLNGGGGDDLGANDEMISFKDEGEQEEKISENSSAERDLADVKSSLVNESETNQNSSSDSEAERRPPPRSESFRDKTRESLEEAAKRQDGGLFKSPPYPGYPFIMIPDLTSPYLPNGSLSPTARTYLQMKWPLLDVQAGSLQSRQALKDARSPSPAHIVSNKVPVVQHPHHVHPLTPLITYSNEHFTPGNPPPHLQADVDPKTGIPRPPHPPDISPYYPLSPGTVGQIPHPLGWLVPQQGQPVYPITTGGFRHPYPTALTVNASMSSLLSSRFPPHMVPPHHSLHTTGIPHPAIVTPNVKQESSHSDIGSLNSSKHQDAKKEEEKKKQPHIKKPLNAFMLYMKEMRAKVVAECTLKESAAINQILGRRWHALSREEQAKYYELARKERQLHMQLYPGWSARDNYGKKKKRKREKQAGEGNEHREYFPNPCLSLPPITDLSAPKKCRARFGLDQQNNWCGPCSPNLLSFCSNTSSL,,fin morphogenesis (GO:0033334) (0.4709); regulation of transcription by RNA polymerase II (GO:0006357) (0.3318); positive regulation of gene expression (GO:0010628) (0.2486); neural crest cell migration (GO:0001755) (0.2391); forebrain neuron differentiation (GO:0021879) (0.2329); somitogenesis (GO:0001756) (0.2084); pectoral fin development (GO:0033339) (0.1991); negative regulation of transcription by RNA polymerase II (GO:0000122) (0.1319); Wnt signaling pathway (GO:0016055) (0.1169); canonical Wnt signaling pathway (GO:0060070) (0.1031); hypothalamus cell differentiation (GO:0021979) (0.1018); posterior lateral line neuromast deposition (GO:0048922) (0.0888); regulation of DNA-templated transcription (GO:0006355) (0.0799); fin regeneration (GO:0031101) (0.0694); animal organ development (GO:0048513) (0.0569),beta-catenin-TCF complex (GO:1990907) (0.3021); nucleus (GO:0005634) (0.0675),"DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981) (0.1298); RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978) (0.1135)","CTNNB1 binding, N-teminal (IPR013558) (0.4529); Catenin binding domain superfamily (IPR027397) (0.3785); Transcription factor TCF/LEF (IPR024940) (0.2971); High mobility group box domain (IPR009071) (0.1498)",4.10.900.10 (0.6025); 1.10.30.10 (0.0746),Wnt signaling pathway (0.9822); Transcription (0.9386); Transcription regulation (0.6957); Reference proteome (0.5721); DNA-binding (0.3972); Nucleus (0.2790); Activator (0.2694); Repressor (0.1354),
MAADSTMSNGQETACLNGEPALKRSRDSLDSLRVPREPQNKVTVVLGAQWGDEGKGKVVDLLAMDADIVCRCQGGNNAGHTVVVDSVEYDFHLLPSGVLNKKATSFIGNGVVIHLPGLFDEAEKNLQKGNGLQGWEERLKISDRAHIVFNFHQAVDGIQEQLRQQQAGKNLGTTKKGIGPAYSSKAARNGLRVCDLVSDFSVFEEKFRVLAGHYQTTYPNLNIDIDAELQQLKNFAERLRPLVTDGVYFMHKALTGPSKKILVEGANAALLDIDFGTYPFVTSSNCTVGGVCTGLGVPPSHVGRVYGVVKAYTTRVGVGAFPTEQNNEIGDLLQSRGREFGVTTGRRRRCGWLDLVLVRYAHMVNGFSAIALTKLDILDTLPEIKIGTAYTVDGKPLPSFPANMDVLTKVQVTYETFPGWSCSTEGVRSFDELPTQAQSYIKFIEDFLQVPVKWVGVGKSRESMIKLF,adenylosuccinate synthase (6.3.4.4) (0.9991),'de novo' AMP biosynthetic process (GO:0044208) (0.6480); IMP metabolic process (GO:0046040) (0.3910); purine nucleotide biosynthetic process (GO:0006164) (0.1951); AMP biosynthetic process (GO:0006167) (0.1450); muscle cell cellular homeostasis (GO:0046716) (0.1279); cellular response to electrical stimulus (GO:0071257) (0.1225); response to ammonium ion (GO:0060359) (0.0969),cytoplasm (GO:0005737) (0.3209),GTP binding (GO:0005525) (0.2837); magnesium ion binding (GO:0000287) (0.1753),"Adenylosuccinate synthase, GTP-binding site (IPR018220) (0.5951); Adenylosuccinate synthetase, domain 2 (IPR042110) (0.2893); Adenylosuccinate synthetase (IPR001114) (0.2858); Adenylosuccinate synthetase, domain 3 (IPR042111) (0.1332); Adenylosuccinate synthase, active site (IPR033128) (0.1223); P-loop containing nucleoside triphosphate hydrolase (IPR027417) (0.0995)",1.10.300.10 (0.3484); 3.90.170.10 (0.2593); 3.40.440.10 (0.1638),Purine biosynthesis (0.6270); Nucleotide-binding (0.6070); Magnesium (0.4742); Cytoplasm (0.3655); Ligase (0.3053); Reference proteome (0.2944); GTP-binding (0.2865); Proteomics identification (0.1547); Metal-binding (0.1478),Mg(2+) (0.3430)
MRDGLTGLCIGIILLLNGGLVVMRRQDSSSALGSIFRTRCAARCLSLHSTRIALSPRHFQSNGSLGWCQSHKQCAKCLEPCKDSWELKDGPCRDLCEHAFPKRHGECVTSCEFLRSVMVVKQGDCPPPERASGFAAACVEGCEEDGECSGQKKCCPNGCGHTCQSPKNLYRGAPLKPRKELVFEELESGVLEVRWSSKFNVSAEPVLNVLQRRWNYGIHPSEDGATEWQVVARTSEERVWLTDIRPGRWYQFRVAAVNVHGTRGYTTPSRHFRSSKDPPPPPAPSDLHVSDMTFGADHSASVRLSWSISADLDIPVNHYKLSWSSSDHTLPPKLKKRETVNGDSTYAELDDLRENGSYTVELQAVSYWGQVPLKSSKAILQFTTSQTQSDLEPTVSPVFIKPQSDLLDVGTPFYQDGQLQVRVYWKKKDPTVNRYRVQWAPEFCSHNRSRTQEKLITQENFASLSGLQFSCKYKVIIQPVGLKGRAQVESTTFYTPSCATIQSKSPKPIPCSSVPVVQPKVLVKAENLTAAFSVYLGNVTGLFSWVVAMPQQPQQVTGYQVTWAEVITESRRNNLPNSLISQSQILPPERNILVVSGLQLASLYRLEVQVITAAGQGPATSRTFQTPTHSKPVLHYKPRIKKHHLRSVIERH,,regulation of cell growth (GO:0001558) (0.5382); negative regulation of peptidase activity (GO:0010466) (0.4308); neuron differentiation (GO:0030182) (0.3760); signal transduction (GO:0007165) (0.1602); axon guidance (GO:0007411) (0.1216); neuron migration (GO:0001764) (0.1113),extracellular region (GO:0005576) (0.5271); extracellular matrix (GO:0031012) (0.3405); cell surface (GO:0009986) (0.3296),serine-type endopeptidase inhibitor activity (GO:0004867) (0.2528); peptidase inhibitor activity (GO:0030414) (0.1433),"Anosmin-1, cysteine rich domain (IPR040957) (0.5027); Anosmin-1 (IPR042447) (0.4169); Fibronectin type III (IPR003961) (0.3268); Immunoglobulin-like fold (IPR013783) (0.2525); Fibronectin type III superfamily (IPR036116) (0.2282); WAP-type 'four-disulfide core' domain (IPR008197) (0.2096); Elafin-like superfamily (IPR036645) (0.2073)",4.10.75.10 (0.4129); 2.60.40.10 (0.2917),Reference proteome (0.4985); Glycoprotein (0.4753); Secreted (0.4433); Proteomics identification (0.2641); Signal (0.2601); Membrane (0.1413); Disulfide bond (0.0578); Protease inhibitor (0.0462),
MSYPGYPPAGGSYPPASGPYQQPAAGYPPQPGAYPPQAGYYPPQPGAFPPQPGAFPPQPGAFPPGAGYPPQAGGYPAAPGGGFPPQAGGYPAAQPGAYPNMPAAGGWGGHPGFGAPAGGMPQGYPGVPAPGQQPMPAYPGAPVPNPGMPGYGGGAPTGPTPPAPAINRGFRGTIKDFPGADPLRDVEVLRKAMKGFGTDENAIIELLGSRSNKQRVPLLAAYKTTYGKDLVRDLKSELTGHFEELVLAMLKSPAQFDASECKEAISGAGTDEACLIEILSSRSNAEIQEINRIYKAEYGKSLEDAISNDTSGHFRRLLVSLCQGNRDERETVDISLAKQDAQKLYSAGENKVGTDESQFNAILCARSKPHLRQVFQEYQQMCGRDIEKSICREMSGDLESGMVAVVKCIKNTPAYFAERLHKAMQGAGTKDRTLIRIMVSRSELDMLDIRQEYLRLFGKSLYTHISGDTSGDYKKLLLKLCGGSD,,phagocytosis (GO:0006909) (0.6755); cytokinetic process (GO:0032506) (0.6366); response to calcium ion (GO:0051592) (0.4612); epithelial cell differentiation (GO:0030855) (0.1154); blood coagulation (GO:0007596) (0.0535),nuclear envelope (GO:0005635) (0.5442); vesicle membrane (GO:0012506) (0.3529); midbody (GO:0030496) (0.2917); cytoplasm (GO:0005737) (0.2595); spindle (GO:0005819) (0.1773); plasma membrane (GO:0005886) (0.1712); nucleus (GO:0005634) (0.1535),calcium-dependent phospholipid binding (GO:0005544) (0.2753); S100 protein binding (GO:0044548) (0.1765); phosphatidylserine binding (GO:0001786) (0.1354); calcium-dependent protein binding (GO:0048306) (0.1278); phosphatidylethanolamine binding (GO:0008429) (0.1194),"Annexin repeat, conserved site (IPR018252) (0.2459); Annexin superfamily (IPR037104) (0.2283); Annexin repeat (IPR018502) (0.1595); Annexin (IPR001464) (0.1375)",,Reference proteome (0.5264); Calcium (0.3074); Annexin (0.2783); Calcium/phospholipid-binding (0.2534); Cytoplasm (0.1570); Repeat (0.1040); Proteomics identification (0.0854),
MFPRSGKSIIFDSFPDPSDTWEIIETIGKGTYGKVYKVHNKVDGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFFGMFYKKDVKTGDQLWLVLELCNGGSVTDLAKGMLKRGDRMEEPIIAFILHEALMGLQHLHVNKTIHRDVKGNNILLTTDGGIKLVDFGVSAQLTNTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDERCDVWSLGITAIELGDGDPPLAELHPMRALFKIPRNPPPTLHQPELWSNDFNDFIRKCLIKDFELRPNVLDLLQHVFIKQIVGREKTLQKQLMELIDLNQQMGIIEKTSLLGKSDRDSDSRHERIHTKKNSYMKSQSQTCDDADDLATLEVLDENTITEQLQRRYTKEQIYTYVGDILIAVNPFHKTELYTPEHTKSYVGAKRTSNPPHIYAVADIAYQSMVSYNADQCIVISGESGAGKTESAHLLVQQLTVLGKANNRTLQEKILLVNSLVEAFGNACTVINDNSSRFGKYLEMKFTCGGTVVGAQISDYLLEKSRVVHHAVGERNFHIFYYIYAGLAERKKLGHYKLSDSKTPRYLHNENVKLVPDIVGNAFYKEQFETVEQCFKVIGFTLEELGSVYGILAGILNTGDVEFTSVASEHQTDKSNISNMAVLESAASLLCIRADELQEALTSHCVVTRGETIVRSNTVEKATEVRDAMGKALYGRLFSWIVNRINSLLKPDNQSGEDDKGLNIGILDIFGFENFKRNSFEQLCINIANEQIQFYFNQHIFAWEQDEYLNEDVDARVIEYEDNRPLLDLFLQKPMGMLSLLDEESRFPQATDQTLVEKFEDNLKSKNFWRPKRVDLGFGIHHYAGKVIYNAGGFLAKNRDALPADIVLLLRSSENELTRKLVTHPLTKTGNLAHTKGKAVGSARMGTQQSQRFAKLDCLLLFSSVSFSESSSRKLTPPIDKSMLALPVDSVQTTESTGDTTHHPRETTNMKTQTVASYFRYSLMDLLSKMVAGQPHFVRCIKPNNDRQAHKFDREKVLIQLRYTGILETAKIRRQGYSHRILFNNFIERYSILAFRANEEPAISPETCAVILEKAKLENWILGKTKVFLKYYHVEQLNLMVRQTTDRIVLVQAYVRGWMAFKRYCLLKEKREQSAVVLQSAYRGHKARKSIADDRSKAKSEIVFTQLQAWCRGYLARQNYKELLDEKNKAAAKIQAHYRGQKERKSFQRKKEAMQKENTEKTERVTEVPLEADDPVSEEPLQEGGEVEMDDADEKAAVVLQSNYRGYRERKKFKERQERNKTLSGDELDASSSTPEEMTSGEDLEATREDTQENVEKEGNEVEEGGGDEDPEQEAKAATVLQSNFRGHKERKRLQEEGKIPVRGKKEIKSPTDEEELPIPDPPPPEELMEFSEEMEFTEENPPGEEDEAKAAVVLQSNFRGHKERKRLQEEGKIPKKKTKEEMDDPGASEPDIAIEELPPPPLELEHDQELDSSPSGGDEEHAATVLQSNFRGHRERKRLRAEKEEATGGGQSTGDVEEQENNDVLDITDVQLERREEEEEGQYDEEQAAIKIQSNFRGYKDRKNLKATSQKQDEEVESLFKQVSKASEDYLSLQKKLNEIILAHQLNPSKNGMFVKGQPMNGYMGYYQPPADTKQSRTPRRAQQPKTLNTPEDSTYYTLIHRSVQDDKRRPRKQSPKKLDNDDQYYQGLSSSKSTSLPNERRRSSKRRASDERRSSERPLSDVPKSEIPKDPLEKRHSFSKMPSTESQSEDNPYDYRKILRKTSQRRRLITQP,non-specific serine/threonine protein kinase (2.7.11.1) (0.9219),protein phosphorylation (GO:0006468) (0.4347); system development (GO:0048731) (0.2759); sensory perception of sound (GO:0007605) (0.0855),myosin complex (GO:0016459) (0.6164); cytoplasm (GO:0005737) (0.4103); cell projection (GO:0042995) (0.1516),protein serine/threonine kinase activity (GO:0004674) (0.4549); ATP binding (GO:0005524) (0.4461); actin binding (GO:0003779) (0.4257); cytoskeletal motor activity (GO:0003774) (0.1705); microfilament motor activity (GO:0000146) (0.1166),"IQ motif, EF-hand binding site (IPR000048) (0.3422); Protein kinase domain (IPR000719) (0.1637); Myosin head, motor domain (IPR001609) (0.1507)",1.20.120.720 (0.2587); 1.20.5.190 (0.2475); 1.20.58.530 (0.2202); 6.20.240.20 (0.1569),Vision (0.8315); Nucleotide-binding (0.6512); Serine/threonine-protein kinase (0.5596); Cell projection (0.3973); Cytoskeleton (0.3869); Motor protein (0.3416); Cytoplasm (0.3193); Kinase (0.2624); ATP-binding (0.2527); Actin-binding (0.2065); Sensory transduction (0.1987); Reference proteome (0.1499); Transferase (0.1392); Myosin (0.1331),
MDSTVLEAERGAAAIKSQFLTSKEKFHEFLSSGRSSQKNEEDPDGGEPEKKKIRLENEGETAEQEKKKIKMRGQNKSRPHVKPHTYEDKRLCTSIIQERDSVCPYGEKCRFLHDVSEYLSTKAADLGDQCHLFNTLGKCPYGLTCRYAKAHTSADLKNMVNTELYRASAGRENTTNLLDKELQKRLRKKQQRFPGADAFLKSISRAPRPEHNSREQREKHEDQRQKHEEQREQTDEQSKNTEDQTQTNNQRENANIQSKNTEDQRQSVEDPSKNGSDSANRRETQVPPIKTIGPITDADIIKLRPCEKKQVDFRDKLYLAPLTTCGNLPFRRVCKRFGADITCGEMAMCTNLLQGQASEWALLKRHASEDLFGVQLEGCFPDTMTRCAELLNQNIDVDFVDINSGCPIDLVYKKGGGCGLMTRTSKFEQIVRGMNSVLDVPLTVKIRTGVQQNSNIAHKLIPEMKKWGVSLITLHGRSREQRYTKLADWDYINTCAQLAAPVPLFGNGDILSYEDAMKARETGVSGIMVARGALIKPWLFTEIKETRHWDISSTERLDILRDFTHFGLEHWGSDTQGVEKTRNFLLEWLSFLCRYIPVGLLERVPQRINERPPFYMGRDYLETLMASQHVDDWIQISEMLLGPVPKNFSFLPKHKANAYK,1.3.1.- (0.9887); tRNA-dihydrouridine47 synthase [NAD(P)+] (1.3.1.89) (0.8759),mRNA processing (GO:0006397) (0.4618); tRNA dihydrouridine synthesis (GO:0002943) (0.4081); regulation of translation (GO:0006417) (0.3760),cytoplasm (GO:0005737) (0.2748); nucleus (GO:0005634) (0.1139),metal ion binding (GO:0046872) (0.7473); mRNA dihydrouridine synthase activity (GO:0106414) (0.3841); tRNA dihydrouridine synthase activity (GO:0017150) (0.2122); tRNA-dihydrouridine47 synthase activity (GO:0102265) (0.1770); flavin adenine dinucleotide binding (GO:0050660) (0.1437),"tRNA-dihydrouridine synthase, conserved site (IPR018517) (0.5272); DUS-like, FMN-binding domain (IPR035587) (0.4546); Zinc finger, CCCH-type (IPR000571) (0.4031); Aldolase-type TIM barrel (IPR013785) (0.3171)",3.20.20.70 (0.5989); 4.10.1000.10 (0.1913),tRNA processing (0.9979); Zinc-finger (0.9746); NAD (0.6948); Oxidoreductase (0.5567); Reference proteome (0.4838); Zinc (0.4131); FMN (0.3953); Flavoprotein (0.3074); NADP (0.3040); Repeat (0.2594); Metal-binding (0.2281); Ubl conjugation (0.2036); Proteomics identification (0.1201),FMN (0.3953)
MGLNNDPNFIKLEQWYKSSAGNLNMRQMFEADADRFNKFSLQLSTDDGDLLLDFSKNLINEDVMSLLFDMARSVGVEAAREQMFAGEKINFTEGRAVLHTALRNRSNTPIIVDGKDVMPEVNRVLEQMKSFCHKVRSGAWKGFSGKSITDVVNIGIGGSDLGPLMVTEALKPYSKGGPNVWFVSNIDGTHMAKTLAQLNAETTLFIIASKTFTTQETITNAETAREWFLQAAKDKSAVAKHFVALSTNAPKVKEFGIDTNNMFEFWDWVGGRYSLWSAIGLSIALHIGFDNFEQLLSGAHWMDNHFRSAPLEQNAPVILALLGVWYVNFFQAETHALLPYDQYMHRFAAYFQQGDMESNGKYITKSGTRVNYHTGPIVWGEPGTNGQHAFYQLIHQGTRLIPADFLIPAQSQHPIRDNLHHKILMANFLAQTEALMRGKTSDEAKKELQASGLSGDSLEKLLPHKVFQGNKPSNSIIFKKLTPFMLGALVAMYEHKIFVQGVMWNINSYDQWGVELGKQLAKKIEPELQDDAEVHSHDSSTNGLIGFFKKNRF,glucose-6-phosphate isomerase (5.3.1.9) (0.9256),gluconeogenesis (GO:0006094) (0.6476); positive regulation of immunoglobulin production (GO:0002639) (0.3850); glucose 6-phosphate metabolic process (GO:0051156) (0.3448); glycolytic process (GO:0006096) (0.2550); fructose 6-phosphate metabolic process (GO:0006002) (0.2044); positive regulation of endothelial cell migration (GO:0010595) (0.1211); canonical glycolysis (GO:0061621) (0.1082),extracellular space (GO:0005615) (0.1019); cytosol (GO:0005829) (0.0813),glucose-6-phosphate isomerase activity (GO:0004347) (0.3524); cytokine activity (GO:0005125) (0.2861); monosaccharide binding (GO:0048029) (0.1519),"Phosphoglucose isomerase (PGI) (IPR001672) (0.2961); Phosphoglucose isomerase, conserved site (IPR018189) (0.2095); SIS domain superfamily (IPR046348) (0.1677); Phosphoglucose isomerase, SIS domain 1 (IPR035476) (0.1594); Phosphoglucose isomerase, SIS domain 2 (IPR035482) (0.1300)",1.10.1390.10 (0.6023),Gluconeogenesis (0.5517); Cytoplasm (0.1843); Glycolysis (0.1370),
MSDMGKKKLFVLVDVMCVVVASLPFVAMTIASHPYERGIFCQDESIGYPVKTDTITNVTLAAVTITCTILIICSGEAYLVYSKKIHSNSSFNQYVSAIYKVLGAFLFGGAVSQSLTDLAKYTIGRPRPNFLAVCAPKVCKGFVNLNNCTGNPADVTEARLSFYSGHSSFAMYCMLFLAFYVQARLNAKWARLLRPTIQFFLVAFAVYVGYTRVSDYKHHWSDVMVGLLQGALIAILTVRFVSNFFKVSPSPECSNQENAVNEERKPSNSYRYSGPV,phosphatidate phosphatase (3.1.3.4) (0.8845); diacylglycerol diphosphate phosphatase (3.6.1.75) (0.4696); 3.1.3.- (0.4652); 2-lysophosphatidate phosphatase (3.1.3.106) (0.3805),sphingosine metabolic process (GO:0006670) (0.8367); phospholipid dephosphorylation (GO:0046839) (0.7803); ceramide metabolic process (GO:0006672) (0.6033); phospholipid metabolic process (GO:0006644) (0.5597); signal transduction (GO:0007165) (0.2772),membrane raft (GO:0045121) (0.1722); membrane (GO:0016020) (0.1702); caveola (GO:0005901) (0.1368); apical plasma membrane (GO:0016324) (0.1103),phosphatidate phosphatase activity (GO:0008195) (0.3868); sphingosine-1-phosphate phosphatase activity (GO:0042392) (0.2732); diacylglycerol diphosphate phosphatase activity (GO:0000810) (0.0996); ceramide-1-phosphate phosphatase activity (GO:0106235) (0.0791),Phosphatidic acid phosphatase type 2/haloperoxidase superfamily (IPR036938) (0.2946); Phosphatidate (PA) phosphatase-related (IPR043216) (0.2457); Phosphatidic acid phosphatase type 2/haloperoxidase (IPR000326) (0.2136),1.20.144.10 (0.1595),Lipid metabolism (0.4315); Reference proteome (0.3862); Membrane (0.3834); Transmembrane (0.3315),
MKLFIGEGNPHCLKVLAALELSGVRCETQLVKHEEKVVPYLTHPVLPILQLPSGQHLFSPNSICQYLFDISGQKATDATNQWLEWEATNLQPAVLQSLQLVALQGKRVEAAAVMKEPLSWLEQSLSKRKASFLTDEVVSVADVVLWAALYPLLSDSAFEPGDLQAVRGWFERVCSVSACQSAALRVLQGKGAEALKSFLQKQPVTHTPRRDSPSNSTEAEDSERELSPEEIEEAAQVYSEGLKDFTVVTERKHPVLPQEGKRNVLITSALPYVNNVPHLGNIIGCVLSADVFARYGRLRGWNLLYICGTDEYGTATENKAREEGLTPQQICDKYHCIHASIYQWFQIDFDFFGRTTTQHQTEIAQDIFWRLHERGFLLEDTVEQLRCEGCQRFLADRFVEGECPHCRYPEARGDQCDKCGRLINAVELKNPQCKVCKETPVIRSSKHLFLNLPKLEQDLEQWLQTSTAAGDWTTNARHITRSWLRDGLKPRCITRDLKWGTPVPHPDYKEKVFYVWFDAPIGYLSITANYTDQWERWWKNPQQVELYNFMAKDNVPFHSVVFPCSLLGAQDNYTLVNNLIATEYLNYEDTKFSKSRGVGVFGDMAKDTGIPSDVWRFYLLYLRPEGQDSAFSWTDMALKNNSELLNNLGNFINRAGMFVSKFFDGCVPEMLLNDDDKRLIAQVCWELKQYIQLLDKVRIRDALKCILNMSRHGNQYIQLNEPWKKIKGGAEDRCRAGTVTGVSVNVACLLAAVLEPFMPTVSLSIRSQLQAPESSSRAMLSGPGAFICTLPAGHRIGTVSPLFQKLENEQIEALRKRFGGLQPEEESAGLKTPSNSSVAVESKPNAGAAQHTPASVTADPERAKQLTALVAEQGEKVRALKAQKAEKSAIGVEVAKLLDLKNQLCLAEGKTPEPPAQKTKKK,methionine-tRNA ligase (6.1.1.10) (0.9971),methionyl-tRNA aminoacylation (GO:0006431) (0.9963),cytosol (GO:0005829) (0.9651); aminoacyl-tRNA synthetase multienzyme complex (GO:0017101) (0.4849),methionine-tRNA ligase activity (GO:0004825) (0.7295); ATP binding (GO:0005524) (0.7119),"uS15/NS1, RNA-binding domain superfamily (IPR009068) (0.8239); WHEP-TRS domain (IPR000738) (0.4752); Aminoacyl-tRNA synthetase, class I, conserved site (IPR001412) (0.4718); Methionyl/Leucyl tRNA synthetase (IPR015413) (0.4710); Methionyl-tRNA synthetase, anticodon-binding domain (IPR041872) (0.4544); Thioredoxin-like superfamily (IPR036249) (0.4021); Aminoacyl-tRNA synthetase, class Ia, anticodon-binding (IPR009080) (0.3992); Glutathione S-transferase, C-terminal-like (IPR010987) (0.3968); Rossmann-like alpha/beta/alpha sandwich fold (IPR014729) (0.3523); Methionine--tRNA ligase, N-terminal (IPR041598) (0.3079); Glutathione S-transferase, C-terminal domain superfamily (IPR036282) (0.2511); Methionyl-tRNA synthetase (IPR014758) (0.1377); Glutathione S-transferase, C-terminal (IPR004046) (0.1165)",3.40.50.620 (0.5257); 3.40.30.10 (0.4794); 2.20.28.20 (0.3735); 1.10.287.10 (0.2425); 1.20.1050.10 (0.1690),Reference proteome (0.7402); Nucleotide-binding (0.5138); Aminoacyl-tRNA synthetase (0.3701); Ligase (0.3686); Protein biosynthesis (0.3582); ATP-binding (0.3510); Proteomics identification (0.1474),
MSIFTPTNQIRLTNVAVVRMKKGGKRFEIACYKNKVMSWRSGAEKDLDEVLQTNTVFVNVSKGQVAKKEDLSNAFGTDDLTEICKQILSKGELQVSDKERQSQLEQMFRDIATIVAEKCVNPETKRPYTVNLIERAMKDIHFSVKANKSTKQQALEVIKQLKESIQIQRAHMRLRFVLPAKDGKRLKEKLKPLIKAVENEDFDDQLEMVCLIDPGCFRDIDELIRCETKGKGTLEVLSLKDVEEGDEKLE,,rRNA processing (GO:0006364) (0.6231); leukocyte chemotaxis (GO:0030595) (0.4649); mitotic spindle organization (GO:0007052) (0.4440); bone mineralization (GO:0030282) (0.3059); hematopoietic progenitor cell differentiation (GO:0002244) (0.3007); inner cell mass cell proliferation (GO:0001833) (0.2844); cytosolic ribosome assembly (GO:0042256) (0.2420); bone marrow development (GO:0048539) (0.1634); translation (GO:0006412) (0.0766),spindle pole (GO:0000922) (0.4598); cytosol (GO:0005829) (0.2852); nucleolus (GO:0005730) (0.2845); nucleoplasm (GO:0005654) (0.1895),rRNA binding (GO:0019843) (0.2266),"Ribosome maturation protein SDO1/SBDS, C-terminal domain (IPR046928) (0.4688); Ribosome maturation protein Sdo1/SBDS-like (IPR039100) (0.4208); Ribosome maturation protein SBDS, conserved site (IPR018023) (0.3777); Ribosome maturation protein Sdo1/SBDS, central domain superfamily (IPR037188) (0.3303); Ribosome maturation protein SDO1/SBDS, central domain (IPR018978) (0.3140); Ribosome maturation protein Sdo1/SBDS (IPR002140) (0.2859)",1.10.10.900 (0.3462); 3.30.70.240 (0.2938); 3.30.1250.10 (0.2454),Ribosome biogenesis (0.9798); Reference proteome (0.3937); Nucleus (0.3220); Acetylation (0.2000); Cytoplasm (0.1808); Proteomics identification (0.1689); Protein transport (0.1492); Cytoskeleton (0.1184),
MYLELSFCTMVIMEVPTIDSASLRDMLEGDDPDCLVLDCRSFFSFSVSHISGSSNVRFSTIVRRRARGGLGLEHIVPNEDTRNRLLSGEYQSVVFLDDHSLEMGEVKKDGTLMLAVNALCRKQCGASVYLLKGGFDTFSAEFPEKCTKTVPPQGLSLPLSSNCHSNTADSSCNTCTTPLYDQGGPVEILPFLYLGSAYHASRKDMLDMLGITALINVSSNCPNHFEDHYQYKSIPVEDNHKANISSWFNEAIEFIDSVRNKGGRVFVHCQAGISRSATICLAYLMRTNRVKLEEAFEFVKQRRSIISPNFSFMGQLLQFESQVLASSTCSSEAGSPAIGKNSTVFNFPVHTAASPLSFLQSPITTSPSC,protein-serine/threonine phosphatase (3.1.3.16) (0.9452); protein-tyrosine-phosphatase (3.1.3.48) (0.7323),endoderm formation (GO:0001706) (0.6896); cellular response to chemokine (GO:1990869) (0.4341); peptidyl-threonine dephosphorylation (GO:0035970) (0.4234); protein dephosphorylation (GO:0006470) (0.4189); negative regulation of cell adhesion (GO:0007162) (0.2081); negative regulation of MAP kinase activity (GO:0043407) (0.1913); negative regulation of p38MAPK cascade (GO:1903753) (0.1797); negative regulation of cell population proliferation (GO:0008285) (0.1553); peptidyl-serine dephosphorylation (GO:0070262) (0.1276); negative regulation of monocyte chemotaxis (GO:0090027) (0.1071); negative regulation of meiotic cell cycle (GO:0051447) (0.0899); negative regulation of MAPK cascade (GO:0043409) (0.0786),cytoplasm (GO:0005737) (0.2490),myosin phosphatase activity (GO:0017018) (0.3067); MAP kinase tyrosine phosphatase activity (GO:0033550) (0.2136); MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017) (0.1656); protein tyrosine/threonine phosphatase activity (GO:0008330) (0.1282),"Dual specificity protein phosphatase domain (IPR020422) (0.5127); Protein-tyrosine phosphatase-like (IPR029021) (0.3618); Rhodanese-like domain superfamily (IPR036873) (0.2585); Dual specificity phosphatase, catalytic domain (IPR000340) (0.2350); Mitogen-activated protein (MAP) kinase phosphatase (IPR008343) (0.2349); Tyrosine-specific protein phosphatases domain (IPR000387) (0.2251); Protein-tyrosine phosphatase, active site (IPR016130) (0.2132); Rhodanese-like domain (IPR001763) (0.1857)",3.40.250.10 (0.4000); 3.90.190.10 (0.3687),Hydrolase (0.2705); Nucleus (0.2467); Tyrosine-protein kinase (0.1770); Reference proteome (0.1586),
MATAPYNYSYIFKYIIIGDMGVGKSCLLHQFTEKKFMADCPHTIGVEFGTRIMEVSGQKIKLQIWDTAGQERFRAVTRSYYRGAAGALMVYDITRRSTYNHLSSWLTDARNLTNPNTVIILIGNKADLEAQRDVTYEEAKQFAEENGLLFLEASAKTGENVEDAFLEAAKKIYQNIQDGSLDLNAAESGVQHKPSAPQGGRLTSETQPQREGCGC,small monomeric GTPase (3.6.5.2) (0.6331),Golgi to endosome transport (GO:0006895) (0.8439); defense response to bacterium (GO:0042742) (0.2418); intracellular protein transport (GO:0006886) (0.2158); endocytic recycling (GO:0032456) (0.2139); phagosome maturation (GO:0090382) (0.1989); early endosome to Golgi transport (GO:0034498) (0.1562); endosomal vesicle fusion (GO:0034058) (0.1348); phagolysosome assembly involved in apoptotic cell clearance (GO:0090387) (0.1033); vesicle-mediated transport (GO:0016192) (0.0598),phagocytic vesicle (GO:0045335) (0.3157); early endosome membrane (GO:0031901) (0.2924); trans-Golgi network (GO:0005802) (0.2719); cytosol (GO:0005829) (0.2093); recycling endosome (GO:0055037) (0.2046); early endosome (GO:0005769) (0.1441),GTPase activity (GO:0003924) (0.2668); GTP binding (GO:0005525) (0.1506),Ras-related protein Rab14 (IPR030702) (0.6117); Rab GTPases family involved in membrane trafficking (IPR050209) (0.2888); P-loop containing nucleoside triphosphate hydrolase (IPR027417) (0.1293),3.40.50.300 (0.1365),Reference proteome (0.4444); Prenylation (0.2571); Nucleotide-binding (0.2361); Endosome (0.2359); Methylation (0.1353); Lipoprotein (0.1207),
MWTYIFVIYVILQSQSSASTCEWLGRYRIITTESLNLLKNMGGKYADLETPFPSRLYTLMDKSKVEDQVKFLVLTLDHIIHLMDAREHMNSVNWDQNTVEDFLNILHRKSSDLKECVARYAKPAHKESYEIRIKRHFRTLKKILKKKQYSAEAWEQIRRVVKSHLQRMDIIASNARVNPRV,,T cell activation involved in immune response (GO:0002286) (0.4420); B cell differentiation (GO:0030183) (0.3305); positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427) (0.3192); cytokine-mediated signaling pathway (GO:0019221) (0.2590); cellular response to virus (GO:0098586) (0.2145); adaptive immune response (GO:0002250) (0.2066); positive regulation of protein phosphorylation (GO:0001934) (0.2034); natural killer cell activation involved in immune response (GO:0002323) (0.1871); negative regulation of cell population proliferation (GO:0008285) (0.1556); humoral immune response (GO:0006959) (0.1519); defense response to virus (GO:0051607) (0.1509); positive regulation of gene expression (GO:0010628) (0.1432); immune response (GO:0006955) (0.1224); positive regulation of DNA-templated transcription (GO:0045893) (0.1204); positive regulation of autophagy (GO:0010508) (0.0854); regulation of DNA-templated transcription (GO:0006355) (0.0727); defense response to bacterium (GO:0042742) (0.0719); protein catabolic process (GO:0030163) (0.0700); cell surface receptor signaling pathway (GO:0007166) (0.0615); response to virus (GO:0009615) (0.0438),extracellular space (GO:0005615) (0.7541); extracellular region (GO:0005576) (0.0964),cytokine receptor binding (GO:0005126) (0.2711),Interferon alpha/beta/delta (IPR000471) (0.5754),1.20.1250.10 (0.2565),Secreted (0.9569); Cytokine (0.4583); Signal (0.3932); Reference proteome (0.2413); Direct protein sequencing (0.1317); 3D-structure (0.0527),
MAMLGVFISAVLFLGTAQGASLGAVLTEGGMVQGKSRSVGLFRYMDTFKGIPFAAPPKRFEKPVAHPGWEGVLKTTDYRKRCLQLNLLATDVIGSEDCLYLNIWVPQGRTVSSNLPVMVFIYGGAFLLGGGQGANFLDNYLYDGEEMADRGNVIVVTFNYRVGALGFMSTGDDGIPGNYGLWDQHAAISWVHRNIKAFGGNPDNITLFGESAGAASVNFQIITPKNKGMIRRAISQSGVALCPWAISRNPRQFAEEIATKVGCPIDSGMADCLKRADPKAVTLAGKLKLTSSPDAPIVHNLYLSPVIDGDFIPDEPETLFGNAADIDYIAGVNDMDAHIFATIDIPSINNALTTTPVEEVQALATALSRDRGQDAGIATFQEYTVNWGDKPNKEKVKQTVVELETDYMFLVPTQAALYLHTDNAKSARTFSYLFTESSRIPVFPLWMGADHADELQYVFGKPFATPLGYFPRHRDVSKYMIAYWSNFAQTGDPNKGESKVPVTWPEFSNPGHQYLDINNKMNKNNVKQMLRTRLVYYWTTVFASYPTVRN,triacylglycerol lipase (3.1.1.3) (0.6719); acetylesterase (3.1.1.6) (0.4352); carboxylesterase (3.1.1.1) (0.3611); 3.1.1.- (0.3592); sterol esterase (3.1.1.13) (0.1645),pancreatic juice secretion (GO:0030157) (0.2496); ceramide catabolic process (GO:0046514) (0.2338); epithelial cell differentiation (GO:0030855) (0.1563); intestinal cholesterol absorption (GO:0030299) (0.1158); short-chain fatty acid catabolic process (GO:0019626) (0.0957); lipid catabolic process (GO:0016042) (0.0811),extracellular region (GO:0005576) (0.0912); extracellular space (GO:0005615) (0.0850),triglyceride lipase activity (GO:0004806) (0.5287); sterol esterase activity (GO:0004771) (0.2974); acetylesterase activity (GO:0008126) (0.1476),"Carboxylesterase type B, conserved site (IPR019819) (0.4302); Carboxylesterase, type B (IPR002018) (0.3633); Carboxylesterase type B, active site (IPR019826) (0.3042); Neuroligin and Bile salt-activated lipase (IPR051093) (0.2863); Alpha/Beta hydrolase fold (IPR029058) (0.2639)",3.40.50.1820 (0.3239),Serine esterase (0.8916); Signal (0.8288); Reference proteome (0.6425); Lipid metabolism (0.5342); Secreted (0.4318); Hydrolase (0.3823); Glycoprotein (0.2928); Endoplasmic reticulum (0.0997); Lipid degradation (0.0951); Steroid metabolism (0.0431),
MSAPAMGTSKTAHSESGHKKKKGPGTLATAYLVIYNVIMTAGWLVIAVGLVRAYLARGSYHGLYYSIEKPLKFFQTGALLEILHCAVGIVPSSVVLTGFQVMSRVFLTWAVTHSVREVQSEDSVLLFVVAWTVTEIIRYSFYTFSLLNHLPYLIKWARYTFFIVLYPMGVMGELLTIYAALPYVQKAGLYSITLPNKYNFSFDYHTFLIFVMISYIPLFPQLYFHMMRQRKKVLGHVEEYSKVE,very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase (4.2.1.134) (0.9826),fatty acid elongation (GO:0030497) (0.6002); sphingolipid biosynthetic process (GO:0030148) (0.3169); negative regulation of developmental growth (GO:0048640) (0.1357); very long-chain fatty acid biosynthetic process (GO:0042761) (0.1150); myotube differentiation (GO:0014902) (0.1066); long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) (0.1011); regulation of G1/S transition of mitotic cell cycle (GO:2000045) (0.0751); regulation of G2/M transition of mitotic cell cycle (GO:0010389) (0.0531),endoplasmic reticulum membrane (GO:0005789) (0.1178); endoplasmic reticulum (GO:0005783) (0.0816); rough endoplasmic reticulum (GO:0005791) (0.0709),3-hydroxyacyl-CoA dehydratase activity (GO:0018812) (0.4115); very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase activity (GO:0102158) (0.1253); enzyme binding (GO:0019899) (0.0773),"Protein-tyrosine phosphatase-like, PTPLA (IPR007482) (0.2960)",,Lyase (0.4767); Membrane (0.4627); Transmembrane (0.3992); Fatty acid metabolism (0.3286); Lipid metabolism (0.2889); Fatty acid biosynthesis (0.2884); Endoplasmic reticulum (0.2762); Transmembrane helix (0.2686); Lipid biosynthesis (0.2173); Glycoprotein (0.1843); Reference proteome (0.1646),
MSLPQLGYKYIRPLYSTERRGGAEISVTGSGSLSSALSGVYGAPFASTAQGYSAFLPYSSDLSVLNQLSSQYEFKDSPGLQHAGFPHAAFYPYGHQYQFGDPSRPKNATRESTSTLKAWLSEHRKNPYPTKGEKIMLAIITKMTLTQVSTWFANARRRLKKENKMTWVPKTRTDEDGNVYTSDNEDAEKRDEDEEIDLENIDTEDIEDKQDCDYQDDDKSTPKGSDSEEYDDARAEKRIIEDEEQIKKSPAEEQEPSNNISPALKPKIWSLAEIATTPDSPKKTWIQRNCDAQTVRNPLHVQNWTKMAISAHQMAFTSHYLGLKHQSIANIHVKHAEQRTHSL,,brain development (GO:0007420) (0.3195); mesoderm development (GO:0007498) (0.2779); cell development (GO:0048468) (0.2474); neuron differentiation (GO:0030182) (0.1893); positive regulation of DNA-templated transcription (GO:0045893) (0.1876); dorsal/ventral pattern formation (GO:0009953) (0.1736); specification of pronephric tubule identity (GO:0039005) (0.1726); embryonic development via the syncytial blastoderm (GO:0001700) (0.1710); negative regulation of transcription by RNA polymerase II (GO:0000122) (0.1588); embryonic digestive tract morphogenesis (GO:0048557) (0.1417); regulation of transcription by RNA polymerase II (GO:0006357) (0.1072); compound eye morphogenesis (GO:0001745) (0.0980); muscle organ development (GO:0007517) (0.0907); positive regulation of neuron differentiation (GO:0045666) (0.0803); proximal/distal pattern formation (GO:0009954) (0.0719); maintenance of kidney identity (GO:0072005) (0.0647); Spemann organizer formation at the dorsal lip of the blastopore (GO:0060062) (0.0451); dorsal appendage formation (GO:0046843) (0.0404); negative regulation of neuron differentiation (GO:0045665) (0.0402),nucleus (GO:0005634) (0.1597),RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978) (0.0744),"Iroquois-class homeodomain protein (IPR003893) (0.1291); Homeobox, conserved site (IPR017970) (0.1052); KN homeodomain (IPR008422) (0.1003); Homeodomain (IPR001356) (0.0930)",1.10.10.60 (0.1552),Homeobox (0.5573); Neurogenesis (0.4983); Reference proteome (0.2690); Transcription (0.1948); Differentiation (0.1783); Nucleus (0.1721); Developmental protein (0.1616); DNA-binding (0.1298),
MYIGNQFCVFLSIFLYISGCLGENYDIDDSLGLGQTFDGIGGLSGGGATSRLLVNYEEPYQSQILDYLFKPKFGASLQILKVEIGGDAQTTDGTEPSHMHYEDDENYFRGYEWWLMVEAKKRNPNITLIGLPWAFPGWVGNGKNWPYDFPDITASYVVAWIHGAKKYHDLDIDYIGIWNEKSFNVKYIKLLRYLLDKRGLEKVKIIASDDLWEPITSAVFADKELYDAIEVLGVHYPGTKTVPRALKTGKKLWSSEDYSTFNDNVGGGCWARILNQNYVNGKMTATISWNLVASYYENLPFGRDGIMTANEPWSGNYVVESPVWTTAHTTQFTEPGWTYLQTVGHFTHGGSYVALTDQRGNLSIITETMTHDHSVCIRPPLRPYNVTVQNVTFNLKGTFAFISQLDVWHSKFDFKTDKTVLFQKLDPVKVIGGSFSIELDVDEIYTFTTITNGQRGTYPDPPPSAPFPKSYRDDFNVSGNFSEAPNFADQTGVFEYFTNLTDPGPHVFTLRQVVTQRPITWAADADQTISVIGDYAWHDVMVSCDVYMEAVQTGGVFIAARVDRGGGVIRSTRGVFFWVYADGTYKITNDLRGLAVLAKGSAGTRARTWYTLTLRVQGNYASADLNGYSLWKNAVLLNPLHGWVAIGTSSFQLAQFDNFVIEAE,galactosylceramidase (3.2.1.46) (0.9914),galactosylceramide catabolic process (GO:0006683) (0.8112),extracellular region (GO:0005576) (0.2638); lysosome (GO:0005764) (0.2547); endoplasmic reticulum (GO:0005783) (0.0864),galactosylceramidase activity (GO:0004336) (0.1291),"Aldolase-type TIM barrel (IPR013785) (0.3864); Glycoside hydrolase, family 59 (IPR001286) (0.3385); Glycosyl hydrolase family 59, central domain (IPR035394) (0.1991); Glycosyl hydrolase family 59, C-terminal lectin domain (IPR049162) (0.1511); Glycoside hydrolase superfamily (IPR017853) (0.1195); Glycosyl hydrolase, all-beta (IPR013780) (0.0748)",3.20.20.80 (0.3858); 3.20.20.70 (0.1527),Signal (0.8040); Sphingolipid metabolism (0.7489); Glycoprotein (0.4986); Reference proteome (0.4626); Hydrolase (0.3981); Lipid degradation (0.2825); Glycosidase (0.2474); Lipid metabolism (0.1717); Disulfide bond (0.1380); Repeat (0.0727); 3D-structure (0.0669),
MSDPAITDAKYVLGDKMDEGIPDFPNGPLDIYRKKASFSWKDMMRFLEGDELIAFKQHVFRTLERDPLFARQPGEDVPVEQKRELTFLRCKQLFKYDFITREELMQNPWKMIVLNDCLGMYDWSLCAKYFLNKGMFGATVLNTGSQRHLKFVKDIERMMTFGCFSLTELSHGSNTRALRTTAKYDPNTQEFVINSPDFEAAKFWVGNLGKTATHSVVFAQLYTPDGKCHGLHSFIVQVRDPKTLLAMPGVMVGDMGKKLGQNGLDNGFAVFHNVRIPRENLLNKTGDVAPDGQYVSPFKDPNKRFGASLGALSGGRVGITRMALVNLKLAVTVAVRFSATRRQFGPKEDEEIPVLEYQLQQWRLIPFLAAVYALEHFTKSFSRNFVEFQMGLLMKDKSDRQAELGREIHALSCASKPLGSWTAQRGIQECREACGGHGYLAMNRLGDMRDDNDPNCTYEGDNNVLLQQTSNYLLSWIQHKQEGNGRIESPLETVNFLDDMSSILQSKFTVGSVEECMNSAVPLAAYKWLVCFLLGESQRKLFQEKSSGLGDFEARNNSQVYYCRTLAIAFIEHTVLQRFHDLIQDEQTPAALRSVLGRLCALYGLWTLTNHMAILYQGGYFSGGQPVDFIQTAILTLCGQLKDDAVALVDVFAPPDFILNSPIGKADGELYKNLWSTVMQGKNVLERPSWWAEFCSDKPVVGSLRAKL,acyl-CoA oxidase (1.3.3.6) (0.6776),fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) (0.3333); lipid homeostasis (GO:0055088) (0.1557); fatty acid beta-oxidation (GO:0006635) (0.1332); fatty acid metabolic process (GO:0006631) (0.1214); lipid metabolic process (GO:0006629) (0.1097); prostaglandin metabolic process (GO:0006693) (0.1009),peroxisome (GO:0005777) (0.3183),pristanoyl-CoA oxidase activity (GO:0016402) (0.5787); FAD binding (GO:0071949) (0.4233); fatty acid binding (GO:0005504) (0.2915),"Acyl-CoA oxidase, C-terminal (IPR002655) (0.5034); Acyl-CoA oxidase/dehydrogenase, middle domain superfamily (IPR046373) (0.3171); IPR055060 (0.2974); Acyl-CoA oxidase (IPR012258) (0.2511); Acyl-CoA oxidase/dehydrogenase, middle domain (IPR006091) (0.2477); Peroxisomal acyl-coenzyme A oxidase (IPR034171) (0.2010); Acyl-CoA dehydrogenase/oxidase, N-terminal and middle domain superfamily (IPR009100) (0.1798); Acyl-CoA dehydrogenase-like, C-terminal (IPR036250) (0.1069)",2.40.110.10 (0.2447); 1.20.140.10 (0.1936),Peroxisome (0.7615); FAD (0.5312); Flavoprotein (0.5266); Oxidoreductase (0.3008); Lipid metabolism (0.2576); Fatty acid metabolism (0.2065); Reference proteome (0.1803); Proteomics identification (0.1717),FAD (0.5312)
MNNSYENCGSEERMDVEIDSGHAGTDRGRLETGTRATCSSNGSGGEEDEMEAADREREATGSSTPRSADGVSLGGGREQEVSVEIGETYLCQRTDKTWHSAEVIQSRLNEQEGREEFYVHYVGFNRRLDEWVGKARLALTKTVKDAVRKSVEEGGGGELVDQPERKITRNQKRKHDEINHVQKTYAEMDPTTAALEKEHEAITKVKYVDKIQIGNFEIDAWYFSPFPEDYGKQPKLWICEYCLKYMKYEKTFRYHLSQCQWRQPPGKEIYRKNNISVYEVDGKDHKIYCQNLCLLAKLFLDHKTLYFDVEPFIFYILTEVNKQGAHIVGYFSKEKESPDGNNVACILTLPPYQRRGYGKFLIAFSYELSKLESTVGSPEKPLSDLGKLSYRSYWSWVLLEILRDFRGTLSIKDLSQMTSITQSDIISTLQSLNMVKYWKGQHVICVTPKLVEEHLKSAQYKKPPITVDTHCLKWAPPKHKQAKFSKK,histone acetyltransferase (2.3.1.48) (0.9781),positive regulation of transcription by RNA polymerase II (GO:0045944) (0.2373); chromatin remodeling (GO:0006338) (0.2314); regulation of transcription by RNA polymerase II (GO:0006357) (0.2275); transcription initiation-coupled chromatin remodeling (GO:0045815) (0.2232); negative regulation of DNA-templated transcription (GO:0045892) (0.1886); positive regulation of DNA-templated transcription (GO:0045893) (0.1601),nucleus (GO:0005634) (0.3640); MSL complex (GO:0072487) (0.2740); NSL complex (GO:0044545) (0.1262); chromatin (GO:0000785) (0.1075); NuA4 histone acetyltransferase complex (GO:0035267) (0.0975); Swr1 complex (GO:0000812) (0.0539),transcription coregulator activity (GO:0003712) (0.3460); histone H4K16 acetyltransferase activity (GO:0046972) (0.2800); chromatin binding (GO:0003682) (0.1305); histone acetyltransferase activity (GO:0004402) (0.1089),Winged helix-like DNA-binding domain superfamily (IPR036388) (0.2149); Chromo/chromo shadow domain (IPR000953) (0.2133); Acyl-CoA N-acyltransferase (IPR016181) (0.1585); MYST family histone acetyltransferases (IPR050603) (0.1473); Chromo-like domain superfamily (IPR016197) (0.1143),3.40.630.30 (0.3910); 1.10.10.10 (0.1713); 3.30.60.60 (0.1187),Zinc-finger (0.6250); Transcription (0.3356); Transcription regulation (0.3169); Acyltransferase (0.3021); Reference proteome (0.2843); Zinc (0.2273); Nucleus (0.2270); Transferase (0.1914); Acetylation (0.1794),
MARPKVFFDLTAGGSPVGRVVMELRTDVVPRTAENFRQLCTGQPGYGYKGSSFHRVIPGFMCQGGDFTNHNGTGGKSIYGNKFADENFNLKHTGAGCLSMANAGPNTNGSQFFICTALTSWLDGKHVVFGQVVEGLDVIKKVEGFGSSSGKTSAKIIIADCGQL,peptidylprolyl isomerase (5.2.1.8) (0.9933),protein peptidyl-prolyl isomerization (GO:0000413) (0.9658); apoptotic process (GO:0006915) (0.6499); protein folding (GO:0006457) (0.6317); platelet aggregation (GO:0070527) (0.2140); negative regulation of protein kinase activity (GO:0006469) (0.1337); response to ischemia (GO:0002931) (0.0969); neutrophil chemotaxis (GO:0030593) (0.0885); platelet activation (GO:0030168) (0.0638); lipid droplet organization (GO:0034389) (0.0586),cytoplasm (GO:0005737) (0.2853); nucleus (GO:0005634) (0.2107); extracellular region (GO:0005576) (0.1955),peptidyl-prolyl cis-trans isomerase activity (GO:0003755) (0.1569); cyclosporin A binding (GO:0016018) (0.1347),"Cyclophilin-like domain superfamily (IPR029000) (0.2265); Cyclophilin-type peptidyl-prolyl cis-trans isomerase domain (IPR002130) (0.1611); Cyclophilin-type peptidyl-prolyl cis-trans isomerase, conserved site (IPR020892) (0.1460); Cyclophilin-type peptidyl-prolyl cis-trans isomerase (IPR024936) (0.1352)",2.40.100.10 (0.4718),Rotamase (0.8083); Isomerase (0.4285); Ubl conjugation (0.1903); Acetylation (0.1859); Cytoplasm (0.1817); Phosphoprotein (0.1568); Isopeptide bond (0.1460); Reference proteome (0.1451); Nucleus (0.1284); Apoptosis (0.1105),
MIKLKSNQTRTYDRDGYKKRAACLCFRSEREEEVLLVSSSSHPDRWIVPGGGMEPEEEPSVAAVREVCEEAGVKGTLGRLVGVFENRDRKHRTYVYVLIVTEVLEDWEDSVNIGRKREWFKTEDARRVLQCHKPVQASYFEALQQDCMTSNGTSLVATYNINQNSLSSIR,diphosphoinositol-polyphosphate diphosphatase (3.6.1.52) (0.7931); diadenosine hexaphosphate hydrolase (ATP-forming) (3.6.1.61) (0.1896); 5'-(N7-methyl 5'-triphosphoguanosine)-[mRNA] diphosphatase (3.6.1.59) (0.1866); endopolyphosphatase (3.6.1.10) (0.1769),adenosine 5'-(hexahydrogen pentaphosphate) catabolic process (GO:1901911) (0.5409); diadenosine hexaphosphate catabolic process (GO:1901909) (0.4016); diadenosine pentaphosphate catabolic process (GO:1901907) (0.2869); diphosphoinositol polyphosphate catabolic process (GO:0071544) (0.2190); diphosphoinositol polyphosphate metabolic process (GO:0071543) (0.1470); glucose homeostasis (GO:0042593) (0.1204); RNA decapping (GO:0110154) (0.1154); nucleotide metabolic process (GO:0009117) (0.0994),glutamatergic synapse (GO:0098978) (0.3246); cytosol (GO:0005829) (0.2920); cytoplasm (GO:0005737) (0.2273); nucleus (GO:0005634) (0.1542),"inositol diphosphate pentakisphosphate diphosphatase activity (GO:0052842) (0.2389); inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity (GO:0052848) (0.2314); magnesium ion binding (GO:0000287) (0.2055); metal ion binding (GO:0046872) (0.1912); endopolyphosphatase activity (GO:0000298) (0.0774); inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity (GO:0052845) (0.0748)","Diphosphoinositol polyphosphate phosphohydrolase-like, NUDIX domain (IPR047198) (0.3405); NUDIX hydrolase domain (IPR000086) (0.1888); NUDIX hydrolase-like domain superfamily (IPR015797) (0.1763)",3.90.79.10 (0.2524),Metal-binding (0.4295); Reference proteome (0.2838); Hydrolase (0.2372); RNA-binding (0.2247); Cytoplasm (0.1702); Nucleus (0.1631),
MLMSTDVASVMLPVSRGILDRDLDSGSAAVRGMKRGDPEPEGAAAAGDSTGAECKRARMDGTEDIAQGSQDSMCGEEGAVVPFFPPPPPPPPQNGLSLEFSSGGGGGSSVYSSSGQTEAVAGTSSGASNPSTQLSDASPQPDNQLVLVSNAVAIREDSSEAKGTPKRLHVSNIPFRFRDPDLRQMFGQFGKILDVEIIFNERGSKGFGFVTFESSGDAEKARERLHGTIVEGRKIEVNNATARVMTNKKMVSPYANGDSLSTLPYAGWKLSPMMGAMYGPEFYAVPGFPYPTTAAAAAAASTAASFRGAHLRGRGRPVYGAVRAAVPQPAIPAYPGVVYQDGFYGATELYSGYTAYRYTQPTAVASPTAAAAAAAAAYSDSYGRVYAADPYAAALATPAAAAAAAYGVGAMATLYRGGYSRFSPY,,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381) (0.9776); mRNA processing (GO:0006397) (0.5030); neuromuscular process controlling balance (GO:0050885) (0.4774); RNA splicing (GO:0008380) (0.4056); regulation of definitive erythrocyte differentiation (GO:0010724) (0.3630); nervous system development (GO:0007399) (0.2809); heart process (GO:0003015) (0.2367); radial glia guided migration of Purkinje cell (GO:0021942) (0.2134); dendrite morphogenesis (GO:0048813) (0.1262)",nucleus (GO:0005634) (0.3871); cytoplasm (GO:0005737) (0.1439),mRNA binding (GO:0003729) (0.2131),"Nucleotide-binding alpha-beta plait domain superfamily (IPR012677) (0.3529); RNA-binding domain superfamily (IPR035979) (0.2778); RNA recognition motif domain (IPR000504) (0.2310); RNA binding protein fox-1 homolog 1-like (IPR047131) (0.2025); FOX1, RNA recognition motif (IPR034237) (0.1686); RNA binding protein fox-1 homolog 1-3 (IPR017325) (0.1005)",3.30.70.330 (0.1816),mRNA splicing (0.9139); Reference proteome (0.6143); RNA-binding (0.5137); Nucleus (0.3787); Cytoplasm (0.3702); Translation regulation (0.3529); mRNA processing (0.3335); Alternative splicing (0.0786),
MQRVLTLRLARLFTQRHKLLPSVRTAAPNMSTLLINQPEYNWLKELGLKEDNDGVYNGSWGGQGEVVTSYCPANNEPIARVRQATIAEYEETIQKALDAWKVWADVPAPKRGEIVRQIGEALRRKIKALGSLVSLEMGKIYVEGVGEVQEYVDVCDYAVGLSRMIGGPILPSERPGHVLIEQWNPVGLVGIITAFNFPVAVYGWNNAIALICGNACLWKGAPTTPLTSVAVTKIVAEVLEQNHLPGAICSMTCGGADIGMAMAKDERVGLLSFTGSTHVGKQVAMMVQERFGRQLLELGGNNAIIVFEDADLSLVVPSAVFASVGTAGQRCTTTRRLMLHESIHDEVVERIAKAYKQIRIGDPWDPNTLYGPLHTKQAVQQYLAAIEQAKQQGGTLVCGGKIMDRPGNYVEPTIITGLPHNASIVHTETFVPILYVLKFKTEEEAFSWNNEVKQGLSSSIFTKDMGRVFRWLGPKGSDCGIVNVNIPTSGAEIGGAFGGEKHTGGGRESGSDSWKQYMRRSTCTINYSKDLPLAQGIKFE,aldehyde dehydrogenase (NAD+) (1.2.1.3) (0.9199); L-aminoadipate-semialdehyde dehydrogenase (1.2.1.31) (0.2328); betaine-aldehyde dehydrogenase (1.2.1.8) (0.0555),cellular aldehyde metabolic process (GO:0006081) (0.1663); reactive oxygen species metabolic process (GO:0072593) (0.1007); lipid metabolic process (GO:0006629) (0.0602); valine catabolic process (GO:0006574) (0.0558); ethanol catabolic process (GO:0006068) (0.0403),cytosol (GO:0005829) (0.2898); mitochondrion (GO:0005739) (0.1673); nucleus (GO:0005634) (0.0499),aldehyde dehydrogenase (NAD+) activity (GO:0004029) (0.4965); identical protein binding (GO:0042802) (0.4165); betaine-aldehyde dehydrogenase (NAD+) activity (GO:0008802) (0.0732),"Aldehyde dehydrogenase family 7 member A1-like (IPR044638) (0.4332); Aldehyde dehydrogenase, C-terminal (IPR016163) (0.2263); Aldehyde dehydrogenase, N-terminal (IPR016162) (0.1801); Aldehyde dehydrogenase, glutamic acid active site (IPR029510) (0.1739); Aldehyde dehydrogenase domain (IPR015590) (0.0998)",,Oxidoreductase (0.6077); Mitochondrion (0.5199); NAD (0.5064); Reference proteome (0.3274); Transit peptide (0.1752); Proteomics identification (0.1717); Ubl conjugation (0.1613); 3D-structure (0.1382); Acetylation (0.1266); Cytoplasm (0.1214); Direct protein sequencing (0.0988); Nucleus (0.0540),
MIRMGLLKVLKTQLLCHLIICYVFLVSGIIINLLQLCTLPLWPINKQLARKINCRLGYSIASQLVALLEWWSGTECTLYTDPESFRLYGKENAIVVLNHNFEIDFMTGWTFCERFGVLGSSKVLAKKELSFVPVIGWMWYFLEIVFCKRKWEEDRKTVVQSLRNLQDYPEFFWFLLHCEGTRFTEKKHKISMEVAEKKGLPKLKYHLLPRTKGFCVTVQNLRGKVTAVYDSTLNFRNNEMPTLLGVLNGKKYHADLYVRRIPLDSIPEDESECAAWLHKLYQEKDEFQEHYRQTGRFPGPITNPPRRLWALVNWLFWVCVLVYPICVLLLQLLLSGSTFTIVCTFVFCLAVSAGVRWMIGQTEIDKGSNYGVKDVQMNNN,1-acylglycerol-3-phosphate O-acyltransferase (2.3.1.51) (0.9874),phospholipid metabolic process (GO:0006644) (0.3126); phospholipid biosynthetic process (GO:0008654) (0.2717); CDP-diacylglycerol biosynthetic process (GO:0016024) (0.2681); glycerophospholipid metabolic process (GO:0006650) (0.0933); phosphatidic acid biosynthetic process (GO:0006654) (0.0749); phosphatidylinositol acyl-chain remodeling (GO:0036149) (0.0659),endoplasmic reticulum (GO:0005783) (0.4507); nuclear envelope (GO:0005635) (0.3383); endoplasmic reticulum membrane (GO:0005789) (0.2214); mitochondrial outer membrane (GO:0005741) (0.0746); endomembrane system (GO:0012505) (0.0429),1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841) (0.7937),"Phospholipid/glycerol acyltransferase (IPR002123) (0.1924); Acyltransferase, C-terminal domain (IPR032098) (0.0863)",,Endoplasmic reticulum (0.6504); Membrane (0.6087); Phospholipid metabolism (0.5270); Reference proteome (0.5238); Phospholipid biosynthesis (0.4501); Lipid biosynthesis (0.4455); Lipid metabolism (0.3361); Acyltransferase (0.3235); Transferase (0.2345); Proteomics identification (0.1393); Phosphoprotein (0.1219),
MVCSVSGSISWCYHSPSCSEVTWPIIAEKHCNGTQQSPINIVTANVKANANLTSFTYVGYNDSTALTVIKNTGTSIQVTLDPKKMRVAGGNLPGRFASTEFHLHWGNGSAMPGSEHTVNGKRFPMELHIVNKPVSNTSDSLAVLGVFIEASNETGKPESWKTLTSYLTRIVKAGDKASLFRNFSMDDLLSGVDRTKYYRYLGSLTTPNCNEGVIWTVFKDPIRVSRDLIDLFSTTVYINNSSNSPLMTNIFRSVQPVNGRIVMSQVAGTKTPGLLNPTSIAANLSPSLMYPILSLTFLYCVLAFL,carbonic anhydrase (4.2.1.1) (0.9767),one-carbon metabolic process (GO:0006730) (0.6154); regulation of intracellular pH (GO:0051453) (0.3687); regulation of pH (GO:0006885) (0.2944); carbon dioxide transport (GO:0015670) (0.1814); bicarbonate transport (GO:0015701) (0.1205); glucose metabolic process (GO:0006006) (0.0693); regulation of monoatomic anion transport (GO:0044070) (0.0606),apical part of cell (GO:0045177) (0.2581); extracellular exosome (GO:0070062) (0.2341); cytoplasm (GO:0005737) (0.1705); plasma membrane (GO:0005886) (0.1649); brush border membrane (GO:0031526) (0.1501); secretory granule membrane (GO:0030667) (0.1499); transport vesicle membrane (GO:0030658) (0.1384); rough endoplasmic reticulum (GO:0005791) (0.1292),zinc ion binding (GO:0008270) (0.3359); carbonate dehydratase activity (GO:0004089) (0.2800),"Carbonic anhydrase, alpha-class, conserved site (IPR018338) (0.3580); Carbonic anhydrase, alpha-class (IPR023561) (0.2953); Alpha carbonic anhydrase domain (IPR001148) (0.2441); Carbonic anhydrase, CA4/CA15 (IPR041874) (0.2090); Alpha carbonic anhydrase domain superfamily (IPR036398) (0.1360)",3.10.200.10 (0.0505),Zinc (0.8125); Lyase (0.5292); GPI-anchor (0.1851); Membrane (0.0828); Reference proteome (0.0768),Zn(2+) (0.1926)
MCGCGCSFISSLMKRLGRSACCSDLLSCSHTSEHLQRLATGCPSQHKNAKSLSSSDSLAKVQEVASWLLEMNQDLLSGGSGSRAAQQQRPRPGTAGAGNSISGRTPQPQPEHPDQVLEEPEQEEAQQQRREPAEEEDEGGPERQQDGDEQPWPSGGEPMEDGEGRRSEVNGDEKGAQWLWEQEQRRRRRPHREEEEENEEEEENNNSGREGQVGAGLRSEEDDDRPEEDNEGEEEMDQDSDEFEHSEESEREEEEEDGEEEEGEEGLHSPSLRTSVSDHNDNTDQSSGRQRQSLRSPNRMKRKLDHGPEVRSFTTGKKPCPSPTGQQYPATFGDLRAVNGQVPQRRRITSIQPPTGLQEWLRTFQSWSGPEKLLALDELIDSCEPTQVKHMMQVIEPQFQRDFISLLPRELALHVLSFLEPKDLLQAAQTCRYWRILAEDNLLWKEKCKEEGIDEPLHIKRRKVIKPGFTHSPWKSAYIRQHRIDTNWRRGDLKSPKVLKGHDDHVITCLQFCGNRIVSGSDDNTLKVWSAVTGKCLRTLVGHTGGVWSSQMRDNIIISGSTDRTLKVWNAETGECIHTLYGHTSTVRCMHLHEKRVVSGSRDATLRVWDIETGQCLHVLMGHVAAVRCVQYDGRRVVSGAYDFMVKVWDPETETCLHTLQGHTNRVYSLQFDGIHVVSGSLDTSIRVWDVETGNCIHTLTGHQSLTSGMELKDNILVSGNADSTVKIWDIKTGQCLQTLQGPHKHQSAVTCLQFNKNFVITSSDDGTVKLWDLRTGEFIRNLVTLESGGSGGVVWRIRASNTKLVCAVGSRNGTEETKLLVLDFDVDMK,,vasculogenesis (GO:0001570) (0.4140); Notch signaling pathway (GO:0007219) (0.3653); lung development (GO:0030324) (0.3533); positive regulation of ERK1 and ERK2 cascade (GO:0070374) (0.3178); protein ubiquitination (GO:0016567) (0.2379); protein polyubiquitination (GO:0000209) (0.2026); SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146) (0.2005); ubiquitin-dependent protein catabolic process (GO:0006511) (0.1716); regulation of protein localization (GO:0032880) (0.1706); protein stabilization (GO:0050821) (0.1582); sister chromatid cohesion (GO:0007062) (0.1540); negative regulation of glial cell proliferation (GO:0060253) (0.1436); positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060) (0.1334); protein destabilization (GO:0031648) (0.1149); negative regulation of apoptotic process (GO:0043066) (0.1025); regulation of cell migration involved in sprouting angiogenesis (GO:0090049) (0.0942); angiogenesis (GO:0001525) (0.0610),SCF ubiquitin ligase complex (GO:0019005) (0.1449); nucleolus (GO:0005730) (0.0960); cytoplasm (GO:0005737) (0.0664); nucleus (GO:0005634) (0.0644),ubiquitin-like ligase-substrate adaptor activity (GO:1990756) (0.1082),WD40-repeat-containing domain superfamily (IPR036322) (0.4223); F-box-like domain superfamily (IPR036047) (0.3892); G-protein beta WD-40 repeat (IPR020472) (0.3689); WD40 repeat (IPR001680) (0.2227); F-box domain (IPR001810) (0.1947); WD40/YVTN repeat-like-containing domain superfamily (IPR015943) (0.1427),2.130.10.10 (0.1717),WD repeat (0.8865); Repeat (0.6195); Reference proteome (0.2392); Ubl conjugation pathway (0.0951),
MGDWNLLGSILEEVHIHSTIVGKIWLTILFIFRMLVLGVAAEDVWVDEQSEFVCNTDQPGCKNVCYDQAFPISLIRFWVLQIIFVSSPSLVYMGHALYQLRSLEKERHRRKIQLRAELEETEPLLEEHRKLEKELRRLEEQKKMKKAPLRGSLLRTYIIHILTRSVVEVAFIVGQYILYGIGLDPLYKCERVPCPNSVDCYVSRPTEKTIFMVFMIVIAGVSLFLNLLEISHLGVRKIKQTLSGLQFVEEDSLCKPKHSTIQQLCVMTEYSPHKNPQLKTFIPQGQMDKHLFSSSSNDILRHNSLAASTLPVSCITQQPRQMRQPSQGMIHELHSQGSLRLLEDQENQHPDSSNCSERDIRPFNSGHPGSEGHTEIPACLRNALHRPSRLADLADDAMESSESDFCPPNRKASFMVRMPSESMSGSPSCPSTRSSESELGSLNDLPMNPPPGGGRRMSMSVFLDISSIMKK,,cell-cell signaling (GO:0007267) (0.5011); mitral valve development (GO:0003174) (0.4705); atrial septum development (GO:0003283) (0.4268); ventricular septum development (GO:0003281) (0.3004); heart development (GO:0007507) (0.2189); angiogenesis (GO:0001525) (0.2092); regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) (0.1928); pulmonary valve formation (GO:0003193) (0.1706); gap junction assembly (GO:0016264) (0.1528); cell development (GO:0048468) (0.1492); vasculogenesis (GO:0001570) (0.1473); regulation of atrial cardiac muscle cell action potential (GO:0098910) (0.1320); outflow tract morphogenesis (GO:0003151) (0.1254); regulation of bundle of His cell action potential (GO:0098905) (0.1128); regulation of Purkinje myocyte action potential (GO:0098906) (0.1023); regulation of AV node cell action potential (GO:0098904) (0.0986); detection of light stimulus involved in visual perception (GO:0050908) (0.0639); visual perception (GO:0007601) (0.0545),connexin complex (GO:0005922) (0.3687); nucleoplasm (GO:0005654) (0.1209),gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling (GO:0086076) (0.1265); gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling (GO:0086077) (0.1109); gap junction channel activity (GO:0005243) (0.0961),"Connexin (IPR000500) (0.3935); Connexin, N-terminal domain superfamily (IPR038359) (0.3752); Gap junction protein, cysteine-rich domain (IPR019570) (0.3601); Connexin, conserved site (IPR017990) (0.2399); Connexin, N-terminal (IPR013092) (0.0872)",1.20.1440.80 (0.1519),Transmembrane helix (0.5116); Membrane (0.4346); Gap junction (0.3129); Cell membrane (0.3012); Cell junction (0.1916),
MSFVVKMNGVQNNGIHGNGMNGSIMNGNGVHHVSVRTHVSVNPAKLKAGSHRQRWNVRPSEMSKKTLNPIRAIVDGMKLTPNPEKPMIALSIGDPTVFGNLPTDDAVLHAMKDAIDSHKYNGYAPSVGYQKSREAVANFYSCPEAPLEGKDVILASGCSQAIELAISVLCNPGDNILVPRPGFSLYKTLAVSMGIQVKHYNLLPEKSWEIDLQHLESLIDNKTACLIVNNPSNPCGSVFTKEHQQKIISVASRNCIPILADEIYGDMVFPGCDFRALAPLSSDVPILSCGGLAKRWLVPGWRMGWILIHDRNNIFGSGIREGLVKLSQRILGPCTVVQGALESILNETPPEFYQSTISFLKSNSEICFSELSTVSGLNPVMPSGAMYIMVGIEMEHFPEFQNDVEFTERLVTEQSVFCLPATAFEYPNYFRIVVTVPEEMMIEACIRIREFCARHYRPRSQDSHELDQ,tyrosine transaminase (2.6.1.5) (0.9728),tyrosine catabolic process (GO:0006572) (0.6340); 2-oxoglutarate metabolic process (GO:0006103) (0.4296); L-phenylalanine catabolic process (GO:0006559) (0.3893); glutamate metabolic process (GO:0006536) (0.1682); biosynthetic process (GO:0009058) (0.1330); response to mercury ion (GO:0046689) (0.1115),mitochondrion (GO:0005739) (0.1492); cytosol (GO:0005829) (0.1337); cytoplasm (GO:0005737) (0.0918),L-tyrosine:2-oxoglutarate aminotransferase activity (GO:0004838) (0.3477); identical protein binding (GO:0042802) (0.1064),"Aminotransferase, class I/classII (IPR004839) (0.4284); Pyridoxal phosphate-dependent transferase, major domain (IPR015421) (0.2702); Tyrosine aminotransferase ubiquitination region (IPR011715) (0.2632); Pyridoxal phosphate-dependent transferase, small domain (IPR015422) (0.2325); Aminotransferases, class-I, pyridoxal-phosphate-binding site (IPR004838) (0.2050); Tyrosine aminotransferase (IPR005957) (0.1887); Pyridoxal phosphate-dependent transferase (IPR015424) (0.1680); Tyrosine/nicotianamine aminotransferase (IPR005958) (0.1103)",3.90.1150.10 (0.3782); 3.40.640.10 (0.3311),Tyrosine catabolism (0.9782); Transferase (0.8600); Phenylalanine catabolism (0.8498); Pyridoxal phosphate (0.6598); Reference proteome (0.6120); Phosphoprotein (0.1242); Aminotransferase (0.1068),pyridoxal 5'-phosphate (0.3697)
MVVNTVHWFRKGLRLHDNPSLRDSIKGADNLRCVYILDPWFAGSSNVGISRWRFLLQCLEDLDASLRKLNSRLFVIRGQPTDVFPRLFKEWKISRLSYEYDSEPFGKDRDAAIRKLATEAGVEVFVRISHTLYDLDKIIEFNGGQSPLTYKRFQTLISRMDPVEMPAETITAEIMGKCSTPVSDDHDDKFGVPSLEELGFETEGLSTAVWPGGETEALTRLERHLERKAWVANFERPRMNANSLLASPTGLSPYLRFGCLSCRLFYFKLTDLYRKVKKNSTPSLSLYGQLLWREFFYTAATNNPHFDKMEFNPICVQIPWDRNPEALAKWAEGQTGFPWIDAIMTQLRQEGWIHHLARHAVACFLTRGDLWISWEEGMKVFEELLLDADWSVNAGSWMWLSCSSFFQQFFHCYCPVGFGRRTDPNGDYIRRYLPILRGFPAKFIYDPWNAPESVQKVAKCIIGVHYPKPMVNHAEASRINIERMKQIYQQLSCYRGLGLLATVPSNTANNEDSNGAGPSSGDTQERTHITVHTLPASSQSEFPAFAVSCGQQLVNSVQPQPGYSGAGMVGQAHKQTQRVRGMTAFKRHGEDRTTDFPSKIQRNDCN,,entrainment of circadian clock by photoperiod (GO:0043153) (0.7693); circadian regulation of gene expression (GO:0032922) (0.6486); negative regulation of DNA-templated transcription (GO:0045892) (0.5625); phototransduction (GO:0007602) (0.0670); rhythmic process (GO:0048511) (0.0552),nucleus (GO:0005634) (0.6060); cytoplasm (GO:0005737) (0.3168); photoreceptor outer segment membrane (GO:0042622) (0.1443),DNA binding (GO:0003677) (0.4841); FAD binding (GO:0071949) (0.2723); photoreceptor activity (GO:0009881) (0.2301),"DNA photolyase, N-terminal (IPR006050) (0.4649); Cryptochrome/DNA photolyase, FAD-binding domain (IPR005101) (0.3674); Cryptochrome/DNA photolyase class 1 (IPR002081) (0.2991); Cryptochrome/photolyase, N-terminal domain superfamily (IPR036155) (0.2880); Cryptochrome/DNA photolyase, FAD-binding domain-like superfamily (IPR036134) (0.2622); Rossmann-like alpha/beta/alpha sandwich fold (IPR014729) (0.1576)",3.40.50.620 (0.3366); 1.25.40.80 (0.2206); 1.10.579.10 (0.1544),Repressor (0.6644); Photoreceptor protein (0.6345); Receptor (0.6195); Sensory transduction (0.6097); Nucleus (0.4794); FAD (0.4642); Transcription regulation (0.4611); Biological rhythms (0.4522); Reference proteome (0.3971); Cytoplasm (0.3480); Transcription (0.3228); Chromophore (0.3123); Nucleotide-binding (0.2858); Flavoprotein (0.1975),"FAD (0.4642); (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate (0.1392)"
MTDCGEDAKLEATKQASKEFKESENVAEKYSAMTATKHSDVNMNVGELSAAFTAVPTHKSVKKIQFANQEDKQEFSKFPTKTGRRSLSRSISQSSTDSYSSAASYTDSSDDETSPREKSQVNSKGSSDFCVKNIKQAEFGRREIEIAEQDMSALISLRKRAQGEKPLAGAKVAGCTHITAQTAVLIETLVALGAQCRWTACNIYSTQNEVAAALAESGVSVFAWKGESEDDFWWCIDRCVNMDGWQANMILDDGGDLTHWVYKKYPSVFKKVRGIVEESVTGVHRLYQLSKAGKLCVPAMNVNDSVTKQKFDNLYCCRESILDGLKRTTDVMFGGKQVVVCGYGEVGKGCCSALKALGAIVCVTEIDPICALQACMDGFRVVKLNEVVRQMDMVITCTGNKNVVTREHLDRMKNGCIVCNMGHSNTEIDVASLRTPELTWERVRSQVDHVIWPDGKRVILLAEGRLLNLSCSTVPSFVLSITATTQALALIELYNAPEGRYKQDVYLLPKKMDEYVASLHLPNFDAHLTELSDEQAKYMGLNKNGPFKPNYYRY,adenosylhomocysteinase (3.13.2.1) (0.5611),one-carbon metabolic process (GO:0006730) (0.7072); regulation of monoatomic ion transmembrane transporter activity (GO:0032412) (0.5195); positive regulation of sodium ion transport (GO:0010765) (0.5058); epithelial fluid transport (GO:0042045) (0.4242); S-adenosylmethionine cycle (GO:0033353) (0.3546); protein export from nucleus (GO:0006611) (0.3335); regulation of mRNA 3'-end processing (GO:0031440) (0.2492); regulation of monoatomic anion transport (GO:0044070) (0.2297); angiotensin-activated signaling pathway (GO:0038166) (0.1212); apoptotic process (GO:0006915) (0.0852),mitochondria-associated endoplasmic reticulum membrane contact site (GO:0044233) (0.2240); cytosol (GO:0005829) (0.1011),enzyme regulator activity (GO:0030234) (0.1353),"S-adenosyl-L-homocysteine hydrolase, conserved site (IPR020082) (0.4396); Adenosylhomocysteinase-like superfamily (IPR042172) (0.3504); Adenosylhomocysteinase-like (IPR000043) (0.3299); NAD(P)-binding domain superfamily (IPR036291) (0.2498); S-adenosyl-L-homocysteine hydrolase, NAD binding domain (IPR015878) (0.2180)",3.40.50.1480 (0.4024); 3.40.50.720 (0.1476),One-carbon metabolism (0.6437); Reference proteome (0.6146); NAD (0.1642); Phosphoprotein (0.0521),NAD(+) (0.4618)
MDPSCFTTAQRLSCKIMNPDMFKASPAAPPPAKPSRSKSEHVKPELAQVVVDAKTGRSYCKGKLLGKGGFARCYEMTDLANNKMYAVKVIPQSRVSKPHQREKIINEIELHKSLQHKHVVKFSHHFEDQDNIYIFLELCSRKSLAHIWKARHTLTDPEVRYYLRQIISSLKYLHNKGILHRDLKLGNFFVNENMELRLGDFGLAAKLETVEQRKKTICGTPNYLAPEVLNRQGHGTESDVWSLGCVMYTLLCGNPPFETLDLKETYKCIKEVKYSLPSSLTPSAQKLISSILQKNPCDRLTLDQILAHDYFTKGFTPEKLPPSSCVMVPELNPPSPAKKFFTKMAKSLFGKKKSKTVEKTTSEEKDDISKLVSGMVKHSIGRQMSYKTMGVNEATSPTVQLASSGPLDTPAEEESRKSASRSFKGTVASSTDGCDDIPTPSAVAESAMKVLNSCLSSMPTASRNPPCLVKTKPFIWVTKWVDYSNKYGFGYQLSNQNVGVLFNEGTHLSLCDQRRTVHYCLTNNKHFSFPANALPEKLQSQKHIVDLMANYMEQNLMEGGDINCEDQSSSSSPLLLQWIKTDHALVMLFDNRTLQVNFYTDHTKIILCKPSDASYLVTFISKERVSYSYPLNVLSELGCSPELRQRLHYVVQLLQHYTNA,polo kinase (2.7.11.21) (0.9993),DNA damage response (GO:0006974) (0.6827); protein phosphorylation (GO:0006468) (0.5659); mitotic G1/S transition checkpoint signaling (GO:0044819) (0.4018); mitotic spindle organization (GO:0007052) (0.2889); Golgi disassembly (GO:0090166) (0.2527); G1/S transition of mitotic cell cycle (GO:0000082) (0.2222); regulation of synaptic plasticity (GO:0048167) (0.1559); mitotic sister chromatid segregation (GO:0000070) (0.0458),kinetochore (GO:0000776) (0.6164); spindle pole (GO:0000922) (0.3685); chromatin (GO:0000785) (0.2456); centrosome (GO:0005813) (0.1431); nucleus (GO:0005634) (0.1291),ATP binding (GO:0005524) (0.3625); protein serine/threonine kinase activity (GO:0004674) (0.1790),"POLO box domain superfamily (IPR036947) (0.5902); Second polo-box domain (IPR033695) (0.4339); First polo-box domain (IPR033701) (0.4145); POLO box domain (IPR000959) (0.3851); Serine/threonine-protein kinase, active site (IPR008271) (0.1935); Protein kinase domain (IPR000719) (0.1934); Protein kinase, ATP binding site (IPR017441) (0.1711)",3.30.1120.30 (0.7610); 1.10.510.10 (0.1685),Kinase (0.2227); Transferase (0.1931); Serine/threonine-protein kinase (0.1868); Nucleotide-binding (0.1829); ATP-binding (0.1783); Reference proteome (0.1581),
MANQRQQQLLFSTIVLIFVGHVNTSVYTPSTVAPLFHRPFVLLWNAPISKCHQLKVPLDLSLFQAVTTPARVHNQSLSLFYKTRLGLFPYVDLHSMKEYNGGIPQRGNLSASLEKAKEEFLQFIPDSSSGLAVMDWEEWLPIFDRNFDLKKIYMELSINYTLEQNSSLSPQQAATEAKQQFQKEARRFMEETLKKGINLRPRYLWGYYLFPDCYNYGFDESNYTGTCSEYTKQLNNELLWLWEVSTALYPSAYLPVSKSGSKSAALFVRHQVEEAMRVASLPKHVHTAPVYVYLRPLLTNQKKLYMNEIDLVSSIGESAALGASGAVLWGSSADYNDKTSCEALSAYLSDKLNPYILNVTTAAHLCSKNLCQGEGRCVRKNNNSDDFLHISSESHHIGRNAGKYVVTGTPSASDLADWKSKFTCQCYEDRNCTATMPSF,hyaluronoglucosaminidase (3.2.1.35) (0.9941),carbohydrate metabolic process (GO:0005975) (0.8595); cartilage development (GO:0051216) (0.7150); penetration of zona pellucida (GO:0007341) (0.6229); cellular response to tumor necrosis factor (GO:0071356) (0.3362); hyaluronan catabolic process (GO:0030214) (0.2775); fusion of sperm to egg plasma membrane involved in single fertilization (GO:0007342) (0.1683); response to antibiotic (GO:0046677) (0.1121); cell adhesion (GO:0007155) (0.1020); response to reactive oxygen species (GO:0000302) (0.1012); inflammatory response (GO:0006954) (0.0676),acrosomal vesicle (GO:0001669) (0.5361); early endosome (GO:0005769) (0.1491); sperm midpiece (GO:0097225) (0.1377); endoplasmic reticulum (GO:0005783) (0.1173); extracellular space (GO:0005615) (0.0960),hyalurononglucosaminidase activity (GO:0004415) (0.2550),Hyaluronidase (IPR018155) (0.3024); Glycoside hydrolase superfamily (IPR017853) (0.2958); Hyaluronidase PH20/Hyaluronidase-5 (IPR001439) (0.2317); Aldolase-type TIM barrel (IPR013785) (0.2110),3.20.20.70 (0.1520),Glycosidase (0.7530); Signal (0.5623); Membrane (0.3411); Reference proteome (0.2727); Secreted (0.2079); GPI-anchor (0.1874); Hydrolase (0.1642); Glycoprotein (0.0695),
MSAKTERTFIAVKPDGVQRGLMGEIIKRFEQKGFRLVAMKFLQASEDLLKQHYIDLKDRPFYPGLVKYMSSGPVLAMVWEGLNVVKTGRVMLGETNPADSKPGTIRGDFCIEVGRNIIHGSDSVDSANTEISLWFKPEELVSFKSCAQQWIYE,nucleoside-diphosphate kinase (2.7.4.6) (0.9903),GTP biosynthetic process (GO:0006183) (0.8249); UTP biosynthetic process (GO:0006228) (0.7575); CTP biosynthetic process (GO:0006241) (0.6899); phosphorylation (GO:0016310) (0.3100); endocytosis (GO:0006897) (0.2255); integrin-mediated signaling pathway (GO:0007229) (0.1503); regulation of apoptotic process (GO:0042981) (0.1496); kidney development (GO:0001822) (0.0435),lamellipodium (GO:0030027) (0.2642); nucleus (GO:0005634) (0.2556); cytoplasm (GO:0005737) (0.1991); ruffle (GO:0001726) (0.1593),nucleoside diphosphate kinase activity (GO:0004550) (0.2539); ATP binding (GO:0005524) (0.1363),"Nucleoside diphosphate kinase, active site (IPR023005) (0.2601); Nucleoside diphosphate kinase-like domain superfamily (IPR036850) (0.2073); Nucleoside diphosphate kinase-like domain (IPR034907) (0.1420); Nucleoside diphosphate kinase (IPR001564) (0.1204)",3.30.70.141 (0.1763),Transferase (0.5780); Neurogenesis (0.2923); Nucleotide metabolism (0.2368); Nucleotide-binding (0.2245); ATP-binding (0.1752); Kinase (0.1671); Cytoplasm (0.1636); Endocytosis (0.1434); Reference proteome (0.1217); Nucleus (0.0449),
MAGVIRRLDETVVNRIAAGEIIQRPANAIKEMMENCLDAKSTNIQITVKEGGLKLILIQDNGTGIRKDDMEIVCERFTTSKLQSFEDLSSIATYGFRGEALASISHVAHVTITTKTADAKCAYRANYCDGKLKSPPKPCAGNQGTLISVEDLFYNVSTRRKALKSPSEEYSRIVEVVSRYAIHNSGKSFSVKKQGEMVADVKTLPNASVLDNIRVVFGVAVSRELIEVECEDQKFAFKVKGYISNANYSVKKCILILFINHRLVESSALKKAIETVYTAYLPKNTHPFLYLSLEIAPQNIDVNVHPTKHEVHFLHEDSIIESIQKHIESKLLGSNSSRTYFTQTLLPGLSASASVAKASSSSADSQERVYAHQMVRTDSKAQKLDAFLQPSASSSSTAAQRKTEKTSSTSTAVQDLVELDDAELLTAADVEPCGGKDPQTDAQPPGDEAPPRKRPHVEEVKEDLTAASLPRRRIVKLTSIKELRDQIELQTHKGLQELLQNHSFVGSVSPQWTLVQHQTKLYLLNTTKLSQELFYQILVYDFGNFGVLRLSNPAPLYDLAMLALDSEESGWTEEDGPKEGLAQYIVDFLKQKAEMLEEYFSLEIDAEGNLTGLPMLLDNYTPAMEGLPMFILRLATEVNWDKEKECFREFSVECSHFYSIRKSYTLEADADEPQDAEMSWQWKVEHVLFKALRSLFSPAKHLSEDGSVLQIASLPDLYKVFERC,,mismatch repair (GO:0006298) (0.6332); somatic hypermutation of immunoglobulin genes (GO:0016446) (0.5076); mitotic recombination (GO:0006312) (0.3731); oogenesis (GO:0048477) (0.1685); meiotic spindle midzone assembly (GO:0051257) (0.1415); female meiosis chromosome segregation (GO:0016321) (0.1400); positive regulation of isotype switching to IgA isotypes (GO:0048298) (0.1156); spermatogenesis (GO:0007283) (0.1115); nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289) (0.1107); male meiosis chromosome segregation (GO:0007060) (0.0950); pollen development (GO:0009555) (0.0752); resolution of meiotic recombination intermediates (GO:0000712) (0.0603),MutLalpha complex (GO:0032389) (0.2959); chiasma (GO:0005712) (0.0735),ATP binding (GO:0005524) (0.3723); ATP hydrolysis activity (GO:0016887) (0.1398); ATP-dependent DNA damage sensor activity (GO:0140664) (0.1171),"DNA mismatch repair protein Mlh1, C-terminal (IPR032189) (0.3936); DNA mismatch repair protein MutL/Mlh/Pms-like (IPR038973) (0.2673); Ribosomal protein uS5 domain 2-type superfamily (IPR020568) (0.2082); Histidine kinase/HSP90-like ATPase superfamily (IPR036890) (0.1998); DNA mismatch repair protein MutL/Mlh/PMS (IPR002099) (0.1403); DNA mismatch repair, conserved site (IPR014762) (0.1317); DNA mismatch repair protein, S5 domain 2-like (IPR013507) (0.1192)",3.30.230.10 (0.2308); 3.30.565.10 (0.1684),Reference proteome (0.7017); Nucleus (0.6569); DNA repair (0.4298); DNA damage (0.3583); Proteomics identification (0.0765),
MDLSDALDAPLQQNNQQAGGPVWPGQPANPVWPGQPANPTWPGQPNQPAWPGQPNQQWPGQPGQPTAPGWPGPAPQTGPYGAPGQVPQVLTVPLDFPLQNGAYNKMLITINGEVKPNAKQFTVNLRRGNDIAFHINPRFSEGGKPVIVRNSMIGNNWGREERELPSFPFVPGKPFEMKILITDTEYKVAVNKSHLLEFKHRVFELNQITGLSIYNDVTLSTVNVETLQ,,monocyte chemotaxis (GO:0002548) (0.9708); negative regulation of endocytosis (GO:0045806) (0.5680); macrophage chemotaxis (GO:0048246) (0.5577); neutrophil chemotaxis (GO:0030593) (0.5465); negative regulation of extrinsic apoptotic signaling pathway (GO:2001237) (0.4578); RNA splicing (GO:0008380) (0.4213); positive regulation of calcium ion import (GO:0090280) (0.3232); eosinophil chemotaxis (GO:0048245) (0.2821); positive chemotaxis (GO:0050918) (0.1605); mRNA processing (GO:0006397) (0.0496),spliceosomal complex (GO:0005681) (0.3580); nucleus (GO:0005634) (0.1119); extracellular space (GO:0005615) (0.0832),IgE binding (GO:0019863) (0.3186); laminin binding (GO:0043236) (0.2377); disaccharide binding (GO:0048030) (0.1332),"Galectin-like (IPR044156) (0.2856); Galectin, carbohydrate recognition domain (IPR001079) (0.2252); Concanavalin A-like lectin/glucanase domain superfamily (IPR013320) (0.2055)",2.60.120.200 (0.4104),Lectin (0.7511); mRNA splicing (0.5535); IgE-binding protein (0.4668); mRNA processing (0.4021); Acetylation (0.2284); Differentiation (0.2275); Secreted (0.1242); Innate immunity (0.1157); Reference proteome (0.1011); Nucleus (0.0426),
MLSVLHTGHLKRDWRTINLETLRRLALCVCGHHHHHHQRCPVRMRMLCCRRVLQQWVFALFLLCSPVPHHGRPVDALSSRMKRSVTHAQLMHDKGRTLQDFKRRMWLQELLHEVHTAEIREAQQPRGGVSISSGAGGGVGTGVSITLPAGVGVSTGAGTAHPKPAGGTKNLPIGFGLEDEEGTNLPQETHKSQNYKDNMMKGIRRKKKSRTGKRREGEKRKRRARSLQEFSSGVHLQPYSC,,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189) (0.8978); bone mineralization (GO:0030282) (0.7010); positive regulation of inositol phosphate biosynthetic process (GO:0060732) (0.2979); osteoblast development (GO:0002076) (0.2550); phosphate ion homeostasis (GO:0055062) (0.2504); positive regulation of transcription by RNA polymerase II (GO:0045944) (0.1459); response to xenobiotic stimulus (GO:0009410) (0.0948); positive regulation of bone mineralization (GO:0030501) (0.0915); memory (GO:0007613) (0.0810); positive regulation of glycogen biosynthetic process (GO:0045725) (0.0628); intracellular calcium ion homeostasis (GO:0006874) (0.0562),extracellular region (GO:0005576) (0.4349); cytoplasm (GO:0005737) (0.0718),peptide hormone receptor binding (GO:0051428) (0.3866); hormone activity (GO:0005179) (0.2405),Parathyroid hormone/parathyroid hormone-related protein (IPR001415) (0.5947); Parathyroid hormone-related protein (IPR003626) (0.0495),,Hormone (0.7380); Signal (0.5009); Secreted (0.4708); Reference proteome (0.4391); Cleavage on pair of basic residues (0.1841),
MNLLDMVLFKLLILLYCLSDSNGQYGKPLNKYIRHYEGLSYDTDVLHSKHQRAKRALSHQDQFIHLEFHAHGRHFNLRMKRDTSLFTHNLKVEVSGVEVPYDTSHIYTGEIYGEKDSLTHGSVVDGKFEGFIKSHHGTYYVEPSERYLKDQNVPYHSVIYHEDDIDYPHKYGSEGGCADHSVFERMKKYQASAMEEPTQTNHIIDEEVADGPVILRTRRAAQAEKNTCQLFIQTDHLFFKYYGSREAVIAQISSHVKAINSIYQGTDFQGIRNISFMVKRIKINTTIDEKDSSNPFRFGNIGVEKFLELNSEQNHDEYCLAYVFTDRDFDDGVLGLAWVGAPSGSSGGICEKNKQYSDGKKKSLNTGIITVQNYASHVPPKVSHITFAHEVGHNFGSPHDSGSDCTPGESKTTDQKEKGNYIMYARATSGDKFNNNKFSICSVRNISQVLDKKRSACFVESGQPICGNGLVETNEECDCGYNDQCKDQCCYSADEPEGKKCKLKPETESNPSQGPCCTPQCTYRTGNECRPESDCAFKGLCNGLSAQCPASTPKENYTACHANTQVCINGGCSGSICEKHKLDVCTCATEDGKDDMELCHVCCMEKGKPSTCSSTSSERWASFFDNKVITLQPGSPCNDFKGYCDVFMKCRLVDADGPLARLKKAIFNPELYTSIAEWIVKHWWAVLLMGIALIMLMAGFIKICSVHTPSSNPKLPPPKPLPGTLKRRRAQNPSAQTQPQRPRQQRENYQMGQMRR,ADAM10 endopeptidase (3.4.24.81) (0.9946),Notch signaling pathway (GO:0007219) (0.6727); membrane protein ectodomain proteolysis (GO:0006509) (0.6579); regulation of cellular component organization (GO:0051128) (0.3068); proteolysis (GO:0006508) (0.2815); integrin-mediated signaling pathway (GO:0007229) (0.0634),synaptic membrane (GO:0097060) (0.4084); clathrin-coated vesicle (GO:0030136) (0.0894); Golgi membrane (GO:0000139) (0.0744),metal ion binding (GO:0046872) (0.5412); SH3 domain binding (GO:0017124) (0.5370); metalloendopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902945) (0.3814); metalloendopeptidase activity (GO:0004222) (0.0909),"Disintegrin and Metalloproteinase Domain-Containing (IPR051489) (0.5255); ADAM10, cysteine-rich domain (IPR049038) (0.5067); Disintegrin domain superfamily (IPR036436) (0.4377); Disintegrin domain (IPR001762) (0.4160); Peptidase M12B, ADAM/reprolysin (IPR001590) (0.3581); Metallopeptidase, catalytic domain superfamily (IPR024079) (0.3379); ADAM10/ADAM17 catalytic domain (IPR034025) (0.3156)",3.40.390.10 (0.4883); 4.10.70.10 (0.2850),Zymogen (0.9082); Zinc (0.8779); SH3-binding (0.8307); Cleavage on pair of basic residues (0.6004); Transmembrane (0.5440); Signal (0.4699); Metalloprotease (0.4513); Protease (0.4497); Notch signaling pathway (0.4199); Transmembrane helix (0.3975); Metal-binding (0.3943); Membrane (0.3289); Hydrolase (0.2845); Phosphoprotein (0.2489); Toxin (0.1462); Reference proteome (0.1291),Zn(2+) (0.4360)
MMILSRKPDGPVTAARHGDGLYDSYMRTDHIVNQDADVNGQSPSGLPPLPKHTGVIKPTMKDHQAIRGGQMKVKYVYEDSYNRKLNGVSQHNGTSQVPAKPPPAISKERSVDSNSSVKSSESSTKVTKLGSPMTPEQALKQHRQQMTTLEQQEIHNYSEIYFLGPNAKKRQAVAGGTNNSGYDDDQGGYIHVPHDHLAYRYEFLKVIGKGSFGQVAKVYDHKLQQHVALKIVRNEKRFHRQAAEEIRILEHLKKQDKTGSMNVVHMLENFTFRNHICMTFELLSMNLYELIKRNKFQGFSLPLVRKFAHSILQCLEALHRHKIIHCDLKPENILLKQQGRSGIKVIDFGSSCFDHQRVYTYIQSRFYRAPEVILGSRYGMPIDMWSFGCILAELLTGYPLFPGEDEGDQLACMMELLGMPPSKLLEQAKRAKNFISSKGHPRYCTVSTLSNGTIVLNGSRSRRGKMRGAPGSKEWGTALKGCEDATFIDFLKKCLDWDPSTRMTPVQALRHPWLYKRLPKPAPGGEKTVLPKRISEHSTSFPTIISKVPPVMGSTNNKLRTTMMGDSTGSIPFRTVLPKLVS,dual-specificity kinase (2.7.12.1) (0.9819),protein phosphorylation (GO:0006468) (0.5925); intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771) (0.5786); smoothened signaling pathway (GO:0007224) (0.3992); peptidyl-serine phosphorylation (GO:0018105) (0.2300); nuclear speck organization (GO:0035063) (0.1219); positive regulation of cell cycle G2/M phase transition (GO:1902751) (0.0664),cytoskeleton (GO:0005856) (0.2670); cytoplasm (GO:0005737) (0.1895); cytosol (GO:0005829) (0.1877); nucleus (GO:0005634) (0.1743),magnesium ion binding (GO:0000287) (0.3481); protein serine/threonine kinase activity (GO:0004674) (0.3296); ATP binding (GO:0005524) (0.2169); protein serine/threonine/tyrosine kinase activity (GO:0004712) (0.1990),"Serine/threonine and dual-specificity kinase (IPR050494) (0.3811); Protein kinase domain (IPR000719) (0.2051); Dual specificity tyrosine-phosphorylation-regulated kinase (IPR042521) (0.1796); Protein kinase-like domain superfamily (IPR011009) (0.1749); Serine/threonine-protein kinase, active site (IPR008271) (0.1396)",3.30.10.30 (0.5161); 1.10.510.10 (0.2198),Nucleotide-binding (0.5975); ATP-binding (0.5120); Serine/threonine-protein kinase (0.3297); Reference proteome (0.1928); Kinase (0.1354),
MKTIIVVTIFGILTCAYPTDGEHCAQEKAMEDFDPSRFFNGKWYVVHYGKTGPTVCQKFSTNGTQGAPTQIVETGYDKFEDYLKFQCDETGKKNDYHYSFKCKSYECGSDNIEFEVDFTVLSASYDDFALVCRTITFTSGTKDKDDEVLVLEREKTLDVIDNCRRTYYLTEFEKMSLSSQFLSKKENITMLSFQLK,,acute-phase response (GO:0006953) (0.1762); apoptotic process (GO:0006915) (0.1711); high-density lipoprotein particle clearance (GO:0034384) (0.1389); positive regulation of interleukin-1 beta production (GO:0032731) (0.0994); high-density lipoprotein particle assembly (GO:0034380) (0.0939); production of molecular mediator involved in inflammatory response (GO:0002532) (0.0810); positive regulation of protein phosphorylation (GO:0001934) (0.0806); response to xenobiotic stimulus (GO:0009410) (0.0797); positive regulation of interleukin-1 production (GO:0032732) (0.0670); positive regulation of lipoprotein lipase activity (GO:0051006) (0.0609); positive regulation of apoptotic process (GO:0043065) (0.0608); hemolysis in another organism (GO:0044179) (0.0560); blood vessel endothelial cell migration (GO:0043534) (0.0540),low-density lipoprotein particle (GO:0034362) (0.5378); extracellular region (GO:0005576) (0.2998); very-low-density lipoprotein particle (GO:0034361) (0.2064); platelet alpha granule lumen (GO:0031093) (0.1721); spherical high-density lipoprotein particle (GO:0034366) (0.0762); cell cortex (GO:0005938) (0.0523),phospholipid binding (GO:0005543) (0.2001); peptidase inhibitor activity (GO:0030414) (0.0909); retinoid binding (GO:0005501) (0.0742),Calycin (IPR012674) (0.2410),2.40.128.20 (0.1561),Vasoactive (0.8710); Secreted (0.8092); Vasodilator (0.6352); Signal (0.5256); Disulfide bond (0.3338); Glycoprotein (0.2404); Reference proteome (0.2365); 3D-structure (0.1367); Direct protein sequencing (0.1287); Hemostasis impairing toxin (0.0797),
MAVVPGGPSSRPAVGAQFFCTAGRGLEPFLMREVRERLAATQVEYISGKVFFTTCSDLNMLKQLKSAERLFLLIKKQLPFPVSSVSKGKILNELQRLINDDPESWLNAISIWKNLLELDAKKEKLSHKNANPLKRKVGEDDITAKKLKTEQIQELQETKECQLEKQIEEKILEQGNFITEGEKFQKLQDDVTEAVDTRNQTNLTFRVSCRCSGAVAKTLTAQEVGRVIGIALMKQFGWKADLRNPNLEIFIHLSDVYSVLGIPVFRVPLACRAYIKTAGLRSTIAWAMASLAEIKAGAVVLDPMCGLGTILLEAAKEWPHVYYVGADVSDSQLSGAYDNLRAAGLRDKIELLQVSVIELPLPSESVDIIISDIPFGKKFKLGKDIKRMLQEMERVLRVGGTIVLLLSEDHHRHLKGGEASSGPLNSQGGHTEEPGGEERLTPAEKAAVSEPVSSPFAASNQGRLDRMPPLGSLVPVDCYRVSLGKTDALISKYKKSHSPGR,2.1.1.- (0.8828),tRNA methylation (GO:0030488) (0.3526); DNA repair (GO:0006281) (0.2872); RNA processing (GO:0006396) (0.2399); methylation (GO:0032259) (0.2096); mRNA processing (GO:0006397) (0.1451); DNA-templated DNA replication (GO:0006261) (0.0686),nucleus (GO:0005634) (0.3516); cytoplasm (GO:0005737) (0.3179); nucleoplasm (GO:0005654) (0.1908); GO:0000781 (0.1237); membrane (GO:0016020) (0.1052),RNA binding (GO:0003723) (0.4942); DNA binding (GO:0003677) (0.2251); identical protein binding (GO:0042802) (0.1258); tRNA binding (GO:0000049) (0.1231); snoRNA binding (GO:0030515) (0.0714),"S-adenosyl-L-methionine-dependent methyltransferase superfamily (IPR029063) (0.4973); THUMP domain (IPR004114) (0.2000); Ribosomal RNA large subunit methyltransferase K/L-like, methyltransferase domain (IPR000241) (0.0917)",3.40.50.150 (0.2151); 3.30.2130.30 (0.2081),Phosphoprotein (0.6451); S-adenosyl-L-methionine (0.5604); tRNA-binding (0.5331); Reference proteome (0.4960); tRNA processing (0.4553); Transferase (0.4015); Alternative splicing (0.3702); Ubl conjugation (0.3203); RNA-binding (0.2880); Acetylation (0.2189); Disease variant (0.1999); Methyltransferase (0.1989); Isopeptide bond (0.1779); 3D-structure (0.1658); Nucleus (0.1347); Coiled coil (0.1133); Proteomics identification (0.1001),
MDQFIKQDETGDLIETGMNVANHFLSAPIQGTNLLSKATIIPGVAPVLIGNPEQKNIQYPTASHQGSKSKGRSSGAKPIIVSSSEVGTGGTQIPEPLFAQTGQGGTVTTVYQDPTIQPTGSYRSVELAKIGKERMINRFVEKPRTSTPVTEFKRGGPGAAAQGQTIQEEGIDGNGASAGSKERSGSLSGATPYAHLSLPQQDSTPANVGIAQQSAISANEIMDLLRGMDARLQHLEQKVDKVLAQGSMVTQIKNELSTVKTTLATIEGMMATVKIMDPGNPTGVPVDELRRSFSDHVTIVSGPGDVSFSSSEEPTLYLDELARPIPKPRPAKQPKPQPVKDLAGRKVMITKMITDCVANPQMKQAFEQRLAKASTEDALNDIKRDIIRSAI,,negative stranded viral RNA replication (GO:0039689) (0.3131); DNA-templated transcription (GO:0006351) (0.3128); symbiont-mediated suppression of host cytoplasmic pattern recognition receptor signaling pathway via inhibition of IKBKE activity (GO:0039724) (0.1251); virus-mediated perturbation of host defense response (GO:0019049) (0.1143); viral transcription (GO:0019083) (0.0735); symbiont-mediated suppression of host cytoplasmic pattern recognition receptor signaling pathway via inhibition of MDA-5 activity (GO:0039554) (0.0709); viral genome replication (GO:0019079) (0.0686),host cell cytoplasm (GO:0030430) (0.4517); virion component (GO:0044423) (0.2491); ribonucleoprotein complex (GO:1990904) (0.0998); viral nucleocapsid (GO:0019013) (0.0842),RNA binding (GO:0003723) (0.5366); identical protein binding (GO:0042802) (0.1429); RNA-dependent RNA polymerase activity (GO:0003968) (0.0875),"P/V phosphoprotein, paramyxoviral (IPR004897) (0.3127); Paramyxovirinae protein V, zinc-binding domain (IPR024279) (0.1112)",1.20.5.300 (0.0922),Viral RNA replication (0.8445); Virion (0.6624); 3D-structure (0.6434); Reference proteome (0.3921); Coiled coil (0.3566); Inhibition of host RLR pathway by virus (0.3472); Phosphoprotein (0.3141); Host-virus interaction (0.2714); Inhibition of host innate immune response by virus (0.2489); Viral immunoevasion (0.1283); Methylation (0.1040); Chromophore (0.0494),
MAKTPIPFTTLNDLPDVILSNIIAAVSDTRSRNATALVCHKWLVLERSTRTSLTLRGNIRDLFMLPTCFRSITYLDLSLISPWGHPLLASRATDAPDNDSALIAHLLRHTFPSVTSLTLYARDPNTIQFLPAQWAHTLKHIKLVRWHQRAQLASGDELNLLFIGTPQITSLDLSNFYCWTDDVPPALQSNPNVACNLTRFNLLNASFPEGFKTDEIKVITKCCPNLKEFKVACMFDPRYIGFIGDEALVCLATNCPKLSVLHLADTSVLSNCRGDPNDEGFTVEDAQFSVSTLIEVFSGLSLLEELVFDVCNNVRDSGPALEILKTKCPKLRSLKLGQFHGISMPIESKLDGVALCQGLLSLSIRSVGDLDDMGLIGIGRGCSRLTKFEIECCKKITMRGMRTLASLLRKSLVDVTISCCKNLGASSSLKALEPIQDRIQRLHIDCVWDTVEEFENLDGVEYGFDLNEASGGEASSNPAGFGDTFGSMDDDLMNNRNKRCKYSYDLNSVYVENNGHGNGFCGRTWDRLQYLSLWIGVGELLTPLAAAGLQDCPKLEEIKIKVEGDCRLWSKPSERAFGLSTLIQYPKLVKMHLDCGDIIGYAHTAPSGQMDLSLWERFYLMGIRHLNLRELDYWPPQDRDVNQRSLSLPAAGLLQECVTLRKLFIHGTAHEHFMMFLLRIPNLRDVQLREDYYPAPENDMSTEMRADSLSRFEVALNRRQICD,,response to light stimulus (GO:0009416) (0.7894); response to water deprivation (GO:0009414) (0.7585); SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146) (0.4692); negative regulation of seed germination (GO:0010187) (0.3683); positive regulation of response to water deprivation (GO:1902584) (0.3046); cuticle development (GO:0042335) (0.2564); auxin-activated signaling pathway (GO:0009734) (0.2263); regulation of meristem structural organization (GO:0009934) (0.1951); auxin polar transport (GO:0009926) (0.1782); shoot system morphogenesis (GO:0010016) (0.1613); response to abscisic acid (GO:0009737) (0.1315); response to far red light (GO:0010218) (0.0897),SCF ubiquitin ligase complex (GO:0019005) (0.5401); nucleus (GO:0005634) (0.3359),,"COI1, F-box (IPR041567) (0.7096); Leucine-rich repeat, cysteine-containing subtype (IPR006553) (0.0949)",3.80.10.10 (0.0815),Ubl conjugation pathway (0.7574); Developmental protein (0.1346); Reference proteome (0.0861),
MAQEMRYFSTRGGKETLSFEDAVLTGLAPNGGLYIPTHIPALPKDWKTKWAGLSFPELSHEILSLFVPTSVIPSDDLQSIINTAYSSFRSPATTPIRQTGDNEYVLELWHGPTWAFKDVALQFLGELFRYFLERRNKDKTEDMEELTVVGATSGDTGSAAIYGLRSKPSITIFILYPDGRVSPIQEAQMATVPDANVYCVAVEDSDFDTCQSIVKTLFSDAQFNATHRLGAINSINWARILAQIVYYFSAYFQLPEEARKDGAKLQFVVPTGNFGDILAGWYAKKLGLPMEQLVVATNENDILERFFRTGRYEADDAVQQDQTAETAAVNGSSDGQQAVSAVKATHSPAMDILLSSNFERLLYYLALETNGTEGSDEEKRFKAQERLNDWMSTLKKDGKVDLGEDVRQAAGKDFWAERVSDGQTLEEIQKYYRREKYGPYVVDPHTAVGLTAQERSAKKASPDTTWITLSTAHPAKFSGAVELALSASEFPDFDFRRDVLPDELKKLEGLEKRVHRVKGEEGVRALIEKVKSASHEKVDAEEGRGSL,threonine synthase (4.2.3.1) (0.9560); 4.2.3.- (0.0494),threonine biosynthetic process (GO:0009088) (0.7066); 2-oxobutyrate biosynthetic process (GO:0046360) (0.1166); dephosphorylation (GO:0016311) (0.0850); serine family amino acid catabolic process (GO:0009071) (0.0667); L-methionine salvage from methylthioadenosine (GO:0019509) (0.0433),cytoplasm (GO:0005737) (0.2439); nucleus (GO:0005634) (0.2038),pyridoxal phosphate binding (GO:0030170) (0.6124); threonine synthase activity (GO:0004795) (0.3916),"Tryptophan synthase beta chain-like, PALP domain (IPR001926) (0.3124); Threonine synthase, N-terminal (IPR029144) (0.2214); Serine/threonine dehydratase, pyridoxal-phosphate-binding site (IPR000634) (0.1570); Tryptophan synthase beta chain-like, PALP domain superfamily (IPR036052) (0.1375); Threonine synthase-like (IPR004450) (0.1130); Threonine synthase, N-terminal domain superfamily (IPR037158) (0.0739); Threonine Synthase (IPR051166) (0.0677)",3.90.1380.10 (0.5552); 3.40.50.1100 (0.4753),Threonine biosynthesis (0.9214); Pyridoxal phosphate (0.7031); Reference proteome (0.5797); Lyase (0.5742); Amino-acid biosynthesis (0.1394); Acetylation (0.0775); Nucleus (0.0587),pyridoxal 5'-phosphate (0.3803)
MPARKYKIHVPCTSANIGPGFDVCGIALSLSLSLVVTIPSVSSGAEPLPKIIYTGLDSDNVPLSPYKNLLTRVALYVLRANGITTFPPGVTIEARNEIPFGRGLGSSGAAVIAGVLLGDLLGNLSLPKSRLLDFALMVERHPDNVTAALMGGFVGSYLRELSPEDMSAASIPLAEVLPEYPPDAGPDWGKSPPQPPHGIGHFVRFGWAKEIKAIAVSPRFELATAKARGVLPESYSRKDMIFNLQRLAVLTTALARSPPDPDLIYDAMGDRVHQPYRMTLIPGLPKILSTLTPTSHPGLLGICLSGAGPTILALATHNFEAIANEIERIFGDEQVLVDHKVLNIDEKGSWVEDITEA,homoserine kinase (2.7.1.39) (0.8753),sterol biosynthetic process (GO:0016126) (0.9186); threonine biosynthetic process (GO:0009088) (0.5257); phosphorylation (GO:0016310) (0.1036),cytoplasm (GO:0005737) (0.1547); ribosome (GO:0005840) (0.1224); nucleus (GO:0005634) (0.0737),homoserine kinase activity (GO:0004413) (0.4526); ATP binding (GO:0005524) (0.2206),"GHMP kinase, ATP-binding, conserved site (IPR006203) (0.5377); Small ribosomal subunit protein uS5 domain 2-type fold, subgroup (IPR014721) (0.4269); GHMP kinase, C-terminal domain superfamily (IPR036554) (0.3443); Ribosomal protein uS5 domain 2-type superfamily (IPR020568) (0.2367); Homoserine kinase (IPR000870) (0.2168); GHMP kinase N-terminal domain (IPR006204) (0.1714); GHMP kinase, C-terminal domain (IPR013750) (0.1706)",3.30.230.10 (0.4218); 3.30.70.890 (0.3446),Threonine biosynthesis (0.9588); Nucleotide-binding (0.5464); Sterol metabolism (0.5184); Amino-acid biosynthesis (0.5088); Steroid biosynthesis (0.4440); Steroid metabolism (0.4302); ATP-binding (0.4012); Reference proteome (0.3774); Sterol biosynthesis (0.2956); Lipid biosynthesis (0.2688); Kinase (0.2013); Ribonucleoprotein (0.1774); Lipid metabolism (0.0911); Ribosomal protein (0.0785),
MSFLFFLVVLISIGLWVGPCVADNPENRCIKQFAKTNPACIVHCKYNLYKFTDDNYDITDQHINKFTDVLIKNKAVDGSKKSQVQEHLKKCAEESLKKTHGKNCQRLVEYYSCAVDNKLIDYFKYESAINSYDRSIYTPPYSG,,sensory perception of chemical stimulus (GO:0007606) (0.3084); inflammatory response (GO:0006954) (0.2205); negative regulation of blood coagulation (GO:0030195) (0.1477); vasodilation (GO:0042311) (0.1365); chemotaxis (GO:0006935) (0.1361); killing of cells of another organism (GO:0031640) (0.1296); response to cocaine (GO:0042220) (0.0778); cellular response to glucocorticoid stimulus (GO:0071385) (0.0497),extracellular region (GO:0005576) (0.1622),toxin activity (GO:0090729) (0.5874); IgE binding (GO:0019863) (0.1077),,1.10.238.20 (0.0646),Platelet aggregation inhibiting toxin (0.6127); Vasodilator (0.5900); Direct protein sequencing (0.4741); Toxin (0.3753); Secreted (0.3326); Signal (0.2133); Disulfide bond (0.1986); Hemostasis impairing toxin (0.0826); Allergen (0.0611); Blood coagulation cascade inhibiting toxin (0.0565); 3D-structure (0.0511),
MHRAGAAVTANVWCRAGGIRMAPRPVIPVATQQRLRRQADRQSLGSSGLPALNCTPIRHTIDVMATKPERKTERLAARLTPEQDALIRRAAEAEGTDLTNFTVTAALAHARDVLADRRLFVLTDAAWTEFLAALDRPVSHKPRLEKLFAARSIFDTEG,,plasmid maintenance (GO:0006276) (0.3198); DNA damage response (GO:0006974) (0.2540); regulation of DNA-templated transcription (GO:0006355) (0.2122); response to osmotic stress (GO:0006970) (0.0872); response to oxidative stress (GO:0006979) (0.0825); cellular response to iron ion starvation (GO:0010106) (0.0689); response to lipopolysaccharide (GO:0032496) (0.0663); detoxification (GO:0098754) (0.0638); negative regulation of DNA-templated transcription (GO:0045892) (0.0575); response to antibiotic (GO:0046677) (0.0526); negative regulation of growth (GO:0045926) (0.0411),toxin-antitoxin complex (GO:0110001) (0.1420); ATP-binding cassette (ABC) transporter complex (GO:0043190) (0.0627); periplasmic space (GO:0042597) (0.0588),protein homodimerization activity (GO:0042803) (0.2193); DNA binding (GO:0003677) (0.0594); toxin sequestering activity (GO:0097351) (0.0591); cis-regulatory region sequence-specific DNA binding (GO:0000987) (0.0408),Ribbon-helix-helix (IPR010985) (0.0674),1.10.1220.10 (0.4157),Transcription (0.3056); Stress response (0.2434); Transcription regulation (0.2316); Metal-binding (0.2145); 3D-structure (0.2018); Copper (0.1744); Repressor (0.1640); rRNA-binding (0.1596); Toxin-antitoxin system (0.0905); Transposition (0.0900); Transposable element (0.0865); Antibiotic resistance (0.0796); DNA-binding (0.0792); Periplasm (0.0767); Oxidation (0.0656),
MWPPVDVRSLTAESLGRASLILAVDLLLFVTSILNITVIAFTPDLSDVIGCYLISLSVADLLTAIFVIPLSIYSTLEGNWRIGGDNSIICKSAAYLQIALFCSTVYTFAWICIDRYSAMMKPSRYSEQSLTRCKCWIVFSWLTSMLLCCPIIVARMQVVFYPDAQLCVLDWSATSAYSVTLLLLVFVPTLVTVFNTGWKIWSAMRNPAALDDSQRMLVETDPNFVLTGFLFVTFFLSWLPLITLKVCELIWGPFDMDLSMLTFFFVWLAVSGPCCKFLIYMFTNHQFRRSFLSYISCSMCCSSRSRYEYHDIGNNSFL,,G protein-coupled receptor signaling pathway (GO:0007186) (0.9059); circadian rhythm (GO:0007623) (0.2909); serotonin receptor signaling pathway (GO:0007210) (0.2499); cellular response to light stimulus (GO:0071482) (0.1905); phototransduction (GO:0007602) (0.1885); cellular response to sucrose stimulus (GO:0071329) (0.1208); egg-laying behavior (GO:0018991) (0.1066); olfactory learning (GO:0008355) (0.0717); chemotaxis to folate (GO:0043326) (0.0701); associative learning (GO:0008306) (0.0550); adenylate cyclase-inhibiting serotonin receptor signaling pathway (GO:0007198) (0.0548); calcium-mediated signaling (GO:0019722) (0.0547),dendrite (GO:0030425) (0.2488); presynapse (GO:0098793) (0.2439); perikaryon (GO:0043204) (0.2004); membrane (GO:0016020) (0.0849); plasma membrane (GO:0005886) (0.0473),G protein-coupled photoreceptor activity (GO:0008020) (0.0499),"G-protein coupled receptor opsins (IPR050125) (0.3836); GPCR, rhodopsin-like, 7TM (IPR017452) (0.2107); G protein-coupled receptor, rhodopsin-like (IPR000276) (0.1409)",1.20.1070.10 (0.1667),Transducer (0.6022); Reference proteome (0.5490); Receptor (0.4667); Transmembrane helix (0.4666); Membrane (0.4298); G-protein coupled receptor (0.3779); Vision (0.2875); Phosphoprotein (0.1763); Cell projection (0.1267); Transmembrane (0.0887); Glycoprotein (0.0837),
MIILFRGHMRDNSTEHKTRRAASSKDVRPAELDEVDRRILSLLHGDARMPNNALADTVGIAPSTCHGRVRRLVDLGVIRGFYTDIDPVAVGLPLQAMISVNLQSSARGKIRSFIQQIRRKRQVMDVYFLAGADDFILHVAARDTEDLRSFVVENLNADADVAGTQTSLIFEHLRGAAPI,,negative regulation of DNA-templated transcription (GO:0045892) (0.3183); alanine catabolic process (GO:0006524) (0.2588); gluconeogenesis (GO:0006094) (0.2391); response to amino acid (GO:0043200) (0.0881); response to cadmium ion (GO:0046686) (0.0807); response to oxidative stress (GO:0006979) (0.0806); response to radiation (GO:0009314) (0.0776),cytosol (GO:0005829) (0.2795); protein-DNA complex (GO:0032993) (0.1585); cytoplasm (GO:0005737) (0.1309),sequence-specific DNA binding (GO:0043565) (0.7983); transcription cis-regulatory region binding (GO:0000976) (0.3338); identical protein binding (GO:0042802) (0.2752); DNA-binding transcription activator activity (GO:0001216) (0.1422),"Transcription regulator AsnC-like (IPR019888) (0.1846); Transcription regulator AsnC/Lrp, ligand binding domain (IPR019887) (0.1765); Winged helix-like DNA-binding domain superfamily (IPR036388) (0.1506); AsnC-type HTH domain (IPR000485) (0.0827)",3.30.70.920 (0.4425),Reference proteome (0.7523); Transcription (0.6446); Transcription regulation (0.5096); DNA-binding (0.4097); Activator (0.2126); Virulence (0.2050); Transferase (0.0521); 3D-structure (0.0518),
MLKFLSTKCKQFNSLNHIIKHKIYFPSKSNKSYFSSSVKDVEKKNKEPIIQLTNDAINKMKEINLKYKNSKALKVCVEAGGCSGFQYSFSLIDKNKIKDKEQIVYDKDCIVVIDKQVIDILKNSKIHYINNLISKKFTIENIQNISSKCSCGNSFDIDFV,,iron-sulfur cluster assembly (GO:0016226) (0.7475); biotin biosynthetic process (GO:0009102) (0.0939); intracellular iron ion homeostasis (GO:0006879) (0.0523),iron-sulfur cluster assembly complex (GO:1990229) (0.2681); mitochondrial matrix (GO:0005759) (0.2587); cytoplasm (GO:0005737) (0.1382); nucleus (GO:0005634) (0.0795); mitochondrion (GO:0005739) (0.0697); cytosol (GO:0005829) (0.0654),"2 iron, 2 sulfur cluster binding (GO:0051537) (0.1982); iron ion binding (GO:0005506) (0.1425)",FeS cluster biogenesis (IPR000361) (0.4007); HesB-like domain superfamily (IPR035903) (0.1968),2.60.300.12 (0.3580),Transit peptide (0.5884); Reference proteome (0.1565); 3D-structure (0.1409),
MFNNFLNMYMCTLAEKLCKFKKNNFNNIHRNNNFYRDNNFYRDNNFYRDNNFYRDNNFYRDNNLYTNNNLYRDNNFYRDNNFYRDNNFYRDNNLYTNNNLYRDNNLYTNNNLYRDNNFYNITLRKFHFIQTISNNNFNFEIIKKYGDVINKIMFIHTQKKNKQERFMFNNKKYIKRKEYILNDLNEFISIIPHPEINNEITNNSNQKKNKDNKQNVLSTNQQIITNYNLNHKENVTSNLNFNNKEEDEKKLDKLLKKRNIKKRDIVTITEEAKEELKKIISINKKENNNNYNNMNTICSDNHNDMNTICNDKNILKLFFITKGCNGLTHSFNFISKKDIHKEDEIIYDDQNNILLVIDKNCILYVINTTLDYYKDDLTEKFIFKNPNITSICPCGTSFHFSKKK,,iron-sulfur cluster assembly (GO:0016226) (0.7242); protein maturation by iron-sulfur cluster transfer (GO:0097428) (0.1538); intracellular iron ion homeostasis (GO:0006879) (0.1524); response to iron ion (GO:0010039) (0.0665); response to copper ion (GO:0046688) (0.0568),mitochondrial matrix (GO:0005759) (0.3175); nucleus (GO:0005634) (0.0762); cytoplasm (GO:0005737) (0.0761); cytosol (GO:0005829) (0.0595),"2 iron, 2 sulfur cluster binding (GO:0051537) (0.4690); iron-sulfur cluster binding (GO:0051536) (0.1541); metal ion binding (GO:0046872) (0.0884); ATP binding (GO:0005524) (0.0720); iron ion binding (GO:0005506) (0.0566); zinc ion binding (GO:0008270) (0.0531); electron transfer activity (GO:0009055) (0.0492)","HesB-like domain superfamily (IPR035903) (0.2950); FeS cluster insertion, C-terminal, conserved site (IPR017870) (0.1760); FeS cluster insertion protein (IPR016092) (0.1280)",2.60.300.12 (0.2010),Zinc (0.7557); Reference proteome (0.4547); Vision (0.1732); Iron-sulfur (0.1295); Metal-binding (0.1164); Iron (0.1073); Zinc-finger (0.0802); Transcription (0.0548),
MGIVEEAHNVKILGSGEQTVVLAHGFGTDQSVWKHLVPHLVDDYKVVIFDNMGAGTTNPDYFDFERYSTLEGYAYDVIAILEEFQVGSCIYVGHSVSAMIGVIASIARPDLFTKLVTVSASPRYLNDMDYYGGFEQEDLDQLYEAMRSNYKAWCSGFAPLVIGGDMDSVAIQEFSRTLFNMRPDIALSVLQMIFQSDLRHLLPHVSVPCHIIQSMKDLAVPVVVSEYLHQNLGGGSIVEVMSTEGHLPQLSSPDVVIPVLLRHIHHDIAI,3.1.-.- (0.5117); 1-acylglycerophosphocholine O-acyltransferase (2.3.1.23) (0.1275); 1-acylglycerol-3-phosphate O-acyltransferase (2.3.1.51) (0.0884); 3.-.-.- (0.0595),response to light stimulus (GO:0009416) (0.2051); defense response (GO:0006952) (0.1457); DNA damage response (GO:0006974) (0.0944); cell differentiation (GO:0030154) (0.0863); response to nematode (GO:0009624) (0.0676); epigenetic regulation of gene expression (GO:0040029) (0.0648),cytoplasm (GO:0005737) (0.4543); nucleus (GO:0005634) (0.2485); cytosol (GO:0005829) (0.1707),metal ion binding (GO:0046872) (0.1334); hydrolase activity (GO:0016787) (0.0858),Alpha/beta hydrolase fold-1 (IPR000073) (0.1149); Alpha/Beta hydrolase fold (IPR029058) (0.1066),,Cytoplasm (0.3190); Acetylation (0.2791); 3D-structure (0.2590); Nucleus (0.2454); Hydrolase (0.2143); Membrane (0.1906); Reference proteome (0.1636); Plant defense (0.1629); Meiosis (0.1294); Developmental protein (0.0998); Direct protein sequencing (0.0714),
MLELLCRVSPARLPWRSCMSLAIQPAQRRRFATEAAGKRTETEKSAFTEWRTVYSMPGIRLVAALSRLKVYQAVITAAGTPIVFALGSAGQLSTDALAIYAAIGVTGLITLTLASYASSNLVGFIYVNEEQDLLKLAYVDFWGRRQETLIETEDLLPSWEQGSPSRLRFVSPICLRSDSKRRYKLLNRFGHVSDRQLFEGLFGN,,mitochondrial transport (GO:0006839) (0.1909); brain development (GO:0007420) (0.1661); negative regulation of apoptotic process (GO:0043066) (0.1452); cellular response to retinoic acid (GO:0071300) (0.0928); glycolytic process (GO:0006096) (0.0919); protein-containing complex assembly (GO:0065003) (0.0804); mitochondrial genome maintenance (GO:0000002) (0.0801); heart development (GO:0007507) (0.0771); mitochondrial respiratory chain complex I assembly (GO:0032981) (0.0759); regulation of oxidative phosphorylation (GO:0002082) (0.0735); inner mitochondrial membrane organization (GO:0007007) (0.0652); positive regulation of DNA-templated transcription (GO:0045893) (0.0634); nervous system development (GO:0007399) (0.0545); neural tube closure (GO:0001843) (0.0407),mitochondrial inner membrane (GO:0005743) (0.6371); mitochondrial membrane (GO:0031966) (0.1691); mitochondrion (GO:0005739) (0.1114); mitochondrial intermembrane space (GO:0005758) (0.1048); SAM complex (GO:0001401) (0.0654),,TMEM70/TMEM186/TMEM223 protein family (IPR045325) (0.0845),,Transmembrane helix (0.7288); Transmembrane (0.6944); Disease variant (0.6179); Membrane (0.6051); Reference proteome (0.5220); Proteomics identification (0.4161); Mitochondrion inner membrane (0.3833); Mitochondrion (0.2700); Primary mitochondrial disease (0.2092); Direct protein sequencing (0.0996); 3D-structure (0.0983),
MVCVPSSSSVMELANLISQSIPKLQDESPQRANDARGNVIEACSKMLALVTSPAEMLKEMVLINLASLQVINHYQIASVVPLNGHIPISELANKCGLPVDILRRILRQAMTYGAFSEPEPDCIAQTDVSREIPRLSPLLTYQLDVCLPSMVRLLDWLKDVDGEHACAYQIAHDTKDTWWSYASKRPELIENYGKYMALITSGGAHDVSYVLKGFAWEKLGNAVVVDVGGADGFVGISLAKEYPNLAVIVEDNLGLKDSADDNIPQHLKSRVVFLPHSFFKPQSALSRDADVFLLRHILHDWNDNDCRAILQALAASMKPGASILVAEQILQRPGAASWQRERVMRALDMQMMIQFGSKERAYEDWDALFKSVDPPLEIVDCVQPVGSADSFMELKRRA,2.1.1.- (0.5185),methylation (GO:0032259) (0.1725); aflatoxin biosynthetic process (GO:0045122) (0.0932); biosynthetic process (GO:0009058) (0.0660); fatty acid biosynthetic process (GO:0006633) (0.0624); mycophenolic acid biosynthetic process (GO:0140722) (0.0541); terpenoid biosynthetic process (GO:0016114) (0.0533),cytoplasm (GO:0005737) (0.0893); nucleus (GO:0005634) (0.0732),O-methyltransferase activity (GO:0008171) (0.1120); metal ion binding (GO:0046872) (0.1063); DNA binding (GO:0003677) (0.0621),S-adenosyl-L-methionine-dependent methyltransferase superfamily (IPR029063) (0.4263); O-methyltransferase domain (IPR001077) (0.1841); Winged helix-like DNA-binding domain superfamily (IPR036388) (0.1648); Winged helix DNA-binding domain superfamily (IPR036390) (0.1484); O-methyltransferase COMT-type (IPR016461) (0.1286),3.40.50.150 (0.3676); 1.10.10.10 (0.2660),Virulence (0.4814); S-adenosyl-L-methionine (0.3787); Reference proteome (0.2904); Methyltransferase (0.2624); Cytoplasm (0.2364); 3D-structure (0.1502); Metal-binding (0.0650),
MSTGSTLNQRSGKPVKLRASCDFCALSKVKCDRGQPQCVRCIKSGIDCNYSESRRIGKAWHHCAPSAVRSTSATTQGTRRKQQTIAQHSPRRRIHRDTQALSAADDAMSPYDPSGYATPFSMFHTLPSPVPESTIRSQTHIESYPSLDGTMAPILCSPESADISLPDIPHVAQLRTNELEGESPSVLQYNPSWDRIMAEHSTAIGDAGDCITRAAAVLKSVRDPRTSCVRSRTPPRSHTQSLDATLDDGRTAMDTVKDILACPCAQEIRVALLLVLIIQQVLESYQALLTQQHDTPREESPLGINLSRYDTPMAIGRYLLDNELRSKIIVQVLSSELEKIGLILDILTRHAQSMAHQPDELILGTYIDSLQTTKKEVLESLEQGNDI,,negative regulation of transcription by RNA polymerase II (GO:0000122) (0.3799); positive regulation of transcription by RNA polymerase II (GO:0045944) (0.2491); positive regulation of secondary metabolite biosynthetic process (GO:1900378) (0.2086); aflatoxin biosynthetic process (GO:0045122) (0.1465); positive regulation of transcription from RNA polymerase II promoter by galactose (GO:0000435) (0.1072); filamentous growth of a population of unicellular organisms in response to starvation (GO:0036170) (0.0763); regulation of DNA-templated transcription (GO:0006355) (0.0704); cellular response to starvation (GO:0009267) (0.0476),cytoplasm (GO:0005737) (0.1063); nucleus (GO:0005634) (0.0973),"zinc ion binding (GO:0008270) (0.4057); DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981) (0.1094); sequence-specific DNA binding (GO:0043565) (0.0860); DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228) (0.0710)",Zn(2)Cys(6) fungal-type DNA-binding domain (IPR001138) (0.2836); Zn(2)-C6 fungal-type DNA-binding domain superfamily (IPR036864) (0.2310),4.10.240.10 (0.5826),Virulence (0.7214); Reference proteome (0.3310); Nucleus (0.2277); Metal-binding (0.1682); DNA-binding (0.1557); Transcription (0.1260); Zinc (0.1199); Transcription regulation (0.0527),
MEELTRSLVNDVEVLNNHFVSTGHPLPSFDRHTPTVVLPNDASPDAHAARERILDNALRLFQLAAGPSAYLLNLQTGYQYASCVRWLCHFQIFHLVPLEGSIAYADLAVLAKAPEPQLISVVRMAMTNGLFLESPPQHLAHSATSALLRNDADFHDWAVTMSDLSFPTAFAMVEAHERWPNSVEGNQTAYNIAVGSELPFFSHLAEQSDRKRQFAGFMRSMARSQGTDVEKLAEGWDWAALGQACVVDVGGSTGHTSVALARKYPDLNFVVEDLPEVVAEGPGYLSYLDDAQDLKSRIGYRAHSFFDPQPVQDADVYMLRMILHNWSFDDCVRILSRLVQTLKPGARIIIVDIVLPDPGVVSASKERLLRVQDLIMQQVFNSMERYLENWMDIFRKVDERLEVKRIVEPPGSLMSLIELSMAA,2.1.1.- (0.2603),methylation (GO:0032259) (0.1215); melatonin biosynthetic process (GO:0030187) (0.0698); flavonol biosynthetic process (GO:0051555) (0.0582); lignin biosynthetic process (GO:0009809) (0.0558); fatty acid biosynthetic process (GO:0006633) (0.0421),cytoplasm (GO:0005737) (0.0536),O-methyltransferase activity (GO:0008171) (0.0983); DNA binding (GO:0003677) (0.0435),S-adenosyl-L-methionine-dependent methyltransferase superfamily (IPR029063) (0.3514); Winged helix-like DNA-binding domain superfamily (IPR036388) (0.1296); O-methyltransferase domain (IPR001077) (0.1142); Winged helix DNA-binding domain superfamily (IPR036390) (0.1070); O-methyltransferase COMT-type (IPR016461) (0.0791),3.40.50.150 (0.1993); 1.10.10.10 (0.1883),Reference proteome (0.2242); S-adenosyl-L-methionine (0.2129); Methyltransferase (0.2023); 3D-structure (0.1900); Cell cycle (0.0939); Cytoplasm (0.0917); Virulence (0.0746),
MKYPKQIRTYCPFCKRHTIHKVEKVKKRPRSELSAGQRRFRRKLKGYTGFPRPNPAGREKPVKKLDLRFRCTVCGKAHTRGQGFRVKKFELVEV,,cytoplasmic translation (GO:0002181) (0.4566); translation (GO:0006412) (0.3067); ribosomal large subunit assembly (GO:0000027) (0.1364); regulation of cell cycle (GO:0051726) (0.1293); rRNA processing (GO:0006364) (0.0885); positive regulation of DNA-templated transcription (GO:0045893) (0.0714); negative regulation of apoptotic process (GO:0043066) (0.0685),cytosol (GO:0005829) (0.4398); cytosolic large ribosomal subunit (GO:0022625) (0.1092); ribonucleoprotein complex (GO:1990904) (0.0632),large ribosomal subunit rRNA binding (GO:0070180) (0.3077); structural constituent of ribosome (GO:0003735) (0.2425); zinc ion binding (GO:0008270) (0.2227); RNA binding (GO:0003723) (0.2091); 5S rRNA binding (GO:0008097) (0.1827); metal ion binding (GO:0046872) (0.0876),Large ribosomal subunit protein eL42 (IPR000552) (0.4165); Eukaryotic Ribosomal Large Subunit eL42 (IPR053708) (0.2471); Zinc-binding ribosomal protein (IPR011332) (0.1542),3.10.450.80 (0.2853),rRNA-binding (0.9342); Zinc-finger (0.7708); Zinc (0.6681); RNA-binding (0.6247); 3D-structure (0.5956); Reference proteome (0.5636); Ribosomal protein (0.5579); Ribonucleoprotein (0.2426); Phosphoprotein (0.2136); Metal-binding (0.1411); Proteomics identification (0.1098); Direct protein sequencing (0.0772); Cytoplasm (0.0667),
MIMLKTQRRIAAELLKCGENRIWIDPERIEDVAAAITREDIKRLIHDGVIKKKPIKGQSRARARAFQEARKKGRHRGPGSKKGKKTARMGKKEVWMMTIRALRKELRKLKAEGKLDAHTYRRLYIRAKGGQFKNKRQLYMFMQEHGILKE,,"translation (GO:0006412) (0.6113); cytoplasmic translation (GO:0002181) (0.2212); maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462) (0.2062); regulation of translation (GO:0006417) (0.0996); maintenance of translational fidelity (GO:1990145) (0.0684); rRNA processing (GO:0006364) (0.0547)",cytosol (GO:0005829) (0.6139); cytosolic large ribosomal subunit (GO:0022625) (0.3672); cytoplasm (GO:0005737) (0.2121),large ribosomal subunit rRNA binding (GO:0070180) (0.2990); structural constituent of ribosome (GO:0003735) (0.2034); RNA binding (GO:0003723) (0.1767),"Large ribosomal subunit protein eL19 (IPR039547) (0.3893); Large ribosomal subunit protein eL19 domain (IPR000196) (0.3738); Large ribosomal subunit protein eL19, domain 1 (IPR015972) (0.3277); Large ribosomal subunit protein eL19, archaeal (IPR033936) (0.3041); Large ribosomal subunit protein eL19, conserved site (IPR023638) (0.2770); Large ribosomal subunit protein eL19 superfamily (IPR035970) (0.2074)",1.10.1650.10 (0.3681); 1.10.1200.240 (0.0865),rRNA-binding (0.9456); Ribonucleoprotein (0.8696); RNA-binding (0.6893); Ribosomal protein (0.5276); Reference proteome (0.4704); Direct protein sequencing (0.3331); 3D-structure (0.2989); Translation regulation (0.2055); Isopeptide bond (0.1696); tRNA-binding (0.0514),
MPPLGVLLLLVALGHSTQGHRPLPIRKAHKFDWWERGNFYQIYPRSFKDSDGDGIGDLKGITQTIDYLKTIGIDGVWLSPIFKSPMNDFGYDISDFYAIQEEYGTMEDFEELAAKCASIGLKLILDFVPNHSSDEHEHFRLSEEGIEPYKDYYIWHSGVLDANGTRHPPSNWISVFRGSAWQWSDKRQQYYLHQFQKKQPDLNYRNPALVEEMKNVMRFWLNKGIAGFRIDALPYLFESEEVDGHYRDEPLSGQATDDPDNPAYLTHTETKDQPETYDMVHQWRQVVDEYTARDNFTRIILTEAYTAVQNMTRFYGTPAAPGAQIPFNFQLITLLTVNSTGRDFVNAVQSWTRAMPSGAIANWVLGNHDNSRIASRLGVARADLYNIALQTLPGIAVTYYGEEIAMVDQWISWNDTIDPAACNADPATYELYSRDPVRTPFQWSNGTNAGFSNASRTWLPVADGYRELNVAAQLAAPRSHLKTFMQLTAYRKRRLLAEGNFVLRTVGRDLVMYKRSVPGVGYVVVALNFGPEPATLPVASQFPGTGEHWLKVIASSLQAQPQAGTWINTRLYKLAPDSGIVLERLTGRNDLMT,"alpha-glucosidase (3.2.1.20) (0.3891); oligo-1,6-glucosidase (3.2.1.10) (0.2639); alpha-amylase (3.2.1.1) (0.1845)",oligosaccharide catabolic process (GO:0009313) (0.3363); carbohydrate metabolic process (GO:0005975) (0.2189); L-cystine transport (GO:0015811) (0.1090); glycosphingolipid catabolic process (GO:0046479) (0.1037); lipid metabolic process (GO:0006629) (0.0979); aspartate transmembrane transport (GO:0015810) (0.0870),endoplasmic reticulum (GO:0005783) (0.3929); lysosomal lumen (GO:0043202) (0.3478); apical plasma membrane (GO:0016324) (0.1150); extracellular exosome (GO:0070062) (0.1083); Golgi apparatus (GO:0005794) (0.0930); extracellular space (GO:0005615) (0.0583),metal ion binding (GO:0046872) (0.2027),"Glycosyl hydrolase, family 13, catalytic domain (IPR006047) (0.4468); Oligo-1,6-glucosidase, domain 2 (IPR045857) (0.2280); Glycosyl hydrolase, all-beta (IPR013780) (0.1980); Alpha amylase (IPR006046) (0.1145)",2.60.40.1180 (0.4562); 3.20.20.80 (0.1719),Reference proteome (0.7464); Hydrolase (0.5114); Signal (0.5008); Glycosidase (0.3051); Direct protein sequencing (0.2818); Alternative splicing (0.2589); Lysosome (0.1724); Metal-binding (0.1724); Disulfide bond (0.1715); Chloride (0.1668); 3D-structure (0.1430),
MEDDDFSIKDKKENYETCSTETISSYISINEKCQLIEKDINDDNHENPYMIFNKISSSLIAMLQGVEVLCNLSIIYLLKDNYHLHPASLSIVMCFIKIPWSIKLVWAVISDNYPIFGYRRKYYLLLGSFLCILSLICLGLITHNNLFITILLLFIYFFGSSLCNVIGEAQVVESNRNCSINSSARNVSLFFAFRKLSFAIMSYLSGYLLLLISKKHIFLIGSFLPICVFTSGFFIIEKRNYTKSSIKDQIKCIYSIIKLSYLKNFIIFIFIMMSTPSCGNTLFFYITNELKFSPNLLGKMAMFQSLASFISIISYMLFFTKIDIRKLLLYSTIIITPFCLLPLVVIKKVNYFLFIPNTLFFITDTVLIEFIAEFQTMPILVLCSRLIPEGFESTIYSLLLSSNNFASIISSFLSSLLTYSLNITSTNFTNLPYMIIICCLTNIIPIFFLYILPNHSQKKNLQHSNSHTQKYYSYPSTDYISSQKSDSSEITKFSADMQIDDITLE,,transmembrane transport (GO:0055085) (0.1363); iron ion transmembrane transport (GO:0034755) (0.0882); intracellular iron ion homeostasis (GO:0006879) (0.0859); macroautophagy (GO:0016236) (0.0799); iron ion transport (GO:0006826) (0.0736); folic acid transport (GO:0015884) (0.0681); defense response to bacterium (GO:0042742) (0.0438); peptide transport (GO:0015833) (0.0404),mitochondrion (GO:0005739) (0.5316); plasma membrane (GO:0005886) (0.0952); endosome membrane (GO:0010008) (0.0920); endoplasmic reticulum membrane (GO:0005789) (0.0672); membrane (GO:0016020) (0.0628),,MFS transporter superfamily (IPR036259) (0.1984); Folate-biopterin transporter (IPR004324) (0.1505),,Transmembrane (0.8962); Transport (0.8945); Membrane (0.6573); Glycoprotein (0.4003); Transmembrane helix (0.3816); Reference proteome (0.2357); Meiosis (0.0873); Mitochondrion (0.0821); Virulence (0.0571),
MNGNQIKQLKKLYRHILNEASKFENINYNVYFSNKAKEKFREFCSDTNFESEKLKTFQNECWDYLNMLKRQTIIHNLYHVDKPLVNK,cysteine desulfurase (2.8.1.7) (0.0516); RING-type E3 ubiquitin transferase (2.3.2.27) (0.0499),iron-sulfur cluster assembly (GO:0016226) (0.3001); response to oxidative stress (GO:0006979) (0.2658); positive regulation of transcription by RNA polymerase II (GO:0045944) (0.2228); cell surface receptor signaling pathway (GO:0007166) (0.1699); apoptotic process (GO:0006915) (0.1146); negative regulation of Ras protein signal transduction (GO:0046580) (0.1025); aerobic respiration (GO:0009060) (0.0941); negative regulation of neuron apoptotic process (GO:0043524) (0.0577); cellular response to reactive oxygen species (GO:0034614) (0.0488),mitochondrial matrix (GO:0005759) (0.3257); cytosol (GO:0005829) (0.2898); nucleus (GO:0005634) (0.2767); L-cysteine desulfurase complex (GO:1990221) (0.0997),"2 iron, 2 sulfur cluster binding (GO:0051537) (0.1535)","Complex 1 LYR protein domain (IPR008011) (0.2687); LYRM4, LYR domain (IPR045297) (0.1305)",,Reference proteome (0.4826); Transport (0.4679); Nucleus (0.3588); Cytoplasm (0.2948); Phosphoprotein (0.2710); Ubiquinone (0.2314); Mitochondrion (0.2092); Membrane (0.1879); Proteomics identification (0.1772); Metal-binding (0.1332); Oxidoreductase (0.1315); Acetylation (0.1260); Respiratory chain (0.1032); Direct protein sequencing (0.0886),
MIEKSNNPFLSIDPIVERTKSNGEGLPLLSEKTKKGFDFTQIVVYLVGLSDGLTHLASLAIYYLFKDYFRLTPYQVSLILMYPYIPFILKPVIALITDSFSIFGMRRKPYLFLFSLFQSLNFLALAFLNLSVIQASLILFFISLCASFCTTVAEALVVESSMGQTYSQGTNKVTEFIASKAIGSLSVAYFSGYFLEKMPREYIFIATSIFPLIISLSCLFLKEKEYSTNRNIFNQLSDLIKFINTPIFLGPFLYIFVYMSGPDYDDAFFFFCTNKLGFRPSFMGTLRLTYGIASLIGIIIYRVFLKNCSLRKTLIITTLVSFPIYISPIILTEHINKFLGISNELFVLSGGFLIEAITEIQLLPLFILTANICQPGLEASVFATILSVKNLGSLTKKGTSSFITYLMKIDSYNFDNLSLYILTCGFFLLFSLTLVPLLPNEEHIEKLKNKETSKG,,transmembrane transport (GO:0055085) (0.1125); folic acid transport (GO:0015884) (0.1050); peptide transport (GO:0015833) (0.0702); heme transport (GO:0015886) (0.0646); protein targeting to vacuole (GO:0006623) (0.0579); iron ion transmembrane transport (GO:0034755) (0.0575); glycolytic process (GO:0006096) (0.0573); monoatomic ion transport (GO:0006811) (0.0507); peptidoglycan transport (GO:0015835) (0.0495); defense response to bacterium (GO:0042742) (0.0492); mitochondrion organization (GO:0007005) (0.0466); peroxisome organization (GO:0007031) (0.0414),mitochondrion (GO:0005739) (0.4525); plasma membrane (GO:0005886) (0.1438); endosome membrane (GO:0010008) (0.1162); membrane (GO:0016020) (0.1119); plastid (GO:0009536) (0.0457),folic acid transmembrane transporter activity (GO:0008517) (0.3265),MFS transporter superfamily (IPR036259) (0.2308); Folate-biopterin transporter (IPR004324) (0.1375); Biopterin transporter family (IPR039309) (0.1038),,Transmembrane (0.8953); Transport (0.8563); Membrane (0.7047); Reference proteome (0.4959); Glycoprotein (0.3811); Transmembrane helix (0.2374); Mitochondrion (0.0616); Vacuole (0.0586),
MKSKILCNLFKGKSCICLYTNCLNENNVNKCYYNLVRNYSDHVKDHFNKPRNVGSFDKNEKNIGTSIVGKASCGDVIKLQLKIENDVIKDARFMAFGCGSAIASSSYATELIKGKTIDEALKIKNNDIASHLSLPPVKIHCSLLAEDAIKHAIKNYREKVLT,,intracellular iron ion homeostasis (GO:0006879) (0.8675); iron-sulfur cluster assembly (GO:0016226) (0.2879); response to iron ion (GO:0010039) (0.0686),mitochondrial matrix (GO:0005759) (0.4784); iron-sulfur cluster assembly complex (GO:1990229) (0.1692); nucleus (GO:0005634) (0.1350); cytoplasm (GO:0005737) (0.1062); mitochondrion (GO:0005739) (0.0719); nuclear replication fork (GO:0043596) (0.0449),"ferrous iron binding (GO:0008198) (0.4362); 2 iron, 2 sulfur cluster binding (GO:0051537) (0.1122); metallochaperone activity (GO:0016530) (0.0490); zinc ion binding (GO:0008270) (0.0449)","NIF system FeS cluster assembly, NifU, N-terminal (IPR002871) (0.1818)",3.90.1010.10 (0.2416),Transit peptide (0.6436); Mitochondrion (0.3966); Metal-binding (0.2492); Reference proteome (0.1921); Zinc (0.1328); 3D-structure (0.0981),
MLGELIFLLRSLHGFLASSGPIGAALAWLISFKPILFAFLLLLLLLSNWLVKQEHNLAPSPPQEEAETTTAPEVHPKNNVKNKEELEKINACFALQDKVLERLMFSEMKLKALENQVFVIWNKINRRRWSSRQRNFSRRRHRSRRHDSTFSTLSKCTTVTPTECD,,negative regulation of DNA-binding transcription factor activity (GO:0043433) (0.4200); apoptotic process (GO:0006915) (0.3136); activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919) (0.2184); cellular response to reactive oxygen species (GO:0034614) (0.1605); positive regulation of gene expression (GO:0010628) (0.1487); selenocysteine incorporation (GO:0001514) (0.1103); cellular response to heat (GO:0034605) (0.0967); cell differentiation (GO:0030154) (0.0818); positive regulation of cell population proliferation (GO:0008284) (0.0722); positive regulation of cytokine production (GO:0001819) (0.0696); protein import into nucleus (GO:0006606) (0.0598); negative regulation of DNA-templated transcription (GO:0045892) (0.0570); amyloid-beta metabolic process (GO:0050435) (0.0445); alpha-beta T cell differentiation (GO:0046632) (0.0411),membrane (GO:0016020) (0.1293); plasma membrane (GO:0005886) (0.1209); nuclear inner membrane (GO:0005637) (0.1074); protein-containing complex (GO:0032991) (0.1057); PML body (GO:0016605) (0.0640); nucleus (GO:0005634) (0.0477); cytoplasm (GO:0005737) (0.0418),protein domain specific binding (GO:0019904) (0.1035); signaling receptor binding (GO:0005102) (0.0422),,,Reference proteome (0.2864); Transmembrane (0.2238); Differentiation (0.2086); Membrane (0.1822); Glycoprotein (0.1551); Cytoplasm (0.1220); Nucleus (0.0949); Phosphoprotein (0.0911); Transmembrane helix (0.0713); Signal (0.0489),
MEEVTSQEAAESPRGHFQPLENQSECLSPELRFLQDTDMEQGFSGGFPISKPDGISEREQDLQVFDLESKNREVIRGDCSDGETREENKLLIPKRKISEEVHSYKVRVGKFKQDIAQVPETREVYKSEDRLERLQEILRKFLFLEREFRQITISKKTFSSEKNTEPEKSFSLDSTLDTDQRVLRIQTTDDSKYDMNFNQNPAVGEQEPINLTENFQSTDYKESLMDLSHLNKWESMPTTDRSYKCDTCGKTFHQASALTRHQRIHTREKPYKCKECEKSFSQSSSLSRHKRIHTREKSYKCEASDKSCDAPDKSCSQSSDVLQHKKGHAKAKSYKCGTCERVFSRSVHLTQHQRTHKDMSCKCTVCGSDFCHTSYLVEHQRLHHQEKSYEYDECGLAYVKQQGIRFQEKPYSCNECGKDFRLNSHLIQHQRIHTGEKLHECNECGKSFSQTSCLIQHHKMHRKEKSYEYNNYEESFSHSSDLTLQQEVPIRERVFDCDAWEENFSQRAHLIQHERVHTKEKPYECSELGETFSQVQASFNM,,regulation of transcription by RNA polymerase II (GO:0006357) (0.5945); positive regulation of erythrocyte differentiation (GO:0045648) (0.4903); positive regulation of cell population proliferation (GO:0008284) (0.4867); negative regulation of transcription by RNA polymerase II (GO:0000122) (0.1474); negative regulation of DNA-templated transcription (GO:0045892) (0.1169); positive regulation of kinase activity (GO:0033674) (0.0810); positive regulation of transcription by RNA polymerase II (GO:0045944) (0.0755),nucleus (GO:0005634) (0.2488); cytoplasm (GO:0005737) (0.2196); nucleolus (GO:0005730) (0.1448); cytosol (GO:0005829) (0.0934); nucleoplasm (GO:0005654) (0.0598),"metal ion binding (GO:0046872) (0.1852); RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978) (0.1106); DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981) (0.0582)",Zinc finger C2H2-type (IPR013087) (0.5801); Zinc finger C2H2 superfamily (IPR036236) (0.0952); Krueppel-associated box (IPR001909) (0.0416),3.30.160.60 (0.2663),Ubl conjugation (0.9171); Zinc-finger (0.7972); Repeat (0.6495); Isopeptide bond (0.4157); Nucleus (0.3231); DNA-binding (0.2958); Reference proteome (0.2248); Transcription regulation (0.2246); Metal-binding (0.2067); Transcription (0.1871); Activator (0.1855); Proteomics identification (0.1533); Phosphoprotein (0.1499); Zinc (0.1468); Cytoplasm (0.0907); Repressor (0.0813),
MAVFPLSAKHRKYALRALAVSIILVSAAYIASTERTERVRPQRVEQNLPPLSWGGSGVQTAYWVQEAVQPGDSLADVLARSGMARDEIARITEKYGGEADLRHLRADQSVHVLVGGDGGAREVQFFTDEDGERNLVALEKKGGIWRRSASEADMKVLPTLRSVVVKTSARGSLARAEVPVEIRESLSGIFAGRFSLDGLKEGDAVRLMYDSLYFHGQQVAAGDILAAEVVKGGTRHQAFYYRSDKEGGGGGNYYDEDGKVLQEKGGFNIEPLVYTRISSPFGYRMHPILHTWRLHTGIDYAAPQGTPVRASADGVITFKGRKGGYGNAVMIRHANGVETLYAHLSAFSQAEGNVRGGEVIGFVGSTGRSTGPHLHYEARINGQPVNPVSVALPTPELTQADKAAFAAQKQKADALLARLRGIPVTVSQSD,3.4.24.- (0.4183); 3.4.11.- (0.2321),septum digestion after cytokinesis (GO:0000920) (0.4752); proteolysis (GO:0006508) (0.4453); peptidoglycan metabolic process (GO:0000270) (0.1645); chitin catabolic process (GO:0006032) (0.0432),plasma membrane (GO:0005886) (0.3381); cell outer membrane (GO:0009279) (0.1022),metalloendopeptidase activity (GO:0004222) (0.5019); peptidoglycan binding (GO:0042834) (0.3188); metal ion binding (GO:0046872) (0.1608),"Bacterial cell wall metabolism enzyme (IPR050570) (0.8095); Peptidase M23 (IPR016047) (0.4584); Duplicated hybrid motif (IPR011055) (0.4117); Csd3-like, second N-terminal domain (IPR045834) (0.1271)",2.70.70.10 (0.3396); 3.10.450.350 (0.1800),Zinc (0.5850); Signal (0.4210); Hydrolase (0.3816); Metalloprotease (0.3698); Zymogen (0.3611); Transmembrane (0.3596); Metal-binding (0.2992); Cell membrane (0.2913); Membrane (0.2604); Virulence (0.2364); Sporulation (0.2302); Transmembrane helix (0.2099); 3D-structure (0.2050); Calcium (0.1993); Protease (0.1935); Reference proteome (0.1623); Direct protein sequencing (0.1238); Septation (0.0885),Zn(2+) (0.3433)
MLRYRQVVGLLQRRNFSAGATSNGSGSSGGDKSGEDLHPIRRTLRLLGNDMRKVKEFFVPKEPETEKVPIPTQSQFHFSGERDKSKEATVPDDFQTHCDVLIIGGGGVGSSIAYWLKEKARDGLNVVVVEKDDTYAQSATRVSVGGLCQQFSLPENIQMSLFAADFLRSARKHFGEEVPLQFTPHGHLMLAGEEHAESLKRSSQLQNELGARNELLTADRLTARFPWLNTKGIALGCLGLEKEGWFNPLALLSNFRRSASGYGAHFISGQVVDFEFKSQTDISVVTDLGSNEGAYTGLEKAVIQLPDGTRRTCKFALCVISAGASSEQIARLARIGVGPGILRVPLPINARKRYMYAINSQAQSAPGMNMPMTIDPSGIFIRRDGLGGNYICVQDSTEEYNSAMIDPQYFAQHIRPHLYNRIPVLGEAQVVDSWAGCYDHNVYDENGILGAHPYYNNLYLATGFSGHGVQQSLAVGRAISELIMDGQFRTIDLSRLSFDRLIVDQPMFELNNVLS,dimethylglycine dehydrogenase (1.5.8.4) (0.0592),mitochondrial respiratory chain complex I assembly (GO:0032981) (0.3595); circadian rhythm (GO:0007623) (0.1220); positive regulation of DNA-templated transcription (GO:0045893) (0.0779),mitochondrial inner membrane (GO:0005743) (0.4827); cytoplasm (GO:0005737) (0.2887); mitochondrion (GO:0005739) (0.2156); membrane (GO:0016020) (0.1860); extracellular region (GO:0005576) (0.1420); mitochondrial matrix (GO:0005759) (0.0676),oxidoreductase activity (GO:0016491) (0.1379); ATP binding (GO:0005524) (0.0732); electron transfer activity (GO:0009055) (0.0480),FAD/NAD(P)-binding domain superfamily (IPR036188) (0.6784); FAD dependent oxidoreductase (IPR006076) (0.1599),3.50.50.60 (0.4089); 3.30.9.10 (0.1353),Reference proteome (0.8254); FAD (0.5757); Phosphoprotein (0.5704); Transport (0.4788); Transit peptide (0.4727); Mitochondrion (0.3534); Flavoprotein (0.3292); Oxidoreductase (0.2525); Electron transport (0.1757); Alternative splicing (0.0551),FAD (0.5757)
MEVNQKWNWDTKPILVKCGGFSSQLAKNVTEKVDGDPLWGSRFDATNPEAVIQTHLDFLRNGADIILTNTYQSSVEGFVKYLGVTRERGVELIQKSVQLAKQAKEQYLSEIGSEAESALPLIMGSIGPYGAYLHDGSEYTGNYADKMSKEELRAWHKTRIEICLAAGVDGLALETLPCLMEAEAVTELVLDNFPDAKFWVSLQCMDEKHMASGENFAEAALSLWRLVQSRKAENRLLGIGLNCVNPLFVTPLLSSLTKVAGSDRIPLVVYSNRGEIYDVEQGDWTGTGEEVVKFVPEWIQLGVRIVGGCCRVYPTDVLAIRKYVDGLNIKP,homocysteine S-methyltransferase (2.1.1.10) (0.6742); 2.1.1.- (0.0867),methionine biosynthetic process (GO:0009086) (0.3435); response to bacterium (GO:0009617) (0.2044); response to ethanol (GO:0045471) (0.0989); methylation (GO:0032259) (0.0982); response to osmotic stress (GO:0006970) (0.0837); 'de novo' L-methionine biosynthetic process (GO:0071266) (0.0780); response to light stimulus (GO:0009416) (0.0753),nucleus (GO:0005634) (0.1972); cytosol (GO:0005829) (0.1335),S-methylmethionine-homocysteine S-methyltransferase activity (GO:0061627) (0.1466); zinc ion binding (GO:0008270) (0.0600),"Homocysteine-binding domain superfamily (IPR036589) (0.2562); Homocysteine-binding domain (IPR003726) (0.2241); Homocysteine S-methyltransferase (IPR051486) (0.2023); Betaine-homocysteine S-methyltransferase, BHMT (IPR017226) (0.1910)",3.20.20.330 (0.5005),Zinc (0.9022); Reference proteome (0.7842); Methyltransferase (0.4902); Metal-binding (0.4427); Nucleus (0.0718),Zn(2+) (0.1027)
MSQLRSKVISLYKHLQYLGREYPGLNGPQKFRKQIHDAFMNHKDEQDPKKIVALLAQGRYLAKEVEALYSLKKYRSVKQRYSYND,,DNA repair (GO:0006281) (0.6487); aerobic respiration (GO:0009060) (0.4795); negative regulation of apoptotic process (GO:0043066) (0.3152); regulation of autophagy (GO:0010506) (0.2288); protein destabilization (GO:0031648) (0.0846); negative regulation of release of cytochrome c from mitochondria (GO:0090201) (0.0663); positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436) (0.0463); negative regulation of neuron apoptotic process (GO:0043524) (0.0426); regulation of insulin secretion (GO:0050796) (0.0400),mitochondrion (GO:0005739) (0.2185); nucleus (GO:0005634) (0.1229); mitochondrial matrix (GO:0005759) (0.1013); nuclear body (GO:0016604) (0.0998); cytosol (GO:0005829) (0.0762),protein homodimerization activity (GO:0042803) (0.0951); protein-containing complex binding (GO:0044877) (0.0648),Complex 1 LYR protein domain (IPR008011) (0.6594),,Phosphoprotein (0.6602); Respiratory chain (0.6413); Reference proteome (0.5308); Proteomics identification (0.4715); Transport (0.4086); Membrane (0.3610); Mitochondrion (0.2071); Mitochondrion inner membrane (0.1903); Cytoplasm (0.1858); Acetylation (0.1843); Disease variant (0.1802); Zinc-finger (0.1541); Lipid-binding (0.1506); Primary mitochondrial disease (0.0678); 3D-structure (0.0462),
MALSRAKPDELPRDAVVITEDQALKYQWKIITSWDKIGEVWSLRYTPGILSALAAGTGAYINNHYRTKLRLGGHGRLSTYLPIVAVPAIFTMLAHKFFIQRPILLNPLGECPVCIQMRSAAFQTSLGIVYPTILAPFAAFLFATRCYTYRIPSITENPREVFLLWRKFTRPIVPALGTLIGLQALLTMFLTGQEDKQNFKLMLRMREIEHQVEEEHLPQRMDF,NADH:ubiquinone reductase (H+-translocating) (7.1.1.2) (0.1952),mitochondrial respiratory chain complex I assembly (GO:0032981) (0.3951); protein insertion into mitochondrial inner membrane from matrix (GO:0032979) (0.1395); mitochondrial protein quality control (GO:0141164) (0.1335); mitochondrion organization (GO:0007005) (0.1263); protein insertion into mitochondrial inner membrane (GO:0045039) (0.0989); DNA replication (GO:0006260) (0.0832); regulation of protein catabolic process (GO:0042176) (0.0690); regulation of translation (GO:0006417) (0.0581); ATP biosynthetic process (GO:0006754) (0.0515),mitochondrial intermembrane space (GO:0005758) (0.3962); mitochondrion (GO:0005739) (0.1847); protein-containing complex (GO:0032991) (0.0952); mitochondrial inner membrane (GO:0005743) (0.0938),,,,Disease variant (0.6359); Primary mitochondrial disease (0.4993); Reference proteome (0.3799); Mitochondrion (0.3057); Phosphoprotein (0.2480); Membrane (0.2015); Transit peptide (0.2009); Transmembrane (0.1737); Acetylation (0.1567); 3D-structure (0.1178); Neurodegeneration (0.1155); Mitochondrion inner membrane (0.1074); Intellectual disability (0.0792); Alternative splicing (0.0461),
MIARTLRTVGRQGRNLLLPRITACRPLHAIPANFSKAYDHDGKTKVTIFNTETDLGLMVTGYSQYGFRLNNDMVLIGPISVFPRSVLSWNVNSFEDINEDSLSLFPTLEPKIDVLIIGIGDQAPPPALSKRIIEFMKKYKINVEILRTEQACATFNFLNAENRMVACALIPPLHLSYNENDILQAKLRKKELYETE,,"regulation of mitochondrion organization (GO:0010821) (0.3098); cellular respiration (GO:0045333) (0.2604); mitochondrial respiratory chain complex I assembly (GO:0032981) (0.1924); tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) (0.1801); visual perception (GO:0007601) (0.1179); DNA repair (GO:0006281) (0.1066); double-strand break repair (GO:0006302) (0.0851); negative regulation of apoptotic process (GO:0043066) (0.0802); brain development (GO:0007420) (0.0698)",mitochondrial inner membrane (GO:0005743) (0.6308); nucleus (GO:0005634) (0.3528); nucleoplasm (GO:0005654) (0.2086); mitochondrial matrix (GO:0005759) (0.0791); TIM23 mitochondrial import inner membrane translocase complex (GO:0005744) (0.0567),,MTH938-like superfamily (IPR036748) (0.2943); NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 3 (IPR034095) (0.1075); NDUFAF3/Mth938 domain-containing protein (IPR007523) (0.0589),3.40.1230.10 (0.5630),Transport (0.6885); Mitochondrion inner membrane (0.4870); Membrane (0.4262); Mitochondrion (0.2695); Phosphoprotein (0.2694); Nucleus (0.2682); Proteomics identification (0.1823); 3D-structure (0.1596); Disease variant (0.1083); Reference proteome (0.1072); Cardiomyopathy (0.0844); Direct protein sequencing (0.0733); Ubl conjugation (0.0660),
MSTFGAEVDQVWPAVTGDSPHLTNFGRKLLKDCRQVQKPIGGYENLGNVIKLSAEFPLEFGVNSVKVYRQSPSRLARINEEVASAYPLIHERTLGLYLQYLEHKCRWGNAVEKPIYRNLSLCGFVQRLLVKRCASFFARNDKYLLVSGESGASGFEAVGTREEKAPLVLANVLSYDDIKLSALLSVSSRTEFVNEGERTNCGHVDLNTKTLERHGVIVGMIGARLSRRNLMEFQDIVIARQQNTRERGYGMALDEPATTRDEDYRRLWREFYATRDLIHGQAVIDNQRFGPSKNKMDVFDNLVMKRRYAISFDMLLLEAEARAKRVKKLAYIHVVGFGLGVWKAAEQQERIFMETFEQRMRTLGNRLNNVGLVHFSWFSITHCGGLSNGSLIEIPGHPKDGIRVLISKRNPARKLSDPEHAGMLLVVSYAWDGNALPGNEFWMKMLQSTGDSSTACSTLVAELHNPYINTKFCNGGNLHIASPEHGVLHIAEYAKRVIRSESDAL,3.2.2.- (0.1135); protein-synthesizing GTPase (3.6.5.3) (0.1107); 2.1.1.- (0.0669),DNA recombination (GO:0006310) (0.2456); mitotic cell cycle (GO:0000278) (0.1426); DNA repair (GO:0006281) (0.1010); wing disc development (GO:0035220) (0.0648); photomorphogenesis (GO:0009640) (0.0621); epithelial cell differentiation (GO:0030855) (0.0597); cytoplasmic microtubule organization (GO:0031122) (0.0509); Notch signaling pathway (GO:0007219) (0.0469); kidney development (GO:0001822) (0.0444); regulation of gene expression (GO:0010468) (0.0438),nucleus (GO:0005634) (0.3710); mitochondrion (GO:0005739) (0.2053); extracellular region (GO:0005576) (0.1928); nuclear envelope (GO:0005635) (0.1195),,Protein of unknown function DUF4804 (IPR032063) (0.1771),,Cytoplasm (0.4651); Developmental protein (0.3102); Reference proteome (0.2631); mRNA processing (0.2549); 3D-structure (0.2403); Proteomics identification (0.1958); Ubl conjugation (0.1957); Alternative splicing (0.1570); Mitochondrion (0.1431); ATP-binding (0.1253),
MRSFLYMLSQRPKLACLCGKSIIIWPGKRTNLPENAFTQRMLQECGQMAKPDASVDLDNFKAISEQSPAEFGIDSCRVKAQPEDRSDRIREQIASAYPVIHERTLLLFISFLEHKLTFGSEQEKAIYKDMTVVDLVQRLLAKRCVWFFGANDYYRTMQGNIGNEGFEAVGTPAEKEPLTLTSVLSYDEIKLSALLYVSCHSEFINNGSRVNGGEVLQNKDTIEREGVVIGLIGARFERPDVMEYQDIMITKTQNTEANGYGFDLEQISSETVTPASDLRRIWREFYEEPRDFIYADTPYDTTRFEEVSQGIFDHQVMRKRYAISFDTLLLEAQDRAFKAGKPAYIHVVGIGLGVWKAARQQERTFLESFEGRLRALGERLSHIGVVHFSWFHLACVGSLHDGAIIPVDKHPQGGIRIRNSVRNPGDKLTEDMLPVVTYAWDGNALPGNEFWANMLISTGDPAAACSTLISELQNPHINVHYMNGANLHIASVEHGLLHVGDYARRLIV,RING-type E3 ubiquitin transferase (2.3.2.27) (0.0946),DNA repair (GO:0006281) (0.5314); mitotic cell cycle (GO:0000278) (0.5199); kidney development (GO:0001822) (0.1962); cellular response to lipopolysaccharide (GO:0071222) (0.1531); Wnt signaling pathway (GO:0016055) (0.1348); heart development (GO:0007507) (0.1056); wing disc development (GO:0035220) (0.1053); regulation of protein stability (GO:0031647) (0.0622); Notch signaling pathway (GO:0007219) (0.0548); mitotic cytokinesis (GO:0000281) (0.0495),nucleus (GO:0005634) (0.3986); nuclear envelope (GO:0005635) (0.1374); cytosol (GO:0005829) (0.1060); extracellular region (GO:0005576) (0.1031); mitochondrion (GO:0005739) (0.0985),,Protein of unknown function DUF4804 (IPR032063) (0.3457),,Cytoplasm (0.6526); Reference proteome (0.4765); mRNA processing (0.3808); 3D-structure (0.2389); Developmental protein (0.2363); Proteomics identification (0.2344); Acetylation (0.1664); Mitochondrion (0.1283); Allosteric enzyme (0.1064); Alternative splicing (0.0787); Cytoskeleton (0.0422); Aromatic amino acid biosynthesis (0.0420),
MGSNITSTSIIFLLTGVPGLEAFHTWISIPFCFLSVTALLGNSLILFATITQPSLHEPMYYFLSMLSATDLGLSISTLVTMLSIFWFNVREISFNACLSHMFFIKFFTVMESSVLLAMAFDRFVAVSNPLRYAMILTDSRIAQIGVASVIRGLLMLTPMVALLIRLSYCHSQVLHHSYCYHPDVMKLSCTDTRINSAVGLTAMFSTVGVDLLLILLSYVLIIRTVLSVASPEERKETFSTCVSHIVAFAIYYIPLISLSIVHRFGKQAPAYVHTMIANTYLLISPLMNPVIYSVKTKQIRRAVIKILHSKET,,G protein-coupled receptor signaling pathway (GO:0007186) (0.3666); sensory perception of smell (GO:0007608) (0.2663); cell migration (GO:0016477) (0.2360); sensory perception of sound (GO:0007605) (0.2329); adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189) (0.1933); melanocyte differentiation (GO:0030318) (0.1387); positive regulation of blood pressure (GO:0045777) (0.1345); positive regulation of renin secretion into blood stream (GO:1900135) (0.1273); steroid hormone receptor signaling pathway (GO:0043401) (0.0977); signal transduction (GO:0007165) (0.0897); response to light stimulus (GO:0009416) (0.0664); cellular response to fatty acid (GO:0071398) (0.0628); melanocyte proliferation (GO:0097325) (0.0599); regulation of angiogenesis (GO:0045765) (0.0543),plasma membrane (GO:0005886) (0.2689); early endosome membrane (GO:0031901) (0.1717),nuclear steroid receptor activity (GO:0003707) (0.3614); G protein-coupled receptor activity (GO:0004930) (0.1997); olfactory receptor activity (GO:0004984) (0.1503),"GPCR, rhodopsin-like, 7TM (IPR017452) (0.3018); Human and Mouse Olfactory Receptor (IPR050402) (0.2655); Olfactory receptor (IPR000725) (0.2376); G protein-coupled receptor, rhodopsin-like (IPR000276) (0.1990)",1.20.1070.10 (0.2754),Transducer (0.9910); Transmembrane helix (0.8143); Olfaction (0.7971); G-protein coupled receptor (0.5962); Sensory transduction (0.5500); Reference proteome (0.4873); Signal (0.3144); Receptor (0.2583); Glycoprotein (0.2444); Cell membrane (0.1732); Transmembrane (0.1409); Membrane (0.0915),
MAFYQQQPFYNPRIPFRGPIQGGLQDGKSIIISGRVLPGANRFHVNLQCGSHSGANVALHFNPRYEDTDYVVHNSYLNRTWGSEERKYESPFAKGQTFTLQILVAQDRYKISTNGRHFMDYKHRIPFTQVDTVAVEGMVEVNSVAFQNPAPYFPPQPAFPGFIPPQAGYAPQYAVPPGCGFPAFPSAPNYTIPYKTVMNGGLHPGKNIVINGIVNPNAKRITFNLCYRSGIAFHYNPRFDENVVVRNTNQMEKWGAEERFGGLPFHKGQPFQVTISCNPQHYNVFVNGKQVHTYKHRYTKLNDIDILEICGDLQLTSVQA,,monocyte chemotaxis (GO:0002548) (0.7951); neutrophil chemotaxis (GO:0030593) (0.6596); negative regulation of endocytosis (GO:0045806) (0.5962); macrophage chemotaxis (GO:0048246) (0.4028); RNA splicing (GO:0008380) (0.3000); negative regulation of extrinsic apoptotic signaling pathway (GO:2001237) (0.2743); positive chemotaxis (GO:0050918) (0.2596); eosinophil chemotaxis (GO:0048245) (0.2163); positive regulation of calcium ion import (GO:0090280) (0.2009); innate immune response (GO:0045087) (0.0638),nucleus (GO:0005634) (0.1709); extracellular space (GO:0005615) (0.1566); cytoplasm (GO:0005737) (0.1503),carbohydrate binding (GO:0030246) (0.2340); IgE binding (GO:0019863) (0.2278); disaccharide binding (GO:0048030) (0.0980),"Galectin-like (IPR044156) (0.3406); Concanavalin A-like lectin/glucanase domain superfamily (IPR013320) (0.2238); Galectin, carbohydrate recognition domain (IPR001079) (0.1368)",2.60.120.200 (0.3485),Lectin (0.7019); IgE-binding protein (0.4177); Immunity (0.3179); Innate immunity (0.1826); 3D-structure (0.1491); Cytoplasm (0.1385); mRNA splicing (0.1333); Reference proteome (0.1190); Secreted (0.0935); Repeat (0.0895); mRNA processing (0.0695),
MEMKTLVSCVGFLLLFVWLSPSQALYFHIGETEKKCFIEEIPDETMVIGRYRTQLWDKQAGSFLPSTPGLGMHVEIKDPETKVILSRQYGSDGRFTFTSHTPGEHQICLHSNSTKMALFAGGKLRVHLDIQVGEHTNNYPEIAAKDKLTELQLRVRQLLDQVEQIQKEQNYQRYREERFRMTSESTNQRVLWWSIAQTVILIITGIWQMKHLKSFFEAKKLV,,"intracellular protein transport (GO:0006886) (0.9335); endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888) (0.7176); Golgi organization (GO:0007030) (0.2972); COPI coating of Golgi vesicle (GO:0048205) (0.2662); positive regulation of protein secretion (GO:0050714) (0.1987); positive regulation of organelle organization (GO:0010638) (0.1815); positive regulation of interleukin-1 production (GO:0032732) (0.1073); retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890) (0.0766)",endoplasmic reticulum (GO:0005783) (0.3698); COPII-coated ER to Golgi transport vesicle (GO:0030134) (0.2807); endoplasmic reticulum membrane (GO:0005789) (0.2758); Golgi membrane (GO:0000139) (0.2517); endoplasmic reticulum-Golgi intermediate compartment (GO:0005793) (0.1910); Golgi apparatus (GO:0005794) (0.1389),cargo receptor activity (GO:0038024) (0.4927); protein transmembrane transporter activity (GO:0008320) (0.0563),GOLD domain (IPR009038) (0.2487); Transmembrane emp24 domain-containing protein (IPR015720) (0.1756),,Transmembrane (0.7373); Endoplasmic reticulum (0.6387); Signal (0.3966); Reference proteome (0.2746); Membrane (0.2369); Transmembrane helix (0.2233); Protein transport (0.1819); Coiled coil (0.1730); Proteomics identification (0.1626); Glycoprotein (0.1436); Golgi apparatus (0.1049); Transport (0.0970),
MAAPTQGEDSDDGMDEFMEKFKTQKYHNAFNESNWEEEFEKVPMFMKTAPENIDPEKHPDLACIQHIIHDDDRTPEEKARSLKDEGNEYFKEKKYKKAVVSYTEGLKTSCVNPELNAVLYTNRAAAHFHLGNMRSALNDATAAKKLKPDHNKAIIRGAQCLLELRNYAGALQWCDEGLKLFPTDKKLQELRATADKQKREADRDARKAKVKAKKQQNEKEALLAAIKERGIKLLKTEKPPHRASDSEDEDRDEDTSRALADLQLDGISSQEATGARVYMDEQGVLHWPVMFLYPEHSQTDFISAFSENASFIDHLAVMFGEELPPWDIDQKYQPQNLQMFFEDPEKGNLYQVDLQESLLRVLQHQRCSVKAGTPSFIVLVSESPFSRQFLSGKKVQRLKLLK,protein-serine/threonine phosphatase (3.1.3.16) (0.1314),innate immune response (GO:0045087) (0.7974); protein folding (GO:0006457) (0.6985); defense response to virus (GO:0051607) (0.3082); cell differentiation (GO:0030154) (0.0429),nucleus (GO:0005634) (0.4764); cytoplasm (GO:0005737) (0.2106); nucleoplasm (GO:0005654) (0.2006); cytosol (GO:0005829) (0.0963),Hsp90 protein binding (GO:0051879) (0.5457); Hsp70 protein binding (GO:0030544) (0.4808),"Cns1/TTC4, wheel domain (IPR044059) (0.5503); Tetratricopeptide-like helical domain superfamily (IPR011990) (0.1536); Tetratricopeptide repeat (IPR019734) (0.1255)",1.25.40.10 (0.1767),Reference proteome (0.6575); Repeat (0.5112); Ubl conjugation (0.4464); TPR repeat (0.3787); Cytoplasm (0.2626); Translation regulation (0.2079); Nucleus (0.1773); Proteomics identification (0.1768); Phosphoprotein (0.1512); Innate immunity (0.1444); 3D-structure (0.0865),
MWWFQEGLCVLPVALVVWTAATFIFAYITAVVLRHVDPLVPYISDTGTVAPERCVFGVMLNVSAFLGVATMYVRYKQLQALADVEDTRLNRLNVVGFVFGCCSSFGMCVVANFQKTTLFSMHLVGAILTFGIGALYVFIQTALSYLMQPHIHSKTMFWTRLSVGIWTLSSIISMFVSSVIMYSTLPGVEVNKKLHWTPGEPGFTAHIVSTISEWSLALSFISFFLTYIRDFKKINLRASAELQSNHLYESQHYRPVSARGPTETSPLLTGSI,,apoptotic process (GO:0006915) (0.9233); photoreceptor cell maintenance (GO:0045494) (0.7302); cell population proliferation (GO:0008283) (0.5375); retina development in camera-type eye (GO:0060041) (0.2103); regulation of autophagy (GO:0010506) (0.1774); autophagy (GO:0006914) (0.1356); visual perception (GO:0007601) (0.1152); phloem or xylem histogenesis (GO:0010087) (0.1087); myeloid cell homeostasis (GO:0002262) (0.0916),Golgi apparatus (GO:0005794) (0.3206); lysosome (GO:0005764) (0.2573); photoreceptor inner segment (GO:0001917) (0.2223); lysosomal membrane (GO:0005765) (0.2152); apical plasma membrane (GO:0016324) (0.2127); endosome membrane (GO:0010008) (0.1072),,DRAM/TMEM150 Autophagy Modulator (IPR050911) (0.1935); Frag1/DRAM/Sfk1 (IPR019402) (0.1019),,Membrane (0.7899); Transmembrane (0.4607); Reference proteome (0.4125); Lysosome (0.2530); Autophagy (0.1932); Cytoplasmic vesicle (0.1832); Cell membrane (0.1739); Golgi apparatus (0.1372); Endosome (0.1122),
MKTAVDRRKLDLLYSRYKDPQDENKIGVDGIQQFCDDLMLDPASVSVLIVAWKFRAATQCEFSRQEFLDGMTDLGCDSPEKLKSLLPRLEQELKDSGKFRDFYRFTFSFAKSPGQKCLDLEMAVAYWNLILSGRFKFLGLWNTFLLEHHKKSIPKDTWNLLLDFGNMIADDMSNYDEEGAWPVLIDDFVEFARPIVTAENLQTL,,DNA damage response (GO:0006974) (0.8299); regulation of cell growth (GO:0001558) (0.6480); protein neddylation (GO:0045116) (0.4248); regulation of protein neddylation (GO:2000434) (0.2423); regulation of protein ubiquitination (GO:0031396) (0.1619); positive regulation of protein neddylation (GO:2000436) (0.1579); regulation of cell cycle process (GO:0010564) (0.0592); G1/S transition of mitotic cell cycle (GO:0000082) (0.0557),nucleus (GO:0005634) (0.3103); cytoplasm (GO:0005737) (0.1881); ubiquitin ligase complex (GO:0000151) (0.1868); nucleoplasm (GO:0005654) (0.1404),ubiquitin conjugating enzyme binding (GO:0031624) (0.2148); cullin family protein binding (GO:0097602) (0.1708),"Defective-in-cullin neddylation protein (IPR014764) (0.3238); DCN1-like, PONY binding domain (IPR042460) (0.1897)",1.10.238.10 (0.5870); 1.10.238.200 (0.1602),Reference proteome (0.3250); Membrane (0.1761); Ubl conjugation pathway (0.1670); Proteomics identification (0.1118),
MFEESSQEMRALNAGTPSSTMSFTDEAVSILTSSSLLARSLLGRTSALKRKDVSPSSISSARRKREFIPHEKKDDGYWDKRKKNNEAAKRSREKRRVNDMVLENRVLTLLEENARLRAELLALKFRFGLIKDPSNASILPLTTGSCVPQPSAQHYYLPRGDSAHHTGPMPSNQSPTQSAPPSSRSIRDTSSMSEDSGFSTPGGSSVGSPVFFEDRLSDHGKLSPHRADELCYESHHSPSDLLAVGNHNMPSTRLESMDGMKSLPHKLRFKSPGGGDCENLGERQSAAIPMANARVHSYTHEGAGYWTPHDGEDARKVIQQQHVNYSHNVNANESQYQAENSMLKSQLSSLSEEVAQLKKLFSEQLLTKTN,,positive regulation of gene expression (GO:0010628) (0.6458); positive regulation of DNA-templated transcription (GO:0045893) (0.5376); regulation of DNA-templated transcription (GO:0006355) (0.4259); circadian rhythm (GO:0007623) (0.2292); transcription by RNA polymerase II (GO:0006366) (0.2129); cellular response to interleukin-4 (GO:0071353) (0.2019); negative regulation of transcription by RNA polymerase II (GO:0000122) (0.1997); response to hypoxia (GO:0001666) (0.1625); regulation of transcription by RNA polymerase II (GO:0006357) (0.0711); negative regulation of gene expression (GO:0010629) (0.0634),RNA polymerase II transcription regulator complex (GO:0090575) (0.3815); nucleus (GO:0005634) (0.1883),RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978) (0.1212); protein homodimerization activity (GO:0042803) (0.1157); identical protein binding (GO:0042802) (0.1095),Basic-leucine zipper domain superfamily (IPR046347) (0.4779); Basic-leucine zipper domain (IPR004827) (0.1726); Nuclear factor interleukin-3-regulated protein (IPR016743) (0.1662); Nuclear factor interleukin-3-regulated protein-like (IPR047229) (0.0993),1.20.5.170 (0.5323),Transcription regulation (0.9674); Transcription (0.8637); DNA-binding (0.5332); Reference proteome (0.3751); Nucleus (0.2891); Biological rhythms (0.1101),
MALRPDSDKEPRIELFIKAGHDGENVGNCPFCQRLFMVLWLKGVKFTVTTVDMRKKPDELKDLAPGTNPPFLLYNGTLKTDFIKIEEFLETTLAPPRYPHLSPRYKESFDVGADIFAKFSAFIKNSPNNAFHEKALLREFKRLDDYLNTPLQDELDQNISVSKRKFLDGNRLTLADCNLLPKLHVIKVAARKYCNFDIPTQFTGVWRYLQSAYEREEFSQTCPADIEIEKAYLSVVKRN,1.8.-.- (0.2083),chloride transport (GO:0006821) (0.5714); negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) (0.4127); regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) (0.1296),plasma membrane (GO:0005886) (0.2926); chloride channel complex (GO:0034707) (0.2771); cytosol (GO:0005829) (0.1852); cytoplasm (GO:0005737) (0.1680),chloride channel activity (GO:0005254) (0.2445); protein-disulfide reductase (glutathione) activity (GO:0019153) (0.1820); oxidoreductase activity (GO:0016491) (0.0920),"Chloride intracellular channel protein 2, C-terminal domain (IPR030253) (0.3775); Intracellular chloride channel (IPR002946) (0.3572); Thioredoxin-like superfamily (IPR036249) (0.1787); Glutathione transferase family (IPR040079) (0.1709); CLIC, N-terminal domain (IPR053823) (0.1260); Glutathione S-transferase, C-terminal domain superfamily (IPR036282) (0.1045)",3.40.30.10 (0.1989); 1.20.1050.10 (0.1165),Voltage-gated channel (0.9320); Transmembrane helix (0.7152); Transmembrane (0.7133); Cytoplasm (0.6955); Oxidoreductase (0.5258); Reference proteome (0.4797); Chloride channel (0.3718); Chloride (0.3281); Membrane (0.2988); Ion channel (0.2739); Ion transport (0.2208); Transport (0.1515); Phosphoprotein (0.1473); Nucleus (0.1140); Disulfide bond (0.0640),
MNSVSMAQKDGMLADSYTDNLIGTLLAIFGNLLVSISVSIQKQSHVTLAGNKDPRQYYYTKTWLLGLVLMVLGEGALFVSYAFAPLSLIAPLNAVSVISSSILGFLFLREKWKAQEFLKRYILTFLGCAMTAGGTYLFVTFGPNSHEKLNAENIVKHVISWPFLLYLLLGIIAFCLVLYYYKQRNANYLVLILLLVALLGSVTVITVKAVSGMIVLSIVGPLQLSYPIFYVMFVCMVATIVFQASFLAQASHLYDSSLIACVNYIFCTTFAIGGGAVFYQEFNHEDVLHICLFLLGCAICFLGVFLITKNKRKAKSFEPYVTMDMAKGIPTIHNKGWAVQPDYNGSFSYGALENNDSVAPVTLPVNHEQSVSPGPVSSYQPSELKKD,,magnesium ion transport (GO:0015693) (0.4494); establishment of localization in cell (GO:0051649) (0.1746); exocytosis (GO:0006887) (0.1173); monoatomic ion transport (GO:0006811) (0.1069); cell adhesion (GO:0007155) (0.1040); cerebral cortex development (GO:0021987) (0.0901); regulation of calcium-mediated signaling (GO:0050848) (0.0451),early endosome (GO:0005769) (0.3559); plasma membrane (GO:0005886) (0.2414); basolateral plasma membrane (GO:0016323) (0.1483); membrane (GO:0016020) (0.1316); neuronal cell body (GO:0043025) (0.1276),magnesium ion transmembrane transporter activity (GO:0015095) (0.1930),,,Phosphoprotein (0.6802); Reference proteome (0.6607); Transmembrane helix (0.5850); Transmembrane (0.4195); Glycoprotein (0.3621); Cell membrane (0.3449); Membrane (0.3106); Repeat (0.3006); Endosome (0.2526); Proteomics identification (0.2151); Alternative splicing (0.1689); Transport (0.1287); Ion transport (0.1135),
MTCRKSEALAFSLVTEINHAMARLVDIWDSIGIMEDQRVERMQTVKKHIDGLLHSMIMEEEALRHRIKTDIITFQKQLDTLCLELTLEPFKLEEKLTVLQMEKNLRCHVESLQKEKNERLREMNDFKKQDEELCVTLCADPYYIPTGSVPSRTQLQELKEHVERLNKEKESRVKVFSGLREDIRNLMEELGHEPESSLERESICPDADIFLLTHDNIKALKLLLSQLEIKKESLISARDSLKERAMSLWNRLSCPESEAEVFQEPAMSTLSDDIRRWQRFVEHLEELQKAQLEEVINKVRQELVVLWDKCMFGPDQRQAFDVHFCDDQYTTELLALHDSELLRMKIFYEEAQPILEDLEKWKRNWALFQEFERKAADPSRFSNRGGSLLRETKERGKVQKLLPKLEEELRGRVEDWEIVKGLSFLVYGQRVMDYISSQWEEHRLQKDKEKNERMSKKTETPQFKTPTKRAHGMTCAATPTPNKIRKTPSQLAPRSATVSSISSASSSGSSTTFLCVPGRPQLSAKRTKTTETSTGPRLPLQDFNSDKKPVQMSYSAFTSEFSRKANGDAVLNSTVKDVL,,positive regulation of cell population proliferation (GO:0008284) (0.3736); mitotic cytokinesis (GO:0000281) (0.3552); positive regulation of G2/M transition of mitotic cell cycle (GO:0010971) (0.3034); regulation of cytokinesis (GO:0032465) (0.2758); mitotic spindle midzone assembly (GO:0051256) (0.2624); initial mitotic spindle pole body separation (GO:0000073) (0.1274); attachment of mitotic spindle microtubules to kinetochore (GO:0051315) (0.0976); cell division (GO:0051301) (0.0860); microtubule bundle formation (GO:0001578) (0.0768),mitotic spindle (GO:0072686) (0.5103); nucleoplasm (GO:0005654) (0.3388); spindle (GO:0005819) (0.2847); mitotic spindle midzone (GO:1990023) (0.2589); spindle pole (GO:0000922) (0.2415); cytoplasm (GO:0005737) (0.2080); plasma membrane (GO:0005886) (0.1153); midbody (GO:0030496) (0.1062); intercellular bridge (GO:0045171) (0.0827),microtubule binding (GO:0008017) (0.1396),,1.20.58.1520 (0.1042),Reference proteome (0.8865); Coiled coil (0.5660); Membrane (0.4091); Phosphoprotein (0.2948); Microtubule (0.2873); Cytoskeleton (0.2574); Nucleus (0.2085); Cell membrane (0.1627); Mitosis (0.1402); Alternative splicing (0.1160); Protein transport (0.0525),
MDEMISRGLLCILVCSLSSSAREHSDVLKLTDADFDYLAPEHETLLVKFYAPWCGHCKKLAPEFESAASRLKGTVTLAKVDCTANTEICKHYGVNGYPTLKIFRNGHESSSYDGPRSADGIVDYMKKQAGPDSVLLHSELDLEKFINHFDASVVGLFSGTDSSQLAEFLKGASLMRESFRFAHTTDLQLGQKYGVTHESILLFRAPRLSSKFEESVVPHTGSLSVTGLRRFIRDNIFGLCPHMTKDNKEVLRKRDLLTAYYDLDYLHNPKGSNYWRNRVLKVATKFSSQGMLFSVANRNDFMEELEEEFGLSASDGNELPFVTIRTRTGDKYSMREEFTRDGKSLESFLEDYFAGRLKRYVKSEPVPAINNGVVKVVVADTFEEIVNDPEKDVLIEFYAPWCGHCKKLEPKYTALGEMLYSDPNIVIAKMDATVNDVPAGYDVQGFPTIYFAAAGRKSEPKRYEGAREVKDFVNFLKREATKPLILNGVKEEL,protein disulfide-isomerase (5.3.4.1) (0.9941),protein folding (GO:0006457) (0.5602); response to endoplasmic reticulum stress (GO:0034976) (0.4574); peptide antigen assembly with MHC class I protein complex (GO:0002502) (0.2999); platelet aggregation (GO:0070527) (0.2924); positive regulation of extrinsic apoptotic signaling pathway (GO:2001238) (0.2063); cellular response to interleukin-7 (GO:0098761) (0.1159); extrinsic apoptotic signaling pathway (GO:0097191) (0.0958); peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401) (0.0621),melanosome (GO:0042470) (0.3139); cell surface (GO:0009986) (0.3070); endoplasmic reticulum lumen (GO:0005788) (0.3027); Tapasin-ERp57 complex (GO:0061779) (0.2660); endoplasmic reticulum (GO:0005783) (0.1413); extracellular space (GO:0005615) (0.0998),protein disulfide isomerase activity (GO:0003756) (0.3792); protein-disulfide reductase activity (GO:0015035) (0.2804); identical protein binding (GO:0042802) (0.1935),"Protein disulfide-isomerase A3, first redox inactive TRX-like domain b (IPR041868) (0.2119); Protein disulphide isomerase (IPR005792) (0.2099); Thioredoxin, conserved site (IPR017937) (0.1942); Thioredoxin-like superfamily (IPR036249) (0.1565)",,Redox-active center (0.6314); Isomerase (0.5873); Reference proteome (0.1915); Endoplasmic reticulum (0.1392); Disulfide bond (0.1309),
MALAAAARRCASSALFSKSLSLPELRPACSYHKKVVDHYENPRNVGSLDKNAKNVGTGLVGAPACGDVMKLQIQVDENGKIIDARFKTFGCGSAIASSSLATEWVKGKSIDEALKIKNTEIAKELCLPPVKLHCSMLAEDAIKAALADYRLKQKDEKETLAEARN,,"intracellular iron ion homeostasis (GO:0006879) (0.8294); iron-sulfur cluster assembly (GO:0016226) (0.4552); positive regulation of mitochondrial electron transport, NADH to ubiquinone (GO:1902958) (0.1127); response to iron ion (GO:0010039) (0.0739); tRNA wobble uridine modification (GO:0002098) (0.0682)",mitochondrial matrix (GO:0005759) (0.4857); iron-sulfur cluster assembly complex (GO:1990229) (0.2378); nucleus (GO:0005634) (0.1987); mitochondrion (GO:0005739) (0.1391); nucleoplasm (GO:0005654) (0.0649),"ferrous iron binding (GO:0008198) (0.5211); iron ion binding (GO:0005506) (0.1558); 2 iron, 2 sulfur cluster binding (GO:0051537) (0.0862)","NIF system FeS cluster assembly, NifU, N-terminal (IPR002871) (0.1507); Iron-sulfur cluster assembly scaffold protein IscU (IPR011339) (0.1487)",3.90.1010.10 (0.3922),Transit peptide (0.6917); Mitochondrion (0.5671); Metal-binding (0.2670); Reference proteome (0.1594); 3D-structure (0.1119); Zinc (0.0511),
MKQCEARNEAAGMADQTLTVLLKLSAAGFYGISSFLIVVVNKSVLTNYRFPSSICVGIGQMLATVVVLRVGKALRVITFPEFDGSIPRKTFPLPLLYVGNQITGLFGTKRLNLPMFTVLRRFSILFTMLAEGFLLKKKFSRPVQLTVFTMILGAFVAASADLAFDLQGYVFILMNDVLTAANGAFVKQKLDSKELGKYGLLYYNALFMILPTLLLAHVTGDMDKAFDYDGWSDVLFISQFFLSCIMGFILMYSTVLCTQYNSALTTTIVGCLKNILVTYIGMVFGGDYIFSWTNFIGLNISIAGSLVYSYITFTEEQITKQSENTNKLEVKGKVAV,,"chondroitin sulfate biosynthetic process (GO:0030206) (0.6228); heparan sulfate proteoglycan biosynthetic process (GO:0015012) (0.4571); heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014) (0.1624); nucleotide-sugar transmembrane transport (GO:0015780) (0.1085); negative regulation of gene expression (GO:0010629) (0.0591); respiratory gaseous exchange by respiratory system (GO:0007585) (0.0553); embryonic skeletal system development (GO:0048706) (0.0421); blastocyst hatching (GO:0001835) (0.0412)",Golgi apparatus (GO:0005794) (0.4993); Golgi membrane (GO:0000139) (0.2939); membrane (GO:0016020) (0.1224),UDP-glucuronic acid transmembrane transporter activity (GO:0005461) (0.2353); antiporter activity (GO:0015297) (0.2349); UDP-N-acetylglucosamine transmembrane transporter activity (GO:0005462) (0.1555),Triose Phosphate/Phosphate Translocator (IPR050186) (0.5174); Sugar phosphate transporter domain (IPR004853) (0.2913),,Membrane (0.5566); Transmembrane (0.2872); Reference proteome (0.2555); Golgi apparatus (0.1026),
MSMDWLGYGYAALITIGGIVGYAKAGSFISLVAGLMFGVAAFVGAYQMSKNDKDIWVSLGTSGSLTALMGVRFLSSWKIMPAGFMAGASLLMFLRIGVKVLQSSQKKRS,,mitochondrial transport (GO:0006839) (0.4706); heme biosynthetic process (GO:0006783) (0.3547); regulation of mitochondrion organization (GO:0010821) (0.2855); regulation of cell growth (GO:0001558) (0.2258); innate immune response (GO:0045087) (0.1942); negative regulation of apoptotic process (GO:0043066) (0.1813); negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029) (0.1216); erythrocyte differentiation (GO:0030218) (0.1203); apoptotic process (GO:0006915) (0.1011); response to hypoxia (GO:0001666) (0.0950); response to glucose (GO:0009749) (0.0805),nucleus (GO:0005634) (0.1757); mitochondrion (GO:0005739) (0.1735); plasma membrane (GO:0005886) (0.1265); cytosol (GO:0005829) (0.0939); cytoplasm (GO:0005737) (0.0813),,TMEM14 family (IPR005349) (0.3792); TMEM14 superfamily (IPR044890) (0.1807),1.10.10.1740 (0.2247),Membrane (0.8714); Transmembrane (0.8089); Reference proteome (0.6570); Transmembrane helix (0.5340); Acetylation (0.4664); 3D-structure (0.1115); Alternative splicing (0.0832); Direct protein sequencing (0.0791); Isopeptide bond (0.0421),
MALWIQAQQLQGDALHQMQSLYGQHFPIEVRHYLAQWLEAQPWDAIDLENQQDEFKAKRLLDGLIQELQKKAEHQMGEDGFLLKIKLGHYATQLKNSYDACPLELVRCVKHILYTEQRLVQEASNTSSPGSGPVDGTPQRYQQINQTFEELRVMTQDTENDLRKLQHSQEYFIIQYQESLRIQAQIVSLASLPPTERAQREASLQSRKSTLETWLTREANTLQKYRQELAEKHQRTLALLRKQQTVIVDDELIQWKRRQQLAGNGGPSEGGLDILQAWCEKLADMIWQNRQQIRRVEHLTQQLPIPGPTEELLTELNAIVTDIISTLVTSTFIIEKQPPQVLKTQTKFSATVRLLVGGKLNVHMNPPQVKATIISEQQAKAILKNENTRNESSGDILNNNCVMEYHQTTGNLSAHFRTMSLKRIKRSDRRGAESVTEEKFTILFESQFSVGVNELVFHVKTLSLPVVVIVHGSQDNNATATVLWDNAFSEPGRVPFVVPDKVVWPQLCEALNMKYKSEVQSDRGLSEDNLVFLAQKAFSSSSNNPEDYSSMTITWSQFNRESLPGRNFTFWQWFDGVIELMKKHLKSHWNDGAILGFLNKQQAQDMLMSKPNGTFLLRFSDSEIGGITIAWVAENPNKAGERMVWNLMPFTTKDFSIRSLADRISDLNHLLFLYPSQPKEEVFSRYCTPPNSKAVGDGYVKPEIKQVVKVEFSSPNPEPSPGNSFMDHAASPTVNQHHNFTIYPAMNDTMIDAEGEFDLDETMDMARQVEEFLRQPMETTWSGQQS,,cell surface receptor signaling pathway via JAK-STAT (GO:0007259) (0.9524); cytokine-mediated signaling pathway (GO:0019221) (0.9321); defense response (GO:0006952) (0.7101); regulation of cell population proliferation (GO:0042127) (0.6044); growth hormone receptor signaling pathway via JAK-STAT (GO:0060397) (0.5646); cell surface receptor signaling pathway (GO:0007166) (0.1356); signal transduction (GO:0007165) (0.1202),cytosol (GO:0005829) (0.4625); nucleus (GO:0005634) (0.3012),"RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978) (0.5003); DNA binding (GO:0003677) (0.2044); DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981) (0.1592); DNA-binding transcription factor activity (GO:0003700) (0.0892)","Transcription factor STAT (IPR001217) (0.5119); STAT5a/5b, coiled-coil domain (IPR046994) (0.4176); STAT transcription factor, DNA-binding, N-terminal (IPR012345) (0.3463); SH2 domain (IPR000980) (0.3350); p53-like transcription factor, DNA-binding domain superfamily (IPR008967) (0.3315); STAT transcription factor, DNA-binding (IPR013801) (0.2952); STAT5a/5b, DNA-binding domain (IPR035858) (0.2572); STAT transcription factor, N-terminal domain superfamily (IPR036535) (0.2572); STAT transcription factor, protein interaction (IPR013799) (0.2460); Signal transducer and activator of transcription, linker domain (IPR048988) (0.2184); SH2 domain superfamily (IPR036860) (0.1925); STAT transcription factor, all-alpha domain (IPR013800) (0.1600)",2.60.40.630 (0.4812); 1.20.1050.20 (0.3277); 1.10.238.10 (0.3096); 1.10.532.10 (0.1569); 3.30.505.10 (0.1566),SH2 domain (0.9199); Transcription (0.8093); Transcription regulation (0.6996); Cytoplasm (0.6781); Phosphoprotein (0.5402); DNA-binding (0.3315); Reference proteome (0.2916); Nucleus (0.2915); Activator (0.1177),
MNPSSLDWSIQSALSSLFPPFEATAPTVLSQLFRTIEERYHGDALQCLLNFLIPAKHILESVQQAACAAYSDVLFQCEGWPLCLSDRVVIQLAAINPLLLRPGDFYLQVEPFGEQSARIVLKSLLVQEDLLGQENLILQAGSRVLECPTIEETPILETSYPCIFTESWLREINEGRQGNRLSRCVLSSDKGVVKVPWTEVANPEFLDRPKSNVWPDSKPCSTATIRVRDLNTEISDIESKVVVDFLPLEMETRIVPAIDGLALSVQLVESGSRLVKVNQAHTISSFAGKPVGWVSPNTWDSRQTQELEGEYVDLLEFNKEKETLVPNKIAMPMKPLGFKLVRTAQPSSKSNVSICGVDCNPNKQPSEIMQHDPDSKCRYRQSYMAALRNPVNFERASMLPCLDETRTDAGKAEPSCEGYGVGLRLQPSSCMFGQTPNQADRNPMQSFENSAQQKQSPKNSTQPSQNVPHDRKSRENADSPDQHMTQLITSMVQARQHHKSFLTGQPDLPQTVLGTKALPDKRHPCLNNAIRQDSFHMRISGQKHAKTQHLPKMGLRALPDHGGHRHDANLCLQGFSPIQHSQNQPTHITEQTPQPQISQNPFRNENSLLDCNVFCDDRHCGRGPGSPVQVIKGKSRSKSRSSLSVSETARQCLQSNKPTNRSHSDVYPEIIPMLPAIHGIKHTADLVSPKLNRPQEARKVSLSGKAGAPVVNGVELQKLQHSDQPTTGQSVTEIQGIYISQDPTIKSLLQLGIICLPGGRDRAGRAVVEVYGGRNGWISPQVSPLELCRLLLYLHSIPRSEVRELGLTVVIDSRKCPLTSVFYKSLLMVQEQALHAVHTILMLVDKDANPRPEKHPGLQIDVVTSLKALHKTVDGHQLTSDLSGSFPYSHEDWLQFHQKLSLFQIELEAASSLLHTAIRRLDVKRTDTAKDVQSCIQEQRSSMKMVLEDTRLVALQREGGAILARMRREESRFAHSEDFRDSLESVTCLYDQVEESVHTLVMKSNQSLQHLEHVLLLRETQDSLHTIQKWCDAEERLWQKDKDDAEKTLQKIQQRLQDTQTLLRQAKENKERGMLLIKDVERKSKGTHYPETDAFRCYTTGFKTRMTGFLLKAEERKSDLQTSVDLYRFCEEASSLVKECMEYLDHMKSSNSPMSVCWSSLHAFEQRFQHFSPQHFQDRSAALLERLPDGIWMWNAVQTQCRDIRQRLSEILQAAHTHKDSQDEAQLNPVSGQTQNRAAEQGDNETLTYLQSAEGSKFEQVMTSSVHEQSASRIQQSVECTEQETRHLHETKDKLHNASSMHNESTSHAQQSVQCTVQKASMLQETNNTSRNPSMHKDSASHIQESVQCTDQNTSHLHEPQAISHHPSDRKLKEHHHKHSHSDDDLRKSGRIHKFGQTAHYKVFIRSQSAESCLRGYRYNIPLCKTDAAASCVGASLEGLSSELNQHDSFCSSASGFSQKCSSDCGSEDHGSGVRCSDNAFTKQEESVCKPECILENTSTALKLQRIMQELLQTEQEYVRALAYVVENYMPELERPDVPQDLRGQRGLIFGNLEKLRDFHQHHFIQELELCLEKPFSVGRCFLKHKESFGLYALYSKNKPRSENLLIQHGKDFFKQKQQLLKDALDLSSYLLKPVQRISKYSLLLQDLLRECECVTNAELQRTEIHTALNIIQFQLRHGNNLLAMDDIYGCDVNLKEQGQLIRQDEFLLTFRKKKCYRHIFLFQDLILFSKTRKTDVGNDTYIYKQSFKTSDIGMTHNSGDSGLCFEIWFRRRKTQDTYVLQAASREVKESWTRDLERILWEQAIHNREIRMQERVFMGIGHKPFMDIKPSEMAISDRAINCVLTGRGGVSVLRLNSIGSASGTSSSGSQSSCSSGWGSPSTSAVCPVGGDDVRYIQETSGILEEDDLDQESGNHSTLVASSESSGESVSCFSTSAHSCSSVIGGDCEHTPSELGKQHKQDHLKTTNQTRDQSGSKVQSSIGKSTEV,,cell differentiation (GO:0030154) (0.4678); DNA recombination (GO:0006310) (0.2174); spermatogenesis (GO:0007283) (0.2073); proteolysis (GO:0006508) (0.1309); cytoskeleton organization (GO:0007010) (0.1177); regulation of DNA-templated transcription (GO:0006355) (0.1057); regulation of small GTPase mediated signal transduction (GO:0051056) (0.0688); intracellular signal transduction (GO:0035556) (0.0620),nucleus (GO:0005634) (0.1048); cytoplasm (GO:0005737) (0.0606),ATP binding (GO:0005524) (0.2495); guanyl-nucleotide exchange factor activity (GO:0005085) (0.1401); zinc ion binding (GO:0008270) (0.0873),"Pleckstrin homology domain (IPR001849) (0.6825); PH-like domain superfamily (IPR011993) (0.4604); Dbl homology (DH) domain (IPR000219) (0.3803); Dbl homology (DH) domain superfamily (IPR035899) (0.2477); CRAL-TRIO lipid binding domain (IPR001251) (0.1425); IPR055251 (0.1420); Protein kinase, ATP binding site (IPR017441) (0.0851)",2.30.29.30 (0.4913); 1.20.900.10 (0.3401); 1.20.58.60 (0.0818),Reference proteome (0.4754); Zinc (0.1481); Metal-binding (0.1233); Repeat (0.1110); Phosphoprotein (0.0947); Proteomics identification (0.0789),
MADLWEELQSVANAAPASFAAAPGERGTIKAKANFNVSEDVAALRKAIEGVGTNEKTLIEILTHRSSSQKQEIAKAYRETTKRILANDLKGETHGNFEKVLVGLARPLAVNDAEWLHEALKGAGTDNNILIEILSSRTNKQIKELSAAYAEETKKTLTQALKTEVSGHYGKAIILLAEGARDENPSVNVDKAREDAQALYQAGEKKLGTDESKFIEILCKRSFPQLRQTILEYKNFSKNTLQKSIEKEMSGNLEELLVSIVKCAISTPAYFAEKLNKSMKGAGTDETTLTRVMVSRGEVDMLDIRAEYKTLYKSSLYKAISSDVSGDYADCLKMICGGDD,,positive regulation of endothelial cell migration (GO:0010595) (0.3859); pollen development (GO:0009555) (0.2138); phagocytosis (GO:0006909) (0.1763); epithelial cell differentiation (GO:0030855) (0.1126); blood coagulation (GO:0007596) (0.1029); calcium ion transport (GO:0006816) (0.0930); plasma membrane repair (GO:0001778) (0.0662),vesicle membrane (GO:0012506) (0.4722); cytoplasm (GO:0005737) (0.2910); plasma membrane (GO:0005886) (0.2831); nucleus (GO:0005634) (0.2187); late endosome membrane (GO:0031902) (0.0786); focal adhesion (GO:0005925) (0.0772); mitochondrion (GO:0005739) (0.0577); midbody (GO:0030496) (0.0541),"phosphatidylserine binding (GO:0001786) (0.2912); calcium-dependent phospholipid binding (GO:0005544) (0.2207); calcium ion binding (GO:0005509) (0.2004); chondroitin sulfate binding (GO:0035374) (0.0875); phosphatidylinositol-4,5-bisphosphate binding (GO:0005546) (0.0860)","Annexin (IPR001464) (0.1999); Annexin repeat, conserved site (IPR018252) (0.1736); Annexin repeat (IPR018502) (0.0951)",,Calcium/phospholipid-binding (0.3465); Repeat (0.3243); Calcium (0.3125); Reference proteome (0.2949); Cytoplasmic vesicle (0.2569); Annexin (0.1897); Acetylation (0.0888),
MNMNSGRLYSRLRLCRFYSGGVRATYHRTLDRIELMLPPKLRPVYNHPAGPKTVFFWAPVFKWGLVAAGFSDMTRPPEKLSVSQSCVITATGLIWSRYCLVIIPKNWALFAVNFFLGMCGSIQLFRIWRYNQELKQKEAEVQQT,,pyruvate metabolic process (GO:0006090) (0.5137); acetyl-CoA biosynthetic process from pyruvate (GO:0006086) (0.3767); mitochondrial pyruvate transmembrane transport (GO:0006850) (0.1741); positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774) (0.1294); neurotransmitter secretion (GO:0007269) (0.0914); negative regulation of reactive oxygen species biosynthetic process (GO:1903427) (0.0800); mitochondrial transport (GO:0006839) (0.0685); thalamus development (GO:0021794) (0.0684); proton motive force-driven mitochondrial ATP synthesis (GO:0042776) (0.0542),mitochondrial inner membrane (GO:0005743) (0.6215); mitochondrion (GO:0005739) (0.1141); mitochondrial membrane (GO:0031966) (0.0428),,Mitochondrial pyruvate carrier (IPR005336) (0.2195),,Transport (0.6805); Reference proteome (0.6009); Mitochondrion inner membrane (0.5003); Transmembrane helix (0.4885); Transmembrane (0.4294); Membrane (0.3776); Mitochondrion (0.3263); Disease variant (0.2658); Proteomics identification (0.2121); Alternative splicing (0.1650); Epilepsy (0.1204),
MINFWIFGLFCLIGISSTHPNAPPVFVKLGESVNMSCIYQSQMARHFSWYKHKPGQNPMLISTIYKNVQFSDSATYYCGGAYSNVMEVVKGTRLIVQGLEKHTVVKQHDLIPSHSGDSVSLTCTVLNQKCVGNHSMYWLIIESQDSPPRIISTHGTPVDQCEWISDADFRALRCVYSFSRKDFRLSNSATYSCTVTACGEKLDRNGSKLDIDADSTEEMMILVLLSIARTCLLLLVIVMVIIWYCVYSKRISKNVHYPSDVAFRNRQSPRKRRPGLMINSVSNQQ,,natural killer cell activation (GO:0030101) (0.3628); serotonin secretion (GO:0001820) (0.2426); detection of lipopolysaccharide (GO:0032497) (0.1677); adaptive immune response (GO:0002250) (0.1549); mast cell degranulation (GO:0043303) (0.1251); establishment of localization in cell (GO:0051649) (0.1028); response to bacterium (GO:0009617) (0.1027); inflammatory response (GO:0006954) (0.0736); positive regulation of interleukin-4 production (GO:0032753) (0.0588); positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) (0.0533); positive regulation of type II interferon production (GO:0032729) (0.0441),cell surface (GO:0009986) (0.1831); plasma membrane (GO:0005886) (0.1254); early endosome membrane (GO:0031901) (0.0918),protein phosphatase binding (GO:0019903) (0.3599); metal ion binding (GO:0046872) (0.2278); interleukin-4 receptor binding (GO:0005136) (0.0580),Immunoglobulin-like fold (IPR013783) (0.1812); Immunoglobulin-like domain superfamily (IPR036179) (0.1587); Immunoglobulin subtype (IPR003599) (0.0725),2.60.40.10 (0.1749),Signal (0.7341); Transmembrane (0.7306); Transmembrane helix (0.7306); Reference proteome (0.5379); Membrane (0.4692); Immunoglobulin domain (0.4644); Cell membrane (0.3032); Glycoprotein (0.2970); Disulfide bond (0.2683); Receptor (0.2204); Immunity (0.1717),
MIMCDKEMESGLLNVSAETVYGEKSAFTQTEHNIVAAYLITAGVISLSSNIVVLLMFVKFRELRTATNAIIINLAFTDIGVAGIGYPMSAASDLHGSWKFGYMGCQIYAALNIFFGMASIGLLTVVAIDRYLTICRPDIGQKLTTRSYTLLIVAAWLNAVFWSSMPIVGWAGYAPDPTGATCTINWRNNDTSFVSYTMTVITVNFIIPLSVMFYCYYNVSATVKRFKASNCLDSINMDWSDQMDVTKMSVIMIVMFLAAWSPYSIVCLWASFGDPQKIPAPMAIIAPLLAKSSTFYNPCIYVIANKKFRRAIIGMIRCQTRQRVTINNQLPMMASSVPLNP,,"G protein-coupled receptor signaling pathway (GO:0007186) (0.7413); phototransduction (GO:0007602) (0.7093); visual perception (GO:0007601) (0.4157); cellular response to light stimulus (GO:0071482) (0.3565); phototransduction, visible light (GO:0007603) (0.2182); absorption of visible light (GO:0016038) (0.1809)",photoreceptor outer segment (GO:0001750) (0.2134); plasma membrane (GO:0005886) (0.1665); membrane (GO:0016020) (0.1337); cytoplasm (GO:0005737) (0.1112); perikaryon (GO:0043204) (0.0860),G protein-coupled photoreceptor activity (GO:0008020) (0.6978); 11-cis retinal binding (GO:0005502) (0.0860),"G-protein coupled receptor opsins (IPR050125) (0.4507); GPCR, rhodopsin-like, 7TM (IPR017452) (0.3345); Visual pigments (opsins) retinal binding site (IPR027430) (0.3142); Peropsin (IPR002962) (0.1942); G protein-coupled receptor, rhodopsin-like (IPR000276) (0.0550)",1.20.1070.10 (0.1832),Vision (0.9574); Transducer (0.8541); Reference proteome (0.7900); Sensory transduction (0.7235); Retinal protein (0.7234); Membrane (0.6534); Photoreceptor protein (0.4865); Receptor (0.4610); G-protein coupled receptor (0.4498); Disulfide bond (0.2343); Chromophore (0.2120); Transmembrane (0.1020); Glycoprotein (0.0942); Proteomics identification (0.0603); Phosphoprotein (0.0447),
MAVSTFGIAIAVMTLLWGLVGGVIPWFIPKGANRGVIVTMLVLTAVCCYLFWLIAILSQLNPLFGPVLKNDTIWYLYYHWP,,regulation of macroautophagy (GO:0016241) (0.2106); transmembrane transport (GO:0055085) (0.2056); vacuolar acidification (GO:0007035) (0.1825); synaptic vesicle lumen acidification (GO:0097401) (0.1244); protein processing (GO:0016485) (0.0986); sensory perception of sound (GO:0007605) (0.0944); pH reduction (GO:0045851) (0.0918); sodium ion transport (GO:0006814) (0.0821); regulation of blood pressure (GO:0008217) (0.0819); membrane protein ectodomain proteolysis (GO:0006509) (0.0743),plasma membrane (GO:0005886) (0.2300); synaptic vesicle membrane (GO:0030672) (0.1765); recycling endosome (GO:0055037) (0.1623); cytoplasmic vesicle (GO:0031410) (0.1103); clathrin-coated vesicle membrane (GO:0030665) (0.1028); Golgi apparatus (GO:0005794) (0.0977); cell cortex (GO:0005938) (0.0629); membrane (GO:0016020) (0.0551),"proton-transporting ATPase activity, rotational mechanism (GO:0046961) (0.0543)","ATPase, V0 complex, subunit e1/e2 (IPR008389) (0.1843); ATPase, V0 complex, subunit e1/e2, metazoa (IPR017385) (0.0893)",,Transmembrane helix (0.7490); Transport (0.6871); Transmembrane (0.6713); Membrane (0.3093); Reference proteome (0.3057); Cytoplasmic vesicle (0.2977); Ion transport (0.2724); Hydrogen ion transport (0.2551); Ubl conjugation (0.1519); Synapse (0.1455); Glycoprotein (0.0973); Lysosome (0.0884),
MSSSGEYMNGHVHLEESDMDESDGKLFLTEAFNIIMEEILNKGRDLKEKVCEWKDPDQLRSLLDLELRDHGECHEKLLQRVRDVAKYSVKTCHPRFFNQLFAGVDYHALTGRLITETLNTSQYTYEVAPVFVLMEEEVISKLRSLVGWSEGDGIFCPGGSMSNMYAINVARYWAFPQVKTKGLWAAPRMAIFTSQQSHYSVKKGAAFLGIGTENVFIVQVDESGSMIPEDLEAKIVQAKSQDAVPFFVNATAGTTVQGAFDPLKRIADICERNGMWMHVDAAWGGSVLFSKKHRHLVAGIERANSVTWNPHKMLLTGLQCSVILFRDTTNLLMHCHSAKATYLFQQDKFYDTSLDTGDKSIQCGRKVDCLKLWLMWKAIGASGLSQRVDKAFALTRYLVEEMEKRENFQLVCKGPFVNVCFWFIPPSLKGKENSPDYQERLSKVAPVIKERMMKRGTMMVGYQPMDEHVNFFRMVVVSPQLTTKDMDFFLDEMEKLGKDL,aspartate 1-decarboxylase (4.1.1.11) (0.4483); glutamate decarboxylase (4.1.1.15) (0.4269),glutamate decarboxylation to succinate (GO:0006540) (0.6398); carboxylic acid metabolic process (GO:0019752) (0.2484); glutamate catabolic process (GO:0006538) (0.1494); gamma-aminobutyric acid biosynthetic process (GO:0009449) (0.1140); taurine biosynthetic process (GO:0042412) (0.0926),cytoplasm (GO:0005737) (0.2836); Golgi membrane (GO:0000139) (0.2804); cytosol (GO:0005829) (0.2694); presynaptic membrane (GO:0042734) (0.2066); axon (GO:0030424) (0.1013); cell cortex (GO:0005938) (0.0698),pyridoxal phosphate binding (GO:0030170) (0.3587),"Pyridoxal phosphate-dependent decarboxylase (IPR002129) (0.3075); Pyridoxal phosphate-dependent transferase, major domain (IPR015421) (0.2518); Pyridoxal phosphate-dependent transferase (IPR015424) (0.1774)",3.40.640.10 (0.1267); 3.90.1150.170 (0.1123),Pyridoxal phosphate (0.7436); Lyase (0.6626); Reference proteome (0.6194); Decarboxylase (0.4549); Phosphoprotein (0.1046); Neurotransmitter biosynthesis (0.0482),pyridoxal 5'-phosphate (0.3647)
MADEAGKLPLRRLEPPIQKFIKVAIPTDLERLHQHQHNIEKFQRNRQWDKLHHEHINSSRTVQQLRSNLREMEKLCGRVRSVDAEALEKLVQPIRDRASAAIQEFLQIHSDAVNRQNFNEAIATVAETSHSEDDTGVSGSPVTQTQLLLPEIPSEQNAAESWDSLAEDLLQLNGLVNEFSTIVHAQQEKIDSIEANVSIAAANVEEGTQSLGKAARAKLAVLPVAGAVVGGVLGGPLGLLAGFKVAGVAAAFGGGLLGFAGGNLIQRKRKERIDLQLQELHSNNNSKNDTQ,,intracellular protein transport (GO:0006886) (0.9799); exocytosis (GO:0006887) (0.6036); vesicle docking (GO:0048278) (0.4839); vesicle fusion (GO:0006906) (0.2841); Golgi organization (GO:0007030) (0.2328); endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888) (0.2237); autophagosome membrane docking (GO:0016240) (0.1636); synaptic vesicle docking (GO:0016081) (0.1599); macroautophagy (GO:0016236) (0.1114); protein localization to phagophore assembly site (GO:0034497) (0.1012),SNARE complex (GO:0031201) (0.3130); autophagosome membrane (GO:0000421) (0.3096); endomembrane system (GO:0012505) (0.2711); endoplasmic reticulum membrane (GO:0005789) (0.2328); plasma membrane (GO:0005886) (0.2023); mitochondrion (GO:0005739) (0.1743); phagocytic vesicle (GO:0045335) (0.1320); HOPS complex (GO:0030897) (0.0642),SNARE binding (GO:0000149) (0.2921); SNAP receptor activity (GO:0005484) (0.2578),"SNARE (IPR010989) (0.3580); Syntaxin-17, SNARE motif (IPR028676) (0.2541); Target SNARE coiled-coil homology domain (IPR000727) (0.2421); Syntaxin (IPR045242) (0.1655); Syntaxin/epimorphin, conserved site (IPR006012) (0.1524)",1.20.5.110 (0.1557),Transmembrane (0.8169); Membrane (0.6551); Transmembrane helix (0.6456); Coiled coil (0.2437); Transport (0.1683); Reference proteome (0.0692),
MMQQKRNIQIIEWEDLDKRKFYSLGVFMTMTTRAAVYPFTLIRTRLQVQKGKSLYNGTFDAFCKILKVEGARGLYRGFMINTFTLISGQAYITTYELVRKYVSWYSSNNTVKSLVAGGAASLVAQSITVPIDVVSQQLMVQGQGCQLTRFKLKPKMAMATGKHKYTFGQTRDIVVQIFHADGFRGFYRGYVASLLTYIPNSAVWWPFYHFYGEQLSRLAPADCPHLILQAIAGPMAAATASTLTNPMDVVRARVQVEGRSSVIETFKQLMAEEGIWGLTKGLSARIISSTPTSIMIVIGYETLKRLSLRPELVHSRHW,,branched-chain amino acid catabolic process (GO:0009083) (0.4294); regulation of cold-induced thermogenesis (GO:0120161) (0.2364); branched-chain amino acid transport (GO:0015803) (0.1080); regulation of oxidative phosphorylation (GO:0002082) (0.0795); sensory perception of sound (GO:0007605) (0.0694),mitochondrion (GO:0005739) (0.8321); mitochondrial inner membrane (GO:0005743) (0.1405); mitochondrial membrane (GO:0031966) (0.0914),branched-chain amino acid transmembrane transporter activity (GO:0015658) (0.3066),Mitochondrial carrier domain superfamily (IPR023395) (0.3298); Mitochondrial substrate/solute carrier (IPR018108) (0.1529); Mitochondrial carrier protein (IPR002067) (0.1141),1.50.40.10 (0.3016),Transport (0.9908); Reference proteome (0.9028); Transmembrane (0.7424); Membrane (0.6186); Disease variant (0.2686); Proteomics identification (0.2452); Mitochondrion (0.2221); Transmembrane helix (0.1981); Repeat (0.0997); Direct protein sequencing (0.0939),
MLRPLLENFERLRRNKTVLCLKFSTSSVMAKSKFEYVRNFELDDTCLRNCYIVVRLDGRNFHKFSDQHNFTKPNDDRALGLMSRSACSVMEELDDITIAYGQSDEFSFVFKRSTNWFKRRASKLMTHVTSQFSSSFVFYWKEYFGEQPLLYPPSFDGRVVLYPSNRNVRDYLSWRQADCHINNLYNTAFWTLVQKGGLTTTQAEERLNGTLATDKNEILFSEFNINYNNESSVYKKGTTLIWEKVNETTTKQIKRPNEEETEVTVTRTRKKVTSHSCDVIGDQFWDEHPDILESEQC,tRNAHis guanylyltransferase (2.7.7.79) (0.9926),tRNA modification (GO:0006400) (0.8622); response to oxidative stress (GO:0006979) (0.4616); stress-induced mitochondrial fusion (GO:1990046) (0.3546); tRNA processing (GO:0008033) (0.3408); protein homotetramerization (GO:0051289) (0.2153); mitochondrial fusion (GO:0008053) (0.0564),transferase complex (GO:1990234) (0.2672); cytosol (GO:0005829) (0.1711); mitochondrion (GO:0005739) (0.1196),tRNA guanylyltransferase activity (GO:0008193) (0.3855); GTP binding (GO:0005525) (0.3597); magnesium ion binding (GO:0000287) (0.2682); ATP binding (GO:0005524) (0.1398),tRNAHis guanylyltransferase Thg1 superfamily (IPR038469) (0.3900); Thg1 C-terminal domain (IPR025845) (0.2784); tRNAHis guanylyltransferase catalytic domain (IPR024956) (0.2732); tRNAHis guanylyltransferase Thg1 (IPR007537) (0.2146),3.30.70.3000 (0.4319),tRNA processing (0.9184); Nucleotidyltransferase (0.8161); Nucleotide-binding (0.5890); Metal-binding (0.4266); GTP-binding (0.3961); Magnesium (0.3260); Transferase (0.3232); Reference proteome (0.1684); Ubl conjugation (0.1488),Mg(2+) (0.2413)
MAVAGRCSCIKENVPLCFCFLVVLLSVLTNAQIRYSVQEELESGTVVGDLVRDLGLELRKLSARRIRISSDTARRYFNINHKTGKLVISDRIDRETLCEFSGTCTLSLDVVLESPFEQHSVDVEILDANDNSPLFPRDEYQLEISEGAQPGARFSIEGAQDSDDASNSVRHYRLTPNEHLALDSTKPPADGKQVELVLKKPFDRELLQSHQFLITATDGGSPPRSGTARINVRVLDTNDNVPVFDSSVYKVKLRENSPVGALVIKLNATDRDEGSNGEVYYSFSSYTPDKVRQMFSVDADSGEIRVKSNVDYEETNSYEMYIQAADRGQGAVAVHCKVVVEVLDVNDNPPEIVLSSLSSPVREDARADTVVALISINDKDSGQNKQVSLDIIPPDLPFKIKSFRNHYTIVTSALLDRETISSYNVTVTATDGGTPPLSSSMTVRVEVADINDNPPRFKQTSYTVYVSENNAPSAPLCVIKATDPDAGENARITYTILTDNNHGVSVGSYVSVKPATGEVYALRSFDFEKLREFHFQVKAQDNGVPPLSRVATVYIYIMDSNDHSPKFARAVVNGSHSTETILRHSEAGVLVSRALAWDLDAGENAWLLYNLHHAPELDLFKIHEHTGEIRTTRRVIEDNSTVFSLTVHVRDHGSPARSASTTINVAVMELPPKVAPDPKRIIRPHGTMMFSEVTLYLLIALSATTFVFLLTVFVLAIVRCHAYCSQPDACSCSPCCGSKKKKTTTMKKAPKDGGGGGGGGGATGGGAAGGVTVHQQAAVMRRDLKVEPHYIEVRGNGSLTKTYCYKTCLTATSGSDTFMFYNTGRPLSGTWGSGADRFFTGQSGQFVRRLSMPDATAIQVCAPKVPSSDWRYSASLRAGMQSSVRMEESSVMQGAQGVLVQNWPTVSSAPDNEGGEVSPPVGAGVDSNSWHFRYGPGPGGPPHLKPGEVPPEAFIIPGSPAIISIRQGQDGDDKSDFITFGKKEEAKKLKKKKKKEKKDKREKGKDDDD,,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) (0.6392); cell adhesion (GO:0007155) (0.2542); axon extension (GO:0048675) (0.2502); locomotory behavior (GO:0007626) (0.2351); chemical synaptic transmission (GO:0007268) (0.2350); cell morphogenesis (GO:0000902) (0.2145); presynaptic active zone assembly (GO:1904071) (0.1691); adult behavior (GO:0030534) (0.1058); regulation of axonogenesis (GO:0050770) (0.0851); calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) (0.0835); modulation of chemical synaptic transmission (GO:0050804) (0.0751),glutamatergic synapse (GO:0098978) (0.2561); plasma membrane (GO:0005886) (0.1724); cytoplasm (GO:0005737) (0.1710); synapse (GO:0045202) (0.0895),calcium ion binding (GO:0005509) (0.3084); identical protein binding (GO:0042802) (0.1599),"Cadherin-like (IPR002126) (0.3408); Cadherin, N-terminal (IPR013164) (0.3256); Cadherin, C-terminal catenin-binding domain (IPR031904) (0.2791); Cadherin conserved site (IPR020894) (0.2231); Protocadherin/Cadherin-related Cell Adhesion (IPR050174) (0.1608); Cadherin-like superfamily (IPR015919) (0.1449)",2.60.40.60 (0.2420),Transmembrane helix (0.7347); Transmembrane (0.6699); Reference proteome (0.6248); Signal (0.4809); Glycoprotein (0.4807); Membrane (0.4199); Repeat (0.2572); Calcium (0.1364); Cell adhesion (0.1233); Vision (0.0675); Wnt signaling pathway (0.0556),
MAFSSVWKYWAPLPLLLLLYSHTARGQAVQAENVTVLEGGTAQISCRLQNYDGSIVVIQNPRRQTLFFNGTRALKDDRFQMVLFTPKLVRITLTNVSVSDEGGYFCQLYTDDTHHQVATLSVVVPPEVPSVEVKTEAVEGGEVELTCLSLRSKPPATLRWVRDRREIPGVISQQENGKTVSVSNTIRIPVERKDNRAALSCEASHPALVSQKRVRHYSLDVHFAPTVKIVPPQGILREGDSLSLTCSVTGNPLPRDIQWSRVNDTLPERAEKTGNILHMSRLSQSHNGTYLCQAHNNYGRAADHYTLLVYDPGAVVETHSAVPFAVIGGILALLVFTVICVLIVTIWCSVRQKGSYLTHEASGLDEHGEVQEAFLNGNDASQGKKEYLL,,regulation of wound healing (GO:0061041) (0.8418); negative regulation of peptidyl-threonine phosphorylation (GO:0010801) (0.8099); regulation of cell population proliferation (GO:0042127) (0.7801); acrosome assembly (GO:0001675) (0.4296); regulation of Rac protein signal transduction (GO:0035020) (0.3353); negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) (0.2988); positive regulation of cytokine production (GO:0001819) (0.2871); regulation of cell motility (GO:2000145) (0.2420); negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732) (0.1152); protein localization (GO:0008104) (0.0747),membrane (GO:0016020) (0.4424); cell-cell contact zone (GO:0044291) (0.3416); cell leading edge (GO:0031252) (0.1407),vascular endothelial growth factor receptor 2 binding (GO:0043184) (0.3297),Immunoglobulin-like domain superfamily (IPR036179) (0.3292); Neurexin/syndecan/glycophorin C (IPR003585) (0.3281); Immunoglobulin-like fold (IPR013783) (0.2624); Immunoglobulin subtype (IPR003599) (0.1724); Immunoglobulin V-set domain (IPR013106) (0.1558); Immunoglobulin-like domain (IPR007110) (0.1394); Immunoglobulin subtype 2 (IPR003598) (0.1161),2.60.40.10 (0.5334),Immunoglobulin domain (0.3382); Membrane (0.2701); Reference proteome (0.2413); Signal (0.2018); Glycoprotein (0.1142); Transmembrane helix (0.0414),
MGQRRPDQRRERRVKILFFVVLFVYGKTVLAQIRYSISEEQKDGTAVGNVAKDLGIDPKTLKERGFRIVSTSGESMFSVNQNDGVLYVKGKLDRENVCERSTPCLINLKIALENPLEIHYVTVDVIDVNDHAPMFPEQEKRLEISETVLPGARFQLQAARDPDSGSNSVQTYKLSHTEYFRIEIKDRYEDGKVPVLILQKPLDREVTKSIKLQLTALDGGRPPKSGKMTIIIDVLDINDNAPVFIKEVYSVTLNENTPVGTTILRVNATDLDEGQNGVVVYSLGHDVNDKLRKLFNVNPVTGEIVVTGLLDFEVKDIYEIDIQASDKGIAPLTTDKSVTIKIADVNDNEPQIEVTSLSSTIPEDSKPGTTVALISVSDLDSGINGRVTCSLSENIPFQLMPSSQENTYSLVTTSALDRETIAHYDITLEAKDAGQPPLSSVKSVTVQISDVNDNSPEFSSSPYAFYVMENNAPGKSLFSVSASDKDTGANSAVSYQIWRDGGAENKFTSFININSENGEIYALKSFDFETSKTFQFHILATDSGSPSLSSNVTVNVFILDQNDNVPVILYPVSANGSAEGVEEIPRNVNAGHLVTKVRAYDADIGYNGWLLFSLQEVSDHSLFALDRYTGQIRTLRSFTETDEAQHKLVILVKDNGNVSLSATATVIVKVVEPKEAFAASDVKNAEKDEEENNVTFYLIITLGSVSVLFVISIIVLIVMQCSKSTDYSSKYLQDTNYDGTLCHSIQYRSGDKRYMLVGPRMSIGSTIAPGSNRNTLVIPDRRRRDSGESTLKPKVPSSDWRYSASLRAGMQSSVRMEESSVMQGAQGVLVQNWPTVSSAPDNEGGEVSPPVGAGVDSNSWHFRYGPGPGGPPHLKPGEVPPEAFIIPGSPAIISIRQGQDGDDKSDFITFGKKEEAKKLKKKKKKEKKDKREKGKDDDD,,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) (0.8471); axon extension (GO:0048675) (0.4504); chemical synaptic transmission (GO:0007268) (0.2964); cell adhesion (GO:0007155) (0.2679); locomotory behavior (GO:0007626) (0.2156); calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) (0.1949); cell morphogenesis (GO:0000902) (0.0762),cytoplasm (GO:0005737) (0.4515); membrane (GO:0016020) (0.2396); plasma membrane (GO:0005886) (0.2155); glutamatergic synapse (GO:0098978) (0.2072); catenin complex (GO:0016342) (0.1814); synapse (GO:0045202) (0.1394),calcium ion binding (GO:0005509) (0.3728); identical protein binding (GO:0042802) (0.2036),"Cadherin, N-terminal (IPR013164) (0.4886); Cadherin-like (IPR002126) (0.3181); Protocadherin/Cadherin-related Cell Adhesion (IPR050174) (0.2203); Cadherin-like superfamily (IPR015919) (0.1012)",2.60.40.60 (0.3592),Reference proteome (0.6388); Glycoprotein (0.4696); Transmembrane helix (0.4109); Membrane (0.3857); Transmembrane (0.2797); Repeat (0.2512); Metal-binding (0.2298); Cell adhesion (0.1916); Synapse (0.1817); Calcium (0.1597); 3D-structure (0.1086); Cell membrane (0.1063); Alternative splicing (0.0736); Vision (0.0667),
MGVNMDISEDRWSFYWICIVVFLTNWNYADGQIVYSVSEEVNTGTTVGNLAKDLNLNVQDLERRGFQIVSGPNKQYFDLHARNGILFVRERIDREELCGRSSKCALELEAIVSAPMSIYRFEVNILDVNDNAPTFRTSKLFLNISEQTYPGQRFTLPSAFDLDAGVNSVKSYKLSANEHFSLDVQSAGDQSVSAELVLQKALDREKQPVIRLTLTAVDGGKPPMSGTTQIIVNVVDVNDNIPVFDKPLYKARIAENSAIGASVITVSAKDADEGLNGEVIYSFINHDNENSINAFLINPNTGEITVKGPLDYEENAAIEIRVQAEDKGQNPRASHCKVLIEIIDLNDNTPEISIMSLVNEVKEDSAPGTMVGLITVKDGDAGKNGVVRLQIRDSAQFRLENTYKNRFSLVVNGPLDREVASEYNVTISAADEGTPPLSSTSVIAVHVSDVNDNAPRFPEPVINVYVKENSQIGAVLHTVSAVDPDVGDNARITYSLLESSKSGPVTSMININSDTGDLHSLQSFNYEEIKTFEFKVQATDSGVPPLSSNVTVNVFVLDENDNSPAILAPYSELGSVNTENIPYSAEAGYFVAKIRAVDADSGYNALLSYHISEPKGNNLFRIGTSSGEIRTKRRMSDNDLKTHPLVILVCDNGEPSLSATVSIDAVVVESGGDVKTPFRHAPVKEESFSDLNLYLLIAIVSVSVIFLLSLISLIAVKCHRTDSSLGRYSAPMITTHPDGSWSYSKSTQQYDVCFSSDTLKSDVVVFPAPFPPADAELISINGGDTFTRTQTLPNKEKPKVPSSDWRYSASLRAGMQSSVRMEESSVMQGAQGVLVQNWPTVSSAPDNEGGEVSPPVGAGVDSNSWHFRYGPGPGGPPHLKPGEVPPEAFIIPGSPAIISIRQGQDGDDKSDFITFGKKEEAKKLKKKKKKEKKDKREKGKDDDD,,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) (0.6811); locomotory behavior (GO:0007626) (0.3510); cell adhesion (GO:0007155) (0.2694); calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) (0.2118); presynaptic active zone assembly (GO:1904071) (0.1796); adult behavior (GO:0030534) (0.1501); chemical synaptic transmission (GO:0007268) (0.1449); axon extension (GO:0048675) (0.1244),glutamatergic synapse (GO:0098978) (0.2975); plasma membrane (GO:0005886) (0.2794); postsynaptic membrane (GO:0045211) (0.1814); cytoplasm (GO:0005737) (0.1793); synapse (GO:0045202) (0.1687); catenin complex (GO:0016342) (0.0690),calcium ion binding (GO:0005509) (0.2182); identical protein binding (GO:0042802) (0.0978),"Cadherin, C-terminal catenin-binding domain (IPR031904) (0.3130); Cadherin, N-terminal (IPR013164) (0.2633); Cadherin-like (IPR002126) (0.2532); Protocadherin/Cadherin-related Cell Adhesion (IPR050174) (0.2189); Cadherin-like superfamily (IPR015919) (0.1768); Cadherin conserved site (IPR020894) (0.1371)",2.60.40.60 (0.1824),Reference proteome (0.8045); Transmembrane helix (0.6885); Transmembrane (0.5590); Membrane (0.4857); Glycoprotein (0.3361); Repeat (0.2481); Proteomics identification (0.2389); Cell membrane (0.2244); Calcium (0.1580); Vision (0.0510),
MFSMHRRRSVVACFVLVVLVCFWDAASGQLSYSVSEEVSPGTTVGNLAKDLNLNVQELESRMFQIVTGAKKKYFEVNLKTGFLYVNERIDREELCAKAPKCTVSVEAVINNPLKLYQIEINIVDVNDNKPTFNSKTQYLDVAENTLPGVKFPLSYASDADVGKNTVSTYKLSQNEYFSLAVHKGEEQSVSAELVLQKALDREKQPLVQLTLTAADGGNPPKSGTSQIIIRVLDINDNAPVFSRPLYKASLVENVPIGSTVIIINATDKDEGTNSDIIYSLRETDQDHILDIFQIDAITGAITVKGDVNFEKNNAFEIRAQASDKGQPPMSTHCKVLVEVLDINDNEPEITVTSLLSTVKEDASIGTAVALVSVIDRDGGRNGVVNCAVSNNVPFKLQTNYKNYYSLVVDGPLDRERASEYNVTISAADEGSPPLSSTSVIAVHVSDVNDNAPRFPEPVINVYVKENSQIGAVLHTVSAVDPDVGDNARITYSLLESSKSGPVTSMININSDTGDLHSLQSFNYEEIKTFEFKVQATDSGVPPLSSNVTVNVFVLDENDNSPAILAPYSELGSVNTENIPYSAEAGYFVAKIRAVDADSGYNALLSYHISEPKGNNLFRIGTSSGEIRTKRRMSDNDLKTHPLVILVCDNGEPSLSATVSIDAVVVESGGDVKTPFRHAPVKEESFSDLNLYLLIAIVSVSVIFLLSLISLIAVKCHRTDSSLGRYSAPMITTHPDGSWSYSKSTQQYDVCFSSDTLKSDVVVFPAPFPPADAELISINGGDTFTRTQTLPNKEKPKVPSSDWRYSASLRAGMQSSVRMEESSVMQGAQGVLVQNWPTVSSAPDNEGGEVSPPVGAGVDSNSWHFRYGPGPGGPPHLKPGEVPPEAFIIPGSPAIISIRQGQDGDDKSDFITFGKKEEAKKLKKKKKKEKKDKREKGKDDDD,,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) (0.7033); cell adhesion (GO:0007155) (0.5026); calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) (0.2168); presynaptic active zone assembly (GO:1904071) (0.2028); synapse assembly (GO:0007416) (0.1646); adult behavior (GO:0030534) (0.1570); chemical synaptic transmission (GO:0007268) (0.1224); modulation of chemical synaptic transmission (GO:0050804) (0.0793); spermatogenesis (GO:0007283) (0.0411),plasma membrane (GO:0005886) (0.2544); glutamatergic synapse (GO:0098978) (0.2193); synapse (GO:0045202) (0.1430); cytoplasm (GO:0005737) (0.0905); postsynaptic membrane (GO:0045211) (0.0736),calcium ion binding (GO:0005509) (0.2888); identical protein binding (GO:0042802) (0.2076),"Protocadherin/Cadherin-related Cell Adhesion (IPR050174) (0.3583); Cadherin, N-terminal (IPR013164) (0.3251); Cadherin-like (IPR002126) (0.2889); Cadherin, C-terminal catenin-binding domain (IPR031904) (0.1771); Cadherin-like superfamily (IPR015919) (0.1409); Cadherin conserved site (IPR020894) (0.1062)",2.60.40.60 (0.1544),Signal (0.8147); Reference proteome (0.7393); Transmembrane helix (0.6054); Transmembrane (0.5841); Repeat (0.4956); Membrane (0.4735); Glycoprotein (0.3797); Alternative splicing (0.2882); Cell membrane (0.2848); Proteomics identification (0.2721); Cell adhesion (0.1751); Calcium (0.1739); Vision (0.1460),
MEAGGQRRTGEHWWMIICFCFILCFGQQLSAQIRYSIPEEVKEGFVVGNIAKDLGLDVSSLMDRRFRIVSGSDDSQFVVNPNNGVLRVQRKIDREELCDGIGACLINLKIVVENPLEIHYIAVEITDVNDHSPTFTEKEKRLEISENTLIGTRFQLQAARDPDSGVNSVRSYKLSQNEHFDLEIRDRAEDKLPFLVLQKPLDRENKAEHYLILTAIDGGNPQRSGTLNITVIVLDVNDNRPMFSHDVYSSTVHENVQLGTLVLKVMASDSDYGPNGEVSYSFGGDNSDNIFHIFSLDRITGEIRVTGEVDFEKNNVYKLDIQAVDSGQPPLNTDCRVIIKILDLNDNKPTIEVTSLSNVVSEDSKPGTLISLISVTDRDTGINGRVVCSLSEHVPFELKPSVQENMFSLVTKGKLDRETLSHFDITITATDLGQPPLSSYKTLSVQVSDVNDNPPEFSLNPVELYMIENNAAGAPILTLSAFDKDLNENAIISYQIIKGNGSQSDLTSFLNVNSETGAVYALKSFDFETVKKFQFHILATDSGSPSLSSNVTVNVFILDQNDNVPVILYPVSANGSAEGVEEIPRNVNAGHLVTKVRAYDADIGYNGWLLFSLQEVSEHSLFALDRYTGQIRTLRSFTETDEAQHKLVILVKDNGNVSLSATATVIVKVVEPKEAFAASDVKNAVKDEEENNVTFYLIITLGSVSVLFVISIIVLIVMQCSKSTDYSSKYLQDTNYDGTLCHSIQYRSGDKRYMLVGPRMSIGSTIAPGSNRNTLVIPDRRRRDSGEPKVPSSDWRYSASLRAGMQSSVRMEESSVMQGAQGVLVQNWPTVSSAPDNEGGEVSPPVGAGVDSNSWHFRYGPGPGGPPHLKPGEVPPEAFIIPGSPAIISIRQGQDGDDKSDFITFGKKEEAKKLKKKKKKEKKDKREKGKDDDD,,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) (0.7208); locomotory behavior (GO:0007626) (0.4515); cell adhesion (GO:0007155) (0.3529); axon extension (GO:0048675) (0.2233); calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) (0.1457); adult behavior (GO:0030534) (0.1386); chemical synaptic transmission (GO:0007268) (0.1066); spermatogenesis (GO:0007283) (0.0616),cytoplasm (GO:0005737) (0.4416); membrane (GO:0016020) (0.2453); plasma membrane (GO:0005886) (0.2278); glutamatergic synapse (GO:0098978) (0.1447); synapse (GO:0045202) (0.0929); catenin complex (GO:0016342) (0.0806),calcium ion binding (GO:0005509) (0.3208); identical protein binding (GO:0042802) (0.2724),"Cadherin-like (IPR002126) (0.4541); Protocadherin/Cadherin-related Cell Adhesion (IPR050174) (0.2702); Cadherin, N-terminal (IPR013164) (0.2156); Cadherin-like superfamily (IPR015919) (0.1530)",2.60.40.60 (0.4129),Reference proteome (0.6803); Membrane (0.5158); Transmembrane helix (0.4658); Glycoprotein (0.4390); Transmembrane (0.3820); Repeat (0.3525); Cell membrane (0.2163); Signal (0.1941); Calcium (0.1750); Metal-binding (0.1437); Proteomics identification (0.1423); 3D-structure (0.0867); Vision (0.0494),
MLTSTPGNVIVCLLFALSVYLSKTASAQISYNVLEEVKPGTTVGNLAKDINLSVKELQSRGFRIVSGSKKQYFSVNVDTGALQVSERIDREELCAGAVACSVNLEAVVNSPLQLYRVRINILDINDNSPVFPTSSVVINVSESTAPGVRFPLESAHDADIGVNSVKTYKLATNDYFSLDMQTHTDKTISAELVLQKALDREKTPRLEFTVTAFDGGSPARTGTVMIEVNVLDINDHAPVFSKTLYKVSVAEHALVGTAVARLQARDLDEGLNAEIVYSFVDRTAQNIREKFEIDAQSGDVKIKGDIDYEESTAFEIRVQATDKGQVTMSGHTKLLIEVLDVNDNPPDVTVTSLLSPVEENAGRGTVIALMTVSDPDSGKNGAVHVRLSGFNPFKLQSSFQNYYSLVLDGVLDRENVTEYNVTVIAEDEGSPSMSRVKVIRVEVSDVNDNAPRFASSVEYAYLRENSNVGTVIMTLTASDADIRDNAHLTYSLLQSSVGGTPISALLKVNSLTGEIESMLTFDYEEIKTFEFKVQATDSGVPPLSSNVTVNVFVLDENDNSPAILAPYSELGSVNTENIPYSAEAGYFVAKIRAVDADSGYNALLSYHISEPKGNNLFRIGTSSGEIRTKRRMSDNDLKTHPLVILVCDNGEPSLSATVSIDAVVVESGGDVKTPFRHAPVKEESFSDLNLYLLIAIVSVSVIFLLSLISLIAVKCHRTDSSLGRYSAPMITTHPDGSWSYSKSTQQYDVCFSSDTLKSDVVVFPAPFPPADAELISINGGDTFTRTQTLPNKEKPKVPSSDWRYSASLRAGMQSSVRMEESSVMQGAQGVLVQNWPTVSSAPDNEGGEVSPPVGAGVDSNSWHFRYGPGPGGPPHLKPGEVPPEAFIIPGSPAIISIRQGQDGDDKSDFITFGKKEEAKKLKKKKKKEKKDKREKGKDDDD,,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) (0.7591); cell adhesion (GO:0007155) (0.5252); synapse assembly (GO:0007416) (0.2385); calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) (0.2064); chemical synaptic transmission (GO:0007268) (0.1891); presynaptic active zone assembly (GO:1904071) (0.0743),plasma membrane (GO:0005886) (0.2637); synapse (GO:0045202) (0.2063); glutamatergic synapse (GO:0098978) (0.2037); postsynaptic membrane (GO:0045211) (0.1457),calcium ion binding (GO:0005509) (0.2701); identical protein binding (GO:0042802) (0.1399),"Cadherin, N-terminal (IPR013164) (0.3898); Cadherin-like (IPR002126) (0.3394); Cadherin, C-terminal catenin-binding domain (IPR031904) (0.2446); Protocadherin/Cadherin-related Cell Adhesion (IPR050174) (0.2222); Cadherin-like superfamily (IPR015919) (0.1479)",2.60.40.60 (0.1782),Reference proteome (0.8184); Signal (0.7561); Transmembrane helix (0.6111); Transmembrane (0.5767); Repeat (0.5442); Membrane (0.5219); Proteomics identification (0.3172); Cell membrane (0.2902); Cell adhesion (0.2896); Glycoprotein (0.2849); Calcium (0.2540); Alternative splicing (0.2235); Vision (0.1596),
MANENTRTWMSRIFYLMCLLFNSGGKAAQINYSLQEESKIGVNVGNIAKDLGIDPTSLENRNFRIVVGTKQELFRVNHEDGALFVSQRIDREELCAKINPCLINLKAVIENPLEMHQISVDIIDVNDNPPSFLDENYKLEILESAMTGARFQVETAHDPDIGSNDLQSYKLSQNHYFRLETEDMGDEGKIPVLILQKPLDREKSARHNLILTATDGGKPHKSAAANITIVVSDVNDNTPVCDKQKYTVTVKEDAPEGTFLLRVNASDSDEGVNGEIEYSLRNKFRKGASDVFDLDNITGELKIKGGLNFEERQVYELKILAADKGAVSLSTQCNVLVNVEDVNDNRPEIDVTSLSSHIPEDAAPGTVVALIGVTDLDSGMNGKIICSLPKNIPFDLKPSPDGNFYSLVTKENIDKEAKSSYDITITAKDLGSPSLSSTRSIHVEVTDVNDNSPKFAQSPYTFYVTENNKPGIAVFSLSASDLDEGENARVSYTIDRINSDQSMTSFLSINEANGTVYSLKSFDFESLKTFHFFVVAKDSGSPSLSSNVTVNVFILDQNDNVPVILYPVSANGSAEGVEEIPRNVNAGHLVTKVRAYDADIGYNGWLLFSLQEVSEHSLFALDRYTGQIRTLRSFTETDEAQHKLVILVKDNGNVSLSATATVIVKVVEPKEAFAASDVKNAVKDKEENNVTFYLIITLGSVSVLFVISIIVLIVMQCSKSTDYSSKYLQDTNYDGTLCHSIQYRSGDKRYMLVGPRMSIGSTIAPGSNRNTLVIPDRRRRDSGEPKVPSSDWRYSASLRAGMQSSVRMEESSVMQGAQGVLVQNWPTVSSAPDNEGGEVSPPVGAGVDSNSWHFRYGPGPGGPPHLKPGEVPPEAFIIPGSPAIISIRQGQDGDDKSDFITFGKKEEAKKLKKKKKKEKKDKREKGKDDDD,,cell adhesion (GO:0007155) (0.5351); homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) (0.4931); presynaptic active zone assembly (GO:1904071) (0.3119); adult behavior (GO:0030534) (0.2733); modulation of chemical synaptic transmission (GO:0050804) (0.1831); chemical synaptic transmission (GO:0007268) (0.1463); locomotory behavior (GO:0007626) (0.1424); axon extension (GO:0048675) (0.1218); excitatory postsynaptic potential (GO:0060079) (0.1110); neural tube formation (GO:0001841) (0.0717); regulation of presynapse assembly (GO:1905606) (0.0572),glutamatergic synapse (GO:0098978) (0.3114); plasma membrane (GO:0005886) (0.1507); cytoplasm (GO:0005737) (0.1342); membrane (GO:0016020) (0.1158); postsynaptic membrane (GO:0045211) (0.1076),calcium ion binding (GO:0005509) (0.3224); identical protein binding (GO:0042802) (0.2254),"Cadherin-like (IPR002126) (0.3437); Cadherin, N-terminal (IPR013164) (0.2406); Protocadherin/Cadherin-related Cell Adhesion (IPR050174) (0.1745); Cadherin-like superfamily (IPR015919) (0.1373)",2.60.40.60 (0.2947),Reference proteome (0.7138); Transmembrane helix (0.6385); Transmembrane (0.5245); Signal (0.5146); Glycoprotein (0.4173); Membrane (0.4093); Proteomics identification (0.1893); Repeat (0.1690); Alternative splicing (0.1567); Calcium (0.1145); Vision (0.0873); Cell membrane (0.0715),
MAHIIVMSGIVICLVLLLLMPSASAQVAYSISEEANTGTFVGNIAKDLNLNIQELESRGFHIPAVSGRKYFEVNLKTGVLFVSERIDREAFCPASPQCSVNLEAIVNNPLNLFRIEINIVDINDNSPSFRVRSMHINVSEYAFIGDRFQLPRASDPDVGANSVKSYKLSPNEHFSLDVQSGGEQSASAELVLQKALDREKQPAIHLTLTAVDGGKPPKSGTMQIAIHVQDVNDNAPVFGKALYKVRIVENAPLGTLVINLNATDLDEGLNSEIIYSLVQQDSDDKASSVFKIDSATGVVSMQGRVDFEERNAYEIHAQAKDKGASPRSAHCKILVEVLDVNDNEPEISLTSQVNTVREDAKRETTVALITISDKDSGKNGNVHGKVVGDVPFKLQSSYKNYYSLVVDEPLDRERVDRYNVTIMASDEGAPPLSATRVFTVYVSDVNDNPPSFPNPVINVFVKENGPMDQIIYTLSAVDPDLNENSKITYGLLEPLHKSGSTYSAITINSDTGDLHSLQSFNYEEIKTFEFKVQATDSGVPPLSSNVTVNVFVLDENDNSPAILAPYSELGSVNTENIPYSAEAGYFVAKIRAVDADSGYNALLSYHISEPKGNNLFRIGTSSGEIRTKRRMSDNDLKTHPLVILVCDNGEPSLSATVSIDAVVVESGGDVKTPFRHAPVKEESFSDLNLYLLIAIVSVSVIFLLSLISLIAVKCHRTDSSLGRYSAPMITTHPDGSWSYSKSTQQYDVCFSSDTLKSDVVVFPAPFPPADAELISINGGDTFTRTQTLPNKEKPKVPSSDWRYSASLRAGMQSSVRMEESSVMQGAQGVLVQNWPTVSSAPDNEGGEVSPPVGAGVDSNSWHFRYGPGPGGPPHLKPGEVPPEAFIIPGSPAIISIRQGQDGDDKSDFITFGKKEEAKKLKKKKKKEKKDKREKGKDDDD,,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) (0.7501); calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) (0.2802); cell adhesion (GO:0007155) (0.2585); chemical synaptic transmission (GO:0007268) (0.1561); presynaptic active zone assembly (GO:1904071) (0.1397); adult behavior (GO:0030534) (0.1120); modulation of chemical synaptic transmission (GO:0050804) (0.0931); locomotory behavior (GO:0007626) (0.0931),plasma membrane (GO:0005886) (0.4190); glutamatergic synapse (GO:0098978) (0.3874); postsynaptic membrane (GO:0045211) (0.1057); synapse (GO:0045202) (0.0945); cell surface (GO:0009986) (0.0615),calcium ion binding (GO:0005509) (0.2935); cadherin binding (GO:0045296) (0.0770); identical protein binding (GO:0042802) (0.0465),"Protocadherin/Cadherin-related Cell Adhesion (IPR050174) (0.3240); Cadherin-like (IPR002126) (0.2494); Cadherin, N-terminal (IPR013164) (0.2242); Cadherin-like superfamily (IPR015919) (0.1837); Cadherin conserved site (IPR020894) (0.0915)",2.60.40.60 (0.2221),Signal (0.7818); Reference proteome (0.7648); Transmembrane helix (0.6074); Transmembrane (0.5281); Membrane (0.4753); Cell membrane (0.3619); Repeat (0.3442); Glycoprotein (0.2914); Proteomics identification (0.2832); Vision (0.1512); Calcium (0.1453); Alternative splicing (0.1292),
MAIVPLHNCLSVILFYVVFCFGSTAEGHIVYTVSEETNPGTTVGNLAKDLNLNLQDITNRGFQLVSGANKRYFELNSKTGFLHINDRIDRDELCGRSLKCSFPLEAIVNAPLNVYRFEVSIIDINDNSPTFRSPVKYFNISESAFPGERFPLPTAFDADVGSNSVKSYKLSANEHFSLDVQSGGEQSVSAELVLQKALDREKQPVIKLTLTAVDGGKPPRSGTINIIVNIEDVNDNIPVFSKPLFKTRVVENSPFGTSVIQVHASDPDEGPNSEIVYSLLSQDNENNADAFAIDPETGVITVKGTVDYEKNAAVEIRVQAKDKGHKPRAAYCKVLVEITDINDNTPEISVTSLVNTVKEDAANGTVVSMITVLDNDAGKNGEIQLKIRDSLPFKVQNSYKNYYTLIVNGHLDRETASEYNVTISAADEGTPPLSSTSVIAVHVSDVNDNAPRFPEPVINVYVKENSQIGAVLHTVSAVDPDVGDNARITYSLLESSKSGPVTSMININSDTGDLHSLQSFNYEEIKTFEFKVQATDSGVPPLSSNVTVNVFVLDENDNSPAILAPYSELGSVNTENIPYSAEAGYFVAKIRAVDADSGYNALLSYHISEPKGNNLFRIGTSSGEIRTKRRMSDNDLKTHPLVILVCDNGEPSLSATVSIDAVVVESGGDVKTPFRHAPVKEESFSDLNLYLLIAIVSVSVIFLLSLISLIAVKCHRTDSSLGRYSAPMITTHPDGSWSYSKSTQQYDVCFSSDTLKSDVVVFPAPFPPADAELISINGGDTFTRTQTLPNKEKPKVPSSDWRYSASLRAGMQSSVRMEESSVMQGAQGVLVQNWPTVSSAPDNEGGEVSPPVGAGVDSNSWHFRYGPGPGGPPHLKPGEVPPEAFIIPGSPAIISIRQGQDGDDKSDFITFGKKEEAKKLKKKKKKEKKDKREKGKDDDD,,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) (0.7901); cell adhesion (GO:0007155) (0.5597); synapse assembly (GO:0007416) (0.2298); calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) (0.2034); chemical synaptic transmission (GO:0007268) (0.1717); adult behavior (GO:0030534) (0.1160); axon extension (GO:0048675) (0.1037); excitatory postsynaptic potential (GO:0060079) (0.0823),glutamatergic synapse (GO:0098978) (0.2803); plasma membrane (GO:0005886) (0.2451); synapse (GO:0045202) (0.2420); postsynaptic membrane (GO:0045211) (0.1169); cytoplasm (GO:0005737) (0.1101),calcium ion binding (GO:0005509) (0.2165); identical protein binding (GO:0042802) (0.1187),"Cadherin, N-terminal (IPR013164) (0.5876); Protocadherin/Cadherin-related Cell Adhesion (IPR050174) (0.3361); Cadherin-like (IPR002126) (0.2476); Cadherin, C-terminal catenin-binding domain (IPR031904) (0.2328); Cadherin-like superfamily (IPR015919) (0.1422)",2.60.40.60 (0.2088),Reference proteome (0.7661); Signal (0.6805); Transmembrane helix (0.6326); Transmembrane (0.5272); Membrane (0.4695); Repeat (0.4123); Glycoprotein (0.3423); Proteomics identification (0.3019); Cell membrane (0.2545); Cell adhesion (0.2491); Alternative splicing (0.2102); Calcium (0.1385); Vision (0.0893),
MRSMRPWKQTALWLLFFSVLWSTTGAQIRYTIPEELKEGSVVGNIAKDIGLDIVHIANRKLRIASDSGTQFFSVDTRSGELIVNGRIDREALCGQSDSCLMPLQLIIEDPLQLYRVNIEIQDINDNAPNFHTKDNVLKIAESVAVGAKFPFESAEDLDVGSNSLKSYALSNNGFFRLNVKTVEDGKKVPELIVDKPLDREKQSVHKLILTALDGGDPVKSGTIVIQVIVQDTNDNEPKFEHSQYKASVLESTKPGSSVLTVKATDLDEGLNGEIQYFFGAHTPDAVKKCFNINTDTGDITVIGILDYEVTKLYTFDVCAKDKGSPEQEGHSSVRLHIIDENDNIPEIILTSLPSPVSENATVGTVVALINVKDLDSGDNGKVNLTISSRFPFKLKPAFDNHYSLVTDSLLDREAKAEYEIQLVATDSGSPPLKSTKTVNVRLLDVNDNPPLFSQPSYTVYIKENSLPGASLFSISATDIDKDRNAMLSYSVLDLSSSQIPASSYFYINSENGTIYSMSSFDYEKMKLISIVVQAKDQGSPFLSSNATVHVFILDQNDNAPAVIYPSTSMGSVSHQRMPRSAKTGHLVTKVTAVDADSGHNAWLFYRLAEATDASLFSVNLHTGEVRTKRAVSEHDDSSQRLVLEIKDNGEPIQSTTVTVDILIEDGFHEPISDYREKTIEPNRKSGKITLYLIISLASVSLLCLMTFFILLVKCARGSRGGSSCCIRRTNSDYKNPNRNLQIQLNTDGPIKYVEVLGGDMMSQSQSFGSYLSPMSEFSDLTLIKPSSTTNFTDTLNTLDASLPDSAWTFESQQQKPPNTDWRFPPNQRPGPSGAGARPEEAGAGAGVIAGTGPWPNPPTEAEQLQAMMAAANASEATATLGPRYNLQYGPDYRQNVYIPGSTATLTANPQQQVLQQALPPPQALPPTEAPKAAQTPASKKKPTKKDKK,,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) (0.7522); cell adhesion (GO:0007155) (0.6334); adult behavior (GO:0030534) (0.2923); modulation of chemical synaptic transmission (GO:0050804) (0.2434); calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) (0.1354); chemical synaptic transmission (GO:0007268) (0.0834),plasma membrane (GO:0005886) (0.2710); glutamatergic synapse (GO:0098978) (0.2348); membrane (GO:0016020) (0.1980); synapse (GO:0045202) (0.1380); presynaptic membrane (GO:0042734) (0.0829),calcium ion binding (GO:0005509) (0.3719); identical protein binding (GO:0042802) (0.1262); cadherin binding (GO:0045296) (0.0747),"Cadherin-like (IPR002126) (0.4397); Cadherin, C-terminal catenin-binding domain (IPR031904) (0.2473); Protocadherin/Cadherin-related Cell Adhesion (IPR050174) (0.2273); Cadherin-like superfamily (IPR015919) (0.2100); Cadherin, N-terminal (IPR013164) (0.1118)",2.60.40.60 (0.3281),Reference proteome (0.7439); Transmembrane helix (0.6995); Transmembrane (0.6334); Signal (0.5634); Membrane (0.4582); Glycoprotein (0.4341); Repeat (0.4256); Cell membrane (0.3061); Cell adhesion (0.2200); Proteomics identification (0.2128); Calcium (0.1998); Synapse (0.1915); Alternative splicing (0.1861); Vision (0.0715),
MSSSLFLYQIILTLVCQALCDDPIKDFNCFNDYEAEMTCSFSSESLRNCSGYNMNVTQKLAYEINRYSCVFERSHHNAICECKIEVEGFITEEIFSTTLLKGTKVLLQRDFKTIDYIKPKTPVLFVKKTENGNFHVTWVDSYEQRNVFTDNLFITLTYRIKGEIETNSTKVANTVGFCDIVGSLLQPKTEYILTAKMSSNYNGQKIYSDQSAAVHFTTGL,,production of molecular mediator involved in inflammatory response (GO:0002532) (0.8131); immune response (GO:0006955) (0.3958); cell surface receptor signaling pathway via JAK-STAT (GO:0007259) (0.2888); positive regulation of type II interferon production (GO:0032729) (0.2662); cytokine-mediated signaling pathway (GO:0019221) (0.2495); response to lipopolysaccharide (GO:0032496) (0.2420); defense response to protozoan (GO:0042832) (0.1832); positive regulation of immunoglobulin production (GO:0002639) (0.1435); negative regulation of interleukin-10 production (GO:0032693) (0.1434); natural killer cell activation (GO:0030101) (0.1114); DNA damage response (GO:0006974) (0.1104); inflammatory response (GO:0006954) (0.1087); interleukin-3-mediated signaling pathway (GO:0038156) (0.0933); T cell mediated cytotoxicity (GO:0001913) (0.0881); T cell differentiation (GO:0030217) (0.0867); immunoglobulin mediated immune response (GO:0016064) (0.0678); defense response to virus (GO:0051607) (0.0639),external side of plasma membrane (GO:0009897) (0.8595); plasma membrane (GO:0005886) (0.1189); intracellular membrane-bounded organelle (GO:0043231) (0.0905); cytosol (GO:0005829) (0.0833),cytokine receptor activity (GO:0004896) (0.0792),Immunoglobulin-like fold (IPR013783) (0.2365); Fibronectin type III superfamily (IPR036116) (0.2015),2.60.40.10 (0.3595),Signal (0.6566); Reference proteome (0.3826); Transmembrane helix (0.2822); Disulfide bond (0.1372); Membrane (0.1162); Transmembrane (0.1081),
MKRIGKWELAALWLYALSLLWSTVGAQIRYTIPEELKEGSIVGNIAKDLGFDISDIAERKLRIASESNRQYFSVDSGKGDLVVNGRIDRETLCGQSASCLMPLQIVIENPLQLHRVEIEIQDINDNPPTFHTKDVILKISELVAPGTRFSLESAEDLDVSSNSLKTYTLNNNDFFRLNVKTLKNGRKVPELVVEKALDREKQSIHELILTALDGGNPVKSGTSLLQIIVQDINDNEPKFEVASYKASVVEKATFDLSVLKIKATDPDEGLNGEIEYLFAAHTPESVRNVFRVNVETGEIKVIGGLDYETKKSYTFDVCAKDKGNPELEGQSSVQIDIIDENDNPPEIILTSLPSPVPENATVGTVVALINVKDLDSGNNGKVELTISTGAPFKIITSFENHYSLITDSFLDRELNSEYNIEILARDLGVPSLITTKAVNVKVLDVNDNSPVFSQSSYNVYINENNLAGFSLFSVSATDSDQDKNAMLTYSVLDLSPNHVPASSYFYINSENGTIYSMSSFDYEKMKLISIVVQAKDQGSPSLSSNATVHVFILDQNDNAPAVIYPSTSMGSVSHQRMPRFAKAGHLVTKVTAVDADSGHNAWLFYRLAEATDASLFSVNLHTGEVRTKRAVSEHDDSSQRLVLEIKDNGDPIQSTTVTVDILIEDGFHEPVSDYREKTNEPSKKTGKITLYLIISLASVSLLCLMTFFILLVKCARGSRGGTSCCIRRTNSDYKNPNRNLQIQLNTDGPIKYVEVLGGDMMSQSQSFGSYLSPMSEFSDLTLIKPSSTTNFTDTLNTLDASLPDSAWTFESQQQKPPNTDWRFPPNQRPGPSGAGARPEEAGAGAGVIAGTGPWPNPPTEAEQLQAMMAAANASEATATLGPRYNLQYGPDYRQNVYIPGSTATLTANPQQQVLQQALPPPQALPPTEAPKAAQTPASKKKPTKKDKK,,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) (0.8117); cell adhesion (GO:0007155) (0.5173); adult behavior (GO:0030534) (0.1974); calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) (0.1370); negative regulation of neuron apoptotic process (GO:0043524) (0.0994); chemical synaptic transmission (GO:0007268) (0.0835); synapse organization (GO:0050808) (0.0722); axon extension (GO:0048675) (0.0521),plasma membrane (GO:0005886) (0.2664); glutamatergic synapse (GO:0098978) (0.2378); synapse (GO:0045202) (0.2320); membrane (GO:0016020) (0.1717); cytoplasm (GO:0005737) (0.0931),calcium ion binding (GO:0005509) (0.2774); identical protein binding (GO:0042802) (0.1410),"Cadherin-like (IPR002126) (0.3772); Cadherin, N-terminal (IPR013164) (0.2551); Protocadherin/Cadherin-related Cell Adhesion (IPR050174) (0.2150); Cadherin, C-terminal catenin-binding domain (IPR031904) (0.1730); Cadherin-like superfamily (IPR015919) (0.1598)",2.60.40.60 (0.2863),Reference proteome (0.7345); Transmembrane helix (0.6543); Transmembrane (0.6307); Membrane (0.4741); Glycoprotein (0.3229); Repeat (0.3179); Signal (0.2728); Proteomics identification (0.2257); Cell membrane (0.2189); Alternative splicing (0.2066); Calcium (0.1281),
MVNVTPSIDPTAAHEGYNYLALICGVPLILIIILGNVLVCLSVLTERSLKTATNYFIVSLAVADLLLAILVLPLYVYSEFLGGIWTLSMYICDALMTMDVMLCTASILNLCAISVDRYIAVVVPLKYNRNQFSVRQLALITATWVLSLGVASPVIFGLNQVPNRNPHVCKLEDNQFVVYSSVCSFFVPCPVMLFLYYWMFRGLKRWSSGRNRSHLRRPPRGRRSLSLRLGAALQKEKGRAREKVVYLMPAGLSPTSLTATPTTPISSTSPVTLTTDDLAEGQMPGAESDPMTTQMDSVSDAENPERATEDDSGRENGVGKNHRPHTGRRHSKSNRVSGRERKAMKVLPVVVGVFLACWTPFFVVHVTKALCESCDIGPTLISVVTWLGYVNSAVNPIIYTAFNVEFRNVFHKLLCCRS,,"adenylate cyclase-inhibiting dopamine receptor signaling pathway (GO:0007195) (0.7854); negative regulation of synaptic transmission, glutamatergic (GO:0051967) (0.6361); regulation of dopamine secretion (GO:0014059) (0.4522); negative regulation of adenylate cyclase activity (GO:0007194) (0.4153); negative regulation of cytosolic calcium ion concentration (GO:0051481) (0.4109); regulation of potassium ion transport (GO:0043266) (0.4072); adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880) (0.2961); positive regulation of MAPK cascade (GO:0043410) (0.2370); phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) (0.1903); negative regulation of voltage-gated calcium channel activity (GO:1901386) (0.1799); response to amphetamine (GO:0001975) (0.1441)",plasma membrane (GO:0005886) (0.3238); synapse (GO:0045202) (0.2511),"dopamine neurotransmitter receptor activity, coupled via Gi/Go (GO:0001591) (0.3708); G protein-coupled receptor activity (GO:0004930) (0.1249); alpha2-adrenergic receptor activity (GO:0004938) (0.1182)","Dopamine receptor family (IPR000929) (0.4615); Dopamine D4 receptor (IPR002185) (0.2874); GPCR, rhodopsin-like, 7TM (IPR017452) (0.1142); G protein-coupled receptor, rhodopsin-like (IPR000276) (0.1034)",1.20.1070.10 (0.1806),Transmembrane helix (0.8278); G-protein coupled receptor (0.6126); Reference proteome (0.5871); Transducer (0.5488); Transmembrane (0.5125); Receptor (0.4497); Membrane (0.2409); Glycoprotein (0.2340); Disulfide bond (0.2140); Cell membrane (0.1359); Ubl conjugation (0.0457),
MSNTIVKSKAWAFVTQVFNLPMALLRRMITNLLNRVMMMSSLPPPKMDSQVDCKKRKMVVGLGNPGMTGSRHSVGMAVLTTLAERLGAPDGWRSDRKVSGEVVVTQLQDVQLVLLRPKLLMNVNGVSVAKAASRYLIQPEHILLIHDELDKPLGKFGIKHGGSARGHNGVRSCVDCLQTDVMPRLRIGIGRPSDKTPIDRYVLGRFSKEEQNVLDSVIKQSLDVLLDYLTDSRSQTSPAEGRRAAQKKKARTLSPPQNSSEEQTQS,aminoacyl-tRNA hydrolase (3.1.1.29) (0.4690); 3.1.1.- (0.0739); 3.1.3.- (0.0729),translation (GO:0006412) (0.5654); negative regulation of protein phosphorylation (GO:0001933) (0.2102); mitochondrial translation (GO:0032543) (0.1807); mRNA processing (GO:0006397) (0.0988); protein stabilization (GO:0050821) (0.0720); ribosome biogenesis (GO:0042254) (0.0503),mitochondrial matrix (GO:0005759) (0.3027); mitochondrial inner membrane (GO:0005743) (0.1816); mitochondrion (GO:0005739) (0.1027); nucleus (GO:0005634) (0.0936),aminoacyl-tRNA hydrolase activity (GO:0004045) (0.3086); rRNA binding (GO:0019843) (0.0831),Peptidyl-tRNA hydrolase (IPR001328) (0.3373); Peptidyl-tRNA hydrolase superfamily (IPR036416) (0.1266),3.40.50.1470 (0.5734),Transit peptide (0.8529); Membrane (0.2666); Mitochondrion (0.2367); Hydrolase (0.2174); Reference proteome (0.1978); Golgi apparatus (0.1939); mRNA processing (0.1110); Cell membrane (0.0810); rRNA-binding (0.0684),
MLNFCPQCGSKLQAGFRFCPSCGEKLPENPTDEDEPSPQQESHINAVISSVSAMEVDCAGDSSPSALSRPPLRTTRRKTLSNTNTEYTEQKPVPSSRKRKSSQLVKEEEEVAKKTQSILSQTPDKTSFTPPRKGKASPQIKEQDEIKQTNLSTLQTPDKMSSMSLQKYKASPLIKDEEAKKTSPAIQSPSKCKSKKRVSSVDPVLEGTVVCDQSGKKWKLIELLWKTELDVTYGVCQANQHAESDECKYMLRLGAKEGHLFNEQNFHLRAAKPDAVEKWGKLHKLDFLGIPSCVGFGLHETYRFLVFPCMGQPLQTELDEGTGSLSEKNVLQLALRLLDSLEFIHEKEYAHADIHAGNIYIKSSSHTEVFLSGFGHAFRFCPGGKHVEYRQGSRTAHQGNISFISLDSHKGAGPSRRSDLQSLGYCMLCWMTGSLPWSHLSHNSSSVAAEKERYMSDVPGLLTYCYKQKKASSALQEYLCNVMALQYTEKPDYTLLKGGLQQSLQKMGGSLK,non-specific serine/threonine protein kinase (2.7.11.1) (0.9479),signal transduction (GO:0007165) (0.5954); protein phosphorylation (GO:0006468) (0.4156); Wnt signaling pathway (GO:0016055) (0.3401); peptidyl-serine phosphorylation (GO:0018105) (0.0886); regulation of translation (GO:0006417) (0.0605),cytoplasm (GO:0005737) (0.5608); nucleus (GO:0005634) (0.3143); nucleoplasm (GO:0005654) (0.1065),protein phosphatase binding (GO:0019903) (0.3660); protein serine/threonine kinase activity (GO:0004674) (0.3517); ATP binding (GO:0005524) (0.1102),Casein Kinase 1 Ser/Thr Protein Kinase (IPR050235) (0.3686); Zinc-ribbon domain (IPR026870) (0.2484); Protein kinase domain (IPR000719) (0.1063),1.10.510.10 (0.1076),Wnt signaling pathway (0.8297); Cytoplasm (0.7025); Serine/threonine-protein kinase (0.4853); Reference proteome (0.4803); Proteomics identification (0.4556); Phosphoprotein (0.4161); Nucleotide-binding (0.3752); ATP-binding (0.3215); Transferase (0.2217); Kinase (0.1509); Nucleus (0.0979); Alternative splicing (0.0883); tRNA processing (0.0426),
MSNLNSENASTLENAMQLMIQTFHKYSGNEGDKYTLSRQELKEMLTQELGNYLGNAQDKDAVDKVMGDLDSNNDGEVDFTEFIILVGALTVACNDFFLEYHEKDGKKDDKK,,positive regulation of sprouting angiogenesis (GO:1903672) (0.3132); regulation of heart contraction (GO:0008016) (0.2449); positive regulation of nitric-oxide synthase activity (GO:0051000) (0.1577); positive regulation of cell population proliferation (GO:0008284) (0.0889); signal transduction (GO:0007165) (0.0875),ruffle (GO:0001726) (0.1821); nucleus (GO:0005634) (0.1445); sarcoplasmic reticulum (GO:0016529) (0.1199); cytoplasm (GO:0005737) (0.1088),calcium ion binding (GO:0005509) (0.3923); S100 protein binding (GO:0044548) (0.2517); protein homodimerization activity (GO:0042803) (0.1777); calcium-dependent protein binding (GO:0048306) (0.1080); tropomyosin binding (GO:0005523) (0.0666),"S100/Calcium binding protein 7/8-like, conserved site (IPR001751) (0.5140); EF-Hand 1, calcium-binding site (IPR018247) (0.4946); S100/CaBP-9k-type, calcium binding, subdomain (IPR013787) (0.2602); EF-hand domain (IPR002048) (0.1577)",1.10.238.10 (0.0711),S-nitrosylation (0.3759); Metal-binding (0.3413); Reference proteome (0.1808); Calcium (0.1489); Repeat (0.1173),
MKSDAEELMPRLLPVDSCDTEEYTLTEPPRNPQEYLRFVQREASLCPDVVVAQIDPKKLKKQSVNVSITGCLAAPEGFSPSFKWQQQQVSRFSEVRQSVNKHRQHWKAQFLDDNVVMPKTEDEDGWKRFCFGENVCLEIQLKEEDGVNPGLDYVKTGFPPFLSIVSKLSQSTVSAVLEYLINWFEERDFVPQLGRWLYALLACLEKPLLPEAHSLIRQLARRCSAVRANLESKDDDRLSALNLMICIVARYFEQNDLADKE,,spliceosomal complex assembly (GO:0000245) (0.8370); spliceosomal snRNP assembly (GO:0000387) (0.7794); RNA splicing (GO:0008380) (0.0670),SMN complex (GO:0032797) (0.4523); nucleus (GO:0005634) (0.3461); Gemini of coiled bodies (GO:0097504) (0.3304); spliceosomal complex (GO:0005681) (0.2788); cytosol (GO:0005829) (0.2200); SMN-Sm protein complex (GO:0034719) (0.2005); U12-type spliceosomal complex (GO:0005689) (0.1303); nucleoplasm (GO:0005654) (0.1184),,Gemin2/Brr1 (IPR035426) (0.3317); Gem-associated protein 2 (IPR017364) (0.2732),1.20.5.220 (0.3702); 1.20.58.1070 (0.1846),mRNA splicing (0.8412); mRNA processing (0.8321); Reference proteome (0.7433); Cytoplasm (0.6151); Proteomics identification (0.2119); Phosphoprotein (0.1970); Nucleus (0.1443),
MADNVIEESGNYPGKDELDWGYEEGVEWGLLFPEANGEYQSPINLNSREARYDPQLLDVGLNPNYVVCRDCEVINDGHTVRIMLKSKSVVTGGPLPSDHEYELSEVRFHWGKENQRGSEHTVNFKAFPMELHLIHWNSTLFNSVEEAMGKKRGILIIALFVQVGKEHLGLKAITDVLQDLQYKGKTKIIPCFNPNTLLPDPLLRDYWVYEGSLTTPPCSENVTWILYRYPLTISQMQIEEFRRLRSHVKGAELPEGNDGMLGDNFRPTQPLSDRVVRAAFQ,carbonic anhydrase (4.2.1.1) (0.9058),"response to bacterium (GO:0009617) (0.2149); positive regulation of synaptic transmission, GABAergic (GO:0032230) (0.2104); response to hypoxia (GO:0001666) (0.1626); one-carbon metabolic process (GO:0006730) (0.1477); positive regulation of cellular pH reduction (GO:0032849) (0.1130); learning or memory (GO:0007611) (0.0909); neuron cellular homeostasis (GO:0070050) (0.0576); bicarbonate transport (GO:0015701) (0.0514)",cytoplasm (GO:0005737) (0.3576); cytosol (GO:0005829) (0.1619); plasma membrane (GO:0005886) (0.0819),zinc ion binding (GO:0008270) (0.2935); carbonate dehydratase activity (GO:0004089) (0.1494),"Alpha carbonic anhydrase domain (IPR001148) (0.2673); Carbonic anhydrase, alpha-class, conserved site (IPR018338) (0.1726); Alpha carbonic anhydrase domain superfamily (IPR036398) (0.1653); Carbonic anhydrase, alpha-class (IPR023561) (0.1567); Carbonic anhydrase-related protein VIII (IPR041877) (0.0825)",3.10.200.10 (0.2127),Zinc (0.5626); Lyase (0.3293); Reference proteome (0.2545); Metal-binding (0.1589); Phosphoprotein (0.1259); 3D-structure (0.0903),
MSRAADRLKVVLNHLDRSHDAVRASFTSAQNVSYHHHPQSLQYTFDTDVLTQEQIIAYEENGFILIRNLVSEEDIDRFKNEFERICKREVKVPGLTVMKDVSIAKSEFVEGEKAVTKLQDYQEDPELFRYCVLPQILKYVECFTGPNIMAMHTMLINKPPDTGKKTSRHPMHQDLHYFPFRPADRIVCSWTAMEKVHRENGCLVVLPGSHRGSLQEHDYPEWEGGVNKMYHGVRNYDPNHPRVHLEMEKGDTVFFHPLLIHGSGMNQTNGFRKAISCHYASGDCYYIDVNGTTQENISNEVKDLASRKFGADDSVTFADTWAIRGRLVQGDRISM,phytanoyl-CoA dioxygenase (1.14.11.18) (0.9544),fatty acid alpha-oxidation (GO:0001561) (0.9339); methyl-branched fatty acid metabolic process (GO:0097089) (0.7471); 2-oxoglutarate metabolic process (GO:0006103) (0.2113); 2-oxobutyrate catabolic process (GO:0019606) (0.1595); isoprenoid metabolic process (GO:0006720) (0.1372); response to hypoxia (GO:0001666) (0.1018),9+0 non-motile cilium (GO:0097731) (0.4303); peroxisome (GO:0005777) (0.0719),ferrous iron binding (GO:0008198) (0.2417); L-ascorbic acid binding (GO:0031418) (0.1730); phytanoyl-CoA dioxygenase activity (GO:0048244) (0.1569),Phytanoyl-CoA dioxygenase (IPR047128) (0.3443); Phytanoyl-CoA dioxygenase-like (IPR008775) (0.2133),2.60.120.620 (0.2858),Vitamin C (0.7953); Peroxisome (0.6159); Reference proteome (0.5359); Oxidoreductase (0.3961); Iron (0.3947); Dioxygenase (0.3431); Metal-binding (0.1240); cGMP (0.1159); Transit peptide (0.0632); Phenylalanine catabolism (0.0609),Fe cation (0.1871); Fe(2+) (0.1370); ATP (0.1351); L-ascorbate (0.1264)
MATLLQPEKVLYLVRGEKKIRVPLSQLYFCRYCSELRSLECVSHEVDSHFCPSCLENMPSAEAKLKKNRCANCFDCPCCMHTLSTRATNIPAPLPDDPTKTTMKKAYYLACGFCRWTSRDVGMADKSVASGGWQEPENPHTQRINKLIEYYQQLAQREKLERDRKKMARRRPFMPQAFSQHTIHVVEKYGLGTRLQRQRSGAPISALYGLSLKEGEDQKEITIEPAQALDEVEPLPEDYYTRPVNLPEVTTLRQRLLQPDFQPAGASQLHPRHKHLLMKRSLRCRKCEHNLSKPEFNPTSIKFKIQLVAVSYIPEVRIMSIPNLRHMKESQVLLTLTNPVENITHVSLYTCEEEDQDDINSTAKVLVPSKELVLAGKDAAAEYDELAEPQGFQDDPDVVAFRKSNKIGFFIKVIPQQEEGDVTVAFKLRHDFRNLAAPIRPTEEGETTAEAIWLTHHVELSLGPLAT,,negative regulation of apoptotic process (GO:0043066) (0.2067); positive regulation of DNA-templated transcription (GO:0045893) (0.1303); negative regulation of cell migration (GO:0030336) (0.1000),centrosome (GO:0005813) (0.3488); sarcomere (GO:0030017) (0.3206); stress fiber (GO:0001725) (0.2648); dynactin complex (GO:0005869) (0.2275); kinetochore (GO:0000776) (0.2173); cytosol (GO:0005829) (0.1986); nucleoplasm (GO:0005654) (0.1192); midbody (GO:0030496) (0.0896); cytoskeleton (GO:0005856) (0.0869); cell cortex (GO:0005938) (0.0858),,Dynactin subunit 4 (IPR008603) (0.1921),,Reference proteome (0.7195); Ubl conjugation (0.6901); Phosphoprotein (0.6653); Acetylation (0.5116); Coiled coil (0.3965); Cytoskeleton (0.3887); Isopeptide bond (0.3527); Zinc (0.2186); Alternative splicing (0.1739); Proteomics identification (0.1144); Cytoplasm (0.1120),
MSSSSTRTYMSSGGSSRVSVSGGGAGRVTGMRAGSVYGGAGGSGVRISSSSLSRSYSSGSTGYGAGFHLSDAIDVSANEKATMQNLNDRLASYLEKVRTLERANADLELKIRQFLDSKTAPSARDYSAYYATISDLQVKIQHATGLNGGIYLSIDNAKLAADDFRVKYENELSMRQSVEADIAGLRRVLDELTMTRSDLELQIEGLREELIFLKKNHEEELLAVRAQMTGQVNVEVDAAPQEDLTKIMAEIREHYESVAAKNRKDLEAWFQAKTETLTKEVAVSTETLQISRSEITEVKRTLQSLEIELQSQLSMKASLEGTLADTQARYAAMLSGYQFQVSSLEEQLVQLRGDLERQSQEYKMLLDIKTRLEMEIAEYRRLLDGEATSVSSSSSSSTTRKVVTIVEEVVDGKVVSSSSQSTSEVVSQKH,,epithelial cell differentiation (GO:0030855) (0.1953); Notch signaling pathway (GO:0007219) (0.1850); negative regulation of apoptotic process (GO:0043066) (0.1826); extrinsic apoptotic signaling pathway (GO:0097191) (0.1808); tumor necrosis factor-mediated signaling pathway (GO:0033209) (0.1509); hepatocyte apoptotic process (GO:0097284) (0.1470); inflammatory response (GO:0006954) (0.1418); keratinocyte differentiation (GO:0030216) (0.1389); morphogenesis of an epithelium (GO:0002009) (0.0924); intermediate filament bundle assembly (GO:0045110) (0.0882); cellular response to starvation (GO:0009267) (0.0834); intermediate filament organization (GO:0045109) (0.0629); negative regulation of cell migration (GO:0030336) (0.0573),cytoplasm (GO:0005737) (0.2515); intermediate filament (GO:0005882) (0.2358); cytoskeleton (GO:0005856) (0.1427); keratin filament (GO:0045095) (0.0926); cytosol (GO:0005829) (0.0851); plasma membrane (GO:0005886) (0.0780); cell periphery (GO:0071944) (0.0760),structural molecule activity (GO:0005198) (0.2117); structural constituent of cytoskeleton (GO:0005200) (0.1134),"Intermediate filament protein, conserved site (IPR018039) (0.2078); Keratin, type I (IPR002957) (0.1831); Intermediate filament, rod domain (IPR039008) (0.1063)",1.20.5.170 (0.1267); 1.20.5.500 (0.1126),Reference proteome (0.5512); Phosphoprotein (0.4871); Keratin (0.4484); Ubl conjugation (0.3514); Cytoplasm (0.3032); Coiled coil (0.2540); Intermediate filament (0.2528); Proteomics identification (0.1958); Isopeptide bond (0.1541); Direct protein sequencing (0.1316); Nucleus (0.0600),
MASEPLEGFHEVNLASPTTPDVHGVIDPSPPKHNAPPSTLYRTHSLSSSQNAASALRADQLPTQPVYSAPRHLGGDDTLNGSGNDPAAVDAVDADGEDGLGPSTDGLSRLRSPSVMEVREKGYEKLKEELAKAQRELKLKDEECERLSKVRDQLGQELEELTASLFEEAHKMVHEANLKQATAEKQLKEALGKIDVLQAEVAALKTLVLSTSPTSPCKEMPPGPKAPFKKGHVRNKSTSSAMLGSQQEVAVTQPIVRECKEVDSLLFTEFKAWKEEPTLERSCSFLERIYREDIYPCLTFSKSELGSAILEAVEQNTLSVEPVGFQPLPVVRASAVECGGPKKCALCGQTKTCKHRIKFGDSSSYYYVSPFCRYRITSVCNFFTYIRYILQGLVKQQDAEQMFWEVLQLRKEMSNAKLGFYKDEL,,protein transport (GO:0015031) (0.6351); protein targeting to membrane (GO:0006612) (0.2893); exocytosis (GO:0006887) (0.2429); protein localization to motile cilium (GO:0120229) (0.1906); positive regulation of cilium assembly (GO:0045724) (0.1734); negative regulation of filopodium assembly (GO:0051490) (0.0972); regulation of GTPase activity (GO:0043087) (0.0938); melanosome transport (GO:0032402) (0.0401),Golgi to plasma membrane transport vesicle (GO:0070319) (0.2992); nucleus (GO:0005634) (0.2472); cytosol (GO:0005829) (0.2463); nucleoplasm (GO:0005654) (0.1589); cytoplasm (GO:0005737) (0.1103); cytoskeleton (GO:0005856) (0.0903); trans-Golgi network membrane (GO:0032588) (0.0774),guanyl-nucleotide exchange factor activity (GO:0005085) (0.3195); small GTPase binding (GO:0031267) (0.1065); identical protein binding (GO:0042802) (0.0628),"Guanine nucleotide exchange factor RAB3IL/RAB3IP/Sec2 (IPR040351) (0.2978); GDP/GTP exchange factor Sec2, N-terminal (IPR009449) (0.1774)",1.20.5.4880 (0.3144),Reference proteome (0.5613); Protein transport (0.5579); Transport (0.5364); Coiled coil (0.4924); Phosphoprotein (0.3423); Membrane (0.2832); Proteomics identification (0.2786); 3D-structure (0.1555); Guanine-nucleotide releasing factor (0.1360); Cytoplasm (0.1116); Alternative splicing (0.0863); Direct protein sequencing (0.0545),
MKTPVLRAIHLVFFLFYPIQSNSEANCKLWKELDLTVVHKEGDVILAGMFPIHSKGIDQELNFRNQPDQRKCWGFNMRVFRWSQAMIFFIEEINRNPTLLPNITLGYRLYDTCGLIALSLRTALSVVSQPMKRSSSEMCSSPSIPIIIGDSGSTLSMAISRLLNLFHIPLVSYFASCACLSNKHQFPYFFRTIPSDVNQANALARLVKHFGWTWVGTVGADDAYGRTGIDLFTAAVTQLGVCVSYRIIIPKLPTQQQLQDIVRTIRDSSAHVLVAFAIEEDIKPVVDEIVLQNVTGKQWVASEAWVTSTLISTKENFPSLSGTIGFAIRRAEIPGLKHFLDSIQPLADPYNVFAREFWETQFQCTLNTSLPTSSTMDPVNYSHSCTGMERMQDTQSIFNDVSQLRVTYNMYKAVYTVAHALHNLLLCQREHRSALTQQCPDIHNLQPWQVIEVLRKVNYTNMFGDLIYFDENGDPVGSYDIVNWQKGGDDVPVQYITVGRFDSSLPKGQQLVLNQNKIVWHGGTNKVPVSVCSASCPPGYRKVRLEGQPVCCYDCMLCAEGSISNTTDQAECLLCPEDFWSNKHRNYCVPKEIEFLSYLEAFGMVLAAIAILGAVAAISVGVVFFRHRDTPLVRANNSELSFLLLISLTLCFICALTFLGQPSHWACPLRRISFGLTFALCLSCLLSKTLVVLIAFKSTLPGNNTARWFRPPQQRLGVFICSLLQGGVCIAWLTTASPYPVKNTWLYRDRIILECHLGSVVYFCCVLGYIGCLAAFCFILAFLARKLPDNFNEAKFITFSMLIFCAVWITFIPAYVSSPGKFTVAVEIFAILASSYGVLLCIFAPKCYIIIFMPEKNSKKYLMTQK,,calcium-mediated signaling (GO:0019722) (0.4378); intracellular calcium ion homeostasis (GO:0006874) (0.1996); regulation of testosterone biosynthetic process (GO:2000224) (0.1886); G protein-coupled receptor signaling pathway (GO:0007186) (0.0903); calcium ion import (GO:0070509) (0.0777); detection of calcium ion (GO:0005513) (0.0760),plasma membrane (GO:0005886) (0.4918); cytoplasm (GO:0005737) (0.0618),amino acid binding (GO:0016597) (0.2865); G protein-coupled receptor activity (GO:0004930) (0.2011); metal ion binding (GO:0046872) (0.1673),"Receptor, ligand binding region (IPR001828) (0.4385); GPCR, family 3, nine cysteines domain (IPR011500) (0.3339); Periplasmic binding protein-like I (IPR028082) (0.3309); GPCR, family 3, conserved site (IPR017979) (0.2854); GPCR, family 3, nine cysteines domain superfamily (IPR038550) (0.2749); GPCR family 3, C-terminal (IPR017978) (0.2584); GPCR, family 3 (IPR000337) (0.1648); GPCR, family 3, extracellular calcium-sensing receptor-related (IPR000068) (0.1603)",3.40.50.2300 (0.5511); 2.10.50.30 (0.2458),Transducer (0.8057); Transmembrane helix (0.7124); Reference proteome (0.6119); Transmembrane (0.5182); G-protein coupled receptor (0.4891); Signal (0.3830); Membrane (0.3506); Metal-binding (0.2011); Ubl conjugation (0.1694); Calcium (0.1370); Sensory transduction (0.1338); Cell membrane (0.1324); Receptor (0.1234); Glycoprotein (0.1188),
MTESAGTKTEDCHAANGVKPGRNGMVKNHHHHLQYQKQEKVYHAACNGELYSRPFIESFEETPMLVAVLTYMGYGILTIFGYLRDFMREWKIEKCHIAREREEQKDFVPLYQDFENFYTRNLYMRIRDSWNRPICSVPGAKFDLVERSSNDYNWTFEYTGRVVKDVINLGSYNYLGFAENTGSCATAAGEVTVKFGVGVASTRQEMGNLDRHEKLEKLVASFLRVESAMAFGMGFATNSMNIPALAGKGCLILSDELNHASLVLGARLSGSTIRVFKHNNMQSLEKLLRDAIVHGQPRTHRPWKKILILVEGIYSMEGSIIRLPEVIALKKKYKAYLYLDEAHSIGALGPGGRGVVEYFGLDPRDVDIMMGTFTKSFGAAGGYIGGRKDLIDYLRTHSHSAVYASSMSAPVVEQIITSMKCIMGEDGTTIGRSRIQRLAENTVYFRRRLREMGFIIYGNNDSPVVPMMLYMPAKIGAFGREMLKRNIGVVVVGFPATPIIESRARFCISAAHSKEMLDRALDVISEVGDLLQLKYSRHKVLPSLDRPFDETTYEENEE,serine C-palmitoyltransferase (2.3.1.50) (0.8807),sphingolipid biosynthetic process (GO:0030148) (0.3325); sphingomyelin biosynthetic process (GO:0006686) (0.2766); photomorphogenesis (GO:0009640) (0.2632); sphingosine biosynthetic process (GO:0046512) (0.2132); ceramide biosynthetic process (GO:0046513) (0.1492); positive regulation of lipophagy (GO:1904504) (0.1427); sphingolipid metabolic process (GO:0006665) (0.1019),endoplasmic reticulum membrane (GO:0005789) (0.3917); serine palmitoyltransferase complex (GO:0017059) (0.1814); membrane (GO:0016020) (0.1109),serine C-palmitoyltransferase activity (GO:0004758) (0.3515); pyridoxal phosphate binding (GO:0030170) (0.1843),"Aminotransferase, class-II, pyridoxal-phosphate binding site (IPR001917) (0.5151); 8-amino-7-oxononanoate synthase class-II (IPR050087) (0.3157); Aminotransferase, class I/classII (IPR004839) (0.3078); Pyridoxal phosphate-dependent transferase (IPR015424) (0.2173); Pyridoxal phosphate-dependent transferase, major domain (IPR015421) (0.1863); Pyridoxal phosphate-dependent transferase, small domain (IPR015422) (0.1701)",3.40.640.10 (0.1023); 3.90.1150.10 (0.0947),Reference proteome (0.5810); Membrane (0.5214); Transferase (0.4355); Acyltransferase (0.4185); Sphingolipid metabolism (0.4163); Endoplasmic reticulum (0.3975); Pyridoxal phosphate (0.2221); Transmembrane helix (0.1773); Lipid metabolism (0.1618); Phosphoprotein (0.0792),pyridoxal 5'-phosphate (0.1602)
MEAEAEAPELDVDGLQQNQTAGEPEVPKRSDVKVYKEFCDFYVRYNMTNALANAVCERCKSSFSPTEKMVNSNGELYHEQCFTCAQCFQQLIQGLFYEFEGRKYCEHDFQMLFAPCCHQCGEFVVGRVIKAMNSSWHPDCFCCEVCEAVLADVGFVKSGGRPLCRSCHSRQKALSLGKHVCQKCLCVVEEPLMYRSDPYHPDHFNCSHCGKELTADARELKGELYCLPCHDKLGVPICGACRRPVEGRVVNAMGKQWHVEHFVCVKCEKPFLGHRHYERKGLAYCETHYNQLFGDVCFQCNRVIEGDVVSALNKAWCVRCFSCSTCTSRLTLKDKFVEIDLKPVCKHCYERMPDELKRRLSREQESRDKRKRRPMCL,,cell-cell junction organization (GO:0045216) (0.6419); neural precursor cell proliferation (GO:0061351) (0.5808); negative regulation of neural precursor cell proliferation (GO:2000178) (0.5182); positive regulation of substrate adhesion-dependent cell spreading (GO:1900026) (0.4205); positive regulation of gene expression (GO:0010628) (0.3231); muscle organ development (GO:0007517) (0.2900); establishment of protein localization (GO:0045184) (0.2575); negative regulation of DNA-templated transcription (GO:0045892) (0.2279); positive regulation of integrin-mediated signaling pathway (GO:2001046) (0.1948); integrin-mediated signaling pathway (GO:0007229) (0.1708); positive regulation of focal adhesion assembly (GO:0051894) (0.1647); negative regulation of cholangiocyte proliferation (GO:1904055) (0.1340); tumor necrosis factor-mediated signaling pathway (GO:0033209) (0.1208); negative regulation of hepatocyte proliferation (GO:2000346) (0.0843); transforming growth factor beta receptor signaling pathway (GO:0007179) (0.0673); negative regulation of apoptotic process (GO:0043066) (0.0645); cell-matrix adhesion (GO:0007160) (0.0553),focal adhesion (GO:0005925) (0.4864); plasma membrane (GO:0005886) (0.2063); cell-cell junction (GO:0005911) (0.1727); perinuclear region of cytoplasm (GO:0048471) (0.1383); cell leading edge (GO:0031252) (0.0960),metal ion binding (GO:0046872) (0.1646),LIM and senescent cell antigen-like-containing domain protein 1/2-like (IPR047946) (0.2450),2.10.110.10 (0.1535),Zinc (0.7570); Metal-binding (0.5528); LIM domain (0.4929); Reference proteome (0.0840); Repeat (0.0501),
MDNSGKEKEAMQLMAEADKKVKSSGSFLGGMFGGNHKVEDACEMYARAANMFKMAKNWSAAGNAFCQAARLHMQMQNKLDSATSFVDAGNAYKKADPQEAINCLNAAIDIYTDMGRFTIAAKHHMTIAEIYESELVDIEKAIAHFEQAADYYKGEESNSSANKCLLKVGSYSAQLEQYPKAIEIFEQVASNTMDNPLLKYNAKEYFWKAALCHFIVDELNAKLAIEKYEGMFPAFSDSRECKLLKKLLEAHEEQNSEAFTEAVKEFDSISRLDQWQTTMLLRIKKTIQGDSGDLK,,intracellular protein transport (GO:0006886) (0.9244); regulation of synaptic vesicle priming (GO:0010807) (0.6926); neuron differentiation (GO:0030182) (0.2591); synaptic vesicle priming (GO:0016082) (0.2359); brain development (GO:0007420) (0.2308); apical protein localization (GO:0045176) (0.1759); membrane fusion (GO:0061025) (0.1622); endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888) (0.1432); SNARE complex disassembly (GO:0035494) (0.1383); synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629) (0.1207); mitotic cytokinesis (GO:0000281) (0.0423),terminal bouton (GO:0043195) (0.3234); synaptobrevin 2-SNAP-25-syntaxin-1a complex (GO:0070044) (0.2164); glutamatergic synapse (GO:0098978) (0.1494); plasma membrane (GO:0005886) (0.1411); presynapse (GO:0098793) (0.1005); cytosol (GO:0005829) (0.0809); membrane (GO:0016020) (0.0706); presynaptic active zone membrane (GO:0048787) (0.0420),soluble NSF attachment protein activity (GO:0005483) (0.2322); syntaxin binding (GO:0019905) (0.0826),NSF attachment protein (IPR000744) (0.2846),1.25.40.10 (0.1029),Transport (0.9717); Reference proteome (0.8084); Protein transport (0.6813); Membrane (0.5696); ER-Golgi transport (0.2495); Coiled coil (0.1578),
MPGHALETVVIGQQKSSAFVLKKIMNIPPPNILEDQDDDIEKEKQASAGDGASAGSGASGGVSASLTPAIWEKTIPYDGETFHLEYMDLDEFLLENGIPVSLEEELNRGLEAERRDGETQASSENSEEPAAVPEMPEQMQTEQDEDLSDSQTAEQELSEETTAEPSSVPERATPSPVSPEDIEVNVSFQPDPTDLVLSSVPGGELFNPRKHRFSEDELKPQPMIKKAKKVFVPEDAKDDKYWSRRKKNNVAAKRSRDARRLKENQIAVRASFLERENAALRQQVAELRKDCGRCQKIMALYEAKYGSL,,regulation of transcription by RNA polymerase II (GO:0006357) (0.6010); positive regulation of transcription by RNA polymerase II (GO:0045944) (0.1325); response to starvation (GO:0042594) (0.1071); positive regulation of DNA-templated transcription (GO:0045893) (0.0982); regulation of DNA-templated transcription (GO:0006355) (0.0725); nucleosome disassembly (GO:0006337) (0.0544); response to toxic substance (GO:0009636) (0.0453),nucleus (GO:0005634) (0.1780); chromatin (GO:0000785) (0.1405),"RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978) (0.2946); DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228) (0.2385); identical protein binding (GO:0042802) (0.1973); RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977) (0.1208)",Basic-leucine zipper domain (IPR004827) (0.1595); PAR basic leucine zipper protein (IPR040223) (0.1476),1.20.5.170 (0.2198),Transcription regulation (0.8272); Reference proteome (0.5996); Transcription (0.4181); Biological rhythms (0.3933); Activator (0.3620); Nucleus (0.3145); Phosphoprotein (0.2672); Ubl conjugation (0.1484),
MEYALFWGRFFACFVAVILLLPITVCADLNYNIPEETKSQYVIGNIAKDLGIDVKQLSARKSRIDTEDISKRYCDINMKTGDLIVAETIDREELCGSRMSCFLNYELVLENPLDVHRIIFQIQDINDNAPRFPNERINFEITESADKGQRFRLHEAHDSDIGRNAVNGYLLEKNNHFYLNVHDTAYGGKYAELVLEKELDREQQKEMDLILTATDGGSPQRSGTAVIHITVLDANDNVPVFDQPVYKVTLAENTPSGTEIIRVSATDADEGPNGEVTYEFSRISDKASKQFSIDKKTGQILVTEKIDYESEKNYEIGIHAQDGSGLASTATVIIDITDVNDNPPRIILKSLNNPIPENSEPGAEVGIINVQDKDSGENRQIRCSVQQNVPFKLNPSVKNYFSLVTTKALDREKESDYNITITATDGGSPPLSTSMTIHLFVSDVNDNPPVFEQQAYSAYINENNKVGTSVCSVSANDPDWRQNGTVLYSLVPSEVSGVPVSSFLSINGDTGVIHTVRSFDYEQFRNFSVKVVARDNGSPPLSSNVTVKVFITDENDNSPQILYPVPDGKTLMTEMVPKATLSGSLVSKVIAVDADSGQNAWLSFQILKSTDPGLFTIGLHSGEIKTQRDISESDNMKQNLVISVKDNGQPSLSTTCVVNLLISDNLSEVPELKDMSYEDNNSELTSYLIIALVSVCTFFLTFIIMMLAVKFCHRRKPRLLFDGAVAVPSAYLPPNYADVDGAGTIRSSYNHDAYLTTGSRTSDFKFVSSYNENTLQAGGSLKSVQSDSFGAHVVTLINTEEAEEQKPPNTDWRFPPNQRPGPSGAGARPEEAGAGAGVIAGTGPWPNPPTEAEQLQAMMAAANASEATATLGPRYNLQYGPDYRQNVYIPGSTATLTANPQQQVLQQALPPPQALPPTEAPKAAQTPASKKKPTKKDKK,,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) (0.3540); cell adhesion (GO:0007155) (0.3401); axon extension (GO:0048675) (0.2527); cell morphogenesis (GO:0000902) (0.2504); locomotory behavior (GO:0007626) (0.2328); chemical synaptic transmission (GO:0007268) (0.2018); adult behavior (GO:0030534) (0.2001); neural tube formation (GO:0001841) (0.1459); presynaptic active zone assembly (GO:1904071) (0.1339); excitatory postsynaptic potential (GO:0060079) (0.1266); modulation of chemical synaptic transmission (GO:0050804) (0.1261),cytoplasm (GO:0005737) (0.3518); synapse (GO:0045202) (0.2652); plasma membrane (GO:0005886) (0.2494); membrane (GO:0016020) (0.2005); catenin complex (GO:0016342) (0.1211); glutamatergic synapse (GO:0098978) (0.1062),calcium ion binding (GO:0005509) (0.3026); identical protein binding (GO:0042802) (0.2441),"Cadherin-like (IPR002126) (0.3062); Protocadherin/Cadherin-related Cell Adhesion (IPR050174) (0.2103); Cadherin, N-terminal (IPR013164) (0.1962); Cadherin-like superfamily (IPR015919) (0.1932); Cadherin conserved site (IPR020894) (0.1786); Cadherin (IPR039808) (0.1249)",2.60.40.60 (0.3570),Transmembrane helix (0.6465); Membrane (0.5698); Transmembrane (0.5526); Reference proteome (0.5350); Cell adhesion (0.2539); Signal (0.2467); Glycoprotein (0.2417); Repeat (0.1205); Proteomics identification (0.1080),
MKNKKIGERKWAAFWLFAFSLLWSTIGAQIRYTIPEELKEGSVVGNIAKDLGFDISDIAERKLRIASESNRQYFSVDLGKGDLLVNGRIDRETLCGQSSGCLMSIQIVIENPLQMHSVEIEIQDINDNAPNFHTKDATLKISELIAPGTRFILESAEDLDVGSNSLKTYSLSNNNYFRLNVKNLKDGRIGPELVVEKPLDREKQSMHKLILTALDGGNPVKSGTSVLQIAVQDINDNEPKFELSAYKASILETAITGSNVLKIKATDLDEGLNGEIQYLLSAHTPEFVRNVFSVNADTGEITVTGTLDYETKKSYAFDVCAKDKGNPELEGQSSVQIDIIDENDNAPEIILTSLPSPVPENATVGTVVALITVKDLDSGDNGKVDLIVSPDVPFKLKPFHNHYSLITDSLLDREVRPEYNVEIIAMDSGVPPIKTAKTVNIKVLDTNDNSPLFSQTSYNVYINENNLAGASLFSVSASDIDLNKNAFLTYSILDSGSNYVPASSYFYINSENGSIYCMSTFDYEKVKLFSVVVQAKDQGSPSLSSNATVHVFILDQNDNAPAVIYPSTSMGSVSQQRMPRSTKAGHLVTKVTAVDADSGHNAWLFYRLAEATDTSLFSVNLHTGEVRTKRAVSEHDDSSQRLVIEIKDNGEPIQSTTVTVDILIEDGFHEPISDFREKTIEPNRKSGKITLYLIISLASVSLLCLMTFFILLVKCARGSRGGTSCCIRRTNSDYKNPNRNLQIQLNTDGPIKYVEVLGGDMMSQSQSFGSYLSPMSEFSDLTLIKPSSTTNFTDTLNTLDASLPDSAWTFESQQQKPPNTDWRFPPNQRPGPSGAGARPEEAGAGAGVIAGTGPWPNPPTEAEQLQAMMAAANASEATATLGPRYNLQYGPDYRQNVYIPGSTATLTANPQQQVLQQALPPPQALPPTEAPKAAQTPASKKKPTKKDKK,,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) (0.7742); cell adhesion (GO:0007155) (0.4430); adult behavior (GO:0030534) (0.1868); calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) (0.1792); chemical synaptic transmission (GO:0007268) (0.1362); axon extension (GO:0048675) (0.0967),synapse (GO:0045202) (0.2479); glutamatergic synapse (GO:0098978) (0.2100); membrane (GO:0016020) (0.2052); plasma membrane (GO:0005886) (0.1626); cytoplasm (GO:0005737) (0.1596),calcium ion binding (GO:0005509) (0.2825); identical protein binding (GO:0042802) (0.1569),"Cadherin-like (IPR002126) (0.3973); Cadherin, N-terminal (IPR013164) (0.3150); Cadherin, C-terminal catenin-binding domain (IPR031904) (0.2497); Protocadherin/Cadherin-related Cell Adhesion (IPR050174) (0.2432); Cadherin-like superfamily (IPR015919) (0.2159); Cadherin conserved site (IPR020894) (0.1079)",2.60.40.60 (0.3826),Reference proteome (0.7123); Transmembrane helix (0.6351); Transmembrane (0.5702); Membrane (0.4592); Glycoprotein (0.3685); Cell membrane (0.3076); Repeat (0.2498); Synapse (0.2285); Calcium (0.2090); Proteomics identification (0.2067); Alternative splicing (0.1037); Cell adhesion (0.0859); Toxin (0.0592),
MKTMLDAMIQHSVLILTLLVYIARGQVSYSIPEEMAKGSMVGNIAQDLGLDLQRLKSGKARIFSRDSTEYIELNRNTGLLLIKEKMDRESLCAKTTPCALHLQMILDNPMELYTITVEITDINDNAPNFQKRDFKFEISESAMVGARFMLGKAFDPDVGTNSLQSYSLKPTDKFRLELQSQADGSKNVEMILQKALDREMQSSFTLLLEAFDGGDPVLSGTVQIHIAVLDINDNAPVFMQKEYKATATEEAPKGSILTVVSATDTDEGSNSEVTYYISDTMDSVMADMFLVNEQTGELILNGHFDYEKVSHYELTIHAKDQGGLSNACKVIIDVLDVNDNSPSINILSSSHSVSEGSKFGTVIAMLNVDDLDSGASGQVQCVMSEEIPFVIKSQSSNFFSLQTEQELDRERETEYNISVICSDEGVPSLSSSVSLTVQISDVNDNPPVFKKSNYEAFVMENNTPGLSIFTVKASDADWNQNARVSYILEDSTVSGVSVSSYVSVHPDSGLITAVRSFDYETLKDFHFRVKAQDGGSPPLSSNVTVKVTVQDQNDNAPQVLYPVQTGTSVVAEIVPRAADVGYLVTKVVAVDVDSGQNAWLSYKLQKAPDRALFEVGLQNGEIRTVRQVTDKDAVKQKLTVVVEDNGQPSRSAVVSINVAVADSFPEVLSEFTDFTHEKQYNDSLTFYLVLALAAVSFLFITCVVVIISVKIYRWRQSRFLYQSNLPVIPYYPPHYADTGVTGTLPHGYNYEVCMTTDSRKSDCKFSTLGGQNVLVVDPSFAETMKHTIKKNSSIDDLQSTESQKPPNTDWRFPPNQRPGPSGAGARPEEAGAGAGVIAGTGPWPNPPTEAEQLQAMMAAANASEATATLGPRYNLQYGPDYRQNVYIPGSTATLTANPQQQVLQQALPPPQALPPTEAPKAAQTPASKKKPTKKDKK,,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) (0.4979); cell adhesion (GO:0007155) (0.4631); calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) (0.3282); chemical synaptic transmission (GO:0007268) (0.2908); adult behavior (GO:0030534) (0.2132); presynaptic active zone assembly (GO:1904071) (0.0856); synapse assembly (GO:0007416) (0.0696); cell morphogenesis (GO:0000902) (0.0628),synapse (GO:0045202) (0.3168); plasma membrane (GO:0005886) (0.1683); postsynaptic membrane (GO:0045211) (0.1539); extracellular region (GO:0005576) (0.1006),calcium ion binding (GO:0005509) (0.3262); identical protein binding (GO:0042802) (0.1935),"Cadherin-like (IPR002126) (0.4379); Cadherin, C-terminal catenin-binding domain (IPR031904) (0.2243); Cadherin, N-terminal (IPR013164) (0.2198); Protocadherin/Cadherin-related Cell Adhesion (IPR050174) (0.2047); Cadherin-like superfamily (IPR015919) (0.1785); Cadherin conserved site (IPR020894) (0.1061)",2.60.40.60 (0.3559),Reference proteome (0.7000); Transmembrane helix (0.6558); Transmembrane (0.4942); Signal (0.4941); Membrane (0.4917); Glycoprotein (0.4297); Repeat (0.1936); Calcium (0.1861); Cell membrane (0.1736); Proteomics identification (0.1417); Vision (0.0629),
MCRVDKEALTSEIEVLEEDQDSYGEEDVTDAKPDRKGRFRLFGNFKKNDGKLQEKGESESHYRIVSPTFQYKMSHQRVGKCIIINNKNFDEKTGMNVRNGTDRDAGELFKCFKSLGFDVAVYNDQTCRNMERLLKAVSEEDHSDSSCFACILLSHGEEGMIYGTDGAMPIKTMTSLFKGDVCKSLVGKPKLFFIQACRGSEFDDGVQTDSGPPNDTIETDANPRHKIPVEADFLFAYSTVPGYYSWRNPGRGSWFVQALCNVLSEFGKQLEIMQILTRVNYMVATSFESWSEDPRFSEKKQIPCVVSMLTKELYFN,caspase-3 (3.4.22.56) (0.4685); caspase-7 (3.4.22.60) (0.1968),protein catabolic process (GO:0030163) (0.4566); lymphocyte apoptotic process (GO:0070227) (0.4337); fibroblast apoptotic process (GO:0044346) (0.4329); response to UV (GO:0009411) (0.3734); defense response to bacterium (GO:0042742) (0.2866); cellular response to staurosporine (GO:0072734) (0.2551); execution phase of apoptosis (GO:0097194) (0.2475); protein processing (GO:0016485) (0.2338); positive regulation of neuron apoptotic process (GO:0043525) (0.2061); proteolysis (GO:0006508) (0.1955); activation of innate immune response (GO:0002218) (0.1542); neuron differentiation (GO:0030182) (0.1324); activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919) (0.1316); positive regulation of apoptotic process (GO:0043065) (0.1103),nucleus (GO:0005634) (0.2053); cytoplasm (GO:0005737) (0.1142),cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153) (0.2645); cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200) (0.2635),"Peptidase family C14A, His active site (IPR016129) (0.3831); Peptidase family C14A, cysteine active site (IPR033139) (0.2312); Peptidase C14A, caspase catalytic domain (IPR015917) (0.1751); Peptidase C14, caspase non-catalytic subunit p10 (IPR002138) (0.1579); Caspase-like domain superfamily (IPR029030) (0.1327); Peptidase C14, p20 domain (IPR001309) (0.1279)",3.40.50.1460 (0.2979); 3.30.70.1470 (0.1227),Zymogen (0.9966); Thiol protease (0.6081); Apoptosis (0.3761); Hydrolase (0.3658); Protease (0.3267); S-nitrosylation (0.3237); Reference proteome (0.2340); Cytoplasm (0.1698); Ubl conjugation (0.0692),
MAKTSKLCLGKWRLWITSLLFCVTAADVRYSVPEETKTKFVIGNLSKDVNLDYNRLRFRKARLDYQGDRRYCEIDLDSGNLFVSERIDREMLCGTASPCIMHFEFILENPLELHNIALEVQDVNDNPPVFPKGSIKLEISEGAPTGSKLQLTRARDLDVGINSVQTYILSQNKHFVLDTKSSKDRYVDIVLKNSLDRETRGEHSLILSAVDGGNPPNSGTVVIEVVVIDMNDNAPLFLQPLYNARLSENSALGTSVIKITATDEDEGANGEIKYYINHLSDNTKQLFKIDENYGEISVIGQLDHEKASSYEVEVQAEDGGGQTGHCKVVIEIDDVNDNAPVISVKSLKNKIPENTTPGTEIAVINVKDQDSGENSRISCSISPNLPFQLQPYIKSYFILTTSSSLDREQIDNYNVTIIATDGGIPPLFSNISLNIQVSDVNDNSPRFELQSYFIYISENKQAGTSVCSVSANDPDWRQNGTVLYSLVPSEVNGVPMSSFLSINGDTGVIHTVRSFDYEQFRNFSVKVVARDNGSPPLSSNVTVKVFITDENDNSPQILYPVPDGKTLMTEMVPKATLSGSLVSNVIAVDADSGQNAWLSYQILKSTDPGLFTIGLHSGEIKTQRDISESDNMKQNLVISVKDNGQPSLSTTCVVNLLISDNLSEVPELKDMSYEDNNSKLTSYLIIALVSVCTFFLTFIILMLAVKFCHRRKPRLLFDGAVAVPSAYLPPNYADVDGAGTIRSSYNYDAYLTTGSRTSDFKFVSSYNENTLPAGGILDKSKIDFNMLRLSDVGECTEQKPPNTDWRFPPNQRPGPSGAGARPEEAGAGAGVIAGTGPWPNPPTEAEQLQAMMAAANASEATATLGPRYNLQYGPDYRQNVYIPGSTATLTANPQQQVLQQALPPPQALPPTEAPKAAQTPASKKKPTKKDKK,,cell adhesion (GO:0007155) (0.5899); homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) (0.3833); excitatory postsynaptic potential (GO:0060079) (0.2313); modulation of chemical synaptic transmission (GO:0050804) (0.1875); chemical synaptic transmission (GO:0007268) (0.1817); axon extension (GO:0048675) (0.1434); adult behavior (GO:0030534) (0.1387); neural tube formation (GO:0001841) (0.1314); presynaptic active zone assembly (GO:1904071) (0.1282); brain morphogenesis (GO:0048854) (0.0694),cytoplasm (GO:0005737) (0.3265); glutamatergic synapse (GO:0098978) (0.3029); plasma membrane (GO:0005886) (0.2669); membrane (GO:0016020) (0.1250); postsynaptic membrane (GO:0045211) (0.1092); synapse (GO:0045202) (0.0741),calcium ion binding (GO:0005509) (0.3431); identical protein binding (GO:0042802) (0.1837),"Cadherin, N-terminal (IPR013164) (0.3230); Cadherin-like (IPR002126) (0.3042); Protocadherin/Cadherin-related Cell Adhesion (IPR050174) (0.2818); Cadherin-like superfamily (IPR015919) (0.1497); Cadherin conserved site (IPR020894) (0.1469)",2.60.40.60 (0.3124),Transmembrane helix (0.7020); Reference proteome (0.6461); Transmembrane (0.5282); Signal (0.5240); Membrane (0.5062); Cell adhesion (0.2889); Repeat (0.2556); Glycoprotein (0.2245); Calcium (0.1286); Proteomics identification (0.1186); Vision (0.0989),
MDLHILDHRLRVTCISKSGLQHYTHPLIKLIFLRNRTRCKFFSLTETPENYTVVLDEEGFKELHPSEHLQVEGSTWLPLNVVSNGNASSSSQAVGVTKIAKSVIAPLAEQHVSVFMLSTYQTDFILVREKDLSVVVETLVEEFNIFREEGGESVPVHSQDSCNGLQRNGREVPHATVHPVLIPENHFCVMSLDPDTLPAIATTLIDVLFYSNSPKEGASVDQDMECIKFFSFSLIDGYVSLVMDTDAQRQFPADLLFTSSSGELWRMVRIGGQPLGFDECGIVAQISQPLADSDISAYYISTFSFDHALVPEEDITSVMEMLQTQRKEMSS,,cellular response to L-arginine (GO:1903577) (0.7566); response to hypoxia (GO:0001666) (0.3343); positive regulation of TORC1 signaling (GO:1904263) (0.2201); cellular response to cAMP (GO:0071320) (0.2156); cellular response to amino acid starvation (GO:0034198) (0.1579); negative regulation of TORC1 signaling (GO:1904262) (0.0816); meiotic cell cycle (GO:0051321) (0.0785); response to metal ion (GO:0010038) (0.0717),cytosol (GO:0005829) (0.2319),identical protein binding (GO:0042802) (0.2556); arginine binding (GO:0034618) (0.1648),"Cytosolic arginine sensor for mTORC1 (IPR051719) (0.4518); CASTOR, ACT domain (IPR027795) (0.4228); CASTOR family (IPR026249) (0.2923); CASTOR1, N-terminal (IPR040778) (0.2274); Cytosolic arginine sensor for mTORC1 subunit 1/2, ACT-like (IPR049479) (0.1797)",3.30.2130.10 (0.1999),Ubl conjugation (0.9040); Cytoplasm (0.2651); Tumor suppressor (0.1746); Phosphoprotein (0.1680),
MRKIGKWKWAAFWLFAFSLLWSTIGAQIRYTIPEELKEGSVVGNIAKDLGFDISDIAERKLRIASESNRQYFSVDSGKGDLVVNGRIDRETLCGQSASCLMPLQIVIENPLQLHKVEIDVLDINDNAPSFHNKNGILNISELTAPGARFTLEMADDLDVGSNSLKTYSLSSNNFFRLNLKTIKNGGQVPELVLDKPLDREKQAVHKLILTAVDGGNPVKSGTSILQVIVQDFNDNEPKFEVVSYKASVLESAIIGSSVLKIKASDLDEGLNCEIKYLFSAHTPELVRNVFSLNAETGEITVTGTLDYETKKSYAFDVCAKDKGNPELEGQSSVQIDIIDENDNPPEIILTSLPSPVPENATVGTVVALINVKDLDSGNNGKIELTVSPNVPFKLKPAFDSHYTLVTDGALDREFNSEYNVEILAMDSGVPPLKTVKSVNVKLLDVNDNHPLFSQSSYNVYINENNQAGTSLFSVSASDFDLGKNAQLTYSISDLSSNEVPSSSSYFYINSENGTIYSMSSFDYEKIKLLNIVVQVKDQGSPSLSSNATVHVFILDRNDNAPAVIYPSTSMGSVSHQRMPRSAKAGHLVTKVTAVDADSGHNAWLFYRLAEATDASLFSVNLHTGEVRTKRAVSEHDDSSQRLVLEIKDNGEPIQSTTVTVDILIEDGFHEPISDYREKTIEPNRKTGRITLYLIISLASVSLLCLMTFFILLVKCARGSRGGTGCCIRRTNSEYKNPNRNLQIQLNTDGPIKYVEVLGGDMMSQSQSFGSYLSPMSEFSDLTLIKPSSTTNFTDTLNTLDASLPDSAWTFESQQQKPPNTDWRFPPNQRPGPSGAGARPEEAGAGAGVIAGTGPWPNPPTEAEQLQAMMAAANASEATATLGPRYNLQYGPDYRQNVYIPGSTATLTANPQQQVLQQALPPPQALPPTEAPKAAQTPASKKKPTKKDKK,,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) (0.8278); cell adhesion (GO:0007155) (0.5073); adult behavior (GO:0030534) (0.2104); calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) (0.1727); synapse organization (GO:0050808) (0.0836); chemical synaptic transmission (GO:0007268) (0.0718),glutamatergic synapse (GO:0098978) (0.2523); synapse (GO:0045202) (0.2226); plasma membrane (GO:0005886) (0.2198); membrane (GO:0016020) (0.2003); cytoplasm (GO:0005737) (0.1233),calcium ion binding (GO:0005509) (0.2937); identical protein binding (GO:0042802) (0.1339),"Cadherin-like (IPR002126) (0.4311); Cadherin, N-terminal (IPR013164) (0.2682); Protocadherin/Cadherin-related Cell Adhesion (IPR050174) (0.2289); Cadherin, C-terminal catenin-binding domain (IPR031904) (0.2078); Cadherin-like superfamily (IPR015919) (0.1664); Cadherin conserved site (IPR020894) (0.1357)",2.60.40.60 (0.4127),Reference proteome (0.7589); Transmembrane helix (0.6699); Transmembrane (0.5591); Membrane (0.4659); Glycoprotein (0.3966); Repeat (0.3459); Cell membrane (0.2842); Signal (0.2804); Synapse (0.2094); Proteomics identification (0.1867); Calcium (0.1690); Cell adhesion (0.0886); Alternative splicing (0.0871),
MESGGKGWRYGSLFFYTLCAMALFSSRVSGQIRYSIPEEMQVGSFVGNIASDLGFEPKRLVSGKARVFTTDSSEYIGLDKENGHLVIKNKIDREELCGEISACSVSFDVILENPMELYRVTVDIQDINDNSPAFLKSKIEQEISELVLIGARFPLESAVDPDVGVNALQKYTLQPTDHFKLNVQNAEDGSKNVEIVLHSPLDREKKNHHSLILTAFDGGKPQRSATLHINIIILDVNDNAPVFSQSSYKTSIVENAPKSTVVIRVSATDADESSHGIQYYFEHATPTVKALFSIDADSGDVKVTGQIDYEKHKQFKIKVKAKDHGGLTDSSEIIIDVIDVNDNKPKITIMSFSSAVSEDAAPGTVIAMINVQDLDSGDNSKISCSIDLNSPFKIISSLTNYYNLVTDSELDREQTAEYNITITAVDGGNPPLSVKEILNLKISDVNDHAPQFVQESYNAFIAENNPPSTTILTVKAEDMDWGPNAKVSYFLIDADLNGAPLASYISINSESGVVYAEKSFDYEQLKSFKMQVKAQDGGSPPLSSNVTLNIIIQDQNDNAPQVLYPVQTGASVVAEIVPRAADVGYLVTKVVAVDVDSGQNAWLSYKLQKAADRALFEVGLQNGEIRTVRQVTDKDAVKQKLTVVVEDNGQPSRSAVVSINVAVADSFPEVLSEFTDFTHEKQYNDNLTFYLVLALAVVSLLFIVSIISIISVKIYRWRQNKLFYKSGANLPVIPYYPPVYADGTLQHVYNYEMCGTTDSRMSDVKFVRPYSQNTLVSQSRVGTVQRERKEQEVDELTLEQKPPNTDWRFPPNQRPGPSGAGARPEEAGAGAGVIAGTGPWPNPPTEAEQLQAMMAAANASEATATLGPRYNLQYGPDYRQNVYIPGSTATLTANPQQQVLQQALPPPQALPPTEAPKAAQTPASKKKPTKKDKK,,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) (0.7167); cell adhesion (GO:0007155) (0.3542); adult behavior (GO:0030534) (0.3444); calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) (0.2388); presynaptic active zone assembly (GO:1904071) (0.1960); chemical synaptic transmission (GO:0007268) (0.1931); modulation of chemical synaptic transmission (GO:0050804) (0.1202); somitogenesis (GO:0001756) (0.0835); excitatory postsynaptic potential (GO:0060079) (0.0723),glutamatergic synapse (GO:0098978) (0.4080); postsynaptic membrane (GO:0045211) (0.2182); plasma membrane (GO:0005886) (0.2089); synapse (GO:0045202) (0.1044); presynaptic membrane (GO:0042734) (0.0603),calcium ion binding (GO:0005509) (0.2458); identical protein binding (GO:0042802) (0.1505); cadherin binding (GO:0045296) (0.1405),"Cadherin, N-terminal (IPR013164) (0.2652); Protocadherin/Cadherin-related Cell Adhesion (IPR050174) (0.2632); Cadherin-like (IPR002126) (0.2495); Cadherin-like superfamily (IPR015919) (0.2284); Cadherin conserved site (IPR020894) (0.1270)",2.60.40.60 (0.3678),Reference proteome (0.6526); Transmembrane helix (0.6082); Transmembrane (0.5324); Glycoprotein (0.4909); Signal (0.4505); Membrane (0.4461); Repeat (0.1678); Proteomics identification (0.1630); Vision (0.1233); Alternative splicing (0.1214); Calcium (0.1165); Cell membrane (0.1060),
MNRRLYPISFFAFFVALLLFILKIASADLSYNIPEETKRHYVIANIAKDFKMDVKQLSARKARIDPEDSSKRYCDINPNTGDLFVAETIDREELCGSRMSCILNYELVLENPLDVHRIIFQIQDINDNTPRFPNERINFEIRESAVKGQRFRLDEAHDSDIGKNSINDYSLEKNEHFVLTVQTADEEKYAELVLEKELDREQQKEMDLILTATDGGLPQRSGTAVIHITVLDANDNVPVFDQPIYKVTLAENTPSGTDIIRVSATDADEGPNGEVTYEFSRISDKTAKLFSIDKTTGQILVKGEIDYESEKNYELGIQAKDASGLASIAKVIIDITDVNDNPPRIILKSLNNPIPENSEPGAEVGIINVQDKDSGENRQIRCSVQQNVPFKLNPSVKNYFSLVTTKALDREKESDYNITITATDGGSPPLSTSMTIHLFVSDVNDNPPVFEQQAYSAYINENNKADTSVCSVSANDPDWRQNGTVLYSLVPSEVSGVPVSSFLSINGDTGVIHAVRSFDYEQFRNFSVKVVARDNGSPPLSSNVTVKVFITDENDNSPQILYPVPDGKTLMTEMVPKATLSGSLVSKVIAVDADSGQNAWLSYQILKSTDPGLFTIGLHSGEIKTQRDISESDNMKQNLVISVKDNAQPSLSTTCVVNLLISDNLSEVPELKDMSYEDNNSKLTSYLIIALVSVCTFFLTFIILMLAVKFCHRRKPRLLFDGAVAVPSAYLPPNYADVDGAGTLRSSYNYDAYLTTGSRTSDFKFVSSYNENTLPASGTLNKEHNIHFGSSIITLDVTGDKVEQKPPNTDWRFPPNQRPGPSGAGARPEEAGAGAGVIAGTGPWPNPPTEAEQLQAMMAAANASEATATLGPRYNLQYGPDYRQNVYIPGSTATLTANPQQQVLQQALPPPQALPPTEAPKAAQTPASKKKPTKKDKK,,adult behavior (GO:0030534) (0.4212); homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) (0.3814); cell adhesion (GO:0007155) (0.3582); excitatory postsynaptic potential (GO:0060079) (0.2099); locomotory behavior (GO:0007626) (0.2072); modulation of chemical synaptic transmission (GO:0050804) (0.1861); presynaptic active zone assembly (GO:1904071) (0.1577); cell morphogenesis (GO:0000902) (0.1363); chemical synaptic transmission (GO:0007268) (0.0996),cytoplasm (GO:0005737) (0.2869); plasma membrane (GO:0005886) (0.2510); glutamatergic synapse (GO:0098978) (0.2365); synapse (GO:0045202) (0.1964); membrane (GO:0016020) (0.1851),identical protein binding (GO:0042802) (0.2989); calcium ion binding (GO:0005509) (0.2758),"Cadherin-like (IPR002126) (0.2642); Protocadherin/Cadherin-related Cell Adhesion (IPR050174) (0.2580); Cadherin, N-terminal (IPR013164) (0.2221); Cadherin-like superfamily (IPR015919) (0.1745); Cadherin conserved site (IPR020894) (0.1566)",2.60.40.60 (0.3909),Transmembrane helix (0.6837); Reference proteome (0.5867); Transmembrane (0.5694); Membrane (0.5610); Signal (0.2581); Glycoprotein (0.2396); Cell adhesion (0.2007); Synapse (0.1148); Proteomics identification (0.1135); Repeat (0.1125); Vision (0.0536),
MAFFVMWHGAVFFMILSRYAVKGQISYSIPEEIPKGSIVENNSQGLGLDLKRLNSGKARIFAGDNRRFVGLNKEKGILLTEEKIDREALCAKTTPCASHLQLILENPMQKYDVTVEIIDINDNAPSFPKGEIRFEISETAVTGARFMLENPIDLDVGTNSHLSYSLKPTDNFILSSQGQTDGDKNMEMVLQKALDRENKEKLSLMLTAVDGGEPSLTSTVRIHVTVLDANDNPPVFSQRVYKATFAEITPKDTVIASVSASDADEGSNAIITYYMSSTGDVNDLFTVDTRSRDIRLKGSADFEKASRYQFNIQARDQGGLSDSCKVIIDLTDINDNKPIISIVSMSNSISEQSRPGTVVAMLNVNDFDSGMNGRVHCYRNDNIPFTIASSSSFFSLQTEQELDREKEAEYNISVICSDEGVPALSSSVSLRVQISDVNDNAPVFEKSNYEAFVVENNTPGLSIFTVKASDADWNQNARVSYILEDSIVNGVSISSYVSVHPESGLITAVRSFDYETLKDFHFRVKAQDGGSPPLSSNVTVKVTVQDHNDNAPQVLYPVQTGASVVAEIVPRAADVGYLVTKVVAVDVDSGQNAWLSYKLQKATDRALFEVGLQNGEIRTVRQVTDKDAVKQKLTVVVEDNGQPSRSAVVSINVAVADSFPEVLSEFTDFTHEKQYNDSLTFYLVLALAAVSFLFITCVVVIISVKIYRWRQSRFLYQSNLPVIPYYPPHYADTGVTGTLPHGYNYEVCMTTDSRKSDCKFSTLGRQNVLVVDPSFTETMQHTIKKKCSIDGLRITKSQKPPNTDWRFPPNQRPGPSGQHRFHTLQQRWTPYEKSRAGARPEEAGAGAGVIAGTGPWPNPPTEAEQLQAMMAAANEERNTHRFETSGRK,,cell adhesion (GO:0007155) (0.5784); homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) (0.3254); adult behavior (GO:0030534) (0.2980); chemical synaptic transmission (GO:0007268) (0.2714); brain morphogenesis (GO:0048854) (0.2213); calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) (0.2025); spermatogenesis (GO:0007283) (0.1879); synapse assembly (GO:0007416) (0.1142); presynaptic active zone assembly (GO:1904071) (0.0742); excitatory postsynaptic potential (GO:0060079) (0.0652); neural tube formation (GO:0001841) (0.0517),cell surface (GO:0009986) (0.2823); glutamatergic synapse (GO:0098978) (0.2792); extracellular region (GO:0005576) (0.2151); postsynaptic membrane (GO:0045211) (0.1298); plasma membrane (GO:0005886) (0.1193); synapse (GO:0045202) (0.0822); cytoplasm (GO:0005737) (0.0773),calcium ion binding (GO:0005509) (0.3053); identical protein binding (GO:0042802) (0.1586),"Cadherin, N-terminal (IPR013164) (0.3566); Cadherin-like (IPR002126) (0.3265); Protocadherin/Cadherin-related Cell Adhesion (IPR050174) (0.1945); Cadherin-like superfamily (IPR015919) (0.1486); Cadherin conserved site (IPR020894) (0.1213)",2.60.40.60 (0.2757),Reference proteome (0.6936); Transmembrane (0.6355); Signal (0.5967); Transmembrane helix (0.5749); Membrane (0.4955); Repeat (0.3061); Glycoprotein (0.2648); Vision (0.2361); Cell membrane (0.1509); Alternative splicing (0.1479); Calcium (0.1228); Proteomics identification (0.1163); Cell adhesion (0.0815),
MTKRVALKWWRHYLLFFFLFLLLWNTTEGQTRYSIPEELNVGAVVGNIAKDLGLKISELYDRKLRIASEKGKQYFSLDLSRGEIVVNERIDRETICGENANCLLPLQIVIEDPLQLYRVEVDIQDINDNYPHFQSSDRVLKIAESTVPGMRFPLESAVDLDVGSNSLKTYTLSKDECFSLKIKDLGDGRKIPELVLEKPLDREKKPMHLLMLTALDGGNPVRSGTSQINVTVLDNNDNNPVFEKNVYKVAIAENTNKGTTFLKVEAKDVDEGANGEIKYSLGEHTSDTLRSLFQIDEKTGDIFLNGELDYETTPMYNIEVRARDKGVPEMEGHCTVKIEVSDINDNPPQILLTSKPNPVREDAPSGTVVALISARDTDSGDNGKVRLHTQSDLPFILKRSFSNEYSLVTNGNLDREGYPEYNVEITAFDSGSLSLSSKTIIPVKILDVNDNAPKFSDNVYYVYVTENNTPGSIICSVSAKDIDVGVNGKISYSIENPKGWDTPVSSYMYINSDNGSIFSMHSFDFEKIKVFEVIVQAKDHGSPFLGSNATVYVFILDQNDNVPFVIYPSTSMGSVSHQRMPHSAKAGHLVTKVTAVDADSGHNAWLFYRLAEATDASLFSVNLHTGEVRTKRAVSEHDDSSQRLVIEIKDNGDPELSTTVTLDILIEDGFHEPVSDYYKKNVEPSKKSGKITLYLIISLAAVSLLSLVTFFILLVKCARGSRGGSSCCIRRTNSDYKNPNRNLQIQLNTDGPIKYVEVLGGDMMSQSQSFGSYLSPMSEFSDLTLIKPSSTTNFTDTLNTLDASLPDSAWTFESQQQKPPNTDWRFPPNQRPGPSGAGARPEEAGAGAGVIAGTGPWPNPPTEAEQLQAMMAAANASEATATLGPRYNLQYGPDYRQNVYIPGSTATLTANPQQQVLQQALPPPQALPPTEAPKAAQTPASKKKPTKKDKK,,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) (0.7273); cell adhesion (GO:0007155) (0.7186); chemical synaptic transmission (GO:0007268) (0.2464); calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) (0.1947); adult behavior (GO:0030534) (0.1303); modulation of chemical synaptic transmission (GO:0050804) (0.1061),plasma membrane (GO:0005886) (0.3636); membrane (GO:0016020) (0.2422); synapse (GO:0045202) (0.1774); glutamatergic synapse (GO:0098978) (0.1700); presynaptic membrane (GO:0042734) (0.0946); extracellular region (GO:0005576) (0.0649),calcium ion binding (GO:0005509) (0.3291); identical protein binding (GO:0042802) (0.1200); cadherin binding (GO:0045296) (0.0818),"Cadherin-like (IPR002126) (0.3935); Protocadherin/Cadherin-related Cell Adhesion (IPR050174) (0.2867); Cadherin, N-terminal (IPR013164) (0.2599); Cadherin-like superfamily (IPR015919) (0.2581)",2.60.40.60 (0.2279),Reference proteome (0.7291); Transmembrane helix (0.6961); Signal (0.6246); Repeat (0.5306); Transmembrane (0.5185); Membrane (0.4472); Cell membrane (0.3978); Glycoprotein (0.3967); Cell adhesion (0.3717); Proteomics identification (0.2767); Alternative splicing (0.2282); 3D-structure (0.1904); Calcium (0.1685),
MGKADFLTPKAIANRIKAKGLQKLRWYCQMCQKQCRDENGFKCHCMSESHQRQLLLASENPNQFLSYFSDEFKTDFLELLRRRFGTKRVHNNIVYNEYISHREHVHMNATQWETLTDFTKWLGREGFCKVDETPKGWYVQYIDRDPETIRRQEELERKKKQDLDDEERSAKFIEEQVRRGREGREPTEEPVFTELQRKSEDEKVAFNLEIAAAGPSKPSTTLGPSALKTTASVKRKESSLSGEFKDKKKKSALDEIIEMEEQKKKSVRSDNWIQENIVVKVVTKKLGEKYYKKKAIIRELQGKYTAVVKMVDSGDKLKLDQSHVETVIPAPGKRVLILNGQYRGTEAILEGINEHKFSATLTLDSGRMKGKTVEGIAYEDFSKLA,,DNA replication (GO:0006260) (0.9892); DNA damage response (GO:0006974) (0.6078); mRNA processing (GO:0006397) (0.0746),nuclear matrix (GO:0016363) (0.4089); nucleus (GO:0005634) (0.3559); nucleoplasm (GO:0005654) (0.2938),double-stranded DNA binding (GO:0003690) (0.4883); metal ion binding (GO:0046872) (0.1442); RNA binding (GO:0003723) (0.1126),"DNA/RNA-binding protein KIN17, WH-like domain superfamily (IPR038254) (0.5816); Large ribosomal subunit protein uL2, domain 2 (IPR014722) (0.3598); Zinc finger C2H2 superfamily (IPR036236) (0.3139); KIN17-like protein (IPR037321) (0.3086); DNA/RNA-binding protein Kin17, WH-like domain (IPR019447) (0.2984); Zinc finger C2H2-type (IPR013087) (0.1300); KN17, SH3-like C-terminal domain (IPR041330) (0.1298); Kin17, KOW domain (IPR041995) (0.0728)",1.10.10.2030 (0.6705); 2.30.30.140 (0.1888); 2.30.30.30 (0.1750),Zinc (0.8217); Zinc-finger (0.6448); Reference proteome (0.5644); Metal-binding (0.3214); DNA-binding (0.1826); Coiled coil (0.1723); mRNA processing (0.1451); Nucleus (0.1328); mRNA splicing (0.1314); RNA-binding (0.1292); DNA damage (0.1285); DNA repair (0.1240); Transport (0.0959),
MSEEREKCSSPTGSCSSECPDECDSDPSCSPAGPAALRMGQQAEDEDGRFPVCIRDAVSQVLKGYDWSLVPMPVRVSGSGKSKPHVKRPMNAFMVWAQAARRKLADQYPHLHNAELSKTLGKLWRLLTESEKRPFVEEAERLRVQHKKDHPDYKYQPRRRKSVKPGHAESEAGSELMQHMYKAEPGMGRLTGSPDHITDHTGHTHGPPTPPTTPKTEHPQAPKQNIDFSNVDISELSTDVIGNLTFDLQEFDQYLPLTPDQGACSRRAPPAGAHLHPQRVHIKTEQRSPQHYSEHSSTLYSSSSAQCEYTEHSFYSPYSSYPYPYPYLHRPILNIPAPHSSSAHWDPPVYTTLSRP,,negative regulation of transcription by RNA polymerase II (GO:0000122) (0.9395); morphogenesis of an epithelium (GO:0002009) (0.2957); in utero embryonic development (GO:0001701) (0.2945); skeletal muscle cell differentiation (GO:0035914) (0.2444); neural crest cell migration (GO:0001755) (0.1510); positive regulation of transcription by RNA polymerase II (GO:0045944) (0.1499); melanocyte differentiation (GO:0030318) (0.1426); spermatogenesis (GO:0007283) (0.1395); positive regulation of DNA-templated transcription (GO:0045893) (0.1269); embryonic pectoral fin morphogenesis (GO:0035118) (0.1242); cell maturation (GO:0048469) (0.1111); oligodendrocyte differentiation (GO:0048709) (0.0966); heart valve development (GO:0003170) (0.0953); positive regulation of gliogenesis (GO:0014015) (0.0939); central nervous system myelination (GO:0022010) (0.0745); male gonad development (GO:0008584) (0.0715); developmental growth (GO:0048589) (0.0691); negative regulation of myoblast differentiation (GO:0045662) (0.0592); regulation of transcription by RNA polymerase II (GO:0006357) (0.0558); positive regulation of gene expression (GO:0010628) (0.0536),nucleus (GO:0005634) (0.1629); cytoplasm (GO:0005737) (0.1238),"chromatin binding (GO:0003682) (0.1625); DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981) (0.1281)",Sox developmental protein N-terminal (IPR022151) (0.3145); High mobility group box domain superfamily (IPR036910) (0.1529),1.10.30.10 (0.0787),Transcription regulation (0.8667); Transcription (0.8525); DNA-binding (0.4212); Reference proteome (0.3603); Nucleus (0.3143); Cytoplasm (0.1357); Activator (0.0812); Ubl conjugation (0.0732),
MEQNGVFLWICGFAIVVCGNQETLQQPPISAKLPSLINMNNDFAFNLYKRLIESPDYQSKNIFFSPFSVSMALSELSLGAGGDTKQQLLSGIGYNSTIFSTEEMHQLFHSLLEDIGNRTGVDIDVGTALYASDRFKPHSKFLEDMKEFYHSDGFTVDFRVKETVDQINKYVEEKTHGKINQAVDDLEEDTFMLLLTYIYFKGKWDKPFNPETTSESTFHIDDKTTVPVQMMHQYERFKVYYDAELSTKVLCLNYDSFSMFLAVPDVHMGRKTIKDLEMTVSRQHIEKWRRSVSERKVDIYVPKLSLKTSYSLKDILKGMGMADMFSDKADFTGVSEEKIFVSKVLHKATLDIDEKGTTAAAVTTVYASVMSYSPMSDLRFDRPFMIFITDHTNDNILFFGKVVNPNEKL,,negative regulation of peptidase activity (GO:0010466) (0.6869); response to cytokine (GO:0034097) (0.2943); spermatogenesis (GO:0007283) (0.1939); protein phosphorylation (GO:0006468) (0.1123); blood coagulation (GO:0007596) (0.1104); negative regulation of endopeptidase activity (GO:0010951) (0.0471),platelet alpha granule (GO:0031091) (0.1413); extracellular space (GO:0005615) (0.0949); extracellular exosome (GO:0070062) (0.0467),serine-type endopeptidase inhibitor activity (GO:0004867) (0.2443); protease binding (GO:0002020) (0.2089); identical protein binding (GO:0042802) (0.0826),"Serpin family (IPR000215) (0.5442); Serpin, conserved site (IPR023795) (0.1625); Serpin superfamily (IPR036186) (0.1377); Serpin domain (IPR023796) (0.1267); Serpin superfamily, domain 1 (IPR042178) (0.0813)",3.30.497.10 (0.0857),Secreted (0.6118); Glycoprotein (0.5682); Serine protease inhibitor (0.5575); Signal (0.4897); Protease inhibitor (0.3363); Reference proteome (0.1890); Proteomics identification (0.1625); Direct protein sequencing (0.0622); Phosphoprotein (0.0576); 3D-structure (0.0530),
MQKYGRGFLWIPALFLTLAGRGDAQADASNVVTVADANWTLILQGEWMIKFYAPWCPACQHLQADWENLGRQSDSLGISVGRVDVTQQPGLSGRFLVTTLPTIFHAKNGDFRKYVSSRTIEDIQAYVVHRKWATVEPVPGWKSPSSLLMSGMAHLFRLSVWIRQIHTYLTNTLGIPSWGSYVIFAIITLFMGLVLGLMLVLIADCIWPSRPKRRQDKTVVTVKEDVSEEEEEEKQDLESERVSEESTEEETADADTDAETTVRRRVQNKSTTEGT,protein disulfide-isomerase (5.3.4.1) (0.1422),positive regulation of ERAD pathway (GO:1904294) (0.6049); negative regulation of triglyceride biosynthetic process (GO:0010868) (0.5467); response to endoplasmic reticulum stress (GO:0034976) (0.4515); negative regulation of platelet aggregation (GO:0090331) (0.3560); regulation of calcium ion transport (GO:0051924) (0.2008),endoplasmic reticulum (GO:0005783) (0.3650); mitochondria-associated endoplasmic reticulum membrane contact site (GO:0044233) (0.2453); endoplasmic reticulum membrane (GO:0005789) (0.2332); endomembrane system (GO:0012505) (0.1445); nuclear inner membrane (GO:0005637) (0.0749),disulfide oxidoreductase activity (GO:0015036) (0.5261); enzyme inhibitor activity (GO:0004857) (0.1213),Thioredoxin-like superfamily (IPR036249) (0.2338); Thioredoxin-related transmembrane domain-containing protein (IPR052454) (0.2268); Thioredoxin domain (IPR013766) (0.1008),3.40.30.10 (0.1195),Endoplasmic reticulum (0.7077); Transport (0.6034); Transmembrane (0.6004); Signal (0.5420); Reference proteome (0.4846); Disulfide bond (0.3575); Electron transport (0.3290); Redox-active center (0.2583); Transmembrane helix (0.2361); Membrane (0.1655); Proteomics identification (0.1617),
MDLKGVLEVLEQLAPLSLAESWDNVGLLVEPSRPRPIKTILLTNDLTAAVMDEAVGMKCDLIVSYHPPLFRPFKRLLQKDWKQRLAVRAIENGIGIFSPHTSWDSVEGGVNDWLVGGMGRGKVSVLSQAVSSGAQKHRIEFSCMDDGEVNSLLEQLRHTEGSETFQCTRIKSESGGQQVNLTCRSSALTGAVQILLSHPHTSKSLNITQVQQPPLLGCGQGRLSVLEEPVSVSTAVQKMKTHLGLPHLRLALGDQQTLDSMVKTVAVCAGSGASVIQGVTADLYITGEMSHHEVLDAVSKGTSVILSEHSNSERGFLGVFRERLSARLDHTVSIVISQTDRDPLQVV,,negative regulation of transcription by RNA polymerase II (GO:0000122) (0.8410); neuron migration (GO:0001764) (0.2455); positive regulation of DNA-templated transcription (GO:0045893) (0.1493); neuron differentiation (GO:0030182) (0.1416); endocrine pancreas development (GO:0031018) (0.1229); protein homotetramerization (GO:0051289) (0.1198); regulation of transcription by RNA polymerase II (GO:0006357) (0.0988); liver development (GO:0001889) (0.0776); long-term memory (GO:0007616) (0.0553),cytoplasm (GO:0005737) (0.5245); nucleus (GO:0005634) (0.4517); cytosol (GO:0005829) (0.1095); mitochondrion (GO:0005739) (0.0537),RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629) (0.3821); identical protein binding (GO:0042802) (0.3088); DNA binding (GO:0003677) (0.1530),DUF34/NIF3 (IPR002678) (0.3589); DUF34/NIF3 superfamily (IPR036069) (0.2293),3.40.1390.30 (0.5249),Cytoplasm (0.7388); Reference proteome (0.6777); Nucleus (0.2879); Chaperone (0.0728); 3D-structure (0.0683); Direct protein sequencing (0.0403),
MSLSSGTAGGKGVDSNAVDTYDSGDEWDIGVGNLIIDLDADLEKDKLEMSGTKDGGGMAAPPSAVAALPDNIKFVSPVSAPQGKESKSKSKRNKNSKDNSSKSQAADGAKKDHQGRTQGEVTGATGSSGGGNSAPGKGIEKGAKASRGVPNSKKEKDVSSGKNKKDKNESGPVAVVAIEKDIVTSAQAFGSTRNTAFDNTQNADMAVTEQLGNNTLETVGIVSPSIKSEPEELDGECRALKKVKNEKMESPVSTPAPPPLHLLASIGNSDIASPCEQLMVRTRSVAVNTSDVALSTEPECLGPCEPGTSVNLEGIVWQETEDGMLVVNVTWRNKTYVGTLLDCTRHDWAPPRFCESPTSDLEMRNGRGRGKRMRPNSNTPVNENSNSSDNKGSNNSKTRASSNSKGRRGSQNSSERRTPPNSNTEDIKASPSSASKRKSKPASDMEPNSSSEDSKGNKRMRTNSNGGMTSSALPIPIIKTESLPPPLDRTCPSPVLIDCPHPNCNKKYKHINGLKYHQARAHNDDDVKLDMDGDSEYGEESSLHPEPGSCNGASITQKGSLSPARSVTPKGRGFDAQSPSPSPGKFGSKSKKKNGDTEADVCSTSMEVCEDGPCVTADEASNDGMEDRKSKKPNSNVKSEKMSQKNMKSSRNMAPSIPSQQMYSLQPTSFSGGSPNHPPVMANMLQGIPKSPQLKGIQSKLGAPGDSSPINPALSSSKDKKKKDKKKKDLAKDADSPKLPGKSGKTEEGKSPYSESSDPGNRSEGHLNGSSDPHQSRLASMKAEADKIYSFTDNAPSPSIGVASRVDSSGQPLTPLHVVTQNGADSSSVKTNSPAYSDISDAGEDGEGKVEGVKVKTEDQSSRDGAKKALFPSQASSKESSYYPGYDNYYSPSYSHPSPGGATAGGPLPDGQAVKLKKEEEQELVEEKVKVDMQDERKAEVASSQPHQQQQASVIQQRSNMYMQPLYYNQYYVPQYGYPDQVYHNHLMNTNPTYRQQYEERQRLMAEQHRSAEKKPDSGLKDRESSLKEDWKQKGPVPPGLTKAPSLSDLGKPQAPGKQRDTSSEAAKSVIIPKGEETKLQPQQAEGLKMKLSEAGHHGKDDSKASVESARLGMEQAMWYRQYPDSQRPPDDDRDRERERDRKGKEERSRQKDSSSKEDNKDVVDVSCPPSIEDQRSGGKDPRPNPHIPFGSPLAQHQPYLHYMHGYPFGQSYDPNHPGYRGMSSMMNYPGSYLPAGYPFSPYGSKMISGEEGEKSRSSPTVSSKSASESKALDILHQHANQYKSKSPTVADKPSHERERGLGDRERERERDREREREIDRPRSSPSQRIMAPHHHLGYPLVAGQYDLSYATGLSSSAIVASQQASAPSLYPPARR,RING-type E3 ubiquitin transferase (2.3.2.27) (0.3352),cell migration (GO:0016477) (0.6802); regulation of transcription by RNA polymerase II (GO:0006357) (0.5007); negative regulation of transcription by RNA polymerase II (GO:0000122) (0.4103); regulation of DNA-templated transcription (GO:0006355) (0.1339); positive regulation of neuron migration (GO:2001224) (0.0681); lamellipodium assembly (GO:0030032) (0.0582); protein ubiquitination (GO:0016567) (0.0544); regulation of G1/S transition of mitotic cell cycle (GO:2000045) (0.0453),nucleus (GO:0005634) (0.5582); nucleoplasm (GO:0005654) (0.1647); cytoplasm (GO:0005737) (0.0488),promoter-specific chromatin binding (GO:1990841) (0.4523); cAMP response element binding protein binding (GO:0008140) (0.1486); transcription corepressor activity (GO:0003714) (0.1208),Zinc finger C2H2-type (IPR013087) (0.2468); Zinc finger protein 608/609 (IPR040010) (0.0842),,Zinc-finger (0.9562); Ubl conjugation (0.9384); Repeat (0.6867); Reference proteome (0.5433); Transcription regulation (0.5272); Phosphoprotein (0.5035); Isopeptide bond (0.2857); Metal-binding (0.2337); Methylation (0.2095); Neurogenesis (0.2050); Alternative splicing (0.1879); Coiled coil (0.1568); Synapse (0.1559); Chromatin regulator (0.1446); Transcription (0.1388); Nucleus (0.1102); Intellectual disability (0.0941); Zinc (0.0707),
MGGAVSAGEDNDDLIDNLKEAQYIRTERVEQAFRAIDRGDYYLEGYRDNAYKDLAWKHGNIHLSAPCIYSEVMEALKLQQGLSFLNLGSGTGYLSTMVGLIIGPFGVNHGVELHKDVVEYANERLDDFIKNSDSFDRFEFCEPHFVVGNCLEISSDSHQYDRIYCGAGVQKDHENYMKILLKVGGILVMPIEDQLTQIIRTGQSSWESKNILAVSFAPLVQQNRTDSNKSEAVVLPALSVRSLQDLSRIYIRRTLSSLINEENPNRTNTPRASQKRKRRRCRRRRRINTYVFVGNQLIPQPLDSEEDECIEQESKDEEQEKDIEPIKPEEPQVNHLRDKILSLPLPESLKAYLLYYRKK,2.1.1.- (0.2383); protein-L-isoaspartate(D-aspartate) O-methyltransferase (2.1.1.77) (0.0581),protein modification process (GO:0036211) (0.4537); methylation (GO:0032259) (0.2878); neuronal action potential (GO:0019228) (0.1293); DNA damage response (GO:0006974) (0.1209); protein ubiquitination (GO:0016567) (0.0927); proteolysis (GO:0006508) (0.0832); positive regulation of transcription by RNA polymerase II (GO:0045944) (0.0692); intracellular signal transduction (GO:0035556) (0.0657),membrane (GO:0016020) (0.5497); nucleus (GO:0005634) (0.3768); cytoplasm (GO:0005737) (0.3338); Cul5-RING ubiquitin ligase complex (GO:0031466) (0.1570); plasma membrane (GO:0005886) (0.1505); nucleoplasm (GO:0005654) (0.0536),protein-L-isoaspartate (D-aspartate) O-methyltransferase activity (GO:0004719) (0.5826); ubiquitin-like ligase-substrate adaptor activity (GO:1990756) (0.5638),Protein-L-isoaspartate(D-aspartate) O-methyltransferase (IPR000682) (0.2501),,Reference proteome (0.8464); Transferase (0.8006); Myristate (0.7152); Membrane (0.5448); Lipoprotein (0.3885); Proteomics identification (0.2619); Methyltransferase (0.1138); Zinc (0.0616),
MAAVGKVKRSTRDLPRGVERLKDEHRKVVKDCRSQIEHWEKVGKDYESLQDRLRTLPDKLSYDIMVPFGPLAFMPGKLVHTNEVTVLLGDNWFAKCSAKQADTLVEHRKKHVENALDDLQKVIKNFQNRADFTDDLKKLSGETGDYVDIREEVVNEEEITKGKHRLAHKPNSKPKQEYILELKDNKEKEDEEEEDDDDDEERKAKVLSEEELWARLDELERQEELQDQRFRLDSTDTNGEDTTSSSEEEKEADGGSDVQVNGHQKENGWKASSLTAQMNGTNGSHPEEEEDDEDCEEETDNGLPTIYFSHTVEFKKVRINTGKNTTLKFSERKEQKEQAKHKKKSGKSSGHSPLESYKITSPADIYRVFVDLVNGEPIPRKSILKSRSRENSVCSDTSESSTADFEERRAAFGRSWSHDDATHSDTSDGITEEDSPTGTSPHMNGRFEAFTGTVIEKDPLPCSIPHLTIAPPALPTIPERKLEEVVPDVPQELPKRMSKFKATRLHHK,,negative regulation of transcription by RNA polymerase II (GO:0000122) (0.9547); regulation of cell growth (GO:0001558) (0.8133); negative regulation of intrinsic apoptotic signaling pathway (GO:2001243) (0.3603); cellular response to growth factor stimulus (GO:0071363) (0.3499); negative regulation of phosphatase activity (GO:0010923) (0.2769); nervous system development (GO:0007399) (0.1675); response to virus (GO:0009615) (0.1278); regulation of transcription by RNA polymerase II (GO:0006357) (0.0929); neuron differentiation (GO:0030182) (0.0642),nucleus (GO:0005634) (0.4688); cytoplasm (GO:0005737) (0.2402); cytosol (GO:0005829) (0.1715),phosphoprotein binding (GO:0051219) (0.6173); chromatin binding (GO:0003682) (0.4997); transcription corepressor activity (GO:0003714) (0.2824); identical protein binding (GO:0042802) (0.0988),Prefoldin (IPR009053) (0.3586); RNA polymerase II subunit 5-mediating protein (IPR052255) (0.1741); Prefoldin alpha-like (IPR004127) (0.1573),1.10.287.370 (0.1359),Reference proteome (0.4130); Proteomics identification (0.0941); Coiled coil (0.0646); Mitochondrion (0.0643),
MADTEQVADLTEIKDEETGDSPADECEQEPEQNQDDTNGDKTDTEDKSESKEKNSGGRKSHRYHPYKERSGGADKKTTHRNRVFISNIPYDKKWQAIKDLMREKVGEVTYVELFKDGEGKSRGCGVVEFKDEEFVKKAIEVMSKHDLNGRPLNIKEDPDGEHARRVLQRSGRMYGGGRGQDSSGINIPPSIANNPNIPHEIISALQAGRLGATIFVANLDFKVGWKKLKEVFGMAGTVRRADVKEDKDGKSRGMGTVTFEQPLEAVQAISMFNGQMLFDRQMHVKMDDKSLPPDDFRPVEKSPQLPRGLGGIGMGLGPGGQPINANCLSGSSMGPGGMDGGCSNMNRMSGMGGGFSGIDCMAGMGGFSGRDMSMGRMGDMYRSGMGGMDRDFGRNDLGMSRSFGDSFSSLGGGFGGMGNSGMGPMGSGLGMGNMGMDRMNSGFDRMSSSMDMSRGFGQFGGSGYMGGMSDRSKGGCQIFVRNLSYDLSWQKLKEKFSHCGQVMYAEIKMENGKSKGCGTVRFDSPESAEKACRLMNGTKINGREVDVRLDRNA,,"myotube differentiation (GO:0014902) (0.5902); alternative mRNA splicing, via spliceosome (GO:0000380) (0.3094); negative regulation of transcription by RNA polymerase II (GO:0000122) (0.2760); positive regulation of transcription by RNA polymerase II (GO:0045944) (0.1584); mRNA processing (GO:0006397) (0.1267); innate immune response (GO:0045087) (0.0626); regulation of transcription by RNA polymerase II (GO:0006357) (0.0605); mitochondrial transcription (GO:0006390) (0.0556)",nucleus (GO:0005634) (0.6204); cytoplasm (GO:0005737) (0.1769); ribonucleoprotein complex (GO:1990904) (0.0961); spliceosomal complex (GO:0005681) (0.0640); cytosol (GO:0005829) (0.0611),RNA binding (GO:0003723) (0.1310); mRNA binding (GO:0003729) (0.1213),RNA-binding domain superfamily (IPR035979) (0.4998); RNA recognition motif domain (IPR000504) (0.2722); Nucleotide-binding alpha-beta plait domain superfamily (IPR012677) (0.2327); RRT5/SRSF/Splicing Factor SR (IPR050374) (0.2154),3.30.70.330 (0.1306),Reference proteome (0.4987); Repressor (0.4599); Repeat (0.4175); DNA-binding (0.3933); Nucleus (0.2784); mRNA processing (0.2782); mRNA splicing (0.2697); RNA-binding (0.2163); Cytoplasm (0.1823); Methylation (0.1724); Transcription regulation (0.1611); Phosphoprotein (0.1292); Proteomics identification (0.1284); Transcription (0.1268),
MIPAGSMEVNATDKAFLSVDGTATLTSCSYHSATVDASLQCTHPESKARVVRSSSTGKRPSSSERKPRRSLDPLSQLHKTKHMRYEVKNDELVSVKPSHYRRVVVLGAPRVGKTALIRRFLGEEVFEEHYEPTSEDFHSKLYHIRGERYQLDILDASKERDFPAKRRLTILTGDIFLLVFSVTDRDSFTEVCSLREEIFTAKSKLTKSKENRQLPIIICANKADVDSPRAVQRSDVAQCLGEDSVLFEVSAKTCTNLEEMFETLAVLGGLPTETRPSLHRDISIHTYHALSSRKRNKRAVNEPCGAVHPLARRPSFSSDLRRVLGPSTPKKSTPIERCQIQ,3.6.5.- (0.3633),"signal transduction (GO:0007165) (0.3973); small GTPase-mediated signal transduction (GO:0007264) (0.1216); response to xenobiotic stimulus (GO:0009410) (0.1096); nitric oxide mediated signal transduction (GO:0007263) (0.1057); synaptic transmission, dopaminergic (GO:0001963) (0.0753); cellular response to starvation (GO:0009267) (0.0643); positive regulation of MAPK cascade (GO:0043410) (0.0533)",mitochondrion (GO:0005739) (0.2081); membrane (GO:0016020) (0.1418); plasma membrane (GO:0005886) (0.1225); cytoplasm (GO:0005737) (0.1068),GTP binding (GO:0005525) (0.3046); G protein activity (GO:0003925) (0.1705); GTPase activity (GO:0003924) (0.1397); G-protein beta-subunit binding (GO:0031681) (0.1233),Small GTPase (IPR001806) (0.1874); Small GTPase RasD (IPR052236) (0.1861); Small GTP-binding protein domain (IPR005225) (0.1584),3.40.50.300 (0.1965),Methylation (0.7731); Nucleotide-binding (0.5228); Prenylation (0.4751); GTP-binding (0.4546); Membrane (0.3611); Lipoprotein (0.3461); Cytoplasm (0.2385); Reference proteome (0.0486),
MDIIWEIFIILQANLIVCTSAQPNPPKIHEGWWAYKEVVQGSFVPVPSFWGLVNSAWNLCSVGKRQSPVNIETSHMIFDPFLTPLRLNTGGRKVGGTMYNTGRHVSLRLDKEHLVNISGGPMTYSHRLEEIRLHFGSEDGQGSEHLLNGQAFSGEVQLIHYNHELYTNYTEAAKSPNGLVIVSIFMKISETSNSFLNRMLNRDTITRITYKNDAYLLSGLNIEEVYPETASFITYEGSMTIPPCYETATWILMNKPIYVTKMQMHSMRLLSQNQPSQIFLSMSDNVRPVQPLNNRCIRTNINFSMQGKDCPNNRAQKLQYRVNEWLLK,carbonic anhydrase (4.2.1.1) (0.9250),germ cell migration (GO:0008354) (0.1683); neuron cellular homeostasis (GO:0070050) (0.1628); glucose metabolic process (GO:0006006) (0.1352); response to bacterium (GO:0009617) (0.1335); bicarbonate transport (GO:0015701) (0.1036); long-term memory (GO:0007616) (0.0825); learning or memory (GO:0007611) (0.0786); positive regulation of defense response to virus by host (GO:0002230) (0.0770); response to xenobiotic stimulus (GO:0009410) (0.0680),basolateral plasma membrane (GO:0016323) (0.3402); cytoplasm (GO:0005737) (0.3102); apical plasma membrane (GO:0016324) (0.1797); extracellular region (GO:0005576) (0.1200); cytoplasmic vesicle membrane (GO:0030659) (0.0484),zinc ion binding (GO:0008270) (0.5446),Alpha carbonic anhydrase domain superfamily (IPR036398) (0.2321); Carbonic anhydrase-related protein X/XI (IPR041878) (0.2277); Alpha carbonic anhydrase domain (IPR001148) (0.1048),3.10.200.10 (0.3121),Reference proteome (0.6290); Zinc (0.4557); Lyase (0.3781); Direct protein sequencing (0.3237); Disulfide bond (0.2546); Metal-binding (0.1743); Proteomics identification (0.1740); Zymogen (0.1203); Glycoprotein (0.0962); 3D-structure (0.0846),
MGAAMGPLLLWLQDVAAVTLLRARRTLLRAAILLCVLVLLLWVSIFLYGSFYYSYMPSVSFSTPVHYYYRTDCEASDAVLCSFPMANVSLLKNGRDQVMMSGQAYRISLELEMPESPVNEQLGMFMVKMSCYSNDGTVVHSVARSTMLHYRSNLLQTLSTLLFSPLLLSGVSEQKQLVEVELFPDLKLDIYHPAVGAVIEIQSRRVQIYSAQLRIHAYFTGVRFLLYNFPVMSAIVGVASNFTFLSVIVLFSYLQFIWGGLYPPEQVRVKVMIGDSTRLQQRREEARKRMHSSASTPVMTYGRDGSELLSDPLQHPKQTVRNKGDLDTPSVIGTEDLNNQQEDETGKNIT,triacylglycerol lipase (3.1.1.3) (0.1773); 3.1.-.- (0.0497),lipid droplet organization (GO:0034389) (0.5093); lipid metabolic process (GO:0006629) (0.4933); lipid droplet formation (GO:0140042) (0.4201); lipid storage (GO:0019915) (0.2650); positive regulation of cold-induced thermogenesis (GO:0120162) (0.2076); regulation of lipid storage (GO:0010883) (0.1212); lipid catabolic process (GO:0016042) (0.1196); fat cell differentiation (GO:0045444) (0.1146); lipid homeostasis (GO:0055088) (0.1047),lipid droplet (GO:0005811) (0.2161); endoplasmic reticulum membrane (GO:0005789) (0.1620); cytosol (GO:0005829) (0.0914),phospholipid binding (GO:0005543) (0.0827),Seipin family (IPR009617) (0.1272),,Membrane (0.5158); Lipid metabolism (0.3694); Phosphoprotein (0.3544); Reference proteome (0.3276); Transmembrane (0.2292); Lipid droplet (0.2195); Endoplasmic reticulum (0.1961); Lipid degradation (0.1939); Disease variant (0.1757); Proteomics identification (0.1286); Transmembrane helix (0.1132),
MVDKGPLLTSAIIFYLSIGAAIFQVIEEPNWEIAVRKYRADKESILKQYPCLTKADLDYILEVVSDAAGQGITITGDKTFNNWNWPNAVIFAATVITTIGYGNIAPKTPSGRVFCIFYGLFGVPLCFTWISELGKFFGGRAKHLGWYLTKKGVTLRKTQLTCTAVFLLWGVLIHLVIPPFVFMTQEGWTYIEGLYFSFVTLTTIGFGDLVAGVDPNAEYPTLYRYFVEVWIYLGLAWLSLFFNWKVRMVVEAHKALKKHRKRRRLSLDELQLKESHKTLHLPPTPNDVNIFSFLSKKKEGYNDLIKQIGADKGENQCVSTMNSRKNAAAKRSKSCSDALSINGNTIVSLDGSPRLKRHYSFSDRVAVALSKSKGYLFSQEECLLMTEKLEEGDTDLQCMGMSGNQLDKEAGESHQALIYEGCRNGPITWDSKGHQTNMFPNANITFIDEDNFVNNNREDENDFMPSFKSDEPDFRKEEDSESETSVFTRCGSDHGQSYERLVEEYSKEDNTDI,,potassium ion transport (GO:0006813) (0.6323); stabilization of membrane potential (GO:0030322) (0.5119); regulation of resting membrane potential (GO:0060075) (0.3696); potassium ion import across plasma membrane (GO:1990573) (0.2650); potassium ion transmembrane transport (GO:0071805) (0.2239); cellular response to mechanical stimulus (GO:0071260) (0.0627),plasma membrane (GO:0005886) (0.2605); monoatomic ion channel complex (GO:0034702) (0.0569),outward rectifier potassium channel activity (GO:0015271) (0.5185); potassium ion leak channel activity (GO:0022841) (0.1367); potassium channel activity (GO:0005267) (0.1000),"Two pore domain potassium channel, TASK family (IPR003092) (0.1870); Potassium channel domain (IPR013099) (0.1617); Two pore domain potassium channel (IPR003280) (0.1390)",1.10.287.70 (0.0859),Transmembrane (0.6895); Transport (0.5556); Potassium channel (0.5049); Voltage-gated channel (0.4853); Reference proteome (0.4488); Potassium transport (0.4305); Potassium (0.3414); Membrane (0.2757); Ion channel (0.2729); Ion transport (0.2133); Ubl conjugation (0.1936); Transmembrane helix (0.1935); Phosphoprotein (0.1547); Metal-binding (0.1545); Glycoprotein (0.1492); Mitochondrion (0.1296); Disulfide bond (0.0986),
MPCTGSALSSLAIEDCEDAELAYTMRDLPPRAAHTFPENQTMDRQPDGSTAPHTPGTPTTTRPINRSFLGSEQELFRRGQLSSVSSLDSPLSPSRPKSPWARFDPYDSAEDQDKEYVGFATLPNQVHRKSVKKGFAFTLMVAGESGLGKSTLVNSLFLTDLYKDRKMPNAEERIAQTVEITKHTVAIEEKGVKLRLTIVDTPGFGDAVNNTESWRAIVDYIDQQFEQYFRDESGLNRKNIQDNRVHCCLYFISPFGHGLRPIDVEFMKILHEKVNIVPVLAKTDSLTPEEVRKMKMKIREEIERFDIMIYQFPECESDEEDEFKLQQQELKDSVPFAVIGSNVQVESQGRRFRGRQYPWGLVEVENPEHSDFLKLRNMLVRTHMQDLKDVTRETHYENYRAQCIQNMTRMVVRERKRSLNSRLRESPSDLPVPLVPVDTETERLIWEKDEELRRMQEVLERIQEQMRQGHEDLPIN,,spermatogenesis (GO:0007283) (0.2482); cytoskeleton-dependent cytokinesis (GO:0061640) (0.2252); protein localization (GO:0008104) (0.1874); regulation of exocytosis (GO:0017157) (0.1835); cell differentiation (GO:0030154) (0.1591); flagellated sperm motility (GO:0030317) (0.0834),septin complex (GO:0031105) (0.4409); septin ring (GO:0005940) (0.3858); microtubule cytoskeleton (GO:0015630) (0.3296); synaptic vesicle (GO:0008021) (0.2706); cell division site (GO:0032153) (0.2249),GTPase activity (GO:0003924) (0.4140); GTP binding (GO:0005525) (0.2666),P-loop containing nucleoside triphosphate hydrolase (IPR027417) (0.3051); Septin (IPR016491) (0.2320),3.40.50.300 (0.2872),Differentiation (0.4573); Spermatogenesis (0.4372); Nucleotide-binding (0.3780); Coiled coil (0.2859); Reference proteome (0.2169); Phosphoprotein (0.2089); Ubl conjugation (0.1911); Cell cycle (0.1760); GTP-binding (0.1688); Cytoplasm (0.1444); Cell division (0.0855),
MGKDPNKPRGKTSSYAFFVQTCREEHKKKNPGTSVNFSEFSKKCSERWRTMSSKEKGKFEEMAKTDKVRYDREMKNYVPPKGAKGGKKKKDPNAPKRPPSAFFVFCSDHRPKVKGDNPGISIGDIAKKLGEMWSKLSPKEKSPYEQKAMKLKEKYEKDVAAYRAKGGKPDGAKKGGPGRPAGKKAEADDDDDEDEDEEDEEEEDEEDEDDDDE,,inflammatory response to antigenic stimulus (GO:0002437) (0.4704); regulation of transcription by RNA polymerase II (GO:0006357) (0.2974); DNA topological change (GO:0006265) (0.2613); innate immune response (GO:0045087) (0.2355); defense response to Gram-negative bacterium (GO:0050829) (0.2342); DNA recombination (GO:0006310) (0.1958); positive regulation of gene expression (GO:0010628) (0.1613); defense response to Gram-positive bacterium (GO:0050830) (0.1342); DNA metabolic process (GO:0006259) (0.1190); DNA geometric change (GO:0032392) (0.1188),nucleus (GO:0005634) (0.2882); chromosome (GO:0005694) (0.2319); cytoplasm (GO:0005737) (0.0543),"DNA binding, bending (GO:0008301) (0.2619); four-way junction DNA binding (GO:0000400) (0.2273); cis-regulatory region sequence-specific DNA binding (GO:0000987) (0.1287); DNA binding (GO:0003677) (0.1102)","High Mobility Group Box (HMGB) (IPR050342) (0.4080); High mobility group box domain superfamily (IPR036910) (0.1898); High mobility group box domain (IPR009071) (0.1780); HMG box A DNA-binding domain, conserved site (IPR017967) (0.1601)",1.10.30.10 (0.1592),Oxidation (0.7025); DNA recombination (0.5674); Transcription regulation (0.4958); Nucleus (0.3929); Secreted (0.3713); Inflammatory response (0.2950); Disulfide bond (0.2682); Cytoplasm (0.2257); Reference proteome (0.2010); Transcription (0.1574); Immunity (0.1279); Innate immunity (0.1165); DNA-binding (0.1042); Chromosome (0.0666),
MAAAAGSGVKVPRNFRLLEELEEGQKGVGDGTVSWGLEDDEDMTLTRWRGMIIGPPRTIYENRMYSLRVECGPRYPETPPFVRFVTKINLNGVHNSNGVVDMRAVSSLAKWQNSYSIRVVLQELRRLMMCKENMKLPQPPEGQIYSN,,protein polyubiquitination (GO:0000209) (0.5317); postreplication repair (GO:0006301) (0.5045); positive regulation of protein K63-linked ubiquitination (GO:1902523) (0.3075); positive regulation of canonical NF-kappaB signal transduction (GO:0043123) (0.2664); positive regulation of double-strand break repair (GO:2000781) (0.2292); positive regulation of DNA repair (GO:0045739) (0.1641); protein ubiquitination (GO:0016567) (0.1073); protein autoubiquitination (GO:0051865) (0.1069); negative regulation of neuron apoptotic process (GO:0043524) (0.0988); protein monoubiquitination (GO:0006513) (0.0952); DNA damage response (GO:0006974) (0.0884); DNA double-strand break processing (GO:0000729) (0.0625); double-strand break repair via homologous recombination (GO:0000724) (0.0532),UBC13-MMS2 complex (GO:0031372) (0.2785); nucleus (GO:0005634) (0.1918); protein-containing complex (GO:0032991) (0.1739); ubiquitin ligase complex (GO:0000151) (0.1485); cytosol (GO:0005829) (0.1074),,Ubiquitin-conjugating enzyme/RWD-like (IPR016135) (0.0829),3.10.110.10 (0.4730),Ubl conjugation pathway (0.9861); Reference proteome (0.7485); Acetylation (0.3492); Nucleus (0.2484); Proteomics identification (0.1963); Ubl conjugation (0.1303); Alternative splicing (0.0534),
MFFSAETWTLLAFLVALLVIYGSWPHRYFKKLGIPGPKTIPFFGTMLRYKDGFHVFDMDCFEKYGRIWGIYDGRQPVLCIMDQTIIKTVLIKECYSLFTNRRNFRLNGALYDAVSIAEDDDWRRIRSVLSPSFTSGRLKEMFGIMKKHSHILVDSMGKTAKRGESADIKEFFGAYSMDVVTSTAFSVDIDSLNNPKDPFVTNIKKMLKFDLLNPLFLLIAFFPFMAPVLEKMDFALFPTSVTDFFYAALQKIKSDRDTKTVAKDNTKKRVDFLQLMVDSQTGVKHKSDGEHTEKGLSDHEILSQSMIFIFAGYETSSSTLSFLFYNLATNPETMKKLQEEIDETFPNQAPVDYETLMSMDYLDAALSESLRLYPVAARLERVCKKTVEINGLLIPKDLVVMVPTYALHRDPDYWSEPESFKPERFTKGNKESIDPYMYMPFGLGPRNCIGMRFAQVTMKLAIVEILQRFDVSVCDETQVPLELGFNGLLSPKDPIKLKLQPRKLSQSPDVCNNNQKS,1.14.14.- (0.5193); unspecific monooxygenase (1.14.14.1) (0.2788),lipid hydroxylation (GO:0002933) (0.5244); estrogen metabolic process (GO:0008210) (0.3414); retinoic acid metabolic process (GO:0042573) (0.2204); oxidative demethylation (GO:0070989) (0.1882); steroid metabolic process (GO:0008202) (0.1880); xenobiotic catabolic process (GO:0042178) (0.1390); alkaloid catabolic process (GO:0009822) (0.0729); xenobiotic metabolic process (GO:0006805) (0.0643),endoplasmic reticulum membrane (GO:0005789) (0.2356),"heme binding (GO:0020037) (0.2914); testosterone 6-beta-hydroxylase activity (GO:0050649) (0.2871); estrogen 16-alpha-hydroxylase activity (GO:0101020) (0.2758); oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen (GO:0016712) (0.2154); iron ion binding (GO:0005506) (0.2099)","Cytochrome P450 3A (IPR050705) (0.7399); Cytochrome P450, E-class, group II (IPR002402) (0.2278); Cytochrome P450, E-class, CYP3A (IPR008072) (0.1571); Cytochrome P450 superfamily (IPR036396) (0.0699); Cytochrome P450, conserved site (IPR017972) (0.0526)",1.10.630.10 (0.0953),Monooxygenase (0.5718); Endoplasmic reticulum (0.3638); Heme (0.3443); Membrane (0.2758); Microsome (0.2401); Iron (0.2339); Metal-binding (0.1889); Oxidoreductase (0.1586); Transmembrane helix (0.1570); Transmembrane (0.1005),heme (0.3018)
MASYSPTPAEEASPEVSNGNLKASSSQESMKLKKEISLLNGVCLIVGNMIGSGIFVSPKGVLMYSGSYGLSLVVWTIGGIFSVFGALCYAELGTTITKSGASYAYILEAFGGFLAFIRLWTSLLIIEPTSQAVIAITFSNYMVQPIFPTCIAPYVANRLLAAACICLLTFVNCAYVKYGTRVQDFFTYVKVVALIAVIITGLVKIFQGYTQNFEGLFSDSSHDPGDVALALYSALFSYSGWDTLNFVTEEIKNPERNLPLAIAISMPIVTVIYILTNLAYYTILPIPAILDSDAVAVTFADQVFGYLNWTIPVAVAFSCFGGLNASIVAASRLFFVGSREGHLPDYLCMIHITRFTPIPALLFNGAMALVYLCVEDVFKLINYYSFSYWFFVGLSILGQLYLRWKQPDRPRPLKLSLFFPIIFCLCTVFLVVVPLYSDTINSLIGIGIALSGVPVYFLCCHLPATRRPMWLRKFIASSGVLIQKVCFCVLTEMDKEEEKTE,,amino acid transmembrane transport (GO:0003333) (0.5284); L-leucine transport (GO:0015820) (0.4461); neutral amino acid transport (GO:0015804) (0.3327); L-leucine import across plasma membrane (GO:1903801) (0.2638); xenobiotic transport (GO:0042908) (0.2425); nitric oxide biosynthetic process (GO:0006809) (0.1504); glycine betaine transport (GO:0031460) (0.1452); regulation of arginine metabolic process (GO:0000821) (0.1380); L-arginine transmembrane transport (GO:1903826) (0.0946); valine transport (GO:0015829) (0.0922); proline transport (GO:0015824) (0.0762); L-histidine transport (GO:1902024) (0.0732); phenylalanine transport (GO:0015823) (0.0596),plasma membrane (GO:0005886) (0.1130); basolateral plasma membrane (GO:0016323) (0.0761); membrane (GO:0016020) (0.0709),arginine binding (GO:0034618) (0.2978); protein heterodimerization activity (GO:0046982) (0.0713); neutral L-amino acid transmembrane transporter activity (GO:0015175) (0.0625); L-lysine:L-arginine antiporter activity (GO:0106439) (0.0527),Cellular Amino Acid Transporter (IPR050598) (0.2266),,Transport (0.7613); Transmembrane (0.5214); Membrane (0.4938); Transmembrane helix (0.4077); Reference proteome (0.4020); Disulfide bond (0.2801); Amino-acid transport (0.2763); Ubl conjugation (0.1997); Phosphoprotein (0.1193),
MMTGERKPASCFLDEKTFRLCCRLFLQHSESIQDGWIWEQIKGSDEGFMKKTVLIPVKSSLLDKQHESIQAENTELPTDDFEADAEDETAGVDAVCESHAVLRYEYHVLYSCSYQIPVLYFRASALDGRSLSLEEVWSNVHPNYRQRLKQEPWDTLTQQEHPLLGQPFFMLHPCRTEEFMKPALELAHAQNRKVNYIVSWLSVVGPVVGLDVPLSFSTAVSAPD,2.3.2.- (0.2874),autophagosome assembly (GO:0000045) (0.6831); autophagy (GO:0006914) (0.3748); macroautophagy (GO:0016236) (0.3510); nucleophagy (GO:0044804) (0.3131); protein lipidation (GO:0006497) (0.2270); autophagy of mitochondrion (GO:0000422) (0.1431); protein modification by small protein conjugation (GO:0032446) (0.1020); positive regulation of protein modification process (GO:0031401) (0.1006),cytoplasm (GO:0005737) (0.1948); phagophore assembly site (GO:0000407) (0.1748); cytosol (GO:0005829) (0.0954); nucleus (GO:0005634) (0.0691),ubiquitin-like protein transferase activity (GO:0019787) (0.3915); Atg12 transferase activity (GO:0019777) (0.3411),Ubiquitin-like-conjugating enzyme Atg3/Atg10 (IPR007135) (0.5251),3.30.1460.50 (0.4068),Ubl conjugation pathway (0.9812); Transport (0.7563); Transferase (0.5810); Reference proteome (0.5010); Cytoplasm (0.3152); Autophagy (0.3149); Membrane (0.3011); Transmembrane helix (0.1207); Ubl conjugation (0.1162); Protein transport (0.1099); Transmembrane (0.0696),
MSLIENNTEQCGNSLTRELTQNPLKKIWVPSSRNGLPDRHISQKKVCMTNCPTLIVTVGLPARGKTYISKKLTRYLNWIDVPTKEFNVGQYRRECVKIYKSFEFFRPDNEEGLKIRKQCALAALNDVRQFLTDEGGQVAVFDATNTTRERRDTIIRFAEQNGFKVFFVESVCEDPDVIAENIVQVKLGSPDYTHCNTEEAVADFMKRIKCYENSYQPLDEELDRDLSFIKIIDVGRRYLVNRVQDHIQSRIVYYLMNIHITPRSIYLCRHGESDLNIKGRIGGDSGLSARGKKYAETLGQFIQSQNIHELKVWTSQMKRTIQTAEAVGVPYEQWKALNEIDAGVCEELMYEEIQQRYPLEFALRDQDKYRYRYPKGESYEDLVQRLEPVIMELERQENVLVICHQAVMRCLLAYFLDKTAEELPYLKCPLHTVLKLTPVAYGCKVESIDLKVEAVNTHRDRPTNVDVSRLAEEALLTVPDHH,"6-phosphofructo-2-kinase (2.7.1.105) (0.9747); fructose-2,6-bisphosphate 2-phosphatase (3.1.3.46) (0.7814)","fructose metabolic process (GO:0006000) (0.8713); glycolytic process (GO:0006096) (0.5348); fructose 2,6-bisphosphate metabolic process (GO:0006003) (0.3707); apoptotic process (GO:0006915) (0.0692); response to glucagon (GO:0033762) (0.0441); glucose catabolic process (GO:0006007) (0.0430)","cytosol (GO:0005829) (0.1482); 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex (GO:0043540) (0.0773); nucleoplasm (GO:0005654) (0.0674)","fructose-2,6-bisphosphate 2-phosphatase activity (GO:0004331) (0.4752); ATP binding (GO:0005524) (0.2886)","Histidine phosphatase superfamily, clade-1 (IPR013078) (0.3407); P-loop containing nucleoside triphosphate hydrolase (IPR027417) (0.2609); 6-phosphofructo-2-kinase (IPR013079) (0.2490); Fructose-2,6-bisphosphatase (IPR003094) (0.2431); Histidine phosphatase superfamily (IPR029033) (0.1987); Phosphoglycerate/bisphosphoglycerate mutase, active site (IPR001345) (0.1755)",3.40.50.300 (0.1825); 3.40.50.1240 (0.1337),Reference proteome (0.6484); Multifunctional enzyme (0.4987); Phosphoprotein (0.4420); Nucleotide-binding (0.3702); ATP-binding (0.2987); Kinase (0.2773); Acetylation (0.2706); Ubl conjugation (0.2488),
MKRVNSFQRFMNTRAAANCRYQPTCYEHAANCYTHALLIMPAFVGMALLHRLSDDRWERFTAWVYGMGLIALFLVSTVFHIISWKKSHMRTMEHCFHMCDRVVIYFFIAASYTPWLNLRELGPLAAHMRWFVWLMAAAGTIYVFNYHEKYKLVELMFYLTMGFFPALVVTSMTNTEGLSELAFGGLVYCLGVFFFKCDGVIPFAHAIWHVFVALAAAIHYYAIWKYLYRSPALEDIRDA,,positive regulation of protein kinase activity (GO:0045860) (0.3029); positive regulation of MAPK cascade (GO:0043410) (0.2417); regulation of protein localization (GO:0032880) (0.1874); negative regulation of epithelial cell migration (GO:0010633) (0.1661); establishment of planar polarity (GO:0001736) (0.1252); positive regulation of Ras protein signal transduction (GO:0046579) (0.1171); neural crest cell migration (GO:0001755) (0.0978); regulation of gene expression (GO:0010468) (0.0674); neuron differentiation (GO:0030182) (0.0637); positive regulation of gene expression (GO:0010628) (0.0569); protein phosphorylation (GO:0006468) (0.0484),nucleus (GO:0005634) (0.1089); cytoplasmic side of apical plasma membrane (GO:0098592) (0.0684); perinuclear region of cytoplasm (GO:0048471) (0.0581),protein kinase activity (GO:0004672) (0.3485); pore-forming activity (GO:0140911) (0.0958); signaling receptor activity (GO:0038023) (0.0532),Hly-III (IPR005744) (0.5056); AdipoR/Haemolysin-III-related (IPR004254) (0.2639),,Membrane (0.5648); Reference proteome (0.4807); Transmembrane (0.3641); Zinc (0.1598); Receptor (0.1579),
MNLDRLRKRVRHYIDQQQYQSALFWADKIASLSHEDPQDIYWLAQCLYLTAQYHRASHALRSRKLDKLYGACQYLAARCHYAAKEYQQALDILDMEEAASKKLLDKNLKEENGSREIVKDWEMSPASINSSICLLRGKIYDAMDNRPLATSSYKEALKLDVYCFEAFDLLTSHHMLTAQEEKDFLDSLPLSQQCTEEEVELLHFLFENKLKKYNKPSEMVVPDIVNGLQDNLDVVVSLAERHYYNCDFKMCYSLTSMVMVKDPFHANCLPVHIGTLVELSKANELFYLSHKLVDLYPSNPVSWFAVGCYYLMVGHKNEHARRYLSKATTLERTYGPAWIAYGHSFAVESEHDQAMAAYFTAAQLMKGCHLPMLYIGLEYGLTNNPKLAEHFFSQALSIAPEDPFVIHEVAVVAFQNGDYKTSEKLFLDAMEKIKAIGNEVTVDKWEPLLNNLGHVCRKLKKYEQALEYHRQALVLIPQNASTYSAIGYVHSLKGDFESAIDYFHTALGLKRDDTFSVTMLGHCIEMYISDSDAYIGTDIKDKVRKTLNTPALMKMLNTSADGNESRAQPVEEVNVCIETPSFNADKQTDAFQRFLLECDMHESDMMLETSMSDTST,,mitotic cell cycle (GO:0000278) (0.6700); regulation of mitotic metaphase/anaphase transition (GO:0030071) (0.5034); cell division (GO:0051301) (0.4272); regulation of mitotic cell cycle (GO:0007346) (0.2615); anaphase-promoting complex-dependent catabolic process (GO:0031145) (0.2577); positive regulation of mitotic metaphase/anaphase transition (GO:0045842) (0.2228); protein ubiquitination (GO:0016567) (0.2091); protein K48-linked ubiquitination (GO:0070936) (0.2089); protein branched polyubiquitination (GO:0141198) (0.1983),anaphase-promoting complex (GO:0005680) (0.5865); cytoplasm (GO:0005737) (0.1666); centrosome (GO:0005813) (0.1221),,Tetratricopeptide repeat (IPR019734) (0.1895),1.25.40.10 (0.6868),TPR repeat (0.8527); Reference proteome (0.7867); Ubl conjugation pathway (0.7216); Mitosis (0.6625); Phosphoprotein (0.5402); Repeat (0.4681); Cell division (0.2439); Ubl conjugation (0.2351); Cell cycle (0.2278); Proteomics identification (0.1369); Nucleus (0.1227); Cytoplasm (0.0970); Acetylation (0.0959); Spermatogenesis (0.0714); 3D-structure (0.0684),
MTTLTKRNRRSEPPAERWSNAEEEEEKKREEEEEEEDTDCKTLRLTLMEEILLLGLKDKEGYTSFWNDSISSGLRSCMLVELGLRGRIQLEPQGTRRRKLLERKVLLKSAAPTGDVLLDEALKHIKNTEPAENMASWIELLTGETWNPMKMHFQMRNVRERLAKSLVEKGVLTTEKQNFLLFDMTTHPLTDRTEKERLLQRVQDSLLDRWTNDSRRISHRMLALLLLAHVSDVLENALSSLPDECYELASTRSRTLLEADPDQESSRVSSPAEEIVWAILAAFNKS,,"Golgi to plasma membrane protein transport (GO:0043001) (0.3501); asymmetric Golgi ribbon formation (GO:0090164) (0.2922); Golgi organization (GO:0007030) (0.2534); glycoprotein biosynthetic process (GO:0009101) (0.2506); endoplasmic reticulum unfolded protein response (GO:0030968) (0.2152); Golgi vesicle budding (GO:0048194) (0.1972); retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890) (0.1934); regulation of mitochondrion organization (GO:0010821) (0.1667); protein N-linked glycosylation (GO:0006487) (0.1492); protein secretion (GO:0009306) (0.1408); cellular response to rapamycin (GO:0072752) (0.1396); protein targeting to Golgi apparatus (GO:0140450) (0.1269); lamellipodium assembly (GO:0030032) (0.1255); positive regulation of protein secretion (GO:0050714) (0.1102); protein glycosylation (GO:0006486) (0.1060); positive regulation of TOR signaling (GO:0032008) (0.1019); protein retention in Golgi apparatus (GO:0045053) (0.0848); leukocyte tethering or rolling (GO:0050901) (0.0762)",Golgi cisterna (GO:0031985) (0.2546); Golgi membrane (GO:0000139) (0.2324); Golgi cisterna membrane (GO:0032580) (0.2266); Golgi apparatus (GO:0005794) (0.1681); trans-Golgi network (GO:0005802) (0.1615),cargo adaptor activity (GO:0140312) (0.2868),Golgi phosphoprotein 3-like domain superfamily (IPR038261) (0.2862); Golgi phosphoprotein 3-like (IPR008628) (0.2707),1.10.3630.10 (0.3798),Reference proteome (0.7497); Membrane (0.5178); Golgi apparatus (0.3191); Lipid-binding (0.1574); Transport (0.1255),
MMLDHADVSLSPEERVRALTKKGGAVEMNESVPLRRYFRSGMEMIRMAHVYAEEGNTEHAFVLYNKYITLFIEKLPKHPEYKLSNIPEKKEILRKLKDTAFPQAEQLKKLLLRRYEREHADYISKKRVEAEAVERELSRQRELDAERRRVAELQRRQQEQEQFSIFEEMIQQQERHRHPHTHHTPAAPQTDTPLIPGIQGPPVPFPESPTPPQSPQQPSANHSTPSAPAPPTFDRSLKPSHLTTLIDGLRQIAVPAELCGKFLRLANNNTIRAVETCGILCGTLNRNAFTVTHVVVPKQCGGPDYCDTENEEELFLVQDQYNLITLGWIHTHPTQTAFLSSVDLHTHCSYQMMLPESIAIVCSPKFNQTGYFRLTDYGMEEISTCAQKGFHPHPKDPPLFTGGSHIIITEDTVSMLDLR,3.4.19.- (0.7598),proteolysis (GO:0006508) (0.7318); positive regulation of TORC1 signaling (GO:1904263) (0.5400); negative regulation of Ras protein signal transduction (GO:0046580) (0.3827); negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction (GO:0051898) (0.2804); Wnt signaling pathway (GO:0016055) (0.2507); protein K63-linked deubiquitination (GO:0070536) (0.1616); hippocampal neuron apoptotic process (GO:0110088) (0.1526); negative regulation of hippocampal neuron apoptotic process (GO:0110091) (0.1061); mitotic cytokinesis (GO:0000281) (0.1016),endosome (GO:0005768) (0.2944); cleavage furrow (GO:0032154) (0.2376); cytosol (GO:0005829) (0.0779),K63-linked deubiquitinase activity (GO:0061578) (0.4431); metal-dependent deubiquitinase activity (GO:0140492) (0.2640); protein domain specific binding (GO:0019904) (0.1807); metal ion binding (GO:0046872) (0.1389),"USP8 dimerisation domain (IPR015063) (0.3130); MPN domain (IPR037518) (0.1809); STAMBP/STALP-like, MPN domain (IPR044098) (0.1257)",3.40.140.10 (0.2165); 1.20.58.80 (0.1969),Ubl conjugation pathway (0.7633); Protease (0.6727); Metalloprotease (0.4241); Membrane (0.3329); Zinc (0.2700); Hydrolase (0.2368); Reference proteome (0.2350); Proteomics identification (0.2286); Coiled coil (0.1672); Metal-binding (0.1667); Phosphoprotein (0.1083); Acetylation (0.0981),Zn(2+) (0.1551)
MLILGNRLKLCSVAFTAARLYSTGVQANNNPVVFFDIAADNQPLGRVTFELNADVVPKTAENFRALCTGEHGFGYKGSIFHRVIPQFMCQGGDFTNHNGTGGKSIYGPRFPDENFKLKHTGPGILSMANAGVNTNGSQFFICTAKTEWLDGRHVVFGSVKEGMDVVRKVEALGSRSGRTAQRISITDCGELK,peptidylprolyl isomerase (5.2.1.8) (0.9846),"protein peptidyl-prolyl isomerization (GO:0000413) (0.9890); protein folding (GO:0006457) (0.8257); cellular response to hydrogen peroxide (GO:0070301) (0.4890); negative regulation of ATP-dependent activity (GO:0032780) (0.4175); apoptotic mitochondrial changes (GO:0008637) (0.2290); regulation of mitochondrial membrane permeability involved in programmed necrotic cell death (GO:1902445) (0.2115); skeletal muscle fiber differentiation (GO:0098528) (0.1790); negative regulation of oxidative phosphorylation (GO:0090324) (0.1634); apoptotic process (GO:0006915) (0.1570); regulation of proton-transporting ATPase activity, rotational mechanism (GO:0010849) (0.1241); response to oxidative stress (GO:0006979) (0.1149); negative regulation of release of cytochrome c from mitochondria (GO:0090201) (0.1052); mitochondrial depolarization (GO:0051882) (0.0829); negative regulation of stress-activated MAPK cascade (GO:0032873) (0.0819); response to ischemia (GO:0002931) (0.0662)",mitochondrion (GO:0005739) (0.2544); cytoplasm (GO:0005737) (0.1480); protein-containing complex (GO:0032991) (0.1247); mitochondrial permeability transition pore complex (GO:0005757) (0.1108); extracellular exosome (GO:0070062) (0.0598),peptidyl-prolyl cis-trans isomerase activity (GO:0003755) (0.2083),"Cyclophilin-type peptidyl-prolyl cis-trans isomerase domain (IPR002130) (0.4096); Cyclophilin-type peptidyl-prolyl cis-trans isomerase, conserved site (IPR020892) (0.1877); Cyclophilin-like domain superfamily (IPR029000) (0.1621)",2.40.100.10 (0.1799),Rotamase (0.9238); Isomerase (0.2559); Reference proteome (0.0442),
MLTITLKTLQQQTFKVQIDEELTVKALKEKIEEEKGKDGFPAVGQKLIYAGKILNDDIPLKEYKIDEKNFVVVMVTKPKSAASPQTPTPVPVSETPTHQPTTPVAPPNASIVPETTPDPAPVEPAASVEPIDPPVTAPPAASEDTVETTEPVSATPAPVVEEEIQGQEEQAIAQSEASLTDELSLLEAAASILVTGQAYENLVTEIMSMGYEREQVIAALRASFNNPDRAVEYLLTGIPAESEQPPQEVVRPTPSSNPTPPAPQRAQPPPAAAGAESGGAQASANPLEFLRHQPQFQQMRQIIQQNPSLLPALLQQLGRDNPQLLQQITQHQERFVQMLNEPEAEAPAAPQTNYIQVTPQEKEAIERLKALGFPEGLVIQAYFACEKNENLAANFLLQQNFDDE,,nucleotide-excision repair (GO:0006289) (0.9560); proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161) (0.5105); spermatogenesis (GO:0007283) (0.2792); protein destabilization (GO:0031648) (0.1944); ERAD pathway (GO:0036503) (0.0923),nucleoplasm (GO:0005654) (0.4847); XPC complex (GO:0071942) (0.2639); proteasome complex (GO:0000502) (0.2405); cytosol (GO:0005829) (0.1613); nucleotide-excision repair factor 2 complex (GO:0000111) (0.1109); nucleus (GO:0005634) (0.1054),damaged DNA binding (GO:0003684) (0.5279); proteasome binding (GO:0070628) (0.2279); ubiquitin binding (GO:0043130) (0.2006); peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity (GO:0000224) (0.1809); polyubiquitin modification-dependent protein binding (GO:0031593) (0.1417),Ubiquitin-like domain (IPR000626) (0.3964); UV excision repair protein Rad23 (IPR004806) (0.3090); XPC-binding domain (IPR015360) (0.2857); Ubiquitin-associated domain (IPR015940) (0.2423); Ubiquitin-like domain superfamily (IPR029071) (0.2307); XPC-binding domain superfamily (IPR036353) (0.2254); UBA-like superfamily (IPR009060) (0.1401),1.10.10.540 (0.5311),Repeat (0.6618); Reference proteome (0.4608); Proteasome (0.3913); DNA repair (0.3531); Cytoplasm (0.3427); DNA damage (0.3180); Nucleus (0.2394),
MKFICLLLLTACGIKDSRSEQYDVIGAAVAVFASVGDDVILPCSVKPNISVVDMIVEWRRSDLKDSLVHLYEDHEDRETEQNESYRGRTQLIHPELQRGNASLRLSSVKVSDEGRYKCIIGSESSKHEATVDLTVEALGWAPVITIDGFNPSGGLHLQCESEGWYPEPHLEWLDHEGVSLRPETTETHQKAGMFSIKHTIIVYHSDDKIHCRVKLKHHMLEAQIITSREVFKIWRTTAVLISVIVVFSGFAAMMFAVLLHKYRENSQLKIENKRLKQELDQLLQSQKTPEVTLDAGDSGKTCHTGPEDKEILVDNADP,,"positive regulation of T cell proliferation (GO:0042102) (0.8320); negative regulation of T cell proliferation (GO:0042130) (0.6719); immune response (GO:0006955) (0.6187); negative regulation of CD8-positive, alpha-beta T cell activation (GO:2001186) (0.3156); T cell costimulation (GO:0031295) (0.3038); cell surface receptor signaling pathway (GO:0007166) (0.2868); regulation of cytokine production (GO:0001817) (0.1510); T cell receptor signaling pathway (GO:0050852) (0.1151)",external side of plasma membrane (GO:0009897) (0.0978),signaling receptor binding (GO:0005102) (0.2476),"Immunoglobulin superfamily BTN/MOG domain-containing protein (IPR050504) (0.4038); Immunoglobulin-like domain superfamily (IPR036179) (0.3825); Immunoglobulin subtype (IPR003599) (0.3060); Butyrophilin subfamily 3 member A2-like, Ig-C domain (IPR053896) (0.2946); Immunoglobulin-like fold (IPR013783) (0.2451); Immunoglobulin-like domain (IPR007110) (0.2031); Immunoglobulin V-set domain (IPR013106) (0.1966)",2.60.40.10 (0.2916),Membrane (0.4113); Immunoglobulin domain (0.2452); Reference proteome (0.1712); Coiled coil (0.1491),
MAECVNDSDEDSRIAYGDYVVLKRGEVFKSVQVENKKKVIFEKQWFFMDNAVGQLYGTMFEIVAGGSLKHKPVKRAGDSLDSKEAGQDNRHIVDDGRSQKLTRDDIETLKEQGLKGQEIVQQLIDNSTTFKDKTEFAQEKYIKKKKKKYESDITVLKPSTRLLAMMYHGREPGKICHLRYDTLAQMLTLGNIHAGSKIIVFETCAGLVLGSVMERMGGFGSVIQMFPGGGPTRAGMESFGFPSHFHQTLHEFPLCKVNAVLAGKLDLSEKDTENSRSEETAAEKNSEAQSMEISLDPQEQMRIAERDRLRELRAQEKKVKMEEKRKKLASAAALLQDRNADGLVIASRFHPCPVLMGLLKFVAPSRPFVVYCQYREPLIECYNKLREQGGVINLRLTDSWLRHYQVLPNRTHPVLLMSGGGGYLLSGTTVDAGTAKTKNPHKSEEPDAKRLKLEEKASSCDSSV,2.1.1.- (0.7859),mRNA processing (GO:0006397) (0.4365); tRNA methylation (GO:0030488) (0.3879); tRNA modification (GO:0006400) (0.1634); tRNA processing (GO:0008033) (0.0624),nucleus (GO:0005634) (0.6132); nucleoplasm (GO:0005654) (0.2906); extracellular exosome (GO:0070062) (0.2149); cytosol (GO:0005829) (0.1218); cytoplasm (GO:0005737) (0.1140); tRNA (m1A) methyltransferase complex (GO:0031515) (0.0795),RNA binding (GO:0003723) (0.3283); protein heterodimerization activity (GO:0046982) (0.1890),tRNA (adenine(58)-N(1))-methyltransferase non-catalytic subunit TRM6 (IPR017423) (0.2454); S-adenosyl-L-methionine-dependent methyltransferase superfamily (IPR029063) (0.1333),3.40.50.150 (0.0972),tRNA processing (0.9997); Nucleus (0.6686); 3D-structure (0.5182); Reference proteome (0.4098); Phosphoprotein (0.3737); RNA-binding (0.3173); Ubl conjugation (0.2761); Coiled coil (0.2329); Acetylation (0.1558); Cytoplasm (0.0991); Direct protein sequencing (0.0875); Methyltransferase (0.0697); Isopeptide bond (0.0619),
MHHSARLCLFSLLCVLSGTYGGKVLVFPLDGSHWVNMKVLIEELHRKGHNVTVVRPSNSWYIKEESPFYSSITIPNTGGFDEEFSGLLINRLLEIKRGGYFVLNRVRLEFEIMMKFKTMHEDMLQMMDRMLEDEKVMNSIQDAKFDVVLADPAVGGGPILAYKFNIPLVFNVRWTIQGEGHFAIAPSPLSYIPVPGVELTDKMSFLQRVKNVLIYLISQIQMQIMVEPIYAPFCHKHFGPNVTYFSLFQDADIWLMRNDFTFEFPRPTMPNIVYMSGFQCKPAKPLPNDLEKFVESSGEHGVIVMSLGTLIAQLPQDMTDDIAAAFAELPQKVIWRYTGPRPVTLGNNTLLVEWLPQNDLLGHPQIKVFVAHGGTNGIQEAIYHGVPILGLPLVFDQPDNLFRMEAKGTAKIVDIATLDKTVFLEALKEVLYNPSYRENMQRLSKLHHDQPLKPLDRAMFWIEFVMRNKGAPHLRTQSFRMSWIEYHSIDVILTLMVTGFVFALMIGYTIKYFCLCVFRKKVKRE,glucuronosyltransferase (2.4.1.17) (0.8372),liver development (GO:0001889) (0.3303); cellular response to glucocorticoid stimulus (GO:0071385) (0.3148); estrogen metabolic process (GO:0008210) (0.2789); steroid metabolic process (GO:0008202) (0.1836); response to immobilization stress (GO:0035902) (0.1390); xenobiotic metabolic process (GO:0006805) (0.1160); response to peptide hormone (GO:0043434) (0.0668); response to ethanol (GO:0045471) (0.0560); cellular response to ethanol (GO:0071361) (0.0538); bile acid metabolic process (GO:0008206) (0.0495); response to xenobiotic stimulus (GO:0009410) (0.0449); cellular glucuronidation (GO:0052695) (0.0423),endoplasmic reticulum membrane (GO:0005789) (0.1698),glucuronosyltransferase activity (GO:0015020) (0.5375); enzyme inhibitor activity (GO:0004857) (0.0601),"UDP-glycosyltransferase family, conserved site (IPR035595) (0.3844); UDP-glycosyltransferase (IPR050271) (0.3503); UDP-glucuronosyl/UDP-glucosyltransferase (IPR002213) (0.1534)",3.40.50.2000 (0.3317),Transferase (0.7740); Transmembrane helix (0.7503); Reference proteome (0.5199); Membrane (0.3938); Glycosyltransferase (0.3257); Endoplasmic reticulum (0.2794); Glycoprotein (0.2717); Transmembrane (0.2539); Signal (0.1987); Alternative splicing (0.1166),
MTRLCICEMCSCGRHRCTHRPTTLYKKDPQTNVLSEYIEKYPPYKGHTRPKSLKPQLKYKAHQDTMDATTTFRTDYIPYPVTHRPEKQQLEYKPKSGEIDLGTTYKQDFNPYEVQPFTPLRPKERVHVVNAKLDTVPTYKEDFRQWEIIRRELTKPDTTYQPPATKFGNSTTFQDDFVHRGLVPRESYKPSNVAKLSDTPFEKNTSNKLSYVPHPLEARYVKPPEEYKPSSHPFHDVTTHRQDYQGLPSQSTKSCKPEPVKVASNKPFQSSTEFRDQYQHWPVSLPQMQKSVEYTSPTANMDLTTTSHSDYIKHQIQPFVSSKPFSLPAKSSRPFQGNTTMRDDFQPWVAQRQSIIRKQAELQRPSGKMEDLTTFRAHFVQHEAQPSFSFKPQNSPLHTDIPLQADTMYRTDFTPKKISMCPASFETPPGFVFENRDDQGHRFFRKMTSSDRIETPKEMVLTA,,spermatogenesis (GO:0007283) (0.3844); cell projection organization (GO:0030030) (0.2385); protein stabilization (GO:0050821) (0.2088); positive regulation of cilium assembly (GO:0045724) (0.1939); cellular response to cold (GO:0070417) (0.1570); cold acclimation (GO:0009631) (0.1301); Golgi organization (GO:0007030) (0.1211); microtubule cytoskeleton organization (GO:0000226) (0.0607),ciliary basal body (GO:0036064) (0.4830); nucleus (GO:0005634) (0.2668); centriole (GO:0005814) (0.2050); cytoplasm (GO:0005737) (0.1723); sperm flagellum (GO:0036126) (0.1547); axonemal microtubule (GO:0005879) (0.1509),microtubule binding (GO:0008017) (0.0752),,,Reference proteome (0.5699); Repeat (0.5584); Cilium biogenesis/degradation (0.5181); Cytoskeleton (0.4330); Proteomics identification (0.2427); Cell projection (0.2292); Cytoplasm (0.1954); Nucleus (0.1913); Phosphoprotein (0.1761); 3D-structure (0.1671); Alternative splicing (0.1579),
MGSDVRDLSALLPAVPTLPVGNSNSLPVGGASQWGPMLDFHPASPYGSLPSHSFVKQEPGWGPPDPYEDPHCGLGAFTVHFSGQLTGMHGPFADPPSSQSRMFSNGPYLPGCMESPPAPRNQGYGTVAVDGIPSYGHTPTQHSPPFPNDTFKHEDPMSPQSTMGEQQFSVPPPVYGCHSPPDQTLLLRNSLNSDNLYQMKSQLECVAWNPVSSLTPSIKSSSYETEASSGAPPLVYSCSTQYHIHTHGLFRGLQDVRRVPGIPSSGKSSSDSSEKRPFVCSYPGCSKRYFKLSHLQMHGRKHTGEKPYQCDYTGCGRRFSRSDQLKRHQRRHTGVKPFQCETCQRKFSRSDHLKTHTRTHTGKTSEKPFTCRWPSCQKKFARSDELVRHHSMHQRNMSKLQPTV,,negative regulation of transcription by RNA polymerase II (GO:0000122) (0.6047); regulation of transcription by RNA polymerase II (GO:0006357) (0.3017); negative regulation of apoptotic process (GO:0043066) (0.2697); podocyte differentiation (GO:0072112) (0.1848); negative regulation of cell population proliferation (GO:0008285) (0.1802); regulation of DNA-templated transcription (GO:0006355) (0.1473); pronephros development (GO:0048793) (0.1128); adrenal gland development (GO:0030325) (0.1121); pronephric glomerulus development (GO:0039021) (0.0860); anatomical structure morphogenesis (GO:0009653) (0.0829); glomerular basement membrane development (GO:0032836) (0.0794); cell migration involved in sprouting angiogenesis (GO:0002042) (0.0762); sex determination (GO:0007530) (0.0660),nuclear speck (GO:0016607) (0.2807); cytoplasm (GO:0005737) (0.1407),RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978) (0.0942); double-stranded methylated DNA binding (GO:0010385) (0.0678),"Zinc finger C2H2-type (IPR013087) (0.3344); Zinc finger C2H2 superfamily (IPR036236) (0.3122); Wilm's tumour protein, N-terminal (IPR000976) (0.1677)",3.30.160.60 (0.1582),Zinc-finger (0.8930); Repeat (0.7296); Transcription regulation (0.4965); Metal-binding (0.4572); Transcription (0.3834); RNA-binding (0.3220); Ubl conjugation (0.3051); Zinc (0.1743); DNA-binding (0.1671); Nucleus (0.0882),
MQKVVAVLGGGIGGLSACHHLSKSPNVSKIVLLEGSGRCGGWLSSVRRDDGAVFEQGPRGVRPGGAVGRNTLNMVSELGLESELLPITSDHLASQNRFLYVKGQLHKMPSGLGGVLRTIPPFSRPIIQSVLKELVISKGTEEDESVHAFVSRRLGSELADIAIDCLCRGVFAGDSRQLSVRSCFPPLYEAEQARGSIVLGMLMGSGAGPKVVPSGLAKRASKESWTQWSLKRGMQTLPEALEDSLRRRNGVELHHHAKVKRLNVDSTGWEIKLDDGTSLKADHVISTLPASALASVLPPAAQTLSEQLRSIASVNVALVNLEYEGFILPVTGFGHLVPSTEDAGVLGVVYDSVPFPEHNRSGGATTRLTVMMGGAWFEQTFGSPDLVMEQTLLDRAVQAVNSHLSVTSQPVWSCVALLKNCIPQYHLGHWKRLEKMRQYISNHNLALTLAGASYDGVSVNDVIFSGRTAAEGLVGKI,protoporphyrinogen oxidase (1.3.3.4) (0.9863),protoporphyrinogen IX biosynthetic process (GO:0006782) (0.7895); heme O biosynthetic process (GO:0048034) (0.6685); heme A biosynthetic process (GO:0006784) (0.3314); heme B biosynthetic process (GO:0006785) (0.2526); heme biosynthetic process (GO:0006783) (0.2241); porphyrin-containing compound biosynthetic process (GO:0006779) (0.1162),mitochondrial intermembrane space (GO:0005758) (0.1405); mitochondrial inner membrane (GO:0005743) (0.0945); mitochondrion (GO:0005739) (0.0830),oxygen-dependent protoporphyrinogen oxidase activity (GO:0004729) (0.4234),Protoporphyrinogen oxidase (IPR004572) (0.2522); Zeta Carotene Desaturase and Related Oxidoreductases (IPR050464) (0.2354); FAD/NAD(P)-binding domain superfamily (IPR036188) (0.1756),3.50.50.60 (0.2006),Porphyrin biosynthesis (0.8968); Flavoprotein (0.4080); Oxidoreductase (0.3812); Heme biosynthesis (0.3541); Reference proteome (0.2866); Membrane (0.1913); FAD (0.1771); Mitochondrion inner membrane (0.0831); Direct protein sequencing (0.0822),FAD (0.1771)
MSYRVANVPKATGKDGMWGVGFIKLGMGLFVSSAVIGPVGSVSVEAALTEGRLICVGVNNQSYYCDSGYCCDESQCCSYYYEVWWFWLVLTLIVILGCCCVCHHRRAKHRLQQQQRQHEINLIAYREAHNYSSLPFYFRFLPGYLLPAYEEVENRPPTPPPPYSASQPGHSTSSDPLCSEQPDELCPPLQSSPVTPSASENHSPEPCTEQPQTPTTHHPAKPQYLSLEEDGRLQQVACATSHSLLKQDSSGEDLSQPGDCSPDSKDKTPGRHRRFTGDSGIEVCVCNQGPGDGEEEEEMKELVGHMDARGLEEQDFCDSCNPRSSSPPRGPGDVEQGLADSDVPLEPQRPPVCLQLHTISEQDGPNHTSNTDPPS,,negative regulation of Wnt signaling pathway (GO:0030178) (0.5950); innate immune response (GO:0045087) (0.3215); protein catabolic process (GO:0030163) (0.1917); inflammatory response (GO:0006954) (0.0997); response to oxidative stress (GO:0006979) (0.0920); cell surface receptor signaling pathway (GO:0007166) (0.0810); negative regulation of cytokine production (GO:0001818) (0.0808); response to bacterium (GO:0009617) (0.0781); gene expression (GO:0010467) (0.0729); defense response (GO:0006952) (0.0641); positive regulation of protein ubiquitination (GO:0031398) (0.0581); tumor necrosis factor-mediated signaling pathway (GO:0033209) (0.0454),lysosome (GO:0005764) (0.2217); late endosome membrane (GO:0031902) (0.1780); lysosomal membrane (GO:0005765) (0.1347),ubiquitin-protein transferase activity (GO:0004842) (0.1227),WW domain-binding (IPR051994) (0.1444),,Transmembrane (0.8908); Reference proteome (0.5788); Membrane (0.4732); 3D-structure (0.4449); Transmembrane helix (0.2793); Lysosome (0.1757); Signal-anchor (0.1681); Alternative splicing (0.1412); Disease variant (0.1211); Endosome (0.0685),
MTYTNVPNGFTECLPCSVCDPNNGLREKQACTSTSDTLCGPLTHYYCVDQLFNCKKAIKHSTCSPGQYINQTEYEVEERCCPMCAPGTHVLWHCTQDKITTCVPCLESTFISELNGLMNCFPCTICDASRGLRVNKGCSQSSDTVCEPLERFYCIVKKKSSCTSALQHSKCRPGQYIKQAGTSSTDTVCADCTGDTYSNGSFSSCLPHTKCEAMRLTEKNPGTHSSDTECGKPYNSLTIIAPSVIVTLTIITCVSVFSVTCFCKRKRKRSVVGGKIKS,,response to type II interferon (GO:0034341) (0.7022); apoptotic process (GO:0006915) (0.6479); defense response to protozoan (GO:0042832) (0.5383); positive regulation of interleukin-12 production (GO:0032735) (0.5323); positive regulation of cytokine production involved in immune response (GO:0002720) (0.4540); TRIF-dependent toll-like receptor signaling pathway (GO:0035666) (0.4501); defense response to Gram-positive bacterium (GO:0050830) (0.4334); positive regulation of angiogenesis (GO:0045766) (0.3903); negative regulation of alpha-beta T cell proliferation (GO:0046642) (0.3819); positive regulation of T cell migration (GO:2000406) (0.3818); immune response (GO:0006955) (0.3729); positive regulation of blood vessel endothelial cell migration (GO:0043536) (0.2955); positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531) (0.2744); immune response-regulating cell surface receptor signaling pathway (GO:0002768) (0.2516); CD40 signaling pathway (GO:0023035) (0.2445); defense response to Gram-negative bacterium (GO:0050829) (0.2433); positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731) (0.1970); signal transduction (GO:0007165) (0.1655); negative regulation of apoptotic process (GO:0043066) (0.1573); positive regulation of B cell proliferation (GO:0030890) (0.1529); B cell activation (GO:0042113) (0.1451); adaptive immune response (GO:0002250) (0.1205); defense response to virus (GO:0051607) (0.1048); positive regulation of ERK1 and ERK2 cascade (GO:0070374) (0.1047); positive regulation of endothelial cell apoptotic process (GO:2000353) (0.0940); T cell migration (GO:0072678) (0.0564),external side of plasma membrane (GO:0009897) (0.5290); plasma membrane (GO:0005886) (0.0758),transmembrane signaling receptor activity (GO:0004888) (0.0735),TNFR/NGFR cysteine-rich region (IPR001368) (0.7288); Tumor Necrosis Factor Receptor Superfamily Member 5 (IPR052135) (0.1807); Fas receptor (IPR008063) (0.1807),2.10.50.10 (0.3400),Membrane (0.3839); Reference proteome (0.2317); Disulfide bond (0.1849); Receptor (0.1613); Transmembrane (0.1229),
MMELSASDSESEDHAQPLLRRKDTEDIQKAPACGSSRYGLAFLSCYGFFVAYALRVNLSVAMVDMLKNSSKANTSSSICPPHNIPVPKHNHTAMVYDWNSETQGWILGSFFYGYIITQIPGGYLARKYGAKWLLGLGILCTVIFTLLTPLAADLGAGYLIAVRVLEGIGEGVTYPAMHAMWASWAPPLERSRLLTISYTGAQLGTVVALPLSGQICFYLDWTYVFYIFGAVGLLWFFLWICFVSNSPSSHKRITEAEKTYIMSSLKNELSPTQDYIPWTSIFKSMPLWAIVVAHFSYNWTFYTLLTLLPTYMNDVLGFSIQQNGMLSALPYLGCWLLALLGGQLADLLRERFLFRTVIVRKAFTVVGMAGPAVFLVAAGYTGCNYILAVAFLTISSSLGGISASGFNINHLDIAPSYAGILLGITNSFATIPGMVGPVIARSLTKSNTIPEWQIVFYISAAINIFGAVFFTIFGKGTVQPWAVQTIHIQ,,monoatomic anion transport (GO:0006820) (0.7147); sodium ion transport (GO:0006814) (0.7007); neurotransmitter loading into synaptic vesicle (GO:0098700) (0.5446); sialic acid transport (GO:0015739) (0.2187); autophagy (GO:0006914) (0.0847); neurotransmitter transport (GO:0006836) (0.0483),plasma membrane (GO:0005886) (0.2984); lysosomal membrane (GO:0005765) (0.2385); cytoplasm (GO:0005737) (0.1917); mucin granule (GO:0098594) (0.1332); lysosome (GO:0005764) (0.1065); synaptic vesicle membrane (GO:0030672) (0.0682); membrane (GO:0016020) (0.0401),D-glucuronate transmembrane transporter activity (GO:0042880) (0.3054); sialic acid transmembrane transporter activity (GO:0015136) (0.1970); symporter activity (GO:0015293) (0.1695),Major Facilitator Superfamily Sodium/Anion Cotransporter (IPR050382) (0.4727); Major facilitator superfamily domain (IPR020846) (0.1887); Major facilitator superfamily (IPR011701) (0.1435); MFS transporter superfamily (IPR036259) (0.1279),1.20.1250.20 (0.2731),Transmembrane (0.9523); Reference proteome (0.7787); Transport (0.7771); Symport (0.5545); Membrane (0.3647); Transmembrane helix (0.3000); Sodium (0.2776); Lysosome (0.2449); Glycoprotein (0.1796); Alternative splicing (0.1482); Cytoplasmic vesicle (0.1435); Sodium transport (0.1059); Signal (0.0453); Ubl conjugation (0.0407),
MATPAALLPATPMAHAPPMSISAVVNSSTPATLSPSPSVTPAGPSLFRTELLSSASPGIPIGSLPHKPVYSTPSPVENTPQNNECKMVEVRGAKLASFTVNGNELICLPQAFDLFLKHLVGGLHTVYTKLKRLEITPVVCNVEQVRILRGLGAIQPGVNRCKLISRKDFEVLYNDCTNASSRPGRPPKRTQNVTSPDSPHVLPHSVSGLMSSGLMSHTGLTAATLAEAMKKKIKLEVMNSYHGNNNHSADSENGDITSSMGLELPFMMMPHPLIPVSLPPASVTMAMNQMNHLSTIASMAAAAQVQSVPSRMVTSVIKERVPDSPSPVPSLDDGRRSGSHLSSRQSSSVSSSPAHTESSSDRPHLHQNGLSLGHALLGLSPSAPPGPKEGDLATHDTVHETKRASTEKEENVLCTPTSRDSYERLSHSGPTLPPGFPAPLLFPEGLSSIETLLTNIQGLLKVAIDNARAQEKQVQLERTELKMELYRERELRETLERQLCVEQKNRALIQKRLKKEKKTKRKLQEALEVESKRRDHAEQTLQRTTSCERSPIHNDSQQELETIHNTSKTDTERTIQDGRLFLKSTMMY,,negative regulation of transcription by RNA polymerase II (GO:0000122) (0.6079); type B pancreatic cell proliferation (GO:0044342) (0.5918); regulation of transcription by RNA polymerase II (GO:0006357) (0.5193); regulation of DNA-templated transcription (GO:0006355) (0.4145); development of primary female sexual characteristics (GO:0046545) (0.3916); regulation of nuclear cell cycle DNA replication (GO:0033262) (0.3682); respiratory gaseous exchange by respiratory system (GO:0007585) (0.2904); suckling behavior (GO:0001967) (0.2021); negative regulation of transcription by competitive promoter binding (GO:0010944) (0.1831); negative regulation of cell migration (GO:0030336) (0.0964); negative regulation of DNA-templated transcription (GO:0045892) (0.0959); negative regulation of fibroblast proliferation (GO:0048147) (0.0761),transcription regulator complex (GO:0005667) (0.3331); cytoplasm (GO:0005737) (0.2055); cytosol (GO:0005829) (0.1952); nucleus (GO:0005634) (0.1926); Golgi apparatus (GO:0005794) (0.1461),"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227) (0.2120); RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978) (0.2106); sequence-specific double-stranded DNA binding (GO:1990837) (0.1185); DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981) (0.0986)","Ski-like, DNA-binding domain superfamily (IPR037000) (0.3196); Putative DNA-binding domain superfamily (IPR009061) (0.1717); Dachshund domain-containing protein (IPR052417) (0.1415); SKI/SNO/DAC domain (IPR003380) (0.1357)",3.10.260.20 (0.8315),Coiled coil (0.1993); Nucleus (0.1930); Reference proteome (0.1778),
MLTEIWRMEFCLCDLLQYSLILALVVLLLVVIAAHVTAKMVDQTRHEKEKQFLTADGKREDFPSLMEPPSIDLSVVVPSYNEELRLPVMMDEAMDYLEKRQKENPSFTYEVIVVDDGSKDKTTEVAMKYTKKYGAKKVRVLTLVKNRGKGGAVKMGTLSCRGRLILMADADGATKFADVEKVEEGLESITEKPDNMAISCGSRAHLEKESVAQRSMFRTFLMYGFHFLVWFFCVRGIKDTQCGFKLFTREAALKTFSSLHVERWAFDVELLFIAQCFDIPIEEVAVNWTEIEGSKLVPFWSWLQMGRDLIFIRLRYLTGAWRLESEKKTQ,dolichyl-phosphate beta-glucosyltransferase (2.4.1.117) (0.9359),protein N-linked glycosylation (GO:0006487) (0.6133); endoplasmic reticulum organization (GO:0007029) (0.3195); protein O-linked glycosylation (GO:0006493) (0.2138); dolichol-linked oligosaccharide biosynthetic process (GO:0006488) (0.1572); gastrulation involving germ band extension (GO:0010004) (0.1039); mesoderm migration involved in gastrulation (GO:0007509) (0.0949); dorsal/ventral pattern formation (GO:0009953) (0.0759); plasma membrane organization (GO:0007009) (0.0528); muscle contraction (GO:0006936) (0.0475); protein glycosylation (GO:0006486) (0.0450); chondrocyte proliferation (GO:0035988) (0.0420),endoplasmic reticulum membrane (GO:0005789) (0.3222); cytoplasmic side of rough endoplasmic reticulum membrane (GO:0098556) (0.1671),dolichyl-phosphate beta-glucosyltransferase activity (GO:0004581) (0.2428),Nucleotide-diphospho-sugar transferases (IPR029044) (0.4153); Glycosyltransferase 2-like (IPR001173) (0.2786); Dolichyl-phosphate beta-glucosyltransferase (IPR035518) (0.1579),,Transferase (0.8418); Reference proteome (0.6153); Sporulation (0.4066); Signal-anchor (0.4063); Endoplasmic reticulum (0.3749); Glycosyltransferase (0.3101); Membrane (0.2271); Transmembrane (0.0925),
MDGQHSRCKVVVVGDTQCGKTALLHVFAKDNYPENYVPTVFENYTASFEIDKHRIELNMWDTSGSSYYDNVRPLAYPDCDAVLICFDISRPETLDSITKKWQVEAQEYCPNAKLVLVGCKLDMRTDVSTLRELSKQRLIPVTHEQGSLRARELGAVAYVECSSRMCVNSVRDVFHITTLVSVRREPAPSLKRSTSRRTLKRISNQPLLPVTSQATPLEATPTLREDRAKSCTIM,,cell migration (GO:0016477) (0.6616); small GTPase-mediated signal transduction (GO:0007264) (0.3178); signal transduction (GO:0007165) (0.2932); actin filament organization (GO:0007015) (0.2000); establishment or maintenance of cell polarity (GO:0007163) (0.1359); ameboidal-type cell migration (GO:0001667) (0.0856); microtubule cytoskeleton organization (GO:0000226) (0.0835); positive regulation of transcription by RNA polymerase II (GO:0045944) (0.0819); regulation of actin cytoskeleton organization (GO:0032956) (0.0767); neuron remodeling (GO:0016322) (0.0402),cytosol (GO:0005829) (0.2901); plasma membrane (GO:0005886) (0.2715); actin cytoskeleton (GO:0015629) (0.0744); cytoskeleton (GO:0005856) (0.0651),GTP binding (GO:0005525) (0.2646); protein kinase binding (GO:0019901) (0.2095); GTPase activity (GO:0003924) (0.1147),P-loop containing nucleoside triphosphate hydrolase (IPR027417) (0.2431); Small GTP-binding protein domain (IPR005225) (0.1313); Rho-related GTP-binding protein RhoN (IPR041842) (0.1112); Small GTPase Rho (IPR003578) (0.1057); Small GTPase (IPR001806) (0.0983),3.40.50.300 (0.2060),Methylation (0.7895); Lipoprotein (0.6838); GTP-binding (0.4224); Nucleotide-binding (0.2420); Prenylation (0.2270); Cell membrane (0.1499); Membrane (0.1336); Hydrolase (0.0418),
MNAKINYSLAAVFLSALFETVHAYYTYAQIQCHVSDSLQKIEFIFSVTYNMIELVRYNSTEDTFFGYTAIGQKFAEEYNKDKVLLAQHDFVLNQCRELGDVILPNAVWLAVKPEVIIRSVTEAKGNRKAVLVCSAYDFYPKGIKLTWMRDDKKVTAELTSSEVMADGHWHYQIHSYLEYFPQTGEKISCVVDHASSLKPMIYYWDPSLPESERSKIILGAVGLLMGIFTAAAGVIYYKRKQTGFYRLPVCLLPMETMNDTELQ,,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886) (0.7762); adaptive immune response (GO:0002250) (0.6617); peptide antigen assembly with MHC class II protein complex (GO:0002503) (0.6096); positive regulation of T cell activation (GO:0050870) (0.3649); positive regulation of immune response (GO:0050778) (0.1676); T cell receptor signaling pathway (GO:0050852) (0.1411); positive regulation of T cell proliferation (GO:0042102) (0.1022); immune response (GO:0006955) (0.0681); B cell affinity maturation (GO:0002344) (0.0641),late endosome membrane (GO:0031902) (0.4804); MHC class II protein complex (GO:0042613) (0.3475); endoplasmic reticulum (GO:0005783) (0.1261); external side of plasma membrane (GO:0009897) (0.1238); multivesicular body (GO:0005771) (0.1014); plasma membrane (GO:0005886) (0.1009); cell surface (GO:0009986) (0.0533),MHC class II protein complex binding (GO:0023026) (0.0767),"Immunoglobulin-like domain (IPR007110) (0.4218); MHC class II, alpha/beta chain, N-terminal (IPR014745) (0.3747); Immunoglobulin-like fold (IPR013783) (0.2396); MHC class II, beta chain, N-terminal (IPR000353) (0.1764); Major Histocompatibility Complex/Immunoglobulin (IPR050160) (0.1671); Immunoglobulin C1-set (IPR003597) (0.1660); Immunoglobulin-like domain superfamily (IPR036179) (0.0998)",2.60.40.10 (0.2510),Glycoprotein (0.7242); Signal (0.5514); Reference proteome (0.4768); Membrane (0.4421); Transmembrane (0.3937); Transmembrane helix (0.3766); 3D-structure (0.1179); Disulfide bond (0.1075); Adaptive immunity (0.0950); Immunity (0.0683),
MQSAGFLLLCVPLISLLCESILSLPTGKTPTGEFPESVTARSCRELLKKYGHKKDGLYYLRSKDNEVYQTYCDMSTNGGGWTLVASVHENNIHGSCTVGDRWTSQQGSSSYHPAGDGSWSNKVLFGTAEAATNDDYKNPGYYDIKAKDIAVWHVHNDNELEFWKVASVLRYHTNSNFLTPFGGNLYHFFKKYHLQYGIGTCNDRGISVPIVYDIGSDMRVNELYGESVRADFDTGYVTFRVFNNYQEAYAMCSGVRPKGCYAQYYCIGGGGYFPNTFCSDFAYLNANNGATNGYGASKEIINAAVFIFYR,,response to nematode (GO:0009624) (0.7909); positive regulation of protein phosphorylation (GO:0001934) (0.2854); positive regulation of cytosolic calcium ion concentration (GO:0007204) (0.1527); protein homotrimerization (GO:0070207) (0.0791); positive regulation of cytokine production (GO:0001819) (0.0754); response to symbiotic bacterium (GO:0009609) (0.0693),plasma membrane (GO:0005886) (0.2738); extracellular region (GO:0005576) (0.1478); extracellular space (GO:0005615) (0.1180); membrane raft (GO:0045121) (0.0841); brush border membrane (GO:0031526) (0.0813),oligosaccharide binding (GO:0070492) (0.2713); calcium ion binding (GO:0005509) (0.1671); identical protein binding (GO:0042802) (0.1590),"Fibrinogen, alpha/beta/gamma chain, C-terminal globular, subdomain 1 (IPR014716) (0.2098); Fibrinogen-like, C-terminal (IPR036056) (0.1532); Fibrinogen, alpha/beta/gamma chain, C-terminal globular domain (IPR002181) (0.1408)",3.90.215.10 (0.4241),Signal (0.7184); Reference proteome (0.6200); Membrane (0.5460); Secreted (0.4794); Lectin (0.4331); Glycoprotein (0.3764); GPI-anchor (0.3507); Cell membrane (0.3188); Metal-binding (0.2959); Direct protein sequencing (0.2373); Disulfide bond (0.1816); Calcium (0.1336); Lipoprotein (0.0752); Zinc (0.0535),
MSERTPLLHYRLSASGHEPGEPREHRQTTSAGHEEPDTRSRRPGARNPAAAQPPKLNTFFGVVIPTLLSMFSVVVFLRIGFVVGQCGLYQTIAMLLVAYFIISMTVLSVCAISTNGALDAGGAYYMISRALGPEFGGSIGIMFFLANVCGSALYVLGLVEAVLTTFGLPDDGSLSMSRSAVLPVGYWWSLLYGTVILLLCVLVCLVGAHIYAKATFLIFIIVMVVLGTIFISFFAVPFRTVQLPGSNSTIGPSRANFTGFKLDTLTGNLQADYTLDYTTKAMMSFATVFAVMFNGCTGIMAGSNMSGDLKNPSYSIPRGTITAVIFTFIIYNLLSLLISCTCDRILLQKDYGFLRDINVWGPFVTVGVYSSTLSAAMSNLIGASRILFALAKDDLFGRVLSPAKRTSASGNPWVSVLISWFLVQVCVSFSTANIRRLMLEGIQLLPEVKENYVY,,cell volume homeostasis (GO:0006884) (0.6373); fertilization (GO:0009566) (0.3435); multicellular organism growth (GO:0035264) (0.3009); potassium ion homeostasis (GO:0055075) (0.2721); gene expression (GO:0010467) (0.1567); chloride transport (GO:0006821) (0.1438); neuromuscular process (GO:0050905) (0.1359); brain development (GO:0007420) (0.1317); positive regulation of gene expression (GO:0010628) (0.1148); spermatogenesis (GO:0007283) (0.0952); monoatomic ion transport (GO:0006811) (0.0942); response to xenobiotic stimulus (GO:0009410) (0.0886),membrane (GO:0016020) (0.2435); apical plasma membrane (GO:0016324) (0.1340); extracellular exosome (GO:0070062) (0.0788); basolateral plasma membrane (GO:0016323) (0.0736); cytoplasm (GO:0005737) (0.0647); cell surface (GO:0009986) (0.0605); sperm flagellum (GO:0036126) (0.0586); centriolar satellite (GO:0034451) (0.0567); plasma membrane (GO:0005886) (0.0550); apical part of cell (GO:0045177) (0.0481),ATP binding (GO:0005524) (0.0495); potassium:chloride symporter activity (GO:0015379) (0.0422),Amino acid permease/ SLC12A domain (IPR004841) (0.2170); SLC12A transporter family (IPR004842) (0.1311),1.20.1740.10 (0.1245),Transport (0.8013); Reference proteome (0.7355); Transmembrane (0.6896); Ion transport (0.5705); Transmembrane helix (0.4028); Membrane (0.2748); Proteomics identification (0.2143); Symport (0.1030); Chloride (0.0622),
MSSPNVSSPAMAVTSAAAEQKTSPALFEIYGKIWNVQARLGQGVSASVYRVSSGRATSAVKEFQVDPQGGDYGYLKESSVLEKIQGHKNIVTLYGMFTNHNPFGVATHCLLLELLDVSVSELLVRASNQGHSMWLIQHCARDVLESLTFLHREGFVHADLKPRNVLWSADDECFKLIDFGLSFKEGHQDVKYIQTDGYRAPEAELQNSLAQAGVESDSGCTTAVDLWSLGIVLLEMYSGMKLKETVKSQEWKDNSSTIVDHIFSSNALVYPAIPVFHLRDLIKSMLHNDPKLRSTAKAALMSPFFSIPFAPHIEDLVLLPTPVLRLLNVIDDSHLYNEDEYEDIIEDMKEECQKYGTVVSLLIPKENPGKGQVFVEYANAGDSKEAQRLLTGRTFDGKFVVATFYPLSAYKRGYLYQTVQ,non-specific serine/threonine protein kinase (2.7.11.1) (0.9566),regulation of protein export from nucleus (GO:0046825) (0.8876); peptidyl-serine phosphorylation (GO:0018105) (0.6306); regulation of cell cycle (GO:0051726) (0.2873); neuron projection development (GO:0031175) (0.2457); protein autophosphorylation (GO:0046777) (0.2161); positive regulation of translational initiation (GO:0045948) (0.1352); protein phosphorylation (GO:0006468) (0.1038),neuronal ribonucleoprotein granule (GO:0071598) (0.2916); nucleus (GO:0005634) (0.2862); dendrite cytoplasm (GO:0032839) (0.1750); Golgi apparatus (GO:0005794) (0.1665); cytoplasm (GO:0005737) (0.1613); cytosol (GO:0005829) (0.1009),ATP binding (GO:0005524) (0.4066); protein serine/threonine kinase activity (GO:0004674) (0.3232); splicing factor binding (GO:1990935) (0.2940); RNA binding (GO:0003723) (0.1203),"Nucleotide-binding alpha-beta plait domain superfamily (IPR012677) (0.7275); RNA-binding domain superfamily (IPR035979) (0.5886); RNA recognition motif domain (IPR000504) (0.4756); Protein kinase, ATP binding site (IPR017441) (0.1908); Serine/threonine-protein kinase Kist (IPR034372) (0.1845); Protein kinase domain (IPR000719) (0.1507); UHMK1, RNA recognition motif (IPR034371) (0.1474); Protein kinase-like domain superfamily (IPR011009) (0.0971)",1.10.510.10 (0.5268); 3.30.70.330 (0.3503),mRNA splicing (0.6315); ATP-binding (0.3899); Kinase (0.3138); Nucleotide-binding (0.2194); RNA-binding (0.1968); mRNA processing (0.1195); Reference proteome (0.0930),
MFIVLYTCSALILPCVWTQNSIPSVVVEARNITVPVGSDVVLPCHNQRMVWRQDRLRDRQRVVHWDLIRNQPDYTVERILDMFSGGTERLYNDYNKGRVTIAKDAFSDGNFSLVINNVDMNDKGIYTCNLHHHYCKVHQSVQMQLNVTKSPRKEKRVWDGEKAVFVVLVGKSVVLPCVIRRQLWTDSQRDEGQQQVVHWDWQAPGVTRDRAERLIDMYASGEKRQYGPLYLQKKMNISADAFSLGDFSLSLHNIQPADKGLFSCHLHHHYCGLHERRIYRLILGPSVQALPPVRSSTEAQKNPARTVLPADDPNTNMVEAPHVLNVILPENQTHLLHQVGYILVVFLLLLLMLIGIIMTTRHCRKKGYELDVGRNECGRMTSIELDVTELQPYNQEDMRLNYKNNIMKERAESNNYPSPKVIDFNREMERMSWK,,cell adhesion (GO:0007155) (0.9818); cell differentiation (GO:0030154) (0.5523); establishment of glial blood-brain barrier (GO:0060857) (0.1547),bicellular tight junction (GO:0005923) (0.7803); plasma membrane (GO:0005886) (0.3121); cell surface (GO:0009986) (0.3012); nucleus (GO:0005634) (0.2005); cytoplasm (GO:0005737) (0.1409); cytosol (GO:0005829) (0.0989),,Matrix remodeling-associated protein 8 (IPR042472) (0.3971); Immunoglobulin subtype (IPR003599) (0.3416); Immunoglobulin V-set domain (IPR013106) (0.3173); Immunoglobulin-like fold (IPR013783) (0.2779); Immunoglobulin-like domain (IPR007110) (0.2264),2.60.40.10 (0.3083),Transmembrane helix (0.7548); Immunoglobulin domain (0.6143); Reference proteome (0.5115); Cell membrane (0.4927); Signal (0.4511); Transmembrane (0.3645); Cell adhesion (0.3455); Disulfide bond (0.3277); Membrane (0.3123); Tight junction (0.2793); Glycoprotein (0.2617); Cell projection (0.1064); Coiled coil (0.1014),
MHSHIHLGLFLLLCVLSRSYAGKLLVVPVEGSHWVNMKVLIVELHSRGHSITVVRGSSSWYIEEQSPLYTSITVDNGVFDDDFMEKFLPHLLKIQRQGKSFWNEMALADEMIHFVTETHKQSCNMTAILFENETLMNSLKDAAYDVVLTDPAYGSGVLLAHRLGLPLVYNVRWTVYGEAHFDIAPSPLSYVPVSGLQLTDKMTFSQRVMNMMTYIMIRYKYSKNFGSPYQELTQKYFGPNVNFFSLLQDADLWLMRNDFTFEFPRPTMPNVVYMGGFQCKPAKPLPGDLEEFVQSSGEHGVIMMSLGTVFGQLLSELNDEIAAAFAQLPQKVIWRYTGPRPANLGNNTLIVNWLPQNDLLGHPKTKLFVAHGGTNGLQEAIYHGVPIVGLPLAFDQPDNLSRMRAKGTAKIVEFATLDRAVFLEALKEVLHNPSYRENMQRLSKLHHDQPMKPLDRAIFWIEFVMRNKGAPHLRAQSFRMSWIEYQSIDVILTLMLMVLVFVLLTVYTMKYFCLCLFRKKVKRE,glucuronosyltransferase (2.4.1.17) (0.8328),cellular response to glucocorticoid stimulus (GO:0071385) (0.4424); estrogen metabolic process (GO:0008210) (0.3643); liver development (GO:0001889) (0.2640); steroid metabolic process (GO:0008202) (0.1438); xenobiotic metabolic process (GO:0006805) (0.1142); response to immobilization stress (GO:0035902) (0.0952); bile acid metabolic process (GO:0008206) (0.0474); cellular glucuronidation (GO:0052695) (0.0464); response to peptide hormone (GO:0043434) (0.0457); cellular response to ethanol (GO:0071361) (0.0453); response to xenobiotic stimulus (GO:0009410) (0.0450); response to ethanol (GO:0045471) (0.0417),endoplasmic reticulum membrane (GO:0005789) (0.1069),glucuronosyltransferase activity (GO:0015020) (0.4924),"UDP-glycosyltransferase family, conserved site (IPR035595) (0.4491); UDP-glycosyltransferase (IPR050271) (0.3206); UDP-glucuronosyl/UDP-glucosyltransferase (IPR002213) (0.2306)",3.40.50.2000 (0.2727),Transmembrane helix (0.7482); Transferase (0.5711); Reference proteome (0.5415); Membrane (0.3920); Glycoprotein (0.3532); Glycosyltransferase (0.3323); Endoplasmic reticulum (0.2108); Microsome (0.1787); Transmembrane (0.1459); Signal (0.1334),
MSVTMAKFETGRTSPVVRQIDKQFLVCSICLDHYHNPKVLPCLHTFCERCLQNYIPPQSLTLSCPVCRQTSILPEKGVAALQNNFFITNLMEVLQRDSECSRPEACSVLESVSAAAAGKPLSCPNHEGKVMEFYCESCETAMCLECTEGEHREHVTVPLRDVLEQHKAVLKNQLDAIRNRLPQLTAAIEMVNEISKQLTERKNEAVNEINMTFEELERALHQRKAALITDLENICSTKQKVLQAQLSSLLQGKEHIQSSCSFTEQALSHGSATEVLLVQKQMSERVSALACHDFPERPHENAHLDCQIETEGLRRSIQNLGVLLTTGAVGHTSVATGEGLRHALVGQHVTVTVTTKDKDSELVRTGNAALRAEIMGQDGAQVTEAEVVDNKNGTYEVGYTLKGEGEYLFSLILYGQPVRGSPFKLRAIKPSDVPQSPDDVKRRVKSPSGTGGHIRQKAVRRPSSMYSTTKKKENPIEDELIYRVGTRGREKGEFTNLQGISASISGRVIVADSNNQCIQVFTNDGQFKARFGVRGRSPGQLQRPTGVAVDTNGDVIVADYDNRWISIFSPDGKFKNKIGAGRLMGPKGVAVDRNGHIIAVDNKACCVFIFQSNGKLVTKFGARGTSDRQFAGPHFVAVNNKNEIVVTDFHNHSVKVYSADGEFLFKFGSHGEGNGQFNAPTGVAVDVNGNIIVADWGNSRIQVFDSAGSFLSYINTSADPLYGPQGLALTSDGHVVVADSGNHCFKVYRYLQ,RING-type E3 ubiquitin transferase (2.3.2.27) (0.9974),protein polyubiquitination (GO:0000209) (0.9333); nervous system development (GO:0007399) (0.7043); proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161) (0.5175); neural precursor cell proliferation (GO:0061351) (0.1845); protein K63-linked ubiquitination (GO:0070534) (0.1402),cytoplasm (GO:0005737) (0.3374),translation repressor activity (GO:0030371) (0.4709); zinc ion binding (GO:0008270) (0.3094); ubiquitin protein ligase activity (GO:0061630) (0.1342),"B-box-type zinc finger (IPR000315) (0.5655); Filamin/ABP280 repeat (IPR001298) (0.5179); Filamin/ABP280 repeat-like (IPR017868) (0.4385); Tripartite Motif and NHL Repeat Containing E3 Ligases (IPR050952) (0.3838); Immunoglobulin E-set (IPR014756) (0.3517); NHL repeat (IPR001258) (0.2743); B-box, C-terminal (IPR003649) (0.2309); Zinc finger, RING-type (IPR001841) (0.2298); Zinc finger, RING-type, conserved site (IPR017907) (0.2019); Zinc finger, RING/FYVE/PHD-type (IPR013083) (0.1629)",2.120.10.30 (0.4850); 3.30.160.60 (0.4184); 2.60.40.10 (0.3866); 3.30.40.10 (0.2361),Zinc-finger (0.9741); Zinc (0.8333); Repeat (0.6584); Ubl conjugation pathway (0.6208); Reference proteome (0.4254); Coiled coil (0.2788); Metal-binding (0.2425); Transferase (0.1530),
MKEGEKSNAEGCKMAELQMLLEEEIPAGKRALVESYQNLSRVAEYCENNYVQAQDKRKALEETKAYTTQSLASVAYQINALANNVLQLLDIQASQLRRMESSINHISQTVDIHKEKVARREIGILTTNKNTSRTHKIIAPGNMERPVRYIRKPIDYTLLDDVGHGVKQGNNQPARGGGGTLSRTNPPTQKPPSPPMAGRGTLGRNTPYKTLEPVKPPVVPNDYMTSPARLGSQNSPGRTASLNQRPRTHSGSSGGSGGRENSSNSMGIPLAVPTPSPPSMAPAVPPGPGLGPIPMSQFGTISRQISRHNSSTTSSSASMVSATGTYRRAPASSSQFSVPQPHLNGGPTFPQTTMTVAPPPPPVVQLTPQIPLTGFVARVQENITDSPSPPPPPLPEDTPLFEEAAPPPPPPPVDYDEEDAALVHYNDPYADGDPHWAPKSYIEKVVAIYDYSKDKDDELSFMEGAIIYIIKKNDDGWFEGVCNGVTGLFPGNYVESIMHYAD,,somitogenesis (GO:0001756) (0.7455); dendrite morphogenesis (GO:0048813) (0.5788); neuron migration (GO:0001764) (0.5372); megakaryocyte development (GO:0035855) (0.4967); lamellipodium morphogenesis (GO:0072673) (0.3798); positive regulation of protein tyrosine kinase activity (GO:0061098) (0.3261); mitophagy (GO:0000423) (0.0808); learning or memory (GO:0007611) (0.0686); defense response to tumor cell (GO:0002357) (0.0497),lamellipodium (GO:0030027) (0.7162); SCAR complex (GO:0031209) (0.3384); filopodium tip (GO:0032433) (0.1497); neuron projection (GO:0043005) (0.1360); actin-based cell projection (GO:0098858) (0.1096); dendrite (GO:0030425) (0.0956),SH3 domain binding (GO:0017124) (0.2940); signaling adaptor activity (GO:0035591) (0.1586),"ABI family (IPR028457) (0.2976); Abl-interactor, homeo-domain homologous domain (IPR012849) (0.2378); Abl Interactor 1, SH3 domain (IPR035725) (0.2033); Target SNARE coiled-coil homology domain (IPR000727) (0.1982)",6.10.140.1620 (0.3266); 2.30.30.40 (0.2013),SH3 domain (0.8916); Cell projection (0.4937); Reference proteome (0.4883); Coiled coil (0.4742); Cytoplasm (0.3462); Membrane (0.1700); Cytoskeleton (0.1192); Synapse (0.0558); Ubl conjugation (0.0407),
MDSSAALHLNLLTLTVMFCFSLLCGFSPGFFMRQAARYTSDPGSRLRALSLASCLSSGVFLGFSLLDLLPKYLTDMRDTFSRLDITLRFPLSEFLLAMGVLLVLLVEQMLLAFREQVCVSSVEKQTLIERTRLYVEDSRTHEALRVCLLLLCVCVRSLLEGVCAVPPPLWSCGAALLREGLLAFGLALQLAPAGLRRAVATGGLVLFCSARPVAMGTAMLRGTPGDQAYTADVVRCAVEGLTCGIFICISISGLLFPESSSPKQRMHKVAFLLTGFALVTAVLISQV,,zinc ion transmembrane transport (GO:0071577) (0.6941); zinc ion transport (GO:0006829) (0.3778); intracellular zinc ion homeostasis (GO:0006882) (0.2230); bicarbonate transport (GO:0015701) (0.1166); embryonic cranial skeleton morphogenesis (GO:0048701) (0.0899); limb development (GO:0060173) (0.0620); intracellular monoatomic cation homeostasis (GO:0030003) (0.0459),apical plasma membrane (GO:0016324) (0.4820); endoplasmic reticulum membrane (GO:0005789) (0.1337); basolateral plasma membrane (GO:0016323) (0.0648),,Zinc/iron permease (IPR003689) (0.0828),,Ion transport (0.6306); Reference proteome (0.4522); Cell membrane (0.4291); Zinc (0.3845); Ubl conjugation (0.3320); Membrane (0.2790); Transmembrane (0.2205); Zinc transport (0.2188); Glycoprotein (0.1803); Signal (0.1470); Transmembrane helix (0.0883),
MSRVVKKRQADPKVVQYVWSAIEVIRNQKQIANMDRISKYLSRVYGMHPKDTARQLVLAVKDGLVVETLTVGCKGSKAGIEQEGYWLPGDEMEQMSEGSKPSLPSEALFPDDWEAESHDWYCFECHLPGDVMECDGCFRVYHLRCVSEDHRPRDTTSHWQCGICRGSKRKNLNKQEMTTYLKFILGRMKERAVDLHKRGKEAKQPIYKRLIHTPLDVENIQENISDGKYKSFEEFRADAQLIVHNTAILHGVNSDQTEIARLLYNDTCHELNELMLCRTCFYLSNARPDNWFCYPCSPNHELVWARMKGFGYWPAKVMQREGNQVDVRFFGHQHQRAWIPSDNIQDITVSVQQLQVKRSSGWKKACDELELHQRFVREGRTWKGKPEEKNDRSERHERQEERQEEAESSISSTSNEQSRVNQEPKAKKSRRSQVAEPKEEEPEPEMEAVSSSQEIPTAVPHQPERMSVSTQTKKSSSPSSSSSPAPRMIHKGTQTVNEGNCQNMCHDKYSKIFSDVKEMMKAENKRETERVLKEALDKLRGEMEEEKRQAVNKAVSSTQAEMERKCKQVKEKCKEELMEEMKKMVSQHKQLLSQTKKKQWCYNCEEEAMYHCCWNTSYCSIKCQQEHWHADHKRTCRRKR,,regulation of transcription elongation by RNA polymerase II (GO:0034243) (0.9013); regulation of signal transduction (GO:0009966) (0.6688); chromatin organization (GO:0006325) (0.1614),nucleus (GO:0005634) (0.4094),DNA binding (GO:0003677) (0.9271); transcription corepressor activity (GO:0003714) (0.7099); metal ion binding (GO:0046872) (0.3437); methylated histone binding (GO:0035064) (0.2157),"PWWP domain (IPR000313) (0.5334); Zinc finger MYND domain-containing protein 11, PWWP domain (IPR047268) (0.4292); Zinc finger, PHD-type (IPR001965) (0.4083); SAM domain-containing protein 1-like, WH domain (IPR048589) (0.4019); Bromodomain (IPR001487) (0.3243); Zinc finger, FYVE/PHD-type (IPR011011) (0.3057); Bromodomain-like superfamily (IPR036427) (0.2958); Zinc finger, RING/FYVE/PHD-type (IPR013083) (0.2556); Zinc finger, PHD-type, conserved site (IPR019786) (0.2301); Zinc finger, MYND-type (IPR002893) (0.1607); Zinc finger MYND domain-containing protein 11 (IPR047269) (0.0615)",2.30.30.140 (0.3044); 1.20.920.10 (0.2270); 6.10.140.2220 (0.1696),Zinc-finger (0.9973); Zinc (0.8281); Ubl conjugation (0.8029); Repressor (0.5568); Bromodomain (0.3711); Chromatin regulator (0.3544); Reference proteome (0.3422); Phosphoprotein (0.2579); Metal-binding (0.2456); Isopeptide bond (0.2419); Coiled coil (0.1910),
MDEQRHPVNIQLLGVMQKEMTKLYMTTVLWSDGNEITVYRSLEDFKKMHRQLKKKFPPSNPFKRSARIVPEFKEVRVQKSLQKWSGSKSVLRMKALEEYCGQLLKSDAQVCRSSELIQFLLPKAHDLNADFAKNCIVIMPSDVTLGSSKAESNSGVTQPFVTETYRCIANYETKDTKNRPFKVEVDETVDVLIKDQKGWWLVENESKHLAWFPAPYLERAEMADDGPDEMDNESVFYVATKAYKATNSDELSVELGSVLEVLQKSDNGWWIVRYNRKAGYVPSMYLQPHNNPRILLKSTQKEISRSTLDLAQLQHPQTLQDSRLRELSRSQGNLLLQPAETDIMDKQKSRSLGRLPDAARANPPSIRVEFAESGKQSSQSDDSEEFSDDSSFSCSDSLDRSDAEECFRRSRTPTAETLTPESAGGITASRSDPCLNKMPSTPKVPPRPAVQEILTRCTTVTRKNMQRNS,,superoxide metabolic process (GO:0006801) (0.6683); superoxide anion generation (GO:0042554) (0.4555); protein targeting to membrane (GO:0006612) (0.3188); in utero embryonic development (GO:0001701) (0.1702); extracellular matrix disassembly (GO:0022617) (0.0976); leukotriene metabolic process (GO:0006691) (0.0535),cytoplasm (GO:0005737) (0.7207); NADPH oxidase complex (GO:0043020) (0.1108); nucleoplasm (GO:0005654) (0.1003); plasma membrane (GO:0005886) (0.0962); cytosol (GO:0005829) (0.0953); nucleus (GO:0005634) (0.0415),superoxide-generating NADPH oxidase activator activity (GO:0016176) (0.5400); phosphatidylinositol binding (GO:0035091) (0.4320); identical protein binding (GO:0042802) (0.2811),"NADPH Oxidase and PX Domain-Containing (IPR051228) (0.4052); SH3-like domain superfamily (IPR036028) (0.2731); PX domain superfamily (IPR036871) (0.2503); SH3 domain (IPR001452) (0.2221); Neutrophil cytosol factor 1, C-terminal (IPR015039) (0.2195); Phox homology (IPR001683) (0.1945)",2.30.30.40 (0.2448); 3.30.1520.10 (0.2415),SH3 domain (0.9814); Repeat (0.6853); Reference proteome (0.4800); Cytoplasm (0.3008); Phosphoprotein (0.1833); Membrane (0.1065),
MTTRKRNKPSLPESDSDKTECEAAKRLAHCQSDMNTVGHNDPLHHHLSPYFSMRHSPRLTYSFFNQPCVELAKAFLGKVLVRKLTDGTELRGKIVETEAYLGGEDKASHSAGGKRTERNTAMFMKPGTIYVYPIYGIYLCMNVSSQGEGAAVLLRSLEPLSGQDVMRGLRAAKRKPGAKSLKDKELCNGPSKLCQALDIQRSFDRRDLATDVEVWLEMDPEKEAIVDAGEVVMAPRIGVDSHGEWATKPLRFYLRGHPCVSVLNKDAERRMDSQSDTERTVC,DNA-3-methyladenine glycosylase II (3.2.2.21) (0.7658); 3.2.2.- (0.1940),base-excision repair (GO:0006284) (0.7731); tRNA decay (GO:0016078) (0.0819); chromosome condensation (GO:0030261) (0.0495),nucleus (GO:0005634) (0.2324); mitochondrion (GO:0005739) (0.2211); nucleoplasm (GO:0005654) (0.1612),alkylbase DNA N-glycosylase activity (GO:0003905) (0.3650); DNA-3-methylguanine glycosylase activity (GO:0052822) (0.3533); DNA-7-methyladenine glycosylase activity (GO:0052821) (0.3007); DNA binding (GO:0003677) (0.1032); DNA-3-methyladenine glycosylase activity (GO:0008725) (0.0888); DNA-7-methylguanine glycosylase activity (GO:0043916) (0.0862),"Methylpurine-DNA glycosylase superfamily (IPR036995) (0.2307); Methylpurine-DNA glycosylase (IPR003180) (0.2135); Formyl transferase-like, C-terminal domain superfamily (IPR011034) (0.2074)",3.10.300.10 (0.3574),Reference proteome (0.3574); DNA repair (0.2405); Hydrolase (0.2200); DNA-binding (0.1910); Nucleus (0.1767); Glycosidase (0.1400); RNA-binding (0.0991),
MFNTTMQRIRISASTVTQICKSKDCLGVLIMIPHGRRCLSSSSCLYGKVFPRQKPRVVPEIAGLEPVTYADRMHFVPGLAKPRFPKWERGWKNPNHYESPKPEEMKLFKDKPCYIFNQRTSVVEGVRQALWLSKSAVIKEFPAQILSLAEDPANQIEDQDERVQNAIKSALLWDTTDDQPPRERYCPMLVHRLLHLCGVLQVRHPELAKRMLAEKYNLAATWRRGEDVFQVRGHNGLLLNSMNPLPVLAGPEQIQGTADQELETFFPIAPTIDLQCTNVYQEKSTTGFREGYPCPHAHTLYVMEMGNTPKLLPEQLRAKMIMFCFGNALVRAKALYGDEPRVLEKPIVVQSVATNGRIFQFVVFQLNTTELQSDSGVKNLVWVDEDKPLYEHAQARAHIKRRVVKIPAGLSGYQPETFKKFLALFLHGAT,,mitochondrial translation (GO:0032543) (0.5523); translation (GO:0006412) (0.2534); mitochondrion organization (GO:0007005) (0.2231); mitochondrial genome maintenance (GO:0000002) (0.1514),presynapse (GO:0098793) (0.6397); mitochondrial inner membrane (GO:0005743) (0.2644); mitochondrion (GO:0005739) (0.2070); cytosol (GO:0005829) (0.1535); nucleoplasm (GO:0005654) (0.1223); synapse (GO:0045202) (0.0415),RNA binding (GO:0003723) (0.0676),Mitochondrial large ribosomal subunit mL37 (IPR052482) (0.1134),,Transit peptide (0.9603); Ribosomal protein (0.9592); Reference proteome (0.8513); Ribonucleoprotein (0.7889); Proteomics identification (0.4982); Mitochondrion (0.3318); Direct protein sequencing (0.3097); 3D-structure (0.2417); Disease variant (0.2064); Phosphoprotein (0.1603),
MTYIIHLTVFMLIVNIERTCCLNPPQDLKIVKSQLLWKPPEVDEDLRYSLQYKLDSKAEDKWYNVSSHINKNVFNITDEFYGALFRVRAEKGNHISEWAISNRVNCVNVNSCAPVVNLSEKPGIVSLTLAHMDQSLEKEHGEHLEFNISSWSVNSRENPEEDVVINSKDYIFNDLESGQIYCFQVEYLLYHKPYGKASKERCVFIPETPEAKKKRVLIYGPLITCFVLMVCGFCIFLFCKCKSNKRVQSVVKEWFQPFKLDLPDHYKEFLSSEFPVGLAPSPSIPSLQSDDFIILKENADVEENGQEAEQQKTEIL,,cell surface receptor signaling pathway via JAK-STAT (GO:0007259) (0.6543); response to lipopolysaccharide (GO:0032496) (0.5720); defense response to virus (GO:0051607) (0.4022); cytokine-mediated signaling pathway (GO:0019221) (0.1305); cellular response to interferon-alpha (GO:0035457) (0.0921); production of molecular mediator involved in inflammatory response (GO:0002532) (0.0808); blood coagulation (GO:0007596) (0.0746),cytosol (GO:0005829) (0.3213); lysosome (GO:0005764) (0.3025); plasma membrane (GO:0005886) (0.2580),JAK pathway signal transduction adaptor activity (GO:0008269) (0.3709); type I interferon receptor activity (GO:0004905) (0.1682); metal ion binding (GO:0046872) (0.1520),Fibronectin type III superfamily (IPR036116) (0.3973); Interferon/interleukin receptor domain (IPR015373) (0.3632); Immunoglobulin-like fold (IPR013783) (0.3587); Fibronectin type III (IPR003961) (0.1581); Tissue factor (IPR001187) (0.0877),2.60.40.10 (0.4030),Repeat (0.7850); Transmembrane helix (0.7563); Phosphoprotein (0.6174); Signal (0.5268); Transmembrane (0.3531); Membrane (0.3492); Reference proteome (0.3237); Receptor (0.2979); Disulfide bond (0.2510); 3D-structure (0.1943); Glycoprotein (0.1718); Lipoprotein (0.1451); Direct protein sequencing (0.1231); Endosome (0.0927); Alternative splicing (0.0721),
MAAARKHKRMAASQPGFLPLKSDLDGSISNAKRRKRVNKNKKKNWNKYSDIRDVEDFLDDVRLQEKATGGLISEKPDDSLFFVDTGEKEKDKQPQTTAKKGKRSKPLRIDLILQPDSHIPPPKNVLAYQQPNAKKQRRMAEKAAKLAAMGVLPRREKLLQLRRAAAASGVSVKEKPVANNNPERPFYDLWSEGTPETADPFYLEQTKKKLIKRPDRLNEKPSVLPAIEVIAAGGSYNPDFFSHQELLREAHEVEVKKLKVEEKLARQLAVNQDIATEESTFKEQVEGLIEEDEDQPEDADGDADDTVIGPTAIQEKKTERQRKKEKAEKVKELQRKAEREVIDKKQQLFQLRSIRANLKNQEQRTKMRQAQRKAKQEAEKSMPRRLGRLKYQEPDLDIQLSDELASSLRSLKPEGSILKDRFKSLQKRNLIEPRERAKFKRRYKLKYSEKRAFREIQ,,ribosomal large subunit assembly (GO:0000027) (0.9648); DNA repair (GO:0006281) (0.5070); protein stabilization (GO:0050821) (0.4935); negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435) (0.4024); negative regulation of transcription by RNA polymerase II (GO:0000122) (0.3825); cellular response to hypoxia (GO:0071456) (0.3153); negative regulation of protein-containing complex assembly (GO:0031333) (0.2265); mitotic G2 DNA damage checkpoint signaling (GO:0007095) (0.2086); protein localization to nucleolus (GO:1902570) (0.1834); protein localization to nucleoplasm (GO:1990173) (0.1791); negative regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901837) (0.1764); rRNA processing (GO:0006364) (0.1700); regulation of apoptotic process (GO:0042981) (0.1463); regulation of protein phosphorylation (GO:0001932) (0.1203); negative regulation of signal transduction by p53 class mediator (GO:1901797) (0.1190); maturation of 5.8S rRNA (GO:0000460) (0.0884); regulation of cell cycle (GO:0051726) (0.0847); innate immune response (GO:0045087) (0.0785); positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436) (0.0620),nucleoplasm (GO:0005654) (0.5936); nucleolus (GO:0005730) (0.2539),5S rRNA binding (GO:0008097) (0.3519); identical protein binding (GO:0042802) (0.0735),Ribosome biogenesis protein Nop53/GLTSCR2 (IPR011687) (0.5428),,Ribosome biogenesis (0.9362); Reference proteome (0.3795); Nucleus (0.1843); Proteomics identification (0.1808); Phosphoprotein (0.1050),
MNSAIKVTNSTAIRAEVRRHENLQKTINKFIKQLERVEDQQLRTGLKVFLHSIQASCANSQEWTLTRTIPELRLGVLGSIRSGKSALVNRFITGSYLPLESHEGGRYKKEVLVEGQSQLLLIREESGPPSAQLCNWLDGLILVFSLENEASFQEVYKNYSELSAHRNIAEIPIIAVGTQDKISSTNARVIEDKRVQQLCIDVRRCTYYETCATYGLNVDRVFNEMTQKIVAAKKQAALLASCKSLPNSPSHSGASTPVSGPGQASNGAQSSDYPSSLPSTPVISHKDIRGGASGDGVTQRNPPRRRTSLFANRRGSDSEKRSSDSRSDTSRSVPIKQGTLWKRSERSLNKEWKKKYVTLSNSGMLTYHSNINEFLQNAQGKEMDLLRVTVKVPGKRLHRAAAPGAPSPGPALVPVPGVNGLSKDKQTPEGGAASNLLTVEEASRAGLSYPNDQKVKRCPSSVSNKGFSVDSSIEGATSPPLGKEHMPSSPMTDRKKKKRNRSINLKGDAAAGQAEEEESVDFIIISSTGQSWHFEAQSQEDRDAWVQAIESQILASLQSCESRNKARRNSQSEAVALQAIRNAKGNDLCVDCAAPNPTWASLNLGALICIECSGIHRNLGTHLSRVRSLDLDVWPSELTKVLSAIGNHMANHIWETCTQGCQKLTPEATREQRESWIRAKYEQRAFVSPLPAQCSEDTMSTWLLKAVINRDLPNLLLLLAHSTKELINIPPEGAGQQHHSALHAACQLGDVVMTQLLVWYGSDVKSKDPQGRTALTLARQAGSKECAEILVQHGCPSETSPTSPTPVLSRKSSITSVGRVNSRRRVS,,cell surface receptor signaling pathway via JAK-STAT (GO:0007259) (0.3493); positive regulation of mammary gland epithelial cell proliferation (GO:0033601) (0.3288); activation of GTPase activity (GO:0090630) (0.3236); negative regulation of neuron apoptotic process (GO:0043524) (0.3139); mitotic cell cycle (GO:0000278) (0.2292); endosomal transport (GO:0016197) (0.1858); exocytosis (GO:0006887) (0.0988),nucleus (GO:0005634) (0.7006); synapse (GO:0045202) (0.1197),GTPase activity (GO:0003924) (0.4901); GTP binding (GO:0005525) (0.3792); metal ion binding (GO:0046872) (0.3175); GTPase activator activity (GO:0005096) (0.2867),"Small GTPase (IPR001806) (0.3793); Arf-GAP with GTPase, ANK repeat and PH domain-containing protein (IPR051282) (0.3524); Ankyrin repeat-containing domain superfamily (IPR036770) (0.2101); Arf GTPase activating protein (IPR001164) (0.1954); ARFGAP/RecO-like zinc finger (IPR037278) (0.1794); P-loop containing nucleoside triphosphate hydrolase (IPR027417) (0.1691); Pleckstrin homology domain (IPR001849) (0.1313); Ankyrin repeat (IPR002110) (0.1224); PH-like domain superfamily (IPR011993) (0.1180)",2.30.29.30 (0.3134); 3.40.50.300 (0.2492); 1.25.40.20 (0.1501); 1.10.220.150 (0.1303),Zinc-finger (0.7174); ANK repeat (0.3929); Reference proteome (0.3617); Transport (0.2626); Zinc (0.2491); Metal-binding (0.2092); GTPase activation (0.0971),
MRGFILLAVLAITFLQRSTALLEVKGPSEPILEGQDVTLECVDTESELNMSMVHFERFSKYMKKWYRLETDQQFFYRRCFLYDVDVRREEGKLFVFIASMQSWSEGPYRCITEDNSTAKNTSDPLTVPIHYMREVAVHRAGLGYLTRYFNSVQDLRVRLGDDVELECSTSASEEPEYFWAKKGEDWLLPSNKLKLDKVKDDDSGRYTCSAQSPTVRSLMKKRTISITVLKEDAAWYESTIGRIVLVVCPGFVLLAVAVAMTTFLCHRSKQRQSKGPIDDRSQKKPIYRSSVESLPSTLSDKQPLV,,positive regulation of cell migration (GO:0030335) (0.6880); positive regulation of B cell proliferation (GO:0030890) (0.4165); cellular response to amyloid-beta (GO:1904646) (0.3252); intestinal epithelial cell maturation (GO:0060574) (0.3195); cellular response to hydroperoxide (GO:0071447) (0.2502); cell aggregation (GO:0098743) (0.2403); defense response to bacterium (GO:0042742) (0.2219); defense response to Gram-negative bacterium (GO:0050829) (0.1644); B cell activation (GO:0042113) (0.1610); regulation of B cell proliferation (GO:0030888) (0.1553); immune response (GO:0006955) (0.1536); positive regulation of ERK1 and ERK2 cascade (GO:0070374) (0.1506); adaptive immune response (GO:0002250) (0.0886); mitochondrion localization (GO:0051646) (0.0880); negative regulation of B cell receptor signaling pathway (GO:0050859) (0.0865); negative regulation of type I interferon production (GO:0032480) (0.0794); protein localization (GO:0008104) (0.0724); T cell costimulation (GO:0031295) (0.0549),extracellular region (GO:0005576) (0.2151); external side of plasma membrane (GO:0009897) (0.1724); cell surface (GO:0009986) (0.1203); plasma membrane (GO:0005886) (0.1188); early endosome (GO:0005769) (0.0803); T cell receptor complex (GO:0042101) (0.0643),host cell surface receptor binding (GO:0046789) (0.0635),Immunoglobulin subtype 2 (IPR003598) (0.3760); Immunoglobulin subtype (IPR003599) (0.3155); Immunoglobulin-like domain (IPR007110) (0.2629); Immunoglobulin-like fold (IPR013783) (0.2419); Immunoglobulin-like domain superfamily (IPR036179) (0.2404),2.60.40.10 (0.0464),Immunoglobulin domain (0.5006); Membrane (0.4032); Signal (0.3433); Transmembrane helix (0.2051); Reference proteome (0.2038); Disulfide bond (0.1643); Viral immunoevasion (0.1173); Transmembrane (0.1015),
MPATMTSQLYAPSQSRHHRIIRAPKPHVGSLIHIMWILTMGFTPESQAASSDTQPHSIKIEGDITLGGLFPVHSRGPAGIPCGEVKKEKGIHRMEAMLYALDQINSDPDLLPNITLGARILDTCSRDTYALEQSLTFVQALIQKDNSDVRCSNGEPPIIPKPERVVGVIGASASSVSIMVANVLRLFAIPQISYASTAPELSDNNRYDFFSRVVPPDSFQAQAMVDIVKAMGWNYVSTLASEGNYGESGVDAFIQISREAGGLCIAQAIKIPREPRPGEFDKIIKRLMETSNARGVIIFANEDDIKRVLEAAKRANLTGHFLFVGSDSWGAKISPILNQEDVAEGAVTILPKRASIEGFDQYFTTRSLENNRRNIWFAEFWEDDFKCKLTRPGIRGDGGLRKCTGEERIGRDSGYEQEGKVQFVIDAVYAMAHALHSMHIDLCPGSMGVCDKMDPVDGRMLLTYIRAVNFNGSAGTGVMFNENGDAPGRYDIFQYQLSNTTNPGYKLIGQWTNHLRLSAEDMQWSGGEKLVPDSVCSFPCESGERKRMVKGVPCCWHCELCDGYQFLLDEFNCDMCPFDMRPTPNRTACRPTPIIKLEWSSPWAIIPVFLAVLGILATTGVIATFIRFNDTPIVRASGRELSYVLLTGIFLIYLITFLMIAEPGTVVCAFRRLLLGLGMCISYSAMLTKTNRIYRIFEQGKKSVTPPKFISPTSQLIITFILISVQLLGIFIWFGVVPPHTNVDFDELRPPNPEFARGILKCDMSDLSLIGCLSYSMGLMVTCTVYAIKSRGVPETFNEAKPIGFTMYTTCIIWLAFVPIFFGTSQSTEKMFIQTTTLTVSMSLSATVSLGMLYIPKVYVIIFHPEQNVQKRKRSFKAVAQAATVSTHLSQKSSDKQNGETKVEPDRSQ,,"sensory perception of sound (GO:0007605) (0.3611); phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200) (0.2022); chemical synaptic transmission (GO:0007268) (0.2014); G protein-coupled glutamate receptor signaling pathway (GO:0007216) (0.1973); glycosylation (GO:0070085) (0.1828); regulation of synaptic transmission, glutamatergic (GO:0051966) (0.1826); adult feeding behavior (GO:0008343) (0.0772); axon development (GO:0061564) (0.0437)",dendrite (GO:0030425) (0.3633); plasma membrane (GO:0005886) (0.2924); axon (GO:0030424) (0.1096); cell cortex (GO:0005938) (0.0776); cytoplasm (GO:0005737) (0.0734); endoplasmic reticulum membrane (GO:0005789) (0.0644),glutamate receptor activity (GO:0008066) (0.1156); group III metabotropic glutamate receptor activity (GO:0001642) (0.1097); protein heterodimerization activity (GO:0046982) (0.1092); adenylate cyclase inhibitor activity (GO:0010855) (0.0884),"Metabotropic Glutamate Receptor (IPR050726) (0.5242); GPCR, family 3, nine cysteines domain superfamily (IPR038550) (0.5080); Receptor, ligand binding region (IPR001828) (0.3683); GPCR family 3, C-terminal (IPR017978) (0.2881); GPCR, family 3, conserved site (IPR017979) (0.2540); Periplasmic binding protein-like I (IPR028082) (0.2329); GPCR, family 3, metabotropic glutamate receptor (IPR000162) (0.1740); GPCR, family 3 (IPR000337) (0.1184); GPCR, family 3, metabotropic glutamate receptor 4 (IPR001786) (0.0949)",3.40.50.2300 (0.2017); 2.10.50.30 (0.1450),Transmembrane helix (0.7186); G-protein coupled receptor (0.5884); Reference proteome (0.5689); Transducer (0.5470); Membrane (0.4652); Receptor (0.3418); Transmembrane (0.2894); Signal (0.2102); Cell membrane (0.1490); Ubl conjugation (0.1463); Glycoprotein (0.1381),
MVPKTRLGKRSPLGTLVCGSSAEGLTETGAHGCQDGGLHRSKLYPGQKVYVHCGGQECGGVVEQHNHVDNEVSIFLPQLNQHVHRKLEDVWTSPTSSSTSSVSSSIDVPRRSVEAVDMDEIMAAMVLTSLSCSPVVQHSTQGSVTPALCGMENGGSELSDGGYWSCDHGNGSPAPSPPIEETDKSNPHADEGLDMEMDQMLFNEPTPRKRKNSVKVAYWCLWPNCGKVLTTVVGIKRHIRNSHLGQSDEHSQREEDFYYTEVYQDFEQTAPPGGHRASCTSPSPIPSQHTPPSPSTPDTLQPSPLSQSAPGSFWQVHSEHSYQAPAPVQVVTQSKPVPVPVSCHWTPSLTVHQSKQGSPFRRRSVSVGEQWLQNNSASFRPHPASVSPPRNHCTSRRIRGEAKKCRKVYGIEHRDQWCTACRWKKACQRFLD,,regulation of transcription by RNA polymerase II (GO:0006357) (0.5901); negative regulation of cell population proliferation (GO:0008285) (0.1707); negative regulation of DNA-templated transcription (GO:0045892) (0.1284); B cell receptor signaling pathway (GO:0050853) (0.1153); response to insulin (GO:0032868) (0.0879); negative regulation of transcription by RNA polymerase II (GO:0000122) (0.0792); positive regulation of transcription by RNA polymerase II (GO:0045944) (0.0715); regulation of DNA-templated transcription (GO:0006355) (0.0538); regulation of gene expression (GO:0010468) (0.0512); cell-matrix adhesion (GO:0007160) (0.0453),nucleus (GO:0005634) (0.4152); nucleoplasm (GO:0005654) (0.1166); cytoplasm (GO:0005737) (0.1081),"DNA-binding transcription factor activity (GO:0003700) (0.3144); RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978) (0.2704); DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227) (0.1213); DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228) (0.1178); metal ion binding (GO:0046872) (0.1068); cis-regulatory region sequence-specific DNA binding (GO:0000987) (0.0883); sequence-specific double-stranded DNA binding (GO:1990837) (0.0819); transcription cis-regulatory region binding (GO:0000976) (0.0749)",Zinc finger C2H2-type (IPR013087) (0.3113); CR1/CR2 motif-containing transcription regulator (IPR052253) (0.1596),,Zinc (0.9287); Zinc-finger (0.8781); Reference proteome (0.7148); Transcription regulation (0.2564); DNA-binding (0.2145); Transcription (0.2099); Metal-binding (0.1318); Phosphoprotein (0.0994); Alternative splicing (0.0948); tRNA processing (0.0742); Nucleus (0.0534),
MEGSETVGLWADISICVFSNIHCTNQTNVTNSSTMAGIILSPYYQHSLPTAALFTLAYLFIFLLCLMGNALVCVIVLRNRHMRTVTNIFILNLAVSDLLVGIFCIPTTLVDNLITGWPFSNTVCKLSGLVQGMSVSASVFTLVAIAVDRFRCIVYPFKPKLTLFIAKVSIGTIWLLALTIMFPSVLMLTVEQERAHFMIYNDDYNNTYPLYSCYETWPDPEMRKIYTTVLFIHIYVIPLALIMLMYGRIGAKLYSAAVSEHANAQGKRKIRVVKMLIMVALLFMLSWLPLWTLMMLTDYGHPDNDSLEILTSYIFPLSHWLAFSNSSVNPIIYGYFNENFKRGFQAVFQRQACFRRRRKMRFRVKRPRQGCSPLNTGVLGSKTNRIFTESDLTGCVRLELEHRRASTIENKAEGGNSGSSGRREIHFEEIEKVSSVGGKIYNAWEH,,G protein-coupled receptor signaling pathway (GO:0007186) (0.8398); regulation of MAPK cascade (GO:0043408) (0.5111); neuropeptide signaling pathway (GO:0007218) (0.3598); regulation of cAMP-dependent protein kinase activity (GO:2000479) (0.0978); eating behavior (GO:0042755) (0.0620); response to pain (GO:0048265) (0.0557); regulation of adenylate cyclase activity (GO:0045761) (0.0524),plasma membrane (GO:0005886) (0.5233); cilium (GO:0005929) (0.0611),neuropeptide receptor activity (GO:0008188) (0.4897); opioid receptor binding (GO:0031628) (0.1879); peptide binding (GO:0042277) (0.1353),"GPCR, rhodopsin-like, 7TM (IPR017452) (0.3071); G protein-coupled receptor, rhodopsin-like (IPR000276) (0.2376)",1.20.1070.10 (0.4748),Transducer (0.8980); Membrane (0.7427); Transmembrane helix (0.7322); Reference proteome (0.6487); Cell membrane (0.4044); Transmembrane (0.3858); Receptor (0.1867); G-protein coupled receptor (0.1342),
MRDSGGSLSQNRWQGELSLTVSQEASSVAGMGGGLMDPNSPPNATSPIHLKLSNRERVWSEDYIEPVELDEEAGFDENEDDMEEDEEEDEEERDEEDIDSECAPWEEKDDLEDWQMPFESQPHVMLANTYQQQVTLTEGEAKSQARDFSENPFQMRLHGLRQQRLNRWRRLRSSARLRNRLVQNWKTWRQQAQWVGTLGYRRARRWRQYSLYASKKREKGCDTKGSTLRGLVTTSERETENQFSAYNGYGDSQSVSSLSGVREYLSMPMKPTIQRIEMTLTEEHKAYVHGLIEDDLRKYGSLIPVHADDIAEQLQSIFNEDFSQTHRKMAVQHLIQSYQRSSGTAMVKGFRVNYKRHVLTMDDLSTLYGQNWLNDQVMNMYGDLVMDSVPEKVHFFNSFFYDKLRTKGYDGVKRWTKNVDIFQKDLLLIPIHLEVHWSLVSVDIKRRSITYFDSQRTLNRRCPKHIFKYLQAEAMIKEKRDFLTGWKGFFKMNVGRQNNDSDCGAFVLQYCKCLALGQPFSFSQQDMPKLRRMMYKELCHCKLSL,3.4.22.- (0.9324),proteolysis (GO:0006508) (0.7821); Wnt signaling pathway (GO:0016055) (0.1952); protein desumoylation (GO:0016926) (0.1417); protein sumoylation (GO:0016925) (0.1262); negative regulation of double-strand break repair via homologous recombination (GO:2000042) (0.0986); central nervous system projection neuron axonogenesis (GO:0021952) (0.0938); positive regulation of protein ubiquitination (GO:0031398) (0.0758); fat cell differentiation (GO:0045444) (0.0714); negative regulation of protein binding (GO:0032091) (0.0653); labyrinthine layer development (GO:0060711) (0.0619); oligodendrocyte differentiation (GO:0048709) (0.0471),nucleus (GO:0005634) (0.2914); nucleolus (GO:0005730) (0.1251); cytoplasm (GO:0005737) (0.1225),deSUMOylase activity (GO:0016929) (0.1937),"Papain-like cysteine peptidase superfamily (IPR038765) (0.2883); Ulp1 protease family, C-terminal catalytic domain (IPR003653) (0.1991)",,Ubl conjugation pathway (0.9679); Reference proteome (0.6764); Thiol protease (0.4007); Protease (0.3331); Proteomics identification (0.2758); Nucleus (0.2478); Cytoplasm (0.2050); Hydrolase (0.1472); Developmental protein (0.1121); Ubl conjugation (0.0553),
MEQTYGEVNQLGGVFVNGRPLPNAIRLRIVELAQLGIRPCDISRQLRVSHGCVSKILARYNETGSILPGAIGGSKPRVTTPNVVKNIRDYKQSDPGIFAWEIRDRLLADGVCDKYNVPSVSSISRILRNKIGNLSQPNPYENGKQAPPQSSLSYNHIYPYSYPNAMSPSGTKMSSPPGVPVTGGHVSISRGWPSAHTVSNILGIRAFMDPTAIASAEGYAPKMEDWGVNRATFQSHGVNGIDKSSIDADIKYPQPSSTLSSYVPACAYSPSNQYGVYSGPAGGYVSPGHHWQAQGTSLTHPGGGVAMHPSDIHSSMAFKHAVRDGDRKPPSPLSKQQHEALSGIHGLSLSTSSS,,endoderm development (GO:0007492) (0.4519); regulation of transcription by RNA polymerase II (GO:0006357) (0.2630); adult behavior (GO:0030534) (0.1811); urogenital system development (GO:0001655) (0.1403); central nervous system development (GO:0007417) (0.1010); positive regulation of transcription by RNA polymerase II (GO:0045944) (0.0902); pronephros development (GO:0048793) (0.0902); bone morphogenesis (GO:0060349) (0.0871); thyroid gland development (GO:0030878) (0.0841); embryonic cranial skeleton morphogenesis (GO:0048701) (0.0772); somitogenesis (GO:0001756) (0.0641); odontogenesis (GO:0042476) (0.0420),nucleus (GO:0005634) (0.0883); nucleoplasm (GO:0005654) (0.0459),"RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978) (0.2066); DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981) (0.1036)",PAX family (IPR043565) (0.5296); Paired domain (IPR001523) (0.4006); Paired DNA-binding domain (IPR043182) (0.1867); Winged helix-like DNA-binding domain superfamily (IPR036388) (0.1571); Homedomain-like superfamily (IPR009057) (0.0802),1.10.10.10 (0.0952),Transcription regulation (0.9758); Paired box (0.6053); Reference proteome (0.5476); Developmental protein (0.4937); Transcription (0.4146); Nucleus (0.4020); DNA-binding (0.1620),
MADPEGESLESWLNKATNPSNRQEEWEYIIGFCDQINKELEGPQISVRLLAHKIQSPQEWESLQALTVLEACMKNCGGRFHNEVGKFRFLNELIKLVSPKYLGDRVSERVKTKVIELLYNCSVALPDEAKIAEAYHMLKKQGIVTKDPEVHVDRTLIPSPKTKNPVFDNEEKSKRLAELLKSKKPEDLQEANRIIKNMVKEDEALQQKVSNRVSTLEKVNNSVKLLNEMLSHFKTDESTQEDKELLKDLYNDCDNLRTAVFRLATETEDDDSALGDILHASDDLSRVINSYKKIVEGQTIVIDVPASTPSGCINDRSSSEILIDLADLGSGTPSPLRHGLTPPQHSDSPAADLLTLTSLMGAQPSSSNTSSGSSSFQTSPPSSQLPSSLSLLDEELGSFGLGSLDSNSRTSAEKTTKEAQSNQWISSQISNPVTDFLCSSTPLNPPNSAAPPTSKTTSITDFENSLQQSFKDLVLLDLDKTKSLSNYSSLSSRELAAGKENIHPALNTLSLSAGITPLPSAGSSAKPQSFAPDSPVFRSLSPTLPSSQSSSGSDISLTSVFVPLEAIKPSKECPVTAYDKDGVRVLLHFATDHPTGRPDVLVIVVSMLNTAPLLVRNVMLQAAVPKSMRVKLQPPSGTEMAPFNPFMPPSSITQIMLLANPLKEKVRMRYKLTFILGDQPVTASGEIDQFPLVEKWCHL,,intracellular protein transport (GO:0006886) (0.9238); protein localization to cell surface (GO:0034394) (0.8289); Golgi to plasma membrane transport (GO:0006893) (0.7255); Golgi to plasma membrane protein transport (GO:0043001) (0.2202); protein catabolic process (GO:0030163) (0.1271); protein targeting to lysosome (GO:0006622) (0.0601); protein destabilization (GO:0031648) (0.0466); vesicle-mediated transport (GO:0016192) (0.0415),early endosome membrane (GO:0031901) (0.6196); trans-Golgi network (GO:0005802) (0.5298); protein-containing complex (GO:0032991) (0.3142),ubiquitin binding (GO:0043130) (0.5844); small GTPase binding (GO:0031267) (0.2025); phosphatidylinositol binding (GO:0035091) (0.2014),"GAT domain (IPR004152) (0.2621); ADP-ribosylation factor-binding protein GGA1-3 (IPR027422) (0.1968); Clathrin adaptor, appendage, Ig-like subdomain superfamily (IPR013041) (0.1461); ENTH/VHS (IPR008942) (0.1352); Clathrin adaptor, alpha/beta/gamma-adaptin, appendage, Ig-like subdomain (IPR008152) (0.1132); Gamma-adaptin ear (GAE) domain (IPR008153) (0.1079)",1.20.58.160 (0.4044); 1.25.40.90 (0.3205); 1.20.5.170 (0.1611),Ubl conjugation (0.9976); Transport (0.7929); Protein transport (0.6417); Golgi apparatus (0.4486); Endosome (0.3154); Reference proteome (0.2879),
MEGDNTLITENTSLYMNISAGLNASSPVSLSVSEYSDAEVVLISILIGILVLVIVFGNALVISAIVRFQRLQTVTNYFISSLACADLVMGLMVVPFGACYILLNTWHFGNFFCEFWTATDVLCVTASIETLCVIALDRYIAIMWPLRYQSMLTKRKACGMVIGVWAVAALISFLPIHMEWWVSDEPEALSCLEEPTCCDFNTNAAYAVTSSIISFYIPLVIMAFVYSRVFQEARRQLQKIDRIEGRIRTQSLSTQEGNEIKNRRTKFCMKDHKALKTLGIIMGTFTLCWLPFFVLNVVAAIWKMDNIMLPFRILNWIGYANSAFNPLIYCRSPEFRCAFQEILCWRPSHLPSTRSKKGYLYSGHSWKVHTKTTRPREPSPACETEIGAECLTAGTKNKNGNYNKTVTSI,,norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure (GO:0002025) (0.6919); negative regulation of smooth muscle contraction (GO:0045986) (0.4392); response to cold (GO:0009409) (0.3245); positive regulation of MAPK cascade (GO:0043410) (0.3232); negative regulation of G protein-coupled receptor signaling pathway (GO:0045744) (0.2838); positive regulation of cold-induced thermogenesis (GO:0120162) (0.1202); adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880) (0.0998); diet induced thermogenesis (GO:0002024) (0.0846); positive regulation of heart rate by epinephrine-norepinephrine (GO:0001996) (0.0732); receptor-mediated endocytosis (GO:0006898) (0.0730),early endosome (GO:0005769) (0.5490); plasma membrane (GO:0005886) (0.1712); Golgi apparatus (GO:0005794) (0.1207),norepinephrine binding (GO:0051380) (0.5938); beta2-adrenergic receptor activity (GO:0004941) (0.4162); protein homodimerization activity (GO:0042803) (0.1964),"GPCR, rhodopsin-like, 7TM (IPR017452) (0.2810); Beta 2 adrenoceptor (IPR000332) (0.2495); G protein-coupled receptor, rhodopsin-like (IPR000276) (0.0823)",1.20.1070.10 (0.2071),Transducer (0.5671); Receptor (0.5180); Reference proteome (0.4865); Membrane (0.4004); Ubl conjugation (0.3598); Transmembrane (0.3226); Palmitate (0.3078); Glycoprotein (0.3012); Transmembrane helix (0.2955); Lipoprotein (0.2926); Disulfide bond (0.2860); G-protein coupled receptor (0.2745); Cell membrane (0.2234); Endosome (0.1780),
MSEYSAVPPPGPGAALGAGGLKKDAFADAVQRARQIAAKIGGDVTGPPMSNNGGAESYPFPTPKRSLEDGDQPESKKMASDRDNAAALSIGAQLAALSKQSVRPSSMTEEYRVPDGMVGLIIGRGGEQINKIQQDSGCKVQIAPDSGGLPDRSVSITGGPEAIQKAKMMLDDIVSRGRGTPPSFHESTNGSGHMQEMVIPAGKAGLIIGKGGETIKQLQERAGVKMILIQDASQGPNMDKPLRIIGDPYKVQQAREMVQEILRERDHPGFERNEYGSRMGGGGGGGGGGGGGGGGIEVPVPRHSVGVVIGRSGEMIKKIQNDAGVRIQFKPDDGTGPDKIAHIMGPPDRCEHAASIINELLQSIRVREEGGGGPPGPPGTGMPPGGRGRGRGPGGNWGGPPGSEMTFSIPAHKCGLVIGRGGENVKAINQQTGAFVEISRQPPPNGDPNFKLFTIRGSPQQIDHAKQLIEDKIEGPLCPVGPGPGGPGPAGPMGPYNPNPYQPGPPGGPPHGGPPGGQYPQGWGNAYQQWQPHDPSKAATDPNAAWAAYYAQYYQQPGGAAMPGQTPAAQPAAPGPADQSQAAPGAAQPDYTKAWEEYYKKMAAAGGGAAPAAAGGAQPAGAAAAAGQTDYSAAWAEYYRQQAAYYGQTGQTPGQPGATPQGQQAQ,,"regulation of transcription by RNA polymerase II (GO:0006357) (0.6514); mRNA processing (GO:0006397) (0.2545); intracellular mRNA localization (GO:0008298) (0.2417); mRNA catabolic process (GO:0006402) (0.2078); positive regulation of mRNA catabolic process (GO:0061014) (0.1558); regulation of mRNA stability (GO:0043488) (0.1210); positive regulation of gene expression (GO:0010628) (0.1137); positive regulation of DNA-templated transcription (GO:0045893) (0.1058); regulation of DNA-templated transcription (GO:0006355) (0.0920); RNA splicing (GO:0008380) (0.0705); nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) (0.0539)",cytoplasm (GO:0005737) (0.2882); nucleoplasm (GO:0005654) (0.1737); nucleus (GO:0005634) (0.1547); cytoplasmic stress granule (GO:0010494) (0.1126),mRNA binding (GO:0003729) (0.3549),"Far upstream element-binding protein, C-terminal (IPR015096) (0.3800); K Homology domain (IPR004087) (0.3721); K Homology domain, type 1 (IPR004088) (0.3024); Far upstream element-binding protein 2, first type I K homology domain (IPR047372) (0.2331); Far upstream element-binding protein 2, second type I K homology domain (IPR047369) (0.2308); K Homology domain, type 1 superfamily (IPR036612) (0.2236); Far upstream element-binding protein 2, fourth type I K homology domain (IPR047371) (0.0938)",3.30.1370.10 (0.2915),Nucleus (0.6086); RNA-binding (0.5002); Reference proteome (0.4753); Repeat (0.3408); mRNA splicing (0.2755); Phosphoprotein (0.2513); mRNA processing (0.2221); mRNA transport (0.1666); Acetylation (0.1501); Transcription regulation (0.1361); Alternative splicing (0.1266); Isopeptide bond (0.1259); Proteomics identification (0.1051); Transcription (0.0892); DNA-binding (0.0858),
MNFIALLLTSTCFFSCINAKYHYNQDKDKELKYLLEPLVFAEVSARRGHAAILPCVMRFKPSHYRVKWTKLEPSSRGVENIVLITNGHADKQYGSVGPRAALQRAHDLDVSLRLSDLELEDDGSYRCELINGIEDESVIITLRIEGVVFPYQSQKGRYRFTFFDAKEACAEQDATLATYKQLYRAWTEGLDWCNAGWLIDGTVSYPVLHPRPACGGDLLSGIRSYGPRHKTRENYDAFCFTSTTKGSVFFIEGQLNFAEAERACRRDGAGLAKTGQIYSSWRFQQLDRCDGGWLEDGSVRFPIINPREHCGGIAEPGVRSFGFPSKSMRLYGAYCYR,,"positive regulation of neuroblast proliferation (GO:0002052) (0.9919); cell adhesion (GO:0007155) (0.8548); glial cell differentiation (GO:0010001) (0.7994); skeletal system development (GO:0001501) (0.7840); fin regeneration (GO:0031101) (0.3707); synaptic transmission, GABAergic (GO:0051932) (0.2892); central nervous system development (GO:0007417) (0.2385); axon extension involved in axon guidance (GO:0048846) (0.2070); extracellular matrix organization involved in endocardium development (GO:0061148) (0.0735)",perineuronal net (GO:0072534) (0.6436); extracellular space (GO:0005615) (0.3185); synapse (GO:0045202) (0.3014); plasma membrane (GO:0005886) (0.1895),hyaluronic acid binding (GO:0005540) (0.5924),Immunoglobulin subtype (IPR003599) (0.2833); Immunoglobulin-like fold (IPR013783) (0.2678); Immunoglobulin-like domain (IPR007110) (0.2423); Immunoglobulin V-set domain (IPR013106) (0.2081); Link domain (IPR000538) (0.1928); Immunoglobulin subtype 2 (IPR003598) (0.1694); Hyaluronan-binding Proteoglycan (IPR050691) (0.1563); C-type lectin fold (IPR016187) (0.1283); C-type lectin-like/link domain superfamily (IPR016186) (0.1211),2.60.40.10 (0.2020); 3.10.100.10 (0.1781),Secreted (0.7347); Signal (0.6887); Repeat (0.4339); Reference proteome (0.2583); Disulfide bond (0.2360); Membrane (0.2013); Direct protein sequencing (0.1883); Hyaluronic acid (0.1768); Transmembrane (0.1552); Extracellular matrix (0.1438),
MESSFIAYSMFICIVLSGLWDAAQGRRLHLGSCKVNIHTHELRHHFQYVRQGMISGDDHKGIRLLRKDVMSSLQATESCCFLSQLLHFYMDTVFISYTSSHSLHRRTTSVLANSFLSISKDLRVCHANAHCECGENTRLQLKSIQTAYEKLDQAAGTVKAIGELDSLLEWIESFQQQ,,immune response (GO:0006955) (0.3342); negative regulation of inflammatory response (GO:0050728) (0.2925); positive regulation of immunoglobulin production (GO:0002639) (0.2851); negative regulation of cell population proliferation (GO:0008285) (0.2749); negative regulation of T cell proliferation (GO:0042130) (0.2498); positive regulation of DNA-templated transcription (GO:0045893) (0.2373); negative regulation of endothelial cell apoptotic process (GO:2000352) (0.1841); positive regulation of gene expression (GO:0010628) (0.1481); positive regulation of cytokine production (GO:0001819) (0.1468); negative regulation of transcription by RNA polymerase II (GO:0000122) (0.1354); negative regulation of B cell proliferation (GO:0030889) (0.1202); cellular response to lipopolysaccharide (GO:0071222) (0.1129); response to lipopolysaccharide (GO:0032496) (0.0825); cellular response to leukemia inhibitory factor (GO:1990830) (0.0822); defense response to bacterium (GO:0042742) (0.0758); positive regulation of miRNA transcription (GO:1902895) (0.0752); positive regulation of transcription by RNA polymerase II (GO:0045944) (0.0708); negative regulation of BMP signaling pathway (GO:0030514) (0.0701); positive regulation of p38MAPK cascade (GO:1900745) (0.0642); cellular response to tumor necrosis factor (GO:0071356) (0.0599); positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427) (0.0588); negative regulation of low-density lipoprotein particle clearance (GO:0010989) (0.0515); positive regulation of stress-activated MAPK cascade (GO:0032874) (0.0450); negative regulation of angiogenesis (GO:0016525) (0.0424),extracellular space (GO:0005615) (0.3041),cytokine activity (GO:0005125) (0.3651),"Interleukin-10, conserved site (IPR020423) (0.2813); Interleukin-10 family cytokines (IPR050594) (0.1653); Interleukin-22 (IPR020453) (0.1363)",,Signal (0.9559); Secreted (0.8797); Cytokine (0.5875); Disulfide bond (0.3033); Reference proteome (0.2176); Glycoprotein (0.1005),
MIPECPRTTDSRSRIRCESGHNRSGLLREIRTAIRSEPFTERYDVIPGKELGRGKFAVVRKCVEKSSGKEFAAKYMRKRRKGQDCRTEIIHEIAVLELAAACPRVVNLHEVYEMPSEMVLVLEYAAGGEIFNQCVADRDEAFTEQEVKRLMKQILEGVSFLHNNNVVHLDLKPQNILLTSESPLGDIKIVDFGLSRLLSNSHEVREIMGTPEYVAPEVLNYEPISTATDMWSIGVLVYVMLTGISPFLGDDKQETFLNISQINISYSEEELEQLDGSAIRFIKSLLIKEPENRATAEDCLKHQWLQTEEQDLIESSVSPGTSSPDEEEEEELIVMAAYTLGQCRQTPEQKDVSKRFKFEELSGDFIY,non-specific serine/threonine protein kinase (2.7.11.1) (0.9454),protein phosphorylation (GO:0006468) (0.9194); intracellular signal transduction (GO:0035556) (0.7404); positive regulation of apoptotic process (GO:0043065) (0.5277); positive regulation of fibroblast apoptotic process (GO:2000271) (0.5275); apoptotic process (GO:0006915) (0.4432); cellular response to type II interferon (GO:0071346) (0.1098); protein autophosphorylation (GO:0046777) (0.1042); positive regulation of gene expression (GO:0010628) (0.0811); establishment of cell polarity (GO:0030010) (0.0517),nucleus (GO:0005634) (0.2593); actin cytoskeleton (GO:0015629) (0.1955); nucleoplasm (GO:0005654) (0.0931); cytosol (GO:0005829) (0.0665),ATP binding (GO:0005524) (0.2768); protein serine/threonine kinase activity (GO:0004674) (0.2670); protein serine kinase activity (GO:0106310) (0.2158),"Protein kinase domain (IPR000719) (0.3547); Protein kinase, ATP binding site (IPR017441) (0.3243); Serine/threonine-protein kinase, active site (IPR008271) (0.3053); Protein kinase-like domain superfamily (IPR011009) (0.2668)",1.10.510.10 (0.4038),Serine/threonine-protein kinase (0.7873); Transferase (0.7030); Nucleotide-binding (0.6293); Kinase (0.3697); ATP-binding (0.2660); Reference proteome (0.2488); Phosphoprotein (0.0785),
MDFDLPPSVPVSGIPWERVLPPLFPRLNGTIGPYSWTPTEFLIPVTEQTGAAKVTCDHNGFTVEVDVKHFSPEELLVKVSGDYVVVEGKHEQKKDGSGLVTRQFNRRYRIPNGVNIMALESAMSPEGMLVISAPLTQTIPEH,,response to heat (GO:0009408) (0.4270); negative regulation of protein-containing complex assembly (GO:0031333) (0.2229); locomotory behavior (GO:0007626) (0.2163); protein refolding (GO:0042026) (0.1815); determination of adult lifespan (GO:0008340) (0.1792); mRNA processing (GO:0006397) (0.1715); negative regulation of apoptotic process (GO:0043066) (0.1361); response to virus (GO:0009615) (0.1147); negative regulation of DNA-templated transcription (GO:0045892) (0.0838),nucleus (GO:0005634) (0.2717),unfolded protein binding (GO:0051082) (0.1870); metal ion binding (GO:0046872) (0.1857); protein homodimerization activity (GO:0042803) (0.1274),"Alpha crystallin/Small heat shock protein, animal type (IPR001436) (0.3428); HSP20-like chaperone (IPR008978) (0.3278); Alpha crystallin/Hsp20 domain (IPR002068) (0.2035)",2.60.40.790 (0.1382),Stress response (0.6112); Metal-binding (0.1838); Reference proteome (0.1091),
MAYSSSHSAPPEISILFKQEPPLGKKQVTYRIPALIYISDKQTFLAFAEKRKTPSDTDADVLVMRKGLWKNDNQVEWVSDQQVFTSACLPNHRSMNPCPVYERESKTLFLFFICVPLGVSERKQIKEDKNQARLCYITSKDTGETWSAVSDLTADVIGEQEKNWATFAVGPGHGVQMKSGRLIIPAYAYRYTDKPVCILCCCLSFCTPYALAFYSDDQGITWKAGQQMDVESCECQMAEIVGEKGDSTLYCNARTRLGYRTEALSNNAGEDFDTVLSSNKLIETGKGCQGSVLSFLEQSSPPQTWLLYSHPSNPKKRVDLGLYLNKSPLDSSGWSDEPLMILHHGPSAYSDLVEFEPGHFACLMECGKEYENEEIAFLLFKLPEKKL,exo-alpha-sialidase (3.2.1.18) (0.9987),ganglioside catabolic process (GO:0006689) (0.5479); oligosaccharide catabolic process (GO:0009313) (0.5309); positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742) (0.4354); glycoprotein catabolic process (GO:0006516) (0.3349); negative regulation of clathrin-dependent endocytosis (GO:1900186) (0.1189); lipid catabolic process (GO:0016042) (0.0506),cytoplasm (GO:0005737) (0.3798); early endosome membrane (GO:0031901) (0.2077); lysosomal membrane (GO:0005765) (0.1824); membrane (GO:0016020) (0.1648); lysosome (GO:0005764) (0.1294); plasma membrane (GO:0005886) (0.1161),exo-alpha-(2->6)-sialidase activity (GO:0052795) (0.4250); exo-alpha-(2->8)-sialidase activity (GO:0052796) (0.3320); exo-alpha-sialidase activity (GO:0004308) (0.2931); exo-alpha-(2->3)-sialidase activity (GO:0052794) (0.2509),Sialidase (IPR011040) (0.2578); Sialidase superfamily (IPR036278) (0.1825),2.120.10.10 (0.2817),Reference proteome (0.5409); Glycosidase (0.3763); Lipid degradation (0.3381); Lipid metabolism (0.2874); Repeat (0.2580); Hydrolase (0.2573); Carbohydrate metabolism (0.2566); Proteomics identification (0.2246); Membrane (0.1732),
MRRFSELIVCLVTLVVAEDQLPEIRAIAGEDAVLRCSAKSETGVQYRSVIWYKVDEAEPSQQLTGLVRKRLTEDDGKVEKYNGVEREVVLLEDSKNLILSNVTAEDSGIYRCFLSAPLGYQNQRGDIILTVYKPQTVERMEFNKSSLVYLGEIAAIAGLFLGFLFFGISYVYIRSFNQRGKKLSLLKMPSPGKNLITSNHLICKTLPEVYV,,immune response (GO:0006955) (0.3563); positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002860) (0.2496); negative regulation of type II interferon production (GO:0032689) (0.1832); monoatomic ion transmembrane transport (GO:0034220) (0.1504); inflammatory response (GO:0006954) (0.1377); innate immune response (GO:0045087) (0.1144); mitochondrial fusion (GO:0008053) (0.0874); negative regulation of regulatory T cell differentiation (GO:0045590) (0.0764); defense response to virus (GO:0051607) (0.0733); T cell activation (GO:0042110) (0.0684),plasma membrane (GO:0005886) (0.2308); virion membrane (GO:0055036) (0.1003); external side of plasma membrane (GO:0009897) (0.0953),protein homodimerization activity (GO:0042803) (0.5685); identical protein binding (GO:0042802) (0.0427),Immunoglobulin-like domain (IPR007110) (0.3178); Immunoglobulin-like domain superfamily (IPR036179) (0.2670); Immunoglobulin subtype (IPR003599) (0.2360); Immunoglobulin V-set domain (IPR013106) (0.1923),2.60.40.10 (0.2547),Signal (0.5854); Transmembrane helix (0.4362); Reference proteome (0.3594); Transmembrane (0.2640); Membrane (0.2587); Immunoglobulin domain (0.2125); Disulfide bond (0.1109); Glycoprotein (0.0872); 3D-structure (0.0659),
MMGLGSENKTVSTSSKFALQQLGEGKEEEELARTTTDRAEATRLANVEQQAAEPRETWGRRLEFVLATIGYAVGLGNVWRFPYLCYRSGGGAFLIPYMIMLFLCGIPLLFMEFTVGQYTRLGPVHALAQICPLFKGVGLATVVISYVLCTYYNVLMTWALYYLLHSFSPSLPWQSCNNTWNTVANCSTGFPGNATHLQSASQQFFDHKVLEMTSGIERAGGVRWELFGLLVLAWGIVYFCIFKGVKSTGKVVYFTATFPYFILFALLVNNVQLPGAKNGILFFLMPNWSKLLEVQVWVNAAAQIFNSIGISFGSMISMASYNKYNNNILRDTFIVSLANSATSIVAGFVIFSAIGYMAHIHNLPVDDIATDGPGLVFVVYPEVFSTMPVSQLWAPLFFIMLLCLGLDSQFAMVEVAVTFIMDGFGRKALKVFKRKELIVLAVCSFGFLLGIPHITRGGIYVFQLMDHYTAVVSLMFLAFFEVLAVTLIFGVKRLSVMVENMLGKKPNLFFRICWQYLSPMLVLGILISSIVQYTPARYGKSYTYPLWAELLGWFISLVSIIWIPLGALHELWTTEGSLLQRLKKSITPTVDLESVSEKPSTESIALFNAP,,amino acid import across plasma membrane (GO:0089718) (0.2788); amino acid transport (GO:0006865) (0.2563); neurotransmitter transport (GO:0006836) (0.1943); positive regulation of multicellular organism growth (GO:0040018) (0.1622); sodium ion transmembrane transport (GO:0035725) (0.1545); response to toxic substance (GO:0009636) (0.1505); glycine import across plasma membrane (GO:1903804) (0.1393); taurine transmembrane transport (GO:0015734) (0.1072); locomotory behavior (GO:0007626) (0.1045); inhibitory postsynaptic potential (GO:0060080) (0.0739),plasma membrane (GO:0005886) (0.1251); presynapse (GO:0098793) (0.0965); apical plasma membrane (GO:0016324) (0.0731); membrane (GO:0016020) (0.0635); dense core granule (GO:0031045) (0.0508),neurotransmitter transmembrane transporter activity (GO:0005326) (0.0473); alanine transmembrane transporter activity (GO:0022858) (0.0465),Sodium:neurotransmitter symporter superfamily (IPR037272) (0.3624); Sodium:neurotransmitter symporter (IPR000175) (0.1906),,Transport (0.9303); Neurotransmitter transport (0.7790); Sodium (0.5288); Transmembrane (0.5022); Reference proteome (0.4833); Symport (0.4164); Transmembrane helix (0.3209); Synapse (0.1977); Disulfide bond (0.1180); Amino-acid transport (0.1067); Phosphoprotein (0.0872); Membrane (0.0765); Cell membrane (0.0640),
MFTFGVLLTLMVLNSSLAFSEVKKVIVYGGTGALGLESVRYFRAQNWWVASIAHSVNKEASANVKVKMTESFTDQAKQVTVGVGKLLGDEKVDAIYCVAGGQAEGNAKANSLYKYADLMWKENVWTSTICTHLATKYLREGGLLTLSGAKVALGPTAESVSFGMAKASVHQLTQSLSGPNSGLPPRSVALAILPETLDTPTNRRIMPNADVSSWTPLNHVTQLFFKWTVGESRPPSGSLVELVTANGRTVATPIKSP,"6,7-dihydropteridine reductase (1.5.1.34) (0.9022)",tetrahydrobiopterin biosynthetic process (GO:0006729) (0.6291); L-phenylalanine catabolic process (GO:0006559) (0.1927); L-phenylalanine metabolic process (GO:0006558) (0.1665); fatty acid metabolic process (GO:0006631) (0.0658),cytoplasm (GO:0005737) (0.1657); plasma membrane (GO:0005886) (0.0787); dendrite (GO:0030425) (0.0635),"6,7-dihydropteridine reductase activity (GO:0004155) (0.4960); NADH binding (GO:0070404) (0.2897); NADPH binding (GO:0070402) (0.1967); identical protein binding (GO:0042802) (0.1096)",NAD(P)-binding domain superfamily (IPR036291) (0.2985); Short-chain dehydrogenase/reductase SDR (IPR002347) (0.1024),3.40.50.720 (0.3314),Tetrahydrobiopterin biosynthesis (0.9066); Reference proteome (0.6569); Direct protein sequencing (0.6314); Oxidoreductase (0.5867); Phosphoprotein (0.4772); NADP (0.3616); 3D-structure (0.1934); NAD (0.1431); Acetylation (0.1123); Signal (0.0825),
METSGPFNPKLPSQFSSAPAPKPAPGPPPTAPKPALSFLPPPELQDHPSPAPWAEELRARTRPANLSTASVPAPVQSVAKGPAVAPKTNFPPSQLNSNLASKTVSPAPSGGARGFNHTVKSPPQSTFPPPPPAAPPAPIPPPANIPKPAFNHSETSPIGSHQSFAPPSPAAPKTSPVSTFNRPAGNNVPSKVSGSGTGSGPGGAPLTMREVEELEKMTKDFIQHMDKHPPVITSPATEVCGKCGETLSRSQPAVRAMDKLFHSHCFCCVSCQRPLQGMQFYDRDGTPQCEECYMSSLSVCSRCGERITDRVLKAMGQCFHAHCFLCTTCNCSLEGAPFITDDDNKPYCVKDYHRRFSPLCVSCNEPIIPDPGSEETVRVVALEKNFHLKCYRCEDCARPLSIEADADGCYPLNGKILCMKCHTQRNKQAKQ,,integrin-mediated signaling pathway (GO:0007229) (0.5988); cell adhesion (GO:0007155) (0.3843); response to hypoxia (GO:0001666) (0.3819); stress fiber assembly (GO:0043149) (0.2567); transforming growth factor beta receptor signaling pathway (GO:0007179) (0.1583); positive regulation of cell migration (GO:0030335) (0.1494); cellular response to type II interferon (GO:0071346) (0.0959); cell-matrix adhesion (GO:0007160) (0.0724); chordate embryonic development (GO:0043009) (0.0641); negative regulation of apoptotic process (GO:0043066) (0.0572),focal adhesion (GO:0005925) (0.5165); stress fiber (GO:0001725) (0.4173); cytoplasm (GO:0005737) (0.1693); plasma membrane (GO:0005886) (0.1380); adherens junction (GO:0005912) (0.1274); cytosol (GO:0005829) (0.0990); nucleus (GO:0005634) (0.0985); fibrillar center (GO:0001650) (0.0640),metal ion binding (GO:0046872) (0.1037),"Zinc finger, LIM-type (IPR001781) (0.0451)",2.10.110.10 (0.0649),Zinc (0.9298); Cytoplasm (0.6405); Repressor (0.5785); Cell adhesion (0.4280); Nucleus (0.2649); Metal-binding (0.2442); Reference proteome (0.2420); Cytoskeleton (0.2077); Repeat (0.1978); Transcription (0.1910); Cell junction (0.1815); LIM domain (0.1268); Transcription regulation (0.0629),
MMFALLVTLCISAVFAASSIDIQLDDHWNSWKSQHGKSYHEDVEVGRRMIWEENLKKIEQHNFEYSYGNHTFKMGMNQFGDMTNEEFRQAMNGYKHDPNRTSQGPLFMEPSFFAAPQQVDWRQRGYVTPVKDQKQCGSCWSFSSTGALEGQLFRKTGKLISMSEQNLVDCSRPQGNQGCNGGLMDQAFQYVKENKGLDSEQSYPYLARDDLPCRYDPRFNVAKITGFVDIPRGNELALMNAVAAVGPVSVAIDASHQSLQFYQSGIYYERACSSSRLDHAVLVVGYGYQGADVAGNRYWIVKNSWSDKWGDKGYIYMAKDKNNHCGVATTASYPLM,cathepsin L (3.4.22.15) (0.4670); 3.4.22.- (0.2406),immune response (GO:0006955) (0.8464); positive regulation of apoptotic signaling pathway (GO:2001235) (0.3102); positive regulation of peptidase activity (GO:0010952) (0.2568); proteolysis involved in protein catabolic process (GO:0051603) (0.2542); protein autoprocessing (GO:0016540) (0.1028); receptor-mediated endocytosis of virus by host cell (GO:0019065) (0.0685),extracellular space (GO:0005615) (0.4509); lysosome (GO:0005764) (0.3526); late endosome (GO:0005770) (0.0678),cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656) (0.4045); cysteine-type endopeptidase activity (GO:0004197) (0.1155),"Cathepsin propeptide inhibitor domain (I29) (IPR013201) (0.3068); Papain-like cysteine peptidase superfamily (IPR038765) (0.2956); Cysteine peptidase, cysteine active site (IPR000169) (0.2691); Peptidase C1A (IPR013128) (0.1928); Papain-like cysteine endopeptidase (IPR039417) (0.1775); Cysteine peptidase, histidine active site (IPR025660) (0.1450); Peptidase C1A, papain C-terminal (IPR000668) (0.1436); Cysteine peptidase, asparagine active site (IPR025661) (0.1269)",3.90.70.10 (0.2683),Zymogen (0.9830); Thiol protease (0.8644); Signal (0.8124); Reference proteome (0.5203); Protease (0.3536); Hydrolase (0.1896); Disulfide bond (0.1615),
MNTAVFSKFDQLRFEESGQNVERSSRSYLELIDGQRSDLLTSHKVMDGNDALKHRRNGGGKVRHKRQALQDMARPLKQWLYKHRDNPYPTKTEKILLALGSHMTLVQVSNWFANARRRLKNTVRQPDLSWALRIKLYNKYVQGNAERLSISSDDTASDDGENNLQMQASESDYNRAVHKSVIQDSRVKVGRNADPSVCDDYVSPPKYKNSLLNRYLNDSLRHVMASDKVMDSRKRNHSGSFSSNEYEDDFLSPSSEAEANFTYHTVTLDCGTRQSESGARKGGNNETYWKELHAAMALTNLAQVKESSAAGTTSCIIQKSSHIAEIKTVKVPIQPRH,,negative regulation of transcription by RNA polymerase II (GO:0000122) (0.4084); brain development (GO:0007420) (0.3456); embryonic hemopoiesis (GO:0035162) (0.2796); mesoderm development (GO:0007498) (0.2035); regulation of transcription by RNA polymerase II (GO:0006357) (0.1283); eye development (GO:0001654) (0.1169); positive regulation of gene expression (GO:0010628) (0.1039); retina development in camera-type eye (GO:0060041) (0.0952); neurogenesis (GO:0022008) (0.0911); muscle organ development (GO:0007517) (0.0838); negative regulation of DNA-templated transcription (GO:0045892) (0.0818); tendon cell differentiation (GO:0035990) (0.0788); regulation of DNA-templated transcription (GO:0006355) (0.0678); definitive hemopoiesis (GO:0060216) (0.0600); artery morphogenesis (GO:0048844) (0.0584); lens development in camera-type eye (GO:0002088) (0.0570); midgut development (GO:0007494) (0.0521); adrenal gland development (GO:0030325) (0.0508); anterior/posterior pattern specification (GO:0009952) (0.0494); neuron differentiation (GO:0030182) (0.0472); proximal/distal pattern formation (GO:0009954) (0.0448),nucleus (GO:0005634) (0.2499); chromatin (GO:0000785) (0.0404),"RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978) (0.3191); sequence-specific double-stranded DNA binding (GO:1990837) (0.1247); DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981) (0.1155)","Homeobox, conserved site (IPR017970) (0.2475); KN homeodomain (IPR008422) (0.2047); Homedomain-like superfamily (IPR009057) (0.1461); Homeodomain (IPR001356) (0.1290)",,Homeobox (0.3709); Repressor (0.3549); DNA-binding (0.3461); Nucleus (0.3124); Reference proteome (0.3055); Transcription (0.2542); Differentiation (0.1221); Developmental protein (0.0971),
MSCFMPLCLSIWAVLMVPGRTSALNDNIEVMVMLPRNNTYLFSYTRVFPAIEYAKKALREADAYAGLRFNVRFENSACGMDALYALVDRQKDERPDLVLGPVCEYAASSVTRVASHWNIPVISAGALATGFNSKTPEYSHLTRIAPTYLKMAETFQAIFGHFGWRTAYLIYDDDKDERNCYFTMEGVFTVLSEYHISTDFAVLNSNEERVDPDGIITSVYGSEVVIMCSKADIVRDLMLAAHRRKLTSDSHIFFNIELFNSSSYGDGSWRRRDKYDDEARAAYSFLNTVTLLRSTKPEFEDFSIEMKKSLQQSNIPICEDCSAVNMFMEGFHDALLLYAIALREVKSKGLTKKNGLEITHSMWNRTFEGIAGQVSLDANGDRNGDFSVVRMTDPESGKHETVMNYFGTNGSFQILPGFKREWFSLRTIPPPKPLDPSCGLGVSAVTGIIVGGILGTALLLAFYFFRKNYRITIERRTLREECDIGKHRQLREDSIRSNFSAA,,skeletal system development (GO:0001501) (0.8188); blood vessel remodeling (GO:0001974) (0.7000); osteoclast proliferation (GO:0002158) (0.5393); regulation of osteoblast proliferation (GO:0033688) (0.5273); response to ischemia (GO:0002931) (0.4913); regulation of blood pressure (GO:0008217) (0.3312); positive regulation of urine volume (GO:0035810) (0.3122); angiogenesis (GO:0001525) (0.2719); signal transduction (GO:0007165) (0.2607); adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193) (0.0917); chemotaxis (GO:0006935) (0.0732),protein-containing complex (GO:0032991) (0.3713); plasma membrane (GO:0005886) (0.0871); membrane (GO:0016020) (0.0713),natriuretic peptide receptor activity (GO:0016941) (0.5211); peptide hormone binding (GO:0017046) (0.2034),"Periplasmic binding protein-like I (IPR028082) (0.4885); Adenylyl cyclase class-4/guanylyl cyclase (IPR001170) (0.3041); Atrial Natriuretic Peptide Clearance Receptor (IPR052612) (0.2347); Receptor, ligand binding region (IPR001828) (0.1993)",3.40.50.2300 (0.3318),Membrane (0.4241); Transmembrane helix (0.4098); Reference proteome (0.3066); Transmembrane (0.2799); Signal (0.2573); Glycoprotein (0.2238); Receptor (0.1209); Nucleotide-binding (0.0916),
MSIPCSILGMNDVPWQETQCGTLHTNGAPETGGVRVHAGCPLATVGGARQVPGGVHPLQGMANPNPCTQPLLSGRSQDDATVGYFFQRQPGEQMGGCTGNKHRWPTGDGNHVDQLRSVDEMNYNFQALALESRGMGELLPAKKLWESDELAKDGRKAMLVGEEWRENAWSSSHHALSQPIMVQKRPGQGYNGTGETSSVLSPRSEGGGLGVSMVEYVLSSSPGDKMDGRYRNGGYGEADADPDGREKGESKEKSSPFEENKSPEMKVGDEGDTSKANARGLLNGMDRDCKDFNPTPGSRQASPTEAVERLGPSQAGLEIMVQHHQHTLQAPNPVTNKPPPEDFQSQEAQNMGGMEQQAGLEALQFDYGGNQIQLDSSGAAVGLFNYDSQQQLFQRSSHLTVQQLNAAQQQQYALAAAQQQHLGLAPAFVPNPYIINAAPPGADPYTAAGLAAAATLAGPAVVPPQYYGVPWGVYPANLFQQQATAAASHSANQQASSQGPGQQVIRAGSNQRPLTPGQSQQSQQESLAAAATNPTLAFPGMSGYQVLAPAAYYDQTGALVMGPGTRTGLGGPVRLVQTPLLINPAAAQAAAAASVSGSGNSMSGPANGLYRSMACQQPQQPQPQQQLPPPSSGLPSNSFYGSGSVAPSSQSSSLFSHTSAAPPPSTSLGFSSTSGSLGVGLGSALGAFGSSVSSSTNSSAVRRDSLLASSELYKRGGGGSLTPIGQSFYNSLGYSSSPSPIGLTPGHSPLTPPPSLPSSHGSSSSIHLGGLPNGSGRYISAAPGAEAKYRSSGSTSSLFSSSSQLFPPPRARYSRSDVMPSGRSRLLEDFRNNRFPNLQLRDLPGHMVEFSQDQHGSRFIQQKLERATSAERQMVFGEILQAAYQLMTDVFGNYVIQKFFEFGSADQKLALATRIRGHVLPLALQMYGCRVIQKALESISSDQQVISDIVRELDGHVLKCVKDQNGNHVVQKCIECVQPQALQFIIDAFQGQVFVLSTHPYGCRVIQRILEHCTQEQTLPILEELHQHSEQLGQKYQGVSLEMTPKTYYTVSSDALFKDQYGNYVIQHVLEHGRPEDKSKIVAEVRGKVLALSQHKFASNVVEKCVIHSSRAERALLIDEVCCQKDGPHSALYTMMKDQYANYVVQRMIDMAEPAQRKIIMHKIRPHIATLRKYTYGKHILAKLEKYYMKSGSDLGPIGGPTNGLM,,skeletal system development (GO:0001501) (0.4773); regulation of mRNA stability (GO:0043488) (0.4559); hair follicle development (GO:0001942) (0.3735); regulation of chromosome segregation (GO:0051983) (0.3509); post-transcriptional gene silencing (GO:0016441) (0.2727); positive regulation of miRNA-mediated gene silencing (GO:2000637) (0.2643); miRNA processing (GO:0035196) (0.2278); positive regulation of RIG-I signaling pathway (GO:1900246) (0.2144); adult locomotory behavior (GO:0008344) (0.1918); adipose tissue development (GO:0060612) (0.1782); respiratory electron transport chain (GO:0022904) (0.1552); spermatogenesis (GO:0007283) (0.1351); regulation of translation (GO:0006417) (0.1307); mitochondrion organization (GO:0007005) (0.1135); chromosome organization (GO:0051276) (0.0954); regulation of postsynapse assembly (GO:0150052) (0.0930),nuclear membrane (GO:0031965) (0.1995); cytoplasm (GO:0005737) (0.1346); perinuclear region of cytoplasm (GO:0048471) (0.1286); cytosol (GO:0005829) (0.1175),mRNA 3'-UTR binding (GO:0003730) (0.3579); lncRNA binding (GO:0106222) (0.1665); miRNA binding (GO:0035198) (0.1272); RNA binding (GO:0003723) (0.0872),"Pumilio RNA-binding repeat (IPR001313) (0.4909); Pumilio homology domain (IPR033133) (0.4508); Pumilio, RNA binding domain (IPR033712) (0.3145); Armadillo-like helical (IPR011989) (0.2148)",1.25.10.10 (0.0952),Repeat (0.6071); Reference proteome (0.1134),
MEDNVCHSNREQLGLQFTIDYLLYNKGRSTGRAEPEDNVNPSEDLQSTVNEPEQKTLSEQDSEKSEEQENDEDHENTHVKSEGTDEKPAQSYIALISMAILDSDEKKLLLCDIYQWIMDHYPYFKSKDKNWRNSVRHNLSLNECFIKAGRSDNGKGHFWAIHPANFQDFSNGDYHRRRARRRIRRVTGQLPYALPAHYQTLGRLKRTPCWCCPPSHPLLCFPPRVYWSWAALQTQRTPALHGLI,,regulation of transcription by RNA polymerase II (GO:0006357) (0.3883); negative regulation of transcription by RNA polymerase II (GO:0000122) (0.2724); anatomical structure morphogenesis (GO:0009653) (0.2260); cell differentiation (GO:0030154) (0.2140); cerebral cortex development (GO:0021987) (0.1727); somitogenesis (GO:0001756) (0.1613); negative regulation of neuron apoptotic process (GO:0043524) (0.1334); heart development (GO:0007507) (0.0912); visual learning (GO:0008542) (0.0817); positive regulation of transcription by RNA polymerase II (GO:0045944) (0.0806); blood vessel development (GO:0001568) (0.0544); lens development in camera-type eye (GO:0002088) (0.0526),nucleus (GO:0005634) (0.0764),"RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978) (0.1100); DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981) (0.1074); DNA-binding transcription factor activity (GO:0003700) (0.0918); DNA binding (GO:0003677) (0.0877)",Winged helix DNA-binding domain superfamily (IPR036390) (0.4555); Winged helix-like DNA-binding domain superfamily (IPR036388) (0.2771); Fork head domain (IPR001766) (0.0886),1.10.10.10 (0.3161),Transcription regulation (0.4129); Ubl conjugation (0.3972); Nucleus (0.3586); Reference proteome (0.3354); Activator (0.2647); DNA-binding (0.2283); Zinc (0.1148); Transcription (0.0981),
MSLPHILEETLIKRSQQKKRTSPLNYKERVFVLTKSKLTYYELRAEKRFKKGSVDLQRVKCVEIVKNNTTVIPCQNKYPFQVVYDSSTLYIFAPSNESRSVWVQNIKEEIRNNPLIADKYHSQFWQEGEWLCCGQVDKLAPGCEGYNLFGDVSRKPLPPVPEDQNISCTGRRPPPPPPGETKQEEEEPEEEVVIALYDFEGLEPHDLTLKTGEEYVILEKCEVNWYKARNKEGKQGYIPSNYVTEKASDKLEQFIWFSKNVNRNKAEELLRKEGKEGGFMVRLSSNTGTYTVSLYTKSTSDGAAAIRHYQIKEIHASPKQFYLAEKYIFTSIPELIEYHKHNAAGLVSRLRHAVGDQKREAPTTAGFSYDKWEINPSELTFMKELGSGQFGVVRLGKWRAQHKVAIKTIREGAMSEDDFIEEAKIMMNLSHRNLVQLYGVCTQQKPIYLVTEFMELGCLLNFLRQRRGTLAAQDLLGICHDISQGMQHLEENRFIHRDLAARNCLVNSSMVVKVSDFGMTRYVLDDQYWSSSGTKFPVKWSPPEVFNFCRYSSKSDVWSFGVLMWEVFTEGKMPFEHSQNHEVVLMVTQGHRLYRPKKAAPHIYNIMKMCWMEKPDERPTFSETSLMITNELEDDGSVS,non-specific protein-tyrosine kinase (2.7.10.2) (0.9504),adaptive immune response (GO:0002250) (0.9695); protein phosphorylation (GO:0006468) (0.7210); B cell receptor signaling pathway (GO:0050853) (0.2109); intracellular signal transduction (GO:0035556) (0.0896),plasma membrane (GO:0005886) (0.4291),metal ion binding (GO:0046872) (0.1944); non-membrane spanning protein tyrosine kinase activity (GO:0004715) (0.1730); protein tyrosine kinase activity (GO:0004713) (0.1648); ATP binding (GO:0005524) (0.1175),"Non-receptor tyrosine kinases involved in cell signaling (IPR050198) (0.3320); Serine-threonine/tyrosine-protein kinase, catalytic domain (IPR001245) (0.3216); Protein kinase-like domain superfamily (IPR011009) (0.2352); SH3-like domain superfamily (IPR036028) (0.2297); SH3 domain (IPR001452) (0.1817); Protein kinase domain (IPR000719) (0.1747); Tyrosine-protein kinase, active site (IPR008266) (0.1088); Zinc finger, Btk motif (IPR001562) (0.0965)",2.30.29.30 (0.3714); 1.10.510.10 (0.3388); 2.30.30.40 (0.2208); 3.30.505.10 (0.0972),Zinc-finger (0.9178); Zinc (0.7491); Tyrosine-protein kinase (0.5556); ATP-binding (0.5083); SH3 domain (0.3312); Reference proteome (0.2976); SH2 domain (0.2742); Nucleotide-binding (0.2113); Kinase (0.2086); Transferase (0.2084); Metal-binding (0.0851),Zn(2+) (0.2850)
MHYLLAYLALMLVSESESFHLEPLSRFDWQKSIQTGERCPKKCHPERCPDVRQLQGCPAGLVRDQCGCCWECGNDEGQLCDPEPRSGLAFYGRCAEGLRCRAPRRNLAGQPRAVCVCGKQEALCGSDGKTYKNICQLQAAQHKQSKGPMLTMVHHGPCKTKPVITYAPRDIITSKGSDVMFSCEVSSYPLASIQWSKDGDVISFPADDSSTAVQARGGPRRFEMTGWLQIQGVGPSDAGVYTCIARNAFGEVSASARLQVTHGGSQLSKEFQQKQPGAYKISGEDENIDDEDYEGQPSGHMYL,,regulation of cell growth (GO:0001558) (0.9264); negative regulation of peptidase activity (GO:0010466) (0.8214); regulation of signal transduction (GO:0009966) (0.2031),extracellular region (GO:0005576) (0.5504); extracellular space (GO:0005615) (0.4509),insulin-like growth factor binding (GO:0005520) (0.5553); serine-type endopeptidase inhibitor activity (GO:0004867) (0.5071),"Immunoglobulin subtype 2 (IPR003598) (0.3851); Insulin-like growth factor-binding protein, IGFBP (IPR000867) (0.3706); Kazal domain (IPR002350) (0.3423); Insulin-like growth factor binding protein-related protein (IGFBP-rP), MAC25 (IPR011390) (0.1632); Immunoglobulin subtype (IPR003599) (0.1525); Kazal domain superfamily (IPR036058) (0.1304); Immunoglobulin-like domain (IPR007110) (0.1266); Immunoglobulin-like domain superfamily (IPR036179) (0.0919)",4.10.40.20 (0.5571); 3.30.60.30 (0.1205),Secreted (0.7393); Signal (0.5403); Immunoglobulin domain (0.4658); Serine protease inhibitor (0.3486); Disulfide bond (0.3217); Reference proteome (0.2569); Membrane (0.1036),
MWNDTDLLRNDSFSCASPSVEGYRYFGVLLGSAVTIVGTIGNILTVLAFVTDANLRTRFNVLIVNLAFADLLYCTILQPVSVDSYLHLHWRGGATWCRMFGLLLFLSNSVSIITLCLIAMSRYLVVAHRTSSCARLLLSQRGVAALLISSWVLGLASFAPLWPVYVFAPQVCTCSFHRTKGRPYTTVLLFLYFFLGLGFVGLFYFLIYRKVSVAAKAFLKYRPSRRSSKRKQAEAEGTTDDSGISAGASTTQSCEISSDGAVAEQHGKQAQEGQTTTQNATQHASSETTSKASPVVIQNTPAAANSGEDNEFKRVTRMCFTVFLCFVGCFAPFLLLNVADKKNRAPQVIHMICANLTWLNSCINPLLYAAMNRQFNQAYKDLLSKAAHPLRWFGRTHWFTSR,,"G protein-coupled receptor signaling pathway (GO:0007186) (0.6175); phototransduction (GO:0007602) (0.1377); cellular response to light stimulus (GO:0071482) (0.0810); learning or memory (GO:0007611) (0.0535); egg-laying behavior (GO:0018991) (0.0447); G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187) (0.0439); neuronal action potential (GO:0019228) (0.0433); regulation of receptor recycling (GO:0001919) (0.0421); cellular response to sucrose stimulus (GO:0071329) (0.0419)",receptor complex (GO:0043235) (0.3210); endosome (GO:0005768) (0.2130); presynaptic membrane (GO:0042734) (0.1997); plasma membrane (GO:0005886) (0.1552); cilium (GO:0005929) (0.1181),G protein-coupled receptor activity (GO:0004930) (0.1791); G protein-coupled photoreceptor activity (GO:0008020) (0.0765),"G protein-coupled receptor, rhodopsin-like (IPR000276) (0.2423); GPCR, rhodopsin-like, 7TM (IPR017452) (0.1487)",1.20.1070.10 (0.3152),Transducer (0.7222); Reference proteome (0.6727); Membrane (0.5572); G-protein coupled receptor (0.5412); Receptor (0.4118); Transmembrane helix (0.3744); Endosome (0.1732); Transmembrane (0.1119); Vision (0.1038); Glycoprotein (0.1029),
MERRTSAKLHNYLSIFTFLCCFSSGELAQLVLPYENVDVIQGKMVVLQASYSSTDFQKNTVVWNYMQSATSTEMIISFVNGDFSHGTSQFAGRVGFFHNMPNTNLSLYINNTKVSDSGRYVCQVMIPGASGLTGTLNLNVKVPPSIPVCKVKEKPVLKANITLSCNSNEGKPAPKYKWIKTSPTSEVFFSPALNETAGTLKLNNLSSNMSGKYVCTSTNSAGEETCYINLEVITSTNAGMIAGVTFGCIVALILIVIFLIFMWTRRKDTEEDLANDIKEDAQAPKRVSWAKSGTGSDIISKNGTLSSIHTSSYPRDAHNHHHYPHSDTASIITATGSTAGYRSQPPVDATLERSLPGYNTNPAPTRGPFGPPSNNGGSQHTSMPRTAPAQPQIPRPPVLPTTVTAANISRMGGVPIMVPAQNQAGSLV,,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) (0.8077); protein localization (GO:0008104) (0.5243); bicellular tight junction assembly (GO:0070830) (0.2303); protein localization to cell junction (GO:1902414) (0.2230); cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742) (0.1279); homotypic cell-cell adhesion (GO:0034109) (0.0992); protein localization to cell surface (GO:0034394) (0.0846); postsynaptic modulation of chemical synaptic transmission (GO:0099170) (0.0674); cell-cell junction assembly (GO:0007043) (0.0456),adherens junction (GO:0005912) (0.4054); bicellular tight junction (GO:0005923) (0.1927); plasma membrane (GO:0005886) (0.1261); membrane (GO:0016020) (0.1113); protein-containing complex (GO:0032991) (0.0867); centrosome (GO:0005813) (0.0594); glutamatergic synapse (GO:0098978) (0.0594),cell-cell adhesion mediator activity (GO:0098632) (0.0800),Immunoglobulin-like fold (IPR013783) (0.1821); Immunoglobulin subtype 2 (IPR003598) (0.1638); Immunoglobulin subtype (IPR003599) (0.1533); Endothelial cell-selective adhesion molecule (IPR042757) (0.1429); Immunoglobulin-like domain (IPR007110) (0.1145),2.60.40.10 (0.1634),Signal (0.7495); Transmembrane helix (0.6021); Transmembrane (0.5687); Membrane (0.4441); Reference proteome (0.3402); Disulfide bond (0.3375); Cell membrane (0.3355); Cell adhesion (0.3177); Glycoprotein (0.2747); Receptor (0.1971); Immunoglobulin domain (0.0892); Cell junction (0.0862); Repeat (0.0738); Tyrosine-protein kinase (0.0502),
MESRGSQEQNEIAKLTQMKSKVNRLKRSPKAAAPLNKNTAEFKTPTRPARGQFRRLIPDDSPSNDPDCHQDIVWDTTSPSPIRHGRGQRRAANVRAVDISDIANRIAPKSGRLEEADSSLLQWIGDSAIPCTPEVQQNKVKHTTTKQSTVDDLMRLAKQFDFNMRQDEAQEHNSPPEPPAHADPFSTAHYTSATSRASERPNDHKPVTQSKLNQEMDDDLDLLFDGPTQQLSGRLSQTLINRTQNVPERDNAKSDASQRHPSFATETNQDDFDDDWSSDGLFEDSLLLEMTQNPDLFAAPQYSSTQKQAHEVKNTVSVMTNKPCEAKNVGLHKTKVSQNNSQIQINGGLHRIGNQVENSCTNPKIGDQNKIKIVPQSCISTNQKQRFEHKAQHVVQKLSELNNACHFQKNERNAIKPSQSKPSSMHQNLISKQREDTNTGLDGFIDEDLDSFFASDDIWDDGVEDDDLFFEVCDNLEETSVTKAPQNKSFATSENAVFAHPYPPKRPAANVFTSSANTWVSQKAAGPGCNVSCDAARPSGSSSNGAYKFKQVRSSSVVGHGTCAALTQRGGQERGVLAVIQSEARDTDNHRFKKPHGELVRSAPVLAKDVCNPAVVKCSDAEIERKKQQAMERRRLKMLSNQNLRAPF,3.1.-.- (0.1660),DNA repair (GO:0006281) (0.4023); DNA damage response (GO:0006974) (0.3755); mitotic G2/M transition checkpoint (GO:0044818) (0.3732); regulation of DNA damage checkpoint (GO:2000001) (0.2216); DNA replication checkpoint signaling (GO:0000076) (0.2113); replication fork processing (GO:0031297) (0.1787); response to radiation (GO:0009314) (0.1780); mitotic intra-S DNA damage checkpoint signaling (GO:0031573) (0.1190); positive regulation of protein serine/threonine kinase activity (GO:0071902) (0.1037); mitotic sister chromatid segregation (GO:0000070) (0.0881); cellular response to ionizing radiation (GO:0071479) (0.0695),cytosol (GO:0005829) (0.6122); nuclear replication fork (GO:0043596) (0.4502); nucleoplasm (GO:0005654) (0.3972); chromosome (GO:0005694) (0.0999),,,,Ubl conjugation (0.7194); Nucleus (0.5255); Phosphoprotein (0.4324); DNA damage (0.3936); Mitosis (0.3812); Reference proteome (0.3303); Chromosome (0.2317); Proteomics identification (0.2295); Cytoplasm (0.2112); 3D-structure (0.1968); Isopeptide bond (0.1745); Cell cycle (0.1474); DNA repair (0.0938),
METVTDEDVTSSKLSKIELRKLKLAEYLAAKGRLKVPNPKPYLKGKPVTNKPAVNNQKIKITGNEKENCGISGANAKEVKRVKTLSGVDENTSLKKGLNIHSLAKAPVQFSSKLCNTQQANFNALRTKNNGTASLQNPKLLHKAEKTCTTRTHPQFLQNAQNKAQPASHVANKSQKSSLVSICGPSHSVYIKSSLKCTDPTYNSKTELKSAKILSKKLTELNIKTTTTATLKSRGPLNTTGTKFQTKNISKTQEKPTLQPKCQSGVPKYGTLSRNPALITWKSNSATNRSDINQRKDVSCMITKATKIQSHNPVTNRETKTSVSNVQAKPAQRPRSQSVVPVGTLNVNSQRINQKPNSATNRSDVYQRKDISCITMKVDGKKAIVSSIAANLKGSATITTKQHATLKASNAAASTKLHSRNTRSCVLPQTTSEHKELQQPVMRSNHTKPTVQFQTPKSSICPSSTQGVRTAPADGKKRLTEAQEERLRKLQEWRESRGITYKRPPMPVRLVRRKTVSAIPQPYWTSMENEDEGQDIVFAVERSLDDCIQLLQQGFPVEQVRDVMSRVPMAQKFAKYWICQARLMEREGNLEVLSLFEEAIRVVREPVDELRAVIFEILKKKQSQGQSPVSKESEEAETTVDDEHEDGDLMCTPKPVGALICGMRGDSSVVKYKITATPGGKRSQQGAEPGQVDGHEIRFFTPVRRSVRIEKTARRYPTALQEHDPCVTSMCDLAGESKEEVKDDSQPQSSPLYVYRENEALRDCVQVKLVYPEEVES,,negative regulation of microtubule depolymerization (GO:0007026) (0.5919); in utero embryonic development (GO:0001701) (0.2039); regulation of cell growth (GO:0001558) (0.1858); apoptotic process (GO:0006915) (0.1579); immune response (GO:0006955) (0.0798); fever generation (GO:0001660) (0.0683); cell division (GO:0051301) (0.0660); negative regulation of cell growth (GO:0030308) (0.0568); positive regulation of DNA-templated transcription (GO:0045893) (0.0546),mitotic spindle (GO:0072686) (0.8976); spindle pole (GO:0000922) (0.4478); cytoplasm (GO:0005737) (0.2885); microtubule organizing center (GO:0005815) (0.2001); nucleoplasm (GO:0005654) (0.1674); cytosol (GO:0005829) (0.1234); intercellular bridge (GO:0045171) (0.0566),,"Cytoskeleton-associated protein 2-like (IPR052855) (0.2170); Cytoskeleton-associated protein 2, C-terminal (IPR029197) (0.0894)",,Reference proteome (0.8871); Phosphoprotein (0.6332); Alternative splicing (0.3879); Cytoskeleton (0.3543); Proteomics identification (0.3413); Isopeptide bond (0.3304); Cytoplasm (0.3146); 3D-structure (0.2440); Mitosis (0.2059); DNA-binding (0.2013); Ubl conjugation (0.1960); Microtubule (0.1791); Repeat (0.1632); Cell cycle (0.1543); Nucleus (0.0581),
MATGSSFPSGGSGTRNGPSFASPSTSSVTSSGVPGQAQPMAVVWEWQDDLGFWRPYTGQVSSYIEQCLQHQRGAAVAGSSICLAQADPSLSSYIIDIPNLKQFRQDTGKMRAVRRSLFPQSSALGSGVLWEWSNDEGGWTAYEIRTSILLEHSYQAGQATADLSPHGYNYIVDLGALEQVNKATSYRRRVRRQGNVPYPLASGSVIHSGPACTCHQCVTNSSTAGPMLSRSRHSFSAGQAIRPSLQTQHGRLPVTSSSSSAYSPYPRRPLSMGSLLWNGPWSTPPSVPHPTGPPQNFSHHSNGLSIPTIPLHMNGSSSVNSALAAPAQKPEEVIKKYMEEVPVVPDEDCIICMERLSCPSGYEVPAECSQSLQPSTVGKLTKCAHTFHMLCMLAMYNNGTKDGSLQCPSCKTIYGEKTGTQPKGKMEIYSIPQSLPGHPDCGTIQIIYNIPPGIQGPEHPNPGQPYTCRGFPRFCFLPDNDKGRKVLELLKVAWTRRLIFTVGTSSTTGEPDTVIWNEIHHKTEMMSNVSGHGYPDPNYLDNVLSELASQGVTEDCLKRDAQGSAM,RING-type E3 ubiquitin transferase (2.3.2.27) (0.9960),Notch signaling pathway (GO:0007219) (0.9612); protein ubiquitination (GO:0016567) (0.7486); negative regulation of innate immune response (GO:0045824) (0.0928); proteasomal protein catabolic process (GO:0010498) (0.0674),cytoplasm (GO:0005737) (0.3889); nucleoplasm (GO:0005654) (0.2380); cytosol (GO:0005829) (0.0870); centrosome (GO:0005813) (0.0740),zinc ion binding (GO:0008270) (0.2239); ubiquitin protein ligase activity (GO:0061630) (0.1638),"WWE domain (IPR004170) (0.4476); WWE domain, subgroup (IPR018123) (0.2624); WWE domain superfamily (IPR037197) (0.2597); Deltex, C-terminal domain superfamily (IPR039399) (0.2177); Deltex, C-terminal (IPR039396) (0.1938); Zinc finger, RING-type (IPR001841) (0.1015)",3.30.390.130 (0.2533); 3.30.720.50 (0.1951); 3.30.40.10 (0.1417),Zinc-finger (0.9663); Transferase (0.8202); Zinc (0.7182); Notch signaling pathway (0.4925); Cytoplasm (0.2286); Repeat (0.2283); Metal-binding (0.2176); Reference proteome (0.1812),
MEADNAESWFSQSENGTILNSSKLGFLNASSPVGLWGDAQDKEVTRLEEIVHAQERAYKDFTTTIQVFILIGSLLGNTAVLWCTIYTNVFKSVTNLFIKNLACSGICAGLVCVPFDIALSASPLCCLWVHTLLLCKAIKFLHRLFCSATVLSFAVIALDRYYSVLYPLERKISDARSRDLVIYIWVHAVLASVPVFAVSNVTDVYATSSCSDGQSLGHLVYMITYSITTLILPLAVVFLAMVLIRRALSTSQKKKVIIAALRTPQNSISIPYVSQREAELHATLLSIVLVFTLCSTPYAALLIYHAILGAAKASSWLRLTAIWLPKVSLLTNPLFLLTVNRSVRRCLLDMLARLHRRYSRRNMVSIGGLAEVGPLGGETVVRSGSQLLEMFNIGQQQIFRPNEDEEDENEISSVASANFQPKDEGQGGNAGATDNTHQPQPGEGVKEEVLVLPKHSPIQSCAYSSSQVAPATPTDPEDATQFGFGPFELPPQWLPETRNSKKRLLPPLGNTPEELIQTKQPRVRPERRISRNNKVSTFPNVDP,,"G protein-coupled receptor signaling pathway (GO:0007186) (0.6401); adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193) (0.4498); circadian behavior (GO:0048512) (0.2026); associative learning (GO:0008306) (0.0934); serotonin receptor signaling pathway (GO:0007210) (0.0914); calcium-mediated signaling (GO:0019722) (0.0858); determination of adult lifespan (GO:0008340) (0.0821); cellular response to sucrose stimulus (GO:0071329) (0.0687); cellular response to reactive oxygen species (GO:0034614) (0.0654); G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187) (0.0542); chemical synaptic transmission (GO:0007268) (0.0491)",plasma membrane (GO:0005886) (0.3123); presynaptic membrane (GO:0042734) (0.1167); perikaryon (GO:0043204) (0.0760); dendrite (GO:0030425) (0.0616),G protein-coupled receptor activity (GO:0004930) (0.1989); G protein-coupled peptide receptor activity (GO:0008528) (0.1115),"GPCR, rhodopsin-like, 7TM (IPR017452) (0.0491)",1.20.1070.10 (0.1978),Transducer (0.9088); Reference proteome (0.7307); Ubl conjugation (0.5679); Membrane (0.4526); G-protein coupled receptor (0.4265); Transmembrane helix (0.3771); Receptor (0.3416); Glycoprotein (0.2431); Cell membrane (0.1986); Alternative splicing (0.0681); Transmembrane (0.0679); Cell projection (0.0556),
MAEQASGSTRPPQHDGVEQEQDRTDFLKLKQQLEMEFNQKRAKFKELYLSKEEELKRQTAILEKAQAEMCSVQEELADAKAEMETIKAVATLSESTKQEAIDQVKQLWQEEVASLQAIMKDAEREFKLQFQQKLEQERAQWTQYRDGVEREIAELRRRLSEGQEEENLENEMKKAQEDAEKLRSVVMPMESEIAALKAKLSSSEDRVKELEAAKVKELNHVLEAEKSCRTDLEMYVAVLNTQKSVLQEDAEKLRKELHEVVHLLELERQQHNQLKHTWQRANDQFLESQRLLMQDMQRIESVLSSEQLRQVEEIKKRDQEEDEQERLSQAKEASEDDGTEHAEAVEDSLLGLSIEESHLSHSIHSSLHSLDADTPGRPDSSDPYKDGLRRVQSTDSLGSSGGSLQPHGLGGHNNKAKSASQLDESDFGPLVGADCGGFDSMDTSSISSLQPGHFLLTKDQEKAIKAMTPEQEETASLLSSISHTADTAYLPPSGYRLVSESEWNLLQQELKNAGRKLGRRCDMCSNYEKQLQVIQGQEAETRDQVKKLQAILRQANDQLERTMNEKQELEDSVKQANEDTTAKISELKQKVQESESLFSALQQAFSQAKRNTQEQMAVLLQSREQVSEELNRLQRDNESLQGKHRLHMTLQQQEDFHMPTTVQELQKLVLQYREDIVSARTAAEHLEEKLKAEILFLKEQIQAEQCLKENLEDTLQLEIEGCKEEIASFSSLKTELERVKSEKEQLESSLAEKSQMLESVQRLKNSLEEQLKDTLGSKSALETQVFEEKDKSQRLQAELDVSEQVQRDFVKLSQTLQVQLERIRQAESLDRIRAILNDTNLTDISQLPET,,endocytosis (GO:0006897) (0.8792); protein transport (GO:0015031) (0.4742); protein localization to ciliary membrane (GO:1903441) (0.4379); Golgi to plasma membrane transport (GO:0006893) (0.3811); regulation of postsynaptic neurotransmitter receptor internalization (GO:0099149) (0.3774); macroautophagy (GO:0016236) (0.0440),endosome (GO:0005768) (0.2974); endocytic vesicle (GO:0030139) (0.2554); early endosome (GO:0005769) (0.2084); protein-containing complex (GO:0032991) (0.1474); secretory granule (GO:0030141) (0.1291); intracellular membrane-bounded organelle (GO:0043231) (0.1188); glutamatergic synapse (GO:0098978) (0.0833),growth factor activity (GO:0008083) (0.5017); GTPase activator activity (GO:0005096) (0.2437); protein homodimerization activity (GO:0042803) (0.1923); protein domain specific binding (GO:0019904) (0.0814),"Rabaptin, GTPase-Rab5 binding domain (IPR015390) (0.3432); Rabaptin (IPR003914) (0.2283)",1.20.5.730 (0.3041); 1.20.5.340 (0.2171),Transport (0.9915); Protein transport (0.7774); Endosome (0.5869); Endocytosis (0.5588); Reference proteome (0.4143); Coiled coil (0.4131); Cytoplasm (0.3714); Phosphoprotein (0.3262),
MRLVVCFLSLLTVFSAGQCGNILVWHTEGSHWINLKIVLDTLLDRGHNVTVLMPDGALFMKAKESDRFSYQNFSVSTSAQDMQDFLDELLHFSVFEMEQLNLLQIQMKFFDLGSRHQDMGLSYCDGILKSPELMDKLKTGKFDVLLSDPMYPCSDIVAEVLNVPLVFTLRFSIAHTMERICGQIPAPPSYVPGAMSKLTDKMSFTERIFNTLFYLSMDTFSIIAWKKFDNYYTEYFGRPTSYCEMMGRADIWLIRTYWDFEFPRPFVPNFKYIGGLHCTPAKPLPKDMEEFVQSSGDDGIVVFTLGSMIDKVPKEMSNRIASALAQIPQKVLWRYGGEKPDTLGENTRIYKWMPQNDLLGHPKTRAFITHGGTNGIYEAIYHGVPMVGIPLFGDQPDNMVHMTTRGAAVVVDSIKSMQPQELVDKLNTVINDPSYKENAMRLSRIHHDRPMKPLDESVFWIEFVMRNKGAKHLRVEAHNLTWYQYHCLDVFAFLTTVLTLVLYICFKMAKFFIMRCCFRSKRKSKKE,glucuronosyltransferase (2.4.1.17) (0.8636),cellular response to glucocorticoid stimulus (GO:0071385) (0.2613); estrogen metabolic process (GO:0008210) (0.1801); liver development (GO:0001889) (0.1458); steroid metabolic process (GO:0008202) (0.1430); xenobiotic metabolic process (GO:0006805) (0.1409); response to immobilization stress (GO:0035902) (0.1379); response to ethanol (GO:0045471) (0.1174); response to peptide hormone (GO:0043434) (0.1075); response to zinc ion (GO:0010043) (0.0874); cellular glucuronidation (GO:0052695) (0.0791); cellular response to ethanol (GO:0071361) (0.0713); sensory perception of smell (GO:0007608) (0.0542),endoplasmic reticulum membrane (GO:0005789) (0.2409); membrane (GO:0016020) (0.0728),glucuronosyltransferase activity (GO:0015020) (0.5948),"UDP-glycosyltransferase family, conserved site (IPR035595) (0.5489); UDP-glycosyltransferase (IPR050271) (0.3613); UDP-glucuronosyl/UDP-glucosyltransferase (IPR002213) (0.1224)",3.40.50.2000 (0.1715),Transmembrane helix (0.8834); Transferase (0.7404); Reference proteome (0.5459); Endoplasmic reticulum (0.3947); Membrane (0.3436); Glycoprotein (0.3410); Glycosyltransferase (0.3239); Transmembrane (0.3066); Signal (0.1792); Microsome (0.1523); Alternative splicing (0.1251); Proteomics identification (0.0892); Steroid metabolism (0.0758),
MTHPSTHLRLFLLLCVLSRSHAGKLLVVPVDGSHWINMKVLLVELHSKGHSITVVRASNSWYIEEQSPLYTSITVENGEFDADFGEKFLPHLLKMQRQGKSFWTEMALADETYSRFTEIHQEICKMTATMFENETLMNSLKDAAYDVVLTDPAFGGGVLLAHRLGLPLVFNVRWTMYGEAHFVIAPSPLSYVPVSGLQLTDKMTFSQRVMNMMTYIMILYKNSKYFGSPYQELTQKYFGPNVNFFSLLQDADLWLMRNDFTFEFPRPTMPNVVYMGGFQCKPAKPLPGDLEEFVQSSGEHGVIMMSLGAVFGQLLSELNDEIAAAFAQLPQKVIWRYTGPRPANLGNNSLIVNWLPQNDLLGHPKTKLFVAHGGTNGLQEAIYHGVPIVGLPLAFDQPDNLSRMRAKGTAKIVDIATLDRAVFLEALKEVLHNPSYRENMQRLSKLHHDQPMKPLDRAIFWIEFVMRNKGAPHLRTQSFRMSWIEYQSIDVILTLMVMVLVFALVTAYMTKYFCLRLFRKKVKRE,glucuronosyltransferase (2.4.1.17) (0.8231),cellular response to glucocorticoid stimulus (GO:0071385) (0.4118); estrogen metabolic process (GO:0008210) (0.3416); liver development (GO:0001889) (0.2556); steroid metabolic process (GO:0008202) (0.1226); xenobiotic metabolic process (GO:0006805) (0.1063); response to immobilization stress (GO:0035902) (0.0933); response to peptide hormone (GO:0043434) (0.0571); regulation of protein stability (GO:0031647) (0.0503); bile acid metabolic process (GO:0008206) (0.0499); response to ethanol (GO:0045471) (0.0477); cellular glucuronidation (GO:0052695) (0.0457); response to xenobiotic stimulus (GO:0009410) (0.0453); cellular response to ethanol (GO:0071361) (0.0415),endoplasmic reticulum membrane (GO:0005789) (0.1080),glucuronosyltransferase activity (GO:0015020) (0.5513),"UDP-glycosyltransferase family, conserved site (IPR035595) (0.4175); UDP-glycosyltransferase (IPR050271) (0.3348); UDP-glucuronosyl/UDP-glucosyltransferase (IPR002213) (0.1651)",3.40.50.2000 (0.2837),Transmembrane helix (0.7804); Reference proteome (0.5219); Transferase (0.4938); Membrane (0.3918); Glycosyltransferase (0.3351); Glycoprotein (0.2991); Endoplasmic reticulum (0.2256); Transmembrane (0.1915); Microsome (0.1831); Signal (0.1273),
MSGDPGLGIQLGLFYAILCQCVFGVVPPPANLSVVCHNFKNVLYWNYSSAVQQPTFTVNLIPYESKPQTVKTSQTHLDISSYSSEAIDHYVVSVTADVGQEISESLSVEFTYSTDFYNEKTHKCTLDFPAVDASVHKDVIEVSFKHPSAFYERASLEEEFEYTIILNPSSSSVPHLQEKSSHSCFEDELGYLCETKVHVNQSVVVQWVVLKFEGKIASIPVHTYKNVSVPQLEPASAKTEWIAAILCGSIALLFIVFVVLWFIHKNFSKIPKVPSILRNIVTRPYSTPYSQPESPHVSSMTSATHTPVLLYNNEPLLDFVHDEVSKTTDTLVNTEEEEPAPSEEEYDSSGGFGKSSDYDSPKCLLEMSPGDFPEGYGPRPPILQA,,cell surface receptor signaling pathway via JAK-STAT (GO:0007259) (0.8408); positive regulation of type II interferon production (GO:0032729) (0.5100); defense response to virus (GO:0051607) (0.4856); cytokine-mediated signaling pathway (GO:0019221) (0.2394); type II interferon-mediated signaling pathway (GO:0060333) (0.1254); positive regulation of activated T cell proliferation (GO:0042104) (0.1102); definitive hemopoiesis (GO:0060216) (0.0872); type I interferon-mediated signaling pathway (GO:0060337) (0.0843); response to lipopolysaccharide (GO:0032496) (0.0842); response to interferon-beta (GO:0035456) (0.0607); negative regulation of protein secretion (GO:0050709) (0.0431),plasma membrane (GO:0005886) (0.1954); cytosol (GO:0005829) (0.1561); external side of plasma membrane (GO:0009897) (0.0922); intracellular membrane-bounded organelle (GO:0043231) (0.0694),coreceptor activity (GO:0015026) (0.1236); cytokine receptor activity (GO:0004896) (0.0753),Fibronectin type III superfamily (IPR036116) (0.5620); Fibronectin type III (IPR003961) (0.3346); Immunoglobulin-like fold (IPR013783) (0.3050),2.60.40.10 (0.1380),Transmembrane helix (0.8428); Repeat (0.6045); Transmembrane (0.4693); Reference proteome (0.4156); Receptor (0.3800); Phosphoprotein (0.3449); 3D-structure (0.3392); Membrane (0.1775); Direct protein sequencing (0.1013); Alternative splicing (0.0979); Signal (0.0940),
MPSLPATLLAFLSILSLVFGGKVLVFPLDGSHWVNMKVLIEELHTRGHNVTVLRASNSWYIKEESPFYTSITVYNSGGIEKELFEEFSRNILVIRRQKRSFWTKLKLVSEVGAVFEEMHRNQLNLMGNIFKNKDLMDSLQTAKYDLLLTDPAVGGGFFLAYRLGLPLVLNVRWTMHGEAHFEIAPSPLSYIPVPGLELTDKMTFVQRVQNILVYMFSKFQKARTVSKHYRSFCEKYFGSEINYKAILQDADIWLMRNDFTFEFPRPTMPNIVYMGGFQCKPSKPLPDDLEEFVKSSGDHGLIVMSLGTLFTHLPEDITEEIAAAFAGLPQKIIWRHTGPRPVNIGDNTLLVDWLPQNDLLGHAKTKVFITHGGTNGIQEAIYHGVPILGLPLVFDQPDNLSRMKVRGTAKLLDIAELNRTMFLEALKEVLYNPSYKENIQRLSKVHHDQPMKPLDRAMFWIEFVMRNKGASHLRTQSFRMSWIEYHSIDVILTLLMILVLFCVLIYSIVKYTCLKVVFKKKVKTQ,glucuronosyltransferase (2.4.1.17) (0.8570),"cellular response to glucocorticoid stimulus (GO:0071385) (0.4544); estrogen metabolic process (GO:0008210) (0.2773); liver development (GO:0001889) (0.1570); xenobiotic metabolic process (GO:0006805) (0.1146); steroid metabolic process (GO:0008202) (0.1069); response to immobilization stress (GO:0035902) (0.0923); response to ethanol (GO:0045471) (0.0838); response to peptide hormone (GO:0043434) (0.0484); regulation of circadian sleep/wake cycle, sleep (GO:0045187) (0.0481); visual perception (GO:0007601) (0.0474); cellular response to ethanol (GO:0071361) (0.0435); cellular glucuronidation (GO:0052695) (0.0433); sensory perception of smell (GO:0007608) (0.0433)",endoplasmic reticulum membrane (GO:0005789) (0.0745),glucuronosyltransferase activity (GO:0015020) (0.5064),"UDP-glycosyltransferase family, conserved site (IPR035595) (0.4537); UDP-glycosyltransferase (IPR050271) (0.3351); UDP-glucuronosyl/UDP-glucosyltransferase (IPR002213) (0.1836)",3.40.50.2000 (0.2649),Transmembrane helix (0.7474); Transferase (0.6818); Reference proteome (0.5175); Membrane (0.3919); Glycoprotein (0.3216); Glycosyltransferase (0.3134); Endoplasmic reticulum (0.2324); Transmembrane (0.1645); Signal (0.1545); Microsome (0.1302),
MQEGGLDGAIGKGRVSNLISRFEENRHTDGRREGTPPKQVSRSPNCSPPRKNYQRPREQTSDSSPHHALKPPNGVLAKMNRDRDKERDMEGVTHAPVPIARINKQGLLNGDSVDLTNREITEEECVDSPDVHLNQAKEEEEQEKRKVSEQSDIVRMNSIPEQKETNEQKLYKIANELLQTEKAYVARLNLLDKVFYTKLMEEARKDTFPVDVVKSIFSNITSINAFHSQFLLPDLEKRMGEWTSTPRIGDILQKLTPFLKMYAEYVRNFDHAMDLLKQWIDRSPPFKAIILDIQSQEVCGNLTLQHHMLEPVQRVPRYEMLLKDYLKKLPPEHMDRRDAEKSLEIIGMAATHSNTAIRKTENLKKLLEIYEMLGEEEDIVNPSNELIKEGHILKLAARNTSAMDRYLFLFNNMLLYCVPKFSLVGQKFTVRTRIGIEGMNVKETFNEDYPHTFQVSGKERTLELQASSKLDKESWIKAFTETIDISLQKNETFKSAIKDTEEASDLNISELGKRAPRWIRDNEVTMCMKCKEGFNAITRRRHHCRACGYVVCWKCSDYKATLEYDGNKISKVCKHCYFILTGRTDSDDREGKKKGILEIEAAQFCGSSIMCGFLQYCERNKPWQKVWCVIPEKEALVLYLYGAPQDVKAQSTIPLLGYHVEDNPKATDPPASFRLSQSKSIHSFAAESEELKQRWLKVIRMAVTGEVPESPEENSSAEITEELNSNGN,,cytoskeleton organization (GO:0007010) (0.8235); filopodium assembly (GO:0046847) (0.3694); actin cytoskeleton organization (GO:0030036) (0.2198); microspike assembly (GO:0030035) (0.1956); regulation of cell shape (GO:0008360) (0.1354),early endosome (GO:0005769) (0.5387); lamellipodium (GO:0030027) (0.3451); cytoskeleton (GO:0005856) (0.3377); filopodium (GO:0030175) (0.2924); cytoplasm (GO:0005737) (0.2921); nucleus (GO:0005634) (0.1629); ruffle (GO:0001726) (0.1369),small GTPase binding (GO:0031267) (0.1448); guanyl-nucleotide exchange factor activity (GO:0005085) (0.1382),"Dbl homology (DH) domain (IPR000219) (0.3687); Dbl homology (DH) domain superfamily (IPR035899) (0.3234); Zinc finger, FYVE/PHD-type (IPR011011) (0.2846); PH-like domain superfamily (IPR011993) (0.2779); FYVE, RhoGEF and PH domain-containing (IPR051092) (0.2722); FYVE zinc finger (IPR000306) (0.2044); Zinc finger, RING/FYVE/PHD-type (IPR013083) (0.1614)",2.30.29.30 (0.4247); 3.30.40.10 (0.3038); 1.20.900.10 (0.2144),Zinc-finger (0.5787); Repeat (0.5113); Metal-binding (0.4507); Cytoskeleton (0.4075); Reference proteome (0.3058); Cytoplasm (0.2532); Guanine-nucleotide releasing factor (0.1649); Zinc (0.1284); Proteomics identification (0.1054),
MDPGQDLLLAALSESGICPNDLFDVDVQDSVPLVSSQQPVSLNALDIGLSNEASGVVRIDPPVPPTPTVTIREKPQPSTTTFVLNQLNQLPSLGTIVVSKPSTGSSTRQTITVTKVLHSSSPAQRSSASPSVCTAAPANTEQIRLKDLLRSSSLKSSSLGELMKLKPPADIAPPVATATGTTEVNNGLKKEVSSKDVARIWINDDMKMRSFSPVNKLPGMKEEEEPEEEEEEELGHAETYAEYMPMKLRIGLRHPDPVVETSSLSSVNPPDVWYRLSIPEETIDRGWLSALQLEAVTYAAQQHETFLPNGDRAAYLIGDGAGVGKGRTIAGIIYENYLLGRKRSLWFSVSNDLKYDAERDLRDIGAKNIQVHSLNKFKYGKISSKHNGSVKKGVIFATYSSLIGESQSGGKYKTRFKQLLHWCGDDFDGVIVFDECHKAKNVCPIGSSKPTKTGLAVLELQNKLPKARVVYASATGASEPRNMAYMNRLGIWGEGTPFREFANFIQAVERRGVGAMEIVAMDMKLRGMYIARQLSFTGVTFKIEEVPLTLDYIKMYNKAVRLWVSAREKFQQAAQLMDAEQRMKKSMWGQFWSAHQRFFKYLCIASKVRRVVQLAREDVKNGKCVVIGLQSTGEARTLEALEEGGGELNDFVSTAKGVLQSLVEKHFPAPDRQKLFSLLGIDLSAKKTPSPAENKTEQKGKKRKGPESKKHVKKARKSGGLSGSSSDDSSSEDSDRDAESDDSFKSISSGDEDDFNPFKDDSSEDEEDDPWLIRKDSKKSKDKRNKKKKKSIDPDSIQSALLASGLGTTRPTFTAPIKPANPTLAVAKSDPEESSCVTSQDAVEDAQRMKRDLLEKLELLAEDLPPNTLDQLIDELGGPDNVAEMTGRKGRVVSNDDGSISYESRSELDVPVEILNLTEKQRFMDGDKNIAIISEAASSGISLQADRRVKNQRRRVHMTLELPWSADRAIQQFGRTHRSNQVTAPEYVFLISELAGEQRFASIVAKRLESLGALTHGDRRATETRDLSRFNFDNKYGRNALEIVMKSIVSLDSPLVSPPADFDGDFFKEIRNGLIGVGLINVEDRSGVLSLDKDYNNIGKFLNRILGMEVQQQNALFQYFSDTLSAVIQNAKKSGRYDMGILDLGSGDEKVKKVDVKKFLTPGYSTSGHVELYTVSVERGMSWEEATHVWADQNGPDDGFYVQVRNNKKIAILVKEVNPRKRLFMVYRPNIGKQVKLETYTDIKKRSKKVLSDDAKQHWMDQYSCSADVCSHAYWRGNCKKASVGLQCEIGLRCRTYFVLCGSVLSVWTKVEGVLASVSGANVKMQIVRLRTEDGQRIVGLIIPQNCVSPLVNILSSSDQSQQLAVQQQHLWQQLHPQSLTHTPLT,,regulation of DNA-templated transcription (GO:0006355) (0.6929); response to UV (GO:0009411) (0.1792); negative regulation of DNA-templated transcription (GO:0045892) (0.1281); negative regulation of transcription by RNA polymerase II (GO:0000122) (0.0826); meiotic cell cycle (GO:0051321) (0.0800); meristem structural organization (GO:0009933) (0.0632); macrophage activation involved in immune response (GO:0002281) (0.0514),nucleus (GO:0005634) (0.5051),histone binding (GO:0042393) (0.2520); chromatin DNA binding (GO:0031490) (0.2153),"Strawberry notch, AAA domain (IPR039187) (0.4394); Strawberry notch, helicase C domain (IPR026937) (0.2305); Protein strawberry notch (IPR026741) (0.1883)",3.40.50.300 (0.1049),Transcription (0.6447); Acetylation (0.5136); Reference proteome (0.3956); Transcription regulation (0.3329); Nucleotide-binding (0.1693); Alternative splicing (0.1492); Hydrolase (0.1384); Nucleus (0.1380); Phosphoprotein (0.1186); Direct protein sequencing (0.1148); DNA-binding (0.0910); Cytoplasm (0.0596),
MMFMHVLMRAGFGLFSVALVAFVQGPAGVFASRNPQDVDECAEALDSCSIDAICQNTLKSYKCICKSGYKGDGKHCEDIDECASEYNGGCVHECINIPGNYRCTCYDGFRLAHDGHNCLDVDECAEGNGGCQQICVNMMGSYECRCRDGFLLSDNQHTCIQRPKVRFNGTKDVATCMDKNHGCAHICRETPKGTIACECRPGFQLTKNNRDCKLTCNYGNGGCQHICEETDHGPKCSCHMKFALHSDGKTCVETCAVNNGGCDSTCHDAVTGVRCSCPVGFTLQPDRKTCKDIDECRMNNGGCDHVCRNTVGSFECSCKKGYKLLTNERTCQDIDECSFDRACDHTCINSPGSFQCYCHKGYVLYGVAHCGDIDECSINQGGCKSGCLNTLGSYECTCPPGYKLHWNKKDCVELIKCASNLVAPKATLACSKTGKKESCSLTCASKAHYLSESDSSYSVSCGISILRGKSQSRVNTSSIQSCIETQVHPVKQTASFRIKNAKCHLHPKHKGRAEDNGRQIGPGGQPCNNCLVTFVNLKCDSSKKTKGGRRARNPTNKEVTRITLELEAEVKPGDATGNCNMMCQRQHMEQQMKTYIKTLKKSINQERFLLRVAGLEYEVAQKLTQTALKQENCGPGREKDSGRCVRCLPGSYYHGEQERCIQCPPGTFQEREGQLACDLCPGGDRHGPQGARNITSCAGQCPPGHFSSDGFKPCQPCPLGKYQPDPGRTLCFSCGGGLSTKREGASSFNDCEVKVLCSPGHYYNTSVHRCIRCPHGTYQAEFRQNYCISCPGNTTTDFDGAISVSQCKNRECGGEIGEFIGYIESPNYPGNYPANVECVWTINPPHKRKILIVVPEIFLPSEDECGDVLVMRKNWSATSITTYETCQTYERPIAFTARSRRLWINFKSNDVNSARGFQIPYVTYDEDYEQLVEDIVRDGRLYASENHQEILKDKKLIKTLFDVLAHPHNYYKYSTRDSTEMLPRSFIRLIHSKVSAFLRPYN,,signal transduction (GO:0007165) (0.7037); positive regulation of BMP signaling pathway (GO:0030513) (0.6588); positive regulation of osteoblast differentiation (GO:0045669) (0.2428); animal organ development (GO:0048513) (0.0834),extracellular region (GO:0005576) (0.1957); plasma membrane (GO:0005886) (0.1913); extracellular space (GO:0005615) (0.1345); cytoplasmic vesicle (GO:0031410) (0.0828),calcium ion binding (GO:0005509) (0.4194),"CUB domain (IPR000859) (0.3710); Complement Clr-like EGF domain (IPR026823) (0.3636); EGF-type aspartate/asparagine hydroxylation site (IPR000152) (0.2674); Growth factor receptor cysteine-rich domain superfamily (IPR009030) (0.2250); NOTCH1 EGF-like calcium-binding domain (IPR049883) (0.1999); EGF-like calcium-binding domain (IPR001881) (0.1949); Spermadhesin, CUB domain superfamily (IPR035914) (0.1912); Signal peptide, CUB and EGF-like domain-containing protein (IPR052071) (0.1818); EGF-like calcium-binding, conserved site (IPR018097) (0.1777); EGF-like domain (IPR000742) (0.1770)",2.60.120.290 (0.2529); 2.10.25.10 (0.2204); 2.10.50.10 (0.0938),Secreted (0.8509); Reference proteome (0.6941); Calcium (0.5446); Repeat (0.5284); EGF-like domain (0.3782); Glycoprotein (0.3311); Disulfide bond (0.3210); Signal (0.1782),
MIKMKRVEKESEGCGGGERKAQKDQSWIPKMIKKRVCTTFVEDSCSNGALCQCGGARDLHVSTTADDHVVGQWDRARDTSDYPTDAFGQLEFVGAGRRHCPFLRLSFDTPPDNVYSLMTSQWGLPVPNLVVSMVGGDEKEMAKPWVREVIRQGLVHAAQSTGAWIMTSGLKEGVSRCVGEAVRHHCAMASSLSQAKVIAVGVAPWGLIYQRHQLVNPQGSFPARYYVHDMPSASSCLDNNHQAFLLVDDGSVGHRGSETSFRANLEDFISHQRTGIWGSGSIEIPVLCVLIAGDATMLERVDLSLKNSTPWLVLAGSGSASDLIAGILKDLSAPLSPPVSPTLQSDSEESSKSSSIELRDRVKERIRKHFPSETELDKLVDQALSIYHNRDLITIFHGDEDGSDDFDTIILKALVRAAKRDSNDASEYTEELKLAVAWNRVDIAKTELFNGDVHWRYEDLEESMTDALVNDKPDFVRLFVESGLNILAYLTYHRLESLYSSLSDCDLVSSFLQRRLQERVGLAASQTRLTPQPDDNSSFKSQATNLTTPSAARDLTLYEVSRVLSEIMEDVCQPFYYTTLGLDHRVNSRKAMKHVNKLLLNESTYRRQRCTSPWISLFIWAVLQNRREMSLYFWKMTGESVLSALAGCKILRELSKLETETETKLSMKELAQTFENLAHDVFSECYQSNEKRSFKLLIRQSPIWGGATCLQMATSADARLFFSHDGVQTLLSEIWWGDMDSNTEVWKLVFSFFLPPFIYTKLINFKVEEADEKAEDFGQGKEFDSTDGAETLADMTNMDEDVEECNALRGKPKASKVIAKKRPFIFHRWRQFWFAPVTSFLGNVLMYFLFLFLFAYVLLIDFKPPPPDGPAPLELVLYFWVFTLACEEIRQSFFVGSTTLTQRMKVYIQDIWNKCDITALGLFVLGLLCRMFPWTYNFGRAVMCVDYTVFTLRLIHIFAVHKQLGPKIIIVGKMVKDVFFFLFFLGVWLMAYGVANQALLYSYDSRPGWVARRVFYRPYMHIYGQIPLDEIDADKRHDKRCTDNVTLIHEGAEPCPDSDANWLVLILLSVYLLVTNILLVNLLIAMFSYTFNKVQERSDVYWKFQRYNLIVEYHSRPCLAPPFIIISHLHIFIKRVIQRLPSLKSQHFMLDLTSKETSLLNTWELSLKENLLSTESKKKRESDTERLKRTSTKVDSVLKQMVEIRDHDRRLRKLESEVEYCSTALSWIVEALSQSDLVKQTRPPPYPSKGIASKRPTFSR,,calcium ion transmembrane transport (GO:0070588) (0.4691); intracellular calcium ion homeostasis (GO:0006874) (0.2747); positive regulation of cold-induced thermogenesis (GO:0120162) (0.2169); response to cold (GO:0009409) (0.1842); response to heat (GO:0009408) (0.1691); positive regulation of cell population proliferation (GO:0008284) (0.1613); monoatomic cation transport (GO:0006812) (0.1573); membrane depolarization during Purkinje myocyte cell action potential (GO:0086047) (0.1435); cellular response to ATP (GO:0071318) (0.1200); calcium ion transport (GO:0006816) (0.1148); sodium ion import across plasma membrane (GO:0098719) (0.0557); regulation of heart rate by cardiac conduction (GO:0086091) (0.0527),neuronal cell body (GO:0043025) (0.1430); sodium channel complex (GO:0034706) (0.1236); plasma membrane (GO:0005886) (0.0541),calcium channel activity (GO:0005262) (0.1439); identical protein binding (GO:0042802) (0.1302); calcium-activated cation channel activity (GO:0005227) (0.0796),"Ion transport domain (IPR005821) (0.2603); Transient receptor potential cation channel M (IPR050927) (0.1571); TRPM, SLOG domain (IPR041491) (0.1255)",,Reference proteome (0.6399); Transmembrane (0.6226); Transport (0.5867); Membrane (0.5617); Transmembrane helix (0.4821); Ion channel (0.2792); Coiled coil (0.2706); Voltage-gated channel (0.1971); Ion transport (0.1927); Zinc (0.1397); Calcium (0.0837),
MAMCWQRAAVVRWFLLMLLWHWAPLGPLSWFLALAERLDQKTSPFSSISGRSSGQLDWLLSDKGPFHRCPEYTEFKERFQQGFSTRYKIYREFSHWKVNSLVTEKRDFFKAPLPLAPEFLRNLRLLGRRPSLQQIHENLIKKYGTHFLVSATLGGEESLTIFLDKQKLSKKSEGNGNSSVVSLEILHQLAASYFTDRESTLRRLHHLQIATSAIKVTETRTGPLGCSNYDSLDSVSSVLVHSPENKIHLKGLQDVLPEFLRNRFVEAALSYVACNSEGELLCRNNDCWCRCSTKFPDCNCPFADIKAMEESLRKSKESWINLNQDFIESDEFKAFLKKLPTDHFLNTSAVLKFWTSDLVLQRRYGLLEASTKVVLGKAIKIVRKLFALSKRCPTQPKISLPRERTLGFWLNKAQSLLYCSEHGVHGTFSEDLQGCICAAEQRTVCQGTVPCRVGEGTLCSSCAPDNITRCGTCLPGSILHMGFCRPNIANSLDHYVNFDFDMPDAEMRYLLQRLDSRMEVHAIYISNDVRLGSWFNPAWRKRMLLTLKSNKNKSNLIHMLMGISFQICSTKNSTLEPVPAIYVNPFGGSHSESWFMPVNQQDFPDWERTKLDASLQCYNWTLPLGSKWKSFFETVHIYLRSRIITDDPTVNETLFYEPLDLDDHSANLGYMKINSLKVFGYSMHFDPEGIKDLILQLDYPYTQGSQDAAFLMLLEMRDRINRLSPPGAQPLDLFSCLLRHRLKLSSSEVVRIREALQSFNTKLPNSNEPELSQLCS,,brain development (GO:0007420) (0.6116); maternal behavior (GO:0042711) (0.4095); exploration behavior (GO:0035640) (0.3308); nervous system development (GO:0007399) (0.3134); angiogenesis (GO:0001525) (0.3025); gene expression (GO:0010467) (0.2993); neurogenesis (GO:0022008) (0.2762); cell population proliferation (GO:0008283) (0.2622); social behavior (GO:0035176) (0.2112); behavioral fear response (GO:0001662) (0.1547); negative regulation of neurogenesis (GO:0050768) (0.1523); short-term memory (GO:0007614) (0.1443); cellular response to retinoic acid (GO:0071300) (0.1392); negative regulation of cell cycle (GO:0045786) (0.1358); positive regulation of neuron differentiation (GO:0045666) (0.0833); homeostasis of number of cells within a tissue (GO:0048873) (0.0792); regulation of gene expression (GO:0010468) (0.0643); positive regulation of cell migration (GO:0030335) (0.0638),cytoplasm (GO:0005737) (0.3285); dendrite (GO:0030425) (0.2158); membrane (GO:0016020) (0.1185); neuronal cell body (GO:0043025) (0.1084); nucleus (GO:0005634) (0.1066); nucleoplasm (GO:0005654) (0.0796),,Membrane attack complex component/perforin (MACPF) domain (IPR020864) (0.1233),,Growth arrest (0.6802); Alternative splicing (0.5554); Reference proteome (0.3666); Neurogenesis (0.1713); Glycoprotein (0.1171); Proteomics identification (0.1139); Membrane (0.1128); Cell cycle (0.0696); Cytoplasm (0.0646),
MKIYWSFFMVSCITSSVFCTTTKYFTFEEDATGTEIGNLSQDLKIDPSEDPETSFKFIQTSNSIIDMRQMDGLLTVGEVIDREKLCQRSPQCLITFDVVAFSKEKFQLIHVEIEVKDINDHSPQFTRNETHLDISEDAPLNSRFPLDVAVDHDVGDNYIQSYHISHNSHFVVEVSTREDGEKSAELVLIKSLDRETEDFYTIEVTATDGGAPQKSGSTTLYIRVLDFNDNSPTFEHSSLKVELSEDSPIGSRVLKVHAFDPDAGINGEIVYGFVEGSPSEVTRVFQIDLISGEVTLKDIVDYETKKSYELHIQASDLGANSVSSTCRAIVDIIDVNDNAPEIIIKPMTSTSDGVAFITEAAAEESFVALISTSDKDSGPNGYVRTSLEGHEHFKLQQAYSDTFMIITTTTLDRESISEYNLTVISEDLGTPPFKTVKHYTIRITDENDNPPLFSKSIYDVSVIENNIPGSYMTTVVARDLDAGKNGKVSYSLVESKAPDGSSISTFVSVDPHSGSLYTLRSFDFETLKDVQFSVKATDKGFPSLSSTTLIQVRVVDDNDNFPYFTYPVLRNNSAEIPIPMNANAGYLALKVAAKDEDSGINSELNYHILEDEAKLFSIDKNTGEIILKRKLTASCGEILQIYVSVVDGAREPLSSSANIRFIVTDTGAQEDQIVVLLRAEDDETFEFDLWSILVISFAGGCVLLLTAIIILTVSCTIKRRRRSFGRDALYGSTPLSKNNPAGPSIYSGPNGFLRSEGDSMQPCLYEDKSLSFEEKLFLPCKPFEQTFLWQDEKYCLQRSGTTDQLSVKDSGKGDSDFNDSDSDSSGGAQKPGLTTFQPLARGSFCSSSDWKIKPCVIQTRNLHAPPGSSYTLGFSRTPLYSHSHCSSHMWRDGAGGTLNTQRPLQTFRSGTLPSYTAHQMRRAVMEIQEQNEDLQDTLMINAAAEVATTF,,cell adhesion (GO:0007155) (0.5287); homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) (0.4787); somitogenesis (GO:0001756) (0.2405); chemical synaptic transmission (GO:0007268) (0.1560); modulation of chemical synaptic transmission (GO:0050804) (0.1269); morphogenesis of embryonic epithelium (GO:0016331) (0.1221); calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) (0.0949),glutamatergic synapse (GO:0098978) (0.2724); plasma membrane (GO:0005886) (0.2077); cytoplasm (GO:0005737) (0.1867); extracellular region (GO:0005576) (0.0615),calcium ion binding (GO:0005509) (0.3379),"Cadherin-like (IPR002126) (0.4618); Cadherin, N-terminal (IPR013164) (0.3168); Protocadherin/Cadherin-related Cell Adhesion (IPR050174) (0.1430)",2.60.40.60 (0.1912),Glycoprotein (0.6862); Reference proteome (0.5513); Signal (0.5108); Membrane (0.4344); Transmembrane (0.4065); Transmembrane helix (0.3492); Repeat (0.2667); Alternative splicing (0.2014); Calcium (0.1467); Cell adhesion (0.1078),
MPTVSSVTLTGRLLLLLLWAAHLAMATNWLSLARLSRSRPVSGAEPCGRLRGLSPGQVGVCRARGEVMESVRKASEMVIEECQHQFRNRRWNCSTTPRGINVFGRVMNQGTREAAFVHALSSAAVAVAVTRGCSRGELERCGCDRKVRGVSPEGFQWSGCSDNLSYGVAFSQTFVDEPERAKGMSSGRPLMNIHNNEAGRKAILHNMQVECKCHGVSGSCELRTCWKVMPPFRRVGAVLKERFDGATEVRLTRVGSRTALLPRDPQVKPPATRDLVYLAPSPDFCRLDPDNGIPGTAGRRCNGTSRLAPDGCELLCCGPGFRAGRAEVVQRCSCKFSWCCSVRCQQCKNTVLIHTCRE,,branching involved in ureteric bud morphogenesis (GO:0001658) (0.5645); cell fate commitment (GO:0045165) (0.3806); neuron differentiation (GO:0030182) (0.2730); hematopoietic stem cell differentiation (GO:0060218) (0.2367); midbrain dopaminergic neuron differentiation (GO:1904948) (0.1888); canonical Wnt signaling pathway (GO:0060070) (0.1791); axis specification (GO:0009798) (0.1729); cardiac epithelial to mesenchymal transition (GO:0060317) (0.1694); positive regulation of gene expression (GO:0010628) (0.1452); kidney development (GO:0001822) (0.1031); keratinocyte differentiation (GO:0030216) (0.1016); male gonad development (GO:0008584) (0.1001); odontogenesis of dentin-containing tooth (GO:0042475) (0.0973); cell proliferation in midbrain (GO:0033278) (0.0842); roof of mouth development (GO:0060021) (0.0813); oxidative stress-induced premature senescence (GO:0090403) (0.0784); bone remodeling (GO:0046849) (0.0760); cell morphogenesis (GO:0000902) (0.0665),extracellular space (GO:0005615) (0.4118); cytoplasm (GO:0005737) (0.1691),frizzled binding (GO:0005109) (0.1881); cytokine activity (GO:0005125) (0.1557),"Wnt (IPR005817) (0.3182); Wnt protein, conserved site (IPR018161) (0.2373); Wnt, C-terminal domain (IPR043158) (0.1827)",3.30.2460.20 (0.2325),Wnt signaling pathway (0.9985); Signal (0.9600); Secreted (0.9335); Lipoprotein (0.7051); Developmental protein (0.4921); Extracellular matrix (0.4591); Reference proteome (0.1784); Glycoprotein (0.0477),
MSGYLRSALLLGTRGRHLSSSFAASQHVLPDVACRALLFSSPARSFSSRGGRSDGSSGQEGENRLHPPRHEMDFQMSRLQINAVLRANEQSVRVPEFDGRGGPSPVLRFESNQLPANTPLEDRRSSASSLQTRSMLFGVFDGHGGHACAQAVSERLPYYISVAMMAESVLEDLEAAMETSRPVPPILQWYKHHNDYNYRESAALYVDHLRVFWQELLASEEHGDGMRPADALSYAFQRLDTDLSLEAQVPLANDLMRNTALQAAFAGCTACVAHVGPEGVHVANAGDCRAVLGVQETDGSWSALPLTKDHNAANVAEMERVWRQHPASERQTVVVDDRLLGVLMPLRAFGDVRFKWSRELQQSVLENGDSDLEALNIYQYAPPNYLTPPYLEVTPEVTHHRLRPQDRFLILASDGLWDEMSNDEAVRLVAEHLTGVHLQAPVSARQLNLGQMHQLLLRRRARATPALDLNAATHLIRHALGTNEYGEMDQERLATMLALPSDLARMYRDDITVTVIYFNPNFNKNNNKEH,[pyruvate dehydrogenase (acetyl-transferring)]-phosphatase (3.1.3.43) (0.5357); protein-serine/threonine phosphatase (3.1.3.16) (0.3310),protein dephosphorylation (GO:0006470) (0.6942); cellular response to starvation (GO:0009267) (0.3399); response to cAMP (GO:0051591) (0.1694); peptidyl-threonine dephosphorylation (GO:0035970) (0.0878); positive regulation of apoptotic process (GO:0043065) (0.0828); branched-chain amino acid catabolic process (GO:0009083) (0.0614),mitochondrion (GO:0005739) (0.2453); mitochondrial matrix (GO:0005759) (0.1157),protein serine/threonine phosphatase activity (GO:0004722) (0.2562); metal ion binding (GO:0046872) (0.1099),"PPM-type phosphatase, divalent cation binding (IPR000222) (0.5348); PPM-type phosphatase-like domain superfamily (IPR036457) (0.1497); Protein phosphatase 2C (IPR015655) (0.0786); PPM-type phosphatase-like domain (IPR001932) (0.0740)",3.60.40.10 (0.1584),Transit peptide (0.6904); Protein phosphatase (0.5562); Mitochondrion (0.5318); Metal-binding (0.4261); Magnesium (0.4064); Acetylation (0.3123); Manganese (0.1870); Hydrolase (0.1397); Alternative splicing (0.1293); Reference proteome (0.1242); Pyruvate (0.0686),Mg(2+) (0.1204); Mn(2+) (0.1116)
MTIIMESGRRRGLNSVLSSLSLLCVVLDLQLDGVLGATPVEIEHHLEMGRKLLAAGQLAEALSHYHSAVEGDSKNYLTYYKRATVFLAMGKSKSALPDLTQAIQLKPDFLAARLQRGNILLKQGSTQEAREDFQAVLNHSPDHEEAHDQLLKADKLESLQEEAHEAHRRGDCRIAVQVLEHVIELSPWDPESRELRAECYIQLGEPRKAIMDLTPASRLRADNRAAFLKLSQLHYSLGEHHDSLNQVRECLKLDQDDKECFALYKQVKKLSKQLDSAEELISEQRFQEAIEKYESVMRTEPNVAFYTNKAKERTCFCLVKMKSAEEAVDICSEAHQREPQNIHILRDRAEAYILMQEYEKAVEDYQEAREFDQENQELREGLDRAHKLLKISRKRDYYKILGVSRSANKQEIIKAYRKLAQQWHPDNFQSEADKKEAEKKFIDIASAKEVLTDPEMRQKFDSGEDPLDPENQQGGGGGGPREWPFGFNPFEGGNFHFKFNFN,,response to unfolded protein (GO:0006986) (0.8895); positive regulation of translation initiation in response to endoplasmic reticulum stress (GO:0036494) (0.7536); protein folding in endoplasmic reticulum (GO:0034975) (0.5770); cellular response to cold (GO:0070417) (0.5033); proteolysis involved in protein catabolic process (GO:0051603) (0.1425); negative regulation of apoptotic process (GO:0043066) (0.0934); negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation (GO:1903912) (0.0822); chaperone-mediated protein folding (GO:0061077) (0.0678),endoplasmic reticulum lumen (GO:0005788) (0.3251); cytosol (GO:0005829) (0.1702); endoplasmic reticulum (GO:0005783) (0.1503),protein kinase binding (GO:0019901) (0.4601); protein-folding chaperone binding (GO:0051087) (0.2689); protein kinase inhibitor activity (GO:0004860) (0.1847),Chaperone J-domain superfamily (IPR036869) (0.4096); DnaJ domain (IPR001623) (0.2871); Tetratricopeptide-like helical domain superfamily (IPR011990) (0.1862); DnaJ Homolog Subfamily C Member 3 Co-Chaperones (IPR051727) (0.1325),1.10.287.110 (0.2841); 1.25.40.10 (0.1890),Unfolded protein response (0.9488); TPR repeat (0.6006); Signal (0.4703); Repeat (0.4690); Endoplasmic reticulum (0.3991); Reference proteome (0.3115); Phosphoprotein (0.1164); Stress response (0.0998); Translation regulation (0.0744),
MLSTRIQCALALLSLALAVSSVSAAPSDAKLRQLLQRSLLSPAGKQELARYTLADLLSDLVQAENEALEPEDLSRAAEKDDVRLELERAAGPMLAPRERKAGCKNFFWKTFTSC,,response to heat (GO:0009408) (0.3304); response to immobilization stress (GO:0035902) (0.2374); response to hypoxia (GO:0001666) (0.2095); response to ethanol (GO:0045471) (0.1828); hyperosmotic response (GO:0006972) (0.1709); signal transduction (GO:0007165) (0.1676); response to xenobiotic stimulus (GO:0009410) (0.1498); G protein-coupled receptor signaling pathway (GO:0007186) (0.1356); negative regulation of appetite (GO:0032099) (0.1221); positive regulation of transcription by RNA polymerase II (GO:0045944) (0.1206); regulation of postsynaptic membrane neurotransmitter receptor levels (GO:0099072) (0.1197); neuropeptide signaling pathway (GO:0007218) (0.1110); chemical synaptic transmission (GO:0007268) (0.0897); osteoblast differentiation (GO:0001649) (0.0774); ossification (GO:0001503) (0.0702); negative regulation of neuron apoptotic process (GO:0043524) (0.0637); cell-cell signaling (GO:0007267) (0.0438); regulation of cell migration (GO:0030334) (0.0417),cytoplasm (GO:0005737) (0.4334); extracellular space (GO:0005615) (0.0964); nucleus (GO:0005634) (0.0777),hormone activity (GO:0005179) (0.1584); neuropeptide hormone activity (GO:0005184) (0.1006),"Somatostatin/Cortistatin, C-terminal (IPR018142) (0.3435); Somatostatin (IPR004250) (0.2389)",,Hormone (0.8470); Secreted (0.8137); Reference proteome (0.6473); Signal (0.3878); Cleavage on pair of basic residues (0.3425); Disulfide bond (0.2142),
MLYAMFFAMLSTMMGLSFARPGFFNELEEHLAVESEPKVRSEAIRRLLEVFGMEDPPAALGHKQPPQYMLDLYNTIADVDGVTKDPTLLEGNTVRSFFDKLHSERIEYLFNMSTVAKSEKILTAELHLFKLRPKTSIVLNRHHFCQVSVYQVLDSSKKNVSQGKKLLSSRLVPIHSTGWEVFTITQAVRSWMSDEGSNLGLLVSVRTLAGSQMDLKMVRFASGRDHHHSKQPMLVLFTDDGRRAASLEATSKGSDVSPGGSSQPLPSVPASRRSSRSVDYDERGEKMACQRQPLYVDFEEIGWSGWIVSPKGYNAYHCKGSCIFPLSQNMRPTNHAIVQSIINTLKLNKGIQTPCCVPDKLYSISLLYFDDDENVVLKQYDDMVAGSCGCR,,BMP signaling pathway (GO:0030509) (0.3770); ossification (GO:0001503) (0.2388); determination of ventral identity (GO:0048264) (0.2165); positive regulation of SMAD protein signal transduction (GO:0060391) (0.1898); positive regulation of gene expression (GO:0010628) (0.1833); kidney development (GO:0001822) (0.1648); mesodermal cell fate commitment (GO:0001710) (0.1262); cartilage development (GO:0051216) (0.1183); positive regulation of DNA-templated transcription (GO:0045893) (0.1074); activin receptor signaling pathway (GO:0032924) (0.1040); apoptotic process (GO:0006915) (0.0824); gland morphogenesis (GO:0022612) (0.0796); determination of left/right symmetry (GO:0007368) (0.0744); liver development (GO:0001889) (0.0698); positive regulation of chondrocyte differentiation (GO:0032332) (0.0536),,growth factor activity (GO:0008083) (0.1425),"Transforming growth factor-beta-related (IPR015615) (0.2674); Cystine-knot cytokine (IPR029034) (0.2630); Transforming growth factor beta, conserved site (IPR017948) (0.1802); TGF-beta, propeptide (IPR001111) (0.1266); Transforming growth factor-beta, C-terminal (IPR001839) (0.1251)",2.60.120.970 (0.4468); 2.10.90.10 (0.2195),Signal (0.8418); Secreted (0.5665); Reference proteome (0.4227); Growth factor (0.2790); Disulfide bond (0.2434); Glycoprotein (0.2377); Developmental protein (0.2088); Cleavage on pair of basic residues (0.1137); Osteogenesis (0.0979),
MVKMGKDYYSVLGIQKGASDDEIKKAYRKQALKYHPDKNKSAGAEEKFKEIAEAYDVLSDPKKKDIYDRFGEEGLKGGAPGGGGGGGNYTYTFQGDPHAMFSEFFGGRNPFEHIFGHNGGMDENMETDDPFASFGMGGIGGFPRSFTTHSHGGRMERKQDPAVIHDLRVSLDEVFTGCTKKMKISRKRLNPDGRTTRSEDKILTVEVKKGWKEGTKITFPREGDETPSNIPADVVFVLKDKPHPVYKRDGSDIIYPAKITLKEALCGCVINVPTLDGRTVKVTSQDIVRPGMKRRLTGEGLPLPKAPDRRGDLVVEYEVRFPEKLSQNAKDTIANVLPAS,,cellular response to heat (GO:0034605) (0.6745); protein folding (GO:0006457) (0.6004); chaperone cofactor-dependent protein refolding (GO:0051085) (0.4252); negative regulation of transcription by RNA polymerase II (GO:0000122) (0.3184); negative regulation of inclusion body assembly (GO:0090084) (0.1955); response to unfolded protein (GO:0006986) (0.1911); positive regulation of ATP-dependent activity (GO:0032781) (0.0927),cytosol (GO:0005829) (0.3460); nucleoplasm (GO:0005654) (0.1340); nucleus (GO:0005634) (0.1190); postsynaptic density (GO:0014069) (0.1035); midbody (GO:0030496) (0.0917); cytoplasm (GO:0005737) (0.0790),protein-folding chaperone binding (GO:0051087) (0.2727); transcription regulator inhibitor activity (GO:0140416) (0.2175); transcription corepressor activity (GO:0003714) (0.1691); unfolded protein binding (GO:0051082) (0.1127); ATPase activator activity (GO:0001671) (0.1074),"DnaJ homolog subfamily B (IPR051339) (0.2236); DnaJ domain, conserved site (IPR018253) (0.2042); DnaJ domain (IPR001623) (0.1120); Chaperone DnaJ, C-terminal (IPR002939) (0.1021)",2.60.260.20 (0.2952),Reference proteome (0.6310); Chaperone (0.2530); Proteomics identification (0.2159),
MAEKRRSPCTMSLKAHAFSVEALIGTEKKRKLEEEDSENCFEEINEVPRMTESPQPSTGRTCPSTRSCEIDCTSDESPEPEDVLLDSPQPASQGAQVLVQSATSSGEEMRVDLQGSDLWKRFHEIGTEMIITKAGRRMFPAMRVKIAGLDPHQQYYIAMDIVPVDNKRYRYVYHSSKWMVAGNADSPVPPRVYIHPDSPASGETWMRQVISFDKLKLTNNELDDQGHIILHSMHKYQPRVHVIRKECGEELSPVKAVPTGDGVKAFSFTETVFTTVTAYQNQQITRLKIDRNPFAKGFRDSGRNRMGLEALVESYAFWRPSLRTLTFEDIPGITKQGAAGSHGVVGSSAHLLSSSSCPSPTFHLGSGAGPVCDYSTCSRTSHPLHRYGPSLSADSYSRLTSPTADAFSTSRSSTYVSGTESEAFSCTQTGLPIQIHSMPSTTSQLQYLMPGHAHNAFSTNQSTQGSYNGFRLHNPYGLYGYNFSTSPRLATSPEKAAATQTSFLGSSPSGTLTDRQVLSTMDGLHMLSSSQQNLFDSRTLGLTSSSSQVTAHMA,,negative regulation of transcription by RNA polymerase II (GO:0000122) (0.6658); morphogenesis of embryonic epithelium (GO:0016331) (0.2371); regulation of transcription by RNA polymerase II (GO:0006357) (0.2159); cell fate specification (GO:0001708) (0.1580); cerebral cortex development (GO:0021987) (0.1298); embryonic cranial skeleton morphogenesis (GO:0048701) (0.1153); positive regulation of DNA-templated transcription (GO:0045893) (0.1027); branching involved in blood vessel morphogenesis (GO:0001569) (0.0989); negative regulation of cell migration (GO:0030336) (0.0675); heart development (GO:0007507) (0.0616); oligodendrocyte development (GO:0014003) (0.0513),nucleus (GO:0005634) (0.1495); chromatin (GO:0000785) (0.0985),"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227) (0.2386); RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978) (0.1506); DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981) (0.1297)","T-box transcription factor, DNA-binding domain (IPR046360) (0.5055); Transcription factor, T-box, conserved site (IPR018186) (0.3330); T-box superfamily (IPR036960) (0.3027); T-box transcription factor (IPR001699) (0.1177)",2.60.40.820 (0.2987),Transcription regulation (0.9421); Transcription (0.6061); Nucleus (0.5578); Reference proteome (0.4102); DNA-binding (0.3057),
MDRAPSSSPSGTSQTSQPTQHEPISFGIDQILSGTDQESQQNSTRNSSESSSGSSSASGGCYHLGSPTGASATPYTTLTGTFHGIAAPYEESSPYGMNLTLAPGGVIRVPAHRPLAAAVPPPMASAVPGLGSLSFPWMESSQRFAKDRFAAALTPFTVARRIGHPYQNRTPPKRKKPRTSFSRVQICELEKRFHRQKYLASAERAALAKTLKMTDAQVKTWFQNRRTKWRRQTAEEREAERQQANRLMIQLQHDAFQKSLTDSVPTDPLCIHNSSLFALQNLQPWASEESSKLGGVTALV,,cell fate determination (GO:0001709) (0.3794); regulation of transcription by RNA polymerase II (GO:0006357) (0.3180); neuron migration (GO:0001764) (0.2166); GABAergic neuron differentiation (GO:0097154) (0.2060); anterior/posterior pattern specification (GO:0009952) (0.1118); brain development (GO:0007420) (0.0982); endocrine pancreas development (GO:0031018) (0.0863); Wnt signaling pathway (GO:0016055) (0.0860); neuron differentiation (GO:0030182) (0.0773); mesoderm development (GO:0007498) (0.0600); embryonic hemopoiesis (GO:0035162) (0.0591); central nervous system development (GO:0007417) (0.0581); positive regulation of DNA-templated transcription (GO:0045893) (0.0519); negative regulation of DNA-templated transcription (GO:0045892) (0.0486); pancreatic A cell differentiation (GO:0003310) (0.0436),nucleus (GO:0005634) (0.2378); protein-DNA complex (GO:0032993) (0.1666),RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978) (0.3027),"T-cell leukemia homeobox protein 1/2/3 (IPR042247) (0.6681); Homedomain-like superfamily (IPR009057) (0.1878); Homeodomain, metazoa (IPR020479) (0.1787); Homeobox, conserved site (IPR017970) (0.1596); Homeodomain (IPR001356) (0.1496)",1.10.10.60 (0.1378),Homeobox (0.5712); Nucleus (0.3702); Developmental protein (0.3359); Reference proteome (0.2057); DNA-binding (0.0804),
MDNSTYFTTVILTGYIDIGDIKYLCFVVLILLFAAIIVANLFIIGIIYKEKSLHEPMYVFLCSLCANQLCGSFALFPFVLGNMLRSKTPEVPLTVCHAQIFALYSYAQVEFCNLAMMSYDRYVAICHPLEYHRIMSPARTMTLIALGWSLEIMILSFSFSVNVQLKFCGNVLDKVWCDQYMLVKLACSDTTPNNIIGITGIPLAIGPPLLIIFFSYAKILRVCLKFTRQKAKKSLYTCSLHLITLLNFTVGCSFELIQSRFGKLPIPAVVRVILSLYFLVCPPLINPIMYGVSLTNIKKALKKCIGV,,regulation of angiogenesis (GO:0045765) (0.3107); G protein-coupled receptor signaling pathway (GO:0007186) (0.2344); negative regulation of insulin receptor signaling pathway (GO:0046627) (0.1935); regulation of DNA-templated transcription (GO:0006355) (0.1842); adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189) (0.1661); negative regulation of cell population proliferation (GO:0008285) (0.1660); response to wounding (GO:0009611) (0.1015); response to bacterium (GO:0009617) (0.0959); angiogenesis (GO:0001525) (0.0937); detection of chemical stimulus involved in sensory perception of smell (GO:0050911) (0.0875); sensory perception of sound (GO:0007605) (0.0824); positive regulation of blood pressure (GO:0045777) (0.0790),plasma membrane (GO:0005886) (0.2725); presynaptic membrane (GO:0042734) (0.2020); cytoplasm (GO:0005737) (0.1922),olfactory receptor activity (GO:0004984) (0.3547); odorant binding (GO:0005549) (0.1355),"Olfactory receptor (IPR000725) (0.3952); GPCR, rhodopsin-like, 7TM (IPR017452) (0.2857); G protein-coupled receptor, rhodopsin-like (IPR000276) (0.0998)",1.20.1070.10 (0.2149),Transducer (0.9508); Transmembrane helix (0.8696); Reference proteome (0.5285); Olfaction (0.5269); G-protein coupled receptor (0.5037); Receptor (0.4554); Sensory transduction (0.2616); Membrane (0.2056); Transmembrane (0.1144); Cell membrane (0.1121),
MDISTPPEDQELRNVIDKLAQFVARNGPEFEKMTMEKQKDNAKFSFLFGGEFFGYYKYKLAIEQQQHSGTHDDEYNMEVISNIPGNEAADVSATMAILGPPAIPAAAPSMEELIQQSQWNLQQQEQHLLSLRQEQITAAISLAMEQQMQKLLVETQLDMNELDNLLQPIIDTCTKDAISAGKNWMFGNAKTPQHCELMASHLRNRITADEAHFELRLHLIYLTNDVLHHCQRKNQKDLLAALQKVVVPIYCTSFLSVEEDKQQKITRLLQLWEKNGYFDDVTIQQLQSPALGLGQYQASLITEYAPVVQPIQMAFQQQIQALKTQHEEFVSNLNQQQTVAAAAVAVAQLTPADAEVTSQTPIASQPDLKPPLSGPPSSEYEGSQNRSSDSNPALSPEMSSSKPGWFDPQHNMPAWNPQQPPPFDPSQAPPPCPPWNSHEGLWNEQRDPNWSDPRDGGPWSGQNDPPPSWSGQYEQPPWSSQQDQPPPWGQREPPFRMQRPPHFRGPFPPHQQPPPFNQPPPPHNFGRFPPRFMQDDFPPRHHFERPPYPPHHFDYPQGDFPGEIGPPPHHHPNQRIPPPGLSDPPPWGGNQHEFGPPPHGFNGQAPHIRRHNPPHVSQDDPSLVPNVPYFDLPAGLMAPLVKLEDHDYKPLDPKDIRLPPPMPPSDRLLAAVEAFYSPPSHDRPRNSEGWEQNGLYEFFRAKMRARRKKEQDKRSSARGSRSRSRSHSRGRSSSHSSSRSSKSSRSRSRSRSRSRSRSYSRSRSRSQSRSRSRSGSRSRSKSRSRSRSPEKRPHATKSRSPTPPSTSGLGSSSAAIPPDLRLGEENKGHQMLMKMGWSGSGGLGAKEQGIQDPIKGGDIRDKWDQYKGVGVALDDPYVNYRRNKSYNFVARMKAREKVSRDPQEPASTE,,negative regulation of cell population proliferation (GO:0008285) (0.5970); positive regulation of calcineurin-NFAT signaling cascade (GO:0070886) (0.5659); RNA processing (GO:0006396) (0.5373); intracellular calcium ion homeostasis (GO:0006874) (0.3941); mRNA processing (GO:0006397) (0.3646); olfactory learning (GO:0008355) (0.0549),perinuclear region of cytoplasm (GO:0048471) (0.0936); Z disc (GO:0030018) (0.0863); sarcoplasmic reticulum membrane (GO:0033017) (0.0832); cytoplasm (GO:0005737) (0.0719); nucleus (GO:0005634) (0.0445),RNA binding (GO:0003723) (0.2147); transmembrane transporter binding (GO:0044325) (0.0934),G-patch domain (IPR000467) (0.2093); ENTH/VHS (IPR008942) (0.1807); SWAP/Surp superfamily (IPR035967) (0.1785); Calcium homeostasis endoplasmic reticulum protein (IPR039037) (0.1455); SWAP/Surp (IPR000061) (0.1054); CID domain (IPR006569) (0.0841),1.25.40.90 (0.7602); 1.10.10.790 (0.0998),Proteomics identification (0.4882); Alternative splicing (0.2627); Endoplasmic reticulum (0.2104); mRNA splicing (0.2006); Reference proteome (0.1833); Spermatogenesis (0.1572); Ubl conjugation (0.1540); Cytoplasm (0.1418); 3D-structure (0.1399); Differentiation (0.1164); Phosphoprotein (0.1149),
MYPRVILKETLYKKSQQKRRTSPCNYKERTFILNTQDLAYFEQRPGKKPTQKGCIELSHIKCVEIVRSDVPIPCDYKYPFQIIHDSYYLYVFAPDNDCRLKWVKALKEAIQNNSLFLKYHPDFWGEGKWRCCQQTEKLATGCSEYYPNGAKPLPPTPDPSRRSSEPEERIVVALRNFTPKEHTDLPLQKDEEYFIVDCSEPNWWTVKDKDGNVGSVPCIYVTEKLSNNIEKFEWYNKDINRTEAEDLLMQENKDGGFMVRNSKHAGVYTVSIFTRVSGSNGEKCPQVKHYQIKVQSEGEKVLYYLAEKYLFPTIPELIRYHQHNPAGLITRLRHCVSRNVPNSARIKELSSDKWEIHPDEVKLSVELGSGQFGLVWKGSWQDMEVAVKTVREGFMSEEEFKEEAQVMMKLSHNRLVQLYGVVTQRSPIYLVFEFMENGCLTEFLRAKKGKLSQKALLEMCLDVSEGMAYLESSNFIHRDLAARNCLVSENSVVKIADFGMTRFVLDDQYTSSHGSKFPVRWSSPEVIKFGKYSSKSDVWSFGVFMWEVYSEGRTPYDNRSNSEVVETLNAGHRLLKPRLCPQSVYELMQWSWKEKPEDRPSFALLLHELACLDQEP,non-specific protein-tyrosine kinase (2.7.10.2) (0.8796),adaptive immune response (GO:0002250) (0.9703); protein phosphorylation (GO:0006468) (0.5792); B cell receptor signaling pathway (GO:0050853) (0.3583); intracellular signal transduction (GO:0035556) (0.1422); T cell receptor signaling pathway (GO:0050852) (0.1106),plasma membrane (GO:0005886) (0.3665),non-membrane spanning protein tyrosine kinase activity (GO:0004715) (0.2379); protein tyrosine kinase activity (GO:0004713) (0.0981),"Serine-threonine/tyrosine-protein kinase, catalytic domain (IPR001245) (0.4010); SH3 domain (IPR001452) (0.3241); Protein kinase domain (IPR000719) (0.3060); SH3-like domain superfamily (IPR036028) (0.2302); Non-receptor tyrosine kinases involved in cell signaling (IPR050198) (0.1551); Tyrosine-protein kinase, active site (IPR008266) (0.1498); SH2 domain (IPR000980) (0.1149); Pleckstrin homology domain (IPR001849) (0.1087)",2.30.29.30 (0.3711); 1.10.510.10 (0.2100); 2.30.30.40 (0.1420),Tyrosine-protein kinase (0.8008); Zinc-finger (0.7648); SH2 domain (0.5731); ATP-binding (0.5220); Zinc (0.3108); Nucleotide-binding (0.2273); Transferase (0.2237); SH3 domain (0.1752); Kinase (0.1716); Reference proteome (0.1282),Zn(2+) (0.2893)
MPGGDGFPDGEQDNSSPGPDIHTGQTDQTSSGQDPGTSGNISASGEEEEAEERIGRRSSGCEESGGEQTHEDVDMNSTHTSSSGNDSIHHRHHHHHRHHHHHHHHSSSNCSPGSTTGSGSTKSSKSATGSSSSSFHSTHHTECGEQTETGREHTHREMMHTVQEMKKRLPSEKRSRSKASTVEALHYALNCVKQVQANSEYYNLLMSSGLDERRDATVCTLEELEGFTSEHTLKNTDSFVVVFSLASGKVVYASEQASSVLHCKRKFLESAKFVEMLYHQDVNVFYSHTAQPRLPSWNLGTDSAAVLFECAQVKSFFCRIRGGKDRDGDMRYSPFRITPYLLKVQGSSGEEEPCCLALAERIISGYEAPRIPMDKRIFSTTHSPGCVFLEVDDRAVPLLGYLPQDLIGTSVLTCLHPDDRLLMLAMHRKIVKYAGQPPFEHSPIRFRCQNGDYVTLDSSWSSFINPWSRKVAFIIGRHKVRTGPLNEDVFAARSKADQPVTCEDVKELQAMIHKLFLQPVHNNGSSGYGSLGSNGSHEHYISVASSSDSNGNLWEDSHRETMTLQQFCADVNKVKNWGQQAYLESRKKLTALGPATAVAGAGVHASSSHDLGIRDHLKQSLQKARKQPHIPSYQQINCVDSIIRYLESCATSALKRKCESLSITTSSSSSTSEEDKPTSAAHENTDEAALDAARALDSQVSAGSATTAAVVGAPLTDITISTEAMSVVSVTSQCSYSSTIVHVPQPESEVTALEDAPMGSEPADSAPAPASPAPDSGSASTSQEELLVLGLTKEVLSAHTQKEEQQFVDRFRHRILQSPYSSYLQQDNSSNAHSHHRGDVVRQPNKHKRPKPEDSSDSYECSQPGNYWSLPGPTAAPHSSWPSSESSQPPPSNIGFVPPMAVPMQTPPYFNIIGADQQPVMLQPDPGVQNLQPMTPMMVVLLPSFPMYPPNNGMYFPMAAPGVVPYNIGGFVPPGAPMPAEAPLQGHNLESAGVGVPAEPDSIPEPWFGEDLDAAQPTALFSSSRSSSPIQLNLLQEELTKPSEAQTSTNADSLQEPHTKTDDARSECGHQDAHSSSSEMLDQLLQEDARSGTGSNASGSGSGESGGSLGSGSGLGSNGTSTSHTGSSNSSKYFASNDSSDTSRKARKSAEAQERERSGFKKHVDDPLWSMIKQTPEPVMLTYQISSRDQAQVLQEDREKLILMQPMQPWFTSDQKKELAEVHPWIQQNTVPQEINTQGCVSCNTIEPNKKLNLQTDSPNPPDISCPQDCPPQENRPDTDT,,negative regulation of transcription by RNA polymerase II (GO:0000122) (0.9534); circadian regulation of gene expression (GO:0032922) (0.3021); entrainment of circadian clock by photoperiod (GO:0043153) (0.2962); regulation of hair cycle (GO:0042634) (0.2937); locomotor rhythm (GO:0045475) (0.2076); circadian rhythm (GO:0007623) (0.1985); response to cold (GO:0009409) (0.1657); long-term memory (GO:0007616) (0.1657); post-transcriptional regulation of gene expression (GO:0010608) (0.1246); response to oxidative stress (GO:0006979) (0.1096); negative regulation of JNK cascade (GO:0046329) (0.1084); positive regulation of transcription by RNA polymerase II (GO:0045944) (0.0900); response to light stimulus (GO:0009416) (0.0841),cytoplasm (GO:0005737) (0.2094); nucleus (GO:0005634) (0.1936); nucleoplasm (GO:0005654) (0.0808),transcription cis-regulatory region binding (GO:0000976) (0.4597); transcription corepressor binding (GO:0001222) (0.1505),"Period circadian protein homolog 1-3, PAS-A domain (IPR048814) (0.4094); Period circadian regulator (IPR050760) (0.3910); PAS fold-3 (IPR013655) (0.1935); Period circadian-like, C-terminal (IPR022728) (0.1899); PAS domain superfamily (IPR035965) (0.1045)",3.30.450.20 (0.1039),Transcription regulation (0.6240); Ubl conjugation (0.4967); Reference proteome (0.3907); Biological rhythms (0.3477); Transcription (0.3053); Cytoplasm (0.2793); Nucleus (0.1436),
MKVLWSLLGLFLLYLSTECLLPPSKEELNQMSQVGEKYLDRQIENAISGVKEMKTVMERSEEEHKRMLSEMEKTQKEKENALKMAQEMKEKLSEEQSVCNETMEALWEECKPCLRKTCVKFYSRTCRSGSGLVGRQLEEILNRTSPISIFINGQSIETLLSEDQQQTRHFQDLEESYTEVSDGVENMFTDSMKVFDHMQMFHHPGFFPSRFQFPSMFGGHEGSTHAGRIYRSPMHDSLFHSLQSLFRPMERSMSMFGKNEERNFTSEGWKLNEKVTTDDKMTCKEIRRNSFGCVKLKDECEKCQQIQHIDCSGKRPLEGPLKEELERALGKAEEFTQEFNNLLNIFQEQMFNTSSLLDLFNKQFGWVSSLANHTQNEDGFFQIQAVMSKGSDNAENPADTRVSVKLFDGPDMIYTVPGDIPWSDPKFSEVVAQEALDRYKQNAVITKL,,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436) (0.7944); regulation of apoptotic process (GO:0042981) (0.5437); positive regulation of apoptotic process (GO:0043065) (0.0794); regulation of cell population proliferation (GO:0042127) (0.0689); negative regulation of amyloid fibril formation (GO:1905907) (0.0677); immune complex clearance (GO:0002434) (0.0647),chromaffin granule (GO:0042583) (0.4834); nucleus (GO:0005634) (0.4400); mitochondrial membrane (GO:0031966) (0.2365); endoplasmic reticulum (GO:0005783) (0.2074); cytosol (GO:0005829) (0.1932); extracellular space (GO:0005615) (0.1876); perinuclear region of cytoplasm (GO:0048471) (0.1797),misfolded protein binding (GO:0051787) (0.1119),"Clusterin, C-terminal (IPR016015) (0.4195); Clusterin-like (IPR000753) (0.2876); Clusterin, N-terminal (IPR016014) (0.2031); Clusterin, conserved site (IPR033986) (0.1802); Clusterin (IPR016016) (0.1734)",,Secreted (0.9077); Ubl conjugation (0.8577); Signal (0.6625); Reference proteome (0.6564); Mitochondrion (0.5415); Disulfide bond (0.5141); Nucleus (0.5128); Cytoplasm (0.4630); Glycoprotein (0.3596); Membrane (0.2912); Chaperone (0.2530); Endoplasmic reticulum (0.2065); Cytoplasmic vesicle (0.1751); Coiled coil (0.1369); Phosphoprotein (0.0430),
MASTTCEKALGPKKKSEKKIASKEEYRLLSNIMGVMNNLRKQGILCDVILVVEGKHILAHRVVLSAASHFFSLMFTSSMMEASNHEVELGGAEPEIIELLVEFIYTARISVNSNNVQSLLNAANQYQIDPVKKMCVDFLKEQVDATNCLGISALAECLNCPELKVAADDFIHQHFTNVYKMDEFLQLDVKQVTHLLQQDTLTVRAEDQIYDAAVRWLKYDVLNRQHYIVDILGKVRFPLVSKNFLSKTVQAEPLIQDNPECLKMVICGMRYHLLSPEDREELGESSRPRRKKHDYRIALFGGSQPQSCRYFNPKDYSWSDIRCPFEKRRDAASVFWDNVVYILGGSQLFPIKRMDCYNVVKDSWYSKLGPPNPRDSLAACASKGKIYTSGGSEVGSSALNLFECYDTRTEAWQTKPNMLMPRCSHGSVEANGLIYVCGGSLGNNVSGRVLNDCEVYDPNTEEWRGLCGMREARKNHGLVVVNSRIYAVGGQNTLGGLDSVEYYEIGSNEWKMASPMPWRGVTVKCAAVGSVIYVLAGFQGVGRLGHIMEYYTDTDKWVVSSKVRAFPVTSCLICLVDTCGANEEDMSFTPSSSSSSSSASLADGRM,,protein ubiquitination (GO:0016567) (0.3541); protein stabilization (GO:0050821) (0.1920); cytoskeleton organization (GO:0007010) (0.0958); ubiquitin-dependent protein catabolic process (GO:0006511) (0.0952); negative regulation of apoptotic process (GO:0043066) (0.0889),perinuclear region of cytoplasm (GO:0048471) (0.4059); cytoplasm (GO:0005737) (0.2582); cytosol (GO:0005829) (0.2254); nucleoplasm (GO:0005654) (0.1863); nucleus (GO:0005634) (0.0998); Cul3-RING ubiquitin ligase complex (GO:0031463) (0.0878),protein homodimerization activity (GO:0042803) (0.2080),"BTB-kelch protein (IPR017096) (0.4032); Kelch repeat type 1 (IPR006652) (0.3169); Kelch-like protein 7, BTB/POZ domain (IPR030599) (0.2295); Kelch-like protein 7, BACK domain (IPR047060) (0.2076); Kelch-type beta propeller (IPR015915) (0.1387); BTB/Kelch-associated (IPR011705) (0.1323); BTB/POZ domain (IPR000210) (0.0756)",1.25.40.420 (0.4711); 2.120.10.80 (0.3412),Translation regulation (0.7298); Reference proteome (0.6381); Ubl conjugation pathway (0.5368); Cytoplasm (0.3076); Kelch repeat (0.2275); Nucleus (0.2223); Repeat (0.2160); Alternative splicing (0.1332); 3D-structure (0.0943); Developmental protein (0.0720); Proteomics identification (0.0699); Cell cycle (0.0560),
MMMNVLSALLLLFIHCQLCWSADFQLTLLHTNDVHARVEETNKDSGKCSKPPCFAGVSRRSTKIKEIRSKEKNVLLLDAGDQFQGTVWFNYYKGAEAAYFMNQLKYDAMALGNHEFDNGVDGLLKPFLQEVNCTVLSANIKADETLAPRISGYYFPYKIFTLGSEKVGVVGYTSAETPALSLPGPHLKFEDEITALQPQVDKLLTLGVNKIIALGHSGFLMDQMIAKKVQGVDVVIGGHTNTFLYTGDPPSTEVPAGPYPLMVKSDDGRQVPVVQAYAFGKYLGFLKVTFDANGNVLESTGNPILLNSSVEPDPDIQAKVDSWRMNLANYSSQQVGQTLVFLNGTFEECRFRECNLGNLICDAMVHHNIKYADELQWNHVSSCILNGGGIRAPIDERNRNGSITMEDLIAVLPFGGTFDLVQLNGSTLLEAFEHSVRRHGGNTGEFLQVSGFQVVYDLSKAPGSRVKSVKVLCTQCRVPHYEPLVPNKVYKVVLPSYLVDGGDGFAMIKEKKLKHDSGDLDISVVAGYISERKRVHPAVEGRIQFSSSCAGLRGYTSTVLLLWAVWLMLV,5'-nucleotidase (3.1.3.5) (0.9721),AMP catabolic process (GO:0006196) (0.9040); ADP catabolic process (GO:0046032) (0.4828); leukocyte cell-cell adhesion (GO:0007159) (0.3339); response to ATP (GO:0033198) (0.3089),plasma membrane (GO:0005886) (0.2731); side of membrane (GO:0098552) (0.1527),GMP 5'-nucleotidase activity (GO:0050484) (0.6231); thymidylate 5'-phosphatase activity (GO:0050340) (0.3637); 5'-nucleotidase activity (GO:0008253) (0.3516); XMP 5'-nucleosidase activity (GO:0106411) (0.3407); nucleotide binding (GO:0000166) (0.3270); identical protein binding (GO:0042802) (0.1686); IMP 5'-nucleotidase activity (GO:0050483) (0.1409); metal ion binding (GO:0046872) (0.1298); 5'-deoxynucleotidase activity (GO:0002953) (0.1193),"Calcineurin-like phosphoesterase domain, ApaH type (IPR004843) (0.4511); 5'-Nucleotidase, C-terminal domain superfamily (IPR036907) (0.3336); 5'-Nucleotidase, conserved site (IPR006146) (0.2009); 5'-Nucleotidase, C-terminal (IPR008334) (0.1630); 5'-Nucleotidase/apyrase (IPR006179) (0.1139)",3.90.780.10 (0.1600),Nucleotide-binding (0.7336); Zinc (0.7167); Reference proteome (0.4705); Signal (0.2309); Hydrolase (0.1822),
MSSVNASFSQNISIVRPEYFFISGLSGIPYSSYYYIFLFVVYFISVIGNSVVLLIIAVDRSLHSPKYIGVFNLALADIGETNALIPNMMKTFLFNSQYISYNGCMANMFFVFLFNSIQSFTLVALAYDRFIAICLPLRYHAIVNNTSMILIFLAIWAFNSSVVASMVSMITRLSICKSNVIPSYFCDHGPIFRLACNDIKINEFFAFFISILYLTMPMVIIALSYLNIFLALIKITTWEGRLKALKTCVSHLLLVGIFFLPLLCTYIAQVLLALTPNARVISTSLSYAIPPMLNPIIYVLNTAEIKYIIRKLFKRRLRSVSDNISK,,"chemotaxis (GO:0006935) (0.2740); negative regulation of insulin receptor signaling pathway (GO:0046627) (0.2586); sensory perception of sound (GO:0007605) (0.1859); G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187) (0.1841); detection of chemical stimulus involved in sensory perception of smell (GO:0050911) (0.1680); adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189) (0.1578); G protein-coupled receptor signaling pathway (GO:0007186) (0.1520); regulation of angiogenesis (GO:0045765) (0.1249); signal transduction (GO:0007165) (0.1179); phototransduction (GO:0007602) (0.1087); response to xenobiotic stimulus (GO:0009410) (0.0753); gene expression (GO:0010467) (0.0615); sensory perception of smell (GO:0007608) (0.0610); cell migration (GO:0016477) (0.0538)",plasma membrane (GO:0005886) (0.1084); membrane (GO:0016020) (0.1031); cytoplasm (GO:0005737) (0.0960),olfactory receptor activity (GO:0004984) (0.2055); G protein-coupled receptor activity (GO:0004930) (0.1251),"Olfactory receptor (IPR000725) (0.4776); GPCR, rhodopsin-like, 7TM (IPR017452) (0.2326); Olfactory G-protein coupled receptor 1 (IPR050939) (0.2099); G protein-coupled receptor, rhodopsin-like (IPR000276) (0.2077)",1.20.1070.10 (0.1551),Olfaction (0.9095); Transducer (0.9064); Reference proteome (0.7862); Transmembrane helix (0.7428); Glycoprotein (0.4431); G-protein coupled receptor (0.4009); Sensory transduction (0.2247); Membrane (0.1845); Receptor (0.1324); Transmembrane (0.1118); Cell membrane (0.0665),
MEGDKIAALKRSFEVEEDTSTNPSPLSRRTTNPLRSSGTSSSSRFHDLRSLNSEPMSRHASDSSSNQRSPKSSLRRVELSGGRVPETVSRRTEISIDISSKQVDSSPSPGIARFGLKRPEVSLQSKATDAPLHRRAEGNHSRAQEPPAPPRRADPPVSTSRIPELSQRRAEPPSPLDISAPSRRAEMHVNRQLSDTQSPARESENSFTSAASITPTFNEYKTPPSVHEAPIRPLERSEVTSSYSSSSSSSSSIMADSVISEIPPTMCLEKPSIDFSYVGIDAILEQMRRKAMKQGFELNIMVVGQSGLGKSTLMNTLFKSKVSRKSFMGTAEEKIPKTIEIKSVSHDIEEKGVRMKLTVIDTPGFGDQINNENCWQPIMKFINDQYEQYLQEEINIDRKKRIPDSRVHCCIYFIPPTGHCLRPLDVEFMRRLSKVVNIVPVIAKADTLTLEERDFFKKKIREELRANGIDVYPQKEFDEDAEDRMINEKIREMIPFAVVGSDQEYQVNGRRLLGRKTKWGTIEVENIAHCEFAYLRDLLIRTHMQNIKDITSSIHYEMYRVCRLNENNTQANGLADHHPASHEI,,protein localization (GO:0008104) (0.3710); spermatogenesis (GO:0007283) (0.1998); cytoskeleton-dependent cytokinesis (GO:0061640) (0.1822); positive regulation of non-motile cilium assembly (GO:1902857) (0.1614); flagellated sperm motility (GO:0030317) (0.1098); cell differentiation (GO:0030154) (0.0821),microtubule cytoskeleton (GO:0015630) (0.4227); stress fiber (GO:0001725) (0.3464); septin complex (GO:0031105) (0.2037); non-motile cilium (GO:0097730) (0.1640); septin ring (GO:0005940) (0.1526); cell division site (GO:0032153) (0.1175); cytoplasm (GO:0005737) (0.1129); spindle (GO:0005819) (0.0896); perinuclear region of cytoplasm (GO:0048471) (0.0654),GTPase activity (GO:0003924) (0.2682); molecular adaptor activity (GO:0060090) (0.2405); GTP binding (GO:0005525) (0.1436),P-loop containing nucleoside triphosphate hydrolase (IPR027417) (0.1973); Septin (IPR016491) (0.1642),3.40.50.300 (0.2495),Reference proteome (0.6794); Nucleotide-binding (0.5605); Cytoplasm (0.3332); Phosphoprotein (0.2773); GTP-binding (0.2707); Differentiation (0.1867); Cytoskeleton (0.1317); Spermatogenesis (0.0737),
MDPEQPERDWQQLEPSYGLKVFLTVLYCLILSLGVLGNSATIHVAQVLQRNGYLQRSVAEHMVSLACSDLLVLLIGLPVELYSAIWFPFLSRSGDAACRIYNFLFELCSYATILNVATLSLERYLAICHPFRYRALRGGRTRRLLLAAWLCSALVALPLLVATGTEGYVPAGRQTPVQNLTFCTSLSQHWVMYRTSIFTAFVLYLLVLAGVAFMCRAMILVLRAPMGPAEAGASGDHKHQSARGKASRKQTILFLVLIVCALFVCWMPNQIRRLMTAAVPKSSWTGSYLTSYIKLHPVADSFFYLSSVLNPMLYNLSSRQFRSAFLQTLLCRLSLQHANRRTLENSGASKSSNNTLRPLLQRSLNRIRMATSSRSTPPSSAERRDSLNTTDRPQGEGKLTLDPQNTTNWPQGEGELTSDSQEKERNQLTHCPTLPDEQTS,,diet induced thermogenesis (GO:0002024) (0.5261); neuronal action potential (GO:0019228) (0.2826); insulin secretion (GO:0030073) (0.2341); G protein-coupled receptor signaling pathway (GO:0007186) (0.1893); adult feeding behavior (GO:0008343) (0.1882); negative regulation of interleukin-1 beta production (GO:0032691) (0.1803); negative regulation of inflammatory response (GO:0050728) (0.1739); insulin secretion involved in cellular response to glucose stimulus (GO:0035773) (0.1200); adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193) (0.0899); gastric emptying (GO:0035483) (0.0800); gastric acid secretion (GO:0001696) (0.0627); positive regulation of appetite (GO:0032100) (0.0525),cell surface (GO:0009986) (0.0958); plasma membrane (GO:0005886) (0.0915),G protein-coupled receptor activity (GO:0004930) (0.2624); peptide hormone binding (GO:0017046) (0.1403); hormone binding (GO:0042562) (0.1218),"Zinc-sensing G-protein coupled receptor (IPR052676) (0.4127); GPCR, rhodopsin-like, 7TM (IPR017452) (0.2640)",1.20.1070.10 (0.1636),Reference proteome (0.7388); Transducer (0.5674); Membrane (0.5396); G-protein coupled receptor (0.5204); Zinc (0.4855); Receptor (0.4300); Transmembrane helix (0.2666); Transmembrane (0.2184); Disulfide bond (0.1677); Glycoprotein (0.1217),
MNHIIYVIIFLFHPQVSGKNNCTVDQVDEVLTTQEGHIVLLPCLLLEDHFHRVIWYKQVLGEKPVVIVSSYHHSQPNEFSSDFKETQRFHAVRKADSFNLTIRRTLKSDSGTYFCGSAFANVVSFGTGTILLVKGADLKPAVIQHPVHAFIKPESNVTLRCSVEGKTCDKGVQSVYWFRQSLNTTHQGIVYTHGKSKNECADSSDTQSCLQNLAKMSVDVSEAGLYYCSVVTCDEVLFGNGTTLVIKDGFISESIQKCILIGLTVLSAVSLTINILLSLPLRRNGGKPQQMQTNDDITRVQFQNADDVNYAALNLSSKRGQRKMTLEKTPTQTNAAR,,adaptive immune response (GO:0002250) (0.3908); innate immune response (GO:0045087) (0.2947); B cell receptor signaling pathway (GO:0050853) (0.2158); negative regulation of cytokine production (GO:0001818) (0.1641); response to bacterium (GO:0009617) (0.1319); serotonin secretion (GO:0001820) (0.1027); positive regulation of B cell proliferation (GO:0030890) (0.1003); cell surface receptor signaling pathway (GO:0007166) (0.0970); inflammatory response (GO:0006954) (0.0915); regulation of immune response (GO:0050776) (0.0820); positive regulation of chemokine production (GO:0032722) (0.0631); negative regulation of interleukin-6 production (GO:0032715) (0.0618); natural killer cell activation (GO:0030101) (0.0611); positive regulation of type II interferon production (GO:0032729) (0.0523); negative regulation of type II interferon production (GO:0032689) (0.0450),B cell receptor complex (GO:0019815) (0.1351); external side of plasma membrane (GO:0009897) (0.1037),protein phosphatase binding (GO:0019903) (0.2002); MHC class I protein binding (GO:0042288) (0.1837); coreceptor activity (GO:0015026) (0.1646); peptide antigen binding (GO:0042605) (0.1083); signaling receptor activity (GO:0038023) (0.0914),Immunoglobulin V-set domain (IPR013106) (0.2416); Immunoglobulin-like fold (IPR013783) (0.1991); Immunoglobulin subtype (IPR003599) (0.1103); T cell receptor complex component (IPR052051) (0.0706),2.60.40.10 (0.1804),Immunity (0.7017); Signal (0.6366); Membrane (0.5451); Receptor (0.5274); Cell membrane (0.4931); Reference proteome (0.4189); Transmembrane helix (0.3517); Immunoglobulin domain (0.3129); Transmembrane (0.3069); Disulfide bond (0.1364); 3D-structure (0.0742); Glycoprotein (0.0670),
MSSSEDIIMAIPRELTQNPLRKIWMPCKNGLPEKHISQKRVCMTNCPTLIVTVGLPARGKTYISKKLTRYLNWIGVPTHEFNVGQYRRECVKIYKSFEFFRPDNEEGLKIRKQCASAALNDVREYLSVEGGQVAVFDATNTTRERRNIIMKFADQNGYKVFFVESVCEDPKVIAENIVQVKLGSPDYTDRNTEEAIQDFMKRIKCYESSYQPLDENLDRELSYIKIMDVGQRYLVNRVLDHIQSRIVYYLMNIHITPRSIYLCRHGESDLNVRGRIGGDSGLSHRGKEFAHSLGRFIQDQNIKDLKVWTSQMKRTIQTAESLGVPYEQWKALNEIDAGVCEEMMYEEIQEHYPQEFALRDQDKYRYRYPKGESYEDLVQRLEPVIMELERQENVLVICHQAVMRCLLAYFLDKSADELPYLKCPLHTVLKLTPVAYGCKVESIYLNVEAVNTHRDKPENVNISRLPEEALLTVPAHY,"6-phosphofructo-2-kinase (2.7.1.105) (0.9740); fructose-2,6-bisphosphate 2-phosphatase (3.1.3.46) (0.7979)","fructose metabolic process (GO:0006000) (0.8576); fructose 2,6-bisphosphate metabolic process (GO:0006003) (0.4459); glycolytic process (GO:0006096) (0.4440); apoptotic process (GO:0006915) (0.1658)","cytosol (GO:0005829) (0.1637); 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex (GO:0043540) (0.1504); nucleoplasm (GO:0005654) (0.0808)","fructose-2,6-bisphosphate 2-phosphatase activity (GO:0004331) (0.5673); ATP binding (GO:0005524) (0.2408)","Histidine phosphatase superfamily, clade-1 (IPR013078) (0.3511); P-loop containing nucleoside triphosphate hydrolase (IPR027417) (0.2661); 6-phosphofructo-2-kinase (IPR013079) (0.2626); Fructose-2,6-bisphosphatase (IPR003094) (0.2356); Histidine phosphatase superfamily (IPR029033) (0.1817); Phosphoglycerate/bisphosphoglycerate mutase, active site (IPR001345) (0.1811)",3.40.50.300 (0.2023); 3.40.50.1240 (0.1503),Multifunctional enzyme (0.6033); Reference proteome (0.5673); Phosphoprotein (0.4603); Nucleotide-binding (0.3604); Ubl conjugation (0.3332); Acetylation (0.2819); ATP-binding (0.2807); Kinase (0.2368); Hydrolase (0.1043),
MSQTAKSATNQGTDAKEKGAPAPAATSKASKTGDPGFMGNYKIFLFDQENFQGRMMEVQNECMNVCERGMDRVRSIIVECGPFVAFEQTNFRGEMFILEKGEYPRWDTWSNSYRSDCLMSLRPIRMDPMEHKICLFELSDFKGNKMEIQEDDVPTLWAHGFCDRVGSVRVPGGAWVGYQYPGYRGYQYLFECGDYRHYNEFCAFQPQIQSVRRVRDMQFHQRGCFNMTAAKQ,,lens development in camera-type eye (GO:0002088) (0.7678); visual perception (GO:0007601) (0.4613); negative regulation of TOR signaling (GO:0032007) (0.2072); negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction (GO:0051898) (0.1352); positive regulation of anoikis (GO:2000210) (0.1234); phagocytosis (GO:0006909) (0.1223); camera-type eye development (GO:0043010) (0.0867); cellular response to retinoic acid (GO:0071300) (0.0769); negative regulation of cytokine production (GO:0001818) (0.0447),nucleus (GO:0005634) (0.1841); nucleoplasm (GO:0005654) (0.0680); cytoplasm (GO:0005737) (0.0557),structural constituent of eye lens (GO:0005212) (0.2996); identical protein binding (GO:0042802) (0.1191),Beta/gamma crystallin (IPR001064) (0.3452); Beta/Gamma-Crystallin (IPR050252) (0.1113),2.60.20.10 (0.1528),Membrane (0.2109); Eye lens protein (0.1972); Disease variant (0.1874); Direct protein sequencing (0.1789); 3D-structure (0.1768); Repeat (0.1653); Reference proteome (0.1622); Acetylation (0.1580); Cataract (0.1338),
MSEGEVFHEKQRLELCAIHALNNVLQERVFTKETADDICKRLAPQCVMNPHRSVLGTGNYDVNVIMAALQSRGLAAVWWDKRRSVQNLCLDKIQGFILNVPSRVSLGIVSLPLRRRHWLAVREVHGHFYNLDSKLKGPACIGGETELRSFLTEQLSQDVAEMLLVVQKEVDEDGTWLKPDDTRK,ubiquitinyl hydrolase 1 (3.4.19.12) (0.9554),proteolysis (GO:0006508) (0.4607); protein deubiquitination (GO:0016579) (0.3178); microtubule cytoskeleton organization (GO:0000226) (0.1534); negative regulation of MAP kinase activity (GO:0043407) (0.1409); protein K63-linked deubiquitination (GO:0070536) (0.1403); platelet activation (GO:0030168) (0.1395); protein localization to cell surface (GO:0034394) (0.1032); cellular response to misfolded protein (GO:0071218) (0.0690); autophagy (GO:0006914) (0.0635); blood coagulation (GO:0007596) (0.0618); protein K48-linked deubiquitination (GO:0071108) (0.0547); intermediate filament cytoskeleton organization (GO:0045104) (0.0541); membrane organization (GO:0061024) (0.0448),plasma membrane (GO:0005886) (0.2101); cytosol (GO:0005829) (0.1944); presynaptic cytosol (GO:0099523) (0.1853); endoplasmic reticulum membrane (GO:0005789) (0.1201); cytoplasm (GO:0005737) (0.1121); dendritic spine (GO:0043197) (0.0434),cysteine-type deubiquitinase activity (GO:0004843) (0.3133); transmembrane transporter binding (GO:0044325) (0.0979); K63-linked deubiquitinase activity (GO:0061578) (0.0936),Josephin domain (IPR006155) (0.7598); Josephin-1/2 (IPR040053) (0.0494),3.90.70.40 (0.3225); 1.10.287.10 (0.0516),Phosphoprotein (0.7487); Zinc (0.6781); Reference proteome (0.5289); Ubl conjugation (0.3882); Hydrolase (0.3683); Cytoplasm (0.3617); Ubl conjugation pathway (0.3103); Membrane (0.2632); Proteomics identification (0.2174); Protease (0.1967); 3D-structure (0.0681); Nucleus (0.0553),
MADTWWNHAIVTHILVALFGMGSWISVDSIWVELPVVVGVLPEGWNLPAYISVLIAFGNLGPVVVTLTHHFAPGWLNERLAIHIIQALAVVASAFLALFWSQVAMVSGELRSVPFLLLTFILSLFCCTSNVTFLPFMYRYPPQYIRTFFVGQGLSALFPCVVALGQGVGKLECIEKSNGTEAHYLKENFPAQIFFWILTVMLVISATSFLALTYRVVIQAPAEEAPKAKQEMGNTEEETHPLQNGDSPVSEEQVEVEKQAPVVAFWTSRNIYMLLLLGISNALTNGVLPSVQSFTCLPYGNMTFHLSVVLGNIANPLACFVAMFVILRSSVGLGMMSIGGIIFAAYLMALAALSPCPPLLGSQFGVALVILSWIVFTGLFSYLKVVVGTLLHEAGHAALLWCGVFIQAGSLIGALTMFPMVSVYQVFQRARDCTDVCS,,riboflavin transport (GO:0032218) (0.3482); endocytosis (GO:0006897) (0.2448); riboflavin metabolic process (GO:0006771) (0.1586); establishment of localization in cell (GO:0051649) (0.1267); sensory perception of sound (GO:0007605) (0.0584); cell wall organization (GO:0071555) (0.0536); auxin polar transport (GO:0009926) (0.0481); nucleoside transmembrane transport (GO:1901642) (0.0464),plasma membrane (GO:0005886) (0.4770),identical protein binding (GO:0042802) (0.2356); riboflavin transmembrane transporter activity (GO:0032217) (0.1291),,,Transport (0.8258); Transmembrane (0.5527); Membrane (0.5191); Reference proteome (0.5177); Phosphoprotein (0.3335); Cell membrane (0.1420); 3D-structure (0.1415); Glycoprotein (0.1359); Ubl conjugation (0.1277); Disease variant (0.1238); Alternative splicing (0.1191); Transmembrane helix (0.1048); Vacuole (0.0571),
MFRMKSMRSFMFLICPVMVLVFFYYSSGRLQLKNSVQKSQADLDSLLSVGRVVASVYDKQGFLLKLDKKLPLELQYKYGNLSKGECKQGFAQAKMTLIYPKFSKPAPMFLDPNYKRLSKISSYPPPFGVRTQERIIDNILAATRSYSLGPELDSIPCKKCIIIGNGGILFNKSLGTKIDQYDVVVRLNEAPVAGFEKDVGSKTTMRITYPEGAIQRAERYEKSSLFVLSAFKSNDFKWLRHMVYKDRLWRMDGFWKSVARVVPRAPQDMRILNPYFIQEASFRLIGLPHNNGLMGRGNIPTLGTVAITMALHNCDEVAVAGFGYDMNTPHAPLHYYEKLRMSAIKESWTHNISREKEFLRKLVKAGVIEDLTHGI,"N-acetyllactosaminide alpha-2,3-sialyltransferase (2.4.3.6) (0.5252); beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminide alpha-2,3-sialyltransferase (2.4.3.2) (0.1168)",protein glycosylation (GO:0006486) (0.3410); glycolipid biosynthetic process (GO:0009247) (0.2263); oligosaccharide biosynthetic process (GO:0009312) (0.2070); O-glycan processing (GO:0016266) (0.1762); cognition (GO:0050890) (0.1501); lipid glycosylation (GO:0030259) (0.1460); keratan sulfate biosynthetic process (GO:0018146) (0.1369); glycosphingolipid biosynthetic process (GO:0006688) (0.0894),membrane (GO:0016020) (0.3818); Golgi membrane (GO:0000139) (0.0943); Golgi apparatus (GO:0005794) (0.0836),"N-acetyllactosaminide alpha-2,3-sialyltransferase activity (GO:0008118) (0.5584); beta-galactoside (CMP) alpha-2,3-sialyltransferase activity (GO:0003836) (0.1242); sialyltransferase activity (GO:0008373) (0.1136)",Glycosyltransferase 29 (IPR051142) (0.2584); Glycosyl transferase family 29 (IPR001675) (0.2300); GT29-like superfamiliy (IPR038578) (0.1776),3.90.1480.20 (0.2579),Transferase (0.8922); Signal-anchor (0.7609); Glycoprotein (0.6144); Reference proteome (0.4937); Glycosyltransferase (0.4794); Membrane (0.4190); Transmembrane (0.3767); Golgi apparatus (0.3036); Alternative splicing (0.1151); Secreted (0.0904); Transmembrane helix (0.0666); Proteomics identification (0.0541),
MTGRQAVKAYLDLMSQPCRAVLIFLKHNKIPHTVEQIAIRKGEQKTPEFTKLNPMQKVPVLEDNGFVLTESDAILKYLATTYKVPDHWYPKLPEKRARVDEYTAWHHMNTRMHAATVFWQEVLLPLMTGQPANTAKLEKALSDLSGTLDKLENMFLKRQAFLCGDDISLADLLAICELMQPMSSGRDILKDRPKLLSWRSRVQSALSDSFDEAHTIVYRLRDKFTAKL,glutathione transferase (2.5.1.18) (0.6234); glutathione peroxidase (1.11.1.9) (0.0826),response to toxic substance (GO:0009636) (0.4498); glutathione metabolic process (GO:0006749) (0.3269); linoleic acid metabolic process (GO:0043651) (0.2206); arachidonic acid metabolic process (GO:0019369) (0.1954); negative regulation of interleukin-1 beta production (GO:0032691) (0.1655); response to bacterium (GO:0009617) (0.1089); response to xenobiotic stimulus (GO:0009410) (0.1060); response to salicylic acid (GO:0009751) (0.0898); positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) (0.0818); xenobiotic metabolic process (GO:0006805) (0.0563),cytosol (GO:0005829) (0.5066); cytoplasm (GO:0005737) (0.1134),glutathione transferase activity (GO:0004364) (0.2501); signaling receptor binding (GO:0005102) (0.1152); glutathione peroxidase activity (GO:0004602) (0.0673),"Glutathione S-transferase Theta, C-terminal (IPR040077) (0.6008); Glutathione S-transferase, C-terminal (IPR004046) (0.4594); Glutathione S-transferase, C-terminal-like (IPR010987) (0.3932); Glutathione S-transferase, N-terminal (IPR004045) (0.2377); Glutathione transferase family (IPR040079) (0.1859); Glutathione S-transferase Theta, N-terminal (IPR040075) (0.1649); Thioredoxin-like superfamily (IPR036249) (0.1184)",1.20.1050.10 (0.3121); 3.40.30.10 (0.2903),Reference proteome (0.5656); Cytoplasm (0.3033); Proteomics identification (0.2849); Phosphoprotein (0.1767),
MSGEVECPKPEEVRDCETENGVEIIIKPTSGDPQNNNDQNVNQQTIFNDIRQNHSRVSKELFQAVGEEDENDDDDDDDDDSGTHYLNGDDRPCTHLQRAERPGNGGLPDTFQTDNLLYYERFKAYQDYMLGDSKPSEVQSFTAEYLEKIVEPCDWQGIWHTDVFDVLVEVVDVDCKALKAKVELVLPMACETRGCDLTEESMKALLEATLHKVPLMELSVVYDESGDFDQTALALEHLRFFYKHIWRKWDEEDEDDDFDYFVRCVEPRLRLYYDILEDRVPAGLVAEYHSLLALCSEKFQEFSSLRSDLNSDSESEQDNVSMVEGLRMYEQLEALKRKLRIIENPLLRYVLGYKVNSGQQSCRAKGPRPAGGRVVHLVSASATVHQLQSLITDKLMPCYSSEEFEVQFHSDPVLAVNGCFEGDVVIVCPGLYSITSSISIVDSIEIEGYGLPDEVVIEKRNKGDAFVESTGANVKLSNIKFIQRDAIEGILCVRQGKLEMENCVMQCETTGVIVRSAAQLTMNMCDLYGSKGAGVEIYPGSVCSLVGNGIHHCKEGILIKDFADELDVTPKITMVNNVIHNNQGYGVILVKPGDSTVEDLPAELNATDEKEEVYEDMGVKPDADMNDDDDVGVNVPIIVVEEECPSIKYSCTIPPDCEGNDAIKQELVATSARKLGRQKSRMKALGDMQADENLLSQEMFISIHGNQFKHNGKGSFGTFHY,,spermatogenesis (GO:0007283) (0.4387); fibroblast growth factor receptor signaling pathway (GO:0008543) (0.2658); cell differentiation (GO:0030154) (0.2347); male meiosis cytokinesis (GO:0007112) (0.1778); negative regulation of cell migration (GO:0030336) (0.0599),spindle (GO:0005819) (0.8187); midbody (GO:0030496) (0.3523); nucleus (GO:0005634) (0.2562); cytoplasm (GO:0005737) (0.1811); meiotic spindle (GO:0072687) (0.1311); nucleoplasm (GO:0005654) (0.0652),,SHC SH2 domain-binding protein 1-like (IPR045140) (0.1161); Pectin lyase fold/virulence factor (IPR011050) (0.0916),2.160.20.10 (0.2764),Reference proteome (0.8707); Repeat (0.8547); Alternative splicing (0.3212); Cytoplasm (0.2941); Phosphoprotein (0.2928); Host-virus interaction (0.2849); Membrane (0.2066); Proteomics identification (0.1769); Cytoskeleton (0.1753),
MMASSYNAKEEDGHHSGTAGLGGTAIRTRKPDNTAFKQQRLPAWQPILTAGTVLPAFFVIGLIFIPIGIGLYVTSNNIKEFEIDYTGTDMSSPCFNCSQSFSWNSTTPCKCTLSFSLDQPFESNVFMYYGLSNFYQNHRRYVKSRDDSQLNGDERSLKEPSKECEPYRINDNKRIAPCGAIANSMFNDTLDLFYIDPNGTKTQIPMIKKGIAWWTDKHVKFRNPGGNNPNLTAVFIDTAKPINWRKPVYELDTDPENNGFINEDFIVWMRTAALPTFRKLYRIIQKKNNMTPTLPRGNYSLEVTYNYPVRSFEGRKRMILSTISWMGGKNPFLGIAYITVGSICFFLGVVLLFIHHKYGNRNNSSDIPS,,protein localization to endosome (GO:0036010) (0.7421); xenobiotic transmembrane transport (GO:0006855) (0.7228); positive regulation of neuron projection development (GO:0010976) (0.4672); positive regulation of phospholipid translocation (GO:0061092) (0.3357); positive regulation of protein exit from endoplasmic reticulum (GO:0070863) (0.3189); phospholipid translocation (GO:0045332) (0.1351); endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888) (0.0415),Golgi apparatus (GO:0005794) (0.5528); phospholipid-translocating ATPase complex (GO:1990531) (0.3841); transport vesicle membrane (GO:0030658) (0.3377); early endosome membrane (GO:0031901) (0.2476); endoplasmic reticulum (GO:0005783) (0.1919); late endosome membrane (GO:0031902) (0.1800); plasma membrane (GO:0005886) (0.0642),aminophospholipid flippase activity (GO:0015247) (0.1559),CDC50/LEM3 family (IPR005045) (0.2501),,Transport (0.9775); Transmembrane (0.6970); Membrane (0.6164); Reference proteome (0.5561); Glycoprotein (0.4289); Disulfide bond (0.4182); Lipid transport (0.4065); Golgi apparatus (0.3720); Cytoplasmic vesicle (0.2602); Cell membrane (0.1834); Alternative splicing (0.1743); Phosphoprotein (0.1388); Transmembrane helix (0.1233),
MAEIKTGIFAKNVQKRINRAQEKVLQKLGKADETKDEQFEQCVQNFKRQEFEGSRLQREMKAYIAAVKGMQQASMNLTESLHEVYEPDWHGKDDVMTIGKNCDALWEDFHQKLVDSTINTLETYLTQFPDLKVRVAKRSRKLIDYDSARHHLETLQTSTMRNEKRIAKAEEDLKKAQRVFDDLNVGLQDELPTLWDSRVGFYVSTFKNVSSLEARFHREISFLCHKLYEVMNKLAEQHSDKMFTIQGAPSDSGPLRLARTPSPPDDESPDSSPAASPNHTLRPTSPGPPRPKSPSQLKMGPPKPPPPKVTPTRELQQEQIIDLFDGGFPEISVTSPQPNERPGESLLDLDFDPFKPDTSTPIGQTQSPVSQTLPWDLWTGDAAQPAQPATDAGFTANWAADFGSSATTVTDESANTQPAADGQGWPPADGWPTDSTPQPQGETATDEDATVPTFMADFDKMPEAEAEAPEGDVAEGEGEASPASEPEGGEGPVTTPPTDTQPEEITASSPPAETPTSTVESPVSAEPEAAEQAELPVEDIEKEQLSEESPDSVPVQETEKESPTEAALASVEDKESPIEETPTIDAKPEEETSSLEARPGDEPDNVEPKPTDEPDKVETQPGEVPDNIEPKPGDAPDNVEPQPGDETSKEGAANNGNEEEKMPIPSVVIEPASSNEGDDDRDGDITSPIATGDNGMIADCQTTKDSSGMPPRFLFKVETMHDFEAANPDELELKKGDIVLVVPTELAEDQDAGWLTGIRESDWQQRGASAKKGLFPENFTQRLE,,synaptic vesicle endocytosis (GO:0048488) (0.7501); nucleus organization (GO:0006997) (0.2415); cell adhesion (GO:0007155) (0.1060); negative regulation of transcription by RNA polymerase II (GO:0000122) (0.0848); gene expression (GO:0010467) (0.0515); endosome to lysosome transport (GO:0008333) (0.0424),synaptic vesicle (GO:0008021) (0.5009); cytoplasm (GO:0005737) (0.2269); presynapse (GO:0098793) (0.2225); synapse (GO:0045202) (0.2079); glutamatergic synapse (GO:0098978) (0.1232); cytoskeleton (GO:0005856) (0.1011); postsynapse (GO:0098794) (0.0926); cytosol (GO:0005829) (0.0770),,SH3 domain (IPR001452) (0.3396); AH/BAR domain superfamily (IPR027267) (0.2298); SH3-like domain superfamily (IPR036028) (0.0987); BAR domain (IPR004148) (0.0938),,SH3 domain (0.8906); Reference proteome (0.6735); Membrane (0.2460); Cytoplasm (0.1985); Coiled coil (0.1971); Phosphoprotein (0.1705); Proteomics identification (0.1534); Cytoskeleton (0.1239); Alternative splicing (0.0856),
MDAGFFRGTSAEQDNRFSNKHKKLLKQLKFAECLEKKVDMTKVNLEVIKPWITQRVTEILGFEDDVVIEFVFNQLEEKNPDGKMMQINLTGFLNGKNAREFMKDLWPLLLSAQENIAGIPSAFLEQKKEEIKQRQIEQEKLASLKKVDEDKREKENKERAQSKSPKRRKSRSPVKRDRKSSPSRSRSPRRKISPAASPPSSPPNHKEEPKREPDQSESSKPEPLIQEASSTSDLVTEMKPDSVSEPVKESSPDKTSKSEDRPKPRDREKDGRKDRPRHRSRSRSPRSRRRPRSRSRSFSPRRRTSPRRRISPRRRSPPRRQPPSRHRRSRSPVRRRRSRSRSSSGSSSSRSPHKRAGKRGSATPPRKLARRTDLSSPPRRRGRSPSGPDTSPSAGKHRPGGRNDSRSPSPKPRRSDASDSEEDKLGKGSTADSVQQRRQYRRQNQQSSSDTGSSSSSEDEGPRRQNRGAGARNGEIRRRRSHSPASPRRRHRDASPRKRRSPSPPGRRHRSQSPVRRRRSPSPPPRRRSPSPPPRRFTPPIQRRYSPPSPSPAQKRRSSGSPPKRRRSPSPMPKRRIPPSPPPKRRMSPSPPPKRRKSPSPMSKRRTSPSVSKRRTSPSPVAKHRRSPSPMSKRRTCASPVSKRRNSPSPAPQRRSSPSPMPKHRGSPSPVTKRHTSRSPKRSRGTSPGKRRTPPSSASPPPRHRRNSPNPPAAQRGRDTRSSPPAHTTRVSSSPPGRYGASGSSPQRQRRQTSPSHSTRPIRRVSRTPEPRKSQRGSQSPPPERRQVSRSPSASPPPAQKRPASVSPSRSTSRSPPPPAKKNSSVSPSPSPNKNSDAEGGKKKKKKKEKKHKKDKKHKKHKKQKKEKGGEEKSGGATGGHGPEAEPDSDQKKRVK,,"mRNA splicing, via spliceosome (GO:0000398) (0.8412); RNA splicing (GO:0008380) (0.4253); RNA splicing, via transesterification reactions (GO:0000375) (0.2797); regulation of mRNA splicing, via spliceosome (GO:0048024) (0.1683); spliceosomal complex assembly (GO:0000245) (0.1171)",spliceosomal complex (GO:0005681) (0.4343); catalytic step 2 spliceosome (GO:0071013) (0.3632); nuclear speck (GO:0016607) (0.1997); nucleoplasm (GO:0005654) (0.1551); nucleus (GO:0005634) (0.1320); U2-type precatalytic spliceosome (GO:0071005) (0.0798),,PWI domain superfamily (IPR036483) (0.3665); PWI domain (IPR002483) (0.3087); Serine/arginine repetitive matrix (IPR052225) (0.2397),1.20.1390.10 (0.3013),mRNA splicing (0.9547); mRNA processing (0.8816); Ubl conjugation (0.8006); Reference proteome (0.5975); Phosphoprotein (0.4712); Spliceosome (0.4704); Isopeptide bond (0.3628); Proteomics identification (0.3464); Acetylation (0.2785); Alternative splicing (0.2333); Repeat (0.1254); Nucleus (0.1092); Nonsense-mediated mRNA decay (0.1004); Coiled coil (0.0953),
MSKPNYTGVYNMISQDNFEEYLAALDVNYALRKVVCILKPSKHIEHDVNTDRMKIKTVTTFKNFDMDFTLGQEFTEDLGPVDGRKCQTTVDWDGDKLICVQRGEKEGRGWTHWLEGNILHLELRAQGVTAKQVFKKVE,nicotinamide-nucleotide adenylyltransferase (2.7.7.1) (0.0683),"retinoic acid biosynthetic process (GO:0002138) (0.3809); fatty acid transport (GO:0015908) (0.2551); vitamin A metabolic process (GO:0006776) (0.2190); Wnt signaling pathway (GO:0016055) (0.1800); retinol metabolic process (GO:0042572) (0.1796); regulation of granulocyte differentiation (GO:0030852) (0.1403); fatty acid metabolic process (GO:0006631) (0.0908); retinoic acid metabolic process (GO:0042573) (0.0751); circadian rhythm (GO:0007623) (0.0724); positive regulation of fatty acid beta-oxidation (GO:0032000) (0.0706); phagocytosis, recognition (GO:0006910) (0.0492)",nucleoplasm (GO:0005654) (0.1758); nucleus (GO:0005634) (0.1728); cytosol (GO:0005829) (0.1407),fatty acid binding (GO:0005504) (0.3853); cyclin binding (GO:0030332) (0.1272); retinoid binding (GO:0005501) (0.0971); retinol binding (GO:0019841) (0.0760),Cytosolic fatty-acid binding (IPR000463) (0.3226); Intracellular lipid binding protein (IPR031259) (0.1265),,Transport (0.7745); Vitamin A (0.5628); Reference proteome (0.5199); Retinol-binding (0.4380); Cytoplasm (0.2537); 3D-structure (0.1928); Nucleus (0.1859); Direct protein sequencing (0.1683); Lipid-binding (0.1581); Membrane (0.1571); Ubl conjugation (0.1373); Zinc (0.0965),
MLSFFWRNGIETPEPLKADVSGSIPPWLQGTLLRNGPGLFSVGNTSYKHWFDGMALIHSFTFKDGEVFYRSKYLKSETYKKNIAADRIVVSEFGTMVYPDPCKNIFSRAFSYMMNAIPDFTDNNLINIIKYGEDYYASSEVNYINQIDPLTLETLGRTNYRNHIAINLATAHPHYDEEGNTYNMGTAIMNLGRPKYVIFKVPANTSDKENKKPALSEVEQVCSIPIRSSLYPSYFHSFGMTENYIIFVEQAFKLDIVKLATAYFRDINWGSCLKFDQDDINVFHLVNKKTGKAVSVKYYTDPFVTFHHINAYEDDGHVVFDLITYKDSKLYDMFYIQNMKQDVKRFIETNKDFAQPVCQRFVLPVNVDKETPQDINLVKLQDTTATAVLKEDGSVYCTPDIIFKGLELPAINYKFNSKKNRYFYGTRVEWSPYPNKVAKVDVVTRTHKIWTEEECYPSEPVFIASPDAVDEDDGVILSSVVSFNPQRPPFLVVLDAKSFKEIARATIDASIHMDLHGLFIHDKST,"1.13.11.- (0.2973); beta-carotene 15,15'-dioxygenase (1.13.11.63) (0.2208); retinoid isomerohydrolase (3.1.1.64) (0.0721)",retinoid metabolic process (GO:0001523) (0.7036); retinal metabolic process (GO:0042574) (0.5154); regulation of mitochondrial membrane potential (GO:0051881) (0.3912); lycopene catabolic process (GO:1901176) (0.2180); zeaxanthin catabolic process (GO:1901826) (0.1786); visual perception (GO:0007601) (0.1570); lutein catabolic process (GO:0062172) (0.1424); carotene catabolic process (GO:0016121) (0.1180); regulation of reactive oxygen species metabolic process (GO:2000377) (0.0798); retina homeostasis (GO:0001895) (0.0785); retinol metabolic process (GO:0042572) (0.0768),cytosol (GO:0005829) (0.0660),"beta-carotene 15,15'-dioxygenase activity (GO:0003834) (0.4046); carotenoid dioxygenase activity (GO:0010436) (0.1591); monooxygenase activity (GO:0004497) (0.1510)",Carotenoid oxygenase (IPR004294) (0.2013),,Oxidoreductase (0.6763); Dioxygenase (0.3960); Metal-binding (0.3806); Iron (0.3796); Lipid metabolism (0.2439); Reference proteome (0.1726); Proteomics identification (0.0818); Cytoplasm (0.0803); Monooxygenase (0.0683),Fe(2+) (0.2357)
MAAAAPNPEDASRNSSSPSTPSALMGDGESEEAEEFASATHCSELSRRQNEQRKLGLFCDVTLAFSSAPGAANNFEFNAHRSVLAAATDYFTPLLGGQFSESVTRRVEMKEWSSEAGLDQETVESVIQFMYTGEIRVSTANVHEVLELADRFLLVQLKDFCGEFLKRKLSLGNCVAIHSLAHMYTLDQLALRAADMIRRNFHKVIQDEEFYTLPFHLVRDWLSDAEITVDSEEVLFDAVVKWVQKNSEERVKYFEELFRLLRLPQIKPTYLTRVVKNEPLVAQNAACLQLVSEAVEGHAIRFENLKSADTEFWASYMATFQPRFGQNMDVIMVVGGVSEGGDYLSECVGYFVYEDRWVNLPHIHNHLDGHAIAATDTHVYVAGSMEPGFAKTVERYNPNRNTWEQVSNLTTRKHSFGLTCIKNILYSIGGHGNFSPGFKDVSVYEPDQDKWHNLESAPKILRDVKAISVEDRYVYVTARTPVDTDSDDGLKTVTTRYDTDSRQWQEVDSLPLIDNYCLFQMAVASTNFYHTASCCPKSYTNVRDDVARQKISARISDDILESLPPEVTSIEGAAICYLGDDVFVIGGWKNSDDVDKQYRKEAYRYCAERKRWMLLPPMPQPRCRATACHVRIPYRFLYGCQRYPMPQNLARQRDRMQQMQQLHRRTLTLRRQLQSQIEC,,protein monoubiquitination (GO:0006513) (0.2853); cell division (GO:0051301) (0.1309); negative regulation of type I interferon production (GO:0032480) (0.1133); positive regulation of cell growth (GO:0030307) (0.1070); protein polyubiquitination (GO:0000209) (0.0756); protein ubiquitination (GO:0016567) (0.0729); response to UV (GO:0009411) (0.0661); innate immune response (GO:0045087) (0.0638); regulation of mitotic cell cycle (GO:0007346) (0.0603); mitotic cytokinesis (GO:0000281) (0.0444),cytosol (GO:0005829) (0.3516); mitotic spindle (GO:0072686) (0.1457); cytoplasm (GO:0005737) (0.1274); spindle (GO:0005819) (0.1048); nucleus (GO:0005634) (0.0605),RNA binding (GO:0003723) (0.0946),Kelch repeat type 1 (IPR006652) (0.4700); BTB-kelch protein (IPR017096) (0.3316); BTB/Kelch-associated (IPR011705) (0.3231); Kelch-type beta propeller (IPR015915) (0.1901),1.25.40.420 (0.5924); 2.120.10.80 (0.3609),Translation regulation (0.8602); Kelch repeat (0.8292); Reference proteome (0.6098); Cytoplasm (0.4068); Repeat (0.3062); Cytoskeleton (0.2153); Developmental protein (0.2010); Proteomics identification (0.1460); Differentiation (0.1439); Phosphoprotein (0.1061); Golgi apparatus (0.0931); Ubl conjugation pathway (0.0838); Meiosis (0.0665); 3D-structure (0.0485),
MERLEKPKKERLRVCVATCNRADYSKLAPIMFGIKSHPDIFDLEVVVLGSHLIDDYGNTFRMIEQDDFDIGSKLHTIVRGEDEAAMVESVGLALVKLPDVLQRLAPDILLVHGDRFDALALATAAALMNIRILHLEGGEVSGTIDDSIRHAISKLAHYHAVCTLSAERHLISMCEDHSRILLAGCPSYDKLLSAYKRDDYADIIKSWIGDDVKEQDYIVALQHPVTTDIKNSIKIYELMLDALISFNKKTLILFPNIDAGSKEMVRVMRRKGIEQHQNFRAVKHVPFDQFIQLVAHAGCMIGNSSCGVREAGAFGTPVINLGTRQTGRETGENVLHVRDADTHNKIYHALELQFGKRYPCSKIYGDGNAVQRILKFLQTIDLSEPLQKKFCFPPVKECISQDIDHILETQSALSVDLGGTNLRVGIVSMKGKVVKKYVQLNPKTFEERIELILTMCKQAMADAVHLNCRILGVGVSTGGRVNPQDGVVLHSTKLIKEWSSVDIRTPLSSALHLPVWVDNDGNCAALAERKFGHGKGVENFVTIITGTGIGGGIIQHNELIHGNTFCAAELGHIVVSLEGPECMCGGHGCIEAYSSGLALQREAKRLHDEDLLLVEGMTLNNKEQVNAIHLINAARLGNSKAETVLHTAGTALGLGIVNILHMINPSLVILSGVLAVHYETPVRQVIGQRALLTAQGTKVMVSDLEDPALLGAASMVLDYTTRRTY,UDP-N-acetylglucosamine 2-epimerase (hydrolysing) (3.2.1.183) (0.8916); N-acylmannosamine kinase (2.7.1.60) (0.7084),N-acetylglucosamine biosynthetic process (GO:0006045) (0.7974); N-acetylneuraminate biosynthetic process (GO:0046380) (0.6558); UDP-N-acetylglucosamine metabolic process (GO:0006047) (0.1130); glycosylation (GO:0070085) (0.0996); CMP-N-acetylneuraminate biosynthetic process (GO:0006055) (0.0587),nucleus (GO:0005634) (0.0885); cytosol (GO:0005829) (0.0765),metal ion binding (GO:0046872) (0.8696); UDP-N-acetylglucosamine 2-epimerase activity (GO:0008761) (0.5097); ATP binding (GO:0005524) (0.2663); N-acylmannosamine kinase activity (GO:0009384) (0.0492),"ATPase, nucleotide binding domain (IPR043129) (0.2925); ROK family (IPR000600) (0.2715); Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (IPR020004) (0.1826)",3.40.50.2000 (0.4181); 3.30.420.40 (0.3730),Zinc (0.9489); Reference proteome (0.7173); ATP-binding (0.6877); Kinase (0.6605); Metal-binding (0.5915); Nucleotide-binding (0.5636); Cytoplasm (0.4911); Phosphoprotein (0.3596); Transferase (0.2103); Hydrolase (0.1945); Proteomics identification (0.1544); Magnesium (0.1257); Alternative splicing (0.1120); Ubl conjugation (0.1041); Multifunctional enzyme (0.1026); 3D-structure (0.0545),Mg(2+) (0.0984)
MEEKAFAKELDQWIEQLNECKQLSETQVKTLCEKAKEILTKESNVQEVRCPVTVCGDVHGQFHDLMELFRIGGKSPDTNYLFMGDYVDRGYYSVETVSLLVALKVRYRERVTILRGNHESRQITQVYGFYDECLRKYGNANVWKFFTDLFDYLPLTALVDGQIFCLHGGLSPSIDTLDHIRALDRLQEVPHEGPMCDLLWSDPDDRGGWGISPRGAGYTFGQDISETFNHANGLTLVSRAHQLVMEGYNWCHDRNVVTIFSAPNYCYRCGNQAAIMELDDTLKYSFLQFDPAPRRGEPHVTRRTPDYFL,protein-serine/threonine phosphatase (3.1.3.16) (0.9880),mitotic cell cycle (GO:0000278) (0.6619); peptidyl-threonine dephosphorylation (GO:0035970) (0.1310); negative regulation of hippo signaling (GO:0035331) (0.1157); negative regulation of epithelial to mesenchymal transition (GO:0010719) (0.0982); negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction (GO:0051898) (0.0914); response to hydrogen peroxide (GO:0042542) (0.0892); T cell homeostasis (GO:0043029) (0.0882); G1/S transition of mitotic cell cycle (GO:0000082) (0.0739); protein dephosphorylation (GO:0006470) (0.0539),protein phosphatase type 2A complex (GO:0000159) (0.1523); spindle pole (GO:0000922) (0.1292); FAR/SIN/STRIPAK complex (GO:0090443) (0.1199); cytosol (GO:0005829) (0.0955); GO:0000775 (0.0801); nucleus (GO:0005634) (0.0774),myosin phosphatase activity (GO:0017018) (0.1100); protein serine/threonine phosphatase activity (GO:0004722) (0.0994),"Serine/Threonine protein phosphatase PP2A-like (IPR047129) (0.1823); Calcineurin-like phosphoesterase domain, ApaH type (IPR004843) (0.1627); Metallo-dependent phosphatase-like (IPR029052) (0.1265); Serine/threonine-specific protein phosphatase/bis(5-nucleosyl)-tetraphosphatase (IPR006186) (0.1074)",3.60.21.10 (0.1416),Protein phosphatase (0.3794); Methylation (0.3444); Meiosis (0.2364); Phosphoprotein (0.1960); Hydrolase (0.1846); Manganese (0.1814); Reference proteome (0.1728); Cytoplasm (0.1000); Centromere (0.0950),
MSKEGQPREPEQLRKLFIGGLSFETTDDSLRAHFEQWGTLTDCVVMKDPNTKRSRGFGFVTYSSVDEVNASMDARPHKVDGRLVEPKRAVSREDSSKPFAHTTVKKIFVGGIKDDTEENHLRDYFDQFGKIEVVEIMVDHKTGNKRGFAFVTFDDHDSVDRIVIQKYHTVNGHNCEVRKALSKQEMANTGRGGGGGGGGGGGNFNRYGNNGGYNNDFGGGGGGGNRDGYFGRGGRGNNFGGGGGGGGYGGGGDCYNNNNGFGGGGYGGGGGNGGGSPGNYGGNRGYGGGGGGGHGYGNQGGGYGGGNSGGGGGGYNNYNNGNGNFGGGNFGGGGGGGGNSGGGGNYNDFGNYNSQQSNYGPMKGNFGGGGRNSGPYGGGYGGGSSGSGGGGSGYGGGSGGRRF,,"mRNA splicing, via spliceosome (GO:0000398) (0.6711); primary miRNA processing (GO:0031053) (0.1441); regulation of alternative mRNA splicing, via spliceosome (GO:0000381) (0.1189); compound eye morphogenesis (GO:0001745) (0.0620); negative regulation of transcription by RNA polymerase II (GO:0000122) (0.0595)",extracellular exosome (GO:0070062) (0.2015); cytoplasm (GO:0005737) (0.1671); nucleoplasm (GO:0005654) (0.0923); nucleus (GO:0005634) (0.0920); catalytic step 2 spliceosome (GO:0071013) (0.0794),mRNA 3'-UTR binding (GO:0003730) (0.1675); miRNA binding (GO:0035198) (0.1393),"Nucleotide-binding alpha-beta plait domain superfamily (IPR012677) (0.2471); hnRNP A1, RNA recognition motif 1 (IPR034845) (0.1306); RNA recognition motif domain (IPR000504) (0.1126); Heterogeneous nuclear ribonucleoprotein A1/A2, C-terminal (IPR021662) (0.1078); RNA-binding domain superfamily (IPR035979) (0.1026)",3.30.70.330 (0.0851),mRNA transport (0.5931); mRNA processing (0.3993); Ubl conjugation (0.3931); mRNA splicing (0.3518); Reference proteome (0.2902); Spliceosome (0.2835); Repeat (0.1977); RNA-binding (0.1922); Nucleus (0.1909); Ribonucleoprotein (0.1874); Methylation (0.1750); Transport (0.1679); Proteomics identification (0.1213); Acetylation (0.1200),
MALHCGRACRQYLLHLAHDNVDFRLAEIKALLSLRDRPFETPETFKEKSPFWHLNGLSEDDIRSVMSRTVCGKSAFELWGHGKTTEELRRSLLEYPSENMAPYLQQNSTYKINVYTFNKTLEFKDRIKKIDALDFLPFEGTVNLKDPEHIFCLLEDYGTDPNDIPEEPVYVYFGRWIADGQRELIRSYSVKKRHFIGNTSMDAGLSFIMANHAKVKANDLVYDPFVGTGSLLVACSHFGAYVCGTDIDYNTIHGIGKASRKNQKWRGPDENIRANLRQYGAENLYVDVMVSDASKLVWRRNAQFDAIITDPPYGIRESTRRTGSHKDIIKPPEDFSGESHVPVSMAYHLSDIFADLLNFAAHHLVLGGRLVYWLPIYRPEYCEEMVPLHPCLTLISNCEQTLSSHTSRRLITMEKTKDPEDSDSLAHLADPRFTPYHGHNSFREKYFSGLTKKNGKNAKVTAENED,2.1.1.- (0.9296),tRNA modification (GO:0006400) (0.6831); tRNA processing (GO:0008033) (0.3854); methylation (GO:0032259) (0.3728),nucleus (GO:0005634) (0.4891); cytoplasm (GO:0005737) (0.3259); cytosol (GO:0005829) (0.1324); nucleolus (GO:0005730) (0.0646),tRNA binding (GO:0000049) (0.8363); tRNA (guanine(10)-N2)-methyltransferase activity (GO:0160102) (0.3825); methyltransferase activity (GO:0008168) (0.0501),"tRNA guanosine-2'-O-methyltransferase, TRM11 (IPR016691) (0.4021); Ribosomal RNA large subunit methyltransferase K/L-like, methyltransferase domain (IPR000241) (0.3927); DNA methylase, N-6 adenine-specific, conserved site (IPR002052) (0.2208); S-adenosyl-L-methionine-dependent methyltransferase superfamily (IPR029063) (0.1490)",3.40.50.150 (0.2504),tRNA-binding (0.9997); S-adenosyl-L-methionine (0.9848); tRNA processing (0.9726); Reference proteome (0.8575); RNA-binding (0.5725); Transferase (0.5655); Methyltransferase (0.4919); Mitochondrion (0.0944); Proteomics identification (0.0836); Acetylation (0.0818),
MKNHLYCSAPVCLILLELWGTLATQCRWEDGCVCPVCPAGHEPTACGEPEGTREIGLCRICPAGTFSDSQDTEPCRPQTSCGTLNRWISTKPTSTSDAVCGGCLPGFHPAATRRPSTLHACVRKPHSRRRRNVVKGTSIRAGAGSGNTTSVQAPEEKTTEYAVFALVPVFCVMGLLGILICNLLKKKGYRCSAEKDGMDAEAATPQKEGNPCPYIVDDPNEDTISILVRLITEKKENAAALEELLQEYEDKQMALNKSSSIKFPGLPHFSQFRSLPRLCTHQHHLHTINGLASRSGVCCSRCSQKKWPELLLPALALPTDMHKSPTNMVKAPEVTILSVGRFQVAQIPEMKSSLKEAPQPESSDTDSMDSSQTEPAEERSLLGVSSSSNSASAKARQELNL,,apoptotic process (GO:0006915) (0.9852); signal transduction (GO:0007165) (0.2288); cell differentiation (GO:0030154) (0.1443); negative regulation of Wnt signaling pathway (GO:0030178) (0.0973); glucose homeostasis (GO:0042593) (0.0859),plasma membrane (GO:0005886) (0.7375); sarcolemma (GO:0042383) (0.1864); extracellular region (GO:0005576) (0.0785),,"TNFR/NGFR cysteine-rich region (IPR001368) (0.3062); Tumour necrosis factor receptor 19-like (IPR022333) (0.2964); Tumor necrosis factor receptor 19-like, N-terminal (IPR034048) (0.1793)",2.10.50.10 (0.2205),Signal (0.6985); Transmembrane (0.5310); Apoptosis (0.5294); Phosphoprotein (0.4562); Reference proteome (0.4433); Receptor (0.4055); Membrane (0.4001); Glycoprotein (0.3578); Coiled coil (0.3146); Transmembrane helix (0.2876); Disulfide bond (0.2335); Proteomics identification (0.1952); Alternative splicing (0.1590); Differentiation (0.1285); Cytoplasm (0.1153); Cell membrane (0.1001); Repeat (0.0802),
MPPSAKRGLRREELQMELVCEWGSCQETFDRMQDFCQHVEKHYKVTVDNKTDFPEEEHNCLWRDCGFCSVEGDEEFLRHIFFHCYHTKLKQWGLAILKSHSDMGACSVGLHNRNIVPEVQENFLCLWEHCEMSMDNPEWFYRHVEMHAQCLEANEENVLFCGWKDCEASFKGRFKLREHMRSHTQEKLVACPTCGGMFANNTKFFDHIRRQTSIEGQRFQCSHCSKRFATERLLRDHMRNHVNHYKCPLCEMTCPSPSSLRNHIKFRHSNEKPYSCDYCEYSCKNLIDLRKHLDTHSSEPAYRCDFPDCDYSTRSFYSIKNHYKRAHEGDYTPRYKCHVCEQCFTRGNNLTAHLRKRHQFKWPSGHPRFRYKEHEDGFMRLQLIRYESVELTEQLIRERQGDGDGSESSQQNVHPGEELEETPEPFSAITEAKSRKDETEVCRTQDNSESVFLVLTAGTSSQADSIREGSVMLQLQDTAQQLGMEVV,,DNA repair (GO:0006281) (0.6086); DNA damage checkpoint signaling (GO:0000077) (0.3927); establishment of protein localization (GO:0045184) (0.3615); G1/S transition of mitotic cell cycle (GO:0000082) (0.3112); in utero embryonic development (GO:0001701) (0.2482); negative regulation of DNA-templated transcription (GO:0045892) (0.2400); mitotic cell cycle (GO:0000278) (0.2269); negative regulation of gene expression (GO:0010629) (0.2221); positive regulation of gene expression (GO:0010628) (0.2178); regulation of transcription by RNA polymerase II (GO:0006357) (0.1720); negative regulation of transcription by RNA polymerase II (GO:0000122) (0.1463); chromatin organization (GO:0006325) (0.1080); embryonic viscerocranium morphogenesis (GO:0048703) (0.0692),,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228) (0.1475); metal ion binding (GO:0046872) (0.0998); DNA binding (GO:0003677) (0.0747); RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978) (0.0736); DNA-binding transcription factor activity (GO:0003700) (0.0509)",Zinc finger E-box-binding homeobox (IPR051574) (0.2227); Zinc finger C2H2-type (IPR013087) (0.2199); Zinc finger C2H2 superfamily (IPR036236) (0.2155),3.30.160.60 (0.2883),Zinc-finger (0.9864); Nucleus (0.5067); Repeat (0.3809); DNA-binding (0.1704); Transcription (0.1700); Metal-binding (0.1501); Activator (0.1431); Reference proteome (0.1091),
MAATKVGCEHYVRSCLLKAPCCGKFYVCRLCHDAEETHQMDRFKVQEVKCAVCNTIQEAQQICKECEVKFGEYYCDICHLFDKDKKQYHCQPCGICRIGPREKYFHCTKCNLCLGTELKDKHKCVENVSRQNCPVCMEDIHTSRVGAHVLPCGHLLHGTCFDDMLKTGAYRCPLCMHSAFNMKEYWKQMDEEISQTPMPTEYQDSTVKIICNDCQARSTVSFHVLGMKCSSCGSYNTAQDGGLMGTPAANTQTLPEEPDAEQHH,RING-type E3 ubiquitin transferase (2.3.2.27) (0.4536); 2.3.2.- (0.1830),positive regulation of protein ubiquitination (GO:0031398) (0.9170); positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436) (0.6510); rescue of stalled ribosome (GO:0072344) (0.4771); ubiquitin-dependent protein catabolic process (GO:0006511) (0.4091); protein ubiquitination (GO:0016567) (0.3890),nucleus (GO:0005634) (0.2739); ubiquitin ligase complex (GO:0000151) (0.2106); nucleoplasm (GO:0005654) (0.1211),zinc ion binding (GO:0008270) (0.3017); ubiquitin protein ligase activity (GO:0061630) (0.2470); ubiquitin-protein transferase activity (GO:0004842) (0.2130); p53 binding (GO:0002039) (0.1943); protein homodimerization activity (GO:0042803) (0.0675),"Zinc finger, CTCHY-type (IPR017921) (0.4230); Zinc finger, RING-type (IPR001841) (0.3425); Zinc finger, RING/FYVE/PHD-type (IPR013083) (0.2662); Zinc finger, CHY-type (IPR008913) (0.1889)",2.20.28.10 (0.5862); 3.30.40.10 (0.1731),Zinc (0.5976); Reference proteome (0.3817); Zinc-finger (0.3169); Metal-binding (0.3013); Cytoplasm (0.1121); Ubl conjugation pathway (0.0853),
MAKKAVGLGPLSRRPDNSAFKQQRLPAWSPSLTAQTVLPIFYILAVVCLLLGIWLLITVQNTHQLKVDYTDAGTCERCFELHANNTRTVCTCSVNFYVPRPFPGDVFFYYGLRNFHQNLRRYMDSRDDAQMVGRKNNLKAPSSYCAPFHYDANGVPIAPCGAVANSMFNDSFTLMYHQANGAEVQVPLYRKGIAWYTDKNVKFRNPPTNNTFSLRQAFEGTTRPLYWQHSVYELDDTDSNNNGFINDDLIVWMREAAFPNFKKLYGVLNRAQEPFTEGLPAGNYNISIDYNFPVEPFRGRKELVISMVTWFGGQNYFLPIAYLVTSGLILVTAVVLTTVFVKFGKNGKNMEE,,phospholipid translocation (GO:0045332) (0.3839); protein localization to endosome (GO:0036010) (0.2877); aminophospholipid transport (GO:0015917) (0.2569); xenobiotic transmembrane transport (GO:0006855) (0.1841); positive regulation of protein exit from endoplasmic reticulum (GO:0070863) (0.1492); positive regulation of phospholipid translocation (GO:0061092) (0.1473); spermatogenesis (GO:0007283) (0.0688); endocytosis (GO:0006897) (0.0625); phospholipid transport (GO:0015914) (0.0614),phospholipid-translocating ATPase complex (GO:1990531) (0.5033); Golgi apparatus (GO:0005794) (0.4900); late endosome membrane (GO:0031902) (0.1962); early endosome membrane (GO:0031901) (0.1713); late endosome (GO:0005770) (0.1068); endoplasmic reticulum (GO:0005783) (0.0933); plasma membrane (GO:0005886) (0.0898),aminophospholipid flippase activity (GO:0015247) (0.1495),CDC50/LEM3 family (IPR005045) (0.4216),,Transport (0.7850); Disulfide bond (0.3937); Membrane (0.3682); Endoplasmic reticulum (0.2687); Meiosis (0.2585); Lipid transport (0.2278); Glycoprotein (0.2210); Phosphoprotein (0.2075); Reference proteome (0.2038); Alternative splicing (0.2000); 3D-structure (0.1437); Transmembrane (0.1342); Cell membrane (0.0741); Ubl conjugation (0.0735); Transmembrane helix (0.0414),
MRRMWIYLSSALCALVFTGVYQVEGMEVFTSSELEAVNGTEIRLKCTFKSNRPLSEERTSVSWSFMPLGKTKEEPFFHYQGHAYLPPGGLFKDHVVWSGDVMKGDGSITLQDVQFSFNGTYSCQVLNPPDIQGFAGEIKLRVVQKVSFSEIGILAIAVGGSIGVILLILIIYIVVRVFRRREEDMTVETEDHRLKDQVL,,cell adhesion (GO:0007155) (0.6121); cell-cell adhesion (GO:0098609) (0.3898); apoptotic process (GO:0006915) (0.2297); protein phosphorylation (GO:0006468) (0.0816); cell differentiation (GO:0030154) (0.0670); spermatogenesis (GO:0007283) (0.0456); cardiac muscle contraction (GO:0060048) (0.0424),plasma membrane (GO:0005886) (0.6683),protein domain specific binding (GO:0019904) (0.2158); kinase binding (GO:0019900) (0.1288),Myelin P0 protein-related (IPR000920) (0.2232); Immunoglobulin-like domain superfamily (IPR036179) (0.2204); Immunoglobulin V-set domain (IPR013106) (0.2031); Immunoglobulin subtype (IPR003599) (0.1790); Immunoglobulin-like fold (IPR013783) (0.1274),2.60.40.10 (0.0767),Signal (0.5970); Transmembrane helix (0.5659); 3D-structure (0.3488); Membrane (0.3391); Reference proteome (0.3053); Direct protein sequencing (0.2997); Cell membrane (0.2630); Immunoglobulin domain (0.2425); Alternative splicing (0.2078); Transmembrane (0.1389); Disulfide bond (0.1352); Glycoprotein (0.1206); Phosphoprotein (0.0939); Disease variant (0.0768),
MLCVLVLALLASASAQRLSRGCGSCDRTQCAPLPAQGCSSGTLRDSCGCCELCAAAEGEPCGGRGVSARRCGSGLECVKPDKKSKSGICVCKSGVPVCGTDGRNYNSGCALRAASARALQEKQPEIRVHNTGRCAQGPEIVTPPGEVWNITGSQVFLSCEAIGVPTPVLTWRKVSGGSEKPVPLPGDKDNLAVQTRGGPEKHQVTGWVLISPLTKAEDGSYECHASNTQGEASAVGSIHVVESISDIPVQMVKDSEL,,regulation of cell growth (GO:0001558) (0.9137); regulation of signal transduction (GO:0009966) (0.6177); cell adhesion (GO:0007155) (0.5288); negative regulation of peptidase activity (GO:0010466) (0.2324); response to organic cyclic compound (GO:0014070) (0.1341); negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512) (0.0616),extracellular region (GO:0005576) (0.2772); extracellular space (GO:0005615) (0.1783); collagen-containing extracellular matrix (GO:0062023) (0.0592),insulin-like growth factor binding (GO:0005520) (0.6147); serine-type endopeptidase inhibitor activity (GO:0004867) (0.1137),"Kazal domain (IPR002350) (0.3769); Insulin-like growth factor binding protein-related protein (IGFBP-rP), MAC25 (IPR011390) (0.3288); Insulin-like growth factor-binding protein, IGFBP (IPR000867) (0.3035); Growth factor receptor cysteine-rich domain superfamily (IPR009030) (0.1765); Kazal domain superfamily (IPR036058) (0.1205)",4.10.40.20 (0.7420); 3.30.60.30 (0.1112),Secreted (0.7758); Signal (0.6735); Reference proteome (0.3527); Immunoglobulin domain (0.2492); Disulfide bond (0.1607),
MVLLKLKFPFQKRVRLAQGLWLLSWVAMFSGAVTFATGVFLKTELHRRSEVMHSMDIHIVPNLLMAVGLASVGINICAGKVCQDSLDPSRFPRWKTLLLPFFCLSVFFTSLLLVAMILSYALQPSLEESLKIGLKNGIRFYKDTDTPGRCFQKETIDRLQIEFQCCGNTNYRDWFEVQWISNRYLDFTSKEVKDRVRSNVDGRYLLDGVPFSCCNPASPRPCIQYSLLDNNAHYNYEYQSEELNLYNRGCRQALVSYYMGLMNTIGPCVLLVFLLQMAILVGLRYLQTAMEGVLGQENVEIETEGYILEKGVKETLLETKEKMMKLLQFAQVGDASAETPGSEPEAEKPATA,,cell adhesion (GO:0007155) (0.7786); retina development in camera-type eye (GO:0060041) (0.5721); protein heterooligomerization (GO:0051291) (0.4288); protein homooligomerization (GO:0051260) (0.4194); photoreceptor cell outer segment organization (GO:0035845) (0.2307); detection of light stimulus involved in visual perception (GO:0050908) (0.1538); cell population proliferation (GO:0008283) (0.1258); brain development (GO:0007420) (0.0844); protein maturation (GO:0051604) (0.0706),plasma membrane (GO:0005886) (0.2605); membrane (GO:0016020) (0.1369); photoreceptor inner segment (GO:0001917) (0.1203); photoreceptor outer segment (GO:0001750) (0.1134),protein homodimerization activity (GO:0042803) (0.6546),"Peripherin, extracellular domain (IPR042026) (0.3618); Peripherin/rom-1, conserved site (IPR018498) (0.2128); Peripherin/rom-1 (IPR000830) (0.1294); Tetraspanin, EC2 domain superfamily (IPR008952) (0.1294)",1.10.1450.10 (0.1737),Vision (0.9517); Membrane (0.5396); Transmembrane (0.4837); Disulfide bond (0.4136); Cell adhesion (0.3699); Reference proteome (0.2602); Glycoprotein (0.1970); Sensory transduction (0.1435),
MRSALDLIRTSRLFLLSRMGFVALVLLCALTGLVFGDNKPKTCSDIRLFYSNKGFNLNGVPQTEISGEHLRVCAQGYTCCTSVMEENLLNLSRREFETQVKESGRSLQAKLNGQFKSFDEYFLELLNRSEASLQSSFQSGFGSLFSQMSKVFQDLFSDLRRYFRGSNVNLEEALNEFWARLLDRLFKALNPQYSIGEEYLECVAKQSEKLKPFGETPRELKTKITRTVIAARTFVQGLVISGEAVRKVSQVSLSTECVRAVMKQTYCPHCSGVALAKPCSNYCRNVLKGCLANQADLDTEWRNLADAMLEVVDKLSRPYSVDSVVLSLPKRIAEAILYMQDNQDMFINKVFLECGTPAPSSNIQEQIKRGRNTAEEVSSTPGAQLERLLSDVSRMLRDMMQYWVHLPRKLCVDRESGPGESDRCWNGMSVGRYLPEVMGDGLASQINNPEVEIDITKPDMAVRKQIMQLKIMINRLKYAVNGNDVDFQDTSDDISGSGSGMCLDDQCSRGPRLMSPNTDKPKVYASPSENKKVVNGRSSQNLPCISLYLLSLVTVLLRR,,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) (0.5845); cell migration (GO:0016477) (0.4449); regulation of protein localization to membrane (GO:1905475) (0.3407); regulation of signal transduction (GO:0009966) (0.2194); positive regulation of skeletal muscle cell differentiation (GO:2001016) (0.1995); heparan sulfate proteoglycan catabolic process (GO:0030200) (0.1838); Schwann cell differentiation (GO:0014037) (0.0918); positive regulation of skeletal muscle satellite cell proliferation (GO:1902724) (0.0746); negative regulation of satellite cell differentiation (GO:1902725) (0.0710),synapse (GO:0045202) (0.4914); plasma membrane (GO:0005886) (0.3375); extracellular region (GO:0005576) (0.3076); collagen-containing extracellular matrix (GO:0062023) (0.2086); external side of plasma membrane (GO:0009897) (0.0910); cell surface (GO:0009986) (0.0906); side of membrane (GO:0098552) (0.0819),laminin binding (GO:0043236) (0.1440),Glypican (IPR001863) (0.2397),,Glycoprotein (0.6531); Proteoglycan (0.5574); Transmembrane helix (0.5192); Signal (0.4802); Membrane (0.4071); Reference proteome (0.3778); GPI-anchor (0.3311); Lipoprotein (0.3009); Heparan sulfate (0.2905); Cell membrane (0.1734); Secreted (0.1082); Disulfide bond (0.0569),
MQLLILVSLFAVGAMAGKYSKEMNEKNASDKSNSQVEFRIAKLNQVWEKAIRMQLAPVRLSELHSDLKIQEKDELQWKKLKAEGMDEDGEREAKLRRNFNIILAKYGMDGKKDTRTLDSNRLKDHEVKVGDTFDDPKLDKLWNKARTSGKFSDEELQTLHREFQHHKDKIHEYNIVMDTVSRTEEIHKNVISPLEGDVKENVLHQKHTDLKQRMRDLNQGFERLRKITHEGYTDDSEFREPRVIELWEMAKRSNLSKDELDSLKEELRHFETKVEKHQHYQEQLELSHQKLKHVEALGDEDHIMRNKEKYNTLAEKAREMGYKMKKHLQDLTNKLSKNGLQHNEL,,negative regulation of very-low-density lipoprotein particle clearance (GO:0010916) (0.9759); negative regulation of receptor internalization (GO:0002091) (0.9662); negative regulation of amyloid-beta clearance (GO:1900222) (0.6095); regulation of receptor-mediated endocytosis (GO:0048259) (0.1710); amyloid-beta clearance by transcytosis (GO:0150093) (0.1270),endosome (GO:0005768) (0.6414); plasma membrane (GO:0005886) (0.5323); cis-Golgi network (GO:0005801) (0.4230); endosome lumen (GO:0031904) (0.3395); endomembrane system (GO:0012505) (0.3286); rough endoplasmic reticulum lumen (GO:0048237) (0.3186); Golgi apparatus (GO:0005794) (0.2822); cell surface (GO:0009986) (0.1380); endoplasmic reticulum-Golgi intermediate compartment (GO:0005793) (0.1274),low-density lipoprotein particle receptor binding (GO:0050750) (0.3476); very-low-density lipoprotein particle receptor binding (GO:0070326) (0.3303); receptor antagonist activity (GO:0048019) (0.3184); receptor ligand activity (GO:0048018) (0.1547); lipase binding (GO:0035473) (0.1236); heparin binding (GO:0008201) (0.1189),"Alpha-2-macroglobulin RAP, domain 3 (IPR037999) (0.3602); Alpha-2-macroglobulin RAP, domain 2 (IPR038001) (0.2791); Alpha-2-macroglobulin receptor-associated protein, domain 1 (IPR009066) (0.1975); Alpha-2-macroglobulin receptor-associated protein (IPR038003) (0.1525); Alpha-2-macroglobulin RAP, C-terminal (IPR010483) (0.1305)",1.20.81.10 (0.2011),Signal (0.7337); Reference proteome (0.7261); Coiled coil (0.3982); Receptor (0.2883); Lipoprotein (0.1501),
MRELVILAALVSALHAASLPKDSGVEYNCQENQDNNAVLAAEQFINAHHHHGYKFRFVSQDSRSAEKKADSCEVVFGVTLEETECHIVNPKPLDQCDRRLETETKVTAKCNVTVSSFEGKAAVKRYNCDTEPASHEDLVKKCPDCPGLLPLHEPKALESVNAALAKFNKQSNHKSYFKLMEVGRISSQWMPMGQSYFTQFAIMETNCTKKDAPQNPEACKALCGDQATYGFCKSSKVGSEEPEVECEIYEDQNFTHPMQHPAQSRRDCKFHDHRPGSVHPLGPDHRGHWDKGHGHRGPPERGDKKHDHGGRPEHGGRPEHAHGDKDKKPGHGGRPEHAHGDKDKKPGHEGHPEHGGRSEHAHGDKDKKHDHGGRPEHRHHDDKDKKHDHRFHPEHPCPKSPTGVPEPSPEGGRHEFPCHGYVKIPPSIYPICPFPPPRLCRGPPDLPRPTSSPKQ,,negative regulation of endopeptidase activity (GO:0010951) (0.4167); acute-phase response (GO:0006953) (0.2634); heme transport (GO:0015886) (0.2431); regulation of platelet activation (GO:0010543) (0.2425); negative regulation of bone mineralization (GO:0030502) (0.1789); fibrinolysis (GO:0042730) (0.1601); negative regulation of blood coagulation (GO:0030195) (0.1467); vasodilation (GO:0042311) (0.1304); negative regulation of proteolysis (GO:0045861) (0.1252); ossification (GO:0001503) (0.1149); retinoid metabolic process (GO:0001523) (0.1141); defense response to fungus (GO:0050832) (0.1024); regulation of peptidyl-tyrosine phosphorylation (GO:0050730) (0.0993); blood coagulation (GO:0007596) (0.0901); negative regulation of fibrinolysis (GO:0051918) (0.0865); negative regulation of peptidase activity (GO:0010466) (0.0583); chemotaxis (GO:0006935) (0.0539),blood microparticle (GO:0072562) (0.6714); extracellular region (GO:0005576) (0.0433),endopeptidase inhibitor activity (GO:0004866) (0.1794); cysteine-type endopeptidase inhibitor activity (GO:0004869) (0.1715),Kininogen/Fetuin/Histidine-rich Glycoprotein (IPR050735) (0.2699); Cystatin domain (IPR000010) (0.1253),3.10.450.10 (0.1349),Secreted (0.7651); Signal (0.5104); Zinc (0.4173); Reference proteome (0.3049); Vasodilator (0.2528); Metalloenzyme inhibitor (0.2463); Metalloprotease inhibitor (0.2310); Thiol protease inhibitor (0.2010); Protease inhibitor (0.1797); Disulfide bond (0.1756); Copper (0.1472); Repeat (0.1359); Phosphoprotein (0.1157); Inflammatory response (0.0972),
MRQATRTKKPDVKVVILGDMNVGKTSLLHRYTERKFKDTISTVGGAFFLKQWGPYNISIWDTAGREQFHGLGSMYCRGAAAVILTYDVTNWQSLAELENRFLSLTDTANADCIFALVGNKADLTDPFAQEPDSESESDPQPVASCPTPPASPVQHKQVSREDAVALYARVLRYKGLDEKTCLPAERMCFETSAKTGYNVDALFETLFDLVLPSILKKRSEGEATVDLETPLEVRRTKAGCCA,3.6.5.- (0.0865),intracellular protein transport (GO:0006886) (0.4844); phagosome acidification (GO:0090383) (0.4395); negative regulation of toll-like receptor 9 signaling pathway (GO:0034164) (0.2577); late endosome to Golgi transport (GO:0034499) (0.2089); protein transport (GO:0015031) (0.1890); positive regulation of megakaryocyte differentiation (GO:0045654) (0.1011); endosomal transport (GO:0016197) (0.0854); phagosome-lysosome fusion (GO:0090385) (0.0748); phagosome maturation (GO:0090382) (0.0703); vesicle-mediated transport (GO:0016192) (0.0514),phagocytic vesicle (GO:0045335) (0.2289); phagocytic vesicle membrane (GO:0030670) (0.1950); endomembrane system (GO:0012505) (0.1343); Golgi apparatus (GO:0005794) (0.1265); cytosol (GO:0005829) (0.1190),GTPase activity (GO:0003924) (0.2939); GTP binding (GO:0005525) (0.2813),Rab20 (IPR041836) (0.3691); Small GTPase (IPR001806) (0.2995); P-loop containing nucleoside triphosphate hydrolase (IPR027417) (0.0937),3.40.50.300 (0.1210),Membrane (0.5517); Reference proteome (0.5111); Cytoplasmic vesicle (0.4641); Lipoprotein (0.3412); Transport (0.3391); Methylation (0.2941); Endosome (0.2734); Proteomics identification (0.2438); GTP-binding (0.1753); Cell projection (0.1615); Protein transport (0.1496); Prenylation (0.1290); Golgi apparatus (0.1275); Nucleotide-binding (0.1027); Cytoplasm (0.1014),
MLSLGPTEPWSIREKLCLASSVMRSGDQNWVSVSRAIKPFSESGRPPDWFSQKHCASQYSQLLETTEAPKRKRGEKGEVVETIEDVIVRRLTAERIEELKRLIKDTQEKYRKLKKEVDLIQAGHVDPKLEELWAEIELKKKQEEEEAEQKKRATEAAYQIRQAAKNTPKRVPSVTVRSPPGASSPSMDILQPDASQPMTDESCASPMAQGVTVFMPVSDVMGPGPKESGLSSLVDDSPQKKHLAPKATPPPSPLLSELLKKGSLIAASSRLVVEGEVATGLSNGSHAVELHTSATVLPATQDITADAPTLSRLLESVTPAQQPVSADPPKPPTVVPPAPDHLSVPKSGDAAIAEGSGAEAVMAGSSTPAEVEGKETELVEEDTVVSVSYMGHELDLETVGDIIAIIEEKVDDPVEALDAAAVEAALSLCEDPAVGGHPLTSPWESQTFKAAEPEPMIQQSAIPAGAESAPNSAIVQGEMEVLVEEATETEAVEGVTEEPEVPSAPETEQSQDSEVKTEVERGGEGEGGVEETAQPENRTPSPAVKCEGEDWVQPETVTPCLDSEDSSASAKDAKEVKEEDGGSEVDVDEGMEMKECGDGDGEGPYLSEVDPPASESEDGYGSHSQRYTTADSTASSPASSQFSMCSEDQEALQAQKIWKKAIMLVWRAAANHRYASVFLQPVSDDIAPGYHSIVHRPMDLSAIKKNIESGQIRTTAEFQRDIMLMFQNAVMYNSSDHDVYHMALEMQRDVLEQIQQFLATQLIMQTSESGISTKSLRGREANRKQDPNEKTLSPAHKEPHLEPEPPARRKRNNSKQDTVEKDGGTRGRRSAIEADMKMKK,,positive regulation of DNA-templated transcription (GO:0045893) (0.5003); positive regulation of transcription by RNA polymerase II (GO:0045944) (0.3700); negative regulation of transcription by RNA polymerase II (GO:0000122) (0.2418); cellular response to thyroid hormone stimulus (GO:0097067) (0.2259); regulation of cell cycle (GO:0051726) (0.1773); chromatin organization (GO:0006325) (0.1725); DNA repair (GO:0006281) (0.0957); regulation of DNA-templated transcription (GO:0006355) (0.0630); negative regulation of gene expression (GO:0010629) (0.0609); positive regulation of myoblast differentiation (GO:0045663) (0.0600),nucleus (GO:0005634) (0.2715); NuA4 histone acetyltransferase complex (GO:0035267) (0.1573); Swr1 complex (GO:0000812) (0.1536); nucleoplasm (GO:0005654) (0.1168); cytoplasm (GO:0005737) (0.1078),nuclear receptor coactivator activity (GO:0030374) (0.1677),"Brd8, Bromo domain (IPR037966) (0.3611); Bromodomain (IPR001487) (0.1569)",1.20.920.10 (0.2934),Reference proteome (0.7150); Ubl conjugation (0.6714); Transcription regulation (0.5996); Bromodomain (0.4814); Coiled coil (0.3226); Proteomics identification (0.3080); Methylation (0.2068); Isopeptide bond (0.1676); Nucleus (0.1668); Alternative splicing (0.1594); Intellectual disability (0.1579); Cytoplasm (0.1578); Disease variant (0.1508); Transcription (0.1456); 3D-structure (0.1386); Acetylation (0.0979),
MKMDQAASRYQVLHNEDDSSEGAASAEPSTSTQAVGALEGISNLAVDTEAPPPPYASVALGATAAPESTFAGDFPVPPPYSIATSLPTYDEAEKAKAAAMAASAVEVIPRDEDFPVRDDFSDADQLRVGNDGIFMLAFFMAFLFNWIGFCLSFCLTNTIAGRYGAICGFGLSLIKWILIVRFSDYFTGYFNGQYWLWWIFLVLGLLLFFRGFVNYLKVRNMSESMVSSLRTRFFLLY,,negative regulation of type 2 immune response (GO:0002829) (0.6767); regulation of myeloid leukocyte differentiation (GO:0002761) (0.6535); metal ion transport (GO:0030001) (0.5114); positive regulation of protein ubiquitination (GO:0031398) (0.4222); regulation of lymphocyte differentiation (GO:0045619) (0.4169); ubiquitin-dependent protein catabolic process (GO:0006511) (0.3743); negative regulation of transporter activity (GO:0032410) (0.3687); positive regulation of protein catabolic process (GO:0045732) (0.3339); vacuolar transport (GO:0007034) (0.3232); negative regulation of isotype switching to IgE isotypes (GO:0048294) (0.1937); negative regulation of gene expression (GO:0010629) (0.1826); negative regulation of protein transport (GO:0051224) (0.1649); intracellular iron ion homeostasis (GO:0006879) (0.1312); negative regulation of interleukin-4 production (GO:0032713) (0.0820),Golgi apparatus (GO:0005794) (0.2105); Golgi membrane (GO:0000139) (0.1931); membrane (GO:0016020) (0.1412); cell cortex (GO:0005938) (0.1311); mitochondrion (GO:0005739) (0.1292),WW domain binding (GO:0050699) (0.2100),NEDD4/Bsd2 (IPR019325) (0.2920),,Reference proteome (0.5672); Ubl conjugation (0.4740); Membrane (0.4002); Transmembrane helix (0.3776); Transmembrane (0.3087); Repeat (0.1821); Golgi apparatus (0.1124),
MTLNSNKNEPAVILERVNSARTALSDLYLEQLLQNKPKSEKAAMQTYECKGQEVFSNGSAGHMNGRDATRMREVAFEKNPSEPLGVTLKLNEKQRCTVARILHGGMIHRQGSLHEGDEIAEINGKSVSNQSVDQLQKILKDTNGVVTLKIISNQQSRPMACEMYMRAQFDYDPAKDELIPCKEAGLKFQTGDIIHIINKKDPNWWQGKVDSSSTDFAGLIPSPELQEWRVASKSKATREAGQSCSPFGKKKKCKDKYLAKHSSIFDQLDVISYEEVVRLPAFNRKTLVLIGAHGVGRSLIKNSLLSKYPEKFAYPAPHTTRPQKKDEENGKEYYFISNDEMTKGIVGNELLEYGSYQGHMFGTKIETIHKIHEQGKIAVLDVEPQTLKVLRTAEFAPLVIFIAPTNTGNQSEAVQNIQKESDSLLAAHRHFFDEILVNNDVDESVKGVEDAIERASSSPQWVPISWVY,,regulation of neutrophil chemotaxis (GO:0090022) (0.7241); protein localization (GO:0008104) (0.1311); egg activation (GO:0007343) (0.0436),centriolar satellite (GO:0034451) (0.5389); cell-cell junction (GO:0005911) (0.5009); stereocilium (GO:0032420) (0.4837); plasma membrane (GO:0005886) (0.2975),signaling receptor binding (GO:0005102) (0.3653),"P-loop containing nucleoside triphosphate hydrolase (IPR027417) (0.2800); PDZ superfamily (IPR036034) (0.2780); Guanylate kinase-like domain (IPR008144) (0.2329); PDZ domain (IPR001478) (0.2221); SH3-like domain superfamily (IPR036028) (0.2073); Guanylate kinase, conserved site (IPR020590) (0.1990); SH3 domain (IPR001452) (0.1876); Guanylate kinase/L-type calcium channel beta subunit (IPR008145) (0.1396); MPP1, SH3 domain (IPR035475) (0.1354)",2.30.30.40 (0.1475); 3.40.50.300 (0.1445); 2.30.42.10 (0.1047),SH3 domain (0.7944); Reference proteome (0.7652); Lipoprotein (0.4599); Membrane (0.3089); Palmitate (0.2778); Phosphoprotein (0.1986); Proteomics identification (0.1965),
MSGRGKTGGKARAKAKSRSSRAGLQFPVGRVHRLLRKGNYAQRVGAGAPVYLAAVLEYLTAEILELAGNAARDNKKTRIIPRHLQLAVRNDEELNKLLGGVTIAQGGVLPNIQAVLLPKKTEKAAKGKXISXRSNMSGRGKTGGKARAKAKTRSSRAGLQFPVGRVHRLLRKGNYAQRVGAGAPVYLAAVLEYLTAEILELAGNAARDNKKTRIIPRHLQLAVRNDEELNKLLGGVTIAQGGVLPNIQAVLLPKKTEKAAKGK,,heterochromatin formation (GO:0031507) (0.2012); DNA damage checkpoint signaling (GO:0000077) (0.1712); double-strand break repair via homologous recombination (GO:0000724) (0.1649); DNA repair (GO:0006281) (0.1488); nucleosome disassembly (GO:0006337) (0.1410); silent mating-type cassette heterochromatin formation (GO:0030466) (0.1112); DNA damage response (GO:0006974) (0.1062),nucleus (GO:0005634) (0.2193); site of double-strand break (GO:0035861) (0.1793); nucleosome (GO:0000786) (0.1454); GO:0000781 (0.1007),chromatin-protein adaptor activity (GO:0140463) (0.3310); protein heterodimerization activity (GO:0046982) (0.2072); DNA binding (GO:0003677) (0.1892); structural constituent of chromatin (GO:0030527) (0.1869); nucleosomal DNA binding (GO:0031492) (0.1375),Histone H2A (IPR002119) (0.1372); Histone H2A conserved site (IPR032458) (0.1118); Histone-fold (IPR009072) (0.0989),1.10.20.10 (0.1353),Nucleosome core (0.5550); Ubl conjugation (0.4930); Nucleus (0.3735); Reference proteome (0.3572); Methylation (0.2193); Chromosome (0.2122); Phosphoprotein (0.1861); DNA-binding (0.1423); Acetylation (0.1285),
MPFQQQPITRKHPYTLIPIHFMDLWGKLEHPEETHANTGRTCKLRTEMPADPAEARTSNLLAMAAPAVVPRSRPKSIKVLPTNGTAADLSPIGVHAMNGGDRVKTNTHLIYAQREVELVNHCFADVEHFMARLQQTAEAKNIQEQLKRSKKKSRKKNKTKKNKKEDDEPTPQKVTPPSEQEFVDIFQKIKYSFCLLDRLKMKISEPSSEELLHHVFVPLQLMVKTTGGPKLASSISSPALTSGAISLLQHNLNEQEKTLWTSLGPNWTLPYSQLSETVPQYTPVFLDGWQPIAVDANGQPIEDPIEVQHKHEALIQTQQVIDQARLTVHQENDGMEPLPPNEERMYRCSYDFVARNSSELSVLHGESLEVLESSKRWWKCKNSYGQTGFVPHNILEPINHAEVDSTNVVMRNQSTKAPISPLRGGRMSYAAPKSESAVHPDPRPLSMPSFADDGEKVVLMNDELIQRLANGRAASVRPMVINKANETTVPLDYHSPQAEVQEWLKAKGFNNITVQSLGVLNGAQLFSLNKEELRAVCPEEGARVYSQITVQKSLLEDVRKATELEAIMKKQKMKADLKTEGGEF,,Rho protein signal transduction (GO:0007266) (0.7179); adult locomotory behavior (GO:0008344) (0.5258); regulation of Rho protein signal transduction (GO:0035023) (0.5105); sensory perception of sound (GO:0007605) (0.3233); positive regulation of ruffle assembly (GO:1900029) (0.3081); Rac protein signal transduction (GO:0016601) (0.2829); actin crosslink formation (GO:0051764) (0.2207); phosphorylation (GO:0016310) (0.1900); behavioral response to ethanol (GO:0048149) (0.1854); exocytosis (GO:0006887) (0.1099); actin polymerization-dependent cell motility (GO:0070358) (0.1081),synapse (GO:0045202) (0.4414); plasma membrane (GO:0005886) (0.2427); NMDA selective glutamate receptor complex (GO:0017146) (0.1722); cytosol (GO:0005829) (0.1110); vesicle (GO:0031982) (0.1099); ruffle membrane (GO:0032587) (0.0937); stereocilium (GO:0032420) (0.0672); dendrite (GO:0030425) (0.0612),actin binding (GO:0003779) (0.2065),SH3 domain (IPR001452) (0.3478); SH3-like domain superfamily (IPR036028) (0.3456); SAM domain (IPR041418) (0.2886); IPR055093 (0.2448); Epidermal growth factor receptor kinase substrate 8-like (IPR039801) (0.2296),2.30.30.40 (0.4319); 1.10.150.50 (0.1009),SH3 domain (0.9628); Receptor (0.5563); Reference proteome (0.3038); Phosphoprotein (0.2356); Kinase (0.1386); Coiled coil (0.1333),
MEPDSDSMPEQAEGALQMQPFQAAPGQFGDEVRQPGLYCWRVEKMKAVPLNQAEVGAFFNGDSYLVLDNRGDQGADLHMWIGEKSSRDEQVACAMLATQLDNFLGGDPVQHRQVQGYESPEFMKLFPRGVSYKEGGVESGFRRAQSGPGPVQRLYQIKGKRNIRAKEVDLSWQSFNKGDCFILDLGETIVSWIGSQANIFEKQKVREIASLIRDTDRHGKAQITNVNEGEETQEMLKVLGPVPELKESTPEEDSKADASNSASLYKVSDATGSMKLTKVSEKSPFAKDLLVRDDCFILDNGANGKIFVWKGSGANAEEKRVALKMADDFIQQMNYPKMKTQVEILPQGRETVIFKQFFQSWN,,central nervous system development (GO:0007417) (0.8678); actin polymerization or depolymerization (GO:0008154) (0.6717); cell projection assembly (GO:0030031) (0.4729); actin filament depolymerization (GO:0030042) (0.4201); positive regulation of apoptotic process (GO:0043065) (0.2617); cilium assembly (GO:0060271) (0.1642); actin filament severing (GO:0051014) (0.1528); barbed-end actin filament capping (GO:0051016) (0.1279),actin cytoskeleton (GO:0015629) (0.2793); cytosol (GO:0005829) (0.2048); cytoplasm (GO:0005737) (0.1886); phagocytic vesicle (GO:0045335) (0.1270); sarcoplasm (GO:0016528) (0.1270); nucleus (GO:0005634) (0.1059); Flemming body (GO:0090543) (0.0809); lamellipodium (GO:0030027) (0.0608),"actin filament binding (GO:0051015) (0.1306); phosphatidylinositol-4,5-bisphosphate binding (GO:0005546) (0.0701); protein domain specific binding (GO:0019904) (0.0604)",ADF-H/Gelsolin-like domain superfamily (IPR029006) (0.0826),3.40.20.10 (0.0933),Phosphoprotein (0.3230); Reference proteome (0.3099); Actin-binding (0.2245); Zinc (0.1826); Calcium (0.0545),
MPWTPYRTDMLYEYASWEDFKQNRATTTYKLPNRVDGTGFVVYDGAVFYNKERTRNIVKYDLRTRIKSGEAIVNNANYHDTSPYRWGGKSDIDLAVDENGLWVIYATEANNGRLVVSQVNPYTLRFEGTWETSFDKRLASNAFMACGVLYAVRSVYQDDDSEAGGDLVLYAYNTNRAREEPVHIPFPNPYQYVSSVDYNPRDNQLYVWNNYNVLRYPLEFGPPDPTAGPPVTTQMSSSTTTAARPITSTSLPSTIRPLPPTAHPIGAINKAPDLRPITATVPVTRRPLRVPPQGPEIEVCESRVARGVQWPATQKGETVDRPCPKGSLGIASFQCLSSPVLWNPRGPDLSNCTSPWVNQVAQKIKSGENAANIAAELVNHTQGRIHAGDVSSSVRLIEQLLDILDAQLQALRPGNKESAARNYNKWQKRERTCRAYVQAVVQTVDNLLRAEALESWQDMNSTEQAHTATMLLDVMEKGAFLLANNMYNNHFSDHAANVDLEVRVLNTETDSQDLSFPQSGPSDSSIQLSASTFKQYSRNGQVKVVFVLYKNLGSFLSTENATVKMEMEAGIGGRGLAVNSHVIAASINKESSRVFLTEPVVFTLRHLQLENHFSPNCSFWNYSERSMTGQWSSQGCRLIETNSTHTTCSCSHLTNFAVLMVHHEPDYPGRMHELILFVITWVGIVISLVCLAICISTFCFLRGLQTDRNTIHKNLCINLFIAELLFLIGIDKTQYHIACPIFAGLLHFFFLAAFSWMCLEGIQLYLMLVEVFESEYSRKKYYYLCGYCFPALVVGISAAIDYRSYGTKKACWLRVDNYFIWSFIGPVSFIIMLNLVFLMITLHKMIRNSSALKPDSSRLDNIKSWALGAIALLFLLGLTWAFGLLFINENTVIMAYLFTTFNAFQGMFIFIFHCALQKKVHKEYSKCLRHSYCCSRTSTTSSHGSLKNSALRTNNRYYTGSQTRHAAVHRQSRIRRMWNDTVRKQTESSFMAGDINSTPTLNRGTMGNHLLTNPVLQTRTGSSPYNTLLAETFTPPSPGVFNSTGTFRDPKSTLSKNRDHGGMETLPLNGNFNNSYSLRSVGGSGAPGGSCDFLGGGGGDSPPPLLNPRGSETLGGIRRNLSDAAAFEKMIISELVHNNLRGGGGVGGGDRTCGSLARGHGHLGMGRAGGGVEPVIGMEDDEDFRSREARQRTPQDVELLYKALEEPLLLQRAQSVLYQSDPDESESYTADLTESLGHSGHSAQSAAGQGHSGPPDSPARDSLYTSITNLRDSPYPDSSPEPLEVVPRSAQPPEELYYSSGRPAIGSRGAPMQTFYQAPPRRPSTEAHPAPEAPHSEGDGQMQLVTSL,,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157) (0.9428); cell surface receptor signaling pathway (GO:0007166) (0.9300); adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189) (0.7391); positive regulation of synapse assembly (GO:0051965) (0.0422); locomotory behavior (GO:0007626) (0.0409),axon (GO:0030424) (0.7998); presynaptic membrane (GO:0042734) (0.3246); plasma membrane (GO:0005886) (0.0511),latrotoxin receptor activity (GO:0016524) (0.9320); G protein-coupled receptor activity (GO:0004930) (0.1780),"GPCR, family 2, latrophilin, C-terminal (IPR003334) (0.5363); GPCR, family 2, secretin-like (IPR000832) (0.5280); GPCR, family 2, latrophilin (IPR003924) (0.4683); GPCR family 2, extracellular hormone receptor domain superfamily (IPR036445) (0.4569); GPCR, family 2, extracellular hormone receptor domain (IPR001879) (0.4388); GPS motif (IPR000203) (0.4152); GAIN domain, N-terminal (IPR032471) (0.3636); GAIN domain superfamily (IPR046338) (0.3609); Latrophilin-1, , transmembrane domain (IPR031234) (0.3284); GPCR, family 2-like, 7TM (IPR017981) (0.2769); Olfactomedin-like domain (IPR003112) (0.2176); D-galactoside/L-rhamnose binding SUEL lectin domain (IPR000922) (0.1014)",1.20.1070.10 (0.3806); 4.10.1240.10 (0.3260); 1.25.40.610 (0.2284),Transmembrane helix (0.8205); Transducer (0.7635); Transmembrane (0.5899); Membrane (0.5644); Reference proteome (0.4016); Disulfide bond (0.3850); Receptor (0.3533); G-protein coupled receptor (0.3016); Signal (0.2510); Synapse (0.1229); Glycoprotein (0.1049),
MRVHKINNVNKALDFIASKGVKLVSIGAEEIVDGNAKMTLGMIWTIILRFAIQDISVEETSAKEGLLLWCQRKTAPYKNVNVQNFHISWKDGLAFNALIHRHRPELIDYDKLRKDDPVTNLNNAFEVAERYLDIPKMLDAEDIVGTLRPDEKAIMTYVSCFYHAFSGAQKAETAANRICKVLAVNQENEHLMEDYEKLASDLLEWIRRTIPWLENRAPEKTMAEMQQKLEDFRDYRRVHKPPKVQEKCQLEINFNTLQTKLRLSNRPAFMPSEGRMVSDINGAWHKLEGAEKGYEEWLLNEIRRLERLDHLAEKFRQKAAIHEGWTDGKEAMLTQKDYETASLSEIKALLKKHEAFESDLAAHQDRVEQIAAIAQELNELDYYDSPSVNARCQKICEQWDALGSLTQNRRESLERTEKQLESIDELYLEYAKRAAPFNNWMEGAMEDLQDMFIVHNIDEIQGLITAHEQFKSTLPEANKEREAIQAIQAEVQKIANYNGIKLAGNNPYTTITPQSIDKKWEKVQQLVPQRDQALQEELTRQQSNDHLRRQFANQANMIGPWIQNKMEEIGRISIEMNGTLEDQLTHLSQYEQSIIEYKPNIDQLEGDHQLIQEALIFDNKYTAYTMEHLRVGWEQLLTTIARTINEIENQVLTRDAKGISQEQLHEYRTSFNHFDKDHSGLLQSEEFKACLISLGYDVENDKQKRTGIMDSDDFRALLISTGNSLGDAEFARIMGIVDPNNSGAVTFQAFIDFMSRETTDTDTADQVIASFKILAGDKNYITAEELRRELPPDQAEYCIARMAPYSGPDAVAGALDYMSFSTALYGESDL,,actin cytoskeleton organization (GO:0030036) (0.7775); muscle cell development (GO:0055001) (0.5594); focal adhesion assembly (GO:0048041) (0.0773); protein localization to plasma membrane (GO:0072659) (0.0622); actin filament bundle assembly (GO:0051017) (0.0456),stress fiber (GO:0001725) (0.7490); perinuclear region of cytoplasm (GO:0048471) (0.4717); plasma membrane (GO:0005886) (0.4373); cortical actin cytoskeleton (GO:0030864) (0.4117); Z disc (GO:0030018) (0.3815); cell projection (GO:0042995) (0.3285); anchoring junction (GO:0070161) (0.2546); cell junction (GO:0030054) (0.2368); ruffle (GO:0001726) (0.1229),calcium ion binding (GO:0005509) (0.6416); actin filament binding (GO:0051015) (0.4416),"Calponin homology domain (IPR001715) (0.4665); CH domain superfamily (IPR036872) (0.4050); Spectrin repeat (IPR002017) (0.3984); EF-hand, Ca insensitive (IPR014837) (0.2698); Actinin-type actin-binding domain, conserved site (IPR001589) (0.2416); EF-hand domain pair (IPR011992) (0.2279); EF-hand domain (IPR002048) (0.1822); Spectrin/alpha-actinin (IPR018159) (0.1366); EF-Hand 1, calcium-binding site (IPR018247) (0.1289)",1.10.418.10 (0.1780); 1.20.58.60 (0.1086),Transport (0.5193); Reference proteome (0.4648); Metal-binding (0.3514); Protein transport (0.3308); Repeat (0.3267); Cytoplasm (0.2047); Coiled coil (0.1804); Cytoskeleton (0.1719); Cell junction (0.1487); Calcium (0.1181); Proteomics identification (0.0751),
MSRRSSLIVPMKSIERELICPICKELFTHPLILPCQHSICHRCVKELLFPNHEDSFSTDAGSESSNPGSPRSRVPSPGLDKLVRSGSICSPGWRRSSVTPRVTSFPCPGCQHDIDLGERGISMLFRNFTLESIVERYRQAARAAVAIMCGVCKPPPQEATKSCMDCKASFCNECFKLHHPWGTPRAQHEYVGPTTNFRPKVLMCPEHEMEKVNMYCEVCRRPVCHLCKLGGSHANHRVTSMSSAYKILKEKLSKSIHYLISKEEQVRTQITALELLMRSTEENGQLAERRANEHFERLQVALQERRAEMLWAVQQCRSRRVERLRAQVEEYQGMLENSGLVGYAQEVLKETDQSCFVQTAKLLHVRIQKATDSLKTFQPAASSSFEEFQLDTSREEILLKELSFGGVPDAPVLDLSRCRVYNEALLHWRLPEDSVPTDRHLLEFRKLQQDEEEEKEEVERCWRTSESVYGSSTVVCDLDRDARYAFRVKSCRNGVCSAYSPEVTLHTPPAPVFSFLFSDSCGFSAERLQLSRRRASVESVAGMSVLLAAERVQTGSYTCLDYIIGDTGISQGRHYWAFRVDPASYLVKVGVASDCKLADWFHGPRDSSSPRFDQDSGHDSGSEDVCVDVCQPFLLLTVGMGRLFVPKPPAPESRVLPLPARIGVCLDYEAGRVSFYDGDSLRCPCVRPVECSGEHVSSIRPDGGAEPYTWRSQSQPSGSHTCEEESDCVCVCVCACACACVSVRASQ,RING-type E3 ubiquitin transferase (2.3.2.27) (0.8450),spindle organization (GO:0007051) (0.6326); acrosome reaction (GO:0007340) (0.1805),cytoplasm (GO:0005737) (0.2480); microtubule (GO:0005874) (0.1815); acrosomal vesicle (GO:0001669) (0.1650); cytoskeleton (GO:0005856) (0.1519),ubiquitin-protein transferase activity (GO:0004842) (0.5645); zinc ion binding (GO:0008270) (0.3238),"B-box-type zinc finger (IPR000315) (0.8618); E3 ubiquitin-protein ligase Trim36, B-box-type 2 zinc finger (IPR047065) (0.6072); Fibronectin type III (IPR003961) (0.5922); Zinc finger, RING-type (IPR001841) (0.5056); Zinc finger, RING-type, conserved site (IPR017907) (0.4801); Fibronectin type III superfamily (IPR036116) (0.4606); E3 ubiquitin-protein ligases and FN3/SPRY domain-containing proteins (IPR050617) (0.3821); Midline-1, COS domain (IPR040859) (0.3392); Concanavalin A-like lectin/glucanase domain superfamily (IPR013320) (0.2316); Immunoglobulin-like fold (IPR013783) (0.2209); B30.2/SPRY domain superfamily (IPR043136) (0.2108); E3 ubiquitin-protein ligase Trim36, B-box-type 1 zinc finger (IPR047066) (0.1902); COS domain (IPR017903) (0.1630); B30.2/SPRY domain (IPR001870) (0.1533); Zinc finger, RING-type, eukaryotic (IPR027370) (0.1435); Zinc finger, RING/FYVE/PHD-type (IPR013083) (0.0916); B-box, C-terminal (IPR003649) (0.0791)",4.10.830.40 (0.6186); 1.20.5.170 (0.5648); 3.30.160.60 (0.5054); 2.60.40.10 (0.2933); 3.30.40.10 (0.2182); 2.60.120.920 (0.2181),Zinc-finger (0.9890); Zinc (0.9333); Cytoplasm (0.6686); Reference proteome (0.6579); Metal-binding (0.5534); Cytoskeleton (0.3487); Coiled coil (0.3039),
MDMWWKVGLVLVMFWGLTSSEDREEHRESPPRTAMLRAPVETLDFGFVPSVVYETHAYYEPGPMGILFHMVHAFLYVVQPNPFPKDLIVKMVQQNMGGIKGDDYKKPENVVLLLQTIYYELGFIVLSVLGVFFVLLMPIVGLCFCVCRCCENCGGEMHQRQKKNGDCLRGFYMATLIATSVFLAVGVTVAYVANQNITSQIKSTRRLVSTNIRDLKAFANYTPAQIDYLTAQYTTAKNKVLSDLDNIGTLLGGQIHNKLESEVVPALDHALRMTAAMRETKESLESVSTSLETLQEGTGRLQVSLQSERVSLSNTLNDWACSNEDVTHTCNSIRGTLNQLALSANFNGLPDVEAPLANLDAVLKTDLSNIVQKGYSSFNDTPQLVREQTKGIVSALPKVKGLLDKSGAEIIGFTKMFPVEPALQNFSKFLTDSQKNIEAYYPQIDQLDFYRWIGCVLICCLVVLVLAFNFLGLLCGSCGYDKNSTPTTRGCLSNTGGNLLMASVGFSFIFSWVLMGVVVTTFIVGGNIEKLVCEPLANRQIFKIIDTPYMVHPTKKNFLPGMLFQDPNIDLTIGSMYRDCYENNGLYSALQLETKFNFNKFLNATVFNPEIGDIFNNVNVDLQGMLLLEQEGKDNLIDFANTGIGDIDYQAYLTEVNKGVTVVDLLSYANELDAQADNLPRGALENALKGHASSIRQIHKDQVVPMEQAMSNLNQSIRQLEKTSRELPVKVTNVLNAIEAAEYLISNNASHVVKQESDKFIKKIIGYFSQYTEWVKHSLAMEVAQCKPISNIVDSAEIVACSFIVDSVNTFWFGLGGCCVLLIPSIIMSVKLAKFYRRMDTEDVFDDGSENWS,,camera-type eye photoreceptor cell differentiation (GO:0060219) (0.9173); photoreceptor cell maintenance (GO:0045494) (0.4663); podocyte differentiation (GO:0072112) (0.4637); retina layer formation (GO:0010842) (0.3774); retina morphogenesis in camera-type eye (GO:0060042) (0.2505); positive regulation of nephron tubule epithelial cell differentiation (GO:2000768) (0.2259); glomerular parietal epithelial cell differentiation (GO:0072139) (0.0725); in utero embryonic development (GO:0001701) (0.0483),endoplasmic reticulum (GO:0005783) (0.4544); extracellular exosome (GO:0070062) (0.4189); apical plasma membrane (GO:0016324) (0.2843); microvillus (GO:0005902) (0.2793); prominosome (GO:0071914) (0.2595); microvillus membrane (GO:0031528) (0.2152); endoplasmic reticulum-Golgi intermediate compartment (GO:0005793) (0.2058); photoreceptor outer segment membrane (GO:0042622) (0.1643); photoreceptor outer segment (GO:0001750) (0.1138),cadherin binding (GO:0045296) (0.5329); cholesterol binding (GO:0015485) (0.1468); actinin binding (GO:0042805) (0.1123),Prominin (IPR008795) (0.3588),,Reference proteome (0.4613); Membrane (0.3513); Glycoprotein (0.2908); Signal (0.0991),
MKLEVFSASRLVDKPLDLCSDMDVNVASPLSTEEELGSDGDCSANSPGPGAPVPDGKAKPYTRRPKPPYSYIALIAMAIRDSNTGRLTLAEINEYLMKKFPFFRGSYTGWRNSVRHNLSLNDCFLKVLRDPSRPWGKDNYWMLNPHSEYTFADGVFRRRRKRISKKILGSAESPERVPADDSRLPARDESVSKFSSSFAIDSILSKPFMRREQSTDDTCFGTTRLMLSAAPHFLPVAMGYPPQSRFQVSSEVSNVFPIYRCNTADISNISRMADIQSSLPGLAHSHTTLQEAGFHPFRIDSLLS,,anatomical structure morphogenesis (GO:0009653) (0.2573); regulation of transcription by RNA polymerase II (GO:0006357) (0.1998); negative regulation of transcription by RNA polymerase II (GO:0000122) (0.1984); cell differentiation (GO:0030154) (0.1948); dorsal/ventral pattern formation (GO:0009953) (0.1706); cell fate specification (GO:0001708) (0.1255); regulation of DNA-templated transcription (GO:0006355) (0.1129); somitogenesis (GO:0001756) (0.0838); positive regulation of transcription by RNA polymerase II (GO:0045944) (0.0719); hair follicle morphogenesis (GO:0031069) (0.0700),nucleus (GO:0005634) (0.1318),"RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978) (0.1673); DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981) (0.1568); DNA binding (GO:0003677) (0.1435); sequence-specific DNA binding (GO:0043565) (0.1206)",Winged helix DNA-binding domain superfamily (IPR036390) (0.4638); Winged helix-like DNA-binding domain superfamily (IPR036388) (0.4324); Forkhead box domain-containing protein (IPR050211) (0.2322); Fork head domain conserved site 2 (IPR030456) (0.1120); Fork head domain (IPR001766) (0.0788),1.10.10.10 (0.2316),Reference proteome (0.4887); DNA-binding (0.3600); Nucleus (0.3437); Transcription regulation (0.1165); Ubl conjugation (0.1049),
MMPFILLWSNSHNPRMIFTHSKWQVVFFILCLYGMDVVYCNVRYSIPEEMPEGSFVGNIAKDLGIEISRLISGKARVVTKSGRQYVDLSRDKGTLVVKERIDREELCKQTTPCSFSFDLIVENPIQLHRVTVEVQDINDNAPLFPKESVNLEISENAVLGARFPLDRAMDTDVGLNGIQSYKLHPTDNFKLEVHSLTDGNKYIEMILQRELDREERDEIKLVLLATDGGSPQKSGTVKIHVTILDANDNAPVCKQSVFKTEVRENSPAGTVMGTVSAADADEGVNGHVSYYFALANKEERELFNINSETGEVTLLAHLDYESQNSYQLNINARDKGGLSDTCKIVIDVTDENDNPPTIQLMSFSNTIAENSPVGTTVAVINVEDADSGKNGLVHFSINQNIPFKIESTFSEYYSLITDDMLDRETVTEYNITILVSDQGSPARHSNKTLNVKISDVNDNPPKFGSDEYKTFVNENNSPGVTILTVKANDADWGPNAQLSYFLKDEDIRGAPLSSLVSVDALTGTVHAVKSFDFEQLKSFSFNVTARDGGSPPLSSEVTITINIQDQNDNAPQVLYPVQTGASVVAEIVPRAVDVGYLVTKVVAVDVDSGQNAWLSYKLQKAPDRALFEVGLQNGEIRTVRQVTDKDAVKQKLTVVVEDNGQPSRSAVVSINVAVADSFPEVLSEFTDITHEKQYNDSLTFYLVLALAAVSFLFITCVVVIISVKIYRWRQSRFLYQSNLPVIPYYPPHYADTGVTGTLPHGYNYEVCMTTDSRKSDCKFSTLGGQSVLVVDPSFTETMQRAMKEKNILENSELHEMQKPPNTDWRFPPNQRPGPSGAGARPEEAGAGAGVIAGTGPWPNPPTEAEQLQAMMAAANASEATATLGPRYNLQYGPDYRQNVYIPGSTATLTANPQQQVLQQALPPPQALPPTEAPKAAQTPASKKKPTKKDKK,,cell morphogenesis (GO:0000902) (0.3576); homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) (0.3543); chemical synaptic transmission (GO:0007268) (0.2702); calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) (0.2625); morphogenesis of embryonic epithelium (GO:0016331) (0.1845); cell adhesion (GO:0007155) (0.1281); locomotory behavior (GO:0007626) (0.1183); retina morphogenesis in camera-type eye (GO:0060042) (0.1079); adult behavior (GO:0030534) (0.0892); presynaptic active zone assembly (GO:1904071) (0.0666),plasma membrane (GO:0005886) (0.3217); cytoplasm (GO:0005737) (0.1968); membrane (GO:0016020) (0.1411); glutamatergic synapse (GO:0098978) (0.1157); synapse (GO:0045202) (0.1084); postsynaptic membrane (GO:0045211) (0.0938),calcium ion binding (GO:0005509) (0.1804); identical protein binding (GO:0042802) (0.1803),"Cadherin-like (IPR002126) (0.2969); Protocadherin/Cadherin-related Cell Adhesion (IPR050174) (0.2490); Cadherin, N-terminal (IPR013164) (0.2129); Cadherin-like superfamily (IPR015919) (0.1760); Cadherin conserved site (IPR020894) (0.1126); Cadherin, cytoplasmic C-terminal domain (IPR032455) (0.1094)",2.60.40.60 (0.3149),Reference proteome (0.7515); Transmembrane helix (0.6420); Transmembrane (0.5609); Membrane (0.5368); Glycoprotein (0.3311); Repeat (0.1836); Calcium (0.1309); Proteomics identification (0.1004),
MRCLLSAYLLPLILHACTGADWCYQTQVSCDSHCKGPEKWREVNADCGKDRQSPINIVTKQTKLDERLTPFRFTGYQTVFDGTLKNNGHSVQVSIPVPATISGGNLAEPYKAVQFHLHWGISSGPGSEHTIDGEQYPMELHIVHMKQKYIRIEDALKDPSGVAVLGFFYEVSSTTNRKYDLFAHALRSVQNTNGNTTLRKISLNQLILPEVNMTNYYRYDGSLTTPGCTEAVVWTVFEKPIPLDSEQLQAFSSLKFRDGKPMVGTFRPVQPRNGRVVYRSSGGTLLVSVFLLMASVSTAFTITRLN,carbonic anhydrase (4.2.1.1) (0.9498),bicarbonate transport (GO:0015701) (0.5307); one-carbon metabolic process (GO:0006730) (0.3837); platelet activation (GO:0030168) (0.1307); gluconeogenesis (GO:0006094) (0.1251); glycolytic process (GO:0006096) (0.0554); positive regulation of urine volume (GO:0035810) (0.0481); signal transduction (GO:0007165) (0.0449); regulation of intracellular pH (GO:0051453) (0.0423),endoplasmic reticulum-Golgi intermediate compartment (GO:0005793) (0.4156); transport vesicle membrane (GO:0030658) (0.3614); rough endoplasmic reticulum (GO:0005791) (0.3004); brush border membrane (GO:0031526) (0.2247); external side of plasma membrane (GO:0009897) (0.1843); extracellular exosome (GO:0070062) (0.1709); apical plasma membrane (GO:0016324) (0.1675); plasma membrane (GO:0005886) (0.1492); perinuclear region of cytoplasm (GO:0048471) (0.1472); cell surface (GO:0009986) (0.1156),zinc ion binding (GO:0008270) (0.3405); identical protein binding (GO:0042802) (0.1254); carbonate dehydratase activity (GO:0004089) (0.1141),"Carbonic anhydrase, CA4/CA15 (IPR041874) (0.5392); Alpha carbonic anhydrase domain (IPR001148) (0.2616); Carbonic anhydrase, alpha-class (IPR023561) (0.2181); Alpha carbonic anhydrase domain superfamily (IPR036398) (0.1717); Carbonic anhydrase, alpha-class, conserved site (IPR018338) (0.1524)",3.10.200.10 (0.2483),Zinc (0.5861); Reference proteome (0.5145); Membrane (0.4877); Lyase (0.3642); GPI-anchor (0.3272); Transmembrane (0.3233); Lipoprotein (0.2197); Glycoprotein (0.1853); Signal (0.1792); Cell membrane (0.1428),Zn(2+) (0.1085)
MASLSLESTEQTENGPKESAQNEAKVKEETDPDEVSEQLLQSFQNSALSFSTDQVACLCEALLQAGNVDRLWRFLATIPPSADLLRGNETLLKAQALVAFHRDEFKELYAILDSHDFHPSNHGFLQDLYLKARYKEAERSRGRSLGAVDKYRLRKKFPLPKTIWDGEETVYCFKEKSRNALKECYKINRYPTPAEKKNLAKVTGLSLTQVSNWFKNRRQRDRTPSGTNSKSESDGNHSTEDEASKGDLEDITDKPAAQETGSSNASLISVPGAPCGTGQLVLNSPGGFLTSPHPLLLNGSPILSGAGTGVIINGLTLSDGHTVTLSPVTANAPLLLNGAQVISKDERGISDLEAQGSLTTVVLNPQASLTSTIPLSLSEDTKSTSSNVSPLDFISLPEALKNTDNTHPVPANSISLPTISTSVISSTSLSSGILAPNSISASIPGSVSSVISSPVVPLQPTQPPEIVVLGKAEPLSSTCSSFSSPQVLSLPQVVPSIQGVPVSQLMQPPSGTTVSSRPQLVPVSPVNPQLSQVSIPQFPTQTFHMGPRLAQAQPQNGSVTLNTSSALTLPQIADGQVTQVLTPQLGNESTLASLPQIQTSLGTQVIPISSPTQVVPISQTKDSSQMVPLSLPQLMPVSSITGTTGTFSFPQVVPATPSLSIPSHGGAFQILTSGAGTGLSVAQGPIRLSPIGPPQSVPTGTIPGVQLLNSGVIKLPTASPGNILLAGGIGSSPILSVQNGKLILTIPAGIQFASMPVKSVPDNSVSSNSNLDSQISTVHSLENQPAPPLIAQTSNSLQSSPLAFVGSSALYCSPEPGTTANTTPGASPNTPDSSSTPTPTSILQSQQALSPDSMLSLSPICSGVVTGHHLSQPAWSPVPLSSSASLTLFDMRGKGELPEDPALLGLPGGESLLLGTPSPGEDMERDSHLDDDMDGDSKILTQLQSVPVDDDLGL,,male sex determination (GO:0030238) (0.4647); inner ear morphogenesis (GO:0042472) (0.4272); protein localization to nucleus (GO:0034504) (0.3849); male gonad development (GO:0008584) (0.3061); regulation of transcription by RNA polymerase II (GO:0006357) (0.2244); embryonic cranial skeleton morphogenesis (GO:0048701) (0.2150); olfactory placode formation (GO:0030910) (0.1917); regulation of epithelial cell proliferation (GO:0050678) (0.1895); regulation of synaptic assembly at neuromuscular junction (GO:0008582) (0.1350); myoblast migration (GO:0051451) (0.1003); generation of neurons (GO:0048699) (0.0793); thymus development (GO:0048538) (0.0764); positive regulation of transcription by RNA polymerase II (GO:0045944) (0.0571); negative regulation of DNA-templated transcription (GO:0045892) (0.0552),cytoplasm (GO:0005737) (0.1225); nucleus (GO:0005634) (0.1169); transcription regulator complex (GO:0005667) (0.1030); nucleoplasm (GO:0005654) (0.0586),"DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981) (0.1801); RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978) (0.1428)","Homeobox, conserved site (IPR017970) (0.4606); Homedomain-like superfamily (IPR009057) (0.3727); Homeodomain (IPR001356) (0.1455)",1.10.10.60 (0.1470),Nucleus (0.7225); Reference proteome (0.3924); Homeobox (0.2372); DNA-binding (0.1818); Proteomics identification (0.0486),
MRTARRASTMEVPSFLRQLVKETEKMVTFFFKGGRRDSGSDDDYYENDPDACSPYLERPILAKDSAEGESKWGITYAMASMQGWRAQMEDSHTCMPEMSDALPDWSYFAVYDGHAGRTVAQYSSRHLLDFILDTGCVTVEEDVEQVKDGIREGFLAIDRHMHTLSRNESWDHSGSTAASVMISPRNFYFINCGDSRTFLCRDGHVVFYTEDHKPCNPREKERIQNAGGSVTLQRINGSLAVSRALGDFDFKEVEWRAQTEQLVSPEPEVYELERSPEDEFLVVACDGVWDAIGNEDLCAFVRNRLHVCDDLREICSQVIDLCLYKGSLDNMTIIIICFDGAPKVTQEALQQEAELEQLIEQKVAEIIHVIRSKDEEPDLLYVMKFLASEPIPGLPPGGGVSCKRDCIIAAYQKYAAAFRPLEPMDTGGSDDST,protein-serine/threonine phosphatase (3.1.3.16) (0.4086),negative regulation of canonical NF-kappaB signal transduction (GO:0043124) (0.5089); protein dephosphorylation (GO:0006470) (0.4554); peptidyl-threonine dephosphorylation (GO:0035970) (0.2321); positive regulation of canonical Wnt signaling pathway (GO:0090263) (0.2081); positive regulation of canonical NF-kappaB signal transduction (GO:0043123) (0.1969); regulation of growth (GO:0040008) (0.0683),cytosol (GO:0005829) (0.5191); nucleus (GO:0005634) (0.4857); membrane (GO:0016020) (0.2031),manganese ion binding (GO:0030145) (0.4271); magnesium ion binding (GO:0000287) (0.3244); protein serine/threonine phosphatase activity (GO:0004722) (0.2351); myosin phosphatase activity (GO:0017018) (0.1650),"Protein serine/threonine phosphatase 2C, C-terminal (IPR012911) (0.5178); Phosphatase 2C, C-terminal domain superfamily (IPR036580) (0.4975); PPM-type phosphatase, divalent cation binding (IPR000222) (0.1849); PPM-type phosphatase-like domain superfamily (IPR036457) (0.1675); Protein phosphatase 2C (IPR015655) (0.1622); PPM-type phosphatase-like domain (IPR001932) (0.0934)",3.60.40.10 (0.4402); 1.10.10.430 (0.2477),Lipoprotein (0.6442); Membrane (0.5763); Phosphoprotein (0.5297); Myristate (0.4777); Protein phosphatase (0.4681); Reference proteome (0.4378); Cytoplasm (0.4220); Hydrolase (0.3036); Manganese (0.2329); Metal-binding (0.1707); Nucleus (0.1342); Proteomics identification (0.0837),Mn(2+) (0.2825); Mg(2+) (0.1429)
MALTRTHVLRSWIFFSVFLCCWIFTNGQIVYSISEEANPGTAVGNLAKDFNLNVQDIERRGFQIVSESNKRYFDFNFKTGVLHVKERIDREELCEQKIKCSLPLEAIVNSPLNVFRFEINVLDINDNPPKFRTPKTTINISESALPGEQFALPSAFDADVGINSVKSYKLSPNEHFSLDVQSGGEQSVSAELVLQKALDREKQPLIRLTLTAVDGGKPLRSGTMQITVHVEDVNDNIPVFSKSLYKARVNENAPPGTSIITVQASDPDEGVNGQIVYALVNHDNDRNVESFAINPETGEITVKGDVDYERKNAVELRVQAKDKGHKPRAALCKVLLEIIDVNDNVPEISVTSLVNTVKEDALIDTVVGMITVTDNDAGKNGQVILNIQGSSPFKVQNSYKNYYTLFVNGPLDRERASEYNVTISAADEGTPPLSSTSVIAVHVSDVNDNAPRFPEPVINVYVKENSQIGAVLHTVSAVDPDVGDNARITYSLLESSKSGPVTSMININSDTGDLHSLQSFNYEEIKTFEFKVQATDSGVPPLSSNVTVNVFVLDENDNSPAILAPYSELGSVNTENIPYSAEAGYFVAKIRAVDADSGYNALLSYHISEPKGNNLFRIGTSSGEIRTKRRMSDNDLKTHPLVVLVCDNGEPSLSATVSIDAVVVESGGDVKTPFRHAPVKEESFSDLNLYLLIAIVSVSVIFLLSLIGLIAVKCHRTDSSLGRYSAPMITTHPDGSWSYSKSTQQYDVCFSSDTLKSDVVVFPAPFPPADAELISINGGDTFTRTQTLPNKEKPKVPSSDWRYSASLRAGMQSSVRMEESSVMQGAQGVLVQNWPTVSSAPDNEGGEVSPPVGAGVDSNSWHFRYGPGPGGPPHLKPGEVPPEAFIIPGSPAIISIRQGQDGDDKSDFITFGKKEEAKKLKKKKKKEKKDKREKGKDDDD,,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) (0.7639); cell adhesion (GO:0007155) (0.4530); synapse assembly (GO:0007416) (0.2010); chemical synaptic transmission (GO:0007268) (0.1523); axon extension (GO:0048675) (0.1445); adult behavior (GO:0030534) (0.1366); calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) (0.1238); presynaptic active zone assembly (GO:1904071) (0.0915),plasma membrane (GO:0005886) (0.2243); synapse (GO:0045202) (0.2013); glutamatergic synapse (GO:0098978) (0.1965); postsynaptic membrane (GO:0045211) (0.1709); cytoplasm (GO:0005737) (0.1236),calcium ion binding (GO:0005509) (0.2928); identical protein binding (GO:0042802) (0.0902),"Cadherin, N-terminal (IPR013164) (0.3824); Cadherin-like (IPR002126) (0.3613); Protocadherin/Cadherin-related Cell Adhesion (IPR050174) (0.2723); Cadherin, C-terminal catenin-binding domain (IPR031904) (0.1936); Cadherin-like superfamily (IPR015919) (0.1346)",2.60.40.60 (0.1730),Reference proteome (0.8092); Transmembrane helix (0.6653); Signal (0.5867); Transmembrane (0.5298); Membrane (0.4669); Proteomics identification (0.3512); Glycoprotein (0.3165); Repeat (0.2705); Cell membrane (0.2698); Cell adhesion (0.2532); Alternative splicing (0.1975); Calcium (0.1942); Vision (0.0436),
MSKQGFKSWMYCIAALSLWNITDGQIVYSISEEADPGTTVGPIAKDLNLNLHELQLRGFQLVSGPNKRYFDVNLKSGVLLVKERIDRELLCGRSSRCSLEIEAIVNSPLNMYRLEVNVLDINDNGPIFKSSKTELNIVESAFPGERFTLPDAFDADVGSNSVKSYKLSANEHFTLDVQSGGEQSVSAELVLQKALDREKQPVIKLTLTAVDGGKPQKSGTTQIIINVEDVNDNIPVFSTSLYKTRIMENAAVGTSVITVQASDADEGLNGEIIYSFISHDGDNRVNAFTIDSVSGVISVKGNIDYETSNAVEIRVQAKDKGQKPRAAHCKVLIEIVDVNDNIPEISVTSLAETVREDAAAGTMVGLITVKDGDAGKNGAVVLNIRGSAPFRIQNTYKNKYYLLVDGQLDRETASEYNVTISAADEGSPPLSSTSVIAVHVSDVNDNAPRFPEPVINVYVKENSQIGAVLHTVSAVDPDVGDNARITYSLLESSKSGPVTSMININSDTGDLHSLQSFNYEEIKTFEFKVQATDSGVPPLSSNVTVNVFVLDENDNSPAILAPYSELGSVNTENIPYSAEAGYFVAKIRAVDADSGYNALLSYHISEPKGNNLFRIGTSSGEIRTKRRMSDNDLKTHPLVILVCDNGEPSLSATVSIDAVVVESGGDVKTPFRHAPVKEESFSDLNLYLLIAIVSVSVIFLLSLISLIAVKCHRTDSSLGRYSAPMITTHPDGSWSYSKSTQQYDVCFSSDTLKSDVVVFPAPFPPADAELISINGGDTFTRTQTLPNKEKPKVPSSDWRYSASLRAGMQSSVRMEESSVMQGAQGVLVQNWPTVSSAPDNEGGEVSPPVGAGVDSNSWHFRYGPGPGGPPHLKPGEVPPEAFIIPGSPAIISIRQGQDGDDKSDFITFGKKEEAKKLKKKKKKEKKDKREKGKDDDD,,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) (0.5607); cell adhesion (GO:0007155) (0.3681); presynaptic active zone assembly (GO:1904071) (0.3496); modulation of chemical synaptic transmission (GO:0050804) (0.1937); locomotory behavior (GO:0007626) (0.1752); chemical synaptic transmission (GO:0007268) (0.1730); calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) (0.1024); adult behavior (GO:0030534) (0.0988); axon extension (GO:0048675) (0.0667),glutamatergic synapse (GO:0098978) (0.3687); postsynaptic membrane (GO:0045211) (0.3195); cytoplasm (GO:0005737) (0.2346); plasma membrane (GO:0005886) (0.1744); synapse (GO:0045202) (0.1337),calcium ion binding (GO:0005509) (0.2754); identical protein binding (GO:0042802) (0.1092),"Cadherin, C-terminal catenin-binding domain (IPR031904) (0.3256); Cadherin, N-terminal (IPR013164) (0.2582); Cadherin-like (IPR002126) (0.2095); Protocadherin/Cadherin-related Cell Adhesion (IPR050174) (0.1808); Cadherin-like superfamily (IPR015919) (0.1697)",2.60.40.60 (0.1591),Reference proteome (0.7450); Transmembrane (0.6456); Transmembrane helix (0.6150); Signal (0.5761); Membrane (0.4120); Repeat (0.3295); Glycoprotein (0.3187); Vision (0.1908); Proteomics identification (0.1885); Calcium (0.1741); Cell membrane (0.1324),
MVILWKYYQRSIRYVHTLYLGVQSRWHGGPGQRHFYWRLMFESADINMLRLLEAFLKSAPQLVLQLSIMIHSNHILPLQGLSASASLVSLAWMIASYQKVLRDSRDDKLPMSYKAVIVQMLWHLFTIGARTIAFALFASVFQLYFGIFIVAHWCAMTFWIIQGETDFCMSKWEEIIYNMVVGIIYIFCWFNVKEGRARFRLGVYYCVTLFENVALTAAWYIHRGPHTSDFYALIIVCVVVCSYALGTFFMFVYYCLLHPDGPILGTQWSCVEEGMGVIGLGGIGDLGTPLPQPDVVTSPPRTLPRTTGGDRENGAGDRDSCMPVFQVRPPSVPPPSSPRPPRTEGPVIRIDLPRKRYPAWDAHFIDRRLRKTILVLENTSPVTPRIQYQTFSNPKEVMEYETTV,,regulation of cytosolic calcium ion concentration (GO:0051480) (0.5078); positive regulation of interleukin-6 production (GO:0032755) (0.3907); apoptotic process involved in development (GO:1902742) (0.3411); skeletal muscle fiber development (GO:0048741) (0.2204); apoptotic process (GO:0006915) (0.2031); phosphatidylserine exposure on apoptotic cell surface (GO:0070782) (0.1761); MAPK cascade (GO:0000165) (0.1343); regulation of autophagy (GO:0010506) (0.1121); temperature homeostasis (GO:0001659) (0.1079); regulation of T cell cytokine production (GO:0002724) (0.1034); intracellular calcium ion homeostasis (GO:0006874) (0.0998); embryo implantation (GO:0007566) (0.0835); release of cytochrome c from mitochondria (GO:0001836) (0.0780); positive regulation of mitochondrial membrane potential (GO:0010918) (0.0563); negative regulation of cell growth (GO:0030308) (0.0439); response to oxidative stress (GO:0006979) (0.0410),plasma membrane (GO:0005886) (0.2252); Z disc (GO:0030018) (0.1075),,XK-related protein (IPR018629) (0.3662); XK-related phospholipid scramblase (IPR050895) (0.1998),,Cell membrane (0.7031); Transmembrane (0.5358); Membrane (0.4263); Reference proteome (0.3630); Phosphoprotein (0.2438); Apoptosis (0.0798); Lipoprotein (0.0491),
MFVTKVTFGLLALMLVYSAEGKPAQLSVSELLHRANRGIIPEADEPKLLDDIAVNEKNADPCTSYGCLWPKYSDGKIYVPYVIANHYSSRELEIIQRGLDSFSYSTCIRFFPRGNERDYISIESRSGCYSYVGRQGYAQTVSLARSGCLYHSTVQHELLHALGFNHEQTRNDRDNHIQVIWENILDDMKYNFNKINTLNQGTPYDYSSVMQYERYAFSKNGLPTMIPIPNNNAALGTSTEMSQNDIIRINRLYQC,3.4.24.- (0.5032); choriolysin H (3.4.24.67) (0.0859); astacin (3.4.24.21) (0.0430),proteolysis (GO:0006508) (0.9075); protein processing (GO:0016485) (0.1836); prevention of polyspermy (GO:0060468) (0.1614); inflammatory response (GO:0006954) (0.1558); negative regulation of binding of sperm to zona pellucida (GO:2000360) (0.1364); defense response to Gram-negative bacterium (GO:0050829) (0.1142); positive regulation of protein processing (GO:0010954) (0.0667); cell adhesion (GO:0007155) (0.0514),extracellular region (GO:0005576) (0.2290); cortical granule (GO:0060473) (0.1947),metalloendopeptidase activity (GO:0004222) (0.2032); zinc ion binding (GO:0008270) (0.1684); aspartic-type peptidase activity (GO:0070001) (0.1263); peptidase activity (GO:0008233) (0.1156); identical protein binding (GO:0042802) (0.1100),"Metallopeptidase, catalytic domain superfamily (IPR024079) (0.3934); Peptidase M12A (IPR001506) (0.3280); Hatching enzyme, peptidase domain (IPR034039) (0.1136)",3.40.390.10 (0.1060),Zymogen (0.7908); Hydrolase (0.5410); Metalloprotease (0.4151); Metal-binding (0.3750); Protease (0.3449); Disulfide bond (0.3334); Glycoprotein (0.2901); Zinc (0.2803); Secreted (0.2387); Toxin (0.1360); Direct protein sequencing (0.1214); 3D-structure (0.0848),Zn(2+) (0.3773)
MLLLNRFSVWLSAFAVLLLTQPISTSEVMACGAAVDPPANIEITDPGFLGYLNIQWTRPASLQNLTGCTVRYQLRYFDTYEERWRSVRTVKLTYAAQFDLEKPVKLRILTVLKCACTNGTEVQGEETETVYTPEPTGLAGSRIRDFHCIYYGKEHMECTWKSGPVQPPNSEHYLYYWHREMEETKECPEYIVSSNNERGCRFPRQSLLEFSKFNMCVNGSSSTGSLRPAYFSIEIQNYVKPAAVSSLDVLETDGRLKLEWAPPSGQVPEHCLDYEVESSTLMANGKELKQTEILENLDLGTSYELPREAESKKTCFNLRSKVNMYCADGGFWSDWSQTKCTVKPTLNYRLLDLVMIGTAGVIIFCLSLWILTRICIKPCSKKDVIYTLYKQKVNENMPSIFSPIFK,,negative regulation of immunoglobulin production (GO:0002638) (0.6655); cytokine-mediated signaling pathway (GO:0019221) (0.6236); positive regulation of cell population proliferation (GO:0008284) (0.1555); interleukin-5-mediated signaling pathway (GO:0038043) (0.0972); cell surface receptor signaling pathway via JAK-STAT (GO:0007259) (0.0650),extracellular region (GO:0005576) (0.3457); receptor complex (GO:0043235) (0.2858); external side of plasma membrane (GO:0009897) (0.2801); membrane (GO:0016020) (0.1298),cytokine binding (GO:0019955) (0.3304); cytokine receptor activity (GO:0004896) (0.2326); metal ion binding (GO:0046872) (0.1303),"Short hematopoietin receptor, family 2, conserved site (IPR003532) (0.2600); Fibronectin type III (IPR003961) (0.2175); Type I cytokine receptor, cytokine-binding domain (IPR015321) (0.1815); Fibronectin type III superfamily (IPR036116) (0.1458); Type I Cytokine Receptor (IPR050379) (0.0679)",2.60.40.10 (0.3294),Signal (0.7775); Transmembrane helix (0.6488); Reference proteome (0.5209); Transmembrane (0.4389); 3D-structure (0.3959); Receptor (0.3339); Membrane (0.3078); Repeat (0.2998); Direct protein sequencing (0.2583); Disulfide bond (0.2007); Alternative splicing (0.0831); Ubl conjugation (0.0404),
MEERFAFLAEWYDPSAALLRRYQLLYYPKDGSVEMFDMKNQRTFLRRTKLEELQPEDLFVGNRVNIFSRQLNLISYGDQYTANKLGSKKERTLAMIKPDAVSKVGDIIQMIYDANLIVTKAKMTKLTWKQAADFYMEHQSKSFFNNLVQFVSSGPVIAMELMGDEAVSTWRKVLGPTDSGVAQKEAAHSLRGQFGTDGTKNAGHGSDSLASAARELEYFFPSTAGHGLSNTAKYSDCTCCIIKPHAISEALTGKILKSIIENGFEISALQMFNMDRANAEEFLEVYKGVVAEYTKMVDELCSGPCMALEIHATDAPRTFREFCGPADPEIARHLRPKTLRALYGKNKLQNGVHCTDLPEDGILEVQYFFKILDG,nucleoside-diphosphate kinase (2.7.4.6) (0.7486),phosphorylation (GO:0016310) (0.8355); GTP biosynthetic process (GO:0006183) (0.7617); CTP biosynthetic process (GO:0006241) (0.5925); UTP biosynthetic process (GO:0006228) (0.2018),ruffle (GO:0001726) (0.5321); cytoplasm (GO:0005737) (0.4623); lamellipodium (GO:0030027) (0.4605); nucleus (GO:0005634) (0.4441); centrosome (GO:0005813) (0.3635),3'-5' exonuclease activity (GO:0008408) (0.5850); ATP binding (GO:0005524) (0.2273); nucleoside diphosphate kinase activity (GO:0004550) (0.1929),"Nucleoside diphosphate kinase-like domain superfamily (IPR036850) (0.3711); NDPK7, second NDPk domain (IPR037993) (0.3091); Nucleoside diphosphate kinase 7 (IPR011410) (0.2956); Nucleoside diphosphate kinase-like domain (IPR034907) (0.2824); DM10 domain (IPR006602) (0.2697); Nucleoside diphosphate kinase, active site (IPR023005) (0.2380); NDPK7, first NDPk domain (IPR035525) (0.1642); Nucleoside diphosphate kinase (IPR001564) (0.0897)",2.30.29.170 (0.2553); 3.30.70.141 (0.1842),Cytoplasm (0.5302); Cell cycle (0.5051); Reference proteome (0.4659); Cytoskeleton (0.4614); Nucleus (0.3833); Nucleotide-binding (0.3745); ATP-binding (0.3372); Kinase (0.2077); Hydrolase (0.1609); Cell projection (0.1286),
MGNSTGSTVDDLQAVEMHLWYKKFMTECPSGQLTLHEFKQFFGLRGLDPEANAYIEQMFRTFDMNKDGYIDFMEYVAALSLVMRGKMEHKLRWYFRLYDVDGNGCIDRYELLNIIKAIRAINGSETQESSAEEFTNRVFERIDINGDGELSLDEFVAGARSDEEFMEVMMKSLDLTHIVAMIHNRRHSV,,phototransduction (GO:0007602) (0.4250); visual perception (GO:0007601) (0.4091); positive regulation of cGMP-mediated signaling (GO:0010753) (0.3631); positive regulation of guanylate cyclase activity (GO:0031284) (0.1692); cellular response to calcium ion (GO:0071277) (0.1682); signal transduction (GO:0007165) (0.1625); detection of calcium ion (GO:0005513) (0.1178),cone photoreceptor outer segment (GO:0120199) (0.4304); photoreceptor inner segment (GO:0001917) (0.3098); photoreceptor disc membrane (GO:0097381) (0.1629); photoreceptor outer segment (GO:0001750) (0.1048); membrane (GO:0016020) (0.0740),guanylate cyclase regulator activity (GO:0030249) (0.2118); calcium ion binding (GO:0005509) (0.2088); calcium sensitive guanylate cyclase activator activity (GO:0008048) (0.1758),"EF-hand domain (IPR002048) (0.3852); EF-Hand 1, calcium-binding site (IPR018247) (0.1802); Recoverin family (IPR028846) (0.1274); EF-hand domain pair (IPR011992) (0.0974)",1.10.238.10 (0.2097),Vision (0.8919); Myristate (0.7835); Repeat (0.6558); Lipoprotein (0.6224); Reference proteome (0.4510); Calcium (0.1478); Sensory transduction (0.1447); Metal-binding (0.1343); Membrane (0.1103); Cell projection (0.0645),
MRVGAAAVLLCVLTLRSTSAVFLSKDEASALLQRFRRANSGFLEEMKAGNLERECVEEICDYEEAREVFEDDDRTKQFWLSYSNKEPCLTNPCRNNGTCVYLADSYYCLCSEGYEGKYCEKGLEETLKCQYVNGGCEQFCDGSGARRSCSCAEGYALADDGTSCVSQVDYPCGKIPVQKNTSQNQFLGGIHCPRGHCPWQVLIDYNGESVCGGALLEGPWLITAAHCVHQKDTRFLKAVTGEHDLDVLDGSEEPYEVSAVFIHPNYDPETLDSDLALLRLRVPVQRSLYAVPICLPTPQLARSELWAARFHTLSGWGTRTAGHNLRREKGLKGPASGTLQRLAVPLLPAAQCGNANTTANMFCAGYTEGDHASCRGHDGSPLVTRYGETSFLTGVVSWGRGCGPPGYYWIYTKVENFLIWMDTVMKTNTEDKSEQIANVSTKN,coagulation factor VIIa (3.4.21.21) (0.8230); coagulation factor IXa (3.4.21.22) (0.0556),blood coagulation (GO:0007596) (0.9570); proteolysis (GO:0006508) (0.2215),extracellular space (GO:0005615) (0.6676); Golgi lumen (GO:0005796) (0.4858),serine-type endopeptidase activity (GO:0004252) (0.2069); calcium ion binding (GO:0005509) (0.1955),"Peptidase S1, PA clan (IPR009003) (0.6817); Serine proteases, trypsin domain (IPR001254) (0.6770); Gamma-carboxyglutamic acid-rich (GLA) domain (IPR000294) (0.6577); Peptidase S1A, chymotrypsin family (IPR001314) (0.6164); EGF-type aspartate/asparagine hydroxylation site (IPR000152) (0.5789); Peptidase S1 family, coagulation factors (IPR050442) (0.5459); Peptidase S1A, coagulation factor VII/IX/X/C/Z (IPR012224) (0.5348); EGF-like domain (IPR000742) (0.5161); Peptidase S1, PA clan, chymotrypsin-like fold (IPR043504) (0.4844); Serine proteases, trypsin family, histidine active site (IPR018114) (0.2826); Coagulation factor-like, Gla domain superfamily (IPR017857) (0.2643); EGF-like calcium-binding domain (IPR001881) (0.1652); Gamma-carboxyglutamic acid-rich (GLA) domain superfamily (IPR035972) (0.1142)",2.10.25.10 (0.4048); 4.10.740.10 (0.3326); 2.40.10.10 (0.3169),Zymogen (0.9783); Secreted (0.9412); Reference proteome (0.5877); Signal (0.5807); EGF-like domain (0.4843); Blood coagulation (0.3691); Disulfide bond (0.3522); Glycoprotein (0.2141); Calcium (0.1886); Hydroxylation (0.1597); Repeat (0.1204); Serine protease (0.1080),
MEELSAVGEQVFDAECILNKRTRKGKLEYLVKWRGWSSKHNSWEPQENLLDPRLLVAFNKREQEKELLISKKGKRPRGRPRKIMETIPVVSKSSSSSSSSSSSGSSSSSSSSSSSTDDDDEDDHNMTPKPIPRPREHLPVPQKKAQIVVAKPGPPKKRGRKALPPELKAIRQVKGTRKILKPISRDSDLRGIKKPLMPASFTYTGLNRTSGREPMAMHNRGSFTHKSSLSSLGRSIGSVSSSPTLNRSPQTKSASDFKLSVSDMNSGLDPKTPTCKSPGVAALNLHSSNGQTCPQLSPTVPKDQTLLQRSASLPKSPSSSFSSLKTPSSLQALNLQSVNKTVQGNGTDLKTSPHSGRKSSGFNTSSAPNTPSKFQTSQQALKSPQKLKADDLAERLGKKSQARTEKILPTEGRDSQPAQDRPSSKDPSKQSKTLSELSTGEEGSSSDTDHDSSFPRDSHDLSISVQAGQDWRPTRSLIEHVFVTDVTANLVTVTVKESPTSVGFFSIRNY,,negative regulation of transcription by RNA polymerase II (GO:0000122) (0.9845); positive regulation of cell population proliferation (GO:0008284) (0.2550); chromatin organization (GO:0006325) (0.1749); development of primary sexual characteristics (GO:0045137) (0.1633); negative regulation of DNA-templated transcription (GO:0045892) (0.1159); anterior/posterior axis specification (GO:0009948) (0.0710),nucleoplasm (GO:0005654) (0.2242); euchromatin (GO:0000791) (0.1866); PRC1 complex (GO:0035102) (0.1794); nucleus (GO:0005634) (0.1633); heterochromatin (GO:0000792) (0.1607); chromatin (GO:0000785) (0.1520); cytosol (GO:0005829) (0.1344),methylated histone binding (GO:0035064) (0.4059); chromatin binding (GO:0003682) (0.3541),"CBX family C-terminal motif (IPR033773) (0.3226); Chromo domain (IPR023780) (0.2728); Chromo/chromo shadow domain (IPR000953) (0.1844); Chromo-like domain superfamily (IPR016197) (0.1754); Chromobox protein homolog 2 (IPR042796) (0.1664); Chromo domain, conserved site (IPR023779) (0.1443)",2.40.50.40 (0.4359),Repressor (0.6174); Reference proteome (0.4555); Phosphoprotein (0.4519); Transcription (0.3526); Chromatin regulator (0.3142); Ubl conjugation (0.2519); Transcription regulation (0.1505); Nucleus (0.0833); Proteomics identification (0.0566); Alternative splicing (0.0520),
MSQKVAVVTGANKGIGLAIVKGLCKAGFTGDILLTARNEKLGQEAIAGLQSEGFKNVVFHQLDICDQGSCMKLKKFLEEKYGGLDVLINNAGIAFKNAATEPFGEQAEVTMRTNFWGTLWACHALLPILRANARVVNVSSFVSKKSLDQCSAELQAKFRNKDLSEEELCLLMGEFVQDAQAGDHSAKGWPNTAYGTTKIGVTVLSRIQARVLNETRPGDGILLNACCPGWVRTDMAGPKAPKSPEEGAETPVYLAMLPEGAKEPHGQLVWDKTVQEW,carbonyl reductase (NADPH) (1.1.1.184) (0.9388); prostaglandin-E2 9-reductase (1.1.1.189) (0.7742); 15-hydroxyprostaglandin-D dehydrogenase (NADP+) (1.1.1.196) (0.6259); 15-hydroxyprostaglandin dehydrogenase (NADP+) (1.1.1.197) (0.3303); alcohol dehydrogenase [NAD(P)+] (1.1.1.71) (0.2876); NADPH dehydrogenase (quinone) (1.6.5.10) (0.0471),vitamin K metabolic process (GO:0042373) (0.5360); glucocorticoid metabolic process (GO:0008211) (0.3820); xenobiotic metabolic process (GO:0006805) (0.2595),extracellular exosome (GO:0070062) (0.1329); cytosol (GO:0005829) (0.0783); cytoplasm (GO:0005737) (0.0490),S-nitrosoglutathione reductase (NADPH) activity (GO:0160163) (0.4500); carbonyl reductase (NADPH) activity (GO:0004090) (0.2152); prostaglandin E2 9-reductase activity (GO:0050221) (0.1960); 15-hydroxyprostaglandin dehydrogenase (NADP+) activity (GO:0047021) (0.1751); 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity (GO:0047020) (0.1644),Carbonyl reductase [NADPH] 1-like (IPR045313) (0.2748); NAD(P)-binding domain superfamily (IPR036291) (0.1463); Short-chain dehydrogenase/reductase SDR (IPR002347) (0.0808),3.40.50.720 (0.2816),NADP (0.4247); Cytoplasm (0.2472); Oxidoreductase (0.1964); Reference proteome (0.1430); Phosphoprotein (0.1214),
MYTTGLNPFYASNFSLWTAYCSAGFAVDSMKKPSFCIADILHVGDAENIQGSSSLMAHIGARAQVHSSGSPLRPSPVTPDARLHPAYLRHGIHLTSRAAINAPPPTSKDLKFGIDRILSTDFEPKSKESPSLRDLTSIVSPNRQSAVHVSASPYFASIDPTMSETSSLMGSIGNAARQSGQHQFQDTFPGPYAVLSKDTMPQTYKRKRSWSRAVFSNLQRKGLEKRFEIQKYVTKPDRKQLAAMLGLTDAQVKVWFQNRRMKWRHSKEAQAQKDKEKEQPDKSAAETEQKERDDSECETEPSESEFEDGPEDKSDVDISDLNKASVIIPGPLPVSTQDTSSTNPTTEPNTATQMLL,,cell fate determination (GO:0001709) (0.3756); regulation of transcription by RNA polymerase II (GO:0006357) (0.2178); T-helper 2 cell differentiation (GO:0045064) (0.1703); liver development (GO:0001889) (0.1427); embryonic digestive tract morphogenesis (GO:0048557) (0.1218); negative regulation of transcription by RNA polymerase II (GO:0000122) (0.1143); negative regulation of monocyte differentiation (GO:0045656) (0.0974); spinal cord motor neuron differentiation (GO:0021522) (0.0932); heart formation (GO:0060914) (0.0905); cell population proliferation (GO:0008283) (0.0883); positive regulation of gene expression (GO:0010628) (0.0856); type B pancreatic cell development (GO:0003323) (0.0677); epithelial cell proliferation (GO:0050673) (0.0621); regulation of mitotic cell cycle (GO:0007346) (0.0618); negative regulation of T-helper 2 cell differentiation (GO:0045629) (0.0604); tissue regeneration (GO:0042246) (0.0483); T-helper 1 cell differentiation (GO:0045063) (0.0437); negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) (0.0420); forebrain neuron differentiation (GO:0021879) (0.0407),nucleus (GO:0005634) (0.3287),"RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978) (0.1810); DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981) (0.1191)","Homeobox, conserved site (IPR017970) (0.3539); H2.0 Homeobox Transcription Factors (IPR052497) (0.3260); Homeodomain, metazoa (IPR020479) (0.1665); Helix-turn-helix motif (IPR000047) (0.1249)",1.10.10.60 (0.0702),Nucleus (0.4380); Developmental protein (0.4228); Reference proteome (0.3025); Homeobox (0.2156); DNA-binding (0.1421),
MAPSQPKSGLFVGINKGHVVTKRELPPRPSDRKGKGTKRVHFVRNLIREVAGFAPYEKRITELLKVGKDKRALKVAKRKLGTHKRAKKKREEMSSVLRKMRSAGGGAGDKKK,,cytoplasmic translation (GO:0002181) (0.9117); GO:0140236 (0.2620); translation (GO:0006412) (0.2301); GO:0140242 (0.1996),cytoplasm (GO:0005737) (0.2488); cytosolic ribosome (GO:0022626) (0.2450); postsynapse (GO:0098794) (0.2423); nucleolus (GO:0005730) (0.2399); extracellular exosome (GO:0070062) (0.1788); focal adhesion (GO:0005925) (0.1257); ribosome (GO:0005840) (0.1235); cytosol (GO:0005829) (0.1071); cytosolic large ribosomal subunit (GO:0022625) (0.0729),structural constituent of ribosome (GO:0003735) (0.1486); mRNA binding (GO:0003729) (0.1387),Large ribosomal subunit protein eL36 domain superfamily (IPR038097) (0.3830),1.10.10.1760 (0.2449),Ribonucleoprotein (0.9209); Ribosomal protein (0.8570); Reference proteome (0.6090); Proteomics identification (0.3063); Cytoplasm (0.2716); Phosphoprotein (0.2621); Diamond-Blackfan anemia (0.2171); 3D-structure (0.1509); Acetylation (0.1448); Isopeptide bond (0.1174); Nucleus (0.1077); Ubl conjugation (0.0550),
MATKGRKVVEVRDASRTDGKGDAADVHVVREGKSDHDTAGGVGHRGASRTDGHGDAGGKVGDFRGIDGKDSLKIVAMQAPVTVERPVRGDLEEHVPKPYLARALAAPDMYHPEGTTDDHQHHNMSVLQQHVAFFDRDNNGIIYPWETYDGCRAVGFNVFMSAFIAFLVNLVMSYPTLPGWLPNPLFPIYVHNIHKSKHGSDSGTYDKEGRFMPVNFENIFSKYARTYPDRLSYRELWRMTEGCREVFDFFGWVAMKLEWSFLYVLARDDEGYLSREAIRRMYDGSLFEYMERQRMEHVKMS,plant seed peroxygenase (1.11.2.3) (0.8291),response to abscisic acid (GO:0009737) (0.1845); regulation of reactive oxygen species metabolic process (GO:2000377) (0.1560); response to water deprivation (GO:0009414) (0.1280); response to desiccation (GO:0009269) (0.1143); response to salt stress (GO:0009651) (0.1122); drought recovery (GO:0009819) (0.1075); stomatal movement (GO:0010118) (0.1040); negative regulation of lipid storage (GO:0010888) (0.1031); response to salicylic acid (GO:0009751) (0.0832); defense response (GO:0006952) (0.0799); seed germination (GO:0009845) (0.0683),monolayer-surrounded lipid storage body (GO:0012511) (0.1665); chloroplast (GO:0009507) (0.1109),plant seed peroxygenase activity (GO:1990137) (0.2800); calcium ion binding (GO:0005509) (0.1612); heme binding (GO:0020037) (0.0635),Caleosin-related (IPR007736) (0.1896),,Lipid droplet (0.3461); Oxidoreductase (0.2941); Endoplasmic reticulum (0.1998); Calcium (0.1995); Heme (0.1553); Membrane (0.1383); Microsome (0.1267); Acetylation (0.1123),
MRRLHLAAAVLAVFLPLAVSAAGGKAAAAKAPVAPPAPPNITAAMAKGGCKAFAALVAASPDAHSTFQSAGDGGVTAFCPSDDAVRSFMPRYKNLSADGKASLLLFHAVPVYYAPRSLKSNNGVMNTLATDGSANNFNFTVQNEGEQVTIKTDASDHAARVKSTVYDKDPIAIYAVDTVLEPVELFEPAESPAPAPAPAPVADAPKAPKKQARHRPVADAPGPAAEDAAPADQRKNSKKSAASAAPCLPWAAVLPVVVAVAAALA,gamma-glutamyltransferase (2.3.2.2) (0.3171),shoot system development (GO:0048367) (0.4314); response to salt stress (GO:0009651) (0.3818); response to abscisic acid (GO:0009737) (0.3786); abscisic acid-activated signaling pathway (GO:0009738) (0.1797); response to cold (GO:0009409) (0.1192); root development (GO:0048364) (0.0969),secretory vesicle (GO:0099503) (0.1854); side of membrane (GO:0098552) (0.1573); apoplast (GO:0048046) (0.1447); plasma membrane (GO:0005886) (0.0708); endoplasmic reticulum (GO:0005783) (0.0465),leukotriene C4 gamma-glutamyl transferase activity (GO:0103068) (0.1861),"FAS1 domain superfamily (IPR036378) (0.1725); Fasciclin-like arabinogalactan protein, group A (IPR045003) (0.1576); FAS1 domain (IPR000782) (0.0928)",2.30.180.10 (0.3796),GPI-anchor (0.6596); Membrane (0.3761); Cell membrane (0.3496); Reference proteome (0.3255); Signal (0.2689); Proteoglycan (0.2386); Lipoprotein (0.1827); Glycoprotein (0.1781); Vacuole (0.1333),
MAVVEPVPGGDVKLFNRWTFEDVQVSDISLNDYLAVTSMKHYTFLPHSAGRYSAKRFRKAQCPIIERLTNSLMMHGRNNGKKIMAVRIIKHTMEIIHLLTDANPIQIIVDAIINSGPREDATRIGSAGVVRRQAVDISPLRRVNQAIYLLTTGARESAFRNVKTIAECLADELINAAKGSSNSYAIKKKDEIERVAKANR,,ribosomal small subunit assembly (GO:0000028) (0.7802); translation (GO:0006412) (0.4862); cytoplasmic translation (GO:0002181) (0.1929); ribosomal subunit export from nucleus (GO:0000054) (0.1228); regulation of translational fidelity (GO:0006450) (0.1156); ribosomal small subunit biogenesis (GO:0042274) (0.1133),cytoplasm (GO:0005737) (0.3626); cytosolic small ribosomal subunit (GO:0022627) (0.2923); nucleolus (GO:0005730) (0.2495); cytosol (GO:0005829) (0.1615); membrane (GO:0016020) (0.1355); small-subunit processome (GO:0032040) (0.0898); synapse (GO:0045202) (0.0586),mRNA binding (GO:0003729) (0.3426); rRNA binding (GO:0019843) (0.3028); structural constituent of ribosome (GO:0003735) (0.2990),"Ribosomal protein uS7, eukaryotic/archaeal (IPR005716) (0.2568); Small ribosomal subunit protein uS7, conserved site (IPR020606) (0.2470); Small ribosomal subunit protein uS7 (IPR000235) (0.1961); Small ribosomal subunit protein uS7 domain superfamily (IPR036823) (0.1047)",1.10.455.10 (0.2577),Ribonucleoprotein (0.9513); Reference proteome (0.5937); Ribosomal protein (0.5877); Cytoplasm (0.3658); Ubl conjugation (0.3238); Phosphoprotein (0.3172); 3D-structure (0.2886); Acetylation (0.2868); Nucleus (0.1989); Isopeptide bond (0.1619); RNA-binding (0.0538); rRNA-binding (0.0446),
MAARSLRRGESHFCFHPQIPQKNISPHRRNEARDDTARLGVFTRSLEKAPFPRTTDAQLELNAFLSLSPSEKASDAPYVTMILFSSRSVLLSVYYPQIFLILTSGSYLALSSVVALGANIICNKIPGLAPRQRAICQSRPDAIIVIGEGAQLGINECQYQFRYGRWNCSALGERTVFGQELRVGSREAAFTYAITAAGVAHAVTAACSQGNMSHCGCDREKQGYYNQEEGWKWGGCSADIKYGIEFSRKFVDAREIKKNARRLMNLHNNEAGRKVLEERMKLECKCHGVSGSCTTKTCWTTLPKFREIGYVLKDKYNKAVQVEVVRASRLRQPTFLKVKRTRHQKPLETDLVYIERSPNYCEEDAKTGSVGTQGRLCNRTSPHTDGCDLMCCGRGYNTHQYTKVWQCNCKFQWCCFVKCNTCSERTEVFTCK,,embryonic axis specification (GO:0000578) (0.3496); cell fate commitment (GO:0045165) (0.3137); positive regulation of JNK cascade (GO:0046330) (0.2874); neuron differentiation (GO:0030182) (0.1896); positive regulation of gene expression (GO:0010628) (0.1825); embryonic forelimb morphogenesis (GO:0035115) (0.1254); hematopoietic stem cell differentiation (GO:0060218) (0.1209); canonical Wnt signaling pathway (GO:0060070) (0.1198); positive regulation of epithelial cell proliferation involved in wound healing (GO:0060054) (0.1173); cell-cell signaling (GO:0007267) (0.1039); chondrocyte differentiation (GO:0002062) (0.0919); axis specification (GO:0009798) (0.0915); positive regulation of transcription by RNA polymerase II (GO:0045944) (0.0692); negative regulation of apoptotic signaling pathway (GO:2001234) (0.0651); kidney development (GO:0001822) (0.0514); embryonic skeletal joint development (GO:0072498) (0.0492); bone regeneration (GO:1990523) (0.0473),extracellular space (GO:0005615) (0.4060); membrane (GO:0016020) (0.0719),frizzled binding (GO:0005109) (0.2199); cytokine activity (GO:0005125) (0.1920),"Wnt protein, conserved site (IPR018161) (0.3472); Wnt, C-terminal domain (IPR043158) (0.2429); Wnt (IPR005817) (0.1998)",3.30.2460.20 (0.3326),Wnt signaling pathway (0.9711); Extracellular matrix (0.4801); Secreted (0.4183); Transmembrane helix (0.4018); Lipoprotein (0.2426); Reference proteome (0.2325); Signal (0.2046); Developmental protein (0.1443); Membrane (0.1311),
MGIGGGLVFTIYNAPSGKVETINSRETAPMSASENMFGTNPEKAKPGLFIAVPGELRGYALAHKRHGKLPWKELFQPSIKLASEGFKIGKALANAINETRATIQRNATLCEVFCDSNNIVLKENDTIRFPKLAETYRKISEEGPDAFYNGSLTQSIVDDIKAAGGIITREDLKAYGPVLTEHALNFTVGKYIFHAPGAPFGGPVLALILKVMKGYNISWKSMATTGNKTLTYHRLIEAFRFADVQKSKLGDPLFENITEHVKNMVSDSFADHIRSKIKDDLKQTSYDEQEDINTVPEDHGTSHVSVLAKDGSAVAVTSSINNYFGSGVMSRSTGIIFNDQMWDFIEPELMSGPNKNNKIKPGKRPLSSMCPTIIFEKDDRKNKVRMVVGGAGGTNITTSVAQVILNHLFFGFDLQKSVNTSRVQITLNVTNVEKDFDKAVIEGLKQKNHHILHDTALSVVQAIGRKGKKVCAQSDTRNDGHAAGY,gamma-glutamyltransferase (2.3.2.2) (0.9875); glutathione gamma-glutamate hydrolase (3.4.19.13) (0.9269); leukotriene-C4 hydrolase (3.4.19.14) (0.5962),glutathione catabolic process (GO:0006751) (0.4611); peptide modification (GO:0031179) (0.3043); leukotriene D4 biosynthetic process (GO:1901750) (0.3038); glutathione biosynthetic process (GO:0006750) (0.1546); inflammatory response (GO:0006954) (0.1474); regulation of immune system process (GO:0002682) (0.1023); fatty acid metabolic process (GO:0006631) (0.0735); adaptive immune response (GO:0002250) (0.0502),plasma membrane (GO:0005886) (0.1124),leukotriene-C(4) hydrolase (GO:0002951) (0.2214); glutathione hydrolase activity (GO:0036374) (0.2185); acyltransferase activity (GO:0016746) (0.1094),"Gamma-glutamyltranspeptidase, small subunit (IPR043137) (0.3740); Gamma-glutamyltranspeptidase (IPR000101) (0.2245); Gamma-glutamyltranspeptidase, large subunit, C-terminal domain (IPR043138) (0.2099); Nucleophile aminohydrolases, N-terminal (IPR029055) (0.1701)",1.10.246.130 (0.3786); 3.60.20.40 (0.3079),Zymogen (0.5465); Transferase (0.5268); Hydrolase (0.5050); Acyltransferase (0.2870); Immunity (0.2502); Reference proteome (0.1923); Secreted (0.1757); Protease (0.1656); Glutathione biosynthesis (0.1457); Transmembrane helix (0.1267); Toxin (0.1022); Differentiation (0.1019); Zinc (0.0811); Innate immunity (0.0541),
MGHTSLEKIIALQKKTAHIRNLCILAHVDHGKTTLADCLVASNGIISSRLAGKLRYLDSREDEQIRGITMKSSAISLHFATGGVEFLINLIDSPGHVDFSSEVSTAVRLCDGAIVVVDAVEGVCPQTQVVLRQAWLENIRPVLVINKIDRLIAELKLTSQEAYVHLQKILEQVNAVTGTLFTSKVLEERAEKDAGSQSSFTENESGDHVYDWSAGLEETDDSDLYFSPDRGNVVFASAIDGWGFSIHQFAEMYSQKMGIRSSVLLKTLWGDFYLNAKAKKIMKGAQSKGKKPLFVQFILDNIWSMYDAVVTRRDKEKVEKMMTSLGLKVMSRDLRHSDPKVLLSAICSQWLPLSQAVLSMVCEKLPSPAEISAERVEKLMSVGARRFDSLPDKTQELKKAFLDCSADETAPVIVFVSKMFAVDSKALPQNKQRPLTHEEISQRRELARQRHAEKQAANQSAESLASGDAGGDSIPAPAAAGVTDALCAQTEALSVKTTVEEENKEHFVAFARVYSGVVRKGQKVFVLGPKYDPSLALRALPEGCSVSDVLPSIPHMSYCTVDSLYLLMGRELEELDEVPSGNVLGIGGLEDVILKSATISTSPACPPFTPLNFEATPIVRVAVEPKHPSEMPKLVRGMKLLNQADPCAEVLIQETGEHVLVTAGEVHLQRCLDDLRERFAKIEISSSKPIIPFRETVVRPPRVDMVNEDLGKQQKVAVIHQVKEEQSKNPECVQVDSSGLVSLTTPNKMATVGVRAIPLPEQVTCLLEDNVELIRTMEQFNLSVREGKTLDISQKILDNIQDFKVKLESHLQGHKWRNAVDHIWAFGPRRCGPNILLNSIEGYRRPSVWQCLETEKTESSALRDFDNSIASGFQLATLAGPMCEEPLMGVCFSVESWDMKISTPVAQQDSVDEGSQPAELNNEHSEVSPVSSSRSRSKAEAAGSSVDCYGPFSGQLIAAVKEACRYAFQAKPQRLMAAMYTCEIMATAEVLGRVYAVLSKREGRVLQEEMKEGTDMFIIKAVLPVAESFGFADEIRKRTSGLASPQLIFSHWEVIGSDPFWVPTTEEEYLHFGEKADSTNQALKYMNAVRKRKGLYVEEKIVEHAEKQRTLGKNK,3.6.5.- (0.2672); protein-synthesizing GTPase (3.6.5.3) (0.1090),cytosolic ribosome assembly (GO:0042256) (0.5671); translation (GO:0006412) (0.0918),ribonucleoprotein complex (GO:1990904) (0.3747); cytosol (GO:0005829) (0.2253); ribosome (GO:0005840) (0.2204); nucleus (GO:0005634) (0.2058); nuclear body (GO:0016604) (0.0677),ribosome binding (GO:0043022) (0.5593); GTPase activity (GO:0003924) (0.5003); translation elongation factor activity (GO:0003746) (0.4378); GTP binding (GO:0005525) (0.3942),"Translational (tr)-type GTP-binding domain (IPR000795) (0.5405); Elongation factor EFG, domain V-like (IPR000640) (0.5058); Translation protein, beta-barrel domain superfamily (IPR009000) (0.3971); Small ribosomal subunit protein uS5 domain 2-type fold, subgroup (IPR014721) (0.3462); Elongation Factor G, domain II (IPR041095) (0.3420); P-loop containing nucleoside triphosphate hydrolase (IPR027417) (0.1830); Ribosomal protein uS5 domain 2-type superfamily (IPR020568) (0.1828); EF-G domain III/V-like (IPR035647) (0.1780)",3.30.70.870 (0.7250); 2.40.30.10 (0.5398); 3.90.1430.10 (0.3540); 3.30.230.10 (0.2836); 3.40.50.300 (0.2383); 3.30.70.240 (0.1479),Reference proteome (0.5751); Nucleotide-binding (0.5054); Protein biosynthesis (0.4246); Elongation factor (0.2143); GTP-binding (0.1306); Ribonucleoprotein (0.1286); Transit peptide (0.0810),
MRLVVCFLSLLTVFSAGQCGNILVWYTEGSHWINLKIVLDTLLDRGHNVTVLVPDGALFMKAKESDRFSYQHFSVSTSAQDMQDFLDEFLHFSVFELENSNLLQIQMKFFDLLSKHQHMSLSYCDGILKSPELMDKLKTGKFDVLLSDPMYPCSDIVAEELNVPLVYTFRFSLAHTMERMCGQIPAPPSYVPGATSKLTDKMSFTERIYSMLFYLSIDTFYRLIWKRFDNYYTEYLGRPTSYCEMMGRADIWLIRTYWDFEFPRPFVPNFKYIGGLHCTPAKPLPKDMEEFVQSSGDDGIVVFTLGSMIDKVPKEMSNRIASALAQIPQKVLWRYGGEKPDTLGENTRIYKWMPQNDLLGHPKTRAFITHGGTNGIYEAIYHGVPMVGIPLFGDQPDNMVHMTTRGAAVVVDSIKSMQPQELVDKLNTVINDPSYKENAMRLSRIHHDRPMKPLDESVFWIEFVMRNKGAKHLRVEAHNLTWYQYHCLDVFAFLTTVLTLVLYICFKMAKFFIMRCCFRSKRKSKKE,glucuronosyltransferase (2.4.1.17) (0.8621),cellular response to glucocorticoid stimulus (GO:0071385) (0.2581); estrogen metabolic process (GO:0008210) (0.1616); response to immobilization stress (GO:0035902) (0.1542); steroid metabolic process (GO:0008202) (0.1364); liver development (GO:0001889) (0.1356); xenobiotic metabolic process (GO:0006805) (0.1327); response to ethanol (GO:0045471) (0.1152); response to peptide hormone (GO:0043434) (0.0924); response to zinc ion (GO:0010043) (0.0898); cellular glucuronidation (GO:0052695) (0.0731); sensory perception of smell (GO:0007608) (0.0632),endoplasmic reticulum membrane (GO:0005789) (0.2193); membrane (GO:0016020) (0.0712),glucuronosyltransferase activity (GO:0015020) (0.5937),"UDP-glycosyltransferase family, conserved site (IPR035595) (0.5242); UDP-glycosyltransferase (IPR050271) (0.3789); UDP-glucuronosyl/UDP-glucosyltransferase (IPR002213) (0.1301)",3.40.50.2000 (0.1836),Transmembrane helix (0.8695); Transferase (0.7136); Reference proteome (0.5598); Glycoprotein (0.3668); Endoplasmic reticulum (0.3621); Membrane (0.3551); Glycosyltransferase (0.3266); Transmembrane (0.3032); Signal (0.1544); Microsome (0.1397); Proteomics identification (0.0957); Steroid metabolism (0.0736),
MTSYNVSLSGPPPWGFRLQGGKDFNMPLTVSRITPGSKAASSNLIQGDIIVAIDGVSTDGMTHLEAQNKIKSANFNLALTMQRSKRPTPVPIATPRIESPMPVIPHQKVITHAPANNEFLPSFNPIALKDTALSTNKPIEVKGPGGKATIIHAQYNTPISMYSQDAIMDAIAGQSQARGSEMSGNETDSQLSNLPVKERVIDSASPVYQAVIPSEIDQLGPADWARRAAQLQSKSFRVLAHITGTEYMQDPDEEALRKSRERFESEAKGPRFAKLKNWHNGLSAQILNVPQ,,mesoderm development (GO:0007498) (0.2590); positive regulation of Rho protein signal transduction (GO:0035025) (0.2090); actin cytoskeleton organization (GO:0030036) (0.2008); somitogenesis (GO:0001756) (0.1985); heart development (GO:0007507) (0.1903); sarcomere organization (GO:0045214) (0.1241); muscle structure development (GO:0061061) (0.1130); border follicle cell migration (GO:0007298) (0.1017); locomotory behavior (GO:0007626) (0.0865); actin filament organization (GO:0007015) (0.0775); negative regulation of microtubule polymerization (GO:0031115) (0.0575),Z disc (GO:0030018) (0.3800); filamentous actin (GO:0031941) (0.2481); phagocytic cup (GO:0001891) (0.2418); stress fiber (GO:0001725) (0.1857); adherens junction (GO:0005912) (0.1777); cytosol (GO:0005829) (0.0656); actin cytoskeleton (GO:0015629) (0.0603),cytoskeletal protein binding (GO:0008092) (0.1815); muscle alpha-actinin binding (GO:0051371) (0.1684); actinin binding (GO:0042805) (0.1557); actin binding (GO:0003779) (0.1195),"Zasp-like motif (IPR006643) (0.6195); PDZ and LIM domain protein 1-4/Zasp-like, middle domain (IPR031847) (0.2873); PDZ superfamily (IPR036034) (0.1804); PDZ and LIM domain-containing (IPR050604) (0.1632)",2.30.42.10 (0.1434),Reference proteome (0.1701),
MAFFNSFFQKISQDGSKGSPAPFQDAGPSGTVKFSQAFNAQNDAAVLKKAIETKGVDEAAIIEVLAKRSNAQRQQIKAAYQQSTGKPLADALKKALSSHLEDVVLALLMTPSEYDAFEMRKAMKGLGTNEAVLSEILGTRTNNEIKAMKNSFREAYGELLEENIKSEVSGQLETTLLALCQATRPEGYNIDDALAHTDAKALYEAGEHRIGTVVSVLIDVLTTRSDAQLVKTFQYYGQLSKKGFAKALESELHGHLEDCLLTIVKSAWNKPAYFAEKLHLAMKGLGTDNDTLIRIIVSRSEIDLTKIMQEYSTMQGQSLQAAIQKETKGDYQKILLTICGAH,,cellular response to glucocorticoid stimulus (GO:0071385) (0.1871); positive regulation of endothelial cell migration (GO:0010595) (0.1511); adaptive immune response (GO:0002250) (0.1444); negative regulation of phospholipase A2 activity (GO:1900138) (0.1273); response to red or far red light (GO:0009639) (0.1240); phagocytosis (GO:0006909) (0.1041); inflammatory response (GO:0006954) (0.1021); growth plate cartilage chondrocyte differentiation (GO:0003418) (0.0831); fin regeneration (GO:0031101) (0.0692),extracellular space (GO:0005615) (0.3849); plasma membrane (GO:0005886) (0.2727); nucleus (GO:0005634) (0.2119); cytoplasm (GO:0005737) (0.1843); vesicle membrane (GO:0012506) (0.1249); focal adhesion (GO:0005925) (0.1044); mitochondrion (GO:0005739) (0.1033); vesicle (GO:0031982) (0.0751),"calcium-dependent phospholipid binding (GO:0005544) (0.3832); protease binding (GO:0002020) (0.2894); calcium ion binding (GO:0005509) (0.2717); phospholipase A2 inhibitor activity (GO:0019834) (0.2695); phosphatidylserine binding (GO:0001786) (0.2404); phosphatidylinositol-4,5-bisphosphate binding (GO:0005546) (0.2269); virion binding (GO:0046790) (0.1212)","Annexin (IPR001464) (0.1435); Annexin repeat, conserved site (IPR018252) (0.0912)",,Repeat (0.7165); Reference proteome (0.5138); Calcium (0.3334); Calcium/phospholipid-binding (0.2958); Annexin (0.2122); Phospholipase A2 inhibitor (0.1543),
MNPILRVSANDDGFDPILWNTSTDTHPPWLRFHLGISRWQMYQHKDPNLSALNQQLASHRIVSAVQKSGGTQLKLVMSFPNYGQALFKPMKQERHEETNVNLYYFSDFERHNAEIAAFHLDRILGFRRIPPVIGRLINVIKEIKEVTTDHKLVTTFFNSPVGNTCFHGHCSYYCSTEHAVCGRPIKLEGSLAVMLPDLSLAPRHSWRSPWRRSYSRTNQAEWETNSNYCDTVKQTPPYDRGTRLVDVIDMSILDFLMSNMDRHHYETFEKFGNDTFLIHLDNGRAFGRHSKDEPSILAPLVQCCRVRRSTLLRLRLLSLPPYRLSDVMRASLSRDPLAEVAPLLTEPHLSALDRRLETVMQAIQDCLQQHQHHSDVIYDDIMDYPQA,non-specific serine/threonine protein kinase (2.7.11.1) (0.6806); 2.7.1.- (0.0421),protein phosphorylation (GO:0006468) (0.5713); osteoclast maturation (GO:0036179) (0.4355); enamel mineralization (GO:0070166) (0.3222); regulation of phosphorus metabolic process (GO:0051174) (0.2832); odontoblast differentiation (GO:0071895) (0.2808); dentinogenesis (GO:0097187) (0.2657); positive regulation of bone mineralization (GO:0030501) (0.2454); regulation of fibroblast growth factor receptor signaling pathway (GO:0040036) (0.2102); biomineral tissue development (GO:0031214) (0.1939),Golgi membrane (GO:0000139) (0.2763); Golgi apparatus (GO:0005794) (0.1371),protein serine/threonine kinase activity (GO:0004674) (0.2712); ATP binding (GO:0005524) (0.2628); manganese ion binding (GO:0030145) (0.1819); protease binding (GO:0002020) (0.1789),"FAM20, C-terminal (IPR009581) (0.2024)",,Manganese (0.5475); Reference proteome (0.4274); Nucleotide-binding (0.4127); ATP-binding (0.3332); Metal-binding (0.2437); Golgi apparatus (0.2378); Glycoprotein (0.2282); Transferase (0.2214); Disulfide bond (0.1786); Serine/threonine-protein kinase (0.1742),Mn(2+) (0.2325)
MNTTVWIVDNYQEAITKHIVIVFLALIVNVINGMLVVTFFSSHVFSRDSRYILYIHLVINDMLMICASVAIYVLTYIAPVVNASLCYILMSLGKVFFMITPLNLAGMAIERFIAVCKPLHHSQICTPQRTYVFFCLLWGIAAIRSVVDIMISLLTQPISFFRSFVPCYPTYMFPSKAHDDHNTASQVICMSMVWIIICYTYCRVLFAARKAVSKGSASKARSTILLHGVQLLLCMLSYVTPFMYTLIIPLFPLQRTNIAFCIYVFTNIMPRLLSPLIYGVRDQKFIKQMKEVFTCKVIFLKIVPS,,spermatogenesis (GO:0007283) (0.5264); intracellular water homeostasis (GO:0009992) (0.2478); ovarian follicle development (GO:0001541) (0.1116); hematopoietic progenitor cell differentiation (GO:0002244) (0.0887); chemosensory behavior (GO:0007635) (0.0806); male courtship behavior (GO:0008049) (0.0795); negative regulation of cell population proliferation (GO:0008285) (0.0782); cellular response to oxygen levels (GO:0071453) (0.0701); G protein-coupled receptor signaling pathway (GO:0007186) (0.0421),dendrite (GO:0030425) (0.3902); cytoplasm (GO:0005737) (0.3172); synapse (GO:0045202) (0.2774); plasma membrane (GO:0005886) (0.1884); cilium (GO:0005929) (0.0982); presynaptic membrane (GO:0042734) (0.0574); presynapse (GO:0098793) (0.0446),odorant binding (GO:0005549) (0.1263); G protein-coupled receptor activity (GO:0004930) (0.0915),"G-protein Coupled Receptor 1 Superfamily Member (IPR052921) (0.1175); GPCR, rhodopsin-like, 7TM (IPR017452) (0.0898); G protein-coupled receptor, rhodopsin-like (IPR000276) (0.0708)",1.20.1070.10 (0.2428),Transmembrane helix (0.6000); Reference proteome (0.5807); G-protein coupled receptor (0.3265); Receptor (0.2935); Membrane (0.2825); Cell membrane (0.2024); 3D-structure (0.1534); Transducer (0.1484); Endosome (0.1101); Transport (0.1061); Transmembrane (0.0811),
MASTLLSPMVDYYNDEEELDSVDEDEDRSFRGRDSEEDTEDASETDLAKHDEDDYVEIKEQMYQDKLASLKRQLQQLQEGTLQEYQKRMKKLDQQYKERLRNADLFLQLETEQVERNYIKEKKAAVKEFDDKKVELKENLIAELEEKKKMVENEKLTMELTGDSMEVKPIMTRKLRRRPNDPVPIPDKRRKPAPAQLNYLLSDEQIMEDLRTLNKLKSPKRQGMDVLSFRASPSSPEHLPSTPVDTPSQRYEARIEEGKLYYDKRWYHKSQAIYLESKENTKISCVISSVGTNEIWVRKTSDSTKMRIYLGQLQRGAFIIRRRSAA,,negative regulation of transcription by RNA polymerase II (GO:0000122) (0.9627); negative regulation of stem cell population maintenance (GO:1902455) (0.6171); blastocyst hatching (GO:0001835) (0.4539); negative regulation of DNA-templated transcription (GO:0045892) (0.3889); negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512) (0.3060); chromatin remodeling (GO:0006338) (0.2079); positive regulation of stem cell population maintenance (GO:1902459) (0.1299); apoptotic process (GO:0006915) (0.1270); regulation of DNA-templated transcription (GO:0006355) (0.1217); negative regulation of cell migration (GO:0030336) (0.1062); chromatin organization (GO:0006325) (0.0927),Sin3-type complex (GO:0070822) (0.4199); nucleus (GO:0005634) (0.1388); cytosol (GO:0005829) (0.0996); nuclear body (GO:0016604) (0.0649),histone deacetylase binding (GO:0042826) (0.3096); enzyme binding (GO:0019899) (0.1945),Sds3-like (IPR013907) (0.1791),,Ubl conjugation (0.7853); Transcription (0.7780); Reference proteome (0.7309); Repressor (0.6527); Tumor suppressor (0.4749); Nucleus (0.4603); Transcription regulation (0.3028); Coiled coil (0.2412); Phosphoprotein (0.2379); Isopeptide bond (0.2274); Chromatin regulator (0.2086); Proteomics identification (0.2052); 3D-structure (0.1908); Acetylation (0.1214),
MLSRMTDNTTLSPPSNSKISTDFEKTTVDMVFYAIIVLLGTTGNSVVIWVAGFCMKPNVTNVWLVNLAVADLIFSMTRIISLIKNLFFDYWPFGIFLCKFNGFFKYANMFCSVFLLAVISVDRVLCVWRPVFTRKRRTVCAARVVSVGVWIVAVIFSSPYFVYREVFVRSNNLSHCSLGGKDGAEGGNLPKYVYYFVRFICGFLLPFLVIFICYTLAAIGIRRTRFSGKSRPLRILAVLVCAFFLCWAPYHFLGLVKLVNKDNEVVKIGWNMASNLAYFNSCINPILYFFMGLDVSRRCNQSLSGIFHRALMEEGQSLSQQGTEESCNSFPKTAGDECVAKI,,complement receptor mediated signaling pathway (GO:0002430) (0.8004); positive regulation of cytosolic calcium ion concentration (GO:0007204) (0.4349); inflammatory response (GO:0006954) (0.4002); adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193) (0.3476); positive regulation of macrophage chemotaxis (GO:0010759) (0.3063); negative regulation of interleukin-12 production (GO:0032695) (0.2282); chemotaxis (GO:0006935) (0.2234); G protein-coupled receptor signaling pathway (GO:0007186) (0.2204); positive regulation of ERK1 and ERK2 cascade (GO:0070374) (0.2058); ERK1 and ERK2 cascade (GO:0070371) (0.1472); positive regulation of cold-induced thermogenesis (GO:0120162) (0.0643),plasma membrane (GO:0005886) (0.3574),G protein-coupled receptor activity (GO:0004930) (0.2614); peptide binding (GO:0042277) (0.0534),"G protein-coupled receptor, rhodopsin-like (IPR000276) (0.4711); GPCR, rhodopsin-like, 7TM (IPR017452) (0.3584); Formyl peptide receptor-related (IPR000826) (0.1303)",1.20.1070.10 (0.1392),Transducer (0.7855); Transmembrane helix (0.6848); Reference proteome (0.6445); Receptor (0.6435); Membrane (0.5744); G-protein coupled receptor (0.4297); Glycoprotein (0.2309); Phosphoprotein (0.2007); Cell membrane (0.1433); Ubl conjugation (0.1265); Transmembrane (0.1218),
MMSLPHLLALWVTIQLCIFASSSLVLGLKKFCSLCPSGELKSHRSGDEMTSMLALDEPCGVYTLPCALGLRCIPPTGEQSPLQALLQGRGACRNSKNTISDIPPPTDYEPSTTENNEKGPCRKLLNSVLQSIELTVIHSVQDIYIPNCDKQGSFRRKQCRSSRGMQRGHCWCVDEKGSKISSRRRSDGSISCSSA,,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567) (0.8722); response to hypoxia (GO:0001666) (0.5543); positive regulation of MAPK cascade (GO:0043410) (0.3168); positive regulation of stress-activated MAPK cascade (GO:0032874) (0.1976); regulation of signal transduction (GO:0009966) (0.1681); positive regulation of ERK1 and ERK2 cascade (GO:0070374) (0.1354); negative regulation of canonical Wnt signaling pathway (GO:0090090) (0.1161); negative regulation of BMP signaling pathway (GO:0030514) (0.0977); T cell activation involved in immune response (GO:0002286) (0.0886); response to glucose (GO:0009749) (0.0723); gene expression (GO:0010467) (0.0691); regulation of growth (GO:0040008) (0.0562); regulation of cell growth (GO:0001558) (0.0555); skeletal system development (GO:0001501) (0.0545),extracellular region (GO:0005576) (0.1422); extracellular space (GO:0005615) (0.1348); insulin-like growth factor ternary complex (GO:0042567) (0.1326); cytoplasm (GO:0005737) (0.1286),insulin-like growth factor I binding (GO:0031994) (0.3932); fibronectin binding (GO:0001968) (0.2266); receptor ligand activity (GO:0048018) (0.2080); insulin-like growth factor binding (GO:0005520) (0.1600); insulin-like growth factor II binding (GO:0031995) (0.1499); identical protein binding (GO:0042802) (0.1239),"Insulin-like growth factor-binding protein, IGFBP (IPR000867) (0.5748); Thyroglobulin type-1 superfamily (IPR036857) (0.1740); Thyroglobulin type-1 (IPR000716) (0.1593)",4.10.800.10 (0.3282); 4.10.40.20 (0.2638),Reference proteome (0.5757); Secreted (0.5047); Disulfide bond (0.4932); Growth factor binding (0.1505),
MGGQTVWMTLSFKLLLYYCMISVLMPAIFILATRARVDKFRKFNESTQTKSSQELFEEAFEEQGYYLQRLFLQYGDNGTLTYEGLQKLLGSLGLGEVSVLEIRHGEAKHPSQSISHSHSHEDHHPSQRTTNSPPLRESLDAKSALSGSPAELGRSDYFLHPALRNKQEESVSLLSDHPTEKHLHGNCLNVTQLLWNFGLGQASHITPAHFTFLCPALLYQIESGVCLRHTEDHSQTSKTSEGFLIALGWASLALLVISLPSLVALGMAPLLQPSVLQVFLCPMAGMAVGTLCGDALLHLMPHAIFSQHTDHQNAVFKGLSVLGGLYLLFIFESLLGLKQHFKNLKRRKHDAECGRELDALQGTSSANQNESSGHGHSHGQAEPGQTGIRSMAWMVVMGDGIHNLTDGLAIGVAFSQSLTGGFSTAIAVFCHELPHELGDLAVLLSAGWPVRRLLVFSGLSALLGFVGVLAGSALGNHWASHSPWILTLTAGVFLYVALADMMPEMLHGACGSVSPLKRFLLQALGLLTGGXHHAVHRALRGSHRCQSGRKQSGRKLTT,,intracellular zinc ion homeostasis (GO:0006882) (0.4356); zinc ion transmembrane transport (GO:0071577) (0.3574); zinc ion transport (GO:0006829) (0.3035); zinc ion import across plasma membrane (GO:0071578) (0.2931); intracellular monoatomic cation homeostasis (GO:0030003) (0.2647); cellular response to zinc ion starvation (GO:0034224) (0.2608),plasma membrane (GO:0005886) (0.1890); apical plasma membrane (GO:0016324) (0.1884); late endosome membrane (GO:0031902) (0.1560); basolateral plasma membrane (GO:0016323) (0.0987),monoatomic cation:bicarbonate symporter activity (GO:0140410) (0.3051); zinc ion transmembrane transporter activity (GO:0005385) (0.1793),Zinc Iron Protein (ZIP) Transporter (IPR050799) (0.4457); Zinc/iron permease (IPR003689) (0.0747),,Ion transport (0.5576); Membrane (0.4839); Reference proteome (0.4830); Cell membrane (0.2736); Zinc transport (0.1930); Glycoprotein (0.1370); Phosphoprotein (0.0872),
MLHTMVDFSEKYLERAKDMKNRLAFLRRRNESPGSTPASKLDKTMKSVKPTPEEAMKWGESLDKLLVHKYGLAAFRAFLRTEFSEENLDFWLACEDYKKIKSQSKMTSKAKKIFAEFIAIQSCKEVNLDSYTREHTKENLQNINRSCFELAQRRIYGLMEKDSYPRFLRSELYMDLVNQKKPSTTSTSSSS,,response to amphetamine (GO:0001975) (0.5277); regulation of G protein-coupled receptor signaling pathway (GO:0008277) (0.4950); G protein-coupled receptor signaling pathway (GO:0007186) (0.2614); regulation of translation (GO:0006417) (0.2530); negative regulation of cardiac muscle hypertrophy (GO:0010614) (0.2492); adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193) (0.2424); relaxation of vascular associated smooth muscle (GO:0060087) (0.2250); positive regulation of GTPase activity (GO:0043547) (0.1945); spermatogenesis (GO:0007283) (0.1619); negative regulation of MAP kinase activity (GO:0043407) (0.1574); negative regulation of cell growth involved in cardiac muscle cell development (GO:0061052) (0.1271); brown fat cell differentiation (GO:0050873) (0.1066); positive regulation of cardiac muscle contraction (GO:0060452) (0.1048); positive regulation of neuron projection development (GO:0010976) (0.1046); response to ethanol (GO:0045471) (0.0951); relaxation of cardiac muscle (GO:0055119) (0.0879); regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway (GO:0071877) (0.0791); negative regulation of G protein-coupled receptor signaling pathway (GO:0045744) (0.0774); sensory perception of sound (GO:0007605) (0.0449),dendrite (GO:0030425) (0.3296); cytoplasm (GO:0005737) (0.1183); membrane (GO:0016020) (0.0835),GTPase activator activity (GO:0005096) (0.2833); G-protein alpha-subunit binding (GO:0001965) (0.2159),"RGS domain superfamily (IPR036305) (0.3601); RGS domain (IPR016137) (0.2670); RGS, subdomain 2 (IPR044926) (0.2562); RGS, subdomain 1/3 (IPR024066) (0.1501)",1.10.196.10 (0.6162); 1.10.167.10 (0.2641),Signal transduction inhibitor (0.8690); Reference proteome (0.3973); Nucleus (0.3319); GTPase activation (0.2652); Membrane (0.1235); Cell membrane (0.1152); Cytoplasm (0.0995),
MALSKTFGQKPIKFQLEEDGDFYMIGSEVGNYLRMFRGSLYKRYPSLWRRLASVEERKKIVASSHATSVTLLKASECEEIFEGNDEKYKAVSISTEPPAYLREQKAKRNSQWVPTLPNSSHHLDAVPCSTTINRNRMGRDKKRTFPLCFDDHDPAVIHENASQAEVLVPIRLDMEIDGQKLRDAFTWNMNEKLMTPEMFAEILCDDLDLNPLTFVPAIASAIRQQIESYPTDSILEEQTDQRVIIKLNIHVGNISLVDQFEWDMSEKENSPESFALKLCSELGLGGEFVTTIAYSIRGQLSWHQRTYAFSENPLPTVEIAIRNTGDADQWCPLLETLTDAEMEKKIRDQDRNTRRMRRLANTAPAW,,negative regulation of cell population proliferation (GO:0008285) (0.4746); blastocyst hatching (GO:0001835) (0.4417); positive regulation by host of viral transcription (GO:0043923) (0.3570); chromatin remodeling (GO:0006338) (0.3132); nucleosome disassembly (GO:0006337) (0.2924); positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838) (0.2796); positive regulation of DNA-binding transcription factor activity (GO:0051091) (0.2737); positive regulation of glucose mediated signaling pathway (GO:1902661) (0.2431); single stranded viral RNA replication via double stranded DNA intermediate (GO:0039692) (0.1773); hepatocyte differentiation (GO:0070365) (0.1346); cell dedifferentiation (GO:0043697) (0.1179),npBAF complex (GO:0071564) (0.2108); nBAF complex (GO:0071565) (0.1715); germ cell nucleus (GO:0043073) (0.1593); SWI/SNF complex (GO:0016514) (0.1592); nuclear chromosome (GO:0000228) (0.1394); nucleus (GO:0005634) (0.1197); nucleoplasm (GO:0005654) (0.0981); fibrillar center (GO:0001650) (0.0933),p53 binding (GO:0002039) (0.2544); DNA binding (GO:0003677) (0.1733); transcription coactivator activity (GO:0003713) (0.1256),"Chromatin-remodeling complex component Sfh1/SNF5 (IPR017393) (0.5818); SWI/SNF Subunit INI1, DNA binding domain (IPR048664) (0.3730); SNF5/SMARCB1/INI1 (IPR006939) (0.0420)",,Reference proteome (0.6833); Transcription regulation (0.6727); Transcription (0.4478); Nucleus (0.2608); Activator (0.2456); DNA-binding (0.1777); Ubl conjugation (0.0508),
MAANETDVYAENVFLCFPLRLDSCLSAQRLTTVKVAMYILMLLIIFLTVFGNLLVVVSISYFKHLQSPTHLIVQSLAACDCLLGSLVMPYSMVRSIEGCWYLGDVICKVHSSLDMTLSISSKMHLSLISVDRYWAICDPLMYRTRVTNYSITVFIMCAWLFAFVYSFSIVFSEVNLIGLEVLVLQISCLGSCVLLFNKPSALICSILTFFLPGAIMSSLYVKIFRVASKHAKVLSERVSVLEIKSQTYAQRERKAAKIVAIVVGAFLLCWLPFFVATALDPFLDFWTPADVFDALVWFGYFNSTCNPLIYGFFYPRFQKAFKILMSTVMCGSSSSRTLAFG,,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187) (0.6458); chemical synaptic transmission (GO:0007268) (0.3156); adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189) (0.2149); bone remodeling (GO:0046849) (0.1607); adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193) (0.1362); G protein-coupled receptor signaling pathway (GO:0007186) (0.1052); cell surface receptor signaling pathway (GO:0007166) (0.0934); regulation of synaptic plasticity (GO:0048167) (0.0660); sensory perception of chemical stimulus (GO:0007606) (0.0582); circadian rhythm (GO:0007623) (0.0537)",plasma membrane (GO:0005886) (0.3707); dendrite (GO:0030425) (0.3161); synapse (GO:0045202) (0.2226); membrane (GO:0016020) (0.0525); cytoplasm (GO:0005737) (0.0484),neurotransmitter receptor activity (GO:0030594) (0.2192); G protein-coupled serotonin receptor activity (GO:0004993) (0.1991),"GPCR, rhodopsin-like, 7TM (IPR017452) (0.5808); G protein-coupled receptor, rhodopsin-like (IPR000276) (0.1978); Trace amine associated receptor family (IPR009132) (0.1490)",1.20.1070.10 (0.2771),Transducer (0.9510); Transmembrane helix (0.9223); Reference proteome (0.8205); Membrane (0.8049); G-protein coupled receptor (0.5182); Receptor (0.3691); Cell membrane (0.1428); Behavior (0.1208); Lipoprotein (0.0783); Glycoprotein (0.0783); Palmitate (0.0534); Transmembrane (0.0452),
MFLQFICAADLSQRTDRPLRSERGTRANRTTLIDFALSTHSRSDSCVWQSVMMGVRSVCCFLLISLLKSSSAHSDFFTSIGHMTDLLFTEKDLVTSLKDYIKAEESKLEQVKQWAEKLDALTATAVQDPEGFLGHPVNAFKLMKRLNTEWGEVEDLVLKDMSDGFISNLTIQRQYFPNDEDQNGAAKALLRLQDTYKLDTQTISSGDLPGVNTGLPYKSTLTVEDCFELGKIAYSDADYYHTELWMAQALKQLDEGEESSVEIATALDYLSYSVYQQGELERALEYTKRLLTVEPEHQRALGNLKYFDYQLAKQKKAEKEQSTKEESKKEQETSDGKKEYLPEKRKYEKLCRGEGLKMTPRRQKHLFCRYFNGNRHPFYTIGPVKQEDEWDRPRIIRYHEIITEQEIEKIKELSKPRLRRATVHDPQTGKLTTAQYRVSKSAWLAAYEHPVVDRINQRIEDITGLNVKTAEELQVANYGVGGQYEPHFDFGRKDEPDAFKELGTGNRIATWLFYMSDVAAGGATVFPEVGAAVKPLKGTAVFWYNLFPSGEGDYSTRHAACPVLVGNKWVSNKWIHERGQEFRRPCGLKETD,procollagen-proline 4-dioxygenase (1.14.11.2) (0.9908),peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401) (0.3783); protein folding (GO:0006457) (0.0417),cytosol (GO:0005829) (0.3602); endoplasmic reticulum (GO:0005783) (0.1653); nucleoplasm (GO:0005654) (0.1592); endoplasmic reticulum lumen (GO:0005788) (0.1272); intracellular membrane-bounded organelle (GO:0043231) (0.0826); procollagen-proline 4-dioxygenase complex (GO:0016222) (0.0723),L-ascorbic acid binding (GO:0031418) (0.5349); procollagen-proline 4-dioxygenase activity (GO:0004656) (0.3087); iron ion binding (GO:0005506) (0.1436); identical protein binding (GO:0042802) (0.1430),"Prolyl 4-hydroxylase (IPR045054) (0.5299); Tetratricopeptide-like helical domain superfamily (IPR011990) (0.2979); Prolyl 4-hydroxylase, alpha subunit (IPR006620) (0.2032); Prolyl 4-hydroxylase alpha subunit, Fe(2+) 2OG dioxygenase domain (IPR044862) (0.1564); Tetratricopeptide repeat (IPR019734) (0.1278)",1.25.40.10 (0.4423); 2.60.120.620 (0.2743); 6.10.140.1460 (0.1945),TPR repeat (0.8887); Vitamin C (0.7409); Dioxygenase (0.6981); Iron (0.3811); Oxidoreductase (0.3678); Reference proteome (0.3656); Metal-binding (0.3244); Endoplasmic reticulum (0.2793); Glycoprotein (0.2291),L-ascorbate (0.1713)
MQKAGTAPSSRGPSAPGSPATSIVARMDNQVIGYKDLAAIPKDKAILEVERPDLMVYEPHFNMAALDHVGLSRSRERSMSPHSISPPPSPEISASKELKDWSEQGSPGGSNMGSTTQLRKISPASKGPMQHFHRPDSGINLYKKPPIYKNERQTGAPHSKQDLIIVSSKFPAAQPPDPSLPSKIETEYWPCPPSLATMEIEWRRKAAEQGKPMEDDDFEDLTEDAKRLQEQELQKIQSNLGKLILKEEIEKSGLIRRKTRSLPDGTNIHLGSSASTTKSASLPPCSRTGLTRLQSADFSSTDNGKAKTGVPNGDSQSGRMDRGNSLPSILEQKIYPYEMLIVTHRGRTKLPPGVDRTRLERHLSPEEFHSLFGMPITEFDRLSLWKRNDMKKKVSLF,,regulation of lamellipodium assembly (GO:0010591) (0.6363); positive regulation of fibroblast migration (GO:0010763) (0.4741); erythrocyte development (GO:0048821) (0.4222); lamellipodium assembly (GO:0030032) (0.3692); actin cytoskeleton organization (GO:0030036) (0.3169); regulation of cell shape (GO:0008360) (0.2600); smooth endoplasmic reticulum calcium ion homeostasis (GO:0051563) (0.2368); regulation of filopodium assembly (GO:0051489) (0.1750); actin filament bundle assembly (GO:0051017) (0.1397); cytoskeleton organization (GO:0007010) (0.1065); negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732) (0.0712),perinuclear region of cytoplasm (GO:0048471) (0.3811); plasma membrane (GO:0005886) (0.3346); postsynaptic density (GO:0014069) (0.2740); platelet dense tubular network membrane (GO:0031095) (0.1876); cytoplasm (GO:0005737) (0.1661); spectrin-associated cytoskeleton (GO:0014731) (0.1451); actin filament (GO:0005884) (0.1325); actin cytoskeleton (GO:0015629) (0.1234); cortical cytoskeleton (GO:0030863) (0.1025); stress fiber (GO:0001725) (0.0885); nucleus (GO:0005634) (0.0556),spectrin binding (GO:0030507) (0.2253); actin filament binding (GO:0051015) (0.1604),Actin-binding LIM (IPR051618) (0.4517); Putative adherens-junction anchoring domain (IPR032402) (0.1788); Villin headpiece domain superfamily (IPR036886) (0.1426),1.10.950.10 (0.2088),Repeat (0.4633); Cytoplasm (0.4560); Proteomics identification (0.2299); Phosphoprotein (0.2181),
MFLQFICAADLSQRTDRPLRSERGTRANRTTLIDFALSTHSRSDSCVWQSVMMGVRSVCCFLLISLLKSSSAHSDFFTSIGHMTDLLFTEKDLVTSLKDYIKAEESKLEQVKQWAEKLDALTATAVQDPEGFLGHPVNAFKLMKRLNTEWGEVEDLVLKDMSDGFISNLTIQRQYFPNDEDQNGAAKALLRLQDTYKLDTQTISSGDLPGVNTGLPYKSTLTVEDCFELGKIAYSDADYYHTELWMAQALKQLDEGEESSVEIATALDYLSYSVYQQGELERALEYTKRLLTVEPEHQRALGNLKYFDYQLAKQKKAEKEQSTKEESKKEQETSDGKKEYLPEKRKYEKLCRGEGLKMTPRRQKHLFCRYFNGNRHPFYTIGPVKQEDEWDRPRIIRYHEIITEQEIEKIKELSKPRLRRATISNPITGVLETAHYRISKSAWLAAYEHPVVDRINQRIEDITGLNVKTAEELQVANYGVGGQYEPHFDFGRKDEPDAFKELGTGNRIATWLFYMSDVAAGGATVFPEVGAAVKPLKGTAVFWYNLFPSGEGDYSTRHAACPVLVGNKWVSNKWIHERGQEFRRPCGLKETD,procollagen-proline 4-dioxygenase (1.14.11.2) (0.9903),peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401) (0.3917),cytosol (GO:0005829) (0.3793); endoplasmic reticulum (GO:0005783) (0.1523); nucleoplasm (GO:0005654) (0.1474); mitochondrion (GO:0005739) (0.1127); intracellular membrane-bounded organelle (GO:0043231) (0.0698); procollagen-proline 4-dioxygenase complex (GO:0016222) (0.0659),L-ascorbic acid binding (GO:0031418) (0.5342); procollagen-proline 4-dioxygenase activity (GO:0004656) (0.3122); identical protein binding (GO:0042802) (0.1419); iron ion binding (GO:0005506) (0.1226),"Prolyl 4-hydroxylase (IPR045054) (0.5036); Tetratricopeptide-like helical domain superfamily (IPR011990) (0.2969); Prolyl 4-hydroxylase, alpha subunit (IPR006620) (0.2006); Prolyl 4-hydroxylase alpha subunit, Fe(2+) 2OG dioxygenase domain (IPR044862) (0.1693)",1.25.40.10 (0.4477); 2.60.120.620 (0.2705); 6.10.140.1460 (0.1892),TPR repeat (0.8764); Vitamin C (0.7637); Dioxygenase (0.6962); Reference proteome (0.3777); Oxidoreductase (0.3765); Iron (0.3741); Metal-binding (0.3290); Endoplasmic reticulum (0.2560); Glycoprotein (0.2263),L-ascorbate (0.1666)
MTEELQGANFSHTKFLLTGFPEIYKYRRFLFLPFFLTYLLLLVGNSLLLFVIKSTESLHSPMYIFVSALAVVDIIVSTAIIPAMLLGFLFDLNEITLSGCLTQMFVTHFFSSVESTILLAMALDRFVAICKPLHYNEIMNSSMFLKLFLFTLIRSGTIMSTLVALASPLSFCGSNVIYHCYCDHMALVSLACDSIAQNQTMGLIVIICFVGIDTSVIFFSYVKILHVVLGTAAGEDRWKAFHTCGTHLMVMICFYFVGSVTFLSRNLNIPIPIDVNTFLGVMYIVFPASVNPIIYGVRTKEIRTALFKIFKNKINKVSIVKVSTIRN,,"adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189) (0.2857); G protein-coupled receptor signaling pathway (GO:0007186) (0.1988); regulation of angiogenesis (GO:0045765) (0.1957); chemotaxis (GO:0006935) (0.1713); detection of chemical stimulus involved in sensory perception of smell (GO:0050911) (0.1630); sensory perception of sound (GO:0007605) (0.1605); G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187) (0.1228); single fertilization (GO:0007338) (0.1182); phototransduction (GO:0007602) (0.1084); negative regulation of insulin receptor signaling pathway (GO:0046627) (0.0818); response to light stimulus (GO:0009416) (0.0571); gene expression (GO:0010467) (0.0552); positive regulation of blood pressure (GO:0045777) (0.0403)",membrane (GO:0016020) (0.2159); plasma membrane (GO:0005886) (0.1614); cytoplasm (GO:0005737) (0.0843),olfactory receptor activity (GO:0004984) (0.2428); G protein-coupled receptor activity (GO:0004930) (0.1880),"Olfactory receptor (IPR000725) (0.3936); GPCR, rhodopsin-like, 7TM (IPR017452) (0.2662); G protein-coupled receptor, rhodopsin-like (IPR000276) (0.1625)",1.20.1070.10 (0.2504),Transducer (0.9374); Olfaction (0.9041); Reference proteome (0.8210); Sensory transduction (0.7840); Transmembrane helix (0.6375); G-protein coupled receptor (0.4588); Glycoprotein (0.4050); Transmembrane (0.3092); Membrane (0.2733); Receptor (0.2575),
MMGQLPEEDLVGGFTTEELECKICYCAYSLSSRRPKVLKCCHCLCAKCLAKIHDLGESSPNAVICPFCRYITELPREDVDSLPDEYNLVSALLSFQMRKSHNLQDNQGEILLSPRRLTSLVGHSASASPTSIRSNYVVITIMEPRQESVIPSPGRDYRSSSLDSMASVTNRWTVWNCAALLCQTSARVLVWLLGLLYFSSLPLGVYLLIMQHTTIGVLMVSLVPVSLLIVMVYGLCQCLCREFWDCVPP,RING-type E3 ubiquitin transferase (2.3.2.27) (0.9974),protein polyubiquitination (GO:0000209) (0.4439); protein ubiquitination (GO:0016567) (0.2893); protein autoubiquitination (GO:0051865) (0.2435); apoptotic process (GO:0006915) (0.1574); ubiquitin-dependent protein catabolic process (GO:0006511) (0.0522),cytoplasm (GO:0005737) (0.4723); nucleus (GO:0005634) (0.2331); nucleoplasm (GO:0005654) (0.2203); cytosol (GO:0005829) (0.1102),ubiquitin-protein transferase activity (GO:0004842) (0.4770); metal ion binding (GO:0046872) (0.4491),"Zinc finger, RING/FYVE/PHD-type (IPR013083) (0.4176); E3 ubiquitin-protein ligase RNF182, RING finger, HC subclass (IPR047986) (0.2456); E3 ubiquitin-protein ligase RNF182 (IPR042285) (0.1376); Zinc finger, RING-type (IPR001841) (0.1326); Zinc finger, RING-type, conserved site (IPR017907) (0.1202)",3.30.40.10 (0.3279),Ubl conjugation pathway (0.9809); Transmembrane helix (0.7614); Transmembrane (0.7371); Transferase (0.5840); Metal-binding (0.3713); Reference proteome (0.3574); Membrane (0.3549); Cytoplasm (0.3080); Zinc-finger (0.1899); Ubl conjugation (0.1759); Cell membrane (0.1672); Nucleus (0.1252); Proteomics identification (0.1150),
MSGRGKTGGKTRAKAKTRSSRAGLQFPVGRVHRLLRKGNYAQRVGAGAPVYLAAVLEYLTAEILELAGNAARDNKKTRIIPRHLQLAVRNDEELNKLLGGVTIAQGGVLPNIQAVLLPKKTEKATKGKXIAGNXXLLTTKMSGRGKTGGKARAKAKSRSSRAGLQFPVGRVHRLLRKGNYAQRVGAGAPVYLAAVLEYLTAEILELAGNAARDNKKTRIIPRHLQLAVRNDEELNKLLGGVTIAQGGVLPNIQAVLLPKKTEKAAKGK,,heterochromatin formation (GO:0031507) (0.2246); nucleosome disassembly (GO:0006337) (0.1589); double-strand break repair via homologous recombination (GO:0000724) (0.1366); DNA damage response (GO:0006974) (0.1198); chromatin organization (GO:0006325) (0.1100); nucleosome assembly (GO:0006334) (0.1036),nucleus (GO:0005634) (0.2213); nucleosome (GO:0000786) (0.1844); site of double-strand break (GO:0035861) (0.1791); GO:0000781 (0.0925); cytosol (GO:0005829) (0.0755); heterochromatin (GO:0000792) (0.0663),chromatin-protein adaptor activity (GO:0140463) (0.3120); protein heterodimerization activity (GO:0046982) (0.2133); DNA binding (GO:0003677) (0.2105); structural constituent of chromatin (GO:0030527) (0.1958); nucleosomal DNA binding (GO:0031492) (0.1535),Histone H2A (IPR002119) (0.1322); Histone H2A conserved site (IPR032458) (0.1161),1.10.20.10 (0.1053),Nucleosome core (0.5542); Ubl conjugation (0.4912); Reference proteome (0.3664); Nucleus (0.3480); Methylation (0.2185); Chromosome (0.2076); Phosphoprotein (0.1932); DNA-binding (0.1392); Acetylation (0.1281),
MDVTLIDFGCGNLFHETEYHTFSGTEMYCPPEFFETGKYFARPATVYSLGVLLYTMVCGYMPDHTDREKMQHWLWYLPSLSCECSHLINACLHPDPSERITLEQILLHDWFTITSSDMEDERPVLVMQEELISQAC,non-specific serine/threonine protein kinase (2.7.11.1) (0.9986),protein autophosphorylation (GO:0046777) (0.9163); cellular response to type II interferon (GO:0071346) (0.7022); positive regulation of cardiac muscle cell proliferation (GO:0060045) (0.2964); regulation of mitotic cell cycle (GO:0007346) (0.2808); negative regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061179) (0.2741); protein phosphorylation (GO:0006468) (0.2411); negative regulation of apoptotic process (GO:0043066) (0.1879); positive regulation of brown fat cell differentiation (GO:0090336) (0.1707),nucleus (GO:0005634) (0.2266); cytosol (GO:0005829) (0.1127); cytoplasm (GO:0005737) (0.1043),ATP binding (GO:0005524) (0.1311),"Serine/threonine-protein kinase pim-1/2/3 (IPR017348) (0.4804); Protein kinase-like domain superfamily (IPR011009) (0.1783); PIM Serine/Threonine Kinase (IPR051138) (0.1238); Protein kinase, ATP binding site (IPR017441) (0.0960)",1.10.510.10 (0.0796),Reference proteome (0.4339); Cell cycle (0.3805); Nucleotide-binding (0.3652); Kinase (0.2123); Serine/threonine-protein kinase (0.1939); Cytoplasm (0.1442); Transmembrane (0.1080); Membrane (0.1072); Apoptosis (0.0834); Nucleus (0.0761),Mg(2+) (0.1041)
MSSLPGTVPRMMRPAPGQNYPRTGFPLEVSTPLGQGRVNQLGGVFINGRPLPNHIRHKIVEMAHHGIRPCVISRQLRVSHGCVSKILCRYQETGSIRPGAIGGSKPRQVATPDVEKRIEEYKRENPGMFSWEIRDKLLKDGVCDRSTVPSGEASSVSSISRVLRARFGKKDDEDDCDKKDDTGEKKTKHSIDGILGDKGRMDEVSDVESEPDLPLKRKQRRSRTTFTAEQLEELEKAFERTHYPDIYTREELAQRTKLTEARVQVWFSNRRARWRKQAGANQLAAFNHLLPGGFPPTGMPTLPTYQLPESSYPTTTLPQDVSGTVHRPQPLPPSTMHQGGLSSDSSSAYGLSSNRHSFSSYTDTFMSQSASSNHMNPVSNGLSPQVMSILSNPSAVAPQPQHEFSISPLHSSLEASNPISASCSQRSEPIKTADSLPSSQSYCPPTYSTTSYSVDPVTAGYQYSQYGQTAVDYLAKNVSLSTQRRMKLGEHSAVLGLLQVETGQAY,,regulation of transcription by RNA polymerase II (GO:0006357) (0.4294); neural crest cell migration (GO:0001755) (0.1713); nervous system development (GO:0007399) (0.1579); heart development (GO:0007507) (0.1195); sensory perception of sound (GO:0007605) (0.1135); regulation of DNA-templated transcription (GO:0006355) (0.0777); anterior/posterior pattern specification (GO:0009952) (0.0690); regulation of gene expression (GO:0010468) (0.0579); cartilage development (GO:0051216) (0.0564); dorsal/ventral neural tube patterning (GO:0021904) (0.0535); Wnt signaling pathway (GO:0016055) (0.0523),nucleus (GO:0005634) (0.2614); nucleoplasm (GO:0005654) (0.1059),"DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981) (0.2374); RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978) (0.1737)","PAX family (IPR043565) (0.6107); Paired box protein 7, C-terminal (IPR022106) (0.4653); Paired domain (IPR001523) (0.2066); Paired DNA-binding domain (IPR043182) (0.1840); Homeodomain (IPR001356) (0.1584); Winged helix-like DNA-binding domain superfamily (IPR036388) (0.1317); Homeobox, conserved site (IPR017970) (0.1106)",1.10.10.60 (0.2490); 1.10.10.10 (0.1430),Transcription regulation (0.8466); Paired box (0.5639); Nucleus (0.4750); Reference proteome (0.2918); Developmental protein (0.2874); Transcription (0.2819); Homeobox (0.2211); DNA-binding (0.2066); Neurogenesis (0.1809); Proteomics identification (0.0746),
MKAFFVLATLLWCLATSLSWAAKIVVVPPIMFESHLYIFKTLASALHAEGHDTVFLVSEGREIPPSNHYRLQRYPGIFNSTSADDFLQSKVRNIFSGRLTALELFDILDHYSQNCDAVVGSTSVMEQLKREHFDLLLVDPNEMCGFVIAHILGVQYAVFSTGLWYPAEVGAPAPLSYVPEFNSLLTDHMSLFQRVANTAVYLVSRFGVQFLVLPKYDRIMRKYNIQPSVSMHDLVQNSRLWMLCTDMALEFPRPTLPHVVYVGGILTKPPSPLPQEFETWVKDTDEDGFVVVSFGAGVKYLSDDIAQKLAGALSRLPQRVIWRFSGVPPSNLGNNTKLVDWMPQNDLLGQTNTRAFLSHGGLNSIYEAMYHGVPVVGVPLFGDHYDTMTRVQAKGMGIMLEWKRMSEEDLYTAMVNVITDKRYRERAQLLSQIHKDQPGHPVSRAVYWISYILRHRGAEHLRSAVYEIPTYQYFLLDVAMVIGVCLLLTGYCLYRIVKFIQFRLGRGSSPGEKVNGHCHNGIPNGKHKRNGHVKSMEKKLK,N-acylsphingosine galactosyltransferase (2.4.1.47) (0.3438); glucuronosyltransferase (2.4.1.17) (0.1088),protein localization to paranode region of axon (GO:0002175) (0.7037); cytoskeleton organization (GO:0007010) (0.4127); paranodal junction assembly (GO:0030913) (0.3459); galactosylceramide biosynthetic process (GO:0006682) (0.2731); response to immobilization stress (GO:0035902) (0.2044); axonogenesis (GO:0007409) (0.0895); sterol metabolic process (GO:0016125) (0.0533); sensory perception of smell (GO:0007608) (0.0448); myelination (GO:0042552) (0.0415); regulation of smooth muscle contraction (GO:0006940) (0.0402),endoplasmic reticulum membrane (GO:0005789) (0.2092); membrane (GO:0016020) (0.1729); endoplasmic reticulum (GO:0005783) (0.1467),N-acylsphingosine galactosyltransferase (GO:0003851) (0.3611); glucuronosyltransferase activity (GO:0015020) (0.1634),"UDP-glycosyltransferase (IPR050271) (0.3963); UDP-glycosyltransferase family, conserved site (IPR035595) (0.3007); UDP-glucuronosyl/UDP-glucosyltransferase (IPR002213) (0.2690)",3.40.50.2000 (0.2066),Transmembrane helix (0.6673); Transferase (0.4751); Glycoprotein (0.4590); Membrane (0.4340); Reference proteome (0.4080); Glycosyltransferase (0.3189); Endoplasmic reticulum (0.2228); Ubl conjugation (0.1203); Signal (0.1050),
MRAQLTLGVFILFLAVRQTHTTESASAHDTSQEKSLNIHKKRLSLQNTAEIQQCLVNAGDVGCGMFECFNNNSCEIRGLHDICMTFLHNAGKFDSQGKSFIKDTLKCMAHGLRHKFSCVSRKCVAVKEMVFQLQRECYLKHNLCLAVRENVNVMVEMIHFKDLFPKGPHVELVNILLGCGEEVRVAIGRRIRTQCEQNWGALCGTLSLCALGKVENQASSTLAPVPDVTTTPGANTNALHPTSFPHPEADGQAVWTLTETREEENLSSGPQDNSSDAQKELKRSPNATKRR,,endoplasmic reticulum unfolded protein response (GO:0030968) (0.6666); regulation of hormone biosynthetic process (GO:0046885) (0.6125); negative regulation of gene expression (GO:0010629) (0.5823); response to oxidative stress (GO:0006979) (0.4205); intracellular calcium ion homeostasis (GO:0006874) (0.3439); embryo implantation (GO:0007566) (0.2067); negative regulation of transcription by RNA polymerase II (GO:0000122) (0.1640); kidney development (GO:0001822) (0.1110); signal transduction (GO:0007165) (0.0893); negative regulation of multicellular organism growth (GO:0040015) (0.0834); response to vitamin D (GO:0033280) (0.0664); decidualization (GO:0046697) (0.0625); response to calcium ion (GO:0051592) (0.0538); negative regulation of apoptotic process (GO:0043066) (0.0481),perinuclear region of cytoplasm (GO:0048471) (0.3425); endoplasmic reticulum (GO:0005783) (0.2873); Golgi apparatus (GO:0005794) (0.2527); cytoplasm (GO:0005737) (0.1826); endoplasmic reticulum lumen (GO:0005788) (0.0779),enzyme binding (GO:0019899) (0.2937); protein homodimerization activity (GO:0042803) (0.2596),Stanniocalcin (IPR004978) (0.2171),,Secreted (0.7475); Reference proteome (0.4299); Glycoprotein (0.4242); Hormone (0.3931); Signal (0.2311); Direct protein sequencing (0.2047); Disulfide bond (0.1366); Disease variant (0.0939),
MFNDLKLCSLCTGFDDYYNYNETGHVAPPCNNGNAKAFSEVFLPTLYSIVFIVGFIGNGLVVWVLIRHRQKSNMTDVCLFNLALADLIFLVSLPFWAHNAMDEWILGRFMCHTITGLFMIGLYASIFFMVLMTLDRYAIIVHAHSVFSRNRSTKMGLALASLVWMLSLFASLPNIIFANANNGTNSKSSCRPDFPDNTSWMSFTYINMNLLSLIFPLIIMSFCYSRIIPTLLSIKSQKRHKVVRLILAVVAVYFLFWTPYNIVMFLMFLQRMEYMFSCEWHNGLSLAMQWVETIALSHCCLNPIIYAFAGEKFRRAVLKVLKDQFPMCFKQCASFSQQLSERRSSIFSRSSEISSTQIA,,calcium-mediated signaling (GO:0019722) (0.7471); positive regulation of cytosolic calcium ion concentration (GO:0007204) (0.5694); adaptive immune response (GO:0002250) (0.3757); immune response (GO:0006955) (0.3622); intracellular calcium ion homeostasis (GO:0006874) (0.3545); inflammatory response (GO:0006954) (0.1665); cell chemotaxis (GO:0060326) (0.1623); blood vessel remodeling (GO:0001974) (0.0893); brain development (GO:0007420) (0.0838); social behavior (GO:0035176) (0.0559),external side of plasma membrane (GO:0009897) (0.2259),C-C chemokine receptor activity (GO:0016493) (0.6344); C-C chemokine binding (GO:0019957) (0.2599); chemokine receptor activity (GO:0004950) (0.1440),"GPCR, rhodopsin-like, 7TM (IPR017452) (0.3531); Chemokine receptor family (IPR000355) (0.2520); G-protein coupled receptor 1 (IPR050119) (0.2449); G protein-coupled receptor, rhodopsin-like (IPR000276) (0.1757)",1.20.1070.10 (0.2229),Transducer (0.8481); Membrane (0.5524); Reference proteome (0.4821); Receptor (0.4437); Ubl conjugation (0.3872); Disulfide bond (0.2751); Glycoprotein (0.2677); G-protein coupled receptor (0.2261); Transmembrane helix (0.1534); Transmembrane (0.1282); Sulfation (0.0856),
MSSSSVLSAIQQYSDKMAFSKLINRLKKAFGVKCANEQPCEPLEPTGSTTENHRHLMTDDPAVAAGKQAGRQKKRKLKLSPIFFACFSRRRATVVDQLCVQEIHELHAEPISSSKFFCTAVSNLELEVLQPPALDAPADEDLDFKPEVNSFDSAVVIENDSAELHFPEDNESSLSEDSLEQELDSPPSSPSDEDNELPVSQQLITDDICDSALDENSNPLPDQVSQEDSAVKSTADDGTCLDNNDISCRYKLGKQLGEGGFGSVYEGIRIQDGLQVAVKFVQKTPNMQDVSSSCDQPLPLEITLANMASGGSRCANIIQLLDWQVFENHYVMVMERPSPSMDLEAFLEVSGGVLSEKTAHTIMRQAVYAANVCCYRGVFHRDIKLQNLLVNPDTLEVKLIDFGCGDFMMESAYSLFSGTEAYIPPEFYEKGCYRAKPATVYSLGVLLFTMLHGEFPSAYDLYYLQHDWSKFTLSQECCDMMTACLHENPECRIPLEEMPYHDWSMLEF,non-specific serine/threonine protein kinase (2.7.11.1) (0.9984),protein phosphorylation (GO:0006468) (0.8868); regulation of mitotic cell cycle (GO:0007346) (0.5880); apoptotic process (GO:0006915) (0.2112); protein autophosphorylation (GO:0046777) (0.2082); macroautophagy (GO:0016236) (0.0606); negative regulation of apoptotic process (GO:0043066) (0.0571),nucleus (GO:0005634) (0.4166); cytoplasm (GO:0005737) (0.1966),protein serine kinase activity (GO:0106310) (0.4240); ATP binding (GO:0005524) (0.2218); protein serine/threonine kinase activity (GO:0004674) (0.1557),"Protein kinase domain (IPR000719) (0.2672); Protein kinase, ATP binding site (IPR017441) (0.2250); PIM Serine/Threonine Kinase (IPR051138) (0.1729)",,Serine/threonine-protein kinase (0.7279); Nucleotide-binding (0.4104); Tyrosine-protein kinase (0.3858); Kinase (0.3507); Phosphoprotein (0.3336); Reference proteome (0.3016); Transferase (0.2926); ATP-binding (0.2479); Cytoplasm (0.2271); Ubl conjugation (0.2108); Apoptosis (0.2052); Magnesium (0.0586),Mg(2+) (0.2757)
MTLGNLLNRSQRCIMVQQRTHKYSSVMDSNSSREVFVGLAAEDDAEVFGHVPSNKDPNWCKTPTGHIKRPMNAFMVWSQIERRKIMEQWPDMHNAEISKRLGKRWKLLPDYEKIPFIKEAERLRLKHMADYPDYKYRPRKKSKGSTPVKLGEKLPMKSSKPLPGRSSGLSCKGLKIKPASSKHKMNFSSNKYKSYSESMSDDDTMDVNLESPVTQQDDRNTSSHFVLHQQATVQSEDQQPIPELRVKVPISQTSSIQSLSSDSECQAFPESTTSEPRGSTSGRSSTPTSTSSSSLVSSACSDEELDEELLHIISNSMPMDCSTLDKDFEAFNANSGSHFDFPDYCTPEVNEMISGDLLVPSISDLVFTY,,negative regulation of transcription by RNA polymerase II (GO:0000122) (0.9059); brain development (GO:0007420) (0.6512); closure of optic fissure (GO:0061386) (0.2903); positive regulation of gene expression (GO:0010628) (0.1828); heart development (GO:0007507) (0.1415); lens morphogenesis in camera-type eye (GO:0002089) (0.0917); embryonic pectoral fin morphogenesis (GO:0035118) (0.0865); neuron differentiation (GO:0030182) (0.0830); regeneration (GO:0031099) (0.0769); artery development (GO:0060840) (0.0702); positive regulation of transcription by RNA polymerase II (GO:0045944) (0.0633); lens development in camera-type eye (GO:0002088) (0.0563); negative regulation of smoothened signaling pathway (GO:0045879) (0.0478),cytoplasm (GO:0005737) (0.2335); nucleus (GO:0005634) (0.1119),RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978) (0.1200),Transcription factor SOX-12/11/4 (IPR017386) (0.1327); High mobility group box domain (IPR009071) (0.1261),1.10.30.10 (0.2443),Transcription regulation (0.8965); Reference proteome (0.5257); Nucleus (0.5131); Transcription (0.3224); Developmental protein (0.2624); Cytoplasm (0.2143); DNA-binding (0.2126); Activator (0.1948); Differentiation (0.1849); Transferase (0.0634),
MNRIFGRSKQAASPNLSDCIGNVDTRIESIDKKIARIDAELMKYKDQMKKMRDGPSKNTVKQKAMRVLKQKRMYEGQRDQLSQQSFNMEQANYTIQSLRDTKTTVEAMKIGAKEMKKAYKQVKMDQIEDLQDQLEDMMEEANEVQEALSRSYGTPEIDEDELEAELDALGDELLLDDDSSYLDEASSAPSIPEGMPSDTKTNKDGVLVDEFGLPQIPAT,,plasma membrane repair (GO:0001778) (0.9793); mitotic metaphase chromosome alignment (GO:0007080) (0.6199); regulation of receptor recycling (GO:0001919) (0.4427); nuclear membrane reassembly (GO:0031468) (0.3865); viral budding via host ESCRT complex (GO:0039702) (0.3842); autophagosome maturation (GO:0097352) (0.3560); regulation of centrosome duplication (GO:0010824) (0.3415); vesicle budding from membrane (GO:0006900) (0.3102); regulation of mitotic spindle assembly (GO:1901673) (0.3051); lysosome organization (GO:0007040) (0.2734); late endosome to lysosome transport (GO:1902774) (0.2448); viral budding from plasma membrane (GO:0046761) (0.2396); midbody abscission (GO:0061952) (0.2292); late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511) (0.1640); cellular response to muramyl dipeptide (GO:0071225) (0.1634); ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162) (0.1632),multivesicular body membrane (GO:0032585) (0.2968); kinetochore (GO:0000776) (0.2819); plasma membrane (GO:0005886) (0.2310); cytosol (GO:0005829) (0.1976); nuclear pore (GO:0005643) (0.1943); amphisome membrane (GO:1904930) (0.1577); kinetochore microtubule (GO:0005828) (0.1370); multivesicular body (GO:0005771) (0.1261),,Snf7 family (IPR005024) (0.4498),6.10.140.1230 (0.2903); 6.10.250.1710 (0.2506),Reference proteome (0.5703); Coiled coil (0.1512),
MSSYNSSGDEQMQLIQVDPVRRNISLALTQVIVWPFIYLIFLMLLIFSKKETFTTEMRYILFGHSLLVDLTFLLLTDFVVLLSYNLVLLPLQFCIPVCMFIETVAVSAPLTVGAMCVERYVAICLPLRHHAISTSRRAFMVILMIWIVSSINPFIDMFILVSTASHEYLTQLTHCHYEIMIPEKIRVFARGLLYIVGLVVILIIEIFCYVMIYLAARAASGDNKKSASKGQRTISLHILQLFLCTAEVMCPYIESVVMQYDIQSYLTVRFINFLAFSITSRAVSPLVYGFRDEKFYTAMVYFIRCKNNTISSDIDKQT,,"spermatogenesis (GO:0007283) (0.1816); adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189) (0.1812); intracellular water homeostasis (GO:0009992) (0.1703); detection of chemical stimulus involved in sensory perception of smell (GO:0050911) (0.1446); G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187) (0.1344); smooth muscle contraction (GO:0006939) (0.0903); lysosome organization (GO:0007040) (0.0900); courtship behavior (GO:0007619) (0.0785); male courtship behavior (GO:0008049) (0.0777); establishment of localization in cell (GO:0051649) (0.0753); chloride transport (GO:0006821) (0.0474); chemosensory behavior (GO:0007635) (0.0418)",dendrite (GO:0030425) (0.3332); cytoplasm (GO:0005737) (0.2816); endoplasmic reticulum (GO:0005783) (0.1077); synapse (GO:0045202) (0.0508); membrane (GO:0016020) (0.0486),protein homodimerization activity (GO:0042803) (0.2076); olfactory receptor activity (GO:0004984) (0.1100),"GPCR, rhodopsin-like, 7TM (IPR017452) (0.2771); G-protein Coupled Receptor 1 Superfamily Member (IPR052921) (0.2561); G protein-coupled receptor, rhodopsin-like (IPR000276) (0.1752)",1.20.1070.10 (0.2024),Transmembrane helix (0.5928); Receptor (0.5661); Reference proteome (0.3311); Transmembrane (0.2630); G-protein coupled receptor (0.2374); Endosome (0.1767); Membrane (0.1424); Transport (0.1162); Olfaction (0.1045); Ion transport (0.0747),
MCCKGFLKVMMFVFNGIIFLAGAAVLAVGIWVAVDRVSLLGFLEHIEDAPPELAQLANIGYLLIGVGAFLAIMGFLGCCGAVKESKCMLLTFFIIVLIIFLVEVAAAVVLFVFEPVVQETLNEIGQKVAKSIKDNYGKDEPFSSIWNTTMNELKCCGYNNYTDFSGSNFVEETSMYPEKCCSSGSQRCDERAAEDAVIAGCFRTLVKLIEDNALLLAGVALGIAALEIAAMVVSMILYKNVGK,,protein transport (GO:0015031) (0.4656); positive regulation of receptor clustering (GO:1903911) (0.4207); humoral immune response mediated by circulating immunoglobulin (GO:0002455) (0.2320); osteoclast fusion (GO:0072675) (0.1928); regulation of protein stability (GO:0031647) (0.1731); regulation of vascular endothelial growth factor signaling pathway (GO:1900746) (0.1606); macrophage fusion (GO:0034238) (0.1062); positive regulation of MAPK cascade (GO:0043410) (0.0983); myoblast fusion involved in skeletal muscle regeneration (GO:0014905) (0.0818); receptor internalization (GO:0031623) (0.0541); adaptive immune response (GO:0002250) (0.0523); lysosome organization (GO:0007040) (0.0406),lysosomal membrane (GO:0005765) (0.3154); plasma membrane (GO:0005886) (0.2105); extracellular exosome (GO:0070062) (0.2072); nucleoplasm (GO:0005654) (0.1626); cell surface (GO:0009986) (0.1131); basolateral plasma membrane (GO:0016323) (0.0985); endosome lumen (GO:0031904) (0.0952); late endosome membrane (GO:0031902) (0.0702),integrin binding (GO:0005178) (0.2996); transferrin receptor binding (GO:1990459) (0.0760); cholesterol binding (GO:0015485) (0.0686); MHC class II protein binding (GO:0042289) (0.0626),"Tetraspanin, animals (IPR000301) (0.0975)",1.10.1450.10 (0.1606),Membrane (0.5890); Lysosome (0.4435); Transmembrane helix (0.1791); Reference proteome (0.1416); Glycoprotein (0.1205); Lipid-binding (0.1096); Disulfide bond (0.0624),
MTGTMMRSVDSSETEIDLRDAGDGEDDEGQQTWKTPLETVLEEEEEDDLISTQSDTKPLINERDPRQINECLKVSFEDVIAEPVSVRSGDRVWIWSHALFEVSRVWFYRIITAVLAVPVSLIAGIVFAVLSFIHIWFFTPCVQVVLINTGWLQTLWSSVLDIIILPFFQSVAKCCSGISVVLTRE,,negative regulation of endothelial cell proliferation (GO:0001937) (0.8323); regulation of cytosolic calcium ion concentration (GO:0051480) (0.6135); caveola assembly (GO:0070836) (0.2579); endoplasmic reticulum organization (GO:0007029) (0.2446); insulin receptor signaling pathway (GO:0008286) (0.2110); viral release from host cell (GO:0019076) (0.2094); cell differentiation (GO:0030154) (0.1852); mitochondrion organization (GO:0007005) (0.1793); vesicle fusion (GO:0006906) (0.1455); endothelial cell proliferation (GO:0001935) (0.0867); vesicle docking (GO:0048278) (0.0778); positive regulation of GTPase activity (GO:0043547) (0.0746); positive regulation of endothelial cell proliferation (GO:0001938) (0.0742); skeletal muscle cell proliferation (GO:0014856) (0.0595),focal adhesion (GO:0005925) (0.4355); Golgi membrane (GO:0000139) (0.4282); caveola (GO:0005901) (0.3048); sarcolemma (GO:0042383) (0.1083),molecular adaptor activity (GO:0060090) (0.1683); protein-macromolecule adaptor activity (GO:0030674) (0.1242); scaffold protein binding (GO:0097110) (0.0799),"Caveolin (IPR001612) (0.4113); Caveolin, conserved site (IPR018361) (0.2806)",,Reference proteome (0.5523); Cell membrane (0.2208); Membrane (0.1939); Golgi apparatus (0.1637); Transmembrane helix (0.0930),
MTDAYTHGFVCPSDLSTLLAVPSRVRDMAVVGFDVGFQNCCIAVVKSGGIETVSNEFTDRCTPSVISFGSKNRAIGNAAKNQMITNPSSTVFHFKRLHSRLYHDKVVQAEKANLPYDLVPLNDGKVGVQVMYLDQEHHFSIEQISAMLLTKLKDIAEANLQKKVLECVISIPSFFTDSERRSVLDAAKIAGLNCLKLMNDSTAVALNYGIYKEDLPGSDENPKIVAFVDLGHSAFQVSICAFNRGKVKVLSTAFDPYLGGKDFDQRLVDHFCAEFKSKYMMDVKSKTRALLRLTQECEKLKKLMSSNSTELSLNIECFIDDKDVCGRMNRAKFEEMCADLIERVKFTLMKAVEQAGVRLQDISAVEIVGGATRIPAVKAQISSFFRRDVSTTLNADEAVARGCALQCAMLSPAFRVREFSITDVIPFPISLSWSSEADEGKSCHEIFSRNHPCPSAKMITFYRNKPFILEAFYSDKSSLPFPEAKIGEYKVQNIQPQENREKAKVKVKVEVNRSGVVSVSSAAVVLRVRSDESEITEINEDVDSHDASDDTDVQDKTEEVNIELSVNKENLPTAQCPPMEKEQNQRETLSMNGEVNSHPPHAKKAKMKVKHVVLPMEETFNQQLPKDRLSAYTEQENKMIQQDRQEKERNNAKNAVEENVYYFRHKLEGSYQTFLNAQEHQAFSELLNGTENWLYDEGADQDKQTYINRLAEIHKLGLPVENRYRESIRRPRMFEELSAKIQSYMTIVEDYKNGSESYCHIDAMDMDKVRVCVKDTQVWMTNIQDSQDKLTPDQEPAIHSTQIQKKLQTLNNVCGEIVSKPKPRVDSPMDDTIQPERLHKHKSPEDVTMDYTDFVQNERKNNHVNI,,response to unfolded protein (GO:0006986) (0.8076); protein folding (GO:0006457) (0.4910); protein refolding (GO:0042026) (0.1820); chaperone-mediated protein complex assembly (GO:0051131) (0.0928); protein insertion into mitochondrial outer membrane (GO:0045040) (0.0742),nucleus (GO:0005634) (0.1951); cytosol (GO:0005829) (0.1036); acrosomal vesicle (GO:0001669) (0.0772); cell surface (GO:0009986) (0.0615),adenyl-nucleotide exchange factor activity (GO:0000774) (0.7232); ATP-dependent protein folding chaperone (GO:0140662) (0.2631); ATP binding (GO:0005524) (0.1135),"ATPase, nucleotide binding domain (IPR043129) (0.2073); Heat shock protein 70kD, peptide-binding domain superfamily (IPR029047) (0.2030); Heat shock protein 70 family (IPR013126) (0.1694); Heat shock protein 70kD, C-terminal domain superfamily (IPR029048) (0.1650)",3.30.420.40 (0.2647); 1.20.1270.10 (0.2042); 3.30.30.30 (0.1812),Reference proteome (0.4646); Nucleotide-binding (0.2380); Stress response (0.1437); Phosphoprotein (0.1139),
MMAEDVQHQQKSSFNGLSKSAKAGASKKLVIKNFKDRPKLTDSYTEDTWLKLRDAVSAIQNSTSIQYNLEELYQAVENLCSYKVSPMLYKQLRQVCEEHVQAQIHQFREESLDSLSFLKRMNRCWQDHCRQTIMIRSIFLFLDRTYVLQNSLLPSIWDTGLELFRTHIVSDAAVQSRTVQGILEQVERERSGETVDRSLLRSLLGMLSDLQVYKDSFEQRFLSETTRLYAAEGQRLMQERDVPEYLHHVARRLEEENDRVISYLDQSTQKPLIATVEKQLLGEHMTTILQKGLRTLLDENRVCELTLLYELFSKVKGGLTALLQSWREYIKSVGAETVCSPERDREMVQELLDFKDQMDSVTQSCFQRNESFINAMKEAFENFINQRPNKPAELIAKYVDSKLRAGNKEATEEELERILDKIMIIFRFIHGKDVFEAFYKKDLAKRLLVGKSASVDAEKSMLSKLKHECGAAFTSKLEGMFKDMELSKDIMIQFKQYMQNQTEPSNIELTVNILTMGYWPSYTPMDVHLPAEMVKLQEVFKLFYLGKHSGRKLQWQPTLGHAVLKTEFKEGKKELQVSLFQTLVLLMFNESDECSVEEIRVATGIEEGELKRTLQSLACGKARVLNKTPRGKEVEDGDRFHFNSDFRHKLFRIKINQIQMKETVEEQVSTTERVFQDRQYQIDAAVVRIMKMRKTLSHNLLVSELYNQLKFPVKPADLKKRIESLIDRDYMERDKENSNQYHYVA,,protein polyubiquitination (GO:0000209) (0.7195); hemopoiesis (GO:0030097) (0.5259); ubiquitin-dependent protein catabolic process (GO:0006511) (0.4685); DNA damage response (GO:0006974) (0.4465); ribosome biogenesis (GO:0042254) (0.3417); positive regulation of G1/S transition of mitotic cell cycle (GO:1900087) (0.3131); proteasomal protein catabolic process (GO:0010498) (0.2230); positive regulation of protein catabolic process (GO:0045732) (0.1975); spermatogenesis (GO:0007283) (0.1774); protein ubiquitination (GO:0016567) (0.1415); heart development (GO:0007507) (0.1083); ubiquitin-dependent protein catabolic process via the C-end degron rule pathway (GO:0140627) (0.0971); astrocyte differentiation (GO:0048708) (0.0834); cell population proliferation (GO:0008283) (0.0692),Cul4A-RING E3 ubiquitin ligase complex (GO:0031464) (0.2611); Cul4-RING E3 ubiquitin ligase complex (GO:0080008) (0.0803); nucleus (GO:0005634) (0.0784),ubiquitin protein ligase binding (GO:0031625) (0.2279); ubiquitin ligase complex scaffold activity (GO:0160072) (0.1565); ubiquitin protein ligase activity (GO:0061630) (0.1474),Cullin (IPR045093) (0.3454); Winged helix-like DNA-binding domain superfamily (IPR036388) (0.2447); Winged helix DNA-binding domain superfamily (IPR036390) (0.1831); Cullin homology domain superfamily (IPR036317) (0.1162),1.20.1310.10 (0.3247); 1.10.10.10 (0.1474),Ubl conjugation pathway (0.6774); Reference proteome (0.2560); Ubl conjugation (0.2443),
MSAPALQTTGFVSGVIGTAGVFAATLMDVWCFRNQQQDQPQRVSSIYTYKGLWKDCEMSGTVFPECQPLYSHPNYSGILQAARALMIIAILVAVIAVFIGFFCLKCLKMKNMQLSTRAKLILSSAIIFFIAGI,,cell adhesion (GO:0007155) (0.7411); spermatogenesis (GO:0007283) (0.3163); paracellular transport (GO:0160184) (0.2822); bicellular tight junction assembly (GO:0070830) (0.1990); positive regulation of gene expression (GO:0010628) (0.1760); renal absorption (GO:0070293) (0.1565); calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) (0.1413); negative regulation of gene expression (GO:0010629) (0.1176); neuronal action potential propagation (GO:0019227) (0.1164); positive regulation of protein phosphorylation (GO:0001934) (0.1129),tight junction (GO:0070160) (0.4621); bicellular tight junction (GO:0005923) (0.2572),paracellular tight junction channel activity (GO:0160187) (0.3384); structural molecule activity (GO:0005198) (0.1926); identical protein binding (GO:0042802) (0.1128),"PMP-22/EMP/MP20/Claudin (IPR004031) (0.2438); Claudin, conserved site (IPR017974) (0.1418); Claudin (IPR006187) (0.1008)",1.20.140.150 (0.1939),Tight junction (0.5895); Membrane (0.5277); Transmembrane helix (0.3813); Reference proteome (0.3793); Cell membrane (0.3299); Williams-Beuren syndrome (0.1185); Transmembrane (0.0952); Cell junction (0.0436),
MWRFQTLLSMLTVFQASSHSPNPFSGPQVTPTDPCYEETGAARRCIPEFINAAFGQEVSVSSVCGRPVSRSCSLVERDDRPAVRTCQICDASDPRNAHPASYLTDLNSAHNLTCWQSENLQSSPLNVTLTLSLGKKFEITYVSLQFCSPRPESLAIYKSMDYGRTWTPYQFYSSQCRRMYNRPNKAAITKQNEQEALCTDGHTDLYPLSGGLIAFSTLDGRPSGKDFDSSPVLQDWVTVTDIRVVFSRPQHTRALPMSGRESEDALGAPGSLPTYYYAVGDFQVGGRCKCNGHASRCVREKDGKLLCECKHNTEGPECDRCKPFHYDRPWQRATGKEANECLPCNCNLHARRCRFNMELYKLSGRKSGGVCMNCRHNTAGRHCHYCKEGFYRDMGKAITHRRACKACDCHPVGAAGKTCNQTTGQCPCKDGVTGITCNRCAKGYQQSRSPVAPCIKIPVIKPTAVISTTEEPADCDSYCKPLKGNLKINMKKYCKKDYAVQVSVLDMETVGDWAKFSVSLMSVYKSRGDPLKRGDHMLWVHMKDLACKCPRIHMGKRFLILGSTEGTANPERPGLQADKNSLVIQWRDIWTRRLRKFQRKEKKGKCSKA,,dendrite development (GO:0016358) (0.4564); negative regulation of axon extension (GO:0030517) (0.4030); glial cell proliferation (GO:0014009) (0.3930); nuclear migration (GO:0007097) (0.3889); anterior/posterior axon guidance (GO:0033564) (0.3616); positive regulation of glial cell proliferation (GO:0060252) (0.3324); mammary gland duct morphogenesis (GO:0060603) (0.3036); anterior commissure morphogenesis (GO:0021960) (0.2541); chemorepulsion of axon (GO:0061643) (0.2152); branching involved in blood vessel morphogenesis (GO:0001569) (0.1951); motor neuron migration (GO:0097475) (0.1826); closure of optic fissure (GO:0061386) (0.1730); motor neuron axon guidance (GO:0008045) (0.1552); positive regulation of axon extension (GO:0045773) (0.1172); animal organ morphogenesis (GO:0009887) (0.1058); tissue development (GO:0009888) (0.1054); inner ear morphogenesis (GO:0042472) (0.0920); axon guidance (GO:0007411) (0.0714),basement membrane (GO:0005604) (0.2807); cytoplasm (GO:0005737) (0.1760),,"Netrin module, non-TIMP type (IPR018933) (0.3028); Laminin-type EGF domain (IPR002049) (0.1903); Netrin domain (IPR001134) (0.1732); Tissue inhibitor of metalloproteinases-like, OB-fold (IPR008993) (0.1419)",2.10.25.10 (0.1847); 2.40.50.120 (0.1530); 2.60.120.260 (0.1471),Secreted (0.9493); Cytoplasm (0.6528); Signal (0.5760); Repeat (0.4230); Laminin EGF-like domain (0.3930); Reference proteome (0.2329); Disulfide bond (0.1816),
MQRFRLWHAFSLLGLPFLSSAIDFKTRTGPQVTDKVFFDITVGGHEVGRIVIGLFGEVAPLTVQNFVSLATGEKGYGYKGSKFHRVIKDFMIQGGDFTAGDGTGGKSIYGNMFADENFRLRHLGAGWVSMANAGPDTNGSQFFITLARAPWLDGKHVVFGKVLEGMAVVHTIELQDTNERNLPYTECVIVNSGKIKVKEPLLVEVEGW,peptidylprolyl isomerase (5.2.1.8) (0.9917),protein peptidyl-prolyl isomerization (GO:0000413) (0.9537); protein folding (GO:0006457) (0.8519); neutrophil chemotaxis (GO:0030593) (0.3983); positive regulation of multicellular organism growth (GO:0040018) (0.3540); lipid droplet organization (GO:0034389) (0.2893); positive regulation of viral genome replication (GO:0045070) (0.1886); positive regulation by host of viral genome replication (GO:0044829) (0.1303); chaperone-mediated protein folding (GO:0061077) (0.0763),intracellular membrane-bounded organelle (GO:0043231) (0.2915); extracellular region (GO:0005576) (0.1814); cytoplasm (GO:0005737) (0.1133); cytosol (GO:0005829) (0.1132); melanosome (GO:0042470) (0.0937); extracellular exosome (GO:0070062) (0.0718); perinuclear region of cytoplasm (GO:0048471) (0.0656),peptidyl-prolyl cis-trans isomerase activity (GO:0003755) (0.1774); cyclosporin A binding (GO:0016018) (0.0927),Cyclophilin-like domain superfamily (IPR029000) (0.1842); Cyclophilin-type peptidyl-prolyl cis-trans isomerase domain (IPR002130) (0.1276),2.40.100.10 (0.2985),Rotamase (0.9131); Signal (0.7707); Isomerase (0.3230); Reference proteome (0.1973); Ubl conjugation (0.0561),
EYVKTQLQLDEKANPPRYRGITDCVSQTVRHHGVKGLYRGLSSLLYGSIPKSAARFGVFEILSNQMKDESGKLDSTRGLLCGLGAGVMEAVLVVCPMETVKVKFIHDQTSANPKYRGFFHGVREIIRTQGIRGTYQGLTATVLKQGSNQAIRFFVMTSLRNWYKGDNPNKSINPVVTGTFGAIAGAASVFGNTPLDVIKTRMQGLEAHKYKNTMDCAMKIMRHEGPAAFYKGTVPRLGRVCLDVAIVFIIYEEVVKILNKAWKTD,,positive regulation of apoptotic process (GO:0043065) (0.5531); adaptive thermogenesis (GO:1990845) (0.3674); apoptotic mitochondrial changes (GO:0008637) (0.3316); cellular response to leukemia inhibitory factor (GO:1990830) (0.2523); mitochondrial citrate transmembrane transport (GO:0006843) (0.1603); osteoblast differentiation (GO:0001649) (0.1450); response to hypoxia (GO:0001666) (0.1143); hepatocyte apoptotic process (GO:0097284) (0.1136); limb development (GO:0060173) (0.1102); glutamine metabolic process (GO:0006541) (0.0681); regulation of gene expression (GO:0010468) (0.0624); neural tube closure (GO:0001843) (0.0504),mitochondrion (GO:0005739) (0.2562); sperm midpiece (GO:0097225) (0.1251); Nebenkern (GO:0016006) (0.0617),antiporter activity (GO:0015297) (0.2422),Mitochondrial substrate/solute carrier (IPR018108) (0.2349); Mitochondrial carrier domain superfamily (IPR023395) (0.1794); Mitochondrial carrier protein (IPR002067) (0.1156),1.50.40.10 (0.2339),Transport (0.8937); Reference proteome (0.6658); Mitochondrion (0.4957); Membrane (0.3213); Transmembrane (0.2583); Antiport (0.1430); Mitochondrion inner membrane (0.0766); Proteomics identification (0.0744); Repeat (0.0696),
MQSFLILVVLLCLAFSIVARAAITLNCGENSVSVQWSEVVSQIDPFLLRLGSCPPSRASVNAQGSEAVFHAEFGACDIRRLVTMGGIVFETEITSVAETVSYPVACVFERPKEWSPPLYDPLAFQTYGQGGLAFHLTLMNDDFSGLATSTTFSLGSTIPISASVEQLGHQPLILFLDECWATTTPILSPESLIHPLITNSGCLVDSKKTNSRFLPRNQLSEIRLGLQAFRFATGQDIYLHCRLVAWDPQALDSSKKACQYDSASSQWVLLDDPSQSSLCSCCDTSCQGTKKREITAGSSAISMLGPLVITK,,binding of sperm to zona pellucida (GO:0007339) (0.8756); oocyte development (GO:0048599) (0.8615); egg coat formation (GO:0035803) (0.8346); humoral immune response mediated by circulating immunoglobulin (GO:0002455) (0.5921); positive regulation of acrosome reaction (GO:2000344) (0.5358); negative regulation of DNA-templated transcription (GO:0045892) (0.1001); positive regulation of leukocyte migration (GO:0002687) (0.0914); lysosomal transport (GO:0007041) (0.0666); negative regulation of binding of sperm to zona pellucida (GO:2000360) (0.0602); regulation of signaling receptor activity (GO:0010469) (0.0590); positive regulation of humoral immune response (GO:0002922) (0.0506); positive regulation of interleukin-4 production (GO:0032753) (0.0495),egg coat (GO:0035805) (0.4685); plasma membrane (GO:0005886) (0.1060); collagen-containing extracellular matrix (GO:0062023) (0.0543),acrosin binding (GO:0032190) (0.2745),"Zona pellucida, ZP-C domain (IPR042235) (0.1436); Zona pellucida domain (IPR001507) (0.1031); Zona pellucida domain, chordate-type (IPR048290) (0.0910)",2.60.40.4100 (0.5610); 2.60.40.3210 (0.1704),Signal (0.7483); Reference proteome (0.4899); Cleavage on pair of basic residues (0.4216); Cell membrane (0.2454); Disulfide bond (0.1603); 3D-structure (0.1207); Membrane (0.1197); tRNA processing (0.0407),
MFDEFYFRKSLRPRESQNHVRNAACEYILKFMKTEGTIVKTYHLGSSLEPWGRKFHERIDRTVFDQDLTPFVKYTLNKKKRWEAEGNPDILYGLQRSYQNMGVMVAERVSLRSTPHYCIVSINNYYRNFFDQFPIRHLHQLQDHNYQCQSTNSIRGQPFKSLQPENRTPTQVTGHQQESSANVSVAYHIITPPKNYEVLRNKDFRVGHSDRNGIRTIARRRRFQFMKEAVFDLKNEILEDFGDSDDDDENEILLCEESCGPRKFYNLHDHLVKSNHNE,,regulation of neuron differentiation (GO:0045664) (0.2544); determination of adult lifespan (GO:0008340) (0.1663); negative regulation of transcription by RNA polymerase II (GO:0000122) (0.1625); memory (GO:0007613) (0.1340); regulation of DNA-templated transcription (GO:0006355) (0.1339); heterochromatin formation (GO:0031507) (0.1327); transforming growth factor beta receptor signaling pathway (GO:0007179) (0.1288); neurogenesis (GO:0022008) (0.1078); mitotic cell cycle (GO:0000278) (0.0788); chromatin organization (GO:0006325) (0.0638); modulation of chemical synaptic transmission (GO:0050804) (0.0518); cell differentiation (GO:0030154) (0.0509); skeletal muscle myosin thick filament assembly (GO:0030241) (0.0436),nucleus (GO:0005634) (0.1877); cytoplasm (GO:0005737) (0.1392),"metal ion binding (GO:0046872) (0.2947); DNA binding (GO:0003677) (0.1852); 4 iron, 4 sulfur cluster binding (GO:0051539) (0.1148)",,,Metal-binding (0.5277); Cytoplasm (0.4484); Reference proteome (0.4064); Zinc (0.3451); Ubl conjugation (0.1403); Transferase (0.0998),
MHTKVYVSEDRTKVFVLFYEAACVFSNFYPSGFEAKPVENFLKDTEKKEKLLKFTCSEQYFMYNKALLVGDMDIAEQILKETNPMKMKLLGRKLSMTKEQLKLWSQKSKDVMYRACLEKFSQNEDCRMILFRTHGMKLVEASPTDKIWGIGLDKADQRCEDERNWRGSNWLGEVLDQVREELWTRQEFKSNREQILKESLETRCQILEHFSH,3.2.2.- (0.2069); 3.1.-.- (0.0874),RNA splicing (GO:0008380) (0.3430); mRNA processing (GO:0006397) (0.1720); defense response to bacterium (GO:0042742) (0.1528); RNA processing (GO:0006396) (0.0544); cell population proliferation (GO:0008283) (0.0516); mitochondrial ATP synthesis coupled electron transport (GO:0042775) (0.0414),perikaryon (GO:0043204) (0.2455); extracellular exosome (GO:0070062) (0.2136); extracellular region (GO:0005576) (0.1042); nucleus (GO:0005634) (0.1011); membrane (GO:0016020) (0.0464),ATP binding (GO:0005524) (0.0947); DNA binding (GO:0003677) (0.0799),YbiA-like superfamily (IPR037238) (0.6852),1.10.357.40 (0.3638),Reference proteome (0.4763); Hydrolase (0.3390); Nucleus (0.2454); Developmental protein (0.1611); Phosphoprotein (0.1606); RNA repair (0.1552); Cytoplasm (0.0815); Membrane (0.0721); DNA-binding (0.0622),
MSPTPRRRATLASLAAELKVSRTTVSNAFNRPDQLSADLRERVLATAKRLGYAGPDPVARSLRTRKAGAVGLVMAEPLTYFFSDPAARDFVAGVAQSCEELGQGLQLVSVGSSRSLADGTAAVLGAGVDGFVVYSVGDDDPYLQVVLQRRLPVVVVDQPKDLSGVSRVGIDDRAAMRELAGYVLGLGHRELGLLTMRLGRDRRQDLVDAERLRSPTFDVQRERIVGVWEAMTAAGVDPDSLTVVESYEHLPTSGGTAAKVALQANPRLTALMCTADILALSAMDYLRAHGIYVPGQMTVTGFDGVPEALSRGLTTVAQPSLHKGHRAGELLLKPPRSGLPVIEVLDTELVRGRTAGPPA,,regulation of DNA-templated transcription (GO:0006355) (0.2635); amino acid transport (GO:0006865) (0.1443); response to oxidative stress (GO:0006979) (0.0553); trehalose metabolic process (GO:0005991) (0.0483); DNA damage response (GO:0006974) (0.0421),"cytoplasm (GO:0005737) (0.3737); ATP-binding cassette (ABC) transporter complex, substrate-binding subunit-containing (GO:0055052) (0.1473); plasma membrane (GO:0005886) (0.0679); membrane (GO:0016020) (0.0514)",identical protein binding (GO:0042802) (0.6491); transcription cis-regulatory region binding (GO:0000976) (0.2973); DNA-binding transcription factor activity (GO:0003700) (0.0824); manganese ion binding (GO:0030145) (0.0592),"Periplasmic binding protein-like I (IPR028082) (0.6410); Transcriptional regulator LacI/GalR-like, sensor domain (IPR046335) (0.1730)",3.40.50.2300 (0.1708); 1.10.260.40 (0.1638),Transcription (0.7668); Transport (0.4616); Reference proteome (0.4306); 3D-structure (0.4243); Transcription regulation (0.3226); DNA-binding (0.2902); Direct protein sequencing (0.2048); Membrane (0.1505); Repressor (0.1440); Metal-binding (0.1344),
MDGRGPYGLACQNCAKGKVKCIAMPDGDGCQRCHRLKKPCHPSHGVRKRESQHFQSPLIEEMDAKLDSVLSLLQSVYLQPSSPNGQAQQYKRKASTPELSSPTQPARTSVSESTYILPPGPLTSPDIVDAEGALNRFREEVLRFCPFLYLPPGLTARQLQQERPFLFETILSVMTRSVQEKMNWSKRIKSTIAHSMVMENESNIDLLLGLLVYACWSQDHYLKRMPTLTRIVELAVSVVMDLNLNKPPPPDAHRLTELGGGNDPNWTRKGPKIRTAEEKRAVLGCFFVSSIISSYFYQMDAMRWTLQMEEDLGSLAASPEWPGDAALAVHVRLQLLAENARKLRDEHGTKPVHIPFFLKSFRFELEAIRNSIPPDLQKDDTILSQLHYVELSIHETAFTANVIPHSINTNNPIGPDAVDCMWHSLLAIKSWDTIYRRMPPDDHTRWSIIQWIHLSRAVVTLYRLSTHPAPDWNRDAVYKTLNIVDVFTHIRASFDQLVPNPGGPFPNDFWAHGWLLGRAIATWLHAPGRLHPPNTDEPTAWAQTSSSHNGEQVLPTWNPPAPALQPQPIQESLQFTNPAWMDGLGLPPGDPTGGMHQAAGLHPTGQMHF,,regulation of DNA-templated transcription (GO:0006355) (0.5917); negative regulation of transcription by RNA polymerase II (GO:0000122) (0.2295); proteolysis (GO:0006508) (0.1022); DNA-templated transcription (GO:0006351) (0.0565); positive regulation of fatty acid beta-oxidation (GO:0032000) (0.0548); positive regulation of transcription by RNA polymerase II (GO:0045944) (0.0441),nucleus (GO:0005634) (0.2991),"DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981) (0.5425); transcription cis-regulatory region binding (GO:0000976) (0.2201); zinc ion binding (GO:0008270) (0.1379); DNA binding (GO:0003677) (0.0613)",Protease transcriptional activator prtT (IPR051089) (0.4968); Zn(2)-C6 fungal-type DNA-binding domain superfamily (IPR036864) (0.1804); Zn(2)Cys(6) fungal-type DNA-binding domain (IPR001138) (0.1427),4.10.240.10 (0.2190),Zinc (0.7722); Reference proteome (0.4422); Metal-binding (0.3474); Transcription regulation (0.3311); Nucleus (0.2963); DNA-binding (0.2646); Transcription (0.2485); Membrane (0.2133); Virulence (0.2089); Transport (0.1680); Transmembrane (0.0627); Unfolded protein response (0.0553),
MATVYDVPGDLLVERVAKALKEVPEIKPPEWAPFVKTGRHKERLPEQEDWWYYRVASVFRKVYIDGPVGIERLRTWYGGRKNRGHAPEHFYKAGGSIIRKALQQLEAAGFVQKVPGEGRIVTPKGQSFLDKIATELKKELEEQIPELKKY,,"ribosomal small subunit assembly (GO:0000028) (0.7190); maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462) (0.6207); maturation of SSU-rRNA (GO:0030490) (0.4177); translation (GO:0006412) (0.4086); ribosomal small subunit biogenesis (GO:0042274) (0.2430); cytoplasmic translation (GO:0002181) (0.1132)",cytosolic small ribosomal subunit (GO:0022627) (0.5195); cytosol (GO:0005829) (0.1826); focal adhesion (GO:0005925) (0.1378); cytoplasm (GO:0005737) (0.0588); small ribosomal subunit (GO:0015935) (0.0498),structural constituent of ribosome (GO:0003735) (0.4831); identical protein binding (GO:0042802) (0.1866); RNA binding (GO:0003723) (0.1843),"Small ribosomal subunit protein eS19, conserved site (IPR018277) (0.1550); Small ribosomal subunit protein eS19 (IPR001266) (0.0983)",,Reference proteome (0.5859); 3D-structure (0.4985); Ribosomal protein (0.4102); Ribonucleoprotein (0.3488); Phosphoprotein (0.3292); Ubl conjugation (0.2027); Zinc (0.1356); Isopeptide bond (0.1307); Cytoplasm (0.1108); RNA-binding (0.1078),
MNKRDELIGLCIDFLAKVKDKTANANIERWLNENYGPDSETYQKISTLVIDGVAEGWAANDEISGPHYRRSRLCEPCAETFYFSITAVYMDSKGHELDNQQRTFRGDYHSHPYGELNMVIPLDEGAVLAGPLGWQGAGWTAPAPGSQHYPEVKNGALIAFFFLPAGRISYDFQAQG,mRNA N6-methyladenine demethylase (1.14.11.53) (0.0903); RING-type E3 ubiquitin transferase (2.3.2.27) (0.0856); gibberellin 2beta-dioxygenase (1.14.11.13) (0.0749); acireductone dioxygenase [iron(II)-requiring] (1.13.11.54) (0.0408),quinolinate biosynthetic process (GO:0019805) (0.1003); DNA damage response (GO:0006974) (0.0891); L-methionine salvage from S-adenosylmethionine (GO:0019284) (0.0804); cellular response to zinc ion starvation (GO:0034224) (0.0751); methionine metabolic process (GO:0006555) (0.0744); defense response to bacterium (GO:0042742) (0.0732); response to ethanol (GO:0045471) (0.0673); regulation of DNA-templated transcription (GO:0006355) (0.0547); one-carbon metabolic process (GO:0006730) (0.0491),cytosol (GO:0005829) (0.0956),zinc ion binding (GO:0008270) (0.2780); SUMO conjugating enzyme activity (GO:0061656) (0.1310); identical protein binding (GO:0042802) (0.1221); endonuclease activity (GO:0004519) (0.0593); DNA binding (GO:0003677) (0.0548),RmlC-like cupin domain superfamily (IPR011051) (0.0922),2.60.120.480 (0.2307),Oxidoreductase (0.4052); Reference proteome (0.2959); 3D-structure (0.2652); Purine metabolism (0.2019); Metal-binding (0.1523); Dioxygenase (0.1317); Virulence (0.1063),Ni(2+) (0.2474)
MLQRVSRRFPSLRRCGLRTASTVPTNQAQPGEVEEEVSATVKRIRSELAADKQKLKWRTPIGDRPEDWNSKLKLFSNAEQTSDFIVMMQKPIDLSPRNIRQWWENREERIERHMQQFVPERHKILGAELAAAHFILYRGGAVKFINDTHWRRASKDGEFKLPNKFDPRYKVEALRCDNMELYYEGLENLRCLDSLKFLSFHNVKSFDDWCLDRISGGGFPNLEVLDLSCTQITSNGLACLYRFPKLKLLILNDPKETLELELSTVMLEEAMPALKIVGADAIHS,,aerobic respiration (GO:0009060) (0.2766); toll-like receptor 4 signaling pathway (GO:0034142) (0.2659); chromatin organization (GO:0006325) (0.2440); regulation of mitochondrion organization (GO:0010821) (0.1502); mitochondrial respiratory chain complex I assembly (GO:0032981) (0.1303); cellular respiration (GO:0045333) (0.1235); RNA splicing (GO:0008380) (0.0805),mitochondrion (GO:0005739) (0.6656); mitochondrial inner membrane (GO:0005743) (0.1030); cytoskeleton (GO:0005856) (0.0983),,Leucine-rich repeat domain superfamily (IPR032675) (0.2354),3.80.10.10 (0.1206),Transit peptide (0.7896); Mitochondrion (0.4790); 3D-structure (0.2795); Direct protein sequencing (0.2488); Reference proteome (0.2264); Phosphoprotein (0.2193); Mitochondrion inner membrane (0.2192); Membrane (0.2125); Proteomics identification (0.1806); Disease variant (0.1664); Respiratory chain (0.1504); Alternative splicing (0.1370); Leucine-rich repeat (0.1364); Repressor (0.1059); Cytoplasm (0.0982); tRNA processing (0.0605),
MSMSIDSNKLLLRKGDMKLDNYPTCAVEALTRLETLIASRNKQNMVMQIISEFIFLERTPKDGDVRKSQALPISQMNLFQEFQLIIALIEYFSRPGRDATRNAIFLSLFGSHLTPQRSKLLSRLISTAVSGSVAPLLSSAGTWMQQVGCKTPLSLEVAQNIVSDFISYSRKTPEQLKQLPMVGPHFAANFMVAVADLYLNEQRSPTLNPPPDALLDTITEWMMENPTLCQASQQPLVLPAGAIAMPFTTPLAGLLRWVVLAPLVSNRSAYSNLHLSLLRALQQLVSSGESTALPSQDLMQIVKSLQSYCARLAESKTDPQADAAYQKCMERFAQAVQIALSSNCITNQIQLLCLLESLPPHKLMKIVIEAHKK,,lipid homeostasis (GO:0055088) (0.5235); protein ubiquitination (GO:0016567) (0.4009); circadian regulation of gene expression (GO:0032922) (0.2339); negative regulation of transcription by RNA polymerase II (GO:0000122) (0.2059); regulation of DNA-templated transcription (GO:0006355) (0.1696); response to heat (GO:0009408) (0.1185); transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972) (0.0939); positive regulation of gene expression (GO:0010628) (0.0935); ubiquitin-dependent protein catabolic process (GO:0006511) (0.0869); circadian rhythm (GO:0007623) (0.0838); protein destabilization (GO:0031648) (0.0710); regulation of nucleocytoplasmic transport (GO:0046822) (0.0634); cellular response to oxidative stress (GO:0034599) (0.0520); endoplasmic reticulum unfolded protein response (GO:0030968) (0.0438),nucleus (GO:0005634) (0.3185); endoplasmic reticulum (GO:0005783) (0.2870); nuclear outer membrane (GO:0005640) (0.0892); chromatin (GO:0000785) (0.0833),,,,Nucleus (0.6428); Reference proteome (0.4995); Endoplasmic reticulum (0.2734); Repressor (0.1673); Acetylation (0.0994); Transmembrane (0.0955); Transmembrane helix (0.0954); Microsome (0.0664); Cytoplasm (0.0443),
MMGKVIFYEDRNFQGRSYECMGDCGDFSSYMNRCHSCRVESGCWMMYDQTNYMGSGYFFRRGEYADYMSMFGMNNCIRSCRMIPMYRGSYRMRIYERDNFMGQMYEMMDDCDNIMNRYRMSHCQSCHVMDGHWLFYDQPNYRGRMWHFGPGQYRNFSNYGGMRFMSMRRIMDSWY,,lens development in camera-type eye (GO:0002088) (0.8246); visual perception (GO:0007601) (0.5083); camera-type eye development (GO:0043010) (0.1379); lens fiber cell morphogenesis (GO:0070309) (0.0900); cellular response to retinoic acid (GO:0071300) (0.0785); protein import into nucleus (GO:0006606) (0.0586),cytoplasm (GO:0005737) (0.1401); nucleus (GO:0005634) (0.1386); extracellular space (GO:0005615) (0.1327),structural constituent of eye lens (GO:0005212) (0.5226); identical protein binding (GO:0042802) (0.0598); IgE binding (GO:0019863) (0.0520),Gamma-crystallin-like (IPR011024) (0.2408); Beta/Gamma-Crystallin (IPR050252) (0.1230); Beta/gamma crystallin (IPR001064) (0.1164),,Reference proteome (0.8050); Disease variant (0.3182); Membrane (0.2849); Repeat (0.1517); Direct protein sequencing (0.1387); Nucleus (0.0930); Alternative splicing (0.0872),
MMGKVVFYEDRNFQGRSYECMGDCGDFSSYMSRCHSCRVESGCWMMYDQPNYMGSGYFFRRGEYADYMSMFGMNNCIRSCRMIPMYRGSYRMRIYERDNFMGQMYEMMDDCDNIMDRYRMSHCQSCHVMDGHWLMYEHANYRGRMWYFGPGEYRNFSNFGGMRFMSMRRIMHSWY,,lens development in camera-type eye (GO:0002088) (0.8672); visual perception (GO:0007601) (0.4962); camera-type eye development (GO:0043010) (0.1487); lens fiber cell morphogenesis (GO:0070309) (0.0873); cellular response to retinoic acid (GO:0071300) (0.0834),nucleus (GO:0005634) (0.1462); cytoplasm (GO:0005737) (0.1230); extracellular space (GO:0005615) (0.1038),structural constituent of eye lens (GO:0005212) (0.5335); identical protein binding (GO:0042802) (0.0599),Gamma-crystallin-like (IPR011024) (0.1778); Beta/gamma crystallin (IPR001064) (0.1617); Beta/Gamma-Crystallin (IPR050252) (0.1224),,Reference proteome (0.7338); Disease variant (0.2761); Membrane (0.2114); Direct protein sequencing (0.1491); 3D-structure (0.0833); Nucleus (0.0821); Alternative splicing (0.0798),
MMGKVVFYEDRNFQGRSYECMGDCGDFSSYMSRCHSCRVESGCWMMYDHPNYMGSGYFFRRGDYADYMSMFGMNNCIRSCRMIPMYRGSYRMRIYERDNFMGQMYEMMDDCDNIMDRYRMSHCQSCHVMDGHWLMYEHANYRGRMWHFGPGEYRNFSNFGGMRFMSMRRIMHSWY,,lens development in camera-type eye (GO:0002088) (0.8630); visual perception (GO:0007601) (0.4072); camera-type eye development (GO:0043010) (0.1313); lens fiber cell morphogenesis (GO:0070309) (0.0855); cellular response to retinoic acid (GO:0071300) (0.0800),nucleus (GO:0005634) (0.1419); cytoplasm (GO:0005737) (0.1173); extracellular space (GO:0005615) (0.0960),structural constituent of eye lens (GO:0005212) (0.5345); identical protein binding (GO:0042802) (0.0583),Gamma-crystallin-like (IPR011024) (0.1764); Beta/gamma crystallin (IPR001064) (0.1643); Beta/Gamma-Crystallin (IPR050252) (0.1209),,Reference proteome (0.7369); Disease variant (0.2935); Membrane (0.2183); Direct protein sequencing (0.1481); Nucleus (0.1013); Alternative splicing (0.0754),
MSDAVRNVAIFGCTGMTGLATLPIAVASGYNVTVLVRDPARLPPDHKASRVVVGDVLNKNDVKKTLEGQDAVIIILGTRNDLSPTTMMSEGTRNIVEVMKARGIRKVVGCMSAFLLWDRSKVPPRLVPVTEDHDRMYTVLKESGLDYIAAMPPHIAGDKPLTEKYIVTENMLKGRVISKYDLGHFFVKCLSTSEWDGKTVGICGEYS,flavin reductase (NADPH) (1.5.1.30) (0.4950); 2.6.99.- (0.4933); 1.3.1.- (0.1961); carbonyl reductase (NADPH) (1.1.1.184) (0.0728),response to nutrient (GO:0007584) (0.2584); heme catabolic process (GO:0042167) (0.1131); response to oxidative stress (GO:0006979) (0.1032); negative regulation of insulin receptor signaling pathway (GO:0046627) (0.0993); response to lead ion (GO:0010288) (0.0712); glucose metabolic process (GO:0006006) (0.0413),cytosol (GO:0005829) (0.2234); plasma membrane (GO:0005886) (0.1992); nucleus (GO:0005634) (0.0720); membrane (GO:0016020) (0.0691); cytoplasm (GO:0005737) (0.0656),FMN reductase (NADPH) activity (GO:0052873) (0.1707); NADP binding (GO:0050661) (0.1566); riboflavin reductase (NADPH) activity (GO:0042602) (0.1095); quinone binding (GO:0048038) (0.0945),NAD(P)-binding domain superfamily (IPR036291) (0.3693); Polyketide Oxidoreductase-like (IPR051606) (0.1669),3.40.50.720 (0.1476),Reference proteome (0.6849); NADP (0.3441); Oxidoreductase (0.3221); Acetylation (0.2878); Direct protein sequencing (0.2780); 3D-structure (0.2197); Nucleus (0.0865); Cytoplasm (0.0844); NAD (0.0824); Transmembrane (0.0592),
MTDSENVAVEGCGAAGRNLTHWLQEQFGNRPLEQSEDTRLHNAAHLGDLDTLRTLLQEDCFRQRINQKLIWSCGLLPCTPLRIAAMMGRSDCVAFLISQGADVDLVDVKGQTALFMAVVNGHLDCVKILLEAGADPNGSRHHRSTPIYHAAQVGRADIMLELIRFHADVDIDHRLEQKVIFRTRTLTTLAACPLYISAAYHHLPCFRMLLKAGANPDYNYNGPVNRDALVKGRASCMLDAVLRLGCDPVFVSLLLDHGADPHVVHWDELDPDTMIRLKVNVEALCVYQEARRNPQRLMNLCRITIRKIFGKKHMSCISSLPLPDTIITFILHND,,exocytosis (GO:0006887) (0.5519); intracellular signal transduction (GO:0035556) (0.3901); protein ubiquitination (GO:0016567) (0.2683); ubiquitin-dependent protein catabolic process (GO:0006511) (0.1685); RNA processing (GO:0006396) (0.0742),plasma membrane (GO:0005886) (0.3264); extracellular region (GO:0005576) (0.3252); cytosol (GO:0005829) (0.2973); cytoplasm (GO:0005737) (0.1721); nucleus (GO:0005634) (0.1598); nuclear speck (GO:0016607) (0.1114); membrane (GO:0016020) (0.1112),toxin activity (GO:0090729) (0.2840); transcription cis-regulatory region binding (GO:0000976) (0.0631),Ankyrin repeat (IPR002110) (0.5890); Ankyrin repeat-containing domain superfamily (IPR036770) (0.3721); SOCS box-like domain superfamily (IPR036036) (0.1662); SOCS box domain (IPR001496) (0.1162),1.25.40.20 (0.3378),Repeat (0.5869); Ubl conjugation pathway (0.5616); Reference proteome (0.5406); Toxin (0.5017); Membrane (0.4643); ANK repeat (0.3652); Presynaptic neurotoxin (0.3541); Neurotoxin (0.2308); Exocytosis (0.2161),
MLSSALRCLRPISSTLVLSRPLAHHMDPSVPRPVETTIRTKLSKALNPEHLEVINESHMHAVPPGSESHFKVLVVSPQFEGLSLLQRHRLVNETLKEELSTCIHALSIQAKTPQQWSSNPSLAKSPPCMGGSRHDHTMAEKLKAGRD,,"iron-sulfur cluster assembly (GO:0016226) (0.4300); intracellular iron ion homeostasis (GO:0006879) (0.1356); cell redox homeostasis (GO:0045454) (0.1304); mitochondrial electron transport, succinate to ubiquinone (GO:0006121) (0.0773); regulation of transcription by RNA polymerase II (GO:0006357) (0.0528)",iron-sulfur cluster assembly complex (GO:1990229) (0.7302); mitochondrion (GO:0005739) (0.2978); cytosol (GO:0005829) (0.1681),,BolA/IbaG family stress response and morphology regulators (IPR050961) (0.2151); BolA-like superfamily (IPR036065) (0.1590); BolA protein (IPR002634) (0.0661),3.30.300.90 (0.1928),Reference proteome (0.7542); Mitochondrion (0.6413); Primary mitochondrial disease (0.4365); Phosphoprotein (0.2341); 3D-structure (0.2337); Disease variant (0.1951); Direct protein sequencing (0.1377); Alternative splicing (0.1055); Proteomics identification (0.1036); Transit peptide (0.0911),
MAGRGRGQLTFSVEIVGIGKGENLPPSCIQPTPLFPPLDQKPVPLQAGEEAEYMLALKQEFRGAMKTLPFYIRPAAPKKDVERYSDKYQKNESFDNSLEWKPDWRRLPKELRVREKRPQRDKSQAVPKRAKQARVDKEEIIRKLETLEQKEKEGSSDEEEGEKKKPEEEEAEAENEYDEEEFEDETDYIMSYFENGEEFGGDSDENMDEAIY,,transcription by RNA polymerase III (GO:0006383) (0.8083); epithelial cell proliferation (GO:0050673) (0.5168); positive regulation of interferon-beta production (GO:0032728) (0.4853); positive regulation of innate immune response (GO:0045089) (0.4027); innate immune response (GO:0045087) (0.1995); positive regulation of canonical NF-kappaB signal transduction (GO:0043123) (0.1595); cell population proliferation (GO:0008283) (0.1377),nucleoplasm (GO:0005654) (0.3977); cytosol (GO:0005829) (0.3031); nucleus (GO:0005634) (0.1803); RNA polymerase III complex (GO:0005666) (0.1263),chromatin binding (GO:0003682) (0.0673),"DNA-directed RNA polymerase III, subunit Rpc31 (IPR024661) (0.2910)",,Isopeptide bond (0.5545); Reference proteome (0.5345); Ubl conjugation (0.3607); Phosphoprotein (0.2060); Nucleus (0.1563); Proteomics identification (0.1198); 3D-structure (0.1021); Transcription regulation (0.0937); Innate immunity (0.0812); Immunity (0.0752); Disease variant (0.0559),
MFGGHLILVSLLSASLCLCLASADTCPAGAMPGLPGIPGFPGRDGRQGMKGEKGDLGIPIKPGDTVKKGERGAFGLKGPPGKRGPHGDPGIMGPPGPPGEPGEAGLVDVSGSQLQSAFSVFRHTRIPPDANKVIRFSKVITNPQGHFSTDESKFVCKIPGTYYFVFHASSHDKKLCVILVHDDKNLVSFCDHTQRGSQQVSSGGLSLYLKENEKVWLMTNALNGMYATADRADSVFSGFLIHAH,,"complement activation, classical pathway (GO:0006958) (0.8740); microglial cell activation (GO:0001774) (0.6265); astrocyte activation (GO:0048143) (0.6121); innate immune response (GO:0045087) (0.3744); response to glucose (GO:0009749) (0.1923); negative regulation of canonical NF-kappaB signal transduction (GO:0043124) (0.1742); neuron remodeling (GO:0016322) (0.1423); complement-mediated synapse pruning (GO:0150062) (0.1102); vertebrate eye-specific patterning (GO:0150064) (0.0831); positive regulation of cytokine production (GO:0001819) (0.0756); fat cell differentiation (GO:0045444) (0.0639); acute-phase response (GO:0006953) (0.0627)",glutamatergic synapse (GO:0098978) (0.3095); complement component C1q complex (GO:0062167) (0.2265); collagen trimer (GO:0005581) (0.1953); extrinsic component of postsynaptic membrane (GO:0098890) (0.1586); extrinsic component of presynaptic membrane (GO:0098888) (0.1086); extracellular region (GO:0005576) (0.0983),hormone activity (GO:0005179) (0.1568); identical protein binding (GO:0042802) (0.1496),Tumour necrosis factor-like domain superfamily (IPR008983) (0.2434); Collagen/C1q domain-containing (IPR050392) (0.1778); C1q domain (IPR001073) (0.1201),2.60.120.40 (0.1453),Secreted (0.9862); Complement pathway (0.6941); Innate immunity (0.6397); Immunity (0.5735); Hydroxylation (0.3416); Signal (0.2377); Disulfide bond (0.2286); Repeat (0.2048); Reference proteome (0.2019); Collagen (0.1110); Direct protein sequencing (0.0501); Proteomics identification (0.0464),
MNCLWLFVFAVATAFESDESNGDIQVNCKDHSVHVKWKLEKTMTANPARLFLGSCFPSVFSNMTQDGAYAEFHYPFSACGFRRISTWKSLVYENQLTYRPLPKPYPPAFTYPVRCVYDSPKGWTPAFQSLSTGEIQGYGQLAFQMAILNHDFSGPAESTVFPLGSFVPIWAAVDQQGHQPLVLFLEECVASATPEMNADTLIHPLITNKGCLVDGKKSFSRFLPRFQSSSIMLHLQAFTFAVGQEVYIHCKLIAWDPDDLNKTKKACNYNKATGEWELLDDPFQNSLCQCCDSTCSGREKKDADFAPQGLVLKSVLGPLTFTEESQ,,oocyte development (GO:0048599) (0.9148); binding of sperm to zona pellucida (GO:0007339) (0.8814); humoral immune response mediated by circulating immunoglobulin (GO:0002455) (0.7791); positive regulation of acrosome reaction (GO:2000344) (0.5606); egg coat formation (GO:0035803) (0.5156); positive regulation of leukocyte migration (GO:0002687) (0.2018); positive regulation of T cell proliferation (GO:0042102) (0.1394); lysosomal transport (GO:0007041) (0.0696); positive regulation of type IV hypersensitivity (GO:0001809) (0.0641),egg coat (GO:0035805) (0.3438); extracellular space (GO:0005615) (0.1166); plasma membrane (GO:0005886) (0.1009); collagen-containing extracellular matrix (GO:0062023) (0.0764); extracellular region (GO:0005576) (0.0533),acrosin binding (GO:0032190) (0.0949),"Zona pellucida, ZP-C domain (IPR042235) (0.1244); Zona pellucida domain (IPR001507) (0.1027)",2.60.40.4100 (0.2339); 2.60.40.3210 (0.2126),Signal (0.8237); Reference proteome (0.6140); Cleavage on pair of basic residues (0.4575); Membrane (0.3912); Cell membrane (0.3652); Disulfide bond (0.1548); Extracellular matrix (0.1499); 3D-structure (0.1071),
MEHKTRKDIIHRFQVNFLAMSLLNTFPWDHLDEEIRNSNTSDIIEDILHKTCLHPICVKNPPSLKYRRRFLTELIKRQEKLSAEPLDILYEALGEVMCAQEEDLCFKTYLLPTGDAVSLAENVALISQGTTGLVTWEAALYLAEWTLENAHIFKNKTVLELGSGIGLTGIVLCRSCSLTKYIFSDCHQTVLQRLKDNITNCLANCDGVSVEELDWENVSDEQLQRIQANTIIAADVVYDPDIIACLVRLLSRLLNCKVEENHPDVYVASTVRNPQTYECFKKELERAGLRHVIMKDSVTQVFPYNRASTIEMIKIYV,2.1.1.- (0.9519),methylation (GO:0032259) (0.3531); chromatin remodeling (GO:0006338) (0.3073); negative regulation of transcription by RNA polymerase II (GO:0000122) (0.1064); peptidyl-lysine trimethylation (GO:0018023) (0.0980); epigenetic regulation of gene expression (GO:0040029) (0.0971); positive regulation of transcription by RNA polymerase II (GO:0045944) (0.0650); protein catabolic process (GO:0030163) (0.0417),protein-containing complex (GO:0032991) (0.4449); nucleus (GO:0005634) (0.3428); cytoplasm (GO:0005737) (0.1085),protein-lysine N-methyltransferase activity (GO:0016279) (0.4255); histone methyltransferase activity (GO:0042054) (0.3018),"Lysine methyltransferase (IPR019410) (0.4795); S-adenosyl-L-methionine-dependent methyltransferase superfamily (IPR029063) (0.3419); FAM86, N-terminal (IPR029426) (0.3199)",3.40.50.150 (0.1855),S-adenosyl-L-methionine (0.7735); Reference proteome (0.4941); Transferase (0.4417); Cytoplasm (0.4110); Methyltransferase (0.3653); Phosphoprotein (0.2327); Ubl conjugation (0.2007); Alternative splicing (0.1764); Proteomics identification (0.1653); 3D-structure (0.1574),
MFPMLTLLSMFYYICLRRRSRSGTRSEALGSRRAVELGQRSALPVTVEVEQYGKEILDFSSHYGSENSMSYTMWNLAGVPNVYPSSGDFTQTAVFRTYGTWWEQCISSTPRFRRTPPSFHSQDYLELAFEEPVYPTAVEVLETYHPGAIVKIMACSLNPFSQNPPTDVRWEVLWSGKPNKALTPQARQFSPNIKQISFTTNLLRLEVNSSLLDYYTELDAVILRGVRERPILALYKIPVIDINDLSDSEEEISEAGGLCCRSTAENRQSLANGYFDRLPYELIQLIVSHLPVPDLCRLAQSCKLFHKHCCDPLQYIQLSLQPYWARLTDASLCHLQSRCTLLQRLNLSWTGNRGAVTPAGFCSFMKACGASLVCLEVSCCHFLTEACLEVITQTCPCLQELNLASCDRLQPQAFNHIAKLTHLRRLVLYRTKVEQSAILSILTFCPELRHLNLGSCVMIEDYDVVVSMLSARCRSLRSLDLWRCRNLSERGLAELVSGCRLLEELDLGWCSTLQSSSGCFQHLARSLPRLRKLFLTANRTVCDADLEELAANCSALQHLDILGTRMVSSASLRKLLQCCPRLKLLDVSFCSQIDSRFVQELNGLFPNVSIKKSFTQ,,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146) (0.3258); protein polyubiquitination (GO:0000209) (0.2402); neuron differentiation (GO:0030182) (0.2063); retina layer formation (GO:0010842) (0.2058); ubiquitin-dependent protein catabolic process (GO:0006511) (0.1716); defense response to virus (GO:0051607) (0.1253); chromatin organization (GO:0006325) (0.1126); protein quality control for misfolded or incompletely synthesized proteins (GO:0006515) (0.1067); autophagy of mitochondrion (GO:0000422) (0.0846); protein ubiquitination (GO:0016567) (0.0769); neuron development (GO:0048666) (0.0672); protein K48-linked ubiquitination (GO:0070936) (0.0484); regulation of protein stability (GO:0031647) (0.0469),cytosol (GO:0005829) (0.5598); nuclear speck (GO:0016607) (0.2811); mitochondrial intermembrane space (GO:0005758) (0.2017); nucleoplasm (GO:0005654) (0.1088); centrosome (GO:0005813) (0.0436),,"Leucine-rich repeat, cysteine-containing subtype (IPR006553) (0.3379); Leucine-rich repeat domain superfamily (IPR032675) (0.2805); Leucine-rich repeat (IPR001611) (0.2683); F-box domain (IPR001810) (0.2355)",3.80.10.10 (0.5576); 1.20.1280.50 (0.1020),Reference proteome (0.5641); Ubl conjugation pathway (0.5560); Cytoplasm (0.3490); Membrane (0.2967); Phosphoprotein (0.2416); Leucine-rich repeat (0.1768); Mitochondrion (0.1705); Repeat (0.1664); Disease variant (0.1613); Signal (0.1425); Proteomics identification (0.0918),
MKRVTRHACDDVPIPEEQETEGQRQLHNLLLQQLDTDVDIDRCVAKKKCFAPAAVYKPFGEQAAGVRSLSQFQALQDGDQELAALRELGLTDAEILLWRSREQPESSLKDRGVCVAPEARNERLQAIRDKMAAHAELLSRPQRFSSSRALSRREMEIEKALFQGSDRSSFLTALYHQDGDSHVSQQRATSPKTMDHFYKDFLEEQNKTFGDVSTLQPETVTNIQCTSSDSKSDQSQSPTVSESGLPEYQHKCTKSDIVNQPQPQEKSIQPVKITVSQSVGKLNSAFVQGHNGPVALSGRIKEVSDEEIKSNRETEEAIRNIPRFKNYQRGKPSKVLCVKNISPRASLAQLVSLFSRFQKDESQPILYRLLTGRLKGQAFITLADAEIAQAALDLLNGYKLLEKPLVIEFGRARSKETDLQTDETSVDPNTLSVQNNKHT,,"mRNA splicing, via spliceosome (GO:0000398) (0.6771); mRNA transport (GO:0051028) (0.1948); U2-type prespliceosome assembly (GO:1903241) (0.1479); spliceosomal complex assembly (GO:0000245) (0.1362); stem cell population maintenance (GO:0019827) (0.0865); mRNA processing (GO:0006397) (0.0584)",catalytic step 2 spliceosome (GO:0071013) (0.3971); nucleoplasm (GO:0005654) (0.3421); spliceosomal complex (GO:0005681) (0.2512); cytoplasm (GO:0005737) (0.2279); nuclear speck (GO:0016607) (0.1964); U2-type catalytic step 2 spliceosome (GO:0071007) (0.1260); precatalytic spliceosome (GO:0071011) (0.1149); nucleus (GO:0005634) (0.0939); chromosome (GO:0005694) (0.0618),pre-mRNA intronic binding (GO:0097157) (0.3649); U2 snRNA binding (GO:0030620) (0.2219); RNA binding (GO:0003723) (0.0749),RNA-binding domain superfamily (IPR035979) (0.2775); RNA recognition motif domain (IPR000504) (0.2212); Nucleotide-binding alpha-beta plait domain superfamily (IPR012677) (0.2064),3.30.70.330 (0.4568),mRNA processing (0.8696); Spliceosome (0.7639); mRNA splicing (0.7546); Ubl conjugation (0.6200); Proteomics identification (0.3571); 3D-structure (0.3366); Reference proteome (0.3293); Disease variant (0.2696); Alternative splicing (0.2523); RNA-binding (0.2377); Nucleus (0.2062); Phosphoprotein (0.1695); Direct protein sequencing (0.1603); Ribonucleoprotein (0.1582); rRNA-binding (0.1563); Repeat (0.1496); Acetylation (0.1066); Transport (0.0828); rRNA processing (0.0523),
MCTKMRTFEPLAKGELKTQGFTVMSTMKNSVVVGPPAAGAFRERPAKPTAFRKFYERGDFPIALEHDSKGNRIAWKVEIEKLDYHHYLPLFFDGLCETVHPYEFFARQGIHDMLEHGGNKVLPVIPQLIIPIKNALNTRNRQVICTTLKVLQHLVVSAEMVGEALVPYYRQILPILNIFKNMNKNSGDGIDYSQQKRENIGDLIQETLEVFERYGGEDAFINIKYMVPTYESCLLN,,flagellated sperm motility (GO:0030317) (0.8342); spermatid development (GO:0007286) (0.7444); protein localization (GO:0008104) (0.7079); cellular response to unfolded protein (GO:0034620) (0.2022); establishment of left/right asymmetry (GO:0061966) (0.0862); epithelial cilium movement involved in extracellular fluid movement (GO:0003351) (0.0716); determination of left/right symmetry (GO:0007368) (0.0401),axonemal microtubule (GO:0005879) (0.4453); cytoplasm (GO:0005737) (0.2046); axonemal B tubule inner sheath (GO:0160112) (0.2003); cytosol (GO:0005829) (0.1848); sperm midpiece (GO:0097225) (0.1635); manchette (GO:0002177) (0.1623); perinuclear region of cytoplasm (GO:0048471) (0.1605); vesicle (GO:0031982) (0.1391),Hsp90 protein binding (GO:0051879) (0.2582); Hsp70 protein binding (GO:0030544) (0.2284); beta-tubulin binding (GO:0048487) (0.1507); G protein-coupled receptor binding (GO:0001664) (0.1211); actin binding (GO:0003779) (0.1079); alpha-tubulin binding (GO:0043014) (0.0960),Parkin co-regulated protein (IPR019399) (0.2442),,Reference proteome (0.5604); Cell projection (0.3082); Flagellum (0.1941); Cytoskeleton (0.1884); Cytoplasm (0.1679); Repeat (0.0948),
MGMAFLCGSPVTFRVWLTLLISGYPALAFSVAGQQETTCEANGSVYYVGEWYFLDSDPCTQCECTADGSACARTECTSLPTACIHVSHYPTDCCPRCEKIGCEYGGEVYELGQHFQPSACEQCTCYSDGIAHCQVADCAPPPCVDPVYQKGECCPQCKDGPNCYVNASRTQVIPGGESVWVDSCTKCRCHDIQDAGYWEGNRLAMCSRIRNCQPDEGLN,RING-type E3 ubiquitin transferase (2.3.2.27) (0.0909),negative regulation of BMP signaling pathway (GO:0030514) (0.3783); spermatogenesis (GO:0007283) (0.2818); podocyte development (GO:0072015) (0.1821); endothelial cell migration (GO:0043542) (0.1617); positive regulation of neuron differentiation (GO:0045666) (0.1559); epithelial tube morphogenesis (GO:0060562) (0.1449); response to oxidative stress (GO:0006979) (0.0710); response to mechanical stimulus (GO:0009612) (0.0665); blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:0002043) (0.0639); face morphogenesis (GO:0060325) (0.0547); imaginal disc-derived wing morphogenesis (GO:0007476) (0.0522); dorsal/ventral pattern formation (GO:0009953) (0.0404),extracellular space (GO:0005615) (0.4498); basement membrane (GO:0005604) (0.0415),,von Willebrand factor C domain-containing protein 2-like (IPR042979) (0.1170),6.20.200.20 (0.0863),Synapse (0.9412); Reference proteome (0.5779); Developmental protein (0.4986); Secreted (0.2643); Signal (0.2553); Repeat (0.2532); Proteomics identification (0.1666),
MLLGDQTPQYNPYLSRRGNSMRIHQGILQEGYNQYHANKHDEKSNPHGIINLGTSENKLCFDLLQKRLTRPDMLNIEPAFLQYPDWKGHSFLREEVAKFLSDYCCSPKPLKPENVVVMNGCGSLFSALAATLCDPEDAILIPSPFYGVITEDVDLYSSVKLHHVPLYSQPRGSDVRPFQLTVDKLENSLKEAKTEGLNVKALILLNPHNPLGEVYSSEEMTGFLQFAKMHQLHVIVDEIYMLSVFGEKHTFRSVLSLDGLPDPQRTHVMWGVSKDFAMAGMRVGTIYSENKDLVQALDQLGCFHGVPGPTQYQMAQLLRDRDWLNSEFLPENKRRLKEAHKYLTEELKKLDIPFLHRGAGFFIWADLSKFLKEKTFAEELCVWRCFLKHRLLLSCGQAFSCASPGWFRIIFTDQQHKLQLGVQRMKTALEELQGSLVPEDQRTTAVELKTSAGRATRTDTKTTDECKETTLKSSSAQTKLENTRIKTEPLSLADENFAILNGQSNMHSESLDTLIGALQKQIHSSDWLEKHRPELAAGVDPTQLEVFTDLLEKARK,1-aminocyclopropane-1-carboxylate synthase (4.4.1.14) (0.5911),amino acid metabolic process (GO:0006520) (0.9241); biosynthetic process (GO:0009058) (0.1890); folic acid metabolic process (GO:0046655) (0.1567); positive regulation of cell population proliferation (GO:0008284) (0.0710); response to peptide hormone (GO:0043434) (0.0518); L-kynurenine catabolic process (GO:0097053) (0.0513),cytosol (GO:0005829) (0.2838); cytoplasm (GO:0005737) (0.1865),pyridoxal phosphate binding (GO:0030170) (0.5473),"Ethylene and sulfur compound biosynthesis-related protein (IPR050478) (0.7399); Aminotransferase, class I/classII (IPR004839) (0.2911); Aminotransferases, class-I, pyridoxal-phosphate-binding site (IPR004838) (0.2019); Pyridoxal phosphate-dependent transferase, small domain (IPR015422) (0.1819); Pyridoxal phosphate-dependent transferase (IPR015424) (0.1779)",3.90.1150.10 (0.1964),Ubl conjugation (0.5360); Reference proteome (0.4756); Pyridoxal phosphate (0.3267); Lyase (0.1481); Ethylene biosynthesis (0.1339); S-adenosyl-L-methionine (0.1273),pyridoxal 5'-phosphate (0.1090)
MSIMLSPSRELSHNKIEPIANEESDTNVIVQSDGDQSKSCGFCGYILTFFSCLLIFFTFPVSVWFCMKVVQEYERAVIFRLGRLLGGAKGPGLFWIIPCMDTFRKVDLRTVSFDIPAQEVLTKDSVTIMVDAVVYYRIFNPTVSITKVENANYATQMLAQTTLRNMLGTKSLADILKDREEMSEQMEAVLYSASKNWGIKVERVELKDVKLPTTLQRAMAAEAEASRDARAKVIAAEGEMKASRALKEAANVMSESPAALQLRYMQTLTEIASERNSTIIFPVPMDLMSGFMRR,,positive regulation of viral process (GO:0048524) (0.5562); signal transduction (GO:0007165) (0.4322); regulation of monoatomic ion transmembrane transport (GO:0034765) (0.2667); positive regulation by host of viral genome replication (GO:0044829) (0.2586); gene expression (GO:0010467) (0.0966); positive regulation of protein targeting to membrane (GO:0090314) (0.0929); detection of mechanical stimulus involved in sensory perception of touch (GO:0050976) (0.0778),endoplasmic reticulum (GO:0005783) (0.4894); cytoskeleton (GO:0005856) (0.2143); plasma membrane (GO:0005886) (0.1910); mitochondrion (GO:0005739) (0.1797); membrane raft (GO:0045121) (0.0907); perinuclear region of cytoplasm (GO:0048471) (0.0906); cytoplasm (GO:0005737) (0.0847); neuron projection (GO:0043005) (0.0719); actin cytoskeleton (GO:0015629) (0.0652),ion channel inhibitor activity (GO:0008200) (0.1216),"Band-7 stomatin-like (IPR043202) (0.4527); Band 7 domain (IPR001107) (0.3560); Stomatin/HflK family (IPR001972) (0.3133); Band 7/SPFH domain superfamily (IPR036013) (0.2137); Band 7/stomatin-like, conserved site (IPR018080) (0.1179)",6.10.250.2090 (0.4381),Reference proteome (0.1086); Membrane (0.1040),
MNPHCARCGKIVYATEKVNCLDKYWHKGCFHCEVCKMTLNMNNYKGYEKKPYCNAHYPKQTFTIVADTPENLRLRQQSELQSQVKYRKDFEQSKGRGLKFVLDTPELQRLRKAQDQISNAKYHKDFEVSGLQGVTQGMRGTYAVRSQMTPNNETVANSTHKAVHQYIMEMDRRPGVIVAPVLPGAYYPNSHSHGHSYMHQTSMHSLRSMQLRSQQMSMTVYRALYDYMAQDYDEVSFRDGDIIQNVQPIDEGWMYGTVQRTGRSGMLPANYVEGIR,,monoatomic ion transport (GO:0006811) (0.9567); sarcomere organization (GO:0045214) (0.1153); spermatogenesis (GO:0007283) (0.0625),cell cortex (GO:0005938) (0.5822); focal adhesion (GO:0005925) (0.1594); A band (GO:0031672) (0.0949); cytoplasm (GO:0005737) (0.0888); Z disc (GO:0030018) (0.0766),actin filament binding (GO:0051015) (0.4920); metal ion binding (GO:0046872) (0.3038),"Zinc finger, LIM-type (IPR001781) (0.1575); SH3 domain (IPR001452) (0.1570); SH3-like domain superfamily (IPR036028) (0.1356); Nebulin repeat (IPR000900) (0.1249)",2.10.110.10 (0.2844),Repeat (0.6887); Acetylation (0.6198); Reference proteome (0.5916); Zinc (0.5666); SH3 domain (0.5504); LIM domain (0.4570); Cytoplasm (0.4560); Cytoskeleton (0.2346); Metal-binding (0.2053); Methylation (0.1355); Ion transport (0.1047); 3D-structure (0.0917); Phosphoprotein (0.0905); Actin-binding (0.0537),
MTMHRSSKTLQKFSSQSVFASAGGSSGGLVMNGFGSSGSSLSFGGQNFSSSSGFGARISRSVSTSSLDMTGNEAILCASEKQTMQNLNDRLASYLERVRSLEQENKKLELQIKEFYDSKSPMQSKDMSAYFKTISELRAQIHGRFLENAELHLKLDNIRLAAEDFHIKYESELNMRTIVEADSARLRGVLSEIKLSIGDLQSQFTLLKEEQVYLKKNHEEDLHLLREQHSGSVNVEMDCADQSHLDEELREMRAQYEKLIEKNRREAERWFHSKAEVLQTQVDTSSTEIKTSQTQLTDLRRTFQSLEIELQGVLTMKQNLENTLADVGIRYTTQLSQLQLRIDHLQEELQKLNTNIRQQASEYQILLDIKMRLEMEIAEYRRLLEGETQTTVISTSSSSMTKTVTETETVSKTVEIIEEEEYNPHVQRRVKVIVEELVDGKVVSSSVEEKVHEIS,,tumor necrosis factor-mediated signaling pathway (GO:0033209) (0.3704); Golgi to plasma membrane protein transport (GO:0043001) (0.2859); hepatocyte apoptotic process (GO:0097284) (0.2857); extrinsic apoptotic signaling pathway (GO:0097191) (0.2540); cellular response to starvation (GO:0009267) (0.1994); inflammatory response (GO:0006954) (0.1764); negative regulation of apoptotic process (GO:0043066) (0.1416); intermediate filament cytoskeleton organization (GO:0045104) (0.1400); epithelial cell differentiation (GO:0030855) (0.0983); regulation of cell population proliferation (GO:0042127) (0.0948); regulation of transcription by RNA polymerase II (GO:0006357) (0.0828),intermediate filament (GO:0005882) (0.2815); cytoskeleton (GO:0005856) (0.1995); cell periphery (GO:0071944) (0.1487); cytosol (GO:0005829) (0.1436); cytoplasm (GO:0005737) (0.0909),structural molecule activity (GO:0005198) (0.1233),"Intermediate filament protein, conserved site (IPR018039) (0.2774); Keratin, type I (IPR002957) (0.0810); Intermediate filament, rod domain (IPR039008) (0.0615)",1.20.5.170 (0.2770),Reference proteome (0.7653); Phosphoprotein (0.4629); Keratin (0.4103); Proteomics identification (0.2768); Cytoplasm (0.2613); Coiled coil (0.2439); Intermediate filament (0.2346); Ubl conjugation (0.1822); Nucleus (0.1153),
MLPGARPLLLCVLSHMTSAWAFSRMSDAVELRSAFSVARTSSMEGGPKMVVTFDKVYVNIGSDFDPKSGLFRCRIPGAYYFSFTVGKFPRRDLSVMLMKNRNEVQAIVYDENAGEERKVQSQSAMLQLDFGDTVWLRLHGDPRYAIYSNTGHYTTFNGYLIYPDVYGYQEHTHKEHDSAHQPPKITDHLPSEQENTITKDTAVRMKEERRDEEVKEEDSRDGEEEDDDQRSAFSVGRTQSIVGVDQGHPEHQPIIFDTEFVNIGNDFNLSSGVFKCRVAGAYYFSFNAGKLPHKTLSVKLMKNHLEVQTMIYDDSDTEKALQSQSLMLSLQDGDTVWLYSHQRDGFGAYSNHAKYITFTGFLVYPELHLSLPQPQKQDKTL,,microglial cell activation (GO:0001774) (0.3732); positive regulation of cholesterol efflux (GO:0010875) (0.2527); positive regulation of tumor necrosis factor production (GO:0032760) (0.2359); cell-cell signaling (GO:0007267) (0.1541); establishment of localization in cell (GO:0051649) (0.1213); positive regulation of cytokine production (GO:0001819) (0.1113); response to virus (GO:0009615) (0.0970); inflammatory response (GO:0006954) (0.0863); response to bacterium (GO:0009617) (0.0843); regulation of lipid metabolic process (GO:0019216) (0.0785); astrocyte activation (GO:0048143) (0.0760); positive regulation of cytosolic calcium ion concentration (GO:0007204) (0.0748); negative regulation of platelet activation (GO:0010544) (0.0731); fatty acid oxidation (GO:0019395) (0.0668); protein secretion (GO:0009306) (0.0606); negative regulation of cell growth (GO:0030308) (0.0543); positive regulation of angiogenesis (GO:0045766) (0.0412),extracellular region (GO:0005576) (0.2673); cell surface (GO:0009986) (0.2466); collagen trimer (GO:0005581) (0.1690); plasma membrane (GO:0005886) (0.1183); extracellular space (GO:0005615) (0.1123); collagen-containing extracellular matrix (GO:0062023) (0.0793),identical protein binding (GO:0042802) (0.2396); signaling receptor binding (GO:0005102) (0.2148),Cerebellin Synaptic Organizer (IPR050822) (0.2284); C1q domain (IPR001073) (0.1312); Tumour necrosis factor-like domain superfamily (IPR008983) (0.1182),2.60.120.40 (0.2890),Secreted (0.8446); Signal (0.7757); Reference proteome (0.6203); Glycoprotein (0.4825); Disulfide bond (0.1597); Direct protein sequencing (0.1440); 3D-structure (0.1108); Collagen (0.0718); Repeat (0.0550),
MAFSEWRLSLKLVDQPSLPKSLLQFPEAEPGDVPPGEYRVSTLKQLVSAQIPDAIPDPELIELVYCGRKLKDDLTLESYGIQSGSTVHILRKSWPEPEIHPEPVDKVAAAREFRVLQAALHTSTAYRESVFKMLNNKESLDQIIVATPGLSSDPVALGVLQDKDLFLQFTDPNMLDTLANSHPALVNAIILVLHSVAGSVPPQQSTSSSRNVSSGSYSDMPGGFLFEGMSDDEEDFQSGNRGGPSTLASGLAGMRPASLGYNGAVGPRPITQSELATALALASTPESSAVTPTTGNQGPSSGVSPIPAGTPITNDLFNQALQQALQVSSMSSLHNQWQSQLQQLRDMGIRDEELILRALQATGGDIQAALELIFAGGAP,,ubiquitin-dependent protein catabolic process (GO:0006511) (0.7932); positive regulation of ERAD pathway (GO:1904294) (0.2844); ERAD pathway (GO:0036503) (0.2142); regulation of macroautophagy (GO:0016241) (0.1290); regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434) (0.1058); protein export from nucleus (GO:0006611) (0.0452),cytoplasm (GO:0005737) (0.4762); nucleoplasm (GO:0005654) (0.1792); protein-containing complex (GO:0032991) (0.1282); nucleus (GO:0005634) (0.1127); cytosolic proteasome complex (GO:0031597) (0.1116); cytosol (GO:0005829) (0.0819),polyubiquitin modification-dependent protein binding (GO:0031593) (0.1832); protein-macromolecule adaptor activity (GO:0030674) (0.0923),"Ubiquitin-associated domain (IPR015940) (0.5396); Ubiquitin-like domain superfamily (IPR029071) (0.2747); Ubiquitin-like domain (IPR000626) (0.2025); Ubiquitin-like protein 7, UBA domain (IPR047878) (0.1429); UBA-like superfamily (IPR009060) (0.0937)",,Reference proteome (0.7237); Ubl conjugation pathway (0.4727); Phosphoprotein (0.4358); Ubl conjugation (0.3716); DNA damage (0.2838); Cytoplasmic vesicle (0.1966); Cytoplasm (0.1584); Endoplasmic reticulum (0.1423); 3D-structure (0.1302); Repeat (0.1128); Innate immunity (0.1105); Nucleus (0.0964),
MALATYIVGQTPFPEFSVVVMLDDLQLAYYDSIGWKTIYRSGSDSKYYDEEQSDAGIVFRDMFYDMKDRAFYLKDHQNHTDGVHVHQRLVGCELLNNEKTGPLHYWDAFGGQNMEEFIFDTEKHTIQVKMPWVITWDQLKRLHENFMYDNVYHPICIKTLRRYLNMEKKNVMRKVKPRVRLMQKKLSDSQGLQISCLATGFYPRHINLTLFRDAELVDDDQITGGEILPNGDGTYQMRKSLIVSEEELQKGHKYNCTANYLNLDNKMDIVFDVAESDPGSFSVSVVMGVLVFVGLSVLSITALIMRRKRRDTGSVSGTSQNQYVYAQTSVQDAT,,"immune response (GO:0006955) (0.7950); positive regulation of T cell mediated cytotoxicity (GO:0001916) (0.4688); positive regulation of immune response (GO:0050778) (0.3359); antigen processing and presentation, exogenous lipid antigen via MHC class Ib (GO:0048007) (0.0902); antigen processing and presentation of endogenous peptide antigen via MHC class Ib (GO:0002476) (0.0752); adaptive immune response (GO:0002250) (0.0739); positive regulation of immunoglobulin production (GO:0002639) (0.0587); positive regulation of macrophage activation (GO:0043032) (0.0480)",external side of plasma membrane (GO:0009897) (0.7671); extracellular space (GO:0005615) (0.6143); endoplasmic reticulum (GO:0005783) (0.0721); plasma membrane (GO:0005886) (0.0537),T cell receptor binding (GO:0042608) (0.3077),Immunoglobulin-like domain superfamily (IPR036179) (0.4529); Immunoglobulin-like fold (IPR013783) (0.4105); Immunoglobulin C1-set (IPR003597) (0.2808); Immunoglobulin-like domain (IPR007110) (0.1841),2.60.40.10 (0.2657); 3.30.500.10 (0.1636),Transmembrane helix (0.5557); Glycoprotein (0.3372); Reference proteome (0.3297); Immunity (0.2398); Immunoglobulin domain (0.1463); Membrane (0.1378); Signal (0.1016); Viral immunoevasion (0.0566),
MYRFTRSAMMQPMISSGMGMAPFFRVTVFEQEHFQGKCQEFTNECCNIQCCGFDNIRSIRVESGAWVGYEHHDFQGQQFILERGEYPHWDAYSGNLSYHVERLMSFRPIYCASHQSSRMTIFERENFLGRNAELCDDYPSLQAMGWCRPEVGSMHVQCGAFVCYEFPGYKGRQYIMECERHSGDFQHWRNWGSHSQTPQIQSIRRIQH,,lens development in camera-type eye (GO:0002088) (0.7350); visual perception (GO:0007601) (0.4637); negative regulation of TOR signaling (GO:0032007) (0.3015); positive regulation of anoikis (GO:2000210) (0.1448); negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction (GO:0051898) (0.1372); negative regulation of cytokine production (GO:0001818) (0.1315); phagocytosis (GO:0006909) (0.0738); negative regulation of apoptotic process (GO:0043066) (0.0702),nucleus (GO:0005634) (0.1629),structural constituent of eye lens (GO:0005212) (0.3816); identical protein binding (GO:0042802) (0.1702),Beta/gamma crystallin (IPR001064) (0.5049); Beta/Gamma-Crystallin (IPR050252) (0.0438),2.60.20.10 (0.1829),Eye lens protein (0.3020); Reference proteome (0.2688); Disease variant (0.2087); Repeat (0.2084); Acetylation (0.1533); Direct protein sequencing (0.1513); Membrane (0.1343); Cataract (0.1327); Methylation (0.1048),
MEMESEMERGPQSKQNLISENDGSLGCCGWILVIISAFFSILVFPISIFISIKIVKEYERAVIFRLGRITARKAKGPGIFFIIPCTDSFIKVDLRTVSFDIPPQEILTKDSVTVSVDGVVYFRVNDPVASVANVSNADYSTRLLAQTTLRNVLGTKNLAEVLSDREGISHSMQTTLDEATDSWGIKVERVEIKDVKLPQQLQRAMAAEAEASREARAKVIAAEGEMNASRALKEASLVIAESPSALQLRYLQTLNTIAAEKNSTIVFPLPIDIMNHFIRK,,regulation of monoatomic ion transmembrane transport (GO:0034765) (0.7691); positive regulation of viral process (GO:0048524) (0.7526); positive regulation by host of viral genome replication (GO:0044829) (0.6261); positive regulation of protein targeting to membrane (GO:0090314) (0.3234); signal transduction (GO:0007165) (0.0686); response to toxic substance (GO:0009636) (0.0636),cytoskeleton (GO:0005856) (0.5141); endoplasmic reticulum (GO:0005783) (0.3926); plasma membrane (GO:0005886) (0.2673); membrane raft (GO:0045121) (0.2134); mitochondrion (GO:0005739) (0.1928); perinuclear region of cytoplasm (GO:0048471) (0.1124),protein homodimerization activity (GO:0042803) (0.1335),"Band 7 domain (IPR001107) (0.4670); Band-7 stomatin-like (IPR043202) (0.3060); Band 7/SPFH domain superfamily (IPR036013) (0.2746); Stomatin/HflK family (IPR001972) (0.2200); Band 7/stomatin-like, conserved site (IPR018080) (0.1298)",6.10.250.2090 (0.3642); 3.30.479.30 (0.1851),Reference proteome (0.2888); Membrane (0.1659),
MAEVERRRRPIIAGRERGPGPGRYALPPTIGYINHDYTKPSSPAYSFHSRMSSNMVSVDSSPGPRYRVDAKMTRFGRDGTPSYSMLGRRKRTASTFQTPGPGAYSPEKAPPLNLHHRPPSYTMSSRTRYRSVDPVPAPNRYTLPNLFGTTVSCKPSSPCFTMSARMKAGGPSEDLSMTPGPGRYNSTDPSVYLNRQPSFSMQSRHNILIDSTGKPGPGTYSSEKVTAHLPRAPSVSLGVRHSEFVTPLIVDVLD,,spermatogenesis (GO:0007283) (0.5347); flagellated sperm motility (GO:0030317) (0.2766); cell differentiation (GO:0030154) (0.2327); spermatid development (GO:0007286) (0.1593); neuron migration (GO:0001764) (0.1279); Notch signaling pathway (GO:0007219) (0.0779),cytoplasm (GO:0005737) (0.3577); motile cilium (GO:0031514) (0.2046); extracellular region (GO:0005576) (0.1700); nucleus (GO:0005634) (0.1565); cilium (GO:0005929) (0.1089); cytoskeleton (GO:0005856) (0.1068); actin cytoskeleton (GO:0015629) (0.0894),small GTPase binding (GO:0031267) (0.0644),Ciliary Microtubule Associated (IPR051291) (0.0850),,Reference proteome (0.8131); Cell projection (0.5600); Cytoplasm (0.5337); Repeat (0.2182); Cilium (0.1594); Developmental protein (0.1449); Flagellum (0.1413); Nucleus (0.1367); Spermatogenesis (0.1118); 3D-structure (0.1000); Cytoskeleton (0.0976); Alternative splicing (0.0698); Repressor (0.0438),
MELSSIGEQVFAVESITKKRIRKGNVEYLLKWQGWSPKYSTWEPEDNILDPRLVLAFEEKAEKDRALAYKKKGLRPRQVILRNIYPMDLRSAHKVPDKPSPRIRLSLTRSMSTEVDQNGRRYRDSVVYRRLKNRYKNRQCRSRLFEGIKPSKQTMRHPLPAKDCTENAWNEDEQKRKVKKMRKDEENTTQVHQDIPSGQEMSEGYNSSAEQESEITIKEDENCSSIFDQEEKPSEDTGTAIGAPESSTITDTEKNEPVTNTAGDEDCVWVSHDTTNTDQSLHKCTKSGAEEGVFDRVQNRPSVIEVRLSARCGQEEVRESAEVGSSEAKDKEGIDAEVTAEFQVPIDQLQTPVTTAVHPGKVIVTQVTINSLTVTFKEAMTAEGFFSECGLEV,,negative regulation of transcription by RNA polymerase II (GO:0000122) (0.9823); positive regulation of DNA-templated transcription (GO:0045893) (0.3647); chromatin remodeling (GO:0006338) (0.2452); positive regulation of DNA methylation-dependent heterochromatin formation (GO:0090309) (0.1911); negative regulation of DNA-templated transcription (GO:0045892) (0.1902); chromatin organization (GO:0006325) (0.1168); protein sumoylation (GO:0016925) (0.1137); positive regulation of transcription by RNA polymerase II (GO:0045944) (0.0715); anterior/posterior axis specification (GO:0009948) (0.0598),PcG protein complex (GO:0031519) (0.2563); heterochromatin (GO:0000792) (0.2359); nucleus (GO:0005634) (0.2175); PRC1 complex (GO:0035102) (0.1978),chromatin binding (GO:0003682) (0.3761); single-stranded RNA binding (GO:0003727) (0.2730); methylated histone binding (GO:0035064) (0.1536),"Chromo domain, conserved site (IPR023779) (0.3440); Chromo domain (IPR023780) (0.3236); Chromo-like domain superfamily (IPR016197) (0.2178); Chromo domain subgroup (IPR017984) (0.2161); CBX family C-terminal motif (IPR033773) (0.1931)",,Transcription regulation (0.7082); Repressor (0.6169); Reference proteome (0.0660); Ubl conjugation (0.0652),
MRVKRHKVFLVCLLGICVVSFLHYYTALHNISLLQEISSPSSHLKTLKMLRGFLWNFPTDDIPFKQDRQKSSHQKDFVDLPDLPDAKQVVTNLHKQIFELRDDSTPFFTHTESGALCFHEGTDLAALASQGRLLKHYEERTPLKDDLIKSGKKDVRCPCRQGWHGPQCGIPTVVYHSNLPSKSKVTPRKIPRRVINAININHEFDLLHTRFHELADVVDTFLVCESNFTAYGDARPLYLKHLILNGTFDYIKHKILYIFLDHFPDGGRMDGWIADDYLRTYLTKNGMARIQGLKPDDVFILNDADEIPSRDGILFLKLYDGWTEPVGIHLRKSLYGFFWRQYGTLNVLSACTAAMLFKVYKGDGIYLRRRSYYTMSGFREYENSTGRILIPWAIGSPVHYAGWHCSWCFKPEGIYYKLVSAQNGDFPRWGDYGEKRKLSYIKDLIRTGGWFDGSEPDYPPTDPKEHMYAPKYLLDNYDKYHYLLENPYAKGKR,"beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase (2.4.1.144) (0.9092)",N-acetylglucosamine metabolic process (GO:0006044) (0.6559); protein N-linked glycosylation (GO:0006487) (0.3776); regulation of cell migration (GO:0030334) (0.2480); lysosomal protein catabolic process (GO:1905146) (0.2134); vulval development (GO:0040025) (0.1565); protein localization to early endosome (GO:1902946) (0.1109); amyloid-beta metabolic process (GO:0050435) (0.1017); lung alveolus development (GO:0048286) (0.0945); protein localization (GO:0008104) (0.0708),Golgi apparatus (GO:0005794) (0.3403); cis-Golgi network (GO:0005801) (0.1164); Golgi membrane (GO:0000139) (0.0841); Golgi medial cisterna (GO:0005797) (0.0840),"beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity (GO:0003830) (0.2339)","Glycosyl transferase, family 17 (IPR006813) (0.2256)",,Glycosyltransferase (0.7140); Reference proteome (0.5791); Membrane (0.4909); Transferase (0.1739); Zinc (0.1590); Transmembrane (0.1417); 3D-structure (0.1269); Golgi apparatus (0.1102); Glycoprotein (0.0780),
MSYKPVTHVLFDMDGLLLDTERLYTVSFQEVCDRFNKQYTWEVKSSVMGKKALDAARIIRDKIGLPMTPEELLEETRKIQERLFPTTSLLPGVEKLVNHLHKHGIPIAVGTSSAGLTFEMKTSRHKEFFSLFSHIVLGDDPDVKNGKPLPDTFLVCAKRFSPPANPKQCLVFEDAPNGVKAGLAAGMQVVMIPDDNLDRSLTQEATLLLRSMEDFRPELFGLPAYA,glycerol-1-phosphatase (3.1.3.21) (0.5942); pseudouridine 5'-phosphatase (3.1.3.96) (0.0922); 3.1.3.- (0.0896),nucleotide metabolic process (GO:0009117) (0.4148); riboflavin biosynthetic process (GO:0009231) (0.1210); dephosphorylation (GO:0016311) (0.0821),extracellular exosome (GO:0070062) (0.2194); Golgi apparatus (GO:0005794) (0.1428); nucleus (GO:0005634) (0.1132); cytoplasm (GO:0005737) (0.0662),phosphatase activity (GO:0016791) (0.4285); magnesium ion binding (GO:0000287) (0.2760); protein homodimerization activity (GO:0042803) (0.1335); metal ion binding (GO:0046872) (0.1150),"Phosphatase Gpp1/Gpp2-like (IPR045228) (0.3923); HAD hydrolase, subfamily IA (IPR006439) (0.3169); Phosphoglycolate phosphatase-like, domain 2 (IPR023198) (0.2976); HAD-like superfamily (IPR036412) (0.2477); Haloacid dehalogenase-like hydrolase (IPR041492) (0.1503); HAD superfamily (IPR023214) (0.1051)",,Reference proteome (0.8485); Phosphoprotein (0.8031); Hydrolase (0.5760); Magnesium (0.4378); Metal-binding (0.4196); 3D-structure (0.4065); Direct protein sequencing (0.1910); Alternative splicing (0.1582); Proteomics identification (0.1552); Nucleus (0.1249); Cobalt (0.1179); Lipoprotein (0.0578); Zinc (0.0516); Ubl conjugation (0.0453),Mg(2+) (0.2502); Ni(2+) (0.0950)
MDVLANYSIFQELQLVHDTGYFSAMPSLEENWQQTCLELERYLQTEPKRLSDLFDEELDGLLSPSFMKEDGDEDLLDPLLPSLNNPPSPSQRKETHSSISPDATLGVNAAQLNAVTSLTPPSSPELGRHLVKPTHTLSASPDGTLTLKLVARKVGLSSAKLVAAHPVPLSPQHGSTGTQSDGEQGGTCTIGVGDMAENKKRVHRCQFNGCRKVYTKSSHLKAHQRTHTGEKPYKCSWEGCEWRFARSDELTRHYRKHTGAKPFKCNHCDRCFSRSDHLALHMKRHV,,negative regulation of transcription by RNA polymerase II (GO:0000122) (0.5262); regulation of transcription by RNA polymerase II (GO:0006357) (0.3652); regulation of epidermal cell differentiation (GO:0045604) (0.2531); Wnt signaling pathway (GO:0016055) (0.2132); positive regulation of miRNA transcription (GO:1902895) (0.1378); positive regulation of DNA-templated transcription (GO:0045893) (0.1264); negative regulation of sprouting angiogenesis (GO:1903671) (0.0842); positive regulation of transcription by RNA polymerase II (GO:0045944) (0.0769); protein import into nucleus (GO:0006606) (0.0663); central nervous system development (GO:0007417) (0.0622); negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051) (0.0593); skeletal muscle cell differentiation (GO:0035914) (0.0590); negative regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061179) (0.0552); maternal process involved in female pregnancy (GO:0060135) (0.0541); DNA-templated transcription (GO:0006351) (0.0519); glucose homeostasis (GO:0042593) (0.0515); circadian rhythm (GO:0007623) (0.0457); cellular response to peptide (GO:1901653) (0.0448),chromatin (GO:0000785) (0.3861); nucleus (GO:0005634) (0.0967); cytoplasm (GO:0005737) (0.0756),"RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978) (0.1058); DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981) (0.0736)",Zinc finger C2H2-type (IPR013087) (0.0890),,Repeat (0.7031); Zinc (0.4494); DNA-binding (0.3952); Zinc-finger (0.3843); Metal-binding (0.1958); Nucleus (0.1250),
MDYRSVFLLLSVCGLTRAFTMDLDYGGVPLWINRFLGEPSVLTLKDRIDPGWYRAVNTQSCPLECDCPIQWPTAIYCDHRGLNQLPSGLPFRLQYLFLQGNNITSLGSRAFDNTTYLRWLILDHNQLLSEQLDNVLFSSLTRLVNLFINHNNLTKVPAGLPSGLKQLRLAYNHIEKISEGDFQNLDSLTLILLQGNRLKTIEEGDFKGLGALNLLDLSHNFLDTFPKHLPPSVQQLYLSNNSLTGLSENSLHGFSGLRYLRLGHNKLRNERLDPGAFNLTSLVELDLSYNRLTEIPSVPITLQYLYLEVNHIQEFNVSSFCRTVGPTSYSRMKILRLDGNKLEYHKLPPDWVFCLRVLHNIYI,,positive regulation of macroautophagy (GO:0016239) (0.5376); hippocampus development (GO:0021766) (0.2332); cell adhesion (GO:0007155) (0.1560); articular cartilage development (GO:0061975) (0.1474); negative regulation of angiogenesis (GO:0016525) (0.1042); ovarian follicle development (GO:0001541) (0.1015); bone growth (GO:0098868) (0.0817); angiogenesis (GO:0001525) (0.0753); negative regulation of neuron projection development (GO:0010977) (0.0437),extracellular matrix (GO:0031012) (0.3077); extracellular space (GO:0005615) (0.1940); extracellular exosome (GO:0070062) (0.1597); Golgi lumen (GO:0005796) (0.1504); lysosomal lumen (GO:0043202) (0.0691),extracellular matrix structural constituent conferring compression resistance (GO:0030021) (0.3541); collagen binding (GO:0005518) (0.1977); heparin binding (GO:0008201) (0.1400); identical protein binding (GO:0042802) (0.0611),"Leucine-rich repeat domain superfamily (IPR032675) (0.1483); Leucine-rich repeat N-terminal domain (IPR000372) (0.1468); Leucine-rich repeat, typical subtype (IPR003591) (0.1361)",3.80.10.10 (0.1513),Sulfation (0.8385); Repeat (0.6739); Proteoglycan (0.4898); Secreted (0.4070); Signal (0.3740); Reference proteome (0.3341); Extracellular matrix (0.3264); Direct protein sequencing (0.3231); Leucine-rich repeat (0.3181); Disulfide bond (0.2929); Glycoprotein (0.2477); Proteomics identification (0.1328),
MESKELFQKTLDLTAVWMVLHALCFATHASELLYSTAEESKPGTIVGHLTKDLGMDIHMIVLRQMRIISESNDKYFNVDLTSGALVIKETMDREILCGGRLHCHIRIQISLQNPLEMHSVSIEIVDVNDNAPQFQSQNTSLEVSEAAAPGTSFRLESAHDPDVGVNSLRAYYLSQNDCFILKIDTKSDGSKIPILVLNKPLDREKMSEYRLILTAVDGGSAEKSGNSAVFINILDVNDNAPHFLNPTKRVTLLENSPHGTLVTLLNASDADHGQNGEISYTFDKYTPDSVLKLFSVDSVTGEIRVTGLIDHELAKVHDVTVLARDKGMPPMEGSCNIKIEIIDVNDNTPEISINMVSSVISEDVTLGTVIALIKVKDEDTGKNGEVNLHIPYGLPFKISSPYKGLFTLMADGLLDREAVAEYTITVTATDSGSPPRSSQKSFVLCLSDVNDNPPVFSQPSYSVDIAENNAPNAPLLSVSASDPDVGENSTISFSILESEALGLSVSSYVYINPNSGQIYAIRKFDYEHLNAFQFVVRVQDRGTPSQSSNATVHVFITDQNDHPPILIYPAPTSDGTLHFFIPRTASIGHLVNRITFVDGDSGHNAWLFYSILGPDAEMFHIDAHTGELRTAQKLSEEDSKSVFSLNVIVKDNGRPSRSASVAVNITLAEKSSDVSSERRSLTSKTPTGSNLTLYLIITLSFIIAFSFLAIIAIAVRWLSHHGYMICLMQKLGFKHTPRAHQHNDLHLQLNTDGPIRFMEVVGATQDFHKHAYTPGLSTISSRSDFVFVKAPESTLSMRLSKRLFAHSLMKQKPPNTDWRFPPNQRPGPSGAGARPEEAGAGAGVIAGTGPWPNPPTEAEQLQAMMAAANASEATATLGPRYNLQYGPDYRQNVYIPGSTATLTANPQQQVLQQALPPPQALPPTEAPKAAQTPASKKKPTKKDKK,,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) (0.6191); cell adhesion (GO:0007155) (0.5490); chemical synaptic transmission (GO:0007268) (0.2146); calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) (0.2024); axon extension (GO:0048675) (0.1559); locomotory behavior (GO:0007626) (0.1468); morphogenesis of embryonic epithelium (GO:0016331) (0.1106); synapse assembly (GO:0007416) (0.0857); nervous system development (GO:0007399) (0.0819); cell morphogenesis (GO:0000902) (0.0482),synapse (GO:0045202) (0.3232); plasma membrane (GO:0005886) (0.2720); glutamatergic synapse (GO:0098978) (0.2311); cytoplasm (GO:0005737) (0.1703); postsynaptic membrane (GO:0045211) (0.1091); membrane (GO:0016020) (0.0749); extracellular region (GO:0005576) (0.0671),calcium ion binding (GO:0005509) (0.2813),"Cadherin-like (IPR002126) (0.2963); Cadherin, C-terminal catenin-binding domain (IPR031904) (0.2379); Cadherin, N-terminal (IPR013164) (0.2134); Cadherin-like superfamily (IPR015919) (0.1772); Protocadherin/Cadherin-related Cell Adhesion (IPR050174) (0.1400); Cadherin conserved site (IPR020894) (0.1351)",2.60.40.60 (0.2066),Reference proteome (0.7099); Transmembrane helix (0.6917); Transmembrane (0.6439); Membrane (0.4557); Glycoprotein (0.4217); Repeat (0.2546); Signal (0.2366); Proteomics identification (0.2030); Alternative splicing (0.1318); Vision (0.1076); Cell membrane (0.0926); Cell adhesion (0.0896),
MMGSRGVLSIIFDLDNTLIDTAGAGRTAIQKVCELLKSTHVQESHIRDICERFLRKLLQESFDPSEGKTIDDVRIQHWCEALQETPGTDPDPALASRCYYTWKNTRLQALSLSSEVRALLEELQKNYKLLLLTNGDTQTQREKIEAVRCEGLFSLVVVGGDHPEQKPARSIFTHCFESAGVRPQDCIMVGDSLTTDIQGGVNAGVRATVWINAGSKSLPQDSVTPDYTLPTVLHLKEVLAQLA,N-acylneuraminate-9-phosphatase (3.1.3.29) (0.7851); 3.1.3.- (0.0926),N-acetylneuraminate biosynthetic process (GO:0046380) (0.4462); dephosphorylation (GO:0016311) (0.2579); N-acetylglucosamine biosynthetic process (GO:0006045) (0.2409); CMP-N-acetylneuraminate biosynthetic process (GO:0006055) (0.0842),nucleus (GO:0005634) (0.2729); cytosol (GO:0005829) (0.2420); cytoplasm (GO:0005737) (0.1780),N-acylneuraminate-9-phosphatase activity (GO:0050124) (0.3621); phosphatase activity (GO:0016791) (0.2299),"HAD-like superfamily (IPR036412) (0.3167); HAD-like hydrolase superfamily enzymes (IPR051400) (0.3155); HAD hydrolase, subfamily IA (IPR006439) (0.2638); HAD-superfamily hydrolase, subfamily IA, CTE7 (IPR011950) (0.1983)",1.20.120.710 (0.1923); 3.40.50.1000 (0.0663),Reference proteome (0.8839); Protein phosphatase (0.5551); Hydrolase (0.4065); Metal-binding (0.3814); Mitochondrion (0.3006); Magnesium (0.2745); Cytoplasm (0.2518); Alternative splicing (0.1910); Direct protein sequencing (0.1723); Nucleus (0.1332); Proteomics identification (0.1196); 3D-structure (0.0584),Co(2+) (0.8113); Mg(2+) (0.2614)
MGKYIEKMEIRWNGRSKRAALWLLSVFLMWSTVGALTRYTIPEELQEGSVVGNIAKDLGFVVSDIANRNLRVVSENSGQYFSVGSERGELVVNSRIDRESLCPQSASCVVPLQVIIENPLQLHRVEIEIQDINDNAPIFQTSEGVLEIAESITLGDRFPLESAEDLDVGKNSLKSYVLSNDECFRLNVKTLADGRKVPELVIDKPLDREKKSAHKLILTAVDGGDPAKTGTTVIQINVLDSNDNAPKFDLPMYKSSLREAAPVGSTVITIKATDLDEGDNGELQYFLGVHTPEPVRKMFALKPDTGEIIVLGNIDYESNKLYRFDVSAKDKGNPELVGHSSVQIDIIDENDNPPEIILTSSPSPVPENASVGTVVALINVKDLDSGVNGRVSINISPGFPFTLKPSFENHYSLVTDSSLDREIYAEYNILLVATDSGVPSLKTEKTINVKVLDVNDNPPSFSQTSYNVYVQENNLAGVSLFSVSATDNDQDKNALLTYSILDLGSNQVPASSYFYINSENGTIYSMSSFDYEKMKLISIVVQAKDQGSPSLSSNATVHVFILDRNDNAPAVIYPSTSMGSVSHQRMPRSAKAGHLVTKVTAVDADSGHNAWLFYRLAEATDASLFSVNLHTGEVRTKRAVSEHDDSSQRLVLEIKDNGEPIQSTTVTVDILIEDGFHEPISDYREKTIEPSKKTGKITLYLIISLASVSLLCLMTFFILLVKCARGSRGGSSCCIRRTNSEYKNPNRNLQIQLNTDGPIKYVEVLGGDMMSQSQSFGSYLSPMSEFSDLTLIKPSSTTNFTDTLNTLDASLPDSAWTFESQQQKPPNTDWRFPPNQRPGPSGAGARPEEAGAGAGVIAGTGPWPNPPTEAEQLQAMMAAANASEATATLGPRYNLQYGPDYRQNVYIPGSTATLTANPQQQVLQQALPPPQALPPTEAPKAAQTPASKKKPTKKDKK,,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) (0.8000); cell adhesion (GO:0007155) (0.3593); adult behavior (GO:0030534) (0.2441); calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) (0.2117); chemical synaptic transmission (GO:0007268) (0.1287); synapse organization (GO:0050808) (0.1123); cell morphogenesis (GO:0000902) (0.0798); excitatory postsynaptic potential (GO:0060079) (0.0789),glutamatergic synapse (GO:0098978) (0.2831); synapse (GO:0045202) (0.2790); plasma membrane (GO:0005886) (0.2617); membrane (GO:0016020) (0.1672); cytoplasm (GO:0005737) (0.1656); postsynaptic membrane (GO:0045211) (0.1184),calcium ion binding (GO:0005509) (0.2196),"Cadherin-like (IPR002126) (0.3954); Protocadherin/Cadherin-related Cell Adhesion (IPR050174) (0.2522); Cadherin-like superfamily (IPR015919) (0.2026); Cadherin conserved site (IPR020894) (0.1849); Cadherin, N-terminal (IPR013164) (0.1706); Cadherin, C-terminal catenin-binding domain (IPR031904) (0.1516)",2.60.40.60 (0.2721),Reference proteome (0.8427); Transmembrane helix (0.6578); Membrane (0.4891); Transmembrane (0.4612); Glycoprotein (0.3715); Synapse (0.2657); Cell membrane (0.2559); Calcium (0.1977); Repeat (0.1845); Proteomics identification (0.1781),
MSSTHVLQALCLLMLFSMTTAQQGYMHESGEDWVNAWRQGFNFQCPHGEVLVAVRSYFSEKEGSDRLWSFECQRTPYGWGEPSECWWDDINRAGMEWSSVCTSNGLVAGVQSKYFEAVLDREWQFYCCRYAQRCPYSCWKTYDVPEYYREEGEMVVPSYGYFIRGAQTTFSGVLRDRQWKYILCRMTDFDCQFQNY,,collagen fibril organization (GO:0030199) (0.4196); cellular response to tumor necrosis factor (GO:0071356) (0.3780); negative regulation of cell population proliferation (GO:0008285) (0.3477); cellular response to interleukin-1 (GO:0071347) (0.1879); spermatogenesis (GO:0007283) (0.1492); blastocyst development (GO:0001824) (0.1369); cell adhesion (GO:0007155) (0.0961); angiogenesis (GO:0001525) (0.0920); single fertilization (GO:0007338) (0.0819); bone mineralization (GO:0030282) (0.0757); response to vitamin D (GO:0033280) (0.0493),extracellular matrix (GO:0031012) (0.2691); collagen-containing extracellular matrix (GO:0062023) (0.0813); extracellular region (GO:0005576) (0.0672),,,,Signal (0.8394); Secreted (0.6917); Sulfation (0.6695); Zinc (0.6015); Reference proteome (0.4962); Glycoprotein (0.4753); Disulfide bond (0.2209); Repeat (0.1461); Disease variant (0.1151); Direct protein sequencing (0.1135); Proteomics identification (0.0974); Extracellular matrix (0.0873); Cell adhesion (0.0739); Toxin (0.0594),
MNNQIETAQCFSDNISQVSVTISDFSDEILLNILRFIPSHDLILNVSRVCRKLRTLCLDKSLRVHVHLHKEYTANDDAVKQLLKVISADIQTLNLNGCYWLAGSTVDQVTRCKSLVSLDLSGCRLTSVRLSHLLSSLSSLKSLALDVGPGFDLHQLSAEGKSALARLQELKQTLLTPSYGVVPCCSALRRLHLYLEASEVWREAGGCAQLMVGQSSVPHYQNLRWFSARLAPGEVNRTLLALYLAVFSMRVPEGLAGLVLSVPGPAPPRPVAMTALMESMASTVGNTVSALQLPRTWLDGAILGRVLAHGCPAYLNVSRCSSPGFNPLHVLLSAGRDLTPLRSLNLRGCGRGPLSESCGKGDEEMDTDSVKALAECCPHLNHLNLSATHYHHNLSTGQDGHLCGTLGRLTGLCSLALPVCALAQSPPTQINNQDSNTDLASRSLLLGLKKTTRIGVPTYRPTSEIAVGQGEERTDRGLCIQPLLQGCPYLVELELIGAGFSSAMPRNEPAIRKDPAACSWSYSVGDGELAALGGMKFLRKLTLAHLPGVLKGTGLIELLQGCKDLHSLSLANLGSLKTMNYTQALLEALSYCTQVRDLRLEQPYFNANAAFFEALSQCGQLRRLCLVSRHGTFQPAAVTAFMQSCSDVIMCHMFMGGTLVACKTLQKTLLDSFSVSRPALSVVIYPLLHEDLAHVIRGMPLCHLDEMTLFKSRVAEEPMSR,,negative regulation of cell population proliferation (GO:0008285) (0.2834); ubiquitin-dependent protein catabolic process (GO:0006511) (0.2674); DNA damage response (GO:0006974) (0.1943); protein ubiquitination (GO:0016567) (0.1844); cellular response to ionizing radiation (GO:0071479) (0.1606); regulation of circadian rhythm (GO:0042752) (0.1484); protein polyubiquitination (GO:0000209) (0.1325); protein K48-linked ubiquitination (GO:0070936) (0.1185); neuron differentiation (GO:0030182) (0.1124); SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146) (0.1024); negative regulation of protein ubiquitination (GO:0031397) (0.0931); G1/S transition of mitotic cell cycle (GO:0000082) (0.0849); proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161) (0.0627); bone mineralization (GO:0030282) (0.0540),cytosol (GO:0005829) (0.2549); nucleoplasm (GO:0005654) (0.1100); perinuclear region of cytoplasm (GO:0048471) (0.0669); nucleus (GO:0005634) (0.0540),,"Leucine-rich repeat domain superfamily (IPR032675) (0.3361); Leucine-rich repeat, cysteine-containing subtype (IPR006553) (0.2597); F-box domain (IPR001810) (0.2158); F-box-like domain superfamily (IPR036047) (0.1835)",3.80.10.10 (0.5379); 1.20.1280.50 (0.3040),Ubl conjugation pathway (0.9129); Leucine-rich repeat (0.3895); Phosphoprotein (0.3089); Reference proteome (0.2407); Cytoplasm (0.1401); Alternative splicing (0.1275),
MFQRVSGAPSVLQRLVFTGCCCRRVYRRSPAVSVRHILLEDHAGGWRTAVLSVTGCRGFTSDTNTGKLRPLLSVRSSFLMQPRRSLTTPEKHERAADIRSDGVSSAADGSELKASKVQQLRQVFQQYGAVGVSFHICISLISLGIFYLAVSSGLDVASLLCKLGFSEAVVQSRLAAGTSVFVLAYAVHKLFAPLRISITLVCVPLIVRHLRRTGLFRSRTSGP,2.3.1.- (0.1833),regulation of cell growth (GO:0001558) (0.1916); response to glucose (GO:0009749) (0.0852); response to nickel cation (GO:0010045) (0.0697); response to nutrient levels (GO:0031667) (0.0679); negative regulation of transcription by RNA polymerase II (GO:0000122) (0.0637); glucose-6-phosphate transport (GO:0015760) (0.0608); apoptotic process (GO:0006915) (0.0558); phosphate ion transmembrane transport (GO:0035435) (0.0555); positive regulation of cold-induced thermogenesis (GO:0120162) (0.0495); cellular response to estradiol stimulus (GO:0071392) (0.0419),mitochondrion (GO:0005739) (0.4325); endoplasmic reticulum membrane (GO:0005789) (0.1262); membrane (GO:0016020) (0.0750); nucleoplasm (GO:0005654) (0.0458),,Protein FAM210A/B-like domain (IPR009688) (0.2205),,Reference proteome (0.4315); Mitochondrion (0.4064); Transit peptide (0.3801); Transmembrane (0.3013); Disease variant (0.2846); Zinc (0.2581); Mitochondrion outer membrane (0.2540); Membrane (0.2226); Tumor suppressor (0.2110); Transport (0.2039); Endoplasmic reticulum (0.1274); Ubl conjugation (0.1106); Transmembrane helix (0.1103); Differentiation (0.0949); Stress response (0.0890); Developmental protein (0.0839); Phosphoprotein (0.0681),
MATSSAENLSNPPFKSLKIRYTFLLLLVAYVSGAVGNREDHVFKHNHEHNANTFLGSEDKDEIQKLSPSEQRKRLVEIVKKIDTNSDKYLTPEEITVWIQRVYRKYALDDAEERFPEFDSNNDGLVSWDEYNMVMHGHTVEVDGDAVLEDPEEESLRFLHAKEKRRFDFANMDGSAGLNLTEFLAFTHPSEVDHMADFAIEDVLSEYDLDKDGFISLSEFIGDLRTNEQDEPSQWEIEETVRFKDLYDQDQDGKLNRDEQLRWVAPNSYGSAREEALHLIKEMDQDGDNRLSETEILKNQDTFMHSEVTDYGRQLHVPHDEL,,response to ethanol (GO:0045471) (0.4063); UV protection (GO:0009650) (0.2061); chromatin organization (GO:0006325) (0.1839); protein secretion (GO:0009306) (0.1315); maintenance of synapse structure (GO:0099558) (0.1252); response to endoplasmic reticulum stress (GO:0034976) (0.1152); positive regulation of peptidase activity (GO:0010952) (0.0968); protein transport (GO:0015031) (0.0726); regulation of Ras protein signal transduction (GO:0046578) (0.0578),endoplasmic reticulum (GO:0005783) (0.4502); membrane (GO:0016020) (0.3065); intracellular membrane-bounded organelle (GO:0043231) (0.1757); melanosome (GO:0042470) (0.0640); cytoplasm (GO:0005737) (0.0567); endoplasmic reticulum lumen (GO:0005788) (0.0532); Golgi apparatus (GO:0005794) (0.0455),calcium ion binding (GO:0005509) (0.5848); identical protein binding (GO:0042802) (0.1088),"EF-Hand 1, calcium-binding site (IPR018247) (0.3122); EF-hand domain (IPR002048) (0.2518); EF-hand domain pair (IPR011992) (0.2139)",1.10.238.10 (0.5377),Reference proteome (0.5573); Sarcoplasmic reticulum (0.4273); Secreted (0.4179); Glycoprotein (0.4068); Phosphoprotein (0.3769); Endoplasmic reticulum (0.3521); Acetylation (0.3116); Signal (0.2892); Repeat (0.2789); Disulfide bond (0.2021); Direct protein sequencing (0.1663); Metal-binding (0.1658); Membrane (0.1461); Calcium (0.1394); 3D-structure (0.1118),
MGTHLSGVNVVLVMTYGCLVFVLLFIFMKRQIMRFAMKSRRGPHVPLGHNAPKDLREEIDLCLSKVNDVRYEPSLLSKDDDRLRHQGQIGCYNYLYRMQTLDAIRDSDLPVLDMSRSASALTGRQYKKWLMDLRISHSLVKFNHSALLDRLLEGYDNARHGTGVFGEAEFVKYKQDLTELAALVKSHSNSSSLNQQHQSAAKDLTSSPGPSSTSTIQVTYLPSSGQRSKRPKHFLELKNFKDNYNTLESTL,,phagocytosis (GO:0006909) (0.5878); in utero embryonic development (GO:0001701) (0.2614); kidney development (GO:0001822) (0.0974); central nervous system development (GO:0007417) (0.0518); intracellular protein transport (GO:0006886) (0.0482); protein glycosylation (GO:0006486) (0.0412),Golgi apparatus (GO:0005794) (0.5183); Golgi membrane (GO:0000139) (0.4530); mitochondrion (GO:0005739) (0.2945); membrane (GO:0016020) (0.1995); cis-Golgi network (GO:0005801) (0.1211),,,,Reference proteome (0.7871); Transmembrane helix (0.7447); Golgi apparatus (0.7311); Transmembrane (0.6859); Mitochondrion (0.3879); Membrane (0.2931); Cytoplasm (0.2574); Proteomics identification (0.2356); Endoplasmic reticulum (0.1739); Phosphoprotein (0.1594); 3D-structure (0.1389); Alternative splicing (0.1206); Zinc (0.0489),
MGDFQNTEQDFYQSGYYIDGQQEDVYGYDPAYLNPEYNDADNSAHLADEYAASAPYTGQVYQPVAQPEQTEYTDSYEDEPPLLEELGINFEHIWQKTLTVLNPLKPADGSIMNETDLTGPVLFCVALGATLLMAGKAHFGYVYGISALGCVGMYMLLNLMSIYSISCGSVASVLGYSLLPMVALSAFAVVYSLQGLLGTLLALIVIGWCSLSASKIFSSTLAMSGQQLLVAYPCALLYGVFALLTVF,,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888) (0.9561); insulin processing (GO:0030070) (0.5251); regulation of ER to Golgi vesicle-mediated transport (GO:0060628) (0.3424); vesicle fusion with Golgi apparatus (GO:0048280) (0.3044); Golgi organization (GO:0007030) (0.2704); protein transport (GO:0015031) (0.2290),endoplasmic reticulum membrane (GO:0005789) (0.4891); nuclear outer membrane-endoplasmic reticulum membrane network (GO:0042175) (0.3289); Golgi membrane (GO:0000139) (0.2623); COPII-coated ER to Golgi transport vesicle (GO:0030134) (0.1666); trans-Golgi network (GO:0005802) (0.0519); endoplasmic reticulum (GO:0005783) (0.0448),,Yip1 domain (IPR006977) (0.3047); Protein Yip1/4-like (IPR045231) (0.2812),,Transmembrane helix (0.8717); Transmembrane (0.8166); Reference proteome (0.8033); Transport (0.7574); Membrane (0.5629); Golgi apparatus (0.4291); Endoplasmic reticulum (0.4289); Protein transport (0.4109); ER-Golgi transport (0.3129); Phosphoprotein (0.1765); Proteomics identification (0.1747); Acetylation (0.1557); 3D-structure (0.1550); Ubl conjugation (0.1503); Unfolded protein response (0.0586),
MDPAAKQKVIYITYLIAALEITWMFLQFSITPYLARRLGFDTIWFGYLQTTVGVIQLLGGPIYGRFADIFGARAALSVSCGASVFYFLLLTVADSPFMLFVHKLPAVFMHALPGAQMVVADLSEKEKRAEALGKLGLCFGIGMIAGSSLGGTLSTRFGERFAASFGAVGSFVSLMLVLNFIPKQTKTQTTPESDEKGSSKSVFNMGEITRLMKFPGVAKTFTVKIISGLPTGIFQVMFSIIAMNFFQLKAEQNGYLMAYFGIVQMVIQGAVIGRLTSSFSENSLLLLSVGVSSLVGLAQALMTNVFQFCFIVIPMMFSLSVFNVITDSMLTKSVSPADTGTMLGLCASVQSLLRTVGPTIGGFLYETYGVPSFGYIQCVINAAVFGLLLTTGGRSQTHRP,,spermatogenesis (GO:0007283) (0.3617); locomotory behavior (GO:0007626) (0.2476); transmembrane transport (GO:0055085) (0.2355); acrosome assembly (GO:0001675) (0.1976); apoptotic process (GO:0006915) (0.1234); cell division (GO:0051301) (0.0927); xenobiotic transport (GO:0042908) (0.0927); monoatomic ion transport (GO:0006811) (0.0699),membrane (GO:0016020) (0.4712); cytoplasm (GO:0005737) (0.2858); plasma membrane (GO:0005886) (0.1750); mitochondrion (GO:0005739) (0.0997); apical plasma membrane (GO:0016324) (0.0846),ubiquitin protein ligase binding (GO:0031625) (0.1607); transmembrane transporter activity (GO:0022857) (0.1026),Tetracycline resistance protein TetA/multidrug resistance protein MdtG-like (IPR001958) (0.4196); MFS transporter superfamily (IPR036259) (0.2115); Major facilitator superfamily domain (IPR020846) (0.1765); Major facilitator superfamily (IPR011701) (0.1214),1.20.1250.20 (0.2295),Transport (0.9904); Transmembrane (0.8204); Membrane (0.7805); Reference proteome (0.6837); Transmembrane helix (0.2884); Proteomics identification (0.2735); Alternative splicing (0.2347); Disease variant (0.1721); Cell membrane (0.1651),
MSDSGVCTIKQEDAEEQIDLLNENKEIEDLIKRGEKHHIKTEENLYSISTIRKDNPCFTCLQCKNTFSCEESLNLHMKIHREVKPHTSDQCDEIFTVKVTNNVNVHAEETVYNCDQCDRTFTDKRNLAAHMKFHSGEKPFMCDLCGRSFLYANTLKKHRNLHSAVKNHVCSKCGKSFFTFSQLKIHHTAHATEKPFKCSHCGKAFKSLQCQRIHEMIHSGEKPHKCDQCEKTFRQRKSLNIHIRIHTGEKPYTCDHCGRSFSRKETLNSHLKTHSGNMLYTCAECGEGFNNTGDFTAHMKTHFGENPFLCDQCGKGFPNRTALKKHQNIHKGLKNHVCSKCGKTFLTNAILKAHERLHTTERPHKCSHCDKAFKLSQHLKIHVKIHTGEKPYSCDPCGKSFRQKRDLDVHIEKHTEEKPHKCDQCGAGFARKLSLANHKNIHTGENTCDQCGMSFATKSSLENHIKIHTGEKPFTCDHCEASFARRDSLANHIKLHTGENLHKCDQCGKSFRRYDVFKAHLLTHSRERIYKCNQCDKSFFKPSLLRDHRKVHTDERPYVCYLCGRSFRYKTALKIHQKRHDGVKDHACSECGKTFYTDSALKDHQSVHTTETPYECSYCDKRFKRLQYLKIHTKIHTGEKLNQSDL,,regulation of transcription by RNA polymerase II (GO:0006357) (0.5336); negative regulation of transcription by RNA polymerase II (GO:0000122) (0.4046); DNA damage response (GO:0006974) (0.1023); post-embryonic development (GO:0009791) (0.0787); regulation of DNA-templated transcription (GO:0006355) (0.0740); regulation of mitotic cell cycle (GO:0007346) (0.0599),nucleus (GO:0005634) (0.3081); nucleoplasm (GO:0005654) (0.1727); chromatin (GO:0000785) (0.1095),"DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981) (0.2319); sequence-specific DNA binding (GO:0043565) (0.2019); RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978) (0.1681); DNA-binding transcription factor activity (GO:0003700) (0.1250); RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977) (0.1141); metal ion binding (GO:0046872) (0.1014)",Zinc finger C2H2-type (IPR013087) (0.3280); Zinc finger C2H2 superfamily (IPR036236) (0.0944),3.30.160.60 (0.2020),Zinc-finger (0.9579); Ubl conjugation (0.8569); Repeat (0.7735); Metal-binding (0.4007); DNA-binding (0.3950); Reference proteome (0.3748); Transcription (0.2614); Nucleus (0.2511); Phosphoprotein (0.2257); Isopeptide bond (0.1593); Alternative splicing (0.0887); Coiled coil (0.0731); Transcription regulation (0.0657); Zinc (0.0531),
MDPASHPEQLSVVNEQVLNSADRSVTAAVCLRRFLCYGSESSTYSTKECPLGIENALSLMQLIEGGRGSEVVDEVRRFNLEGRAVRPNPGLFTLAVCSQHADCKTRQAALRALKELCRSPMQLFTFVQYKKELKEGSGMWGRALRRVVTDWYNGQDGISLAQAVTKCKHRAGWSHQDLLRLSHMKPANDNIALVCKYITKGWKGVEEAYAEKDKSEDLQKVFAYLEAVEKVKHSTDEQELIHLIEEQRLGKEQLLTNHLKSKEVWKALLKEMPVAVLLKHLGKLTANKVLIPGSPDIAAVCGRIQEETVLKKAKTQPFNILAASENYKRGHGKRSKLKWEPDRDLVQALDCAFCKSISTMEATGKRFLVAVDISSSLSSLCRGSSISTVAVAAAVCMIIAQTEPNAQIVVFSEGNLLPCTVSSDMTLMQVAGLLIQTPGGSTDCSLPITWASENEKTVDVFIILTNNQTFGRENPADTLKMYRQKSSVFSKLVVCGLIANNLSIADPEDCGMLDICGFDSQAVDVIHNFALDIF,,immune system development (GO:0002520) (0.7554); regulation of gene expression (GO:0010468) (0.6528); smoothened signaling pathway (GO:0007224) (0.2202); cilium assembly (GO:0060271) (0.1408); neuron differentiation (GO:0030182) (0.0986); in utero embryonic development (GO:0001701) (0.0939); cellular response to interferon-alpha (GO:0035457) (0.0860); cytoskeleton organization (GO:0007010) (0.0425),cytosol (GO:0005829) (0.2347); nucleus (GO:0005634) (0.2310); cytoplasm (GO:0005737) (0.1820); ribonucleoprotein complex (GO:1990904) (0.1567),RNA binding (GO:0003723) (0.3030); metal ion binding (GO:0046872) (0.1850),von Willebrand factor A-like domain superfamily (IPR036465) (0.5177); RNA-binding protein RO60 (IPR040322) (0.1705); TROVE domain superfamily (IPR037214) (0.1007); TROVE domain (IPR008858) (0.0563),3.40.50.410 (0.3497),Ribonucleoprotein (0.5975); Reference proteome (0.5435); Cytoplasm (0.5412); RNA-binding (0.3612); mRNA processing (0.3357); Ubl conjugation (0.2515); Repeat (0.2437); 3D-structure (0.2170); Nucleus (0.1846); Phosphoprotein (0.1794); Proteomics identification (0.1427); Alternative splicing (0.1343); Disease variant (0.0669); Direct protein sequencing (0.0465),
MKMNTALTVVGALLVNIAGSLCQLNVCGRAPLNTKIVGGQNAGAGSWPWQVSLQSPTYGGHFCGGSLINKDWVLSAAHCFQDSLGTVKVKLGLQSQSGSNPYQITKTVVQVINHPNYNNPSNDNDIALVKLDSSVTFNDYIEPVCLAAAGNTYAAGTLSWVTGWGKLSSAANQIPDILQEVEIPIVSNSDCKRAYPGEITSNMICAGLLDQGGKDSCQGDSGGPMVSRNGSQWIQSGIVSFGRGCAEPGYPGVYARVSQYQDWITSSTGSSNPPGFVEFHSSGFRSTSNLFLLSISLTLSIIPFASVLSS,3.4.21.- (0.4277); acrosin (3.4.21.10) (0.2668); trypsin (3.4.21.4) (0.0774),proteolysis (GO:0006508) (0.7345); digestion (GO:0007586) (0.6900); extracellular matrix disassembly (GO:0022617) (0.0978); epithelial cell differentiation (GO:0030855) (0.0754); negative regulation of transcription by RNA polymerase II (GO:0000122) (0.0692); defense response to fungus (GO:0050832) (0.0641); angiogenesis (GO:0001525) (0.0521),extracellular space (GO:0005615) (0.1776); extracellular region (GO:0005576) (0.1414); external side of plasma membrane (GO:0009897) (0.0673); endoplasmic reticulum membrane (GO:0005789) (0.0558),serine-type peptidase activity (GO:0008236) (0.1103); D-mannose binding (GO:0005537) (0.0939); endopeptidase activity (GO:0004175) (0.0532); metal ion binding (GO:0046872) (0.0476),"Peptidase S1, PA clan (IPR009003) (0.4309); Serine proteases, trypsin family, serine active site (IPR033116) (0.2919); Peptidase S1, PA clan, chymotrypsin-like fold (IPR043504) (0.1965); Peptidase S1A, chymotrypsin family (IPR001314) (0.1487); Serine proteases, trypsin family, histidine active site (IPR018114) (0.1408); Serine proteases, trypsin domain (IPR001254) (0.1310)",2.40.10.10 (0.1709),Zymogen (0.8263); Signal (0.5665); Hydrolase (0.4304); Protease (0.4255); Reference proteome (0.4185); Serine protease (0.3594); Transmembrane (0.1042),
MEMYTDILLVTANVGSLFDNVGEIEGDWLREFFTTVHMYKPRFVALHFQEVGGKDYMVNMGHAENFFWTIESSSEMADFDRVCVYVDSHFKAVDNFTALGSMYFIHKSLKNIQQYDFNVKDFKVVSGHNKYVGSLDGVTTMEKEKFPKNFWPDFKWSRKGYMRTRWIIHNQGLDLVNVHLFHDASNLIACNSSPSVYSANRKKALRYVINRITDNTYSPLPFFLFGDFNFRLDTLSLVQNLSLSAEIQTVKKGSSNEVEKIICEEKDNDHKVLLHIETKLFAYLHQAVFRENNGKELLKYDKEISAFHDVITEEDIPFPPSYPYSEDYTKPTQYMNTRCPAWCDRILMSHSARDIIHRREEGEGESSVVYDTLGSNICMGDHKPVFLFFPLKTYAH,inositol-polyphosphate 5-phosphatase (3.1.3.56) (0.9394); phosphoinositide 5-phosphatase (3.1.3.36) (0.0500),phosphatidylinositol dephosphorylation (GO:0046856) (0.2440); intracellular phosphate ion homeostasis (GO:0030643) (0.1817); response to abscisic acid (GO:0009737) (0.0476),nucleus (GO:0005634) (0.0625),"inositol-polyphosphate 5-phosphatase activity (GO:0004445) (0.5773); inositol-1,4,5-trisphosphate 5-phosphatase activity (GO:0052658) (0.2411); inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity (GO:0052659) (0.2237); PH domain binding (GO:0042731) (0.1156)","Type I inositol 1,4,5-trisphosphate 5-phosphatase (IPR039737) (0.1227)",3.60.10.10 (0.0429),Reference proteome (0.4399); Zinc (0.1589); Metal-binding (0.1424); Lipid metabolism (0.1401); Transport (0.1105),Mg(2+) (0.0698)
MCKDVEELLKMRALAEEKYGRDLVAIARKAEGQTEIGTLKASFDKFKEEIEKTGNLHIQLSERIKEEVLKIEVFREHQREQRKKLEEIIEKLQKPKMVLHKKTMESKRLYEQRCKEADESEQALGKKTNVNTSTHRQSEKVMNRARLCRQAANLAEKQYRWNVDQLAKTCQDWESTYRSACEVFQQQESERINILRCVLWEHCNLLSKQCVQDDDCYEEVRKILEQCDIVADNNNFIKMKKTSSHPPAPIEFQCYSDADTNGGVRRIETNRLSVVLSGMSFSGFPEAGNNSGAKYTPDQQRIGVTEEKYMVLYEFKAQEDDELSISKGQVVTITEKGEDGWWKAWCNGVSGLVPGTYLTKMSPNSSRLAAAHPEHNPIK,,actin filament polymerization (GO:0030041) (0.4641); actin cytoskeleton organization (GO:0030036) (0.1938); negative regulation of angiogenesis (GO:0016525) (0.1671); positive regulation of protein phosphorylation (GO:0001934) (0.1483); membrane invagination (GO:0010324) (0.1445); positive regulation of membrane protein ectodomain proteolysis (GO:0051044) (0.1108); neuron projection morphogenesis (GO:0048812) (0.0977); actin filament organization (GO:0007015) (0.0928); cell adhesion (GO:0007155) (0.0855),cytoplasm (GO:0005737) (0.5112); actin filament (GO:0005884) (0.3755); cell cortex (GO:0005938) (0.2277); plasma membrane (GO:0005886) (0.1267); cleavage furrow (GO:0032154) (0.1032); cytoskeleton (GO:0005856) (0.0782); cytoplasmic side of plasma membrane (GO:0009898) (0.0494),identical protein binding (GO:0042802) (0.1265),F-BAR domain (IPR031160) (0.2721); SH3-like domain superfamily (IPR036028) (0.1669); AH/BAR domain superfamily (IPR027267) (0.1536),1.20.1270.60 (0.2883); 2.30.30.40 (0.1867),SH3 domain (0.7758); Reference proteome (0.4594); Coiled coil (0.3226); Phosphoprotein (0.2877); Cell membrane (0.1845); Membrane (0.0802),
MPPSASTNLGYTPPDGGWGWAVVFGSFISIGFSYAFPKSLTIYFKEIQEYFSISYSQIAWVSSIMLATMYAGGPVSSILVNRYGSRPVVIAGGLMVGVAMVTASFGTSILHLYLCVGVIGGFGLAFNLQPALTIIGKYFLVKRPMANGIAMAGSPVFLSTLAPVNQFLFDQFGWRGSFFILGGVLFNCCVAGSLMRPIKIPVSKTTEDNISPQTAGQDESKPSGCSSKLNQFIDISLFKHRGFLIYLVGNVLMFFGFFAPVVFLAPYAKHQGVDEYSAAFLLSIFALVDMFARPGTGLVANTKWIRPKIQYFFSFAVTYNGLCHLMCPLLPGYIDLVVYAVLFGLAFGMVCALLFEVLMDLVGAQRFSSAVGLATIIECGPVLLGPPISGLLVDIFMDYKYMYFACGMMMLAGGVFLFIMNYYNYRWLKKEEKQRNAEELQIFSTKELAAIDEEIKLSIEEKLKD,,plasma membrane lactate transport (GO:0035879) (0.6441); pyruvate transmembrane transport (GO:1901475) (0.4244); response to food (GO:0032094) (0.4020); lipid metabolic process (GO:0006629) (0.3956); centrosome cycle (GO:0007098) (0.2790); lactate transmembrane transport (GO:0035873) (0.2553); glucose homeostasis (GO:0042593) (0.2204); behavioral response to nutrient (GO:0051780) (0.1911); neurotransmitter transport (GO:0006836) (0.1613); pyruvate catabolic process (GO:0042867) (0.1447),intracellular membrane-bounded organelle (GO:0043231) (0.2779); plasma membrane (GO:0005886) (0.1757); basolateral plasma membrane (GO:0016323) (0.1699); centrosome (GO:0005813) (0.0918); cytosol (GO:0005829) (0.0875),identical protein binding (GO:0042802) (0.4747); lactate:proton symporter activity (GO:0015650) (0.1906); lactate transmembrane transporter activity (GO:0015129) (0.1852); symporter activity (GO:0015293) (0.1065),Major facilitator superfamily domain (IPR020846) (0.3377); MFS transporter superfamily (IPR036259) (0.2857); Proton-linked Monocarboxylate Transporter (IPR050327) (0.2711); Major facilitator superfamily (IPR011701) (0.2688); Monocarboxylate transporter (IPR004743) (0.1452),1.20.1250.20 (0.2932),Symport (0.9542); Transport (0.9458); Reference proteome (0.8098); Membrane (0.4431); Cell membrane (0.1072); Transmembrane (0.0802),
MLKFFLCPVTQTMHYGICNPNTTDPLSCSRSQSSIKSARIVHFPNDIVFQDCVRQGELERVGCFIQTRRVSLDTIYHSGMAAIHEAVLSGNMECVKLLVKSGADITQRDEDGWTPLHMACSDGFPEIAKYLISLGADTEAKNDCGEKPADLIDPDCKELLHLFGVGGD,,exocytosis (GO:0006887) (0.9099); signal transduction (GO:0007165) (0.2715); response to light stimulus (GO:0009416) (0.1075); mitotic cell cycle (GO:0000278) (0.0960); negative regulation of ERK1 and ERK2 cascade (GO:0070373) (0.0755); negative regulation of catalytic activity (GO:0043086) (0.0637),extracellular region (GO:0005576) (0.7106); plasma membrane (GO:0005886) (0.4883); host cell presynaptic membrane (GO:0044231) (0.3864); cytoplasm (GO:0005737) (0.1964); cytosol (GO:0005829) (0.0657),toxin activity (GO:0090729) (0.2325); protein kinase binding (GO:0019901) (0.1567); protein phosphatase binding (GO:0019903) (0.0815); protein kinase activator activity (GO:0030295) (0.0724); enzyme inhibitor activity (GO:0004857) (0.0485),Ankyrin repeat (IPR002110) (0.1444); Ankyrin repeat-containing domain superfamily (IPR036770) (0.0731); Protein Phosphatase 1 Regulatory Subunit (IPR051226) (0.0467),1.25.40.20 (0.1454),Toxin (0.9322); Target cell membrane (0.6793); Integrin (0.4674); Target membrane (0.4082); Neurotoxin (0.3870); Presynaptic neurotoxin (0.3358); Reference proteome (0.2425); Exocytosis (0.1114),
MSEENLKLLSCHFTWGLLKEDADLNFLEVKIRERLGVKSGYEGNLKQRELNFLAFIKHLQGFNDEALKNLLLAKEEHPNDDRTVIVTYGNLAWVHSFLSNATEAEAYIEKINEILRAFPTPELHREVLSEKAWSLLKFSKKSYIRAKEIFLEALQKEPDDKEWNTGLAFSLFRLEGLKIGQYHRVRFEESPAVLQLKKALKLDPDNPMILVYLGLKCYKNIKNSEAWQYMTQALKMAPHNLSVVLHVAKFMKKEQCYDRALDVLLEMLKKAPDSSRLHHEVANNYRWKAMQIDDIHNPELLGLCVHHLEKGASLNPGYVYPQLELALRYAELKQAGKAEQKFTELFSKPDLKPADLQAGHRLYGDFKLYRLGSEKAAVEHYKQGMMLGRVSTEWISCRNRLKKILQRDKRDIYEIRVFFDSIRTTNKDD,,innate immune response (GO:0045087) (0.6032); defense response to virus (GO:0051607) (0.4732); response to virus (GO:0009615) (0.2152); response to bacterium (GO:0009617) (0.1648); regulation of DNA-templated transcription (GO:0006355) (0.1470); negative regulation of protein binding (GO:0032091) (0.1100); cellular response to interferon-beta (GO:0035458) (0.0982); mitochondrion organization (GO:0007005) (0.0922); positive regulation of canonical NF-kappaB signal transduction (GO:0043123) (0.0855),cytosol (GO:0005829) (0.1078); mitochondrion (GO:0005739) (0.0851); cytoplasm (GO:0005737) (0.0694); actin cytoskeleton (GO:0015629) (0.0486); plasma membrane (GO:0005886) (0.0470),,Tetratricopeptide repeat (IPR019734) (0.1630); Tetratricopeptide-like helical domain superfamily (IPR011990) (0.0802),1.25.40.10 (0.1310),Repeat (0.8610); TPR repeat (0.7802); Reference proteome (0.5432); Proteomics identification (0.2158); Phosphoprotein (0.1954); 3D-structure (0.1877); Immunity (0.1380); Innate immunity (0.0666); Cytoplasm (0.0612),
MAALEACTALVTGANRGLGLEMVKQLLEADCSKIFAACRDTDGPNSEVLRELAKKNPDVVTLVKLDVADPASIKESAKKVGSLLGEKGLNLLVNNAAILPQKTMLTCSVEDMHNTFNTNVIGPLFVIREYLPYLRAAVKASGKPGMSPGKAAVINISTDAASLNMIPSMKEPFPLFPYSISKVALNMLTVYTARDLKADEILCISIHPGWVRTDMGSYEATLDTRESVEGMLRVIGSLTEKDQGGYMDYTGKTMPW,carbonyl reductase (NADPH) (1.1.1.184) (0.4267); 1.1.1.- (0.4037); prostaglandin-E2 9-reductase (1.1.1.189) (0.0899); 15-hydroxyprostaglandin dehydrogenase (NADP+) (1.1.1.197) (0.0883); all-trans-retinol dehydrogenase (NAD+) (1.1.1.105) (0.0812),response to toxic substance (GO:0009636) (0.1323); response to lipopolysaccharide (GO:0032496) (0.1124); brain development (GO:0007420) (0.0937); xenobiotic metabolic process (GO:0006805) (0.0894); response to testosterone (GO:0033574) (0.0799); positive regulation of DNA-templated transcription (GO:0045893) (0.0616),extracellular exosome (GO:0070062) (0.1254); cytosol (GO:0005829) (0.0970); cytoplasm (GO:0005737) (0.0886); mitochondrion (GO:0005739) (0.0721),"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616) (0.3431); prostaglandin E2 9-reductase activity (GO:0050221) (0.1898); 15-hydroxyprostaglandin dehydrogenase (NADP+) activity (GO:0047021) (0.1686); carbonyl reductase (NADPH) activity (GO:0004090) (0.0839); alcohol dehydrogenase (NADP+) activity (GO:0008106) (0.0478)",Short-chain dehydrogenase/reductase SDR (IPR002347) (0.3078); Carbonyl reductase [NADPH] 1-like (IPR045313) (0.2337),3.40.50.720 (0.2931),Oxidoreductase (0.4668); Reference proteome (0.4126); Phosphoprotein (0.3209); Acetylation (0.2294); Cytoplasm (0.1479); Alternative splicing (0.1283); NADP (0.1279),
MTDFPKTLNFNVGVLGHVDSGKTSLARALSSTASTAAFDKNPQSKERGITLDLGFSAFTVPLPEHLRESCGEKQYDSLQFTLVDCPGHASLIRTIIGGAQIIDLMMLVVDVVKGMQTQTAECLLIGQLTCSRMVVILNKTDLLPSDKRQVAIDKMTKRMHKTLENTRFKDCPIIAVAAKPGGPEAPDTDEPQGITELIDLLKAQSFLPHRDPSGSLLMAVDHCFSIRGQGTVITGTILQGSLSVNDNVEIPALKVTRKVKSVQMFRKPVASAMQGDRVGVCVTQFDPKLLERGVVCTPGSLQTLYAAIISVQKIEYYRGALNSRAKFHITVGHETVMARISFFNRVLPANENGDSKPTSQEQSANSFSFDWEFHHLDEHLTSQAEGGKGEPQQWALLEFERPVTCPPLCLVIGSRLDSDIHGNTCRLAFHGKLLEGFEDKNYTETALPRLKISKDKQKEGAVERVTDDYTVIGRNLFKKETNLQLFVGLKVTLSTGEAGSIEGGFGQSGKIKIRIPEGLKEETKQLLSSSSKKKGKGGSKNESPKLEEAKPDAQPVTIHLNFKRYIYDPHKKMVQS,3.6.5.- (0.1428),selenocysteine incorporation (GO:0001514) (0.9437); mRNA processing (GO:0006397) (0.0720),cytoplasm (GO:0005737) (0.2120); nucleus (GO:0005634) (0.1627); nuclear body (GO:0016604) (0.1198),tRNA binding (GO:0000049) (0.4745); selenocysteine insertion sequence binding (GO:0035368) (0.3909); GTPase activity (GO:0003924) (0.2538); GTP binding (GO:0005525) (0.2231); translation elongation factor activity (GO:0003746) (0.1127),"P-loop containing nucleoside triphosphate hydrolase (IPR027417) (0.4254); Elongation factor Tu GTPase (IPR050055) (0.4083); Translation protein, beta-barrel domain superfamily (IPR009000) (0.3805); Selenocysteine-specific elongation factor, C-terminal RIFT domain (IPR049394) (0.2888); Selenocysteine-specific elongation factor, 3rd domain (IPR049393) (0.2862); Translational (tr)-type GTP-binding domain (IPR000795) (0.1606); Translation elongation factor EFTu-like, domain 2 (IPR004161) (0.1317)",3.40.50.300 (0.2844); 2.40.30.10 (0.1350),Reference proteome (0.6843); Phosphoprotein (0.4108); 3D-structure (0.3880); GTP-binding (0.2557); Nucleotide-binding (0.2501); Elongation factor (0.2487); Nucleus (0.2331); Cytoplasm (0.2239); Protein biosynthesis (0.1944); RNA-binding (0.1908); Mitochondrion (0.1789); Alternative splicing (0.1748); Hydrolase (0.1705); Transit peptide (0.0559),
MGLLVFSLSSVVIMLSTQDSNAQTTYECGVAPLNTRIVGGTDAPAGSWPWQVSIHYNNRHICGGTLIHSQWVMTAAHCIINTNINVWTLYLGRQTQSTSVANPNEVKVGLQSIIVHPSFNNSLLNNDISLMKLSQPVNFSQYIRPICLAANNSIFYNGTSCWATGWGNIGKDQALPAPQTLQQVQIPVVANSLCSTEYESVNNATITPQMICAGKANKGTCQGDSGGPFQCKQGSVWIQAGITSYGTSAGCAVGAYPDVYSRVSEFQSWIKMNVQGSAIDFVTFTSNCTDANITCSNTASPHFTFISNFRILFITLISSFLILMVT,3.4.21.- (0.5014); acrosin (3.4.21.10) (0.1294); Pancreatic elastase II (3.4.21.71) (0.0976),proteolysis (GO:0006508) (0.6069); protein processing (GO:0016485) (0.2529); signal peptide processing (GO:0006465) (0.2106); modulation of process of another organism (GO:0035821) (0.1773); defense response to fungus (GO:0050832) (0.1756); detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) (0.1566); fibrinolysis (GO:0042730) (0.0964); digestion (GO:0007586) (0.0785); defense response to bacterium (GO:0042742) (0.0418); basement membrane disassembly (GO:0034769) (0.0416),acrosomal vesicle (GO:0001669) (0.2638); extracellular space (GO:0005615) (0.0746),D-mannose binding (GO:0005537) (0.1920),"Peptidase S1, PA clan (IPR009003) (0.3780); Serine proteases, trypsin family, serine active site (IPR033116) (0.2970); Peptidase S1, PA clan, chymotrypsin-like fold (IPR043504) (0.1977); Serine proteases, trypsin family, histidine active site (IPR018114) (0.1195); Peptidase S1A, chymotrypsin family (IPR001314) (0.0800)",2.40.10.10 (0.3357),Hydrolase (0.5115); Signal (0.4440); Transmembrane (0.4214); Serine protease (0.3897); Reference proteome (0.3253); Protease (0.2981); Transmembrane helix (0.2711); Membrane (0.2537); Zymogen (0.1504); Glycoprotein (0.0954),
MKCLLVANESAEVLFYWTDSEFEQRLQEQYGVSQEEGEGLPAFEDSINTLFAPIIISCSTMVDRLGDNYTSFSTENNHIYVLHQFDECLYIAVNGDGEETEEDLKRKIYVMKKLTEILFGMVTLSGPLLRKELRPQDTEQRNRLWKKLRSLLETYSRLRENDQSFLVEAVERLIHPTLCEQCIEFLERRLVQQINSSMDRAGEEVLHAFILVHTKQLAFYSSRNASNLNPSDLLALIILVQDLYPSKIDLDDTPEELENSTVPDVFYTPEPSPPERESVTPRKDSPPVFQFVDPDIQMAEDSLQTLEVSTPDPSSPSRVFLEAKECPMMPHSMYCLSLWPGITLVLLTKIPNSHMAVSVYYFLEAFVKLEKRLGEGHEGASAMRGQSSVQEQRSKLEKFIKAWSSMEIQTLQLQNAWTDFKNKAFSRSGTGFTRDLLPSCRNMKTQLCGVYRQFFAAECMGSSQRLAPHLQERALNMVQEKLMDWKDFLLVKSKRNITMVSYLEEFPGLIHFIYVDRSSGQMIAPSLNVTDRTVSELGKGPLADFIKKKVWSLVATARRYLHKGYATVTLRDGDYFYCYFLWFENETGYKLEVTDIPSCPDDTAPIGMLTFDYYRKLLRYYSKKHQNEVVKCYELLTVHLGVIPNEYILQHCSQLARKLWEPTRIPLL,,pigmentation (GO:0043473) (0.4560); cell morphogenesis (GO:0000902) (0.3849); lysosome organization (GO:0007040) (0.3835); respiratory system process (GO:0003016) (0.3380); melanocyte differentiation (GO:0030318) (0.2889); melanosome assembly (GO:1903232) (0.2787); retina development in camera-type eye (GO:0060041) (0.2608); blood coagulation (GO:0007596) (0.2604); protein targeting (GO:0006605) (0.2402); positive regulation of natural killer cell activation (GO:0032816) (0.2109); vesicle-mediated transport (GO:0016192) (0.1476); single fertilization (GO:0007338) (0.1332); negative regulation of cell migration (GO:0030336) (0.1167); lipid homeostasis (GO:0055088) (0.1017); inflammatory response (GO:0006954) (0.0986); gene expression (GO:0010467) (0.0776); protein secretion (GO:0009306) (0.0654); acrosome assembly (GO:0001675) (0.0555),BLOC-3 complex (GO:0031085) (0.3214); cytoplasmic vesicle (GO:0031410) (0.0854),guanyl-nucleotide exchange factor activity (GO:0005085) (0.1121),"FUZ/MON1/HPS1, first Longin domain (IPR043972) (0.4107); FUZ/MON1/HPS1, second Longin domain (IPR043971) (0.3376); BLOC-3 complex member HPS1 (IPR026053) (0.2838); FUZ/MON1/HPS1, third Longin domain (IPR043970) (0.2574)",,Albinism (0.1282); Reference proteome (0.1122),
MNSSNSSTDCEWVCWFQRCVYVPILVFGIPLILGSLWQLLFRVRRWSESTVYLINLIINDSLLMLSLPFKIHAYKKVWTLGRTFCSLLESLLYVNIYGSILLSVCIAVDRYIALQFPFIALRLRSPRKSVIICLILWILVFACSTPIYKLHDEPVNKTDKVYCFQQFSNKTWSKSWIVVSMETVFCSSTIVMVFCSVRVVQILHSMRARNPGDPKLRSNKSLKIVLSNLGVFLACFIPYHIAALIYFHAKTNNWNEDIISHLRYFVHVSICFSNVNILADGACYYFILKENLESAQKERRMAIHVRETRIRGGSRSLTFGENHNGSSVSSEKMEICVDTGFT,,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200) (0.4133); adaptive immune response (GO:0002250) (0.3154); G protein-coupled receptor signaling pathway (GO:0007186) (0.1702); mucosal immune response (GO:0002385) (0.1572); dendritic cell homeostasis (GO:0036145) (0.1269); leukocyte chemotaxis (GO:0030595) (0.1243); dendritic cell chemotaxis (GO:0002407) (0.1210); humoral immune response (GO:0006959) (0.1177); negative regulation of angiogenesis (GO:0016525) (0.1071); positive regulation of Rho protein signal transduction (GO:0035025) (0.0999); mature B cell differentiation involved in immune response (GO:0002313) (0.0558); positive regulation of inflammatory response (GO:0050729) (0.0533); cellular response to fatty acid (GO:0071398) (0.0423),plasma membrane (GO:0005886) (0.3972); membrane (GO:0016020) (0.0533),G protein-coupled receptor activity (GO:0004930) (0.3147); lipopolysaccharide immune receptor activity (GO:0001875) (0.1479),"G protein-coupled receptor, rhodopsin-like (IPR000276) (0.2325); GPCR, rhodopsin-like, 7TM (IPR017452) (0.1690)",1.20.1070.10 (0.1906),Reference proteome (0.6374); Receptor (0.4753); Membrane (0.4382); Transducer (0.4305); G-protein coupled receptor (0.4299); Transmembrane (0.3089); Transmembrane helix (0.2465); Glycoprotein (0.2049); Lipid-binding (0.1423); Ubl conjugation (0.1336); Disulfide bond (0.1218),
MMGKVIFYEDRNFQGRSYECMGDCGDFSSYMNRCHSCRVESGCWMMYDQPNYMGSGYFFRRGEYADYMSMFGMSNCIRSCRMIPMYRGSYRMRIYERENFGGQMYEMMDDCENIMDRYRMSHCQSCHVMDGHWLMYEQANYRGRMWYFGPGEYRNFSNFGGMRFMSMRRIMHSWY,,lens development in camera-type eye (GO:0002088) (0.8567); visual perception (GO:0007601) (0.4681); camera-type eye development (GO:0043010) (0.1364); lens fiber cell morphogenesis (GO:0070309) (0.0888); cellular response to retinoic acid (GO:0071300) (0.0850); protein import into nucleus (GO:0006606) (0.0432),nucleus (GO:0005634) (0.1466); cytoplasm (GO:0005737) (0.1293); extracellular space (GO:0005615) (0.1096); azurophil granule lumen (GO:0035578) (0.0609),structural constituent of eye lens (GO:0005212) (0.4704); identical protein binding (GO:0042802) (0.0699),Gamma-crystallin-like (IPR011024) (0.1958); Beta/gamma crystallin (IPR001064) (0.1463); Beta/Gamma-Crystallin (IPR050252) (0.1248),2.60.20.10 (0.0993),Reference proteome (0.7726); Disease variant (0.2816); Membrane (0.2339); Direct protein sequencing (0.1587); Repeat (0.1586); Alternative splicing (0.0914); Nucleus (0.0837),
MFSRGPFSCAKDDMIHYLRWTVFLWIVNSIPFASGMAVNERIDHTCPPLKLEDKWHTNVNLHREFTGFDLAEKFLLRKGTVTDSDTPLFRLGSKPLFKPTESVFPNGLSHEYSIVATFRIRKTTKKDRWFVLQIFDKGGTSQVSLIVDGAKKSVEFLALGFLKNSLLYVFKNRDLHALFDRQFHKLGVSVESNAVSIYLDCELIERQVTAERSGIDVSGRTFITTRLEDGKPVDVELQEILVFCDSRIADLDRCCDSPGAMCEPTVTHNPTAIPLVTGYLQKMLSMPAQLPTDRCHCPALKVL,,cell adhesion (GO:0007155) (0.7961); bone morphogenesis (GO:0060349) (0.2376); skeletal muscle fiber development (GO:0048741) (0.1552); cell-matrix adhesion (GO:0007160) (0.1364); sensory perception of sound (GO:0007605) (0.0788); skeletal muscle tissue development (GO:0007519) (0.0700),collagen-containing extracellular matrix (GO:0062023) (0.5609); extracellular space (GO:0005615) (0.2778); neuromuscular junction (GO:0031594) (0.1731); interstitial matrix (GO:0005614) (0.0836),metal ion binding (GO:0046872) (0.1943); protein homodimerization activity (GO:0042803) (0.1139),"Thrombospondin-like, N-terminal domain (IPR048287) (0.7318); Concanavalin A-like lectin/glucanase domain superfamily (IPR013320) (0.1861)",2.60.120.200 (0.1267),Zinc (0.6766); Glycoprotein (0.6346); Reference proteome (0.4157); Signal (0.3471); Collagen (0.1786); Disulfide bond (0.1314); Membrane (0.0817),
MMLRLAVCVAGVLLLNISGSLCQLDVCGRAPLKPRIIGGQTAMAGSWPWQVSIHYIPTGGLLCGGTLINREWVLSAAQCFQKLTASNLVVHLGHLSTGDPNVIHNPASQIINHPKYDSAKNKNDIALLKLSTPVSFTDYIKPVCLTASGSSLGKGAVSWITGWGSINTGGTQFPTTLQEVKIPVVSNGDCKSAYGSLITDGMICAGPNEGGKGICVGDGGGPLVHNSSEQWIQSGIASFGRGCAQPKNPGVFTRVSEYESWIKSQISKDQPGFIKFKDSASSVSFSVFLIALIPLIHSLFS,3.4.21.- (0.6962); chymotrypsin (3.4.21.1) (0.0463),proteolysis (GO:0006508) (0.4453); digestion (GO:0007586) (0.3496); angiogenesis (GO:0001525) (0.2755); extracellular matrix disassembly (GO:0022617) (0.2115); fertilization (GO:0009566) (0.0868); epithelial cell differentiation (GO:0030855) (0.0865); protein processing (GO:0016485) (0.0833); spermatogenesis (GO:0007283) (0.0714); response to peptide hormone (GO:0043434) (0.0445),acrosomal vesicle (GO:0001669) (0.5964); extracellular space (GO:0005615) (0.2319); extracellular region (GO:0005576) (0.0513),D-mannose binding (GO:0005537) (0.0869),"Peptidase S1, PA clan, chymotrypsin-like fold (IPR043504) (0.1439); Peptidase S1A, chymotrypsin family (IPR001314) (0.1364); Peptidase S1, PA clan (IPR009003) (0.1341); Serine proteases, trypsin domain (IPR001254) (0.0749)",2.40.10.10 (0.1671),Zymogen (0.9631); Hydrolase (0.3683); Reference proteome (0.3192); Signal (0.3150); Serine protease (0.2748); Protease (0.2199); Glycoprotein (0.1674); Developmental protein (0.1596); Transmembrane (0.0888),
MAEPPKYSLGRRDSIDLPPFMGLSKSLHLTEECQCPVCLDVFTDPVTTPCGHNFCKTCLIQCWDNSQDYRCPLCKETFSKRPEVKSNTVLREIVQIFMDSTKEDPLHTDGPLSEELQCSVCLDVFNNPVTTPCGHNYCKTCLEKCWDYSHVCICPYCKETFSNRPDLKCNTALREIVQLYEKNTDYKREQPMETEYSTSLGTAVHEEPLCKPLMMACSCCVVTENPACFICLESSIDVVWTPCGHSFCKACLKECWEISHDSRCPCCKESFTERETSLLEQLRSQSECSYQMKEVANIKEVIMINPEMIQKLDRALEMFGGDDCVSCVEGDHKTNNTRSAKDESEKKKDINPKIIQKHGALGMFSLGDQTFERFCVEEDHEIHNTVPVKDENEKKKVM,RING-type E3 ubiquitin transferase (2.3.2.27) (0.9440),innate immune response (GO:0045087) (0.4419); protein ubiquitination (GO:0016567) (0.3931); protein polyubiquitination (GO:0000209) (0.1974); apoptotic process (GO:0006915) (0.1879); ubiquitin-dependent protein catabolic process (GO:0006511) (0.1870); protein autoubiquitination (GO:0051865) (0.1775); defense response to bacterium (GO:0042742) (0.1679); negative regulation of viral transcription (GO:0032897) (0.0927); positive regulation of canonical NF-kappaB signal transduction (GO:0043123) (0.0631),nucleus (GO:0005634) (0.1649); cytoplasm (GO:0005737) (0.1157); plasma membrane (GO:0005886) (0.0660),metal ion binding (GO:0046872) (0.1868); transcription coactivator activity (GO:0003713) (0.0883); zinc ion binding (GO:0008270) (0.0644),"Zinc finger, RING-type, eukaryotic (IPR027370) (0.6570); Zinc finger, RING-type (IPR001841) (0.4276); Zinc finger, RING-type, conserved site (IPR017907) (0.2703); Zinc finger, RING/FYVE/PHD-type (IPR013083) (0.2357); U-box domain (IPR003613) (0.0693)",3.30.40.10 (0.1587),Ubl conjugation pathway (0.9421); Zinc-finger (0.9358); Reference proteome (0.3777); Metal-binding (0.3766); Repeat (0.3088); Apoptosis (0.1452); Innate immunity (0.1293); Membrane (0.1141); Immunity (0.0630); Zinc (0.0449),
MSTRQFTNMEEICKGARMEVCEDFLDVKKNSEYSSCSALEYNDLEAAEALVYMSFWSQMSPKPNVFKPRPLTPASDSCDSLLHPEPPETPKDFVSLSSLCMTPPHSPSFTETSNITSVPASPSPLTRPCPSLPSPQRSACPTMASITQVPSSGHPTERTTPPPCRAMATSVIRHTADSFLYQNIPQAVQPQKTEKAPSSPSLCHQPLIDTTTACQSSRSPSKEEKLFITSSTPHSPPPTSSPPIICQMFPMAQPGVISATFIQKPSPGVKSILPQPLLMSSPVPQGTVMFVMPQSPVSSTQQCQQTVMTLGNTKLLPLAPAPVYVPSGQSSATQVDFSRRRNYVCNFPGCRKTYFKSSHLKAHLRTHTGEKPFSCNWEGCDKKFARSDELSRHRRTHTGEKKFVCPVCERRFMRSDHLTKHARRHMTTKKIPSWQTEVRNLNKITAAKTLPTGTALPVSMLLPASN,,bone mineralization (GO:0030282) (0.6281); negative regulation of transcription by RNA polymerase II (GO:0000122) (0.4804); regulation of transcription by RNA polymerase II (GO:0006357) (0.2761); circadian rhythm (GO:0007623) (0.2135); skeletal muscle cell differentiation (GO:0035914) (0.1552); cellular response to peptide (GO:1901653) (0.1524); positive regulation of osteoclast differentiation (GO:0045672) (0.1383); regulation of DNA-templated transcription (GO:0006355) (0.1277),chromatin (GO:0000785) (0.2229); nucleus (GO:0005634) (0.1208); cytosol (GO:0005829) (0.0916),"DNA binding (GO:0003677) (0.2584); DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981) (0.1472); RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978) (0.0774); DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228) (0.0760)",Zinc finger C2H2-type (IPR013087) (0.2275); Zinc finger C2H2 superfamily (IPR036236) (0.1568),3.30.160.60 (0.1782),Zinc-finger (0.9586); Zinc (0.5675); Transcription (0.4458); Repeat (0.3168); Ubl conjugation (0.2978); DNA-binding (0.2067); Metal-binding (0.2006); Nucleus (0.1935); Reference proteome (0.1448); Phosphoprotein (0.1335); Transcription regulation (0.1104); Biological rhythms (0.0933); Ubl conjugation pathway (0.0753),
MDSGGCRMNGGGGGLDMISLEDLESVSEEQLELEEPEPEMEEEDLDQGGRLLQYWRDAARGHQVEVPTDMAQPIQQITSNNDGAHTREPVPYTLITRKEKCGEVLYEKRHYEKAHWACITVHEDTYEQSICYGFMKIMRFICQQNSAGSYLGMTIPIVTVVRTDESNTTLSRAVTVAYYLPTPYQNDPPRPYDPDILIEQWPAAIVYSRSFTGATNELSILHELRSLVEALDSPALGSDSFIVAGYTNPAAAHRHNEIWFLERP,,regulation of protein localization (GO:0032880) (0.2462); canonical NF-kappaB signal transduction (GO:0007249) (0.2320); response to oxidative stress (GO:0006979) (0.1868); response to lipopolysaccharide (GO:0032496) (0.1523); glutathione metabolic process (GO:0006749) (0.0913); response to light stimulus (GO:0009416) (0.0717); dorsal/ventral axis specification (GO:0009950) (0.0676); cellular response to reactive oxygen species (GO:0034614) (0.0676),mitochondrion (GO:0005739) (0.5137); cytoplasm (GO:0005737) (0.2147); extracellular exosome (GO:0070062) (0.1439); nucleoplasm (GO:0005654) (0.1117); cytosol (GO:0005829) (0.0981); extracellular region (GO:0005576) (0.0668),heme binding (GO:0020037) (0.1720); identical protein binding (GO:0042802) (0.0802),"Regulatory factor, effector binding domain superfamily (IPR011256) (0.3437); SOUL haem-binding protein (IPR006917) (0.1747)",3.20.80.10 (0.6380),Reference proteome (0.7513); Cytoplasm (0.3969); 3D-structure (0.1961); Proteomics identification (0.1897); Disease variant (0.1518); Inflammatory response (0.1488); Transmembrane helix (0.0841); Acetylation (0.0666); Transmembrane (0.0616),
MEKFDDDSSKKTSEAEPVNVQSLYTTLGLSSEDVDALAKIPESEISVETLPFLIMQIKTKKATDTSSSADTDHKDKSKDSEEKQETPESCTDAAKPKSKSPPKVPQKRSGSHEQKKKAESHKKTERHSGGRRDSKYSSSREKQSGDHAAAETECADNPTVFPHECTRCKCVVNSIKTWKEHLSGSRHKSHDSQSSQRSSRPHPPPKRPYSSDPFAGDSFTSGMPDHLFPPKPNTRVVVAKFPMGAVTVEDLLVLGKPFGTVVKHLVLPAKGFLEFSAHKEAVNMVNHFQQKPAFVKDTRVGLYLSPRVEGIHSPPKYDEPVPKRLKRTNNPSVVCFSHLPPGEDNQAEVLELAAMFGEVWQSKFLDGKALIEMVDWRDADIMVKYYYSNPLKIQGKSIKVTMSYIKSLREMPGELTPRKSDSGKHSRQKEESSVKDKADDTNQESSEKETKTIKTPEQSQEEGIQLEEGTDGSVVKTEEEEEKVEEEDKQEEGEEVQEEQEKMEVGEEEEEKGKEEDEELEVTEELELTEEPSVAKEENRDQESEHNPEEQDDMEFPEDIEDFVTLDELDNTAGGDSALDSSEPQDGKVVVIWPIKKSPAETMRELISNLSDLCVPFGGLVRYTLSIIKQQAMLELETVEKAQEMVKFYKSHKAMINGRPVSVTMCFAMTTIEVPSGRTVFMGNLPNKWYMRQKYKQSTLLRMAKRYGNLTGFCLNRHQGMCYVQFDSSESAEHMVAQYRRRRRSFSVFGQILNVAICKIGDSQIQWRDPVAEEETSRNSGPEQDTEEKESKDNGQTTKPSTDGNGKARKRGAKQNQQRPAPECEGVGGDPDSEIISEEDGHEEKNPLEPYQPDQTFGVSYVIPVTGFFCKLCNMFYTDENKAKSEHCRSLDHYNNLKLKHAVEEQADGQPDGE,,"heart valve development (GO:0003170) (0.7767); blastocyst formation (GO:0001825) (0.7734); post-transcriptional regulation of gene expression (GO:0010608) (0.3487); activation of innate immune response (GO:0002218) (0.2310); ventricular septum development (GO:0003281) (0.1426); mRNA splicing, via spliceosome (GO:0000398) (0.0960); RNA splicing (GO:0008380) (0.0805); negative regulation of transcription by RNA polymerase II (GO:0000122) (0.0623); spliceosomal complex assembly (GO:0000245) (0.0570)",nucleus (GO:0005634) (0.5219); nucleoplasm (GO:0005654) (0.1783); cytoplasm (GO:0005737) (0.1166); cytosol (GO:0005829) (0.0538); intercellular bridge (GO:0045171) (0.0532),RNA binding (GO:0003723) (0.2161); mRNA binding (GO:0003729) (0.1457); zinc ion binding (GO:0008270) (0.1321),"RNA recognition motif domain (IPR000504) (0.3808); Matrin/U1-C, C2H2-type zinc finger (IPR000690) (0.3217); Nucleotide-binding alpha-beta plait domain superfamily (IPR012677) (0.2953); Zinc finger C2H2-type (IPR013087) (0.2063); RNA-binding domain superfamily (IPR035979) (0.0909)",3.30.70.330 (0.1464),Ubl conjugation (0.7828); Zinc (0.7120); Metal-binding (0.5237); Reference proteome (0.4850); Phosphoprotein (0.4213); RNA-binding (0.3010); Zinc-finger (0.2357); Proteomics identification (0.2228); 3D-structure (0.1429); Nucleus (0.1384); Alternative splicing (0.1343); Cytoplasm (0.1276); Repeat (0.1217); Coiled coil (0.0655),
MASLCKVMINVSSRSSLPPKQCVFATLRSLYSSDASGGDDKHTERPKSGFAAAYNLHSDLQQSGERRMMSPREESSFPALLRQSVLLQMGPAKGKIAIGKIFHIVNDDLYVDFGGKFHCVCKRPAVDGEKYQRGSKVRLRLEDLELTSRFLGATTDTTLLEAEATLLGLLEGKPKE,,mitochondrial translation (GO:0032543) (0.4166); RNA folding (GO:0034337) (0.2669); cellular respiration (GO:0045333) (0.1735); tRNA 3'-end processing (GO:0042780) (0.1341); aerobic respiration (GO:0009060) (0.1141); defense response (GO:0006952) (0.0868),mitochondrial inner membrane (GO:0005743) (0.2633); mitochondrion (GO:0005739) (0.2202); plasma membrane (GO:0005886) (0.0863); nucleoplasm (GO:0005654) (0.0835); presynapse (GO:0098793) (0.0449),RNA binding (GO:0003723) (0.1591),Small ribosomal subunit protein bS1m (IPR019375) (0.0438),2.40.50.140 (0.2359),Transit peptide (0.8789); Reference proteome (0.6949); Phosphoprotein (0.5770); Proteomics identification (0.5172); 3D-structure (0.5007); Direct protein sequencing (0.3909); Ribonucleoprotein (0.3175); Primary mitochondrial disease (0.1980); Respiratory chain (0.1360); Ribosomal protein (0.0882); Disease variant (0.0800); rRNA-binding (0.0706),
MAALGSRANRPENGEKQTKSPLVSPLKVRELLNEGVASEDSVLNCSQQDPNTASPNGLGKAPCEAANKEAFFNRVESYSCLKWAGKPSVLSPLRCARYGWINVDCDMLKCCSCQAFLCASIQATLDFQKYKGRISEVRQQLQTQHEKFCSWPDFPCPDRFWMVPINEPTVLLAAFLERYKSACLLEQQLPAMKPEQLKAMTLTEDIISVLLQLIEDEQAKQGSSPSKVSSDPLSVQVAACILALCGWAASPSLHALNLPILTCSYCMRKVGMWNFYQMDTALEAENPPQSPASSTSVTSTQGMSGDKGTPTSPSQSPTPCRMKLRSQDSTRSEQAESTPLRTRSRDSPTPHDEHPSPLSRGKRPMTRSRGQGEGQGTDVPSSPQRKTKRPRLSSASGPEGLLHRNMFDPVAQHRDWCPWVSVEKEEDNQDASEFVGCEAELPQPGWKAVLALFLSMKQSLNPVGASPSQGPHDKSKRVFSIFRQWQVSSPSQ,peptide-methionine (R)-S-oxide reductase (1.8.4.12) (0.0882); DNA-directed DNA polymerase (2.7.7.7) (0.0832),cell division (GO:0051301) (0.4150); protein transport (GO:0015031) (0.1985); protein ubiquitination (GO:0016567) (0.1984); proteolysis (GO:0006508) (0.1346); regulation of protein localization (GO:0032880) (0.0977); regulation of mitotic cell cycle (GO:0007346) (0.0687); epidermal growth factor receptor signaling pathway (GO:0007173) (0.0562); cell population proliferation (GO:0008283) (0.0537),nuclear pore nuclear basket (GO:0044615) (0.4471); nuclear envelope (GO:0005635) (0.3173); cytosol (GO:0005829) (0.1671); nucleoplasm (GO:0005654) (0.1234); nuclear membrane (GO:0031965) (0.0885); mitotic spindle (GO:0072686) (0.0692),protein kinase binding (GO:0019901) (0.5580); zinc ion binding (GO:0008270) (0.0554),"ZC3HC1/Rsm1-like, C-terminal domain (IPR013909) (0.1295)",,Zinc-finger (0.9818); Proteomics identification (0.5245); Metal-binding (0.4346); Alternative splicing (0.4177); Mitosis (0.3962); Reference proteome (0.3359); Nucleus (0.3314); Zinc (0.3311); Phosphoprotein (0.3186); Ubl conjugation (0.1837); 3D-structure (0.1469); Cell cycle (0.0875); Acetylation (0.0827); Cell division (0.0544),
MGGSGSKPKGVWPFTSSAAGGEAPGEGSEQCLARLRGSKNATPFVFTRRSSLYFDEDGDLAHEFYEETVVTKNGRKKAKLKRIQKNLIPQGIVKLDHPRIHVDFPVILCEI,,regulation of mitochondrial membrane potential (GO:0051881) (0.3525); negative regulation of protein kinase activity (GO:0006469) (0.2749); neutrophil-mediated killing of gram-negative bacterium (GO:0070945) (0.1821); embryo implantation (GO:0007566) (0.1816); signal transduction (GO:0007165) (0.1555); regulation of transcription by RNA polymerase II (GO:0006357) (0.1382); extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625) (0.1354); apoptotic process (GO:0006915) (0.1281); natural killer cell differentiation (GO:0001779) (0.1034); negative regulation of apoptotic process (GO:0043066) (0.0940); phagocytosis (GO:0006909) (0.0912),mitochondrion (GO:0005739) (0.1744); cytoplasm (GO:0005737) (0.1130); cytosol (GO:0005829) (0.0995),,Tumour suppressor candidate 2 (IPR029393) (0.2319),,Vision (0.2933); Myristate (0.2451); Cytoplasm (0.2222); Palmitate (0.2096); Cell projection (0.2087); Reference proteome (0.1893); Lipid-binding (0.1859); Cell cycle (0.1462); Lipoprotein (0.1283); Proto-oncogene (0.1270); Acetylation (0.1168); Necrosis (0.0842); Membrane (0.0823); Phosphoprotein (0.0549),
MMFTSTGSWGLYKAPLSKSLLLLPTVLTVLLTVLLPQYQDLFIYNIQAIRQGKQFWRLVSGRLFCLDLKDTFCSSLLIYNFRIFERRFGSHKFASFLFGAWVLSAFVDLLLTEALRFTFELKVDVLPAGLLGPVFALFVPFYRSIPRVHVTQLLGHFSITNKSLTYIVGAQLLTSSAYMWVVACSGLIAGMLYYSNKLAVQKFLRVPGWAARCGSVILEPIFSDSEPTAEAPLGMGATLDIQRQQRMDMLDQQLLLSQLAHLRRNAQQQQAQTGLLNWNRFFPTLRHRGQNRPHEGPQQPSYTQPTENPAVTEEQVARLMEMGFSRMDAQEALRASNNDINIATNFLLQH,,"negative regulation of canonical Wnt signaling pathway (GO:0090090) (0.6547); Wnt signaling pathway (GO:0016055) (0.4123); endocytosis (GO:0006897) (0.3681); lysosome organization (GO:0007040) (0.1689); negative regulation of retrograde protein transport, ER to cytosol (GO:1904153) (0.1327); protein localization to endoplasmic reticulum (GO:0070972) (0.1226); positive regulation of protein ubiquitination (GO:0031398) (0.1179); positive regulation of gene expression (GO:0010628) (0.0918); negative regulation of natural killer cell activation (GO:0032815) (0.0913); negative regulation of apoptotic process (GO:0043066) (0.0802); protein polyubiquitination (GO:0000209) (0.0693); liver development (GO:0001889) (0.0692)",endoplasmic reticulum (GO:0005783) (0.4817); endoplasmic reticulum membrane (GO:0005789) (0.1171); early endosome (GO:0005769) (0.1160); endoplasmic reticulum quality control compartment (GO:0044322) (0.1151); plasma membrane (GO:0005886) (0.0413),serine-type endopeptidase activity (GO:0004252) (0.2075),"Ubiquitin-associated domain (IPR015940) (0.3204); UBAC2, UBA domain (IPR041928) (0.2704); Rhomboid-like superfamily (IPR035952) (0.1458); UBA-like superfamily (IPR009060) (0.1430)",1.10.8.10 (0.3164); 1.20.1540.10 (0.2116),Wnt signaling pathway (0.9500); Reference proteome (0.7165); Transmembrane (0.6225); Membrane (0.5590); Transmembrane helix (0.4478); Endoplasmic reticulum (0.2210); Proteomics identification (0.2079); 3D-structure (0.1579); Phosphoprotein (0.1364),
MSWFPGAMSCKSKVAPSVDFDHSCSDSVEYLTLNFGPFETVHRWRRLPPCDEFVGARRSKHTVVAYRDAIYVFGGDNGKNMLNDLLRFDVKDCSWCRAFTTGTPPAPRYHHSAVVYGSSMFVFGGYTGDIYSNSNLKNKNDLFEYKFATGQWTEWKVEGRLVARSAHGATVYNDKLWIFAGYDGNARLNDMWTIGLQDREQAYWEEIEQSGEIPPSCCNFPVAVCRDKMFVFSGQSGAKITNNLFQFEFKGHIWTRIPTEHLLRGSPPPPQRRYGHTMVAFDRHLYVFGGAADNTLPNELHCYDVDSQTWEVIQPSIDSEMPSGRLFHAAAVIHDAMYIFGGTVDNNVRSGEMYRFQFSCYPKCTLHEDYGKLWENRQFCDVEFILGEREEKVLGHIAIVTARCKWLRKKILQARDRQKQKSKLECNEESDESGSGSQKDCSGRSSRGPPLLEVSIREADAQPFEVLMQFLYTDKIQYPRRGHVQDVLLIMDVYKLALSFKLSRLEQLCVQYIEASVDLQNVLSVCENADKLQLDQLKEHCLNFVVKESHFNQVIMTKEFEHLSTPLIVEIVRRKQQPPPRVYSDQPVDIGTSLVQDMKAYLEGAGHEFCDIILLLDGHPRPAHKAILAARSSYFEAMFRSFMPEDGQVNISIGEMVPSTQAFESMLRYIYYGDVDMPPEDSLYLFAAPYYYGFSNNRLQAYCKQNLEMNVTVENVLQILEAADKTQALDMKKHCLHIIVHQFTKVSKLPNLRSLSQPLLLDIIDSLASHISDKQCTEMSSDI,,protein ubiquitination (GO:0016567) (0.4743); negative regulation of Ras protein signal transduction (GO:0046580) (0.4550); gene expression (GO:0010467) (0.1416); ubiquitin-dependent protein catabolic process (GO:0006511) (0.1323); protein transport (GO:0015031) (0.0781),Golgi apparatus (GO:0005794) (0.5589); recycling endosome membrane (GO:0055038) (0.3765); endomembrane system (GO:0012505) (0.1032); Cul3-RING ubiquitin ligase complex (GO:0031463) (0.0780); nucleoplasm (GO:0005654) (0.0523); endoplasmic reticulum (GO:0005783) (0.0471); cytoplasm (GO:0005737) (0.0446),small GTPase binding (GO:0031267) (0.4992); phosphatidylinositol phosphate binding (GO:1901981) (0.1414),SKP1/BTB/POZ domain superfamily (IPR011333) (0.1884); Kelch repeat type 1 (IPR006652) (0.1202); LZTR1/Attractin (IPR051568) (0.1187); BTB/POZ domain (IPR000210) (0.0900),2.120.10.80 (0.2353),Repeat (0.6324); Phosphoprotein (0.5362); Endosome (0.4875); Reference proteome (0.4492); Transport (0.4450); Kelch repeat (0.3542); Alternative splicing (0.3041); Ubl conjugation pathway (0.2212); Disease variant (0.2152); 3D-structure (0.1173); Membrane (0.1097); Golgi apparatus (0.0921); Cytoplasm (0.0743),
MNTEVMKREDVVPRVQLFNCVYAECGATFTRQWRLQEHETVHTGVRPYKCGVVGCGRSFTRKSHLNRHTSAHSGVKHFKCNITACGKKFQAADKLKRHVRYVHSENEEYFKCTEPQCSKAFRKRRALKLHLATHGTSSFRCSKNNCGKKFDSHIARNAHDRRHLGYRCLRTECPITVHTWGSLIKHMASHPVSFSCMVCKKAFRKRDALRRHKRTHALQKPVLLCPSQGCQAYFSTTFNLQHHIRKVHLQLLSHCCSFPGCSKTFAMRESLVRHMLHHEPDVAKLKHPHKRSSKSWQKRLEGRNRRPLVEDLHALFSLRMNLNQRAKLEADLTGLFNERKIPHHIDPEVNLRDLFGSRLAQANVAD,,regulation of transcription by RNA polymerase II (GO:0006357) (0.5817); ribosomal large subunit biogenesis (GO:0042273) (0.1298); positive regulation of canonical Wnt signaling pathway (GO:0090263) (0.1046); DNA repair (GO:0006281) (0.0858); response to ecdysone (GO:0035075) (0.0822); negative regulation of transcription by RNA polymerase II (GO:0000122) (0.0728),nucleus (GO:0005634) (0.1468); nucleoplasm (GO:0005654) (0.0739),"metal ion binding (GO:0046872) (0.2336); 5S rRNA binding (GO:0008097) (0.2121); RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978) (0.0958); DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981) (0.0781)",Zinc finger C2H2-type (IPR013087) (0.2166); Zinc finger C2H2 superfamily (IPR036236) (0.1557),3.30.160.60 (0.1706),Repeat (0.6183); Metal-binding (0.5726); Zinc-finger (0.3894); Reference proteome (0.3847); Zinc (0.3004); Nucleus (0.2152); RNA-binding (0.1937); DNA-binding (0.1704); Transcription (0.1126); Ubl conjugation (0.0761); Ribosome biogenesis (0.0758),
MEVTSQPAAFGPQEFQTGLMSCCEDMSICCCGLFCLPCMGCSIASDMNECCLCGLGMPMRSVYRTKYNIQGSMCTDFCIVYNCMPCAACQLKRDIEIRKRLGQF,,negative regulation of transcription by RNA polymerase II (GO:0000122) (0.8005); brown fat cell differentiation (GO:0050873) (0.4553); positive regulation of transcription by RNA polymerase II (GO:0045944) (0.3024); regulation of gene expression (GO:0010468) (0.2644); defense response to bacterium (GO:0042742) (0.2142); response to starvation (GO:0042594) (0.1899); transcription by RNA polymerase II (GO:0006366) (0.1601); positive regulation of cold-induced thermogenesis (GO:0120162) (0.1395); positive regulation of MAPK cascade (GO:0043410) (0.1121); response to cold (GO:0009409) (0.0945); intestinal stem cell homeostasis (GO:0036335) (0.0861); response to heat (GO:0009408) (0.0659),nucleus (GO:0005634) (0.2120); cytosol (GO:0005829) (0.1019); cytoplasm (GO:0005737) (0.0779),,PLAC8 motif-containing protein (IPR006461) (0.0873),,Reference proteome (0.5444); Membrane (0.3492); Cytoplasm (0.2675); Zinc (0.1396); Oxidation (0.1208); Nucleus (0.0469),
MAMNMAHMRDTKWLTLEVCREFQRGTCARSDAECKFAHPAKSCQVENGRVIACFDSLKGRCSRENCKYLHPPPHLKTQLEINGRNNLIQQKNMAMLAQQMQIANAIMPGSQLQPMPMFSVSPSLASNASAAAAAAAAAAFNPYLGPVSPGLMSAEILPSAPVLMAGSPGVASVPSAANAAAAAASAAAAQKLLRTDRLEVCREYQRGNCSRGETDCRFAHPADSTMIDPSDNTVTVCMDYIKGRCSRDKCKYFHPPAHLQAKIKATQHQVNQASAAAAMTQSAVKSLKRPLEATFDLGIPHSVMPPLPKRPALEKANGATSMFSAGMLQYQQALANMQFQQQAAFIPSVPMMHGASPAAVSAATTSATSVPFASASANQDSSLSKLTTNEYMQLIPIISAEHLTSHKYLTQM,,"regulation of RNA splicing (GO:0043484) (0.3563); regulation of alternative mRNA splicing, via spliceosome (GO:0000381) (0.2630); mRNA processing (GO:0006397) (0.2502); muscle organ development (GO:0007517) (0.2379); myoblast differentiation (GO:0045445) (0.2376); negative regulation of transcription by RNA polymerase II (GO:0000122) (0.1782); RNA splicing (GO:0008380) (0.1708); eye development (GO:0001654) (0.1492); heart development (GO:0007507) (0.1464); in utero embryonic development (GO:0001701) (0.1273)",cytoplasm (GO:0005737) (0.2884); nucleoplasm (GO:0005654) (0.2082); nucleus (GO:0005634) (0.1801),RNA binding (GO:0003723) (0.3067); metal ion binding (GO:0046872) (0.1312),"Muscleblind-like, CCCH zinc finger (IPR054429) (0.1165)",3.30.1370.210 (0.0807),Repeat (0.6774); Zinc-finger (0.6161); Cytoplasm (0.5977); Zinc (0.5378); Metal-binding (0.3617); RNA-binding (0.3235); mRNA splicing (0.3188); Reference proteome (0.2624); Proteomics identification (0.1421); Nucleus (0.1045),
MQREEASAQEVFSYAQMSTLERNSGVGTLSRHLERERLERDGYTVDVRASDLQLDQPGPLHPCFSYRVWLYSVVVGSSLLIASAFSLYMGNVFPAAMDYLRCTAGSSIPAAVVSFAIAKNRQVAVSDFQLVYVSSFAVTTTCLVWFGCKLAISPSAININFNLLLLIVLEVLTASTVILSARSVDNCCSHSKPVSEGPMIVTQTSFPTRLFKAFAVIELIVGIAAVFGGIIALNLGALLPEPYLSVTFFWILAACFPSAIASHVVAENPSKSLVEMLIAINSVTSPLLFSASAFLSSSVISFIEIFLHEVALAKQSYDILLLVLMLLLLVPAVLTLATIIQCASYKSQVRMGANEWDTLRKKHCEQLASNGTLRDFDKEKAWKAVVVQMAQ,,positive regulation of intracellular transport (GO:0032388) (0.4513); cellular response to cholesterol (GO:0071397) (0.3561); phagocytosis (GO:0006909) (0.2659); establishment of localization in cell (GO:0051649) (0.2164); vesicle-mediated transport (GO:0016192) (0.1131); response to hypoxia (GO:0001666) (0.0776); translation (GO:0006412) (0.0697); response to toxic substance (GO:0009636) (0.0422); protein transport (GO:0015031) (0.0417),cytoplasm (GO:0005737) (0.3313); plasma membrane (GO:0005886) (0.2555); mitochondrion (GO:0005739) (0.1481); membrane (GO:0016020) (0.1415); perinuclear region of cytoplasm (GO:0048471) (0.1344); cytosol (GO:0005829) (0.1303); membrane raft (GO:0045121) (0.1065),identical protein binding (GO:0042802) (0.1002),Membrane protein MLC1 (IPR033280) (0.3313),,Membrane (0.4051); Transmembrane (0.4008); Reference proteome (0.3690); Transmembrane helix (0.1853); Cytoplasm (0.1426); Phosphoprotein (0.1186); Proteomics identification (0.0886),
MSLFTSVFRQLSACFTPSWGRRLSPQIADIGAEAGESKAMSTQKHRKVKSHHGHRPGKEGEGLKDQAEEEKQALSAENIQSTEREGGNGEPGGKKRKRRKLKNKKTLPLPVEVKPLPAPACFSSSPPVGDQPEHPDVLALPAAGLKPLLKDKESLPRLVEVKPLPASACFSSLTPVGDQPEHPEVLVLPASHLKALSPLSNPASRPQSPVEETDEVLPSSVIQVAPCVSPEPVLLPLQSSSEVASLCSIPSFSEPSLLQSPPETLPIPPIFAFTEVVSLVKPQASECSPSSGLMLFDFEDEELKFMEYTEEDIEAFYESEMKPRRMAAWLEQEEVTEVQKDGGKGASQVIQNPLNEVSRDEAFEELLIQAFCTGPPVYTEIKSRKKPKRNGPLVLFSLMEEKVKKKQEKKLRKEEERNERNLLRERYRNDPKLKHLCINKHNPNFCWS,3.1.-.- (0.3407); 3.1.21.- (0.0621),"mitotic cell cycle (GO:0000278) (0.2462); DNA replication (GO:0006260) (0.1955); double-strand break repair (GO:0006302) (0.1886); meiotic cell cycle (GO:0051321) (0.1691); base-excision repair, gap-filling (GO:0006287) (0.1222); positive regulation of DNA replication (GO:0045740) (0.1076); heart development (GO:0007507) (0.1006); DNA repair (GO:0006281) (0.0987); negative regulation of transcription elongation by RNA polymerase II (GO:0034244) (0.0977); isotype switching (GO:0045190) (0.0949); base-excision repair (GO:0006284) (0.0945); B cell differentiation (GO:0030183) (0.0807)",nucleus (GO:0005634) (0.1644); nucleoplasm (GO:0005654) (0.1316); chromosome (GO:0005694) (0.0972); GO:0000781 (0.0874); nuclear chromosome (GO:0000228) (0.0840),histone binding (GO:0042393) (0.0776); single-stranded DNA binding (GO:0003697) (0.0688); DNA binding (GO:0003677) (0.0583),,,Nucleus (0.5497); Reference proteome (0.4330); Coiled coil (0.2254); Transcription regulation (0.1515); rRNA processing (0.1386); DNA-binding (0.1132); Ubl conjugation (0.0726); DNA recombination (0.0517); Chromatin regulator (0.0452),
MALGSFYSLLVSRMMAVADEIFDSVKESIIDYEQEIERLRQENCCLRSRRCRCVETCNDTSSPRDEVLQGQSGSQLSEIQMKLEVATVMSPDPSGQAVSIVSSLSEDVTEQEPDQCLTILPKEMVKSEDSGGTDALITVKSELFDHQTSEMNSFAALPDRIYQVDYLISEQDVQTDLETFNKKIRKGRQKQKSVICKICGKSFKSKEHLQSHVILHQNERPFSCASCGIRFKTKFNLKEHERIHSGDYRYSCPRCGRGFSRSNHVRNHLKSARCFLIESLNH,,negative regulation of transcription by RNA polymerase II (GO:0000122) (0.3980); regulation of transcription by RNA polymerase II (GO:0006357) (0.2313); gonad development (GO:0008406) (0.1712); spermatogenesis (GO:0007283) (0.1189); positive regulation of neuron differentiation (GO:0045666) (0.0917); regulation of DNA-templated transcription (GO:0006355) (0.0888); transdifferentiation (GO:0060290) (0.0743); locomotion (GO:0040011) (0.0554); positive regulation of gene expression (GO:0010628) (0.0538); trophectodermal cell differentiation (GO:0001829) (0.0523); programmed cell death involved in cell development (GO:0010623) (0.0498); positive regulation of canonical Wnt signaling pathway (GO:0090263) (0.0482),nucleus (GO:0005634) (0.0533),"RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978) (0.2561); metal ion binding (GO:0046872) (0.2269); DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981) (0.1128)",Zinc finger C2H2-type (IPR013087) (0.4444); Zinc finger C2H2 superfamily (IPR036236) (0.2250); Snail/Krueppel C2H2-type Zinc-finger (IPR050527) (0.2068),3.30.160.60 (0.2342),Zinc-finger (0.9807); Metal-binding (0.4276); Repeat (0.3537); Nucleus (0.2312); Reference proteome (0.2294); Transcription regulation (0.1388); Ubl conjugation (0.1202),
MDSYYNQSSDNPHHEWSSVVLTLDPDVDEQELIESMKQFSQIHSLDFSFDEDTNCRHIYVTFEHSGRDQQPDPVVPTSRFIELKTLLVSNLHPMVTEQQLIEKFGALGSISTVQVCRNNIISPAYAFVTFHHRRDAVRAQKALNFTDLLNKPLIIMWGPDKTIEVLSDNDSSSPRQTEERETAGETEERKTSEETEREAAGDTEERKTSRETEREAAGDTEERKTSGETEREAAGDTEERKTSKETEREAAGDTEERANSESSWGRRISNNVKSAVKAAVSSPAAWVGVGIGVCAAYAYFRSRS,,"mRNA stabilization (GO:0048255) (0.4261); RNA splicing (GO:0008380) (0.3812); regulation of alternative mRNA splicing, via spliceosome (GO:0000381) (0.3174); mRNA processing (GO:0006397) (0.1951); mRNA splicing, via spliceosome (GO:0000398) (0.1772); positive regulation of canonical Wnt signaling pathway (GO:0090263) (0.0888); DNA repair (GO:0006281) (0.0661); positive regulation of transcription by RNA polymerase II (GO:0045944) (0.0542)",membrane (GO:0016020) (0.3822); nucleoplasm (GO:0005654) (0.3405); cytoplasm (GO:0005737) (0.2661); nuclear speck (GO:0016607) (0.1719); precatalytic spliceosome (GO:0071011) (0.1311); catalytic step 2 spliceosome (GO:0071013) (0.1010); nucleus (GO:0005634) (0.0889); ribonucleoprotein complex (GO:1990904) (0.0875),RNA binding (GO:0003723) (0.3760); chromatin binding (GO:0003682) (0.3746); manganese ion binding (GO:0030145) (0.1566),Nucleotide-binding alpha-beta plait domain superfamily (IPR012677) (0.2717); RNA recognition motif domain (IPR000504) (0.0856),,mRNA splicing (0.7431); Transmembrane (0.5171); Membrane (0.3850); RNA-binding (0.3522); Reference proteome (0.2597); mRNA transport (0.2226); Transmembrane helix (0.1427); Phosphoprotein (0.1179); Transcription regulation (0.0950); 3D-structure (0.0669); Cytoplasm (0.0573),
MLMLDGMPAVRVKAEPLESERGSPKVHGYPDMEAVPLLLSKVKAEPPEDLLSSDQFQTQTEPVDLSINKTRTSSPLSNNSPVTSAFSPSSSSSSSSSPSVIASVSSGMPSVLTSGSLVGSSHGVRGQQFLHIIHPVPPSSPSKLPSQVHRIPVVVQSLPLMYTTSVRSPSTLSSTIMLPLLDEARCQDKAQTDPNGLSPRQIKSDSDDDDLPNVTLDSVNETGSTALSIARAVQDSMSPFSIESIRRPPPPESPDSKKRRIHRCDFAGCNKVYTKSSHLKAHRRTHTGEKPYKCTWDGCTWKFARSDELTRHYRKHTGVKPFKCGDCDRSFSRSDHLALHRRRHMLV,,negative regulation of transcription by RNA polymerase II (GO:0000122) (0.9774); regulation of transcription by RNA polymerase II (GO:0006357) (0.3647); positive regulation of DNA-templated transcription (GO:0045893) (0.1920); positive regulation of transcription by RNA polymerase II (GO:0045944) (0.1666); negative regulation of DNA-templated transcription (GO:0045892) (0.1630); regulation of DNA-templated transcription (GO:0006355) (0.1118); cellular response to peptide (GO:1901653) (0.0887),chromatin (GO:0000785) (0.1204); nucleoplasm (GO:0005654) (0.0953),"DNA binding (GO:0003677) (0.2024); DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981) (0.1549); DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228) (0.1416); DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227) (0.1347); RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978) (0.0801)",Zinc finger C2H2 superfamily (IPR036236) (0.2036); Zinc finger C2H2-type (IPR013087) (0.1378),3.30.160.60 (0.1242),Ubl conjugation (0.7558); Repeat (0.4848); Zinc-finger (0.4076); DNA-binding (0.2998); Metal-binding (0.1692); Nucleus (0.1370); Zinc (0.0573),
MPFPLFSSLCKEIPSKPCSGSEGHVSDAVCEQMIGEQDWKVCLDVGPFSPEEISVKTRDGYLEITGNHEERQENHRLISRSFARKYKLPADLDLKQISSMLSPDGVLSVEAPLTGSNISFPGEIVIPIHMMDKRLPAKTDELCLTSNQRHSDSQ,,response to heat (GO:0009408) (0.5373); response to virus (GO:0009615) (0.5123); protein refolding (GO:0042026) (0.4564); anterograde axonal protein transport (GO:0099641) (0.3418); negative regulation of protein kinase activity (GO:0006469) (0.3376); protein stabilization (GO:0050821) (0.2618); intracellular signal transduction (GO:0035556) (0.2557); negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176) (0.1996); negative regulation of apoptotic process (GO:0043066) (0.1255); positive regulation of tumor necrosis factor production (GO:0032760) (0.1242); chaperone-mediated protein folding (GO:0061077) (0.1239); regulation of canonical NF-kappaB signal transduction (GO:0043122) (0.1093); cellular response to vascular endothelial growth factor stimulus (GO:0035924) (0.0976); tubulin complex assembly (GO:0007021) (0.0856); regulation of translational initiation (GO:0006446) (0.0528),nucleus (GO:0005634) (0.2836); Z disc (GO:0030018) (0.2737); mitochondrion (GO:0005739) (0.0817),unfolded protein binding (GO:0051082) (0.1529); structural constituent of eye lens (GO:0005212) (0.1318),"HSP20-like chaperone (IPR008978) (0.6244); Alpha crystallin/Small heat shock protein, animal type (IPR001436) (0.3727); Alpha crystallin/Hsp20 domain (IPR002068) (0.2852)",2.60.40.790 (0.0932),,
MAFIKEESEDVKIEETFTVEQEDLQEQTEIIEENERSIEEEHHVKIEEKTFLQTDGILKRRDKNRFTCTQCGKSFGRKDILKIHMMIHTGEKPFTCTQCGKSFSLLWSRNLHMRIHSGEKPFTCTQCGKSFSLSWSRNLHMRIHSGEKPFTCTQCWKSFSSSSHFNYHMRVHTGEKPFTCTQCGKSFSCSSSLNQHMRIHTGEKPFTCTQCGKSFSQSSHLNHHMRIHTGEKPFTCTQCGKSFSQSSHLNHHMRIHTGEKPFTCTQCGKSFSRSSYLNQHMRIHTGKKTFTCT,,negative regulation of transcription by RNA polymerase II (GO:0000122) (0.4244); regulation of transcription by RNA polymerase II (GO:0006357) (0.3690); urogenital system development (GO:0001655) (0.1886); anatomical structure morphogenesis (GO:0009653) (0.1853); positive regulation of transcription by RNA polymerase II (GO:0045944) (0.0960); spermatogenesis (GO:0007283) (0.0873); cell fate commitment (GO:0045165) (0.0744); methylation (GO:0032259) (0.0732),nucleus (GO:0005634) (0.2224); chromatin (GO:0000785) (0.0808),"RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978) (0.2801); DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981) (0.1761); metal ion binding (GO:0046872) (0.1757); DNA-binding transcription factor activity (GO:0003700) (0.1279); sequence-specific DNA binding (GO:0043565) (0.1034); methyltransferase activity (GO:0008168) (0.0616)",Zinc finger C2H2-type (IPR013087) (0.3003); Zinc finger C2H2 superfamily (IPR036236) (0.2743),3.30.160.60 (0.2292),Zinc-finger (0.9895); Repeat (0.6711); Ubl conjugation (0.4916); Metal-binding (0.4439); Zinc (0.3294); Nucleus (0.2539); DNA-binding (0.2434); Reference proteome (0.2389); Transcription regulation (0.0778),
MSESVSRFQAEVAAVLEVLLKVAVVEITKVFEGRSVDSHGCTVDGGARGKEELDCVPDIRAHMKSALNNLSEKMVCSVGVQVGETLLTRPQDECVSTERISCNLQESKREEGLSPSESLCKEPPEAVDLQCMVDLPCTILKETGIGVGRGNLIPDAPWTDDLKKTETIQENGLRGLSLEEPSAHSIVDPDSHLFSSVLDSIPIADLSTDTLSQWDLSLVDVNPLPSLEKPEAPHTSEMSLEDTELSQASASSAASGKKVRFQLTQTPFDCKLLRPCSVQLVNLLMVSSAHKANGSSKKCFSAPKDLRTHQRVHTGRRLCCFKECGNGIWRLQGVLAHGHPHACKICGKKFKRKKMLKRHERFHTGEKPYSCRRCKKTFALRKSLRRHERFHTGERPHTCPHCRKAFRLKNNLKAHLRFHTGEKPYICNLCSKGFRIRKNLEKHRLLHLAPVNFRTLQ,,negative regulation of transcription by RNA polymerase II (GO:0000122) (0.5361); regulation of cytokine production (GO:0001817) (0.3103); in utero embryonic development (GO:0001701) (0.3061); fertilization (GO:0009566) (0.2743); regulation of immune system process (GO:0002682) (0.2589); negative regulation of cell population proliferation (GO:0008285) (0.2181); gonad development (GO:0008406) (0.1816); negative regulation of apoptotic process (GO:0043066) (0.1435); natural killer cell differentiation (GO:0001779) (0.1338); T cell differentiation in thymus (GO:0033077) (0.1114); positive regulation of cell migration (GO:0030335) (0.1073); spermatogenesis (GO:0007283) (0.0975); positive regulation of gene expression (GO:0010628) (0.0811); regulation of transcription by RNA polymerase II (GO:0006357) (0.0798); B cell differentiation (GO:0030183) (0.0536); urogenital system development (GO:0001655) (0.0511),nucleus (GO:0005634) (0.1562); transcription repressor complex (GO:0017053) (0.0946),"DNA-binding transcription factor activity (GO:0003700) (0.1029); DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981) (0.0778); metal ion binding (GO:0046872) (0.0732); chromatin binding (GO:0003682) (0.0643)",Zinc finger C2H2-type (IPR013087) (0.3263); Zinc finger C2H2 superfamily (IPR036236) (0.2333),3.30.160.60 (0.1807),Zinc (0.4855); Zinc-finger (0.3075); Metal-binding (0.1860); Repeat (0.1809),
METMDQGVLGHLMSLERAGVAQQDQHQSERIQMLKVRAASLRAKRDQLKHQANVIKTLKDKISKNLPFEYDEEDEDDETGGFAALQQSLLTAWKMQLKDLQHAHHLIGGFDLVECKEGKSVCVSFHTAYEGVYLDTYNMELDLMRTVQISRHNIPPSFPLEVLAKQSLQKDLKVFLQTVSQNLNALAARRQQVTLVKDLVGSVEVMESNELCNILVLMCSAQSEPPRAVLCTLEYKDLTQSLPTHVSIESEDKTLSGSAQWKTNQALLLESPAHTALLTMKRMGSIV,,DNA damage response (GO:0006974) (0.4261); cell division (GO:0051301) (0.3472); centromere complex assembly (GO:0034508) (0.3284); chromosome segregation (GO:0007059) (0.2570); mitotic sister chromatid segregation (GO:0000070) (0.2194); microtubule cytoskeleton organization (GO:0000226) (0.1055); double-strand break repair (GO:0006302) (0.0915); gamete generation (GO:0007276) (0.0678); attachment of spindle microtubules to kinetochore (GO:0008608) (0.0660); protein ubiquitination (GO:0016567) (0.0651); chromatin organization (GO:0006325) (0.0475),nucleus (GO:0005634) (0.2533); nucleoplasm (GO:0005654) (0.2464); kinetochore (GO:0000776) (0.2421); inner kinetochore (GO:0000939) (0.1967); cytosol (GO:0005829) (0.1616); Mis6-Sim4 complex (GO:0031511) (0.1302); nucleolus (GO:0005730) (0.1269),,Centromere protein O (IPR018464) (0.1776),,Centromere (0.6017); Ubl conjugation (0.5109); 3D-structure (0.4694); Reference proteome (0.4525); Nucleus (0.4484); Mitosis (0.3896); Phosphoprotein (0.3660); Chromosome (0.3340); Transcription (0.2876); Coiled coil (0.2720); Alternative splicing (0.2326); Proteomics identification (0.1611); Transcription regulation (0.1266); Kinetochore (0.1240); Tumor suppressor (0.1142); Disease variant (0.1015); Acetylation (0.0431),
MGSPFSLKNTITSGIVSSAQRGSKELGLSNSNMDYIQTDATIDFGNSGGPLINLDGEVIGINTMKVTAGISFAIPSGRVRLFLDRSADKQKSWFGESGSKRRYIGVMMLTLTPSIIKELRMRDLSFPDVSHGVLIHRVIVGSPANRAGMKPGDVIIEINGVKVNTSEEIYNAVRTSESLNVVVRRGADLLMLHMTPESTE,HtrA2 peptidase (3.4.21.108) (0.8285),positive regulation of apoptotic process (GO:0043065) (0.8573); proteolysis (GO:0006508) (0.5317); programmed cell death (GO:0012501) (0.3310); mitochondrion organization (GO:0007005) (0.2918); apoptotic process (GO:0006915) (0.2397); intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630) (0.2312); cellular response to retinoic acid (GO:0071300) (0.1909); forebrain development (GO:0030900) (0.0795),mitochondrion (GO:0005739) (0.2407); mitochondrial intermembrane space (GO:0005758) (0.1833); nucleus (GO:0005634) (0.1700); cytosol (GO:0005829) (0.1162); mitochondrial membrane (GO:0031966) (0.0808),serine-type endopeptidase activity (GO:0004252) (0.3006); identical protein binding (GO:0042802) (0.2223); ubiquitin ligase inhibitor activity (GO:1990948) (0.1291),"Peptidase S1, PA clan (IPR009003) (0.2394); PDZ superfamily (IPR036034) (0.2281); Peptidase S1C (IPR001940) (0.1504); PDZ domain 6 (IPR041489) (0.1290); PDZ domain (IPR001478) (0.1156); Serine proteases, trypsin domain (IPR001254) (0.0778)",2.40.10.120 (0.2739); 2.30.42.10 (0.1327),Zymogen (0.7321); Reference proteome (0.0693),
MASLSEENFSCPICHEIFKDPVVLSCSHSFCRECLQQYWRAVDIQECPVCRRRSSRDDPPNNLVLKNLCESFLKERKEKPSPGSEEICSLHGEKLKLFCLEDKQPVCLVCRDSEQHDNHKFRPIGEVVSSHKEELNTGLKSLQEKLRHKETIKEEFEKTVQHITAQADHSEHQIKQEFEKLHQFLKDREKGTITALRKEEKQKKQMMKEKLEEINTHISALSDSIRDTKEMLKANDVCFLKEFPGSMERVQISQPDPQTPSGALIHVSQYLGNLQYRVWRKMEDIVHYTPVILDPNTANSHIVLSEDLTSVRESENKQWLPDNPERFDYPCVLGSVGFCSGKHRWDVEVKESRCWSVGVTTASNQRKRDVFFNTDVWSVWHDPYGLIKSSSNEFPVEQYLECVRVELDYDRGTVCFSDPVNNTHLHTFTTTFTDAVFPFLWCDLFSSLRILPFNR,RING-type E3 ubiquitin transferase (2.3.2.27) (0.9272),protein ubiquitination (GO:0016567) (0.7071); innate immune response (GO:0045087) (0.1885); apoptotic process (GO:0006915) (0.1142),extracellular region (GO:0005576) (0.3454); cytoplasm (GO:0005737) (0.2969); nucleus (GO:0005634) (0.0724),zinc ion binding (GO:0008270) (0.8763); ubiquitin protein ligase activity (GO:0061630) (0.1672),"B-box-type zinc finger (IPR000315) (0.8534); B30.2/SPRY domain (IPR001870) (0.4971); Butyrophylin-like, SPRY domain (IPR003879) (0.4901); SPRY domain (IPR003877) (0.4680); Tripartite motif-containing (IPR050143) (0.4164); SPRY-associated (IPR006574) (0.3874); Concanavalin A-like lectin/glucanase domain superfamily (IPR013320) (0.3126); Zinc finger, RING-type, eukaryotic (IPR027370) (0.2689); Zinc finger, RING-type, conserved site (IPR017907) (0.2569); B30.2/SPRY domain superfamily (IPR043136) (0.2556); Zinc finger, RING-type (IPR001841) (0.1869); Zinc finger, B-box, chordata (IPR020457) (0.1848); Zinc finger, RING/FYVE/PHD-type (IPR013083) (0.1603)",3.30.40.10 (0.3244); 2.60.120.920 (0.2084),Zinc-finger (0.9990); Zinc (0.9519); Reference proteome (0.8392); Coiled coil (0.5183); Metal-binding (0.4916); Ubl conjugation pathway (0.2712); Toxin (0.2036); Neurotoxin (0.0733),
MMSSAHTAVKTEFIKEESEEVRIPEPCGDEEEEASTLKKEEPEEHTEQTEVKEEREEQHEHVYDYEQPQYLSCSLNGKSLTQKRAERAGCGFFFTCLECKRSFESKEHLMEHFRNHTGESCTQTQVFMPQCTTEKGACPLPFTCHQCQKSFTCKDHLLHHYRIHTVEKPFPCDECGKSFIHKQSLKNHQKVHSGLRPFVCTLCGKSYIHKDNLTDHMRIHTGEKPHTCKLCGKSFTHKGSLLHHMKIHTGLKPFTCRQCGRHFTHKGNLKIHIRIHSGERPFVCSQCGKTFIYHGNLMGHLKKHSGEKKHRCEECGKSFVEARHLQKHMKTHATVRPFVCAHCGKDFLWPHNFKEHMKVHTGEKPHVCLDCGKPFTRQIYLKRHQRIHLGEKPFKCERCGLCFTTMDSLRVHERVHTGEKPYKCPSCHKSFGRLSTLLTHKKKHCPMLRK,,regulation of transcription by RNA polymerase II (GO:0006357) (0.6038); negative regulation of transcription by RNA polymerase II (GO:0000122) (0.5922); spermatogenesis (GO:0007283) (0.0735); DNA damage response (GO:0006974) (0.0519); positive regulation of transcription by RNA polymerase II (GO:0045944) (0.0502); urogenital system development (GO:0001655) (0.0402),nucleus (GO:0005634) (0.3440); chromatin (GO:0000785) (0.1458); nucleoplasm (GO:0005654) (0.0639),"metal ion binding (GO:0046872) (0.3468); DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981) (0.1884); RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978) (0.1386); sequence-specific DNA binding (GO:0043565) (0.1258); DNA-binding transcription factor activity (GO:0003700) (0.0903); sequence-specific double-stranded DNA binding (GO:1990837) (0.0755)",Zinc finger C2H2-type (IPR013087) (0.2777); Zinc finger C2H2 superfamily (IPR036236) (0.1778),3.30.160.60 (0.2871),Zinc-finger (0.7983); Ubl conjugation (0.7901); Repeat (0.7102); Metal-binding (0.4060); Transcription (0.3403); Reference proteome (0.3078); DNA-binding (0.2575); Nucleus (0.2192); Proteomics identification (0.1994); Zinc (0.1901); Transcription regulation (0.1119); Phosphoprotein (0.1020); Repressor (0.0755); Spermatogenesis (0.0493),
MSLLCSSTTMKDRDSLSLLHYSGSGKTSPQFPSASLHSSSPVLAKPQPFCLQSGPHLIASMQLQKLNSHYQNLTSTATTGPGRGYTASMLSPGQISSPGAAQASGIIDSDPVDEEVLMSLVVELGLDRANELPELWLGQNEFDFIADVPAGC,,melanocyte differentiation (GO:0030318) (0.4169); negative regulation of transcription by RNA polymerase II (GO:0000122) (0.2543); response to estrogen (GO:0043627) (0.2350); response to insulin (GO:0032868) (0.2074); regulation of DNA-templated transcription (GO:0006355) (0.2060); transforming growth factor beta receptor signaling pathway (GO:0007179) (0.1722); response to type II interferon (GO:0034341) (0.1629); response to hypoxia (GO:0001666) (0.1103); response to interleukin-11 (GO:0071105) (0.0773); left/right pattern formation (GO:0060972) (0.0721); autophagy (GO:0006914) (0.0706); response to transforming growth factor beta (GO:0071559) (0.0654); labyrinthine layer development (GO:0060711) (0.0553); osteoclast differentiation (GO:0030316) (0.0530); positive regulation of DNA-templated transcription (GO:0045893) (0.0506); lung alveolus development (GO:0048286) (0.0445); positive regulation of gene expression (GO:0010628) (0.0438),cytoplasm (GO:0005737) (0.3125); nucleus (GO:0005634) (0.1377); cytosol (GO:0005829) (0.0534),,CITED (IPR007576) (0.4268),6.10.140.2200 (0.2613),Transcription regulation (0.4921); Transcription (0.3016); Activator (0.1521); Ubl conjugation (0.1385); Cytoplasm (0.0589); Reference proteome (0.0584),
MLRRKRSVSFGGFGWKQELLTISNVPLSDCPHSPPRTAPPAVKSTQFFDMLDKMEDDYIPYPRIEEVLQRGEPYPQVILPQFGGYWIEDPEAPAAIANWENGFCDDDDEDGRNSGEYGYKLESNFAIRAYRKHFLGREHLNFYCTASNHGNLVLSLRHEEVKEQEYLHIILRAPSKTIYDRISLTGLTELPSVPQLAKLLCEDIVGLRFSPVLYPKGSQLIVNYDEHELNNTFKFGVIYQKFGQTSEEELFGNSEETPAFTEFLRVLGDCVQLQDFKGFRGGLDVSHGQTGSQSVYTVFKGQELMFHISTKLPYIEGDTQQLQRKRHIGNDIVAAVFQEEATPFVPDMIASNFLHAYILVQVENSGTDEATYKVSVTAREDVPQFGPPLPNPPIFKKGPEFREFLLSKLINAELACYRSNRFAKLEERTRTELLDNLHNELHKRTQSMLGHPLNPDEERMENGGHGGILESIKRAMRVRSHSMETMVGTHKHGRCSPAAGAGVPTSLSGVSLTHSSSEAAKNSSPVTSSAKSPLKSPVKRRSGLFPRLYTSMDGQPERHTRSVLCDQRSLDCGHLSQEVKSETSSNPSSPEILNNERPSLKLQEVSGPPDISRSSSSTSSFSSAAGEPETVEEKEPSGVQISPSLSPVFGSLTTDGQAAGAPVIMCRSPTDFRNKTSPRSNLKFRFDRLSQSAAGH,,regulation of cell size (GO:0008361) (0.3234); establishment of localization in cell (GO:0051649) (0.2444); negative regulation of neuron projection development (GO:0010977) (0.2430); regulation of small GTPase mediated signal transduction (GO:0051056) (0.1969); regulation of GTPase activity (GO:0043087) (0.1453); positive regulation of phagocytosis (GO:0050766) (0.1341); signal transduction (GO:0007165) (0.1256); actin cytoskeleton organization (GO:0030036) (0.1106); brain development (GO:0007420) (0.1024); heart development (GO:0007507) (0.0922); phagocytosis (GO:0006909) (0.0667),cytoplasm (GO:0005737) (0.3328); membrane (GO:0016020) (0.1222); Golgi apparatus (GO:0005794) (0.0892); cytosol (GO:0005829) (0.0846); plasma membrane (GO:0005886) (0.0836); axon (GO:0030424) (0.0670),GTPase activator activity (GO:0005096) (0.1540),Rap1/Ran GTPase-activating (IPR050989) (0.1615); Rap/Ran-GAP domain (IPR000331) (0.0958),3.40.50.11210 (0.3009); 6.10.140.210 (0.1547),GTPase activation (0.1754); Reference proteome (0.1430); Alternative splicing (0.1132),
MLRCLFVFVCLLHTMLGVMGAVTPKPIIINGTYINPELGKYHARLRSIARSCLQIKKNHGATQDGMYILTTESGTYYQTFCDMTTAGGGWTLVASVHENNINGKCSFGDRWSSQQGNDQSLPEGEASWANTATFGSAEGSTSDDYKNPGYYDISAQDVSVWHVPNNEQLKKWTSSAILRYHTESQFLKEHGGNLYHLFKKYPVRFGAGQCKSDMGPSSSVVYDTGDKDSTSNLYGPSVRNEFESGFITFRVFNTDQSAMAMCSGIKPSGCNTQHYCIGGGGFFAQPEQCGDFTALDLKETFKQPTQSAVLLFYR,,response to nematode (GO:0009624) (0.6899); positive regulation of protein phosphorylation (GO:0001934) (0.2975); protein homotrimerization (GO:0070207) (0.1537); positive regulation of cytosolic calcium ion concentration (GO:0007204) (0.1436); positive regulation of glucose import (GO:0046326) (0.0654); defense response to nematode (GO:0002215) (0.0492),plasma membrane (GO:0005886) (0.2052); extracellular region (GO:0005576) (0.1609); extracellular space (GO:0005615) (0.1510); brush border membrane (GO:0031526) (0.0975); extracellular exosome (GO:0070062) (0.0543),oligosaccharide binding (GO:0070492) (0.3485); calcium ion binding (GO:0005509) (0.2279); identical protein binding (GO:0042802) (0.2127),"Fibrinogen-like, C-terminal (IPR036056) (0.2284); Fibrinogen, alpha/beta/gamma chain, C-terminal globular domain (IPR002181) (0.1711); Fibrinogen, alpha/beta/gamma chain, C-terminal globular, subdomain 1 (IPR014716) (0.1484)",3.90.215.10 (0.5555),Signal (0.7180); Reference proteome (0.6002); Lectin (0.5141); Glycoprotein (0.4494); Membrane (0.3904); Direct protein sequencing (0.2805); Metal-binding (0.2623); GPI-anchor (0.2537); Disulfide bond (0.2358); Secreted (0.1595); Cell membrane (0.1432); Calcium (0.1403); Zinc (0.0752); Sulfation (0.0482),
MRKSEVIAAESVACLNKALCHLKDIWEEIGIPEDQRLERTNVVKNHVKGLLDMMIAEEESLRKRLMTSIEKCHKELSKLCLELQSPPFQEEKSGTMLQREKELRTHVEVMLKEKNQRMQALKALTEQDQDLCDLLCSQPFSISPGCVPSMEQLENFHQHISCLTAEKERRHKEFVTLKKQIILCMDDLDQLPETSFEKDVVCEDEESFCLSKENIDSLKVLLQQLENRKAENKRVCGSYREKILELWKRLQIPQEERDVISEHMTLSKKRNMEALQVEVKRLEELKLKNMQNVTETLRKEIAVYWEKCFYSADQRQAFMPYYDDDFSEELLSLHDAEIVQLKQYYEDHKELFEGVHKWEENWRLFIELEERAKDPSRFTNRGGNLLKEEKQRADIVKGLPKLEKKLKAEIEQWELEQNREFQVNGQKFMQFVSDQWELYRLEKEREKQERQLKKSKQTEEDMVYGTVIRTPTKRRFLGSTTPCKARKLNPTSSTGTSNSTIRSVIGGTVCHSPISRPPISASKGNGVKTPGHSKPPHQGLLERNKENICHLTGGVAGMTKVPASPQRNFSINSVASTYSEFQRDLSKSSKSKHVPEILNSTIIQL,,microtubule cytoskeleton organization (GO:0000226) (0.7310); positive regulation of cell population proliferation (GO:0008284) (0.3990); positive regulation of G2/M transition of mitotic cell cycle (GO:0010971) (0.3532); regulation of cytokinesis (GO:0032465) (0.3071); mitotic spindle midzone assembly (GO:0051256) (0.2410); positive regulation of microtubule polymerization (GO:0031116) (0.1168); microtubule bundle formation (GO:0001578) (0.0714); cell division (GO:0051301) (0.0699),mitotic spindle (GO:0072686) (0.6947); nucleoplasm (GO:0005654) (0.3656); spindle pole (GO:0000922) (0.3328); spindle (GO:0005819) (0.3109); cytoplasm (GO:0005737) (0.2818); plasma membrane (GO:0005886) (0.2374); mitotic spindle midzone (GO:1990023) (0.1639); nucleus (GO:0005634) (0.1257); intercellular bridge (GO:0045171) (0.1212); midbody (GO:0030496) (0.0881),microtubule binding (GO:0008017) (0.1281),,1.20.58.1520 (0.1772),Reference proteome (0.7196); Coiled coil (0.6228); Phosphoprotein (0.3956); Nucleus (0.3458); Proteomics identification (0.1470); Cytoskeleton (0.1334); Membrane (0.1250); Mitosis (0.1114); Ubl conjugation (0.0579),
MALMDKHKVKRQRLDRICEGIRPPILNGPMHPRPLVALLDGRDCTVEMPILKDVATVAFCDAQSTQEIHEKVLNEAVAALLYHTITLSRDDLDKFKGLRVIVRIGSGFDNVDIKAAAELGIAVCNVPAASVEETADTAMCLILNLYRRVTWMHQALREGTRASSVEQIREVAGGAARIRGETLGIIGLGRVGQAVALRAKAFGFGVIFYDPYLPDGVERSLGLQRMATLQDLLMHSDCVSLHCSLNEHNHHLINDFTIKQMRQGAFLVNTARGGLVDEKALAQALKEGRIRGAALDVHETEPFSFSQGPLKDAPNLICTPHTSWYSEQASIEAREEAAREVRRAITGRIPDSLKNCVNKEYLMAASQWPSMEATTVHSELNGAAAYRFPAGLIGVAAGGLPGAGAGVEGIVAGSLPLAHAIAPVSHPPHTPSPGQPSKAEADRDIPSDQ,1.1.1.- (0.1515),regulation of transcription by RNA polymerase II (GO:0006357) (0.5318); white fat cell differentiation (GO:0050872) (0.2285); positive regulation of DNA-templated transcription (GO:0045893) (0.1639); regulation of cell cycle (GO:0051726) (0.1604); negative regulation of transcription by RNA polymerase II (GO:0000122) (0.1557); synaptic vesicle clustering (GO:0097091) (0.1553); positive regulation of transcription by RNA polymerase II (GO:0045944) (0.1151); positive regulation of retinoic acid receptor signaling pathway (GO:0048386) (0.1092); synaptic vesicle docking (GO:0016081) (0.0436),transcription repressor complex (GO:0017053) (0.5834); nucleus (GO:0005634) (0.3864); glutamatergic synapse (GO:0098978) (0.1859); nucleoplasm (GO:0005654) (0.1381),"transcription corepressor activity (GO:0003714) (0.3293); transcription coactivator activity (GO:0003713) (0.2583); oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616) (0.1958); chromatin binding (GO:0003682) (0.1733); identical protein binding (GO:0042802) (0.1154); RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629) (0.1027); NAD binding (GO:0051287) (0.0965); transcription coregulator binding (GO:0001221) (0.0776)","C-terminal binding protein (IPR043322) (0.2764); D-isomer specific 2-hydroxyacid dehydrogenase, catalytic domain (IPR006139) (0.2582); C-terminal-binding dehydrogenase (IPR051638) (0.2465); D-isomer specific 2-hydroxyacid dehydrogenase, NAD-binding domain conserved site (IPR029753) (0.2028); D-isomer specific 2-hydroxyacid dehydrogenase, NAD-binding domain conserved site 1 (IPR029752) (0.1693); D-isomer specific 2-hydroxyacid dehydrogenase, NAD-binding domain (IPR006140) (0.1469); NAD(P)-binding domain superfamily (IPR036291) (0.1373)",3.40.50.720 (0.2234),Transcription regulation (0.2572); Reference proteome (0.1820); Oxidoreductase (0.1597); Nucleus (0.1354),
MKKAKKRLPASGSRASVGRHEENLPWKKKKLLDIHQALNSDPVDIETLRQAAVSEGGLLTDDIRRKVWPKLLNINVYSLPAKPSKDVREDHKDYRQVVLDVRRSMRRFPKGMRVDEREVLQEQLIDIILDVLRRNPQLHYYQGYHDIVVTFLLVLGERMTIAIMEKLSNHHLRDFMDPTMDSTKHILNYLMPLLERVDRELHDFMIRSEVGTIFALSWLITWYGYVLSDFRHVLRLYDFFLASHPLMAIYFAAVIVLYRQKEVKSSECDMASVHHLLSRMPQDLPYEDLIGRAQSLFSSCPPSQMSRSAALQSRNILAISTFTDFQTSTRTQRPDSVLRQQIQNRQENQLALPMMPQPTGTNQLIKMAVWGLSATLGAAALAVAQTALDWAPEFLSQLF,,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888) (0.6067); positive regulation of ER to Golgi vesicle-mediated transport (GO:1902953) (0.6035); positive regulation by virus of viral protein levels in host cell (GO:0046726) (0.5348); Golgi organization (GO:0007030) (0.4680); lipid droplet organization (GO:0034389) (0.4052); positive regulation of GTPase activity (GO:0043547) (0.3349); acrosome assembly (GO:0001675) (0.3108); spermatogenesis (GO:0007283) (0.1427); positive regulation by host of viral genome replication (GO:0044829) (0.1340); seminiferous tubule development (GO:0072520) (0.1152); COPII-coated vesicle cargo loading (GO:0090110) (0.1097); virion assembly (GO:0019068) (0.0842); in utero embryonic development (GO:0001701) (0.0679); lens development in camera-type eye (GO:0002088) (0.0638),Golgi membrane (GO:0000139) (0.3381); endoplasmic reticulum membrane (GO:0005789) (0.1904),small GTPase binding (GO:0031267) (0.1183),GTPase-activating protein TBC20/Gyp8-like (IPR045913) (0.3963); Rab-GAP-TBC domain superfamily (IPR035969) (0.3469); Rab-GAP-TBC domain (IPR000195) (0.1285),1.10.472.80 (0.3042); 1.10.8.1310 (0.2164),GTPase activation (0.3738); Reference proteome (0.3407); Proteomics identification (0.1236),
MDILKRPGIPEDAVQYKLFVVAADPSAPEKSLQQILQDILAEITPLLVPYIWQNQPFNLTQHPEKGDVPAHLGGVTEFGDNVEDEWFIVYLLKHITHTFTDIAAVVYDNDGQFLLIEAAEHLPKWLDPDSSENRVFLYHGELHIIPMSSSSGEVGFSRDCVPTVRQALEVLHSHTDRCLAKQTIRSALNQRIHGYPDKIQQNVHRAHCYVPAGIAVVLSRRPDLIAPAVSAFYLRDPVDLQACRTFHTFPPDTRVMTSVKFTRCLYAQLQQQSFVPDRRSGFSLPARSHPQYRAHELGMKLAHGFEILCSKNGESSSDQEPSVSSNPLWRGFLESLKKNGYFKGNLEGSARYKELMTSAESFFRQSVTRTHRPDIHNPGGEVLKVLQSASYSLEDLKKQEANLPPEDSDAWLDISPQELERLLAERGGRGGTGEEVQEEESGYSLIAVTQGMKNFINAMSSHEGAEIPRSCLAEPFRFDPDSVTSALDRLLGAKDDELDSDDFEDEDDDDDDDDDEAVQSSVPQEQATGAETLDNLRKYMDEMDQELQSTNIGKSFTQNNRSSNKAEASKSSSSTSASELLEDEIQPLDVDLNLVTNLLESLSSQAGLAGPASNLLQSLGLHIPPDADQP,,"negative regulation of transcription by RNA polymerase II (GO:0000122) (0.4345); mRNA splicing, via spliceosome (GO:0000398) (0.3482); chromatin organization (GO:0006325) (0.2494); RNA splicing (GO:0008380) (0.2035); mRNA export from nucleus (GO:0006406) (0.1741); mRNA processing (GO:0006397) (0.1484); positive regulation of transcription by RNA polymerase II (GO:0045944) (0.0898); regulation of mRNA export from nucleus (GO:0010793) (0.0870); negative regulation of protein ubiquitination (GO:0031397) (0.0733)",nucleus (GO:0005634) (0.3983); nucleoplasm (GO:0005654) (0.2701); cytoplasm (GO:0005737) (0.1979); spliceosomal complex (GO:0005681) (0.1913),,Ecd family (IPR010770) (0.2037),,mRNA splicing (0.8487); mRNA processing (0.7958); Reference proteome (0.5708); Transcription (0.3715); Transcription regulation (0.2312); Cytoplasm (0.2121); Ubl conjugation (0.1985); Nucleus (0.1750); Phosphoprotein (0.1706); Developmental protein (0.1699); Spermatogenesis (0.1119); Repressor (0.1056); Disease variant (0.0857); rRNA processing (0.0853); 3D-structure (0.0743),
MATTKELLEMDLYALLGVESTSTEKQIKKAYRQRALSCHPDKNPDNPKAAELFHQLSQALEVLTDAAAKAAYDKVRAAKKQAEERNRKLDDKRKKIKLDLEARERRAENVKAEEVKITRTLEEEIARLREEGSRELQEQQRLIREQIERERDAHTHTDSSAVQQGGNNVTPKLKLKWKCKKEDESNAGYSHECLQNLFQKYGDVLNILISSKKKGSAVVEFASAKAAELACKNESGLTGNPLKITWLEGQPLQTTLSENTHSGFSATQSCLRTERDYESVVLMRLRQAEERKRLIEQMKREEEDDTA,,"negative regulation of transcription by RNA polymerase II (GO:0000122) (0.2865); negative regulation of transcription elongation by RNA polymerase II (GO:0034244) (0.2427); spliceosomal complex disassembly (GO:0000390) (0.2415); DNA replication (GO:0006260) (0.2052); regulation of alternative mRNA splicing, via spliceosome (GO:0000381) (0.1788); positive regulation of transcription by RNA polymerase II (GO:0045944) (0.1460); regulation of mRNA splicing, via spliceosome (GO:0048024) (0.1433); DNA repair (GO:0006281) (0.1111); mRNA processing (GO:0006397) (0.1104)",nucleus (GO:0005634) (0.4620); cytoplasm (GO:0005737) (0.2812); spliceosomal complex (GO:0005681) (0.0590),RNA binding (GO:0003723) (0.5041); lncRNA binding (GO:0106222) (0.0912); chromatin binding (GO:0003682) (0.0811); protein homodimerization activity (GO:0042803) (0.0716); nucleic acid binding (GO:0003676) (0.0531),Nucleotide-binding alpha-beta plait domain superfamily (IPR012677) (0.4612); RNA recognition motif domain (IPR000504) (0.1591); DnaJ domain (IPR001623) (0.1435),3.30.70.330 (0.4404),Reference proteome (0.6487); mRNA splicing (0.5761); Nucleus (0.4768); Coiled coil (0.2405); Chaperone (0.2269); Phosphoprotein (0.1646); RNA-binding (0.1603); Translation regulation (0.1527); Transcription regulation (0.1191); 3D-structure (0.1109); Cytoplasm (0.1103); Spliceosome (0.0793); mRNA processing (0.0740),
MDIHKLAERLAKAGQSHVIQFWDQLSPEEQGEMSLDLESMNFLEINNFFKSAMKTSGQSSQEKVDTRMEPVPRDVLGSVTRDRECLKEWEKEGLRCIAENKVAVLLLAGGQGTRLGVSFPKGMYDVGLPSHKTLFQIQAERIRKLEQLAEKQHSRKCCIPWYIMTSGRTMDMTKDFFIQHKYFGLKEENVVFFQQGMLPAMDFNGKIILEGKCKLAMAPDGNGGLYRALGTQNIVKDMETRGISYIHVYCVDNILVKVADPAFIGFCTLKGADCGAKVVEKTNPTEAVGVVCKVDGRYQVVEYSEITLATAEKRSTDGRLMFNAGNIANHFFTLTFLREIVRTHEPQLQHHVAQKKIPYVNTEGQLIKPDKPNGIKMEKFVFDIFQFAKKFVVYEVLREDEFSPLKNADSQDGKDNPTTARHALMSLHHRWILNAGGHFVDENGTHIPAIPSLKDGTDLPIKCEISPLVSYGGEGLEHLVNEKVFQPTLIINESGVHELVKNGL,2.7.4.- (0.2264); UDP-N-acetylgalactosamine diphosphorylase (2.7.7.83) (0.1171); UTP-glucose-1-phosphate uridylyltransferase (2.7.7.9) (0.0602); UDP-N-acetylglucosamine diphosphorylase (2.7.7.23) (0.0569),UDP-glucose metabolic process (GO:0006011) (0.3744); cell population proliferation (GO:0008283) (0.3081); innate immune response (GO:0045087) (0.1955); UDP-N-acetylglucosamine biosynthetic process (GO:0006048) (0.1392); sprouting angiogenesis (GO:0002040) (0.1189); positive regulation of type I interferon production (GO:0032481) (0.0959); cell adhesion (GO:0007155) (0.0809),plasma membrane (GO:0005886) (0.6285); cytosol (GO:0005829) (0.3604); nucleoplasm (GO:0005654) (0.2728); nucleus (GO:0005634) (0.1423),protein serine pyrophosphorylase activity (GO:0141090) (0.1711); uridylyltransferase activity (GO:0070569) (0.0988),Nucleotide-diphospho-sugar transferases (IPR029044) (0.2275); UDP-sugar pyrophosphorylase (IPR039741) (0.1998); UDPGP family (IPR002618) (0.1787),2.10.10.100 (0.3309),Nucleotidyltransferase (0.5632); Transferase (0.5332); Reference proteome (0.4847); Innate immunity (0.4417); Direct protein sequencing (0.2188); Cytoplasm (0.1698); Immunity (0.1588); Nucleus (0.1516); 3D-structure (0.1492); Alternative splicing (0.1318); Proteomics identification (0.1122); Phosphoprotein (0.0772),
MSSDGLLNMDVPNGQPSVSTLTAPASERSSSSESLSEKGTSELKSFDAVVFDVLKVTPEEYAGQITLMDAPVFRAIQPEELSSCGWNKKEKHSSAPNAVAFTRRFNQVSFWVVREILHAQTLKIRAEVLSLYIRTAKKLCDMNSLHAVMAVVSALQSAPIFRLTKTWALLSRKDKATFERLEYLMSKEDNYKRLRDYISSQSMTSCIPYLGIYLSDLTYIDSAYPSTGSILENEQRSNLMNNILRIISDLQRSCEYEIPVLPHVQKYLNSVRYIEELQKFVEDDNYKLSLKIEPPATSTPRTTASREDLTGPDISASPLCGRHGNVAEGALPKVPPTPPSPRNLITYGHRKCHSLGYNFIHKTNTVEFKSATFPNAGSRHLLDDSVLESHTPTRGHAESSTLSSGISLGSSEGSELSEEMSWPAFERTRFYHSLGPVTRVGRMSCRGSLRPSSSAESEELAVHLYPGAVTVQGVLRRKTVLKEGKKPTVAAWTKYWVALCGTQLYYYTAKSLKATERKHFKSTASKTVCVLGLMAMMADDPEHPDVFLLTDSEHGNSYKFQAGNRMNALLWFKHLSAACQSNRQQVPANLMSFE,,small GTPase-mediated signal transduction (GO:0007264) (0.4590); Ras protein signal transduction (GO:0007265) (0.4557); B cell receptor signaling pathway (GO:0050853) (0.2248); associative learning (GO:0008306) (0.2182); positive regulation of GTPase activity (GO:0043547) (0.1702); positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742) (0.0915); positive regulation of Ras protein signal transduction (GO:0046579) (0.0885); regulation of Ras protein signal transduction (GO:0046578) (0.0850); negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction (GO:0051898) (0.0847); response to glucose (GO:0009749) (0.0779),plasma membrane (GO:0005886) (0.2728); cytosol (GO:0005829) (0.1638); protein-containing complex (GO:0032991) (0.1568),guanyl-nucleotide exchange factor activity (GO:0005085) (0.2232),"PH-like domain superfamily (IPR011993) (0.3627); Pleckstrin homology domain (IPR001849) (0.2298); Ras guanine-nucleotide exchange factor, catalytic domain superfamily (IPR036964) (0.1100); Ras guanine-nucleotide exchange factors catalytic domain (IPR001895) (0.1094)",2.30.29.30 (0.4724),Guanine-nucleotide releasing factor (0.6278); Membrane (0.2721); Proteomics identification (0.2114); Reference proteome (0.2046); Cytoplasm (0.1347); Cell membrane (0.1305); Phosphoprotein (0.0680),
MPLNPVISKLSGKLVVLASASPRRLEILSNAGLRFEVVPSWFKETLDKSLFKHPCEYAVETAKQKALEVAQRMPFKHLKTPDIVIGADTVVTVDGLILEKPTDKQDAYRMLSRLSGKEHSVFTGVAIVICRDKNSSVTDYKVVDFYEETKVKFAELSEEMLWEYINSGEPMDKAGGYGIQALGGMLVEYVRGDFLNVVGFPLNHFCKQLGSIFNSPPASPAHKIKRDCDEAWTLVNKTTNGDVELLENVKDDSLTSVQEQNVMGLEFAKCNRQDVPHSIISLLDGFKVSKTLFTASKLKVFDVLNTPGGLTLEEVAGQINASLLGTERLLEAAVSLGLLERVRQEEISVYRNTEQASRFLVTDSPVSLHGYILHCNDMVWPLFSHLESAVREGTSQHERAFGKKKEDVFQDVYYSKDEVKIRFMDAMHSIARVTGKDLATAFDLSCYKTACDIGGCTGAMAYEFTKAHPELSVTIFDLPQVIEMRRHFQPKENDERVSFVAGDFFKDDLPKADLYILARVLHDWSDEKLHVLLSKLSKMWTPGCGLLVSEILLDEERRRPSRALLQALSMTEGKQRSTAEYSALLDKHGFTLKHVKHTDNLLDAMLFVKEEQNDKRTLLGCSSASIETAELE,nucleotide diphosphatase (3.6.1.9) (0.6632); 2.1.1.- (0.5472); acetylserotonin O-methyltransferase (2.1.1.4) (0.2233),methylation (GO:0032259) (0.8595); nucleotide metabolic process (GO:0009117) (0.0528),cytoplasm (GO:0005737) (0.1617),nucleoside triphosphate diphosphatase activity (GO:0047429) (0.8166); O-methyltransferase activity (GO:0008171) (0.2301); dTTP diphosphatase activity (GO:0036218) (0.0736),Inosine triphosphate pyrophosphatase-like (IPR029001) (0.7529); Nucleoside triphosphate pyrophosphatase Maf-like protein (IPR003697) (0.5376); Winged helix-like DNA-binding domain superfamily (IPR036388) (0.3608); S-adenosyl-L-methionine-dependent methyltransferase superfamily (IPR029063) (0.3071); Winged helix DNA-binding domain superfamily (IPR036390) (0.1202); O-methyltransferase COMT-type (IPR016461) (0.0759); O-methyltransferase domain (IPR001077) (0.0610),3.90.950.10 (0.4475); 3.40.50.150 (0.1906); 1.10.10.10 (0.1411),Transferase (0.9027); Reference proteome (0.7217); S-adenosyl-L-methionine (0.5043); Methyltransferase (0.4179); Cytoplasm (0.2135); Melatonin biosynthesis (0.0943),a divalent metal cation (0.3084)
MESPAAVDDDICILKHESAYGAVESPVSVCAGDESVASHFALVTAYEDIKKRLRETEKENGLLRRRVKQLEDKHFRPEAPPSEGPQYMNKAFSAYRGIYMEKEDLQLELNRVKKDKQDVERVLTEQLQAKELELLQLRSEMETSQVMKSLTADTSEYWHVDRHSSELKIQNLQEQLDRLQLENNTLNKLYRDTQNASENCIAHEDQSHNTLTDIRSLAVVQSYQDVLSEVCCLRSAVRSQSELMRRLKDRPLLPAFRRAASTVPVQCLDDVERVRDSTPRPPSAPPLASQDLIESTPLRMSSLDDSSWSFPSPPRPSEALFWSPAAD,,negative regulation of canonical NF-kappaB signal transduction (GO:0043124) (0.7103); canonical NF-kappaB signal transduction (GO:0007249) (0.2013); positive regulation of interferon-beta production (GO:0032728) (0.1932); apoptotic process (GO:0006915) (0.1902); innate immune response (GO:0045087) (0.1821); protein import into nucleus (GO:0006606) (0.1804); dendritic cell proliferation (GO:0044565) (0.1456); T cell activation (GO:0042110) (0.1166); protein homotetramerization (GO:0051289) (0.1103); response to hypoxia (GO:0001666) (0.0879); negative regulation of interferon-beta production (GO:0032688) (0.0764); JNK cascade (GO:0007254) (0.0681); brain development (GO:0007420) (0.0591),cytoplasm (GO:0005737) (0.5287); nucleus (GO:0005634) (0.1599); centrosome (GO:0005813) (0.1314); mitochondrion (GO:0005739) (0.0695),identical protein binding (GO:0042802) (0.0985); protein kinase binding (GO:0019901) (0.0750),TBK1 and IKBKE adapter proteins (IPR051891) (0.2473); Tbk1/Ikki binding domain (IPR024581) (0.1212),,Ubl conjugation (0.6397); Reference proteome (0.4043); Coiled coil (0.3329); Cytoplasm (0.1953); Metal-binding (0.1824); Innate immunity (0.1628); Immunity (0.1602); Phosphoprotein (0.0772); 3D-structure (0.0752),
MAAARGVFAGPIKRLLPRGSFTQTRSWCSNGSVSDKKEVRLNRLEGEDNGIVEVLMCRERARNSLGHVFVGQMRDLVSSLQHDSAVRVLVFRSLIPGVFCAGADLKERAQMSNAEAELFVHGLRSLMNDIAALPMPTIAAVDGFALGGGLELALACDLRTAAHCAQMGLIETTRGLLPGAGGSQRLPRTVGFAVAKELIFTGRRVGGEQAVNLGLVNRSVPQNQTGDAAHREALSLAREILPQAPIAVRMAKVAMNRGAEVDISSGMAIEGMCYARLIPTRDRQEGMAAFIEKRPPRYTGE,methylglutaconyl-CoA hydratase (4.2.1.18) (0.7264); enoyl-CoA hydratase (4.2.1.17) (0.1982); itaconyl-CoA hydratase (4.2.1.56) (0.1555),L-leucine catabolic process (GO:0006552) (0.4384); fatty acid beta-oxidation (GO:0006635) (0.1775); branched-chain amino acid catabolic process (GO:0009083) (0.1334),mitochondrion (GO:0005739) (0.4865); mitochondrial matrix (GO:0005759) (0.2951),enoyl-CoA hydratase activity (GO:0004300) (0.2214); methylglutaconyl-CoA hydratase activity (GO:0004490) (0.1628); itaconyl-CoA hydratase activity (GO:0050011) (0.1525),"Enoyl-CoA hydratase, C-terminal (IPR014748) (0.3945); Enoyl-CoA hydratase/isomerase, conserved site (IPR018376) (0.1981); ClpP/crotonase-like domain superfamily (IPR029045) (0.1655); Enoyl-CoA hydratase/isomerase (IPR001753) (0.1184)",1.10.12.10 (0.4051),Transit peptide (0.9786); Reference proteome (0.8780); Mitochondrion (0.8303); Acetylation (0.6316); Lyase (0.5221); Proteomics identification (0.4414); Lipid metabolism (0.3159); Direct protein sequencing (0.3123); Phosphoprotein (0.2727); Disease variant (0.1339); 3D-structure (0.1049); Alternative splicing (0.0988),
MNSLAQEIAGFSTSRLRKQSTRVTTASGQVLLETRSGADYHSTPDTERQSADTCGFVQDFSLDLQVGIITPFLLLSSQDAAHDIDTLKKLKVTHVLNVAFGVENAFPELFTYKTVSMLDLPETDITAYFPECFEFITQARQQDGVVLVHCNAGVSRSASVVIGFLMSELKMSFDEAFSVAKTSRPQIQPNPGFLQQLKTYNPA,protein-serine/threonine phosphatase (3.1.3.16) (0.6316); protein-tyrosine-phosphatase (3.1.3.48) (0.1889),protein dephosphorylation (GO:0006470) (0.5536); negative regulation of MAPK cascade (GO:0043409) (0.3935); cell motility (GO:0048870) (0.3716); positive regulation of apoptotic process (GO:0043065) (0.0895); negative regulation of protein kinase activity (GO:0006469) (0.0855); actin cytoskeleton organization (GO:0030036) (0.0620); JNK cascade (GO:0007254) (0.0600); negative regulation of cell migration (GO:0030336) (0.0538); chemosensory behavior (GO:0007635) (0.0534); cellular response to oxidative stress (GO:0034599) (0.0529); mitochondrion organization (GO:0007005) (0.0432),cytoplasm (GO:0005737) (0.3800); plasma membrane (GO:0005886) (0.0676),protein tyrosine phosphatase activity (GO:0004725) (0.2140); JUN kinase phosphatase activity (GO:0008579) (0.1350); protein tyrosine/serine/threonine phosphatase activity (GO:0008138) (0.1187); MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017) (0.1019); myosin phosphatase activity (GO:0017018) (0.0984),"Dual specificity phosphatase, catalytic domain (IPR000340) (0.3494); Dual specificity protein phosphatase domain (IPR020422) (0.2069); Protein-tyrosine phosphatase-like (IPR029021) (0.2001); Protein-tyrosine phosphatase, active site (IPR016130) (0.1018)",3.90.190.10 (0.0937),Hydrolase (0.4281); Reference proteome (0.3916); Cytoplasm (0.1450); Protein phosphatase (0.0862),
MLQNFTSAYLSLSHFGHLTRWSVCKSLNMDKKLDLSRLSEEEAKHVWEVIQRDFVLRKKEEERLGELKTKIEKEEAKRELLGSQSNLSESHCIRCLQPFKFLVNSRRQCVDCKLFTCKTCSRYNKNEHGWVCDPCRMSRVLKIGTLGWYHDNVHSRFKRFGSAKVMRSLYKRLNEEGHRDDDTQSMPDVRNAYNGHDEEHMDASEAQRYKQMRKTKRLLSVHPMDLEIDDYAVHSRRQSVQYIHDDRGQRNDLEYNSEIYHQHQQRMNRRKSLDRFSRPDDGLYSENRMVRARSLSKINSSMAPRQIYLDTSEEEDMYRYPVYQLPPRRRSRASSQENIQQGAPPINELSKRMSAIESLLNRLEEKITVPSDQPALPPAGHMEEEKLRRKLDELMSDKGLSSDEEDPKRAPQYKRSTVRGDQTAMVLASQEPLSSSSDEMPTEAQKRSTAAALCDITTEILRTINATESAMNELTPSNPNDRLQLAGTDVKQADDAYRELEENVYMTAGKSYEVAKKLQKIEHNAKNHYGGPLTDSELSELEDQVALAVAKVQGTESEVSDIESKLAALSAKGLSIDKAKKKAVSMQQKRKFPQDFSSSRVHF,,intracellular protein transport (GO:0006886) (0.9789); locomotory behavior (GO:0007626) (0.1534); morphogenesis of embryonic epithelium (GO:0016331) (0.1262); exocytosis (GO:0006887) (0.1039); hair cell differentiation (GO:0035315) (0.0538); G protein-coupled receptor signaling pathway (GO:0007186) (0.0499),plasma membrane (GO:0005886) (0.4089); synapse (GO:0045202) (0.2971); photoreceptor outer segment (GO:0001750) (0.1302); perinuclear region of cytoplasm (GO:0048471) (0.1264); extracellular region (GO:0005576) (0.0741); dendrite (GO:0030425) (0.0447); secretory granule (GO:0030141) (0.0445); neuromuscular junction (GO:0031594) (0.0414),actin binding (GO:0003779) (0.2345); small GTPase binding (GO:0031267) (0.2293); metal ion binding (GO:0046872) (0.1355),"Intracellular Transport Effector (IPR051745) (0.5637); Rab-binding domain (IPR010911) (0.4856); Rab effector MyRIP/Melanophilin (IPR006788) (0.2435); Melanophilin, FYVE-related domain (IPR037442) (0.1649); Zinc finger, RING/FYVE/PHD-type (IPR013083) (0.0946); Zinc finger, FYVE/PHD-type (IPR011011) (0.0815)",3.30.40.10 (0.2818),Cytoplasm (0.0637),
MAAASSIQPPSVHGIKRDNSPHPESDSPVSRHEEDAASEGTTILRDLPELEPEEIEKRLEKTRRELSNRRKILIKNLPQDTTNQEVHEILREYELKYCFVDRNKGTAFVTLLNGDQAQDAIRTLHQTSVRGRDINVQLQPTDSLLCVTNLPYTVTATQFQELVRSYGNIERCFLVYSDLTGHSKGYGFVEYMKKDSASRARSELLGKPMGDRVLMVQWADVNQLTSADHLHSKCLCVDRLPLDFEDSEELAHIFSESYKPVFCQLAQDEGSPVRGFAVVEYETAEQAEAVLLEMDRQLIQGQEIRLSLCPPGTSGRSTLAALIAAQGVMLSNKKGLLPEPNLAQFLNSMTNPAALQVLMRPYPTAKRGGKFGRPHNLPFLRPPLTAALLQLGKAQQSAILGNGLVLQNLLHMQMAQQQLLQIKDKQISNVPGLLGDPSRLLLQKVLGLRNPATVPLGKGLLGDSPTELGQDSSLVTSHGVNSGMVSHLPGRSLAEQNGVALTCLAPEKQPAPPGTTGGSLSSQTQLQNFLPGINTSSLGSLLGSAAHKTPANHHSASVQTSTSVTSQSGCQTSLLGDPPKEVKLPSNPYLNLASVLPGVVLQAPCNSKPQTVQAHPGTYSAVLPPATQTHTQYNAESAPAEYTQQYTQQYTQEAMQQWYQHYQAQTYGNTSQDTTAVTDCAKEQPQVVVTSSYGDYSSYMHAVSQYYSQTQMNQTAAQVYQHRDVSKEVEVVKTPLSAPLQTSLNGSAQTLLPTYSALPIMPGFITPTHTHAASPATHTPAAPAATDWNNYYYSQARGQKREYPTLPTQEVTSEGPYVGQHSQGLGGQYADYFKKKRI,,"cell differentiation (GO:0030154) (0.2764); RNA splicing (GO:0008380) (0.2678); spliceosomal complex assembly (GO:0000245) (0.2522); mRNA splicing, via spliceosome (GO:0000398) (0.1709); mRNA processing (GO:0006397) (0.1533); germ cell development (GO:0007281) (0.1142); regulation of RNA splicing (GO:0043484) (0.0652); regulation of mRNA splicing, via spliceosome (GO:0048024) (0.0613)",nucleus (GO:0005634) (0.4251); ribonucleoprotein complex (GO:1990904) (0.1215); catalytic step 2 spliceosome (GO:0071013) (0.0678); nucleoplasm (GO:0005654) (0.0491),RNA binding (GO:0003723) (0.6026),RNA-binding domain superfamily (IPR035979) (0.5800); Nucleotide-binding alpha-beta plait domain superfamily (IPR012677) (0.5646); RNA recognition motif domain (IPR000504) (0.2754); Eukaryotic RNA-binding (IPR050502) (0.1249),3.30.70.330 (0.2711),Reference proteome (0.6381); mRNA processing (0.4697); Methylation (0.4542); mRNA splicing (0.3811); RNA-binding (0.3209); Repeat (0.2719); Ubl conjugation (0.2102); Phosphoprotein (0.1622); Proteomics identification (0.1598); Nucleus (0.1595); Alternative splicing (0.1378); Cytoplasm (0.0997),
MFLFGHQEISYEACLINMFFVFHLMNLQSMSLLVLAYDRLVAICFPLKYHAIITKKSVSLILGNMWLFSIFLFATLAGLVNRLSFCRSTVVSSHFCDHGPVISLSCNSNFINYLMAYISFGLLICMPMLLITISYCCIAAALFKIAHGADRIKAMKTCTSHLMLVAILYLPILSLNIKSIAISIDLNSRIINNSLTQILPPMLNPIIYTLKTEEVMQAIKEMYRRRRKVNTMMEQNVKQRK,,"negative regulation of insulin receptor signaling pathway (GO:0046627) (0.7406); adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189) (0.3076); signal transduction (GO:0007165) (0.2922); G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187) (0.2471); G protein-coupled receptor signaling pathway (GO:0007186) (0.1450); response to xenobiotic stimulus (GO:0009410) (0.1164); dendrite development (GO:0016358) (0.0781); sensory perception of sound (GO:0007605) (0.0779); sensory perception of chemical stimulus (GO:0007606) (0.0661); negative regulation of cell population proliferation (GO:0008285) (0.0557); gene expression (GO:0010467) (0.0534)",synapse (GO:0045202) (0.1411); presynaptic membrane (GO:0042734) (0.1138); cytoplasm (GO:0005737) (0.0818),olfactory receptor activity (GO:0004984) (0.1475); odorant binding (GO:0005549) (0.0913); lipid binding (GO:0008289) (0.0651),"Olfactory receptor (IPR000725) (0.4799); G protein-coupled receptor, rhodopsin-like (IPR000276) (0.2588); GPCR, rhodopsin-like, 7TM (IPR017452) (0.2210)",1.20.1070.10 (0.1380),Olfaction (0.8504); Transducer (0.7357); Sensory transduction (0.5840); Transmembrane helix (0.5302); Receptor (0.4593); Reference proteome (0.4460); G-protein coupled receptor (0.1790); Membrane (0.1640); Transmembrane (0.0640),
MAEGRGNRHHPRNLQGVLQMAVEAGSASDGPSPLEPMTQERMDFLRGALSEVCKGQMDEVEQMKRCLEVLKTDGCKDREVEGEEEEEQEDDEREEALEMLSELCENLDNARDLMKLGGLDLCLSRCLCHTEAGIRWRAAQLIASSAQNMPEVQFYLLNQGALLTLLQLADNDPHSTVRVKALYAVSCLVREQEAGLKDFLSHDGFSVLMRGMQSDSEKLRTKSAFLLLNLLNSHPEHKDTVLSMGMVQQLVSVLRSPHSSVHEHVLGALCCLVEDSPRGMSDCRDPSLGLEELLKQRVQDLRGQEESLEELEFCERLRAVCFPGQTQEDNAMDR,,positive regulation of protein ubiquitination (GO:0031398) (0.7577); positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436) (0.1314); generation of precursor metabolites and energy (GO:0006091) (0.1228); protein targeting (GO:0006605) (0.1035); regulation of translation (GO:0006417) (0.1034),endoplasmic reticulum (GO:0005783) (0.3140); extracellular space (GO:0005615) (0.1155); endoplasmic reticulum-Golgi intermediate compartment (GO:0005793) (0.0973); cytosol (GO:0005829) (0.0849); nucleus (GO:0005634) (0.0782); cytoplasm (GO:0005737) (0.0744),identical protein binding (GO:0042802) (0.2662); adenyl-nucleotide exchange factor activity (GO:0000774) (0.1599); enzyme binding (GO:0019899) (0.0867),Nucleotide exchange factor Fes1 (IPR013918) (0.4115); Armadillo-like helical (IPR011989) (0.3816); Hsp70 Nucleotide Exchange Factors and Inhibitors (IPR050693) (0.2215); Armadillo (IPR000225) (0.0980); Armadillo-type fold (IPR016024) (0.0865),,Repeat (0.7281); Phosphoprotein (0.6786); Reference proteome (0.5633); Proteomics identification (0.3404); Direct protein sequencing (0.2930); Endoplasmic reticulum (0.2659); 3D-structure (0.2409); Transport (0.1269); Acetylation (0.1135); Disease variant (0.1031); Nucleus (0.0852); Intellectual disability (0.0758); Translation regulation (0.0695),
MEKPCILTKTLGAPGSIYKCFEPCIDKHFTIIPYERFVQRKEDFAAKIQAVFSWGPNINVDRDLLQSLPNLKAVINGGVGVDHLDIPLINSFGVKVSNTPHVVDNATADIGMSLMLASARKIIEGQHFSKFRESDDFPESTMGTDVSGATLGIIGMGRIGYKIAKRAQGFDMKILYHNRNRRPENEERAVGATYCASMTELLQRSDFVMVVVNLSPQTHKLISAKEFAMMRPNSTFINISRGLVVDQDALVDALLKKMIRAAALDVTYPEPLPRDHPLLSFPNVIVMPHIGTHTLETSQLMVERMVTNALAILNEGQLPDEVKA,1.1.1.- (0.4326); hydroxypyruvate reductase (1.1.1.81) (0.2667); glyoxylate reductase (NADP+) (1.1.1.79) (0.1500),oxidative photosynthetic carbon pathway (GO:0009854) (0.1681); NADP metabolic process (GO:0006739) (0.1480); lipid metabolic process (GO:0006629) (0.1083); response to cadmium ion (GO:0046686) (0.0872); centrosome cycle (GO:0007098) (0.0610); response to salt stress (GO:0009651) (0.0435),peroxisome (GO:0005777) (0.0667); cytosol (GO:0005829) (0.0550); nucleus (GO:0005634) (0.0447),glyoxylate reductase (NADPH) activity (GO:0030267) (0.2606); NAD binding (GO:0051287) (0.0942); hydroxypyruvate reductase (NADH) activity (GO:0008465) (0.0564); hydroxyphenylpyruvate reductase activity (GO:0047995) (0.0449),"D-isomer specific 2-hydroxyacid dehydrogenase, catalytic domain (IPR006139) (0.4775); NAD(P)-binding domain superfamily (IPR036291) (0.2235); D-isomer specific 2-hydroxyacid dehydrogenase, NAD-binding domain (IPR006140) (0.1806)",3.40.50.720 (0.1994),Reference proteome (0.3443); Oxidoreductase (0.3374); Pyruvate (0.3233); Peroxisome (0.1905); NAD (0.1426); Glycolate pathway (0.1355); Photorespiration (0.0810),
MKTILASETMEIPEEVTVKVSAKMISVTGPRGTLTRNFKHLNLDFQLQEGGRKLKVDAWFGTRKTMAAIRTAISHVQNLITGVTKGFRYKMRFVYAHFPINASITAANKGIEIRNFLGEKKVRKVDMLDGVTILRSEKVKDEIVLDGNDIELVSRSAALINQKCHVKNKDIRKFLDGIYVSDKGAIKEE,,"cytoplasmic translation (GO:0002181) (0.8113); regulation of translation (GO:0006417) (0.1780); rRNA processing (GO:0006364) (0.1393); GO:0140236 (0.1105); maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462) (0.0671); ribosomal large subunit assembly (GO:0000027) (0.0590)",cytosolic large ribosomal subunit (GO:0022625) (0.3552); nucleolus (GO:0005730) (0.2043); cytosolic ribosome (GO:0022626) (0.2024); nucleus (GO:0005634) (0.1828); cytosol (GO:0005829) (0.1406); cytoplasm (GO:0005737) (0.1392); focal adhesion (GO:0005925) (0.0844); membrane (GO:0016020) (0.0716); protein-containing complex (GO:0032991) (0.0561),rRNA binding (GO:0019843) (0.2955); structural constituent of ribosome (GO:0003735) (0.2400),"Large ribosomal subunit protein uL6-like (IPR000702) (0.4879); Large ribosomal subunit protein uL6, conserved site-2 (IPR002359) (0.3375); Large ribosomal subunit protein uL6, alpha-beta domain (IPR020040) (0.2819); Large ribosomal subunit protein uL6-like, alpha-beta domain superfamily (IPR036789) (0.1569)",3.90.930.12 (0.2484),Ribonucleoprotein (0.7155); Reference proteome (0.6651); rRNA processing (0.5658); Cytoplasm (0.3045); Direct protein sequencing (0.2738); 3D-structure (0.2167); Phosphoprotein (0.1927); Nucleus (0.1869); Acetylation (0.1666); Ribosomal protein (0.1141); Ribosome biogenesis (0.0920); RNA-binding (0.0618),
MPAGHGLRSRTRDLFARPFRKKGYIPLTTYLRTYKVGEHVDVKVNGAVHKGMPHKFYHGRTGRVWNVTKRAIGVEINKQVGNRIIKKRIHVRVEHVQPSRCNEEFLQRKLNNDKLKAEAKVRGEVISTKRQPAGPKPGFMVEGTTIETVTPIPYDVVNDLKGGY,,cytoplasmic translation (GO:0002181) (0.7947); translation (GO:0006412) (0.4436); DNA repair (GO:0006281) (0.0599),extracellular exosome (GO:0070062) (0.3427); cytosol (GO:0005829) (0.2802); nucleolus (GO:0005730) (0.2763); nucleus (GO:0005634) (0.1251); endoplasmic reticulum (GO:0005783) (0.1250); cytosolic ribosome (GO:0022626) (0.1190); cytosolic large ribosomal subunit (GO:0022625) (0.0759); cytoplasm (GO:0005737) (0.0611),structural constituent of ribosome (GO:0003735) (0.3123),"Large ribosomal subunit protein eL21 (IPR001147) (0.3753); Large ribosomal subunit protein eL21 superfamily (IPR036948) (0.2923); Large ribosomal subunit protein eL21, conserved site (IPR018259) (0.2851); Translation protein SH3-like domain superfamily (IPR008991) (0.0764)",2.30.30.70 (0.5173); 6.10.250.3260 (0.2871),Ribonucleoprotein (0.8322); Reference proteome (0.7480); Ribosomal protein (0.7423); Ubl conjugation (0.4029); Endoplasmic reticulum (0.3747); Phosphoprotein (0.2541); Proteomics identification (0.1805); Isopeptide bond (0.1461); 3D-structure (0.1314); Diamond-Blackfan anemia (0.1156); Direct protein sequencing (0.0955),
MGRHSSDSEDTSRSRRKRRQRQRSSSSSSESRVTSRSKHSKRRTRSRSRDRNRTTDRRHRNRSHSSSSRGSGHRRRSRSADRGRSHRSHRSRSRSRNRRSRSRHRRSRSCSSGRSSRKRSRERDRGQRRTRDKDRTRDRTKDKDTDKAKEKDKQRETGNIKAGSEHLTSAEQTKARLQVLQTAAKTDDAQKTKENVKVGGAIKEEEEVSLAEQVRRIKDIEAIESDSFVPQAFKSSRDASKVTECPEIKTEAETVKVEVSVLPTSITYNDSDTLAHPNLFVDKEEAERLWLNRLISLRQERLMGSPVS,,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) (0.7330); mRNA splicing, via spliceosome (GO:0000398) (0.4156); RNA splicing (GO:0008380) (0.3822); regulation of translation (GO:0006417) (0.2521); alternative mRNA splicing, via spliceosome (GO:0000380) (0.1918); nucleocytoplasmic transport (GO:0006913) (0.1383); negative regulation of protein ubiquitination (GO:0031397) (0.1116); protein transport (GO:0015031) (0.0541); spliceosomal snRNP assembly (GO:0000387) (0.0529); mRNA transport (GO:0051028) (0.0409)",nucleus (GO:0005634) (0.6889); nuclear speck (GO:0016607) (0.5995); cytoplasm (GO:0005737) (0.3009); cytosol (GO:0005829) (0.0816); nucleoplasm (GO:0005654) (0.0573),DNA binding (GO:0003677) (0.0686),,,mRNA processing (0.8400); mRNA splicing (0.7503); Reference proteome (0.6840); Transcription (0.4952); Phosphoprotein (0.4018); Transcription regulation (0.3468); Nucleus (0.3263); Alternative splicing (0.3174); mRNA transport (0.2256); Acetylation (0.1612); Proteomics identification (0.1379); Methylation (0.1252); Ubl conjugation (0.1233); DNA-binding (0.1101); Cytoplasm (0.1081); Stress response (0.0769); Coiled coil (0.0738); 3D-structure (0.0729),
MAFIKEESEDVKIKETFTVKQEDLQEQTDLIEENEESKEEEHHVKIEEKNNLQTDDILKRRDKNHFTCTQCGKSFGRKHNLKIHMRIHTGEKPYTCNQCGKSFNQSSNLYNHMMIHTGEKPFKCTQCGKSFNRSSDLHQHMRIHTGEKPFTCPQCGKSFYCSSHLHQHMRIHTGEKPFTCSQCGKSFRQSSNFKQHMRIHTEEKPFTCTQCGKSFNQ,,regulation of transcription by RNA polymerase II (GO:0006357) (0.4102); negative regulation of transcription by RNA polymerase II (GO:0000122) (0.2720); urogenital system development (GO:0001655) (0.1380); spermatogenesis (GO:0007283) (0.1062); negative regulation of DNA-templated transcription (GO:0045892) (0.0810); anatomical structure morphogenesis (GO:0009653) (0.0721); regulation of vulval development (GO:0040028) (0.0643); post-embryonic development (GO:0009791) (0.0575); cell differentiation (GO:0030154) (0.0564),nucleus (GO:0005634) (0.1319),"metal ion binding (GO:0046872) (0.2112); DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981) (0.1636); DNA-binding transcription factor activity (GO:0003700) (0.1306); RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978) (0.1239); sequence-specific DNA binding (GO:0043565) (0.1130); RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977) (0.0569)",Zinc finger C2H2-type (IPR013087) (0.2985); Zinc finger C2H2 superfamily (IPR036236) (0.1857),3.30.160.60 (0.1350),Zinc-finger (0.9836); Repeat (0.6677); Ubl conjugation (0.6469); Metal-binding (0.4056); Nucleus (0.2431); Reference proteome (0.2340); Zinc (0.2227); DNA-binding (0.2069),
MAFIKEESEDVKIEETFTVKQEDLQEQTDLIEENEGSKEEEHHVKIEEKTHLQTDDILKRGDKNSFTCTQCGKSFGRKGYLKIHMMIHTREKPFTCTHCGRSFGRNFGLKIHMMIHTGEKPFTCTHCGKSFSQSSHLNQHMRIHTREKPFTCTQCGKSFSRSSHLNEHMMIHSRKKPFTCTQCGKSFGRNFGLKIHMRIHTGENPFTCTHCGKRFSQSSSLNQHMRIHTGEKPFTCIQCGKSFKQSSSLYNHKKIHTREKPFTCTQCGKTYNYSSHLNEHMRIHTREKPFTCTQ,,regulation of transcription by RNA polymerase II (GO:0006357) (0.4297); negative regulation of transcription by RNA polymerase II (GO:0000122) (0.4159); urogenital system development (GO:0001655) (0.1152); spermatogenesis (GO:0007283) (0.0967); post-embryonic development (GO:0009791) (0.0883); anatomical structure morphogenesis (GO:0009653) (0.0808); multicellular organism growth (GO:0035264) (0.0689); methylation (GO:0032259) (0.0557); cell differentiation (GO:0030154) (0.0440); sex determination (GO:0007530) (0.0427); negative regulation of DNA-templated transcription (GO:0045892) (0.0412),nucleus (GO:0005634) (0.1336),"metal ion binding (GO:0046872) (0.2022); RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978) (0.1761); sequence-specific DNA binding (GO:0043565) (0.1646); DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981) (0.1629); DNA-binding transcription factor activity (GO:0003700) (0.1242)",Zinc finger C2H2-type (IPR013087) (0.3305); Zinc finger C2H2 superfamily (IPR036236) (0.1910),3.30.160.60 (0.1695),Zinc-finger (0.9816); Ubl conjugation (0.6884); Repeat (0.6850); Metal-binding (0.4857); Reference proteome (0.3163); Nucleus (0.2750); DNA-binding (0.2139); Zinc (0.1957); Transcription (0.1257); Proteomics identification (0.0832); Transcription regulation (0.0428),
MTCVAFQKKSKYTATRRLLLKTKLMKKATSMLAAEREQNKRERDDALNERVPPLKLSGLSAQELQELCKELHRKIDDVDEARYDLEIKVAKNEIEIQTLTQKIWDMKGSKQRTKLKRVKKSHDSMFGALTESKMSSKADFKANLKTVKKEEEKKEEVTDWRKNVEAMSGMEGRKKLFDAGQ,,regulation of systemic arterial blood pressure by ischemic conditions (GO:0001980) (0.8291); skeletal muscle contraction (GO:0003009) (0.7112); cardiac muscle contraction (GO:0060048) (0.5312); vasculogenesis (GO:0001570) (0.2404); heart development (GO:0007507) (0.2059); negative regulation of ATP-dependent activity (GO:0032780) (0.1716); regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) (0.1371); response to xenobiotic stimulus (GO:0009410) (0.1366); ventricular cardiac muscle tissue morphogenesis (GO:0055010) (0.1211); regulation of heart contraction (GO:0008016) (0.0850); intracellular calcium ion homeostasis (GO:0006874) (0.0828); actin crosslink formation (GO:0051764) (0.0785); embryo development ending in birth or egg hatching (GO:0009792) (0.0551),cardiac myofibril (GO:0097512) (0.3503); Z disc (GO:0030018) (0.1361); sarcomere (GO:0030017) (0.1315); cardiac Troponin complex (GO:1990584) (0.1315); I band (GO:0031674) (0.1002),actin binding (GO:0003779) (0.3969); actin filament binding (GO:0051015) (0.1094); calcium-dependent protein binding (GO:0048306) (0.0648),Troponin I (IPR050875) (0.2865); Troponin (IPR001978) (0.1369); Troponin domain superfamily (IPR038077) (0.1081),1.20.5.350 (0.2923),Reference proteome (0.7176); Muscle protein (0.6635); Actin-binding (0.1305); Acetylation (0.1218); Phosphoprotein (0.0842),
MAYETEDQETQYCFPNINTSCVKENRSKHEYNVLYVFFSLLSAWTVFLNLLVIISISHFKKLHTPTNMIILSLAVNDLLIGLFVMPVEAVRLIDKCWYFGDTFCGFTLILIGVIPSASLSNLVLIAVDRYAAVCYPLLYPQKISMTNTLMSICLSWVYYFAYITALVIYNRYLDTSHRTDECYGECTIMMSFSWIITDLFMCFIFPCTIMITLYLRIFYVVHQQVKVMNSLMKGGKCVTEGLVKRKSESKAALTLGIIVSVYLLCWIPYYICSLTVISSTAINVLIWAVFANSGVNPLVYALFYPWFKKTAKLILTLKIFQPASSLINIFTELEL,,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187) (0.7262); chemical synaptic transmission (GO:0007268) (0.3433); G protein-coupled receptor signaling pathway (GO:0007186) (0.1612); adenylate cyclase-inhibiting serotonin receptor signaling pathway (GO:0007198) (0.1599); serotonin receptor signaling pathway (GO:0007210) (0.0747); response to toxic substance (GO:0009636) (0.0624); calcium-mediated signaling (GO:0019722) (0.0433); phototransduction (GO:0007602) (0.0414)",plasma membrane (GO:0005886) (0.2989); dendrite (GO:0030425) (0.2586); perikaryon (GO:0043204) (0.1284); endoplasmic reticulum (GO:0005783) (0.0969); synapse (GO:0045202) (0.0883); endomembrane system (GO:0012505) (0.0723); endoplasmic reticulum membrane (GO:0005789) (0.0463),G protein-coupled serotonin receptor activity (GO:0004993) (0.2378); neurotransmitter receptor activity (GO:0030594) (0.1820),"G protein-coupled receptor, rhodopsin-like (IPR000276) (0.3329); GPCR, rhodopsin-like, 7TM (IPR017452) (0.3039)",1.20.1070.10 (0.1473),Transmembrane helix (0.9527); Reference proteome (0.8604); Membrane (0.6463); Transducer (0.5868); G-protein coupled receptor (0.5186); Receptor (0.4612); Cell membrane (0.2165); Transmembrane (0.1932); Glycoprotein (0.0839); Palmitate (0.0828),
MANIITFQTQITSVIEVLANAAVAEICKLVEDSYADLQLEISQTQKENSLLKKRLKMIEIRDSFYRRANKLRNESTALNKTSVREKQSGRISVKVSSVCSGANHEEGHVRSSNSSVLQQQQRLDQQAYHQSVEDGEPDVLIIKEERPENTRCEQSEREKQTTENHKDEALNKSSGVCVAGHRENFIDQNTVQHCHQEPVADDESDVIIIKEERPDNMRCERSETELNATNNNGTQYGSAGVFVPVHRESYIDQDTVQHCHQESDAIQPDLLQDENTEVNAIDEDTHLLNGDTRMERRCDGEVDSNLQPVSSYASWVSRRFDASANHPSYTESECNGGPSVNQYLMYRGSTDPMCSYATPINSNSLSVSNIEGHLTHDNEGNISQSEQPPFTPCFSFKQSDSPHMQRKDRFMCKHCGKVFSQPGTLLLHQKLHTRERLHNCTLCGKRFSQASSLKRHHSIHRGEKPFRCQHCGKHFSDQSNLKKHVTVHTGEKPYGCSLCGKMFNQSSNLKTHMKIHTREKPFGCDRCGRMFAHKYILVKHQQRICMSTGQV,,regulation of transcription by RNA polymerase II (GO:0006357) (0.4672); negative regulation of transcription by RNA polymerase II (GO:0000122) (0.3113); gonad development (GO:0008406) (0.2371); spermatogenesis (GO:0007283) (0.1653); locomotion (GO:0040011) (0.0816); urogenital system development (GO:0001655) (0.0758); sex determination (GO:0007530) (0.0563); positive regulation of transcription by RNA polymerase II (GO:0045944) (0.0490); male gonad development (GO:0008584) (0.0430),nucleus (GO:0005634) (0.1936); cytoplasm (GO:0005737) (0.0709),"DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981) (0.2077); RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978) (0.1657); RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977) (0.1034); metal ion binding (GO:0046872) (0.0980)",Zinc finger C2H2-type (IPR013087) (0.2974); Zinc finger C2H2 superfamily (IPR036236) (0.1265),3.30.160.60 (0.1708),Zinc-finger (0.8988); Repeat (0.4498); Nucleus (0.3338); Ubl conjugation (0.3085); Metal-binding (0.2992); Reference proteome (0.2980); Proteomics identification (0.1383); Transcription regulation (0.1060); DNA-binding (0.1044); Zinc (0.0835),
MAQDLLPGVESSAVSVLKRAVQLDNCSRFQEALVCYQEGIQLLLDVLKAVKDEAKKMHYREKIKGYMERAEQIKEHTTKLKEEGKYHEQIKIADSSTGYSYESLFKPYITDGLTEVWVEDPYVRHVHQLYNFLRFCEMLLKCPSTVKTIHLLTSQDEDSSTQQSSALAEMKQSLLSKDICLDIQYSSTIHDREIRFNNGWIIKIGRGLDYFKKPKGRFSVGYCDYDLRECHETTVDIFHTKHTKKT,,mitotic cytokinesis (GO:0000281) (0.4935); catabolic process (GO:0009056) (0.2155); midbody abscission (GO:0061952) (0.2145); proteolysis (GO:0006508) (0.2071); protein hexamerization (GO:0034214) (0.1050); vesicle-mediated transport (GO:0016192) (0.0629); neuron remodeling (GO:0016322) (0.0628); protein homotetramerization (GO:0051289) (0.0484),cytoplasm (GO:0005737) (0.2703); late endosome membrane (GO:0031902) (0.2569); nucleoplasm (GO:0005654) (0.1918); midbody (GO:0030496) (0.1327); membrane (GO:0016020) (0.1219),protein domain specific binding (GO:0019904) (0.6560); identical protein binding (GO:0042802) (0.1534); phosphatidylinositol binding (GO:0035091) (0.1299),"MIT domain (IPR007330) (0.3635); MITD1, N-terminal domain (IPR045331) (0.3212); MIT domain-containing protein 1 (IPR052817) (0.2084); MIT domain superfamily (IPR036181) (0.1821); MITD1, C-terminal phospholipase D-like domain (IPR032341) (0.1612)",3.30.870.30 (0.3722); 1.20.58.80 (0.2188),Reference proteome (0.5910); Membrane (0.3190); Transport (0.2960); Alternative splicing (0.1690); Endosome (0.1499); Cell cycle (0.1443),
MMIHTGEKPFTCTQCGKSFRDSSHLNYHMMIHTGEKPFTCTQCGKSFRHVSSFNKHMTIHTGVKPFICSQCGASFSLSSSLNQHMRIHTGEKPFTCPQCGKSFRHSSNFSKHKMIHTGEKPYACSQCGKSFSHSSHRNRHMRIHTGEKPHTCTQCGKSFSQLLSLNQHMMIHTGEKPFTCSQCGKSFSLSSRLTQHMKIHTGEKPHKCDHCSKTFLRPSKLKVHLALHRSEKPYSCPVCEKSFTLESKLKRHQTSHTAVRQYMCFECKKTYITATQLKLHERIHTGEKPFKCSHCDKRFSLLGSLKSHEKVHTGEKLYKCLQCSKRFSLLGTLRRHERIHTGEKPYTCDQCSQSFTYPEQLKKHMNIHTGEKLHK,,negative regulation of transcription by RNA polymerase II (GO:0000122) (0.4776); regulation of transcription by RNA polymerase II (GO:0006357) (0.4225); multicellular organism growth (GO:0035264) (0.2444); spermatogenesis (GO:0007283) (0.1103); DNA damage response (GO:0006974) (0.1023); post-embryonic development (GO:0009791) (0.0996); hemopoiesis (GO:0030097) (0.0815); gastrulation with mouth forming second (GO:0001702) (0.0769); urogenital system development (GO:0001655) (0.0644); positive regulation of transcription by RNA polymerase II (GO:0045944) (0.0626),nucleus (GO:0005634) (0.1280); cytosol (GO:0005829) (0.0880),"metal ion binding (GO:0046872) (0.1585); RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978) (0.1270); DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981) (0.0979); sequence-specific DNA binding (GO:0043565) (0.0890); double-stranded DNA binding (GO:0003690) (0.0667)",Zinc finger C2H2-type (IPR013087) (0.2096); Zinc finger C2H2 superfamily (IPR036236) (0.1638),3.30.160.60 (0.1387),Zinc-finger (0.8975); Repeat (0.4907); Metal-binding (0.4448); Zinc (0.4135); Ubl conjugation (0.2878); Transcription (0.2230); Reference proteome (0.1408); Proteomics identification (0.1173); DNA-binding (0.1110); Nucleus (0.1006),
MAYETEHQETQYCFPDINSSCVKEKHFSHGYNILYIFVSLLSVWTVILNLLVIISISHFKKLHTPTNMIILSLAVTDLLIGLIVMPVEAVKLIDKCWYFGDTFCGLTLILIWVIPSASLSNLVLIAVDRYMAVCHPLLYPQKITMANTLMSICLSWVYYSAYNTALLFDNGYFDTSHRTDVCYGDCSVMMSFSWRVTDLFMCFIFPCVMIITLYLRIFYAVHQQVKVINSLMKGGKCVLKGSVKRKSESKAALTLGIIVTVYLLCWIPYYICTLTVNSSTVISVLTWIVYANSGLNPLVYALFYPWFKKTVKLILTLKIFHLASSLVNIFTHHEL,,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187) (0.5254); chemical synaptic transmission (GO:0007268) (0.4782); G protein-coupled receptor signaling pathway (GO:0007186) (0.2848); adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188) (0.1372); response to toxic substance (GO:0009636) (0.0866); chemosensory behavior (GO:0007635) (0.0712); regulation of feeding behavior (GO:0060259) (0.0689); adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193) (0.0599); behavioral fear response (GO:0001662) (0.0463)",synapse (GO:0045202) (0.3325); dendrite (GO:0030425) (0.2659); plasma membrane (GO:0005886) (0.2275); perikaryon (GO:0043204) (0.1064); cytoplasm (GO:0005737) (0.0975),G protein-coupled serotonin receptor activity (GO:0004993) (0.1317); neurotransmitter receptor activity (GO:0030594) (0.1190),"GPCR, rhodopsin-like, 7TM (IPR017452) (0.3897); G protein-coupled receptor, rhodopsin-like (IPR000276) (0.3777)",1.20.1070.10 (0.2236),Transmembrane helix (0.9560); Reference proteome (0.9047); Transducer (0.7609); Membrane (0.6901); G-protein coupled receptor (0.5947); Receptor (0.3458); Cell membrane (0.1960); Palmitate (0.1066); Glycoprotein (0.0958); Transmembrane (0.0803),
MAEAKALNMASKTQFLLLLVAVMITSYNAVGGIDTATYEPLNCTTKCITNGTFNCTNNCTANGTFNCTNNCTDNGIAACLANCMVNVTVNCTNNCTANGTITCTVNGLNLIYNCTPGINNMTSSNITINSTTNNGTTNNSTTNNSTTNNSTTNNSTSWTTPSSNHGNSIAPSFSLVGIMGLSGLLLFYATDINDIFTNLHMLVARDKYSYVIIK,,positive regulation of nephron tubule epithelial cell differentiation (GO:2000768) (0.2024); calcium ion transport (GO:0006816) (0.1880); transcription by RNA polymerase II (GO:0006366) (0.1453); receptor internalization (GO:0031623) (0.1128); epithelial to mesenchymal transition (GO:0001837) (0.0761); lung development (GO:0030324) (0.0673); glomerular parietal epithelial cell differentiation (GO:0072139) (0.0483); response to electrical stimulus (GO:0051602) (0.0454); cell adhesion (GO:0007155) (0.0410),external side of plasma membrane (GO:0009897) (0.3304); extracellular region (GO:0005576) (0.1375); host cytoskeleton (GO:0044163) (0.0591),,,,Virion (0.5311); Lipoprotein (0.3735); Signal (0.2898); Membrane (0.2224); Reference proteome (0.1490); Secreted (0.1393); GPI-anchor (0.1192); Malaria (0.0872),
MAASLGVCRLHFRSLGGLDRFCLGLEPQTQRRCTSTIPAIKTPTGTKTADFAKKSKTFQAIQEERREQAERSVLISCPAKFSEKKFLDFFSKHGTVNKHFFYNSFGAYAVVEFSNKESIASLKESTGIPAVDHEAAVPFKSRLLSLKWPGIQSSNYPTPNFKEQSPPNIGDITNLLLQKHSVDEQLQCLTETLQLTEENISLRFLVCSLLGDIAGAYFPECIIRPFGSTVNSFGKLGCDVDMILDLDGIYARSQKKGSGLSLEYQVKTGPSERAVTQSILSVVGKCVDQFGPGCVGVQNILQARCPIVRFAHQPSGFQCDLTANNKVAMKSSELLFLYGHLDPRVRHLVFSVRCWARAHSITSSIPGAWITNFSLTVMVVFFLQQRSPAMLPTLDRLKELAGPSDKCVIEGNDCTIVSDLSKIALQKNTDTLEKLLQEFFEFYGNFPFNKASINIRKGKEQSKPEAAALHIQNPFEATLNVSKNVNAAQLERFVKLCQESAWLFQQKENLEPGSTQSNGSVSPWGFAALLAPSVASGTGVKSRRKKKTEPASSRIKNLLDSLKIKGGETVAKKGSANSSR,polynucleotide adenylyltransferase (2.7.7.19) (0.5677),"histone mRNA catabolic process (GO:0071044) (0.6517); mitochondrial RNA 3'-end processing (GO:0000965) (0.1387); co-transcriptional mRNA 3'-end processing, cleavage and polyadenylation pathway (GO:0180010) (0.0876)",mitochondrion (GO:0005739) (0.3265); nucleoplasm (GO:0005654) (0.2332); mitochondrial inner membrane (GO:0005743) (0.1324),ATP binding (GO:0005524) (0.3669); protein homodimerization activity (GO:0042803) (0.3163); UTP binding (GO:0002134) (0.3025); magnesium ion binding (GO:0000287) (0.2900); manganese ion binding (GO:0030145) (0.2051); metal ion binding (GO:0046872) (0.1549); poly(A) RNA polymerase activity (GO:1990817) (0.1208),IPR054708 (0.7438); PAP/25A-associated (IPR002058) (0.3107); Nucleotidyltransferase superfamily (IPR043519) (0.3103); RL domain (IPR041252) (0.2696),3.30.460.10 (0.2666); 1.10.1410.10 (0.2314),Reference proteome (0.6131); Transferase (0.6082); Magnesium (0.5052); Mitochondrion (0.4644); Proteomics identification (0.4420); Manganese (0.4034); Nucleotide-binding (0.2979); Nucleotidyltransferase (0.2878); Alternative splicing (0.2497); ATP-binding (0.2225); Transit peptide (0.2106); Cytoplasm (0.2028); RNA-binding (0.1922); 3D-structure (0.1872); Metal-binding (0.1860),Mg(2+) (0.2785); Mn(2+) (0.2279)
MAMTLGTNTHHNSPMEVFSENIIIPPKPEASIHHHTHQRTDRGRKERMTAGQLRERPRIAIFHTQNEGPDLEGLSPVRLEMEPADKRRVMTPRKKTFMGSDSLIQEKMNISPGAETPEKAMRRPTVRKVFGGHITRAPHEEESLASGKKRRVSFDQRLNKASFGSPTEPVLPAATVGTFILPITAAVDGNPNPSSEPQVRRYLGGDVAPTFNMALFDWTDYEDMRPGDKKQYSKKQGSEKQATQSPSTGLVRLTSENNVCKHHLDCLPGSCCNLRKHVCELHNRGFNNKCYDSCMCEEGLRCYAKSHRHYRITRKKGQCVDPEDLNHGMFIIV,,forebrain development (GO:0030900) (0.7912); negative regulation of canonical Wnt signaling pathway (GO:0090090) (0.6648); Wnt signaling pathway (GO:0016055) (0.4022); dorsal spinal cord development (GO:0021516) (0.3097); axon guidance (GO:0007411) (0.2932); commissural neuron differentiation in spinal cord (GO:0021528) (0.2597); somitogenesis (GO:0001756) (0.2190); ossification (GO:0001503) (0.1419); positive regulation of protein phosphorylation (GO:0001934) (0.1085); neuron migration (GO:0001764) (0.0875); negative regulation of neuron projection development (GO:0010977) (0.0757); regulation of cell cycle (GO:0051726) (0.0740); dorsal/ventral pattern formation (GO:0009953) (0.0690); positive regulation of transcription by RNA polymerase II (GO:0045944) (0.0434),extracellular region (GO:0005576) (0.1254),,Draxin (IPR029094) (0.5534),,Developmental protein (0.7749); Reference proteome (0.6843); Secreted (0.4218); Wnt signaling pathway (0.2341); Glycoprotein (0.1297),
MFCPRFLKAAVSFTCRKFSMGQISRQGKTLDMAEVRNRLREVVGASTNWQDQQQVLSERSSLCQYLARSQDDLPAKRMKDSLIEAHLPLGSQPALREKYLNSHNSVRFGRILEDLDCLGVLICYSHTWNEELQSSPLSIVTALVDKIDMRQNVIYPDCDIKFTGHVTWVGKTSIEAKMHMSQYQNGTYADLLDATFVMVARDPDNKRAAFVNPLKPVGQEEEAIFLQGEINKKRRVELSTASLLKVAPTAEERTLIHNQFLNTLDTRTVSFRSRILPPNSVWMEDAKLKGLEICHPQERNIFNRIFGGFLMRKAYELGRANACAFAGCRPTVVAVDDILFRKPVEIGSLLLLSSQVCYTEGMYVQVRVHSEVLDPLTRQHSTTNVFHFTFRLEKEVPAVVPQSYGESMLYLDGKRHFDGAMRNHS,3.1.2.- (0.7169); palmitoyl-CoA hydrolase (3.1.2.2) (0.0502); palmitoyl[protein] hydrolase (3.1.2.22) (0.0484),acyl-CoA metabolic process (GO:0006637) (0.8219); fatty acid metabolic process (GO:0006631) (0.3340); long-chain fatty acid metabolic process (GO:0001676) (0.1333); short-chain fatty acid metabolic process (GO:0046459) (0.0500),mitochondrial matrix (GO:0005759) (0.4106); mitochondrion (GO:0005739) (0.2686); nucleoplasm (GO:0005654) (0.1408); mitochondrial inner membrane (GO:0005743) (0.0973); extracellular exosome (GO:0070062) (0.0963),acetyl-CoA hydrolase activity (GO:0003986) (0.5652); fatty acyl-CoA hydrolase activity (GO:0047617) (0.2415); long-chain fatty acyl-CoA hydrolase activity (GO:0052816) (0.1469),HotDog domain superfamily (IPR029069) (0.2475); Hotdog acyl-CoA thioesterase (ACOT)-type domain (IPR033120) (0.1727),3.10.129.10 (0.2097),Reference proteome (0.7402); Serine esterase (0.7402); Repeat (0.7044); Transit peptide (0.6826); Mitochondrion (0.5629); Proteomics identification (0.3585); Hydrolase (0.2651); Acetylation (0.2646); Alternative splicing (0.2561); 3D-structure (0.2281); Disease variant (0.1956); Membrane (0.1265); Phosphoprotein (0.1133); Transport (0.1004),
MEDSSGVAVLVPHSRGQQDTVFIPDRCLLGVEDQQRQQQKQAADSLIQVIEKLSKIVEKRPRRCTISGKKRPPITCASVSVPDIRDDTKGTTPSKKPREQRDDRLASSSTTGHLIKQGPSSPGARTVTCYQCSMCRFISPTLEQLKEHLLCHDEQHSDLILMCSECQFTSNHQEEVVAHVRLHLEEGDHARCILDEQGTELARSVHQKTAVLRAISLESEKTSTPKKWYSFEQGRYRCLICNYECRQQRNLKTHAWKHAGLVDCSYPIFEDETECPETLQSASPPLIPPCKEDTIVVLAAVGGKSQTLHSSSSLQLELCASPEMKHHEETQALKTVETKIPVINHLFSFKDSEERLMEVQVTPEAQMELELETDSQHAVSDSLLSSAQKIINCSGNSAGHVNVIVERLPSAEEPVSSKSLLLSPEVGGDKTLLDSEEQELESQHHPVYYKQKEDVVISWNGEDGQQGEETISSGSPSDENVPPVRRRTYSESLRLHSLAAEVLVAMPMRAPELSKTTAKGIHDLSTQSPDTGQRMVETDTANPKSSSGELNGGESTALINLGLQGSKDSREVLVEGPSKAGISMSLLTVIERLQERSDQNTSDEDILKELQDNAQSQHAGGVPGGVAVSGDVSTADSLVEYIAGSERPYRCRLCLYSSGNKGYIKQHLRVHRQRQPYQCPICEHIACDSKDLERHMIHHFKPRLYSCKQCTERFHYKSQLRNHERDGHGIDDISSSLTHAEESTAIMEESAKMTDEDPVGEQSVFKCDVCDYTSSTYVGVRNHRRIHNSDKPYRCCSCDFATTNMNSLKSHMKRHPQEHQAMQLLEQYRCSLCGYVCSHPPSLKSHMWKHAGDQNYNYEQVNKAINEAISQSSRSPSVKSTPEPAVERPYIVLSRKDKVCPEGSSGSTGAEGNPVSGSSTRDQSGGTVAWRSSSGQTRAGMEYCVLLFCCCICGFESTSKEQLMEHMKQHEGDLISIILSKENQATETSKSQ,,negative regulation of transcription by RNA polymerase II (GO:0000122) (0.5324); positive regulation of transcription by RNA polymerase II (GO:0045944) (0.2221); negative regulation of DNA-templated transcription (GO:0045892) (0.1783); regulation of gene expression (GO:0010468) (0.1640); spermatogenesis (GO:0007283) (0.1596); regulation of DNA-templated transcription (GO:0006355) (0.1206); regulation of transcription by RNA polymerase II (GO:0006357) (0.1099); heart development (GO:0007507) (0.0781); chromatin organization (GO:0006325) (0.0708),cytoplasm (GO:0005737) (0.2816); nucleus (GO:0005634) (0.1306); transcription repressor complex (GO:0017053) (0.0792),"metal ion binding (GO:0046872) (0.3241); DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981) (0.1226); RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978) (0.0941)",Zinc finger C2H2 superfamily (IPR036236) (0.3025); Zinc finger and ubiquitin peptidase domain-containing protein (IPR050688) (0.1156); Zinc finger C2H2-type (IPR013087) (0.0951),3.30.160.60 (0.2052),Ubl conjugation (0.6341); Repeat (0.3620); Zinc-finger (0.3310); Repressor (0.3002); Transcription regulation (0.2743); Nucleus (0.1861); Transcription (0.1820); Metal-binding (0.1774); Reference proteome (0.1664),
MGAHSKPLEEEEALLCLPQDRVCVSSPCQIISDVDSKKLESADSLHWCPVDDSLMAYEIEDQETQYCFPDINSSCVKEKRSSQGYIIIYLFASLLSAWTVFLNLLVIISISHFKKLHTPTNMIILSLAVNDLLIGVVMPIEAIRQTETCWYFGNIFCGLYLLFISLLMSASLSNLVLIAVDRYVAVCHPLLYPQKITITKTLMIICLSWVWLSAYSIALLINNGYFDTSHRSDECYGECLAIISFSWIITDLFMSFMFPCPLIMMLYLRIFYVVHQQVKVINSLMKGGKCVTEGSVKRKSESKAALTLGIIVAVYMLCWIPYYICSLIVISSTAMIVIIWAVYANSALNPLVYALFYPWFKKTAKLIVTLKILQPASSLSNICTQH,,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187) (0.4933); chemical synaptic transmission (GO:0007268) (0.1842); adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193) (0.1206); adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188) (0.1205); adenylate cyclase-inhibiting serotonin receptor signaling pathway (GO:0007198) (0.0958); G protein-coupled receptor signaling pathway (GO:0007186) (0.0843); DNA replication (GO:0006260) (0.0754); cellular response to light stimulus (GO:0071482) (0.0513)",plasma membrane (GO:0005886) (0.3459); dendrite (GO:0030425) (0.1608); perikaryon (GO:0043204) (0.1110); membrane (GO:0016020) (0.0941); cytoplasm (GO:0005737) (0.0894),protein heterodimerization activity (GO:0046982) (0.1339); neurotransmitter receptor activity (GO:0030594) (0.0975),"GPCR, rhodopsin-like, 7TM (IPR017452) (0.3699); G protein-coupled receptor, rhodopsin-like (IPR000276) (0.1205)",1.20.1070.10 (0.2497),Transducer (0.6453); G-protein coupled receptor (0.6220); Transmembrane helix (0.5324); Receptor (0.4472); Reference proteome (0.4285); Membrane (0.1949); Transmembrane (0.1186); Zinc (0.1094); Nucleotide-binding (0.0891); Transport (0.0834); Cell membrane (0.0682),
MVFGVLGNALVLVVKVVCKEHFECRYWLPLFSLTLSDFLCSVLIICGSLLAVLSAGQVSPWCEVVSLLKFTFITSSIGSLALLCVQRFIDIPSKGTRLSVVMAIACAASWATGTIFGAVPVVYDWIKYDSAEMLCAVFWESSYSDMLVYILCAFSISIFIPLLLIFSCSILTCAGYRKDSRSREDLSSITPLLVIVYLFCYAPFAASELVLLGRLDLSPSPAWLRSLSSVMAYLDCCLNPFIYLTNKDFRRAVLILMWHRRRATFPEPVLTGITRIEL,,phototransduction (GO:0007602) (0.3921); positive regulation of cytosolic calcium ion concentration (GO:0007204) (0.3246); G protein-coupled receptor signaling pathway (GO:0007186) (0.3159); mesodermal cell migration (GO:0008078) (0.1235); chemotaxis (GO:0006935) (0.1226); response to lipopolysaccharide (GO:0032496) (0.1098); myeloid cell differentiation (GO:0030099) (0.0805); response to insulin (GO:0032868) (0.0745); calcium-mediated signaling (GO:0019722) (0.0518); regulation of metabolic process (GO:0019222) (0.0457),cytoplasm (GO:0005737) (0.3514); cell surface (GO:0009986) (0.1498); external side of plasma membrane (GO:0009897) (0.1347); cytosol (GO:0005829) (0.0925); nuclear speck (GO:0016607) (0.0552); early endosome (GO:0005769) (0.0517); membrane raft (GO:0045121) (0.0473),G protein-coupled receptor activity (GO:0004930) (0.3432); heme binding (GO:0020037) (0.0949); metal ion binding (GO:0046872) (0.0565),"G-protein coupled receptor opsins (IPR050125) (0.3819); GPCR, rhodopsin-like, 7TM (IPR017452) (0.3206); G protein-coupled receptor, rhodopsin-like (IPR000276) (0.2397)",1.20.1070.10 (0.2152),Membrane (0.6099); Ubl conjugation (0.3857); G-protein coupled receptor (0.2712); Transducer (0.2496); Glycoprotein (0.2026); Receptor (0.1148),
MTFCKSLSIPSWNWRVSSSLQTVFGALWPVECPVHFIRDHLQLSDDGLVALDWAVVGAAHHKRRRTSSNSTSPVLLIIPNSFGRITRNVLKLCEAALSHGYLPVIFNRRSQNGTPLSTIRLQQFGDPTDLREAVRYIRYRQPAGQIYAVSESTGSGLLLSYLGECGSSSYVTAAACLSPIFRCQSWFESGPSWPFHWALLLYQKICLSRYKTVLGELVHIDSVFSSCSLKEMEEALFCHFSSKGVPVEGTGSWEAYWERNDPLRDIDEVAIPVLCVCSQDDPIRGDPRTTLPLELFENNPHFFLLLTACGGHCGFSTSDEGPVVWSHQALLEFFRATTDFFAAEERAKLAARRRGLSGAGKTFRHRSVSTCKRLPVCSHNIHAIYNWQRSYTR,acylglycerol lipase (3.1.1.23) (0.3093); 3.1.1.- (0.2557); acetylesterase (3.1.1.6) (0.1517); alcohol O-acetyltransferase (2.3.1.84) (0.0791),lipid catabolic process (GO:0016042) (0.4974); acylglycerol catabolic process (GO:0046464) (0.3982); medium-chain fatty acid catabolic process (GO:0051793) (0.3034); sperm capacitation (GO:0048240) (0.2576); cellular lipid metabolic process (GO:0044255) (0.1399); response to wounding (GO:0009611) (0.1295); phospholipid metabolic process (GO:0006644) (0.1221); proteolysis (GO:0006508) (0.1220); cholesterol homeostasis (GO:0042632) (0.0990); long-term synaptic depression (GO:0060292) (0.0832); medium-chain fatty acid biosynthetic process (GO:0051792) (0.0488),sperm plasma membrane (GO:0097524) (0.3837),acetylesterase activity (GO:0008126) (0.3904); acylglycerol lipase activity (GO:0047372) (0.2802); short-chain carboxylesterase activity (GO:0034338) (0.1490); hormone-sensitive lipase activity (GO:0033878) (0.1081),"AB hydrolase 4 family (IPR012020) (0.3832); Alpha/Beta hydrolase fold (IPR029058) (0.3058); AB hydrolase superfamily, subfamily 4 (IPR050960) (0.2599); Alpha/beta hydrolase fold-1 (IPR000073) (0.0561)",3.40.50.1820 (0.1403),Reference proteome (0.8389); Serine esterase (0.3830); Membrane (0.3388); Hydrolase (0.3091); Lipid degradation (0.2426); Secreted (0.1641); Lipid metabolism (0.1538); Phosphoprotein (0.1282); Proteomics identification (0.1217); Endoplasmic reticulum (0.1025); Phospholipid metabolism (0.0915),
MLFSLFSCALGLSLLPLHLFQCPAHACPARCECSVPTRSVSCHRRRLAQVPEGIPIETRSLDLSKNRLRIVTPQNFSSLLLLEELDLSNNLLSSVEPNSFRAQPRLRSLRLRSNQLTLLPRGALAGLSELTLLDVSQNRLVILLDYGFEEQRRLRVLELSDNELVFIAPRAFSGLASLRSLTLQRCNLSTVPTHALAHLHGLTSLRLRDLGIAELQAHTFKGLPRLKHLEVDRWPLLEGFPTSALQGLNLSTLSITHTNLTSVPVVTNLLYLTHLNLSYSRIRVLPAGWLRGMDRLEVLRVRQANLLSVEPQAFQGASSLRILDLCYNRLATLERSVFPVTEALQTLLIGQNPLVCDCRLRWLLERTPPLLYGDVQPECSAPAPLAGKPLRDLVEAQISRYVICTKPRVISMASYPAQAEEGQRAWLYCSADGAPPPSVSWLTPLRRHITTKSTGRVVVHTNGSLEFRMAEPQDSGMYVCVASNPAGNATLSVTLAVKTSGIRDRALYANRSFLFDPDYNSSLINGTEEYTIRVVLDFTTILVSTAMGCLSFLGVVLFCFLLLFAWSRGKGKHRGSVDIQYVPRKRKGANSELTETSGPRRVNMKMI,,regulation of postsynaptic density assembly (GO:0099151) (0.4274); myelination (GO:0042552) (0.2831); regulation of presynapse assembly (GO:1905606) (0.1834); synaptic membrane adhesion (GO:0099560) (0.1665); central nervous system neuron development (GO:0021954) (0.1585); positive regulation of synapse assembly (GO:0051965) (0.1557); excitatory synapse assembly (GO:1904861) (0.0471),plasma membrane (GO:0005886) (0.4016); postsynaptic density membrane (GO:0098839) (0.2892); extracellular space (GO:0005615) (0.1457); extracellular matrix (GO:0031012) (0.1284); glutamatergic synapse (GO:0098978) (0.1090),signaling receptor binding (GO:0005102) (0.3461),"Immunoglobulin subtype 2 (IPR003598) (0.4404); Immunoglobulin-like fold (IPR013783) (0.3130); Immunoglobulin I-set (IPR013098) (0.2718); Immunoglobulin-like domain superfamily (IPR036179) (0.2533); Leucine-rich repeat domain superfamily (IPR032675) (0.2521); Multifunctional Developmental and Immune Receptor (IPR050328) (0.2410); Immunoglobulin subtype (IPR003599) (0.2212); Immunoglobulin-like domain (IPR007110) (0.2138); Leucine-rich repeat, typical subtype (IPR003591) (0.2070); Leucine-rich repeat (IPR001611) (0.1950)",3.80.10.10 (0.3123); 2.60.40.10 (0.2611),Signal (0.8081); Transmembrane helix (0.7310); Reference proteome (0.5976); Leucine-rich repeat (0.5595); Transmembrane (0.5313); Membrane (0.4610); Immunoglobulin domain (0.3314); Disulfide bond (0.3212); Repeat (0.3208),
MESLFGGQLGLLGGSEGLKEDGCGVGWSNSPLSDDMYSASQFALISAYQDIKTRLAGLERENADIKRKLKIYEIKFPMISEFGEDRNSYCSFEPKDTALLQSENGSLQQRVNMLTLELQKSKEREEQLEDVIQAYEKIHMEKSSLQRDLDKMTSLVEKHVERIHGLEAALRQRESSLHKLNTQLHNKDMQYLQLHSPDSHMLDCPMTLQSSRSLDTLSDLKLQRLEAELEGARHEAQGACQREEEIKAECERLREELRELQSNHRQRDVSSTCGQCDVEWIKKVGDEQVNLALAYTELTEELGKLQALTSKQTEILRKASQEPASPVQRHSPVPHQRHSPVPQRHSPIQQRHSPIQQRHSPVPQRRSPVLQRLSPDMHRRSPLPELSDGPASYSCRPTSHHLRASFQGRRSYSEVADPSAYQRPPRFTLDPVSTLPKPRPYVDSYHKQQQQQQQQQQQQHGGSQHMLVQRQSSQSGVGGDGGLVETPRLSRELSFHHSEVSHLHFDPQPSPAPLHSSPQPPQSSEDEEEWSCPHPISPPRTLGVSSPSSSSRGPASCSAFPIPSRPNTLSCHPPGYLHAEHAQSWPSINLWMETEEEGDVRSCPLCQLIFPVGYPDDALIKHIDSHLENSKI,RING-type E3 ubiquitin transferase (2.3.2.27) (0.1215),canonical NF-kappaB signal transduction (GO:0007249) (0.4589); protein localization to Golgi apparatus (GO:0034067) (0.3155); cellular response to tumor necrosis factor (GO:0071356) (0.2910); negative regulation of canonical NF-kappaB signal transduction (GO:0043124) (0.2098); cellular response to interleukin-1 (GO:0071347) (0.1649); centrosome cycle (GO:0007098) (0.1563); negative regulation of type I interferon production (GO:0032480) (0.1538); innate immune response (GO:0045087) (0.1081); positive regulation of macroautophagy (GO:0016239) (0.0991); positive regulation of transcription by RNA polymerase II (GO:0045944) (0.0859); CD40 signaling pathway (GO:0023035) (0.0817),cytoplasm (GO:0005737) (0.5077); Golgi apparatus (GO:0005794) (0.2501); nucleus (GO:0005634) (0.2109); perinuclear region of cytoplasm (GO:0048471) (0.1186); cell body (GO:0044297) (0.0849); recycling endosome (GO:0055037) (0.0847); cell projection (GO:0042995) (0.0821); protein-containing complex (GO:0032991) (0.0707); plasma membrane (GO:0005886) (0.0441),metal ion binding (GO:0046872) (0.2653),"CALCOCO1/2, zinc finger UBZ1-type (IPR041641) (0.3700); Tbk1/Ikki binding domain (IPR024581) (0.1284); TBK1 and IKBKE adapter proteins (IPR051891) (0.1055)",,Zinc-finger (0.9473); Reference proteome (0.7415); Metal-binding (0.6169); Zinc (0.5051); Alternative splicing (0.4512); Coiled coil (0.3905); Innate immunity (0.2729); Cytoplasm (0.1778); Immunity (0.1527); Ubl conjugation (0.0958); Cell projection (0.0717); Phosphoprotein (0.0714),
MSRDTFAFSSASLRSLRLEQELQDWEDARRALAHRRVMLRRPLPAAPRLRHGNERIQTVHAPPPQIKCRDTAIHNTFMCGDMKGVYAVLKEPGMVNALMETVHEEMVWTPEMGMWTLSSKIKQTSALRLAASRGHSACVEELLFRGAEVDADPGGRTALHDACSGGHDVCVRLLLDHAADPDLLAMDGNAPLHLCNAPHTYQCAELLVSSGALVNVAQRDSCLTPLHVACRRGLEEHVELYLSYGGDVMARSQEGETPLNAACAGAERPAEMGRYLRIVQNLLAAGADAQTCGRKKHTALHNACGNCCPRIVKLLLEHGARADVENCAGYTPMDCLLQVIEDYPEQQPEIVAQFLLNYGAKPPSPRMLKLCLPSLATLEVMLNCYPVIPACEEWLEDTTDQITKDHQCFLDAVRQMSGQLRSLQHLCRCALRRHLGSLCHISISQLNIPSTLKDYLLLHNDGQLR,,"intracellular signal transduction (GO:0035556) (0.4191); ubiquitin-dependent protein catabolic process (GO:0006511) (0.3712); exocytosis (GO:0006887) (0.2561); protein ubiquitination (GO:0016567) (0.2398); protein polyubiquitination (GO:0000209) (0.0733); retrograde transport, endosome to Golgi (GO:0042147) (0.0694)",extracellular region (GO:0005576) (0.4588); plasma membrane (GO:0005886) (0.2733); Cul5-RING ubiquitin ligase complex (GO:0031466) (0.2503); cytoplasm (GO:0005737) (0.2234); cytosol (GO:0005829) (0.2129); membrane (GO:0016020) (0.1218); nucleus (GO:0005634) (0.1037),toxin activity (GO:0090729) (0.2169),Ankyrin repeat (IPR002110) (0.3818); SOCS box domain (IPR001496) (0.3091); Ankyrin repeat-containing domain superfamily (IPR036770) (0.2574); SOCS box-like domain superfamily (IPR036036) (0.1339); Cul2-RING E3 Ligase Substrate-Recognition Fem-1 (IPR050842) (0.1229),1.25.40.20 (0.3132),Ubl conjugation pathway (0.8630); Reference proteome (0.6619); Repeat (0.5145); Membrane (0.4051); ANK repeat (0.2642); Exocytosis (0.1902); Presynaptic neurotoxin (0.1436); Neurotoxin (0.1358); Proteomics identification (0.1319); Toxin (0.0524),
MSLPTLLCKRLGDEDTYSFYQRGDVVLGGIFPLHSSPVSSLFSFRTKPKPTSYKFFTPRALRWMQTMIFAVREINQRQDLLPNLSLGYHIRDSGDDIPVSVKRSLLLVNGQPEKGSGQSCEDIQMQPSPVIVGDAASGVSMTVLRTLGSFKIPLVSYFASCSCLSNKREFPAFMRTMPSDLFQIKALVKLINYFQWTWVGLIGVNSDYAHFAIQLFLKESEQFNICPAYVHFYPVVLMEDALEELVNILKASSATVIINFSGESELHSILKECRRQNVTHLQWIASEAWATSKSLWEEFGDLLKGTLGFAIHRADIPHLGSYLKEIRPQTSHFLSEFWEETFRCRLNGSLNTHAHGEQAQNWPACNGSENLDNVYTTYSDVSQLRVSYNVYKAVYLIAHALHDMSTCVPGKGPFQNGTCGSLYQIQPWQLLYYMKQANFTILGEEVRFDENGDPIASYDLMNWQRGSDSSLQLVRVGFYDASLEDDKDLVVEESVIMWHRAEKAPKSMCSQSCLPGTRKARQKGKPVCCFDCISCAEGEISNQTDSIDCLTCSKETWPNQAQDRCIPKTLEFLSFQEPLGIILWVFSAFGACAALAVLCVFVMYRKTPVVRGNNIELSFLLLLFLCACFLIGLTFLGKPTDWLCQIRYPAFGISFTLCISCILAKTVVVLMAFRATIPGNNVMKWFGPVKQRSSVILCTCVQALICIIWLTTKPPLASYNSKFMSETIIVECSVGSEIGFWCVLGYVGLLACLCFLMAFLARKLPDNFNEAKFITFSMLIFFAVWVTFIPVYVSSSGKYMVAVHVFAILASAFGLLMCIFAPKCYVVLLKPERNDKKHMMKK,,calcium-mediated signaling (GO:0019722) (0.2239); detection of calcium ion (GO:0005513) (0.2172); calcium ion transport (GO:0006816) (0.1796); calcium ion import (GO:0070509) (0.1440); intracellular calcium ion homeostasis (GO:0006874) (0.1278); response to heat (GO:0009408) (0.1193); detection of chemical stimulus involved in sensory perception of sweet taste (GO:0001582) (0.1101); regulation of testosterone biosynthetic process (GO:2000224) (0.0875),plasma membrane (GO:0005886) (0.4061); cytosol (GO:0005829) (0.0990); cytoplasm (GO:0005737) (0.0656); mitochondrion (GO:0005739) (0.0482),G protein-coupled receptor activity (GO:0004930) (0.1681); metal ion binding (GO:0046872) (0.1151); amino acid binding (GO:0016597) (0.0966),"Receptor, ligand binding region (IPR001828) (0.4984); GPCR, family 3, nine cysteines domain superfamily (IPR038550) (0.3602); GPCR, family 3, conserved site (IPR017979) (0.3598); GPCR family 3, C-terminal (IPR017978) (0.3199); Periplasmic binding protein-like I (IPR028082) (0.2814); GPCR, family 3, nine cysteines domain (IPR011500) (0.1777); GPCR, family 3, extracellular calcium-sensing receptor-related (IPR000068) (0.0904); GPCR, family 3 (IPR000337) (0.0814)",3.40.50.2300 (0.2738); 2.10.50.30 (0.1382),Ubl conjugation (0.6640); Reference proteome (0.6393); Transducer (0.5054); Membrane (0.3800); Transmembrane (0.3772); G-protein coupled receptor (0.3436); Metal-binding (0.2645); Transmembrane helix (0.2499); Signal (0.1633); Calcium (0.1486); Cell membrane (0.1474); Glycoprotein (0.0954); Receptor (0.0713); Zinc (0.0688),
MAGCPHLSLSGLLVLLITASITHGQSCPQRCDCIPHQRAVMCQNKRLGSIPGGIPADTRLLDLSCNSLRWVEYNDLSTLLRLEELDLSENLISVLEPNAFSSLLNLRVLRLRANQLKLVPMGAFSRLTNLTTLDLSGNKLVILLDFTFQDLRNLRNLEVGDNDLVYISNKAFLGLVGLRELTIERCNLTSISGQSLSYLRGLVTLRLRYLSIASLEEQNFRKLGGLRGLEIDHWPFLEYISPHSFQGLNLSWLSITNTNISTVPTGALRNLIHLASLNLSYNPISVLESWALRDLVRLKELHLVGTNLISVQPYGLGGLQQIRLLNLSNNGLVTLEEGSFHSVNTLETLRVDGNPLSCDCRLLWILQRRKTLNFDGKSPVCTAPVEVRGKSLSTFTDSALFDHFTCQRPKIRNRKLQQLTAREGQVVSFVCRAEGDPTPVIFWISPQRRRITTKSTGRVIVLPEGTLEIRYAQVTDTGTYICIASNAGGNDTYFATLTVSGLPLDSALSANRTYYVGDLNDTNLNDTRVFLKFTLDLKTILVSTAMGCIMFLGVVLFCFILLFVWSRGRGQHKNNFSVEYSFRKVDGPAASGGQGGARKFNMKMI,,central nervous system neuron development (GO:0021954) (0.3467); negative regulation of oligodendrocyte differentiation (GO:0048715) (0.3214); myelination (GO:0042552) (0.2225); regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) (0.1334); regulation of postsynaptic density assembly (GO:0099151) (0.0815); negative chemotaxis (GO:0050919) (0.0647); negative regulation of cytokine production (GO:0001818) (0.0564),plasma membrane (GO:0005886) (0.4113); extracellular matrix (GO:0031012) (0.2348); extracellular space (GO:0005615) (0.0949),epidermal growth factor receptor binding (GO:0005154) (0.2768),"Immunoglobulin-like fold (IPR013783) (0.4264); Immunoglobulin subtype 2 (IPR003598) (0.3131); Multifunctional Developmental and Immune Receptor (IPR050328) (0.2892); Leucine-rich repeat, typical subtype (IPR003591) (0.2758); Immunoglobulin subtype (IPR003599) (0.2508); Leucine-rich repeat domain superfamily (IPR032675) (0.2304); Immunoglobulin I-set (IPR013098) (0.2210); Immunoglobulin-like domain (IPR007110) (0.1939); Leucine-rich repeat (IPR001611) (0.1495); Leucine-rich repeat N-terminal domain (IPR000372) (0.0952)",3.80.10.10 (0.2368); 2.60.40.10 (0.2048),Signal (0.6647); Transmembrane (0.4416); Reference proteome (0.4258); Immunoglobulin domain (0.4045); Membrane (0.3982); Leucine-rich repeat (0.3541); Transmembrane helix (0.3077); Disulfide bond (0.2862); Cell membrane (0.1811); Repeat (0.1632),
MKDPPAQNTSFTVFTLNGFYSLGEWRPFLFIPFFLLFVLSVTANSILIYLIKSQKSLHSPMYVLIGVMAVVDLILPIIFVPNMLFSFLFNWSGISLTGCLIQMFSLHFVGTFQNTLLLWMALDRYFAICKPLFYHKCMEMTNFLKFVAVPVIRNVLLIIIMVSLVGRLSYCLTNVIDHCFCEHMALVQLACGDTSVNNIIGLVSAFLIPTADFIVITLSYVVIFTSVLKSGKAHAKALNTCITHLIVLTFSLTSALTAFLSYRIKNNISSNNRVFISIVYLFLLVVFTH,,"adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189) (0.4575); G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187) (0.1977); sensory perception of sound (GO:0007605) (0.1704); detection of chemical stimulus involved in sensory perception of smell (GO:0050911) (0.1112); negative regulation of insulin receptor signaling pathway (GO:0046627) (0.1097); sensory perception of smell (GO:0007608) (0.1085); response to wounding (GO:0009611) (0.0934); positive regulation of cAMP-mediated signaling (GO:0043950) (0.0751); negative regulation of apoptotic process (GO:0043066) (0.0624); protein phosphorylation (GO:0006468) (0.0539); phototransduction (GO:0007602) (0.0495)",early endosome membrane (GO:0031901) (0.1345); membrane (GO:0016020) (0.0963); dendrite (GO:0030425) (0.0858); neuronal cell body (GO:0043025) (0.0718); plasma membrane (GO:0005886) (0.0635); receptor complex (GO:0043235) (0.0507),G protein-coupled receptor activity (GO:0004930) (0.0799); olfactory receptor activity (GO:0004984) (0.0739),"GPCR, rhodopsin-like, 7TM (IPR017452) (0.4367); Olfactory receptor (IPR000725) (0.2791); G protein-coupled receptor, rhodopsin-like (IPR000276) (0.1684); Human and Mouse Olfactory Receptor (IPR050402) (0.1267)",1.20.1070.10 (0.2665),Transducer (0.9761); Transmembrane helix (0.8976); Olfaction (0.7720); Sensory transduction (0.6511); Reference proteome (0.6503); G-protein coupled receptor (0.6300); Receptor (0.3086); Cell membrane (0.1348); Membrane (0.1012); Transmembrane (0.0558),
MANETEDQETQYCFPDINSSCVKGLLSNHGYIITYVFASLLSAWTVFLNLLVIISISHFKKLHTPTNMIILSLAVTDLFIGVVMPVEAIRLIETCWYFGDTFCALYLLFVELLLSASLSNLVLIAVDRYVAVCHPLLYPQKITITKTLMSICLSWAWLLAYIVAPVINSRHFYTSHGTDECYGECLVLISFSWTVTDLFMSFIFPCTVIIMLYSRIFFVVHQQVKVINSLMKGGKCVTEGSVKRKSESKAALTLGIIVTVYLLCWIPYYICSLTVISSTIINVLIWFLYVNSGLNPLVYALFYPWFKKTAKLILTLKIFQPASSLVNIFKDH,,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187) (0.3797); G protein-coupled receptor signaling pathway (GO:0007186) (0.3782); chemical synaptic transmission (GO:0007268) (0.3543); adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188) (0.1488); neuronal action potential (GO:0019228) (0.0808); cellular response to light stimulus (GO:0071482) (0.0576); locomotory behavior (GO:0007626) (0.0560); positive regulation of cytosolic calcium ion concentration (GO:0007204) (0.0465); regulation of feeding behavior (GO:0060259) (0.0451)",plasma membrane (GO:0005886) (0.2807); dendrite (GO:0030425) (0.2433); perikaryon (GO:0043204) (0.1522); synapse (GO:0045202) (0.1366),G protein-coupled serotonin receptor activity (GO:0004993) (0.1950); neurotransmitter receptor activity (GO:0030594) (0.1100); protein heterodimerization activity (GO:0046982) (0.1061),"GPCR, rhodopsin-like, 7TM (IPR017452) (0.3712); G protein-coupled receptor, rhodopsin-like (IPR000276) (0.3356)",1.20.1070.10 (0.2476),Reference proteome (0.9236); Transmembrane helix (0.8773); Transducer (0.8222); G-protein coupled receptor (0.6011); Membrane (0.5639); Palmitate (0.2870); Receptor (0.2664); Cell membrane (0.1999); Lipoprotein (0.1171); Biological rhythms (0.0776); Transmembrane (0.0475); Phosphoprotein (0.0448); Synapse (0.0430),
MKTFTGHEGGKVEIRCPYNAKYEEMEKYLCRGECPIYDKDIPVESGSEPVDKRFSLTDNRTAHIFTITITDLRTDDQGKYWCAVKTGIGSFDKYTEIYLEIKQVSRVSGEPGKHLSITCSYTRDLKELIRFLCKGSDPSDCKNIIKVSSKTKTNGRFSLTDDSETVFTVNIRDLTEEDSGIYWCGAAEKQAQEYTWISAIDLHITEPTSAPRLPKNTSTASFHTSKPADPASSRPVTPSSSASSSSISMFLNASTNAASSHTPLGFTAFIMLMVVVMLTVFGLSLFLYLKRKQKKKGAQTKDDIYYQPENLPNGNTETTREASHGVSDYEEISSSLNNPIYSSVSPAFSKQDVSVYAVAQLPSSPSDHLNYSTVRFSASHLSDRTSGGLDTCDYATVNV,,"regulation of peptidyl-tyrosine phosphorylation (GO:0050730) (0.3151); regulation of plasma membrane bounded cell projection organization (GO:0120035) (0.2947); innate immune response (GO:0045087) (0.1659); detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) (0.1445); positive regulation of ERK1 and ERK2 cascade (GO:0070374) (0.1311); positive regulation of phosphoprotein phosphatase activity (GO:0032516) (0.1276); receptor clustering (GO:0043113) (0.1189); phagocytosis, recognition (GO:0006910) (0.0944); defense response to bacterium (GO:0042742) (0.0933); neutrophil migration (GO:1990266) (0.0774); immune response-regulating signaling pathway (GO:0002764) (0.0569)",plasma membrane (GO:0005886) (0.1769); early endosome (GO:0005769) (0.1644); early endosome membrane (GO:0031901) (0.1435); Golgi apparatus (GO:0005794) (0.0871),IgM binding (GO:0001791) (0.1134),Immunoglobulin V-set domain (IPR013106) (0.3724); Immunoglobulin subtype (IPR003599) (0.2801); Immunoglobulin-like fold (IPR013783) (0.1637); Immunoglobulin-like domain superfamily (IPR036179) (0.1533); Immunoglobulin-like domain (IPR007110) (0.1139),2.60.40.10 (0.1485),Immunoglobulin domain (0.6645); Secreted (0.3221); Reference proteome (0.2879); Membrane (0.1672); Glycoprotein (0.1617); Transmembrane helix (0.1560),
MDSCASPTNVLRAVFSLVSEQKEQEFTSQCHLPLTALVAESGSSQSLAVAGMLGPFRVPMVSYFSTCACLSDRKKYPSFFRTIPSDFYQAKALASLVKQFGWTWIGALQSDNDYGRNGISAFTKEVEKMGVCIAFVGTILRTYPQSKITEVVEMIKESTVKVILAFVPEGDLYPLMKEVVNRNITGIQWIASEAWVTAARPSTPEMFKSFGGTVGFVVRKMAMLKLRPYLENISPYSPTQSAFVSDFWETVVGCKPCLNCEPSANSTLNGQMCTGQEKLTFTDKFFDVTQVRVTYNVYQAVYAIAHAIHKVLYCQGDNNLSKMCLNVSQITPKQVSDQLERVNFIDEYGENVFFDENGDPPASYELINWQLNQGEVQHVTVGYFSKSPDGTYKLTIKEDNVHWSTENLIPKAVCSDTCPKGTRKAQIKGRPVCCFDCIPCADGSISNTTGAADCTLCPKEYWSNERRDKCLVKTIEFLSYTETMGIILTALSLFGASLTVATMIVFIHYRETPIVKANNSELSSLLLSSLFFCFLCPLTFIGEPTHWSCMLRHTAFGLTFALCISCVLGKTIVVVTAFRATLPGNKLSGKFGPVQQRAIVFLCTAIQIVICALWLLIKPPFPDKALRYDHKKIILECNTGSDAGFYAALGYVGLLSTICLILAFLGRKLPDNFNEAKFISFSMLIFCAVWVTFIPAYISSPGKYTVAVEIFAILSSAFGLLLCIFAPKCFIILIKPERNTRKHVMGKSKTSL,,calcium-mediated signaling (GO:0019722) (0.2930); response to heat (GO:0009408) (0.2721); calcium ion transport (GO:0006816) (0.2072); detection of calcium ion (GO:0005513) (0.1822); intracellular calcium ion homeostasis (GO:0006874) (0.1183); defense response to fungus (GO:0050832) (0.1151); defense response to bacterium (GO:0042742) (0.0879); G protein-coupled receptor signaling pathway (GO:0007186) (0.0721); calcium ion import (GO:0070509) (0.0515),plasma membrane (GO:0005886) (0.3787); mitochondrion (GO:0005739) (0.0753),G protein-coupled receptor activity (GO:0004930) (0.1702); amino acid binding (GO:0016597) (0.1476); metal ion binding (GO:0046872) (0.1408); protein homodimerization activity (GO:0042803) (0.1308),"GPCR family 3, C-terminal (IPR017978) (0.4386); Periplasmic binding protein-like I (IPR028082) (0.3994); Receptor, ligand binding region (IPR001828) (0.3358); GPCR, family 3, nine cysteines domain (IPR011500) (0.3044); GPCR, family 3, nine cysteines domain superfamily (IPR038550) (0.2797); GPCR, family 3, conserved site (IPR017979) (0.2504); GPCR, family 3, extracellular calcium-sensing receptor-related (IPR000068) (0.1052)",3.40.50.2300 (0.4206); 2.10.50.30 (0.1098),Transducer (0.8281); Reference proteome (0.6737); Transmembrane helix (0.6536); Membrane (0.4604); Transmembrane (0.4354); G-protein coupled receptor (0.2982); Signal (0.2508); Metal-binding (0.2432); Ubl conjugation (0.2425); Cell membrane (0.1056); Glycoprotein (0.0915); Sensory transduction (0.0626); Zinc (0.0491),
MPPPNNCHHNPNEDEVDSLTSPLYFLDQNYQELQQKCLTESTLYSDELFPPDNSSIGLFDEVPPEVDMSQIVWKRPSELVSDPNLIVDDVSRFDYAQGSVLGNCWFLASIGALTFEKDIMKQVLPAEQSFTKDYAGIFHFRFWRFEKWIDVVIDDQLPTIDDELLFVCSKTSNEFWPALLEKAYAKVCGSYADLNAGFISEALMDFTGGTHMYYTLSSAPADLWKIMECAFISKTLIGCGSNSEGSPEENELLHGIIADHAYTVTGVFEVISEENPVQLVRLLNPWGEEEWQGDWSDESPLWETVCEEARKCCREVLNDGEFWMSMEDFTRLFESIDICCLCPDFLDGSSDCHWTSKRHFGRWNAEKFMYNTFIHHLTAGGDIIKTETFWKNPQFRVTIDELNEDCASGQRPENILVSLMQNHEKRNRNSQENYDIGFYVFEVSIGRQSDAYLRTVRKDTQL,3.4.22.- (0.4238),blastocyst development (GO:0001824) (0.4326); proteolysis (GO:0006508) (0.2315); regulation of actin cytoskeleton organization (GO:0032956) (0.2131); cell fate specification (GO:0001708) (0.0997); embryo development ending in seed dormancy (GO:0009793) (0.0742); regulation of catalytic activity (GO:0050790) (0.0740); mitochondrion organization (GO:0007005) (0.0672); cellular response to insulin stimulus (GO:0032869) (0.0589),cytoplasm (GO:0005737) (0.3043); mitochondrion (GO:0005739) (0.3028); cytosol (GO:0005829) (0.1163); nucleus (GO:0005634) (0.1077),calcium-dependent cysteine-type endopeptidase activity (GO:0004198) (0.0898),"Peptidase C2, calpain, large subunit, domain III (IPR022682) (0.6449); Peptidase C2, calpain, domain III (IPR022683) (0.2788); Calpain large subunit, domain III superfamily (IPR036213) (0.2361); Peptidase C2, calpain family (IPR022684) (0.1923); Papain-like cysteine peptidase superfamily (IPR038765) (0.1821); Calpain (IPR050420) (0.1350); Cysteine peptidase, cysteine active site (IPR000169) (0.1240)",3.90.70.10 (0.2844); 2.60.120.380 (0.1093),Thiol protease (0.8681); Reference proteome (0.3431); Protease (0.3248); Hydrolase (0.2057); Metal-binding (0.1989); Cytoplasm (0.1238),
MEGDIMDKLEDMASVYEFDPLTGNIPATKVEITVSCRNLLDRDTFSKSDPLCVLYTQGVETKQWREFGRTEVIDNTLNPDFVRKYILDYFFEEKQNLRFDLYDVDSKSPDLSKHDFLGQMFCTLGEIVGSPASRLEKPLGGISGKNCGTIVLSAEELGNCRDSATMQFCANKLDKKDFFGKSDPFMVFYRSNEDGTFTICHKTEVVKNTLNPVWQPFTIPVRALCNGDYDRTIKVEVYDWDRDGSHDFIGEFTTSYRELARGQSQFNVYEVVNPKKKMKKKKYVNSGTVTLLSFSVESESTFLDYIKGGTQINFTVAIDFTASNGNPSQSTSLHYMNPYQMNAYALALKAVGEIIQDYDSDKMFPALGFGAKLPPDGRVSHEFPLNGNIENPYCNGIEGILEAYHQSLKTVQLYGPTNFAPVVNHVARYAAAVQDGSQYFILLIITDGVISDMSQTKEAIVNAAKLPMSIIIVGVGQAEFDAMVELDGDDIRISSRGKLAERDIVQFVPFRDYMDRTGNHVLSMARLAKDVLAEIPDQFISYMKSRGIKPNPAPPPYTPPGHTHHTQI,,cellular response to calcium ion (GO:0071277) (0.4792); cell differentiation (GO:0030154) (0.4788); positive regulation of dendrite extension (GO:1903861) (0.0910); actin cytoskeleton organization (GO:0030036) (0.0790),plasma membrane (GO:0005886) (0.2614); nucleoplasm (GO:0005654) (0.2056); glutamatergic synapse (GO:0098978) (0.1606); cytoplasm (GO:0005737) (0.1352); nucleus (GO:0005634) (0.1068); extracellular exosome (GO:0070062) (0.0930),metal ion binding (GO:0046872) (0.2258); calcium-dependent phospholipid binding (GO:0005544) (0.1443),"Copine (IPR045052) (0.2339); Copine, C2B domain (IPR037768) (0.1668); von Willebrand factor, type A (IPR002035) (0.1645); C2 domain (IPR000008) (0.0969)",2.60.40.150 (0.2456),Metal-binding (0.4258); Calcium (0.2663); Reference proteome (0.1857); Repeat (0.1559); Membrane (0.1116); Cell membrane (0.1107),Ca(2+) (0.2161)
MGTLRDLQYALQEKIEELRQRDALIDELELELDQKDELIQKLQNELDKYRSVIRPATQQVHKQSALQEHQRTKRQAISAEPTAFDIQDLSHVTLPFYPKSPQSKELIKEAILDNDFMKNLELSQIQEIVDCMYPVEYDKESCIIKEGDVGSLVYVMEDGKVEVTKEGMKLCTMGPGKVFGELAILYNCTRTATVQTLTNVKLWAIDRQCFQTIMMRTGLIKHAEYMEFLKSVPTFQGLQEEILSKLADVLEETHYSDGEYIIRQGARGDTFFIISKGKVNVTREDAPNGTPVYLRALGKGDWFGEKALQGEDIRTANVIAAEAVTCLVIDRESFKHLIGGLDDVSNKGYDDAGAKAK,cGMP-dependent protein kinase (2.7.11.12) (0.1008); non-specific protein-tyrosine kinase (2.7.10.2) (0.0466),regulation of protein phosphorylation (GO:0001932) (0.7226); protein kinase A signaling (GO:0010737) (0.7120); phosphorylation (GO:0016310) (0.1835); protein phosphorylation (GO:0006468) (0.1755); modulation of chemical synaptic transmission (GO:0050804) (0.1195); cellular response to glucose starvation (GO:0042149) (0.1013); cGMP-mediated signaling (GO:0019934) (0.0822); intracellular signal transduction (GO:0035556) (0.0552),plasma membrane (GO:0005886) (0.4459); cAMP-dependent protein kinase complex (GO:0005952) (0.2124); multivesicular body (GO:0005771) (0.0673),cAMP binding (GO:0030552) (0.4385); ATP binding (GO:0005524) (0.1932); cGMP-dependent protein kinase activity (GO:0004692) (0.1533); cAMP-dependent protein kinase regulator activity (GO:0008603) (0.0654),"Cyclic nucleotide-binding domain (IPR000595) (0.2730); Cyclic nucleotide-binding domain superfamily (IPR018490) (0.2072); Cyclic nucleotide-binding, conserved site (IPR018488) (0.1169); cGMP-dependent protein kinase, N-terminal coiled-coil domain (IPR031831) (0.1138); cAMP-dependent protein kinase regulatory subunit (IPR012198) (0.0667)",1.20.5.170 (0.2744); 2.60.120.10 (0.1874),cAMP (0.9335); cAMP-binding (0.8733); Nucleotide-binding (0.7134); Transferase (0.6436); Reference proteome (0.6362); Phosphoprotein (0.3677); Membrane (0.2930); ATP-binding (0.1392); Coiled coil (0.1160); Kinase (0.0945); Proteomics identification (0.0567),
MGLGMNPKVGGNQSSEKKAKAETGGPVPEEAQKCCGCRFPLLVALLQLLLGIAVAAVAFLMLAISSSLLARETPHWAGIIMCVVSLLGFVLFCITRVPDERALLQFVIKLLYFFLCTMGLVMSVVVIAFQCYHYTLTNSFSCREMREDCICTLDPEDPIARMFVFSAVSDCSDITSTLPMYYLLQVLLNLAQAIVCLLGAFLIWKHRYQVFFAGLQTGSPAAQHWQKA,,sensory perception of sound (GO:0007605) (0.2475); cell adhesion (GO:0007155) (0.2009); establishment of localization in cell (GO:0051649) (0.1240); chemotaxis (GO:0006935) (0.1054); cell-matrix adhesion (GO:0007160) (0.0790); cilium assembly (GO:0060271) (0.0687); endosomal lumen acidification (GO:0048388) (0.0682); brain development (GO:0007420) (0.0478),plasma membrane (GO:0005886) (0.3809); sarcolemma (GO:0042383) (0.3436); basal part of cell (GO:0045178) (0.1462); dystrophin-associated glycoprotein complex (GO:0016010) (0.1254); cell projection (GO:0042995) (0.1085); cell-cell junction (GO:0005911) (0.0565),,,,Transmembrane (0.5456); Reference proteome (0.5078); Transmembrane helix (0.4797); Disease variant (0.4174); Membrane (0.3842); Cell membrane (0.3116); Postsynaptic cell membrane (0.2767); Sensory transduction (0.2671); Phosphoprotein (0.1093); Glycoprotein (0.1045); Alternative splicing (0.0888); Direct protein sequencing (0.0615),
MAGVPDPLEDMLYSEVDEKAVSDLVGSLESQLGGQNKTVGPQGDARRASNALNPHLGKLLPAQVGTTLEQQQRQRQAERNQEGNSQENGPDRIPASNCVPATANLPANTSANLVPAANLAQYHSSNPSTCSSDAAAPTDSHPNTNHIACAVRTVPARTQPVNGSSSTLNSSVIASAPASVNGIDVGSGGGSGNKSNMSAPTSTNTAFVPAQPNSTLPHANVSLDSQANPTIALHRPPNTITSVVHNGGDPKVSGLPVQGAALVPTPVAFTNTEPKSDPQNQIKAIVPNQLPGAPVGLHPSTPTQIIVSSSPVVTSLPVASTPSALPKPTATALVGQPTTLLRPATPTQGTPTATPQQRPGAPTTQLIVRPPQQTTIQLPPGFTIPPGMVLVRTEAGQLALVPQQVLAQAKAQNQNKGTLSPRPATPTAGAPFRVTTPVAQQKTAVVTITSAQKPTTTVITAGARVQPAPQTVLKPSVTPQSPVTPPVTVSANRAPVLSQEMQENVKKCKNFLATLIKLASHNSPSPETSRNVKALVQDLLDAKIEPEEFTNRLQTELKSSPQPYLIPFLKKSLPALRLTLLNSQQSLTQLSQTSATAAAPLPVNTIKAPAPSTLSTTIRPTTALTPASALAVKRPGVQTTPTRMPVVITQTVRAQGAIGTPLQVRSPMGVAIHASANQKQKLNDPGGGTFRDDDDINDVASMAGVNLNEENARILATGSELVGTQIRSCKDEAFLPASLLHKRLLETAKKFGVTEVSMETVTLISHATQSRLRSMLEKVSAVAQHRADSCKDEDLYEQTSDVRTQLKFFEQLEKIEKQRKDDEERELLMKAAKSRSRQEDPEQARLKQKAKEMQQQELAQMRQRDANLTALAAIGPRKKRKLDSPGASAGAELPAGSSGSATGSTSSSSSSVRQTRQRITRVNLRDLIFCLEQERTTARSTLLYKALLK,,mRNA transcription by RNA polymerase II (GO:0042789) (0.6628); transcription initiation at RNA polymerase II promoter (GO:0006367) (0.2828); positive regulation of transcription initiation by RNA polymerase II (GO:0060261) (0.2526); regulation of DNA repair (GO:0006282) (0.1432); RNA polymerase II preinitiation complex assembly (GO:0051123) (0.0825); transcription by RNA polymerase II (GO:0006366) (0.0617),nucleus (GO:0005634) (0.6390); transcription factor TFIID complex (GO:0005669) (0.1368),protein heterodimerization activity (GO:0046982) (0.4300); DNA binding (GO:0003677) (0.2603),"Transcription initiation factor TFIID component TAF4, C-terminal (IPR007900) (0.4217); Transcription initiation factor TFIID component TAF4 (IPR045144) (0.4080); Histone-fold (IPR009072) (0.1892)",1.10.20.10 (0.2009),Transcription regulation (0.9638); Reference proteome (0.9069); Transcription (0.6093); Nucleus (0.5688); Proteomics identification (0.1116),
